id,drugbank_id,name,type,groups,categories,SMILES,PubChem_CID
5,DB00006,Bivalirudin,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Anticoagulants|Antithrombin Proteins|Antithrombins|Blood and Blood Forming Organs|Enzyme Inhibitors|Hematologic Agents|Peptides|Protease Inhibitors|Proteins|Serine Protease Inhibitors|Serpins|Thrombin Inhibitors",CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,16129704
6,DB00007,Leuprolide,small molecule,approved|investigational,"Adrenal Cortex Hormones|Agents Causing Muscle Toxicity|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Endocrine Therapy|Fertility Agents|Fertility Agents, Female|Gonadotropin Releasing Hormone Receptor Agonist|Gonadotropin Releasing Hormone Receptor Agonists|Gonadotropin-releasing hormone agonist|Gonadotropins|Hormones|Hormones and Related Agents|Hyperglycemia-Associated Agents|Hypothalamic Hormones|Moderate Risk QTc-Prolonging Agents|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Photosensitizing Agents|Pituitary Hormone-Releasing Hormones|Proteins|QTc Prolonging Agents|Reproductive Control Agents",CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,
13,DB00014,Goserelin,small molecule,approved,"Adrenal Cortex Hormones|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|Drugs that are Mainly Renally Excreted|Endocrine Therapy|Gonadotropin Releasing Hormone Receptor Agonist|Gonadotropin Releasing Hormone Receptor Agonists|Gonadotropin-releasing hormone agonist|Gonadotropins and Antigonadotropins|Hormones|Hormones and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Hypothalamic Hormones|Miscellaneous Therapeutic Agents|Moderate Risk QTc-Prolonging Agents|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary Hormone-Releasing Hormones|Proteins|QTc Prolonging Agents",CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O,5311128
25,DB00027,Gramicidin D,small molecule,approved,"Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Local|Membrane Proteins|P-glycoprotein inhibitors|P-glycoprotein substrates|Peptides|Peptides, Cyclic|Pore Forming Cytotoxic Proteins|Proteins|Throat Preparations",CC(C)C[C@@H](NC(=O)CNC(=O)[C@@H](NC=O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCCO,45267103
33,DB00035,Desmopressin,small molecule,approved,"Agents that produce hypertension|Amino Acids, Peptides, and Proteins|Antidiuretic Agents|Arginine Vasopressin|Cardiovascular Agents|Coagulants|Drugs that are Mainly Renally Excreted|Factor VIII Activator|Hematologic Agents|Hemostatics|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Increased Coagulation Factor VIII Activity|Increased Coagulation Factor VIII Concentration|Natriuretic Agents|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormones|Pituitary Hormones, Posterior|Posterior Pituitary Lobe Hormones|Proteins|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Vasopressin Analog|Vasopressin and Analogues|Vasopressins",NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,
47,DB00050,Cetrorelix,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Anti-Gonadotropin-Releasing Hormones|Decreased GnRH Secretion|Fertility Agents|Fertility Agents, Female|Gonadotropin Releasing Hormone Receptor Antagonists|Gonadotropin-releasing Hormone Antagonists|Hormone Antagonists|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormone-Releasing Hormones|Proteins|Reproductive Control Agents|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CN=CC=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)NC(C)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,25074887
63,DB00067,Vasopressin,small molecule,approved,"Amino Acids, Peptides, and Proteins|Antidiuretic Agents|Arginine Vasopressin|Arginine Vasopressin, agonists|Arginine Vasopressin, analogs & derivatives|Arginine Vasopressin, antagonists & inhibitors|Cardiovascular Agents|Coagulants|Hematologic Agents|Hemostatics|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Natriuretic Agents|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary|Pituitary Hormones|Pituitary Hormones, Posterior|Proteins|Vasoconstrictor Agents|Vasopressin and Analogues|Vasopressins|Vasopressins, antagonists & inhibitors",NCCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(CC2=CC=C(O)C=C2)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O.NC1CSSCC(NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC2=CC=C(O)C=C2)NC1=O)C(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O,
74,DB00080,Daptomycin,small molecule,approved|investigational,"Agents Causing Muscle Toxicity|Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cyclic Lipopeptides|Drugs that are Mainly Renally Excreted|Lipids|Lipopeptide Antibacterial|Lipopeptides|Peptides|Peptides, Cyclic",CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2=CC=CC=C2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@H](C)CC(O)=O,16134395
84,DB00091,Cyclosporine,small molecule,approved|investigational|vet_approved,"Agents causing hyperkalemia|Agents Causing Muscle Toxicity|Agents that produce hypertension|Agents that produce neuromuscular block (indirect)|Agents that reduce seizure threshold|Amino Acids, Peptides, and Proteins|Anti-Inflammatory Agents|Antirheumatic Agents|BCRP/ABCG2 Inhibitors|BSEP/ABCB11 Inhibitors|BSEP/ABCB11 Substrates|Calcineurin Inhibitor Immunosuppressant|Calcineurin Inhibitors|Cyclosporins|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Enzyme Inhibitors|Immunologic Factors|Immunosuppressive Agents|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Neurotoxic agents|OAT1/SLC22A6 inhibitors|OAT1/SLC22A6 Substrates|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 inhibitors|Ophthalmologicals|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Peptides|Peptides, Cyclic",CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,5284373
86,DB00093,Felypressin,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Cardiovascular Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary Hormones|Pituitary Hormones, Posterior|Proteins|Vasoconstrictor Agents|Vasopressin and Analogues|Vasopressins",NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,14257662
95,DB00104,Octreotide,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Bradycardia-Causing Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Gastrointestinal Agents|Hyperglycemia-Associated Agents|Hypoglycemia-Associated Agents|Hypothalamic Hormones|Miscellaneous Therapeutic Agents|Peptides|Peptides, Cyclic|Pituitary and Hypothalamic Hormones and Analogues|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Somatostatin and Analogues|Somatostatin Receptor Agonists|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",[H][C@]1(NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N[C@H](CO)[C@@H](C)O)NC(=O)[C@H](N)CC1=CC=CC=C1)[C@@H](C)O,448601
97,DB00106,Abarelix,small molecule,approved|investigational|withdrawn,"Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Endocrine Therapy|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Peptides",CC(C)C[C@H](NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)N(C)C(=O)[C@H](CO)NC(=O)[C@@H](CC1=CN=CC=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=C(C=CC=C2)C=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,16131215
105,DB00114,Pyridoxal phosphate,small molecule,approved|investigational|nutraceutical,"Alimentary Tract and Metabolism|Coenzymes|Diet, Food, and Nutrition|Dietary Supplements|Enzymes and Coenzymes|Food|Food and Beverages|Growth Substances|Micronutrients|Physiological Phenomena|Picolines|Pyridines|Supplements|Vitamin B Complex|Vitamins",CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O,1051
106,DB00115,Cyanocobalamin,small molecule,approved|nutraceutical,"Antianemic Preparations|Blood and Blood Forming Organs|Corrinoids|Diet, Food, and Nutrition|Drugs that are Mainly Renally Excreted|Food|Food and Beverages|Growth Substances|Heterocyclic Compounds, Fused-Ring|Iron Preparations|Micronutrients|Vitamin B 12, biosynthesis|Vitamin B Complex|VITAMIN B12 AND FOLIC ACID|Vitamins",C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,70678590
107,DB00116,Tetrahydrofolic acid,small molecule,nutraceutical,"Biological Factors|Coenzymes|Dietary Supplements|Enzymes and Coenzymes|Folic Acid and Derivatives|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Pteridines|Pterins|Supplements|Vitamin B Complex|Vitamins",NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2)N1,91443
108,DB00117,Histidine,small molecule,investigational|nutraceutical,"Amino Acids|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Dietary Supplements|Supplements",N[C@@H](CC1=CNC=N1)C(O)=O,6274
109,DB00118,Ademetionine,small molecule,approved|investigational|nutraceutical,"Alimentary Tract and Metabolism|Amino Acids|Amino Acids and Derivatives|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Carbohydrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Dietary Supplements|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides|Sulfur Compounds|Supplements",C[S+](CC[C@H](N)C([O-])=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N,34755
110,DB00119,Pyruvic acid,small molecule,approved|investigational|nutraceutical,Dietary Supplements|Keto Acids|Pyruvates|Supplements,CC(=O)C(O)=O,1060
111,DB00120,Phenylalanine,small molecule,approved|investigational|nutraceutical,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Dietary Supplements|Immunosuppressive Agents|Myelosuppressive Agents|Supplements",N[C@@H](CC1=CC=CC=C1)C(O)=O,6140
112,DB00121,Biotin,small molecule,approved|investigational|nutraceutical,"Alimentary Tract and Metabolism|Coenzymes|Diet, Food, and Nutrition|Dietary Supplements|Enzymes and Coenzymes|Food|Food and Beverages|Growth Substances|Imidazoles|Micronutrients|Physiological Phenomena|Supplements|Vitamin B Complex|Vitamins",[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,171548
113,DB00122,Choline,small molecule,approved|nutraceutical,Alcohols|Amines|Amino Alcohols|Ammonium Compounds|Analgesics|Antimetabolites|Central Nervous System Agents|Dietary Supplements|Ethanolamines|Gastrointestinal Agents|Hypolipidemic Agents|Lipid Regulating Agents|Lipotropic Agents|Nervous System|Nitrogen Compounds|Nootropic Agents|Noxae|OCT1 inhibitors|OCT1 substrates|OCT2 Inhibitors|OCT2 Substrates|Onium Compounds|Other Nutritional Agents|Quaternary Ammonium Compounds|Salicylic Acid and Derivatives|Supplements|Toxic Actions|Trimethyl Ammonium Compounds|Vitamin B Complex|Vitamins,C[N+](C)(C)CCO,305
114,DB00123,L-Lysine,small molecule,approved|nutraceutical,"Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Dietary Supplements|I.V. Solution Additives|Lysine|Supplements",NCCCC[C@H](N)C(O)=O,5962
115,DB00125,Arginine,small molecule,investigational|nutraceutical,"Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Arginine|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Dietary Supplements|I.V. Solution Additives|Pituitary Function|Supplements",N[C@@H](CCCNC(N)=N)C(O)=O,6322
116,DB00126,Ascorbic acid,small molecule,approved|nutraceutical,"Acids, Acyclic|Alimentary Tract and Metabolism|Antioxidants|Carbohydrates|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Food|Food and Beverages|Gastrointestinal Acidifying Agents|Genito Urinary System and Sex Hormones|Growth Substances|Gynecological Antiinfectives and Antiseptics|Hydroxy Acids|Micronutrients|Ophthalmologicals|Organic Acids|Physiological Phenomena|Protective Agents|Sensory Organs|Sugar Acids|Urinary Acidifying Agents|Vitamin C and analogues|Vitamins",[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,54670067
117,DB00127,Spermine,small molecule,experimental|nutraceutical,Amines|Biogenic Amines|Biogenic Polyamines|Diamines|Dietary Supplements|OCT1 substrates|Polyamines|Supplements,NCCCNCCCCNCCCN,1103
118,DB00128,Aspartic acid,small molecule,approved|nutraceutical,"Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Dietary Supplements|Excitatory Amino Acids|Supplements",N[C@@H](CC(O)=O)C(O)=O,5960
119,DB00129,Ornithine,small molecule,approved|nutraceutical,"Alimentary Tract and Metabolism|Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Peptides, and Proteins|Bile and Liver Therapy|Dietary Supplements|Liver Therapy|Liver Therapy, Lipotropics|Oligopeptides|Peptides|Supplements",NCCC[C@H](N)C(O)=O,6262
120,DB00130,L-Glutamine,small molecule,approved|investigational|nutraceutical,"Alimentary Tract and Metabolism|Amino Acids|Amino Acids and Derivatives|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Dietary Supplements|Glutamine|Supplements",N[C@@H](CCC(N)=O)C(O)=O,5961
121,DB00131,Adenosine phosphate,small molecule,approved|investigational|nutraceutical,"Adenine Nucleotides|Carbohydrates|Dietary Supplements|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides|Supplements",NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1,6083
122,DB00132,alpha-Linolenic acid,small molecule,approved|investigational|nutraceutical,"Diet, Food, and Nutrition|Dietary Fats|Dietary Fats, Unsaturated|Dietary Supplements|Fats|Fatty Acids|Fatty Acids, Essential|Fatty Acids, Omega-3|Fatty Acids, Unsaturated|Fish Oils|Food|Food and Beverages|Linolenic Acids|Lipids|Oils|Physiological Phenomena|Supplements",CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O,5280934
123,DB00133,Serine,small molecule,investigational|nutraceutical,"Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Dietary Supplements|Supplements",N[C@@H](CO)C(O)=O,5951
124,DB00134,Methionine,small molecule,approved|nutraceutical,"Amino Acids|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Antidotes|Dietary Supplements|Sulfur Compounds|Supplements",CSCC[C@H](N)C(O)=O,6137
125,DB00135,Tyrosine,small molecule,approved|investigational|nutraceutical,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Dietary Supplements|Supplements",N[C@@H](CC1=CC=C(O)C=C1)C(O)=O,6057
126,DB00136,Calcitriol,small molecule,approved|nutraceutical,"Alimentary Tract and Metabolism|Antipsoriatics|Antipsoriatics for Topical Use|Bone Density Conservation Agents|Calcium-Regulating Hormones and Agents|Cholestanes|Cholestenes|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Diet, Food, and Nutrition|Food|Food and Beverages|Fused-Ring Compounds|Growth Substances|Lipids|Membrane Lipids|Membrane Transport Modulators|Micronutrients|Misc. Skin and Mucous Membrane Agents|Physiological Phenomena|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)",C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C,5280453
127,DB00137,Lutein,small molecule,approved|investigational|nutraceutical,"Alkenes|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Dietary Supplements|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Supplements|Terpenes|Xanthophylls",C\C(\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C,5281243
128,DB00138,Cystine,small molecule,approved|nutraceutical,"Acids|Acids, Noncarboxylic|Amino Acids|Amino Acids, Diamino|Amino Acids, Dicarboxylic|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Anions|Cysteine|Dietary Supplements|Disulfides|Electrolytes|Gases|Hydrogen Sulfide|Ions|Sulfhydryl Compounds|Sulfides|Sulfur Compounds|Supplements",N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O,67678
129,DB00139,Succinic acid,small molecule,approved|nutraceutical,"Acids, Acyclic|Dicarboxylic Acids|Dietary Supplements|OAT3/SLC22A8 Substrates|Succinates|Supplements",OC(=O)CCC(O)=O,1110
130,DB00140,Riboflavin,small molecule,approved|investigational|nutraceutical|vet_approved,"Alimentary Tract and Metabolism|Biological Factors|Coenzymes|Dermatologicals|Diet, Food, and Nutrition|Enzymes and Coenzymes|Flavins|Food|Food and Beverages|Growth Substances|Heterocyclic Compounds, Fused-Ring|Micronutrients|OAT1/SLC22A6 inhibitors|Ophthalmologicals|Photosensitizing Agents|Physiological Phenomena|Pigments, Biological|Pteridines|Radiation-Sensitizing Agents|Sensory Organs|Vitamin B Complex|Vitamins",CC1=C(C)C=C2N(C[C@H](O)[C@H](O)[C@H](O)CO)C3=NC(=O)NC(=O)C3=NC2=C1,493570
131,DB00141,N-Acetylglucosamine,small molecule,approved|investigational|nutraceutical,Dietary Supplements|Supplements,[H]C(=O)[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@H](O)CO,1738118
132,DB00142,Glutamic acid,small molecule,approved|nutraceutical,"Acid Preparations|Alimentary Tract and Metabolism|Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Dietary Supplements|Digestives, Incl. Enzymes|Excitatory Amino Acids|Gastrointestinal Acidifying Agents|Gastrointestinal Agents|Glutamates|Supplements",N[C@@H](CCC(O)=O)C(O)=O,33032
133,DB00143,Glutathione,small molecule,approved|investigational|nutraceutical,"Amino Acids, Peptides, and Proteins|Antidotes|Dietary Supplements|Glutathione, antagonists & inhibitors|Oligopeptides|Peptides|Supplements",N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O,124886
134,DB00144,Phosphatidyl serine,small molecule,approved|investigational|nutraceutical,Alcohols|Carbohydrates|Dietary Supplements|Glycerophosphates|Glycerophospholipids|Lipids|Membrane Lipids|Phosphatidic Acids|Phosphatidylserines|Phospholipids|Sugar Alcohols|Sugar Phosphates|Supplements|Triose Sugar Alcohols,CCCC(=O)O[C@H](COC(=O)CC)COP(O)(=O)OC[C@H](N)C(O)=O,6323481
135,DB00145,Glycine,small molecule,approved|nutraceutical|vet_approved,"Amino Acids|Amino Acids, Peptides, and Proteins|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Dietary Supplements|Glycine Agents|Irrigating Solutions|Neurotransmitter Agents|Supplements",NCC(O)=O,750
136,DB00146,Calcifediol,small molecule,approved|nutraceutical,"Alimentary Tract and Metabolism|Bone Density Conservation Agents|Cholestanes|Cholestenes|Diet, Food, and Nutrition|Food|Food and Beverages|Fused-Ring Compounds|Growth Substances|Lipids|Membrane Lipids|Micronutrients|Physiological Phenomena|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)",C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,5283731
137,DB00147,Pyridoxal,small molecule,experimental|nutraceutical,"Diet, Food, and Nutrition|Dietary Supplements|Food|Food and Beverages|Growth Substances|Micronutrients|Physiological Phenomena|Picolines|Pyridines|Supplements|Vitamin B Complex|Vitamins",CC1=NC=C(CO)C(C=O)=C1O,1050
138,DB00148,Creatine,small molecule,approved|investigational|nutraceutical,"Amidines|Amino Acids|Amino Acids, Peptides, and Proteins|Dietary Supplements|Guanidines|Supplements",CN(CC(O)=O)C(N)=N,586
139,DB00149,Leucine,small molecule,investigational|nutraceutical,"Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Dietary Supplements|Supplements",CC(C)C[C@H](N)C(O)=O,6106
140,DB00150,Tryptophan,small molecule,approved|nutraceutical|withdrawn,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Antidepressive Agents|Antidepressive Agents, Second-Generation|Central Nervous System Agents|Central Nervous System Depressants|Dietary Supplements|Miscellaneous Antidepressants|Nervous System|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Supplements|Tryptophan",N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O,6305
141,DB00151,Cysteine,small molecule,approved|nutraceutical,"Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Caloric Agents|Cysteine|Dietary Supplements|Nutritional Support|Sulfhydryl Compounds|Sulfur Compounds|Supplements",N[C@@H](CS)C(O)=O,5862
142,DB00152,Thiamine,small molecule,approved|investigational|nutraceutical|vet_approved,"Alimentary Tract and Metabolism|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Micronutrients|OCT1 substrates|OCT2 Inhibitors|Physiological Phenomena|Pyrimidines|Sulfur Compounds|Thiazoles|Vitamin B Complex|Vitamins",CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N,1130
143,DB00153,Ergocalciferol,small molecule,approved|nutraceutical,"Alimentary Tract and Metabolism|Bone Density Conservation Agents|Calcium-Regulating Hormones and Agents|Diet, Food, and Nutrition|Food|Food and Beverages|Fused-Ring Compounds|Growth Substances|Lipids|Micronutrients|Physiological Phenomena|Secosteroids|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)",CC(C)[C@@H](C)\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,5280793
144,DB00154,Dihomo-gamma-linolenic acid,small molecule,investigational|nutraceutical,"Autacoids|Biological Factors|Dietary Supplements|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Supplements",CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O,5280581
145,DB00155,Citrulline,small molecule,approved|investigational|nutraceutical,"Amino Acids|Amino Acids, Diamino|Amino Acids, Peptides, and Proteins|Dietary Supplements|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Substrates|Proteins|Supplements",N[C@@H](CCCNC(N)=O)C(O)=O,9750
146,DB00156,Threonine,small molecule,approved|nutraceutical,"Amino Acids|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Dietary Supplements|Supplements|Threonine, antagonists & inhibitors",C[C@@H](O)[C@H](N)C(O)=O,6288
147,DB00157,NADH,small molecule,approved|nutraceutical,"Adenine Nucleotides|Carbohydrates|Coenzymes|Dietary Supplements|Enzymes and Coenzymes|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides|Supplements",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O,439153
148,DB00158,Folic acid,small molecule,approved|nutraceutical|vet_approved,"Antianemic Preparations|Autacoids|BCRP/ABCG2 Substrates|Biological Factors|Diet, Food, and Nutrition|Dietary Supplements|Drugs that are Mainly Renally Excreted|Folic Acid and Derivatives|Food|Food and Beverages|Growth Substances|Hematinics|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|Micronutrients|OAT1/SLC22A6 inhibitors|Pteridines|Pterins|Supplements|Vitamin B Complex|VITAMIN B12 AND FOLIC ACID|Vitamins",NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,6037
149,DB00159,Icosapent,small molecule,approved|nutraceutical,"Agents causing hyperkalemia|Agents that produce hypertension|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Autacoids|Biological Factors|Diet, Food, and Nutrition|Dietary Fats|Dietary Fats, Unsaturated|Dietary Supplements|Eicosanoids|Fats|Fatty Acids|Fatty Acids, Omega-3|Fatty Acids, Unsaturated|Fish Oils|Food|Food and Beverages|Hypolipidemic Agents|Inflammation Mediators|Lipids|Nephrotoxic agents|Non COX-2 selective NSAIDS|Oils|Physiological Phenomena|Supplements",CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O,446284
150,DB00160,Alanine,small molecule,nutraceutical,"Alanine|Amino Acids|Amino Acids, Peptides, and Proteins|Dietary Supplements|Supplements",C[C@H](N)C(O)=O,5950
151,DB00161,Valine,small molecule,approved|nutraceutical,"Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Dietary Supplements|Valine",CC(C)[C@H](N)C(O)=O,6287
152,DB00162,Vitamin A,small molecule,approved|nutraceutical|vet_approved,"Adjuvants, Immunologic|Alimentary Tract and Metabolism|Alkenes|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anticarcinogenic Agents|Antioxidants|Biological Factors|Carotenoids|Compounds used in a research, industrial, or household setting|Cyclohexanes|Cyclohexenes|Cycloparaffins|Dermatologicals|Diagnostic Agents|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Immunologic Factors|Micronutrients|Nasal Preparations|Ophthalmologicals|Physiological Phenomena|Pigments, Biological|Polyenes|Protective Agents|Retinoids|Retinoids for Topical Use in Acne|Sensory Organs|Terpenes|Tests for Fat Absorption|Vitamin A|Vitamins|Vitamins (Fat Soluble)",C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,445354
153,DB00163,Vitamin E,small molecule,approved|nutraceutical|vet_approved,"Antioxidants|Basic Ointments and Protectants|Benzopyrans|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Diet, Food, and Nutrition|Dietary Supplements|Food|Food and Beverages|Growth Substances|Heterocyclic Compounds, Fused-Ring|Micronutrients|Physiological Phenomena|Protective Agents|Pyrans|Supplements|Vitamin E|Vitamin E, analogs & derivatives|Vitamins|Vitamins (Fat Soluble)",CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C,14985
154,DB00165,Pyridoxine,small molecule,approved|investigational|nutraceutical|vet_approved,"Alimentary Tract and Metabolism|Analogs/Derivatives|Antiinfectives for Systemic Use|Antimycobacterials|Diet, Food, and Nutrition|Drugs for Treatment of Tuberculosis|Drugs that are Mainly Renally Excreted|Food|Food and Beverages|Micronutrients|Picolines|Pyridines|Vitamin B Complex|Vitamins",CC1=C(O)C(CO)=C(CO)C=N1,1054
155,DB00166,Lipoic acid,small molecule,approved|investigational|nutraceutical,"Alimentary Tract and Metabolism|Antioxidants|Coenzymes|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Dietary Supplements|Enzymes and Coenzymes|Fatty Acids|Food|Food and Beverages|Growth Substances|Hypoglycemia-Associated Agents|Lipids|Micronutrients|Physiological Phenomena|Protective Agents|Sulfur Compounds|Supplements|Thiophenes|Various Alimentary Tract and Metabolism Products|Vitamin B Complex|Vitamins",OC(=O)CCCC[C@@H]1CCSS1,6112
156,DB00167,Isoleucine,small molecule,investigational|nutraceutical,"Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Dietary Supplements|Supplements",CC[C@H](C)[C@H](N)C(O)=O,6306
157,DB00168,Aspartame,small molecule,investigational|nutraceutical,"Amino Acids, Peptides, and Proteins|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Dietary Supplements|Dipeptides|Flavoring Agents|Food|Food Additives|Food and Beverages|Food Ingredients|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|Oligopeptides|Peptides|Pharmaceutic Aids|Pharmaceutical Preparations|Physiological Phenomena|Supplements|Sweetening Agents",COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CC(O)=O,134601
158,DB00169,Cholecalciferol,small molecule,approved|nutraceutical,"Alimentary Tract and Metabolism|Bone Density Conservation Agents|Calcium-Regulating Hormones and Agents|Cholecalciferol, antagonists & inhibitors|Cholestanes|Cholestenes|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Diet, Food, and Nutrition|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Food|Food and Beverages|Fused-Ring Compounds|Growth Substances|Lipids|Membrane Lipids|Micronutrients|Musculo-Skeletal System|Physiological Phenomena|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)",CC(C)CCC[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,5280795
159,DB00170,Menadione,small molecule,approved|nutraceutical,"Antifibrinolytic Agents|Blood and Blood Forming Organs|Coagulants|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Diet, Food, and Nutrition|Dietary Supplements|Diterpenes|Fibrin Modulating Agents|Food|Food and Beverages|Growth Substances|Hematologic Agents|Hemostatics|Micronutrients|Naphthalenes|Naphthoquinones|Physiological Phenomena|Phytol|Quinones|Supplements|Terpenes|Vitamin K|Vitamins|Vitamins (Fat Soluble)",CC1=CC(=O)C2=CC=CC=C2C1=O,4055
160,DB00171,ATP,small molecule,investigational|nutraceutical,"Adenine Nucleotides|Adenosine Triphosphate|Carbohydrates|Dietary Supplements|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides|Supplements",NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O,5957
161,DB00172,Proline,small molecule,nutraceutical,"Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Dietary Supplements|Imines|Imino Acids|Supplements",OC(=O)[C@@H]1CCCN1,145742
162,DB00173,Adenine,small molecule,approved|nutraceutical,"Dietary Supplements|Heterocyclic Compounds, Fused-Ring|Purines|Supplements|UGT1A1 Inhibitors",NC1=C2NC=NC2=NC=N1,190
163,DB00174,Asparagine,small molecule,approved|investigational|nutraceutical,"Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Dietary Supplements|Supplements",N[C@@H](CC(N)=O)C(O)=O,6267
164,DB00175,Pravastatin,small molecule,approved,"Agents Causing Muscle Toxicity|Anticholesteremic Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|BSEP/ABCB11 Substrates|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Hypolipidemic Agents|Hypolipidemic Agents Indicated for Hyperlipidemia|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Noxae|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein substrates|Photosensitizing Agents|Toxic Actions",[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,54687
165,DB00176,Fluvoxamine,small molecule,approved|investigational,"Amines|Anti-Anxiety Agents|Antidepressive Agents|Antidepressive Agents, Second-Generation|BSEP/ABCB11 Substrates|Central Nervous System Agents|Central Nervous System Depressants|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strong)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Hydroxylamines|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Oximes|P-glycoprotein inhibitors|Psychoanaleptics|Psychotropic Drugs|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Tranquilizing Agents",COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,3404
166,DB00177,Valsartan,small molecule,approved|investigational,"Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Angiotensin 2 Receptor Blocker|Angiotensin II Antagonists and Calcium Channel Blockers|Angiotensin II Antagonists and Diuretics|Angiotensin II receptor blockers (ARBs) and calcium channel blockers|Angiotensin II receptor blockers (ARBs) and diuretics|Angiotensin II receptor blockers (ARBs), plain|Angiotensin II Type 1 Receptor Blockers|Angiotensin II Type 2 Receptor Blockers|Angiotensin Receptor Antagonists|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Cardiovascular Agents|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Hypotensive Agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates",CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,60846
167,DB00178,Ramipril,small molecule,approved,"ACE Inhibitors and Calcium Channel Blockers|ACE Inhibitors and Diuretics|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Cardiovascular Agents|Cholinesterase Inhibitors|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Lipid Modifying Agents|Photosensitizing Agents|Protease Inhibitors",[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,5362129
168,DB00179,Masoprocol,small molecule,approved|investigational,"Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Antioxidants|Benzene Derivatives|Benzyl Compounds|Catechols|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Lignans|Lipoxygenase Inhibitors|Peripheral Nervous System Agents|Phenols|Protective Agents|Sensory System Agents",C[C@@H](CC1=CC(O)=C(O)C=C1)[C@H](C)CC1=CC(O)=C(O)C=C1,71398
169,DB00180,Flunisolide,small molecule,approved|investigational,"Adrenal Cortex Hormones|Adrenals|Agents to Treat Airway Disease|Anti-Asthmatic Agents|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids for Systemic Use|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Drugs for Obstructive Airway Diseases|Fused-Ring Compounds|Immunosuppressive Agents|Nasal Preparations|Pregnadienes|Pregnanes|Respiratory System Agents|Steroids|Steroids, Fluorinated",[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,82153
170,DB00181,Baclofen,small molecule,approved,"Agents Causing Muscle Toxicity|Amino Acids|Amino Acids, Peptides, and Proteins|Aminobutyrates|Butyrates|Central Nervous System Agents|Central Nervous System Depressants|Drugs that are Mainly Renally Excreted|GABA Agents|GABA Agonists|GABA-B Receptor Agonists|Gaba-derivative Skeletal Muscle Relaxants|gamma-Aminobutyric Acid-ergic Agonist|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neurotransmitter Agents",NCC(CC(O)=O)C1=CC=C(Cl)C=C1,2284
171,DB00182,Amphetamine,small molecule,approved|illicit|investigational,"Adrenergic Agents|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that produce hypertension|Agents that reduce seizure threshold|Amines|Amphetamines|Antidepressive Agents|Autonomic Agents|Benzene Derivatives|Biogenic Amines|Biogenic Monoamines|Catechols|Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Stimulants|Central Nervous System Stimulation|Centrally Acting Sympathomimetics|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Uptake Inhibitors|Drugs that are Mainly Renally Excreted|Membrane Transport Modulators|Monoamine Oxidase Inhibitors|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Peripheral Nervous System Agents|Phenethylamines|Phenols|Photosensitizing Agents|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetics",CC(N)CC1=CC=CC=C1,3007
172,DB00183,Pentagastrin,small molecule,approved,"Amino Acids, Peptides, and Proteins|Diagnostic Agents|Gastrins|Gastrointestinal Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Pentagastrin, antagonists & inhibitors|Peptide Hormones|Peptides|Proteins|Tests for Gastric Secretion",CSCC[C@H](NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,9853654
173,DB00184,Nicotine,small molecule,approved,"Agents producing tachycardia|Alkaloids|Autonomic Agents|Cholinergic Agents|Cholinergic Agonists|Cholinergic Nicotinic Agonist|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP2E1 Inducers (strength unknown)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs Used in Addictive Disorders|Drugs Used in Nicotine Dependence|Ganglion Blockers|Ganglionic Stimulants|Miscellaneous Autonomic Drugs|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Nervous System|Neurotransmitter Agents|Nicotine, antagonists & inhibitors|Nicotine, metabolism|Nicotinic Agonists|OCT1 inhibitors|OCT2 Inhibitors|Peripheral Nervous System Agents|Pyridines|Smoking Cessation Agents|Solanaceous Alkaloids",CN1CCC[C@H]1C1=CN=CC=C1,89594
174,DB00185,Cevimeline,small molecule,approved,Autonomic Agents|Cholinergic Agents|Cholinergic Agonists|Cholinergic Receptor Agonist|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Muscarinic Agonists|Nervous System|Neurotransmitter Agents|Parasympathomimetics|Peripheral Nervous System Agents|Sulfur Compounds,CC1O[C@@]2(CS1)CN1CCC2CC1,25137844
175,DB00186,Lorazepam,small molecule,approved,"Anti-Anxiety Agents|Anticonvulsants|Antiemetics|Autonomic Agents|Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|GABA Agents|GABA Modulators|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Hypnotics and Sedatives|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Neurotransmitter Agents|Peripheral Nervous System Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents",OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,3958
176,DB00187,Esmolol,small molecule,approved,"Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-1 Receptor Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Beta Blocking Agents, Selective|Beta-Blockers (Beta1 Selective)|Bradycardia-Causing Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Hypotensive Agents|Neurotransmitter Agents|Potential QTc-Prolonging Agents|Propanols|QTc Prolonging Agents",COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1,59768
177,DB00188,Bortezomib,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Boron Compounds|Boronic Acids|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Hepatotoxic Agents|Hypotensive Agents|Immunosuppressive Agents|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|OATP1B3 inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Potential QTc-Prolonging Agents|Proteasome Inhibitors|Pyrazines|QTc Prolonging Agents",CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,387447
178,DB00189,Ethchlorvynol,small molecule,approved|illicit|withdrawn,Alcohols|Central Nervous System Agents|Central Nervous System Depressants|Chlorohydrins|Hypnotics and Sedatives|Nervous System|Psycholeptics,CCC(O)(\C=C\Cl)C#C,5281077
179,DB00190,Carbidopa,small molecule,approved,Amines|Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Aromatic Amino Acid Decarboxylase Inhibitors|Aromatic L-amino Acid Decarboxylase Inhibitors|Benzene Derivatives|Biogenic Amines|Biogenic Monoamines|Catecholamines|Catechols|Central Nervous System Agents|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Hydrazines|Phenols,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,34359
180,DB00191,Phentermine,small molecule,approved|illicit,"Adrenergic Agents|Agents producing tachycardia|Agents that produce hypertension|Alimentary Tract and Metabolism|Amines|Amphetamines|Anti-Obesity Agents|Antiobesity Preparations, Excl. Diet Products|Appetite Depressants|Appetite Suppression|Autonomic Agents|Central Nervous System Agents|Centrally Acting Antiobesity Products|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Increased Sympathetic Activity|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenethylamines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetic Amine Anorectic|Sympathomimetics",CC(C)(N)CC1=CC=CC=C1,4771
181,DB00192,Indecainide,small molecule,approved,,CC(C)NCCCC1(C(N)=O)C2=CC=CC=C2C2=CC=CC=C12,52195
182,DB00193,Tramadol,small molecule,approved|investigational,Agents producing tachycardia|Agents that reduce seizure threshold|Alcohols|Amines|Analgesics|Anticholinergic Agents|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cyclohexanes|Cyclohexanols|Cycloparaffins|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dimethylamines|Drugs that are Mainly Renally Excreted|Muscarinic Antagonists|Narcotics|Nervous System|NMDA Receptor Antagonists|Opiate Agonists|Opioid Agonist|Opioids|Peripheral Nervous System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists|UGT1A1 Substrates,COC1=CC=CC(=C1)[C@@]1(O)CCCC[C@@H]1CN(C)C,33741
183,DB00194,Vidarabine,small molecule,approved|investigational,"Anti-Infective Agents|Antiinfectives for Systemic Use|Antimetabolites|Antiviral Agents|Antivirals for Systemic Use|Arabinonucleosides|Carbohydrates|Direct Acting Antivirals|Glycosides|Heterocyclic Compounds, Fused-Ring|Noxae|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors|Ophthalmologicals|Purine Nucleosides|Purines|Ribonucleosides|Sensory Organs|Toxic Actions",NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,21704
184,DB00195,Betaxolol,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-1 Receptor Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antiglaucoma Preparations and Miotics|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Autonomic Agents|Beta Blocking Agents, Selective|Beta-adrenergic Agents|Beta-Blockers (Beta1 Selective)|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Hypotensive Agents|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|Ophthalmologicals|Peripheral Nervous System Agents|Phenoxypropanolamines|Propanolamines|Propanols|QTc Prolonging Agents|Sensory Organs|Sympatholytics",CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,2369
185,DB00196,Fluconazole,small molecule,approved|investigational,"14-alpha Demethylase Inhibitors|Agents causing hyperkalemia|Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Antiinfectives for Systemic Use|Antimycotics for Systemic Use|Azole Antifungals|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strong)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Imidazole and Triazole Derivatives|P-glycoprotein inhibitors|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Steroid Synthesis Inhibitors|Triazole Derivatives|Triazoles",OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,3365
186,DB00197,Troglitazone,small molecule,approved|investigational|withdrawn,"Alimentary Tract and Metabolism|Benzopyrans|Blood Glucose Lowering Agents|BSEP/ABCB11 Inhibitors|Chromans|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs Used in Diabetes|Heterocyclic Compounds, Fused-Ring|OATP1B1/SLCO1B1 Inhibitors|Pyrans|Sulfur Compounds|Thiazoles|Thiazolidinediones|UGT1A1 Substrates|UGT1A3 substrates|UGT1A4 substrates|UGT1A6 Inhibitors|UGT1A6 substrate|UGT1A9 Substrates|UGT2B7 substrates",CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)O2)C(C)=C1O,5591
187,DB00198,Oseltamivir,small molecule,approved,Acetamides|Acetates|Amides|Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Direct Acting Antivirals|Drugs that are Mainly Renally Excreted|Neuraminidase Inhibitors|OAT3/SLC22A8 Substrates,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,65028
188,DB00199,Erythromycin,small molecule,approved|investigational|vet_approved,"Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antiinfectives for Treatment of Acne|BSEP/ABCB11 Inhibitors|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Enzyme Inhibitors|Erythromycin and similars|Erythromycins|Gastrointestinal Agents|Lactones|Macrolide Antimicrobial|Macrolides|Macrolides, Lincosamides and Streptogramins|Moderate Risk QTc-Prolonging Agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 inhibitors|OATP1B3 substrates|Ophthalmologicals|P-glycoprotein inhibitors|P-glycoprotein substrates|Protein Synthesis Inhibitors|QTc Prolonging Agents",CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,12560
189,DB00200,Hydroxocobalamin,small molecule,approved,"Antianemic Preparations|Antidotes|Blood and Blood Forming Organs|Corrinoids|Diet, Food, and Nutrition|Drugs that are Mainly Renally Excreted|Food|Food and Beverages|Growth Substances|Hematinics|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|Micronutrients|Nutritional Support|Physiological Phenomena|Vitamin B Complex|VITAMIN B12 AND FOLIC ACID|Vitamins",[N+]1=2[Co-3]345([N+]6=C7[C@H]([C@@](CC(=O)N)(C)[C@@]6([C@@]6(N3C(=C(C)C3=[N+]4C(C(C)(C)[C@@H]3CCC(=O)N)=CC3=[N+]5C(=C7C)[C@@](CC(=O)N)([C@@H]3CCC(=O)N)C)[C@@](C)([C@H]6CC(=O)N)CCC(NC[C@@H](C)OP(=O)(O[C@@H]3[C@H](O[C@H](N(C4=CC(=C(C=C14)C)C)C=2)[C@@H]3O)CO)[O-])=O)[H])C)CCC(=O)N)O[H],70678542
190,DB00201,Caffeine,small molecule,approved,"Alkaloids|Anorexigenic Agents & Respiratory and CNS Stimulants|BCRP/ABCG2 Inhibitors|Caffeine and Caffeine Containing Products|Central Nervous System Agents|Central Nervous System Stimulants|Central Nervous System Stimulation|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Diagnostic Agents|Drugs for Obstructive Airway Diseases|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotransmitter Agents|Phosphodiesterase Inhibitors|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Purinergic Agents|Purinergic Antagonists|Purines|Purinones|Respiratory and CNS Stimulants|Tests for Gastric Secretion|Tricarboxylic Acids|Xanthine derivatives",CN1C=NC2=C1C(=O)N(C)C(=O)N2C,2519
191,DB00202,Succinylcholine,small molecule,approved,"Acids, Acyclic|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Ammonium Compounds|Central Nervous System Depressants|Choline Derivatives|Cholinesterase substrates|Dicarboxylic Acids|Ethanolamines|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular Depolarizing Agents|Neuromuscular Depolarizing Blockade|Neurotoxic agents|Nitrogen Compounds|Onium Compounds|Peripheral Nervous System Agents|Quaternary Ammonium Compounds|Succinates|Trimethyl Ammonium Compounds",C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,5314
192,DB00203,Sildenafil,small molecule,approved|investigational,"Agents Causing Muscle Toxicity|Amides|Cardiovascular Agents|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs Used in Erectile Dysfunction|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Phosphodiesterase 5 Inhibitors|Piperazines|Purines|Sulfonamides|Sulfones|Sulfur Compounds|Urological Agents|Urologicals|Vasodilating Agents",CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1,5212
193,DB00204,Dofetilide,small molecule,approved|investigational,"Amides|Amines|Antiarrhythmic agents|Antiarrhythmics, Class III|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Ethylamines|Highest Risk QTc-Prolonging Agents|Membrane Transport Modulators|Narrow Therapeutic Index Drugs|OCT2 Substrates|OCT2 substrates with narrow therapeutic index|Potassium Channel Blockers|QTc Prolonging Agents|Sulfones|Sulfur Compounds",CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,71329
194,DB00205,Pyrimethamine,small molecule,approved|investigational|vet_approved,"Anti-Infective Agents|Antibiotics for Pneumocystis Pneumonia|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Diaminopyrimidines|Enzyme Inhibitors|Folic Acid Antagonists|MATE 1 Inhibitors|MATE 2 Inhibitors|MATE inhibitors|Pyrimidines",CCC1=C(C(N)=NC(N)=N1)C1=CC=C(Cl)C=C1,4993
195,DB00206,Reserpine,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic Uptake Inhibitors|Alkaloids|Antiadrenergic Agents, Centrally Acting|Antidepressive Agents|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Antipsychotic Agents|BSEP/ABCB11 Inhibitors|Cardiovascular Agents|Catecholamine-depleting Sympatholytic|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Decreased Sympathetic Activity|Drugs that are Mainly Renally Excreted|Gastrointestinal Acidifying Agents|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Indole Alkaloids|Indoles|Membrane Transport Modulators|Neurotoxic agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OCT1 inhibitors|OCT2 Substrates|P-glycoprotein inducers|P-glycoprotein inhibitors|P-glycoprotein substrates|Psychotropic Drugs|Secologanin Tryptamine Alkaloids|Tranquilizing Agents",[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2,5770
196,DB00207,Azithromycin,small molecule,approved,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Experimental Unapproved Treatments for COVID-19|Lactones|Macrolide Antimicrobial|Macrolides|Macrolides, Lincosamides and Streptogramins|Moderate Risk QTc-Prolonging Agents|Ophthalmologicals|P-glycoprotein inhibitors|P-glycoprotein substrates|Photosensitizing Agents|Polyketides|QTc Prolonging Agents",CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,447043
197,DB00208,Ticlopidine,small molecule,approved,"Antiplatelet agents|Blood and Blood Forming Organs|Cardiovascular Agents|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (moderate)|Cytochrome P-450 CYP2B6 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (moderate)|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (weak)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Decreased Platelet Aggregation|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Fibrin Modulating Agents|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|Platelet Aggregation Inhibitors Excl. Heparin|Purinergic Agents|Purinergic Antagonists|Purinergic P2 Receptor Antagonists|Purinergic P2Y Receptor Antagonists|Pyridines|Sulfur Compounds|Thienopyridines|Thiophenes",ClC1=CC=CC=C1CN1CCC2=C(C1)C=CS2,5472
198,DB00209,Trospium,small molecule,approved,"Acids, Carbocyclic|Agents producing tachycardia|Alimentary Tract and Metabolism|Alkaloids|Anticholinergic Agents|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Cholinergic Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Diphenylacetic Acids|Drugs for Functional Gastrointestinal Disorders|Drugs for Urinary Frequency and Incontinence|Genito Urinary System and Sex Hormones|Hydroxy Acids|Muscarinic Antagonists|Neurotransmitter Agents|Parasympatholytics|Peripheral Nervous System Agents|Phenylacetates|Tropanes|Urological Agents|Urologicals",[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1,5284632
199,DB00210,Adapalene,small molecule,approved,Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Inflammatory Agents|Dermatologicals|Misc. Skin and Mucous Membrane Agents|Naphthalenes|Retinoids|Retinoids for Topical Use in Acne,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,60164
200,DB00211,Midodrine,small molecule,approved,Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Autonomic Agents|Bradycardia-Causing Agents|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Ethanolamines|Neurotransmitter Agents|Peripheral Nervous System Agents|Sympathomimetics|Vasoconstrictor Agents,COC1=CC(C(O)CNC(=O)CN)=C(OC)C=C1,4195
201,DB00212,Remikiren,small molecule,experimental,Agents Acting on the Renin-Angiotensin System|Antihypertensive Agents|Cardiovascular Agents|Enzyme Inhibitors|Protease Inhibitors|Renin-Inhibitors,CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1,6324659
202,DB00213,Pantoprazole,small molecule,approved,"2-Pyridinylmethylsulfinylbenzimidazoles|Acid Reducers|Alimentary Tract and Metabolism|Anti-Ulcer Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Benzimidazoles|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Gastric Acid Lowering Agents|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Proton Pump Inhibitors|Proton-pump Inhibitors|Pyridines|Sulfoxides|Sulfur Compounds",COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,4679
203,DB00214,Torasemide,small molecule,approved,Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Cardiovascular Agents|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Diuretics|High-Ceiling Diuretics|Hyperglycemia-Associated Agents|Hypotensive Agents|Increased Diuresis at Loop of Henle|Membrane Transport Modulators|Natriuretic Agents|Non Potassium Sparing Diuretics|OATP1B1/SLCO1B1 Substrates|Ototoxic agents|Pyridines|Sodium Potassium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC=CC(C)=C2)C=CN=C1,41781
204,DB00215,Citalopram,small molecule,approved,"Amines|Antidepressive Agents|Antidepressive Agents, Second-Generation|Benzofurans|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (weak)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|Hypoglycemia-Associated Agents|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Nitriles|P-glycoprotein inhibitors|P-glycoprotein substrates|Propylamines|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists|Vasodilating Agents",CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,2771
205,DB00216,Eletriptan,small molecule,approved|investigational,"Agents that produce hypertension|Amines|Analgesics|Antidepressive Agents|Antimigraine Preparations|Biogenic Amines|Biogenic Monoamines|Central Nervous System Depressants|Cytochrome P-450 CYP2A6 Inducers|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Indoles|Nervous System|Neurotransmitter Agents|P-glycoprotein substrates|Selective Serotonin 5-HT1 Receptor Agonists|Selective Serotonin Agonists|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 1b Receptor Agonists|Serotonin 1d Receptor Agonists|Serotonin 5-HT1 Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists|Serotonin-1b and Serotonin-1d Receptor Agonist|Triptans",CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2,77993
206,DB00217,Bethanidine,small molecule,approved,"Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Amidines|Antiadrenergic Agents, Peripherally Acting|Antihypertensive Agents|Autonomic Agents|Cardiovascular Agents|Guanidine Derivatives|Guanidines|Neurotransmitter Agents|Peripheral Nervous System Agents|Sympatholytics",CN\C(NCC1=CC=CC=C1)=N/C,2368
207,DB00218,Moxifloxacin,small molecule,approved|investigational,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Moderate Risk QTc-Prolonging Agents|Ophthalmologicals|QTc Prolonging Agents|Quinolines|Quinolone Antimicrobial|Quinolones|Sensory Organs|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",[H][C@]12CN(C[C@@]1([H])NCCC2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1OC)C(O)=O,152946
208,DB00219,Oxyphenonium,small molecule,approved,"Agents producing tachycardia|Alimentary Tract and Metabolism|Amines|Ammonium Compounds|Anticholinergic Agents|Autonomic Agents|Cholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Mydriatics|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Parasympatholytics|Peripheral Nervous System Agents|Quaternary Ammonium Compounds|Synthetic Anticholinergics, Quaternary Ammonium Compounds",CC[N+](C)(CC)CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,5749
209,DB00220,Nelfinavir,small molecule,approved,"Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BCRP/ABCG2 Inhibitors|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strong)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strong)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Direct Acting Antivirals|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|HIV Protease Inhibitors|Hyperglycemia-Associated Agents|Isoquinolines|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|OCT1 inhibitors|P-glycoprotein inducers|P-glycoprotein inhibitors|P-glycoprotein substrates|Potential QTc-Prolonging Agents|Protease Inhibitors|QTc Prolonging Agents|UGT1A1 Inducers",[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CSC1=CC=CC=C1)NC(=O)C1=C(C)C(O)=CC=C1)[C@@H](C2)C(=O)NC(C)(C)C,64143
210,DB00221,Isoetharine,small molecule,approved,Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Respiratory System Agents,CCC(NC(C)C)C(O)C1=CC(O)=C(O)C=C1,3762
211,DB00222,Glimepiride,small molecule,approved,Alimentary Tract and Metabolism|Antiarrhythmic agents|Blood Glucose Lowering Agents|BSEP/ABCB11 Substrates|Cardiovascular Agents|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Drugs Used in Diabetes|Hypoglycemia-Associated Agents|Immunosuppressive Agents|Sulfones|Sulfonylureas|Sulfur Compounds,CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)C1=O,3476
212,DB00223,Diflorasone,small molecule,approved,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Dermatologicals|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated",[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,71415
213,DB00224,Indinavir,small molecule,approved,Agents Causing Muscle Toxicity|Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (weak)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Direct Acting Antivirals|Enzyme Inhibitors|HIV Protease Inhibitors|Hyperglycemia-Associated Agents|OATP1B1/SLCO1B1 Inhibitors|OCT1 inhibitors|P-glycoprotein inducers|P-glycoprotein inhibitors|P-glycoprotein substrates|Protease Inhibitors|Pyridines|UGT1A1 Inhibitors,CC(C)(C)NC(=O)[C@@H]1CN(CC2=CN=CC=C2)CCN1C[C@@H](O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]1[C@H](O)CC2=CC=CC=C12,5362440
214,DB00225,Gadodiamide,small molecule,approved|investigational,"Acetates|Acids, Acyclic|Amines|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Drugs that are Mainly Renally Excreted|Fatty Acids|Fatty Acids, Volatile|Injections, Intravenous|Lipids|Magnetic Resonance Contrast Activity|Magnetic Resonance Imaging Contrast Media|Miscellaneous Therapeutic Agents|Organometallic Compounds|Paramagnetic Contrast Agent|Paramagnetic Contrast Media|Polyamines",O=C1[O-][Gd+3]234567[O]=C(C[N]2(CC[N]3(CC([O-]4)=O)CC[N]5(CC(=[O]6)NC)CC(=O)[O-]7)C1)NC,24847884
215,DB00226,Guanadrel,small molecule,approved,Adrenergic Antagonists|Amidines|Antihypertensive Agents|Cardiovascular Agents,NC(N)=NCC1COC2(CCCCC2)O1,38521
216,DB00227,Lovastatin,small molecule,approved|investigational,Agents Causing Muscle Toxicity|Anticholesteremic Agents|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Hypolipidemic Agents|Hypolipidemic Agents Indicated for Hyperlipidemia|Lipid Modifying Agents|Lipid Regulating Agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|P-glycoprotein inhibitors|Photosensitizing Agents|UGT1A1 Substrates|UGT1A3 substrates|UGT2B7 substrates,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC,53232
217,DB00228,Enflurane,small molecule,approved|investigational|vet_approved,"Agents that reduce seizure threshold|Anesthetics|Anesthetics, General|Anesthetics, Inhalation|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Ethers|Methyl Ethers|Nervous System",FC(F)OC(F)(F)C(F)Cl,3226
218,DB00229,Cefotiam,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephacetrile|Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|OAT1/SLC22A6 inhibitors|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Second-Generation Cephalosporins|Sulfur Compounds|Thiazines",[H][C@]12SCC(CSC3=NN=NN3CCN(C)C)=C(N1C(=O)[C@H]2NC(=O)CC1=CSC(N)=N1)C(O)=O,43708
219,DB00230,Pregabalin,small molecule,approved|investigational,"Acids, Acyclic|Agents causing angioedema|Amino Acids|Amino Acids, Peptides, and Proteins|Aminobutyrates|Analgesics|Anti-Anxiety Agents|Antiarrhythmic agents|Anticonvulsants|Bradycardia-Causing Agents|Butyrates|Central Nervous System Agents|Central Nervous System Depressants|Drugs that are Mainly Renally Excreted|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Miscellaneous Anticonvulsants|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|Psychotropic Drugs|QTc Prolonging Agents|Sensory System Agents|Tranquilizing Agents|Vasodilating Agents",CC(C)C[C@H](CN)CC(O)=O,5486971
220,DB00231,Temazepam,small molecule,approved|investigational,"Anti-Anxiety Agents|Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|GABA Agents|GABA Modulators|Heterocyclic Compounds, Fused-Ring|Hypnotics and Sedatives|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Psychotropic Drugs|Tranquilizing Agents",CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1,5391
221,DB00232,Methyclothiazide,small molecule,withdrawn,"Amides|Benzothiadiazines|Cardiovascular Agents|Diuretics|Drugs causing inadvertant photosensitivity|Heterocyclic Compounds, Fused-Ring|Hyperglycemia-Associated Agents|Hypotensive Agents|Increased Diuresis|Membrane Transport Modulators|Natriuretic Agents|Photosensitizing Agents|Sodium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds|Thiazides",CN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O,4121
222,DB00233,Aminosalicylic acid,small molecule,approved,"Acids, Carbocyclic|Aminobenzoates|Aminosalicylic Acid and Derivatives|Aminosalicylic Acids|Anti-Bacterial Agents|Anti-Infective Agents|Antiinfectives for Systemic Use|Antimycobacterials|Antituberculosis Agents|Benzene Derivatives|Benzoates|Drugs for Treatment of Tuberculosis|Hydroxy Acids|Hydroxybenzoates|para-Aminobenzoates|Phenols|Salicylates",NC1=CC(O)=C(C=C1)C(O)=O,4649
223,DB00234,Reboxetine,small molecule,approved|experimental,Adrenergic Agents|Adrenergic Uptake Inhibitors|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Membrane Transport Modulators|Morpholines|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Oxazines|P-glycoprotein inhibitors|Psychoanaleptics|Psychotropic Drugs,[H][C@@](OC1=CC=CC=C1OCC)(C1=CC=CC=C1)[C@@]1([H])CNCCO1,127151
224,DB00235,Milrinone,small molecule,approved,"Amines|Aminopyridines|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Hematologic Agents|Phosphodiesterase 3 Inhibitors|Phosphodiesterase 5 Inhibitors|Phosphodiesterase Inhibitors|Protective Agents|Pyridines|Vasodilating Agents",CC1=C(C=C(C#N)C(=O)N1)C1=CC=NC=C1,4197
225,DB00236,Pipobroman,small molecule,approved,"Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Noxae|Piperazines|Toxic Actions",BrCCC(=O)N1CCN(CC1)C(=O)CCBr,4842
226,DB00237,Butabarbital,small molecule,approved|illicit,Anticholinergic Agents|Anticonvulsants|Barbiturates|Central Nervous System Agents|Central Nervous System Depressants|Drugs that are Mainly Renally Excreted|Hypnotics and Sedatives|Nervous System|Nicotinic Antagonists|Psycholeptics|Pyrimidines|Pyrimidinones,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,2479
227,DB00238,Nevirapine,small molecule,approved,Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (weak)|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strong)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Direct Acting Antivirals|Enzyme Inhibitors|Hepatotoxic Agents|Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor|Inducers of Drug Clearance|Non-Nucleoside Reverse Transcriptase Inhibitors|Nonnucleoside Reverse Transcriptase Inhibitors|Nucleic Acid Synthesis Inhibitors|OCT1 inhibitors|Pyridines|Reverse Transcriptase Inhibitors,CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1,4463
228,DB00239,Oxiconazole,small molecule,approved,Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Azole Antifungals|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Imidazole and Triazole Derivatives|Imidazole Derivatives,ClC1=CC(Cl)=C(CO\N=C(/CN2C=CN=C2)C2=CC=C(Cl)C=C2Cl)C=C1,5353853
229,DB00240,Alclometasone,small molecule,approved,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Moderately Potent (Group II)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dermatologicals|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Ophthalmologicals|Pregnadienes|Pregnadienetriols|Pregnanes|Sensory Organs|Steroids",[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])[C@H](Cl)CC2=CC(=O)C=C[C@]12C,5311000
230,DB00241,Butalbital,small molecule,approved|illicit,Anticholinergic Agents|Anticonvulsants|Barbiturates|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Hypnotics and Sedatives|Methemoglobinemia Associated Agents|Nervous System|Nicotinic Antagonists|Psycholeptics|Pyrimidines|Pyrimidinones,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,2481
231,DB00242,Cladribine,small molecule,approved|investigational,"2-Chloroadenosine|Agents Causing Muscle Toxicity|Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Carbohydrates|Cardiotoxic antineoplastic agents|Deoxyadenosines|Deoxyribonucleosides|Glycosides|Heterocyclic Compounds, Fused-Ring|Immunologic Factors|Immunosuppressive Agents|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Analogues|Purine Antimetabolite|Purine Nucleosides|Purines|Ribonucleosides|Selective Immunosuppressants",NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,20279
232,DB00243,Ranolazine,small molecule,approved|investigational,Acetamides|Antianginal Agents|BSEP/ABCB11 Substrates|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|MATE 1 Inhibitors|MATE 2 Inhibitors|MATE inhibitors|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|OCT2 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Piperazines|QTc Prolonging Agents|Sodium Channel Blockers|Vasodilating Agents,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1,56959
233,DB00244,Mesalazine,small molecule,approved,"Agents causing hyperkalemia|Agents that produce hypertension|Aminosalicylate|Aminosalicylic Acids|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Benzene Derivatives|Hydroxybenzoates|Intestinal Antiinflammatory Agents|Nephrotoxic agents|Non COX-2 selective NSAIDS|Phenols|Salicylates",NC1=CC(C(O)=O)=C(O)C=C1,4075
234,DB00245,Benzatropine,small molecule,approved,Agents producing tachycardia|Alkaloids|Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Anticholinergic Agents|Aza Compounds|Central Nervous System Agents|Cholinergic Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Uptake Inhibitors|Drugs that are Mainly Renally Excreted|Ethers of Tropine or Tropine Derivatives|Histamine Antagonists|Histamine H1 Antagonists|Histamine Receptor Antagonists|Membrane Transport Modulators|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Tropanes,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C,1201549
235,DB00246,Ziprasidone,small molecule,approved,Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Anticholinergic Agents|Antidepressive Agents|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Highest Risk QTc-Prolonging Agents|Histamine Antagonists|Histamine H1 Antagonists|Hyperglycemia-Associated Agents|Indole Derivatives|Muscarinic Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Agonists|Serotonin Receptor Antagonists|Sulfur Compounds|Tranquilizing Agents,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,60854
236,DB00247,Methysergide,small molecule,approved,"Agents that produce hypertension|Alkaloids|Analgesics|Antidepressive Agents|Antimigraine Preparations|Cardiovascular Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Ergolines|Ergot Alkaloids and Derivatives|Heterocyclic Compounds, Fused-Ring|Lysergic Acid|Nervous System|Neurotransmitter Agents|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Vasoconstrictor Agents",[H][C@@]12CC3=CN(C)C4=C3C(=CC=C4)C1=C[C@H](CN2C)C(=O)NC(CC)CO,6540428
237,DB00248,Cabergoline,small molecule,approved,"Agents that produce hypertension|Alkaloids|Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Antidepressive Agents|Antineoplastic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Agonists|Ergolines|Ergot Alkaloids and Derivatives|Ergot-derivative Dopamine Receptor Agonists|Genito Urinary System and Sex Hormones|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotransmitter Agents|P-glycoprotein substrates|Prolactine Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists",[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,54746
238,DB00249,Idoxuridine,small molecule,approved|investigational,"Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Carbohydrates|Deoxyribonucleosides|Deoxyuridine|Dermatologicals|Direct Acting Antivirals|Enzyme Inhibitors|Glycosides|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Analog Antiviral|Nucleosides|Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors|Ophthalmologicals|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides|Sensory Organs",OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(I)C(=O)NC1=O,5905
239,DB00250,Dapsone,small molecule,approved|investigational,Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics for Pneumocystis Pneumonia|Antiinfectives for Systemic Use|Antimalarials|Antimycobacterials|Antiparasitic Agents|Antiprotozoals|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Dermatologicals|Drugs causing inadvertant photosensitivity|Drugs for Treatment of Lepra|Enzyme Inhibitors|Folic Acid Antagonists|Leprostatic Agents|Methemoglobinemia Associated Agents|Miscellaneous Antimycobacterials|Miscellaneous Local Anti-infectives|Photosensitizing Agents|Sulfones|Sulfur Compounds,NC1=CC=C(C=C1)S(=O)(=O)C1=CC=C(N)C=C1,2955
240,DB00251,Terconazole,small molecule,approved,Anti-Infective Agents|Antifungal Agents|Antifungal Agents (Vaginal)|Azole Antifungals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Triazole Derivatives,CC(C)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,441383
241,DB00252,Phenytoin,small molecule,approved|vet_approved,Agents Causing Muscle Toxicity|Anti-epileptic Agent|Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|COMT Substrates|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2B6 Inducers (strong)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C18 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (moderate)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strong)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inducers|Cytochrome P-450 CYP3A7 Inducers (weak)|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Decreased Central Nervous System Disorganized Electrical Activity|Enzyme Inducing Antiepileptic Drugs|Hydantoins|Imidazoles|Imidazolidines|Inducers of Drug Clearance|Membrane Transport Modulators|Methemoglobinemia Associated Agents|Narrow Therapeutic Index Drugs|Nervous System|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Phenytoin and Prodrugs|Sodium Channel Blockers|Thyroxine-binding globulin substrates|UGT1A1 Inducers|UGT1A1 Substrates|UGT1A4 substrates|UGT1A6 Inhibitors|UGT1A6 substrate|UGT1A9 Inhibitors|UGT1A9 Substrates|Voltage-Gated Sodium Channel Blockers,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1,1775
242,DB00253,Medrysone,small molecule,approved,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|OAT3/SLC22A8 Substrates|Ophthalmologicals|P-glycoprotein substrates|Pregnanes|Pregnenes|Sensory Organs|Steroids|Thyroxine-binding globulin inhibitors",[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C,247839
243,DB00254,Doxycycline,small molecule,approved|investigational|vet_approved,Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives and Antiseptics for Local Oral Treatment|Antiinfectives for Systemic Use|Antiparasitic Agents|Antiprotozoals|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Naphthacenes|OAT1/SLC22A6 inhibitors|Photosensitizing Agents|Stomatological Preparations|Tetracyclines,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,54671203
244,DB00255,Diethylstilbestrol,small molecule,approved|investigational,"Adrenal Cortex Hormones|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|Benzene Derivatives|Benzylidene Compounds|BSEP/ABCB11 Substrates|Carcinogens|COMT Substrates|Contraceptive Agents, Female|Contraceptive Agents, Male|Contraceptives, Postcoital|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strong)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Endocrine Therapy|Estrogen Contraceptives|Estrogens|Estrogens, Non-Steroidal|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Noxae|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein substrates|Sex Hormones and Modulators of the Genital System|Stilbenes|Synthetic Estrogens, Plain|Thyroxine-binding globulin inducers|Toxic Actions",CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1,3054
245,DB00256,Lymecycline,small molecule,approved|investigational,Agents that produce neuromuscular block (indirect)|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Naphthacenes|Tetracyclines,[H][C@@]12C[C@@]3([H])C(C(=O)C4=C(O)C=CC=C4[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(=O)NCNCCCC[C@H](N)C(O)=O)=C(O)[C@H]2N(C)C,54707177
246,DB00257,Clotrimazole,small molecule,approved|vet_approved,"Anti-Infective Agents|Anti-Infective Agents, Local|Antifungal Agents|Antifungal Agents (Vaginal)|Antifungals for Dermatological Use|Antifungals for Topical Use|Antiinfectives and Antiseptics for Local Oral Treatment|Azole Antifungals|BSEP/ABCB11 Inhibitors|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (strong)|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strong)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A7 Inducers|Cytochrome P-450 CYP3A7 Inducers (strong)|Cytochrome P-450 CYP3A7 Inducers (weak)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Enzyme Inhibitors|Gynecological Antiinfectives and Antiseptics|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Imidazole and Triazole Derivatives|Imidazole Derivatives|Imidazoles|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 inducers|P-glycoprotein inducers|P-glycoprotein inhibitors|P-glycoprotein substrates|Steroid Synthesis Inhibitors|Stomatological Preparations",ClC1=CC=CC=C1C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1,2812
247,DB00258,Calcium acetate,small molecule,approved|investigational,"Acids|Acids, Acyclic|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Arylsulfonates|Arylsulfonic Acids|Benzene Derivatives|Blood Coagulation Factors|Calcium Salts|Chelating Agents|Compounds used in a research, industrial, or household setting|Drugs for Treatment of Hyperkalemia and Hyperphosphatemia|Fatty Acids|Fatty Acids, Volatile|Lipids|Minerals|Phosphate Binder|Phosphate-removing Agents|Sequestering Agents|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",[Ca++].CC([O-])=O.CC([O-])=O,6116
248,DB00259,Sulfanilamide,small molecule,approved,Amides|Amines|Aniline Compounds|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Methemoglobinemia Associated Agents|Short-Acting Sulfonamides|Sulfanilamides|Sulfonamide Antibacterial|Sulfonamides|SULFONAMIDES AND TRIMETHOPRIM|Sulfones|Sulfur Compounds,NC1=CC=C(C=C1)S(N)(=O)=O,5333
249,DB00260,Cycloserine,small molecule,approved,"Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibiotics, Antitubercular|Antiinfectives for Systemic Use|Antimetabolites|Antimycobacterials|Antituberculosis Agents|Drugs for Treatment of Tuberculosis|Isoxazoles|Neurotoxic agents|Noxae|Oxazoles|Oxazolidinones|Renal Agents|Toxic Actions",N[C@@H]1CONC1=O,6234
250,DB00261,Anagrelide,small molecule,approved,"Agents producing tachycardia|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Antiplatelet agents|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (weak)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Decreased Platelet Production|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|Phosphodiesterase 3 Inhibitors|Phosphodiesterase Inhibitors|Platelet-reducing Agents|QTc Prolonging Agents|Thrombocytosis|Vasodilating Agents",ClC1=CC=C2N=C3NC(=O)CN3CC2=C1Cl,2182
251,DB00262,Carmustine,small molecule,approved|investigational,"Alkylating Activity|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Immunosuppressive Agents|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Nitroso Compounds|Nitrosourea Compounds|Nitrosoureas|Noxae|Toxic Actions",ClCCNC(=O)N(CCCl)N=O,2578
252,DB00263,Sulfisoxazole,small molecule,approved|vet_approved,Amides|Amines|Aniline Compounds|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Drugs causing inadvertant photosensitivity|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hypoglycemia-Associated Agents|Moderate Risk QTc-Prolonging Agents|Ophthalmologicals|Photosensitizing Agents|QTc Prolonging Agents|Sensory Organs|Short-Acting Sulfonamides|Sulfanilamides|Sulfonamide Antibacterial|Sulfonamides|SULFONAMIDES AND TRIMETHOPRIM|Sulfones|Sulfur Compounds,CC1=NOC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1C,5344
253,DB00264,Metoprolol,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-1 Receptor Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Beta blocking agents and calcium channel blockers|Beta Blocking Agents and Thiazides|Beta Blocking Agents, Selective|Beta Blocking Agents, Selective, and Thiazides|Beta-Blockers (Beta1 Selective)|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Hypotensive Agents|OCT2 Inhibitors|Photosensitizing Agents|Propanolamines",COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,4171
254,DB00265,Crotamiton,small molecule,approved,"Agrochemicals|Amines|Aniline Compounds|Benzene Derivatives|Compounds used in a research, industrial, or household setting|Pesticides|Scabicides and Pediculicides|Toxic Actions",CCN(C(=O)C=CC)C1=CC=CC=C1C,2883
255,DB00266,Dicoumarol,small molecule,approved,"4-Hydroxycoumarins|Anticoagulants|Benzopyrans|Blood and Blood Forming Organs|Coumarins|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Enzyme Inhibitors|Fibrinolytic Agents|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|Narrow Therapeutic Index Drugs|Pyrans|Uncoupling Agents|Vitamin K Antagonists",OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC2=C1C=CC=C2,54676038
256,DB00267,Cefmenoxime,small molecule,approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephacetrile|Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins",[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,9570757
257,DB00268,Ropinirole,small molecule,approved|investigational,"Anti-Dyskinesia Agents|Anti-Parkinson Agents (Dopamine Agonist)|Anti-Parkinson Drugs|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Agonists|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Nervous System|Neurotransmitter Agents|Nonergot-derivative Dopamine Receptor Agonists",CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,5095
258,DB00269,Chlorotrianisene,small molecule,investigational|withdrawn,"Antineoplastic Agents|Antineoplastic Agents, Hormonal|Benzene Derivatives|Benzylidene Compounds|Estrogens|Estrogens, Non-Steroidal|Genito Urinary System and Sex Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Natural and Semisynthetic Estrogens, Plain|Sex Hormones and Modulators of the Genital System|Stilbenes",COC1=CC=C(C=C1)C(Cl)=C(C1=CC=C(OC)C=C1)C1=CC=C(OC)C=C1,11289
259,DB00270,Isradipine,small molecule,approved|investigational,Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Bradycardia-Causing Agents|BSEP/ABCB11 Substrates|Calcium Channel Blockers|Calcium Channel Blockers (Dihydropyridine)|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dihydropyridine Derivatives|Dihydropyridines|Drugs that are Mainly Renally Excreted|Hypotensive Agents|Membrane Transport Modulators|P-glycoprotein inhibitors|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OC(C)C,3784
260,DB00271,Diatrizoate,small molecule,approved|vet_approved,"Acids, Carbocyclic|Alcohols|Amino Sugars|Benzene Derivatives|Benzoates|Carbohydrates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Drugs that are Mainly Renally Excreted|Hexosamines|Iodinated Contrast Agents|Iodobenzoates|Radiographic Contrast Agent|Roentgenography|Sugar Alcohols|Triiodobenzoic Acids|Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media|X-Ray Contrast Activity|X-Ray Contrast Media, Iodinated",CC(=O)NC1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I,2140
261,DB00272,Betazole,small molecule,approved,Diagnostic Agents|Gastrointestinal Agents|Histamine Agents|Histamine Agonists|Neurotransmitter Agents|Pyrazoles|Tests for Gastric Secretion,NCCC1=CC=NN1,7741
262,DB00273,Topiramate,small molecule,approved,Anti-Obesity Agents|Anticonvulsants|Carbohydrates|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Decreased Central Nervous System Disorganized Electrical Activity|Drugs that are Mainly Renally Excreted|Enzyme Inducing Antiepileptic Drugs|Fructose|Hexoses|Ketoses|Miscellaneous Anticonvulsants|Monosaccharides|Nervous System|Neuroprotective Agents|P-glycoprotein substrates,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,5284627
263,DB00274,Cefmetazole,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|Cephamycins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Second-Generation Cephalosporins|Sulfur Compounds|Thiazines",[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)CSCC#N)OC)C(O)=O,42008
264,DB00275,Olmesartan,small molecule,approved|investigational,"Agents Acting on the Renin-Angiotensin System|Agents causing hyperkalemia|Angiotensin 2 Receptor Blocker|Angiotensin II Antagonists and Calcium Channel Blockers|Angiotensin II receptor blockers (ARBs) and calcium channel blockers|Angiotensin II receptor blockers (ARBs) and diuretics|Angiotensin II receptor blockers (ARBs), plain|Angiotensin Receptor Antagonists|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|BSEP/ABCB11 Inhibitors|Cardiovascular Agents|Hypotensive Agents|Imidazoles|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|Tetrazoles",CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,158781
265,DB00276,Amsacrine,small molecule,approved|investigational,"Acridines|Aminoacridines|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cardiotoxic antineoplastic agents|Compounds used in a research, industrial, or household setting|Heterocyclic Compounds, Fused-Ring|Immunosuppressive Agents|Indicators and Reagents|Intercalating Agents|Laboratory Chemicals|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|P-glycoprotein inhibitors",COC1=C(NC2=C3C=CC=CC3=NC3=CC=CC=C23)C=CC(NS(C)(=O)=O)=C1,2179
266,DB00277,Theophylline,small molecule,approved,"Agents that reduce seizure threshold|Alkaloids|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Drugs for Obstructive Airway Diseases|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Narrow Therapeutic Index Drugs|Neurotransmitter Agents|Peripheral Nervous System Agents|Phosphodiesterase 5 Inhibitors|Phosphodiesterase Inhibitors|Purinergic Agents|Purinergic Antagonists|Purinergic P1 Receptor Antagonists|Purines|Purinones|Respiratory Smooth Muscle Relaxants|Respiratory System Agents|Vasodilating Agents|Xanthine derivatives|Xanthines and Adrenergics",CN1C2=C(NC=N2)C(=O)N(C)C1=O,2153
267,DB00278,Argatroban,small molecule,approved|investigational,Anticoagulants|Antithrombins|Blood and Blood Forming Organs|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Enzyme Inhibitors|Fibrinolytic Agents|Hematologic Agents|Narrow Therapeutic Index Drugs|Piperidines|Protease Inhibitors|Serine Protease Inhibitors|Thrombin Inhibitors,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C1=CC=CC2=C1NCC(C)C2,152951
268,DB00279,Liothyronine,small molecule,approved|vet_approved,"Agents used to treat hypothyroidism|Drugs that are Mainly Renally Excreted|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|l-Triiodothyronine|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein inducers|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thyroid Products|Thyronines|Thyroxine-binding globulin substrates|Triiodothyronine|UGT1A1 Substrates",N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O,5920
269,DB00280,Disopyramide,small molecule,approved,"Agents producing tachycardia|Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ia|Anticholinergic Agents|Blood Glucose Lowering Agents|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Highest Risk QTc-Prolonging Agents|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Muscarinic Antagonists|OCT1 inhibitors|OCT2 Inhibitors|Pyridines|QTc Prolonging Agents|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers",CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,3114
270,DB00281,Lidocaine,small molecule,approved|vet_approved,"Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Agents that reduce seizure threshold|Amide Local Anesthetic|Amides|Amines|Analgesics and Anesthetics|Anesthetics|Anesthetics for Topical Use|Anesthetics, Local|Anilides|Aniline Compounds|Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ib|Antipruritics and Local Anesthetics|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Cardiac Therapy|Cardiovascular Agents|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Local Anesthesia|Membrane Transport Modulators|Methemoglobinemia Associated Agents|Nervous System|Neuraxial Anesthetics|Ophthalmologicals|Otologicals|P-glycoprotein inhibitors|Peripheral Nervous System Agents|Sensory System Agents|Sodium Channel Blockers|Throat Preparations|Vasoprotectives|Voltage-Gated Sodium Channel Blockers",CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,3676
271,DB00282,Pamidronic acid,small molecule,approved,Agents Causing Muscle Toxicity|Antineoplastic Agents|Bisphosphonates|Bone Density Conservation Agents|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Musculo-Skeletal System|Nephrotoxic agents|Organophosphonates|Organophosphorus Compounds,NCCC(O)(P(O)(O)=O)P(O)(O)=O,4674
272,DB00283,Clemastine,small molecule,approved|investigational,"Aminoalkyl Ethers|Anti-Allergic Agents|Antihistamines for Systemic Use|Antihistamines for Topical Use|Antipruritics|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Highest Risk QTc-Prolonging Agents|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Photosensitizing Agents|Pyrrolidines|QTc Prolonging Agents",CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,26987
273,DB00284,Acarbose,small molecule,approved|investigational,Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Carbohydrates|Drugs that are Mainly Renally Excreted|Drugs Used in Diabetes|Enzyme Inhibitors|Glycoside Hydrolase Inhibitors|Hypoglycemia-Associated Agents|Oligosaccharides|Polysaccharides|Trisaccharides,[H]C(=O)[C@H](O)[C@@H](O)[C@]([H])(O[C@@]1([H])O[C@H](CO)[C@@]([H])(O[C@H]2O[C@H](C)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,9811704
274,DB00285,Venlafaxine,small molecule,approved,"Agents producing tachycardia|Agents that reduce seizure threshold|Alcohols|Amines|Antidepressive Agents|Antidepressive Agents, Second-Generation|BCRP/ABCG2 Inducers|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cyclohexanes|Cyclohexanols|Cycloparaffins|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Ethylamines|Fatty Alcohols|Hexanols|Hypoglycemia-Associated Agents|Lipids|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Norepinephrine Uptake Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Phenethylamines|Potential QTc-Prolonging Agents|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin and Noradrenaline Reuptake Inhibitors|Serotonin Modulators",COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,5656
275,DB00286,Conjugated estrogens,small molecule,approved,"Agents causing angioedema|BCRP/ABCG2 Substrates|COMT Substrates|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (weak)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Estradiol Congeners|Estrogens|Estrogens, Conjugated (USP)|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Natural and Semisynthetic Estrogens, Plain|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein substrates|Sex Hormones and Modulators of the Genital System|Thyroxine-binding globulin inducers",,
276,DB00287,Travoprost,small molecule,approved,"Antiglaucoma Preparations and Miotics|Antihypertensive Agents|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Ophthalmics|Ophthalmologicals|Prostaglandin analogs reducing intraocular pressure (IOP)|Prostaglandins|Prostaglandins F, Synthetic|Prostaglandins, Synthetic",CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,5282226
277,DB00288,Amcinonide,small molecule,approved,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Dermatologicals|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Pregnadienes|Pregnanes|Steroids|Steroids, Fluorinated|Thyroxine-binding globulin inhibitors",[H][C@@]12C[C@H]3OC4(CCCC4)O[C@@]3(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,443958
278,DB00289,Atomoxetine,small molecule,approved,"Adrenergic Agents|Agents producing tachycardia|Agents that produce hypertension|Amines|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Membrane Transport Modulators|Miscellaneous Central Nervous System Agents|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Norepinephrine Reuptake Inhibitor|Norepinephrine Uptake Inhibitors|Potential QTc-Prolonging Agents|Propylamines|Psychostimulants, Agents Used for Adhd and Nootropics|QTc Prolonging Agents",CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,54841
279,DB00290,Bleomycin,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Cardiotoxic antineoplastic agents|Cytoprotective Agent|Cytotoxic Antibiotics and Related Substances|Drugs that are Mainly Renally Excreted|Glycoconjugates|Glycopeptides|Immunosuppressive Agents|Narrow Therapeutic Index Drugs|Peptides",[H][C@](C)(NC(=O)[C@@]([H])(NC(=O)C1=NC(=NC(N)=C1C)[C@H](CC(N)=O)NC[C@H](N)C(N)=O)[C@@]([H])(OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(OC(N)=O)C1O)C1=CNC=N1)[C@@H](O)[C@H](C)C(=O)N[C@]([H])(C(=O)NCCC1=NC(=CS1)C1=NC(=CS1)C(=O)NCCC[S+](C)C)[C@@]([H])(C)O,5360373
280,DB00291,Chlorambucil,small molecule,approved,"Agents that reduce seizure threshold|Alkylating Activity|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Hydrocarbons, Halogenated|Immunosuppressive Agents|Mustard Compounds|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Nitrogen Mustard Analogues|Nitrogen Mustard Compounds|Noxae|Toxic Actions",OC(=O)CCCC1=CC=C(C=C1)N(CCCl)CCCl,2708
281,DB00292,Etomidate,small molecule,approved,"Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Central Nervous System Agents|Central Nervous System Depressants|Drugs that are Mainly Renally Excreted|Hypnotics and Sedatives|Imidazoles|Nervous System",CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1,667484
282,DB00293,Raltitrexed,small molecule,approved|investigational,"Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Enzyme Inhibitors|Folic Acid Analogues|Folic Acid Antagonists|Heterocyclic Compounds, Fused-Ring|Immunosuppressive Agents|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Noxae|Sulfur Compounds|Thymidylate Synthase, antagonists & inhibitors|Toxic Actions",CN(CC1=CC2=C(NC(C)=NC2=O)C=C1)C1=CC=C(S1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,104758
283,DB00294,Etonogestrel,small molecule,approved|investigational,"Adrenal Cortex Hormones|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hyperglycemia-Associated Agents|Intravaginal Contraceptives|Norpregnanes|Norpregnenes|Norsteroids|Progesterone Congeners|Progestins|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids",[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC(=C)[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],6917715
284,DB00295,Morphine,small molecule,approved|investigational,"Alkaloids|Analgesics|Anesthetics|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|High-risk opioids|Hypotensive Agents|Narcotics|Natural Opium Alkaloids|Nervous System|Neuraxial Anesthetics|Opiate Agonists|Opiate Alkaloids|Opioid Agonist|Opioids|P-glycoprotein substrates|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|UGT1A1 Substrates|UGT1A3 substrates|UGT2B7 substrates",[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,5288826
285,DB00296,Ropivacaine,small molecule,approved,"Amide Local Anesthetic|Amides|Amines|Anesthetics|Anesthetics, Local|Anilides|Aniline Compounds|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Hypotensive Agents|Local Anesthesia|Nervous System|Neuraxial Anesthetics|Peripheral Nervous System Agents|Sensory System Agents",CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,175805
286,DB00297,Bupivacaine,small molecule,approved|investigational,"Agents that reduce seizure threshold|Amide Local Anesthetic|Amides|Amines|Anesthetics|Anesthetics, Local|Anilides|Aniline Compounds|Central Nervous System Agents|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Hypotensive Agents|Local Anesthesia|Nervous System|Neuraxial Anesthetics|Peripheral Nervous System Agents|Sensory System Agents",CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,2474
287,DB00298,Dapiprazole,small molecule,approved,Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antiglaucoma Preparations and Miotics|Antipsychotic Agents|Central Nervous System Agents|Central Nervous System Depressants|Neurotoxic agents|Neurotransmitter Agents|Ophthalmics|Ophthalmologicals|Sensory Organs|Tranquilizing Agents,CC1=CC=CC=C1N1CCN(CCC2=NN=C3CCCCN23)CC1,3033538
288,DB00299,Penciclovir,small molecule,approved,"Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Dermatologicals|Direct Acting Antivirals|Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor|Heterocyclic Compounds, Fused-Ring|Nucleic Acid Synthesis Inhibitors|Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors|Purines|Purinones|Reverse Transcriptase Inhibitors",NC1=NC(=O)C2=C(N1)N(CCC(CO)CO)C=N2,4725
289,DB00300,Tenofovir disoproxil,small molecule,approved|investigational,"Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Direct Acting Antivirals|Drugs that are Mainly Renally Excreted|Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Heterocyclic Compounds, Fused-Ring|Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Nephrotoxic agents|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Substrates|Organophosphorus Compounds|P-glycoprotein inhibitors|P-glycoprotein substrates|Purines|Reverse Transcriptase Inhibitors|Tenofovir and prodrugs",[H][C@@](C)(CN1C=NC2=C(N)N=CN=C12)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C,5481350
290,DB00301,Flucloxacillin,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|Beta-Lactamase Resistant Penicillins|beta-Lactams|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Lactams|Penicillins|Sulfur Compounds",[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=C(Cl)C=CC=C1F)C(O)=O,21319
291,DB00302,Tranexamic acid,small molecule,approved,"Acids, Carbocyclic|Amino Acids|Antifibrinolytic Agents|Blood and Blood Forming Organs|Coagulants|Cyclohexanecarboxylic Acids|Cyclohexanes|Cycloparaffins|Decreased Fibrinolysis|Fibrin Modulating Agents|Hematologic Agents|Hemostatics",NC[C@H]1CC[C@@H](CC1)C(O)=O,5526
292,DB00303,Ertapenem,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Carbapenems|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Lactams|Penem Antibacterial|Sulfur Compounds",[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,150610
293,DB00304,Desogestrel,small molecule,approved,"Adrenal Cortex Hormones|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Norpregnanes|Norpregnenes|Norsteroids|Progestin Contraceptives|Progestins|Progestogens and Estrogens, Sequential Preparations|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids|UGT1A1 Inducers",[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC(=C)[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H],40973
294,DB00305,Mitomycin,small molecule,approved,"Alkylating Activity|Alkylating Drugs|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Azirines|Cardiotoxic antineoplastic agents|Compounds used in a research, industrial, or household setting|Cross-Linking Reagents|Cytotoxic Antibiotics and Related Substances|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Immunosuppressive Agents|Indicators and Reagents|Indolequinones|Indoles|Mitomycins|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Noxae|Nucleic Acid Synthesis Inhibitors|Toxic Actions",[H][C@]12CN3C4=C([C@@H](COC(N)=O)[C@@]3(OC)[C@@]1([H])N2)C(=O)C(N)=C(C)C4=O,5746
295,DB00306,Talbutal,small molecule,approved|illicit,"Anticholinergic Agents|Barbiturates, Plain|Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Nicotinic Antagonists|Psycholeptics|Pyrimidines|Pyrimidinones",CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,8275
296,DB00307,Bexarotene,small molecule,approved|investigational,"Alkenes|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Biological Factors|Carotenoids|Compounds used in a research, industrial, or household setting|Cyclohexanes|Cyclohexenes|Cycloparaffins|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Hydrocarbons, Acyclic|Immunosuppressive Agents|Myelosuppressive Agents|Naphthalenes|Pigments, Biological|Polyenes|Retinoids|Terpenes|Tetrahydronaphthalenes",CC1=CC2=C(C=C1C(=C)C1=CC=C(C=C1)C(O)=O)C(C)(C)CCC2(C)C,82146
297,DB00308,Ibutilide,small molecule,approved,"Amides|Antiarrhythmic agents|Antiarrhythmics, Class III|Cardiac Therapy|Cardiovascular Agents|Drugs that are Mainly Renally Excreted|Highest Risk QTc-Prolonging Agents|QTc Prolonging Agents|Sulfones|Sulfur Compounds",CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,60753
298,DB00309,Vindesine,small molecule,approved|investigational,"Alkaloids|Antimitotic Agents|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Antineoplastic and Immunomodulating Agents|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Immunosuppressive Agents|Indole Alkaloids|Indoles|Mitosis Modulators|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Secologanin Tryptamine Alkaloids|Tubulin Modulators|Vinca Alkaloids",[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C)[C@@]1([H])[C@](O)([C@H](O)[C@]2(CC)C=CC3)C(N)=O)[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=C2C=CC=C1)C(=O)OC,40839
299,DB00310,Chlorthalidone,small molecule,approved,"Acids, Carbocyclic|Amides|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Benzene Derivatives|Benzophenones|Cardiovascular Agents|Diuretics|Drugs causing inadvertant photosensitivity|Heterocyclic Compounds, Fused-Ring|Hyperglycemia-Associated Agents|Hypotensive Agents|Imides|Increased Diuresis|Isoindoles|Ketones|Low-Ceiling Diuretics and Potassium-Sparing Agents|Low-Ceiling Diuretics, Excl. Thiazides|Membrane Transport Modulators|Natriuretic Agents|Non Potassium Sparing Diuretics|Photosensitizing Agents|Phthalic Acids|Phthalimides|Sodium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds|Thiazide-like Diuretic",NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,2732
300,DB00311,Ethoxzolamide,small molecule,withdrawn,"Amides|Benzothiazoles|Carbonic Anhydrase Inhibitors|Cardiovascular Agents|Diuretics|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Natriuretic Agents|OAT1/SLC22A6 inhibitors|Sulfonamides|Sulfones|Sulfur Compounds|Thiazoles",CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O,3295
301,DB00312,Pentobarbital,small molecule,approved|investigational|vet_approved,"Adjuvants, Anesthesia|Anticholinergic Agents|Anticonvulsants|Barbiturates|Barbiturates, Plain|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2A6 Inducers|Cytochrome P-450 CYP2A6 Inducers (strong)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Nicotinic Antagonists|Psycholeptics|Pyrimidines|Pyrimidinones",CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,4737
302,DB00313,Valproic acid,small molecule,approved|investigational,"Acids, Acyclic|Anti-epileptic Agent|Anticonvulsants|Antimanic Agents|Antineoplastic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2A6 Inducers|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Decreased Central Nervous System Disorganized Electrical Activity|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Fatty Acid Derivatives|Fatty Acids|Fatty Acids, Volatile|GABA Agents|Hepatotoxic Agents|Highest Risk QTc-Prolonging Agents|Histone Deacetylase Inhibitors|Lipids|Methemoglobinemia Associated Agents|Miscellaneous Anticonvulsants|Mood Stabilizer|Narrow Therapeutic Index Drugs|Nervous System|Neurotransmitter Agents|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OAT3/SLC22A8 Substrates with Narrow Therapeutic Index|Pentanoic Acids|Photosensitizing Agents|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Tranquilizing Agents|UGT1A1 Inhibitors|UGT1A1 Substrates|UGT1A1 substrates with narrow therapeutic index|UGT1A3 substrates|UGT1A3 substrates with narrow therapeutic index|UGT1A4 substrates|UGT1A6 substrate|UGT1A6 substrate with narrow therapeutic index|UGT1A9 Substrates|UGT1A9 substrates with narrow therapeutic index|UGT2B7 substrates|UGT2B7 substrates with narrow therapeutic index|Valerates",CCCC(CCC)C(O)=O,3121
303,DB00314,Capreomycin,small molecule,approved,"Agents that produce neuromuscular block (indirect)|Amino Acids, Peptides, and Proteins|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics, Antitubercular|Antiinfectives for Systemic Use|Antimycobacterials|Antituberculosis Agents|Drugs for Treatment of Tuberculosis|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Enzyme Inhibitors|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Peptides|Peptides, Cyclic|Protein Synthesis Inhibitors",[H][C@@]1(CCN=C(N)N1)[C@]1([H])NC(=O)\C(NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CNC1=O)=C/NC(N)=O.[H][C@@]1(CCN=C(N)N1)[C@]1([H])NC(=O)\C(NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC1=O)=C/NC(N)=O,3000502
304,DB00315,Zolmitriptan,small molecule,approved|investigational,"Agents that produce hypertension|Amines|Analgesics|Antidepressive Agents|Antimigraine Preparations|Biogenic Amines|Biogenic Monoamines|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Indoles|Monoamine Oxidase A Substrates|Nervous System|Neurotransmitter Agents|Oxazoles|Selective Serotonin 5-HT1 Receptor Agonists|Selective Serotonin Agonists|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 1b Receptor Agonists|Serotonin 1d Receptor Agonists|Serotonin 5-HT1 Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists|Serotonin-1b and Serotonin-1d Receptor Agonist|Triptans",CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12,60857
305,DB00316,Acetaminophen,small molecule,approved,"Acetaminophen and Prodrugs|Amides|Amines|Analgesics|Analgesics, Non-Narcotic|Anilides|Aniline Compounds|Antipyretics|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Methemoglobinemia Associated Agents|Miscellaneous Analgesics and Antipyretics|Nervous System|P-glycoprotein inhibitors|P-glycoprotein substrates|Sensory System Agents|UGT1A1 Substrates|UGT1A6 substrate|UGT1A9 Substrates",CC(=O)NC1=CC=C(O)C=C1,1983
306,DB00317,Gefitinib,small molecule,approved|investigational,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Kinase Inhibitor|P-glycoprotein inhibitors|P-glycoprotein substrates|Protein Kinase Inhibitors|Quinazolines|Tyrosine Kinase Inhibitors",COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1,123631
307,DB00318,Codeine,small molecule,approved|illicit,"Alkaloids|Analgesics|Antitussive Agents|Central Nervous System Agents|Central Nervous System Depressants|Cough and Cold Preparations|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Morphinans|Morphine Derivatives|Narcotics|Natural Opium Alkaloids|Nervous System|OAT1/SLC22A6 inhibitors|OCT1 inhibitors|OCT1 substrates|Opiate Agonists|Opiate Alkaloids|Opioid Agonist|Opioids|Opium Alkaloids and Derivatives|Phenanthrenes|Respiratory System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|UGT2B7 substrates",[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,5284371
308,DB00319,Piperacillin,small molecule,approved,"Agents that produce neuromuscular block (indirect)|Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|beta-Lactams|Drugs that are Mainly Renally Excreted|Extended-spectrum Penicillins|Heterocyclic Compounds, Fused-Ring|Lactams|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Substrates|Penicillin G|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds",[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=CC=C1)C(O)=O,43672
309,DB00320,Dihydroergotamine,small molecule,approved|investigational,"Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Alkaloids|Analgesics|Analgesics, Non-Narcotic|Antidepressive Agents|Antimigraine Preparations|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Agonists|Ergot Alkaloids and Derivatives|Ergot-derivative Dopamine Receptor Agonists|Ergotamine Derivative|Ergotamines|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotransmitter Agents|P-glycoprotein inhibitors|Peripheral Nervous System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists|Sympatholytic (Adrenergic Blocking) Agents|Vasoconstrictor Agents",[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,10531
310,DB00321,Amitriptyline,small molecule,approved,"Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that produce hypertension|Agents that reduce seizure threshold|Analgesics|Analgesics, Non-Narcotic|Anticholinergic Agents|Antidepressive Agents|Antidepressive Agents, Tricyclic|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Histamine Antagonists|Histamine H1 Antagonists|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Muscarinic Antagonists|Neurotoxic agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Non-Selective Monoamine Reuptake Inhibitors|P-glycoprotein substrates|Psychotropic Drugs|QTc Prolonging Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists|Tertiary amine tricyclic antidepressants|Tricyclics and Other Norepinephrine-reuptake Inhibitors|UGT1A1 Inhibitors|UGT1A1 Substrates|UGT1A4 substrates",CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,2160
311,DB00322,Floxuridine,small molecule,approved,"Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Deoxyribonucleosides|Deoxyuridine|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Glycosides|Immunosuppressive Agents|Myelosuppressive Agents|Noxae|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Analogues|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides|Thyroxine-binding globulin inducers|Toxic Actions",OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(F)C(=O)NC1=O,5790
312,DB00323,Tolcapone,small molecule,approved|withdrawn,Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Benzene Derivatives|Benzophenones|Central Nervous System Agents|Central Nervous System Depressants|COMT Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Hypotensive Agents|Ketones|Nervous System|Nitro Compounds|Nitrophenols|Phenols,CC1=CC=C(C=C1)C(=O)C1=CC(=C(O)C(O)=C1)[N+]([O-])=O,4659569
313,DB00324,Fluorometholone,small molecule,approved|investigational,"Adrenal Cortex Hormones|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Allergic Agents|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Moderately Potent (Group II)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Dermatologicals|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Ophthalmologicals|Pregnadienediols|Pregnadienes|Pregnanes|Sensory Organs|Steroids|Steroids, Fluorinated|Thyroxine-binding globulin inhibitors|Vasoprotectives",[H][C@@]12CC[C@](O)(C(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,9878
314,DB00325,Nitroprusside,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Anions|Antihypertensive Agents|Arteriolar Smooth Muscle, Agents Acting On|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Cyanides|Direct Vasodilators|Drugs that are Mainly Renally Excreted|Electrolytes|Ferric Compounds|Ferricyanides|Hydrogen Cyanide|Hypotensive Agents|Indicators and Reagents|Ions|Iron Compounds|Laboratory Chemicals|Methemoglobinemia Associated Agents|Nitric Oxide Donors|Nitroferricyanide Derivatives|Nitrogen Compounds|Organometallic Compounds|Vasodilating Agents|Vasodilation",O=N[Fe--](C#N)(C#N)(C#N)(C#N)C#N,11963622
315,DB00326,Calcium glucoheptonate,small molecule,approved,"Acids, Acyclic|Alimentary Tract and Metabolism|Calcium Salts|Carbohydrates|Hydroxy Acids|Mineral Supplements|Supplements",[Ca++].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)C([O-])=O,62859
316,DB00327,Hydromorphone,small molecule,approved|illicit,"Alkaloids|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|High-risk opioids|Morphinans|Morphine Derivatives|Narcotics|Natural Opium Alkaloids|Nervous System|Opiate Agonists|Opiate Alkaloids|Opioid Agonist|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Semi-synthetic Opioids|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|UGT1A3 substrates|UGT2B7 substrates",[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CCC2=O,5284570
317,DB00328,Indomethacin,small molecule,approved|investigational,"Acetic Acid Derivatives and Related Substances|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antigout Preparations|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antirheumatic Agents|BSEP/ABCB11 Substrates|Cardiac Therapy|Cardiovascular Agents|Central Nervous System Agents|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Hypoglycemia-Associated Agents|Immunosuppressive Agents|Indoles|Musculo-Skeletal System|Myelosuppressive Agents|Nephrotoxic agents|Non COX-2 selective NSAIDS|OAT1/SLC22A6 inhibitors|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Inhibitors|Ophthalmologicals|Other Nonsteroidal Anti-inflammatory Agents|P-glycoprotein inhibitors|P-glycoprotein substrates|Peripheral Nervous System Agents|Sensory Organs|Sensory System Agents|Tocolytic Agents|Topical Products for Joint and Muscular Pain|UGT1A1 Inhibitors|UGT1A1 Substrates|UGT1A9 Substrates|UGT2B7 Inhibitors|UGT2B7 substrates",COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O,3715
318,DB00330,Ethambutol,small molecule,approved,Amines|Anti-Bacterial Agents|Anti-Infective Agents|Antiinfectives for Systemic Use|Antimycobacterials|Antituberculosis Agents|Diamines|Drugs for Treatment of Tuberculosis|Drugs that are Mainly Renally Excreted|Ethylenediamines|Polyamines,CC[C@@H](CO)NCCN[C@@H](CC)CO,14052
319,DB00331,Metformin,small molecule,approved,Alimentary Tract and Metabolism|Amidines|Biguanides|Blood Glucose Lowering Agents|Drugs that are Mainly Renally Excreted|Drugs Used in Diabetes|Guanidines|MATE 1 Substrates|MATE 2 Substrates|MATE substrates|OCT1 substrates|OCT2 Inhibitors|OCT2 Substrates,CN(C)C(=N)NC(N)=N,4091
320,DB00332,Ipratropium,small molecule,approved|experimental,"Adrenergics, Inhalants|Agents producing tachycardia|Agents to Treat Airway Disease|Alkaloids|Anti-Asthmatic Agents|Anticholinergic Agents|Antimuscarinics Antispasmodics|Atropine Derivatives|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Belladonna Alkaloids|Bronchodilator Agents|Cholinergic Agents|Drugs for Obstructive Airway Diseases|Muscarinic Antagonists|Nasal Preparations|Neurotransmitter Agents|Peripheral Nervous System Agents|Respiratory System Agents|Solanaceous Alkaloids|Tropanes",[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,657308
321,DB00333,Methadone,small molecule,approved,Analgesics|Anticholinergic Agents|Antidepressive Agents|Antitussive Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Diphenylpropylamine Derivatives|Drugs that are Mainly Renally Excreted|Drugs Used in Addictive Disorders|Drugs Used in Opioid Dependence|High-risk opioids|Ketones|Moderate Risk QTc-Prolonging Agents|Narcotics|Nervous System|Nicotinic Antagonists|NMDA Receptor Antagonists|Opiate Agonists|Opioid Agonist|Opioids|P-glycoprotein inhibitors|Peripheral Nervous System Agents|QTc Prolonging Agents|Respiratory System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Thyroxine-binding globulin inducers,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,4095
322,DB00334,Olanzapine,small molecule,approved|investigational,"Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Anticholinergic Agents|Antidepressive Agents|Antiemetics|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Autonomic Agents|Benzazepines|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Diazepines, Oxazepines, Thiazepines and Oxepines|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Histamine Antagonists|Histamine H1 Antagonists|Histamine H2 Antagonists|Hyperglycemia-Associated Agents|Hypotensive Agents|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|P-glycoprotein substrates|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Tranquilizing Agents|UGT1A4 substrates",CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,4585
323,DB00335,Atenolol,small molecule,approved,"Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-1 Receptor Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Autonomic Agents|Beta blocking agents and calcium channel blockers|Beta Blocking Agents and Thiazides|Beta Blocking Agents, Selective|Beta Blocking Agents, Selective, and Thiazides|Beta-Blockers (Beta1 Selective)|Bradycardia-Causing Agents|BSEP/ABCB11 Substrates|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Hypotensive Agents|Peripheral Nervous System Agents|QTc shortening agents|Sympatholytics",CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1,2249
324,DB00336,Nitrofural,small molecule,approved|investigational|vet_approved,"Agents Against Leishmaniasis and Trypanosomiasis|Anti-Infective Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Antiseptics and Disinfectants|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Dermatologicals|Furans|Irrigating Solutions|Medicated Dressings|Medicated Dressings With Antiinfectives|Nitro Compounds|Nitrofuran Derivatives|Nitrofurans|Ophthalmologicals|Otologicals|Sensory Organs",NC(=O)N\N=C\C1=CC=C(O1)[N+]([O-])=O,5447130
325,DB00337,Pimecrolimus,small molecule,approved|investigational,"Agents for Dermatitis, Excluding Corticosteroids|Analgesics|Analgesics, Non-Narcotic|Anti-Bacterial Agents|Anti-Inflammatory Agents|Calcineurin Inhibitor Immunosuppressant|Calcineurin Inhibitors|Central Nervous System Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Enzyme Inhibitors|Immunologic Factors|Immunosuppressive Agents|Lactones|Misc. Skin and Mucous Membrane Agents|Peptidylprolyl Isomerase, antagonists & inhibitors|Peripheral Nervous System Agents|Polyketides|Sensory System Agents",[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC,6509979
326,DB00338,Omeprazole,small molecule,approved|investigational|vet_approved,"2-Pyridinylmethylsulfinylbenzimidazoles|Acid Reducers|Alimentary Tract and Metabolism|Anti-Ulcer Agents|BCRP/ABCG2 Inhibitors|Benzimidazoles|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Enzyme Inhibitors|Gastric Acid Lowering Agents|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|P-glycoprotein inhibitors|P-glycoprotein substrates|Photosensitizing Agents|Proton Pump Inhibitors|Proton-pump Inhibitors|Pyridines|Sulfoxides|Sulfur Compounds",COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,4594
327,DB00339,Pyrazinamide,small molecule,approved|investigational,Anti-Bacterial Agents|Anti-Infective Agents|Antiinfectives for Systemic Use|Antimycobacterials|Antituberculosis Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Drugs for Treatment of Tuberculosis|Drugs that are Mainly Renally Excreted|Hepatotoxic Agents|Photosensitizing Agents|Pyrazines,NC(=O)C1=NC=CN=C1,1046
328,DB00340,Metixene,small molecule,approved,"Agents producing tachycardia|Anti-Parkinson Drugs|Anticholinergic Agents|Heterocyclic Compounds, Fused-Ring|Muscarinic Antagonists|Nervous System|Sulfur Compounds|Tertiary Amines|Xanthenes",CN1CCCC(CC2C3=CC=CC=C3SC3=CC=CC=C23)C1,4167
329,DB00341,Cetirizine,small molecule,approved,"Anti-Allergic Agents|Antihistamines for Systemic Use|Central Nervous System Depressants|Drugs that are Mainly Renally Excreted|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|P-glycoprotein inhibitors|P-glycoprotein substrates|Piperazine Derivatives|Piperazines|Potential QTc-Prolonging Agents|QTc Prolonging Agents",OC(=O)COCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,2678
330,DB00342,Terfenadine,small molecule,approved|withdrawn,"Anticholinergic Agents|Antihistamines for Systemic Use|Benzene Derivatives|Benzhydryl Compounds|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Highest Risk QTc-Prolonging Agents|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Muscarinic Antagonists|Neurotransmitter Agents|P-glycoprotein inhibitors|P-glycoprotein substrates|Piperidines|QTc Prolonging Agents",CC(C)(C)C1=CC=C(C=C1)C(O)CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,5405
331,DB00343,Diltiazem,small molecule,approved|investigational,"Agents causing hyperkalemia|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Antiarrhythmic agents|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Benzazepines|Benzothiazepine Derivatives|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium Channel Blockers (Nondihydropyridine)|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (moderate)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (moderate)|Cytochrome P-450 CYP3A7 Inhibitors (strong)|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Membrane Transport Modulators|Miscellaneous Calcium-channel Blocking Agents|Moderate Risk QTc-Prolonging Agents|P-glycoprotein inhibitors|P-glycoprotein substrates|Photosensitizing Agents|QTc Prolonging Agents|Selective Calcium Channel Blockers With Direct Cardiac Effects|Vasodilating Agents|Vasoprotectives",COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,39186
332,DB00344,Protriptyline,small molecule,approved,"Adrenergic Agents|Adrenergic Uptake Inhibitors|Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Antidepressive Agents, Tricyclic|Benzocycloheptenes|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Dibenzocycloheptenes|Membrane Transport Modulators|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Non-Selective Monoamine Reuptake Inhibitors|P-glycoprotein inhibitors|Potential QTc-Prolonging Agents|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators",CNCCCC1C2=CC=CC=C2C=CC2=CC=CC=C12,4976
333,DB00345,Aminohippuric acid,small molecule,approved|investigational,"Acids, Carbocyclic|Amides|Aminobenzoates|Aminohippuric Acids|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Diagnostic Agents|Hippurates|Indicators and Reagents|Keto Acids|Laboratory Chemicals|OAT1/SLC22A6 inhibitors|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Inhibitors|OCT2 Inhibitors|para-Aminobenzoates|Tests for Renal Function and Ureteral Injuries",NC1=CC=C(C=C1)C(=O)NCC(O)=O,2148
334,DB00346,Alfuzosin,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs Used in Benign Prostatic Hypertrophy|Genito Urinary System and Sex Hormones|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|Peripheral alpha-1 blockers|Potential QTc-Prolonging Agents|Prostatic Hyperplasia|QTc Prolonging Agents|Selective Alfa-1-adrenergic Blocking Agents|Urological Agents|Urologicals",COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N(C)CCCNC(=O)C1CCCO1,2092
335,DB00347,Trimethadione,small molecule,approved,Agents causing hyperkalemia|Anti-epileptic Agent|Antiarrhythmic agents|Anticonvulsants|Bradycardia-Causing Agents|Calcium Channel Blockers|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Decreased Central Nervous System Disorganized Electrical Activity|Nervous System|Oxazoles|Oxazolidine Derivatives|Potential QTc-Prolonging Agents|QTc Prolonging Agents,CN1C(=O)OC(C)(C)C1=O,5576
336,DB00348,Nitisinone,small molecule,approved|investigational,"4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor|4-Hydroxyphenylpyruvate Dioxygenase, antagonists & inhibitors|Acids, Carbocyclic|Alimentary Tract and Metabolism|Benzene Derivatives|Benzoates|Cyclohexanes|Cycloparaffins|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Hydroxyphenylpyruvate Dioxygenase Inhibitors|Ketones|Other Miscellaneous Therapeutic Agents|Various Alimentary Tract and Metabolism Products",[O-][N+](=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C1C(=O)CCCC1=O,115355
337,DB00349,Clobazam,small molecule,approved|illicit,"Anti-Anxiety Agents|Anticonvulsants|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|GABA Agents|GABA Agonists|GABA-A Receptor Agonists|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotransmitter Agents|P-glycoprotein substrates|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents",CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O,2789
338,DB00350,Minoxidil,small molecule,approved|investigational,"Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Arteriolar Smooth Muscle, Agents Acting On|Arteriolar Vasodilation|Arteriolar Vasodilator|Cardiovascular Agents|Dermatologicals|Direct Vasodilators|Hypotensive Agents|Misc. Skin and Mucous Membrane Agents|Piperidines|Pyrimidine Derivatives|Pyrimidines|UGT1A1 Substrates|Vasodilating Agents",NC1=CC(=NC(N)=[N+]1[O-])N1CCCCC1,4201
339,DB00351,Megestrol acetate,small molecule,approved|investigational|vet_approved,"Adrenal Cortex Hormones|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|Appetite Stimulants|Central Nervous System Agents|Central Nervous System Stimulants|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Endocrine Therapy|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hormones and Related Agents|Hyperglycemia-Associated Agents|Megestrol|P-glycoprotein inhibitors|Pregnadien Derivatives|Pregnadienes|Pregnanes|Progestin Contraceptives|Progestins|Progestogens and Estrogens, Sequential Preparations|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids",[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=C(C)C2=CC(=O)CC[C@]12C,11683
340,DB00352,Tioguanine,small molecule,approved,"Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Heterocyclic Compounds, Fused-Ring|Immunosuppressive Agents|Myelosuppressive Agents|Noxae|Purine Analogues|Purines|Thiopurine Analogs|Toxic Actions",NC1=NC(=S)C2=C(N1)N=CN2,2723601
341,DB00353,Methylergometrine,small molecule,approved,"Agents that produce hypertension|Alkaloids|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dopamine Antagonists|Ergolines|Ergonovine|Ergot Alkaloids and Derivatives|Genito Urinary System and Sex Hormones|Heterocyclic Compounds, Fused-Ring|Reproductive Control Agents|Uterotonic agents",[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO,8226
342,DB00354,Buclizine,small molecule,approved,Agents producing tachycardia|Anticholinergic Agents|Antihistamines for Systemic Use|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Muscarinic Antagonists|Neurotransmitter Agents|Piperazine Derivatives|Potential QTc-Prolonging Agents|QTc Prolonging Agents,CC(C)(C)C1=CC=C(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)C=C1,6729
343,DB00355,Aztreonam,small molecule,approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Lactams|Monobactam Antibacterial|Monobactams|Sulfur Compounds",C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(=O)O)\C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O,9568617
344,DB00356,Chlorzoxazone,small molecule,approved,"Benzoxazoles|Central Nervous System Agents|Central Nervous System Depressants|Centrally-mediated Muscle Relaxation|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System|Oxazol, Thiazine, and Triazine Derivatives|Peripheral Nervous System Agents",ClC1=CC2=C(OC(=O)N2)C=C1,2733
345,DB00357,Aminoglutethimide,small molecule,approved|investigational,"Antineoplastic Agents|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|Aromatase Inhibitors|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Endocrine Therapy|Enzyme Inhibitors|Estrogen Antagonists|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Piperidines|Piperidones|Steroid Synthesis Inhibitors",CCC1(CCC(=O)NC1=O)C1=CC=C(N)C=C1,2145
346,DB00358,Mefloquine,small molecule,approved|investigational,"Agents Causing Muscle Toxicity|Agents that reduce seizure threshold|Aminoquinolines|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Cholinesterase Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Methanolquinolines|P-glycoprotein inhibitors|P-glycoprotein substrates|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines",OC(C1CCCCN1)C1=CC(=NC2=C1C=CC=C2C(F)(F)F)C(F)(F)F,4046
347,DB00359,Sulfadiazine,small molecule,approved|investigational|vet_approved,Amides|Amines|Aniline Compounds|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antiparasitic Agents|Antiprotozoals|Blood Glucose Lowering Agents|Coccidiostats|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hypoglycemia-Associated Agents|Intermediate-Acting Sulfonamides|Methemoglobinemia Associated Agents|Sulfanilamides|Sulfonamide Antibacterial|Sulfonamides|SULFONAMIDES AND TRIMETHOPRIM|Sulfones|Sulfur Compounds,NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=N1,5215
348,DB00360,Sapropterin,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Amines|Biological Factors|Breast Cancer Resistance Protein Inhibitors|Coenzymes|Dietary Supplements|Enzymes and Coenzymes|Ethylamines|Heterocyclic Compounds, Fused-Ring|Nitric Oxide Synthase|Other Miscellaneous Therapeutic Agents|P-glycoprotein inhibitors|Phenethylamines|Phenylalanine Hydroxylase Activator|Phenylalanine Hydroxylase Activators|Pigments, Biological|Pteridines|Pterins|Supplements|Various Alimentary Tract and Metabolism Products",[H][C@@]1(CNC2=C(N1)C(=O)NC(N)=N2)[C@@H](O)[C@H](C)O,44257
349,DB00361,Vinorelbine,small molecule,approved|investigational,"Alkaloids|Antimitotic Agents|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Antineoplastic and Immunomodulating Agents|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Immunosuppressive Agents|Indole Alkaloids|Indoles|Mitosis Modulators|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Neurotoxic agents|Secologanin Tryptamine Alkaloids|Tubulin Modulators|Vinca Alkaloids",[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@](CC)([C@@]13[H])[C@@]([H])(OC(C)=O)[C@]2(O)C(=O)OC)[C@]1(C[C@@]2([H])CN(CC(CC)=C2)CC2=C1NC1=CC=CC=C21)C(=O)OC,44424639
350,DB00362,Anidulafungin,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antifungal Agents|Antiinfectives for Systemic Use|Antimycotics for Systemic Use|Echinocandin Antifungal|Echinocandins|Peptides|Peptides, Cyclic",[H][C@]1(NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)[C@H](C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C1=O)NC(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)C1=CC=C(OCCCCC)C=C1)[C@@H](C)O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@@H](C)O,166548
351,DB00363,Clozapine,small molecule,approved,"Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Agents that reduce seizure threshold|Anticholinergic Agents|Antidepressive Agents|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Diazepines, Oxazepines, Thiazepines and Oxepines|Dibenzazepines|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|GABA Agents|GABA Antagonists|Heterocyclic Compounds, Fused-Ring|Histamine Antagonists|Histamine H1 Antagonists|Hyperglycemia-Associated Agents|Hypotensive Agents|Moderate Risk QTc-Prolonging Agents|Muscarinic Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|P-glycoprotein substrates|Photosensitizing Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Tranquilizing Agents|UGT1A4 substrates",CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12,2818
352,DB00364,Sucralfate,small molecule,approved,Alimentary Tract and Metabolism|Aluminium Compounds|Aluminum Complex|Anti-Ulcer Agents|Carbohydrates|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Drugs that are Mainly Renally Excreted|Gastrointestinal Agents|Glycosides|Metal cations|Metal divalent cations|Organometallic Compounds|Protectants|Sulfur Compounds|Thioglycosides,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,70789197
353,DB00365,Grepafloxacin,small molecule,approved|investigational|withdrawn,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|OAT1/SLC22A6 Substrates|OCT2 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",CC1CN(CCN1)C1=C(F)C(C)=C2C(=O)C(=CN(C3CC3)C2=C1)C(O)=O,72474
354,DB00366,Doxylamine,small molecule,approved|vet_approved,Agents producing tachycardia|Aminoalkyl Ethers|Anticholinergic Agents|Antiemetics|Antihistamines for Systemic Use|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Ethanolamine Derivatives|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine Receptor Antagonists|Muscarinic Antagonists|Neurotransmitter Agents|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents,CN(C)CCOC(C)(C1=CC=CC=C1)C1=CC=CC=N1,3162
355,DB00367,Levonorgestrel,small molecule,approved|investigational,"Adrenal Cortex Hormones|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Contraceptives, Postcoital|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hyperglycemia-Associated Agents|Inhibit Ovum Fertilization|Norpregnanes|Norpregnenes|Norsteroids|Progestin Contraceptives|Progestin-containing Intrauterine Device|Progestins|Progestogens and Estrogens, Sequential Preparations|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids",[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],13109
356,DB00368,Norepinephrine,small molecule,approved,"Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Adrenergic beta-1 Receptor Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-3 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Alpha-and Beta-adrenergic Agonists|Amines|Amino Alcohols|Autonomic Agents|Benzene Derivatives|Biogenic Amines|Biogenic Monoamines|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Catecholamines|Catechols|COMT Substrates|Epinephrine and similars|Ethanolamines|Neurotransmitter Agents|Norepinephrine, antagonists & inhibitors|OCT1 substrates|OCT2 Inhibitors|OCT2 Substrates|Peripheral Nervous System Agents|Phenols|Sympathomimetics|Vasoconstrictor Agents",NC[C@H](O)C1=CC(O)=C(O)C=C1,439260
357,DB00369,Cidofovir,small molecule,approved,Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor|Cytosine|Direct Acting Antivirals|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Nephrotoxic agents|Nucleic Acid Synthesis Inhibitors|Nucleosides and Nucleotides|Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors|OAT1/SLC22A6 inhibitors|OAT1/SLC22A6 Substrates|Organophosphonates|Organophosphorus Compounds|Pyrimidines|Pyrimidinones,NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1,60613
358,DB00370,Mirtazapine,small molecule,approved,"Adrenergic Agents|Adrenergic alpha-2 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Anti-Anxiety Agents|Antidepressive Agents|Antidepressive Agents, Tetracyclic|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Miscellaneous Antidepressants|Nervous System|Neurotransmitter Agents|Potential QTc-Prolonging Agents|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin 5-HT3 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists|Tranquilizing Agents",CN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1,4205
359,DB00371,Meprobamate,small molecule,approved|illicit,"Acids, Acyclic|Anti-Anxiety Agents|Carbamates|Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Peripheral Nervous System Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents",CCCC(C)(COC(N)=O)COC(N)=O,4064
360,DB00372,Thiethylperazine,small molecule,approved|withdrawn,"Antiemetics|Antihistamines for Systemic Use|Antipsychotic Agents|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs that are Mainly Renally Excreted|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Neurotoxic agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenothiazine Derivatives|Phenothiazines|Piperazines|Sulfur Compounds",CCSC1=CC2=C(SC3=CC=CC=C3N2CCCN2CCN(C)CC2)C=C1,5440
361,DB00373,Timolol,small molecule,approved,"Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antiglaucoma Preparations and Miotics|Antihypertensive Agents|Beta Blocking Agents and Thiazides|Beta Blocking Agents, Non-Selective|Beta Blocking Agents, Non-Selective, and Thiazides|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|EENT Drugs, Miscellaneous|Hypotensive Agents|Morpholines|Ophthalmologicals|Oxazines|P-glycoprotein substrates|Potential QTc-Prolonging Agents|Propanolamines|Propanols|QTc Prolonging Agents|Sulfur Compounds|Thiadiazoles|Thiazoles",[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,33624
362,DB00374,Treprostinil,small molecule,approved|investigational,"Antihypertensive Agents|Autacoids|Biological Factors|Blood and Blood Forming Organs|Cardiovascular Agents|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Platelet Aggregation Inhibitors Excl. Heparin|Potential QTc-Prolonging Agents|Prostacyclin Analogues|Prostacycline Vasodilator|Prostaglandins|Prostaglandins I|QTc Prolonging Agents|Vasodilating Agents|Vasodilation",[H][C@]12C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])CC1=C(C2)C(OCC(O)=O)=CC=C1,6918140
363,DB00375,Colestipol,small molecule,approved,"Amines|Anion Exchange Resins|Bile Acid Sequestrants|Bile-acid Binding Activity|Compounds used in a research, industrial, or household setting|Hypolipidemic Agents|Hypolipidemic Agents Indicated for Hyperlipidemia|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Macromolecular Substances|Polyamines|Polymers|Sequestering Agents",,62816
364,DB00376,Trihexyphenidyl,small molecule,approved,Agents producing tachycardia|Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Anticholinergic Agents|Central Nervous System Agents|Cholinergic Agents|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|Piperidines|Tertiary Amines,OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1,5572
365,DB00377,Palonosetron,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Antidepressive Agents|Antiemetics|Antiemetics and Antinauseants|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Neurotransmitter Agents|Peripheral Nervous System Agents|Quinuclidines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 3 Receptor Antagonists|Serotonin 5-HT3 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists",[H][C@]12CCCC3=C1C(=CC=C3)C(=O)N(C2)[C@@H]1CN2CCC1CC2,6337614
366,DB00378,Dydrogesterone,small molecule,approved|investigational|withdrawn,"Adrenal Cortex Hormones|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Pregnadien Derivatives|Pregnadienes|Pregnanes|Progestins|Progestogens and Estrogens, Sequential Preparations|Sex Hormones and Modulators of the Genital System|Steroids",[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@@]12C,9051
367,DB00379,Mexiletine,small molecule,approved|investigational,"Amines|Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ib|Benzene Derivatives|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Ethers|Membrane Transport Modulators|Phenols|Phenyl Ethers|Propylamines|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers",CC(N)COC1=C(C)C=CC=C1C,4178
368,DB00380,Dexrazoxane,small molecule,approved|withdrawn,"Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Cytoprotective Agent|Detoxifying Agents for Antineoplastic Treatment|Diketopiperazines|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Immunosuppressive Agents|Miscellaneous Therapeutic Agents|Myelosuppressive Agents|Piperazines|Protective Agents|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1,71384
369,DB00381,Amlodipine,small molecule,approved,ACE Inhibitors and Calcium Channel Blockers|Agents causing hyperkalemia|Angiotensin II Antagonists and Calcium Channel Blockers|Angiotensin II receptor blockers (ARBs) and calcium channel blockers|Antianginal Agents|Antiarrhythmic agents|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium Channel Blockers (Dihydropyridine)|Calcium Channel Blockers and Diuretics|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (weak)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dihydropyridine Derivatives|Dihydropyridines|Hypotensive Agents|Membrane Transport Modulators|P-glycoprotein inhibitors|P-glycoprotein substrates|Pyridines|QTc Prolonging Agents|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC,2162
370,DB00382,Tacrine,small molecule,approved|investigational|withdrawn,"Acridines|Agents Causing Muscle Toxicity|Aminoacridines|Anti-Dementia Drugs|Autonomic Agents|Central Nervous System Agents|Cholinergic Agents|Cholinesterase Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotransmitter Agents|Nootropic Agents|P-glycoprotein substrates|Parasympathomimetics|Peripheral Nervous System Agents|Psychoanaleptics",NC1=C2CCCCC2=NC2=CC=CC=C12,1935
371,DB00383,Oxyphencyclimine,small molecule,approved,"Agents producing tachycardia|Alimentary Tract and Metabolism|Anticholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Synthetic Anticholinergics, Esters With Tertiary Amino Group",CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,4642
372,DB00384,Triamterene,small molecule,approved,"Agents causing hyperkalemia|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Decreased Renal K+ Excretion|Diuretics|Drugs causing inadvertant photosensitivity|Epithelial Sodium Channel Blockers|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Increased Diuresis|Membrane Transport Modulators|Natriuretic Agents|Nephrotoxic agents|Photosensitizing Agents|Potassium-Sparing Diuretics|Pteridines|Sodium Channel Blockers",NC1=NC(N)=C2N=C(C(N)=NC2=N1)C1=CC=CC=C1,5546
373,DB00385,Valrubicin,small molecule,approved,Anthracyclines|Anthracyclines and Related Substances|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Cytotoxic Antibiotics and Related Substances|Enzyme Inhibitors|Glycosides|Naphthacenes|Topoisomerase II Inhibitors|Topoisomerase Inhibitors,[H][C@@]1(C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)COC(=O)CCCC)O[C@H]1C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O1,454216
374,DB00387,Procyclidine,small molecule,approved,Agents producing tachycardia|Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Anticholinergic Agents|Central Nervous System Agents|Cholinergic Agents|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|Pyrrolidines|Tertiary Amines,OC(CCN1CCCC1)(C1CCCCC1)C1=CC=CC=C1,4919
375,DB00388,Phenylephrine,small molecule,approved,"Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Autonomic Agents|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Decongestants and Antiallergics|Ethanolamines|Monoamine Oxidase A Substrates|Mydriatics|Mydriatics and Cycloplegics|Nasal Decongestants|Nasal Decongestants for Systemic Use|Nasal Preparations|Neurotransmitter Agents|Ophthalmologicals|Peripheral Nervous System Agents|Protective Agents|Respiratory System Agents|Sensory Organs|Sympathomimetic (Adrenergic) Agents|Sympathomimetics|Sympathomimetics Excl. Antiglaucoma Preparations|Sympathomimetics Used as Decongestants|Sympathomimetics, Plain|Vasoconstrictor Agents",CNC[C@H](O)C1=CC(O)=CC=C1,6041
376,DB00389,Carbimazole,small molecule,approved|investigational,"Agents Causing Muscle Toxicity|Antithyroid agents|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Imidazoles|Sulfur-Containing Imidazole Derivatives|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thyroid Products",CCOC(=O)N1C=CN(C)C1=S,31072
377,DB00390,Digoxin,small molecule,approved,"Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|BSEP/ABCB11 Substrates|BSEP/ABCB11 Substrates with Narrow Therapeutic Index|Carbohydrates|Cardanolides|Cardenolides|Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Digitalis Glycosides|Digoxin and derivatives|Digoxin, antagonists & inhibitors|Digoxin, immunology|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Fused-Ring Compounds|Glycosides|Narrow Therapeutic Index Drugs|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|P-glycoprotein inducers|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Potential QTc-Prolonging Agents|Protective Agents|QTc Prolonging Agents",[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,2724385
378,DB00391,Sulpiride,small molecule,approved|investigational,"Acids, Carbocyclic|Amides|Antidepressive Agents|Antidepressive Agents, Second-Generation|Antipsychotic Agents|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Central Nervous System Agents|Central Nervous System Depressants|Cholinesterase Inhibitors|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Moderate Risk QTc-Prolonging Agents|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Tranquilizing Agents",CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,5355
379,DB00392,Profenamine,small molecule,approved,"Adrenergic Agents|Adrenergic Antagonists|Agents producing tachycardia|Anti-Parkinson Drugs|Anticholinergic Agents|Cholinergic Agents|Cholinesterase Inhibitors|Heterocyclic Compounds, Fused-Ring|Histamine Agents|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|NMDA Receptor Antagonists|Sulfur Compounds|Tertiary Amines",CCN(CC)C(C)CN1C2=CC=CC=C2SC2=CC=CC=C12,3290
380,DB00393,Nimodipine,small molecule,approved|investigational,Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium Channel Blockers (Dihydropyridine)|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dihydropyridine Derivatives|Dihydropyridines|Hypotensive Agents|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Nicotinic Acids|P-glycoprotein inhibitors|Pyridines|QTc Prolonging Agents|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C,4497
381,DB00394,Beclomethasone dipropionate,small molecule,approved|investigational,"Adrenal Cortex Hormones|Adrenals|Agents to Treat Airway Disease|Alimentary Tract and Metabolism|Anti-Asthmatic Agents|Anti-Inflammatory Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|BCRP/ABCG2 Inhibitors|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids Acting Locally|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Dermatologicals|Drugs for Obstructive Airway Diseases|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Intestinal Antiinflammatory Agents|Nasal Preparations|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein inducers|P-glycoprotein substrates|Pregnadienes|Pregnadienetriols|Pregnanes|Respiratory System Agents|Steroids|Steroids, Chlorinated|Thyroxine-binding globulin inhibitors",[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,21700
382,DB00395,Carisoprodol,small molecule,approved,"Carbamates|Carbamic Acid Esters|Central Nervous System Agents|Central Nervous System Depressants|Centrally-mediated Muscle Relaxation|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 Substrates|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System",CCCC(C)(COC(N)=O)COC(=O)NC(C)C,2576
383,DB00396,Progesterone,small molecule,approved|vet_approved,"Adrenal Cortex Hormones|BCRP/ABCG2 Inducers|BCRP/ABCG2 Inhibitors|BSEP/ABCB11 Inhibitors|Corpus Luteum Hormones|Cytochrome P-450 CYP2A6 Inducers|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inducers|OCT1 inhibitors|OCT2 Inhibitors|P-glycoprotein inducers|P-glycoprotein inhibitors|P-glycoprotein substrates|Pregnanes|Pregnenediones|Pregnenes|Progesterone and Derivatives|Progesterone, antagonists & inhibitors|Progestin-containing Intrauterine Device|Progestins|Sex Hormones and Modulators of the Genital System|Steroids",[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,5994
384,DB00397,Phenylpropanolamine,small molecule,approved|vet_approved|withdrawn,Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Agents that reduce seizure threshold|Alcohols|Amines|Amino Alcohols|Anti-Obesity Agents|Appetite Depressants|Autonomic Agents|Cardiovascular Agents|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Nasal Decongestants|Nasal Decongestants for Systemic Use|Nasal Preparations|Neurotransmitter Agents|Peripheral Nervous System Agents|Propanolamines|Propanols|Respiratory System Agents|Sympathomimetics|Vasoconstrictor Agents,[H][C@@](C)(N)[C@]([H])(O)C1=CC=CC=C1,26934
385,DB00398,Sorafenib,small molecule,approved|investigational,Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Benzene Derivatives|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (moderate)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Immunosuppressive Agents|Kinase Inhibitor|Miscellaneous Therapeutic Agents|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Nicotinic Acids|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Phenylurea Compounds|Potential QTc-Prolonging Agents|Protein Kinase Inhibitors|Pyridines|QTc Prolonging Agents|Tyrosine Kinase Inhibitors|UGT1A1 Inhibitors|UGT1A9 Inhibitors|UGT1A9 Substrates|UGT1A9 substrates with narrow therapeutic index|Vitamin B Complex|Vitamins,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,216239
386,DB00399,Zoledronic acid,small molecule,approved,Bisphosphonates|Bone Density Conservation Agents|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Imidazoles|Musculo-Skeletal System|Organophosphonates|Organophosphorus Compounds,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,68740
387,DB00400,Griseofulvin,small molecule,approved|investigational|vet_approved,"Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Systemic Use|Antifungals for Topical Use|Benzofurans|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Decreased Mitosis|Dermatologicals|Heterocyclic Compounds, Fused-Ring|Microtubule Inhibition|Tubulin Inhibiting Agent",COC1=CC(OC)=C(Cl)C2=C1C(=O)[C@]1(O2)[C@H](C)CC(=O)C=C1OC,441140
388,DB00401,Nisoldipine,small molecule,approved,Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium Channel Blockers (Dihydropyridine)|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Substrates|Decreased Blood Pressure|Dihydropyridine Derivatives|Dihydropyridines|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Hypotensive Agents|Membrane Transport Modulators|P-glycoprotein inhibitors|Photosensitizing Agents|Pyridines|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)C,4499
389,DB00402,Eszopiclone,small molecule,approved|investigational,"Benzodiazepine hypnotics and sedatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Hypnotics (Nonbenzodiazepine)|Hypnotics and Sedatives|Miscellaneous Anxiolytics Sedatives and Hypnotics|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Photosensitizing Agents|Piperazines|Psycholeptics|Pyrazines|Pyridines|Zopiclone and prodrugs",CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1,969472
390,DB00403,Ceruletide,small molecule,approved,"Amino Acids, Peptides, and Proteins|Diagnostic Agents|Oligopeptides|Peptides|Tests for Bile Duct Patency",[H][C@](NC(=O)[C@H](CC1=CC=C(OS(O)(=O)=O)C=C1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,16129675
391,DB00404,Alprazolam,small molecule,approved|illicit|investigational,"Alcohols|Amines|Amino Alcohols|Anti-Anxiety Agents|Benzazepines|Benzene Derivatives|Benzodiazepines and benzodiazepine derivatives|Biogenic Amines|Biogenic Monoamines|Catechols|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Ethanolamines|GABA Agents|GABA Modulators|Heterocyclic Compounds, Fused-Ring|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Phenols|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents|Triazolobenzodiazepines",CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,2118
392,DB00405,Dexbrompheniramine,small molecule,approved,Antihistamines for Systemic Use|Central Nervous System Depressants|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Substituted Alkylamines,CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C1=CC=CC=N1,16960
393,DB00406,Gentian violet cation,small molecule,approved,"Amines|Aniline Compounds|Anti-Infective Agents|Anti-Infective Agents, Local|Antifungals for Dermatological Use|Antifungals for Topical Use|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Miscellaneous Antifungals",CN(C)C1=CC=C(C=C1)C(C1=CC=C(C=C1)N(C)C)=C1C=CC(C=C1)=[N+](C)C,3468
394,DB00407,Ardeparin,small molecule,approved|investigational|withdrawn,Agents causing hyperkalemia|Anticoagulants|Carbohydrates|Cardiovascular Agents|Fibrin Modulating Agents|Glycosaminoglycans|Hematologic Agents|Heparin (Low Molecular Weight)|Heparin and similars|Polysaccharides,,
395,DB00408,Loxapine,small molecule,approved,"Antidepressive Agents|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Agents|Central Nervous System Depressants|Diazepines, Oxazepines, Thiazepines and Oxepines|Dibenzoxazepines|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs causing inadvertant photosensitivity|Heterocyclic Compounds, Fused-Ring|Miscellaneous Antipsychotics|Nervous System|Neurotoxic agents|Neurotransmitter Agents|P-glycoprotein inhibitors|Photosensitizing Agents|Psycholeptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Tranquilizing Agents",CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,3964
396,DB00409,Remoxipride,small molecule,approved|withdrawn,"Acids, Carbocyclic|Amides|Antipsychotic Agents|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Bromobenzoates|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents",CCN1CCC[C@H]1CNC(=O)C1=C(OC)C=CC(Br)=C1OC,54477
397,DB00410,Mupirocin,small molecule,approved|investigational|vet_approved,"Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics for Topical Use|Dermatologicals|Enzyme Inhibitors|Epoxy Compounds|Ethers|Ethers, Cyclic|Fatty Acids|Lipids|Nasal Preparations|Protein Synthesis Inhibitors|Pyrans|RNA Synthetase Inhibitor Antibacterial|RNA Synthetase Inhibitors",C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]1CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O,446596
398,DB00411,Carbamoylcholine,small molecule,approved,"Alcohols|Amines|Amino Alcohols|Ammonium Compounds|Analgesics|Analgesics, Non-Narcotic|Antiglaucoma Preparations and Miotics|Autonomic Agents|Cardiotonic Agents|Cardiovascular Agents|Central Nervous System Agents|Choline Esters|Cholinergic Agents|Cholinergic Agonists|Cholinergic Receptor Agonist|Compounds used in a research, industrial, or household setting|Ethanolamines|Miotics|Nervous System|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Ophthalmologicals|Parasympathomemetic (Cholinergic) Agents|Parasympathomimetics|Peripheral Nervous System Agents|Protective Agents|Quaternary Ammonium Compounds|Sensory Organs|Sensory System Agents|Trimethyl Ammonium Compounds",C[N+](C)(C)CCOC(N)=O,5831
399,DB00412,Rosiglitazone,small molecule,approved|investigational,Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Drugs Used in Diabetes|Hypoglycemia-Associated Agents|OATP1B1/SLCO1B1 Inhibitors|Peroxisome Proliferator Receptor gamma Agonist|Peroxisome Proliferator-activated Receptor Activity|Sulfur Compounds|Thiazoles|Thiazolidinediones|Vasodilating Agents,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,77999
400,DB00413,Pramipexole,small molecule,approved|investigational,"Anti-Dyskinesia Agents|Anti-Parkinson Agents (Dopamine Agonist)|Anti-Parkinson Drugs|Antioxidants|Benzothiazoles|Central Nervous System Agents|Dopamine Agents|Dopamine Agonists|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Nervous System|Neurotransmitter Agents|Nonergot-derivative Dopamine Receptor Agonists|OCT1 substrates|OCT2 Substrates|Restless Legs Syndrome|Sulfur Compounds|Thiazoles",CCCN[C@H]1CCC2=C(C1)SC(N)=N2,119570
401,DB00414,Acetohexamide,small molecule,approved|investigational|withdrawn,Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Drugs Used in Diabetes|Sulfones|Sulfonylureas|Sulfur Compounds,CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,1989
402,DB00415,Ampicillin,small molecule,approved|vet_approved,"Amides|Aminopenicillins|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|beta-Lactams|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Lactams|Ophthalmologicals|Penicillin G|Penicillins|Penicillins With Extended Spectrum|Sensory Organs|Sulfur Compounds",[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,6249
403,DB00416,Metocurine iodide,small molecule,approved|withdrawn,"Alkaloids|Amines|Ammonium Compounds|Anticholinergic Agents|Benzylisoquinolines|Central Nervous System Depressants|Drugs, Chinese Herbal|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular-Blocking Agents (Nondepolarizing)|Nicotinic Antagonists|Nitrogen Compounds|Onium Compounds|Peripheral Nervous System Agents|Quaternary Ammonium Compounds|Tetrahydroisoquinolines",[I-].[I-].[H][C@@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC(OC6=C(OC)C=C(CC[N+]1(C)C)C2=C6)=C(OC)C=C5)=CC(OC)=C4OC)C=C3,24244
404,DB00417,Phenoxymethylpenicillin,small molecule,approved|vet_approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|Beta-Lactamase Sensitive Penicillins|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Natural Penicillins|Penicillin G|Penicillins|Sulfur Compounds",[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)COC1=CC=CC=C1)C(O)=O,6869
405,DB00418,Secobarbital,small molecule,approved|vet_approved,"Adjuvants|Adjuvants, Anesthesia|Anticholinergic Agents|Anticonvulsants|Barbiturates|Barbiturates, Plain|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strong)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Drugs that are Mainly Renally Excreted|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Nicotinic Antagonists|Psycholeptics|Pyrimidines|Pyrimidinones",CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,5193
406,DB00419,Miglustat,small molecule,approved,Alimentary Tract and Metabolism|Alkaloids|Anti-HIV Agents|Anti-Infective Agents|Carbohydrates|Enzyme Inhibitors|Gaucher Disease|Glucosylceramide Synthase Inhibitor|Glucosylceramide Synthase Inhibitors|Glycoside Hydrolase Inhibitors|Imines|Imino Pyranoses|Imino Sugars|Other Miscellaneous Therapeutic Agents|Piperidines|Various Alimentary Tract and Metabolism Products,CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,51634
407,DB00420,Promazine,small molecule,approved|vet_approved,"Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Anticholinergic Agents|Antidepressive Agents|Antiemetics|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Histamine Antagonists|Histamine H1 Antagonists|Moderate Risk QTc-Prolonging Agents|Muscarinic Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenothiazines|Phenothiazines With Aliphatic Side-Chain|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Tranquilizing Agents",CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,4926
408,DB00421,Spironolactone,small molecule,approved,"Agents causing hyperkalemia|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|BSEP/ABCB11 Substrates|Cardiovascular Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Diuretics|Fused-Ring Compounds|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypotensive Agents|Lactones|Mineralocorticoid (Aldosterone) Receptor Antagonists|Mineralocorticoid Receptor Antagonists|Natriuretic Agents|P-glycoprotein inducers|Potassium-Sparing Diuretics|Pregnanes|Pregnenes|Steroids",[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,5833
409,DB00422,Methylphenidate,small molecule,approved|investigational,"Acids, Carbocyclic|Agents that produce hypertension|Agents that reduce seizure threshold|Central Nervous System Agents|Central Nervous System Stimulants|Central Nervous System Stimulation|Centrally Acting Sympathomimetics|Dopamine Agents|Dopamine Uptake Inhibitors|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Membrane Transport Modulators|Methylphenidate and isomer|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Phenylacetates|Piperidines|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Respiratory and CNS Stimulants",COC(=O)C(C1CCCCN1)C1=CC=CC=C1,4158
410,DB00423,Methocarbamol,small molecule,approved|vet_approved,"Acids, Acyclic|Benzene Derivatives|Carbamates|Carbamic Acid Esters|Catechols|Central Nervous System Agents|Central Nervous System Depressants|Centrally-mediated Muscle Relaxation|Ethers|Methyl Ethers|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System|Peripheral Nervous System Agents|Phenols|Phenyl Ethers|Phenylcarbamates",COC1=C(OCC(O)COC(N)=O)C=CC=C1,4107
411,DB00424,Hyoscyamine,small molecule,approved,"Adjuvants, Anesthesia|Agents producing tachycardia|Alimentary Tract and Metabolism|Alkaloids|Anti-Asthmatic Agents|Antiarrhythmic agents|Anticholinergic Agents|Atropine Derivatives|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Belladonna Alkaloids|Belladonna Alkaloids, Tertiary Amines|Belladonna and Derivatives, Plain|Bronchodilator Agents|Cardiovascular Agents|Central Nervous System Agents|Cholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Mydriatics|Neurotransmitter Agents|Parasympatholytics|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Respiratory System Agents|Solanaceous Alkaloids|Tropanes",CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,154417
412,DB00425,Zolpidem,small molecule,approved,"Benzodiazepine hypnotics and sedatives|Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Depression|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|GABA Agents|GABA Agonists|GABA-A Receptor Agonists|gamma-Aminobutyric Acid-ergic Agonist|Hypnotics (Nonbenzodiazepine)|Hypnotics and Sedatives|Miscellaneous Anxiolytics Sedatives and Hypnotics|Nervous System|Neurotransmitter Agents|Psycholeptics|Pyridines|Sleep Aids, Pharmaceutical",CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,5732
413,DB00426,Famciclovir,small molecule,approved|investigational,"Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Direct Acting Antivirals|Enzyme Inhibitors|Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor|Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor|Heterocyclic Compounds, Fused-Ring|Nucleic Acid Synthesis Inhibitors|Nucleosides and Nucleotides|Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors|Ophthalmologicals|Purines|Sensory Organs",CC(=O)OCC(CCN1C=NC2=CN=C(N)N=C12)COC(C)=O,3324
414,DB00427,Triprolidine,small molecule,approved,Anti-Allergic Agents|Antihistamines for Systemic Use|Central Nervous System Depressants|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents,CC1=CC=C(C=C1)C(=C/CN1CCCC1)\C1=CC=CC=N1,5282443
415,DB00428,Streptozocin,small molecule,approved|investigational,"Alkylating Activity|Alkylating Drugs|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Carbohydrates|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP2E1 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Glycosides|Immunosuppressive Agents|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Nitroso Compounds|Nitrosourea Compounds|Nitrosoureas|P-glycoprotein inducers",CN(N=O)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O,29327
416,DB00429,Carboprost tromethamine,small molecule,approved,"Abortifacient Agents|Abortifacient Agents, Nonsteroidal|Alcohols|Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Genito Urinary System and Sex Hormones|Glycols|Inflammation Mediators|Lipids|Pharmaceutical Preparations|Propylene Glycols|Prostaglandins|Prostaglandins F, Synthetic|Prostaglandins, Synthetic|Reproductive Control Agents|Uterotonic agents",OCC([NH3+])(CO)CO.CCCCC[C@@](O)(C)\C=C\[C@H]1[C@@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(=O)[O-],45266502
417,DB00430,Cefpiramide,small molecule,approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins",[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)C1=C(O)C=C(C)N=C1)C1=CC=C(O)C=C1)C(O)=O,636405
418,DB00431,Lindane,small molecule,approved|withdrawn,"Agents that reduce seizure threshold|Agrochemicals|Antiparasitic Products, Insecticides and Repellents|Chlorine Containing Products|Compounds used in a research, industrial, or household setting|Ectoparasiticides, Incl. Scabicides|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Insecticides|Pesticides|Toxic Actions",Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl,727
419,DB00432,Trifluridine,small molecule,approved|investigational,"Anti-Infective Agents|Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Antiviral Agents|Carbohydrates|Deoxyribonucleosides|Drugs that are Mainly Renally Excreted|Glycosides|Immunosuppressive Agents|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Analog Antiviral|Nucleoside Metabolic Inhibitor|Nucleosides|OAT1/SLC22A6 inhibitors|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Substrates|Ophthalmologicals|Pyrimidine Analogues|Pyrimidine Nucleosides|Pyrimidines|Sensory Organs|Toxic Actions",OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(C(=O)NC1=O)C(F)(F)F,6256
420,DB00433,Prochlorperazine,small molecule,approved|vet_approved,"Antiemetics|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs causing inadvertant photosensitivity|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Moderate Risk QTc-Prolonging Agents|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenothiazines|Phenothiazines With Piperazine Structure|Photosensitizing Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Schizophrenia|Sulfur Compounds|Tranquilizing Agents",CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,4917
421,DB00434,Cyproheptadine,small molecule,approved,Agents producing tachycardia|Agents that reduce seizure threshold|Anti-Allergic Agents|Anticholinergic Agents|Antidepressive Agents|Antihistamines for Systemic Use|Antipruritics|Benzocycloheptenes|Central Nervous System Depressants|Dermatologicals|Dibenzocycloheptenes|Drugs causing inadvertant photosensitivity|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Miscellaneous Derivatives|Muscarinic Antagonists|Neurotransmitter Agents|Photosensitizing Agents|Piperidines|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|UGT1A3 substrates,CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12,2913
422,DB00435,Nitric Oxide,small molecule,approved,"Anions|Anti-Asthmatic Agents|Antioxidants|Autonomic Agents|Bronchodilator Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Drugs that are Mainly Renally Excreted|Electrolytes|Endothelium-Dependent Relaxing Factors|Free Radical Scavengers|Free Radicals|Gases|Gasotransmitters|Hypotensive Agents|Ions|Methemoglobinemia Associated Agents|Neurotransmitter Agents|Nitrates and Nitrites|Nitric Oxide, antagonists & inhibitors|Nitrogen Compounds|Nitrogen Oxides|Nitroso Compounds|Oxides|Oxygen Compounds|Peripheral Nervous System Agents|Protective Agents|Reactive Nitrogen Species|Respiratory System Agents|Vasodilating Agents|Vasodilation",[N]=O,145068
423,DB00436,Bendroflumethiazide,small molecule,approved,"Amides|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Benzothiadiazines|Bradycardia-Causing Agents|Cardiovascular Agents|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Heterocyclic Compounds, Fused-Ring|Hyperglycemia-Associated Agents|Hypotensive Agents|Increased Diuresis|Low-Ceiling Diuretics and Potassium-Sparing Agents|Membrane Transport Modulators|Natriuretic Agents|Sodium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds|Thiazides",NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F,2315
424,DB00437,Allopurinol,small molecule,approved,"Antigout Preparations|Antimetabolites|Antioxidants|BCRP/ABCG2 Substrates|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Free Radical Scavengers|Heterocyclic Compounds, Fused-Ring|Musculo-Skeletal System|OAT3/SLC22A8 Substrates|Preparations Inhibiting Uric Acid Production|Protective Agents|Purines|Uricosuric Agents|Xanthine Oxidase Inhibitors",OC1=NC=NC2=C1C=NN2,2094
425,DB00438,Ceftazidime,small molecule,approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephaloridine|Cephalosporins|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|OAT1/SLC22A6 inhibitors|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins",[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,5481173
426,DB00439,Cerivastatin,small molecule,approved|withdrawn,"Agents Causing Muscle Toxicity|Anticholesteremic Agents|BCRP/ABCG2 Substrates|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Hypolipidemic Agents|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Noxae|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|P-glycoprotein substrates|Toxic Actions|UGT1A1 Substrates",COCC1=C(C2=CC=C(F)C=C2)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C(C(C)C)N=C1C(C)C,446156
427,DB00440,Trimethoprim,small molecule,approved|vet_approved,"Agents causing hyperkalemia|Agents Causing Muscle Toxicity|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antibiotics for Pneumocystis Pneumonia|Antiinfectives for Systemic Use|Antimycobacterials|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Folic Acid Antagonists|MATE 1 Inhibitors|MATE 1 Substrates|MATE 2 Inhibitors|MATE 2 Substrates|MATE inhibitors|MATE substrates|OCT2 Inhibitors|P-glycoprotein inducers|P-glycoprotein inhibitors|P-glycoprotein substrates|Photosensitizing Agents|Pyrimidines|Renal Agents|SULFONAMIDES AND TRIMETHOPRIM|Trimethoprim and Derivatives",COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,5578
428,DB00441,Gemcitabine,small molecule,approved,"Anti-Infective Agents|Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Deoxyribonucleosides|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Glycosides|Immunologic Factors|Immunosuppressive Agents|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Metabolic Inhibitor|Nucleosides|P-glycoprotein substrates|Pyrimidine Analogues|Pyrimidine Nucleosides|Pyrimidines|Radiation-Sensitizing Agents|Ribonucleosides|Ribonucleotide Reductases, antagonists & inhibitors|Toxic Actions",NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,60750
429,DB00442,Entecavir,small molecule,approved|investigational,"Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Direct Acting Antivirals|Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Heterocyclic Compounds, Fused-Ring|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|Nucleoside Reverse Transcriptase Inhibitors|Nucleosides and Nucleotides|Purines|Purinones",NC1=NC(=O)C2=C(N1)N(C=N2)[C@H]1C[C@H](O)[C@@H](CO)C1=C,153941
430,DB00443,Betamethasone,small molecule,approved|vet_approved,"Adrenal Cortex Hormones|Adrenals|Agents Causing Muscle Toxicity|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Alimentary Tract and Metabolism|Anti-Inflammatory Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids Acting Locally|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP2A6 Inducers|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (weak)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Dermatologicals|Drugs for Obstructive Airway Diseases|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Intestinal Antiinflammatory Agents|Nasal Preparations|Ophthalmological and Otological Preparations|Ophthalmologicals|Otologicals|P-glycoprotein substrates|Pregnadienes|Pregnadienetriols|Pregnanes|Respiratory System Agents|Steroids|Steroids, Fluorinated|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thyroxine-binding globulin inhibitors|Vasoprotectives",[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,9782
431,DB00444,Teniposide,small molecule,approved,Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Carbohydrates|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Glucosides|Glycosides|Immunosuppressive Agents|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Neurotoxic agents|Podophyllotoxin Derivatives|Topoisomerase II Inhibitors|Topoisomerase Inhibitors,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=C(C=C3OCOC3=C1)[C@H]2O[C@]1([H])O[C@]2([H])CO[C@H](O[C@@]2([H])[C@H](O)[C@H]1O)C1=CC=CS1,452548
432,DB00445,Epirubicin,small molecule,approved,"Anthracycline Topoisomerase Inhibitor|Anthracyclines|Anthracyclines and Related Substances|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Cardiotoxic antineoplastic agents|Cytotoxic Antibiotics and Related Substances|Enzyme Inhibitors|Glycosides|Hepatotoxic Agents|Immunosuppressive Agents|Myelosuppressive Agents|Naphthacenes|Topoisomerase II Inhibitors|Topoisomerase Inhibitors|UGT2B7 substrates|UGT2B7 substrates with narrow therapeutic index",COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,41867
433,DB00446,Chloramphenicol,small molecule,approved|vet_approved,Alcohols|Amphenicols|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antibiotics for Topical Use|Antiinfectives for Systemic Use|Antiinfectives for Treatment of Acne|Benzene Derivatives|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Glycols|Gynecological Antiinfectives and Antiseptics|Immunosuppressive Agents|Myelosuppressive Agents|Nitro Compounds|Nitrobenzenes|OAT1/SLC22A6 inhibitors|Ophthalmological and Otological Preparations|Ophthalmologicals|Otologicals|Propylene Glycols|Protein Synthesis Inhibitors|Sensory Organs,OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O,5959
434,DB00447,Loracarbef,small molecule,approved|investigational|withdrawn,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Second-Generation Cephalosporins|Sulfur Compounds|Thiazines",N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1,5284585
435,DB00448,Lansoprazole,small molecule,approved|investigational,"Acid Reducers|Alimentary Tract and Metabolism|Anti-Ulcer Agents|BCRP/ABCG2 Inhibitors|Benzimidazoles|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Gastric Acid Lowering Agents|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Inhibition Gastric Acid Secretion|OAT3/SLC22A8 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Proton Pump Inhibitors|Proton-pump Inhibitors|Pyridines|Sulfoxides|Sulfur Compounds",CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,3883
436,DB00449,Dipivefrin,small molecule,approved,Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic beta-1 Receptor Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-3 Receptor Agonists|Adrenergic beta-Agonists|Alcohols|Amines|Amino Alcohols|Antiglaucoma Preparations and Miotics|Benzene Derivatives|Biogenic Amines|Biogenic Monoamines|Catecholamines|Catechols|Cholinesterase substrates|Ethanolamines|Mydriatics|Neurotransmitter Agents|Ophthalmics|Ophthalmologicals|Phenols|Sensory Organs|Sympathomimetics in Glaucoma Therapy,CNCC(O)C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C=C1,3105
437,DB00450,Droperidol,small molecule,approved|vet_approved,"Adjuvants, Anesthesia|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antiemetics|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Autonomic Agents|Benzimidazoles|Butyrophenone Derivatives|Butyrophenones|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Ketones|Miscellaneous Anxiolytics Sedatives and Hypnotics|Moderate Risk QTc-Prolonging Agents|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Tranquilizing Agents",FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,3168
438,DB00451,Levothyroxine,small molecule,approved,"Agents used to treat hypothyroidism|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Narrow Therapeutic Index Drugs|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein inducers|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thyroid Products|Thyroxine-binding globulin substrates|UGT1A1 Substrates|UGT1A1 substrates with narrow therapeutic index",N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,5819
439,DB00452,Framycetin,small molecule,approved,Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Carbohydrates|Dermatologicals|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Glycosides|Medicated Dressings|Medicated Dressings With Antiinfectives|Narrow Therapeutic Index Drugs|Nasal Preparations|Nephrotoxic agents|Ophthalmologicals|Sensory Organs,NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O,8378
440,DB00453,Clomocycline,small molecule,experimental,Agents that produce neuromuscular block (indirect)|Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Naphthacenes|Tetracyclines,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(=O)NCO)=C(O)[C@H]2N(C)C)C(=O)C1=C(C(Cl)=CC=C1O)[C@@]3(C)O,54680675
441,DB00454,Meperidine,small molecule,approved,"Adjuvants|Adjuvants, Anesthesia|Agents that reduce seizure threshold|Analgesics|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|High-risk opioids|Isonipecotic Acids|Narcotics|Nervous System|NMDA Receptor Antagonists|Opiate Agonists|Opioid Agonist|Opioids|P-glycoprotein substrates|Peripheral Nervous System Agents|Phenylpiperidine opioids|Piperidines|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators",CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1,4058
442,DB00455,Loratadine,small molecule,approved|investigational,"Anti-Allergic Agents|Antihistamines for Systemic Use|Antipruritics|Benzocycloheptenes|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Dibenzocycloheptenes|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Loratadine and prodrug|Neurotransmitter Agents|P-glycoprotein inhibitors|P-glycoprotein substrates|Piperidines|QTc Prolonging Agents",CCOC(=O)N1CCC(CC1)=C1C2=C(CCC3=C1N=CC=C3)C=C(Cl)C=C2,3957
443,DB00456,Cefalotin,small molecule,approved|investigational|vet_approved,"Agents that reduce seizure threshold|Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephacetrile|Cephalosporins|First-Generation Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|Sulfur Compounds|Thiazines",[H][C@@]1(NC(=O)CC2=CC=CS2)C(=O)N2C(C(O)=O)=C(COC(C)=O)CS[C@]12[H],6024
444,DB00457,Prazosin,small molecule,approved,"Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Alpha-Adrenoreceptor Antagonists and Diuretics|Antiadrenergic Agents, Peripherally Acting|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|BCRP/ABCG2 Substrates|Cardiovascular Agents|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|OCT1 inhibitors|OCT1 substrates|OCT2 Substrates|P-glycoprotein inhibitors|P-glycoprotein substrates|Peripheral alpha-1 blockers|Quinazolines|Vasodilating Agents",COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1,4893
445,DB00458,Imipramine,small molecule,approved,"Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that produce hypertension|Agents that reduce seizure threshold|Anticholinergic Agents|Antidepressive Agents|Antidepressive Agents, Tricyclic|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dibenzazepines|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Histamine Antagonists|Histamine H1 Antagonists|Hypotensive Agents|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Muscarinic Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Non-Selective Monoamine Reuptake Inhibitors|OCT2 Inhibitors|P-glycoprotein substrates|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists|Tertiary amine tricyclic antidepressants|Tricyclics and Other Norepinephrine-reuptake Inhibitors",CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,3696
446,DB00459,Acitretin,small molecule,approved,"Alkenes|Antipsoriatics|Antipsoriatics for Systemic Use|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Dermatologicals|Drugs causing inadvertant photosensitivity|Hepatotoxic Agents|Hydrocarbons, Acyclic|Keratolytic Agents|Misc. Skin and Mucous Membrane Agents|Photosensitizing Agents|Pigments, Biological|Polyenes|Retinoids|Retinoids for Treatment of Psoriasis|Terpenes",COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1,5284513
447,DB00460,Verteporfin,small molecule,approved|investigational,"Antineovascularisation Agents|Biological Factors|Dermatologicals|EENT Drugs, Miscellaneous|Heterocyclic Compounds, Fused-Ring|Ocular Vascular Disorder Agents|Ophthalmologicals|Photoabsorption|Photoenhancer|Photosensitizing Activity|Photosensitizing Agents|Pigments, Biological|Porphyrins|Radiation-Sensitizing Agents|Sensory Organs",COC(=O)CCC1=C2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(CCC(O)=O)=C5C)C(C=C)=C4C)C2=CC=C([C@@H](C(=O)OC)[C@@]32C)C(=O)OC)=C1C,5362420
448,DB00461,Nabumetone,small molecule,approved,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Butanones|COX-2 Inhibitors|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Ketones|Musculo-Skeletal System|Nephrotoxic agents|Other Nonsteroidal Anti-inflammatory Agents|Photosensitizing Agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)",COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2,4409
449,DB00462,Methscopolamine bromide,small molecule,approved,Agents producing tachycardia|Anticholinergic Agents|Muscarinic Antagonists,[Br-].[H][C@]12C[C@@H](C[C@@]([H])(C3OC13)[N+]2(C)C)OC(=O)[C@H](CO)C1=CC=CC=C1,23724781
450,DB00463,Metharbital,small molecule,withdrawn,Anticholinergic Agents|Anticonvulsants|Barbiturates and Derivatives|Central Nervous System Depressants|Nervous System|Nicotinic Antagonists|Pyrimidines|Pyrimidinones,CCC1(CC)C(=O)NC(=O)N(C)C1=O,4099
451,DB00464,Sodium tetradecyl sulfate,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Alcohols|Alkanes|Alkanesulfonates|Alkanesulfonic Acids|Antivaricose Therapy|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Fatty Alcohols|Hydrocarbons, Acyclic|Lipids|Pharmaceutical Preparations|Pharmaceutical Solutions|Sclerosing Agents for Local Injection|Sclerosing Solutions|Solutions|Sulfonic Acids|Sulfur Acids|Sulfur Compounds|Surface-Active Agents|Vasoprotectives",[Na+].CCCCC(CC)CCC(CC(C)C)OS([O-])(=O)=O,23665772
452,DB00465,Ketorolac,small molecule,approved,"Acetic Acid Derivatives and Related Substances|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Musculo-Skeletal System|Mydriatics|Mydriatics and Cycloplegics|Nephrotoxic agents|Non COX-2 selective NSAIDS|Ophthalmologicals|Other Nonsteroidal Anti-inflammatory Agents|Photosensitizing Agents|Sensory Organs|Sympathomimetics Excl. Antiglaucoma Preparations|UGT2B7 substrates",OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,3826
453,DB00466,Picrotoxin,small molecule,experimental,"Antidotes|Central Nervous System Agents|Central Nervous System Stimulants|Compounds used in a research, industrial, or household setting|Convulsants|Cyclohexanes|Cycloparaffins|GABA Agents|GABA Antagonists|Lactones|Neurotransmitter Agents|Protective Agents|Stimulants",[H][C@@]12OC(=O)[C@@]34OC3C[C@@](O)(C3[C@@H](C1OC3=O)C(C)=C)[C@@]24C.[H][C@@]12C[C@@]3(O)C4[C@@H](C(OC4=O)[C@@]4([H])OC(=O)[C@]1(O2)[C@@]34C)C(C)(C)O,31304
454,DB00467,Enoxacin,small molecule,approved|investigational,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N=C12)N1CCNCC1,3229
455,DB00468,Quinine,small molecule,approved,"Agents that produce neuromuscular block (indirect)|Agents that reduce seizure threshold|Alkaloids|Analgesics|Analgesics, Non-Narcotic|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Blood Glucose Lowering Agents|Central Nervous System Agents|Central Nervous System Depressants|Cinchona Alkaloids|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Herbs (Hypotensive Properties)|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|Hypoglycemia-Associated Agents|Methanolquinolines|Methemoglobinemia Associated Agents|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|OATP1B1/SLCO1B1 Inhibitors|OCT1 inhibitors|OCT1 substrates|OCT2 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Peripheral Nervous System Agents|QTc Prolonging Agents|Quinolines|Quinuclidines|Sensory System Agents",[H][C@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@H](O)C1=CC=NC2=CC=C(OC)C=C12,3034034
456,DB00469,Tenoxicam,small molecule,approved,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|OAT3/SLC22A8 Inhibitors|Other Nonsteroidal Anti-inflammatory Agents|Oxicams|Peripheral Nervous System Agents|Sensory System Agents|Sulfur Compounds|Thiazines",CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=C(C=CS2)S1(=O)=O,54677971
457,DB00470,Dronabinol,small molecule,approved|illicit,"Agents producing tachycardia|Alimentary Tract and Metabolism|Analgesics|Analgesics, Non-Narcotic|Antiemetics and Antinauseants|BCRP/ABCG2 Inhibitors|Cannabinoid Receptor Agonists|Cannabinoids and similars|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Hallucinogens|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Miscellaneous Antiemetics|Neurotransmitter Agents|P-glycoprotein inhibitors|Peripheral Nervous System Agents|Psychotropic Drugs|Sensory System Agents|Terpenes",[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=C2C(O)=CC(CCCCC)=C1,16078
458,DB00471,Montelukast,small molecule,approved,"Acids, Acyclic|Agents Causing Muscle Toxicity|Agents to Treat Airway Disease|Anti-Asthmatic Agents|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs for Obstructive Airway Diseases|Fatty Acids|Fatty Acids, Volatile|Heterocyclic Compounds, Fused-Ring|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Leukotriene Antagonists|Leukotriene Modifiers|Lipids|Respiratory System Agents",OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,5281040
459,DB00472,Fluoxetine,small molecule,approved|vet_approved,"Agents that reduce seizure threshold|Amines|Anticholinergic Agents|Antidepressive Agents|Antidepressive Agents, Second-Generation|Central Nervous System Agents|Central Nervous System Depressants|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Highest Risk QTc-Prolonging Agents|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Nicotinic Antagonists|P-glycoprotein inhibitors|Propylamines|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists|Vasodilating Agents",CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,3386
460,DB00473,Hexylcaine,small molecule,approved|withdrawn,Amines|Cyclohexanes|Cycloparaffins,CC(CNC1CCCCC1)OC(=O)C1=CC=CC=C1,10770
461,DB00474,Methohexital,small molecule,approved,"Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Anticonvulsants|Barbiturates|Barbiturates, Plain|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Hypnotics and Sedatives|Nervous System|Psycholeptics|Pyrimidines|Pyrimidinones",CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O,9034
462,DB00475,Chlordiazepoxide,small molecule,approved|illicit|investigational,"Adjuvants, Anesthesia|Anti-Anxiety Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Carbohydrates|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Cytosine Nucleotides|GABA Agents|GABA Modulators|Glycosides|Heterocyclic Compounds, Fused-Ring|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Psycholeptics|Psychotropic Drugs|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides|Tranquilizing Agents",CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,2712
463,DB00476,Duloxetine,small molecule,approved,Agents producing tachycardia|Analgesics|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Nervous System|Neurotransmitter Uptake Inhibitors|Norepinephrine Uptake Inhibitors|P-glycoprotein inhibitors|Peripheral Nervous System Agents|Psychoanaleptics|Psychotropic Drugs|Selective Serotonin Reuptake Inhibitors|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin and Noradrenaline Reuptake Inhibitors|Serotonin Modulators|Sulfur Compounds|Thiophenes,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,60835
464,DB00477,Chlorpromazine,small molecule,approved|investigational|vet_approved,"Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Agents that reduce seizure threshold|Anticholinergic Agents|Antidepressive Agents|Antiemetics|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Autonomic Agents|BSEP/ABCB11 Inhibitors|Central Nervous System Agents|Central Nervous System Depressants|Cholinesterase Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Histamine Antagonists|Histamine H1 Antagonists|Hyperglycemia-Associated Agents|Hypotensive Agents|Moderate Risk QTc-Prolonging Agents|Muscarinic Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|P-glycoprotein inhibitors|P-glycoprotein substrates|Peripheral Nervous System Agents|Phenothiazines|Phenothiazines With Aliphatic Side-Chain|Photosensitizing Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Tranquilizing Agents",CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,2726
465,DB00478,Rimantadine,small molecule,approved|investigational,Adamantanes|Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Cyclic Amines|Cycloparaffins|Enzyme Inhibitors|Influenza A M2 Protein Inhibitor|M2 Protein Inhibitors|Nucleic Acid Synthesis Inhibitors,CC(N)C12CC3CC(CC(C3)C1)C2,5071
466,DB00479,Amikacin,small molecule,approved|investigational|vet_approved,Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Glycosides|Narrow Therapeutic Index Drugs|Nephrotoxic agents,NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O,37768
467,DB00480,Lenalidomide,small molecule,approved,"Acids, Carbocyclic|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Drugs that are Mainly Renally Excreted|Growth Inhibitors|Growth Substances|Heterocyclic Compounds, Fused-Ring|Imides|Immunologic Factors|Immunosuppressive Agents|Isoindoles|Myelosuppressive Agents|P-glycoprotein substrates|Phthalic Acids|Phthalimides|Piperidines|Piperidones|Thalidomide Analog",NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,216326
468,DB00481,Raloxifene,small molecule,approved|investigational,"BCRP/ABCG2 Substrates|Benzene Derivatives|Benzylidene Compounds|Bone Density Conservation Agents|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strong)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Estrogen Agonist-antagonists|Estrogen Agonist/Antagonist|Estrogen Antagonists|Estrogen Receptor Modulators|Genito Urinary System and Sex Hormones|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein substrates|Selective Estrogen Receptor Modulators|Sex Hormones and Modulators of the Genital System|Stilbenes|UGT1A1 Substrates",OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2,5035
469,DB00482,Celecoxib,small molecule,approved|investigational,"Agents causing hyperkalemia|Agents that produce hypertension|Amides|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antineoplastic and Immunomodulating Agents|Antirheumatic Agents|BCRP/ABCG2 Substrates|BSEP/ABCB11 Inhibitors|Central Nervous System Agents|COX-2 Inhibitors|Cyclooxygenase Inhibitors|Cyclooxygenase-2 (COX-2) Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Methemoglobinemia Associated Agents|Musculo-Skeletal System|Nephrotoxic agents|P-glycoprotein substrates|Peripheral Nervous System Agents|Photosensitizing Agents|Pyrazoles|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory System Agents|Sulfonamides|Sulfones|Sulfur Compounds",CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,2662
470,DB00483,Gallamine triethiodide,small molecule,approved,Agents producing tachycardia|Amines|Ammonium Compounds|Anticholinergic Agents|Central Nervous System Depressants|Cholinergic Agents|Cholinesterase Inhibitors|Muscarinic Antagonists|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular-Blocking Agents (Nondepolarizing)|Neurotransmitter Agents|Nicotinic Antagonists|Nitrogen Compounds|Onium Compounds|Peripheral Nervous System Agents|Quaternary Ammonium Compounds,[I-].[I-].[I-].CC[N+](CC)(CC)CCOC1=CC=CC(OCC[N+](CC)(CC)CC)=C1OCC[N+](CC)(CC)CC,6172
471,DB00484,Brimonidine,small molecule,approved,"Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Antiglaucoma Preparations and Miotics|Cardiovascular Agents|Central Nervous System Depressants|Dermatologicals|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Misc. Skin and Mucous Membrane Agents|Ophthalmologicals|Quinoxalines|Sensory Organs|Sympathomimetics in Glaucoma Therapy",BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,2435
472,DB00485,Dicloxacillin,small molecule,approved|investigational|vet_approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|Beta-Lactamase Resistant Penicillins|beta-Lactams|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Heterocyclic Compounds, Fused-Ring|Lactams|Penicillins|Sulfur Compounds",[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=C(Cl)C=CC=C1Cl)C(O)=O,18381
473,DB00486,Nabilone,small molecule,approved|investigational,Agents producing tachycardia|Alimentary Tract and Metabolism|Antiemetics|Antiemetics and Antinauseants|Autonomic Agents|Cannabinoids and similars|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Drugs causing inadvertant photosensitivity|Gastrointestinal Agents|Hypotensive Agents|Miscellaneous Antiemetics|Peripheral Nervous System Agents|Photosensitizing Agents|Psychotropic Drugs|Terpenes|Tranquilizing Agents,[H][C@@]12CC(=O)CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC,5284592
474,DB00487,Pefloxacin,small molecule,approved,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCN(C)CC1,51081
475,DB00488,Altretamine,small molecule,approved,"Alkylating Activity|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Immunosuppressive Agents|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Noxae|Toxic Actions|Triazines",CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,2123
476,DB00489,Sotalol,small molecule,approved,"Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Autonomic Agents|Beta Blocking Agents and Thiazides|Beta Blocking Agents, Non-Selective|Beta Blocking Agents, Non-Selective, and Thiazides|Bradycardia-Causing Agents|Cardiac Rhythm Alteration|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Ethanolamines|Highest Risk QTc-Prolonging Agents|Hypotensive Agents|Narrow Therapeutic Index Drugs|Neurotransmitter Agents|Peripheral Nervous System Agents|QTc Prolonging Agents|Sympatholytics",CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,5253
477,DB00490,Buspirone,small molecule,approved|investigational,Agents that produce hypertension|Azaspirodecanedione Derivatives|Central Nervous System Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Substrates|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs that are Mainly Renally Excreted|Miscellaneous Anxiolytics Sedatives and Hypnotics|Nervous System|Neurotransmitter Agents|P-glycoprotein inhibitors|Piperazines|Psycholeptics|Pyrimidines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Spiro Compounds|Tranquilizing Agents,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,2477
478,DB00491,Miglitol,small molecule,approved,Alimentary Tract and Metabolism|Alkaloids|Blood Glucose Lowering Agents|Carbohydrates|Drugs Used in Diabetes|Enzyme Inhibitors|Glycoside Hydrolase Inhibitors|Hypoglycemia-Associated Agents|Imines|Imino Pyranoses|Imino Sugars|Piperidines,OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,441314
479,DB00492,Fosinopril,small molecule,approved,"ACE Inhibitors and Diuretics|Acids|Acids, Acyclic|Acids, Noncarboxylic|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Cardiovascular Agents|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Hypotensive Agents|Imines|Imino Acids|Organophosphorus Compounds|Phosphinic Acids|Phosphorus Acids|Phosphorus Compounds|Photosensitizing Agents|Protease Inhibitors",CCC(=O)O[C@@H](O[P@](=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C,55891
480,DB00493,Cefotaxime,small molecule,approved,"Agents that reduce seizure threshold|Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephacetrile|Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins",[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,5742673
481,DB00494,Entacapone,small molecule,approved|investigational,Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Benzene Derivatives|Central Nervous System Agents|Central Nervous System Depressants|COMT Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Enzyme Inhibitors|Nervous System|Phenols|UGT1A9 Substrates,CCN(CC)C(=O)C(=C\C1=CC(=C(O)C(O)=C1)[N+]([O-])=O)\C#N,5281081
482,DB00495,Zidovudine,small molecule,approved,"Agents Causing Muscle Toxicity|Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antimetabolites|Antiviral Agents|Antivirals for Systemic Use|BCRP/ABCG2 Substrates|Carbohydrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Deoxyribonucleosides|Dideoxynucleosides|Direct Acting Antivirals|Enzyme Inhibitors|Glycosides|Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Immunosuppressive Agents|Myelosuppressive Agents|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|Nucleoside Reverse Transcriptase Inhibitors|Nucleosides|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|P-glycoprotein substrates|Pyrimidine Nucleosides|Pyrimidines|Reverse Transcriptase Inhibitors|Toxic Actions|UGT1A1 Inducers|UGT1A1 Substrates|UGT2B7 substrates",CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O,35370
483,DB00496,Darifenacin,small molecule,approved|investigational,"Agents producing tachycardia|Anticholinergic Agents|Cholinergic Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs for Urinary Frequency and Incontinence|Genito Urinary System and Sex Hormones|Heterocyclic Compounds, Fused-Ring|Muscarinic Antagonists|Neurotransmitter Agents|Urological Agents|Urologicals",NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,444031
484,DB00497,Oxycodone,small molecule,approved|illicit|investigational,"Alkaloids|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Morphinans|Morphine Derivatives|Narcotics|Natural Opium Alkaloids|Nervous System|Opiate Agonists|Opiate Alkaloids|Opioid Agonist|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Semi-synthetic Opioids|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",COC1=C2O[C@H]3C(=O)CC[C@@]4(O)[C@H]5CC(C=C1)=C2[C@@]34CCN5C,5284603
485,DB00498,Phenindione,small molecule,approved|investigational,Anticoagulants|Blood and Blood Forming Organs|Hematologic Agents|Indans|Indenes|Narrow Therapeutic Index Drugs|Vitamin K Antagonists,O=C1C(C(=O)C2=CC=CC=C12)C1=CC=CC=C1,4760
486,DB00499,Flutamide,small molecule,approved|investigational,"Amides|Amines|Androgen Receptor Antagonists|Androgen Receptor Inhibitor|Anilides|Aniline Compounds|Antiandrogens|Antiandrogens, non-steroidal|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Endocrine Therapy|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Methemoglobinemia Associated Agents",CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F,3397
487,DB00500,Tolmetin,small molecule,approved,"Acetic Acid Derivatives and Related Substances|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antirheumatic Agents|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|OAT1/SLC22A6 inhibitors|Peripheral Nervous System Agents|Sensory System Agents|Topical Products for Joint and Muscular Pain",CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1,5509
488,DB00501,Cimetidine,small molecule,approved|investigational,Acid Reducers|Adjuvants|Agents Causing Muscle Toxicity|Alimentary Tract and Metabolism|Amidines|Anti-Ulcer Agents|BSEP/ABCB11 Inhibitors|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (moderate)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Gastric Acid Lowering Agents|Gastrointestinal Agents|Guanidines|Histamine Agents|Histamine Antagonists|Histamine H2 Antagonists|Imidazoles|MATE 1 Inhibitors|MATE 1 Substrates|MATE 2 Inhibitors|MATE 2 Substrates|MATE inhibitors|MATE substrates|Neurotransmitter Agents|OAT1/SLC22A6 inhibitors|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OCT1 inhibitors|OCT1 substrates|OCT2 Inhibitors|OCT2 Substrates|P-glycoprotein inducers|P-glycoprotein substrates,CN\C(NCCSCC1=C(C)NC=N1)=N\C#N,2756
489,DB00502,Haloperidol,small molecule,approved,Agents that reduce seizure threshold|Anti-Dyskinesia Agents|Antiemetics|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Autonomic Agents|Butyrophenone Derivatives|Butyrophenones|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Gastrointestinal Agents|Hyperglycemia-Associated Agents|Ketones|Moderate Risk QTc-Prolonging Agents|Nervous System|Neurotoxic agents|Neurotransmitter Agents|NMDA Receptor Antagonists|P-glycoprotein inhibitors|P-glycoprotein substrates|Peripheral Nervous System Agents|Photosensitizing Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Tranquilizing Agents|UGT1A9 Substrates,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,3559
490,DB00503,Ritonavir,small molecule,approved|investigational,"Acids, Acyclic|Agents Causing Muscle Toxicity|Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Antivirals for treatment of HCV infections|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Breast Cancer Resistance Protein Inhibitors|BSEP/ABCB11 Inhibitors|BSEP/ABCB11 Substrates|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (weak)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (weak)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strong)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strong)|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Direct Acting Antivirals|Enzyme Inhibitors|Experimental Unapproved Treatments for COVID-19|HIV Protease Inhibitors|Hyperglycemia-Associated Agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein inducers|P-glycoprotein inhibitors|P-glycoprotein substrates|Potential QTc-Prolonging Agents|Protease Inhibitors|QTc Prolonging Agents|Sulfur Compounds|Thiazoles|UDP Glucuronosyltransferases Inducers|UGT1A1 Inducers",CC(C)[C@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)OCC1=CN=CS1)CC1=CC=CC=C1,392622
491,DB00504,Levallorphan,small molecule,approved,"Alkaloids|Central Nervous System Agents|Heterocyclic Compounds, Fused-Ring|Morphinans|Opiate Alkaloids|Opioid Antagonists|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents",[H][C@@]12CCCC[C@@]11CCN(CC=C)[C@@H]2CC2=C1C=C(O)C=C2,5359371
492,DB00505,Tridihexethyl,small molecule,withdrawn,"Agents producing tachycardia|Alimentary Tract and Metabolism|Amines|Ammonium Compounds|Anticholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Nitrogen Compounds|Onium Compounds|Synthetic Anticholinergics, Quaternary Ammonium Compounds",CC[N+](CC)(CC)CCC(O)(C1CCCCC1)C1=CC=CC=C1,20299
493,DB00507,Nitazoxanide,small molecule,approved|investigational|vet_approved,"Anti-Infective Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Sulfur Compounds",CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C(S1)[N+]([O-])=O,41684
494,DB00508,Triflupromazine,small molecule,approved|vet_approved,"Agents producing tachycardia|Anticholinergic Agents|Antidepressive Agents|Antiemetics|Antipsychotic Agents|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cholinesterase Inhibitors|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Muscarinic Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|P-glycoprotein inhibitors|Peripheral Nervous System Agents|Phenothiazines|Phenothiazines With Aliphatic Side-Chain|Psycholeptics|Psychotropic Drugs|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Tranquilizing Agents",CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,5568
495,DB00509,Dextrothyroxine,small molecule,approved|investigational,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Lipid Modifying Agents|Lipid Modifying Agents, Plain",N[C@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,8730
496,DB00511,Acetyldigitoxin,small molecule,approved,"Antiarrhythmic agents|Carbohydrates|Cardanolides|Cardenolides|Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Digitalis Glycosides|Enzyme Inhibitors|Fused-Ring Compounds|Glycosides|Protective Agents|Steroids",[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](OC(C)=O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)C1=CC(=O)OC1,5284512
497,DB00512,Vancomycin,small molecule,approved,"Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antiinfectives for Systemic Use|Carbohydrates|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Glycoconjugates|Glycopeptide Antibacterials|Glycopeptides|Intestinal Antiinfectives|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Peptides",CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,14969
498,DB00513,Aminocaproic acid,small molecule,approved|investigational,"Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Aminocaproates|Antifibrinolytic Agents|Blood and Blood Forming Organs|Caproates|Coagulants|Decreased Fibrinolysis|Fatty Acids|Fatty Acids, Volatile|Fibrin Modulating Agents|Hematologic Agents|Hemostatics|Lipids",NCCCCCC(O)=O,564
499,DB00514,Dextromethorphan,small molecule,approved,"Alkaloids|Anticholinergic Agents|Antidepressive Agents|Antitussive Agents|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cough and Cold Preparations|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Substrates|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Expectorants|Heterocyclic Compounds, Fused-Ring|Morphinans|Narcotics|Nervous System|Neurotransmitter Agents|Nicotinic Antagonists|NMDA Receptor Antagonists|Opiate Alkaloids|Opium Alkaloids and Derivatives|Phenanthrenes|Respiratory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Sigma-1 Agonist|Sigma-1 Receptor Agonists|Uncompetitive N-methyl-D-aspartate Receptor Antagonist|Uncompetitive NMDA Receptor Antagonists",[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,5360696
500,DB00515,Cisplatin,small molecule,approved,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Cardiotoxic antineoplastic agents|Chlorine Compounds|Cholinesterase Inhibitors|Compounds used in a research, industrial, or household setting|Cross-Linking Reagents|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Immunosuppressive Agents|Indicators and Reagents|Laboratory Chemicals|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Nitrogen Compounds|OCT2 Inhibitors|OCT2 Substrates|OCT2 substrates with narrow therapeutic index|P-glycoprotein substrates|Platinum Compounds|Radiation-Sensitizing Agents",[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H],2767
501,DB00516,Bentoquatam,small molecule,approved,"Acids|Acids, Noncarboxylic|Aluminium Compounds|Aluminum Silicates|Anions|Dermatologicals|Electrolytes|Ions|Metal cations|Metal divalent cations|Minerals|Oxides|Oxygen Compounds|Silicates|Silicon Compounds",,
502,DB00517,Anisotropine methylbromide,small molecule,approved,Agents producing tachycardia|Alkaloids|Anticholinergic Agents|Aza Compounds|Azabicyclo Compounds|Cholinergic Agents|Muscarinic Antagonists|Neurotransmitter Agents,[Br-].CCCC(CCC)C(=O)O[C@H]1CC2CCC(C1)[N+]2(C)C,21867154
503,DB00518,Albendazole,small molecule,approved|vet_approved,"Acids, Acyclic|Anthelmintics|Anti-Infective Agents|Anticestodal Agents|Antihelminthic|Antimitotic Agents|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiplatyhelmintic Agents|Benzimidazole Derivatives|Benzimidazoles|Carbamates|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strong)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Mitosis Modulators|P-glycoprotein substrates|Tubulin Modulators",CCCSC1=CC2=C(C=C1)N=C(NC(=O)OC)N2,2082
504,DB00519,Trandolapril,small molecule,approved,"ACE Inhibitors and Calcium Channel Blockers|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Cardiovascular Agents|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Protease Inhibitors",[H][C@@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC3=CC=CC=C3)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O,5484727
505,DB00520,Caspofungin,small molecule,approved,"Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antifungal Agents|Antiinfectives for Systemic Use|Antimycotics for Systemic Use|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Echinocandin Antifungal|Echinocandins|Enzyme Inhibitors|Lipids|Lipopeptides|OAT1/SLC22A6 inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein inhibitors|Peptides|Peptides, Cyclic",CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN,3035406
506,DB00521,Carteolol,small molecule,approved,"Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antiglaucoma Preparations and Miotics|Antihypertensive Agents|Autonomic Agents|Beta Blocking Agents, Non-Selective|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Neurotransmitter Agents|Ophthalmologicals|Peripheral Nervous System Agents|Phenoxypropanolamines|Potential QTc-Prolonging Agents|Propanolamines|Propanols|QTc Prolonging Agents|Quinolines|Quinolones|Sensory Organs|Sympatholytics",CC(C)(C)NCC(O)COC1=CC=CC2=C1CCC(=O)N2,2583
507,DB00522,Bentiromide,small molecule,investigational|withdrawn,"Acids, Carbocyclic|Aminobenzoates|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Diagnostic Agents|Indicators and Reagents|Laboratory Chemicals|Pancreatic Function Tests|Tests for Pancreatic Function",OC(=O)C1=CC=C(NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)C2=CC=CC=C2)C=C1,6957673
508,DB00523,Alitretinoin,small molecule,approved|investigational,"Agents for Dermatitis, Excluding Corticosteroids|Alkenes|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Dermatologicals|Hydrocarbons, Acyclic|Misc. Skin and Mucous Membrane Agents|P-glycoprotein substrates|Pigments, Biological|Polyenes|Retinoids|Terpenes|Tretinoin|Vitamin A|Vitamins|Vitamins (Fat Soluble)",C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O,449171
509,DB00524,Metolazone,small molecule,approved,"Amides|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Cardiovascular Agents|Diuretics|Drugs that are Mainly Renally Excreted|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Heterocyclic Compounds, Fused-Ring|Hyperglycemia-Associated Agents|Hypotensive Agents|Increased Diuresis|Low-Ceiling Diuretics and Potassium-Sparing Agents|Low-Ceiling Diuretics, Excl. Thiazides|Membrane Transport Modulators|Natriuretic Agents|Non Potassium Sparing Diuretics|Quinazolines|Quinazolinones|Sodium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds|Thiazide-like Diuretic",CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,4170
510,DB00525,Tolnaftate,small molecule,approved|investigational|vet_approved,"Acids, Acyclic|Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Carbamates|Dermatologicals|Naphthalenes|Sulfur Compounds|Thiocarbamates",CN(C(=S)OC1=CC2=CC=CC=C2C=C1)C1=CC=CC(C)=C1,5510
511,DB00526,Oxaliplatin,small molecule,approved|investigational,Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Coordination Complexes|Immunosuppressive Agents|Moderate Risk QTc-Prolonging Agents|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|OCT2 Substrates|OCT2 substrates with narrow therapeutic index|Organometallic Compounds|Platinum Compounds|QTc Prolonging Agents,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,6857599
512,DB00527,Cinchocaine,small molecule,approved|vet_approved,"Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Amides|Analgesics and Anesthetics|Anesthetics|Anesthetics for Topical Use|Anesthetics, Local|Antipruritics and Local Anesthetics|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Cell-mediated Immunity|Central Nervous System Agents|Cholinesterase Inhibitors|Dermatologicals|Heterocyclic Compounds, Fused-Ring|Increased Histamine Release|Nervous System|Ophthalmologicals|Otologicals|Peripheral Nervous System Agents|Quinolines|Sensory Organs|Sensory System Agents|Standardized Chemical Allergen|Vasoprotectives",CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC,3025
513,DB00528,Lercanidipine,small molecule,approved|investigational,ACE Inhibitors and Calcium Channel Blockers|Agents causing hyperkalemia|Agents Causing Muscle Toxicity|Angiotensin II receptor blockers (ARBs) and calcium channel blockers|Antiarrhythmic agents|Antihypertensive Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dihydropyridine Derivatives|Hypotensive Agents|Membrane Transport Modulators|Pyridines|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1,65866
514,DB00529,Foscarnet,small molecule,approved,"Acetates|Acids, Acyclic|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Chelating Activity|Direct Acting Antivirals|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|Nephrotoxic agents|Nucleic Acid Synthesis Inhibitors|OAT1/SLC22A6 inhibitors|Organophosphonates|Organophosphorus Compounds|Phosphonic Acid Derivatives|Potential QTc-Prolonging Agents|Pyrophosphate Analog DNA Polymerase Inhibitor|QTc Prolonging Agents|Reverse Transcriptase Inhibitors",OC(=O)P(O)(O)=O,3415
515,DB00530,Erlotinib,small molecule,approved|investigational,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|Kinase Inhibitor|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Protein Kinase Inhibitors|QTc Prolonging Agents|Quinazolines|Tyrosine Kinase Inhibitors|UGT1A1 Inhibitors",COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,176870
516,DB00531,Cyclophosphamide,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Alkylating Activity|Alkylating Drugs|Anions|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Antirheumatic Agents|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Electrolytes|Hydrocarbons, Halogenated|Immunologic Factors|Immunosuppressive Agents|Ions|Methemoglobinemia Associated Agents|Mustard Compounds|Mutagens|Myeloablative Agonists|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Neurotoxic agents|Nitrogen Mustard Analogues|Nitrogen Mustard Compounds|Noxae|Organophosphorus Compounds|Phosphoramide Mustards|Phosphoramides|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Toxic Actions",ClCCN(CCCl)P1(=O)NCCCO1,2907
517,DB00532,Mephenytoin,small molecule,approved|investigational|withdrawn,Anti-epileptic Agent|Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Decreased Central Nervous System Disorganized Electrical Activity|Hydantoins|Imidazoles|Imidazolidines|Nervous System|Thyroxine-binding globulin substrates,CCC1(NC(=O)N(C)C1=O)C1=CC=CC=C1,4060
518,DB00533,Rofecoxib,small molecule,approved|investigational|withdrawn,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|COX-2 Inhibitors|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strong)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory System Agents|Sulfur Compounds",CS(=O)(=O)C1=CC=C(C=C1)C1=C(C(=O)OC1)C1=CC=CC=C1,5090
519,DB00534,Chlormerodrin,small molecule,approved|withdrawn,Alkylmercury Compounds|Organomercury Compounds|Organometallic Compounds,COC(CNC(N)=O)C[Hg]Cl,25210
520,DB00535,Cefdinir,small molecule,approved,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Lactams|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Substrates|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins",[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,6915944
521,DB00536,Guanidine,small molecule,approved,Acetylcholine Releasing Agent|Amidines|Guanidines|Increased Acetylcholine Activity|MATE 1 Substrates|MATE 2 Substrates|MATE substrates|OAT3/SLC22A8 Inhibitors|OCT1 inhibitors|OCT2 Inhibitors,NC(N)=N,3520
522,DB00537,Ciprofloxacin,small molecule,approved|investigational,"Agents Causing Muscle Toxicity|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strong)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (moderate)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|MATE 1 Inhibitors|MATE 1 Substrates|MATE 2 Inhibitors|MATE inhibitors|MATE substrates|Moderate Risk QTc-Prolonging Agents|Ophthalmological and Otological Preparations|Ophthalmologicals|Otologicals|P-glycoprotein substrates|Photosensitizing Agents|QTc Prolonging Agents|Quinolines|Quinolone Antimicrobial|Quinolones|Sensory Organs|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O,2764
523,DB00538,Gadoversetamide,small molecule,approved|investigational,"Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Gadolinium-based Contrast Agent|Magnetic Resonance Contrast Activity|Magnetic Resonance Imaging Contrast Media|Other Diagnostics|Paramagnetic Contrast Agent|Paramagnetic Contrast Media",[Gd+3].COCCNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NCCOC)CC([O-])=O)CC([O-])=O,444013
524,DB00539,Toremifene,small molecule,approved|investigational,"Anti-Estrogens|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|Benzene Derivatives|Benzylidene Compounds|Bone Density Conservation Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Endocrine Therapy|Estrogen Agonist/Antagonist|Estrogen Receptor Modulators|Highest Risk QTc-Prolonging Agents|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|P-glycoprotein inhibitors|P-glycoprotein substrates|QTc Prolonging Agents|Selective Estrogen Receptor Modulators|Stilbenes",CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,3005573
525,DB00540,Nortriptyline,small molecule,approved,"Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that produce hypertension|Agents that reduce seizure threshold|Anticholinergic Agents|Antidepressive Agents|Antidepressive Agents, Tricyclic|Benzocycloheptenes|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dibenzocycloheptenes|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Histamine Antagonists|Histamine H1 Antagonists|Membrane Transport Modulators|Muscarinic Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Non-Selective Monoamine Reuptake Inhibitors|P-glycoprotein substrates|Potential QTc-Prolonging Agents|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists|Tricyclics and Other Norepinephrine-reuptake Inhibitors",CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,4543
526,DB00541,Vincristine,small molecule,approved|investigational,"Agents Causing Muscle Toxicity|Alkaloids|Antimitotic Agents|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|BSEP/ABCB11 Substrates|BSEP/ABCB11 Substrates with Narrow Therapeutic Index|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Immunosuppressive Agents|Indole Alkaloids|Indoles|Mitosis Modulators|Narrow Therapeutic Index Drugs|Neurotoxic agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein inducers|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Secologanin Tryptamine Alkaloids|Tubulin Modulators|Vinca Alkaloids",[H][C@@]12N3CC[C@@]11C4=C(C=C(OC)C(=C4)[C@]4(C[C@H]5C[N@](C[C@](O)(CC)C5)CCC5=C4NC4=CC=CC=C54)C(=O)OC)N(C=O)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC,5978
527,DB00542,Benazepril,small molecule,approved|investigational,"ACE Inhibitors and Diuretics|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Cardiovascular Agents|Decreased Blood Pressure|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Photosensitizing Agents|Protease Inhibitors",[H][C@@]1(CCC2=CC=CC=C2N(CC(O)=O)C1=O)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,5362124
528,DB00543,Amoxapine,small molecule,approved,"Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that produce hypertension|Agents that reduce seizure threshold|Anticholinergic Agents|Antidepressive Agents|Antidepressive Agents, Tetracyclic|Antidepressive Agents, Tricyclic|Antipsychotic Agents|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dibenzoxazepines|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Heterocyclic Compounds, Fused-Ring|Histamine Antagonists|Histamine H1 Antagonists|Membrane Transport Modulators|Muscarinic Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Non-Selective Monoamine Reuptake Inhibitors|P-glycoprotein inhibitors|Potential QTc-Prolonging Agents|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists",ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1,2170
529,DB00544,Fluorouracil,small molecule,approved,Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Fluoropyrimidines|Fluorouracil and prodrugs|Immunologic Factors|Immunosuppressive Agents|Misc. Skin and Mucous Membrane Agents|Moderate Risk QTc-Prolonging Agents|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleoside Metabolic Inhibitor|Photosensitizing Agents|Pyrimidine Analogues|Pyrimidines|Pyrimidinones|QTc Prolonging Agents|Thyroxine-binding globulin inducers|Toxic Actions,FC1=CNC(=O)NC1=O,3385
530,DB00545,Pyridostigmine,small molecule,approved|investigational,Cholinergic Agents|Cholinesterase Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 Enzyme Inducers|Enzyme Inhibitors|Nervous System|Neurotransmitter Agents|Parasympathomemetic (Cholinergic) Agents|Parasympathomimetics|Pyridines|Pyridinium Compounds,CN(C)C(=O)OC1=C[N+](C)=CC=C1,4991
531,DB00546,Adinazolam,small molecule,experimental,"Anti-Anxiety Agents|Antidepressive Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Nervous System|Psycholeptics|Psychotropic Drugs|Triazolobenzodiazepines",CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,37632
532,DB00547,Desoximetasone,small molecule,approved,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Dermatologicals|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Pregnadienediols|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated",[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,5311067
533,DB00548,Azelaic acid,small molecule,approved,"Acids, Acyclic|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Decreased Protein Synthesis|Decreased Sebaceous Gland Activity|Dermatologicals|Drugs that are Mainly Renally Excreted|Misc. Skin and Mucous Membrane Agents",OC(=O)CCCCCCCC(O)=O,2266
534,DB00549,Zafirlukast,small molecule,approved|investigational,"Agents to Treat Airway Disease|Anti-Asthmatic Agents|Benzene Derivatives|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs for Obstructive Airway Diseases|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Leukotriene Antagonists|Leukotriene Modifiers|Respiratory System Agents|Sulfones|Sulfur Compounds",COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,5717
535,DB00550,Propylthiouracil,small molecule,approved|investigational,"Agents Causing Muscle Toxicity|Antimetabolites|Antithyroid agents|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Myelosuppressive Agents|Noxae|Pyrimidines|Pyrimidinones|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thiouracil|Thiouracils|Thyroid Hormone Synthesis Inhibitor|Thyroid Hormone Synthesis Inhibitors|Thyroid Products|Toxic Actions",CCCC1=CC(=O)NC(=S)N1,657298
536,DB00551,Acetohydroxamic acid,small molecule,approved,Amines|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Hydroxy Acids|Hydroxylamines|Urease Inhibitor|Urease Inhibitors|Urologicals,CC(=O)NO,1990
537,DB00552,Pentostatin,small molecule,approved|investigational,"Adenosine Deaminase Inhibitors|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Cardiotoxic antineoplastic agents|Coformycin|Deoxyribonucleosides|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Enzyme Inhibitors|Formycins|Glycosides|Immunosuppressive Agents|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Metabolic Inhibitor|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",OC[C@H]1O[C@H](C[C@@H]1O)N1C=NC2=C1N=CNC[C@H]2O,439693
538,DB00553,Methoxsalen,small molecule,approved,"Antipsoriatics|Antipsoriatics for Systemic Use|Antipsoriatics for Topical Use|Benzopyrans|Coloring Agents|Compounds used in a research, industrial, or household setting|Cross-Linking Reagents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Drugs that are Mainly Renally Excreted|Furocoumarins|Heterocyclic Compounds, Fused-Ring|Indicators and Reagents|Laboratory Chemicals|Photoabsorption|Photoactivated Radical Generator|Photosensitizing Activity|Photosensitizing Agents|Photosensitizing agents used for phototherapy|Psoralens for Systemic Use|Psoralens for Topical Use|Pyrans|Radiation-Sensitizing Agents",COC1=C2OC(=O)C=CC2=CC2=C1OC=C2,4114
539,DB00554,Piroxicam,small molecule,approved|investigational,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antirheumatic Agents|Central Nervous System Agents|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|Ophthalmologicals|Other Nonsteroidal Anti-inflammatory Agents|Oxicams|Peripheral Nervous System Agents|Photosensitizing Agents|Sensory Organs|Sensory System Agents|Sulfur Compounds|Thiazines|Topical Products for Joint and Muscular Pain",CN1C(C(=O)NC2=NC=CC=C2)=C(O)C2=C(C=CC=C2)S1(=O)=O,54676228
540,DB00555,Lamotrigine,small molecule,approved|investigational,Agents causing hyperkalemia|Agents producing tachycardia|Anti-epileptic Agent|Antiarrhythmic agents|Anticholinergic Agents|Anticonvulsants|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Decreased Central Nervous System Disorganized Electrical Activity|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Membrane Transport Modulators|Miscellaneous Anticonvulsants|Mood Stabilizer|Muscarinic Antagonists|Nervous System|OCT1 substrates|OCT2 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Photosensitizing Agents|Potential QTc-Prolonging Agents|Psychotropic Drugs|QTc Prolonging Agents|Sodium Channel Blockers|Tranquilizing Agents|Triazines|UGT1A1 Inducers|UGT1A1 Substrates|UGT1A3 substrates|UGT1A4 substrates,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,3878
541,DB00556,Perflutren,small molecule,approved,"Amino Acids, Peptides, and Proteins|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Hydrocarbons, Fluorinated|Hydrocarbons, Halogenated|Microspheres|Moderate Risk QTc-Prolonging Agents|Other Diagnostics|Proteins|QTc Prolonging Agents|Ultrasound Contrast Activity|Ultrasound Contrast Media",FC(F)(F)C(F)(F)C(F)(F)F,6432
542,DB00557,Hydroxyzine,small molecule,approved,Anti-Anxiety Agents|Antipruritics|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Diphenylmethane Derivatives|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine Receptor Antagonists|Miscellaneous Anxiolytics Sedatives and Hypnotics|Nervous System|Neurotransmitter Agents|P-glycoprotein substrates|Piperazines|Potential QTc-Prolonging Agents|Psycholeptics|QTc Prolonging Agents,OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,3658
543,DB00558,Zanamivir,small molecule,approved|investigational,"Acids, Acyclic|Amidines|Amino Sugars|Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Carbohydrates|Direct Acting Antivirals|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Guanidines|Hydroxy Acids|Neuraminic Acids|Neuraminidase Inhibitors|Pyrans|Sialic Acids|Sugar Acids",[H][C@]1(OC(=C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,60855
544,DB00559,Bosentan,small molecule,approved|investigational,Amides|Antihypertensive Agents|Antihypertensives for Pulmonary Arterial Hypertension|BSEP/ABCB11 Inhibitors|Cardiovascular Agents|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (moderate)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Endothelin Receptor Antagonists|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hepatotoxic Agents|OATP1B1/SLCO1B1 Substrates|Pyrimidines|Sulfonamides|Sulfones|Sulfur Compounds|Vasodilating Agents,COC1=CC=CC=C1OC1=C(NS(=O)(=O)C2=CC=C(C=C2)C(C)(C)C)N=C(N=C1OCCO)C1=NC=CC=N1,104865
545,DB00560,Tigecycline,small molecule,approved,Agents that produce neuromuscular block (indirect)|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Enzyme Inhibitors|Glycylcyclines|Naphthacenes|Protein Synthesis Inhibitors|Tetracyclines,[H][C@@]12CC3=C(C(O)=C(NC(=O)CNC(C)(C)C)C=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2,54686904
546,DB00561,Doxapram,small molecule,approved|vet_approved,Agents that produce hypertension|Central Nervous System Agents|Central Nervous System Stimulants|Increased Medullary Respiratory Drive|Pyrrolidines|Pyrrolidinones|Respiratory System Agents,CCN1CC(CCN2CCOCC2)C(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1,3156
547,DB00562,Benzthiazide,small molecule,approved,"Amides|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Heterocyclic Compounds, Fused-Ring|Hyperglycemia-Associated Agents|Sodium Chloride Symporter Inhibitors|Stimulants|Sulfonamides|Sulfones|Sulfur Compounds|Thiazides",NS(=O)(=O)C1=CC2=C(C=C1Cl)N=C(CSCC1=CC=CC=C1)NS2(=O)=O,2343
548,DB00563,Methotrexate,small molecule,approved,"Abortifacient Agents|Abortifacient Agents, Nonsteroidal|Agents Causing Muscle Toxicity|Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Antirheumatic Agents|BCRP/ABCG2 Substrates|Biological Factors|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Dermatologicals|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Folic Acid Analogues|Folic Acid Antagonists|Hepatotoxic Agents|Heterocyclic Compounds, Fused-Ring|Immunologic Factors|Immunosuppressive Agents|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Noxae|Nucleic Acid Synthesis Inhibitors|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein substrates|Photosensitizing Agents|Pigments, Biological|Pteridines|Pterins|Reproductive Control Agents|Toxic Actions",CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,126941
549,DB00564,Carbamazepine,small molecule,approved|investigational,"Analgesics|Analgesics, Non-Narcotic|Anticonvulsants|Antimanic Agents|Carboxamide Derivatives|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strong)|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strong)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (moderate)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 CYP3A5 Inducers (strong)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Decreased Central Nervous System Disorganized Electrical Activity|Dibenzazepines|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Enzyme Inducing Antiepileptic Drugs|Heterocyclic Compounds, Fused-Ring|Immunosuppressive Agents|Inducers of Drug Clearance|Membrane Transport Modulators|Miscellaneous Anticonvulsants|Mood Stabilizer|Myelosuppressive Agents|P-glycoprotein inducers|P-glycoprotein substrates|Peripheral Nervous System Agents|Psychotropic Drugs|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sodium Channel Blockers|Thyroxine-binding globulin substrates|UGT1A1 Inducers|UGT1A6 inducer|UGT2B7 substrates",NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,2554
550,DB00565,Cisatracurium,small molecule,approved,"Alkaloids|Anticholinergic Agents|Benzylisoquinolines|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular Nondepolarizing Blockade|Neuromuscular-Blocking Agents (Nondepolarizing)|Nicotinic Antagonists|Peripheral Nervous System Agents",COC1=CC2=C(C=C1OC)[C@@H](CC1=CC(OC)=C(OC)C=C1)[N@@+](C)(CCC(=O)OCCCCCOC(=O)CC[N@@+]1(C)CCC3=C(C=C(OC)C(OC)=C3)[C@H]1CC1=CC(OC)=C(OC)C=C1)CC2,62886
551,DB00566,Succimer,small molecule,approved,"Acids, Acyclic|Antidotes|Chelating Agents|Compounds used in a research, industrial, or household setting|Dicarboxylic Acids|Lead Chelating Activity|Lead Chelator|Protective Agents|Sequestering Agents|Succinates|Sulfhydryl Compounds|Sulfur Compounds",OC(=O)[C@@H](S)[C@@H](S)C(O)=O,2724354
552,DB00567,Cephalexin,small molecule,approved|investigational|vet_approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|First-Generation Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|MATE 1 Substrates|MATE substrates|Nephrotoxic agents|OAT1/SLC22A6 inhibitors|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Sulfur Compounds|Thiazines",[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,27447
553,DB00568,Cinnarizine,small molecule,approved|investigational,Agents causing hyperkalemia|Antiarrhythmic agents|Antivertigo Preparations|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Nervous System|Neurotransmitter Agents|Piperazines|QTc Prolonging Agents|Vasodilating Agents,C(C=CC1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,2761
554,DB00569,Fondaparinux,small molecule,approved|investigational,Anticoagulants|Antithrombins|Blood and Blood Forming Organs|Carbohydrates|Cardiovascular Agents|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Factor Xa Inhibitors|Fibrin Modulating Agents|Fibrinolytic Agents|Hematologic Agents|Miscellaneous Anticoagulants|Oligosaccharides|Polysaccharides|Protease Inhibitors|Serine Protease Inhibitors,CO[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]5NS(O)(=O)=O)[C@H](O)[C@H]4O)C(O)=O)[C@H](OS(O)(=O)=O)[C@H]3NS(O)(=O)=O)[C@H](O)[C@H]2OS(O)(=O)=O)C(O)=O)[C@H](O)[C@H]1NS(O)(=O)=O,49852292
555,DB00570,Vinblastine,small molecule,approved,"Alkaloids|Antimitotic Agents|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Antineoplastic and Immunomodulating Agents|BSEP/ABCB11 Inhibitors|BSEP/ABCB11 Substrates|BSEP/ABCB11 Substrates with Narrow Therapeutic Index|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Immunosuppressive Agents|Indole Alkaloids|Indoles|Mitosis Modulators|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein inducers|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Secologanin Tryptamine Alkaloids|Tubulin Modulators|Vinca Alkaloids",[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=C2C=CC=C1)C(=O)OC,13342
556,DB00571,Propranolol,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Beta Blocking Agents and Thiazides|Beta Blocking Agents, Non-Selective|Beta Blocking Agents, Non-Selective, and Thiazides|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Hypotensive Agents|Moderate Risk QTc-Prolonging Agents|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Naphthalenes|Neurotransmitter Agents|OCT2 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Phenoxypropanolamines|Propanolamines|Propanols|QTc Prolonging Agents|Vasodilating Agents",CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,4946
557,DB00572,Atropine,small molecule,approved|vet_approved,"Adjuvants, Anesthesia|Agents producing tachycardia|Agents that produce hypertension|Alimentary Tract and Metabolism|Alkaloids|Anti-Asthmatic Agents|Antiarrhythmic agents|Anticholinergic Agents|Antimuscarinics Antispasmodics|Atropine Derivatives|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Belladonna Alkaloids|Belladonna Alkaloids, Tertiary Amines|Belladonna and Derivatives, Plain|Bronchodilator Agents|BSEP/ABCB11 Substrates|Cardiovascular Agents|Central Nervous System Agents|Cholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Moderate Risk QTc-Prolonging Agents|Muscarinic Antagonists|Mydriatics|Mydriatics and Cycloplegics|Neurotransmitter Agents|Ophthalmologicals|Parasympatholytics|Peripheral Nervous System Agents|QTc Prolonging Agents|Respiratory System Agents|Sensory Organs|Solanaceous Alkaloids|Tropanes",CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,174174
558,DB00573,Fenoprofen,small molecule,approved,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Phenylpropionates|Propionates|Sensory System Agents",CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1,3342
559,DB00574,Fenfluramine,small molecule,approved|illicit|investigational|withdrawn,"Alimentary Tract and Metabolism|Amines|Antidepressive Agents|Antiobesity Preparations, Excl. Diet Products|Central Nervous System Depressants|Centrally Acting Antiobesity Products|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Ethylamines|Membrane Transport Modulators|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Phenethylamines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists|Stimulants",CCNC(C)CC1=CC=CC(=C1)C(F)(F)F,3337
560,DB00575,Clonidine,small molecule,approved,"Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Analgesics|Anesthetics|Anesthetics, General|Antiadrenergic Agents, Centrally Acting|Antiglaucoma Preparations and Miotics|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Antimigraine Preparations|Autonomic Agents|Bradycardia-Causing Agents|Cardiovascular Agents|Central alpha-2 Adrenergic Agonist|Central Alpha-agonists|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Hypotensive Agents|Imidazoles|Imidazoline Receptor Agonists|Imidazolines|Nervous System|Neurotransmitter Agents|Ophthalmologicals|P-glycoprotein substrates|Peripheral Nervous System Agents|Sensory Organs|Sensory System Agents|Sympatholytics|Sympathomimetics in Glaucoma Therapy",ClC1=CC=CC(Cl)=C1NC1=NCCN1,2803
561,DB00576,Sulfamethizole,small molecule,approved|investigational|vet_approved,Amides|Amines|Aniline Compounds|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Irrigating Solutions|Ophthalmologicals|Sensory Organs|Short-Acting Sulfonamides|Sulfanilamides|Sulfathiazoles|Sulfonamides|SULFONAMIDES AND TRIMETHOPRIM|Sulfones|Sulfur Compounds|Thiazoles,CC1=NN=C(NS(=O)(=O)C2=CC=C(N)C=C2)S1,5328
562,DB00577,Valaciclovir,small molecule,approved|investigational,"Acyclovir and prodrug|Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Direct Acting Antivirals|Drugs that are Mainly Renally Excreted|Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor|Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor|Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor|Heterocyclic Compounds, Fused-Ring|Nephrotoxic agents|Nucleic Acid Synthesis Inhibitors|Nucleosides and Nucleotides|Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors|OAT3/SLC22A8 Substrates|Prodrugs|Purines|Purinones",CC(C)[C@H](N)C(=O)OCCOCN1C=NC2=C1NC(N)=NC2=O,60773
563,DB00578,Carbenicillin,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|OAT1/SLC22A6 inhibitors|Penicillin G|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds",[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C(C(O)=O)C1=CC=CC=C1)C(O)=O,20824
564,DB00579,Mazindol,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic Uptake Inhibitors|Alimentary Tract and Metabolism|Anorexigenic Agents & Respiratory and Cerebral Stimulants, Miscellaneous|Anorexigenic Agents & Respiratory and CNS Stimulants|Antidepressive Agents|Antiobesity Preparations, Excl. Diet Products|Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Stimulants|Centrally Acting Antiobesity Products|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Dopamine Agents|Dopamine Uptake Inhibitors|Heterocyclic Compounds, Fused-Ring|Isoindoles|Membrane Transport Modulators|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators",OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1,4020
565,DB00580,Valdecoxib,small molecule,approved|investigational|withdrawn,"Agents causing hyperkalemia|Agents that produce hypertension|Amides|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|COX-2 Inhibitors|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory System Agents|Sulfones|Sulfur Compounds|UGT1A9 Substrates",CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O,119607
566,DB00581,Lactulose,small molecule,approved,Acidifying Activity|Alimentary Tract and Metabolism|Ammonia Detoxicants|Carbohydrates|Disaccharides|Drugs for Constipation|Gastrointestinal Agents|Laxatives|Osmotic Activity|Osmotic Laxatives|Stimulation Large Intestine Fluid/Electrolyte Secretion,OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O,11333
567,DB00582,Voriconazole,small molecule,approved,"14-alpha Demethylase Inhibitors|Anti-Infective Agents|Antifungal Agents|Antiinfectives for Systemic Use|Antimycotics for Systemic Use|Azole Antifungals|Chemically-Induced Disorders|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (moderate)|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (moderate)|Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Photosensitizing Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Steroid Synthesis Inhibitors|Triazole Derivatives|Triazoles",C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,71616
568,DB00583,Levocarnitine,small molecule,approved|investigational,Alimentary Tract and Metabolism|Amines|Amino Acids and Derivatives|Ammonium Compounds|Caloric Agents|Carnitine Analog|Dietary Supplements|Drugs that are Mainly Renally Excreted|Nitrogen Compounds|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Inhibitors|Onium Compounds|Quaternary Ammonium Compounds|Trimethyl Ammonium Compounds|Vitamin B Complex|Vitamins,C[N+](C)(C)C[C@H](O)CC([O-])=O,10917
569,DB00584,Enalapril,small molecule,approved|vet_approved,"ACE Inhibitors and Calcium Channel Blockers|ACE Inhibitors and Diuretics|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents Causing Muscle Toxicity|Amino Acids, Peptides, and Proteins|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 Substrates|Decreased Blood Pressure|Dipeptides|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Hypotensive Agents|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Substrates|Oligopeptides|P-glycoprotein inhibitors|Peptides|Photosensitizing Agents|Protease Inhibitors",CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,5388962
570,DB00585,Nizatidine,small molecule,approved,Acid Reducers|Agents Causing Muscle Toxicity|Alimentary Tract and Metabolism|Anti-Ulcer Agents|Cholinesterase Inhibitors|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Gastric Acid Lowering Agents|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Histamine H2 Antagonists|Neurotransmitter Agents|P-glycoprotein substrates|Sulfur Compounds|Thiazoles,CNC(NCCSCC1=CSC(CN(C)C)=N1)=C[N+]([O-])=O,3033637
571,DB00586,Diclofenac,small molecule,approved|vet_approved,"Acetic Acid Derivatives and Related Substances|Acids, Carbocyclic|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Amines|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antimigraine Agents, Miscellaneous|Antirheumatic Agents|BSEP/ABCB11 Substrates|Central Nervous System Agents|Cyclooxygenase Inhibitors|Cyclooxygenase-2 (COX-2) Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Decreased Prostaglandin Production|Dermatologicals|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Ethylamines|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|Ophthalmologicals|Other Nonsteroidal Anti-inflammatory Agents|P-glycoprotein inducers|Peripheral Nervous System Agents|Phenylacetates|Photosensitizing Agents|Sensory Organs|Sensory System Agents|Topical Products for Joint and Muscular Pain|UGT1A1 Substrates|UGT1A3 substrates|UGT1A9 Substrates|UGT2B7 substrates",OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,3033
572,DB00587,Cinalukast,small molecule,experimental,Sulfur Compounds,CCC(CC)(CC(=O)NC1=CC(\C=C\C2=NC(=CS2)C2CCC2)=CC=C1)C(O)=O,6436135
573,DB00588,Fluticasone propionate,small molecule,approved,"Adrenal Cortex Hormones|Adrenals|Agents to Treat Airway Disease|Androstadienes|Androstanes|Androstenes|Anti-Allergic Agents|Anti-Asthmatic Agents|Anti-Inflammatory Agents|Autonomic Agents|Bronchodilator Agents|Central Nervous System Depressants|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Immunosuppressive Agents|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein substrates|Peripheral Nervous System Agents|Respiratory System Agents|Steroids|Thyroxine-binding globulin inhibitors",[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,444036
574,DB00589,Lisuride,small molecule,approved|investigational,"Agents that produce hypertension|Alkaloids|Analgesics|Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Antidepressive Agents|Antimigraine Preparations|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Agonists|Dopamine Antagonists|Ergolines|Ergot Alkaloids and Derivatives|Ergot-derivative Dopamine Receptor Agonists|Genito Urinary System and Sex Hormones|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotransmitter Agents|Prolactine Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Agonists|Serotonin Receptor Antagonists",[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,28864
575,DB00590,Doxazosin,small molecule,approved,"Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Antiadrenergic Agents, Peripherally Acting|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Cardiovascular Agents|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Neurotransmitter Agents|OCT1 inhibitors|P-glycoprotein inhibitors|Peripheral alpha-1 blockers|Quinazolines",COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1COC2=CC=CC=C2O1,3157
576,DB00591,Fluocinolone acetonide,small molecule,approved|investigational|vet_approved,"Adrenal Cortex Hormones|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Dermatologicals|Drugs that are Mainly Renally Excreted|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Ophthalmologicals|Otologicals|Pregnadienes|Pregnanes|Steroids|Steroids, Fluorinated|Vasoprotectives",[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,6215
577,DB00592,Piperazine,small molecule,approved|vet_approved,"Anthelmintics|Anti-Infective Agents|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Hyperglycemia-Associated Agents|Piperazine and Derivatives|Piperazines",C1CNCCN1,4837
578,DB00593,Ethosuximide,small molecule,approved,Agents causing hyperkalemia|Anti-epileptic Agent|Antiarrhythmic agents|Anticonvulsants|Bradycardia-Causing Agents|Calcium Channel Blockers|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Decreased Central Nervous System Disorganized Electrical Activity|Imides|Nervous System|Potential QTc-Prolonging Agents|Pyrrolidines|Pyrrolidinones|QTc Prolonging Agents|Succinimide Derivatives|Succinimides,CCC1(C)CC(=O)NC1=O,3291
579,DB00594,Amiloride,small molecule,approved,Acid Sensing Ion Channel Blockers|Agents causing hyperkalemia|Cardiovascular Agents|Decreased Renal K+ Excretion|Diuretics|Epithelial Sodium Channel Blockers|Hypotensive Agents|Increased Diuresis|Membrane Transport Modulators|Natriuretic Agents|OCT2 Inhibitors|Potassium-Sparing Diuretics|Pyrazines|Sodium Channel Blockers,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N,16231
580,DB00595,Oxytetracycline,small molecule,approved|investigational|vet_approved,Agents that produce neuromuscular block (indirect)|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antibiotics for Topical Use|Antiinfectives for Systemic Use|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Naphthacenes|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Ophthalmologicals|Sensory Organs|Tetracyclines,[H][C@@]12[C@@H](O)[C@@]3([H])C(C(=O)C4=C(C=CC=C4O)[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C,54675779
581,DB00596,Ulobetasol,small molecule,approved,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Cardiovascular Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Dermatologicals|Fused-Ring Compounds|Immunosuppressive Agents|Pregnadienes|Pregnadienetriols|Pregnanes|Psoriasis|Steroids|Steroids, Fluorinated|Vasoconstrictor Agents",[H][C@@]12C[C@H](C)[C@](O)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,5311167
582,DB00597,Gadoteridol,small molecule,approved|investigational,"Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Drugs that are Mainly Renally Excreted|Elements|Lanthanoid Series Elements|Magnetic Resonance Contrast Activity|Magnetic Resonance Imaging Contrast Media|Metals|Metals, Rare Earth|Other Diagnostics|Paramagnetic Contrast Agent|Paramagnetic Contrast Media",[Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1,60714
583,DB00598,Labetalol,small molecule,approved,Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents producing tachycardia|Alcohols|Alpha and Beta Blocking Agents|Alpha and Beta Blocking Agents and Thiazides|Amides|Amines|Amino Alcohols|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Autonomic Agents|Beta Blocking Agents and Thiazides|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Ethanolamines|Hypotensive Agents|Neurotransmitter Agents|Peripheral alpha-1 blockers|Peripheral Nervous System Agents|Salicylamides|Sympathomimetics|UGT1A1 Substrates|UGT1A9 Substrates|UGT2B7 substrates|Vasodilating Agents,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,3869
584,DB00599,Thiopental,small molecule,approved|vet_approved,"Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Anticholinergic Agents|Anticonvulsants|Barbiturates|Barbiturates, Plain|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Hypotensive Agents|Narrow Therapeutic Index Drugs|Nervous System|Neurotransmitter Agents|Nicotinic Antagonists|Psycholeptics|Pyrimidines|Pyrimidinones|Thiobarbiturates",CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,3000715
585,DB00600,Monobenzone,small molecule,approved,"alpha-Galactosidase, antagonists & inhibitors|Benzene Derivatives|Depigmenting Activity|Depigmenting Agents|Dermatologicals|Melanin Synthesis Inhibitors|Phenols",OC1=CC=C(OCC2=CC=CC=C2)C=C1,7638
586,DB00601,Linezolid,small molecule,approved|investigational,"Acetamides|Acetates|Acids, Acyclic|Agents that produce hypertension|Agents that reduce seizure threshold|Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antidepressive Agents|Antiinfectives for Systemic Use|Central Nervous System Depressants|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Immunosuppressive Agents|Lipids|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Monoamine Oxidase Inhibitors|Myelosuppressive Agents|Oxazoles|Oxazolidinone Antibacterial|Oxazolidinones|Protein Synthesis Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators",CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,441401
587,DB00602,Ivermectin,small molecule,approved|investigational|vet_approved,"Agents Causing Muscle Toxicity|Agrochemicals|Anthelmintics|Anti-Bacterial Agents|Anti-Infective Agents|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Avermectines|BCRP/ABCG2 Substrates|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Insecticides|Lactones|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein inducers|P-glycoprotein inhibitors|P-glycoprotein substrates|Pediculicides|Pesticides|Polyketides|Scabicides and Pediculicides|Toxic Actions",CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1O)O[C@H]1[C@H](C)O[C@H](C[C@@H]1OC)O[C@H]1[C@@H](C)\C=C\C=C2/CO[C@@H]3[C@H](O)C(C)=C[C@@H](C(=O)O[C@H]4C[C@@H](C\C=C1/C)O[C@@]1(CC[C@H](C)[C@@H](C(C)C)O1)C4)[C@]23O.CC[C@@H](C)[C@H]1O[C@@]2(CC[C@@H]1C)O[C@@H]1C\C=C(C)\[C@@H](O[C@@H]3O[C@@H](C)[C@H](O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](OC)C4)[C@@H](OC)C3)[C@@H](C)\C=C\C=C3/CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O[C@@H](C1)C2)[C@]34O,46936176
588,DB00603,Medroxyprogesterone acetate,small molecule,approved|investigational,"Adrenal Cortex Hormones|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptive Agents, Male|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Corpus Luteum Hormones|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Endocrine Therapy|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxyprogesterones|Hyperglycemia-Associated Agents|P-glycoprotein inhibitors|Pregnanes|Pregnen (4) Derivatives|Pregnenediones|Pregnenes|Progesterone and Derivatives|Progesterone Congeners|Progestin Contraceptives|Progestins|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids",[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C,6279
589,DB00604,Cisapride,small molecule,approved|investigational|withdrawn,"Acids, Carbocyclic|Alimentary Tract and Metabolism|Amides|Aminobenzoates|Anti-Ulcer Agents|Antidepressive Agents|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Central Nervous System Depressants|Chlorobenzoates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (moderate)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs for Functional Gastrointestinal Disorders|Gastrointestinal Agents|Highest Risk QTc-Prolonging Agents|Neurotransmitter Agents|para-Aminobenzoates|Piperidines|Propulsives|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Agonists",CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C1=CC(Cl)=C(N)C=C1OC,6917698
590,DB00605,Sulindac,small molecule,approved|investigational,"Acetic Acid Derivatives and Related Substances|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|Cyclooxygenase Inhibitors|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Indenes|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|OAT1/SLC22A6 inhibitors|Other Nonsteroidal Anti-inflammatory Agents|Peripheral Nervous System Agents|Photosensitizing Agents|Sensory System Agents",CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)=O,1548887
591,DB00606,Cyclothiazide,small molecule,approved,"Amides|Antihypertensive Agents|Cardiovascular Agents|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Heterocyclic Compounds, Fused-Ring|Hyperglycemia-Associated Agents|Natriuretic Agents|OAT1/SLC22A6 inhibitors|Receptors, AMPA|Sulfonamides|Sulfones|Sulfur Compounds|Thiazides",NS(=O)(=O)C1=C(Cl)C=C2NC(NS(=O)(=O)C2=C1)C1CC2CC1C=C2,2910
592,DB00607,Nafcillin,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|Beta-Lactamase Resistant Penicillins|beta-Lactams|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (moderate)|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Heterocyclic Compounds, Fused-Ring|Lactams|OAT1/SLC22A6 inhibitors|Penicillins|Sulfur Compounds",[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(OCC)C=CC2=CC=CC=C12)C(O)=O,8982
593,DB00608,Chloroquine,small molecule,approved|investigational|vet_approved,"Agents Causing Muscle Toxicity|Agents that produce neuromuscular block (indirect)|Agents that reduce seizure threshold|alpha-Galactosidase, antagonists & inhibitors|Amebicides|Aminoquinolines|Analgesics|Analgesics, Non-Narcotic|Anti-Infective Agents|Anti-Inflammatory Agents|Antimalarials|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Antirheumatic Agents|Central Nervous System Agents|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Experimental Unapproved Treatments for COVID-19|Filaricides|Heterocyclic Compounds, Fused-Ring|Methemoglobinemia Associated Agents|Moderate Risk QTc-Prolonging Agents|P-glycoprotein inhibitors|P-glycoprotein substrates|Peripheral Nervous System Agents|Photosensitizing Agents|QTc Prolonging Agents|Quinolines|Sensory System Agents",CCN(CC)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,2719
594,DB00609,Ethionamide,small molecule,approved,Anti-Bacterial Agents|Anti-Infective Agents|Antiinfectives for Systemic Use|Antimycobacterials|Antituberculosis Agents|Drugs causing inadvertant photosensitivity|Drugs for Treatment of Tuberculosis|Fatty Acid Synthesis Inhibitors|Hypolipidemic Agents|Isonicotinic Acids|Lipid Regulating Agents|Noxae|Photosensitizing Agents|Pyridines|Thiocarbamide Derivatives|Toxic Actions,CCC1=NC=CC(=C1)C(N)=S,2761171
595,DB00610,Metaraminol,small molecule,approved|investigational,Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Autonomic Agents|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Propanolamines|Propanols|Sympathomimetics|Vasoconstrictor Agents,C[C@H](N)[C@H](O)C1=CC(O)=CC=C1,5906
596,DB00611,Butorphanol,small molecule,approved|illicit|vet_approved,"Alkaloids|Analgesics|Antitussive Agents|Central Nervous System Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Mixed Agonist / Antagonist Opioids|Morphinan Derivatives|Morphinans|Narcotics|Nervous System|Opiate Alkaloids|Opiate Partial Agonists|Opioid Agonist/Antagonist|Opioid Antagonists|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Respiratory System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13O)CCN2CC1CCC1,6916249
597,DB00612,Bisoprolol,small molecule,approved,"Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-1 Receptor Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Autonomic Agents|Beta blocking agents and calcium channel blockers|Beta Blocking Agents and Thiazides|Beta Blocking Agents, Selective|Beta Blocking Agents, Selective, and Thiazides|Beta-Blockers (Beta1 Selective)|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Hypotensive Agents|Neurotransmitter Agents|P-glycoprotein inhibitors|P-glycoprotein substrates|Peripheral Nervous System Agents|Phenoxypropanolamines|Propanolamines|Propanols|Sympatholytics",CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1,2405
598,DB00613,Amodiaquine,small molecule,approved|investigational,"Aminoquinolines|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|P-glycoprotein inhibitors|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines",CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1,2165
599,DB00614,Furazolidone,small molecule,experimental|vet_approved,"Agents that produce hypertension|Agents that reduce seizure threshold|Anti-Infective Agents|Anti-Infective Agents, Local|Anti-Infective Agents, Urinary|Antidepressive Agents|Antiparasitic Agents|Antiprotozoals|Antitrichomonal Agents|Central Nervous System Depressants|Enzyme Inhibitors|Furans|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Monoamine Oxidase Inhibitors|Nitro Compounds|Nitrofurans|Oxazoles|Oxazolidinones|Renal Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",[H]C(=NN1CCOC1=O)C1=CC=C(O1)[N+]([O-])=O,3435
600,DB00615,Rifabutin,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics, Antitubercular|Antiinfectives for Systemic Use|Antimycobacterials|Antituberculosis Agents|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (weak)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (moderate)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (weak)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Drugs for Treatment of Tuberculosis|Heterocyclic Compounds, Fused-Ring|Lactams|Lactams, Macrocyclic|P-glycoprotein inducers|Rifamycin Antimycobacterial|Rifamycins",CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(=O)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C1NC3(CCN(CC3)CC(C)C)N=C21,6323490
601,DB00616,Candoxatril,small molecule,experimental,"Acids, Acyclic|Antihypertensive Agents|Cardiovascular Agents|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Indenes|Lipids|Neprilysin, antagonists & inhibitors|Prodrugs|Protease Inhibitors",COCCOC[C@H](CC1(CCCC1)C(=O)N[C@H]1CC[C@H](CC1)C(O)=O)C(=O)OC1=CC2=C(CCC2)C=C1,5362417
602,DB00617,Paramethadione,small molecule,approved,Anticonvulsants|Central Nervous System Depressants|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Nervous System|Oxazolidine Derivatives,CCC1(C)OC(=O)N(C)C1=O,8280
603,DB00618,Demeclocycline,small molecule,approved,Agents that produce neuromuscular block (indirect)|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antibiotics for Topical Use|Antiinfectives for Systemic Use|Dermatologicals|Drugs causing inadvertant photosensitivity|Naphthacenes|Photosensitizing Agents|Tetracyclines,[H][C@]12C[C@@]3([H])[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C(=O)C1=C([C@H]2O)C(Cl)=CC=C1O,54680690
604,DB00619,Imatinib,small molecule,approved,"Acids, Carbocyclic|Amides|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|BSEP/ABCB11 Substrates|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Highest Risk QTc-Prolonging Agents|Immunosuppressive Agents|Kinase Inhibitor|Myelosuppressive Agents|OCT1 substrates|OCT2 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Photosensitizing Agents|Piperazines|Protein Kinase Inhibitors|Pyrimidines|QTc Prolonging Agents|Tyrosine Kinase Inhibitors",CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,5291
605,DB00620,Triamcinolone,small molecule,approved|vet_approved,"Adrenal Cortex Hormones|Adrenals|Agents Causing Muscle Toxicity|Agents to Treat Airway Disease|Alimentary Tract and Metabolism|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids for Local Oral Treatment|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Corticosteroids, Dermatological Preparations|Corticosteroids, Moderately Potent (Group II)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inducers|Cytochrome P-450 CYP3A7 Inducers (strength unknown)|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Dermatologicals|Drugs for Obstructive Airway Diseases|Enzyme Inhibitors|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunologic Factors|Immunosuppressive Agents|Nasal Preparations|Ophthalmologicals|Pregnadienes|Pregnanes|Protein-Lysine 6-Oxidase, antagonists & inhibitors|Sensory Organs|Steroids|Steroids, Fluorinated|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thyroxine-binding globulin inhibitors|Vasoprotectives",[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,31307
606,DB00621,Oxandrolone,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Anabolic Agents|Anabolic Agents for Systemic Use|Anabolic Steroids|Androgens|Androstan Derivatives|Androstanes|Androstanols|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Thyroxine-binding globulin inhibitors",[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)OC[C@]12C,5878
607,DB00622,Nicardipine,small molecule,approved|investigational,Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents causing hyperkalemia|Agents producing tachycardia|Antiarrhythmic agents|Anticholinergic Agents|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Bradycardia-Causing Agents|BSEP/ABCB11 Substrates|Calcium Channel Blockers|Calcium Channel Blockers (Dihydropyridine)|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dihydropyridine Derivatives|Dihydropyridines|Hypotensive Agents|Membrane Transport Modulators|Muscarinic Antagonists|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,4474
608,DB00623,Fluphenazine,small molecule,approved,"Agents that reduce seizure threshold|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Delayed-Action Preparations|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs causing inadvertant photosensitivity|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotoxic agents|Neurotransmitter Agents|P-glycoprotein inhibitors|Phenothiazines|Phenothiazines With Piperazine Structure|Photosensitizing Agents|Prodrugs|Psycholeptics|Psychotropic Drugs|Sulfur Compounds|Tranquilizing Agents",OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,3372
609,DB00624,Testosterone,small molecule,approved|investigational,"3-Oxoandrosten (4) Derivatives|Androgens|Androgens and Estrogens|Androstanes|Androstenes|Androstenols|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|OAT3/SLC22A8 Inducers|OATP1B3 substrates|P-glycoprotein inhibitors|Sex Hormones and Modulators of the Genital System|Steroids|Testosterone and derivatives|Testosterone Congeners|Thyroxine-binding globulin inhibitors",[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,6013
610,DB00625,Efavirenz,small molecule,approved|investigational,"Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BSEP/ABCB11 Substrates|Central Nervous System Depressants|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (moderate)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (moderate)|Cytochrome P-450 CYP3A7 Inducers|Cytochrome P-450 CYP3A7 Inducers (moderate)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Direct Acting Antivirals|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor|Inducers of Drug Clearance|Moderate Risk QTc-Prolonging Agents|Non-Nucleoside Reverse Transcriptase Inhibitors|Nonnucleoside Reverse Transcriptase Inhibitors|Nucleic Acid Synthesis Inhibitors|OCT1 inhibitors|Oxazines|QTc Prolonging Agents|Reverse Transcriptase Inhibitors|UGT1A1 Inducers",FC(F)(F)[C@]1(OC(=O)NC2=C1C=C(Cl)C=C2)C#CC1CC1,64139
611,DB00626,Bacitracin,small molecule,approved|vet_approved,"Acids, Carbocyclic|Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Local|Antibacterials for Systemic Use|Antibiotics for Topical Use|Antiinfectives for Systemic Use|Bacitracins|Benzene Derivatives|Benzoates|Decreased Cell Wall Synthesis & Repair|Dermatologicals|Hydroxy Acids|Hydroxybenzoates|Nephrotoxic agents|Peptides|Peptides, Cyclic|Phenols|Throat Preparations",CC[C@H](C)[C@H](N)C1=N[C@@H](CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](CC2=CNC=N2)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC1=O)[C@@H](C)CC,10909430
612,DB00627,Niacin,small molecule,approved|investigational|nutraceutical,"Agents Causing Muscle Toxicity|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Hyperglycemia-Associated Agents|Hypolipidemic Agents|Hypolipidemic Agents Indicated for Hyperlipidemia|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Micronutrients|Miscellaneous Antilipemic Agents|Nicotinic Acid and Derivatives|Nicotinic Acids|Noxae|Peripheral Vasodilators|Physiological Phenomena|Pyridines|Thyroxine-binding globulin inhibitors|Toxic Actions|Vasodilating Agents|Vitamin B Complex|Vitamins",OC(=O)C1=CN=CC=C1,938
613,DB00628,Clorazepic acid,small molecule,approved|illicit,"Anti-Anxiety Agents|Anticonvulsants|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|GABA Agents|GABA Modulators|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|Psychotropic Drugs|Tranquilizing Agents",OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2,2809
614,DB00629,Guanabenz,small molecule,approved|investigational,Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Amidines|Antihypertensive Agents|Cardiovascular Agents|Central alpha-2 Adrenergic Agonist|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Guanidines|Neurotransmitter Agents,NC(N)=NN=CC1=C(Cl)C=CC=C1Cl,3517
615,DB00630,Alendronic acid,small molecule,approved,Agents Causing Muscle Toxicity|Bisphosphonates|Bone Density Conservation Agents|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Musculo-Skeletal System|Organophosphonates|Organophosphorus Compounds,NCCCC(O)(P(O)(O)=O)P(O)(O)=O,2088
616,DB00631,Clofarabine,small molecule,approved|investigational,"Adenine Nucleotides|Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Arabinonucleosides|BCRP/ABCG2 Substrates|Carbohydrates|Drugs that are Mainly Renally Excreted|Glycosides|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Immunosuppressive Agents|Myelosuppressive Agents|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Metabolic Inhibitor|Nucleosides|Nucleotides|OAT3/SLC22A8 Substrates|OAT3/SLC22A8 Substrates with Narrow Therapeutic Index|OCT2 substrates with narrow therapeutic index|Purine Analogues|Purine Nucleotides|Purines|Ribonucleotides|Toxic Actions",[H][C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C=NC2=C(N)N=C(Cl)N=C12,119182
617,DB00632,Docosanol,small molecule,approved|investigational,Alcohols|Anti-Infective Agents|Antiviral Agents|Dermatologicals|Lipids,CCCCCCCCCCCCCCCCCCCCCCO,12620
618,DB00633,Dexmedetomidine,small molecule,approved|vet_approved,"Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anesthetics|Anesthetics, General|Bradycardia-Causing Agents|Central alpha-2 Adrenergic Agonist|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Hypnotics and Sedatives|Hypotensive Agents|Imidazoles|Miscellaneous Anxiolytics Sedatives and Hypnotics|Nervous System|Neurotransmitter Agents|Peripheral Nervous System Agents|Psycholeptics|Sensory System Agents",C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1,5311068
619,DB00634,Sulfacetamide,small molecule,approved,"Amides|Amines|Aniline Compounds|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Local|Anti-Infective Agents, Urinary|Antiinfectives for Treatment of Acne|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Ophthalmologicals|Renal Agents|Sensory Organs|Sulfanilamides|Sulfonamide Antibacterial|Sulfonamides|Sulfones|Sulfur Compounds",CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1,5320
620,DB00635,Prednisone,small molecule,approved|vet_approved,"Adrenal Cortex Hormones|Adrenals|Alimentary Tract and Metabolism|Anti-Inflammatory Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids Acting Locally|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Cytochrome P-450 CYP2A6 Inducers|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Intestinal Antiinflammatory Agents|P-glycoprotein inducers|P-glycoprotein inhibitors|P-glycoprotein substrates|Prednisolone and Prodrugs|Pregnadienediols|Pregnadienes|Pregnanes|Steroids|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thyroxine-binding globulin inhibitors",[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,5865
621,DB00636,Clofibrate,small molecule,approved|investigational,"Acids, Acyclic|Agents Causing Muscle Toxicity|Anticholesteremic Agents|Benzene Derivatives|Butyrates|Clofibric Acid|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP2E1 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Ethers|Fatty Acids|Fatty Acids, Volatile|Fibric Acids|Hypolipidemic Agents|Isobutyrates|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Lipids|Noxae|Phenols|Phenyl Ethers|Thyroxine-binding globulin inducers|Toxic Actions",CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1,2796
622,DB00637,Astemizole,small molecule,approved|withdrawn,"Anti-Allergic Agents|Antihistamines for Systemic Use|Benzimidazoles|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Neurotransmitter Agents|P-glycoprotein inhibitors|QTc Prolonging Agents",COC1=CC=C(CCN2CCC(CC2)NC2=NC3=CC=CC=C3N2CC2=CC=C(F)C=C2)C=C1,2247
623,DB00638,Inulin,small molecule,approved|investigational|nutraceutical,"Biopolymers|Carbohydrates|Compounds used in a research, industrial, or household setting|Diagnostic Agents|Diet, Food, and Nutrition|Dietary Carbohydrates|Food|Food and Beverages|Fructans|Glucans|Macromolecular Substances|Physiological Phenomena|Polymers|Polysaccharides|Starch|Tests for Renal Function and Ureteral Injuries",OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(OC[C@@]%12(OC[C@@]%13(OC[C@@]%14(OC[C@@]%15(OC[C@@]%16(OC[C@@]%17(OC[C@@]%18(OC[C@@]%19(OC[C@@]%20(OC[C@@]%21(OC[C@@]%22(OC[C@@]%23(OC[C@@]%24(OC[C@@]%25(OC[C@@]%26(OC[C@@]%27(OC[C@@]%28(OC[C@@]%29(OC[C@@]%30(OC[C@@]%31(OC[C@@]%32(OC[C@@]%33(OC[C@@]%34(OC[C@@]%35(OC[C@@]%36(OC[C@@]%37(O[C@H]%38O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%38O)O[C@H](CO)[C@@H](O)[C@@H]%37O)O[C@H](CO)[C@@H](O)[C@@H]%36O)O[C@H](CO)[C@@H](O)[C@@H]%35O)O[C@H](CO)[C@@H](O)[C@@H]%34O)O[C@H](CO)[C@@H](O)[C@@H]%33O)O[C@H](CO)[C@@H](O)[C@@H]%32O)O[C@H](CO)[C@@H](O)[C@@H]%31O)O[C@H](CO)[C@@H](O)[C@@H]%30O)O[C@H](CO)[C@@H](O)[C@@H]%29O)O[C@H](CO)[C@@H](O)[C@@H]%28O)O[C@H](CO)[C@@H](O)[C@@H]%27O)O[C@H](CO)[C@@H](O)[C@@H]%26O)O[C@H](CO)[C@@H](O)[C@@H]%25O)O[C@H](CO)[C@@H](O)[C@@H]%24O)O[C@H](CO)[C@@H](O)[C@@H]%23O)O[C@H](CO)[C@@H](O)[C@@H]%22O)O[C@H](CO)[C@@H](O)[C@@H]%21O)O[C@H](CO)[C@@H](O)[C@@H]%20O)O[C@H](CO)[C@@H](O)[C@@H]%19O)O[C@H](CO)[C@@H](O)[C@@H]%18O)O[C@H](CO)[C@@H](O)[C@@H]%17O)O[C@H](CO)[C@@H](O)[C@@H]%16O)O[C@H](CO)[C@@H](O)[C@@H]%15O)O[C@H](CO)[C@@H](O)[C@@H]%14O)O[C@H](CO)[C@@H](O)[C@@H]%13O)O[C@H](CO)[C@@H](O)[C@@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O,24763
624,DB00639,Butoconazole,small molecule,approved,Anti-Infective Agents|Antifungal Agents|Antifungal Agents (Vaginal)|Azole Antifungals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Imidazole Derivatives,ClC1=CC=C(CCC(CN2C=CN=C2)SC2=C(Cl)C=CC=C2Cl)C=C1,47472
625,DB00640,Adenosine,small molecule,approved|investigational,"Adenosine, antagonists & inhibitors|Agents producing tachycardia|Alkenes|Analgesics|Antiarrhythmic agents|Antiarrhythmics, Class V|Biological Factors|Carbohydrates|Cardiac Therapy|Cardiovascular Agents|Central Nervous System Agents|Class IV Antiarrythmics|Cyclohexanes|Cyclohexenes|Cycloparaffins|Enzymes|Enzymes and Coenzymes|Glycosides|Heterocyclic Compounds, Fused-Ring|Hydrocarbons, Acyclic|Miscellaneous Cardiac Drugs|Miscellaneous Therapeutic Agents|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Oxidoreductases|Peripheral Nervous System Agents|Pigments, Biological|Polyenes|Purine Nucleosides|Purinergic Agents|Purinergic Agonists|Purinergic P1 Receptor Agonists|Purines|QTc Prolonging Agents|Ribonucleosides|Sensory System Agents|Terpenes|Vasodilating Agents",NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1,60961
626,DB00641,Simvastatin,small molecule,approved,"Agents Causing Muscle Toxicity|Anticholesteremic Agents|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Hypolipidemic Agents|Hypolipidemic Agents Indicated for Hyperlipidemia|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Naphthalenes|Noxae|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|P-glycoprotein inhibitors|P-glycoprotein substrates|Photosensitizing Agents|UGT1A1 Substrates|UGT1A3 substrates|UGT2B7 substrates",[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,54454
627,DB00642,Pemetrexed,small molecule,approved|investigational,"Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Enzyme Inhibitors|Folic Acid Analogues|Folic Acid Antagonists|Glutamates|Heterocyclic Compounds, Fused-Ring|Immunosuppressive Agents|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Nucleic Acid Synthesis Inhibitors|OAT3/SLC22A8 Substrates|Purines|Purinones",NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,446556
628,DB00643,Mebendazole,small molecule,approved|vet_approved,"Acids, Acyclic|Anthelmintics|Anti-Infective Agents|Antihelminthic|Antimitotic Agents|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Benzimidazole Derivatives|Benzimidazoles|Carbamates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Mitosis Modulators|Tubulin Modulators",COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C1=CC=CC=C1,4030
629,DB00644,Gonadorelin,small molecule,approved|investigational|vet_approved,"Adrenal Cortex Hormones|Amino Acids, Peptides, and Proteins|Diagnostic Agents|Gonadotropin-releasing hormone agonist|Gonadotropin-Releasing Hormone, agonists|Gonadotropin-Releasing Hormone, antagonists & inhibitors|Gonadotropins and Antigonadotropins|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Function|Pituitary Hormone-Releasing Hormones|Proteins|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Tests for Fertility Disturbances",CC(C)CC(NC(=O)CNC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CO)NC(=O)C(CC1=CNC2=CC=CC=C12)NC(=O)C(CC1=CN=CN1)NC(=O)C1CCC(=O)N1)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(N)=O,36523
630,DB00645,Dyclonine,small molecule,approved,"Anesthetics|Anesthetics, Local|Central Nervous System Agents|Central Nervous System Depressants|Ketones|Nervous System|Peripheral Nervous System Agents|Sensory System Agents|Throat Preparations",CCCCOC1=CC=C(C=C1)C(=O)CCN1CCCCC1,3180
631,DB00646,Nystatin,small molecule,approved|vet_approved,"Alimentary Tract and Metabolism|Anti-Infective Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antifungal Agents|Antifungal Agents (Vaginal)|Antifungals for Dermatological Use|Antifungals for Topical Use|Compounds used in a research, industrial, or household setting|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Intestinal Antiinfectives|Ionophores|Lactones|Membrane Transport Modulators|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Polyene Antifungal|Polyenes|Polyketides",C[C@H]1O[C@H](OC2CC3O[C@@](O)(CC(O)C3C(O)=O)CC(O)C(O)CCC(O)CC(O)CC(O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\CC\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O,11953884
632,DB00647,Dextropropoxyphene,small molecule,approved|illicit|investigational|withdrawn,"Acids, Acyclic|Agents that reduce seizure threshold|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Diphenylpropylamine Derivatives|Fatty Acids|Fatty Acids, Volatile|High-risk opioids|Lipids|Narcotics|Nervous System|Opioid Agonist|Opioids|Peripheral Nervous System Agents|Propionates|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1,10100
633,DB00648,Mitotane,small molecule,approved,"Antineoplastic Agents|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 Enzyme Inducers|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Narrow Therapeutic Index Drugs|P-glycoprotein inhibitors|Thyroxine-binding globulin inducers",ClC(Cl)C(C1=CC=C(Cl)C=C1)C1=CC=CC=C1Cl,4211
634,DB00649,Stavudine,small molecule,approved|investigational,"Agents Causing Muscle Toxicity|Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antimetabolites|Antiviral Agents|Antivirals for Systemic Use|Carbohydrates|Deoxyribonucleosides|Dideoxynucleosides|Direct Acting Antivirals|Enzyme Inhibitors|Glycosides|Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Neurotoxic agents|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|Nucleoside Reverse Transcriptase Inhibitors|Nucleosides|OAT1/SLC22A6 Substrates|Pyrimidine Nucleosides|Pyrimidines|Reverse Transcriptase Inhibitors|Toxic Actions",CC1=CN([C@@H]2O[C@H](CO)C=C2)C(=O)NC1=O,18283
635,DB00650,Leucovorin,small molecule,approved,"Antidotes|Biological Factors|Coenzymes|Compounds used in a research, industrial, or household setting|Detoxifying Agents for Antineoplastic Treatment|Diet, Food, and Nutrition|Enzymes and Coenzymes|Folate Analog|Folic Acid and Derivatives|Food|Food and Beverages|Formyltetrahydrofolates|Growth Substances|Heterocyclic Compounds, Fused-Ring|Micronutrients|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Physiological Phenomena|Pigments, Biological|Protective Agents|Pteridines|Pterins|Tetrahydrofolates|Vitamin B Complex|Vitamins",[H]C(=O)N1C(CNC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2=C1C(=O)NC(N)=N2,6006
636,DB00651,Dyphylline,small molecule,approved,"Alkaloids|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cardiovascular Agents|Drugs for Obstructive Airway Diseases|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Peripheral Nervous System Agents|Phosphodiesterase Inhibitors|Purines|Purinones|Respiratory System Agents|Vasodilating Agents|Xanthine derivatives|Xanthines and Adrenergics",CN1C2=C(N(CC(O)CO)C=N2)C(=O)N(C)C1=O,3182
637,DB00652,Pentazocine,small molecule,approved|vet_approved,"Adjuvants, Anesthesia|Agents that reduce seizure threshold|Alkaloids|Analgesics|Benzomorphan Derivatives|Benzomorphans|Central Nervous System Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Mixed Agonist / Antagonist Opioids|Morphinans|Narcotics|Nervous System|Opiate Alkaloids|Opiate Partial Agonists|Opioid Antagonists|Opioids|P-glycoprotein substrates|Partial Opioid Agonist/Antagonist|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",C[C@H]1[C@H]2CC3=CC=C(O)C=C3[C@]1(C)CCN2CC=C(C)C,441278
638,DB00653,Magnesium sulfate,small molecule,approved|investigational|vet_approved,"Acids|Acids, Noncarboxylic|Agents causing hyperkalemia|Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Analgesics|Anesthetics|Anions|Antiarrhythmic agents|Anticonvulsants|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Calculi Dissolution Agent|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Dermatologicals|Diagnostic Agents|Drugs for Constipation|Electrolyte Solutions|Electrolytes|I.V. Solution Additives|Ions|Laxatives|Laxatives, magnesium containing|Magnesium Compounds|Magnesium Salts|Membrane Transport Modulators|Metal cations|Metal divalent cations|Mineral Supplements|Miscellaneous Anticonvulsants|Osmotic Laxatives|Paramagnetic Contrast Agent|Peripheral Nervous System Agents|Replacement Preparations|Reproductive Control Agents|Sensory System Agents|Sulfates|Sulfur Acids|Sulfur Compounds|Sulfuric Acids|Tests for Bile Duct Patency|Tocolytic Agents|Vasodilating Agents",[Mg++].[O-]S([O-])(=O)=O,24083
639,DB00654,Latanoprost,small molecule,approved|investigational,"Antiglaucoma Preparations and Miotics|Antihypertensive Agents|Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Lipids|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|Ophthalmologicals|Prostaglandin analogs reducing intraocular pressure (IOP)|Prostaglandins|Prostaglandins F, Synthetic|Prostaglandins, Synthetic|Sensory Organs",CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,5311221
640,DB00655,Estrone,small molecule,approved,"17-Ketosteroids|Adrenal Cortex Hormones|BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Estradiol Congeners|Estranes|Estrenes|Estrogens|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Natural and Semisynthetic Estrogens, Plain|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein inducers|P-glycoprotein substrates|Sex Hormones and Modulators of the Genital System|Steroids|Thyroxine-binding globulin inducers",[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,5870
641,DB00656,Trazodone,small molecule,approved|investigational,"Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Agents that reduce seizure threshold|Anti-Anxiety Agents|Antidepressive Agents|Antidepressive Agents, Second-Generation|Antidepressive Agents, Triazolopyridine|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Histamine Antagonists|Histamine H1 Antagonists|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|P-glycoprotein inducers|Peripheral alpha-1 blockers|Piperazines|Potential QTc-Prolonging Agents|Psychoanaleptics|Psychotropic Drugs|Pyridines|Pyridones|QTc Prolonging Agents|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists|Tranquilizing Agents",ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1,5533
642,DB00657,Mecamylamine,small molecule,approved|investigational,"Agents that produce neuromuscular block (indirect)|Antiadrenergic Agents, Ganglion-Blocking|Anticholinergic Agents|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Autonomic Agents|Autonomic Ganglionic Blocker|Cardiovascular Agents|Cholinergic Agents|Decreased Autonomic Ganglionic Activity|Drugs that are Mainly Renally Excreted|Ganglion Blockers|Hypotensive Agents|Monoterpenes|Neurotransmitter Agents|Nicotinic Antagonists|Norbornanes|Peripheral Nervous System Agents|Secondary and Tertiary Amines|Terpenes",CNC1(C)C2CCC(C2)C1(C)C,4032
643,DB00658,Sevelamer,small molecule,approved,"Amines|Bile Acid Sequestrants|Chelating Agents|Compounds used in a research, industrial, or household setting|Drugs for Treatment of Hyperkalemia and Hyperphosphatemia|Lipid Regulating Agents|Phosphate Binder|Phosphate Chelating Activity|Phosphate-removing Agents|Polyamines|Polystyrene Sulfonates|Sequestering Agents",NCC=C.ClCC1CO1,3085017
644,DB00659,Acamprosate,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Alcohol Deterrents|Alkanes|Alkanesulfonic Acids|Central Nervous System Agents|Drugs Used in Addictive Disorders|Drugs Used in Alcohol Dependence|Hydrocarbons, Acyclic|Miscellaneous Central Nervous System Agents|Nervous System|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",CC(=O)NCCCS(O)(=O)=O,71158
645,DB00660,Metaxalone,small molecule,approved,"Central Nervous System Depressants|Centrally-mediated Muscle Relaxation|Drugs that are Mainly Renally Excreted|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Oxazoles|Peripheral Nervous System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",CC1=CC(OCC2CNC(=O)O2)=CC(C)=C1,15459
646,DB00661,Verapamil,small molecule,approved,ACE Inhibitors and Calcium Channel Blockers|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Amines|Antiarrhythmic agents|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium Channel Blockers (Nondihydropyridine)|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (moderate)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Hypotensive Agents|MATE 1 Inhibitors|MATE 2 Inhibitors|MATE inhibitors|Membrane Transport Modulators|Miscellaneous Calcium-channel Blocking Agents|OATP1B1/SLCO1B1 Inhibitors|OCT1 inhibitors|OCT1 substrates|P-glycoprotein inhibitors|P-glycoprotein substrates|Phenylalkylamine Derivatives|Selective Calcium Channel Blockers With Direct Cardiac Effects|Vasodilating Agents|Verapamil and analogues,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1,2520
647,DB00662,Trimethobenzamide,small molecule,approved|investigational,"Acids, Carbocyclic|Amides|Aminoalkyl Ethers|Antiemetics|Antihistamines for Systemic Use|Autonomic Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Central Nervous System Depressants|Emesis Suppression|Gastrointestinal Agents|Peripheral Nervous System Agents",COC1=CC(=CC(OC)=C1OC)C(=O)NCC1=CC=C(OCCN(C)C)C=C1,5577
648,DB00663,Flumethasone,small molecule,approved|vet_approved,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Moderately Potent (Group II)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dermatologicals|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Otologicals|Pregnadienes|Pregnadienetriols|Pregnanes|Sensory Organs|Steroids|Steroids, Fluorinated",[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,16490
649,DB00664,Sulfametopyrazine,small molecule,approved|withdrawn,"Amides|Amines|Aniline Compounds|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antiparasitic Agents|Antiprotozoals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Long-Acting Sulfonamides|Renal Agents|Sulfanilamides|Sulfonamides|SULFONAMIDES AND TRIMETHOPRIM|Sulfones|Sulfur Compounds",COC1=NC=CN=C1NS(=O)(=O)C1=CC=C(N)C=C1,9047
650,DB00665,Nilutamide,small molecule,approved|investigational,"Androgen Receptor Antagonists|Androgen Receptor Inhibitor|Antiandrogens|Antiandrogens, non-steroidal|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Endocrine Therapy|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Imidazoles",CC1(C)NC(=O)N(C1=O)C1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F,4493
651,DB00666,Nafarelin,small molecule,approved,"Adrenal Cortex Hormones|Agents Causing Muscle Toxicity|Amino Acids, Peptides, and Proteins|Fertility Agents|Fertility Agents, Female|Gonadotropin Releasing Hormone Receptor Agonist|Gonadotropin Releasing Hormone Receptor Agonists|Gonadotropin-releasing hormone agonist|Gonadotropins and Antigonadotropins|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormone-Releasing Hormones|Proteins|Reproductive Control Agents|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",CC(C)C[C@H](NC(=O)[C@@H](CC1=CC2=C(C=CC=C2)C=C1)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,25077405
652,DB00668,Epinephrine,small molecule,approved|vet_approved,"Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Adrenergic beta-1 Receptor Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-3 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Alpha-and Beta-adrenergic Agonists|Amines|Anti-Asthmatic Agents|Antiglaucoma Preparations and Miotics|Autonomic Agents|Benzene Derivatives|Biogenic Amines|Biogenic Monoamines|Bronchodilator Agents|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Catecholamines|Catechols|COMT Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Dental Agents|Drugs for Obstructive Airway Diseases|Epinephrine and similars|Hemostatics|Hyperglycemia-Associated Agents|Local Hemostatics|Mydriatics|Nasal Preparations|Neurotransmitter Agents|OCT1 substrates|OCT2 Inhibitors|OCT2 Substrates|Ophthalmologicals|Peripheral Nervous System Agents|Phenols|Respiratory System Agents|Stomatological Preparations|Sympathomimetic (Adrenergic) Agents|Sympathomimetics|Sympathomimetics in Glaucoma Therapy|Sympathomimetics, Plain|Vasoconstrictor Agents",CNC[C@H](O)C1=CC(O)=C(O)C=C1,5816
653,DB00669,Sumatriptan,small molecule,approved|investigational,"Agents that produce hypertension|Amides|Amines|Analgesics|Antidepressive Agents|Antimigraine Preparations|BCRP/ABCG2 Substrates|Biogenic Amines|Biogenic Monoamines|Cardiovascular Agents|Central Nervous System Depressants|Drugs that are Mainly Renally Excreted|Genito Urinary System and Sex Hormones|Heterocyclic Compounds, Fused-Ring|Indoles|Monoamine Oxidase A Substrates|Nervous System|Neurotransmitter Agents|OATP1B1/SLCO1B1 Substrates|P-glycoprotein substrates|Selective Serotonin 5-HT1 Receptor Agonists|Selective Serotonin Agonists|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 1b Receptor Agonists|Serotonin 1d Receptor Agonists|Serotonin 5-HT1 Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists|Serotonin-1b and Serotonin-1d Receptor Agonist|Sulfonamides|Sulfones|Sulfur Compounds|Triptans|Tryptamines|Vasoconstrictor Agents",CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1,5358
654,DB00670,Pirenzepine,small molecule,approved,"Agents producing tachycardia|Alimentary Tract and Metabolism|Anti-Ulcer Agents|Anticholinergic Agents|Benzazepines|Benzodiazepinones|Cholinergic Agents|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Muscarinic Antagonists|Neurotransmitter Agents",CN1CCN(CC(=O)N2C3=CC=CC=C3C(=O)NC3=C2N=CC=C3)CC1,4848
655,DB00671,Cefixime,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephacetrile|Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins",[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OCC(O)=O)\C1=CSC(N)=N1)C(O)=O,5362065
656,DB00672,Chlorpropamide,small molecule,approved|investigational,Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Drugs Used in Diabetes|Hypoglycemia-Associated Agents|OAT1/SLC22A6 inhibitors|Sulfones|Sulfonylureas|Sulfur Compounds,CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1,2727
657,DB00673,Aprepitant,small molecule,approved|investigational,Alimentary Tract and Metabolism|Antiemetics|Antiemetics and Antinauseants|Aprepitant and Prodrugs|Autonomic Agents|Central Nervous System Agents|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Gastrointestinal Agents|Morpholines|Neurokinin 1 Antagonists|Neurokinin-1 Receptor Antagonists|Neurotransmitter Agents|Oxazines|Peripheral Nervous System Agents|Substance P/Neurokinin-1 Receptor Antagonist,C[C@@H](O[C@H]1OCCN(CC2=NNC(=O)N2)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,6918365
658,DB00674,Galantamine,small molecule,approved,"Alkaloids|Amaryllidaceae Alkaloids|Anti-Dementia Drugs|Autonomic Agents|Benzazepines|Bradycardia-Causing Agents|Central Nervous System Agents|Cholinergic Agents|Cholinesterase Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotransmitter Agents|Nootropic Agents|P-glycoprotein inhibitors|Parasympathomemetic (Cholinergic) Agents|Parasympathomimetics|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|Psychoanaleptics|QTc Prolonging Agents",[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,9651
659,DB00675,Tamoxifen,small molecule,approved,"Anti-Estrogens|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Benzene Derivatives|Benzylidene Compounds|BSEP/ABCB11 Inhibitors|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2A6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (moderate)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Endocrine Therapy|Estrogen Agonist/Antagonist|Estrogen Antagonists|Estrogen Receptor Modulators|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Narrow Therapeutic Index Drugs|P-glycoprotein inducers|P-glycoprotein inhibitors|P-glycoprotein substrates|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Selective Estrogen Receptor Modulators|Stilbenes|Thyroxine-binding globulin inducers|UGT2B7 substrates|UGT2B7 substrates with narrow therapeutic index",CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,2733526
660,DB00676,Benzyl benzoate,small molecule,approved,"Acaricides|Acids, Carbocyclic|Agrochemicals|Antiparasitic Products, Insecticides and Repellents|Benzene Derivatives|Compounds used in a research, industrial, or household setting|Ectoparasiticides, Incl. Scabicides|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Insecticides|Pesticides|Toxic Actions",O=C(OCC1=CC=CC=C1)C1=CC=CC=C1,2345
661,DB00677,Isoflurophate,small molecule,approved|investigational|withdrawn,Cholinergic Agents|Cholinesterase Inhibitors|Enzyme Inhibitors|Neurotransmitter Agents|Ophthalmics|Organofluorophosphonates|Organophosphonates|Organophosphorus Compounds|Protease Inhibitors,CC(C)OP(F)(=O)OC(C)C,5936
662,DB00678,Losartan,small molecule,approved,"Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Angiotensin 2 Receptor Blocker|Angiotensin II receptor blockers (ARBs) and calcium channel blockers|Angiotensin II receptor blockers (ARBs) and diuretics|Angiotensin II receptor blockers (ARBs), plain|Angiotensin II Type 1 Receptor Blockers|Angiotensin II Type 2 Receptor Blockers|Angiotensin Receptor Antagonists|Antiarrhythmic agents|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Benzene Derivatives|Biphenyl Compounds|BSEP/ABCB11 Substrates|Cardiovascular Agents|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Hypotensive Agents|Imidazoles|OAT1/SLC22A6 inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Photosensitizing Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Tetrazoles|UGT1A1 Substrates|UGT1A3 substrates|UGT2B7 substrates",CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,3961
663,DB00679,Thioridazine,small molecule,approved|withdrawn,"Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antidepressive Agents|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs causing inadvertant photosensitivity|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|Hypotensive Agents|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Phenothiazines|Phenothiazines With Piperidine Structure|Photosensitizing Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Tranquilizing Agents",CSC1=CC2=C(SC3=CC=CC=C3N2CCC2CCCCN2C)C=C1,5452
664,DB00680,Moricizine,small molecule,approved|investigational|withdrawn,"Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ic|Antipsychotic Agents|Cardiac Therapy|Cardiovascular Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Membrane Transport Modulators|Morpholines|Neurotoxic agents|Oxazines|Phenothiazines|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sodium Channel Blockers|Sulfur Compounds|Voltage-Gated Sodium Channel Blockers",CCOC(=O)NC1=CC2=C(SC3=CC=CC=C3N2C(=O)CCN2CCOCC2)C=C1,34633
665,DB00681,Amphotericin B,small molecule,approved|investigational,"Agents Causing Muscle Toxicity|Agents that reduce seizure threshold|Alimentary Tract and Metabolism|Amebicides|Anti-Bacterial Agents|Anti-Infective Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antifungal Agents|Antiinfectives and Antiseptics for Local Oral Treatment|Antiinfectives for Systemic Use|Antimycotics for Systemic Use|Antiparasitic Agents|Antiprotozoals|Biomimetic Materials|Carbohydrates|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Drug Carriers|Drug Delivery Systems|Genito Urinary System and Sex Hormones|Glycosides|Gynecological Antiinfectives and Antiseptics|Hypotensive Agents|Intestinal Antiinfectives|Investigative Techniques|Lactones|Lipid-based Polyene Antifungal|Liposomes|Membranes, Artificial|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Pharmaceutical Preparations|Polyene Antifungal|Polyenes|Polyketides|Stomatological Preparations",[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,5280965
666,DB00682,Warfarin,small molecule,approved,"4-Hydroxycoumarins|Agrochemicals|Anticoagulants|Blood and Blood Forming Organs|Compounds used in a research, industrial, or household setting|Coumarins|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C18 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (weak)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|Narrow Therapeutic Index Drugs|Pesticides|Pyrans|Rodenticides|Toxic Actions|Vitamin K Antagonists|Vitamin K Inhibitors",CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(OC1=O)C=CC=C2,54678486
667,DB00683,Midazolam,small molecule,approved|illicit,"Adjuvants, Anesthesia|Anesthetics|Anti-Anxiety Agents|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|GABA Agents|GABA Modulators|Heterocyclic Compounds, Fused-Ring|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents|Triazolobenzodiazepines|UGT1A4 substrates",CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,4192
668,DB00684,Tobramycin,small molecule,approved|investigational,Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Carbohydrates|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Glycosides|Narrow Therapeutic Index Drugs|Nebramycin|Nephrotoxic agents|Ophthalmologicals|Sensory Organs,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,36294
669,DB00685,Trovafloxacin,small molecule,approved|investigational|withdrawn,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|Photosensitizing Agents|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",[H][C@@]12CN(C[C@]1([H])[C@H]2N)C1=NC2=C(C=C1F)C(=O)C(=CN2C1=C(F)C=C(F)C=C1)C(O)=O,62959
670,DB00686,Pentosan polysulfate,small molecule,approved,"Acids|Acids, Noncarboxylic|Anticoagulants|Antivaricose Therapy|Carbohydrates|Drugs causing inadvertant photosensitivity|Genito Urinary System and Sex Hormones|Glycosaminoglycans|Hematologic Agents|Miscellaneous Therapeutic Agents|Photosensitizing Agents|Polysaccharides|Sulfur Acids|Sulfur Compounds|Sulfuric Acids|Urologicals|Vasoprotectives",O[C@@H]1CO[C@@H](O[C@@H]2CO[C@@H](O)[C@H](OS(O)(=O)=O)[C@H]2OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O,37720
671,DB00687,Fludrocortisone,small molecule,approved|investigational,"11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Adrenal Cortex Hormones|Adrenals|Anti-Inflammatory Agents|Corticosteroids|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Mineralocorticoids|Pregnenes|Steroids|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,31378
672,DB00688,Mycophenolate mofetil,small molecule,approved|investigational,"Agents Causing Muscle Toxicity|Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics, Antineoplastic|Antibiotics, Antitubercular|Antimetabolite Immunosuppressant|Antituberculosis Agents|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Fatty Acids|Immunologic Factors|Immunosuppressive Agents|IMP Dehydrogenase, antagonists & inhibitors|Lipids|Mycophenolic Acid and Prodrugs|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein substrates|UGT1A1 Substrates|UGT1A6 substrate|UGT1A9 Substrates|UGT2B7 substrates",COC1=C(C\C=C(/C)CCC(=O)OCCN2CCOCC2)C(O)=C2C(=O)OCC2=C1C,5281078
673,DB00689,Cephaloglycin,small molecule,approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|beta-Lactams|Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines",[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,19150
674,DB00690,Flurazepam,small molecule,approved|illicit|investigational,"Anti-Anxiety Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|GABA Agents|GABA Modulators|Heterocyclic Compounds, Fused-Ring|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|OCT2 Inhibitors|P-glycoprotein inhibitors|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents",CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,3393
675,DB00691,Moexipril,small molecule,approved,"ACE Inhibitors and Diuretics|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Cardiovascular Agents|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Isoquinolines|Photosensitizing Agents|Potential QTc-Prolonging Agents|Protease Inhibitors|QTc Prolonging Agents",CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC(OC)=C(OC)C=C2C[C@H]1C(O)=O,91270
676,DB00692,Phentolamine,small molecule,approved,Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antidotes|Antihypertensive Agents|Cardiovascular Agents|Drugs that are Mainly Renally Excreted|Hypotensive Agents|Imidazoles|Imidazoline Derivatives|Neurotransmitter Agents|Non-selective Alfa-adrenergic Blocking Agents|Peripheral alpha-1 blockers|Peripheral Vasodilators|Sympatholytic (Adrenergic Blocking) Agents|Vasodilating Agents,CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1,5775
677,DB00693,Fluorescein,small molecule,approved,"BSEP/ABCB11 Substrates|Coloring Agents|Colouring Agents|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Agents|Diagnostic Dye|Diagnostic Uses of Chemicals|Fluoresceins|Fluorescent Dyes|Heterocyclic Compounds, Fused-Ring|Indicators and Reagents|Laboratory Chemicals|Luminescent Agents|OAT1/SLC22A6 inhibitors|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Substrates|Ocular Disorders|Ophthalmologicals|Other Diagnostics|Sensory Organs|Spiro Compounds|Xanthenes",OC1=CC=C2C(OC3=CC(O)=CC=C3C22OC(=O)C3=C2C=CC=C3)=C1,16850
678,DB00694,Daunorubicin,small molecule,approved,"Anthracycline Topoisomerase Inhibitor|Anthracyclines|Anthracyclines and Related Substances|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|BSEP/ABCB11 Substrates|Carbohydrates|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Cytotoxic Antibiotics and Related Substances|Enzyme Inhibitors|Glycosides|Immunosuppressive Agents|Myelosuppressive Agents|Naphthacenes|P-glycoprotein inducers|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(C)=O)C(O)=C1C2=O,30323
679,DB00695,Furosemide,small molecule,approved|vet_approved,"Acids, Carbocyclic|Amides|Amines|Aminobenzoates|Aniline Compounds|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Benzene Derivatives|Benzoates|Cardiovascular Agents|Diuretics|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|High-Ceiling Diuretics|High-Ceiling Diuretics and Potassium-Sparing Agents|Hyperglycemia-Associated Agents|Hypotensive Agents|Increased Diuresis at Loop of Henle|Membrane Transport Modulators|Natriuretic Agents|Nephrotoxic agents|Non Potassium Sparing Diuretics|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|Ototoxic agents|Photosensitizing Agents|Sodium Potassium Chloride Symporter Inhibitors|Sulfanilamides|Sulfonamides|Sulfones|Sulfur Compounds|Thyroxine-binding globulin substrates|UGT1A1 Substrates",NS(=O)(=O)C1=C(Cl)C=C(NCC2=CC=CO2)C(=C1)C(O)=O,3440
680,DB00696,Ergotamine,small molecule,approved,"Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Alkaloids|Analgesics|Analgesics, Non-Narcotic|Antidepressive Agents|Antimigraine Preparations|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Ergot Alkaloids and Derivatives|Ergotamine Derivative|Ergotamines|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotransmitter Agents|P-glycoprotein inhibitors|Peripheral Nervous System Agents|Reproductive Control Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists|Sympatholytic (Adrenergic Blocking) Agents|Uterotonic agents|Vasoconstrictor Agents",[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O,8223
681,DB00697,Tizanidine,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Analgesics|Anticonvulsants|Autonomic Agents|Bradycardia-Causing Agents|Central alpha-2 Adrenergic Agonist|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Hypotensive Agents|Imidazoles|Imidazolines|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neurotransmitter Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sensory System Agents",ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,5487
682,DB00698,Nitrofurantoin,small molecule,approved|vet_approved,"Agents causing hyperkalemia|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|BCRP/ABCG2 Substrates|BSEP/ABCB11 Substrates|Drugs that are Mainly Renally Excreted|Furans|Methemoglobinemia Associated Agents|Nitro Compounds|Nitrofuran Antibacterial|Nitrofuran Derivatives|Nitrofurans|P-glycoprotein substrates|Renal Agents|Thyroxine-binding globulin substrates",[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,6604200
683,DB00699,Nicergoline,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Alkaloids|Cardiovascular Agents|Central Nervous System Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Ergolines|Ergot Alkaloids and Derivatives|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|Nootropic Agents|Peripheral Vasodilators|Vasodilating Agents",[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)[C@]1(C[C@@H](COC(=O)C1=CN=CC(Br)=C1)CN2C)OC,34040
684,DB00700,Eplerenone,small molecule,approved,"Agents causing hyperkalemia|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Substrates|Diuretics|Fused-Ring Compounds|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypotensive Agents|Lactones|Mineralocorticoid (Aldosterone) Receptor Antagonists|Mineralocorticoid Receptor Antagonists|Natriuretic Agents|Potassium-Sparing Diuretics|Pregnanes|Pregnenes|Steroids",[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)C[C@H]1O[C@@]11[C@@]2([H])[C@@H](CC2=CC(=O)CC[C@]12C)C(=O)OC,443872
685,DB00701,Amprenavir,small molecule,approved|investigational,"Acids, Acyclic|Amides|Amprenavir and Prodrugs|Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antibiotics, Antitubercular|Antiinfectives for Systemic Use|Antituberculosis Agents|Antiviral Agents|Antivirals for Systemic Use|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Direct Acting Antivirals|Enzyme Inhibitors|HIV Protease Inhibitors|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein inducers|P-glycoprotein substrates|Protease Inhibitors|Sulfones|Sulfur Compounds",CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)C1=CC=C(N)C=C1,65016
686,DB00702,Icodextrin,small molecule,approved|investigational,"Biopolymers|Carbohydrates|Compounds used in a research, industrial, or household setting|Dialysis Solutions|Glucans|Macromolecular Substances|Pharmaceutical Preparations|Pharmaceutical Solutions|Polymers|Polysaccharides|Solutions",,
687,DB00703,Methazolamide,small molecule,approved,Antiglaucoma Preparations and Miotics|Carbonic Anhydrase Inhibitors|Cardiovascular Agents|Diuretics|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hypotensive Agents|Natriuretic Agents|OAT1/SLC22A6 inhibitors|Ophthalmologicals|Photosensitizing Agents|Sensory Organs|Sulfonamides|Sulfur Compounds|Thiadiazoles|Thiazoles,CN1N=C(SC1=NC(C)=O)S(N)(=O)=O,4100
688,DB00704,Naltrexone,small molecule,approved|investigational|vet_approved,"Agents Causing Muscle Toxicity|Alcohol Deterrents|Alimentary Tract and Metabolism|Alkaloids|Analgesics|Antiobesity Preparations, Excl. Diet Products|Central Nervous System Agents|Centrally Acting Antiobesity Products|Drugs Used in Addictive Disorders|Drugs Used in Alcohol Dependence|Heterocyclic Compounds, Fused-Ring|Morphinans|Narcotics|Natural Opium Alkaloids|Nervous System|Opiate Alkaloids|Opiate Antagonists|Opioid Antagonists|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|UGT1A1 Substrates",[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,5360515
689,DB00705,Delavirdine,small molecule,approved,"Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Direct Acting Antivirals|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor|Indoles|Non-Nucleoside Reverse Transcriptase Inhibitors|Nonnucleoside Reverse Transcriptase Inhibitors|Nucleic Acid Synthesis Inhibitors|Piperazines|Reverse Transcriptase Inhibitors",CC(C)NC1=C(N=CC=C1)N1CCN(CC1)C(=O)C1=CC2=C(N1)C=CC(NS(C)(=O)=O)=C2,5625
690,DB00706,Tamsulosin,small molecule,approved|investigational,Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Amides|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Drugs Used in Benign Prostatic Hypertrophy|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hypotensive Agents|Neurotransmitter Agents|Peripheral alpha-1 blockers|Selective Alfa-1-adrenergic Blocking Agents|Sulfonamides|Sulfones|Sulfur Compounds|Urological Agents|Urologicals,CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC(=C(OC)C=C1)S(N)(=O)=O,129211
691,DB00707,Porfimer sodium,small molecule,approved|investigational,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Biological Factors|Dermatologicals|Hematoporphyrin Derivative|Hematoporphyrins|Heterocyclic Compounds, Fused-Ring|Photoabsorption|Photoactivated Radical Generator|Photosensitizing Activity|Photosensitizing Agents|Photosensitizing agents used for phototherapy|Pigments, Biological|Porphyrins|Radiation-Sensitizing Agents|Sensitizers Used in Photodynamic/radiation Therapy",,
692,DB00708,Sufentanil,small molecule,approved|investigational,"Adjuvants, Anesthesia|Agents that produce hypertension|Analgesics|Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Bradycardia-Causing Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fentanyl and fentanyl analogues|High-risk opioids|Hypotensive Agents|Narcotics|Nervous System|Neuraxial Anesthetics|Opiate Agonists|Opioid Agonist|Opioid Anesthetics|Opioids|Opioids, Anilidopiperidine|Peripheral Nervous System Agents|Phenylpiperidine opioids|Piperidines|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCC2=CC=CS2)CC1,41693
693,DB00709,Lamivudine,small molecule,approved|investigational,"Agents Causing Muscle Toxicity|Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BCRP/ABCG2 Substrates|Carbohydrates|Deoxycytidine|Deoxyribonucleosides|Dideoxynucleosides|Direct Acting Antivirals|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Glycosides|Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|Nucleoside Reverse Transcriptase Inhibitors|Nucleosides|OAT1/SLC22A6 Substrates|OCT1 substrates|OCT2 Substrates|P-glycoprotein substrates|Pyrimidine Nucleosides|Pyrimidines|Reverse Transcriptase Inhibitors|Ribonucleosides",NC1=NC(=O)N(C=C1)[C@@H]1CS[C@H](CO)O1,60825
694,DB00710,Ibandronate,small molecule,approved|investigational,Agents Causing Muscle Toxicity|Bisphosphonates|Bone Density Conservation Agents|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Musculo-Skeletal System|Organophosphonates|Organophosphorus Compounds|Potential QTc-Prolonging Agents|QTc Prolonging Agents,CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O,60852
695,DB00711,Diethylcarbamazine,small molecule,approved|investigational|vet_approved,"Acids, Acyclic|Anthelmintics|Anti-Infective Agents|Antihelminthic|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Carbamates|Cholinesterase Inhibitors|Enzyme Inhibitors|Filaricides|Lipoxygenase Inhibitors|Piperazine and Derivatives|Piperazines",CCN(CC)C(=O)N1CCN(C)CC1,3052
696,DB00712,Flurbiprofen,small molecule,approved|investigational,"Acids, Acyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antirheumatic Agents|Benzene Derivatives|Biphenyl Compounds|Central Nervous System Agents|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|OAT1/SLC22A6 inhibitors|Ophthalmologicals|Other Nonsteroidal Anti-inflammatory Agents|Peripheral Nervous System Agents|Photosensitizing Agents|Propionates|Sensory Organs|Sensory System Agents|Throat Preparations|Topical Products for Joint and Muscular Pain|UGT1A1 Inhibitors|UGT1A1 Substrates|UGT1A3 substrates|UGT1A9 Substrates|UGT2B7 substrates",CC(C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1,3394
697,DB00713,Oxacillin,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|Beta-Lactamase Resistant Penicillins|beta-Lactams|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Lactams|Penicillins|Sulfur Compounds",[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1)C(O)=O,6196
698,DB00714,Apomorphine,small molecule,approved|investigational,"Alkaloids|Anti-Parkinson Agents (Dopamine Agonist)|Anti-Parkinson Drugs|Antidepressive Agents|Aporphines|Autonomic Agents|Benzylisoquinolines|Central Nervous System Agents|Central Nervous System Depressants|COMT Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Agonists|Drugs Used in Erectile Dysfunction|Emetics|Gastrointestinal Agents|Genito Urinary System and Sex Hormones|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Isoquinolines|Nervous System|Neurotransmitter Agents|Nonergot-derivative Dopamine Receptor Agonists|Opiate Agonists|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Antagonists|Urologicals",[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23,6005
699,DB00715,Paroxetine,small molecule,approved|investigational,"Agents producing tachycardia|Anticholinergic Agents|Antidepressive Agents|Antidepressive Agents, Second-Generation|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|P-glycoprotein inhibitors|Photosensitizing Agents|Piperidines|Psychoanaleptics|Psychotropic Drugs|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators",FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,43815
700,DB00716,Nedocromil,small molecule,approved|investigational,"4-Quinolones|Anti-Allergic Agents|Anti-Asthmatic Agents|Anti-Inflammatory Agents|Antiallergic Agents, Excl. Corticosteroids|Decongestants and Antiallergics|Decreased Histamine Release|Drugs for Obstructive Airway Diseases|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Mast Cell Stabilizers|Nasal Preparations|Ophthalmologicals|Quinolines|Quinolones|Respiratory Agents, Miscellaneous|Respiratory System Agents|Sensory Organs",CCCC1=C2N(CC)C(=CC(=O)C2=CC2=C1OC(=CC2=O)C(O)=O)C(O)=O,50294
701,DB00717,Norethisterone,small molecule,approved,"Adrenal Cortex Hormones|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Estren Derivatives|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hyperglycemia-Associated Agents|Norpregnenes|Norsteroids|P-glycoprotein inhibitors|Progestin Contraceptives|Progestins|Progestogens and Estrogens, Sequential Preparations|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids",[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],6230
702,DB00718,Adefovir dipivoxil,small molecule,approved|investigational,"Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Direct Acting Antivirals|Enzyme Inhibitors|Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Heterocyclic Compounds, Fused-Ring|Nephrotoxic agents|Nucleic Acid Synthesis Inhibitors|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|Nucleosides and Nucleotides|OAT1/SLC22A6 inhibitors|OAT1/SLC22A6 Substrates|Organophosphorus Compounds|Purines|Reverse Transcriptase Inhibitors",CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N)N=CN=C12)OCOC(=O)C(C)(C)C,60871
703,DB00719,Azatadine,small molecule,approved,Agents that reduce seizure threshold|Antihistamines for Systemic Use|Benzocycloheptenes|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Dibenzocycloheptenes|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Piperidines|Potential QTc-Prolonging Agents|QTc Prolonging Agents,CN1CCC(CC1)=C1C2=CC=CC=C2CCC2=C1N=CC=C2,19861
704,DB00720,Clodronic acid,small molecule,approved|investigational|vet_approved,Bisphosphonates|Bone Density Conservation Agents|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Musculo-Skeletal System|Organophosphonates|Organophosphorus Compounds,OP(O)(=O)C(Cl)(Cl)P(O)(O)=O,25419
705,DB00721,Procaine,small molecule,approved|investigational|vet_approved,"Acids, Carbocyclic|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Agents that reduce seizure threshold|Aminobenzoates|Anesthetics|Anesthetics, Local|Anticholinergic Agents|Antidepressive Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Central Nervous System Depressants|Cholinesterase Inhibitors|Cholinesterase substrates|Esters of Aminobenzoic Acid|Monoamine Oxidase Inhibitors|Nervous System|Nicotinic Antagonists|NMDA Receptor Antagonists|Ophthalmologicals|para-Aminobenzoates|Peripheral Nervous System Agents|Sensory Organs|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Vasoprotectives",CCN(CC)CCOC(=O)C1=CC=C(N)C=C1,4914
706,DB00722,Lisinopril,small molecule,approved|investigational,"ACE Inhibitors and Calcium Channel Blockers|ACE Inhibitors and Diuretics|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Amino Acids, Peptides, and Proteins|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Dipeptides|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Hypotensive Agents|Lipid Modifying Agents|Oligopeptides|Peptides|Photosensitizing Agents|Protease Inhibitors|Protective Agents",NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,5362119
707,DB00723,Methoxamine,small molecule,approved|investigational,Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Autonomic Agents|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Ethylamines|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenethylamines|Propanolamines|Propanols|Sympathomimetics|Vasoconstrictor Agents,COC1=CC(C(O)C(C)N)=C(OC)C=C1,6082
708,DB00724,Imiquimod,small molecule,approved|investigational,"Adjuvants, Immunologic|Aminoquinolines|Antineoplastic Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dermatologicals|Heterocyclic Compounds, Fused-Ring|Immunologic Factors|Immunosuppressive Agents|Increased Cytokine Activity|Increased Cytokine Production|Interferon Inducers|Misc. Skin and Mucous Membrane Agents|Quinolines",CC(C)CN1C=NC2=C1C1=C(C=CC=C1)N=C2N,57469
709,DB00725,Homatropine methylbromide,small molecule,approved,Agents producing tachycardia|Alimentary Tract and Metabolism|Alkaloids|Anticholinergic Agents|Aza Compounds|Azabicyclo Compounds|Drugs for Functional Gastrointestinal Disorders|Muscarinic Agonists|Muscarinic Antagonists,[Br-].C[N+]1(C)C2CCC1CC(C2)OC(=O)C(O)C1=CC=CC=C1,6646
710,DB00726,Trimipramine,small molecule,approved,"Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Adrenergic Uptake Inhibitors|Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Antidepressive Agents, Tricyclic|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 Substrates|Dibenzazepines|Heterocyclic Compounds, Fused-Ring|Histamine Antagonists|Histamine H1 Antagonists|Membrane Transport Modulators|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Non-Selective Monoamine Reuptake Inhibitors|P-glycoprotein substrates|Potential QTc-Prolonging Agents|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists|Tertiary amine tricyclic antidepressants|Tricyclics and Other Norepinephrine-reuptake Inhibitors",CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12,5584
711,DB00727,Nitroglycerin,small molecule,approved|investigational,"Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Antianginal Agents|Antihypertensive Agents|Cardiac Therapy|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Explosive Agents|Hypotensive Agents|Methemoglobinemia Associated Agents|Nitrate Vasodilator|Nitrates and Nitrites|Nitro Compounds|Organic Nitrates|Vasodilating Agents|Vasodilation|Vasodilators Used in Cardiac Diseases|Vasoprotectives",[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,4510
712,DB00728,Rocuronium,small molecule,approved,"Agents producing tachycardia|Androstanes|Androstanols|Anticholinergic Agents|Central Nervous System Depressants|Fused-Ring Compounds|Muscarinic Antagonists|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular Nondepolarizing Blockade|Neuromuscular-Blocking Agents (Nondepolarizing)|Nicotinic Antagonists|OCT1 inhibitors|OCT1 substrates|Peripheral Nervous System Agents|Steroids",[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](O)[C@H](C[C@]12C)N1CCOCC1)[N+]1(CC=C)CCCC1,441290
713,DB00730,Thiabendazole,small molecule,approved|vet_approved,"Anthelmintics|Anti-Infective Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Antihelminthic|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Benzimidazole Derivatives|Benzimidazoles|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Imidazole and Triazole Derivatives|Sulfur Compounds|Thiazoles",N1C2=CC=CC=C2N=C1C1=CSC=N1,5430
714,DB00731,Nateglinide,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Cyclohexanes|Cycloparaffins|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Drugs Used in Diabetes|Glinide|Hypoglycemia-Associated Agents|OAT1/SLC22A6 inhibitors|Phenylalanine|Potassium Channel Antagonists|UGT1A9 Substrates",CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O,5311309
715,DB00732,Atracurium besylate,small molecule,approved,"Alkaloids|Anticholinergic Agents|Benzylisoquinolines|Central Nervous System Depressants|Cholinergic Agents|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Miscellaneous Skeletal Muscle Relaxants|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular-Blocking Agents (Nondepolarizing)|Neurotransmitter Agents|Nicotinic Antagonists|Peripheral Nervous System Agents",[O-]S(=O)(=O)C1=CC=CC=C1.[O-]S(=O)(=O)C1=CC=CC=C1.COC1=CC2=C(C=C1OC)C(CC1=CC(OC)=C(OC)C=C1)[N+](C)(CCC(=O)OCCCCCOC(=O)CC[N+]1(C)CCC3=C(C=C(OC)C(OC)=C3)C1CC1=CC(OC)=C(OC)C=C1)CC2,47320
716,DB00733,Pralidoxime,small molecule,approved|vet_approved,"Amines|Antidotes|Cholinergic Agents|Cholinesterase Reactivators|Compounds used in a research, industrial, or household setting|Drugs that are Mainly Renally Excreted|Enzyme Reactivators|Hydroxylamines|Neurotransmitter Agents|Oximes|Protective Agents",C[N+]1=C(\C=N\O)C=CC=C1,5353894
717,DB00734,Risperidone,small molecule,approved|investigational,Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Histamine Antagonists|Histamine H1 Antagonists|Hyperglycemia-Associated Agents|Nervous System|Neurotoxic agents|Neurotransmitter Agents|P-glycoprotein substrates|Potential QTc-Prolonging Agents|Psycholeptics|Psychotropic Drugs|Pyrimidines|Pyrimidinones|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Tranquilizing Agents,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,5073
718,DB00735,Naftifine,small molecule,approved,"Alkenes|Allyl Compounds|Allylamine Antifungal|Amines|Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Dermatologicals|Hydrocarbons, Acyclic",CN(CC=CC1=CC=CC=C1)CC1=CC=CC2=CC=CC=C12,73342
719,DB00736,Esomeprazole,small molecule,approved|investigational,"2-Pyridinylmethylsulfinylbenzimidazoles|Acid Reducers|Alimentary Tract and Metabolism|Anti-Ulcer Agents|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Benzimidazoles|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Enzyme Inhibitors|Gastric Acid Lowering Agents|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Musculo-Skeletal System|OAT3/SLC22A8 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Photosensitizing Agents|Propionates|Proton Pump Inhibitors|Proton-pump Inhibitors|Pyridines|Sulfoxides|Sulfur Compounds",COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,9568614
720,DB00737,Meclizine,small molecule,approved,Anti-Allergic Agents|Antiemetics|Antihistamines for Systemic Use|Antivertigo Preparations|Autonomic Agents|Benzene Derivatives|Benzhydryl Compounds|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Emesis Suppression|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Peripheral Nervous System Agents|Piperazine Derivatives|Piperazines,CC1=CC(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)=CC=C1,4034
721,DB00738,Pentamidine,small molecule,approved|investigational,"Agents Against Leishmaniasis and Trypanosomiasis|Agents causing hyperkalemia|Amidines|Anti-Infective Agents|Antibiotics for Pneumocystis Pneumonia|Antifungal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Benzamidines|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Hyperglycemia-Associated Agents|Hypoglycemia-Associated Agents|Miscellaneous Antiprotozoals|Moderate Risk QTc-Prolonging Agents|Nephrotoxic agents|QTc Prolonging Agents|Trypanocidal Agents",NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,4735
722,DB00739,Hetacillin,small molecule,approved|vet_approved|withdrawn,"Amides|Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds",[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2N1C(=O)[C@H](NC1(C)C)C1=CC=CC=C1)C(O)=O,443387
723,DB00740,Riluzole,small molecule,approved|investigational,"Anticonvulsants|BCRP/ABCG2 Substrates|Benzothiazoles|Central Nervous System Agents|Central Nervous System Depressants|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Heterocyclic Compounds, Fused-Ring|Miscellaneous Central Nervous System Agents|Nervous System|Neuroprotective Agents|Neurotransmitter Agents|Protective Agents|Sulfur Compounds|Thiazoles",NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2,5070
724,DB00741,Hydrocortisone,small molecule,approved|vet_approved,"11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Adrenal Cortex Hormones|Adrenals|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Alimentary Tract and Metabolism|Anti-Inflammatory Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids Acting Locally|Corticosteroids for Local Oral Treatment|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Corticosteroids, Dermatological Preparations|Corticosteroids, Weak (Group I)|Cytochrome P-450 CYP2A6 Inducers|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Dermatologicals|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydrocortisone and derivatives|Hydroxycorticosteroids|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Intestinal Antiinflammatory Agents|Nasal Preparations|OAT3/SLC22A8 Substrates|Ophthalmological and Otological Preparations|Ophthalmologicals|Otologicals|P-glycoprotein inducers|P-glycoprotein substrates|Pregnanes|Pregnenediones|Pregnenes|Sensory Organs|Steroids|Stomatological Preparations|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Vasoprotectives",[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,5754
725,DB00742,Mannitol,small molecule,approved|investigational,"Agents causing hyperkalemia|Alcohols|Alimentary Tract and Metabolism|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Carbohydrates|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Cough and Cold Preparations|Diet, Food, and Nutrition|Diuretics|Diuretics, Osmotic|Drugs for Constipation|Drugs that are Mainly Renally Excreted|Expectorants|Flavoring Agents|Food|Food Additives|Food and Beverages|Food Ingredients|Hypotensive Agents|i.v. Solutions|Increased Diuresis|Irrigating Solutions|Kidney Function|Laxatives|Natriuretic Agents|Nephrotoxic agents|Osmotic Activity|Osmotic Laxatives|P-glycoprotein substrates|Pharmaceutic Aids|Pharmaceutical Preparations|Physiological Phenomena|Solutions Producing Osmotic Diuresis|Sugar Alcohols|Sweetening Agents",OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,6251
726,DB00743,Gadobenic acid,small molecule,approved|investigational,"Alcohols|Amino Sugars|Carbohydrates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Drugs that are Mainly Renally Excreted|Gadolinium-based Contrast Agent|Hexosamines|Magnetic Resonance Contrast Activity|Magnetic Resonance Imaging Contrast Media|Moderate Risk QTc-Prolonging Agents|Other Diagnostics|Paramagnetic Contrast Agent|Paramagnetic Contrast Media|QTc Prolonging Agents|Sugar Alcohols",[Gd+3].OC(=O)CN(CCN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)C(COCC1=CC=CC=C1)C(O)=O,131704172
727,DB00744,Zileuton,small molecule,approved|investigational|withdrawn,"Agents to Treat Airway Disease|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Decreased Leukotriene Production|Enzyme Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Leukotriene Antagonists|Lipoxygenase Inhibitors|Peripheral Nervous System Agents|Sensory System Agents|UGT1A9 Substrates",CC(N(O)C(N)=O)C1=CC2=CC=CC=C2S1,60490
728,DB00745,Modafinil,small molecule,approved|investigational,"Benzene Derivatives|Benzhydryl Compounds|Central Nervous System Agents|Central Nervous System Stimulants|Central Nervous System Stimulation|Centrally Acting Sympathomimetics|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (moderate)|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (moderate)|Cytochrome P-450 CYP3A5 Inducers (weak)|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (weak)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Increased Sympathetic Activity|Nervous System|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Stimulants|Sympathomimetic-like Agent|Wakefulness-Promoting Agents",NC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1,4236
729,DB00746,Deferoxamine,small molecule,approved|investigational,"Amines|Chelating Agents|Compounds used in a research, industrial, or household setting|Heavy Metal Antagonists|Hydroxamic Acids|Hydroxy Acids|Hydroxylamines|Iron Chelating Activity|Iron Chelating Agents|Sequestering Agents|Siderophores",CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,2973
730,DB00747,Scopolamine,small molecule,approved|investigational,"Adjuvants|Adjuvants, Anesthesia|Agents producing tachycardia|Alimentary Tract and Metabolism|Alkaloids|Anticholinergic Agents|Antiemetics|Antiemetics and Antinauseants|Antimuscarinics Antispasmodics|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Belladonna Alkaloids|Central Nervous System Agents|Central Nervous System Depressants|Cholinergic Agents|Gastrointestinal Agents|Hypnotics and Sedatives|Muscarinic Antagonists|Mydriatics|Mydriatics and Cycloplegics|Nervous System|Neurotransmitter Agents|Ophthalmologicals|P-glycoprotein inhibitors|Peripheral Nervous System Agents|Psycholeptics|Scopolamine Derivatives|Sensory Organs|Solanaceous Alkaloids|Tropanes",CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1,3000322
731,DB00748,Carbinoxamine,small molecule,approved,Aminoalkyl Ethers|Antihistamines for Systemic Use|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|Photosensitizing Agents|QTc Prolonging Agents,CN(C)CCOC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1,2564
732,DB00749,Etodolac,small molecule,approved|investigational|vet_approved,"Acetic Acid Derivatives and Related Substances|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|COX-2 Inhibitors|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Indoleacetic Acids|Indoles|Musculo-Skeletal System|Nephrotoxic agents|OAT1/SLC22A6 inhibitors|Other Nonsteroidal Anti-inflammatory Agents|Peripheral Nervous System Agents|Photosensitizing Agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory System Agents|UGT1A3 substrates|UGT1A9 Substrates|UGT2B7 substrates",CCC1=C2NC3=C(CCOC3(CC)CC(O)=O)C2=CC=C1,3308
733,DB00750,Prilocaine,small molecule,approved,"Amide Local Anesthetic|Amides|Amines|Anesthetics|Anesthetics, Local|Anilides|Aniline Compounds|Central Nervous System Agents|Local Anesthesia|Methemoglobinemia Associated Agents|Nervous System|Peripheral Nervous System Agents|Sensory System Agents",CCCNC(C)C(=O)NC1=CC=CC=C1C,4906
734,DB00751,Epinastine,small molecule,approved|investigational,"Acid Reducers|Antidepressive Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Decongestants and Antiallergics|Decreased Histamine Release|Heterocyclic Compounds, Fused-Ring|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Inhibitors|Histamine H2 Antagonists|Neurotransmitter Agents|Ophthalmics|Ophthalmologicals|P-glycoprotein substrates|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sensory Organs|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists",NC1=NCC2N1C1=CC=CC=C1CC1=CC=CC=C21,3241
735,DB00752,Tranylcypromine,small molecule,approved|investigational,"Agents that produce hypertension|Agents that reduce seizure threshold|Amines|Anti-Anxiety Agents|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Hypotensive Agents|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Monoamine Oxidase Inhibitors|Monoamine Oxidase Inhibitors, Non-Selective|Nervous System|Propylamines|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Tranquilizing Agents",NC1CC1C1=CC=CC=C1,5530
736,DB00753,Isoflurane,small molecule,approved|vet_approved,"Agents that produce hypertension|Agents that reduce seizure threshold|Anesthetics|Anesthetics, General|Anesthetics, Inhalation|Anticholinergic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Ethers|Hydrocarbons, Halogenated|Hypotensive Agents|Methyl Ethers|Nervous System|Nicotinic Antagonists|Potential QTc-Prolonging Agents|QTc Prolonging Agents",FC(F)OC(Cl)C(F)(F)F,3763
737,DB00754,Ethotoin,small molecule,approved,Anti-epileptic Agent|Anticonvulsants|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Decreased Central Nervous System Disorganized Electrical Activity|Hydantoins|Imidazoles|Imidazolidines|Membrane Transport Modulators|Nervous System|Sodium Channel Blockers|Thyroxine-binding globulin substrates|Voltage-Gated Sodium Channel Blockers,CCN1C(=O)NC(C1=O)C1=CC=CC=C1,3292
738,DB00755,Tretinoin,small molecule,approved|investigational|nutraceutical,"Alkenes|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Biological Factors|Cardiotoxic antineoplastic agents|Carotenoids|Cell Stimulants and Proliferants|Cyclohexanes|Cyclohexenes|Cycloparaffins|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Substrates|Dermatologicals|Hydrocarbons, Acyclic|Hypotensive Agents|Immunosuppressive Agents|Keratolytic Agents|Pigments, Biological|Polyenes|Retinoids|Retinoids for Topical Use in Acne|Terpenes|Tretinoin|Vitamin A|Vitamins|Vitamins (Fat Soluble)",C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,5538
739,DB00756,Hexachlorophene,small molecule,approved|withdrawn,"Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Benzene Derivatives|Chlorobenzenes|Chlorophenols|Dermatologicals|Drugs causing inadvertant photosensitivity|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Phenol and Derivatives|Phenols|Photosensitizing Agents",OC1=C(CC2=C(O)C(Cl)=CC(Cl)=C2Cl)C(Cl)=C(Cl)C=C1Cl,3598
740,DB00757,Dolasetron,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Antidepressive Agents|Antiemetics|Antiemetics and Antinauseants|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 3 Receptor Antagonists|Serotonin 5-HT3 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists",[H][C@@]1(C[C@@]2([H])C[C@]3([H])C[C@@]([H])(C1)N2CC3=O)OC(=O)C1=CNC2=C1C=CC=C2,3033818
741,DB00758,Clopidogrel,small molecule,approved,"Antiplatelet agents|Blood and Blood Forming Organs|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (moderate)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Decreased Platelet Aggregation|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|OCT1 inhibitors|OCT2 Inhibitors|P-glycoprotein substrates|P2Y12 Platelet Inhibitor|Platelet Aggregation Inhibitors Excl. Heparin|Purinergic Agents|Purinergic Antagonists|Purinergic P2 Receptor Antagonists|Purinergic P2Y Receptor Antagonists|Pyridines|Sulfur Compounds|Thienopyridines|Thiophenes",[H][C@@](N1CCC2=C(C1)C=CS2)(C(=O)OC)C1=CC=CC=C1Cl,60606
742,DB00759,Tetracycline,small molecule,approved|vet_approved,"Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antibiotics for Topical Use|Antiinfectives and Antiseptics for Local Oral Treatment|Antiinfectives for Systemic Use|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Drugs causing inadvertant photosensitivity|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Naphthacenes|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Ophthalmological and Otological Preparations|Ophthalmologicals|Otologicals|Photosensitizing Agents|Protein Synthesis Inhibitors|Sensory Organs|Stomatological Preparations|Tetracycline, antagonists & inhibitors|Tetracyclines",[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,54675776
743,DB00760,Meropenem,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Carbapenems|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Lactams|Penem Antibacterial|Sulfur Compounds|Thienamycins",[H][C@]1([C@@H](C)O)C(=O)N2C(C(O)=O)=C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)[C@H](C)[C@]12[H],441130
744,DB00761,Potassium chloride,small molecule,approved|withdrawn,"Acids|Acids, Noncarboxylic|Agents causing hyperkalemia|Alimentary Tract and Metabolism|Anions|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Chlorides|Chlorine Compounds|Drugs that are Mainly Renally Excreted|Electrolyte Solutions|Electrolytes|Hemodialysis Solution|I.V. Solution Additives|Ions|Mineral Supplements|Minerals|Potassium Compounds|Potassium Salt|Replacement Preparations",[Cl-].[K+],4873
745,DB00762,Irinotecan,small molecule,approved|investigational,Alkaloids|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Carbohydrates|Cholinesterase substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Substrates|Disaccharides|Enzyme Inhibitors|Immunosuppressive Agents|Myelosuppressive Agents|OATP1B1/SLCO1B1 Inhibitors|Oligosaccharides|P-glycoprotein substrates|Pharmaceutical Preparations|Polysaccharides|Topoisomerase I Inhibitors|Topoisomerase Inhibitors|UGT1A1 Substrates|UGT1A9 Substrates,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,60838
746,DB00763,Methimazole,small molecule,approved,"Antithyroid agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (weak)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Drugs that are Mainly Renally Excreted|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Imidazoles|Immunosuppressive Agents|Myelosuppressive Agents|Sulfur Compounds|Sulfur-Containing Imidazole Derivatives|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thyroid Hormone Synthesis Inhibitor|Thyroid Hormone Synthesis Inhibitors|Thyroid Products",CN1C=CNC1=S,1349907
747,DB00764,Mometasone,small molecule,experimental,"Adrenal Cortex Hormones|Adrenals|Anti-Allergic Agents|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Drugs for Obstructive Airway Diseases|Fused-Ring Compounds|Glucocorticoids|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Nasal Preparations|Pregnadienediols|Pregnadienes|Pregnanes|Steroids|Thyroxine-binding globulin inhibitors",[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,441335
748,DB00765,Metyrosine,small molecule,approved,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Antihypertensive Agents|Catecholamine Synthesis Inhibitor|Enzyme Inhibitors|Methyltyrosines|Tyrosine Hydroxylase Inhibitors",C[C@](N)(CC1=CC=C(O)C=C1)C(O)=O,441350
749,DB00766,Clavulanic acid,small molecule,approved|vet_approved,"Anti-Bacterial Agents|Anti-Infective Agents|beta-Lactamase Inhibitors|beta-Lactams|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Lactams",[H][C@@]12CC(=O)N1[C@@H](C(O)=O)\C(O2)=C\CO,5280980
750,DB00767,Benzquinamide,small molecule,withdrawn,"Agents producing tachycardia|Anticholinergic Agents|Heterocyclic Compounds, Fused-Ring|Histamine Antagonists|Histamine H1 Antagonists|Muscarinic Antagonists|P-glycoprotein inhibitors",CCN(CC)C(=O)C1CN2CCC3=CC(OC)=C(OC)C=C3C2CC1OC(C)=O,2342
751,DB00768,Olopatadine,small molecule,approved,"Anti-Allergic Agents|Anti-Inflammatory Agents|Antiallergic Agents, Excl. Corticosteroids|Antihistamine Drugs|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Decongestants and Antiallergics|Decreased Histamine Release|Dibenzoxepins|Heterocyclic Compounds, Fused-Ring|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Histamine H1 Inhibitors|Mast Cell Stabilizers|Nasal Preparations|Neurotransmitter Agents|Ophthalmologicals|P-glycoprotein substrates|Peripheral Nervous System Agents|QTc Prolonging Agents|Sensory Organs|Sensory System Agents",CN(C)CC\C=C1\C2=CC=CC=C2COC2=C1C=C(CC(O)=O)C=C2,5281071
752,DB00769,Hydrocortamate,small molecule,approved,Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CN(CC)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,84088
753,DB00770,Alprostadil,small molecule,approved|investigational,"Autacoids|Biological Factors|Cardiac Therapy|Cardiovascular Agents|Drugs Used in Erectile Dysfunction|Eicosanoids|Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Genito Urinary System and Sex Hormones|Genitourinary Arterial Vasodilation|Hematologic Agents|Inflammation Mediators|Lipids|Miscellaneous Vasodilatating Agents|OAT1/SLC22A6 inhibitors|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Substrates|Prostaglandin E1 Agonist|Prostaglandin Receptor Agonists|Prostaglandins|Prostaglandins E|Prostaglandins, Synthetic|Urological Agents|Urologicals|Vasodilating Agents|Venous Vasodilation",CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O,149351
754,DB00771,Clidinium,small molecule,approved,"Acids, Carbocyclic|Agents producing tachycardia|Alimentary Tract and Metabolism|Anticholinergic Agents|Autonomic Agents|Benzilates|Central Nervous System Depressants|Decreased Parasympathetic Acetylcholine Activity|Digestive/GI System Activity Alteration|Diphenylacetic Acids|Drugs for Functional Gastrointestinal Disorders|GI Motility Alteration|Hydroxy Acids|Muscarinic Antagonists|Parasympatholytics|Peripheral Nervous System Agents|Phenylacetates|Quinuclidines",C[N@@+]12CC[C@@H](CC1)C(C2)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,2784
755,DB00772,Malathion,small molecule,approved|investigational,"Agrochemicals|Antiparasitic Products, Insecticides and Repellents|Cholinergic Agents|Cholinesterase Inhibitors|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 Substrates|Ectoparasiticides, Incl. Scabicides|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Enzyme Inhibitors|Insecticides|Neurotransmitter Agents|Organophosphates|Organophosphorus Compounds|Organothiophosphates|Organothiophosphorus Compounds|Pesticides|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sulfur Compounds|Toxic Actions",CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC,4004
756,DB00773,Etoposide,small molecule,approved,"Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Benzene Derivatives|Benzyl Compounds|Carbohydrates|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Glucosides|Glycosides|Immunosuppressive Agents|Lignans|Myelosuppressive Agents|Naphthalenes|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Podophyllotoxin|Podophyllotoxin Derivatives|Tetrahydronaphthalenes|Topoisomerase II Inhibitors|Topoisomerase Inhibitors|UGT1A1 Substrates|UGT1A1 substrates with narrow therapeutic index",[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@H]2O[C@@H]1O[C@]2([H])CO[C@@H](C)O[C@@]2([H])[C@H](O)[C@H]1O,36462
757,DB00774,Hydroflumethiazide,small molecule,approved|investigational|withdrawn,"Amides|Antihypertensive Agents|Benzothiadiazines|Cardiovascular Agents|Diuretics|Drugs causing inadvertant photosensitivity|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Increased Diuresis|Membrane Transport Modulators|Natriuretic Agents|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Photosensitizing Agents|Sodium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds|Thiazides",NS(=O)(=O)C1=CC2=C(NCNS2(=O)=O)C=C1C(F)(F)F,3647
758,DB00775,Tirofiban,small molecule,approved,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Antiplatelet agents|Blood and Blood Forming Organs|Cardiovascular Agents|Decreased Platelet Aggregation|Drugs that are Mainly Renally Excreted|Fibrin Modulating Agents|Hematologic Agents|Platelet Aggregation Inhibitors Excl. Heparin",CCCCS(=O)(=O)N[C@@H](CC1=CC=C(OCCCCC2CCNCC2)C=C1)C(O)=O,60947
759,DB00776,Oxcarbazepine,small molecule,approved,"Anti-epileptic Agent|Anticonvulsants|Carboxamide Derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Decreased Central Nervous System Disorganized Electrical Activity|Dibenzazepines|Drugs causing inadvertant photosensitivity|Enzyme Inducing Antiepileptic Drugs|Heterocyclic Compounds, Fused-Ring|Membrane Transport Modulators|Miscellaneous Anticonvulsants|Nervous System|P-glycoprotein inducers|P-glycoprotein substrates|Photosensitizing Agents|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers",NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,34312
760,DB00777,Propiomazine,small molecule,approved,"Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Anticholinergic Agents|Antidepressive Agents|Central Nervous System Depressants|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Heterocyclic Compounds, Fused-Ring|Histamine Antagonists|Histamine H1 Antagonists|Hypnotics and Sedatives|Muscarinic Antagonists|Nervous System|Psycholeptics|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds",CCC(=O)C1=CC2=C(SC3=CC=CC=C3N2CC(C)N(C)C)C=C1,4940
761,DB00778,Roxithromycin,small molecule,approved|investigational|withdrawn,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Erythromycin and similars|Lactones|Macrolides|Macrolides, Lincosamides and Streptogramins|Moderate Risk QTc-Prolonging Agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Polyketides|QTc Prolonging Agents",CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=NOCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O,6915744
762,DB00779,Nalidixic acid,small molecule,approved|investigational,"4-Quinolones|Agents that reduce seizure threshold|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Moderate Risk QTc-Prolonging Agents|Naphthyridines|OAT1/SLC22A6 inhibitors|Photosensitizing Agents|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",CCN1C=C(C(O)=O)C(=O)C2=C1N=C(C)C=C2,4421
763,DB00780,Phenelzine,small molecule,approved,"Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP2E1 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Hydrazines|Hypotensive Agents|Monoamine Oxidase A Substrates|Monoamine Oxidase Inhibitors|Monoamine Oxidase Inhibitors, Non-Selective|Nervous System|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators",NNCCC1=CC=CC=C1,3675
764,DB00782,Propantheline,small molecule,approved,"Agents producing tachycardia|Alimentary Tract and Metabolism|Amines|Ammonium Compounds|Anti-Ulcer Agents|Anticholinergic Agents|Cholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Drugs that are Mainly Renally Excreted|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Muscarinic Antagonists|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds|Synthetic Anticholinergics, Quaternary Ammonium Compounds|Xanthenes",CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC2=CC=CC=C12)C(C)C,4934
765,DB00783,Estradiol,small molecule,approved|investigational|vet_approved,"Adrenal Cortex Hormones|Androgens and Estrogens|Antiandrogens and Estrogens|BCRP/ABCG2 Inhibitors|COMT Substrates|Contraceptive Agents, Female|Contraceptives, Oral|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Estradiol Congeners|Estradiol, agonists|Estranes|Estrenes|Estrogen Contraceptives|Estrogens|Estrogens, agonists|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Intravaginal Contraceptives|Natural and Semisynthetic Estrogens, Plain|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Inhibitors|OCT2 Inhibitors|P-glycoprotein substrates|Progestogens and Estrogens, Sequential Preparations|Sex Hormones and Modulators of the Genital System|Steroids|Thyroxine-binding globulin inducers|UGT1A1 Substrates",[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,5757
766,DB00784,Mefenamic acid,small molecule,approved,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Amines|Aminobenzoates|Analgesics|Analgesics, Non-Narcotic|Aniline Compounds|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Fenamates|Musculo-Skeletal System|Nephrotoxic agents|ortho-Aminobenzoates|Other Nonsteroidal Anti-inflammatory Agents|Peripheral Nervous System Agents|Photosensitizing Agents|Sensory System Agents|UGT1A9 Inhibitors",CC1=C(C)C(NC2=CC=CC=C2C(O)=O)=CC=C1,4044
767,DB00785,Cryptenamine,small molecule,approved,"Alkaloids|Antihypertensive Agents|Cardiovascular Agents|Cevanes|Heterocyclic Compounds, Fused-Ring|Veratrum Alkaloids",,
768,DB00786,Marimastat,small molecule,investigational,"Amines|Enzyme Inhibitors|Hydroxy Acids|Hydroxylamines|Metalloendopeptidases, antagonists & inhibitors",CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,119031
769,DB00787,Acyclovir,small molecule,approved,"Acyclovir and prodrug|Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Dermatologicals|Direct Acting Antivirals|Drugs that are Mainly Renally Excreted|Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor|Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor|Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor|Heterocyclic Compounds, Fused-Ring|MATE 1 Substrates|MATE 2 Substrates|MATE substrates|Nephrotoxic agents|Nucleic Acid Synthesis Inhibitors|Nucleosides and Nucleotides|Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors|OAT1/SLC22A6 inhibitors|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OCT1 inhibitors|OCT1 substrates|Ophthalmologicals|Purines|Purinones|Sensory Organs",NC1=NC(=O)C2=C(N1)N(COCCO)C=N2,2022
770,DB00788,Naproxen,small molecule,approved|vet_approved,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antigout Preparations|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antiinflammatory Products for Vaginal Administration|Antirheumatic Agents|BSEP/ABCB11 Substrates|Central Nervous System Agents|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Musculo-Skeletal System|Naphthaleneacetic Acids|Naphthalenes|Nephrotoxic agents|Non COX-2 selective NSAIDS|OAT1/SLC22A6 inhibitors|Other Nonsteroidal Anti-inflammatory Agents|P-glycoprotein inhibitors|Peripheral Nervous System Agents|Photosensitizing Agents|Propionates|Sensory System Agents|Topical Products for Joint and Muscular Pain|UGT1A1 Substrates|UGT1A3 substrates|UGT1A6 substrate|UGT1A9 Substrates|UGT2B7 substrates",COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O,156391
771,DB00789,Gadopentetic acid,small molecule,approved,"Acetates|Acids, Acyclic|Amines|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Drugs that are Mainly Renally Excreted|Fatty Acids|Fatty Acids, Volatile|Lipids|Magnetic Resonance Contrast Activity|Magnetic Resonance Imaging Contrast Media|Miscellaneous Therapeutic Agents|Organometallic Compounds|Paramagnetic Contrast Agent|Paramagnetic Contrast Media|Polyamines",[Gd+3].OC(=O)CN(CCN(CCN(CC(O)=O)CC([O-])=O)CC([O-])=O)CC([O-])=O,55466
772,DB00790,Perindopril,small molecule,approved,"ACE Inhibitors and Calcium Channel Blockers|ACE Inhibitors and Diuretics|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Cardiovascular Agents|Cholinesterase Inhibitors|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Indoles|Lipid Modifying Agents|Protease Inhibitors",[H][C@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O,107807
773,DB00791,Uracil mustard,small molecule,approved,"Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Hydrocarbons, Halogenated|Mustard Compounds|Narrow Therapeutic Index Drugs|Nitrogen Mustard Compounds|Nitrosoureas|Noxae|Pyrimidines|Pyrimidinones|Toxic Actions",ClCCN(CCCl)C1=CNC(=O)NC1=O,6194
774,DB00792,Tripelennamine,small molecule,approved|vet_approved,"Amines|Aminopyridines|Anti-Allergic Agents|Antihistamines for Systemic Use|Antihistamines for Topical Use|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Diamines|Ethylenediamine Derivatives|Ethylenediamines|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Polyamines|Pyridines|Substituted Ethylene Diamines",CN(C)CCN(CC1=CC=CC=C1)C1=CC=CC=N1,5587
775,DB00793,Haloprogin,small molecule,approved|withdrawn,Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Benzene Derivatives|Dermatologicals|Ethers|Phenols,ClC1=CC(Cl)=C(Cl)C=C1OCC#CI,3561
776,DB00794,Primidone,small molecule,approved|vet_approved,Anti-epileptic Agent|Anticholinergic Agents|Anticonvulsants|Barbiturates|Barbiturates and Derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 CYP1A2 Inducers (strong)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP2E1 Inducers (strength unknown)|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Decreased Central Nervous System Disorganized Electrical Activity|Enzyme Inducing Antiepileptic Drugs|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Nicotinic Antagonists|Phenobarbital and similars|Psycholeptics|Pyrimidines|Pyrimidinones|UGT1A1 Inducers,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1,4909
777,DB00795,Sulfasalazine,small molecule,approved,"Agents causing hyperkalemia|Agents that produce hypertension|Alimentary Tract and Metabolism|Amides|Aminosalicylate|Analgesics|Analgesics, Non-Narcotic|Anti-Infective Agents|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antirheumatic Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Central Nervous System Agents|Gastrointestinal Agents|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Immunosuppressive Agents|Intestinal Antiinflammatory Agents|Methemoglobinemia Associated Agents|Nephrotoxic agents|Non COX-2 selective NSAIDS|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Peripheral Nervous System Agents|Salicylates|Sensory System Agents|Sulfonamides|Sulfones|Sulfur Compounds",OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1,5359476
778,DB00796,Candesartan cilexetil,small molecule,approved,"Agents Acting on the Renin-Angiotensin System|Agents causing hyperkalemia|Angiotensin 2 Receptor Blocker|Angiotensin II Antagonists and Diuretics|Angiotensin Receptor Antagonists|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Benzene Derivatives|Cardiovascular Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|P-glycoprotein inhibitors|UGT1A3 substrates",CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1,2540
779,DB00797,Tolazoline,small molecule,approved|vet_approved,Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antihypertensive Agents|Cardiovascular Agents|Hypotensive Agents|Imidazoles|Imidazoline Derivatives|Imidazolines|Musculo-Skeletal System|Neurotransmitter Agents|Peripheral alpha-1 blockers|Peripheral Vasodilators|Topical Products for Joint and Muscular Pain|Vasodilating Agents,C(C1=NCCN1)C1=CC=CC=C1,5504
780,DB00798,Gentamicin,small molecule,approved|vet_approved,"Agents that produce neuromuscular block (indirect)|alpha-Galactosidase, antagonists & inhibitors|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antibiotics for Topical Use|Antiinfectives for Systemic Use|Carbohydrates|Dermatologicals|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Enzyme Inhibitors|Gentamicins|Glycosides|Narrow Therapeutic Index Drugs|Nephrotoxic agents|OAT1/SLC22A6 inhibitors|Ophthalmological and Otological Preparations|Ophthalmologicals|Otologicals|Protein Synthesis Inhibitors|Sensory Organs",CNC(C)C1CCC(N)C(OC2C(N)CC(N)C(OC3OCC(C)(O)C(NC)C3O)C2O)O1,3467
781,DB00799,Tazarotene,small molecule,approved|investigational,Antipsoriatics|Antipsoriatics for Topical Use|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 Substrates|Dermatologicals|Keratolytic Agents|Misc. Skin and Mucous Membrane Agents|Noxae|Prodrugs|Pyridines|Retinoids|Teratogens|Toxic Actions,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC2=C(SCCC2(C)C)C=C1,5381
782,DB00800,Fenoldopam,small molecule,approved,"Adrenergic and Dopaminergic Agents|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Benzazepines|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Dopamine Agents|Dopamine Agonists|Dopamine D1 Receptor Agonists|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Neurotransmitter Agents|Vasodilating Agents",OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12,3341
783,DB00801,Halazepam,small molecule,approved|illicit|withdrawn,"Anti-Anxiety Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Nervous System|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents",FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,31640
784,DB00802,Alfentanil,small molecule,approved|illicit,"Agents that produce hypertension|Analgesics|Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Bradycardia-Causing Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Substrates|Fentanyl and fentanyl analogues|High-risk opioids|Narcotics|Nervous System|Opiate Agonists|Opioid Agonist|Opioid Anesthetics|Opioids|Opioids, Anilidopiperidine|P-glycoprotein inhibitors|Peripheral Nervous System Agents|Phenylpiperidine opioids|Piperidines|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",CCN1N=NN(CCN2CCC(COC)(CC2)N(C(=O)CC)C2=CC=CC=C2)C1=O,51263
785,DB00803,Colistin,small molecule,approved,"Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antiinfectives for Systemic Use|Antimicrobial Cationic Peptides|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Intestinal Antiinfectives|Lipids|Lipopeptides|Membrane Proteins|Nephrotoxic agents|Peptides|Peptides, Cyclic|Polymyxins|Pore Forming Cytotoxic Proteins|Proteins",CCC(C)CCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)C(NC(=O)[C@@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O,131704173
786,DB00804,Dicyclomine,small molecule,approved,"Acids, Carbocyclic|Agents producing tachycardia|Alimentary Tract and Metabolism|Anticholinergic Agents|Antimuscarinics Antispasmodics|Autonomic Agents|Cholinergic Agents|Cyclohexanecarboxylic Acids|Cyclohexanes|Cycloparaffins|Drugs for Functional Gastrointestinal Disorders|Drugs that are Mainly Renally Excreted|Muscarinic Antagonists|Neurotransmitter Agents|Parasympatholytics|Peripheral Nervous System Agents|Synthetic Anticholinergics, Esters With Tertiary Amino Group",CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1,3042
787,DB00805,Minaprine,small molecule,approved,Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Stimulants|Cholinesterase Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Monoamine Oxidase Inhibitors|Nervous System|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1,4199
788,DB00806,Pentoxifylline,small molecule,approved|investigational,"Alkaloids|Antioxidants|Antiplatelet agents|Blood Viscosity Reducer|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Drugs for Obstructive Airway Diseases|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Free Radical Scavengers|Hematologic Activity Alteration|Hematologic Agents|Hemorrheologic Agents|Heterocyclic Compounds, Fused-Ring|Peripheral Vasodilators|Phosphodiesterase 5 Inhibitors|Phosphodiesterase Inhibitors|Protective Agents|Purine Derivatives|Purines|Purinones|Radiation-Protective Agents|Vasodilating Agents|Xanthine derivatives",CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C,4740
789,DB00807,Proparacaine,small molecule,approved|vet_approved,"Acids, Carbocyclic|Aminobenzoates|Anesthetics|Anesthetics, Local|Benzene Derivatives|Benzoates|Central Nervous System Agents|Ethers|Hydroxy Acids|Hydroxybenzoate Ethers|Hydroxybenzoates|Isomerism|Local Anesthesia|Ophthalmologicals|para-Aminobenzoates|Peripheral Nervous System Agents|Phenols|Phenyl Ethers|Sensory Organs|Sensory System Agents",CCCOC1=C(N)C=C(C=C1)C(=O)OCCN(CC)CC,4935
790,DB00808,Indapamide,small molecule,approved,"Amides|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Diuretics|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Genito Urinary System and Sex Hormones|Heterocyclic Compounds, Fused-Ring|Hyperglycemia-Associated Agents|Hypotensive Agents|Increased Diuresis|Indoles|Lipid Modifying Agents|Low-Ceiling Diuretics, Excl. Thiazides|Membrane Transport Modulators|Natriuretic Agents|Non Potassium Sparing Diuretics|Photosensitizing Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sodium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds|Thiazide-like Diuretic",CC1CC2=CC=CC=C2N1NC(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O,3702
791,DB00809,Tropicamide,small molecule,approved|investigational,Anticholinergic Agents|Autonomic Agents|Cholinergic Agents|Muscarinic Antagonists|Mydriatics|Mydriatics and Cycloplegics|Neurotransmitter Agents|Ophthalmologicals|Peripheral Nervous System Agents|Pyridines|Sensory Organs,CCN(CC1=CC=NC=C1)C(=O)C(CO)C1=CC=CC=C1,5593
792,DB00810,Biperiden,small molecule,approved|investigational,Agents producing tachycardia|Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Anticholinergic Agents|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Central Nervous System Agents|Cholinergic Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|Nicotinic Antagonists|Parasympatholytics|Peripheral Nervous System Agents|Piperidines|Tertiary Amines,OC(CCN1CCCCC1)(C1CC2CC1C=C2)C1=CC=CC=C1,2381
793,DB00811,Ribavirin,small molecule,approved,"Anti-Infective Agents|Antiinfectives for Systemic Use|Antimetabolites|Antiviral Agents|Antivirals for Systemic Use|Antivirals for treatment of HCV infections|Carbohydrates|Direct Acting Antivirals|Drugs that are Mainly Renally Excreted|Glycosides|Noxae|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Analog Antiviral|Nucleosides|Nucleosides and Nucleotides|Ribonucleosides|Toxic Actions",NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,37542
794,DB00812,Phenylbutazone,small molecule,approved|vet_approved,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antirheumatic Agents|Butylpyrazolidines|Central Nervous System Agents|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|Peripheral Nervous System Agents|Pyrazoles|Pyrazolones|Sensory System Agents|Topical Products for Joint and Muscular Pain",CCCCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C1,4781
795,DB00813,Fentanyl,small molecule,approved|illicit|investigational|vet_approved,"Adjuvants|Adjuvants, Anesthesia|Agents that produce hypertension|Agents that reduce seizure threshold|Analgesics|Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Antidepressive Agents|Bradycardia-Causing Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Fentanyl and fentanyl analogues|High-risk opioids|Narcotics|Nervous System|Neuraxial Anesthetics|Opiate Agonists|Opioid Agonist|Opioid Anesthetics|Opioids|Opioids, Anilidopiperidine|P-glycoprotein inhibitors|Peripheral Nervous System Agents|Phenylpiperidine opioids|Piperidines|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators",CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,3345
796,DB00814,Meloxicam,small molecule,approved|vet_approved,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|COX-2 Inhibitors|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Musculo-Skeletal System|Nephrotoxic agents|Other Nonsteroidal Anti-inflammatory Agents|Oxicams|Peripheral Nervous System Agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory System Agents|Sulfur Compounds|Thiazines|Thiazoles",CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C2=C(C=CC=C2)S1(=O)=O,54677470
797,DB00815,Sodium lauryl sulfate,small molecule,experimental,"Acids|Acids, Noncarboxylic|Alcohols|Alkanes|Alkanesulfonates|Alkanesulfonic Acids|Compounds used in a research, industrial, or household setting|Dodecanol|Fatty Alcohols|Hydrocarbons, Acyclic|Lipids|Sulfones|Sulfonic Acids|Sulfur Acids|Sulfur Compounds|Surface-Active Agents",[Na+].CCCCCCCCCCCCOS([O-])(=O)=O,3423265
798,DB00816,Orciprenaline,small molecule,approved,"Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Benzene Derivatives|Bronchodilator Agents|Catecholamines|Catechols|Drugs for Obstructive Airway Diseases|Ethanolamines|Neurotransmitter Agents|Non-selective Beta-adrenergic Agonists|Peripheral Nervous System Agents|Phenols|Reproductive Control Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists|Sympathomimetics|Tocolytic Agents",CC(C)NCC(O)C1=CC(O)=CC(O)=C1,4086
799,DB00817,Rosoxacin,small molecule,approved|investigational,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines",CCN1C=C(C(O)=O)C(=O)C2=C1C=C(C=C2)C1=CC=NC=C1,287180
800,DB00818,Propofol,small molecule,approved|investigational|vet_approved,"Agents Causing Muscle Toxicity|Agents that produce hypertension|Agents that reduce seizure threshold|Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Benzene Derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Hypnotics and Sedatives|Hypotensive Agents|Miscellaneous General Anesthetics|Nervous System|P-glycoprotein inducers|Phenols|Potential QTc-Prolonging Agents|QTc Prolonging Agents|UGT1A1 Inhibitors|UGT1A1 Substrates|UGT1A6 substrate|UGT1A9 Substrates",CC(C)C1=CC=CC(C(C)C)=C1O,4943
801,DB00819,Acetazolamide,small molecule,approved|vet_approved,Anticonvulsants|Antiglaucoma Agents|Antiglaucoma Preparations and Miotics|Carbonic Anhydrase Inhibitors|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Diuretics|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Natriuretic Agents|OAT1/SLC22A6 inhibitors|Ophthalmologicals|Photosensitizing Agents|Sensory Organs|Sulfonamides|Sulfur Compounds|Thiadiazoles|Thiazoles,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,1986
802,DB00820,Tadalafil,small molecule,approved|investigational,"Antihypertensive Agents|Antihypertensives for Pulmonary Arterial Hypertension|Carbolines|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Drugs Used in Erectile Dysfunction|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Heterocyclic Compounds, Fused-Ring|Indoles|Phosphodiesterase 5 Inhibitors|Phosphodiesterase Inhibitors|Pyridines|Urological Agents|Urologicals|Vasodilating Agents",[H][C@]12CC3=C(NC4=CC=CC=C34)[C@H](N1C(=O)CN(C)C2=O)C1=CC2=C(OCO2)C=C1,110635
803,DB00821,Carprofen,small molecule,approved|vet_approved|withdrawn,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antirheumatic Agents|Central Nervous System Agents|Dermatologicals|Heterocyclic Compounds, Fused-Ring|Indoles|Nephrotoxic agents|OAT1/SLC22A6 inhibitors|Peripheral Nervous System Agents|Photosensitizing Agents|Radiation-Sensitizing Agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory System Agents",CC(C(O)=O)C1=CC2=C(C=C1)C1=C(N2)C=CC(Cl)=C1,2581
804,DB00822,Disulfiram,small molecule,approved,"Acetyl Aldehyde Dehydrogenase Inhibitors|Acids|Acids, Acyclic|Acids, Noncarboxylic|Agents that reduce seizure threshold|Alcohol Deterrents|Aldehyde Dehydrogenase Inhibitor|Anions|Antiparasitic Products, Insecticides and Repellents|BSEP/ABCB11 Substrates|Carbamates|Central Nervous System Agents|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Disulfides|Drugs Used in Addictive Disorders|Drugs Used in Alcohol Dependence|Ectoparasiticides, Incl. Scabicides|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Electrolytes|Enzyme Inhibitors|Gases|Hydrogen Sulfide|Ions|Nervous System|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sulfides|Sulfur Compounds|Sulfur Containing Products|Thiocarbamates",CCN(CC)C(=S)SSC(=S)N(CC)CC,3117
805,DB00823,Ethynodiol diacetate,small molecule,approved,"Adrenal Cortex Hormones|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hyperglycemia-Associated Agents|Norpregnanes|Norpregnenes|Norsteroids|Progestin Contraceptives|Progestins|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids",[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CC[C@H](OC(C)=O)C=C3CC[C@@]21[H],9270
806,DB00824,Enprofylline,small molecule,approved|experimental,"Adenosine A2 Receptor Antagonists|Alkaloids|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|Peripheral Nervous System Agents|Purinergic Agents|Purinergic Antagonists|Purinergic P1 Receptor Antagonists|Purines|Purinones|Respiratory System Agents",CCCN1C2=C(NC=N2)C(=O)NC1=O,1676
807,DB00825,Levomenthol,small molecule,approved,"Agents causing hyperkalemia|Alcohols|Antiarrhythmic agents|Antipruritics|Antipruritics and Local Anesthetics|Basic Lotions and Liniments|Bradycardia-Causing Agents|Calcium Channel Blockers|Cyclohexanes|Cyclohexanols|Cycloparaffins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dermatologicals|EENT Drugs, Miscellaneous|Fatty Alcohols|Herbs and Natural Products|Hexanols|Lipids|Monoterpenes|Other Analgesics|Other Cold and Cough Preparations|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Terpenes|Vasodilating Agents",CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O,16666
808,DB00826,Natamycin,small molecule,approved,"Alimentary Tract and Metabolism|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Local|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Antiinfectives and Antiseptics for Local Oral Treatment|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Intestinal Antiinfectives|Lactones|Ophthalmologicals|Polyene Antifungal|Polyene Antimicrobial|Polyketides|Sensory Organs|Stomatological Preparations",[H][C@@]12C[C@H](O)C[C@]3(O)C[C@H](O)[C@@H](C(O)=O)[C@]([H])(C[C@@H](O[C@]4([H])O[C@H](C)[C@@H](O)[C@H](N)[C@@H]4O)\C=C\C=C\C=C\C=C\C[C@@H](C)OC(=O)\C=C\[C@@]1([H])O2)O3,5284447
809,DB00827,Cinoxacin,small molecule,approved|investigational|withdrawn,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Moderate Risk QTc-Prolonging Agents|OAT1/SLC22A6 inhibitors|QTc Prolonging Agents|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",CCN1N=C(C(O)=O)C(=O)C2=CC3=C(OCO3)C=C12,2762
810,DB00828,Fosfomycin,small molecule,approved,"Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Drugs that are Mainly Renally Excreted|Organophosphonates|Organophosphorus Compounds",C[C@@H]1O[C@@H]1P(O)(O)=O,446987
811,DB00829,Diazepam,small molecule,approved|illicit|investigational|vet_approved,"Adjuvants, Anesthesia|Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Anti-Anxiety Agents|Anticonvulsants|Autonomic Agents|Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|GABA Agents|GABA Modulators|Heterocyclic Compounds, Fused-Ring|Hypnotics and Sedatives|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|P-glycoprotein substrates|Peripheral Nervous System Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents",CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,3016
812,DB00830,Phenmetrazine,small molecule,approved|illicit,Agents producing tachycardia|Agents that produce hypertension|Anti-Obesity Agents|Appetite Depressants|Autonomic Agents|Central Nervous System Agents|Central Nervous System Stimulants|Morpholines|Oxazines|Peripheral Nervous System Agents|Sympathomimetics,CC1NCCOC1C1=CC=CC=C1,4762
813,DB00831,Trifluoperazine,small molecule,approved|investigational,"Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antiemetics|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs causing inadvertant photosensitivity|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotoxic agents|Neurotransmitter Agents|P-glycoprotein inhibitors|P-glycoprotein substrates|Peripheral Nervous System Agents|Phenothiazines|Phenothiazines With Piperazine Structure|Photosensitizing Agents|Psycholeptics|Psychotropic Drugs|Sulfur Compounds|Tranquilizing Agents|UGT1A4 substrates",CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,5566
814,DB00832,Phensuximide,small molecule,approved,Anticonvulsants|Central Nervous System Depressants|Imides|Nervous System|Pyrrolidines|Pyrrolidinones|Succinimide Derivatives,CN1C(=O)CC(C1=O)C1=CC=CC=C1,6839
815,DB00833,Cefaclor,small molecule,approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|BSEP/ABCB11 Substrates|Cephalosporins|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Second-Generation Cephalosporins|Sulfur Compounds|Thiazines",[H][C@]12SCC(Cl)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,51039
816,DB00834,Mifepristone,small molecule,approved|investigational,"Abortifacient Agents|Abortifacient Agents, Steroidal|Adrenal Cortex Hormones|Blood Glucose Lowering Agents|BSEP/ABCB11 Substrates|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Contraceptives, Postcoital|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Estranes|Estrenes|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Highest Risk QTc-Prolonging Agents|Hormonal Contraceptives for Systemic Use|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypoglycemia-Associated Agents|Luteolytic Agents|Menstruation-Inducing Agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein inducers|P-glycoprotein inhibitors|Progestational Hormone Receptor Antagonists|Progesterone Receptor Modulators|Progestin Antagonist|QTc Prolonging Agents|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids",[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H],55245
817,DB00835,Brompheniramine,small molecule,approved,Agents producing tachycardia|Anti-Allergic Agents|Anticholinergic Agents|Antihistamines for Systemic Use|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 Substrates|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Muscarinic Antagonists|Neurotransmitter Agents|Photosensitizing Agents|Potential QTc-Prolonging Agents|Propylamine Derivatives|Pyridines|QTc Prolonging Agents|Substituted Alkylamines,CN(C)CCC(C1=CC=C(Br)C=C1)C1=CC=CC=N1,6834
818,DB00836,Loperamide,small molecule,approved,"Agents causing hyperkalemia|Alimentary Tract and Metabolism|Antiarrhythmic agents|Antidiarrheals|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antipropulsives|Bradycardia-Causing Agents|Calcium Channel Blockers|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Gastrointestinal Agents|Moderate Risk QTc-Prolonging Agents|Opioid Agonist|P-glycoprotein substrates|Piperidines|QTc Prolonging Agents",CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1,3955
819,DB00837,Progabide,small molecule,experimental,"Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Aminobutyrates|Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Anticonvulsants|Antidepressive Agents|Butyrates|Central Nervous System Agents|Central Nervous System Depressants|Fatty Acid Derivatives|Fatty Acids|Fatty Acids, Volatile|GABA Agents|GABA Agonists|Lipids|Nervous System|Neurotransmitter Agents|Psychotropic Drugs",NC(=O)CCC\N=C(\C1=CC=C(Cl)C=C1)C1=C(O)C=CC(F)=C1,5361323
820,DB00838,Clocortolone,small molecule,approved,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Moderately Potent (Group II)|Dermatologicals|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Pregnadienediols|Pregnadienes|Pregnanes|Steroids|Steroids, Fluorinated",[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,5311052
821,DB00839,Tolazamide,small molecule,approved|investigational,Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Drugs Used in Diabetes|Hypoglycemia-Associated Agents|Sulfones|Sulfonylureas|Sulfur Compounds,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CCCCCC1,5503
822,DB00840,Hydroxypropyl cellulose,small molecule,approved,"Artificial Tears|Biopolymers|Carbohydrates|Compounds used in a research, industrial, or household setting|Demulcent|Demulcent Activity|Glucans|Macromolecular Substances|Ophthalmics|Polymers|Polysaccharides",,
823,DB00841,Dobutamine,small molecule,approved,"Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Adrenergic beta-1 Receptor Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Amines|Autonomic Agents|Benzene Derivatives|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Catecholamines|Catechols|Compounds used in a research, industrial, or household setting|COMT Substrates|Drugs that are Mainly Renally Excreted|Ethylamines|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenethylamines|Phenols|Protective Agents|Selective Beta 1-adrenergic Agonists|Sympathomimetic (Adrenergic) Agents|Sympathomimetics",CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1,36811
824,DB00842,Oxazepam,small molecule,approved,"Anti-Anxiety Agents|Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Drugs that are Mainly Renally Excreted|GABA Agents|GABA Modulators|Heterocyclic Compounds, Fused-Ring|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents|UGT1A9 Substrates|UGT2B7 substrates",OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2,4616
825,DB00843,Donepezil,small molecule,approved,"Anti-Dementia Drugs|BCRP/ABCG2 Substrates|Bradycardia-Causing Agents|Central Nervous System Agents|Central Nervous System Depressants|Cholinergic Agents|Cholinesterase Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Enzyme Inhibitors|Indans|Indenes|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Neurotransmitter Agents|Nootropic Agents|Parasympathomemetic (Cholinergic) Agents|Piperidines|Psychoanaleptics|QTc Prolonging Agents",COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1,3152
826,DB00844,Nalbuphine,small molecule,approved,"Alkaloids|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Mixed Agonist / Antagonist Opioids|Morphinan Derivatives|Morphinans|Narcotics|Nervous System|Opiate Alkaloids|Opiate Partial Agonists|Opioid Agonist/Antagonist|Opioid Antagonists|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Semi-synthetic Opioids|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5,5311304
827,DB00845,Clofazimine,small molecule,approved|investigational,"Anti-Bacterial Agents|Anti-Infective Agents|Anti-Inflammatory Agents|Antiinfectives for Systemic Use|Antimycobacterials|BCRP/ABCG2 Inhibitors|BSEP/ABCB11 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Drugs for Treatment of Lepra|Heterocyclic Compounds, Fused-Ring|Leprostatic Agents|P-glycoprotein inhibitors|P-glycoprotein substrates|Phenazines|Photosensitizing Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents",CC(C)N=C1C=C2N(C3=CC=C(Cl)C=C3)C3=C(C=CC=C3)N=C2C=C1NC1=CC=C(Cl)C=C1,2794
828,DB00846,Flurandrenolide,small molecule,approved,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dermatologicals|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Pregnanes|Pregnenediones|Pregnenes|Steroids|Steroids, Fluorinated",CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,15209
829,DB00847,Cysteamine,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Amines|Amino Acids and Derivatives|Cystine Depleting Agents|Cystine Disulfide Reduction|EENT Drugs, Miscellaneous|Ethylamines|Mercaptoethylamines|Ophthalmics|Ophthalmologicals|Other Miscellaneous Therapeutic Agents|Sensory Organs|Sulfhydryl Compounds|Sulfur Compounds",NCCS,6058
830,DB00848,Levamisole,small molecule,approved|investigational|vet_approved|withdrawn,"Adjuvants, Immunologic|Anthelmintics|Anti-Infective Agents|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antirheumatic Agents|Imidazoles|Imidazothiazole Derivatives|Immunologic Factors|Levamisole, analogs & derivatives|Sulfur Compounds|Thiazoles",C1CN2C[C@@H](N=C2S1)C1=CC=CC=C1,26879
831,DB00849,Methylphenobarbital,small molecule,approved,Anticholinergic Agents|Anticonvulsants|Barbiturates|Barbiturates and Derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Nicotinic Antagonists|Phenobarbital and similars|Psycholeptics|Pyrimidines|Pyrimidinones,CCC1(C(=O)NC(=O)N(C)C1=O)C1=CC=CC=C1,8271
832,DB00850,Perphenazine,small molecule,approved,"Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs causing inadvertant photosensitivity|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Phenothiazines|Phenothiazines With Piperazine Structure|Photosensitizing Agents|Psycholeptics|Psychotropic Drugs|Sulfur Compounds|Tranquilizing Agents",OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,4748
833,DB00851,Dacarbazine,small molecule,approved|investigational,"Alkylating Activity|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Imidazoles|Immunosuppressive Agents|Myelosuppressive Agents|Noxae|Toxic Actions|Triazenes",CN(C)\N=N\C1=C(N=CN1)C(N)=O,5351166
834,DB00852,Pseudoephedrine,small molecule,approved,Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Alpha-and Beta-adrenergic Agonists|Amines|Amino Alcohols|Amphetamines|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cardiovascular Agents|Ethylamines|Hyperglycemia-Associated Agents|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Nasal Decongestants|Nasal Decongestants for Systemic Use|Nasal Preparations|Norepinephrine Releasing Agent|Peripheral Nervous System Agents|Phenethylamines|Propanolamines|Propanols|Respiratory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetic (Adrenergic) Agents|Sympathomimetics|Vasoconstrictor Agents,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1,7028
835,DB00853,Temozolomide,small molecule,approved|investigational,"Alkylating Activity|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 Enzyme Inducers|Drugs that are Mainly Renally Excreted|Imidazoles|Immunosuppressive Agents|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Noxae|Toxic Actions|Triazenes",CN1N=NC2=C(N=CN2C1=O)C(N)=O,5394
836,DB00854,Levorphanol,small molecule,approved,"Alkaloids|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Morphinans|Narcotics|Opiate Alkaloids|Opioid Agonist|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",[H][C@@]12CCCC[C@@]11CCN(C)[C@@H]2CC2=C1C=C(O)C=C2,5359272
837,DB00855,Aminolevulinic acid,small molecule,approved,"Amino Acids|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Dermatologicals|Enkephalins|Keto Acids|Levulinic Acids|Misc. Skin and Mucous Membrane Agents|Nerve Tissue Proteins|Neuropeptides|Opioid Peptides|Peptides|Photosensitizing Agents|Photosensitizing agents used for phototherapy|Porphyrin Precursor|Proteins|Radiation-Sensitizing Agents|Sensitizers Used in Photodynamic/radiation Therapy",NCC(=O)CCC(O)=O,137
838,DB00856,Chlorphenesin,small molecule,approved|experimental,"Alcohols|Antifungals for Dermatological Use|Antifungals for Topical Use|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Dermatologicals|Glycols|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Peripheral Nervous System Agents|Propylene Glycols",OCC(O)COC1=CC=C(Cl)C=C1,7697
839,DB00857,Terbinafine,small molecule,approved|investigational|vet_approved,Agents Causing Muscle Toxicity|Allylamine Antifungal|Allylamines|Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Systemic Use|Antifungals for Topical Use|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Enzyme Inhibitors|Naphthalenes,CN(C\C=C\C#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12,1549008
840,DB00858,Drostanolone,small molecule,illicit,Androstanes|Fused-Ring Compounds|Steroids,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)[C@H](C)C[C@]12C,6011
841,DB00859,Penicillamine,small molecule,approved,"Agents Causing Muscle Toxicity|Amino Acids|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Antidotes|Antiinflammatory and Antirheumatic Products|Antirheumatic Agents|Chelating Agents|Compounds used in a research, industrial, or household setting|Heavy Metal Antagonists|Immunosuppressive Agents|Musculo-Skeletal System|Myelosuppressive Agents|OATP1B1/SLCO1B1 Substrates|Penicillamine and Similar Agents|Protective Agents|Sequestering Agents|Specific Antirheumatic Agents|Sulfur Compounds",[H][C@](N)(C(O)=O)C(C)(C)S,5852
842,DB00860,Prednisolone,small molecule,approved|vet_approved,"Adrenal Cortex Hormones|Adrenals|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Alimentary Tract and Metabolism|Anti-Inflammatory Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antidotes|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids Acting Locally|Corticosteroids for Local Oral Treatment|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Corticosteroids, Dermatological Preparations|Corticosteroids, Weak (Group I)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Dermatologicals|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Intestinal Antiinflammatory Agents|Nasal Preparations|Ophthalmological and Otological Preparations|Ophthalmologicals|Otologicals|P-glycoprotein substrates|Prednisolone and Prodrugs|Pregnadienes|Pregnadienetriols|Pregnanes|Sensory Organs|Steroids|Stomatological Preparations|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Vasoprotectives",[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,5755
843,DB00861,Diflunisal,small molecule,approved|investigational,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antirheumatic Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Cyclooxygenase Inhibitors|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Hydroxy Acids|Hydroxybenzoates|Nephrotoxic agents|Nervous System|Non COX-2 selective NSAIDS|OAT1/SLC22A6 inhibitors|Other Nonsteroidal Anti-inflammatory Agents|Peripheral Nervous System Agents|Phenols|Photosensitizing Agents|Salicylates|Salicylic Acid and Derivatives|Sensory System Agents|UGT1A9 Inhibitors",OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1,3059
844,DB00862,Vardenafil,small molecule,approved,Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Drugs Used in Erectile Dysfunction|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Imidazoles|P-glycoprotein inhibitors|P-glycoprotein substrates|Phosphodiesterase 5 Inhibitors|Phosphodiesterase Inhibitors|Piperazines|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Urological Agents|Urologicals|Vasodilating Agents,CCCC1=NC(C)=C2N1NC(=NC2=O)C1=C(OCC)C=CC(=C1)S(=O)(=O)N1CCN(CC)CC1,110634
845,DB00863,Ranitidine,small molecule,approved|withdrawn,Acid Reducers|Agents Causing Muscle Toxicity|Alimentary Tract and Metabolism|Anti-Ulcer Agents|Cholinesterase Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Drugs that are Mainly Renally Excreted|Furans|Gastric Acid Lowering Agents|Gastrointestinal Agents|Histamine Antagonists|Histamine H2 Antagonists|OAT1/SLC22A6 inhibitors|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Substrates|OCT1 inhibitors|OCT1 substrates|OCT2 Inhibitors|OCT2 Substrates|P-glycoprotein inhibitors|P-glycoprotein substrates,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C[N+]([O-])=O,3001055
846,DB00864,Tacrolimus,small molecule,approved|investigational,"Agents causing hyperkalemia|Agents Causing Muscle Toxicity|Agents for Dermatitis, Excluding Corticosteroids|Anti-Bacterial Agents|Antineoplastic and Immunomodulating Agents|Calcineurin Inhibitor Immunosuppressant|Calcineurin Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Hyperglycemia-Associated Agents|Immunologic Factors|Immunosuppressive Agents|Lactones|Misc. Skin and Mucous Membrane Agents|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Nephrotoxic agents|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein inducers|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Photosensitizing Agents|Polyketides|Potential QTc-Prolonging Agents|QTc Prolonging Agents",CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC,445643
847,DB00865,Benzphetamine,small molecule,approved|illicit,Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Antidepressive Agents|Appetite Suppression|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Stimulants|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Uptake Inhibitors|Ethylamines|Increased Sympathetic Activity|Membrane Transport Modulators|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Peripheral Nervous System Agents|Phenethylamines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetic Amine Anorectic|Sympathomimetics,C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,5311017
848,DB00866,Alprenolol,small molecule,experimental|withdrawn,"Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antidepressive Agents|Antihypertensive Agents|Autonomic Agents|Beta Blocking Agents, Non-Selective|Bradycardia-Causing Agents|Cardiovascular Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenoxypropanolamines|Propanolamines|Propanols|Serotonin 5-HT1 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sympatholytics",CC(C)NCC(O)COC1=CC=CC=C1CC=C,2119
849,DB00867,Ritodrine,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Autonomic Agents|Ethylamines|Genito Urinary System and Sex Hormones|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenethylamines|Propanolamines|Propanols|Reproductive Control Agents|Sympathomimetics|Sympathomimetics, Labour Repressants|Tocolytic Agents",C[C@H](NCCC1=CC=C(O)C=C1)[C@H](O)C1=CC=C(O)C=C1,33572
850,DB00868,Benzonatate,small molecule,approved,"Alkanes|Amines|Antitussive Agents|Butanes|Central Nervous System Agents|Cholinesterase substrates|Cough and Cold Preparations|Decreased Tracheobronchial Stretch Receptor Activity|Hydrocarbons, Acyclic|Non-narcotic Antitussive|Respiratory System Agents",CCCCNC1=CC=C(C=C1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC,7699
851,DB00869,Dorzolamide,small molecule,approved,"Amides|Antiglaucoma Preparations and Miotics|Antihypertensive Agents|Carbonic Anhydrase Inhibitors|Cardiovascular Agents|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 Substrates|Diuretics|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Intraocular Pressure, drug effects|Ophthalmologicals|Sensory Organs|Sulfonamides|Sulfones|Sulfur Compounds",CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,5284549
852,DB00870,Suprofen,small molecule,approved|withdrawn,"Acids, Carbocyclic|Agents causing hyperkalemia|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Phenylpropionates|Propionates|Sensory System Agents|UGT1A1 Substrates|UGT2B7 substrates",CC(C(O)=O)C1=CC=C(C=C1)C(=O)C1=CC=CS1,5359
853,DB00871,Terbutaline,small molecule,approved,"Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cholinesterase Inhibitors|Drugs for Obstructive Airway Diseases|Drugs that are Mainly Renally Excreted|Ethanolamines|Neurotransmitter Agents|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Reproductive Control Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists|Sympathomimetics|Tocolytic Agents",CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1,5403
854,DB00872,Conivaptan,small molecule,approved|investigational,"Antidiuretic Hormone Receptor Antagonists|Cardiovascular Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Diuretics|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Natriuretic Agents|P-glycoprotein inhibitors",CC1=NC2=C(CCN(C(=O)C3=CC=C(NC(=O)C4=CC=CC=C4C4=CC=CC=C4)C=C3)C3=CC=CC=C23)N1,151171
855,DB14596,Loteprednol etabonate,small molecule,approved,Adrenal Cortex Hormones|Androstadienes|Androstanes|Androstenes|Anti-Allergic Agents|Corticosteroids|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Immunosuppressive Agents|Steroids,[H][C@@]12CC[C@](OC(=O)OCC)(C(=O)OCCl)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,9865442
856,DB00874,Guaifenesin,small molecule,approved|investigational|vet_approved,Benzene Derivatives|Catechols|Cough and Cold Preparations|Ethers|Expectorants|Methyl Ethers|Phenols|Phenyl Ethers|Respiratory System Agents,COC1=CC=CC=C1OCC(O)CO,3516
857,DB00875,Flupentixol,small molecule,approved|investigational|withdrawn,"Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Anticholinergic Agents|Antidepressive Agents|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs causing inadvertant photosensitivity|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|Muscarinic Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|P-glycoprotein inhibitors|P-glycoprotein substrates|Photosensitizing Agents|Piperazines|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Thioxanthene Derivatives|Thioxanthenes|Tranquilizing Agents|Xanthenes",[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,5281881
858,DB00876,Eprosartan,small molecule,approved,"Acids, Acyclic|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents Causing Muscle Toxicity|Angiotensin 2 Receptor Blocker|Angiotensin II receptor blockers (ARBs) and diuretics|Angiotensin II receptor blockers (ARBs), plain|Angiotensin II Type 1 Receptor Blockers|Angiotensin Receptor Antagonists|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Cardiovascular Agents|Hypotensive Agents|Sulfur Compounds",CCCCC1=NC=C(\C=C(/CC2=CC=CS2)C(O)=O)N1CC1=CC=C(C=C1)C(O)=O,5281037
859,DB00877,Sirolimus,small molecule,approved|investigational,"Agents causing angioedema|Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics, Antineoplastic|Antifungal Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Decreased Immunologic Activity|Hyperglycemia-Associated Agents|Immunologic Factors|Immunosuppressive Agents|Kinase Inhibitor|Lactones|Macrolides|mTOR Inhibitor Immunosuppressant|mTOR Inhibitors|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|OATP1B1/SLCO1B1 Inhibitors|Ophthalmologicals|P-glycoprotein inducers|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Polyketides|Protein Kinase Inhibitors|Selective Immunosuppressants|Sensory Organs|Sirolimus and Prodrugs",[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC,5284616
860,DB00878,Chlorhexidine,small molecule,approved|vet_approved,"Alimentary Tract and Metabolism|Amidines|Anti-Infective Agents|Anti-Infective Agents, Local|Antiinfectives and Antiseptics for Local Oral Treatment|Antiseptics and Disinfectants|Biguanides|Biguanides and Amidines|Compounds used in a research, industrial, or household setting|Decreased Cell Wall Integrity|Dental Agents|Dermatologicals|Disinfectants|Guanidines|Household Products|Irrigating Solutions|Medicated Dressings|Medicated Dressings With Antiinfectives|Miscellaneous Anti-infectives|Miscellaneous Local Anti-infectives|Mouthwashes|Ophthalmological and Otological Preparations|Ophthalmologicals|Otologicals|Sensory Organs|Stomatological Preparations|Throat Preparations",ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1,9552079
861,DB00879,Emtricitabine,small molecule,approved|investigational,"Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Carbohydrates|Deoxycytidine|Deoxyribonucleosides|Dideoxynucleosides|Direct Acting Antivirals|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Glycosides|Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor|MATE 1 Substrates|MATE substrates|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|Nucleoside Reverse Transcriptase Inhibitors|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Reverse Transcriptase Inhibitors|Ribonucleosides",NC1=NC(=O)N(C=C1F)[C@@H]1CS[C@H](CO)O1,60877
862,DB00880,Chlorothiazide,small molecule,approved|vet_approved,"Amides|Antihypertensive Agents|Benzothiadiazines|Cardiovascular Agents|Diuretics|Drugs causing inadvertant photosensitivity|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Heterocyclic Compounds, Fused-Ring|Hyperglycemia-Associated Agents|Hypotensive Agents|Increased Diuresis|Membrane Transport Modulators|Natriuretic Agents|OAT1/SLC22A6 inhibitors|Photosensitizing Agents|Sodium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds|Thiazides",NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1,2720
863,DB00881,Quinapril,small molecule,approved|investigational,"ACE Inhibitors and Diuretics|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Cardiovascular Agents|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Isoquinolines|OAT3/SLC22A8 Substrates|Protease Inhibitors|Tetrahydroisoquinolines",CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,54892
864,DB00882,Clomifene,small molecule,approved|investigational,"Benzene Derivatives|Benzylidene Compounds|Clomiphene|Estrogen Agonist-antagonists|Estrogen Agonist/Antagonist|Estrogen Antagonists|Estrogen Receptor Modulators|Fertility Agents|Fertility Agents, Female|Genito Urinary System and Sex Hormones|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Ovulation Stimulants, Synthetic|P-glycoprotein substrates|Reproductive Control Agents|Selective Estrogen Receptor Modulators|Sex Hormones and Modulators of the Genital System|Stilbenes",CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,2800
865,DB00883,Isosorbide dinitrate,small molecule,approved|investigational,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Alcohols|Antianginal Agents|Carbohydrates|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Hypotensive Agents|Methemoglobinemia Associated Agents|Nitrate Vasodilator|Nitrates and Nitrites|Nitric Oxide Donors|Organic Nitrates|Sugar Alcohols|Vasodilating Agents|Vasodilation|Vasodilators Used in Cardiac Diseases|Vasoprotectives,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,6883
866,DB00884,Risedronic acid,small molecule,approved|investigational,Agents Causing Muscle Toxicity|Bisphosphonates|Bone Density Conservation Agents|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Membrane Transport Modulators|Musculo-Skeletal System|Organophosphonates|Organophosphorus Compounds|Pyridines,OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)(O)=O,5245
867,DB00885,Pemirolast,small molecule,approved|investigational,Decreased Histamine Release|Histamine Agents|Mast Cell Stabilizers|Neurotransmitter Agents|Ophthalmics|Pyrimidines,CC1=CC=CN2C(=O)C(=CN=C12)C1=NNN=N1,57697
868,DB00886,Omapatrilat,small molecule,investigational,"Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Azepines|Cardiovascular Agents|Enzyme Inhibitors|Metalloendopeptidases, antagonists & inhibitors|Protease Inhibitors|Sulfur Compounds|Thiepins|Vasopeptidase Inhibitors",[H][C@]12CCC[C@H](N1C(=O)[C@H](CCS2)NC(=O)[C@@H](S)CC1=CC=CC=C1)C(O)=O,656629
869,DB00887,Bumetanide,small molecule,approved,"Acids, Carbocyclic|Agents Causing Muscle Toxicity|Amides|Aminobenzoates|Benzene Derivatives|Benzoates|Cardiovascular Agents|Diuretics|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|High-Ceiling Diuretics|High-Ceiling Diuretics and Potassium-Sparing Agents|Hyperglycemia-Associated Agents|Hypotensive Agents|Increased Diuresis at Loop of Henle|Membrane Transport Modulators|meta-Aminobenzoates|Natriuretic Agents|Nephrotoxic agents|Non Potassium Sparing Diuretics|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Photosensitizing Agents|Sodium Potassium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds",CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O,2471
870,DB00888,Mechlorethamine,small molecule,approved|investigational,"Alkylating Activity|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Cardiotoxic antineoplastic agents|Cholinesterase Inhibitors|Compounds used in a research, industrial, or household setting|Hydrocarbons, Halogenated|Immunosuppressive Agents|Irritants|Mustard Compounds|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Nitrogen Mustard Analogues|Nitrogen Mustard Compounds|Noxae|Poisons|Toxic Actions",CN(CCCl)CCCl,4033
871,DB00889,Granisetron,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Antidepressive Agents|Antiemetics|Antiemetics and Antinauseants|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Indazoles|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Pyrazoles|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 3 Receptor Antagonists|Serotonin 5-HT3 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists",CN1N=C(C(=O)N[C@@H]2C[C@@H]3CCC[C@H](C2)N3C)C2=C1C=CC=C2,5284566
872,DB00890,Dienestrol,small molecule,approved|investigational,"Benzene Derivatives|Estrogens|Estrogens, Non-Steroidal|Genito Urinary System and Sex Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Phenols|Sex Hormones and Modulators of the Genital System|Synthetic Estrogens, Plain",[H]\C(C)=C(/C(=C(\[H])C)/C1=CC=C(O)C=C1)\C1=CC=C(O)C=C1,667476
873,DB00891,Sulfapyridine,small molecule,approved,Amides|Amines|Aniline Compounds|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Methemoglobinemia Associated Agents|Short-Acting Sulfonamides|Sulfanilamides|Sulfonamides|SULFONAMIDES AND TRIMETHOPRIM|Sulfones|Sulfur Compounds,NC1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1,5336
874,DB00892,Oxybuprocaine,small molecule,approved|investigational,"Acids, Carbocyclic|Aminobenzoates|Anesthetics|Anesthetics for Topical Use|Anesthetics, Local|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Benzene Derivatives|Benzoates|Central Nervous System Agents|Cholinesterase substrates|Dermatologicals|Ophthalmologicals|para-Aminobenzoates|Peripheral Nervous System Agents|Sensory Organs|Sensory System Agents",CCCCOC1=CC(=CC=C1N)C(=O)OCCN(CC)CC,4633
875,DB00893,Iron Dextran,small molecule,approved|vet_approved,"Biopolymers|Carbohydrates|Compounds used in a research, industrial, or household setting|Dextrans|Ferric Compounds|Glucans|Hematinics|Hematologic Agents|Iron Compounds|Macromolecular Substances|Organometallic Compounds|Parenteral Iron Replacement|Phosphate Binder|Polymers|Polysaccharides|Supplements",,
876,DB00894,Testolactone,small molecule,approved|investigational,"Androstadienes|Androstanes|Androstenes|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Aromatase Inhibitors|Drugs that are Mainly Renally Excreted|Fused-Ring Compounds|Homosteroids|Steroids",[H][C@@]12CCC3=CC(=O)C=C[C@]3(C)[C@@]1([H])CC[C@]1(C)OC(=O)CC[C@@]21[H],13769
877,DB00895,Benzylpenicilloyl polylysine,small molecule,approved,"Acetamides|Acetates|Acids, Acyclic|Amides|Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Benzene Derivatives|beta-Lactams|Drug Hypersensitivity|Fatty Acids|Fatty Acids, Volatile|Heterocyclic Compounds, Fused-Ring|Lactams|Lipids|Penicillins|Sulfur Compounds",,45266800
878,DB00896,Rimexolone,small molecule,approved,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids for Systemic Use, Plain|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Ophthalmologicals|Pregnanes|Sensory Organs|Steroids|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thyroxine-binding globulin inhibitors",[H][C@@]12C[C@@H](C)[C@](C)(C(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,5311412
879,DB00897,Triazolam,small molecule,approved|investigational,"Adjuvants, Anesthesia|Agents Causing Muscle Toxicity|Anti-Anxiety Agents|Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|GABA Agents|GABA Modulators|Heterocyclic Compounds, Fused-Ring|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents|Triazolobenzodiazepines",CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,5556
880,DB00898,Ethanol,small molecule,approved,"Agents Causing Muscle Toxicity|Alcohols|Anti-Infective Agents|Anti-Infective Agents, Local|Antidotes|Antiseptics and Disinfectants|Central Nervous System Agents|Central Nervous System Depressants|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP2E1 Inducers (moderate)|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Miscellaneous Local Anti-infectives|Miscellaneous Therapeutic Agents|Nerve Depressants|Neurotoxic agents|NMDA Receptor Antagonists|Solvents",CCO,702
881,DB00899,Remifentanil,small molecule,approved,"Acids, Acyclic|Agents producing tachycardia|Agents that produce hypertension|Analgesics|Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Bradycardia-Causing Agents|Central Nervous System Agents|Central Nervous System Depressants|Fatty Acids|Fatty Acids, Volatile|Fentanyl and fentanyl analogues|High-risk opioids|Hypnotics and Sedatives|Hypotensive Agents|Lipids|Narcotics|Nervous System|Opiate Agonists|Opioid Agonist|Opioid Anesthetics|Opioids|Opioids, Anilidopiperidine|Peripheral Nervous System Agents|Phenylpiperidine opioids|Piperidines|Propionates|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",CCC(=O)N(C1=CC=CC=C1)C1(CCN(CCC(=O)OC)CC1)C(=O)OC,60815
882,DB00900,Didanosine,small molecule,approved,"Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antimetabolites|Antiviral Agents|Antivirals for Systemic Use|Carbohydrates|Deoxyribonucleosides|Dideoxynucleosides|Direct Acting Antivirals|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Glycosides|Heterocyclic Compounds, Fused-Ring|Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Neurotoxic agents|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|Nucleoside Reverse Transcriptase Inhibitors|Nucleosides|OAT1/SLC22A6 Substrates|Purine Nucleosides|Purines|Reverse Transcriptase Inhibitors|Ribonucleosides|Toxic Actions",OC[C@@H]1CC[C@@H](O1)N1C=NC2=C1NC=NC2=O,50599
883,DB00901,Bitolterol,small molecule,withdrawn,"Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Drugs for Obstructive Airway Diseases|Neurotransmitter Agents|Peripheral Nervous System Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists",CC1=CC=C(C=C1)C(=O)OC1=C(OC(=O)C2=CC=C(C)C=C2)C=C(C=C1)C(O)CNC(C)(C)C,35330
884,DB00902,Methdilazine,small molecule,approved,"Agents that reduce seizure threshold|Antihistamines for Systemic Use|Heterocyclic Compounds, Fused-Ring|Histamine Antagonists|Histamine H1 Antagonists|Phenothiazine Derivatives|Sulfur Compounds",CN1CCC(CN2C3=CC=CC=C3SC3=CC=CC=C23)C1,14677
885,DB00903,Etacrynic acid,small molecule,approved|investigational,"Acetates|Acids, Acyclic|Agents that produce neuromuscular block (indirect)|Aryloxyacetic Acid Derivatives|Cardiovascular Agents|Diuretics|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Glycolates|High-Ceiling Diuretics|Hydroxy Acids|Hyperglycemia-Associated Agents|Hypotensive Agents|Increased Diuresis at Loop of Henle|Lipids|Natriuretic Agents|Nephrotoxic agents|Non Potassium Sparing Diuretics|OAT1/SLC22A6 inhibitors|Ototoxic agents|Phenoxyacetates|Sodium Potassium Chloride Symporter Inhibitors",CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,3278
886,DB00904,Ondansetron,small molecule,approved,"Anti-Anxiety Agents|Antidepressive Agents|Antiemetics|Antiemetics and Antinauseants|Carbazoles|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Imidazoles|Indoles|Moderate Risk QTc-Prolonging Agents|Peripheral Nervous System Agents|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 3 Receptor Antagonists|Serotonin 5-HT3 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists",CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,4595
887,DB00905,Bimatoprost,small molecule,approved|investigational,"Amides|Antiglaucoma Preparations and Miotics|Antihypertensive Agents|Autacoids|Biological Factors|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Ophthalmologicals|Prostaglandin analogs reducing intraocular pressure (IOP)|Prostaglandins|Prostaglandins F, Synthetic|Prostaglandins, Synthetic|Sensory Organs",CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1,5311027
888,DB00906,Tiagabine,small molecule,approved|investigational,Anti-epileptic Agent|Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Decreased Central Nervous System Disorganized Electrical Activity|Fatty Acid Derivatives|GABA Agents|GABA Uptake Inhibitors|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Nipecotic Acids|Piperidines|UGT1A1 Substrates,CC1=C(SC=C1)C(=CCCN1CCC[C@H](C1)C(O)=O)C1=C(C)C=CS1,60648
889,DB00907,Cocaine,small molecule,approved|illicit,"Agents producing tachycardia|Agents that reduce seizure threshold|Alkaloids|Analgesics and Anesthetics|Anesthetics|Anesthetics, Local|Anticholinergic Agents|Aza Compounds|Azabicyclo Compounds|Cardiovascular Agents|Central Nervous System Agents|Cholinesterase substrates|Cocaine, antagonists & inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Uptake Inhibitors|Esters of Benzoic Acid|Highest Risk QTc-Prolonging Agents|Membrane Transport Modulators|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|OCT2 Inhibitors|Ophthalmologicals|Otologicals|Peripheral Nervous System Agents|QTc Prolonging Agents|Sensory Organs|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Throat Preparations|Tropanes|Vasoconstrictor Agents",[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,446220
890,DB00908,Quinidine,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Agents that produce neuromuscular block (indirect)|Agents that reduce seizure threshold|Alkaloids|Anti-Infective Agents|Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ia|Anticholinergic Agents|Antimalarials|Antiparasitic Agents|Antiprotozoals|Biological Products|Biopolymers|BSEP/ABCB11 Inhibitors|Carbohydrates|Cardiac Therapy|Cardiovascular Agents|Chemically-Induced Disorders|Cholinergic Agents|Cinchona Alkaloids|Complex Mixtures|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strong)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (weak)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|Macromolecular Substances|Membrane Transport Modulators|Muscarinic Antagonists|Narrow Therapeutic Index Drugs|Neurotransmitter Agents|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OCT1 inhibitors|OCT2 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Pharmaceutical Preparations|Photosensitizing Agents|Plant Extracts|Plant Preparations|Polymers|Polysaccharides|QTc Prolonging Agents|Quinolines|Quinuclidines|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers",[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1,441074
891,DB00909,Zonisamide,small molecule,approved|investigational,"Agents causing hyperkalemia|Amides|Anti-epileptic Agent|Antiarrhythmic agents|Anticonvulsants|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Carbonic Anhydrase Inhibitors|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Decreased Central Nervous System Disorganized Electrical Activity|Diuretics|Drugs that are Mainly Renally Excreted|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Isoxazoles|Membrane Transport Modulators|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Nervous System|P-glycoprotein inhibitors|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sulfonamides|Sulfones|Sulfur Compounds|UGT1A1 Substrates",NS(=O)(=O)CC1=NOC2=CC=CC=C12,5734
892,DB00910,Paricalcitol,small molecule,approved|investigational,"Anti-Parathyroid Agents|Bone Density Conservation Agents|Calcium Homeostasis|Cholestanes|Cholestenes|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Lipids|Membrane Lipids|Secosteroids|Steroids|Sterols|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|UGT1A4 substrates|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)",[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1C[C@@H](O)C[C@H](O)C1)[C@H](C)\C=C\[C@H](C)C(C)(C)O,5281104
893,DB00911,Tinidazole,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Alkylating Drugs|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Antitrichomonal Agents|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Drugs that are Mainly Renally Excreted|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Imidazole Derivatives|Imidazoles|Nitro Compounds|Nitroimidazole Antimicrobial|Nitroimidazole Derivatives|Nitroimidazoles|Noxae|Toxic Actions",CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O,5479
894,DB00912,Repaglinide,small molecule,approved|investigational,"Acids, Acyclic|Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs Used in Diabetes|Glinide|Hypoglycemia-Associated Agents|Meglitinides|OATP1B1/SLCO1B1 Substrates|Potassium Channel Antagonists|Stereoisomerism",CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)=C1)C(O)=O,65981
895,DB00913,Anileridine,small molecule,approved|illicit,"Anesthetics|Anesthetics, General|Nervous System|Opioid Anesthetics|Piperidines",CCOC(=O)C1(CCN(CCC2=CC=C(N)C=C2)CC1)C1=CC=CC=C1,8944
896,DB00914,Phenformin,small molecule,approved|investigational|withdrawn,Alimentary Tract and Metabolism|Amidines|Biguanides|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Drugs Used in Diabetes|Guanidines|OCT1 inhibitors|OCT1 substrates|OCT2 Inhibitors,NC(=N)NC(=N)NCCC1=CC=CC=C1,8249
897,DB00915,Amantadine,small molecule,approved,"Adamantane Derivatives|Adamantanes|Analgesics|Analgesics, Non-Narcotic|Anti-Dyskinesia Agents|Anti-Infective Agents|Anti-Parkinson Drugs|Anticholinergic Agents|Antiviral Agents|Central Nervous System Agents|Cycloparaffins|Dopamine Agents|Drugs that are Mainly Renally Excreted|Influenza A M2 Protein Inhibitor|M2 Protein Inhibitors|Nervous System|Neurotransmitter Agents|Nicotinic Antagonists|NMDA Receptor Antagonists|OCT1 inhibitors|OCT1 substrates|OCT2 Inhibitors|OCT2 Substrates|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",NC12CC3CC(CC(C3)C1)C2,2130
898,DB00916,Metronidazole,small molecule,approved,"Agents that reduce seizure threshold|Alimentary Tract and Metabolism|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives and Antiseptics for Local Oral Treatment|Antiinfectives for Systemic Use|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Imidazole Derivatives|Imidazoles|Miscellaneous Antiprotozoals|Miscellaneous Local Anti-infectives|Nitro Compounds|Nitroimidazole Antimicrobial|Nitroimidazole Derivatives|Nitroimidazoles|P-glycoprotein inhibitors|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Stomatological Preparations|UGT1A1 Substrates",CC1=NC=C(N1CCO)[N+]([O-])=O,4173
899,DB00917,Dinoprostone,small molecule,approved,"Autacoids|Biological Factors|Dinoprostone, antagonists & inhibitors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Genito Urinary System and Sex Hormones|Inflammation Mediators|Lipids|OAT1/SLC22A6 inhibitors|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Substrates|OCT1 inhibitors|OCT2 Inhibitors|Prostaglandins|Prostaglandins E|Prostaglandins, Synthetic|Reproductive Control Agents|Uterotonic agents",CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O,5280360
900,DB00918,Almotriptan,small molecule,approved|investigational,"Agents that produce hypertension|Amines|Analgesics|Antidepressive Agents|Antimigraine Preparations|Biogenic Amines|Biogenic Monoamines|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Indoles|Migraine Disorders|Monoamine Oxidase A Substrates|Nervous System|Neurotransmitter Agents|Selective Serotonin 5-HT1 Receptor Agonists|Selective Serotonin Agonists|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 1b Receptor Agonists|Serotonin 1d Receptor Agonists|Serotonin 5-HT1 Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists|Serotonin-1b and Serotonin-1d Receptor Agonist|Triptans",CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N1CCCC1)C=C2,123606
901,DB00919,Spectinomycin,small molecule,approved|investigational|vet_approved,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Carbohydrates|Dioxanes|Glycosides|Heterocyclic Compounds, Fused-Ring",[H][C@@]12O[C@H](C)CC(=O)[C@]1(O)O[C@]1([H])[C@@H](NC)[C@@H](O)[C@@H](NC)[C@H](O)[C@@]1([H])O2,15541
902,DB00920,Ketotifen,small molecule,approved,Anti-Allergic Agents|Antihistamine Drugs|Antihistamines for Systemic Use|Antipruritics|Decongestants and Antiallergics|Dermatologicals|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Inhibitors|Neurotransmitter Agents|Ophthalmologicals|Other Antihistamines|Piperidines|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sensory Organs|Sulfur Compounds|Thiophenes,CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=CC=CC=C12,3827
903,DB00921,Buprenorphine,small molecule,approved|illicit|investigational|vet_approved,"Alkaloids|Analgesics|BCRP/ABCG2 Inhibitors|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs Used in Addictive Disorders|Drugs Used in Opioid Dependence|Heterocyclic Compounds, Fused-Ring|Mixed Agonist / Antagonist Opioids|Morphinans|Narcotics|Nervous System|Opiate Agonists|Opiate Alkaloids|Opiate Partial Agonists|Opioid Antagonists|Opioids|Oripavine Derivatives|P-glycoprotein inhibitors|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|UGT1A1 Substrates|UGT1A9 Substrates",CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,644073
904,DB00922,Levosimendan,small molecule,approved|investigational,"Antiarrhythmic agents|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Hydrazines|Hydrazones|Hypotensive Agents|Moderate Risk QTc-Prolonging Agents|Phosphodiesterase 3 Inhibitors|Phosphodiesterase Inhibitors|Protective Agents|Pyridazines|QTc Prolonging Agents|Vasodilating Agents",C[C@@H]1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1,3033825
905,DB00923,Ceforanide,small molecule,approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Second-Generation Cephalosporins|Sulfur Compounds|Thiazines",[H][C@]12SCC(CSC3=NN=NN3CC(O)=O)=C(N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1CN)C(O)=O,43507
906,DB00924,Cyclobenzaprine,small molecule,approved,"Agents that reduce seizure threshold|Benzocycloheptenes|Central Nervous System Agents|Central Nervous System Depressants|Centrally-mediated Muscle Relaxation|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dibenzocycloheptenes|Drugs causing inadvertant photosensitivity|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System|Neurotoxic agents|Photosensitizing Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Tranquilizing Agents|UGT1A4 substrates",CN(C)CCC=C1C2=CC=CC=C2C=CC2=CC=CC=C12,2895
907,DB00925,Phenoxybenzamine,small molecule,approved,Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Amines|Antihypertensive Agents|Cardiovascular Agents|Ethylamines|Hypotensive Agents|Neurotransmitter Agents|OCT1 inhibitors|OCT2 Inhibitors|Peripheral alpha-1 blockers|Peripheral Vasodilators|Vasodilating Agents,CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1,4768
908,DB00926,Etretinate,small molecule,withdrawn,"Alkenes|Antipsoriatics|Antipsoriatics for Systemic Use|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Dermatologicals|Drugs causing inadvertant photosensitivity|Hydrocarbons, Acyclic|Keratolytic Agents|Photosensitizing Agents|Pigments, Biological|Polyenes|Retinoids|Retinoids for Treatment of Psoriasis|Terpenes",CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)C(C)=C(OC)C=C1C,3312
909,DB00927,Famotidine,small molecule,approved,Acid Reducers|Alimentary Tract and Metabolism|Anti-Ulcer Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Gastric Acid Lowering Agents|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Histamine H2 Antagonists|MATE 1 Inhibitors|MATE inhibitors|Neurotransmitter Agents|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OCT2 Inhibitors|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sulfur Compounds|Thiazoles,NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1,3325
910,DB00928,Azacitidine,small molecule,approved|investigational,"Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Aza Compounds|Carbohydrates|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Glycosides|Immunosuppressive Agents|Myelosuppressive Agents|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Metabolic Inhibitor|Nucleosides|Pyrimidine Analogues|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides|Toxic Actions",NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,9444
911,DB00929,Misoprostol,small molecule,approved,"Abortifacient Agents|Abortifacient Agents, Nonsteroidal|Alimentary Tract and Metabolism|Anti-Ulcer Agents|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Autacoids|Biological Factors|Drugs causing inadvertant photosensitivity|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Gastrointestinal Agents|Genito Urinary System and Sex Hormones|Inflammation Mediators|Lipids|Musculo-Skeletal System|Photosensitizing Agents|Propionates|Prostaglandin E1 Analog|Prostaglandins|Prostaglandins E, Synthetic|Prostaglandins, Synthetic|Reproductive Control Agents|Uterotonic agents",CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC,5282381
912,DB00930,Colesevelam,small molecule,approved,"Alkenes|Allyl Compounds|Allylamine|Amines|Anticholesteremic Agents|Bile Acid Sequestrants|Bile-acid Binding Activity|Hydrocarbons, Acyclic|Hypolipidemic Agents|Hypolipidemic Agents Indicated for Hyperlipidemia|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Noxae|Toxic Actions",,
913,DB00931,Metacycline,small molecule,approved|investigational,Agents that produce neuromuscular block (indirect)|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Naphthacenes|Tetracyclines,[H][C@@]12[C@@H](O)[C@]3([H])C(=C)C4=C(C(O)=CC=C4)C(=O)C3=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C,54675785
914,DB00932,Tipranavir,small molecule,approved|investigational,Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BSEP/ABCB11 Inhibitors|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Direct Acting Antivirals|Drugs causing inadvertant photosensitivity|Hepatotoxic Agents|HIV Protease Inhibitors|Hyperglycemia-Associated Agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein inducers|P-glycoprotein inhibitors|P-glycoprotein substrates|Photosensitizing Agents|Protease Inhibitors|Pyrans|UGT1A1 Inducers,[H][C@@](CC)(C1=CC(NS(=O)(=O)C2=NC=C(C=C2)C(F)(F)F)=CC=C1)C1=C(O)C[C@@](CCC)(CCC2=CC=CC=C2)OC1=O,54682461
915,DB00933,Mesoridazine,small molecule,approved|investigational,"Antidepressive Agents|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Heterocyclic Compounds, Fused-Ring|Moderate Risk QTc-Prolonging Agents|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Phenothiazines|Phenothiazines With Piperidine Structure|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Tranquilizing Agents",CN1CCCCC1CCN1C2=C(SC3=C1C=C(C=C3)S(C)=O)C=CC=C2,4078
916,DB00934,Maprotiline,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that reduce seizure threshold|Anthracenes|Anticholinergic Agents|Antidepressive Agents|Antidepressive Agents, Second-Generation|Antidepressive Agents, Tetracyclic|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Histamine Antagonists|Histamine H1 Antagonists|Membrane Transport Modulators|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Non-Selective Monoamine Reuptake Inhibitors|Potential QTc-Prolonging Agents|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Tricyclics and Other Norepinephrine-reuptake Inhibitors",CNCCCC12CCC(C3=CC=CC=C13)C1=CC=CC=C21,4011
917,DB00935,Oxymetazoline,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Autonomic Agents|Cardiovascular Agents|Decongestants and Antiallergics|Imidazoles|Increased Sympathetic Activity|Nasal Decongestants|Nasal Preparations|Neurotransmitter Agents|Ophthalmologicals|Peripheral Nervous System Agents|Respiratory System Agents|Sensory Organs|Sympathomimetics|Sympathomimetics Used as Decongestants|Sympathomimetics, Plain|Vasoconstriction|Vasoconstrictor Agents",CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C,4636
918,DB00936,Salicylic acid,small molecule,approved|investigational|vet_approved,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Infective Agents|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Benzene Derivatives|Benzoates|Central Nervous System Agents|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Dermatologicals|Enzyme Inhibitors|Hydroxy Acids|Hydroxybenzoates|Keratolytic Agents|Nephrotoxic agents|Nervous System|Nitrogen Binding Agent|Non COX-2 selective NSAIDS|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|Ophthalmologicals|Peripheral Nervous System Agents|Phenols|Salicylates|Salicylic Acid and Derivatives|Sclerosing Solutions|Sensory Organs|Sensory System Agents",OC(=O)C1=CC=CC=C1O,338
919,DB00937,Diethylpropion,small molecule,approved|illicit,"Agents producing tachycardia|Agents that produce hypertension|Alimentary Tract and Metabolism|Amines|Amphetamines|Anti-Obesity Agents|Antiobesity Preparations, Excl. Diet Products|Appetite Depressants|Appetite Suppression|Central Nervous System Depressants|Centrally Acting Antiobesity Products|Ethylamines|Increased Sympathetic Activity|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Stimulants|Sympathomimetic Amine Anorectic|Sympathomimetics",CCN(CC)C(C)C(=O)C1=CC=CC=C1,7029
920,DB00938,Salmeterol,small molecule,approved,"Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics, Inhalants|Agents Causing Muscle Toxicity|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs for Obstructive Airway Diseases|Ethanolamines|Ethylamines|Neurotransmitter Agents|OCT1 inhibitors|OCT1 substrates|OCT2 Inhibitors|Peripheral Nervous System Agents|Phenethylamines|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists|Sympathomimetic (Adrenergic) Agents",OCC1=C(O)C=CC(=C1)C(O)CNCCCCCCOCCCCC1=CC=CC=C1,5152
921,DB00939,Meclofenamic acid,small molecule,approved|vet_approved,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Amines|Aminobenzoates|Analgesics|Analgesics, Non-Narcotic|Aniline Compounds|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antirheumatic Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Cyclooxygenase Inhibitors|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Fenamates|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|OAT1/SLC22A6 inhibitors|ortho-Aminobenzoates|Peripheral Nervous System Agents|Sensory System Agents|Thyroxine-binding globulin substrates|Topical Products for Joint and Muscular Pain",CC1=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C(Cl)C=C1,4037
922,DB00940,Methantheline,small molecule,approved|investigational,"Acid Reducers|Agents producing tachycardia|Alimentary Tract and Metabolism|Amines|Ammonium Compounds|Anticholinergic Agents|Cholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Gastric Acid Lowering Agents|Histamine Antagonists|Histamine H2 Antagonists|Muscarinic Antagonists|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds|Synthetic Anticholinergics, Quaternary Ammonium Compounds",CC[N+](C)(CC)CCOC(=O)C1C2=CC=CC=C2OC2=CC=CC=C12,4097
923,DB00941,Hexafluronium,small molecule,approved,"Amines|Ammonium Compounds|Anticholinergic Agents|Bis-Trimethylammonium Compounds|Central Nervous System Depressants|Cholinergic Agents|Cholinesterase Inhibitors|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neurotransmitter Agents|Nicotinic Antagonists|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds",C[N+](C)(CCCCCC[N+](C)(C)C1C2=C(C=CC=C2)C2=C1C=CC=C2)C1C2=C(C=CC=C2)C2=C1C=CC=C2,3601
924,DB00942,Cycrimine,small molecule,approved,Agents producing tachycardia|Anticholinergic Agents|Muscarinic Antagonists,OC(CCN1CCCCC1)(C1CCCC1)C1=CC=CC=C1,2911
925,DB00943,Zalcitabine,small molecule,approved|investigational,"Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antimetabolites|Antiviral Agents|Antivirals for Systemic Use|Carbohydrates|Deoxycytidine|Deoxyribonucleosides|Dideoxynucleosides|Direct Acting Antivirals|Enzyme Inhibitors|Glycosides|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|Nucleoside Reverse Transcriptase Inhibitors|Nucleosides|OAT1/SLC22A6 Substrates|Pyrimidine Nucleosides|Pyrimidines|Reverse Transcriptase Inhibitors|Ribonucleosides|Toxic Actions",NC1=NC(=O)N(C=C1)[C@H]1CC[C@@H](CO)O1,24066
926,DB00944,Demecarium,small molecule,approved,Amines|Ammonium Compounds|Antiglaucoma Preparations and Miotics|Cholinergic Agents|Cholinesterase Inhibitors|Enzyme Inhibitors|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Ophthalmologicals|Parasympathomimetics|Sensory Organs,CN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C,5966
927,DB00945,Acetylsalicylic acid,small molecule,approved|vet_approved,"Acids, Carbocyclic|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Alimentary Tract and Metabolism|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Anticoagulants|Antiinflammatory and Antirheumatic Products|Antiplatelet agents|Antipyretics|Benzene Derivatives|Blood and Blood Forming Organs|Cardiovascular Agents|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Decreased Platelet Aggregation|Decreased Prostaglandin Production|Drugs that are Mainly Renally Excreted|Hematologic Agents|Hydroxybenzoates|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|P-glycoprotein inducers|P-glycoprotein substrates|Peripheral Nervous System Agents|Platelet Aggregation Inhibitors Excl. Heparin|Salicylates|Salicylic Acid and Derivatives|Sensory System Agents|Stomatological Preparations|UGT1A6 substrate",CC(=O)OC1=CC=CC=C1C(O)=O,2244
928,DB00946,Phenprocoumon,small molecule,approved|investigational,"4-Hydroxycoumarins|Anticoagulants|Benzopyrans|Blood and Blood Forming Organs|Coumarins|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|Narrow Therapeutic Index Drugs|Pyrans|Vitamin K Antagonists|Vitamin K Inhibitors",CCC(C1=CC=CC=C1)C1=C(O)C2=C(OC1=O)C=CC=C2,54680692
929,DB00947,Fulvestrant,small molecule,approved|investigational,"Anti-Estrogens|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Endocrine Therapy|Estradiol Congeners|Estranes|Estrenes|Estrogen Antagonists|Estrogen Receptor Antagonists|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Selective Estrogen Receptor Modulators|Steroids|UGT1A1 Substrates",[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H],17756771
930,DB00948,Mezlocillin,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Penicillin G|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds",[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](NC(=O)N1CCN(C1=O)S(C)(=O)=O)C1=CC=CC=C1)C(O)=O,656511
931,DB00949,Felbamate,small molecule,approved,"Acids, Acyclic|Alcohols|Anti-epileptic Agent|Anticonvulsants|Carbamates|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Decreased Central Nervous System Disorganized Electrical Activity|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Glycols|Nervous System|Neurotransmitter Agents|NMDA Receptor Antagonists|Phenylcarbamates|Potential QTc-Prolonging Agents|Propylene Glycols|QTc Prolonging Agents",NC(=O)OCC(COC(N)=O)C1=CC=CC=C1,3331
932,DB00950,Fexofenadine,small molecule,approved|investigational,"Anti-Allergic Agents|Antihistamines for Systemic Use|Benzene Derivatives|Benzhydryl Compounds|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Neurotransmitter Agents|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein substrates|Piperidines",CC(C)(C(O)=O)C1=CC=C(C=C1)C(O)CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,3348
933,DB00951,Isoniazid,small molecule,approved|investigational,Agents Causing Muscle Toxicity|Agents that reduce seizure threshold|Anti-Bacterial Agents|Anti-Infective Agents|Antiinfectives for Systemic Use|Antimycobacterials|Antituberculosis Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP2E1 Inducers (strength unknown)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (moderate)|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs for Treatment of Tuberculosis|Drugs that are Mainly Renally Excreted|Fatty Acid Synthesis Inhibitors|Hepatotoxic Agents|Hydrazides|Hydrazines|Hypolipidemic Agents|Isonicotinic Acids|Lipid Regulating Agents|Noxae|Pyridines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Toxic Actions,NNC(=O)C1=CC=NC=C1,3767
934,DB00952,Naratriptan,small molecule,approved|investigational,"Agents that produce hypertension|Amines|Analgesics|Antidepressive Agents|Antimigraine Preparations|Biogenic Amines|Biogenic Monoamines|Cardiovascular Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Indoles|Monoamine Oxidase A Substrates|Nervous System|Neurotransmitter Agents|Selective Serotonin 5-HT1 Receptor Agonists|Selective Serotonin Agonists|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 1b Receptor Agonists|Serotonin 1d Receptor Agonists|Serotonin 5-HT1 Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists|Serotonin-1b and Serotonin-1d Receptor Agonist|Triptans|Vasoconstrictor Agents",CNS(=O)(=O)CCC1=CC2=C(NC=C2C2CCN(C)CC2)C=C1,4440
935,DB00953,Rizatriptan,small molecule,approved,"Agents that produce hypertension|Amines|Analgesics|Antidepressive Agents|Antimigraine Preparations|Biogenic Amines|Biogenic Monoamines|Central Nervous System Depressants|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Indoles|Migraine Disorders|Monoamine Oxidase A Substrates|Nervous System|Neurotransmitter Agents|Selective Serotonin 5-HT1 Receptor Agonists|Selective Serotonin Agonists|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 1b Receptor Agonists|Serotonin 1d Receptor Agonists|Serotonin 5-HT1 Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists|Serotonin-1b and Serotonin-1d Receptor Agonist|Triptans",CN(C)CCC1=CNC2=C1C=C(CN1C=NC=N1)C=C2,5078
936,DB00954,Dirithromycin,small molecule,experimental,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Macrolides, Lincosamides and Streptogramins|Polyketides",CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O,6473883
937,DB00955,Netilmicin,small molecule,approved|investigational,Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Carbohydrates|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Enzyme Inhibitors|Gentamicins|Glycosides|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Ophthalmologicals|Protein Synthesis Inhibitors|Sensory Organs,CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O,441306
938,DB00956,Hydrocodone,small molecule,approved|illicit|investigational,"Alkaloids|Analgesics|Antitussive Agents|Central Nervous System Agents|Central Nervous System Depressants|Cough and Cold Preparations|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Morphinans|Morphine Derivatives|Narcotics|Opiate Alkaloids|Opioid Agonist|Opioids|Opium Alkaloids and Derivatives|Peripheral Nervous System Agents|Respiratory System Agents|Semi-synthetic Opioids|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CCC2=O,5284569
939,DB00957,Norgestimate,small molecule,approved|investigational,"Adrenal Cortex Hormones|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hyperglycemia-Associated Agents|Norpregnanes|Norpregnenes|Norsteroids|P-glycoprotein inhibitors|Progestin Contraceptives|Progestins|Progestogens and Estrogens, Sequential Preparations|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids|UGT1A1 Substrates",[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CC\C(C=C3CC[C@@]21[H])=N/O,6540478
940,DB00958,Carboplatin,small molecule,approved,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Compounds used in a research, industrial, or household setting|Cross-Linking Reagents|Drugs that are Mainly Renally Excreted|Immunosuppressive Agents|Indicators and Reagents|Laboratory Chemicals|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Organometallic Compounds|Platinum Compounds",[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],38904
941,DB00959,Methylprednisolone,small molecule,approved|vet_approved,"Adrenal Cortex Hormones|Adrenals|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Inflammatory Agents|Antiemetics|Antineoplastic Agents|Autonomic Agents|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Corticosteroids, Dermatological Preparations|Corticosteroids, Weak (Group I)|Cytochrome P-450 CYP2A6 Inducers|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Dermatologicals|Experimental Unapproved Treatments for COVID-19|Fused-Ring Compounds|Gastrointestinal Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Neuroprotective Agents|Ophthalmologicals|P-glycoprotein inducers|P-glycoprotein substrates|Peripheral Nervous System Agents|Pregnadienes|Pregnadienetriols|Pregnanes|Protective Agents|Sensory Organs|Steroids|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,6741
942,DB00960,Pindolol,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antidepressive Agents|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Beta Blocking Agents, Non-Selective|Bradycardia-Causing Agents|Cardiovascular Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Hypotensive Agents|Neurotransmitter Agents|Phenoxypropanolamines|Propanolamines|Propanols|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Vasodilating Agents",CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,4828
943,DB00961,Mepivacaine,small molecule,approved|vet_approved,"Amide Local Anesthetic|Amides|Anesthetics|Anesthetics, Local|Central Nervous System Agents|Drugs that are Mainly Renally Excreted|Local Anesthesia|Nervous System|Peripheral Nervous System Agents|Piperidines|Sensory System Agents",CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,4062
944,DB00962,Zaleplon,small molecule,approved|illicit|investigational,"Acetates|Acids, Acyclic|Amides|Anticonvulsants|Benzodiazepine hypnotics and sedatives|Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Depression|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Fatty Acids|Fatty Acids, Volatile|GABA Agents|GABA Agonists|GABA Modulators|GABA-A Receptor Agonists|gamma-Aminobutyric Acid A Receptor Agonist|Hypnotics (Nonbenzodiazepine)|Hypnotics and Sedatives|Lipids|Miscellaneous Anxiolytics Sedatives and Hypnotics|Nervous System|Neurotransmitter Agents|Psycholeptics",CCN(C(C)=O)C1=CC=CC(=C1)C1=CC=NC2=C(C=NN12)C#N,5719
945,DB00963,Bromfenac,small molecule,approved,"Agents causing hyperkalemia|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antirheumatic Agents|Benzene Derivatives|Central Nervous System Agents|Cyclooxygenase Inhibitors|Hydrocarbons, Brominated|Hydrocarbons, Halogenated|Ketones|Nephrotoxic agents|Ophthalmologicals|Peripheral Nervous System Agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory Organs|Sensory System Agents",NC1=C(CC(O)=O)C=CC=C1C(=O)C1=CC=C(Br)C=C1,60726
946,DB00964,Apraclonidine,small molecule,approved,"Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Antiglaucoma Preparations and Miotics|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|EENT Drugs, Miscellaneous|Hypotensive Agents|Imidazoles|Imidazolines|Neurotransmitter Agents|Ophthalmics|Ophthalmologicals|Sensory Organs|Sympathomimetics in Glaucoma Therapy",NC1=CC(Cl)=C(NC2=NCCN2)C(Cl)=C1,2216
947,DB00965,Ethiodized oil,small molecule,approved|investigational,"Biological Products|Complex Mixtures|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Iodinated Contrast Agents|Iodized Oil|Lipids|Oils|Plant Oils|Plant Preparations|Radiographic Contrast Agent|Roentgenography|X-Ray Contrast Activity",,
948,DB00966,Telmisartan,small molecule,approved|investigational,"Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Angiotensin 2 Receptor Blocker|Angiotensin II receptor blockers (ARBs) and calcium channel blockers|Angiotensin II receptor blockers (ARBs) and diuretics|Angiotensin II receptor blockers (ARBs), plain|Angiotensin II Type 1 Receptor Blockers|Angiotensin II Type 2 Receptor Blockers|Angiotensin Receptor Antagonists|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|BCRP/ABCG2 Inhibitors|Benzene Derivatives|Benzimidazoles|Biphenyl Compounds|BSEP/ABCB11 Substrates|Cardiovascular Agents|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|P-glycoprotein inhibitors|UGT1A3 substrates",CCCC1=NC2=C(C=C(C=C2C)C2=NC3=CC=CC=C3N2C)N1CC1=CC=C(C=C1)C1=CC=CC=C1C(O)=O,65999
949,DB00967,Desloratadine,small molecule,approved|investigational,"Anticholinergic Agents|Antihistamines for Systemic Use|Benzocycloheptenes|Central Nervous System Depressants|Cholinergic Agents|Dibenzocycloheptenes|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Loratadine and prodrug|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|P-glycoprotein inhibitors|Piperidines|QTc Prolonging Agents",ClC1=CC2=C(C=C1)C(=C1CCNCC1)C1=C(CC2)C=CC=N1,124087
950,DB00968,Methyldopa,small molecule,approved,"Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents Causing Muscle Toxicity|Amines|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Aromatic L-amino Acid Decarboxylase Inhibitors|Autonomic Agents|Benzene Derivatives|Bradycardia-Causing Agents|Cardiovascular Agents|Catecholamines|Catechols|Central alpha-2 Adrenergic Agonist|Central Alpha-agonists|COMT Substrates|Dihydroxyphenylalanine|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Hypotensive Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenols|Phenylalanine|Sympatholytics",C[C@](N)(CC1=CC=C(O)C(O)=C1)C(O)=O,38853
951,DB00969,Alosetron,small molecule,approved|withdrawn,"Alimentary Tract and Metabolism|Antidepressive Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (moderate)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs for Functional Gastrointestinal Disorders|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Indoles|Neurotransmitter Agents|Pyridines|Serotonin 3 Receptor Antagonists|Serotonin 5-HT3 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists",CN1C2=C(C3=CC=CC=C13)C(=O)N(CC1=C(C)NC=N1)CC2,2099
952,DB00970,Dactinomycin,small molecule,approved|investigational,"Actinomycin|Actinomycines|Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Cytotoxic Antibiotics and Related Substances|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Immunosuppressive Agents|Myelosuppressive Agents|Nucleic Acid Synthesis Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Peptides|Peptides, Cyclic|Protein Synthesis Inhibitors",[H][C@@]12CCCN1C(=O)[C@H](NC(=O)[C@@H](NC(=O)C1=C3N=C4C(OC3=C(C)C=C1)=C(C)C(=O)C(N)=C4C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@]3([H])CCCN3C(=O)[C@H](NC1=O)C(C)C)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C2=O)C(C)C,457193
953,DB00971,Selenium Sulfide,small molecule,approved,Antifungals for Dermatological Use|Antifungals for Topical Use|Dermatologicals|Selenium Compounds,S=[Se]=S,24087
954,DB00972,Azelastine,small molecule,approved,"Anti-Allergic Agents|Antiallergic Agents, Excl. Corticosteroids|Antihistamines for Systemic Use|Autonomic Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Decongestants and Antiallergics|Enzyme Inhibitors|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Nasal Preparations|Neurotransmitter Agents|Ophthalmologicals|P-glycoprotein inhibitors|Pyridazines|Respiratory System Agents|Sensory Organs",CN1CCCC(CC1)N1N=C(CC2=CC=C(Cl)C=C2)C2=CC=CC=C2C1=O,2267
955,DB00973,Ezetimibe,small molecule,approved,"Anticholesteremic Agents|Azetines|BCRP/ABCG2 Substrates|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Decreased Cholesterol Absorption|Dietary Cholesterol Absorption Inhibitor|Hypolipidemic Agents|Hypolipidemic Agents Indicated for Hyperlipidemia|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|OATP1B1/SLCO1B1 Substrates|P-glycoprotein substrates|UGT1A1 Substrates|UGT1A3 substrates|UGT2B7 substrates",[H][C@]1(CC[C@H](O)C2=CC=C(F)C=C2)C(=O)N(C2=CC=C(F)C=C2)[C@]1([H])C1=CC=C(O)C=C1,150311
956,DB00974,Edetic acid,small molecule,approved|vet_approved,"Acetates|Acids, Acyclic|Amines|Anticoagulants|Calcium Chelating Activity|Calcium Chelating Agents|Chelating Agents|Compounds used in a research, industrial, or household setting|Decreased Coagulation Factor Activity|Diamines|Diet, Food, and Nutrition|Ethylenediamines|Fatty Acids|Fatty Acids, Volatile|Food|Food Additives|Food and Beverages|Food Ingredients|Heavy Metal Antagonists|Hematologic Agents|Lead Chelating Activity|Lead Chelator|Physiological Phenomena|Polyamines|Sequestering Agents",OC(=O)CN(CCN(CC(O)=O)CC(O)=O)CC(O)=O,6049
957,DB00975,Dipyridamole,small molecule,approved,Anticoagulants|Antiplatelet agents|Blood and Blood Forming Organs|BSEP/ABCB11 Substrates|Cardiovascular Agents|Decreased Platelet Aggregation|Enzyme Inhibitors|Hematologic Agents|Hypotensive Agents|Miscellaneous Vasodilatating Agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Phosphodiesterase 5 Inhibitors|Phosphodiesterase Inhibitors|Platelet Aggregation Inhibitors Excl. Heparin|Pyrimidines|Vasodilating Agents,OCCN(CCO)C1=NC2=C(N=C(N=C2N2CCCCC2)N(CCO)CCO)C(=N1)N1CCCCC1,3108
958,DB00976,Telithromycin,small molecule,approved,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Erythromycin and similars|Ketolide Antibacterial|Ketolides|Lactones|Macrolides|Macrolides, Lincosamides and Streptogramins|Moderate Risk QTc-Prolonging Agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Polyketides|Protein Synthesis Inhibitors|QTc Prolonging Agents|RNA, Ribosomal, 23S",[H][C@@]12[C@@H](C)C(=O)[C@H](C)C[C@@](C)(OC)[C@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@H](C)C(=O)[C@@H](C)C(=O)O[C@H](CC)[C@@]1(C)OC(=O)N2CCCCN1C=NC(=C1)C1=CC=CN=C1,3002190
959,DB00977,Ethinylestradiol,small molecule,approved,"Adrenal Cortex Hormones|Antineoplastic and Immunomodulating Agents|BSEP/ABCB11 inducers|BSEP/ABCB11 Inhibitors|COMT Substrates|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Postcoital|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Endocrine Therapy|Estradiol Congeners|Estrogen Contraceptives|Estrogenic Steroids, Alkylated|Estrogens|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Natural and Semisynthetic Estrogens, Plain|Norpregnanes|Norpregnatrienes|Norsteroids|P-glycoprotein substrates|Progestogens and Estrogens, Sequential Preparations|Sex Hormones and Modulators of the Genital System|Steroids|Thyroxine-binding globulin inducers|UGT1A1 Inducers|UGT1A1 Substrates|UGT1A4 substrates|UGT1A9 Substrates|UGT2B7 substrates",[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,5991
960,DB00978,Lomefloxacin,small molecule,approved|investigational,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Moderate Risk QTc-Prolonging Agents|Ophthalmologicals|Photosensitizing Agents|QTc Prolonging Agents|Quinolines|Quinolones|Sensory Organs|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N3CCNC(C)C3)C(F)=C12,3948
961,DB00979,Cyclopentolate,small molecule,approved,"Acids, Carbocyclic|Anticholinergic Agents|Autonomic Agents|Cholinergic Agents|Cholinesterase substrates|Muscarinic Antagonists|Mydriatics|Mydriatics and Cycloplegics|Neurotransmitter Agents|Ophthalmologicals|Parasympatholytics|Peripheral Nervous System Agents|Phenylacetates|Sensory Organs",CN(C)CCOC(=O)C(C1=CC=CC=C1)C1(O)CCCC1,2905
962,DB00980,Ramelteon,small molecule,approved|investigational,Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Hypnotics and Sedatives|Melatonin Receptor Agonists|Nervous System|Psycholeptics,CCC(=O)NCC[C@@H]1CCC2=C1C1=C(OCC1)C=C2,208902
963,DB00981,Physostigmine,small molecule,approved|investigational,"Acids, Acyclic|Alkaloids|Antidotes|Antiglaucoma Preparations and Miotics|Autonomic Agents|Carbamates|Cholinergic Agents|Cholinesterase Inhibitors|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|Miotics|Neurotransmitter Agents|Ophthalmologicals|Parasympathomimetics|Peripheral Nervous System Agents|Phenylcarbamates|Sensory Organs",[H][C@]12N(C)CC[C@@]1(C)C1=C(C=CC(OC(=O)NC)=C1)N2C,5983
964,DB00982,Isotretinoin,small molecule,approved,"Agents Causing Muscle Toxicity|Alkenes|Anti-Acne Preparations|Anti-Acne Preparations for Systemic Use|Anti-Acne Preparations for Topical Use|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dermatologicals|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Hydrocarbons, Acyclic|Misc. Skin and Mucous Membrane Agents|Narrow Therapeutic Index Drugs|Noxae|Photosensitizing Agents|Pigments, Biological|Polyenes|Retinoids|Retinoids for Topical Use in Acne|Retinoids for Treatment of Acne|Teratogens|Terpenes|Toxic Actions",C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,5282379
965,DB00983,Formoterol,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Drugs for Obstructive Airway Diseases|Ethanolamines|OCT1 inhibitors|OCT1 substrates|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists|UGT1A9 Substrates|UGT2B7 substrates",COC1=CC=C(CC(C)NCC(O)C2=CC(NC=O)=C(O)C=C2)C=C1,3410
966,DB00984,Nandrolone phenpropionate,small molecule,approved|illicit|investigational,"Anabolic Agents|Androgens|Estranes|Estrenes|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Nandrolone and esters|Steroids|Testosterone Congeners|Thyroxine-binding globulin inhibitors",[H][C@@]12CC[C@H](OC(=O)CCC3=CC=CC=C3)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],229455
967,DB00985,Dimenhydrinate,small molecule,approved,"Alkaloids|Amines|Antiemetics|Autonomic Agents|Benzene Derivatives|Benzhydryl Compounds|Central Nervous System Agents|Central Nervous System Depressants|Ethanolamine Derivatives|Ethylamines|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Pharmaceutical Preparations|Purines|Purinones|QTc Prolonging Agents",CN1C2=C(N=C(Cl)N2)C(=O)N(C)C1=O.CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1,441281
968,DB00986,Glycopyrronium,small molecule,approved|investigational|vet_approved,"Adjuvants, Anesthesia|Adrenergics, Inhalants|Agents producing tachycardia|Alimentary Tract and Metabolism|Amines|Ammonium Compounds|Anticholinergic Agents|Antimuscarinics Antispasmodics|Central Nervous System Agents|Cholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Drugs for Obstructive Airway Diseases|Muscarinic Antagonists|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Pyrrolidines|Quaternary Ammonium Compounds|Synthetic Anticholinergics, Quaternary Ammonium Compounds",C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,9933193
969,DB00987,Cytarabine,small molecule,approved|investigational,"Agents Causing Muscle Toxicity|Anti-Infective Agents|Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Arabinonucleosides|Carbohydrates|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Glycosides|Immunologic Factors|Immunosuppressive Agents|Myelosuppressive Agents|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Metabolic Inhibitor|Nucleosides|OCT1 substrates|Pyrimidine Analogues|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides|Toxic Actions",NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,6253
970,DB00988,Dopamine,small molecule,approved,"Adrenergic and Dopaminergic Agents|Agents producing tachycardia|Agents that produce hypertension|Amines|Autonomic Agents|Benzene Derivatives|Biogenic Amines|Biogenic Monoamines|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Catecholamines|Catechols|Compounds used in a research, industrial, or household setting|COMT Substrates|Dopamine Agents|Dopamine, metabolism|Drugs that are Mainly Renally Excreted|Monoamine Oxidase A Substrates|Neurotransmitter Agents|OCT1 substrates|OCT2 Inhibitors|OCT2 Substrates|Peripheral Nervous System Agents|Phenols|Protective Agents|Selective Beta 1-adrenergic Agonists|Sympathomimetics",NCCC1=CC(O)=C(O)C=C1,681
971,DB00989,Rivastigmine,small molecule,approved|investigational,"Acids, Acyclic|Anti-Dementia Drugs|Bradycardia-Causing Agents|Carbamates|Central Nervous System Agents|Cholinergic Agents|Cholinesterase Inhibitors|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 Substrates|Enzyme Inhibitors|Nervous System|Neuroprotective Agents|Neurotransmitter Agents|Parasympathomemetic (Cholinergic) Agents|Phenylcarbamates|Protective Agents|Psychoanaleptics",CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,77991
972,DB00990,Exemestane,small molecule,approved|investigational,"Androstanes|Androstenes|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Aromatase Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Endocrine Therapy|Enzyme Inhibitors|Estrogen Antagonists|Fused-Ring Compounds|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors|Steroids",[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC(=C)C2=CC(=O)C=C[C@]12C,60198
973,DB00991,Oxaprozin,small molecule,approved,"Acids, Acyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|Cyclooxygenase Inhibitors|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Other Nonsteroidal Anti-inflammatory Agents|Oxazoles|Peripheral Nervous System Agents|Photosensitizing Agents|Propionates|Sensory System Agents",OC(=O)CCC1=NC(=C(O1)C1=CC=CC=C1)C1=CC=CC=C1,4614
974,DB00992,Methyl aminolevulinate,small molecule,approved|investigational,"Amino Acids|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Dermatologicals|Keto Acids|Levulinic Acids|Misc. Skin and Mucous Membrane Agents|Photochemotherapy|Photosensitizing Agents|Photosensitizing agents used for phototherapy|Porphyrin Precursor|Radiation-Sensitizing Agents|Sensitizers Used in Photodynamic/radiation Therapy",COC(=O)CCC(=O)CN,157922
975,DB00993,Azathioprine,small molecule,approved,"Antimetabolites|Antineoplastic and Immunomodulating Agents|Antirheumatic Agents|Carbohydrates|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Glycosides|Heterocyclic Compounds, Fused-Ring|Immunologic Factors|Immunosuppressive Agents|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|P-glycoprotein substrates|Purine Antimetabolite|Purines|Sulfhydryl Compounds|Sulfur Compounds|Thionucleosides|Thiopurine Analogs|Toxic Actions",CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,2265
976,DB00994,Neomycin,small molecule,approved|vet_approved,"Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antibiotics for Topical Use|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antiinfectives and Antiseptics for Local Oral Treatment|Antiinfectives for Systemic Use|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Carbohydrates|Dermatologicals|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Enzyme Inhibitors|Glycosides|Intestinal Antiinfectives|Irrigating Solutions|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Neurotoxic agents|Ophthalmological and Otological Preparations|Ophthalmologicals|Otologicals|Ototoxic agents|Protein Synthesis Inhibitors|Sensory Organs|Stomatological Preparations|Throat Preparations",,
977,DB00995,Auranofin,small molecule,approved|investigational,Antiinflammatory and Antirheumatic Products|Antirheumatic Agents|Drugs that are Mainly Renally Excreted|Gold Compounds|Gold Preparations|Musculo-Skeletal System|Organogold Compounds|Organometallic Compounds|Specific Antirheumatic Agents,CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O,70788951
978,DB00996,Gabapentin,small molecule,approved|investigational,"Acids, Acyclic|Acids, Carbocyclic|Amines|Amino Acids|Amino Acids, Peptides, and Proteins|Aminobutyrates|Analgesics|Anti-epileptic Agent|Anticonvulsants|Butyrates|Central Nervous System Agents|Central Nervous System Depressants|Cyclohexanecarboxylic Acids|Cyclohexanes|Cycloparaffins|Decreased Central Nervous System Disorganized Electrical Activity|Drugs causing inadvertant photosensitivity|Gabapentin and Prodrugs|Miscellaneous Anticonvulsants|Nervous System|Neurotransmitter Agents|Peripheral Nervous System Agents|Photosensitizing Agents|Psychotropic Drugs|Sensory System Agents|Tranquilizing Agents",NCC1(CC(O)=O)CCCCC1,3446
979,DB00997,Doxorubicin,small molecule,approved|investigational,"Anthracycline Topoisomerase Inhibitor|Anthracyclines|Anthracyclines and Related Substances|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|BSEP/ABCB11 Substrates|BSEP/ABCB11 Substrates with Narrow Therapeutic Index|Carbohydrates|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Cytotoxic Antibiotics and Related Substances|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Glycosides|Immunosuppressive Agents|Myelosuppressive Agents|Naphthacenes|P-glycoprotein inducers|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Photosensitizing Agents|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,31703
980,DB00998,Frovatriptan,small molecule,approved|investigational,"Agents that produce hypertension|Amines|Analgesics|Antidepressive Agents|Antimigraine Preparations|Biogenic Amines|Biogenic Monoamines|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Indoles|Migraine Disorders|Nervous System|Neurotransmitter Agents|Selective Serotonin 5-HT1 Receptor Agonists|Selective Serotonin Agonists|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 1b Receptor Agonists|Serotonin 1d Receptor Agonists|Serotonin 5-HT1 Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists|Serotonin-1b and Serotonin-1d Receptor Agonist|Triptans",CN[C@@H]1CCC2=C(C1)C1=C(N2)C=CC(=C1)C(N)=O,77992
981,DB00999,Hydrochlorothiazide,small molecule,approved|vet_approved,"Amides|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Benzothiadiazines|Cardiovascular Agents|Diuretics|Drugs causing inadvertant photosensitivity|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Heterocyclic Compounds, Fused-Ring|Hyperglycemia-Associated Agents|Hypotensive Agents|Increased Diuresis|Low-Ceiling Diuretics and Potassium-Sparing Agents|Membrane Transport Modulators|Natriuretic Agents|Nephrotoxic agents|Non Potassium Sparing Diuretics|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Substrates|Photosensitizing Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sodium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds|Thiazides",NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,3639
982,DB01000,Cyclacillin,small molecule,approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Penicillins|Sulfur Compounds",[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1(N)CCCCC1)C(O)=O,19003
983,DB01001,Salbutamol,small molecule,approved|vet_approved,"Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Drugs for Obstructive Airway Diseases|Drugs that are Mainly Renally Excreted|Ethanolamines|Peripheral Nervous System Agents|Phenethylamines|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Reproductive Control Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists|Sympathomimetic (Adrenergic) Agents|Tocolytic Agents",CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,2083
984,DB01002,Levobupivacaine,small molecule,approved|investigational,"Amides|Amines|Anesthetics|Anesthetics, Local|Anilides|Aniline Compounds|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Hypotensive Agents|Nervous System|Neuraxial Anesthetics|Peripheral Nervous System Agents|Sensory System Agents",CCCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,92253
985,DB01003,Cromoglicic acid,small molecule,approved,"Adrenergics, Inhalants|Agents for Dermatitis, Excluding Corticosteroids|Alimentary Tract and Metabolism|Anti-Allergic Agents|Anti-Asthmatic Agents|Antiallergic Agents, Excl. Corticosteroids|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Benzopyrans|Chromones|Cromolyn Sodium|Decongestants and Antiallergics|Decreased Histamine Release|Dermatologicals|Drugs causing inadvertant photosensitivity|Drugs for Obstructive Airway Diseases|Heterocyclic Compounds, Fused-Ring|Intestinal Antiinflammatory Agents|Mast Cell Stabilizers|Mast-cell Stabilizers|Nasal Preparations|Ophthalmologicals|Photosensitizing Agents|Pyrans|Respiratory System Agents|Sensory Organs",OC(COC1=CC=CC2=C1C(=O)C=C(O2)C(O)=O)COC1=CC=CC2=C1C(=O)C=C(O2)C(O)=O,2882
986,DB01004,Ganciclovir,small molecule,approved|investigational,"Agents Causing Muscle Toxicity|Agents that reduce seizure threshold|Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor|Direct Acting Antivirals|Drugs that are Mainly Renally Excreted|Ganciclovir|Ganciclovir and prodrug|Heterocyclic Compounds, Fused-Ring|MATE 1 Substrates|MATE 2 Substrates|MATE substrates|Nucleic Acid Synthesis Inhibitors|Nucleoside Analog Antiviral|Nucleosides and Nucleotides|Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|OCT1 inhibitors|OCT1 substrates|Ophthalmologicals|Purines|Purinones|Sensory Organs",NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1,3454
987,DB01005,Hydroxyurea,small molecule,approved,Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Antisickling Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Hematologic Agents|Immunosuppressive Agents|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Nucleic Acid Synthesis Inhibitors,NC(=O)NO,3657
988,DB01006,Letrozole,small molecule,approved|investigational,"Agents Causing Muscle Toxicity|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Aromatase Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (strong)|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Endocrine Therapy|Enzyme Inhibitors|Estrogen Antagonists|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Nitriles|P-glycoprotein substrates|Steroid Synthesis Inhibitors|Triazoles|UGT2B7 substrates",N#CC1=CC=C(C=C1)C(N1C=NC=N1)C1=CC=C(C=C1)C#N,3902
989,DB01007,Tioconazole,small molecule,approved,"14-alpha Demethylase Inhibitors|Anti-Infective Agents|Antifungal Agents|Antifungal Agents (Vaginal)|Antifungals for Dermatological Use|Antifungals for Topical Use|Azole Antifungals|Chemically-Induced Disorders|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strong)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Imidazole and Triazole Derivatives|Imidazole Derivatives|Steroid Synthesis Inhibitors",ClC1=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=CS1,5482
990,DB01008,Busulfan,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Alcohols|Alkanes|Alkanesulfonates|Alkanesulfonic Acids|Alkylating Activity|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Butylene Glycols|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Glycols|Hydrocarbons, Acyclic|Immunologic Factors|Immunosuppressive Agents|Mesylates|Myeloablative Agonists|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Noxae|Sulfonic Acids|Sulfur Acids|Sulfur Compounds|Toxic Actions",CS(=O)(=O)OCCCCOS(C)(=O)=O,2478
991,DB01009,Ketoprofen,small molecule,approved|vet_approved,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antirheumatic Agents|Central Nervous System Agents|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|Other Nonsteroidal Anti-inflammatory Agents|Peripheral Nervous System Agents|Phenylpropionates|Photosensitizing Agents|Propionates|Sensory System Agents|Topical Products for Joint and Muscular Pain|UGT1A1 Substrates",CC(C(O)=O)C1=CC(=CC=C1)C(=O)C1=CC=CC=C1,3825
992,DB01010,Edrophonium,small molecule,approved,"Amines|Ammonium Compounds|Antidotes|Cholinergic Agents|Cholinesterase Inhibitors|Compounds used in a research, industrial, or household setting|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Phenylammonium Compounds|Protective Agents|Quaternary Ammonium Compounds",CC[N+](C)(C)C1=CC(O)=CC=C1,3202
993,DB01011,Metyrapone,small molecule,approved|investigational,Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Diagnostic Agents|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Noxae|Pyridines|Steroid Synthesis Inhibitors|Tests for Pituitary Function|Toxic Actions,CC(C)(C(=O)C1=CN=CC=C1)C1=CC=CN=C1,4174
994,DB01012,Cinacalcet,small molecule,approved,"Anti-Parathyroid Agents|Calcimimetic Agents|Calcium Homeostasis|Calcium-Regulating Hormones and Agents|Calcium-sensing Receptor Agonist|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Increased Calcium-sensing Receptor Sensitivity|Naphthalenes|Other Miscellaneous Therapeutic Agents|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,156419
995,DB01013,Clobetasol propionate,small molecule,approved,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated|Thyroxine-binding globulin inhibitors",[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,32798
996,DB01014,Balsalazide,small molecule,approved|investigational,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Alimentary Tract and Metabolism|Aminobenzoates|Aminosalicylate|Aminosalicylic Acids|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Colitis, Ulcerative|Gastrointestinal Agents|Hydrazines|Hydroxy Acids|Hydroxybenzoates|Inflammatory Bowel Diseases|Intestinal Antiinflammatory Agents|meta-Aminobenzoates|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Phenols|Prodrugs|Salicylates|Sensory System Agents",OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O,6335412
997,DB01015,Sulfamethoxazole,small molecule,approved,Agents causing hyperkalemia|Agents Causing Muscle Toxicity|Amines|Aniline Compounds|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antibiotics for Pneumocystis Pneumonia|Antiinfectives for Systemic Use|Antimycobacterials|Blood Glucose Lowering Agents|BSEP/ABCB11 Inhibitors|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Drugs for Treatment of Tuberculosis|Drugs that are Mainly Renally Excreted|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hypoglycemia-Associated Agents|Intermediate-Acting Sulfonamides|Methemoglobinemia Associated Agents|Photosensitizing Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sulfanilamides|Sulfonamide Antibacterial|Sulfonamides|SULFONAMIDES AND TRIMETHOPRIM|Sulfones|Sulfur Compounds,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1,5329
998,DB01016,Glyburide,small molecule,approved,Alimentary Tract and Metabolism|BCRP/ABCG2 Substrates|Blood Glucose Lowering Agents|BSEP/ABCB11 Inhibitors|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Drugs Used in Diabetes|Hypoglycemia-Associated Agents|OAT1/SLC22A6 inhibitors|P-glycoprotein inhibitors|Photosensitizing Agents|Sulfones|Sulfonylureas|Sulfur Compounds,COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,3488
999,DB01017,Minocycline,small molecule,approved|investigational,Agents Causing Muscle Toxicity|Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives and Antiseptics for Local Oral Treatment|Antiinfectives for Systemic Use|Drugs causing inadvertant photosensitivity|Naphthacenes|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|Photosensitizing Agents|Stomatological Preparations|Tetracyclines,[H][C@@]12CC3=C(C(O)=CC=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2,54675783
1000,DB01018,Guanfacine,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Amidines|Antiadrenergic Agents, Centrally Acting|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Bradycardia-Causing Agents|Cardiovascular Agents|Central alpha-2 Adrenergic Agonist|Central Alpha-agonists|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Guanidines|Hypotensive Agents|Imidazoline Receptor Agonists|MATE 1 Inhibitors|MATE inhibitors|Neurotransmitter Agents|OCT1 inhibitors|OCT1 substrates|OCT2 Substrates",NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl,3519
1001,DB01019,Bethanechol,small molecule,approved,"Acids, Acyclic|Amines|Ammonium Compounds|Autonomic Agents|Bethanechol Compounds|Carbamates|Choline Esters|Cholinergic Agents|Cholinergic Agonists|Muscarinic Agonists|Nervous System|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Parasympathomemetic (Cholinergic) Agents|Parasympathomimetics|Peripheral Nervous System Agents|Quaternary Ammonium Compounds|Trimethyl Ammonium Compounds",CC(C[N+](C)(C)C)OC(N)=O,2370
1002,DB01020,Isosorbide mononitrate,small molecule,approved,Alcohols|Antianginal Agents|Carbohydrates|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 Substrates|Delayed-Action Preparations|Drugs that are Mainly Renally Excreted|Hypotensive Agents|Methemoglobinemia Associated Agents|Nitrate Vasodilator|Nitrates and Nitrites|Nitric Oxide Donors|Organic Nitrates|Sugar Alcohols|Vasodilating Agents|Vasodilation|Vasodilators Used in Cardiac Diseases,[H][C@]12OC[C@@H](O[N+]([O-])=O)[C@@]1([H])OC[C@@H]2O,27661
1003,DB01021,Trichlormethiazide,small molecule,approved|vet_approved,"Amides|Antihypertensive Agents|Benzothiadiazines|Cardiovascular Agents|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Heterocyclic Compounds, Fused-Ring|Hyperglycemia-Associated Agents|Low-Ceiling Diuretics and Potassium-Sparing Agents|Membrane Transport Modulators|Natriuretic Agents|Sodium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds|Thiazides",NS(=O)(=O)C1=C(Cl)C=C2NC(NS(=O)(=O)C2=C1)C(Cl)Cl,5560
1004,DB01022,Phylloquinone,small molecule,approved|investigational,"Blood and Blood Forming Organs|Coagulants|Diet, Food, and Nutrition|Diterpenes|Drugs that are Mainly Renally Excreted|Fibrin Modulating Agents|Food|Food and Beverages|Growth Substances|Hematologic Agents|Hemostatics|Increased Prothrombin Activity|Micronutrients|Naphthalenes|Naphthoquinones|Physiological Phenomena|Phytol|Quinones|Reversed Anticoagulation Activity|Terpenes|Vitamin K|Vitamins|Vitamins (Fat Soluble)|Warfarin Reversal Agent",CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CC1=C(C)C(=O)C2=C(C=CC=C2)C1=O,5284607
1005,DB01023,Felodipine,small molecule,approved|investigational,ACE Inhibitors and Calcium Channel Blockers|Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Beta blocking agents and calcium channel blockers|Bradycardia-Causing Agents|BSEP/ABCB11 Substrates|Calcium Channel Blockers|Calcium Channel Blockers (Dihydropyridine)|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dihydropyridine Derivatives|Dihydropyridines|Hypotensive Agents|Membrane Transport Modulators|P-glycoprotein inhibitors|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents,CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC,3333
1006,DB01024,Mycophenolic acid,small molecule,approved,"Acids, Acyclic|Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics, Antineoplastic|Antibiotics, Antitubercular|Antimetabolite Immunosuppressant|Antineoplastic and Immunomodulating Agents|Antituberculosis Agents|Caproates|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Immunosuppressive Agents|Lipids|Mycophenolic Acid and Prodrugs|Narrow Therapeutic Index Drugs|Selective Immunosuppressants|UGT1A1 Substrates|UGT1A1 substrates with narrow therapeutic index|UGT1A6 substrate|UGT1A6 substrate with narrow therapeutic index|UGT1A9 Substrates|UGT1A9 substrates with narrow therapeutic index|UGT2B7 substrates|UGT2B7 substrates with narrow therapeutic index",COC1=C(C\C=C(/C)CCC(O)=O)C(O)=C2C(=O)OCC2=C1C,446541
1007,DB01025,Amlexanox,small molecule,approved|investigational|withdrawn,Alimentary Tract and Metabolism|Amines|Anti-Allergic Agents|Decreased Histamine Release|Drugs for Obstructive Airway Diseases|Ophthalmic Solutions|Pyridines|Stomatological Preparations,CC(C)C1=CC2=C(OC3=NC(N)=C(C=C3C2=O)C(O)=O)C=C1,2161
1008,DB01026,Ketoconazole,small molecule,approved|investigational,14-alpha Demethylase Inhibitors|Agents causing hyperkalemia|Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Antiinfectives for Systemic Use|Antimycotics for Systemic Use|Azole Antifungals|BSEP/ABCB11 Inhibitors|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (moderate)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (moderate)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strong)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Gynecological Antiinfectives and Antiseptics|Hepatotoxic Agents|Imidazole and Triazole Derivatives|Imidazole Derivatives|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Photosensitizing Agents|Piperazines|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Steroid Synthesis Inhibitors|UGT1A1 Inhibitors|UGT2B7 Inhibitors,CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1,3823
1009,DB01028,Methoxyflurane,small molecule,approved|investigational|vet_approved,"Agents that produce hypertension|Analgesics|Anesthetics|Anesthetics, General|Anesthetics, Inhalation|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Ethers|Ethyl Ethers|Methyl Ethers|Miscellaneous Analgesics and Antipyretics|Nervous System",COC(F)(F)C(Cl)Cl,4116
1010,DB01029,Irbesartan,small molecule,approved|investigational,"Agents Acting on the Renin-Angiotensin System|Agents causing hyperkalemia|Angiotensin 2 Receptor Blocker|Angiotensin II receptor blockers (ARBs) and calcium channel blockers|Angiotensin II receptor blockers (ARBs) and diuretics|Angiotensin II receptor blockers (ARBs), plain|Angiotensin II Type 2 Receptor Blockers|Angiotensin Receptor Antagonists|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Benzene Derivatives|Biphenyl Compounds|Cardiovascular Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Hypotensive Agents|Spiro Compounds|Tetrazoles|UGT1A3 substrates",CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,3749
1011,DB01030,Topotecan,small molecule,approved|investigational,Alkaloids|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Immunosuppressive Agents|MATE 1 Inhibitors|MATE 1 Substrates|MATE 1 Substrates with a Narrow Therapeutic Index|MATE 2 Substrates|MATE 2 Substrates with a Narrow Therapeutic Index|MATE inhibitors|MATE substrates|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Topoisomerase I Inhibitors|Topoisomerase Inhibitors,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O,60700
1012,DB01031,Ethinamate,small molecule,approved|illicit|withdrawn,"Acids, Acyclic",NC(=O)OC1(CCCCC1)C#C,3284
1013,DB01032,Probenecid,small molecule,approved|investigational,"Adjuvants, Pharmaceutic|Amides|Antigout Preparations|Antirheumatic Agents|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Drugs that are Mainly Renally Excreted|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Musculo-Skeletal System|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|OCT1 inhibitors|OCT2 Inhibitors|Pharmaceutic Aids|Pharmaceutical Preparations|Preparations Increasing Uric Acid Excretion|Renal Agents|Sulfonamides|Sulfones|Sulfur Compounds|UGT1A1 Inhibitors|Uricosuric Agents",CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O,4911
1014,DB01033,Mercaptopurine,small molecule,approved,"Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Drugs for Obstructive Airway Diseases|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Immunologic Factors|Immunosuppressive Agents|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleoside Metabolic Inhibitor|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Purine Analogues|Purines|Sulfhydryl Compounds|Sulfur Compounds|Thiopurine Analogs|Toxic Actions|Xanthine derivatives",S=C1N=CNC2=C1NC=N2,667490
1015,DB01034,Cerulenin,small molecule,experimental,Amides|Anti-Infective Agents|Antifungal Agents|Fatty Acid Synthesis Inhibitors|Hypolipidemic Agents|Lipid Regulating Agents|Noxae|Toxic Actions,[H][C@]1(O[C@]1([H])C(=O)CC\C=C\C\C=C\C)C(N)=O,28517
1016,DB01035,Procainamide,small molecule,approved,"Acids, Carbocyclic|Agents Causing Muscle Toxicity|Agents that produce neuromuscular block (indirect)|Amides|Aminobenzoates|Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ia|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Cardiac Therapy|Cardiovascular Agents|Cholinesterase Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Highest Risk QTc-Prolonging Agents|MATE 1 Substrates|MATE 1 Substrates with a Narrow Therapeutic Index|MATE 2 Substrates|MATE 2 Substrates with a Narrow Therapeutic Index|MATE substrates|Membrane Transport Modulators|Narrow Therapeutic Index Drugs|OCT1 inhibitors|OCT2 Inhibitors|OCT2 substrates with narrow therapeutic index|para-Aminobenzoates|QTc Prolonging Agents|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers",CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,4913
1017,DB01036,Tolterodine,small molecule,approved|investigational,Agents producing tachycardia|Alcohols|Amines|Amino Alcohols|Anticholinergic Agents|Benzene Derivatives|Benzhydryl Compounds|Cholinergic Agents|Cresols|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs for Urinary Frequency and Incontinence|Drugs that are Mainly Renally Excreted|Genito Urinary System and Sex Hormones|Genitourinary Smooth Muscle Relaxants|Muscarinic Antagonists|Neurotransmitter Agents|Phenols|Potential QTc-Prolonging Agents|Propanolamines|Propanols|QTc Prolonging Agents|Urological Agents|Urologicals,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C,443879
1018,DB01037,Selegiline,small molecule,approved|investigational|vet_approved,"Agents that produce hypertension|Agents that reduce seizure threshold|Amines|Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dopamine Agents|Enzyme Inhibitors|Ethylamines|Hypotensive Agents|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Monoamine Oxidase B Inhibitors|Monoamine Oxidase Inhibitors|Nervous System|Neuroprotective Agents|P-glycoprotein inhibitors|Phenethylamines|Protective Agents|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators",C[C@H](CC1=CC=CC=C1)N(C)CC#C,26757
1019,DB01038,Carphenazine,small molecule,withdrawn,Dopamine Antagonists|Dopamine D2 Receptor Antagonists,CCC(=O)C1=CC=C2SC3=C(C=CC=C3)N(CCCN3CCN(CCO)CC3)C2=C1,18104
1020,DB01039,Fenofibrate,small molecule,approved,"Acids, Acyclic|Agents Causing Muscle Toxicity|Benzene Derivatives|Benzophenones|BSEP/ABCB11 Substrates|Butyrates|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Ethers|Fatty Acids|Fatty Acids, Volatile|Fibric Acids|Fribic Acid Derivatives|Hypolipidemic Agents|Hypolipidemic Agents Indicated for Hyperlipidemia|Isobutyrates|Ketones|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Lipids|Noxae|P-glycoprotein inhibitors|Peroxisome Proliferator Receptor alpha Agonist|Peroxisome Proliferator-activated Receptor alpha Agonists|Phenols|Phenyl Ethers|Toxic Actions|UGT1A9 Substrates",CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1,3339
1021,DB01041,Thalidomide,small molecule,approved|investigational|withdrawn,"Acids, Carbocyclic|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Anti-Bacterial Agents|Anti-Infective Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cardiotoxic antineoplastic agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Decreased Immunologically Active Molecule Activity|Drugs causing inadvertant photosensitivity|Growth Inhibitors|Growth Substances|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Imides|Immunologic Factors|Immunomodulatory Agents|Immunosuppressive Agents|Isoindoles|Leprostatic Agents|Myelosuppressive Agents|Noxae|Photosensitizing Agents|Phthalic Acids|Phthalimides|Piperidines|Piperidones|Teratogens|Toxic Actions",O=C1N(C2CCC(=O)NC2=O)C(=O)C2=CC=CC=C12,5426
1022,DB01042,Melphalan,small molecule,approved,"Alkylating Activity|Alkylating Drugs|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Hydrocarbons, Halogenated|Immunologic Factors|Immunosuppressive Agents|Mustard Compounds|Myeloablative Agonists|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Nitrogen Mustard Analogues|Nitrogen Mustard Compounds|Noxae|Phenylalanine|Toxic Actions",N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,460612
1023,DB01043,Memantine,small molecule,approved|investigational,Anti-Dementia Drugs|Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Central Nervous System Agents|Cholinesterase Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (weak)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Drugs that are Mainly Renally Excreted|Excitatory Amino Acid Antagonists|Miscellaneous Central Nervous System Agents|N-methyl-D-aspartate Receptor Antagonist|Nervous System|Neurotransmitter Agents|NMDA Receptor Antagonists|OCT2 Substrates|Psychoanaleptics,CC12CC3CC(C)(C1)CC(N)(C3)C2,4054
1024,DB01044,Gatifloxacin,small molecule,approved|investigational,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Hypoglycemia-Associated Agents|Ophthalmic Solutions|Ophthalmologicals|Pharmaceutical Preparations|Pharmaceutical Solutions|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolone Antimicrobial|Quinolones|Sensory Organs|Solutions|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",COC1=C2N(C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNC(C)C1)C1CC1,5379
1025,DB01045,Rifampicin,small molecule,approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics, Antitubercular|Antiinfectives for Systemic Use|Antimycobacterials|Antituberculosis Agents|BSEP/ABCB11 Inhibitors|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (moderate)|Cytochrome P-450 CYP1A2 Inducers (strong)|Cytochrome P-450 CYP2A6 Inducers|Cytochrome P-450 CYP2A6 Inducers (moderate)|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (moderate)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (moderate)|Cytochrome P-450 CYP2C19 Inducers (strong)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strong)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (moderate)|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP2E1 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strong)|Cytochrome P-450 CYP3A7 Inducers|Cytochrome P-450 CYP3A7 Inducers (strong)|Cytochrome P-450 CYP3A7 Inducers (weak)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs for Treatment of Tuberculosis|Enzyme Inhibitors|Hepatotoxic Agents|Heterocyclic Compounds, Fused-Ring|Lactams|Lactams, Macrocyclic|Leprostatic Agents|Narrow Therapeutic Index Drugs|Nucleic Acid Synthesis Inhibitors|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|OATP1B3 substrates|P-glycoprotein inducers|Rifamycin Antibacterial|Rifamycins|UGT1A1 Inducers|UGT1A9 Inducers|UGT1A9 Inhibitors",CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,5381226
1026,DB01046,Lubiprostone,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Autacoids|Biological Factors|Chloride Channel Agonists|Drugs for Constipation|Drugs that are Mainly Renally Excreted|Eicosanoids|Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Inflammation Mediators|Laxatives|Lipids|Membrane Transport Modulators|Miscellaneous GI Drugs|Prostaglandins E",[H][C@@]12CC(=O)[C@H](CCCCCCC(O)=O)[C@@]1([H])CC[C@@](O)(O2)C(F)(F)CCCC,157920
1027,DB01047,Fluocinonide,small molecule,approved|investigational,"Adrenal Cortex Hormones|Anti-Allergic Agents|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Dermatologicals|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Pregnadienes|Pregnanes|Steroids|Steroids, Fluorinated|Thyroxine-binding globulin inhibitors",[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O,9642
1028,DB01048,Abacavir,small molecule,approved|investigational,"Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Carbohydrates|Deoxyribonucleosides|Direct Acting Antivirals|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Glycosides|Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|Nucleoside Reverse Transcriptase Inhibitors|Nucleosides|Reverse Transcriptase Inhibitors|UGT1A1 Substrates",NC1=NC2=C(N=CN2[C@@H]2C[C@H](CO)C=C2)C(NC2CC2)=N1,441300
1029,DB01049,Ergoloid mesylate,small molecule,approved,"Adrenergic Agents|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Alkaloids|Antidepressive Agents|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dihydroergotoxine|Dopamine Agents|Dopamine Agonists|Ergot Alkaloids and Derivatives|Ergot-derivative Dopamine Receptor Agonists|Ergotamines|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|Nootropic Agents|Peripheral Vasodilators|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Sympatholytic (Adrenergic Blocking) Agents|Vasodilating Agents",,
1030,DB01050,Ibuprofen,small molecule,approved,"Acids, Carbocyclic|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antiinflammatory Products for Vaginal Administration|Antirheumatic Agents|Central Nervous System Agents|COX-1 Inhibitors|COX-2 Inhibitors|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Experimental Unapproved Treatments for COVID-19|Nephrotoxic agents|Nervous System|Non COX-2 selective NSAIDS|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|Other Nonsteroidal Anti-inflammatory Agents|P-glycoprotein inhibitors|P-glycoprotein substrates|Peripheral Nervous System Agents|Phenylpropionates|Propionates|Sensory System Agents|Throat Preparations|Topical Products for Joint and Muscular Pain|UGT1A1 Substrates|UGT1A3 substrates|UGT1A9 Substrates|UGT2B7 substrates",CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,3672
1031,DB01051,Novobiocin,small molecule,approved|investigational|vet_approved,"Aminocoumarins|Anti-Bacterial Agents|Anti-Infective Agents|BCRP/ABCG2 Inhibitors|Benzopyrans|Carbohydrates|Coumarins|Enzyme Inhibitors|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acid Synthesis Inhibitors|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Pyrans",CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=C(C)C3=C(C=C2)C(O)=C(NC(=O)C2=CC=C(O)C(CC=C(C)C)=C2)C(=O)O3)OC1(C)C,54675769
1032,DB01053,Benzylpenicillin,small molecule,approved|vet_approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|Beta-Lactamase Sensitive Penicillins|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Natural Penicillins|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Substrates|Ophthalmologicals|Penicillin G|Penicillins|Sensory Organs|Sulfur Compounds",[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O,5904
1033,DB01054,Nitrendipine,small molecule,approved|investigational,ACE Inhibitors and Calcium Channel Blockers|Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Bradycardia-Causing Agents|BSEP/ABCB11 Substrates|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dihydropyridine Derivatives|Dihydropyridines|Hypotensive Agents|Membrane Transport Modulators|P-glycoprotein inhibitors|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC,4507
1034,DB01055,Mimosine,small molecule,experimental,"Alanine|Amino Acids|Amino Acids, Peptides, and Proteins|Pyridines|Pyridones",N[C@@H](CN1C=CC(=O)C(O)=C1)C(O)=O,440473
1035,DB01056,Tocainide,small molecule,approved,"Amides|Amines|Anilides|Aniline Compounds|Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ib|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (weak)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Membrane Transport Modulators|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers",CC(N)C(=O)NC1=C(C)C=CC=C1C,38945
1036,DB01057,Echothiophate,small molecule,approved,Antiglaucoma Preparations and Miotics|Autonomic Agents|Cholinergic Agents|Cholinesterase Inhibitors|Enzyme Inhibitors|Miotics|Neurotransmitter Agents|Ophthalmologicals|Organophosphates|Organophosphorus Compounds|Organothiophosphates|Organothiophosphorus Compounds|Parasympathomimetics|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sensory Organs|Sulfur Compounds,CCOP(=O)(OCC)SCC[N+](C)(C)C,10548
1037,DB01058,Praziquantel,small molecule,approved|investigational|vet_approved,"Anthelmintics|Anti-Infective Agents|Antihelminthic|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antitrematodals|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Quinoline Derivatives and Related Substances",O=C(C1CCCCC1)N1CC2N(CCC3=CC=CC=C23)C(=O)C1,4891
1038,DB01059,Norfloxacin,small molecule,approved,"Agents Causing Muscle Toxicity|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|OAT1/SLC22A6 inhibitors|Ophthalmologicals|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolone Antimicrobial|Quinolones|Sensory Organs|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCNCC1,4539
1039,DB01060,Amoxicillin,small molecule,approved|vet_approved,"Alimentary Tract and Metabolism|Amides|Aminopenicillins|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|beta-Lactams|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Lactams|OAT1/SLC22A6 inhibitors|Penicillin G|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds",[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,33613
1040,DB01061,Azlocillin,small molecule,approved,"Agents that reduce seizure threshold|Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Penicillin G|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds",[H][C@](NC(=O)N1CCNC1=O)(C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@]12[H])C1=CC=CC=C1,6479523
1041,DB01062,Oxybutynin,small molecule,approved|investigational,"Acids, Carbocyclic|Agents producing tachycardia|Anticholinergic Agents|Autonomic Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs for Urinary Frequency and Incontinence|Genito Urinary System and Sex Hormones|Hydroxy Acids|Muscarinic Antagonists|Neurotransmitter Agents|Parasympatholytics|Peripheral Nervous System Agents|Urological Agents|Urologicals",CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,4634
1042,DB01063,Acetophenazine,small molecule,approved,"Antipsychotic Agents|Central Nervous System Depressants|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotoxic agents|Phenothiazines|Phenothiazines With Piperazine Structure|Psycholeptics|Sulfur Compounds",CC(=O)C1=CC=C2SC3=C(C=CC=C3)N(CCCN3CCN(CCO)CC3)C2=C1,17676
1043,DB01064,Isoprenaline,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic Agonists|Adrenergic and Dopaminergic Agents|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Benzene Derivatives|Bronchodilator Agents|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Catecholamines|Catechols|Compounds used in a research, industrial, or household setting|Drugs for Obstructive Airway Diseases|Ethanolamines|Neurotransmitter Agents|Non-selective Beta-adrenergic Agonists|Peripheral Nervous System Agents|Phenols|Protective Agents|Respiratory System Agents|Sympathomimetics",CC(C)NCC(O)C1=CC(O)=C(O)C=C1,3779
1044,DB01065,Melatonin,small molecule,approved|nutraceutical|vet_approved,"Amines|Antioxidants|Biogenic Amines|Biogenic Monoamines|Central Nervous System Agents|Central Nervous System Depressants|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypnotics and Sedatives|Indoles|Melatonin Receptor Agonists|Melatonin, agonists|Melatonin, antagonists & inhibitors|Nervous System|OAT3/SLC22A8 Inhibitors|Protective Agents|Psycholeptics|Tryptamines",COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,896
1045,DB01066,Cefditoren,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins",[H][C@]12SCC(\C=C/C3=C(C)N=CS3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,9870843
1046,DB01067,Glipizide,small molecule,approved|investigational,Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Drugs Used in Diabetes|Hypoglycemia-Associated Agents|Sulfones|Sulfonylureas|Sulfur Compounds|UGT1A1 Substrates,CC1=NC=C(N=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,3478
1047,DB01068,Clonazepam,small molecule,approved|illicit,"Anticonvulsants|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|GABA Agents|GABA Modulators|Heterocyclic Compounds, Fused-Ring|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System",[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1,2802
1048,DB01069,Promethazine,small molecule,approved|investigational,"Acid Reducers|Agents producing tachycardia|Agents that reduce seizure threshold|Amines|Anti-Allergic Agents|Anticholinergic Agents|Antidepressive Agents|Antidotes|Antihistamines for Systemic Use|Antihistamines for Topical Use|Antipruritics|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Antipsychotic Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H2 Antagonists|Miscellaneous Anxiolytics Sedatives and Hypnotics|Muscarinic Antagonists|Neurotoxic agents|Neurotransmitter Agents|P-glycoprotein inhibitors|Phenothiazine Derivatives|Phenothiazines|Photosensitizing Agents|Potential QTc-Prolonging Agents|Propylamines|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Sulfur Compounds",CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,4927
1049,DB01070,Dihydrotachysterol,small molecule,approved,"Alimentary Tract and Metabolism|Bone Density Conservation Agents|Cholestanes|Cholestenes|Diet, Food, and Nutrition|Food|Food and Beverages|Fused-Ring Compounds|Growth Substances|Lipids|Membrane Lipids|Micronutrients|Physiological Phenomena|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)",CC(C)[C@@H](C)\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1/C[C@@H](O)CC[C@@H]1C,5311071
1050,DB01071,Mequitazine,small molecule,experimental,"Anti-Allergic Agents|Antihistamines for Systemic Use|Bronchodilator Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Phenothiazine Derivatives|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sulfur Compounds",C(C1CN2CCC1CC2)N1C2=CC=CC=C2SC2=CC=CC=C12,4066
1051,DB01072,Atazanavir,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Direct Acting Antivirals|Enzyme Inhibitors|HIV Protease Inhibitors|Hyperglycemia-Associated Agents|Nephrotoxic agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Oligopeptides|P-glycoprotein inducers|P-glycoprotein inhibitors|P-glycoprotein substrates|Peptides|Potential QTc-Prolonging Agents|Protease Inhibitors|Pyridines|QTc Prolonging Agents|UDP Glucuronosyltransferases Inhibitors|UGT1A1 Inhibitors",COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,148192
1052,DB01073,Fludarabine,small molecule,approved,"Adenine Nucleotides|Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Arabinonucleosides|Arabinonucleotides|Carbohydrates|Cardiotoxic antineoplastic agents|DNA (Cytosine-5-)-Methyltransferases, antagonists & inhibitors|Enzyme Inhibitors|Glycosides|Heterocyclic Compounds, Fused-Ring|Immunologic Factors|Immunosuppressive Agents|Myeloablative Agonists|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Metabolic Inhibitor|Nucleosides|Nucleotides|Purine Analogues|Purine Nucleosides|Purine Nucleotides|Purines|Ribonucleosides|Ribonucleotides|Toxic Actions",NC1=NC(F)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,657237
1053,DB01074,Perhexiline,small molecule,approved|investigational,Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Membrane Transport Modulators|Non-Selective Calcium Channel Blockers|Piperidines|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Vasodilating Agents,C(C(C1CCCCC1)C1CCCCC1)C1CCCCN1,4746
1054,DB01075,Diphenhydramine,small molecule,approved|investigational,"Agents producing tachycardia|Amines|Aminoalkyl Ethers|Anesthetics|Anesthetics, Local|Anti-Allergic Agents|Anticholinergic Agents|Antiemetics|Antihistamines for Systemic Use|Antihistamines for Topical Use|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Benzene Derivatives|Benzhydryl Compounds|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Drugs causing inadvertant photosensitivity|Ethanolamine Derivatives|Ethylamines|First Generation Antihistamines|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Hypnotics and Sedatives|Muscarinic Antagonists|OCT2 Inhibitors|Photosensitizing Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sleep Aids, Pharmaceutical",CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1,3100
1055,DB01076,Atorvastatin,small molecule,approved,"Agents Causing Muscle Toxicity|Anticholesteremic Agents|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Fatty Acids|Heptanoic Acids|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Hypolipidemic Agents|Hypolipidemic Agents Indicated for Hyperlipidemia|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Lipids|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein inhibitors|P-glycoprotein substrates|Toxic Actions|UGT1A1 Substrates|UGT1A3 substrates",CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C1=CC=C(F)C=C1)C1=CC=CC=C1,60823
1056,DB01077,Etidronic acid,small molecule,approved,Bisphosphonates|Bone Density Conservation Agents|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Musculo-Skeletal System|Organophosphonates|Organophosphorus Compounds,CC(O)(P(O)(O)=O)P(O)(O)=O,3305
1057,DB01078,Deslanoside,small molecule,approved,"Antiarrhythmic agents|Carbohydrates|Cardanolides|Cardenolides|Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Digitalis Glycosides|Enzyme Inhibitors|Fused-Ring Compounds|Glycosides|Lanatosides|Protective Agents|Steroids",C[C@H]1O[C@H](C[C@H](O)[C@@H]1O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,28620
1058,DB01079,Tegaserod,small molecule,approved|investigational|withdrawn,"Alimentary Tract and Metabolism|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs for Constipation|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Laxatives|P-glycoprotein substrates|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",CCCCCNC(=N)N\N=C\C1=CNC2=C1C=C(OC)C=C2,5362436
1059,DB01080,Vigabatrin,small molecule,approved,"Acids, Acyclic|Aminobutyrates|Anti-epileptic Agent|Anticonvulsants|Butyrates|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Enzyme Inhibitors|Fatty Acid Derivatives|Fatty Acids|GABA Agents|Lipids|Miscellaneous Anticonvulsants|Nervous System|Neurotransmitter Agents",NC(CCC(O)=O)C=C,5665
1060,DB01081,Diphenoxylate,small molecule,approved|illicit,"Alimentary Tract and Metabolism|Analgesics|Antidiarrheals|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antipropulsives|Central Nervous System Agents|Central Nervous System Depressants|Gastrointestinal Agents|Isonipecotic Acids|Opioids|Peripheral Nervous System Agents|Piperidines|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",CCOC(=O)C1(CCN(CCC(C#N)(C2=CC=CC=C2)C2=CC=CC=C2)CC1)C1=CC=CC=C1,13505
1061,DB01082,Streptomycin,small molecule,approved|vet_approved,"Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antiinfectives for Systemic Use|Antimycobacterials|Carbohydrates|Drugs for Treatment of Tuberculosis|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Enzyme Inhibitors|Glycosides|Intestinal Antiinfectives|Narrow Therapeutic Index Drugs|Nephrotoxic agents|OAT1/SLC22A6 inhibitors|Protein Synthesis Inhibitors|Streptomycins",CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]2NC(N)=N)O[C@@H](C)[C@]1(O)C=O,19649
1062,DB01083,Orlistat,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Anti-Obesity Agents|Antiobesity Preparations, Excl. Diet Products|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Enzyme Inhibitors|Intestinal Lipase Inhibitor|Lactones|Lipase Inhibitors|Lipid Regulating Agents|Miscellaneous GI Drugs|Peripherally Acting Antiobesity Products",CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,3034010
1063,DB01084,Emedastine,small molecule,approved,"Anti-Allergic Agents|Decongestants and Antiallergics|Heterocyclic Compounds, Fused-Ring|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Inhibitors|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|Ophthalmologicals|QTc Prolonging Agents|Sensory Organs",CCOCCN1C(=NC2=CC=CC=C12)N1CCCN(C)CC1,3219
1064,DB01085,Pilocarpine,small molecule,approved|investigational,Alkaloids|Antiglaucoma Preparations and Miotics|Autonomic Agents|Cholinergic Agents|Cholinergic Agonists|Cholinergic Receptor Agonist|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (strong)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Miotics|Muscarinic Agonists|Nervous System|Neurotransmitter Agents|Ophthalmologicals|Parasympathomemetic (Cholinergic) Agents|Parasympathomimetics|Peripheral Nervous System Agents|Sensory Organs,CC[C@H]1[C@@H](CC2=CN=CN2C)COC1=O,5910
1065,DB01086,Benzocaine,small molecule,approved|investigational,"Acids, Carbocyclic|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Aminobenzoates|Anesthetics|Anesthetics for Topical Use|Anesthetics, Local|Antipruritics and Local Anesthetics|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Benzene Derivatives|Benzoates|Cell-mediated Immunity|Central Nervous System Agents|Dermatologicals|Esters of Aminobenzoic Acid|Increased Histamine Release|Methemoglobinemia Associated Agents|Nervous System|P-glycoprotein inhibitors|para-Aminobenzoates|Peripheral Nervous System Agents|Sensory System Agents|Standardized Chemical Allergen|Throat Preparations|Vasoprotectives",CCOC(=O)C1=CC=C(N)C=C1,2337
1066,DB01087,Primaquine,small molecule,approved,"Aminoquinolines|Anti-Infective Agents|Antibiotics for Pneumocystis Pneumonia|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Methemoglobinemia Associated Agents|Moderate Risk QTc-Prolonging Agents|P-glycoprotein inhibitors|QTc Prolonging Agents|Quinolines",COC1=CC(NC(C)CCCN)=C2N=CC=CC2=C1,4908
1067,DB01088,Iloprost,small molecule,approved|investigational,"Agents Causing Muscle Toxicity|Anticoagulants|Antiplatelet agents|Autacoids|Biological Factors|Blood and Blood Forming Organs|Cardiovascular Agents|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Fibrinolytic Agents|Hematologic Agents|Hypotensive Agents|Inflammation Mediators|Lipids|Platelet Aggregation Inhibitors Excl. Heparin|Prostacyclin Analogues|Prostaglandins|Prostaglandins, Synthetic|Vasodilating Agents",[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C\C(C2)=C\CCCC(O)=O,5311181
1068,DB01089,Deserpidine,small molecule,approved,"Alkaloids|Antiadrenergic Agents, Centrally Acting|Antihypertensive Agents|Catecholamine-depleting Sympatholytic|Decreased Sympathetic Activity|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|Secologanin Tryptamine Alkaloids",[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2,8550
1069,DB01090,Pentolinium,small molecule,approved,Anticholinergic Agents|Antihypertensive Agents|Autonomic Agents|Cardiovascular Agents|Cholinergic Agents|Ganglion Blockers|Neurotransmitter Agents|Nicotinic Antagonists|Peripheral Nervous System Agents|Pyrrolidines,C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1,5850
1070,DB01091,Butenafine,small molecule,approved,Amines|Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Benzene Derivatives|Benzyl Compounds|Benzylamine Antifungal|Benzylamines|Dermatologicals,CN(CC1=CC=C(C=C1)C(C)(C)C)CC1=CC=CC2=CC=CC=C12,2484
1071,DB01092,Ouabain,small molecule,approved,"Carbohydrates|Cardanolides|Cardenolides|Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Fused-Ring Compounds|Glycosides|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|Protective Agents|Steroids|Strophanthins|Strophanthus Glycosides",[H][C@@]12CC[C@]3(O)C[C@H](C[C@@H](O)[C@]3(CO)[C@@]1([H])[C@H](O)C[C@]1(C)[C@H](CC[C@]21O)C1=CC(=O)OC1)O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O,439501
1072,DB01093,Dimethyl sulfoxide,small molecule,approved|vet_approved,"Antioxidants|Compounds used in a research, industrial, or household setting|Cryoprotective Agents|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Drugs that are Mainly Renally Excreted|Free Radical Scavengers|Genito Urinary System and Sex Hormones|Miscellaneous Therapeutic Agents|Musculo-Skeletal System|Protective Agents|Solvents|Sulfoxides|Sulfur Compounds|Topical Products for Joint and Muscular Pain|Urologicals",CS(C)=O,679
1073,DB01094,Hesperetin,small molecule,experimental,"BCRP/ABCG2 Inhibitors|Benzopyrans|Chromones|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Flavanones|Flavonoids|Heterocyclic Compounds, Fused-Ring|Pyrans",COC1=C(O)C=C(C=C1)[C@@H]1CC(=O)C2=C(O)C=C(O)C=C2O1,72281
1074,DB01095,Fluvastatin,small molecule,approved,"Agents Causing Muscle Toxicity|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Fatty Acids|Heptanoic Acids|Heterocyclic Compounds, Fused-Ring|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Hypolipidemic Agents|Hypolipidemic Agents Indicated for Hyperlipidemia|Indoles|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Lipids|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|UGT1A1 Substrates|UGT1A3 substrates|UGT2B7 substrates",CC(C)N1C(\C=C\[C@H](O)C[C@H](O)CC(O)=O)=C(C2=CC=C(F)C=C2)C2=CC=CC=C12,1548972
1075,DB01096,Oxamniquine,small molecule,approved,"Anthelmintics|Anti-Infective Agents|Antihelminthic|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiplatyhelmintic Agents|Antitrematodals|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Hydroxyquinolines|Nitro Compounds|Nitroquinolines|Quinoline Derivatives and Related Substances|Quinolines|Schistosomicides",CC(C)NCC1CCC2=CC(CO)=C(C=C2N1)[N+]([O-])=O,4612
1076,DB01097,Leflunomide,small molecule,approved|investigational,Adjuvants|Agents Causing Muscle Toxicity|Antineoplastic and Immunomodulating Agents|Antirheumatic Agents|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Disease-modifying Antirheumatic Agents|Enzyme Inhibitors|Immunologic Factors|Immunosuppressive Agents|Isoxazoles|Selective Immunosuppressants,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F,3899
1077,DB01098,Rosuvastatin,small molecule,approved,"Agents Causing Muscle Toxicity|Alimentary Tract and Metabolism|Amides|Anticholesteremic Agents|BCRP/ABCG2 Substrates|Benzene Derivatives|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs Used in Diabetes|Enzyme Inhibitors|Fluorobenzenes|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hydrocarbons, Fluorinated|Hydrocarbons, Halogenated|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Hypolipidemic Agents|Hypolipidemic Agents Indicated for Hyperlipidemia|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Noxae|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|Pyrimidines|Sulfonamides|Sulfones|Sulfur Compounds|Toxic Actions",CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,446157
1078,DB01099,Flucytosine,small molecule,approved|investigational,Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Antiinfectives for Systemic Use|Antimetabolites|Antimycotics for Systemic Use|Cytosine|Dermatologicals|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Fluorouracil and prodrugs|Immunosuppressive Agents|Myelosuppressive Agents|Noxae|Nucleoside Analog Antifungal|Photosensitizing Agents|Pyrimidines|Pyrimidinones|Toxic Actions,NC1=C(F)C=NC(=O)N1,3366
1079,DB01100,Pimozide,small molecule,approved,"Agents that reduce seizure threshold|Anti-Dyskinesia Agents|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Benzimidazoles|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Diphenylbutylpiperidine Derivatives|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|Miscellaneous Antipsychotics|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Neurotransmitter Agents|P-glycoprotein inhibitors|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Tranquilizing Agents",FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=CC=CC=C12)C1=CC=C(F)C=C1,16362
1080,DB01101,Capecitabine,small molecule,approved|investigational,"Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strong)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Deoxycytidine|Deoxyribonucleosides|Drugs that are Mainly Renally Excreted|Fluoropyrimidines|Fluorouracil and prodrugs|Glycosides|Immunosuppressive Agents|Myelosuppressive Agents|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Metabolic Inhibitor|Nucleosides|Pyrimidine Analogues|Pyrimidine Nucleosides|Pyrimidines|Pyrimidinones|Ribonucleosides|Toxic Actions",CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,60953
1081,DB01102,Arbutamine,small molecule,approved,"Adrenergic Agents|Adrenergic Agonists|Adrenergic and Dopaminergic Agents|Adrenergic beta-1 Receptor Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-3 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Amines|Benzene Derivatives|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Catechols|Compounds used in a research, industrial, or household setting|Neurotransmitter Agents|Phenols|Protective Agents",O[C@@H](CNCCCCC1=CC=C(O)C=C1)C1=CC(O)=C(O)C=C1,60789
1082,DB01103,Quinacrine,small molecule,investigational,"Acridines|Aminoacridines|Anti-Infective Agents|Anticestodal Agents|Antimalarials|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiplatyhelmintic Agents|Antiprotozoals|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|OCT2 Inhibitors|P-glycoprotein inhibitors",CCN(CC)CCCC(C)NC1=C2C=C(OC)C=CC2=NC2=C1C=CC(Cl)=C2,237
1083,DB01104,Sertraline,small molecule,approved,Agents that reduce seizure threshold|Amines|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (moderate)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Monoamine Oxidase A Substrates|Naphthalenes|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|P-glycoprotein inhibitors|Photosensitizing Agents|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,68617
1084,DB01105,Sibutramine,small molecule,approved|illicit|investigational|withdrawn,"Agents producing tachycardia|Alimentary Tract and Metabolism|Anti-Obesity Agents|Antidepressive Agents|Antiobesity Preparations, Excl. Diet Products|Appetite Depressants|Appetite Suppression|Central Nervous System Agents|Central Nervous System Depressants|Centrally Acting Antiobesity Products|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cycloparaffins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dopamine Uptake Inhibitors|Drugs that are Mainly Renally Excreted|Norepinephrine Uptake Inhibitors|Norepinephrine, Serotonin, and Dopamine Reuptake Inhibitor Anorectic|Psychotropic Drugs|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin and Noradrenaline Reuptake Inhibitors|Serotonin Modulators|Stimulants",CC(C)CC(N(C)C)C1(CCC1)C1=CC=C(Cl)C=C1,5210
1085,DB01106,Levocabastine,small molecule,approved|investigational,"Anti-Allergic Agents|Antiallergic Agents, Excl. Corticosteroids|Central Nervous System Depressants|Decongestants and Antiallergics|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Nasal Preparations|Neurotransmitter Agents|Ophthalmologicals|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sensory Organs",C[C@@H]1CN(CC[C@]1(C(O)=O)C1=CC=CC=C1)[C@H]1CC[C@](CC1)(C#N)C1=CC=C(F)C=C1,54385
1086,DB01107,Methyprylon,small molecule,approved|illicit|withdrawn,Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Piperidinedione Derivatives|Piperidines|Psycholeptics,CCC1(CC)C(=O)NCC(C)C1=O,4162
1087,DB01108,Trilostane,small molecule,approved|investigational|vet_approved|withdrawn,"3-Hydroxysteroid Dehydrogenases, antagonists & inhibitors|Abortifacient Agents|Abortifacient Agents, Steroidal|Adrenal Cortex Hormones|Androstanes|Androstanols|Antiadrenal Preparations|Anticorticosteroids|Antineoplastic Agents|Corticosteroids|Corticosteroids for Systemic Use|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Enzyme Inhibitors|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Narrow Therapeutic Index Drugs|Oxidative Phosphorylation Coupling Factors|Reproductive Control Agents|Steroids|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Testosterone Congeners",[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]23O[C@@H]2C(O)=C(C[C@]13C)C#N,656583
1088,DB01109,Heparin,small molecule,approved|investigational,Agents causing hyperkalemia|Anticoagulants|Antivaricose Therapy|Blood and Blood Forming Organs|Carbohydrates|Cardiovascular Agents|Fibrin Modulating Agents|Glycosaminoglycans|Hematologic Agents|Heparin and similars|Heparin Group|Heparins or Heparinoids for Topical Use|Miscellaneous Therapeutic Agents|Narrow Therapeutic Index Drugs|Ophthalmologicals|Polysaccharides|Sensory Organs|Thyroxine-binding globulin substrates|Vasoprotectives,,
1089,DB01110,Miconazole,small molecule,approved|investigational|vet_approved,"14-alpha Demethylase Inhibitors|Anti-Infective Agents|Antifungal Agents|Antifungal Agents (Vaginal)|Antifungals for Dermatological Use|Antifungals for Topical Use|Antiinfectives and Antiseptics for Local Oral Treatment|Azole Antifungals|Chemically-Induced Disorders|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (strong)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strong)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Imidazole and Triazole Derivatives|Imidazole Derivatives|Imidazoles|Intestinal Antiinfectives|Otologicals|P-glycoprotein inhibitors|Sensory Organs|Steroid Synthesis Inhibitors|Stomatological Preparations|Vaginal Creams, Foams, and Jellies",ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1,4189
1090,DB01111,Colistimethate,small molecule,approved|vet_approved,"Agents that produce neuromuscular block (indirect)|Amino Acids, Peptides, and Proteins|Antimicrobial Cationic Peptides|Lipids|Lipopeptides|Membrane Proteins|Nephrotoxic agents|Peptides|Peptides, Cyclic|Polymyxin-class Antibacterial|Polymyxins|Pore Forming Cytotoxic Proteins|Proteins",CCC(C)CCCCC(=O)NC(CCNCS([O-])(=O)=O)C(=O)NC(C(C)O)C(=O)NC(CCNCS([O-])(=O)=O)C(=O)NC1CCNC(=O)C(NC(=O)C(CCNCS([O-])(=O)=O)NC(=O)C(CCNCS([O-])(=O)=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCNCS([O-])(=O)=O)NC1=O)C(C)O,70789202
1091,DB01112,Cefuroxime,small molecule,approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Ophthalmologicals|Second-Generation Cephalosporins|Sensory Organs|Sulfur Compounds|Thiazines",[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CC=CO1)C(O)=O,5479529
1092,DB01113,Papaverine,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Alkaloids|Benzylisoquinolines|Cardiovascular Agents|Drugs for Functional Gastrointestinal Disorders|Drugs Used in Erectile Dysfunction|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Isoquinolines|Miscellaneous Vasodilatating Agents|Moderate Risk QTc-Prolonging Agents|Opiate Alkaloids|Papaverine and Derivatives|Phosphodiesterase Inhibitors|QTc Prolonging Agents|Urological Agents|Urologicals|Vasodilating Agents",COC1=C(OC)C=C(CC2=NC=CC3=CC(OC)=C(OC)C=C23)C=C1,4680
1093,DB01114,Chlorpheniramine,small molecule,approved,Anti-Allergic Agents|Antidepressive Agents|Antihistamines for Systemic Use|Antipruritics|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|OCT1 inhibitors|OCT2 Inhibitors|Propylamine Derivatives|Pyridines|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Substituted Alkylamines,CN(C)CCC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1,2725
1094,DB01115,Nifedipine,small molecule,approved,Adrenal Cortex Hormones|Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Beta blocking agents and calcium channel blockers|Bradycardia-Causing Agents|BSEP/ABCB11 Inhibitors|BSEP/ABCB11 Substrates|Calcium Channel Blockers|Calcium Channel Blockers (Dihydropyridine)|Calcium Channel Blockers and Diuretics|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dihydropyridine Derivatives|Dihydropyridines|Drugs that are Mainly Renally Excreted|Hypotensive Agents|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein inducers|P-glycoprotein inhibitors|P-glycoprotein substrates|Pyridines|QTc Prolonging Agents|Reproductive Control Agents|Selective Calcium Channel Blockers With Mainly Vascular Effects|Tocolytic Agents|Vasodilating Agents,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC,4485
1095,DB01116,Trimethaphan,small molecule,approved|investigational,"Adjuvants, Anesthesia|Antiadrenergic Agents, Ganglion-Blocking|Anticholinergic Agents|Antihypertensive Agents|Autonomic Agents|Cardiovascular Agents|Central Nervous System Agents|Cholinergic Agents|Cholinesterase substrates|Ganglion Blockers|Imidazoles|Neurotransmitter Agents|Nicotinic Antagonists|Peripheral Nervous System Agents|Sulfonium Derivatives|Vasodilating Agents",O=C1N(CC2=CC=CC=C2)C2C[S+]3CCCC3C2N1CC1=CC=CC=C1,23576
1096,DB01117,Atovaquone,small molecule,approved,"Anti-Infective Agents|Antibiotics for Pneumocystis Pneumonia|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Miscellaneous Antiprotozoals|Naphthalenes|Naphthoquinones|P-glycoprotein inhibitors|Quinones",OC1=C([C@H]2CC[C@@H](CC2)C2=CC=C(Cl)C=C2)C(=O)C2=CC=CC=C2C1=O,74989
1097,DB01118,Amiodarone,small molecule,approved|investigational,"Agents causing hyperkalemia|Agents Causing Muscle Toxicity|alpha-Galactosidase, antagonists & inhibitors|Antiarrhythmic agents|Antiarrhythmics, Class III|Benzofurans|Bradycardia-Causing Agents|BSEP/ABCB11 Inhibitors|BSEP/ABCB11 Substrates|BSEP/ABCB11 Substrates with Narrow Therapeutic Index|Calcium Channel Blockers|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (moderate)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|Hypotensive Agents|Membrane Transport Modulators|Narrow Therapeutic Index Drugs|OCT2 Inhibitors|P-glycoprotein inducers|P-glycoprotein inhibitors|Photosensitizing Agents|Potassium Channel Blockers|QTc Prolonging Agents|Sodium Channel Blockers|Vasodilating Agents",CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2,2157
1098,DB01119,Diazoxide,small molecule,approved,"Amides|Antihypertensive Agents|Arteriolar Smooth Muscle, Agents Acting On|Benzothiadiazines|Cardiovascular Agents|Direct Vasodilators|Diuretics|Drugs for Treatment of Hypoglycemia|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Heterocyclic Compounds, Fused-Ring|Hyperglycemia-Associated Agents|Hypotensive Agents|Sulfonamides|Sulfones|Sulfur Compounds|Thiazide Derivatives|Vasodilating Agents",CC1=NS(=O)(=O)C2=C(N1)C=CC(Cl)=C2,3019
1099,DB01120,Gliclazide,small molecule,approved,Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Drugs Used in Diabetes|Hypoglycemia-Associated Agents|Sulfones|Sulfonylureas|Sulfur Compounds,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CC2CCCC2C1,3475
1100,DB01121,Phenacemide,small molecule,approved,"Acetamides|Acetates|Acids, Acyclic|Amides|Anticonvulsants|Benzene Derivatives|Central Nervous System Depressants|Fatty Acids|Fatty Acids, Volatile|Lipids|Nervous System",NC(=O)NC(=O)CC1=CC=CC=C1,4753
1101,DB01122,Ambenonium,small molecule,approved,Amines|Ammonium Compounds|Autonomic Agents|Benzylammonium Compounds|Cholinergic Agents|Cholinesterase Inhibitors|Enzyme Inhibitors|Nervous System|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Parasympathomimetics|Peripheral Nervous System Agents|Quaternary Ammonium Compounds,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC1=CC=CC=C1Cl,2131
1102,DB01123,Proflavine,small molecule,approved,"Acridines|Aminoacridines|Anti-Infective Agents|Anti-Infective Agents, Local|Heterocyclic Compounds, Fused-Ring",NC1=CC2=NC3=C(C=CC(N)=C3)C=C2C=C1,7099
1103,DB01124,Tolbutamide,small molecule,approved|investigational,Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Diagnostic Agents|Drugs that are Mainly Renally Excreted|Drugs Used in Diabetes|Hypoglycemia-Associated Agents|OAT1/SLC22A6 inhibitors|Sulfones|Sulfonylureas|Sulfur Compounds|Tests for Diabetes,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1,5505
1104,DB01125,Anisindione,small molecule,approved,Indans|Indenes,COC1=CC=C(C=C1)C1C(=O)C2=CC=CC=C2C1=O,2197
1105,DB01126,Dutasteride,small molecule,approved|investigational,"5-alpha Reductase Inhibitors|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Azasteroids|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Drugs Used in Benign Prostatic Hypertrophy|Enzyme Inhibitors|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors|Steroids|Urologicals",[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])NC(=O)C=C[C@]4(C)[C@@]3([H])CC[C@]12C)C(=O)NC1=CC(=CC=C1C(F)(F)F)C(F)(F)F,6918296
1106,DB01127,Econazole,small molecule,approved,"14-alpha Demethylase Inhibitors|Anti-Infective Agents|Antifungal Agents|Antifungal Agents (Vaginal)|Antifungals for Dermatological Use|Antifungals for Topical Use|Azole Antifungals|Chemically-Induced Disorders|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Imidazole and Triazole Derivatives|Imidazole Derivatives|Imidazoles|P-glycoprotein inhibitors|Steroid Synthesis Inhibitors",ClC1=CC=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1,3198
1107,DB01128,Bicalutamide,small molecule,approved,"Amides|Amines|Androgen Receptor Antagonists|Androgen Receptor Inhibitor|Aniline Compounds|Antiandrogens|Antiandrogens, non-steroidal|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Benzene Derivatives|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Endocrine Therapy|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Narrow Therapeutic Index Drugs|P-glycoprotein inhibitors|Sulfones|Sulfur Compounds",CC(O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC1=CC(=C(C=C1)C#N)C(F)(F)F,2375
1108,DB01129,Rabeprazole,small molecule,approved|investigational,"2-Pyridinylmethylsulfinylbenzimidazoles|Acetates|Acid Reducers|Acids, Acyclic|Alimentary Tract and Metabolism|Anti-Ulcer Agents|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|BCRP/ABCG2 Inhibitors|Benzimidazoles|Butylpyrazolidines|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Gastric Acid Lowering Agents|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Hydroxy Acids|Lipids|Musculo-Skeletal System|Proton Pump Inhibitors|Proton-pump Inhibitors|Pyrazoles|Pyrazolones|Pyridines|Sulfoxides|Sulfur Compounds|Topical Products for Joint and Muscular Pain",COCCCOC1=C(C)C(CS(=O)C2=NC3=CC=CC=C3N2)=NC=C1,5029
1109,DB01130,Prednicarbate,small molecule,approved|investigational,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Dermatologicals|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids",[H][C@@]12CC[C@](OC(=O)OCC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,6714002
1110,DB01131,Proguanil,small molecule,approved,"Amidines|Anti-Infective Agents|Antimalarials|Antimetabolites|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Biguanides|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Folic Acid Antagonists|Guanidines|Noxae|Toxic Actions",CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1,4923
1111,DB01132,Pioglitazone,small molecule,approved|investigational,Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs Used in Diabetes|Hypoglycemia-Associated Agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Peroxisome Proliferator Receptor gamma Agonist|Peroxisome Proliferator-activated Receptor Activity|Sulfur Compounds|Thiazoles|Thiazolidinediones,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,4829
1112,DB01133,Tiludronic acid,small molecule,approved|investigational|vet_approved,"Bisphosphonates|Bone Density Conservation Agents|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Drugs that are Mainly Renally Excreted|Musculo-Skeletal System|Organophosphonates|Organophosphorus Compounds|Phospholipases A, antagonists & inhibitors",OP(O)(=O)C(SC1=CC=C(Cl)C=C1)P(O)(O)=O,60937
1113,DB01134,Desoxycorticosterone pivalate,small molecule,experimental|vet_approved,"Adrenal Cortex Hormones|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Pregnanes|Pregnenediones|Pregnenes|Steroids",[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(=O)COC(=O)C(C)(C)C,11876263
1114,DB01135,Doxacurium,small molecule,approved,"Anticholinergic Agents|Central Nervous System Depressants|Cholinesterase substrates|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Muscarinic Antagonists|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular-Blocking Agents (Nondepolarizing)|Nicotinic Antagonists|Peripheral Nervous System Agents",COC1=CC(CC2C3=C(OC)C(OC)=C(OC)C=C3CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCC3=CC(OC)=C(OC)C(OC)=C3C2CC2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OC,5284551
1115,DB01136,Carvedilol,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Adrenergic beta-1 Receptor Antagonists|Adrenergic beta-Antagonists|Adrenergic beta2-Antagonists|Agents causing hyperkalemia|Alcohols|Alpha and Beta Blocking Agents|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Antioxidants|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Carbazoles|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Indoles|Membrane Transport Modulators|Neurotransmitter Agents|P-glycoprotein inhibitors|Propanolamines|Propanols|Protective Agents|UGT1A1 Substrates|UGT2B7 substrates|Vasodilating Agents",COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,2585
1116,DB01137,Levofloxacin,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|MATE 1 Inhibitors|MATE 1 Substrates|MATE 2 Inhibitors|MATE inhibitors|MATE substrates|Moderate Risk QTc-Prolonging Agents|OAT1/SLC22A6 Substrates|OCT1 inhibitors|OCT2 Inhibitors|Ophthalmologicals|P-glycoprotein inhibitors|P-glycoprotein substrates|Photosensitizing Agents|QTc Prolonging Agents|Quinolines|Quinolone Antimicrobial|Quinolones|Renal Agents|Sensory Organs|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N1CCN(C)CC1,149096
1117,DB01138,Sulfinpyrazone,small molecule,approved,Antigout Preparations|Antiplatelet agents|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Musculo-Skeletal System|Preparations Increasing Uric Acid Excretion|Pyrazoles|Pyrazolones|Renal Agents|Uricosuric Agents,O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(N1C1=CC=CC=C1)C1=CC=CC=C1,5342
1118,DB01139,Cefapirin,small molecule,approved|vet_approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephacetrile|Cephalosporins|First-Generation Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines",[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CSC1=CC=NC=C1)C(O)=O,30699
1119,DB01140,Cefadroxil,small molecule,approved|vet_approved|withdrawn,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|Drugs that are Mainly Renally Excreted|First-Generation Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|Sulfur Compounds|Thiazines",[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,47965
1120,DB01141,Micafungin,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antifungal Agents|Antiinfectives for Systemic Use|Antimycotics for Systemic Use|COMT Substrates|Echinocandin Antifungal|Echinocandins|Lipids|Lipopeptides|Peptides|Peptides, Cyclic",CCCCCOC1=CC=C(C=C1)C1=CC(=NO1)C1=CC=C(C=C1)C(=O)N[C@H]1C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)C1=CC(OS(O)(=O)=O)=C(O)C=C1)[C@H](O)CC(N)=O,477468
1121,DB01142,Doxepin,small molecule,approved|investigational,"Acid Reducers|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Agents that reduce seizure threshold|Anticholinergic Agents|Antidepressive Agents|Antidepressive Agents, Tricyclic|Antipruritics and Local Anesthetics|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Dibenzoxepins|Dopamine Antagonists|Drugs that are Mainly Renally Excreted|Ethers, Cyclic|Heterocyclic Compounds, Fused-Ring|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H2 Antagonists|Hypnotics and Sedatives|Muscarinic Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Non-Selective Monoamine Reuptake Inhibitors|P-glycoprotein substrates|Potential QTc-Prolonging Agents|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists|Sleep Aids, Pharmaceutical|Tertiary amine tricyclic antidepressants|Tricyclics and Other Norepinephrine-reuptake Inhibitors",[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,667468
1122,DB01143,Amifostine,small molecule,approved|investigational,"Compounds used in a research, industrial, or household setting|Cytoprotective Agent|Detoxifying Agents for Antineoplastic Treatment|Free Radical Scavenging Activity|Hypotensive Agents|Organophosphates|Organophosphorus Compounds|Organothiophosphates|Organothiophosphorus Compounds|Protective Agents|Radiation-Protective Agents|Sulfur Compounds",NCCCNCCSP(O)(O)=O,2141
1123,DB01144,Diclofenamide,small molecule,approved|investigational,Amides|Antiglaucoma Preparations and Miotics|Carbonic Anhydrase Inhibitors|Diuretics|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hypotensive Agents|Ophthalmics|Ophthalmologicals|Sensory Organs|Sulfonamides|Sulfones|Sulfur Compounds,NS(=O)(=O)C1=CC(=C(Cl)C(Cl)=C1)S(N)(=O)=O,3038
1124,DB01145,Sulfoxone,small molecule,approved,Antiinfectives for Systemic Use|Antimycobacterials|Drugs for Treatment of Lepra|Sulfones|Sulfur Compounds,OS(=O)CNC1=CC=C(C=C1)S(=O)(=O)C1=CC=C(NCS(O)=O)C=C1,5351
1125,DB01146,Diphenylpyraline,small molecule,approved|investigational,Aminoalkyl Ethers|Antihistamines for Systemic Use|Histamine Antagonists|Histamine H1 Antagonists,CN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1,3103
1126,DB01147,Cloxacillin,small molecule,approved|investigational|vet_approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|Beta-Lactamase Resistant Penicillins|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|OAT1/SLC22A6 inhibitors|Penicillinase-resistant Penicillins|Penicillins|Sulfur Compounds",[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1Cl)C(O)=O,6098
1127,DB01148,Flavoxate,small molecule,approved,"Agents producing tachycardia|Anticholinergic Agents|Autonomic Agents|Benzopyrans|Chromones|Drugs for Urinary Frequency and Incontinence|Drugs that are Mainly Renally Excreted|Flavones|Flavonoids|Genito Urinary System and Sex Hormones|Heterocyclic Compounds, Fused-Ring|Muscarinic Antagonists|Parasympatholytics|Peripheral Nervous System Agents|Pyrans|Urological Agents|Urologicals",CC1=C(OC2=C(C=CC=C2C(=O)OCCN2CCCCC2)C1=O)C1=CC=CC=C1,3354
1128,DB01149,Nefazodone,small molecule,approved|withdrawn,"Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Analgesics|Antidepressive Agents|Antidepressive Agents, Second-Generation|Antidepressive Agents, Triazolopyridine|BSEP/ABCB11 Substrates|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|OATP1B3 inhibitors|P-glycoprotein inducers|P-glycoprotein inhibitors|Psychoanaleptics|Psychotropic Drugs|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin and Noradrenaline Reuptake Inhibitors|Serotonin Modulators|Serotonin Receptor Antagonists",CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1,4449
1129,DB01150,Cefprozil,small molecule,approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Second-Generation Cephalosporins|Sulfur Compounds|Thiazines",[H][C@]12SCC(C=CC)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,5281006
1130,DB01151,Desipramine,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that produce hypertension|Agents that reduce seizure threshold|Anticholinergic Agents|Antidepressive Agents|Antidepressive Agents, Tricyclic|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP2E1 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dibenzazepines|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Histamine Antagonists|Histamine H1 Antagonists|Membrane Transport Modulators|Muscarinic Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Non-Selective Monoamine Reuptake Inhibitors|OCT1 inhibitors|OCT2 Inhibitors|P-glycoprotein inhibitors|Potential QTc-Prolonging Agents|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists|Tricyclics and Other Norepinephrine-reuptake Inhibitors",CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,2995
1131,DB01152,Candicidin,small molecule,approved|withdrawn,Anti-Bacterial Agents|Anti-Infective Agents|Antifungal Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Lactones|Macrolides|Polyketides,CC(CC(C)C1OC(=O)CC(=O)CCCC(=O)CC(O)CC(O)CC(O)CC(=O)CC(O)C(C(O)CC(OC2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\C1C)C(O)=O)C(O)CC(=O)C1=CC=C(N)C=C1,
1132,DB01153,Sertaconazole,small molecule,approved|investigational,Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Azole Antifungals|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Imidazole and Triazole Derivatives|Imidazole Derivatives|Sulfur Compounds,ClC1=CC(Cl)=C(C=C1)C(CN1C=CN=C1)OCC1=CSC2=C1C=CC=C2Cl,65863
1133,DB01154,Thiamylal,small molecule,approved|vet_approved,"Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Anticonvulsants|Barbiturates|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Psycholeptics|Pyrimidines|Pyrimidinones|Thiobarbiturates",CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O,3032285
1134,DB01155,Gemifloxacin,small molecule,approved|investigational,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Moderate Risk QTc-Prolonging Agents|Naphthyridines|QTc Prolonging Agents|Quinolines|Quinolone Antimicrobial|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",CO\N=C1/CN(CC1CN)C1=NC2=C(C=C1F)C(=O)C(=CN2C1CC1)C(O)=O,9571107
1135,DB01156,Bupropion,small molecule,approved,"Agents that reduce seizure threshold|Aminoketone|Antidepressive Agents|Antiobesity Preparations, Excl. Diet Products|Central Nervous System Agents|Central Nervous System Depressants|Centrally Acting Antiobesity Products|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Uptake Inhibitors|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Increased Dopamine Activity|Increased Norepinephrine Activity|Ketones|Miscellaneous Antidepressants|Nervous System|Neurotransmitter Uptake Inhibitors|Norepinephrine Uptake Inhibitors|OCT2 Inhibitors|Photosensitizing Agents|Psychoanaleptics|Psychotropic Drugs|Smoking Cessation Agents",CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,444
1136,DB01157,Trimetrexate,small molecule,approved|investigational,"Acids, Acyclic|Acids, Aldehydic|Anti-Infective Agents|Antimetabolites|Antineoplastic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Carbohydrates|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Folic Acid Antagonists|Hepatotoxic Agents|Heterocyclic Compounds, Fused-Ring|Hydroxy Acids|Narrow Therapeutic Index Drugs|Noxae|Pharmaceutical Preparations|Quinazolines|Sugar Acids|Toxic Actions|Uronic Acids",COC1=CC(NCC2=C(C)C3=C(C=C2)N=C(N)N=C3N)=CC(OC)=C1OC,5583
1137,DB01158,Bretylium,small molecule,approved,"Adrenergic Agents|Adrenergic Antagonists|Amines|Ammonium Compounds|Antiarrhythmic agents|Antiarrhythmics, Class III|Antihypertensive Agents|Benzylammonium Compounds|Bradycardia-Causing Agents|Bretylium Compounds|Cardiac Therapy|Cardiovascular Agents|Hypotensive Agents|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quaternary Ammonium Compounds",CC[N+](C)(C)CC1=CC=CC=C1Br,2431
1138,DB01159,Halothane,small molecule,approved|vet_approved,"Agents that produce hypertension|Anesthetics|Anesthetics, General|Anesthetics, Inhalation|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Hydrocarbons, Halogenated|Hypotensive Agents|Nervous System|NMDA Receptor Antagonists",[H]C(Cl)(Br)C(F)(F)F,3562
1139,DB01160,Dinoprost tromethamine,small molecule,approved|vet_approved,"Abortifacient Agents|Abortifacient Agents, Nonsteroidal|Angiography|Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Prostaglandins|Prostaglandins F|Reproductive Control Agents|Uterotonic agents",NC(CO)(CO)CO.CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O,5282415
1140,DB01161,Chloroprocaine,small molecule,approved,"Acids, Carbocyclic|Aminobenzoates|Anesthetics|Anesthetics, Local|Anticholinergic Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Cholinesterase substrates|Ester Local Anesthetic|Esters of Aminobenzoic Acid|Local Anesthesia|Nervous System|Nicotinic Antagonists|NMDA Receptor Antagonists|para-Aminobenzoates|Peripheral Nervous System Agents|Sensory System Agents",CCN(CC)CCOC(=O)C1=C(Cl)C=C(N)C=C1,8612
1141,DB01162,Terazosin,small molecule,approved,"Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Drugs Used in Benign Prostatic Hypertrophy|Genito Urinary System and Sex Hormones|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Neurotransmitter Agents|P-glycoprotein inhibitors|Peripheral alpha-1 blockers|Quinazolines|Urological Agents|Urologicals",COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1CCCO1,5401
1142,DB01163,Amdinocillin,small molecule,investigational|withdrawn,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Penicillins|Penicillins With Extended Spectrum|Renal Agents|Sulfur Compounds",[H]C(=N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@]12[H])N1CCCCCC1,36273
1143,DB01164,Calcium chloride,small molecule,approved,"Acidifiers|Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Anions|Blood and Blood Forming Organs|Blood Coagulation Factors|Blood Substitutes and Perfusion Solutions|Calcium Compounds|Calcium Salts|Chlorides|Chlorine Compounds|Electrolyte Solutions|Electrolytes|Genito Urinary System and Sex Hormones|Hemodialysis Solution|I.V. Solution Additives|Ions|Mineral Supplements|Phosphate Binder|Replacement Preparations|Supplements|Urologicals",[Cl-].[Cl-].[Ca++],5284359
1144,DB01165,Ofloxacin,small molecule,approved,"Agents Causing Muscle Toxicity|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|BSEP/ABCB11 Substrates|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Moderate Risk QTc-Prolonging Agents|OAT1/SLC22A6 inhibitors|Ophthalmologicals|Otologicals|QTc Prolonging Agents|Quinolines|Quinolone Antimicrobial|Quinolones|Renal Agents|Sensory Organs|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",CC1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N1CCN(C)CC1,4583
1145,DB01166,Cilostazol,small molecule,approved|investigational,"Agents producing tachycardia|Anti-Asthmatic Agents|Antiplatelet agents|Autonomic Agents|Blood and Blood Forming Organs|Bronchodilator Agents|Cardiovascular Agents|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Fibrin Modulating Agents|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|Neuroprotective Agents|Peripheral Nervous System Agents|Phosphodiesterase 3 Inhibitors|Phosphodiesterase Inhibitors|Platelet Aggregation Inhibitors Excl. Heparin|Potential QTc-Prolonging Agents|Protective Agents|QTc Prolonging Agents|Quinolines|Respiratory System Agents|Tetrazoles|Vasodilating Agents",O=C1CCC2=C(N1)C=CC(OCCCCC1=NN=NN1C1CCCCC1)=C2,2754
1146,DB01167,Itraconazole,small molecule,approved|investigational,"14-alpha Demethylase Inhibitors|Agents causing hyperkalemia|Anti-Infective Agents|Antifungal Agents|Antiinfectives for Systemic Use|Antimycotics for Systemic Use|Azole Antifungals|Breast Cancer Resistance Protein Inhibitors|Chemically-Induced Disorders|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strong)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strong)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|P-glycoprotein inhibitors|Photosensitizing Agents|Piperazines|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Steroid Synthesis Inhibitors|Triazole Derivatives|Triazoles",CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1,55283
1147,DB01168,Procarbazine,small molecule,approved|investigational,"Acids, Carbocyclic|Agents Causing Muscle Toxicity|Alkylating Activity|Alkylating Drugs|Amides|Antidepressive Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Central Nervous System Depressants|Immunosuppressive Agents|Methylhydrazines|Monoamine Oxidase Inhibitors|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators",CNNCC1=CC=C(C=C1)C(=O)NC(C)C,4915
1148,DB01169,Arsenic trioxide,small molecule,approved|investigational,Anions|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Arsenicals|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Drugs that are Mainly Renally Excreted|Electrolytes|Highest Risk QTc-Prolonging Agents|Hyperglycemia-Associated Agents|Hypotensive Agents|Immunosuppressive Agents|Ions|Myelosuppressive Agents|Organometallic Compounds|Oxides|Oxygen Compounds|P-glycoprotein substrates|QTc Prolonging Agents,O=[As]O[As]=O,261004
1149,DB01170,Guanethidine,small molecule,approved,"Adrenergic Agents|Adrenergic Antagonists|Amidines|Antiadrenergic Agents, Peripherally Acting|Antiglaucoma Preparations and Miotics|Antihypertensive Agents|Autonomic Agents|Cardiovascular Agents|Catecholamine-depleting Sympatholytic|Drugs that are Mainly Renally Excreted|Gastrointestinal Acidifying Agents|Guanidine Derivatives|Guanidine Derivatives and Diuretics|Guanidines|Neurotransmitter Agents|Ophthalmologicals|Peripheral Nervous System Agents|Sensory Organs|Sympatholytics",NC(N)=NCCN1CCCCCCC1,3518
1150,DB01171,Moclobemide,small molecule,approved|investigational,"Acids, Carbocyclic|Agents that produce hypertension|Agents that reduce seizure threshold|Amides|Antidepressive Agents|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Central Nervous System Agents|Central Nervous System Depressants|Chlorobenzoates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Monoamine Oxidase A Inhibitors|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Monoamine Oxidase Inhibitors|Nervous System|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators",ClC1=CC=C(C=C1)C(=O)NCCN1CCOCC1,4235
1151,DB01172,Kanamycin,small molecule,approved|investigational|vet_approved,"Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antiinfectives for Systemic Use|Carbohydrates|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Enzyme Inhibitors|Glycosides|Intestinal Antiinfectives|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Ophthalmologicals|Protein Synthesis Inhibitors|Sensory Organs",NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,6032
1152,DB01173,Orphenadrine,small molecule,approved,"Agents producing tachycardia|Amines|Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Anticholinergic Agents|Autonomic Agents|Benzene Derivatives|Benzhydryl Compounds|Central Nervous System Agents|Central Nervous System Depressants|Centrally-mediated Muscle Relaxation|Chemically-Induced Disorders|Cholinergic Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Ethers, Chemically Close to Antihistamines|Ethylamines|Histamine Antagonists|Histamine H1 Antagonists|Miscellaneous Skeletal Muscle Relaxants|Muscarinic Antagonists|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System|Nervous System|Neurotransmitter Agents|NMDA Receptor Antagonists|Parasympatholytics|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents",CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1C,4601
1153,DB01174,Phenobarbital,small molecule,approved|investigational,Anticholinergic Agents|Anticonvulsants|Barbiturates|Barbiturates and Derivatives|BSEP/ABCB11 inducers|Central Nervous System Agents|Central Nervous System Depressants|Chemically-Induced Disorders|Cytochrome P-450 2C18 Inducers|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 CYP2A6 Inducers|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strong)|Cytochrome P-450 CYP2C18 Inducers (strength unknown)|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inducers (strong)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP2E1 Inducers (strength unknown)|Cytochrome P-450 CYP2E1 Inducers (weak)|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strong)|Cytochrome P-450 CYP3A7 Inducers|Cytochrome P-450 CYP3A7 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Enzyme Inducing Antiepileptic Drugs|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Methemoglobinemia Associated Agents|Narrow Therapeutic Index Drugs|Nervous System|Neurotransmitter Agents|Nicotinic Antagonists|P-glycoprotein inducers|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Phenobarbital and similars|Psycholeptics|Pyrimidines|Pyrimidinones|UGT1A1 Inducers|UGT2B7 inducers,CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1,4763
1154,DB01175,Escitalopram,small molecule,approved,"Amines|Anticholinergic Agents|Antidepressive Agents|Antidepressive Agents, Second-Generation|Benzofurans|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Nitriles|P-glycoprotein substrates|Photosensitizing Agents|Propylamines|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators",CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,146570
1155,DB01176,Cyclizine,small molecule,approved,Antiemetics|Antihistamines for Systemic Use|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Peripheral Nervous System Agents|Piperazine Derivatives|Piperazines|Potential QTc-Prolonging Agents|QTc Prolonging Agents,CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,6726
1156,DB01177,Idarubicin,small molecule,approved,"Anthracycline Topoisomerase Inhibitor|Anthracyclines|Anthracyclines and Related Substances|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Cytotoxic Antibiotics and Related Substances|Enzyme Inhibitors|Glycosides|Immunosuppressive Agents|Myelosuppressive Agents|Naphthacenes|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]1C[C@@](O)(CC2=C1C(O)=C1C(=O)C3=CC=CC=C3C(=O)C1=C2O)C(C)=O,42890
1157,DB01178,Chlormezanone,small molecule,approved|investigational|withdrawn,"Anti-Anxiety Agents|Central Nervous System Agents|Central Nervous System Depressants|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Oxazol, Thiazine, and Triazine Derivatives|Peripheral Nervous System Agents|Psychotropic Drugs|Sulfur Compounds|Thiazines|Tranquilizing Agents",CN1C(C2=CC=C(Cl)C=C2)S(=O)(=O)CCC1=O,2717
1158,DB01179,Podofilox,small molecule,approved,"Antimitotic Agents|Antineoplastic Agents, Phytogenic|Antiviral Agents|Benzene Derivatives|Benzyl Compounds|Decreased Mitosis|Dermatologicals|Keratolytic Agents|Lignans|Misc. Skin and Mucous Membrane Agents|Mitosis Modulators|Naphthalenes|Tetrahydronaphthalenes|Tubulin Modulators",[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(OC)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@@H]2O,10607
1159,DB01180,Rescinnamine,small molecule,approved,"Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Alkaloids|Angiotensin-Converting Enzyme Inhibitors|Antiadrenergic Agents, Centrally Acting|Antihypertensive Agents|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|Secologanin Tryptamine Alkaloids",[H][C@]12C[C@@H](OC(=O)C=CC3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2,32681
1160,DB01181,Ifosfamide,small molecule,approved,"Acids|Acids, Noncarboxylic|Alkylating Activity|Alkylating Drugs|Anions|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Electrolytes|Hydrocarbons, Halogenated|Immunosuppressive Agents|Ions|Methemoglobinemia Associated Agents|Mustard Compounds|Myelosuppressive Agents|Nitrogen Mustard Analogues|Nitrogen Mustard Compounds|Noxae|Organophosphorus Compounds|Oxazines|Phosphoramide Mustards|Phosphoramides|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Toxic Actions",ClCCNP1(=O)OCCCN1CCCl,3690
1161,DB01182,Propafenone,small molecule,approved,"Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ic|Bradycardia-Causing Agents|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Ketones|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|P-glycoprotein inhibitors|Propiophenones|QTc Prolonging Agents|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers",CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1,4932
1162,DB01183,Naloxone,small molecule,approved|vet_approved,"Alimentary Tract and Metabolism|Alkaloids|Analgesics|Antidotes|Central Nervous System Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Drugs for Constipation|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Morphinans|Narcotics|Natural Opium Alkaloids|Nervous System|Opiate Alkaloids|Opiate Antagonists|Opioid Antagonists|P-glycoprotein substrates|Peripheral Nervous System Agents|Peripheral Opioid Receptor Antagonists|Phenanthrenes|Sensory System Agents|UGT1A1 Substrates",OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,5284596
1163,DB01184,Domperidone,small molecule,approved|investigational|vet_approved,"Alimentary Tract and Metabolism|Antiemetics|Autonomic Agents|Benzimidazoles|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs for Functional Gastrointestinal Disorders|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|Neurotransmitter Agents|P-glycoprotein substrates|Peripheral Nervous System Agents|Piperidines|Prokinetic Agents|Propulsives|QTc Prolonging Agents",ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=CC=CC=C34)CC1)C(=O)N2,3151
1164,DB01185,Fluoxymesterone,small molecule,approved|illicit,"3-Oxoandrosten (4) Derivatives|Anabolic Agents|Androgens|Androstanes|Androstenediols|Androstenes|Androstenols|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Sex Hormones and Modulators of the Genital System|Steroids|Steroids, Fluorinated",[H][C@@]12CC[C@](C)(O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,6446
1165,DB01186,Pergolide,small molecule,approved|investigational|vet_approved|withdrawn,"Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alkaloids|Anti-Parkinson Drugs|Antidepressive Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Dopamine Agonists|Ergolines|Ergot Alkaloids and Derivatives|Ergot-derivative Dopamine Receptor Agonists|Ergot-derived Dopamine Receptor Agonist|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotransmitter Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists",[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,47811
1166,DB01187,Iophendylate,small molecule,approved,"Benzene Derivatives|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Hydrocarbons, Halogenated|Hydrocarbons, Iodinated|Iodobenzenes|Non-Watersoluble X-Ray Contrast Media|X-Ray Contrast Media, Iodinated",CCOC(=O)CCCCCCCCC(C)C1=CC=CC=C1I,3037234
1167,DB01188,Ciclopirox,small molecule,approved|investigational,"Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Cyclohexanes|Cycloparaffins|Decreased DNA Replication|Decreased Protein Synthesis|Decreased RNA Replication|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hydroxypyridones|Protein Synthesis Inhibitors|Pyridines|Pyridones|Vaginal Creams, Foams, and Jellies",CC1=CC(=O)N(O)C(=C1)C1CCCCC1,2749
1168,DB01189,Desflurane,small molecule,approved,"Agents that produce hypertension|Anesthetics|Anesthetics, General|Anesthetics, Inhalation|Central Nervous System Agents|Central Nervous System Depressants|Ethers|Ethyl Ethers|Hydrocarbons, Fluorinated|Hydrocarbons, Halogenated|Hypotensive Agents|Methyl Ethers|Nervous System|Potential QTc-Prolonging Agents|QTc Prolonging Agents",FC(F)OC(F)C(F)(F)F,42113
1169,DB01190,Clindamycin,small molecule,approved|vet_approved,"Agents that produce neuromuscular block (indirect)|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antibiotics for Pneumocystis Pneumonia|Antiinfectives for Systemic Use|Antiinfectives for Treatment of Acne|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Decreased Sebaceous Gland Activity|Dermatologicals|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Glycosides|Gynecological Antiinfectives and Antiseptics|Lincomycins|Lincosamide Antibacterial|Lincosamides|Macrolides, Lincosamides and Streptogramins|Narrow Therapeutic Index Drugs|Neurotoxic agents|P-glycoprotein substrates|Protein Synthesis Inhibitors|Pyrrolidines",CCC[C@@H]1C[C@H](N(C)C1)C(=O)NC(C(C)Cl)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O,446598
1170,DB01191,Dexfenfluramine,small molecule,approved|illicit|investigational|withdrawn,"Alimentary Tract and Metabolism|Amines|Antiobesity Preparations, Excl. Diet Products|Centrally Acting Antiobesity Products|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP2E1 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Ethylamines|Neurotransmitter Agents|Phenethylamines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",CCN[C@@H](C)CC1=CC=CC(=C1)C(F)(F)F,66265
1171,DB01192,Oxymorphone,small molecule,approved|investigational|vet_approved,"Adjuvants|Adjuvants, Anesthesia|Alkaloids|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|High-risk opioids|Morphinans|Morphine Derivatives|Narcotics|Opiate Agonists|Opiate Alkaloids|Opioid Agonist|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,5284604
1172,DB01193,Acebutolol,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-1 Receptor Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Autonomic Agents|Beta Blocking Agents and Thiazides|Beta Blocking Agents, Selective|Beta Blocking Agents, Selective, and Thiazides|Beta-Blockers (Beta1 Selective)|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Hypotensive Agents|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|P-glycoprotein substrates|Peripheral Nervous System Agents|Phenoxypropanolamines|Propanolamines|Propanols|QTc Prolonging Agents|Sympathomimetics",CCCC(=O)NC1=CC=C(OCC(O)CNC(C)C)C(=C1)C(C)=O,1978
1173,DB01194,Brinzolamide,small molecule,approved,Amides|Antiglaucoma Preparations and Miotics|Carbonic Anhydrase Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Diuretics|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Ophthalmics|Ophthalmologicals|Sensory Organs|Sulfonamides|Sulfones|Sulfur Compounds,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,68844
1174,DB01195,Flecainide,small molecule,approved|withdrawn,"Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ic|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|MATE 1 Inhibitors|MATE 1 Substrates|MATE inhibitors|MATE substrates|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Narrow Therapeutic Index Drugs|P-glycoprotein substrates|Piperidines|QTc Prolonging Agents|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers",FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1,3356
1175,DB01196,Estramustine,small molecule,approved|investigational,"Alkylating Activity|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Estradiol Congeners|Estranes|Estrenes|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydrocarbons, Halogenated|Immunosuppressive Agents|Mustard Compounds|Nitrogen Mustard Compounds|Noxae|P-glycoprotein inhibitors|Steroids|Toxic Actions",[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OC(=O)N(CCCl)CCCl)C=C3CC[C@@]21[H],259331
1176,DB01197,Captopril,small molecule,approved,"ACE Inhibitors and Diuretics|Acids, Acyclic|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents Causing Muscle Toxicity|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Cardiovascular Agents|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Hypotensive Agents|Imines|Imino Acids|OAT1/SLC22A6 inhibitors|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Substrates|P-glycoprotein inhibitors|Photosensitizing Agents|Protease Inhibitors",C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O,44093
1177,DB01198,Zopiclone,small molecule,approved,Aza Compounds|Benzodiazepine hypnotics and sedatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Hypnotics (Nonbenzodiazepine)|Hypnotics and Sedatives|Methemoglobinemia Associated Agents|Miscellaneous Anxiolytics Sedatives and Hypnotics|Nervous System|Photosensitizing Agents|Psycholeptics|Sleep Initiation and Maintenance Disorders|Zopiclone and prodrugs,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1,5735
1178,DB01199,Tubocurarine,small molecule,approved,"Alkaloids|Amines|Ammonium Compounds|Anticholinergic Agents|Benzylisoquinolines|Central Nervous System Depressants|Cholinergic Agents|Cholinesterase Inhibitors|Cholinesterase substrates|Curare Alkaloids|Ganglion Blockers|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular-Blocking Agents (Nondepolarizing)|Neurotoxic agents|Neurotransmitter Agents|Nicotinic Antagonists|Nitrogen Compounds|OCT1 substrates|Onium Compounds|Peripheral Nervous System Agents|Quaternary Ammonium Compounds|Tetrahydroisoquinolines",[H][C@@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC(OC6=C(OC)C=C(CCN1C)C2=C6)=C(O)C=C5)=CC(OC)=C4O)C=C3,6000
1179,DB01200,Bromocriptine,small molecule,approved|investigational,"Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Alkaloids|Anti-Dyskinesia Agents|Anti-Parkinson Agents (Dopamine Agonist)|Anti-Parkinson Drugs|Antidepressive Agents|Blood Glucose Lowering Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Agonists|Ergolines|Ergot Alkaloids and Derivatives|Ergot-derivative Dopamine Receptor Agonists|Ergotamines|Genito Urinary System and Sex Hormones|Heterocyclic Compounds, Fused-Ring|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypotensive Agents|Nervous System|Neurotransmitter Agents|P-glycoprotein inhibitors|P-glycoprotein substrates|Prolactine Inhibitors|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists",[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C,31101
1180,DB01201,Rifapentine,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics, Antitubercular|Antiinfectives for Systemic Use|Antimycobacterials|Antituberculosis Agents|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strong)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Drugs for Treatment of Tuberculosis|Heterocyclic Compounds, Fused-Ring|Lactams|Lactams, Macrocyclic|Leprostatic Agents|Rifamycin Antimycobacterial|Rifamycins",CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(\C=N\N1CCN(CC1)C1CCCC1)=C2O,6323497
1181,DB01202,Levetiracetam,small molecule,approved,Acetamides|Amides|Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Decreased Central Nervous System Disorganized Electrical Activity|Miscellaneous Anticonvulsants|Nervous System|P-glycoprotein substrates|Pyrrolidines|Pyrrolidinones,CC[C@H](N1CCCC1=O)C(N)=O,5284583
1182,DB01203,Nadolol,small molecule,approved,"Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Autonomic Agents|Beta Blocking Agents and Thiazides|Beta Blocking Agents, Non-Selective|Beta Blocking Agents, Non-Selective, and Thiazides|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Hypotensive Agents|MATE 1 Substrates|MATE 2 Substrates|MATE substrates|Neurotransmitter Agents|P-glycoprotein substrates|Peripheral Nervous System Agents|Phenoxypropanolamines|Photosensitizing Agents|Propanolamines|Propanols|Sympatholytics",CC(C)(C)NCC(O)COC1=CC=CC2=C1C[C@H](O)[C@H](O)C2,39147
1183,DB01204,Mitoxantrone,small molecule,approved|investigational,Analgesics|Anthracenes|Anthracyclines and Related Substances|Anthraquinones|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Cardiotoxic antineoplastic agents|Central Nervous System Agents|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP2E1 Inducers (strength unknown)|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Cytotoxic Antibiotics and Related Substances|Enzyme Inhibitors|Immunosuppressive Agents|Myelosuppressive Agents|P-glycoprotein inducers|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Peripheral Nervous System Agents|Quinones|Sensory System Agents|Topoisomerase II Inhibitors|Topoisomerase Inhibitors,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(C(O)=CC=C1O)C2=O,4212
1184,DB01205,Flumazenil,small molecule,approved,"Antidotes|Benzazepines|Benzodiazepine Antagonist|Benzodiazepinones|Compounds used in a research, industrial, or household setting|Drugs that are Mainly Renally Excreted|GABA Agents|GABA Modulators|Heterocyclic Compounds, Fused-Ring|Miscellaneous Central Nervous System Agents|Neurotransmitter Agents|Protective Agents",CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1,3373
1185,DB01206,Lomustine,small molecule,approved|investigational,"Alkylating Activity|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Immunosuppressive Agents|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Nitroso Compounds|Nitrosourea Compounds|Nitrosoureas|Noxae|Toxic Actions",ClCCN(N=O)C(=O)NC1CCCCC1,3950
1186,DB01207,Ridogrel,small molecule,experimental,"Acids, Acyclic|Antiplatelet agents|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Gastrointestinal Agents|Hematologic Agents|Lipids|Thromboxane-A Synthase, antagonists & inhibitors|Valerates",OC(=O)CCCCO\N=C(\C1=CN=CC=C1)C1=CC(=CC=C1)C(F)(F)F,5362391
1187,DB01208,Sparfloxacin,small molecule,approved|investigational|withdrawn,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antituberculosis Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|P-glycoprotein substrates|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",C[C@H]1CN(C[C@@H](C)N1)C1=C(F)C(N)=C2C(=O)C(=CN(C3CC3)C2=C1F)C(O)=O,60464
1188,DB01209,Dezocine,small molecule,approved|investigational,Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Naphthalenes|Narcotics|Nervous System|Opioid Antagonists|Opioids|Peripheral Nervous System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,[H][C@@]12CC3=CC=C(O)C=C3[C@@](C)(CCCCC1)[C@H]2N,3033053
1189,DB01210,Levobunolol,small molecule,approved,Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antiglaucoma Preparations and Miotics|Autonomic Agents|Beta-adrenergic Agents|Bradycardia-Causing Agents|Bunolol|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Hypotensive Agents|Naphthalenes|Neurotransmitter Agents|Ophthalmologicals|Peripheral Nervous System Agents|Phenoxypropanolamines|Propanolamines|Propanols|Sensory Organs|Sympatholytics|Tetrahydronaphthalenes,CC(C)(C)NC[C@H](O)COC1=CC=CC2=C1CCCC2=O,39468
1190,DB01211,Clarithromycin,small molecule,approved,"Alimentary Tract and Metabolism|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|BSEP/ABCB11 Substrates|Chemically-Induced Disorders|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strong)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Enzyme Inhibitors|Erythromycin and similars|Lactones|Macrolide Antimicrobial|Macrolides|Macrolides, Lincosamides and Streptogramins|Moderate Risk QTc-Prolonging Agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Other Macrolides|P-glycoprotein inhibitors|P-glycoprotein substrates|Polyketides|Protein Synthesis Inhibitors|QTc Prolonging Agents",[H][C@@]1(C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)O[C@H]1[C@H](C)[C@@H](O[C@]2([H])O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@@H]1C)OC,84029
1191,DB01212,Ceftriaxone,small molecule,approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephacetrile|Cephalosporins|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|P-glycoprotein inhibitors|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins",[H][C@]12SCC(CSC3=NC(=O)C(=O)NN3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,5479530
1192,DB01213,Fomepizole,small molecule,approved|vet_approved,"Antidotes|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP2E1 Inducers (strength unknown)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Protective Agents|Pyrazoles",CC1=CNN=C1,3406
1193,DB01214,Metipranolol,small molecule,approved,"Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antiglaucoma Preparations and Miotics|Antihypertensive Agents|Autonomic Agents|Beta Blocking Agents and Thiazides|Beta Blocking Agents, Non-Selective, and Thiazides|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Hypotensive Agents|Neurotransmitter Agents|Ophthalmologicals|Peripheral Nervous System Agents|Phenoxypropanolamines|Propanolamines|Propanols|Sensory Organs|Sympatholytics",CC(C)NCC(O)COC1=C(C)C(C)=C(OC(C)=O)C(C)=C1,31477
1194,DB01215,Estazolam,small molecule,approved|illicit,"Anti-Anxiety Agents|Anticonvulsants|Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|GABA Agents|GABA Modulators|Heterocyclic Compounds, Fused-Ring|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Photosensitizing Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents|Triazolobenzodiazepines",ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,3261
1195,DB01216,Finasteride,small molecule,approved,"5-alpha Reductase Inhibitors|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Androstanes|Androstenes|Azasteroids|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Substrates|Dermatologicals|Drugs Used in Benign Prostatic Hypertrophy|Enzyme Inhibitors|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Misc. Skin and Mucous Membrane Agents|Steroid Synthesis Inhibitors|Steroids|Urological Agents|Urologicals",[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C,57363
1196,DB01217,Anastrozole,small molecule,approved|investigational,"Antineoplastic Agents|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|Aromatase Inhibitors|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Endocrine Therapy|Enzyme Inhibitors|Estrogen Antagonists|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Nitriles|P-glycoprotein substrates|Steroid Synthesis Inhibitors|Triazoles|UGT1A3 substrates|UGT1A4 substrates|UGT2B7 substrates",CC(C)(C#N)C1=CC(=CC(CN2C=NC=N2)=C1)C(C)(C)C#N,2187
1197,DB01218,Halofantrine,small molecule,approved,"Agents that reduce seizure threshold|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Highest Risk QTc-Prolonging Agents|QTc Prolonging Agents",CCCCN(CCCC)CCC(O)C1=C2C=CC(=CC2=C2C=C(Cl)C=C(Cl)C2=C1)C(F)(F)F,37393
1198,DB01219,Dantrolene,small molecule,approved|investigational,"Agents causing hyperkalemia|Agents that produce neuromuscular block (indirect)|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 Substrates|Dantrolene and Derivatives|Decreased Striated Muscle Contraction|Decreased Striated Muscle Tone|Direct-acting Skeletal Muscle Relaxants|Hepatotoxic Agents|Hydantoins|Imidazoles|Imidazolidines|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Peripheral Nervous System Agents|Thyroxine-binding globulin substrates",[O-][N+](=O)C1=CC=C(C=C1)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,6914273
1199,DB01220,Rifaximin,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics for Topical Use|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strong)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Dermatologicals|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Intestinal Antiinfectives|Lactams|Lactams, Macrocyclic|Rifamycin Antibacterial|Rifamycins",CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C1=C(N=C5C=C(C)C=CN15)C4=C3C2=O,6436173
1200,DB01221,Ketamine,small molecule,approved|vet_approved,"Agents producing tachycardia|Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Analgesics|Anesthetics|Anesthetics, Dissociative|Anesthetics, General|Anesthetics, Intravenous|Central Nervous System Agents|Central Nervous System Depressants|Cholinesterase Inhibitors|Cyclohexanes|Cycloparaffins|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Excitatory Amino Acid Agents|Excitatory Amino Acid Agonists|Excitatory Amino Acid Antagonists|Excitatory Amino Acids|Miscellaneous General Anesthetics|N-Methylaspartate, agonists|N-Methylaspartate, antagonists & inhibitors|Nervous System|Neurotransmitter Agents|NMDA Receptor Antagonists|Peripheral Nervous System Agents|Sensory System Agents|Vasodilating Agents",CNC1(CCCCC1=O)C1=CC=CC=C1Cl,3821
1201,DB01222,Budesonide,small molecule,approved,"Adrenal Cortex Hormones|Adrenals|Agents to Treat Airway Disease|Alimentary Tract and Metabolism|Anti-Asthmatic Agents|Anti-Inflammatory Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Autonomic Agents|Bronchodilator Agents|BSEP/ABCB11 Substrates|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids Acting Locally|Corticosteroids for Systemic Use|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP2A6 Inducers|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (moderate)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Dermatologicals|Drugs for Obstructive Airway Diseases|Drugs that are Mainly Renally Excreted|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Intestinal Antiinflammatory Agents|Nasal Preparations|OAT3/SLC22A8 Substrates|P-glycoprotein substrates|Peripheral Nervous System Agents|Pregnanes|Pregnenediones|Pregnenes|Respiratory System Agents|Steroids",[H][C@@]12C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,5281004
1202,DB01223,Aminophylline,small molecule,approved,"Agents that reduce seizure threshold|Alkaloids|Amines|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Diamines|Drugs for Obstructive Airway Diseases|Enzyme Inhibitors|Ethylenediamines|Heterocyclic Compounds, Fused-Ring|Narrow Therapeutic Index Drugs|Neurotransmitter Agents|Peripheral Nervous System Agents|Pharmaceutical Preparations|Phosphodiesterase Inhibitors|Polyamines|Protective Agents|Purinergic Agents|Purinergic Antagonists|Purinergic P1 Receptor Antagonists|Purines|Purinones|Respiratory Smooth Muscle Relaxants|Respiratory System Agents|Xanthine derivatives|Xanthines and Adrenergics",NCCN.CN1C2=C(NC=N2)C(=O)N(C)C1=O.CN1C2=C(NC=N2)C(=O)N(C)C1=O,9433
1203,DB01224,Quetiapine,small molecule,approved,"Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Anticholinergic Agents|Antidepressive Agents|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Azepines|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Substrates|Diazepines, Oxazepines, Thiazepines and Oxepines|Dibenzothiazepines|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Histamine Antagonists|Histamine H1 Antagonists|Hyperglycemia-Associated Agents|Hypotensive Agents|Moderate Risk QTc-Prolonging Agents|Muscarinic Antagonists|Nervous System|P-glycoprotein substrates|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Thiazepines|Thiepins|Tranquilizing Agents",OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,5002
1204,DB01225,Enoxaparin,small molecule,approved,Agents causing hyperkalemia|Anticoagulants|Blood and Blood Forming Organs|Carbohydrates|Cardiovascular Agents|Fibrin Modulating Agents|Glycosaminoglycans|Hematologic Agents|Heparin (Low Molecular Weight)|Heparin and similars|Heparin Group|Polysaccharides,,
1205,DB01226,Mivacurium,small molecule,approved,"Agents producing tachycardia|Anticholinergic Agents|Central Nervous System Depressants|Cholinergic Agents|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Muscarinic Antagonists|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular-Blocking Agents (Nondepolarizing)|Nicotinic Antagonists|Peripheral Nervous System Agents",COC1=CC(C[C@@H]2C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCCOC(=O)CC\C=C\CCC(=O)OCCC[N+]2(C)CCC3=CC(OC)=C(OC)C=C3[C@H]2CC2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OC,5281042
1206,DB01227,Levacetylmethadol,small molecule,approved|investigational,Analgesics|Anticholinergic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Substrates|Drugs Used in Addictive Disorders|Drugs Used in Opioid Dependence|Ketones|Moderate Risk QTc-Prolonging Agents|Narcotics|Nervous System|Nicotinic Antagonists|Opioids|Peripheral Nervous System Agents|QTc Prolonging Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,15130
1207,DB01228,Encainide,small molecule,approved|investigational|withdrawn,"Amides|Amines|Anilides|Aniline Compounds|Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ic|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Membrane Transport Modulators|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers",COC1=CC=C(C=C1)C(=O)NC1=CC=CC=C1CCC1CCCCN1C,48041
1208,DB01229,Paclitaxel,small molecule,approved|vet_approved,"Agents Causing Muscle Toxicity|Antimitotic Agents|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Antineoplastic and Immunomodulating Agents|BSEP/ABCB11 Inhibitors|BSEP/ABCB11 Substrates|BSEP/ABCB11 Substrates with Narrow Therapeutic Index|Cardiotoxic antineoplastic agents|Cyclodecanes|Cycloparaffins|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Diterpenes|Hypotensive Agents|Immunosuppressive Agents|Microtubule Inhibition|Microtubule Inhibitors|Mitosis Modulators|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Neurotoxic agents|OATP1B3 substrates|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Taxane Derivatives|Taxoids|Terpenes|Tubulin Modulators",[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,36314
1209,DB01230,Pemoline,small molecule,approved|illicit|investigational|withdrawn,"Central Nervous System Agents|Central Nervous System Stimulants|Centrally Acting Sympathomimetics|Nervous System|Oxazoles|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics",NC1=NC(=O)C(O1)C1=CC=CC=C1,4723
1210,DB01231,Diphenidol,small molecule,approved|investigational|withdrawn,Agents producing tachycardia|Anticholinergic Agents|Antiemetics|Autonomic Agents|Central Nervous System Agents|Emesis Suppression|Gastrointestinal Agents|Muscarinic Antagonists|Peripheral Nervous System Agents,OC(CCCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1,3055
1211,DB01232,Saquinavir,small molecule,approved|investigational,"Agents Causing Muscle Toxicity|Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BCRP/ABCG2 Inhibitors|BSEP/ABCB11 Substrates|Chemically-Induced Disorders|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Inhibitors (strong)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A7 Inhibitors (strong)|Cytochrome P-450 CYP3A7 Inhibitors (weak)|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Direct Acting Antivirals|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|HIV Protease Inhibitors|Hyperglycemia-Associated Agents|Isoquinolines|Moderate Risk QTc-Prolonging Agents|OATP1B1/SLCO1B1 Inhibitors|OCT1 inhibitors|P-glycoprotein inducers|P-glycoprotein inhibitors|P-glycoprotein substrates|Protease Inhibitors|QTc Prolonging Agents|Quinolines",[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(N)=O)NC(=O)C1=NC3=C(C=CC=C3)C=C1)[C@@H](C2)C(=O)NC(C)(C)C,441243
1212,DB01233,Metoclopramide,small molecule,approved|investigational,"Acids, Carbocyclic|Agents Causing Muscle Toxicity|Alimentary Tract and Metabolism|Amides|Aminobenzoates|Antiemetics|Autonomic Agents|Benzamides and benzamide derivatives|Benzoates|Central Nervous System Agents|Central Nervous System Depressants|Chlorobenzoates|Cholinesterase Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs for Functional Gastrointestinal Disorders|Drugs that are Mainly Renally Excreted|Gastrointestinal Agents|Hydroxybenzoates|Methemoglobinemia Associated Agents|Neurotransmitter Agents|P-glycoprotein substrates|para-Aminobenzoates|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|Prokinetic Agents|Propulsives|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC,4168
1213,DB01234,Dexamethasone,small molecule,approved|investigational|vet_approved,"Adrenal Cortex Hormones|Adrenals|Agents Causing Muscle Toxicity|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Alimentary Tract and Metabolism|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Inflammatory Agents|Antiemetics|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Autonomic Agents|BCRP/ABCG2 Inhibitors|BSEP/ABCB11 inducers|Central Nervous System Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids for Local Oral Treatment|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Corticosteroids, Dermatological Preparations|Corticosteroids, Moderately Potent (Group II)|Cytochrome P-450 CYP2A6 Inducers|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP2E1 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (moderate)|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (moderate)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inducers|Cytochrome P-450 CYP3A7 Inducers (strength unknown)|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Experimental Unapproved Treatments for COVID-19|Fused-Ring Compounds|Gastrointestinal Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Inducers of Drug Clearance|Nasal Preparations|OAT3/SLC22A8 Substrates|Ophthalmological and Otological Preparations|Ophthalmologicals|Otologicals|P-glycoprotein inducers|P-glycoprotein inhibitors|P-glycoprotein substrates|Peripheral Nervous System Agents|Pregnadienes|Pregnadienetriols|Pregnanes|Sensory Organs|Steroids|Steroids, Fluorinated|Stomatological Preparations|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Vasoprotectives",[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,5743
1214,DB01235,Levodopa,small molecule,approved,"Amines|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Anti-Dyskinesia Agents|Anti-Parkinson Agents (Dopamine Agonist)|Anti-Parkinson Drugs|Benzene Derivatives|Biogenic Amines|Biogenic Monoamines|Catecholamines|Catechols|Central Nervous System Agents|Central Nervous System Depressants|Dihydroxyphenylalanine|Dopa and Dopa Derivatives|Dopamine Agents|Hypotensive Agents|Levodopa, antagonists & inhibitors|Nervous System|Neurotransmitter Agents|Phenols|Phenylalanine|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O,6047
1215,DB01236,Sevoflurane,small molecule,approved|vet_approved,"Agents that produce hypertension|Anesthetics|Anesthetics, General|Anesthetics, Inhalation|Antiplatelet agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Ethers|Hematologic Agents|Hydrocarbons, Fluorinated|Hydrocarbons, Halogenated|Hypotensive Agents|Methyl Ethers|Nervous System|Potential QTc-Prolonging Agents|QTc Prolonging Agents",FCOC(C(F)(F)F)C(F)(F)F,5206
1216,DB01237,Bromodiphenhydramine,small molecule,approved,Amines|Aminoalkyl Ethers|Antihistamines for Systemic Use|Benzene Derivatives|Benzhydryl Compounds|Ethylamines|Histamine Antagonists|Histamine H1 Antagonists,CN(C)CCOC(C1=CC=CC=C1)C1=CC=C(Br)C=C1,2444
1217,DB01238,Aripiprazole,small molecule,approved|investigational,"Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Anticholinergic Agents|Antidepressive Agents|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Aripiprazole and prodrugs|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Agonists|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Heterocyclic Compounds, Fused-Ring|Histamine Antagonists|Histamine H1 Antagonists|Hyperglycemia-Associated Agents|Muscarinic Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Piperazines|Potential QTc-Prolonging Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|QTc shortening agents|Quinolines|Quinolones|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Agonists|Serotonin Receptor Antagonists|Tranquilizing Agents",ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,60795
1218,DB01239,Chlorprothixene,small molecule,approved|experimental|investigational|withdrawn,"Agents producing tachycardia|Anticholinergic Agents|Antidepressive Agents|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Heterocyclic Compounds, Fused-Ring|Histamine Antagonists|Histamine H1 Antagonists|Muscarinic Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|P-glycoprotein inhibitors|Potential QTc-Prolonging Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Thioxanthene Derivatives|Thioxanthenes|Tranquilizing Agents|Xanthenes",CN(C)CC\C=C1\C2=CC=CC=C2SC2=CC=C(Cl)C=C12,667466
1219,DB01240,Epoprostenol,small molecule,approved,"Anticoagulants|Antihypertensive Agents|Antiplatelet agents|Autacoids|Biological Factors|Blood and Blood Forming Organs|Cardiovascular Agents|Drugs that are Mainly Renally Excreted|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Hematologic Agents|Hypotensive Agents|Inflammation Mediators|Lipids|Platelet Aggregation Inhibitors Excl. Heparin|Prostacyclin Analogues|Prostacycline Vasodilator|Prostaglandins|Prostaglandins I|Vasodilating Agents|Vasodilation",[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)CCCCC)[C@@]1([H])C\C(O2)=C\CCCC(O)=O,5280427
1220,DB01241,Gemfibrozil,small molecule,approved,"Acids, Acyclic|Agents Causing Muscle Toxicity|Benzene Derivatives|Butyrates|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Ethers|Fatty Acids|Fatty Acids, Volatile|Fibric Acids|Fribic Acid Derivatives|Hypolipidemic Agents|Hypolipidemic Agents Indicated for Hyperlipidemia|Isobutyrates|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Lipids|Noxae|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Pentanoic Acids|Peroxisome Proliferator Receptor alpha Agonist|Peroxisome Proliferator-activated Receptor alpha Agonists|Phenols|Phenyl Ethers|Photosensitizing Agents|Toxic Actions|UGT1A1 Inhibitors|UGT1A1 Substrates|UGT1A3 Inhibitors|UGT1A3 substrates|UGT1A9 Substrates|UGT2B7 substrates|Valerates",CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1,3463
1221,DB01242,Clomipramine,small molecule,approved|investigational|vet_approved,"Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Antidepressive Agents, Tricyclic|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dibenzazepines|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Non-Selective Monoamine Reuptake Inhibitors|P-glycoprotein inhibitors|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists|Tertiary amine tricyclic antidepressants|Tricyclics and Other Norepinephrine-reuptake Inhibitors",CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,2801
1222,DB01243,Chloroxine,small molecule,approved,"Anti-Bacterial Agents|Anti-Infective Agents|Antifungal Agents|Heterocyclic Compounds, Fused-Ring|Hydroxyquinolines|Quinolines",OC1=C(Cl)C=C(Cl)C2=C1N=CC=C2,2722
1223,DB01244,Bepridil,small molecule,approved|withdrawn,Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Highest Risk QTc-Prolonging Agents|Hypotensive Agents|Membrane Transport Modulators|Non-Selective Calcium Channel Blockers|P-glycoprotein inhibitors|Phenylalkylamine Derivatives|Pyrrolidines|QTc Prolonging Agents|Vasodilating Agents,CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1,2351
1224,DB01245,Decamethonium,small molecule,approved,Amines|Ammonium Compounds|Bis-Trimethylammonium Compounds|Central Nervous System Depressants|Cholinesterase Inhibitors|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular Depolarizing Agents|Neurotoxic agents|Nitrogen Compounds|Onium Compounds|Peripheral Nervous System Agents|Quaternary Ammonium Compounds,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,2968
1225,DB01246,Alimemazine,small molecule,approved|vet_approved,"Antihistamines for Systemic Use|Antipruritics|Antipsychotic Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 Enzyme Inducers|Dermatologicals|Heterocyclic Compounds, Fused-Ring|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotoxic agents|Neurotransmitter Agents|Phenothiazine Derivatives|Phenothiazines|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sulfur Compounds",CC(CN(C)C)CN1C2=CC=CC=C2SC2=CC=CC=C12,5574
1226,DB01247,Isocarboxazid,small molecule,approved,"Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Hypotensive Agents|Isoxazoles|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Monoamine Oxidase Inhibitors|Monoamine Oxidase Inhibitors, Non-Selective|Nervous System|Photosensitizing Agents|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators",CC1=CC(=NO1)C(=O)NNCC1=CC=CC=C1,3759
1227,DB01248,Docetaxel,small molecule,approved|investigational,Agents Causing Muscle Toxicity|Antimitotic Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Cardiotoxic antineoplastic agents|Cyclodecanes|Cycloparaffins|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Diterpenes|Hepatotoxic Agents|Immunosuppressive Agents|Microtubule Inhibition|Microtubule Inhibitors|Mitosis Modulators|Myelosuppressive Agents|OATP1B3 substrates|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Taxane Derivatives|Taxoids|Terpenes|Tubulin Modulators,[H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,148124
1228,DB01249,Iodixanol,small molecule,approved,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Drugs that are Mainly Renally Excreted|Iodinated Contrast Agents|Iodobenzoates|Radiographic Contrast Agent|Roentgenography|Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media|X-Ray Contrast Activity|X-Ray Contrast Media, Iodinated",CC(=O)N(CC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I,3724
1229,DB01250,Olsalazine,small molecule,approved,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Alimentary Tract and Metabolism|Aminosalicylate|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Gastrointestinal Agents|Hydroxy Acids|Hydroxybenzoates|Intestinal Antiinflammatory Agents|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Phenols|Salicylates|Sensory System Agents",OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(O)C(=C1)C(O)=O,6003770
1230,DB01251,Gliquidone,small molecule,approved|investigational,Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Drugs Used in Diabetes|Sulfones|Sulfonylureas|Sulfur Compounds,COC1=CC2=C(C=C1)C(C)(C)C(=O)N(CCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1)C2=O,91610
1231,DB01252,Mitiglinide,small molecule,investigational,"Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Drugs Used in Diabetes|Heterocyclic Compounds, Fused-Ring|UGT1A3 substrates|UGT2B7 substrates",[H][C@@](CC(=O)N1C[C@@]2([H])CCCC[C@@]2([H])C1)(CC1=CC=CC=C1)C(O)=O,121891
1232,DB01253,Ergometrine,small molecule,approved,"Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alkaloids|Antidepressive Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Ergolines|Ergot Alkaloids and Derivatives|Genito Urinary System and Sex Hormones|Heterocyclic Compounds, Fused-Ring|P-glycoprotein inhibitors|Reproductive Control Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Uterotonic agents",[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](C)CO,443884
1233,DB01254,Dasatinib,small molecule,approved|investigational,Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Immunosuppressive Agents|Kinase Inhibitor|Myelosuppressive Agents|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Photosensitizing Agents|Potential QTc-Prolonging Agents|Protein Kinase Inhibitors|Pyrimidines|QTc Prolonging Agents|Sulfur Compounds|Thiazoles|Tyrosine Kinase Inhibitors,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,3062316
1234,DB01255,Lisdexamfetamine,small molecule,approved|investigational,"Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Central Nervous System Agents|Central Nervous System Stimulants|Central Nervous System Stimulation|Centrally Acting Sympathomimetics|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Uptake Inhibitors|Ethylamines|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Phenethylamines|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetics",C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN,11597698
1235,DB01256,Retapamulin,small molecule,approved,Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics for Topical Use|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dermatologicals|Pleuromutilin Antibacterial|Terpenes,[H][C@@]12C(=O)CC[C@]11CC[C@@H](C)[C@@]2(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]1C)OC(=O)CS[C@H]1C[C@@H]2CC[C@H](C1)N2C,6918462
1237,DB01259,Lapatinib,small molecule,approved|investigational,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Hepatotoxic Agents|Heterocyclic Compounds, Fused-Ring|Kinase Inhibitor|P-glycoprotein inhibitors|Potential QTc-Prolonging Agents|Protein Kinase Inhibitors|QTc Prolonging Agents|Quinazolines|Tyrosine Kinase Inhibitors",CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,208908
1238,DB01260,Desonide,small molecule,approved|investigational,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Moderately Potent (Group II)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Dermatologicals|Fused-Ring Compounds|Immunosuppressive Agents|Ophthalmologicals|Pregnadienes|Pregnadienetriols|Pregnanes|Sensory Organs|Steroids",[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,5311066
1239,DB01261,Sitagliptin,small molecule,approved|investigational,"Agents causing angioedema|Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|DPP-IV Inhibitors|Drugs that are Mainly Renally Excreted|Drugs Used in Diabetes|Enzyme Inhibitors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypoglycemia-Associated Agents|Incretins|OAT3/SLC22A8 Substrates|P-glycoprotein substrates|Protease Inhibitors|Triazoles",N[C@@H](CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F)CC1=CC(F)=C(F)C=C1F,4369359
1240,DB01262,Decitabine,small molecule,approved|investigational,"Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Aza Compounds|Carbohydrates|Enzyme Inhibitors|Glycosides|Immunosuppressive Agents|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Metabolic Inhibitor|Nucleosides|Pyrimidine Analogues|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides|Toxic Actions",NC1=NC(=O)N(C=N1)[C@H]1C[C@H](O)[C@@H](CO)O1,451668
1241,DB01263,Posaconazole,small molecule,approved|investigational|vet_approved,"14-alpha Demethylase Inhibitors|Anti-Infective Agents|Antifungal Agents|Antiinfectives for Systemic Use|Antimycotics for Systemic Use|Antiparasitic Agents|Antiprotozoals|Azole Antifungals|Chemically-Induced Disorders|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|P-glycoprotein inhibitors|P-glycoprotein substrates|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Steroid Synthesis Inhibitors|Triazole Derivatives|Trypanocidal Agents",[H][C@@](C)(O)[C@]([H])(CC)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@]2([H])CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,468595
1242,DB01264,Darunavir,small molecule,approved,Amides|Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Carbamates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Direct Acting Antivirals|Enzyme Inhibitors|Experimental Unapproved Treatments for COVID-19|Furans|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|HIV Protease Inhibitors|Hyperglycemia-Associated Agents|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein inducers|P-glycoprotein inhibitors|Protease Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds,[H][C@@]12CCO[C@]1([H])OC[C@@H]2OC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](O)CN(CC(C)C)S(=O)(=O)C1=CC=C(N)C=C1,213039
1243,DB01265,Telbivudine,small molecule,approved|investigational,"Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Carbohydrates|Deoxyribonucleosides|Direct Acting Antivirals|Enzyme Inhibitors|Glycosides|Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|Nucleoside Reverse Transcriptase Inhibitors|Nucleosides|Nucleosides and Nucleotides|Pyrimidine Nucleosides|Pyrimidines",CC1=CN([C@@H]2C[C@@H](O)[C@H](CO)O2)C(=O)NC1=O,159269
1244,DB01266,Sinecatechins,small molecule,approved|investigational|nutraceutical,Antiviral Agents|Dermatologicals,,
1245,DB01267,Paliperidone,small molecule,approved,Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antidepressive Agents|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs that are Mainly Renally Excreted|Highest Risk QTc-Prolonging Agents|Hyperglycemia-Associated Agents|Isoxazoles|Nervous System|Neurotoxic agents|Neurotransmitter Agents|P-glycoprotein inhibitors|P-glycoprotein substrates|Psycholeptics|Psychotropic Drugs|Pyrimidines|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Tranquilizing Agents,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,115237
1246,DB01268,Sunitinib,small molecule,approved|investigational,"Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|Blood Glucose Lowering Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Growth Inhibitors|Growth Substances|Hepatotoxic Agents|Heterocyclic Compounds, Fused-Ring|Hypoglycemia-Associated Agents|Immunosuppressive Agents|Indoles|Kinase Inhibitor|Narrow Therapeutic Index Drugs|P-glycoprotein inhibitors|P-glycoprotein substrates|Potential QTc-Prolonging Agents|Protein Kinase Inhibitors|QTc Prolonging Agents|Tyrosine Kinase Inhibitors",CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,5329102
1251,DB01273,Varenicline,small molecule,approved|investigational,"Benzazepines|Cholinergic Agents|Cholinergic Agonists|Drugs that are Mainly Renally Excreted|Drugs Used in Addictive Disorders|Drugs Used in Nicotine Dependence|Heterocyclic Compounds, Fused-Ring|Miscellaneous Autonomic Drugs|Nervous System|Neurotransmitter Agents|Nicotinic Agonists|OCT2 Inhibitors|OCT2 Substrates|Partial Cholinergic Nicotinic Agonist|Partial Cholinergic Nicotinic Agonists|Quinoxalines|Smoking Cessation Agents",C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,5310966
1252,DB01274,Arformoterol,small molecule,approved|investigational,Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Ethanolamines|Neurotransmitter Agents|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Respiratory System Agents,COC1=CC=C(C[C@@H](C)NC[C@H](O)C2=CC(NC=O)=C(O)C=C2)C=C1,3083544
1253,DB01275,Hydralazine,small molecule,approved,"Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Arteriolar Smooth Muscle, Agents Acting On|Arteriolar Vasodilation|Arteriolar Vasodilator|Cardiovascular Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Direct Vasodilators|Drugs that are Mainly Renally Excreted|Hydrazinophthalazine Derivatives|Hydrazinophthalazine Derivatives and Diuretics|Hypotensive Agents|Phthalazines|Pyridazines|Vasodilating Agents",NNC1=NN=CC2=CC=CC=C12,3637
1256,DB01278,Pramlintide,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Amylin Agonists|Amylin Analog|Amyloid|Amyloidogenic Proteins|Blood Glucose Lowering Agents|Drugs Used in Diabetes|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypoglycemia-Associated Agents|Macromolecular Substances|Multiprotein Complexes|Pancreatic Hormones|Peptide Hormones|Peptides|Proteins",[H]N[C@@H](CCCCN)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@]([H])(NC(=O)[C@H](C)NC(=O)[C@@]([H])(NC(=O)[C@H](CC(N)=O)NC1=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(N)=O,
1258,DB01280,Nelarabine,small molecule,approved|investigational,"Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Glycosides|Immunosuppressive Agents|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Metabolic Inhibitor|Nucleosides|Purine Analogues",COC1=NC(N)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,3011155
1260,DB01282,Carbetocin,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Delayed-Action Preparations|Drug Delivery Systems|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypotensive Agents|Investigative Techniques|Oxytocin and Analogues|Peptide Hormones|Peptides|Pharmaceutical Preparations|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormones|Pituitary Hormones, Posterior|Posterior Pituitary Lobe Hormones|Reproductive Control Agents|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Uterotonic agents",[H][C@]1(NC(=O)[C@H](CC2=CC=C(OC)C=C2)NC(=O)CCCSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)[C@@H](C)CC,16681432
1261,DB01283,Lumiracoxib,small molecule,approved|investigational,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|COX-2 Inhibitors|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Phenylacetates|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory System Agents|UGT1A9 Substrates",CC1=CC=C(NC2=C(Cl)C=CC=C2F)C(CC(O)=O)=C1,151166
1262,DB01284,Tetracosactide,small molecule,approved,"Adrenals|Adrenocortical Insufficiency|Adrenocorticotropic Hormone|Amino Acids, Peptides, and Proteins|Anterior Pituitary Lobe Hormones and Analogues|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Melanocortins|Nerve Tissue Proteins|Neuropeptides|Peptide Hormones|Peptides|Pituitary|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormones|Pituitary Hormones, Anterior|Pro-Opiomelanocortin|Protein Precursors|Proteins|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(O)=O,16133751
1264,DB01288,Fenoterol,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Anticholinergic Agents|Autonomic Agents|Benzene Derivatives|Bronchodilator Agents|Catechols|Drugs for Obstructive Airway Diseases|Ethanolamines|Genito Urinary System and Sex Hormones|Metaproterenol|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenols|Reproductive Control Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists|Sympathomimetics|Sympathomimetics, Labour Repressants|Tocolytic Agents",CC(CC1=CC=C(O)C=C1)NCC(O)C1=CC(O)=CC(O)=C1,3343
1265,DB01289,Glisoxepide,small molecule,investigational,Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Drugs Used in Diabetes|Sulfones|Sulfonylureas|Sulfur Compounds,CC1=CC(=NO1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CCCCCC1,32778
1266,DB01291,Pirbuterol,small molecule,approved,"Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Drugs for Obstructive Airway Diseases|Neurotransmitter Agents|Peripheral Nervous System Agents|Protective Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists",CC(C)(C)NCC(O)C1=NC(CO)=C(O)C=C1,4845
1267,DB01294,Bismuth subsalicylate,small molecule,approved|vet_approved,"Acids, Carbocyclic|Antacids and Adsorbents|Antidiarrheals|Benzene Derivatives|Benzoates|Bismuth containing drugs|Elements|Elements, Radioactive|Gastrointestinal Agents|Helicobacter Infections|Hydroxy Acids|Hydroxybenzoates|Isotopes|Metals|Metals, Heavy|Neurotoxic agents|Phenols|Radioisotopes|Salicylates",O[Bi]1OC(=O)C2=CC=CC=C2O1,16682734
1268,DB01295,Bevantolol,small molecule,experimental,"Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Adrenergic beta-1 Receptor Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antihypertensive Agents|Beta Blocking Agents and Thiazides|Beta Blocking Agents, Selective|Beta Blocking Agents, Selective, and Thiazides|Bradycardia-Causing Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Neurotransmitter Agents|Propanols",COC1=C(OC)C=C(CCNCC(O)COC2=CC=CC(C)=C2)C=C1,2372
1269,DB01296,Glucosamine,small molecule,approved|investigational,"Amino Sugars|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Carbohydrates|Hexosamines|Musculo-Skeletal System",N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O,439213
1270,DB01297,Practolol,small molecule,approved,"Acetanilides|Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-1 Receptor Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amides|Amines|Amino Alcohols|Anilides|Aniline Compounds|Antiarrhythmic agents|Antihypertensive Agents|Beta Blocking Agents, Selective|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Neurotransmitter Agents|Phenoxypropanolamines|Propanolamines|Propanols",CC(C)NCC(O)COC1=CC=C(NC(C)=O)C=C1,4883
1271,DB01298,Sulfacytine,small molecule,approved,Amides|Amines|Aniline Compounds|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Sulfonamides|Sulfones|Sulfur Compounds,CCN1C=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NC1=O,5322
1272,DB01299,Sulfadoxine,small molecule,approved|investigational,"Amides|Amines|Aniline Compounds|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antimalarials|Antiparasitic Agents|Antiprotozoals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Long-Acting Sulfonamides|Renal Agents|Sulfanilamides|Sulfonamides|Sulfones|Sulfur Compounds",COC1=NC=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1OC,17134
1273,DB01301,Rolitetracycline,small molecule,approved,Agents that produce neuromuscular block (indirect)|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Naphthacenes|Tetracyclines,[H][C@@]12C[C@@]3([H])C(C(=O)C4=C(O)C=CC=C4[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(=O)NCN1CCCC1)=C(O)[C@H]2N(C)C,54682938
1274,DB01303,Oxtriphylline,small molecule,approved,"Alcohols|Alkaloids|Amines|Amino Alcohols|Ammonium Compounds|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Drugs for Obstructive Airway Diseases|Ethanolamines|Heterocyclic Compounds, Fused-Ring|Nitrogen Compounds|Onium Compounds|Peripheral Nervous System Agents|Purines|Purinones|Quaternary Ammonium Compounds|Respiratory Smooth Muscle Relaxants|Respiratory System Agents|Trimethyl Ammonium Compounds|Xanthine derivatives|Xanthines and Adrenergics",C[N+](C)(C)CCO.CN1C2=C([N-]C=N2)C(=O)N(C)C1=O,656652
1278,DB01319,Fosamprenavir,small molecule,approved,"Acids, Acyclic|Amides|Amprenavir and Prodrugs|Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Direct Acting Antivirals|Enzyme Inhibitors|HIV Protease Inhibitors|Hyperglycemia-Associated Agents|Organophosphorus Compounds|Protease Inhibitors|Sulfones|Sulfur Compounds",CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)C1=CC=C(N)C=C1,131536
1279,DB01320,Fosphenytoin,small molecule,approved|investigational,Anti-epileptic Agent|Anticonvulsants|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strong)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Decreased Central Nervous System Disorganized Electrical Activity|Enzyme Inducing Antiepileptic Drugs|Hydantoins|Imidazoles|Imidazolidines|Membrane Transport Modulators|Narrow Therapeutic Index Drugs|Nervous System|Phenytoin and Prodrugs|Prodrugs|Sodium Channel Blockers|Thyroxine-binding globulin substrates|UGT1A6 Inhibitors|UGT1A9 Inhibitors,OP(O)(=O)OCN1C(=O)NC(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1,56339
1280,DB01321,Josamycin,small molecule,investigational,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Macrolides, Lincosamides and Streptogramins|Polyketides",CO[C@H]1[C@@H](CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]1O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O2)[C@@H]([C@H]1O)N(C)C)OC(C)=O,5282165
1281,DB01322,Kava,small molecule,approved|investigational|nutraceutical,,COC1=CC(=O)OC(C1)\C=C\C1=CCCC=C1,5281052
1282,DB01323,St. John's Wort,small molecule,approved|investigational|nutraceutical,Antidepressive Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Herbs and Natural Products|Hyperglycemia-Associated Agents|Nervous System|P-glycoprotein inducers|Psychoanaleptics|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,,
1283,DB01324,Polythiazide,small molecule,approved,"Amides|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Benzothiadiazines|Cardiovascular Agents|Diuretics|Drugs causing inadvertant photosensitivity|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Heterocyclic Compounds, Fused-Ring|Hyperglycemia-Associated Agents|Increased Diuresis|Membrane Transport Modulators|Natriuretic Agents|OAT3/SLC22A8 Substrates|Photosensitizing Agents|Sodium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds|Thiazides",CN1C(CSCC(F)(F)F)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O,4870
1284,DB01325,Quinethazone,small molecule,approved,"Amides|Cardiovascular Agents|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Heterocyclic Compounds, Fused-Ring|Low-Ceiling Diuretics, Excl. Thiazides|Membrane Transport Modulators|Natriuretic Agents|Sodium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds",CCC1NC(=O)C2=CC(=C(Cl)C=C2N1)S(N)(=O)=O,6307
1285,DB01326,Cefamandole,small molecule,approved|experimental,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|Second-Generation Cephalosporins|Sulfur Compounds|Thiazines",[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@H]2NC(=O)[C@H](O)C1=CC=CC=C1)C(O)=O,456255
1286,DB01327,Cefazolin,small molecule,approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|First-Generation Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|OAT1/SLC22A6 inhibitors|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Sulfur Compounds|Thiazines",[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O,33255
1287,DB01328,Cefonicid,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Second-Generation Cephalosporins|Sulfur Compounds|Thiazines",[H][C@]12SCC(CSC3=NN=NN3CS(O)(=O)=O)=C(N1C(=O)[C@H]2NC(=O)[C@H](O)C1=CC=CC=C1)C(O)=O,43594
1288,DB01329,Cefoperazone,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins",[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=C(O)C=C1)C(O)=O,44185
1289,DB01330,Cefotetan,small molecule,approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|Cephamycins|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Second-Generation Cephalosporins|Sulfur Compounds|Tetrazoles|Thiazines",[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)C1SC(S1)=C(C(N)=O)C(O)=O)OC)C(O)=O,53025
1290,DB01331,Cefoxitin,small molecule,approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|Cephamycins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Second-Generation Cephalosporins|Sulfur Compounds|Thiazines",[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O,441199
1291,DB01332,Ceftizoxime,small molecule,approved|withdrawn,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephacetrile|Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|OAT1/SLC22A6 inhibitors|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins",[H][C@]12SCC=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,6533629
1292,DB01333,Cefradine,small molecule,approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Drugs that are Mainly Renally Excreted|First-Generation Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|MATE 1 Substrates|MATE substrates|Nephrotoxic agents|OAT1/SLC22A6 inhibitors|Sulfur Compounds|Thiazines",[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CCC=CC1)C(O)=O,38103
1293,DB01336,Metocurine,small molecule,approved,"Agents producing tachycardia|Alkaloids|Amines|Ammonium Compounds|Anticholinergic Agents|Benzylisoquinolines|Central Nervous System Depressants|Curare Alkaloids|Drugs, Chinese Herbal|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Muscarinic Antagonists|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular-Blocking Agents (Nondepolarizing)|Nicotinic Antagonists|Nitrogen Compounds|Onium Compounds|Peripheral Nervous System Agents|Quaternary Ammonium Compounds|Tetrahydroisoquinolines",[H][C@@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC(OC6=C(OC)C=C(CC[N+]1(C)C)C2=C6)=C(OC)C=C5)=CC(OC)=C4OC)C=C3,21233
1294,DB01337,Pancuronium,small molecule,approved,"Agents producing tachycardia|Androstanes|Androstanols|Anticholinergic Agents|Central Nervous System Depressants|Cholinergic Agents|Cholinesterase Inhibitors|Fused-Ring Compounds|Muscarinic Antagonists|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular Nondepolarizing Blockade|Neuromuscular-Blocking Agents (Nondepolarizing)|Neurotransmitter Agents|Nicotinic Antagonists|OCT1 inhibitors|OCT1 substrates|Peripheral Nervous System Agents|Steroids",[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)[N+]1(C)CCCCC1)[N+]1(C)CCCCC1,441289
1295,DB01338,Pipecuronium,small molecule,approved,"Agents producing tachycardia|Anticholinergic Agents|Central Nervous System Depressants|Cholinergic Agents|Cholinesterase Inhibitors|Muscarinic Antagonists|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular-Blocking Agents (Nondepolarizing)|Neurotransmitter Agents|Nicotinic Antagonists|Peripheral Nervous System Agents|Piperazines",[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CC[N+](C)(C)CC1)N1CC[N+](C)(C)CC1,50192
1296,DB01339,Vecuronium,small molecule,approved|investigational,"Androstanes|Androstanols|Anticholinergic Agents|Central Nervous System Depressants|Cholinergic Agents|Fused-Ring Compounds|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular Nondepolarizing Blockade|Neuromuscular-Blocking Agents (Nondepolarizing)|Neurotransmitter Agents|Nicotinic Antagonists|P-glycoprotein substrates|Peripheral Nervous System Agents|Steroids",[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(C)CCCCC1,39765
1297,DB01340,Cilazapril,small molecule,approved,ACE Inhibitors and Diuretics|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Cardiovascular Agents|Enzyme Inhibitors|Hypotensive Agents|P-glycoprotein inhibitors|Protease Inhibitors|Pyridazines,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]1CCCN2CCC[C@H](N2C1=O)C(O)=O,56330
1298,DB01341,Dihydroquinidine barbiturate,small molecule,experimental,,,
1299,DB01342,Forasartan,small molecule,experimental,Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Angiotensin II Type 1 Receptor Blockers|Angiotensin Receptor Antagonists,CCCCC1=NN(CC2=CN=C(C=C2)C2=CC=CC=C2C2=NNN=N2)C(CCCC)=N1,132706
1300,DB01344,Tolevamer,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Benzene Derivatives|Benzylidene Compounds|Cation Exchange Resins|Chelating Agents|Compounds used in a research, industrial, or household setting|Drugs for Treatment of Hyperkalemia and Hyperphosphatemia|Ion Exchange Resins|Laboratory Chemicals|Macromolecular Substances|Plastics|Polymers|Polystyrene Sulfonates|Potassium Binder|Potassium Ion Exchange Activity|Potassium-removing Agents|Sequestering Agents|Styrene|Styrenes|Sulfur Acids|Sulfur Compounds",,
1301,DB01345,Potassium cation,small molecule,approved|investigational,Agents causing hyperkalemia|Diuretics|Drugs that are Mainly Renally Excreted|Increased Large Intestinal Motility|Inhibition Large Intestine Fluid/Electrolyte Absorption|Minerals|Osmotic Activity|Potassium Salt|Replacement Preparations,[K+],5462222
1302,DB01346,Quinidine barbiturate,small molecule,approved,,CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1.COC1=CC2=C(C=CN=C2C=C1)C(O)C1CC2CCN1CC2C=C,53461739
1303,DB01347,Saprisartan,small molecule,experimental,"Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Angiotensin II Type 1 Receptor Blockers|Angiotensin Receptor Antagonists|Antihypertensive Agents|Cardiovascular Agents|Heterocyclic Compounds, Fused-Ring",CCC1=NC(C2CC2)=C(N1CC1=CC2=C(OC(=C2Br)C2=CC=CC=C2NS(=O)(=O)C(F)(F)F)C=C1)C(N)=O,60921
1304,DB01348,Spirapril,small molecule,approved,"Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Amino Acids, Peptides, and Proteins|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Dipeptides|Enzyme Inhibitors|Oligopeptides|Peptides|Protease Inhibitors",CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(O)=O)SCCS2,5311447
1305,DB01349,Tasosartan,small molecule,experimental,"Agents Acting on the Renin-Angiotensin System|Agents causing hyperkalemia|Angiotensin II receptor blockers (ARBs), plain|Angiotensin Receptor Antagonists|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates",CC1=NC(C)=C2CCC(=O)N(CC3=CC=C(C=C3)C3=CC=CC=C3C3=NNN=N3)C2=N1,60919
1306,DB01351,Amobarbital,small molecule,approved|illicit,"Anticholinergic Agents|Anticonvulsants|Barbiturates|Barbiturates, Plain|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Nicotinic Antagonists|Psycholeptics|Pyrimidines|Pyrimidinones",CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,2164
1307,DB01352,Aprobarbital,small molecule,experimental|illicit,"Anticholinergic Agents|Barbiturates, Plain|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Hypnotics and Sedatives|Nervous System|Nicotinic Antagonists|Psycholeptics|Pyrimidines|Pyrimidinones",CC(C)C1(CC=C)C(=O)NC(=O)NC1=O,6464
1308,DB01353,Butobarbital,small molecule,approved|illicit,"Anticholinergic Agents|Barbiturates, Plain|Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Nicotinic Antagonists|Psycholeptics|Pyrimidines|Pyrimidinones",CCCCC1(CC)C(=O)NC(=O)NC1=O,6473
1309,DB01354,Heptabarbital,small molecule,experimental,"Anticholinergic Agents|Barbiturates, Plain|Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Nicotinic Antagonists|Psycholeptics|Pyrimidines|Pyrimidinones",CCC1(C(=O)NC(=O)NC1=O)C1=CCCCCC1,10518
1310,DB01355,Hexobarbital,small molecule,experimental,"Adjuvants|Anesthetics|Anesthetics, General|Anticholinergic Agents|Anticonvulsants|Barbiturates|Barbiturates, Plain|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Nicotinic Antagonists|Psycholeptics|Pyrimidines|Pyrimidinones",CN1C(=O)NC(=O)C(C)(C1=O)C1=CCCCC1,3608
1311,DB01356,Lithium cation,small molecule,experimental,Antidepressive Agents|Antimanic Agents|Antipsychotic Agents|Central Nervous System Depressants|Drugs that are Mainly Renally Excreted|Highest Risk QTc-Prolonging Agents|Lithium Compounds|Mood Stabilizer|Nephrotoxic agents|Neurotoxic agents|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators,[Li+],28486
1312,DB01357,Mestranol,small molecule,approved,"Adrenal Cortex Hormones|Contraceptive Agents, Female|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Estradiol Congeners|Estrogen Contraceptives|Estrogenic Steroids, Alkylated|Estrogens|Ethinyl Estradiol|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Norpregnanes|Norpregnatrienes|Norsteroids|Steroids|Thyroxine-binding globulin inducers",[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC)C=C3,6291
1313,DB01359,Penbutolol,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antidepressive Agents|Antihypertensive Agents|Beta Blocking Agents, Non-Selective|Bradycardia-Causing Agents|Cardiovascular Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Hypotensive Agents|Neurotransmitter Agents|Phenoxypropanolamines|Propanolamines|Propanols|Serotonin 5-HT1 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists",CC(C)(C)NC[C@H](O)COC1=CC=CC=C1C1CCCC1,37464
1314,DB01362,Iohexol,small molecule,approved,"Acids, Carbocyclic|Agents that reduce seizure threshold|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Iodinated Contrast Agents|Iodobenzoates|Radiographic Contrast Agent|Roentgenography|Triiodobenzoic Acids|Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media|X-Ray Contrast Activity|X-Ray Contrast Media, Iodinated",CC(=O)N(CC(O)CO)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I,3730
1316,DB01364,Ephedrine,small molecule,approved,"Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Alimentary Tract and Metabolism|Alpha-and Beta-adrenergic Agonists|Amines|Amino Alcohols|Antidepressive Agents|Antiobesity Preparations, Excl. Diet Products|Autonomic Agents|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Stimulants|Centrally Acting Antiobesity Products|Cholinesterase substrates|Drugs for Obstructive Airway Diseases|Epinephrine and similars|Ethylamines|Herbs and Natural Products|Increased Norepinephrine Activity|Mydriatics and Cycloplegics|Nasal Preparations|Neurotransmitter Agents|Norepinephrine Releasing Agent|Ophthalmologicals|Peripheral Nervous System Agents|Phenethylamines|Propanolamines|Propanols|Sensory Organs|Sympathomimetic (Adrenergic) Agents|Sympathomimetics|Sympathomimetics Excl. Antiglaucoma Preparations|Sympathomimetics, Plain|Vasoconstrictor Agents",CN[C@@H](C)[C@H](O)C1=CC=CC=C1,9294
1317,DB01365,Mephentermine,small molecule,approved,Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Autonomic Agents|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Ethylamines|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenethylamines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetics|Vasoconstrictor Agents,CNC(C)(C)CC1=CC=CC=C1,3677
1318,DB01366,Procaterol,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Drugs for Obstructive Airway Diseases|Ethanolamines|Heterocyclic Compounds, Fused-Ring|Hydroxyquinolines|Neurotransmitter Agents|Peripheral Nervous System Agents|Quinolines|Respiratory System Agents|Selective Beta 2-adrenergic Agonists|Sympathomimetics",CC[C@H](NC(C)C)[C@H](O)C1=C2C=CC(=O)NC2=C(O)C=C1,688561
1319,DB01367,Rasagiline,small molecule,approved,"Agents that produce hypertension|Agents that reduce seizure threshold|Anti-Parkinson Drugs|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Dopamine Agents|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Hypotensive Agents|Indenes|Monoamine Oxidase B Inhibitors|Monoamine Oxidase Inhibitors|Nervous System|Neuroprotective Agents|Protective Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators",C#CCN[C@@H]1CCC2=CC=CC=C12,3052776
1320,DB01369,Quinupristin,small molecule,approved,"Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Peptides|Peptides, Cyclic|Streptogramin Antibacterial|Streptogramins",[H][C@@]12CCCN1C(=O)[C@@H](CC)NC(=O)[C@@H](NC(=O)C1=NC=CC=C1O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@]1([H])CC(=O)[C@]([H])(CS[C@@H]3CN4CCC3CC4)CN1C(=O)[C@H](CC1=CC=C(C=C1)N(C)C)N(C)C2=O)C1=CC=CC=C1,5388937
1321,DB01370,Aluminium,small molecule,approved|investigational,"Aluminium Compounds|Aluminum and magnesium containing antacids|Antacids|Elements|Gastric Acid Lowering Agents|Metal cations|Metal divalent cations|Metals|Metals, Light",[Al],5359268
1322,DB01373,Calcium,small molecule,nutraceutical,"Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Antacids and Adsorbents|Biological Factors|Blood Coagulation Factors|Blood Proteins|Calcium Salts|Calcium-Regulating Hormones and Agents|Calcium, agonists|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Elements|Metals|Metals, Alkaline Earth|Minerals|Musculo-Skeletal System|Phosphate Binder|Phosphate Chelating Activity|Proteins|Replacement Preparations",[Ca],5460341
1323,DB01375,Aluminium monostearate,small molecule,experimental,Fatty Acids|Lipids,CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O,16682987
1324,DB01377,Magnesium oxide,small molecule,approved,"Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Aluminum and magnesium containing antacids|Anions|Antacids|Calculi Dissolution Agent|Drugs for Acid Related Disorders|Drugs for Constipation|Electrolytes|Gastric Acid Lowering Agents|Gastrointestinal Agents|Ions|Laxatives|Laxatives, magnesium containing|Magnesium Compounds|Magnesium Salts|Metal cations|Metal divalent cations|Mineral Supplements|Minerals|Osmotic Laxatives|Oxides|Oxygen Compounds",[O--].[Mg++],14792
1325,DB01378,Magnesium cation,small molecule,approved|nutraceutical,"Agents that produce neuromuscular block (indirect)|Calculi Dissolution Agent|Increased Large Intestinal Motility|Inhibition Large Intestine Fluid/Electrolyte Absorption|Inhibition Small Intestine Fluid/Electrolyte Absorption|Laxatives|Magnesium Ion Exchange Activity|Minerals|Osmotic Activity|Osmotic Laxatives|Polyvalent cation containing laxatives, antacids, oral supplements|Stimulation Large Intestine Fluid/Electrolyte Secretion",[Mg++],888
1326,DB01380,Cortisone acetate,small molecule,approved|investigational,"17-Hydroxycorticosteroids|Adrenal Cortex Hormones|Adrenals|Anti-Inflammatory Agents|Corticosteroids|Corticosteroids for Systemic Use|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Pregnanes|Pregnenes|Steroids",[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,5745
1328,DB01382,Glymidine,small molecule,approved|investigational,Alimentary Tract and Metabolism|Amides|Blood Glucose Lowering Agents|Drugs Used in Diabetes|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Sulfonamides|Sulfones|Sulfur Compounds,COCCOC1=CN=C(NS(=O)(=O)C2=CC=CC=C2)N=C1,9565
1329,DB01384,Paramethasone,small molecule,experimental,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,5875
1330,DB01388,Mibefradil,small molecule,investigational|withdrawn,"Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Benzimidazoles|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Naphthalenes|P-glycoprotein inhibitors|P-glycoprotein substrates|QTc Prolonging Agents|Selective Calcium Channel Blockers With Mainly Vascular Effects|Tetrahydronaphthalenes|Vasodilating Agents",COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C,60663
1331,DB01390,Sodium bicarbonate,small molecule,approved,"Acids|Acids, Noncarboxylic|Alkalies|Anions|Antacids|Antacids and Adsorbents|Bicarbonates|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Carbon Compounds, Inorganic|Carbonates|Carbonic Acid|Electrolyte Solutions|Electrolytes|Gastric Acid Lowering Agents|Hemodialysis Solution|I.V. Solution Additives|Ions|Irrigating Solutions|Radiographic Contrast Agent|Salt Solutions|Sodium Compounds|Urinary Alkalinisers",[Na+].OC([O-])=O,516892
1332,DB01392,Yohimbine,small molecule,approved|investigational|vet_approved,"Adrenergic Agents|Adrenergic alpha-2 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Alkaloids|Antidepressive Agents|Autonomic Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs Used in Erectile Dysfunction|Genito Urinary System and Sex Hormones|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|Mydriatics|Neurotransmitter Agents|Other Miscellaneous Therapeutic Agents|P-glycoprotein inhibitors|Peripheral Nervous System Agents|Secologanin Tryptamine Alkaloids|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Urological Agents|Urologicals",[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2,8969
1333,DB01393,Bezafibrate,small molecule,approved|investigational,"Acids, Acyclic|Acids, Carbocyclic|Agents Causing Muscle Toxicity|Amides|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Butyrates|Chlorobenzoates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Ethers|Fatty Acids|Fatty Acids, Volatile|Fibric Acids|Fribic Acid Derivatives|Hypolipidemic Agents|Hypolipidemic Agents Indicated for Hyperlipidemia|Isobutyrates|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Lipids|Noxae|OATP1B1/SLCO1B1 Inhibitors|Phenols|Phenyl Ethers|Toxic Actions",CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O,39042
1334,DB01394,Colchicine,small molecule,approved,Agents Causing Muscle Toxicity|Alkaloids|Antigout Preparations|Antimitotic Agents|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP2E1 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Immunosuppressive Agents|Mitosis Modulators|Musculo-Skeletal System|P-glycoprotein inducers|P-glycoprotein substrates|Preparations With No Effect on Uric Acid Metabolism|Tubulin Modulators,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1C(CC2)NC(C)=O,2833
1335,DB01395,Drospirenone,small molecule,approved,"Adrenal Cortex Hormones|Agents causing hyperkalemia|Androstanes|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Diuretics|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Mineralocorticoid Receptor Antagonists|Natriuretic Agents|Progesterone Congeners|Progestin Contraceptives|Progestins|Sex Hormones and Modulators of the Genital System|Steroids",[H][C@@]12C[C@]1([H])[C@@]1([H])[C@]3([H])[C@]4([H])C[C@]4([H])[C@@]4(CCC(=O)O4)[C@@]3(C)CC[C@]1([H])[C@@]1(C)CCC(=O)C=C21,68873
1336,DB01396,Digitoxin,small molecule,approved|investigational,"Antiarrhythmic agents|Carbohydrates|Cardanolides|Cardenolides|Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Digitalis Glycosides|Enzyme Inhibitors|Fused-Ring Compounds|Glycosides|Narrow Therapeutic Index Drugs|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Potential QTc-Prolonging Agents|Protective Agents|QTc Prolonging Agents|Steroids",[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)C1=CC(=O)OC1,441207
1337,DB01397,Magnesium salicylate,small molecule,experimental,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antirheumatic Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Hydroxy Acids|Hydroxybenzoates|Magnesium Compounds|Magnesium Salts|Metal cations|Metal divalent cations|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Phenols|Sensory System Agents",[Mg++].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O,54684589
1338,DB01399,Salsalate,small molecule,approved,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antirheumatic Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Hydroxy Acids|Hydroxybenzoates|Nephrotoxic agents|Nervous System|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Phenols|Salicylic Acid and Derivatives|Sensory System Agents",OC(=O)C1=CC=CC=C1OC(=O)C1=CC=CC=C1O,5161
1339,DB01400,Neostigmine,small molecule,approved|vet_approved,Amines|Ammonium Compounds|Antiglaucoma Preparations and Miotics|Autonomic Agents|Cholinergic Agents|Cholinesterase Inhibitors|Enzyme Inhibitors|Nervous System|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Ophthalmologicals|Parasympathomemetic (Cholinergic) Agents|Parasympathomimetics|Peripheral Nervous System Agents|Phenylammonium Compounds|Quaternary Ammonium Compounds|Sensory Organs,CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C,4456
1340,DB01401,Choline magnesium trisalicylate,small molecule,approved,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Ammonium Compounds|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antirheumatic Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Ethanolamines|Hydroxy Acids|Hydroxybenzoates|Nephrotoxic agents|Nitrogen Compounds|Non COX-2 selective NSAIDS|Onium Compounds|Peripheral Nervous System Agents|Phenols|Quaternary Ammonium Compounds|Sensory System Agents|Trimethyl Ammonium Compounds",[Mg++].C[N+](C)(C)CCO.OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O,54682045
1341,DB01403,Methotrimeprazine,small molecule,approved|investigational,"Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anticholinergic Agents|Antidepressive Agents|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs causing inadvertant photosensitivity|Heterocyclic Compounds, Fused-Ring|Histamine Antagonists|Histamine H1 Antagonists|Hyperglycemia-Associated Agents|Muscarinic Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenothiazines|Phenothiazines With Aliphatic Side-Chain|Photosensitizing Agents|Potential QTc-Prolonging Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Tranquilizing Agents",COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1,72287
1342,DB01404,Ginseng,small molecule,approved|investigational|nutraceutical,Herbs and Natural Products,,
1343,DB01405,Temafloxacin,small molecule,withdrawn,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",CC1CN(CCN1)C1=C(F)C=C2C(=O)C(=CN(C2=C1)C1=C(F)C=C(F)C=C1)C(O)=O,60021
1344,DB01406,Danazol,small molecule,approved,"Androgens|Antigonadotropins and Similar Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Estrogen Antagonists|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Pregnadienes|Pregnanes|Sex Hormones and Modulators of the Genital System|Steroids|Thyroxine-binding globulin inhibitors",[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3,28417
1345,DB01407,Clenbuterol,small molecule,approved|investigational|vet_approved,"Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Drugs for Obstructive Airway Diseases|Ethanolamines|Neurotransmitter Agents|Peripheral Nervous System Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists|Sympathomimetics",CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1,2783
1346,DB01408,Bambuterol,small molecule,investigational,Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cholinesterase Inhibitors|Cholinesterase substrates|Delayed-Action Preparations|Drugs for Obstructive Airway Diseases|Ethanolamines|Peripheral Nervous System Agents|Prodrugs|Respiratory System Agents|Selective Beta 2-adrenergic Agonists,CN(C)C(=O)OC1=CC(=CC(OC(=O)N(C)C)=C1)C(O)CNC(C)(C)C,54766
1347,DB01409,Tiotropium,small molecule,approved,"Adrenergics, Inhalants|Agents producing tachycardia|Agents to Treat Airway Disease|Alkaloids|Anti-Asthmatic Agents|Anticholinergic Agents|Antimuscarinics Antispasmodics|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Bronchodilator Agents|Cholinergic Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs for Obstructive Airway Diseases|Drugs that are Mainly Renally Excreted|Muscarinic Antagonists|Neurotransmitter Agents|Parasympatholytics|Peripheral Nervous System Agents|Respiratory System Agents|Scopolamine Derivatives|Tropanes",[H][C@]12O[C@@]1([H])[C@]1([H])C[C@@]([H])(C[C@@]2([H])[N+]1(C)C)OC(=O)C(O)(C1=CC=CS1)C1=CC=CS1,5487427
1348,DB01410,Ciclesonide,small molecule,approved|investigational,"Adrenal Cortex Hormones|Adrenals|Agents to Treat Airway Disease|Anti-Allergic Agents|Corticosteroids|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs for Obstructive Airway Diseases|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Nasal Preparations|Pregnanes|Pregnenes|Steroids|Thyroxine-binding globulin inhibitors",[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(O[C@@H](O2)C1CCCCC1)C(=O)COC(=O)C(C)C,6918155
1349,DB01411,Pranlukast,small molecule,investigational,"Agents to Treat Airway Disease|Anti-Asthmatic Agents|Benzopyrans|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs for Obstructive Airway Diseases|Heterocyclic Compounds, Fused-Ring|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Leukotriene Antagonists|Pyrans|Respiratory System Agents",O=C(NC1=C2OC(=CC(=O)C2=CC=C1)C1=NNN=N1)C1=CC=C(OCCCCC2=CC=CC=C2)C=C1,4887
1350,DB01412,Theobromine,small molecule,investigational,"Alkaloids|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 Substrates|Diuretics|Drugs for Obstructive Airway Diseases|Heterocyclic Compounds, Fused-Ring|Low-Ceiling Diuretics, Excl. Thiazides|Peripheral Nervous System Agents|Purines|Purinones|Respiratory System Agents|Vasodilating Agents|Xanthine derivatives",CN1C=NC2=C1C(=O)NC(=O)N2C,5429
1351,DB01413,Cefepime,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|Fourth-Generation Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines",CO\N=C(/C(=O)N[C@@H]1C(=O)N2[C@]1([H])SCC(C[N+]1(C)CCCC1)=C2C([O-])=O)C1=CSC(N)=N1,5479537
1352,DB01414,Cefacetrile,small molecule,experimental|vet_approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|First-Generation Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|OAT1/SLC22A6 inhibitors|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Sulfur Compounds|Thiazines",[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CC#N)C(O)=O,91562
1353,DB01415,Ceftibuten,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins",[H][C@]12SCC=C(N1C(=O)[C@H]2NC(=O)C(=C/CC(O)=O)\C1=CSC(N)=N1)C(O)=O,5282242
1354,DB01416,Cefpodoxime,small molecule,approved|vet_approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephacetrile|Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Prodrugs|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins",[H][C@]12SCC(COC)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,6335986
1355,DB01418,Acenocoumarol,small molecule,approved|investigational,"4-Hydroxycoumarins|Anticoagulants|Benzopyrans|Blood and Blood Forming Organs|Coumarins|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|Narrow Therapeutic Index Drugs|P-glycoprotein substrates|Pyrans|Vitamin K Antagonists",CC(=O)CC(C1=CC=C(C=C1)[N+]([O-])=O)C1=C(O)C2=CC=CC=C2OC1=O,54676537
1356,DB01419,Antrafenine,small molecule,approved,"Agents causing hyperkalemia|Agents that produce hypertension|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Nephrotoxic agents|Non COX-2 selective NSAIDS",FC(F)(F)C1=CC(=CC=C1)N1CCN(CCOC(=O)C2=CC=CC=C2NC2=C3C=CC(=CC3=NC=C2)C(F)(F)F)CC1,68723
1357,DB01420,Testosterone propionate,small molecule,approved|investigational|vet_approved|withdrawn,"Androgens|Androstanes|Androstenes|Androstenols|COMT Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|P-glycoprotein substrates|Steroids|Testosterone and derivatives|Testosterone Congeners|Thyroxine-binding globulin inhibitors|UGT1A1 Inducers",[H][C@@]12CC[C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,5995
1358,DB01421,Paromomycin,small molecule,approved|investigational,"Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Amebicides|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antiparasitic Agents|Antiprotozoals|Carbohydrates|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Glycosides|Intestinal Antiinfectives|Narrow Therapeutic Index Drugs|Nephrotoxic agents",NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O,165580
1359,DB01422,Nitroxoline,small molecule,experimental,"Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antifungal Agents|Antiinfectives for Systemic Use|Heterocyclic Compounds, Fused-Ring|Nitro Compounds|Quinolines|Renal Agents",OC1=C2N=CC=CC2=C(C=C1)[N+]([O-])=O,19910
1360,DB01423,Stepronin,small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Cough and Cold Preparations|Expectorants|Immunologic Factors|Immunosuppressive Agents|Respiratory System Agents",CC(SC(=O)C1=CC=CS1)C(=O)NCC(O)=O,54120
1361,DB01424,Aminophenazone,small molecule,approved|withdrawn,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Nephrotoxic agents|Nervous System|Non COX-2 selective NSAIDS|OAT1/SLC22A6 inhibitors|Pyrazoles|Pyrazolones",CN(C)C1=C(C)N(C)N(C1=O)C1=CC=CC=C1,6009
1362,DB01425,Alizapride,small molecule,investigational,Alimentary Tract and Metabolism|Antiemetics|Autonomic Agents|Central Nervous System Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs for Functional Gastrointestinal Disorders|Gastrointestinal Agents|Peripheral Nervous System Agents|Propulsives,COC1=CC2=NNN=C2C=C1C(=O)NCC1CCCN1CC=C,43008
1363,DB01426,Ajmaline,small molecule,approved|experimental,"Ajmaline and derivatives|Alkaloids|Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ia|Antiarrhythmics, Class Ic|Cardiac Therapy|Cardiovascular Agents|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|Membrane Transport Modulators|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Secologanin Tryptamine Alkaloids|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers",CC[C@H]1[C@@H]2C[C@H]3[C@@H]4N(C)C5=CC=CC=C5[C@]44C[C@@H](C2[C@H]4O)N3[C@@H]1O,441080
1364,DB01427,Amrinone,small molecule,approved,"Amines|Aminopyridines|Calcium-Regulating Hormones and Agents|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Membrane Transport Modulators|Phosphodiesterase 3 Inhibitors|Phosphodiesterase Inhibitors|Protective Agents|Pyridines|Vasodilating Agents",NC1=CC(=CNC1=O)C1=CC=NC=C1,3698
1365,DB01428,Oxybenzone,small molecule,approved|investigational,"Benzene Derivatives|Compounds used in a research, industrial, or household setting|Cosmetics|Dermatologicals|Drugs that are Mainly Renally Excreted|Household Products|Ketones|Protective Agents|Radiation-Protective Agents|Sunscreen Agents",COC1=CC(O)=C(C=C1)C(=O)C1=CC=CC=C1,4632
1366,DB01429,Aprindine,small molecule,experimental,"Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ib|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Indans|Indenes|Membrane Transport Modulators|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers",CCN(CC)CCCN(C1CC2=CC=CC=C2C1)C1=CC=CC=C1,2218
1367,DB01430,Almitrine,small molecule,approved,"Alkaloids|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|Neuroprotective Agents|Pharmaceutical Preparations|Piperazines|Protective Agents|Respiratory System Agents|Secologanin Tryptamine Alkaloids|Triazines",FC1=CC=C(C=C1)C(N1CCN(CC1)C1=NC(NCC=C)=NC(NCC=C)=N1)C1=CC=C(F)C=C1,33887
1368,DB01431,Allylestrenol,small molecule,experimental,"Adrenal Cortex Hormones|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Estranes|Estren Derivatives|Estrenes|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Progestins|Sex Hormones and Modulators of the Genital System|Steroids",[H][C@@]12CC[C@@](O)(CC=C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H],235905
1369,DB01432,Cholestyramine,small molecule,approved|investigational,"Anion Exchange Resins|Anticholesteremic Agents|Benzene Derivatives|Benzylidene Compounds|Bile Acid Sequestrants|Bile-acid Binding Activity|Compounds used in a research, industrial, or household setting|Hypolipidemic Agents|Hypolipidemic Agents Indicated for Hyperlipidemia|Ion Exchange Resins|Laboratory Chemicals|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Macromolecular Substances|Noxae|Plastics|Polymers|Polystyrenes|Styrene|Styrenes|Toxic Actions",,
1370,DB01433,Methadyl acetate,small molecule,experimental|illicit,Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Ketones|Narcotics|Opioids|Peripheral Nervous System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,CCC(OC(C)=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,10517
1371,DB01434,19-norandrostenedione,small molecule,experimental|illicit,"17-Ketosteroids|Adrenal Cortex Hormones|Androstanes|Androstenes|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Steroids|Testosterone Congeners",[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],92834
1372,DB01435,Antipyrine,small molecule,approved|investigational,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics and Anesthetics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Methemoglobinemia Associated Agents|Nephrotoxic agents|Nervous System|Non COX-2 selective NSAIDS|OAT1/SLC22A6 inhibitors|Otologicals|Peripheral Nervous System Agents|Pyrazoles|Pyrazolones|Sensory Organs|Sensory System Agents",CN1N(C(=O)C=C1C)C1=CC=CC=C1,2206
1373,DB01436,Alfacalcidol,small molecule,approved|nutraceutical,Alimentary Tract and Metabolism|Bone Density Conservation Agents|Cholestanes|Cholestenes|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Fused-Ring Compounds|Lipids|Membrane Lipids|Musculo-Skeletal System|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble),CC(C)CCC[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C,5282181
1374,DB01437,Glutethimide,small molecule,approved|illicit,Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Piperidinedione Derivatives|Piperidines|Piperidones|Psycholeptics,CCC1(CCC(=O)NC1=O)C1=CC=CC=C1,3487
1375,DB01438,Phenazopyridine,small molecule,approved,Amines|Aminopyridines|Antipruritics and Local Anesthetics|Drugs that are Mainly Renally Excreted|Genito Urinary System and Sex Hormones|Methemoglobinemia Associated Agents|Nephrotoxic agents|Pyridines|Urologicals,NC1=NC(N)=C(C=C1)\N=N\C1=CC=CC=C1,4756
1376,DB01439,3-Methylthiofentanyl,small molecule,experimental|illicit,,CCC(=O)N(C1CCN(CCC2=CC=CS2)CC1C)C1=CC=CC=C1,62296
1377,DB01440,gamma-Hydroxybutyric acid,small molecule,approved|illicit|investigational,"Acids, Acyclic|Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Butyrates|Central Nervous System Depressants|Central Nervous System Depression|Decreased Central Nervous System Organized Electrical Activity|Fatty Acids|Fatty Acids, Volatile|Hydroxy Acids|Lipids",OCCCC(O)=O,3037032
1378,DB01441,"5-Methoxy-N,N-diisopropyltryptamine",small molecule,experimental|illicit,"Alkaloids|Amines|Autacoids|Biogenic Amines|Biogenic Monoamines|Biological Factors|Heterocyclic Compounds, Fused-Ring|Indoles|Inflammation Mediators|Morphinans|Morphine Derivatives|Opiate Alkaloids|Phenanthrenes|Tryptamines",COC1=CC2=C(NC=C2CCN(C(C)C)C(C)C)C=C1,151182
1379,DB01442,MMDA,small molecule,experimental|illicit,Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Antidepressive Agents|Central Nervous System Depressants|Ethylamines|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Phenethylamines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists|Sympathomimetics,COC1=CC(CC(C)N)=CC2=C1OCO2,26175
1380,DB01443,19-Nor-5-androstenedione,small molecule,experimental|illicit,,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)CC3=CC[C@@]21[H],18633059
1381,DB01444,Dimethylthiambutene,small molecule,experimental|illicit,,CC(C=C(C1=CC=CS1)C1=CC=CS1)N(C)C,10668
1382,DB01445,Bufotenine,small molecule,experimental|illicit,"Amines|Amphibian Venoms|Autacoids|Biogenic Amines|Biogenic Monoamines|Biological Factors|Bodily Secretions|Central Nervous System Agents|Central Nervous System Depressants|Complex Mixtures|Fluids and Secretions|Hallucinogens|Heterocyclic Compounds, Fused-Ring|Indoles|Inflammation Mediators|Monoamine Oxidase A Substrates|N,N-Dimethyltryptamine|Neurotransmitter Agents|Psychotropic Drugs|Toxins, Biological|Tryptamines|Venoms",CN(C)CCC1=CNC2=C1C=C(O)C=C2,10257
1383,DB01446,Indopan,small molecule,experimental|illicit,"Amines|Biogenic Amines|Biogenic Monoamines|Heterocyclic Compounds, Fused-Ring|Indoles|Stimulants",CC(N)CC1=CNC2=CC=CC=C12,9287
1384,DB01447,4-Methylaminorex,small molecule,experimental|illicit,Central Nervous System Agents|Central Nervous System Stimulants|Street Drugs,CC1N=C(N)OC1C1=CC=CC=C1,92196
1385,DB01448,19-Nor-4-androstenedione,small molecule,experimental|illicit,,,
1386,DB01450,Dihydroetorphine,small molecule,experimental|illicit,"Alkaloids|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Morphinans|Narcotics|Opiate Alkaloids|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]11CC[C@@]2(OC)[C@]([H])(C1)[C@](C)(O)CCC,107765
1387,DB01451,1-Androstenedione,small molecule,experimental|illicit,,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)C=C[C@]12C,11196935
1388,DB01452,Diamorphine,small molecule,approved|illicit|investigational,"Alkaloids|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Drugs Used in Addictive Disorders|Drugs Used in Opioid Dependence|Heroin, agonists|Heterocyclic Compounds, Fused-Ring|Morphinans|Morphine Derivatives|Narcotics|Nervous System|Opiate Alkaloids|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents|Thyroxine-binding globulin inducers",[H][C@@]12C=C[C@H](OC(C)=O)[C@@H]3OC4=C(OC(C)=O)C=CC5=C4[C@]13CCN(C)[C@@H]2C5,5462328
1389,DB01453,Beta-hydroxyfentanyl,small molecule,experimental|illicit,,CCC(=O)N(C1CCN(CC(O)C2=CC=CC=C2)CC1)C1=CC=CC=C1,62278
1390,DB01454,Midomafetamine,small molecule,experimental|illicit|investigational,Adrenergic Agents|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Ethylamines|Hallucinogens|Membrane Transport Modulators|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Phenethylamines|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists|Sympathomimetics,CNC(C)CC1=CC2=C(OCO2)C=C1,1615
1391,DB01455,19-Nor-5-androstenediol,small molecule,experimental|illicit,,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CC[C@H](O)CC3=CC[C@@]21[H],9900246
1392,DB01456,5-androstenedione,small molecule,experimental|illicit,"17-Ketosteroids|Adrenal Cortex Hormones|Androstanes|Androstenes|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Steroids|Testosterone Congeners",[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2CC(=O)CC[C@]12C,160531
1393,DB01458,"2,5-Dimethoxy-4-(n)-propylthiophenethylamine",small molecule,experimental|illicit,,CCCSC1=CC(OC)=C(CCN)C=C1OC,24728635
1394,DB01459,Bezitramide,small molecule,experimental|illicit|withdrawn,"Analgesics|Central Nervous System Agents|Diphenylpropylamine Derivatives|Heterocyclic Compounds, Fused-Ring|Nervous System|Opioids|Peripheral Nervous System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",CCC(=O)N1C(=O)N(C2CCN(CCC(C#N)(C3=CC=CC=C3)C3=CC=CC=C3)CC2)C2=CC=CC=C12,61791
1395,DB01460,Diethyltryptamine,small molecule,experimental|illicit,"Acids, Carbocyclic|Agrochemicals|Amides|Amines|Benzene Derivatives|Benzoates|Biogenic Amines|Biogenic Monoamines|Compounds used in a research, industrial, or household setting|Heterocyclic Compounds, Fused-Ring|Indoles|Insect Repellents|Pesticides|Protective Agents|Toxic Actions",CCN(CC)CCC1=CNC2=CC=CC=C12,6090
1396,DB01461,Dimenoxadol,small molecule,experimental|illicit,"Acids, Carbocyclic|Diphenylacetic Acids|Hydroxy Acids|Phenylacetates",CCOC(C(=O)OCCN(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,17036
1397,DB01462,Etonitazene,small molecule,experimental|illicit,"Heterocyclic Compounds, Fused-Ring",CCOC1=CC=C(CC2=NC3=C(C=CC(=C3)[N+]([O-])=O)N2CCN(CC)CC)C=C1,13493
1398,DB01463,Fencamfamin,small molecule,experimental|illicit|withdrawn,"Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Stimulants|Centrally Acting Sympathomimetics|Monoterpenes|Nervous System|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Psychotropic Drugs|Terpenes|Tranquilizing Agents",CCNC1C2CCC(C2)C1C1=CC=CC=C1,14584
1399,DB01464,Furethidine,small molecule,experimental|illicit,,CCOC(=O)C1(CCN(CCOCC2CCCO2)CC1)C1=CC=CC=C1,61306
1400,DB01465,"2,5-Dimethoxyamphetamine",small molecule,experimental|illicit,Amines|Ethylamines|Phenethylamines,COC1=CC(CC(C)N)=C(OC)C=C1,62787
1401,DB01466,Ethylmorphine,small molecule,experimental|illicit,"Alkaloids|Analgesics|Antitussive Agents|Central Nervous System Agents|Central Nervous System Depressants|Cough and Cold Preparations|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Morphinans|Morphine Derivatives|Narcotics|Ophthalmologicals|Opiate Alkaloids|Opioids|Opium Alkaloids and Derivatives|Peripheral Nervous System Agents|Phenanthrenes|Respiratory System Agents|Sensory Organs|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",[H][C@@]12OC3=C(OCC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,5359271
1402,DB01467,"2,5-Dimethoxy-4-ethylamphetamine",small molecule,experimental|illicit,Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Ethylamines|Phenethylamines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetics,CCC1=CC(OC)=C(CC(C)N)C=C1OC,27402
1403,DB01468,Ethylmethylthiambutene,small molecule,experimental|illicit,,CCN(C)C(C)C=C(C1=CC=CS1)C1=CC=CS1,46424
1404,DB01469,Acetorphine,small molecule,experimental|illicit,,[H][C@@]12OC3=C(OC(C)=O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@@]11C[C@]([H])([C@](C)(O)CCC)[C@]2(OC)C=C1,20055090
1405,DB01470,alpha-methylthiofentanyl,small molecule,illicit,,CCC(=O)N(C1CCN(CC1)C(C)CC1=CC=CS1)C1=CC=CC=C1,62309
1406,DB01471,Bolasterone,small molecule,experimental|illicit,"Anabolic Agents|Androstanes|Androstenes|Androstenols|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone Congeners",[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@H](C)CC2=CC(=O)CC[C@]12C,102146
1407,DB01472,4-Methoxyamphetamine,small molecule,experimental|illicit,Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Amines|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Ethylamines|Hallucinogens|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Phenethylamines|Psychotropic Drugs,COC1=CC=C(CC(C)N)C=C1,31721
1408,DB01473,Betaprodine,small molecule,experimental|illicit,,[H][C@@]1(C)CN(C)CC[C@]1(OC(=O)CC)C1=CC=CC=C1,5284516
1409,DB01474,"17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene",small molecule,experimental|illicit,,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,69259387
1410,DB01475,Dioxaphetyl butyrate,small molecule,experimental|illicit,,CCOC(=O)C(CCN1CCOCC1)(C1=CC=CC=C1)C1=CC=CC=C1,48194
1411,DB01476,Haloxazolam,small molecule,experimental|illicit,"Benzazepines|Heterocyclic Compounds, Fused-Ring",FC1=CC=CC=C1C12OCCN1CC(=O)NC1=C2C=C(Br)C=C1,3563
1412,DB01477,Codeine methylbromide,small molecule,experimental|illicit,,[Br-].[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CC[N+](C)(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,5362447
1413,DB01478,Desmethylprodine,small molecule,experimental|illicit,Isonipecotic Acids|Piperidines,CCC(=O)OC1(CCN(C)CC1)C1=CC=CC=C1,61583
1414,DB01479,BA-2664,small molecule,experimental|illicit,,C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,242493
1415,DB01480,Cyprenorphine,small molecule,experimental|illicit,"Alkaloids|Heterocyclic Compounds, Fused-Ring|Opiate Alkaloids|Phenanthrenes",[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@@]11C[C@]([H])(C(C)(C)O)[C@]2(OC)C=C1,20054882
1416,DB01481,1-Testosterone,small molecule,experimental|illicit|investigational,"Androstanes|Androstenes|Androstenols|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone and derivatives|Testosterone Congeners",[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)C=C[C@]12C,236666
1417,DB01482,Fenethylline,small molecule,experimental,"Alkaloids|Amines|Central Nervous System Agents|Central Nervous System Stimulants|Centrally Acting Sympathomimetics|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Ethylamines|Heterocyclic Compounds, Fused-Ring|Nervous System|Phenethylamines|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Purines|Purinones|Xanthine derivatives",CC(CC1=CC=CC=C1)NCCN1C=NC2=C1C(=O)N(C)C(=O)N2C,102710
1418,DB01483,Barbital,small molecule,illicit,"Anticholinergic Agents|Anticonvulsants|Barbiturates|Barbiturates, Plain|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Nicotinic Antagonists|Psycholeptics|Pyrimidines|Pyrimidinones",CCC1(CC)C(=O)NC(=O)NC1=O,2294
1419,DB01484,"4-Bromo-2,5-dimethoxyamphetamine",small molecule,experimental|illicit,Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Ethylamines|Hallucinogens|Neurotransmitter Agents|Phenethylamines|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Agonists|Sympathomimetics,COC1=CC(Br)=C(OC)C=C1CC(C)N,62065
1420,DB01485,4-Hydroxytestosterone,small molecule,experimental|illicit,"Androstanes|Androstenes|Androstenols|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone and derivatives|Testosterone Congeners",[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=C(O)C(=O)CC[C@]12C,160615
1421,DB01486,Cathine,small molecule,experimental|illicit,"Alcohols|Alimentary Tract and Metabolism|Amines|Amino Alcohols|Anti-Obesity Agents|Antiobesity Preparations, Excl. Diet Products|Appetite Depressants|Centrally Acting Antiobesity Products|Propanolamines|Propanols",C[C@H](N)[C@@H](O)C1=CC=CC=C1,441457
1422,DB01487,Embutramide,small molecule,experimental|illicit,"Acids, Carbocyclic|Amines|Aminobenzoates|Ammonium Compounds|Benzene Derivatives|Benzoates|Nitrogen Compounds|Onium Compounds|para-Aminobenzoates|Pharmaceutical Preparations",CCC(CC)(CNC(=O)CCCO)C1=CC(OC)=CC=C1,27453
1423,DB01488,Dimethyltryptamine,small molecule,experimental|illicit,"Amines|Antidepressive Agents|Biogenic Amines|Biogenic Monoamines|Central Nervous System Agents|Central Nervous System Depressants|Hallucinogens|Heterocyclic Compounds, Fused-Ring|Indoles|Neurotransmitter Agents|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Agonists|Tryptamines",CN(C)CCC1=CNC2=CC=CC=C12,6089
1424,DB01489,Camazepam,small molecule,experimental|illicit,"Anti-Anxiety Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Nervous System|Psycholeptics",CN(C)C(=O)OC1N=C(C2=CC=CC=C2)C2=C(C=CC(Cl)=C2)N(C)C1=O,37367
1425,DB01490,Aminorex,small molecule,experimental|illicit,Oxazoles,NC1=NCC(O1)C1=CC=CC=C1,16630
1426,DB01491,Dipipanone,small molecule,experimental|illicit,Ketones,CCC(=O)C(CC(C)N1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1,13331
1427,DB01493,Ethylestrenol,small molecule,withdrawn,"Alimentary Tract and Metabolism|Anabolic Agents|Anabolic Agents for Systemic Use|Anabolic Steroids|Estren Derivatives|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Norpregnanes|Norpregnenes|Norsteroids|Steroids",[H][C@@]12CC[C@@](O)(CC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H],13765
1428,DB01494,Chloral betaine,small molecule,illicit|withdrawn,,OC(O)C(Cl)(Cl)Cl.C[N+](C)(C)CC([O-])=O,16676
1429,DB01495,Dichloralphenazone,small molecule,approved|illicit,Alcohols|Central Nervous System Depressants|Ethylene Glycols|Glycols|Hypnotics and Sedatives|Nervous System|Psycholeptics|Pyrazoles|Pyrazolones,OC(O)C(Cl)(Cl)Cl.OC(O)C(Cl)(Cl)Cl.CN1N(C(=O)C=C1C)C1=CC=CC=C1,10188
1430,DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione",small molecule,experimental|illicit,Anticholinergic Agents|Nicotinic Antagonists,FC(F)(F)C1=CC=CC=C1C1=CC=C(CC2C(=O)NC(=S)NC2=O)O1,3003157
1431,DB01497,Etorphine,small molecule,illicit|vet_approved,"Alkaloids|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Morphinans|Narcotics|Opiate Alkaloids|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",[H][C@]12CC3=C4C(OC5[C@@]4(CCN1C)[C@]21CC(C(C)(O)CCC)C5(OC)C=C1)=C(O)C=C3,26721
1432,DB01498,Alphamethadol,small molecule,experimental|illicit,,CC[C@@H](O)C(C[C@@H](C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,62709
1433,DB01499,Alphameprodine,small molecule,experimental|illicit,,CC[C@H]1CN(C)CC[C@]1(OC(=O)CC)C1=CC=CC=C1,61119
1434,DB01500,Oxabolone,small molecule,experimental|illicit,,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C(O)=C3CC[C@@]21[H],20055236
1435,DB01501,Difenoxin,small molecule,approved|illicit,"Alimentary Tract and Metabolism|Antidiarrheals|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antipropulsives|Central Nervous System Depressants|Isonipecotic Acids|Piperidines",OC(=O)C1(CCN(CCC(C#N)(C2=CC=CC=C2)C2=CC=CC=C2)CC1)C1=CC=CC=C1,34328
1436,DB01502,Diampromide,small molecule,experimental|illicit,,CCC(=O)N(CC(C)N(C)CCC1=CC=CC=C1)C1=CC=CC=C1,62370
1437,DB01503,1-Androstenediol,small molecule,experimental|illicit,,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@@H](O)C=C[C@]12C,11300765
1438,DB01505,Etoxeridine,small molecule,experimental|illicit,,CCOC(=O)C1(CCN(CCOCCO)CC1)C1=CC=CC=C1,61122
1439,DB01506,1-Phenylcyclohexylamine,small molecule,experimental|illicit,Amines|Cyclohexanes|Cycloparaffins,NC1(CCCCC1)C1=CC=CC=C1,31862
1440,DB01509,Tenamfetamine,small molecule,experimental|illicit,Adrenergic Agents|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Ethylamines|Hallucinogens|Membrane Transport Modulators|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Phenethylamines|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Sympathomimetics,CC(N)CC1=CC2=C(OCO2)C=C1,1614
1441,DB01510,Dehydrochloromethyltestosterone,small molecule,experimental|illicit,Testosterone and derivatives,,
1442,DB01511,Delorazepam,small molecule,experimental|illicit,"Anticonvulsants|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring",ClC1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1,17925
1443,DB01512,Hydromorphinol,small molecule,experimental|illicit,,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CC[C@@H]2O,5463858
1444,DB01513,"17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane",small molecule,experimental|illicit,,C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,101819
1445,DB01514,Furazabol,small molecule,illicit,Androstanes|Fused-Ring Compounds|Steroids,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC3=NON=C3C[C@]12C,14708
1446,DB01515,Benzoylecgonine,small molecule,experimental|illicit,Alkaloids|Aza Compounds|Azabicyclo Compounds|Tropanes,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(O)=O)N2C,448223
1447,DB01516,"3,4,5-Trimethoxyamphetamine",small molecule,experimental|illicit,,COC1=CC(CC(C)N)=CC(OC)=C1OC,31016
1448,DB01518,Benzethidine,small molecule,experimental|illicit,,CCOC(=O)C1(CCN(CCOCC2=CC=CC=C2)CC1)C1=CC=CC=C1,62516
1449,DB01520,Tenocyclidine,small molecule,experimental|illicit|investigational,"Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Neuroprotective Agents|NMDA Receptor Antagonists|Piperidines|Protective Agents|Street Drugs",C1CCN(CC1)C1(CCCCC1)C1=CC=CS1,62751
1450,DB01521,Clostebol,small molecule,experimental|illicit,"Androstanes|Androstenes|Androstenols|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone Congeners",[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=C(Cl)C(=O)CC[C@]12C,68947
1451,DB01522,Betacetylmethadol,small molecule,experimental|illicit,,CC[C@H](OC(C)=O)C(C[C@@H](C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,62710
1452,DB01523,Clonitazene,small molecule,experimental|illicit,,CCN(CC)CCN1C(CC2=CC=C(Cl)C=C2)=NC2=C1C=CC(=C2)[N+]([O-])=O,62528
1453,DB01524,Androstenediol,small molecule,experimental|illicit,"Anabolic Agents|Androstanes|Androstenediols|Androstenes|Androstenols|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone Congeners",[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,10634
1454,DB01525,Ecgonine,small molecule,experimental|illicit,Alkaloids|Analgesics|Aza Compounds|Azabicyclo Compounds|Central Nervous System Agents|Narcotics|Peripheral Nervous System Agents|Sensory System Agents|Tropanes,[H][C@]12CC[C@]([H])([C@H]([C@@H](O)C1)C(O)=O)N2C,91460
1455,DB01526,4-Androstenediol,small molecule,experimental|illicit,,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=C[C@@H](O)CC[C@]12C,136297
1456,DB01527,Clortermine,small molecule,experimental,,CC(C)(N)CC1=CC=CC=C1Cl,25223
1457,DB01528,"4-Methyl-2,5-dimethoxyamphetamine",small molecule,experimental|illicit,,COC1=CC(CC(C)N)=C(OC)C=C1C,85875
1458,DB01529,Dextromoramide,small molecule,experimental|illicit,Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Diphenylpropylamine Derivatives|Morpholines|Narcotics|Nervous System|Opioids|Oxazines|Peripheral Nervous System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,C[C@H](CN1CCOCC1)C(C(=O)N1CCCC1)(C1=CC=CC=C1)C1=CC=CC=C1,92943
1459,DB01530,"5alpha-androstane-3alpha,17beta-diol",small molecule,experimental|illicit,,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](O)CC[C@]12C,15818
1460,DB01531,Desomorphine,small molecule,experimental|illicit,"Alkaloids|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Morphinans|Morphine Derivatives|Narcotics|Opiate Alkaloids|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents|Street Drugs",[H][C@@]12CCC[C@@]3([H])[C@@]4([H])CC5=CC=C(O)C(O1)=C5[C@@]23CCN4C,5362456
1461,DB01532,α-Methylacetylfentanyl,small molecule,illicit,,CC(CC1=CC=CC=C1)N1CCC(CC1)N(C(C)=O)C1=CC=CC=C1,62307
1462,DB01533,Diethylthiambutene,small molecule,experimental|illicit,Sulfur Compounds,CCN(CC)C(C)C=C(C1=CC=CS1)C1=CC=CS1,6833
1463,DB01534,Chlorhexadol,small molecule,experimental|illicit,Aldehydes|Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Psycholeptics,CC(CC(C)(C)O)OC(O)C(Cl)(Cl)Cl,19094
1464,DB01535,Carfentanil,small molecule,illicit|investigational|vet_approved,Analgesics|Carbon Radioisotopes|Central Nervous System Agents|Central Nervous System Depressants|High-risk opioids|Narcotics|Opioids|Peripheral Nervous System Agents|Phenylpiperidine opioids|Piperidines|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,CCC(=O)N(C1=CC=CC=C1)C1(CCN(CCC2=CC=CC=C2)CC1)C(=O)OC,62156
1465,DB01536,Androstenedione,small molecule,experimental|illicit,"17-Ketosteroids|Adrenal Cortex Hormones|Androstanes|Androstenes|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Steroids|Testosterone Congeners",[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,6128
1466,DB01537,"4-Bromo-2,5-dimethoxyphenethylamine",small molecule,experimental|illicit,Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Amines|Ethylamines|Neurotransmitter Agents|Phenethylamines,COC1=CC(Br)=C(OC)C=C1CCN,98527
1467,DB01538,Acetyldihydrocodeine,small molecule,experimental|illicit,Cough and Cold Preparations|Opium Alkaloids and Derivatives,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CC[C@@H]2OC(C)=O,5463874
1468,DB01539,1-Piperidinocyclohexanecarbonitrile,small molecule,experimental|illicit,Piperidines,N#CC1(CCCCC1)N1CCCCC1,62529
1469,DB01540,17alpha-methyl-4-hydroxynandrolone,small molecule,illicit,,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C(O)=C3CC[C@@]21[H],69249407
1470,DB01541,Boldenone,small molecule,illicit|vet_approved,"Anabolic Agents|Androstanes|Androstenes|Androstenols|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone and derivatives|Testosterone Congeners",[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,13308
1471,DB01542,Allylprodine,small molecule,experimental|illicit,,CCC(=O)OC1(CCN(C)CC1CC=C)C1=CC=CC=C1,32938
1472,DB01543,18-methyl-19-nortestosterone,small molecule,experimental|illicit,Testosterone and derivatives,[H][C@@]12CC[C@H](O)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],10039774
1473,DB01544,Flunitrazepam,small molecule,approved|illicit,"Anti-Anxiety Agents|Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|GABA Agents|GABA Modulators|Heterocyclic Compounds, Fused-Ring|Hypnotics and Sedatives|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents|UGT1A1 Inhibitors|UGT1A3 Inhibitors|UGT2B7 Inhibitors",CN1C2=C(C=C(C=C2)[N+]([O-])=O)C(=NCC1=O)C1=CC=CC=C1F,3380
1474,DB01545,Ethyl loflazepate,small molecule,experimental|illicit,"Anti-Anxiety Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Nervous System|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents",CCOC(=O)C1N=C(C2=CC=CC=C2F)C2=C(NC1=O)C=CC(Cl)=C2,3299
1475,DB01546,Etryptamine,small molecule,illicit|investigational|withdrawn,"Amines|Biogenic Amines|Biogenic Monoamines|Heterocyclic Compounds, Fused-Ring|Indoles|Stimulants",CCC(N)CC1=CNC2=CC=CC=C12,8367
1476,DB01547,Drotebanol,small molecule,experimental|illicit,"Alkaloids|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Morphinans|Morphine Derivatives|Narcotics|Opiate Alkaloids|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents",[H][C@]12CC3=C(C(OC)=C(OC)C=C3)[C@@]3(CCN1C)C[C@H](O)CC[C@@]23O,6916258
1477,DB01548,Diprenorphine,small molecule,illicit|vet_approved,"Alkaloids|Central Nervous System Agents|Heterocyclic Compounds, Fused-Ring|Morphinans|Opiate Alkaloids|Opioid Antagonists|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents",[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]11CC[C@@]2(OC)[C@H](C1)C(C)(C)O,443408
1478,DB01549,Rolicyclidine,small molecule,experimental|illicit,Piperidines,C1CCN(C1)C1(CCCCC1)C1=CC=CC=C1,62436
1479,DB01550,Fenproporex,small molecule,experimental|illicit|withdrawn,Amines|Drugs that are Mainly Renally Excreted|Ethylamines|Phenethylamines|Stimulants,CC(CC1=CC=CC=C1)NCCC#N,61810
1480,DB01551,Dihydrocodeine,small molecule,approved|illicit,"Alkaloids|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Morphinans|Morphine Derivatives|Narcotics|Natural Opium Alkaloids|Nervous System|Opiate Alkaloids|Opioid Agonist|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Semi-synthetic Opioids|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",[H][C@@]12OC3=C4C(C[C@H]5N(C)CC[C@@]14[C@@]5([H])CC[C@@H]2O)=CC=C3OC,5284543
1481,DB01552,Betameprodine,small molecule,experimental|illicit,,CC[C@@H]1CN(C)CC[C@]1(OC(=O)CC)C1=CC=CC=C1,12218309
1482,DB01553,Cloxazolam,small molecule,experimental,"Anti-Anxiety Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Nervous System|Psycholeptics",ClC1=CC2=C(NC(=O)CN3CCOC23C2=CC=CC=C2Cl)C=C1,2816
1483,DB01554,Bolandiol,small molecule,experimental|illicit,"Estranes|Estrenes|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone Congeners",C[C@]12CC[C@H]3[C@@H](CCC4=C[C@@H](O)CC[C@H]34)[C@@H]1CC[C@@H]2O,9835303
1484,DB01555,Alphacetylmethadol,small molecule,experimental|illicit,Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Ketones|Narcotics|Opioids|Peripheral Nervous System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,CC[C@@H](OC(C)=O)C(C[C@@H](C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,22308
1485,DB01556,Chlorphentermine,small molecule,illicit|withdrawn,Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Autonomic Agents|Ethylamines|Peripheral Nervous System Agents|Phenethylamines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetics,CC(C)(N)CC1=CC=C(Cl)C=C1,10007
1486,DB01557,α-Methylfentanyl,small molecule,illicit,Designer Drugs|Piperidines|Street Drugs,CCC(=O)N(C1CCN(CC1)C(C)CC1=CC=CC=C1)C1=CC=CC=C1,62281
1487,DB01558,Bromazepam,small molecule,approved|illicit|investigational,"Anti-Anxiety Agents|Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|GABA Agents|GABA Modulators|Heterocyclic Compounds, Fused-Ring|Hypnotics and Sedatives|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents",BrC1=CC2=C(NC(=O)CN=C2C2=CC=CC=N2)C=C1,2441
1488,DB01559,Clotiazepam,small molecule,approved|illicit,Anti-Anxiety Agents|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Nervous System|Psycholeptics,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C1=CC=CC=C1Cl,2811
1489,DB01560,Cathinone,small molecule,illicit,Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Stimulants|Psychotropic Drugs,C[C@H](N)C(=O)C1=CC=CC=C1,62258
1490,DB01561,Androstanedione,small molecule,experimental|illicit,,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C,222865
1491,DB01562,1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine,small molecule,experimental|illicit,Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors,CC(=O)OC1(CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,60977
1492,DB01563,Chloral hydrate,small molecule,approved|illicit|investigational|vet_approved,Alcohols|Central Nervous System Agents|Central Nervous System Depressants|Drugs that are Mainly Renally Excreted|Ethylene Glycols|Glycols|Hypnotics and Sedatives|Miscellaneous Anxiolytics Sedatives and Hypnotics|Nervous System|Psycholeptics,OC(O)C(Cl)(Cl)Cl,2707
1493,DB01564,Calusterone,small molecule,experimental|illicit,"Androstanes|Androstenes|Androstenols|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone and derivatives|Testosterone Congeners",[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](C)CC2=CC(=O)CC[C@]12C,28204
1494,DB01565,Dihydromorphine,small molecule,experimental|illicit,"Alkaloids|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Morphinans|Morphine Derivatives|Narcotics|Opiate Alkaloids|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Semi-synthetic Opioids|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CC[C@@H]2O,5359421
1495,DB01566,Methylenedioxyethamphetamine,small molecule,experimental|illicit,Adrenergic Agents|Amines|Amphetamines|Ethylamines|Membrane Transport Modulators|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Phenethylamines|Sympathomimetics,CCNC(C)CC1=CC2=C(OCO2)C=C1,105039
1496,DB01567,Fludiazepam,small molecule,experimental|illicit,"Anti-Anxiety Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Peripheral Nervous System Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents",CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,3369
1497,DB01568,Codeine-N-oxide,small molecule,experimental|illicit,,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CC[N@+](C)([O-])[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,5359929
1498,DB01569,Formebolone,small molecule,experimental|illicit,Androstanes|Androstenes|Androstenols|Fused-Ring Compounds|Steroids|Testosterone and derivatives,[H][C@@]12CC[C@](C)(O)[C@@]1(C)C[C@@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C(C=O)=C[C@]12C,17150
1499,DB01570,Ohmefentanyl,small molecule,illicit,Analgesics|Central Nervous System Agents|Peripheral Nervous System Agents|Piperidines|Sensory System Agents,CCC(=O)N(C1CCN(CC(O)C2=CC=CC=C2)CC1C)C1=CC=CC=C1,62279
1500,DB01571,3-Methylfentanyl,small molecule,illicit,Analgesics|Central Nervous System Agents|Peripheral Nervous System Agents|Piperidines|Sensory System Agents,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1C)C1=CC=CC=C1,61996
1501,DB01572,Methyl-1-testosterone,small molecule,experimental|illicit,Testosterone and derivatives,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)C=C[C@]12C,
1502,DB01573,Benzylmorphine,small molecule,experimental|illicit,,[H][C@@]12OC3=C(OCC4=CC=CC=C4)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,5362507
1503,DB01574,Attapulgite,small molecule,approved|vet_approved,"Alimentary Tract and Metabolism|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antidotes|Compounds used in a research, industrial, or household setting|Intestinal Adsorbents|Protective Agents",[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[Si+4].[O-][H].[H]O[H].[H]O[H].[H]O[H].[H]O[H],73415752
1504,DB01575,Kaolin,small molecule,approved,"Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Aluminium Compounds|Aluminum Silicates|Anions|Antidiarrheals|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Electrolytes|Gastrointestinal Agents|Intestinal Adsorbents|Ions|Metal cations|Metal divalent cations|Minerals|Oxides|Oxygen Compounds|Silicates|Silicon Compounds",O.O.[Al+3].[Al+3].[O-][Si]([O-])([O-])O[Si]([O-])([O-])[O-],92024769
1505,DB01576,Dextroamphetamine,small molecule,approved|illicit,"Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Central Nervous System Agents|Central Nervous System Stimulants|Central Nervous System Stimulation|Centrally Acting Sympathomimetics|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Uptake Inhibitors|Ethylamines|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Phenethylamines|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetics",C[C@H](N)CC1=CC=CC=C1,5826
1506,DB01577,Metamfetamine,small molecule,approved|illicit,"Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamine Anorectic|Amphetamines|Antidepressive Agents|Appetite Suppression|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Stimulants|Central Nervous System Stimulation|Centrally Acting Sympathomimetics|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Uptake Inhibitors|Drugs that are Mainly Renally Excreted|Ethylamines|Increased Sympathetic Activity|Membrane Transport Modulators|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Peripheral Nervous System Agents|Phenethylamines|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetics",CN[C@@H](C)CC1=CC=CC=C1,10836
1507,DB01578,Metrizamide,small molecule,experimental,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Carbohydrates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Glycosides|Iodobenzoates|Triiodobenzoic Acids|Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media|X-Ray Contrast Media, Iodinated",CN(C(C)=O)C1=C(I)C(C(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO)=C(I)C(NC(C)=O)=C1I,20056604
1508,DB01579,Phendimetrazine,small molecule,approved|illicit,Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Appetite Suppression|Central Nervous System Agents|Central Nervous System Stimulants|Increased Sympathetic Activity|Oxazines|Sympathomimetic Amine Anorectic,C[C@H]1[C@@H](OCCN1C)C1=CC=CC=C1,30487
1509,DB01580,Oxprenolol,small molecule,approved,"Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Anti-Anxiety Agents|Antiarrhythmic agents|Antihypertensive Agents|Autonomic Agents|Beta Blocking Agents and Thiazides|Beta Blocking Agents, Non-Selective|Beta Blocking Agents, Non-Selective, and Thiazides|Bradycardia-Causing Agents|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Hypotensive Agents|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|OCT2 Inhibitors|Peripheral Nervous System Agents|Phenoxypropanolamines|Propanolamines|Propanols|QTc Prolonging Agents|Sympatholytics|Tranquilizing Agents|Vasodilating Agents",CC(C)NCC(O)COC1=CC=CC=C1OCC=C,4631
1510,DB01581,Sulfamerazine,small molecule,approved|vet_approved,Amides|Amines|Aniline Compounds|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Long-Acting Sulfonamides|Sulfanilamides|Sulfonamide Antibacterial|Sulfonamides|SULFONAMIDES AND TRIMETHOPRIM|Sulfones|Sulfur Compounds,CC1=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=NC=C1,5325
1511,DB01582,Sulfamethazine,small molecule,approved|investigational|vet_approved,Amides|Amines|Aniline Compounds|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Short-Acting Sulfonamides|Sulfanilamides|Sulfonamides|SULFONAMIDES AND TRIMETHOPRIM|Sulfones|Sulfur Compounds,CC1=CC(C)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=N1,5327
1512,DB01583,Liotrix,small molecule,approved,"Agents used to treat hypothyroidism|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|l-Triiodothyronine|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein inducers|Pharmaceutical Preparations|Thyroid Products|Thyronines|Thyroxine-binding globulin substrates",[Na+].[Na+].N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C([O-])=O.N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C([O-])=O,71371
1514,DB01586,Ursodeoxycholic acid,small molecule,approved|investigational,Alimentary Tract and Metabolism|Bile Acid Preparations|Bile acids and derivatives|Bile Acids and Salts|Bile and Liver Therapy|Bile Therapy|BSEP/ABCB11 inducers|BSEP/ABCB11 Inhibitors|BSEP/ABCB11 Substrates|Cholagogues and Choleretics|Cholanes|Cholelitholytic Agents|Cholic Acids|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP2E1 Inducers (strength unknown)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Fused-Ring Compounds|Gastrointestinal Agents|Steroids,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,31401
1515,DB01587,Ketazolam,small molecule,approved,"Anti-Anxiety Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Nervous System|P-glycoprotein substrates|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents",CN1C2=C(C=C(Cl)C=C2)C2(OC(C)=CC(=O)N2CC1=O)C1=CC=CC=C1,33746
1516,DB01588,Prazepam,small molecule,approved|illicit,"Anti-Anxiety Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|GABA Agents|GABA Modulators|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents",ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1,4890
1517,DB01589,Quazepam,small molecule,approved|illicit,"Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Hypnotics and Sedatives|Nervous System|Psycholeptics",FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2,4999
1518,DB01590,Everolimus,small molecule,approved,Anti-Bacterial Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Decreased Immunologic Activity|Hyperglycemia-Associated Agents|Immunologic Factors|Immunosuppressive Agents|Kinase Inhibitor|Lactones|Macrolides|mTOR Inhibitor Immunosuppressant|mTOR Inhibitors|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Polyketides|Protein Kinase Inhibitors|Selective Immunosuppressants,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](OCCO)[C@@H](C1)OC,6442177
1519,DB01591,Solifenacin,small molecule,approved,"Agents producing tachycardia|Agents that produce hypertension|Anticholinergic Agents|Cholinergic Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs for Urinary Frequency and Incontinence|Drugs Used in Benign Prostatic Hypertrophy|Genito Urinary System and Sex Hormones|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Muscarinic Antagonists|Neurotransmitter Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinuclidines|Tetrahydroisoquinolines|Urological Agents|Urologicals",O=C(O[C@H]1CN2CCC1CC2)N1CCC2=CC=CC=C2[C@@H]1C1=CC=CC=C1,154059
1520,DB01592,Iron,small molecule,approved,"Alimentary Tract and Metabolism|Antianemia Drugs|Antianemic Preparations|Blood and Blood Forming Organs|Diet, Food, and Nutrition|Elements|Food|Food and Beverages|Growth Substances|Iron Compounds|Iron Preparations|Metals|Metals, Heavy|Micronutrients|Minerals|Organometallic Compounds|Physiological Phenomena|Supplements|Trace Elements|Transition Elements",[Fe],23925
1521,DB01593,Zinc,small molecule,approved|investigational,"Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Copper Absorption Inhibitor|Diet, Food, and Nutrition|Elements|Food|Food and Beverages|Growth Substances|Laxatives|Metal cations|Metal divalent cations|Metals|Metals, Heavy|Micronutrients|Minerals|Physiological Phenomena|Replacement Preparations|Trace Elements|Transition Elements|Vasoprotectives|Zinc Compounds",[Zn],23994
1522,DB01594,Cinolazepam,small molecule,experimental,"Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Hypnotics and Sedatives|Nervous System|Psycholeptics",OC1N=C(C2=CC=CC=C2F)C2=C(C=CC(Cl)=C2)N(CCC#N)C1=O,3033621
1523,DB01595,Nitrazepam,small molecule,approved,"Anti-Anxiety Agents|Anticonvulsants|Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|GABA Agents|GABA Modulators|Heterocyclic Compounds, Fused-Ring|Hypnotics and Sedatives|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents",[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1,4506
1524,DB01597,Cilastatin,small molecule,approved|investigational,Cycloparaffins|Cyclopropanes|Dipeptidase Inhibitors|Enzyme Inhibitors|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|Protease Inhibitors|Renal Dehydropeptidase Inhibitor,CC1(C)C[C@@H]1C(=O)N\C(=C/CCCCSC[C@H](N)C(O)=O)C(O)=O,6435415
1525,DB01598,Imipenem,small molecule,approved,"Agents that reduce seizure threshold|Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|beta-Lactams|Carbapenems|Heterocyclic Compounds, Fused-Ring|Lactams|Neurotoxic agents|Penem Antibacterial|Sulfur Compounds|Thienamycins",[H][C@]12CC(SCC\N=C\N)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,104838
1526,DB01599,Probucol,small molecule,approved|investigational,"Anticholesteremic Agents|Antioxidants|Benzene Derivatives|Compounds used in a research, industrial, or household setting|Hypolipidemic Agents|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Moderate Risk QTc-Prolonging Agents|Noxae|Phenols|Protective Agents|QTc Prolonging Agents|Toxic Actions",CC(C)(SC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C)SC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C,4912
1527,DB01600,Tiaprofenic acid,small molecule,approved,"Acids, Acyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|Fatty Acids|Fatty Acids, Volatile|Lipids|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Other Nonsteroidal Anti-inflammatory Agents|Peripheral Nervous System Agents|Photosensitizing Agents|Propionates|Prostaglandin Antagonists|Sensory System Agents",CC(C(O)=O)C1=CC=C(S1)C(=O)C1=CC=CC=C1,5468
1528,DB01601,Lopinavir,small molecule,approved,Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BSEP/ABCB11 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2B6 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Direct Acting Antivirals|Enzyme Inhibitors|Experimental Unapproved Treatments for COVID-19|HIV Protease Inhibitors|Hyperglycemia-Associated Agents|Nephrotoxic agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors|P-glycoprotein inducers|P-glycoprotein inhibitors|Potential QTc-Prolonging Agents|Protease Inhibitors|Pyrimidinones|QTc Prolonging Agents,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)COC1=C(C)C=CC=C1C)CC1=CC=CC=C1,92727
1529,DB01602,Bacampicillin,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Penicillin G|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds",[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(=O)OC(C)OC(=O)OCC,441397
1530,DB01603,Meticillin,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|Beta-Lactamase Resistant Penicillins|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Penicillins|Sulfur Compounds",[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(OC)C=CC=C1OC)C(O)=O,6087
1531,DB01604,Pivampicillin,small molecule,approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Penicillin G|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds",[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(=O)OCOC(=O)C(C)(C)C,33478
1532,DB01605,Pivmecillinam,small molecule,approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Penicillins|Penicillins With Extended Spectrum|Renal Agents|Sulfur Compounds",[H]C(=N[C@@H]1C(=O)N2[C@@H](C(=O)OCOC(=O)C(C)(C)C)C(C)(C)S[C@]12[H])N1CCCCCC1,115163
1533,DB01606,Tazobactam,small molecule,approved,"Amides|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|beta-Lactamase Inhibitors|beta-Lactams|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Lactams|OAT1/SLC22A6 inhibitors|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Sulfones|Sulfur Compounds",[H][C@@]12CC(=O)N1[C@@H](C(O)=O)[C@](C)(CN1C=CN=N1)S2(=O)=O,123630
1534,DB01607,Ticarcillin,small molecule,approved|investigational|vet_approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds",[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](C(O)=O)C1=CSC=C1)C(O)=O,36921
1535,DB01608,Periciazine,small molecule,approved|investigational,"Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Depressants|Dopamine Antagonists|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotoxic agents|Phenothiazines|Phenothiazines With Piperidine Structure|Psycholeptics|Sulfur Compounds",OC1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C#N)CC1,4747
1536,DB01609,Deferasirox,small molecule,approved|investigational,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Chelating Agents|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Heavy Metal Antagonists|Iron Chelating Activity|Iron Chelating Agents|Sequestering Agents|Triazoles|UGT1A1 Inhibitors|UGT1A1 Substrates|UGT1A3 Inhibitors|UGT1A9 Inhibitors",OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,5493381
1537,DB01610,Valganciclovir,small molecule,approved|investigational,"Agents that reduce seizure threshold|Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor|Direct Acting Antivirals|Drugs that are Mainly Renally Excreted|Ganciclovir|Ganciclovir and prodrug|Heterocyclic Compounds, Fused-Ring|Nucleic Acid Synthesis Inhibitors|Nucleoside Analog Antiviral|Nucleosides and Nucleotides|Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors|Purines|Purinones",CC(C)[C@H](N)C(=O)OCC(CO)OCN1C=NC2=C1NC(N)=NC2=O,64147
1538,DB01611,Hydroxychloroquine,small molecule,approved,"Aminoquinolines|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Antirheumatic Agents|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Immunosuppressive Agents|P-glycoprotein inhibitors|Photosensitizing Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines",CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,3652
1539,DB01612,Amyl Nitrite,small molecule,approved,"Acids|Acids, Noncarboxylic|Anions|Antianginal Agents|Antidotes|Cardiovascular Agents|Electrolytes|Hypotensive Agents|Ions|Methemoglobinemia Associated Agents|Nitrites|Nitrogen Compounds|Organic Nitrates|Vasodilating Agents",CCCCCON=O,10026
1540,DB01613,Erythrityl tetranitrate,small molecule,approved|experimental|investigational,"Acids|Acids, Noncarboxylic|Alcohols|Anions|Antianginal Agents|Carbohydrates|Cardiac Therapy|Cardiovascular Agents|Electrolytes|Erythritol|Ions|Nitrates|Nitric Acid|Nitrogen Compounds|Organic Nitrates|Sugar Alcohols|Vasodilating Agents|Vasodilators Used in Cardiac Diseases",[O-][N+](=O)OC[C@@H](O[N+]([O-])=O)[C@H](CO[N+]([O-])=O)O[N+]([O-])=O,5284553
1541,DB01614,Acepromazine,small molecule,experimental|vet_approved,"Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antidepressive Agents|Antipsychotic Agents|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Phenothiazines|Phenothiazines With Aliphatic Side-Chain|Psycholeptics|Psychotropic Drugs|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Tranquilizing Agents",CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(C)=O,6077
1542,DB01615,Aceprometazine,small molecule,experimental,"Antipsychotic Agents|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Heterocyclic Compounds, Fused-Ring|Histamine Antagonists|Histamine H1 Antagonists|Moderate Risk QTc-Prolonging Agents|Neurotoxic agents|Neurotransmitter Agents|Phenothiazines|Psychotropic Drugs|QTc Prolonging Agents|Sulfur Compounds|Tranquilizing Agents",CC(CN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(C)=O)N(C)C,26035
1543,DB01616,Alverine,small molecule,approved|investigational,Alimentary Tract and Metabolism|Amines|Antidepressive Agents|Autonomic Agents|Central Nervous System Depressants|Drugs for Functional Gastrointestinal Disorders|Parasympatholytics|Peripheral Nervous System Agents|Serotonin 5-HT1 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists,CCN(CCCC1=CC=CC=C1)CCCC1=CC=CC=C1,3678
1544,DB01618,Molindone,small molecule,approved,"Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Heterocyclic Compounds, Fused-Ring|Indole Derivatives|Indoles|Nervous System|Neurotoxic agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents",CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2,23897
1545,DB01619,Phenindamine,small molecule,approved,Antihistamines for Systemic Use|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents,CN1CCC2=C(C1)C(C1=CC=CC=C21)C1=CC=CC=C1,11291
1546,DB01620,Pheniramine,small molecule,approved,"Anti-Allergic Agents|Antihistamines for Systemic Use|Antihistamines for Topical Use|Antipruritics|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Dermatologicals|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents",CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=N1,4761
1547,DB01621,Pipotiazine,small molecule,approved|investigational,"Antipsychotic Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs causing inadvertant photosensitivity|Heterocyclic Compounds, Fused-Ring|Hyperglycemia-Associated Agents|Nervous System|Neurotoxic agents|Phenothiazines|Phenothiazines With Piperidine Structure|Photosensitizing Agents|Psycholeptics|Sulfur Compounds",CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3N2CCCN2CCC(CCO)CC2)C=C1,62867
1548,DB01622,Thioproperazine,small molecule,experimental,"Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antidepressive Agents|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Depressants|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotoxic agents|Phenothiazines|Phenothiazines With Piperazine Structure|Psycholeptics|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds",CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3N2CCCN2CCN(C)CC2)C=C1,9429
1549,DB01623,Thiothixene,small molecule,approved,"Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs causing inadvertant photosensitivity|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Photosensitizing Agents|Potential QTc-Prolonging Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Sulfur Compounds|Thioxanthene Derivatives|Thioxanthenes|Tranquilizing Agents|Xanthenes",CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1,941651
1550,DB01624,Zuclopenthixol,small molecule,approved|investigational,"Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antidepressive Agents|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|Histamine Antagonists|Histamine H1 Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Thioxanthene Derivatives|Thioxanthenes|Tranquilizing Agents|Xanthenes",OCCN1CCN(CC\C=C2\C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1,5311507
1551,DB01625,Isopropamide,small molecule,approved|vet_approved,"Agents producing tachycardia|Alimentary Tract and Metabolism|Amines|Ammonium Compounds|Anticholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Nitrogen Compounds|Onium Compounds|Synthetic Anticholinergics, Quaternary Ammonium Compounds",CC(C)[N+](C)(CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=C1)C(C)C,3775
1552,DB01626,Pargyline,small molecule,approved,Agents that produce hypertension|Agents that reduce seizure threshold|Amines|Antidepressive Agents|Antihypertensive Agents|Benzene Derivatives|Benzyl Compounds|Benzylamines|Cardiovascular Agents|Central Nervous System Depressants|Enzyme Inhibitors|MAO Inhibitors and Diuretics|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Monoamine Oxidase Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,CN(CC#C)CC1=CC=CC=C1,4688
1553,DB01627,Lincomycin,small molecule,approved|vet_approved,"Agents that produce neuromuscular block (indirect)|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Carbohydrates|Enzyme Inhibitors|Glycosides|Lincosamides|Macrolides, Lincosamides and Streptogramins|Neurotoxic agents|Protein Synthesis Inhibitors|Pyrrolidines",[H][C@]1(C[C@@H](CCC)CN1C)C(=O)N[C@H]([C@@H](C)O)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O,3000540
1554,DB01628,Etoricoxib,small molecule,approved|investigational,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|COX-2 Inhibitors|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Pyridines|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory System Agents|Sulfones|Sulfur Compounds",CC1=NC=C(C=C1)C1=C(C=C(Cl)C=N1)C1=CC=C(C=C1)S(C)(=O)=O,123619
1555,DB01629,5-fluorouridine,small molecule,experimental,"Carbohydrates|Fluorouracil and prodrugs|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides|Thyroxine-binding globulin inducers",OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=C(F)C(=O)NC1=O,9427
1556,DB01630,SC-74020,small molecule,experimental,Amides|Amines|Hydroxy Acids|Hydroxylamines|Sulfones|Sulfur Compounds,CCCCCC1=CC=C(C=C1)C(=O)NC1=CC=C(C=C1)S(=O)(=O)N(CCN1CCOCC1)[C@H](C(C)C)C(=O)NO,5288596
1557,DB01631,Methyl nonanoate,small molecule,experimental,,CCCCCCCCC(=O)OC,15606
1558,DB01632,5-O-phosphono-alpha-D-ribofuranosyl diphosphate,small molecule,approved|experimental|investigational,Carbohydrates|Pentosephosphates|Sugar Phosphates,O[C@H]1[C@@H](O)[C@@H](OP(O)(=O)OP(O)(O)=O)O[C@@H]1COP(O)(O)=O,7339
1559,DB01633,Deoxy-2-fluoro-beta-D-cellotrioside,small molecule,experimental|investigational,,[H][C@]1(F)[C@@H](O)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@@H]1O,445968
1560,DB01634,2-Oxy-4-Hydroxy-5-(2-Hydrazinopyridine)Phenylalanine,small molecule,experimental,,[H][C@](N)(C[C@]1([H])C=C(NNC2=CC=CC=N2)C(O)=CC1=O)C(O)=O,17754117
1561,DB01635,"2,2-Dimethylthiazolidine-4-Carboxylic Acid;(Dmt)Thiazolidine",small molecule,experimental,,CC1(C)N[C@@H](CS1)C(O)=O,676443
1562,DB01637,"3,7,11,15-tetramethyl-hexadecan-1-ol",small molecule,experimental|investigational,,CC(C)CCC[C@H](C)CCC[C@H](C)CCC[C@H](C)CCO,444637
1563,DB01638,Sorbitol,small molecule,approved,"Alcohols|Alimentary Tract and Metabolism|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Carbohydrates|Compounds used in a research, industrial, or household setting|Diagnostic Agents|Diet, Food, and Nutrition|Drugs for Constipation|Drugs that are Mainly Renally Excreted|Enemas|Flavoring Agents|Food|Food Additives|Food and Beverages|Food Ingredients|Gastrointestinal Agents|Indicators and Reagents|Irrigating Solutions|Laboratory Chemicals|Laxatives|Osmotic Laxatives|Pharmaceutic Aids|Pharmaceutical Preparations|Physiological Phenomena|Sugar Alcohols|Sweetening Agents|Tests for Bile Duct Patency",OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,5780
1564,DB01639,N-Methyl-Pyridoxal-5'-Phosphate,small molecule,experimental,,CC1=C(O)C(C=O)=C(COP(O)(O)=O)C=[N+]1C,5168640
1565,DB01640,"6-(4-{[2-(3-iodobenzyl)-3-oxocyclohex-1-en-1-yl]amino}phenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one",small molecule,experimental,,C[C@@H]1CC(=O)NN=C1C1=CC=C(NC2=C(CC3=CC(I)=CC=C3)C(=O)CCC2)C=C1,5287540
1566,DB01641,"{(4Z)-2-[(1R,2R)-1-Amino-2-hydroxypropyl]-4-[(4-amino-1H-indol-3-yl)methylene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid",small molecule,experimental,,[H]N([H])C1=C2C(\C=C3/N=C(N(CC(O)=O)C3=O)[C@@]([H])(N([H])[H])[C@@]([H])(C)O)=CN([H])C2=CC=C1,46936180
1567,DB01642,methyl beta-D-glucopyranoside,small molecule,experimental,Carbohydrates|Glucosides|Glycosides|Methylglycosides,CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,445238
1568,DB01643,Thymidine monophosphate,small molecule,experimental,"Carbohydrates|Deoxyribonucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Thymine Nucleotides",CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(O)=O)O2)C(=O)NC1=O,9700
1569,DB01644,"3,6-dihydroxy-xanthene-9-propionic acid",small molecule,experimental,,OC(=O)CCC1C2=CC=C(O)C=C2OC2=C1C=CC(O)=C2,449159
1570,DB01645,Genistein,small molecule,investigational,"Anticarcinogenic Agents|Antineoplastic Agents|BCRP/ABCG2 Inhibitors|Benzopyrans|Chromones|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (weak)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Estrogens, Non-Steroidal|Flavonoids|Heterocyclic Compounds, Fused-Ring|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Isoflavones|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein inhibitors|Phytoestrogens|Protective Agents|Protein Kinase Inhibitors|Pyrans|Tyrosine Kinase Inhibitors",OC1=CC=C(C=C1)C1=COC2=C(C(O)=CC(O)=C2)C1=O,5280961
1571,DB01646,N-Acetylmethionine,small molecule,experimental,"Amino Acids|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Sulfur Compounds",CSCC[C@H](NC(C)=O)C(O)=O,448580
1572,DB01647,Daxalipram,small molecule,experimental,,CCCOC1=CC(=CC=C1OC)[C@]1(C)CNC(=O)O1,449190
1573,DB01648,Methyl 4-thio-beta-D-glucopyranoside,small molecule,experimental,,CO[C@@H]1O[C@H](CO)[C@@H](S)[C@H](O)[C@H]1O,447600
1574,DB01649,7-methyl-GpppA,small molecule,experimental,,CN1C=[N+]([C@@H]2O[C@H](CO[P@](O)(=O)O[P@](O)(=O)O[P@](O)(=O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)N3C=NC4=C(N)N=CN=C34)[C@@H](O)[C@H]2O)C2=C1C(=O)N=C(N)N2,446336
1575,DB01650,trans-2-hydroxycinnamic acid,small molecule,experimental,OAT3/SLC22A8 Inhibitors,OC(=O)\C=C\C1=CC=CC=C1O,637540
1576,DB01651,"Methyl 4,6-O-[(1R)-1-carboxyethylidene]-beta-D-galactopyranoside",small molecule,experimental,,[H][C@@]12CO[C@](C)(O[C@]1([H])[C@H](O)[C@@H](O)[C@H](OC)O2)C(O)=O,445936
1577,DB01652,4-hydroxybenzoyl-CoA,small molecule,experimental,"Adenine Nucleotides|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides|Thioesters of coenzyme A",CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C1=CC=C(O)C=C1,168718
1578,DB01655,L-gulonic acid 6-phosphate,small molecule,experimental,,O[C@@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O,446821
1579,DB01656,Roflumilast,small molecule,approved,"Acids, Carbocyclic|Agents to Treat Airway Disease|Amides|Amines|Benzene Derivatives|Benzoates|Cycloparaffins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Drugs for Obstructive Airway Diseases|Drugs that are Mainly Renally Excreted|Phosphodiesterase 4 Inhibitors|Phosphodiesterase Inhibitors|Pyridines",FC(F)OC1=C(OCC2CC2)C=C(C=C1)C(=O)NC1=C(Cl)C=NC=C1Cl,449193
1580,DB01657,"2-amino-3-[4-hydroxy-6-oxo-3-(2-phenyl-cyclopropylimino)-cyclohexa-1,4-dienyl]-propionic acid",small molecule,experimental,,NC(CC1C\C(=N/C2CC2C2=CC=CC=C2)C(O)=CC1=O)C(O)=O,23644144
1581,DB01658,1'-Deazo-Thiamin Diphosphate,small molecule,experimental,,CC1=C(CCO[P@](O)(=O)O[P@](O)([O-])=O)SC=[N+]1CC1=CC=C(C)N=C1N,5180212
1582,DB01659,"3-(1,10-Phenanthrol-2-Yl)-L-Alanine",small molecule,experimental,,N[C@@H](CC1=CC=C2C=CC3=C(N=CC=C3)C2=N1)C(O)=O,17754134
1583,DB01661,1-(5-phospho-D-ribosyl)-ATP,small molecule,experimental,"Adenine Nucleotides|Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",O[C@@H]1[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=CN(C1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O)C2=N,16019963
1584,DB01662,Trans-O-Hydroxy-Alpha-Methyl Cinnamate,small molecule,experimental,,[H][C@@](C)(CC1=CC=CC=C1O)C(O)=O,17754112
1585,DB01663,"lambda-bis(2,2'-bipyridine)-(5-methyl-2-2'-bipyridine)-C9-adamantane ruthenium (II)",small molecule,experimental,,CC1=CC2=C3C=C(CCCCCCCCC(=O)N[C@H]4[C@H]5C[C@@H]6C[C@@H](C[C@H]4C6)C5)C=CN3[Ru++]34(N5C=CC=CC5=C5C=CC=CN35)(N3C=CC=CC3=C3C=CC=CN43)N2C=C1,23644225
1586,DB01664,(S)-DES-ME-AMPA,small molecule,experimental,,N[C@@H](CC1=CONC1=O)C(O)=O,447195
1587,DB01665,2H-Benzimidazol-2-amine,small molecule,experimental,,NC1N=C2C=CC=CC2=N1,4469371
1588,DB01666,D-Myo-Inositol-Hexasulphate,small molecule,experimental,,[H][C@]1(OS(O)(=O)=O)[C@]([H])(OS(O)(=O)=O)[C@@]([H])(OS(O)(=O)=O)[C@]([H])(OS(O)(=O)=O)[C@]([H])(OS(O)(=O)=O)[C@]1([H])OS(O)(=O)=O,65302
1589,DB01667,8-azaguanine,small molecule,experimental,"Antimetabolites|Antineoplastic Agents|Aza Compounds|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Noxae|Purines|Purinones|Toxic Actions|Xanthine derivatives",NC1=NC2=C(N=NN2)C(=O)N1,8646
1590,DB01668,Nanaomycin D,small molecule,experimental,Naphthalenes|Quinones,[H][C@]12CC(=O)O[C@]1([H])C1=C(C(=O)C3=C(C=CC=C3O)C1=O)[C@]([H])(C)O2,6323454
1591,DB01669,Virginiamycin M1,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Peptides|Peptides, Cyclic|Streptogramin Group A|Streptogramins",CC(C)[C@H]1OC(=O)C2=CCCN2C(=O)C2=COC(=N2)CC(=O)C[C@H](O)\C=C(/C)\C=C\CNC(=O)\C=C\[C@H]1C,5459319
1592,DB01670,Propyl acetate,small molecule,experimental,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids",CCCOC(C)=O,7997
1593,DB01671,p-Hydroxymercuribenzoic acid,small molecule,experimental,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Enzyme Inhibitors|Hydroxy Acids|Hydroxybenzoates|Mercuribenzoates|Organomercury Compounds|Organometallic Compounds|Phenols|Phenylmercury Compounds|Protease Inhibitors",O[Hg]C1=CC=C(C=C1)C(O)=O,14309
1594,DB01672,"2,3-Dihydroxy-Benzoic Acid",small molecule,experimental,,OC(=O)C1=CC=CC(O)=C1O,19
1595,DB01673,Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine,small molecule,experimental,,C[C@H](NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@H](OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@@H]1NC(C)=O)C(O)=O,5496796
1596,DB01674,[2-(1-Amino-2-Hydroxy-Propyl)-4-(4-Fluoro-1h-Indol-3-Ylmethyl)-5-Hydroxy-Imidazol-1-Yl]-Acetic Acid,small molecule,experimental,,[H][C@@](C)(O)[C@]([H])(N)C1=NC(CC2=CNC3=CC=CC(F)=C23)=C(O)N1CC(O)=O,17753789
1597,DB01675,Methacrylyl-Coenzyme A,small molecule,experimental,"Adenine Nucleotides|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N,165390
1598,DB01676,Trinitrotoluene,small molecule,experimental,"Benzene Derivatives|Compounds used in a research, industrial, or household setting|Explosive Agents",CC1=C(C=C(C=C1[N+]([O-])=O)[N+]([O-])=O)[N+]([O-])=O,8376
1599,DB01677,Fumaric Acid,small molecule,experimental|investigational,"Acids, Acyclic|Antipsoriatics|Antipsoriatics for Topical Use|Dermatologicals|Dicarboxylic Acids",OC(=O)\C=C\C(O)=O,444972
1600,DB01678,RU84687,small molecule,experimental,,CC(=O)N[C@@H](CC1=CC=C(OP(O)(O)=O)C(C=O)=C1)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O,5287544
1601,DB01679,Propyl Trihydrogen Diphosphate,small molecule,experimental,,CCCO[P@](O)(=O)OP(O)(O)=O,448670
1602,DB01681,Benzene Hexacarboxylic Acid,small molecule,experimental,"Acids, Carbocyclic|Benzene Derivatives",OC(=O)C1=C(C(O)=O)C(C(O)=O)=C(C(O)=O)C(C(O)=O)=C1C(O)=O,2334
1603,DB01682,6'-Methyl-Thiamin Diphosphate,small molecule,experimental,,CC1=C(CCO[P@](O)(=O)O[P@](O)([O-])=O)SC=[N+]1CC1=C(C)N=C(C)N=C1N,4477692
1604,DB01683,Chymostatin,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Chymotrypsin, antagonists & inhibitors|Enzyme Inhibitors|Peptides|Protease Inhibitors|Serine Protease Inhibitors",CC(C)C[C@H](NC(=O)[C@@H](NC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O)C1CCNC(=N)N1)C(=O)N[C@@H](CC1=CC=CC=C1)C=O,5287931
1605,DB01684,1-Hydroxy-1-Thio-Glycerol,small molecule,experimental,,OC[C@@H](O)CSO,5289354
1606,DB01685,Topiroxostat,small molecule,experimental,BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|UGT1A9 Substrates,N#CC1=NC=CC(=C1)C1=NNC(=N1)C1=CC=NC=C1,5288320
1607,DB01686,"N,N-dimethylarginine",small molecule,experimental,"Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Enzyme Inhibitors|Nitric Oxide Synthase, antagonists & inhibitors",N[C@@H](CCC\N=C(/N)N(C)C)C(O)=O,123831
1608,DB01687,beta-Mannobiose,small molecule,experimental,,OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@H](O)[C@H](O)O[C@@H]2CO)[C@@H](O)[C@@H](O)[C@@H]1O,448165
1609,DB01688,P-Cresol,small molecule,experimental,Benzene Derivatives|Phenols,CC1=CC=C(O)C=C1,2879
1610,DB01689,Inhibitor Idd 384,small molecule,experimental,,CC1=CC=CC=C1CC(=O)NC1=CC(C)=C(C(C)=C1)S(=O)(=O)NCC(O)=O,1944
1611,DB01690,Bis(Adenosine)-5'-Triphosphate,small molecule,experimental,,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,165381
1612,DB01691,Indole Naphthyridinone,small molecule,experimental,,CN(CC1=CN(C)C2=CC=CC=C12)C(=O)\C=C\C1=CN=C2NC(=O)CCC2=C1,5288607
1613,DB01692,Dithioerythritol,small molecule,experimental,"Alcohols|Carbohydrates|Compounds used in a research, industrial, or household setting|Glycosides|Indicators and Reagents|Laboratory Chemicals|Sugar Alcohols|Sulfhydryl Reagents|Sulfur Compounds|Thioglycosides",[H][C@](O)(CS)[C@]([H])(O)CS,439352
1614,DB01694,D-tartaric acid,small molecule,experimental,,O[C@@H]([C@H](O)C(O)=O)C(O)=O,447315
1615,DB01695,N-Hydroxy-4-Phosphono-Butanamide,small molecule,experimental,,ONC(=O)CCCP([O-])([O-])=O,4469994
1616,DB01697,beta-cellotriose,small molecule,experimental,,[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(O[C@]2([H])O[C@]([H])(CO)[C@@]([H])(O[C@]3([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O,440950
1617,DB01698,Rutin,small molecule,approved|experimental|investigational,"Benzopyrans|Capillary Stabilizing Agents|Chromones|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Flavonoids|Flavonols|Heterocyclic Compounds, Fused-Ring|Pyrans|Vasoprotectives",C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3=C(OC4=CC(O)=CC(O)=C4C3=O)C3=CC(O)=C(O)C=C3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,5280805
1618,DB01699,(4e)-4-Aminohex-4-Enoic Acid,small molecule,experimental,,[H]\C(C)=C(/N)CCC(O)=O,5288385
1619,DB01700,AICA ribonucleotide,small molecule,experimental|investigational,"Blood Glucose Lowering Agents|Carbohydrates|Glycosides|Imidazoles|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides",NC(=O)C1=C(N)N(C=N1)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O,65110
1620,DB01701,"1,2-Dichloro-Propane",small molecule,experimental,,C[C@@H](Cl)CCl,445768
1621,DB01702,"2-(3,4-Dihydroxyphenyl)Acetic Acid",small molecule,experimental,,OC(=O)CC1=CC(O)=C(O)C=C1,547
1622,DB01703,N-(2-ferrocenylethyl)maleimide,small molecule,experimental,,N1(C(=O)C=CC1=O)CCC12[Fe]3456789%10C%11C3C4C5C6%11.C7(C8C19)C2%10,11986118
1623,DB01704,"2,4-Dihydroxy-Trans Cinnamic Acid",small molecule,experimental,,OC(=O)\C=C\C1=C(O)C=C(O)C=C1,446611
1624,DB01705,Bis(5-Amidino-Benzimidazolyl)Methane,small molecule,experimental,,NC(=[NH2+])C1=CC2=C(C=C1)N=C(CC1=NC3=C(N1)C=C(C=C3)C([NH3+])=[NH2+])N2,131704176
1625,DB01706,2-Bromo-6-chloro-purine,small molecule,experimental,,[H]N1C=NC2=C1C(Cl)=NC(Br)=N2,5287744
1626,DB01707,"L-Alfa-Lysophosphatidylcholine, Lauroyl",small molecule,experimental,,CCCCCCCCCCCC(=O)OCC(O)COP(O)(=O)OCC[N+](C)(C)C,3045269
1627,DB01708,Prasterone,small molecule,approved|investigational|nutraceutical,"17-Ketosteroids|Adjuvants, Immunologic|Adrenal Cortex Hormones|Alimentary Tract and Metabolism|Anabolic Agents for Systemic Use|Anabolic Steroids|Androgens and Estrogens|Androstan Derivatives|Androstanes|Androstenes|Androstenols|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunologic Factors|Ketosteroids|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|Sex Hormones and Modulators of the Genital System|Steroids|Testosterone Congeners",[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C,5881
1628,DB01709,2-phospho-D-glyceric acid,small molecule,experimental,,OC[C@@H](OP(O)(O)=O)C(O)=O,439278
1629,DB01710,Porphyrin Fe(III),small molecule,experimental,,[Fe+5].[H]C1=C([H])/C2=C([H])/C3=N/C(/C([H])=C3[H])=C([H])\C3=C([H])C([H])=C([N-]3)/C([H])=C3\N=C(C([H])=C3[H])\C(\[H])=C\1/[N-]\2,131704177
1630,DB01711,"2,3,4,5,6-Pentafluorobenzyl Alcohol",small molecule,experimental,Alcohols|Benzene Derivatives|Benzyl Compounds,OCC1=C(F)C(F)=C(F)C(F)=C1F,9923
1631,DB01712,"(3R)-4-(p-toluenesulfonyl)-1,4-thiazane-3-carboxylicacid-L-phenylalanine ethyl ester",small molecule,experimental,,CCOC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H]1CSCCN1S(=O)(=O)C1=CC=C(C)C=C1,46936196
1632,DB01713,UDP-alpha-D-xylose,small molecule,experimental,,O[C@@H]1[C@@H](COP(O)(=O)OP(O)(=O)O[C@H]2OC[C@@H](O)[C@H](O)[C@H]2O)O[C@H]([C@@H]1O)N1C=CC(=O)NC1=O,19235
1633,DB01714,Epsilon-N-methyllysine,small molecule,experimental,"Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins",CNCCCC[C@H](N)C(O)=O,164795
1634,DB01715,"7,8-Diamino-Nonanoic Acid",small molecule,experimental,,C[C@H](N)[C@H](N)CCCCCC(O)=O,445025
1635,DB01716,2-propenyl-N-acetyl-neuramic acid,small molecule,experimental,,[H]N([C@@H]1[C@@H](O)C[C@@](CC=C)(O[C@@]1([H])[C@H](O)[C@H](O)CO)C(O)=O)C(C)=O,449535
1636,DB01717,Bis(Adenosine)-5'-Pentaphosphate,small molecule,experimental,,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,440210
1637,DB01718,Cetrimonium,small molecule,approved,"Amines|Ammonium Compounds|Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Cetrimonium Compounds|Compounds used in a research, industrial, or household setting|Dermatologicals|Medicated Shampoos|Miscellaneous Local Anti-infectives|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds|Throat Preparations|Trimethyl Ammonium Compounds",CCCCCCCCCCCCCCCC[N+](C)(C)C,2681
1638,DB01719,Thio-Maltopentaose,small molecule,experimental,,[H][C@]1(S)O[C@]([H])(CO)[C@@]([H])(O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(S[C@@]3([H])O[C@]([H])(CO)[C@@]([H])(O[C@@]4([H])O[C@]([H])(CO)[C@@]([H])(S[C@@]5([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]5([H])O)[C@]([H])(O)[C@@]4([H])O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O,449625
1639,DB01720,(2Z)-2-(Benzoylamino)-3-[4-(2-bromophenoxy)phenyl]acrylic acid,small molecule,experimental,,[H]N(\C(=C/C1=CC=C(OC2=CC=CC=C2Br)C=C1)C(O)=O)C(=O)C1=CC=CC=C1,657131
1640,DB01721,"N-[2-hydroxy-1-indanyl]-5-[(2-tertiarybutylaminocarbonyl)-4(benzo[1,3]dioxol-5-ylmethyl)-piperazino]-4-hydroxy-2-(1-phenylethyl)-pentanamide",small molecule,experimental,,[H]N([C@@H]1[C@H](O)CC2=CC=CC=C12)C(=O)[C@H](C[C@H](O)CN1CCN(CC2=CC3=C(OCO3)C=C2)C[C@H]1C(=O)N([H])C(C)(C)C)[C@H](C)C1=CC=CC=C1,5496642
1641,DB01723,"{3-[3-(3,4-Dimethoxy-Phenyl)-1-(1-{1-[2-(3,4,5-Trimethoxy-Phenyl)-Butyryl]-Piperidin-2yl}-Vinyloxy)-Propyl]-Phenoxy}-Acetic Acid",small molecule,experimental,,[H][C@](CCC1=CC(OC)=C(OC)C=C1)(OC(=O)[C@]1([H])CCCCN1C(=O)[C@@]([H])(CC)C1=CC(OC)=C(OC)C(OC)=C1)C1=CC(OCC(O)=O)=CC=C1,444590
1642,DB01724,L-Threoninol,small molecule,experimental,,C[C@@H](O)[C@H](N)CO,2033049
1643,DB01725,"2-{2-hydroxy-[1,1'-biphenyl]-3-yl}-1H-1,3-benzodiazole-5-carboximidamide",small molecule,experimental,,NC(=N)C1=CC2=C(NC(=N2)C2=CC=CC(C3=CC=CC=C3)=C2O)C=C1,5353305
1644,DB01726,2-Aminophenol,small molecule,experimental,Amines|Aniline Compounds|Benzene Derivatives|Phenols,NC1=CC=CC=C1O,5801
1645,DB01727,Isocitric Acid,small molecule,experimental,"Acids, Acyclic|Citrates|Tricarboxylic Acids",O[C@@H]([C@H](CC(O)=O)C(O)=O)C(O)=O,447805
1646,DB01728,"1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine",small molecule,experimental,Alcohols|Antiplatelet agents|Carbohydrates|Glycerophosphates|Glycerophospholipids|Hematologic Agents|Lipids|Membrane Lipids|Phosphatidic Acids|Phospholipids|Sugar Alcohols|Sugar Phosphates|Triose Sugar Alcohols,[H][C@@](COC(=O)CCCCCCCCCCCCCCC)(COP(O)(=O)OCCN)OC(=O)CCCCCCCCCCCCCCC,445468
1647,DB01729,"1D-myo-inositol 1,3,4-trisphosphate",small molecule,experimental,Alcohols|Carbohydrates|Sugar Alcohols|Sugar Phosphates,O[C@@H]1[C@@H](O)[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@@H](O)[C@H]1OP(O)(O)=O,439455
1648,DB01731,(S)-wiskostatin,small molecule,experimental,,CN(C)C[C@H](O)CN1C2=CC=C(Br)C=C2C2=C1C=CC(Br)=C2,448668
1649,DB01732,"(4R,5S,6S,7R)-1,3-dibenzyl-4,7-bis(phenoxymethyl)-5,6-dihydroxy-1,3 diazepan-2-one",small molecule,experimental,,O[C@@H]1[C@@H](O)[C@@H](COC2=CC=CC=C2)N(CC2=CC=CC=C2)C(=O)N(CC2=CC=CC=C2)[C@@H]1COC1=CC=CC=C1,444290
1650,DB01733,L-Phospholactate,small molecule,experimental,,C[C@@H](OP(O)(O)=O)C(O)=O,444348
1651,DB01734,3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid,small molecule,experimental,,OC(=O)C(=O)NC1=CC2=C(C=CC=C2)C=C1C(O)=O,1628
1652,DB01735,3-Chloroalaninate,small molecule,experimental,,[NH3+][C@H](CCl)C([O-])=O,5287866
1653,DB01736,[3-(Dodecanoylamino)Propyl](Hydroxy)Dimethylammonium,small molecule,experimental,,CCCCCCCCCCCC(=O)NCCC[N+](C)(C)[O-],94599
1654,DB01737,"Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester",small molecule,experimental,,[H][C@@](CC1=CC=CC(=C1)C(N)=N)(NC(=O)CNS(=O)(=O)C1=CC=C(C)C=C1)C(=O)OC,131624
1655,DB01738,Phosphorylcolamine,small molecule,experimental,Alcohols|Amines|Amino Alcohols,NCCOP(O)(O)=O,1015
1656,DB01739,L-alloisoleucine,small molecule,experimental,"Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins",CC[C@@H](C)[C@H](N)C(O)=O,99288
1657,DB01740,"4-butyl-5-propyl-1,3-selenazol-2-amine",small molecule,experimental,Selenium Compounds,[H]N([H])C1=NC(CCCC)=C(CCC)[Se]1,445180
1658,DB01741,CRA_17693,small molecule,experimental,,NC(=[NH2+])C1=CC=C2NC(=NC2=C1)C1=CC(=CC(=C1[O-])C1=C(F)C=CC=C1)[C@@H](CC([O-])=O)C([O-])=O,52949062
1659,DB01742,(3r)-1-Acetyl-3-Methylpiperidine,small molecule,experimental,,C[C@@H]1CCCN(C1)C(C)=O,449120
1660,DB01744,Camphor,small molecule,approved,"Anti-Infective Agents|Anti-Infective Agents, Local|Antipruritics and Local Anesthetics|Basic Lotions and Liniments|Biological Products|Bornanes|Cardiac Therapy|Complex Mixtures|Ketones|Monoterpenes|Norbornanes|Pharmaceutical Preparations|Plant Extracts|Plant Preparations|Terpenes",[H][C@@]12CC[C@@](C)(C(=O)C1)C2(C)C,159055
1661,DB01745,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester,small molecule,experimental,,COC(=O)C1CCN(CC1)C(=O)[C@H](CC1=CC=CC(=C1)C(N)=N)NS(=O)(=O)C1=CC=C2C=CC=CC2=C1,446605
1662,DB01746,D-Leucine,small molecule,experimental,,CC(C)C[C@@H](N)C(O)=O,439524
1663,DB01747,Coprogen,small molecule,experimental,Amines|Hydroxy Acids|Hydroxylamines|Siderophores,[Fe+3].[H][C@@]1(CCCN([O-])C(=O)\C=C(/C)CCO)NC(=O)[C@]([H])(CCCN([O-])C(=O)\C=C(/C)CCOC(=O)[C@H](CCCN([O-])C(=O)\C=C(/C)CCO)NC(C)=O)NC1=O,76957149
1664,DB01748,N-Benzyl-4-Sulfamoyl-Benzamide,small molecule,experimental,,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=CC=CC=C1,4347
1665,DB01749,"1,2-Dimethoxyethane",small molecule,experimental,Ethers,COCCOC,8071
1666,DB01750,1-naphthaleneacetic acid,small molecule,experimental,Naphthalenes,OC(=O)CC1=C2C=CC=CC2=CC=C1,6862
1667,DB01751,Tetraiodothyroacetic acid,small molecule,experimental,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Thyroid Products",OC(=O)CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1,65552
1668,DB01752,S-adenosyl-L-homocysteine,small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Homocysteine|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides|Sulfur Compounds",N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O,439155
1669,DB01753,4-oxo-nicotinamide-adenine dinucleotide phosphate,small molecule,experimental,,NC(=O)[C@H]1C=[N+](C=CC1=O)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](OP(O)(O)=O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O,49867432
1670,DB01754,"3,4-Dihydroxy-1-Methylquinolin-2(1h)-One",small molecule,experimental,,CN1C(=O)C(O)=C(O)C2=CC=CC=C12,54695768
1671,DB01755,N-[Isoleucinyl]-N'-[adenosyl]-diaminosufone,small molecule,experimental,,[H]N([H])[C@@H]([C@@H](C)CC)C(=O)N([H])S(=O)(=O)N([H])C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N=CN=C12)N([H])[H],446595
1672,DB01756,4-phospho-L-threonic acid,small molecule,experimental,,O[C@@H](COP(O)(O)=O)[C@@H](O)C(O)=O,446947
1673,DB01758,3-Iodo-Tyrosine,small molecule,experimental,,N[C@@H](CC1=CC=C(O)C(I)=C1)C(O)=O,439744
1674,DB01759,Kojic acid,small molecule,experimental,"Antioxidants|Compounds used in a research, industrial, or household setting|Mycotoxins|Protective Agents|Pyrans",OCC1=CC(=O)C(O)=CO1,3840
1675,DB01760,2-Methoxy-3-Isopropylpyrazine,small molecule,experimental,,COC1=NC=CN=C1C(C)C,33166
1676,DB01761,4-[5-[2-(1-phenyl-ethylamino)-pyrimidin-4-yl]-1-methyl-4-(3-trifluoromethylphenyl)-1H-imidazol-2-yl]-piperidine,small molecule,experimental,,C[C@H](NC1=NC(=CC=N1)C1=C(N=C(C2CCNCC2)N1C)C1=CC=CC(=C1)C(F)(F)F)C1=CC=CC=C1,447721
1677,DB01762,Acetoacetic acid,small molecule,experimental,Keto Acids|Ketone Bodies|Ketones,CC(=O)CC(O)=O,96
1678,DB01763,7-thionicotinamide-adenine-dinucleotide phosphate,small molecule,experimental,,[H][C@]1(COP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C([S-])=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O,131704180
1679,DB01764,Dalfopristin,small molecule,approved,"Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Peptides|Peptides, Cyclic|Streptogramin Antibacterial|Streptogramins",CCN(CC)CCS(=O)(=O)[C@@H]1CCN2[C@H]1C(=O)O[C@H](C(C)C)[C@H](C)\C=C\C(=O)NC\C=C\C(\C)=C\[C@@H](O)CC(=O)CC1=NC(=CO1)C2=O,6323289
1680,DB01765,"(5-hydroxyindolo[1,2-a]quinazolin-7-yl)acetic acid",small molecule,experimental,,OC(=O)CC1=C2NC(=O)C3=CC=CC=C3N2C2=C1C=CC=C2,447682
1681,DB01766,Beta-(2-Naphthyl)-Alanine,small molecule,experimental,,[H][C@](N)(CC1=CC=C2C=CC=CC2=C1)C(O)=O,185915
1682,DB01767,Hemi-Babim,small molecule,experimental,,NC(=N)C1=CC2=C(NC(CC3=NC4=C(N3)C=CC=C4)=N2)C=C1,1282
1683,DB01768,Methylumbelliferyl sialic acid,small molecule,experimental,,[H]N([C@@H]1[C@@H](O)C[C@@](OC2=CC3=C(C=C2)C(C)=CC(=O)O3)(O[C@@]1([H])[C@H](O)[C@H](O)CO)C(O)=O)C(C)=O,448470
1684,DB01771,CRA_10991,small molecule,experimental,,NC(=[NH2+])C1=C(Cl)C=C2NC(=CC2=C1)C1=CC=CC(OC2CCCC2)=C1[O-],447488
1685,DB01772,"3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione",small molecule,experimental,,[H][C@@](O)(CO)CNC1=CC=CC(=C1)C1=C(C(=O)NC1=O)C1=CN(C)C2=CC=C(F)C=C12,448238
1686,DB01773,4-[3-carboxymethyl-3-(4-phosphonooxy-benzyl)-ureido]-4-[(3-cyclohexyl-propyl)-methyl-carbamoyl]butyric acid,small molecule,experimental,,CN(CCCC1CCCCC1)C(=O)[C@H](CCC(O)=O)NC(=O)N(CC(O)=O)CC1=CC=C(OP(O)(O)=O)C=C1,448585
1687,DB01774,Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester,small molecule,experimental,,NC1=C2N=CN([C@@H]3O[C@H](CO[P@](O)(=O)O[P@](O)(=O)O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](O)[C@H]3O)C2=NC=N1,16500
1688,DB01775,Dihydroxyacetone,small molecule,experimental,Carbohydrates|Ketoses|Monosaccharides|Trioses,OCC(=O)CO,670
1689,DB01776,M-Cresol,small molecule,experimental,Benzene Derivatives|Phenols,CC1=CC=CC(O)=C1,342
1690,DB01777,CoA-S-trimethylene-acetyl-tryptamine,small molecule,experimental,,[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)N([H])CCC(=O)N([H])CCSCCCCC(=O)N([H])CCC4=CN([H])C5=CC=CC=C45)[C@@H](OP(O)(O)=O)[C@H]3O)C2=NC=N1,446814
1691,DB01778,8-Aminotheophylline,small molecule,experimental,,CN1C2=C(NC(=N)N2)C(=O)N(C)C1=O,95034
1692,DB01779,Glycerol 2-phosphate,small molecule,experimental,Alcohols|Carbohydrates|Lipids|Membrane Lipids|Phospholipids|Sugar Alcohols|Sugar Phosphates|Triose Sugar Alcohols,OCC(CO)OP(O)(O)=O,2526
1693,DB01780,Fusicoccin,small molecule,experimental,Carbohydrates|Mycotoxins,[H]\C1=C2/[C@@]([H])(COC)CC[C@@]2([H])[C@@]([H])(C)[C@@]([H])(O)[C@]([H])(O[C@@]2([H])O[C@]([H])(COC(C)(C)C=C)[C@@]([H])(O)[C@]([H])(OC(C)=O)[C@@]2([H])O)C2=C(C[C@]([H])(O)[C@]12C)[C@]([H])(C)COC(C)=O,447573
1694,DB01782,Pyrazolanthrone,small molecule,experimental,,O=C1C2=CC=CC3=C2C(=NN3)C2=C1C=CC=C2,8515
1695,DB01783,Pantothenic acid,small molecule,approved|nutraceutical|vet_approved,"Alanine|Alimentary Tract and Metabolism|Amino Acids|Amino Acids, Peptides, and Proteins|Blood Coagulation Factors|Cicatrizants|Dermatologicals|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Imides|Micronutrients|Physiological Phenomena|Preparations for Treatment of Wounds and Ulcers|Vitamin B Complex|Vitamins",CC(C)(CO)[C@@H](O)C(=O)NCCC(O)=O,988
1696,DB01784,4-Flourobenzenesulfonamide,small molecule,experimental,,NS(=O)(=O)C1=CC=C(F)C=C1,120231
1697,DB01785,Dimethylallyl Diphosphate,small molecule,experimental,Terpenes,CC(C)=CCO[P@](O)(=O)OP(O)(O)=O,647
1698,DB01786,D-Alanine,small molecule,experimental,,C[C@@H](N)C(O)=O,71080
1699,DB01788,4-Imino-5-Methidyl-2-Methylpyrimidine,small molecule,experimental,,CC1=NC(=N)C(=C)C=N1,4635105
1700,DB01789,"1-Amino-2,3-Dihydroxy-5-Hydroxymethyl Cyclohex-5-Ene",small molecule,experimental,,[H][C@]1(N)C=C(CO)C[C@]([H])(O)[C@@]1([H])O,5287612
1701,DB01790,(Rp)-cAMPS,small molecule,experimental,"Adenine Nucleotides|Carbohydrates|Cyclic AMP-Dependent Protein Kinases, agonists|Cyclic AMP-Dependent Protein Kinases, antagonists & inhibitors|Enzyme Inhibitors|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Nucleotides, Cyclic|Protein Kinase Inhibitors|Purine Nucleotides|Purines|Ribonucleotides|Stereoisomerism|Sulfur Compounds",NC1=C2N=CN([C@@H]3O[C@@H]4CO[P@](S)(=O)O[C@H]4[C@H]3O)C2=NC=N1,6858240
1702,DB01791,Piclamilast,small molecule,experimental,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Enzyme Inhibitors|Phosphodiesterase 4 Inhibitors|Phosphodiesterase Inhibitors",COC1=CC=C(C=C1OC1CCCC1)C(=O)NC1=C(Cl)C=NC=C1Cl,154575
1703,DB01792,Adenylyl-(3'-5')-uridine 3'-monophosphate,small molecule,experimental,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Oligonucleotides|Polynucleotides",NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(O)(O)=O)N2C=CC(=O)NC2=O)[C@H]1O,164908
1704,DB01793,SB-409513,small molecule,experimental,,OC(=O)C1=CC(NC2=C(C(=O)NC2=O)C2=CC(Cl)=CC=C2)=CC=C1Cl,448008
1705,DB01794,bis(molybdopterin)tungsten cofactor,small molecule,experimental,,NC1=NC2=C(NC3C(N2)OC2COP([O-])(=O)O[Mg]OP([O-])(=O)OCC4OC5NC6=C(NC5C5=C4S[W]4(SC2=C3S4)S5)C(=O)NC(N)=N6)C(=O)N1,5460240
1706,DB01795,Phenylboronic acid,small molecule,experimental,"Acids|Acids, Noncarboxylic|Boron Compounds",OB(O)C1=CC=CC=C1,66827
1707,DB01796,Quinolinic Acid,small molecule,experimental,Pyridines|Quinolinic Acids,OC(=O)C1=CC=CN=C1C(O)=O,1066
1708,DB01797,"(2R)-2-(aminomethyl)-2,4-dihydroxy-5-oxo-3-(2-oxoethyl)-2,5-dihydro-1H-imidazol-3-ium",small molecule,experimental,,NC[C@@]1(O)NC(=O)C(O)=[N+]1CC(O)=O,131704181
1709,DB01798,Ethyl Dihydrogen Diphosphate,small molecule,experimental,,CCO[P@](O)(=O)OP(O)(O)=O,448674
1710,DB01799,4-Hydroxy-3-Methyl Butyl Diphosphate,small molecule,experimental,,C[C@H](CO)CCO[P@](O)(=O)OP(O)(O)=O,5288154
1711,DB01800,4-Nitrocatechol sulfate,small molecule,experimental,Benzene Derivatives|Phenols,OC1=CC=C(C=C1OS(O)(=O)=O)[N+]([O-])=O,165879
1712,DB01802,"(4R)-7-Aza-7,8-dihydrolimonene",small molecule,experimental,,CN(C)[C@@H]1CCC(C)=CC1,447259
1713,DB01803,2-(Trimethylammonium)Ethyl Thiol,small molecule,experimental,,C[N+](C)(C)CCS,37851
1714,DB01804,"2-Ammoniobut-3-Enoate, 2-Amino-3-Butenoate",small molecule,experimental,,[NH3+][C@H](C=C)C([O-])=O,5287579
1715,DB01805,Monoisopropylphosphorylserine,small molecule,experimental,,[H][C@](N)(COP(O)(=O)OC(C)C)C(O)=O,17754078
1716,DB01806,10-decarboxymethylaclacinomycin A,small molecule,experimental,,CC[C@@]1(O)C[C@H](O[C@H]2C[C@@H]([C@H](O[C@@H]3C[C@H](O)[C@@H](O[C@H]4CCC(=O)[C@@H](C)O4)[C@H](C)O3)[C@H](C)O2)N(C)C)C2=C(O)C3=C(C=C2C1)C(=O)C1=C(C(O)=CC=C1)C3=O,49866627
1717,DB01807,"N-[(3Z)-5-Tert-butyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-ylidene]-N'-(4-chlorophenyl)urea",small molecule,experimental,,CC(C)(C)C1=NN(C(NC(=O)NC2=CC=C(Cl)C=C2)=C1)C1=CC=CC=C1,656949
1718,DB01808,Thiarsahydroxy-Cysteine,small molecule,experimental,,N[C@@H](CS[AsH]O)C(O)=O,17753936
1719,DB01809,"1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",small molecule,experimental,,CC1=CC=C(C=C1)C1=NN(C2=C1C(N)=NC=N2)C(C)(C)C,1400
1720,DB01810,"[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester",small molecule,experimental,,[H][C@@](C)(NC(=O)[C@@]([H])(CC1=CC=CC=C1)NC(=O)OCC1=CC=CC=C1)\C=C\C(=O)C=O,5287438
1721,DB01811,"3h-Indole-5,6-Diol",small molecule,experimental,,OC1=C(O)C=C2C=CNC2=C1,114683
1722,DB01812,"Adenosine 3',5'-diphosphate",small molecule,experimental,"Adenine Nucleotides|Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Isomerism|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H]1O,159296
1723,DB01813,Pyridoxyl-Glutamic Acid-5'-Monophosphate,small molecule,experimental,,[H][C@@](CCC(O)=O)(NCC1=C(COP(O)(O)=O)C=[NH+]C(C)=C1O)C(O)=O,5289193
1724,DB01814,2-Tridecanoyloxy-Pentadecanoic Acid,small molecule,experimental,,[H][C@](CCCCCCCCCCCC)(CC(O)=O)OC(=O)CCCCCCCCCCCC,445571
1725,DB01815,Nz-(Dicarboxymethyl)Lysine,small molecule,experimental,,N[C@@H](CCCCNC(C(O)=O)C(O)=O)C(O)=O,17754065
1726,DB01816,Castanospermine,small molecule,experimental,"Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|beta-Glucosidase, antagonists & inhibitors|Central Nervous System Agents|Enzyme Inhibitors|Glucosylceramidase, antagonists & inhibitors|Glycoside Hydrolase Inhibitors|Heterocyclic Compounds, Fused-Ring|Immunologic Factors|Immunosuppressive Agents|Peripheral Nervous System Agents|Sensory System Agents|Stereoisomerism",[H][C@]1(O)CCN2C[C@]([H])(O)[C@@]([H])(O)[C@]([H])(O)[C@@]12[H],54445
1727,DB01817,Threonine-Aspartic Ester,small molecule,experimental,,[H][C@](N)(C[C@]([H])(O)O[C@]([H])(C)[C@]([H])(N)C(O)=O)C(O)=O,17753823
1728,DB01818,O3-Sulfonylgalactose,small molecule,experimental,,[H][C@@]1(O)O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(OS(O)(=O)=O)[C@@]1([H])O,444635
1729,DB01819,Phosphoenolpyruvate,small molecule,experimental,Hydroxy Acids,OC(=O)C(=C)OP(O)(O)=O,1005
1730,DB01820,2-{[4-(2-Acetylamino-2-pentylcarbamoyl-ethyl)-naphthalen-1-YL]-oxalyl-amino}-benzoic acid,small molecule,experimental,,[H]N(CCCCC)C(=O)[C@H](CC1=CC=C(N(C(=O)C(O)=O)C2=CC=CC=C2C(O)=O)C2=CC=CC=C12)N([H])C(C)=O,447392
1731,DB01821,"L-N(omega)-Nitroarginine-2,4-L-diaminobutyric amide",small molecule,experimental,,NCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N[N+]([O-])=O)C(N)=O,656910
1732,DB01822,"(4R,5R)-1,2-dithiane-4,5-diol",small molecule,experimental,,O[C@H]1CSSC[C@@H]1O,439407
1733,DB01823,Beta-D-Glucopyranose Spirohydantoin,small molecule,experimental,,OC[C@H]1O[C@]2(NC(=O)NC2=O)[C@H](O)[C@@H](O)[C@@H]1O,11776755
1734,DB01824,"(3S)-Tetrahydro-3-furanyl {(2S,3S)-4-[(2S,4R)-4-{(1S,2R)-2-[(S)-amino(hydroxy)methoxy]-2,3-dihydro-1H-inden-1-yl}-2-benzyl-3-oxo-2-pyrrolidinyl]-3-hydroxy-1-phenyl-2-butanyl}carbamate",small molecule,experimental,,[H]N([H])[C@@]([H])(O)O[C@]1([H])CC2=CC=CC=C2[C@]1([H])[C@]1([H])CN([H])[C@@](CC2=CC=CC=C2)(CC([H])(O)C([H])(CC2=CC=CC=C2)N([H])C(=O)O[C@@]2([H])CCOC2)C1=O,49866494
1735,DB01825,2-amino-8-methyl-4(1H)-quinazolinone,small molecule,experimental,,[H]N([H])C1=NC(=O)C2=CC=CC(C)=C2N1[H],448488
1736,DB01826,N-Butyl Isocyanide,small molecule,experimental,,CCCC[N+]#[C-],76008
1737,DB01827,"2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide",small molecule,experimental,,COC1=C(F)C(F)=C(C(N)=O)C(F)=C1F,657081
1738,DB01828,Methylamine,small molecule,experimental,Amines,CN,6329
1739,DB01829,Desulfo-coenzyme A,small molecule,experimental,"Adenine Nucleotides|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",CCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N,165363
1740,DB01830,AP-22408,small molecule,experimental,,CC(=O)N[C@@H](CC1=CC=C(C(=C1)P(O)(O)=O)P(O)(O)=O)C(=O)N[C@H]1CCCCC2=CC(OCC3CCCCC3)=C(C=C12)C(N)=O,445561
1741,DB01831,Tryptophanyl-5'amp,small molecule,experimental,,N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12,446202
1742,DB01832,4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid,small molecule,experimental,,C[P@@](O)(=O)CC(=O)CC(O)=O,446167
1743,DB01833,Canavanine,small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins",N[C@@H](CCONC(N)=N)C(O)=O,439202
1744,DB01834,"(9R,10R)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene",small molecule,experimental,,[H][C@](N)(CCC(=O)N[C@@]([H])(CS[C@]1([H])C2=CC=CC=C2C2=CC=CC=C2[C@@]1([H])O)C(=O)NCC(O)=O)C(O)=O,449366
1745,DB01835,4R-Fluoro-N6-ethanimidoyl-L-lysine,small molecule,experimental,,[H]N([H])[C@@H](C[C@@H](F)CC\N=C(/C)N([H])[H])C(O)=O,448269
1746,DB01836,"[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone",small molecule,experimental,,ClC1=CC=C2C=C(C=CC2=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1CCN(CC1)C1=CC=NC=C1,446399
1747,DB01837,O-acetyl-L-serine,small molecule,experimental,,CC(=O)OC[C@H](N)C(O)=O,99478
1748,DB01838,"6,4'-Dihydroxy-3-Methyl-3',5'-Dibromoflavone",small molecule,experimental,,CC1=C(OC2=CC=C(O)C=C2C1=O)C1=CC(Br)=C(O)C(Br)=C1,128600
1749,DB01839,Propylene glycol,small molecule,approved|investigational,"Alcohols|Compounds used in a research, industrial, or household setting|Drug Delivery Systems|Glycols|Pegylated agents|Pharmaceutic Aids|Pharmaceutical Preparations|Pharmaceutical Vehicles|Propylene Glycols|Solvents",CC(O)CO,1030
1750,DB01840,2-Deoxy-D-Glucitol 6-(E)-Vinylhomophosphonate,small molecule,experimental,"Alcohols|Carbohydrates|Myo-Inositol-1-Phosphate Synthase, antagonists & inhibitors|Sugar Alcohols",OCC[C@@H](O)[C@H](O)[C@H](O)\C=C\P(O)(O)=O,448372
1751,DB01841,"4,6-Dideoxyglucose",small molecule,experimental,,[H][C@@]1(C)C[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(O)O1,5288437
1752,DB01842,3'-Phosphate-Adenosine-5'-Diphosphate,small molecule,experimental,,[H][C@]1(COP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O,128882
1753,DB01843,"(5S,7R,8S,9S,10R)-3-Amino-8,9,10-trihydroxy-7-(hydroxymethyl)-6-oxa-1,3-diazaspiro[4.5]decane-2,4-dione",small molecule,experimental,,[H]N([H])N1C(=O)N([H])[C@@]2(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C1=O,445717
1754,DB01844,"N,N-dimethylformamide",small molecule,experimental,"Acids, Acyclic|Amides|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 Substrates|Formamides|Formates",CN(C)C=O,6228
1755,DB01846,Oxidized coenzyme A,small molecule,experimental,,[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)N([H])CCC(=O)N([H])CCSO)[C@@H](OP(O)(O)=O)[C@H]3O)C2=NC=N1,5287882
1756,DB01847,N-Carbamyl-D-Valine,small molecule,experimental,,CC(C)[C@@H](NC(N)=O)C(O)=O,448879
1757,DB01849,Dihydrouracil,small molecule,experimental,Pyrimidines|Pyrimidinones,O=C1CCNC(=O)N1,649
1758,DB01850,"(2S,3S,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid",small molecule,experimental,,CO[C@H](CC1=CC=CC=C1)[C@H](C)\C=C(/C)\C=C\[C@H](N)[C@H](C)C(O)=O,5288801
1759,DB01851,Tetrabutylammonium Ion,small molecule,experimental,,CCCC[N+](CCCC)(CCCC)CCCC,16028
1760,DB01852,Kaempherol,small molecule,experimental,,OC1=CC=C(C=C1)C1=C(O)C(=O)C2=C(O1)C=C(O)C=C2O,5280863
1761,DB01853,Bacteriochlorophyll A,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Bacteriochlorophylls|Biological Factors|Chlorophyll|Heterocyclic Compounds, Fused-Ring|Metalloporphyrins|Photoreceptors, Microbial|Pigments, Biological|Porphyrins|Proteins",[Mg++].CC[C@@H]1[C@@H](C)\C2=C\C3=C(C(C)=O)C(C)=C([N-]3)\C=C3/N=C([C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@@H]3C)C3=C4[N-]\C(=C/C1=N2)C(C)=C4C(=O)[C@@H]3C(=O)OC,11953947
1762,DB01854,5-Bromonicotinamide,small molecule,experimental,,NC(=O)C1=CN=CC(Br)=C1,1808
1763,DB01855,5-(Hydroxy-Methyl-Amino)-3-Methyl-Pyrrolidine-2-Carboxylic Acid,small molecule,experimental,,[H][C@@]1(C)C[C@]([H])(N[C@@]1([H])C(O)=O)N(C)O,49866700
1764,DB01856,Pimelic Acid,small molecule,experimental,,OC(=O)CCCCCC(O)=O,385
1765,DB01857,Phosphoaspartate,small molecule,experimental,,N[C@@H](CC(=O)OP(O)(O)=O)C(O)=O,152441
1766,DB01858,[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate,small molecule,experimental,,[H][C@@](CCCC)(NC(=O)OCC1(CC2=CC=C(F)C=C2)CCC1)C(=O)C(=O)NC1=CC=NN1,5288259
1767,DB01859,4-CDP-2-C-methyl-D-erythritol 2-phosphate,small molecule,experimental,,C[C@@](CO)(OP(O)(O)=O)[C@H](O)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(N)=NC1=O,443200
1768,DB01860,Cordycepin Triphosphate,small molecule,experimental,"Adenine Nucleotides|Carbohydrates|Deoxyribonucleotides|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",[H][C@@]1(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C[C@@]([H])(O)[C@@]([H])(O1)N1C=NC2=C(N)N=CN=C12,65562
1769,DB01861,Uridine diphosphate glucose,small molecule,experimental,"Carbohydrates|Deoxyribonucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Diphosphate Sugars|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides|Uracil Nucleotides|Uridine Diphosphate|Uridine Diphosphate Sugars",OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@H](O)[C@@H](O)[C@@H]1O,8629
1770,DB01862,Isopropyl beta-D-thiogalactopyranoside,small molecule,experimental,Carbohydrates|Galactosides|Glycosides|Sulfur Compounds|Thiogalactosides|Thioglycosides,CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O,656894
1771,DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",small molecule,experimental,Alcohols|Carbohydrates|Sugar Alcohols|Sugar Phosphates,O[C@H]1[C@@H](OP(O)(O)=O)[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H]1OP(O)(O)=O,107758
1772,DB01864,5'-Guanosine-Diphosphate-Monothiophosphate,small molecule,experimental,"Carbohydrates|Glycosides|Guanine Nucleotides|Guanosine Triphosphate|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides|Sulfur Compounds|Thionucleotides",NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=S)[C@@H](O)[C@H]2O)C(=O)N1,37792
1773,DB01865,3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide,small molecule,experimental,,CN(CC1=CC2=C(C=CC=C2)N1C)C(=O)\C=C\C1=CN=C(N)C=C1,5287720
1774,DB01866,RU79256,small molecule,experimental,,[H][C@](C(O)=O)(C1=CC=CC=C1)S(O)(=O)=O,447536
1775,DB01868,Glycyl-L-a-Aminopimelyl-E-(D-2-Aminoethyl)Phosphonate,small molecule,experimental,,[H][C@](C)(N=C([O-])CCCC[C@]([H])(N=C(O)CN)C(O)=O)P(O)(O)=O,131704183
1776,DB01870,"1,4-dithio-alpha-D-glucopyranose",small molecule,experimental,,[H][C@@]1(O)[C@@]([H])(O)[C@]([H])(S)[C@@]([H])(CO)O[C@]1([H])S,445237
1777,DB01871,[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester,small molecule,experimental,,[H][C@@](CC1=CC=CC=C1)(NC(=O)[C@]([H])(CC1=CC=CC=C1)NC(=O)OCC1=CC=CC=C1)C(=O)CO,5289424
1778,DB01872,2-deoxy-2-acetamido-beta-D-galactose-4-sulfate,small molecule,experimental,,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS(O)(=O)=O)[C@@H]1O,446101
1779,DB01873,Epothilone D,small molecule,investigational,Anti-Bacterial Agents|Antimitotic Agents|Antineoplastic Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Mitosis Modulators|Polyketides|Tubulin Modulators,[H][C@]1(C\C=C(C)/CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1)C(\C)=C\C1=CSC(C)=N1,447865
1780,DB01874,Tropinone,small molecule,experimental,Alkaloids|Aza Compounds|Azabicyclo Compounds,CN1[C@H]2CC[C@@H]1CC(=O)C2,446337
1781,DB01875,8-azaxanthine,small molecule,experimental,"Alkaloids|Heterocyclic Compounds, Fused-Ring|Purines|Purinones",O=C1NC2=C(NN=N2)C(=O)N1,15113
1782,DB01876,Bis(5-Amidino-2-Benzimidazolyl)Methanone,small molecule,experimental,,NC(=N)C1=CC2=C(C=C1)N=C(N2)C(=O)C1=NC2=C(N1)C=CC(=C2)C(N)=N,2281
1783,DB01877,"N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide",small molecule,experimental,,CON[C@H]1C[C@@H](N(C1)S(=O)(=O)C1=CC=C(OC)C=C1)C(=O)NO,17754173
1784,DB01878,Benzophenone,small molecule,experimental,Benzene Derivatives|Dermatologicals|Ketones|Photosensitizing Agents|Radiation-Sensitizing Agents,O=C(C1=CC=CC=C1)C1=CC=CC=C1,3102
1785,DB01879,(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid,small molecule,experimental,,[H][C@@](CC(O)=O)(N(C)C(=O)C1=C(NS(=O)(=O)C2=CC3=CC=CC=C3C=C2)C=CC(OS(=O)(=O)C2=CC3=CC=CC=C3C=C2)=C1)C(O)=O,656973
1786,DB01880,"3,4-Dihydroxycinnamic Acid",small molecule,experimental|investigational,"Acids, Carbocyclic|Antioxidants|Cinnamates|Compounds used in a research, industrial, or household setting|Protective Agents",OC(=O)\C=C\C1=CC(O)=C(O)C=C1,689043
1787,DB01881,"2-Methylpentane-1,2,4-Triol",small molecule,experimental,,[H][C@@](C)(O)C[C@](C)(O)CO,447583
1788,DB01882,"(2s)-2-Amino-4-(Methylsulfanyl)-1-Pyridin-2-Ylbutane-1,1-Diol",small molecule,experimental,,[H][C@](N)(CCSC)C(O)(O)C1=CC=CC=N1,448220
1789,DB01883,N-(Sulfanylacetyl)Tyrosylprolylmethioninamide,small molecule,experimental,,[H][C@@](CCSC)(NC(=O)[C@]1([H])CCCN1C(=O)[C@]([H])(CC1=CC=C(O)C=C1)NC(=O)CS)C(N)=O,5289343
1790,DB01884,2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One,small molecule,experimental,,[H][C@](N)(C(C)C)C(=O)N1CCCC1,447256
1791,DB01885,D-Galctopyranosyl-1-On,small molecule,experimental,,[H][C@]1(O)C(=O)O[C@]([H])(CO)[C@]([H])(O)[C@]1([H])O,439781
1792,DB01887,"N,N-[2,5-O-Dibenzyl-glucaryl]-DI-[1-amino-indan-2-OL]",small molecule,experimental,,[H]N([C@@H]1CO[C@H](CO)C1)C(=O)[C@H](OCC1=CC=CC=C1)[C@H](O)[C@@H](O)[C@@H](OCC1=CC=CC=C1)C(=O)N([H])[C@@H]1[C@H](O)CC2=CC=CC=C12,449128
1793,DB01888,"4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide",small molecule,experimental,,CC(C)C1=C2N=C(N[C@H]3CC[C@H](N)CC3)C=C(NC3=CC=C(C=C3)S(=O)(=O)N(C)C)N2N=C1,5287990
1794,DB01889,"16,17-Androstene-3-Ol",small molecule,experimental,,[H][C@@]12CC=C[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@]([H])(O)CC[C@]12C,101989
1795,DB01890,"N,N-Bis(3-(D-gluconamido)propyl)deoxycholamide",small molecule,experimental,,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)N(CCCNC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)CCCNC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,446320
1796,DB01891,Tl-3-093,small molecule,experimental,,[H][C@@](CO)(CC1=CC=CC=C1)NC(=O)[C@@]([H])(NC(=O)[C@]([H])(C)NC(=O)OCC1=CC=CC=C1)C(C)C,444425
1797,DB01892,Hyperforin,small molecule,nutraceutical,Benzene Derivatives|OATP1B1/SLCO1B1 Inhibitors|Phenols,CC(C)C(=O)[C@@]12C(O)=C(CC=C(C)C)C(=O)[C@@](CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]1(C)CCC=C(C)C)C2=O,441298
1798,DB01893,N6-Benzyl Adenosine-5'-Diphosphate,small molecule,experimental,,[H][C@]1(COP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(NCC4=CC=CC=C4)N=CN=C23)[C@]([H])(O)[C@]1([H])O,446795
1799,DB01895,Aspartyl-Adenosine-5'-Monophosphate,small molecule,experimental,,[H][C@](N)(CC(O)=O)C(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,444700
1800,DB01896,M-Aminophenylboronic Acid,small molecule,experimental,,NC1=CC=CC(=C1)B(O)O,92269
1801,DB01897,2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride,small molecule,experimental,,O=C1NNC(=O)C2=CC(=CC=C12)[N+]1=NC(\C=C\C2=CC=CC=C2)=NN1C1=NC2=C(S1)C=CC=C2,6105620
1802,DB01898,"(2S,3S)-2-azanyl-3-methyl-pentanedioic acid",small molecule,experimental,,[H][C@](C)(CC(O)=O)[C@]([H])(N)C(O)=O,9898908
1803,DB01899,Nd1-Phosphonohistidine,small molecule,experimental,,N[C@@H](CC1=C[NH+]=CN1P(O)(O)=O)C(O)=O,17754026
1804,DB01901,Sucrosofate,small molecule,experimental,Anti-Ulcer Agents|Carbohydrates|Disaccharides|Gastrointestinal Agents|Oligosaccharides|Polysaccharides,OS(=O)(=O)OC[C@H]1O[C@@](COS(O)(=O)=O)(O[C@H]2O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]2OS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@@H]1OS(O)(=O)=O,444237
1805,DB01902,"1-Ethyl-Pyrrolidine-2,5-Dione",small molecule,experimental,,CCN1C(=O)CCC1=O,16842
1806,DB01903,5-Bromo-2'-deoxyuridine 5'-(dihydrogen phosphate),small molecule,experimental,,O[C@H]1C[C@@H](O[C@@H]1COP(O)(O)=O)N1C=C(Br)C(=O)NC1=O,93036
1807,DB01905,2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine,small molecule,experimental,,COC1=CC=C(O)C(=C1)C1=NC2=C(N1)C=CC(=C2)C(N)=[NH2+],5353303
1808,DB01906,"3-(5-amino-7-hydroxy-(1,2,3)triazolo(4,5-d)pyrimidin-2-yl)benzoic acid",small molecule,experimental,"Acids, Carbocyclic|Benzene Derivatives",NC1=NC2=NN(N=C2C(O)=N1)C1=CC(=CC=C1)C(O)=O,448406
1809,DB01908,RU85493,small molecule,experimental,,CC(=O)N[C@@H](CC1=CC=C(OCC(O)=O)C(=C1)P(O)(O)=O)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O,5287515
1810,DB01909,Alpha-Cyclodextrin (Cyclohexa-Amylose),small molecule,experimental,,[H][C@]1(CO)O[C@]2([H])O[C@]3([H])[C@@]([H])(CO)O[C@]([H])(O[C@]4([H])[C@@]([H])(CO)O[C@]([H])(O[C@]5([H])[C@@]([H])(CO)O[C@]([H])(O[C@]6([H])[C@@]([H])(CO)O[C@]([H])(O[C@]7([H])[C@@]([H])(CO)O[C@]([H])(O[C@@]1([H])[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]7([H])O)[C@]([H])(O)[C@@]6([H])O)[C@]([H])(O)[C@@]5([H])O)[C@]([H])(O)[C@@]4([H])O)[C@]([H])(O)[C@@]3([H])O,444913
1811,DB01910,Sinefungin,small molecule,experimental,"Anti-Infective Agents|Antifungal Agents|Antiparasitic Agents|Antiprotozoals|Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides",[H][C@](N)(CC[C@]([H])(N)C(O)=O)C[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,65482
1812,DB01911,N-Methylmesoporphyrin,small molecule,experimental,"Biological Factors|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Porphyrins",CCC1=C(C)C2=CC3=C(CC)C(C)=C(C=C4N=C(C=C5N\C(=C/C1=N2)C(C)=C5CCC(O)=O)C(CCC(O)=O)=C4C)N3C,444708
1813,DB01912,"2,2':6',2''-Terpyridine Platinum(Ii)",small molecule,experimental,,[Cl-].[Pt++].C1=CC=C(N=C1)C1=CC=CC(=N1)C1=CC=CC=N1,124734
1814,DB01914,D-glucose,small molecule,approved|investigational|vet_approved,"Carbohydrates|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Flavoring Agents|Food|Food Additives|Food and Beverages|Food Ingredients|Glucose|Hexoses|Monosaccharides|Pharmaceutic Aids|Pharmaceutical Preparations|Physiological Phenomena|Sweetening Agents",[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C=O,107526
1815,DB01915,S-Hydroxycysteine,small molecule,experimental,,N[C@@H](CSO)C(O)=O,165339
1816,DB01917,Putrescine,small molecule,experimental,"Amines|Biogenic Amines|Biogenic Polyamines|Diamines|Polyamines|Putrescine, analogs & derivatives|Putrescine, antagonists & inhibitors",NCCCCN,1045
1817,DB01918,[Methyltelluro]Acetate,small molecule,experimental,,C[Te]CC([O-])=O,1954
1818,DB01919,Pentanal,small molecule,experimental,,CCCCC=O,8063
1819,DB01920,1-O-[O-Nitrophenyl]-Beta-D-Galactopyranose,small molecule,experimental,,[H][C@]1(CO)O[C@@]([H])(OC2=CC=CC=C2N(=O)=O)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O,96647
1820,DB01921,Xylose-derived lactam oxime,small molecule,experimental,,[H]N(O)C1=NC[C@@H](O)[C@H](O)[C@H]1O,445614
1821,DB01922,"Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam",small molecule,experimental,,[H][C@]1(CO)O[C@]([H])(O[C@]2([H])[C@@]([H])(CO)O[C@]([H])(O[C@]3([H])[C@@]([H])(CO)N=C(NO)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O,448828
1822,DB01923,L-Xylulose 5-Phosphate,small molecule,experimental,,[H][C@](O)(COP(O)(O)=O)[C@@]([H])(O)C(=O)CO,23615404
1823,DB01924,Benzhydroxamic Acid,small molecule,experimental,Amines|Benzoates|Hydroxy Acids|Hydroxylamines,ONC(=O)C1=CC=CC=C1,10313
1824,DB01925,"2'-Chloro-Biphenyl-2,3-Diol",small molecule,experimental,,OC1=CC=CC(=C1O)C1=C(Cl)C=CC=C1,178518
1825,DB01926,Carboxymycobactin S,small molecule,experimental,,C[C@H]1C[C@H](O)N[C@@H]2CCCCN(O[Fe@@]34O[C@@H](\C=C\CCCCCCC(O)=O)[N@](CCCC[C@H](NC(=O)[C@H]5COC(=N5)C5=CC=CC=C5O3)C(=O)O1)O4)C2=O,46936260
1826,DB01927,Duroquinone,small molecule,experimental,Quinones,CC1=C(C)C(=O)C(C)=C(C)C1=O,68238
1827,DB01929,"5-Chloryl-2,4,6-Quinazolinetriamine",small molecule,experimental,,NC1=C(C2=C(N)N=C(N)N=C2C=C1)[Cl](=O)=O,4627204
1828,DB01930,"2,4-Dihydroxy-3,3-Dimethyl-Butyrate",small molecule,experimental,,CC(C)(CO)[C@@H](O)C([O-])=O,5289105
1829,DB01931,"5,7-Dichlorokynurenic acid",small molecule,experimental,"Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Heterocyclic Compounds, Fused-Ring|Hydroxyquinolines|Neurotransmitter Agents|Quinolines|Xanthurenates",OC(=O)C1=CC(O)=C2C(Cl)=CC(Cl)=CC2=N1,1779
1830,DB01932,5-Methylpyrrole,small molecule,experimental,,CC1=CNC=C1,12023
1831,DB01933,7-Hydroxystaurosporine,small molecule,experimental|investigational,"Alkaloids|Antineoplastic Agents|Carbazoles|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|Protein Kinase C, antagonists & inhibitors|Protein Kinase Inhibitors",[H][C@]12C[C@@H](NC)[C@@H](OC)[C@](C)(O1)N1C3=C(C=CC=C3)C3=C4[C@@H](O)NC(=O)C4=C4C5=C(C=CC=C5)N2C4=C13,72271
1832,DB01934,Arylomycin A2,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Peptides",CC(C)CCCCCCCCC(=O)N(C)[C@H](CO)C(=O)N[C@H](C)C(=O)NCC(=O)N(C)[C@H]1C2=CC(=C(O)C=C2)C2=CC(C[C@H](NC(=O)[C@H](C)NC1=O)C(O)=O)=CC=C2O,9988024
1833,DB01935,3-{[(1r)-1-Benzyl-2-Sulfanylethyl]Amino}-3-Oxopropanoic Acid,small molecule,experimental,,[H][C@](CS)(CC1=CC=CC=C1)NC(=O)CC(O)=O,657144
1834,DB01936,alpha-D-arabinofuranose,small molecule,experimental|investigational,,OC[C@H]1O[C@H](O)[C@@H](O)[C@@H]1O,9996708
1835,DB01937,Guanosine-2'-monophosphate,small molecule,experimental,"Carbohydrates|Glycosides|Guanine Nucleotides|Heterocyclic Compounds, Fused-Ring|Isomerism|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",NC1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2OP(O)(O)=O)C(=O)N1,444571
1836,DB01938,L-Histidine Beta Naphthylamide,small molecule,experimental,,[H][C@@](N)(CC1=CN=CN1)C(=O)NC1=CC=C2C=CC=CC2=C1,6541406
1837,DB01939,5-Amidino-Benzimidazole,small molecule,experimental,,NC(=[NH2+])C1=CC2=C(C=C1)N=CN2,1800
1838,DB01940,Balanol Analog 2,small molecule,experimental,,[H][C@]1(CNCCC[C@@]1([H])OC(=O)C1=CC=C(C=C1)C(=O)C1=CC=CC=C1O)NC(=O)C1=CC=C(O)C=C1,10050566
1839,DB01941,LG-100268,small molecule,experimental,Ligands|Naphthalenes|Pyridines,CC1=C(C=C2C(=C1)C(C)(C)CCC2(C)C)C1(CC1)C1=CC=C(C=N1)C(O)=O,3922
1840,DB01942,Formic acid,small molecule,experimental|investigational,"Acids, Acyclic|Blood Coagulation Factors|Hemostatics",OC=O,284
1841,DB01944,(S)-blebbistatin,small molecule,experimental,,CC1=CC=C2N=C3N(CC[C@@]3(O)C(=O)C2=C1)C1=CC=CC=C1,5287792
1842,DB01945,4-Carbamoyl-1-Beta-D-Ribofuranosyl-Imidazolium-5-Olate-5'-Phosphate,small molecule,experimental,,[H][C@]1(COP(O)([O-])=O)O[C@@]([H])(N2C=NC(C(N)=O)=C2[O-])[C@]([H])(O)[C@]1([H])O,131704184
1843,DB01946,Bisindolylmaleimide VIII,small molecule,experimental,"Acids, Acyclic|Antiplatelet agents|Dicarboxylic Acids|Enzyme Inhibitors|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|Imides|Maleates|Protein Kinase C, antagonists & inhibitors",CN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CN(CCCN)C2=C1C=CC=C2,2403
1844,DB01947,RU78262,small molecule,experimental,,OP(O)(=O)OC1=C(C=O)C=CC=C1,5287463
1845,DB01948,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One",small molecule,experimental,,FC1=CC=C(C(F)=C1)C1=CC(=CC2=C1CCC(=O)N2C1=C(Cl)C=CC=C1Cl)C1CCNCC1,447725
1846,DB01949,"2-Amino-N,3,3-Trimethylbutanamide",small molecule,experimental,,CNC(=O)[C@@H](N)C(C)(C)C,445856
1847,DB01950,AR-AO-14418,small molecule,experimental,"Glycogen Synthase Kinase 3, antagonists & inhibitors|Sulfur Compounds",COC1=CC=C(CNC(=O)NC2=NC=C(S2)[N+]([O-])=O)C=C1,448014
1848,DB01951,Gpi-1046,small molecule,experimental,,[H][C@]1(CCCN1C(=O)C(=O)C(C)(C)CC)C(=O)OCCCC1=CN=CC=C1,445501
1849,DB01952,"1,N6-Ethenoadenine",small molecule,experimental,,N1C=NC2=C1N=CN1C=CN=C21,104994
1850,DB01953,Inhibitor of P38 Kinase,small molecule,experimental,,C(CC1=CC=NC=C1)C1=CNC2=CC=CC=C12,27934
1851,DB01954,Rolipram,small molecule,investigational,Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Enzyme Inhibitors|Phosphodiesterase 4 Inhibitors|Phosphodiesterase Inhibitors|Psychotropic Drugs|Pyrrolidines|Pyrrolidinones,COC1=C(OC2CCCC2)C=C(C=C1)C1CNC(=O)C1,5092
1852,DB01955,"1,4-Butanediol",small molecule,experimental,Alcohols|Glycols,OCCCCO,8064
1853,DB01956,Taurine,small molecule,approved|nutraceutical,"Acids|Acids, Noncarboxylic|Alkanes|Alkanesulfonic Acids|Hydrocarbons, Acyclic|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",NCCS(O)(=O)=O,1123
1854,DB01957,3-Chlorophenol,small molecule,experimental,"Benzene Derivatives|Chlorobenzenes|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Phenols",OC1=CC=CC(Cl)=C1,7933
1855,DB01958,"5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine",small molecule,experimental,,CC(C)(C)C1=CC=C(SC2=CC=CC3=C2C(N)=NC(N)=N3)C=C1,3537
1856,DB01959,"3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",small molecule,experimental,,CCOC(=O)C1=C(C)N(N=C1C)C1=CC(=CC=C1)[N+]([O-])=O,656969
1857,DB01960,"7-methyl-7,8-dihydroguanosine-5'-diphosphate",small molecule,experimental,,CN1CN([C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C2=C1C(=O)NC(N)=N2,147071
1858,DB01961,Cytidine 3'-monophosphate,small molecule,experimental,,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](OP(O)(O)=O)[C@H]1O,66535
1859,DB01962,Phosphonotyrosine,small molecule,experimental,,N[C@@H](CC1=CC=C(OP(O)(O)=O)C=C1)C(O)=O,30819
1860,DB01963,Phenylethane Boronic Acid,small molecule,experimental,"Acids|Acids, Noncarboxylic|Boron Compounds",OB(O)CCC1=CC=CC=C1,65389
1861,DB01964,AL5424,small molecule,experimental,,[H][C@]1(O)CN(C2=CC=C(OC)C=C2)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,444612
1862,DB01965,"2'-Deoxyuridine 5'-alpha,beta-imido-triphosphate",small molecule,experimental,,[H]N(P(O)(=O)OC[C@H]1O[C@H](C[C@@H]1O)N1C=CC(=O)N([H])C1=O)P(O)(=O)OP(O)(O)=O,448381
1863,DB01966,Di-Stearoyl-3-Sn-Phosphatidylethanolamine,small molecule,experimental,,CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](CO[P@](O)(=O)OCCN)OC(=O)CCCCCCCCCCCCCCCCC,17754131
1864,DB01967,"N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide",small molecule,experimental,,[H][C@@]12CCCC[N@]1CC(=O)C1=C2N(CCCNS(=O)(=O)C(C)C)C2=C1C=CC=C2,11987780
1865,DB01968,2-Thioethenamine,small molecule,experimental,,[H]\C(N)=C(/[H])S,17754199
1866,DB01969,Trifluoroacetonyl coenzyme A,small molecule,experimental,,[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)N([H])CCC(=O)N([H])CCSCC(=O)C(F)(F)F)[C@@H](OP(O)(O)=O)[C@H]3O)C2=NC=N1,449575
1867,DB01970,"Hg9a-9, Nonanoyl-N-Hydroxyethylglucamide",small molecule,experimental,,[H][C@](O)(CO)[C@]([H])(O)[C@]([H])(O)[C@]([H])(O)CN(CCO)C(=O)CCCCCCCC,17754023
1868,DB01971,trans-urocanic acid,small molecule,experimental,"Acids, Acyclic|Acrylates|Imidazoles",OC(=O)\C=C\C1=CNC=N1,736715
1869,DB01972,Guanosine-5'-Monophosphate,small molecule,experimental,,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,6804
1870,DB01973,O-Benzylsulfonyl-Serine,small molecule,experimental,,N[C@@H](COS(=O)(=O)CC1=CC=CC=C1)C(O)=O,17754162
1871,DB01974,"2-Amino-3-[5-(Amino-Carboxy-Methyl)-2,3-Dihydro-Isoxazol-3-Ylsulfanyl]-Propionic Acid",small molecule,experimental,,[H][C@](N)(CS[C@@]1([H])NOC(=C1)[C@]([H])(N)C(O)=O)C(O)=O,17753762
1872,DB01975,AMPCPR,small molecule,experimental,,[H][C@]1(O)O[C@]([H])(COP(O)(=O)CP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])O)[C@@]([H])(O)[C@@]1([H])O,446724
1873,DB01976,Aminoanthracene,small molecule,experimental,,NC1=CC=CC2=C1C=C1C=CC=CC1=C2,11885
1874,DB01977,6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine,small molecule,experimental,,NC(=N)C1=CC=C2C=C(C=CC2=C1)C(=O)NC1=CC=CC=C1,447732
1875,DB01978,"7,9-Dimethylguanine",small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Purines|Purinones|Xanthine derivatives",[H][C@@]1(N)NC2=C([N+](C)=CN2C)[C@]([H])(O)N1,131704185
1876,DB01979,Methyl alpha-D-mannoside,small molecule,experimental,,CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O,101798
1877,DB01980,Para-Iodo-D-Phenylalanine Hydroxamic Acid,small molecule,experimental,,[H][C@@](N)(CC1=CC=C(I)C=C1)C(=O)NO,5288643
1878,DB01981,"3,6-Anhydro-2-(hydrogen sulfate)-alpha-D-galactopyranose",small molecule,experimental,,[H][C@@]12CO[C@@]([H])([C@H]1O)[C@@H](OS(O)(=O)=O)[C@@H](O)O2,446806
1879,DB01982,D-Mannuronic Acid,small molecule,experimental,,[H][C@]1(O)O[C@]([H])(C(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@]1([H])O,657117
1880,DB01983,2(S)-Amino-6-Boronohexanoic Acid,small molecule,experimental,,N[C@@H](CCCC[B-](O)(O)O)C(O)=O,444965
1881,DB01984,(4S)-5-[[(1S)-1-Carboxy-2-cyclohexylethyl]amino]-4-[[(2S)-2-[[(3R)-4-cyclohexyl-2-oxo-3-(phenylmethoxycarbonylamino)butanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-oxopentanoic acid,small molecule,experimental,,NC(N)=NCCC[C@H](NC(=O)C(=O)[C@@H](CC1CCCCC1)NC(=O)OCC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1CCCCC1)C(O)=O,17753951
1882,DB01985,N-acetyl-L-arginine,small molecule,experimental,"Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins",CC(=O)N[C@@H](CCCNC(N)=N)C(O)=O,67427
1883,DB01986,3-Fluoro-2-Methyl-Aniline,small molecule,experimental,,CC1=C(N)C=CC=C1F,285553
1884,DB01987,Cocarboxylase,small molecule,approved|experimental,"Coenzymes|Diet, Food, and Nutrition|Enzymes and Coenzymes|Food|Food and Beverages|Growth Substances|Micronutrients|Physiological Phenomena|Pyrimidines|Sulfur Compounds|Thiazoles|Vitamin B Complex|Vitamins",CC1=C(CCO[P@](O)(=O)O[P@](O)([O-])=O)SC=[N+]1CC1=CN=C(C)N=C1N,5431
1885,DB01988,6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine,small molecule,experimental,,C([C@H]1CN(CCN1)C1=NN=C(C2=CC3=CC=CC=C3C=C2)C(=C1)C1=CC=NC=C1)C1=CC=CC=C1,4369379
1886,DB01989,Methyl N-{[(1R)-1-({1-[(benzyloxy)carbonyl]-L-prolyl-6-ammonio-L-norleucyl}amino)-2-phenylethyl](hydroxy)phosphoryl}-L-alanyl-L-prolinate,small molecule,experimental,,[H]N([C@@H](CCCC[N+]([H])([H])[H])C(=O)N([H])[C@@H](CC1=CC=CC=C1)P(O)(=O)N([H])[C@@H](C)C(=O)N1CCC[C@H]1C(=O)OC)C(=O)[C@@H]1CCCN1C(=O)OCC1=CC=CC=C1,16741116
1887,DB01990,Cholesterol sulfate,small molecule,experimental,"Anticarcinogenic Agents|Cholestanes|Cholestenes|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Fused-Ring Compounds|Lipids|Membrane Lipids|Protease Inhibitors|Protective Agents|Serine Protease Inhibitors|Steroids|Sterols",[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)OS(O)(=O)=O)[C@H](C)CCCC(C)C,65076
1888,DB01991,TU-514,small molecule,experimental,Carbohydrates|Glycoconjugates|Lipids,[H]N(O)C(=O)C[C@H]1CO[C@H](CO)[C@@H](O)[C@@H]1OC(=O)CCCCCCCCCCCCC,449223
1889,DB01992,Coenzyme A,small molecule,investigational|nutraceutical,"Adenine Nucleotides|Carbohydrates|Coenzyme A, biosynthesis|Coenzymes|Enzymes and Coenzymes|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS,87642
1890,DB01993,N-(5'-Phosphopyridoxyl)-D-Alanine,small molecule,experimental,,C[C@@H](NCC1=C(O)C(C)=NC=C1COP(O)(O)=O)C(O)=O,446862
1891,DB01994,"2-(Pyrido[1,2-E]Purin-4-Yl)Amino-Ethanol",small molecule,experimental,,OCCNC1=NC=NC2=C1N=C1C=CC=CN21,1522
1892,DB01995,5-methylcytidine 5'-monophosphate,small molecule,experimental,"Carbohydrates|Cytosine Nucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides",CC1=CN([C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N=C1N,192785
1893,DB01996,3-Methylpyridine,small molecule,experimental,Pyridines,CC1=CC=CN=C1,7970
1894,DB01997,3-Bromo-7-Nitroindazole,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Nitric Oxide Synthase, antagonists & inhibitors|Pyrazoles",BrC1=NNC2=C1C=CC=C2N(=O)=O,1649
1895,DB01998,"2-[3,4-Dihydroxy-2-Hydroxymethyl-5-(2-Hydroxy-Nonyl)-Tetrahydro-Furan-2-Yloxy]-6-Hydroxymethyl-Tetra Hydro-Pyran-3,4,5-Triol",small molecule,experimental,,[H][C@@](O)(CCCCCCC)C[C@@]1([H])O[C@@](CO)(O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]2([H])O)[C@@]([H])(O)[C@]1([H])O,17754184
1896,DB01999,"5,10,15,20-Tetrakis(4-Sulpfonatophenyl)-21h,23h-Porphine",small molecule,experimental,,OS(O)(O)C1=CC=C(C=C1)C-1=C2\C=CC(=N2)\C(=C2/N\C(\C=C2)=C(/C2=N/C(/C=C2)=C(\C2=CC=C\-1N2)C1=CC=C(C=C1)S(O)(O)O)C1=CC=C(C=C1)S([O-])([O-])[O-])\C1=CC=C(C=C1)S(O)(O)[O-],131704186
1897,DB02001,"5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine",small molecule,experimental,,NC1=NC2=C(C(N)=N1)C(SC1=CC=C(C=C1)N1CCOCC1)=CC=C2,3534
1898,DB02002,2-Aminoprop-2-Enamide,small molecule,experimental,,NC(=C)C(N)=O,3332061
1899,DB02004,"5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine",small molecule,experimental,,COC1=CC(=CC(OC)=C1)C1=NC(=C(CN)C(N)=N1)C1=CC=C(Cl)C=C1Cl,448436
1900,DB02005,2-Oxo-3-Pentenoic Acid,small molecule,experimental,,[H]\C(C)=C(/[H])C(=O)C(O)=O,5289089
1901,DB02006,Br-Coeleneterazine,small molecule,experimental,,[H][C@@]1(CC2=CC=CC=C2)NC(=CN2C(=O)[C@](CC3=CC=C(Br)C=C3)(OO)N=C12)C1=CC=C(O)C=C1,49866866
1902,DB02007,alpha-D-glucose 6-phosphate,small molecule,experimental,,O[C@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O,439284
1903,DB02008,1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,small molecule,experimental,,CCCCN1C2=C(NC(CC3=CC=C(NC(C)=O)C=C3)=N2)C(=O)N(CC2=CC=CC=C2F)C1=O,447371
1904,DB02009,L-756423,small molecule,experimental,Antiviral Agents|HIV Protease Inhibitors|Indenes,CC(C)(C)NC(=O)[C@@H]1CN(CC2=CC3=C(O2)C=CC=C3)CCN1C[C@@H](O)C[C@@H](CC1=CC=CC=C1)C(=O)NC1[C@H](O)CC2=C1C=CC=C2,5481481
1905,DB02010,Staurosporine,small molecule,experimental,"Alkaloids|Carbazoles|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|P-glycoprotein inhibitors",[H][C@]1(C[C@@]2([H])O[C@](C)(N3C4=CC=CC=C4C4=C5CNC(=O)C5=C5C6=CC=CC=C6N2C5=C34)[C@]1([H])OC)NC,44259
1906,DB02011,N-(Phosphonoacetyl)-L-Ornithine,small molecule,experimental,"Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Peptides, and Proteins",N[C@@H](CCCNC(=O)CP(O)(O)=O)C(O)=O,124992
1907,DB02013,Iron azide hydrate,small molecule,experimental,,O.[Fe].[Fe].[N-]=[N+]=[N-],4475494
1908,DB02014,"5-(2-Fluoro-5-{(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl}phenyl)-1,2-oxazole-3-carboxylic acid",small molecule,experimental,,COC(=O)C1=C(O)C=CC=C1OC\C=C\C1=CC(C2=CC(=NO2)C(O)=O)=C(F)C=C1,447994
1909,DB02015,Dihydrofolic Acid,small molecule,experimental,,NC1=NC2=C(N=C(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CN2)C(=O)N1,98792
1910,DB02016,R048-8071,small molecule,experimental,,CN(CCCCCCOC1=CC=C(C(=O)C2=CC=C(Br)C=C2)C(F)=C1)CC=C,1949
1911,DB02017,Imidazole-Derived Cellobiose,small molecule,experimental,,[H][C@]1(CO)O[C@@]([H])(O[C@]2([H])[C@@]([H])(CO)N3C=CN=C3[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O,657137
1912,DB02018,Amido Phenyl Pyruvic Acid,small molecule,experimental,,NC(=N)C1=CC=C(CC(=O)C(O)=O)C=C1,2138
1913,DB02019,Acetyl Dithranol,small molecule,experimental,,OC(=O)CC1=C(O)C2=C(CC3=C(C(O)=CC=C3)C2=O)C=C1,4471188
1914,DB02020,Alrestatin,small molecule,experimental,"Autonomic Agents|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Parasympatholytics|Peripheral Nervous System Agents",OC(=O)CN1C(=O)C2=CC=CC3=CC=CC(C1=O)=C23,2120
1915,DB02021,Fidarestat,small molecule,experimental,"Aldehyde Reductase, antagonists & inhibitors|Imidazoles",NC(=O)[C@@H]1C[C@]2(NC(=O)NC2=O)C2=C(O1)C=CC(F)=C2,160024
1916,DB02022,4-Amino-5-Hydroxymethyl-2-Methylpyrimidine,small molecule,experimental,,CC1=NC=C(CO)C(N)=N1,777
1917,DB02023,8-oxo-dGMP,small molecule,experimental,"Carbohydrates|Glycosides|Guanine Nucleotides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",NC1=NC2=C(NC(=O)N2[C@H]2C[C@H](O)[C@@H](COP(O)(O)=O)O2)C(=O)N1,447903
1918,DB02024,3-phenylpropionic acid,small molecule,experimental,"Acids, Carbocyclic",OC(=O)CCC1=CC=CC=C1,107
1919,DB02025,ACV tripeptide,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Peptides",CC(C)[C@@H](NC(=O)[C@H](CS)NC(=O)CCC[C@H](N)C(O)=O)C(O)=O,448130
1920,DB02026,"Furo[2,3d]Pyrimidine Antifolate",small molecule,experimental,,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(C=C1)N(C)CC1=COC2=NC(N)=NC(N)=C12)C(O)=O,158376
1921,DB02027,N-{(4S)-4-Amino-5-[(2-aminoethyl)amino]pentyl}-N'-nitroguanidine,small molecule,experimental,,NCCNC[C@@H](N)CCCNC(=N)N[N+]([O-])=O,656911
1922,DB02028,"(1R,2R,3S,4R,6S)-3,4,6-Trihydroxy-5-{[(S)-hydroxy(3-hydroxy-2-oxopropoxy)phosphoryl]oxy}-1,2-cyclohexanediyl bis[dihydrogen (phosphate)]",small molecule,experimental,,OCC(=O)COP(O)(=O)OC1[C@H](O)[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H]1O,5288599
1923,DB02029,N-Cyclohexyl-N'-(4-Iodophenyl)Urea,small molecule,experimental,,IC1=CC=C(NC(=O)NC2CCCCC2)C=C1,4357
1924,DB02030,Alpha-Ribazole-5'-Phosphate,small molecule,experimental,,CC1=CC2=C(C=C1C)N(C=N2)[C@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O,444941
1925,DB02031,"(6S)-5,6,7,8-tetrahydrofolic acid",small molecule,experimental,Folic Acid and Derivatives|Vitamin B Complex|Vitamins,NC1=NC2=C(N[C@@H](CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CN2)C(=O)N1,5460413
1926,DB02032,Epicaptopril,small molecule,experimental,Agents that produce hypertension|Protease Inhibitors,C[C@@H](CS)C(=O)N1CCC[C@H]1C(O)=O,688267
1927,DB02033,"N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide",small molecule,experimental,,OC1=C([C@@H](C2CC2)C2=CC=CC(NS(=O)(=O)C3=CC=CC=C3)=C2)C(=O)OC2=C1CCCCCC2,54687250
1928,DB02034,Tridolgosir,small molecule,experimental,,[H][C@@]1(O)CN2CCC[C@@]([H])(O)[C@]2([H])[C@]1([H])O,51683
1929,DB02035,Hexadecanesulfonyl fluoride,small molecule,experimental,Fatty Acids|Lipids|Palmitic Acids|Sulfur Compounds,CCCCCCCCCCCCCCCCS(F)(=O)=O,3572
1930,DB02036,"2-(3,4-Dihydro-3-Oxo-2h-Benzo[B][1,4]Thiazin-2-Yl)-N-Hydroxyacetamide",small molecule,experimental,,[H][C@]1(CC(=O)NO)SC2=CC=CC=C2NC1=O,448475
1931,DB02037,"2,5-Diaminopyrimidin-4,6-diol",small molecule,experimental,,NC1=NC(O)=C(N)C(O)=N1,2733981
1932,DB02038,"D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide",small molecule,experimental,,CC1=NC=C(COP(O)(O)=O)C(CN[C@@H]2CONC2=O)=C1O,445005
1933,DB02039,S-Acetyl-Cysteine,small molecule,experimental,,[H][C@](N)(CSC(C)=O)C(O)=O,10130120
1934,DB02041,Isoluminol,small molecule,experimental,"Compounds used in a research, industrial, or household setting|Indicators and Reagents|Laboratory Chemicals|Luminescent Agents|Luminescent Measurements|Pyridazines",NC1=CC=C2C(=O)NNC(=O)C2=C1,95014
1935,DB02042,2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol,small molecule,experimental,,COCCOCCOCCOCCOCCO,90255
1936,DB02043,"1,2-Dipalmitoyl-Phosphatidyl-Glycerole",small molecule,experimental,,CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCCCCCCCCCC,65144
1937,DB02044,N-[3-(aminomethyl)benzyl]acetamidine,small molecule,experimental,,CC(=N)NCC1=CC(CN)=CC=C1,1433
1938,DB02045,Amylamine,small molecule,experimental,,CCCCCN,8060
1939,DB02046,N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid,small molecule,experimental,,[H][C@@](CC(C)C)(NC(=O)C1=CC=CO1)C(=O)N[C@@]([H])(CC1=CNC2=C1C=CC=C2)P(O)(O)=O,449500
1940,DB02047,(+)-2-(4-biphenyl)propionic acid,small molecule,experimental,,C[C@H](C(O)=O)C1=CC=C(C=C1)C1=CC=CC=C1,448006
1941,DB02048,"1,2,4-Triazole-Carboxamidine",small molecule,experimental,,NC(=[NH2+])N1C=NC=N1,3387240
1942,DB02049,2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide,small molecule,experimental,,ONC(=O)CC1(CCOCC1)S(=O)(=O)C1=CC=C(OC2=CC=C(Cl)C=C2)C=C1,5111
1943,DB02051,4-Nitrophenyl (3S)-3-({N-[(benzyloxy)carbonyl]-L-phenylalanyl}amino)-5-phenyl-1-pentanesulfonate,small molecule,experimental,,[H]N([C@@H](CC1=CC=CC=C1)C(=O)N([H])[C@@H](CCC1=CC=CC=C1)CCS(=O)(=O)OC1=CC=C(C=C1)[N+]([O-])=O)C(=O)OCC1=CC=CC=C1,5289561
1944,DB02052,Indirubin-3'-monoxime,small molecule,experimental,"Amines|Heterocyclic Compounds, Fused-Ring|Hydroxylamines",O\N=C1\C(\NC2=C\1C=CC=C2)=C1\C(=O)NC2=C1C=CC=C2,5326739
1945,DB02053,Ribose-5-phosphate,small molecule,experimental,Carbohydrates|Pentosephosphates|Sugar Phosphates,[H][C@@](O)(COP(O)(O)=O)[C@@]([H])(O)[C@@]([H])(O)C=O,77982
1946,DB02054,Gabaculine,small molecule,experimental,"Acids, Carbocyclic|Cyclohexanes|Cycloparaffins|Enzyme Inhibitors|Transaminases, antagonists & inhibitors",NC1=CC=CC(=C1)C(O)=O,7419
1947,DB02055,N-Butyl-Benzenesulfonamide,small molecule,experimental,,CCCCNS(=O)(=O)C1=CC=CC=C1,19241
1948,DB02056,Prostaglandin D2,small molecule,investigational,"Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Prostaglandin D2, antagonists & inhibitors|Prostaglandins|Prostaglandins D",[H][C@](O)(CCCCC)\C=C\[C@@]1([H])C(=O)C[C@]([H])(O)[C@]1([H])C\C=C/CCCC(O)=O,448457
1949,DB02057,(S)-AMPA,small molecule,experimental,,CC1=C(C[C@H](N)C(O)=O)C(O)=NO1,158397
1950,DB02058,3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone,small molecule,experimental,Tyrosine Kinase Inhibitors,[H]N1C(=O)C(CC2=CC=C(C=C2)N2CCN(CC2)C=O)C2=CC=CC=C12,1633
1951,DB02059,Adenosine-5-Diphosphoribose,small molecule,experimental,,NC1=C2N=CN([C@@H]3O[C@H](CO[P@@](O)(=O)O[P@@](O)(=O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)C2=NC=N1,447048
1952,DB02060,Cyclohexanone,small molecule,experimental,Cyclohexanes|Cycloparaffins|Ketones,O=C1CCCCC1,7967
1953,DB02061,Cellobiose,small molecule,experimental,"Biopolymers|Carbohydrates|Cellulose|Compounds used in a research, industrial, or household setting|Disaccharides|Glucans|Macromolecular Substances|Oligosaccharides|Polymers|Polysaccharides",OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O,439178
1954,DB02062,"N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine",small molecule,experimental,,[H][C@@](C)(N)[P@](O)(=O)C[C@@]([H])(CC1=CC=C(C=C1)C1=CC=CC=C1)C(=O)N[C@@]([H])(C)C(O)=O,5478838
1955,DB02063,CRA_16847,small molecule,experimental,,[H][C@](CC([O-])=O)(C(O)=O)C1=CC(C2=NC3=C(N2)C=C(C=C3)C(N)=N)=C([O-])C(Br)=C1,131704187
1956,DB02065,4-Deoxylactose,small molecule,experimental,,[H][C@@]1(CO)C[C@]([H])(O)[C@@]([H])(O)[C@]([H])(O[C@]2([H])[C@@]([H])(CO)O[C@@]([H])(O)[C@]([H])(O)[C@@]2([H])O)O1,445801
1957,DB02066,N7-Methyl-Formycin A,small molecule,experimental,,[H][C@]1(CO)O[C@@]([H])(C2=C3N=CN=C(NC)C3=NN2)[C@]([H])(O)[C@]1([H])O,446659
1958,DB02067,Triglu-5-formyl-tetrahydrofolate,small molecule,experimental,Folic Acid and Derivatives|Vitamin B Complex|Vitamins,[H]N([H])C1=NC(=O)C2=C(N([H])C[C@H](CN([H])C3=CC=C(C=C3)C(=O)N([H])[C@@H](CCC(=O)N([H])[C@@H](CCC(=O)N([H])[C@@H](CCC(O)=O)C(O)=O)C(O)=O)C(O)=O)N2C=O)N1[H],6323515
1959,DB02068,Delta-Amino Valeric Acid,small molecule,experimental,,[NH3+]CCCCC(O)=O,449593
1960,DB02069,N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide,small molecule,experimental,,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=CC=CC=C1F,4290
1961,DB02070,Kynurenine,small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins",N[C@@H](CC(=O)C1=CC=CC=C1N)C(O)=O,161166
1962,DB02071,WAY-151693,small molecule,experimental,Amides|Amines|Hydroxy Acids|Hydroxylamines|Sulfones|Sulfur Compounds,COC1=CC=C(C=C1)S(=O)(=O)N(CC1=CC=CN=C1)C1=C(C=CC=C1C)C(=O)NO,4368
1963,DB02072,"2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Thiopyran-3-Carboxylic Acid",small molecule,experimental,,OC(=O)C(=O)NC1=C(C(O)=O)C2=C(CSCC2)S1,1521
1964,DB02073,Biliverdine IX Alpha,small molecule,experimental,,CC1=C(C=C)\C(NC1=O)=C\C1=C(C)C(CCC(O)=O)=C(N1)\C=C1/N=C(/C=C2\NC(=O)C(C=C)=C2C)C(C)=C1CCC(O)=O,5280353
1965,DB02074,Butenoic Acid,small molecule,experimental,,C\C=C\C(O)=O,637090
1966,DB02075,"[(2R,3R,4S,5S)-3,4-Dihydroxy-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)-2-pyrrolidinyl]methyl dihydrogen phosphate",small molecule,experimental,,[H]N1C=C([C@@H]2N([H])[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C2=C1C(=O)N=CN2[H],444833
1967,DB02076,6-phospho-D-gluconic acid,small molecule,experimental,"Acids, Acyclic|Carbohydrates|Hydroxy Acids|Sugar Acids",O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O,91493
1968,DB02077,L-N(omega)-nitroarginine-(4R)-amino-L-proline amide,small molecule,experimental,,N[C@@H](CCC\N=C(/N)N[N+]([O-])=O)C(=O)N[C@H]1CN[C@@H](C1)C(N)=O,656912
1969,DB02078,Triglyme,small molecule,experimental,"Alcohols|Compounds used in a research, industrial, or household setting|Ethylene Glycols|Glycols|Macromolecular Substances|Polymers",COCCOCCOCCOC,8189
1970,DB02079,Aminooxyacetic acid,small molecule,experimental,"Acetates|Acids, Acyclic|Amines|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|GABA Agents|Hydroxylamines|Lipids|Neurotransmitter Agents",NOCC(O)=O,286
1971,DB02080,"1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene",small molecule,experimental,,COCCOCCOCCOC1=CC=C(C=C1)C(C)(C)CC(C)(C)C,446308
1972,DB02081,Bis-Benzamidine,small molecule,experimental,,[H][C@@]1(CC2=CC=C(C=C2)C(N)=N)CCCC[C@@]([H])(CC2=CC=C(C=C2)C(N)=N)C1=O,17753851
1973,DB02082,Phosphoaminophosphonic acid guanylate ester,small molecule,experimental,"Carbohydrates|Glycosides|Guanine Nucleotides|Guanosine Triphosphate|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)NP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,36735
1974,DB02083,"N,N-dimethylglycine",small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins|Epilepsy, drug therapy|N-substituted Glycines|Peptides|Peptoids",CN(C)CC(O)=O,673
1975,DB02084,CRA_17312,small molecule,experimental,,[H][C@](CC([O-])=O)(C(O)=O)C1=CC(=C([O-])C(=C1)C1=NC2=C(N1)C=C(C=C2)C(N)=N)C1=CC=CC=C1OC,131704188
1976,DB02085,1-Aminocyclopropanecarboxylic Acid,small molecule,experimental,,NC1(CC1)C(O)=O,535
1977,DB02086,"(3,4-Dihydroxy-Phenyl)-Triphenyl-Arsonium",small molecule,experimental,,OC1=CC=C(C=C1O)[As+](C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1,5460502
1978,DB02087,"3,5-Difluorobenzenesulfonamide",small molecule,experimental,,NS(=O)(=O)C1=CC(F)=CC(F)=C1,446275
1979,DB02088,Norleucine Phosphonate,small molecule,experimental,,CCCC[C@H](N)P(O)(O)=O,444720
1980,DB02089,CP-526423,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring",ClC1=CC2=C(NC(=C2)C(=O)NCCOCCOCCNC(=O)C2=CC3=C(N2)C=CC(Cl)=C3)C=C1,445383
1981,DB02090,A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor,small molecule,experimental,,[H][C@@](CCCO)(C(=O)NO)[C@@]([H])(CC(C)C)C(=O)N[C@@]1([H])CCCCN(CCOC)C1=O,17754156
1982,DB02091,"4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine",small molecule,experimental,,CC1=NC(C)=C(S1)C1=NC(N)=NC=C1,447956
1983,DB02092,Cholesteryl Linoleate,small molecule,experimental,Cholestanes|Cholestenes|Fused-Ring Compounds|Lipids|Membrane Lipids|Steroids|Sterols,CCCCC\C=C/C\C=C/CCCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@@]3([H])[C@]4([H])CC[C@]([H])([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@]23[H])C1,5287939
1984,DB02093,5-phospho-D-arabinohydroxamic acid,small molecule,experimental,,[H]N(O)C(=O)[C@@H](O)[C@H](O)[C@H](O)COP(O)(O)=O,446761
1985,DB02094,N-2-Thiophen-2-Yl-Acetamide Boronic Acid,small molecule,experimental,,OB(O)CNC(=O)CC1=CC=CS1,2671
1986,DB02095,Isatin,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Indoles",O=C1NC2=CC=CC=C2C1=O,7054
1987,DB02096,FR221647,small molecule,experimental,,[H][C@](CO)(CCC1=CC=CC=C1)N1C=NC(=C1)C(N)=O,447340
1988,DB02097,Cytidine,small molecule,experimental,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,6175
1989,DB02098,Adenosine-2'-5'-Diphosphate,small molecule,experimental,,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O,440141
1990,DB02099,S-azabisabolene,small molecule,experimental,,C[N@H+](CCC=C(C)C)[C@@H]1CCC(C)=CC1,5289326
1991,DB02100,Methyl alpha-galactoside,small molecule,experimental,,CO[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O,76935
1992,DB02101,"(S,R)-fidarestat",small molecule,experimental,,[H]N([H])C(=O)[C@@H]1C[C@@]2(N([H])C(=O)N([H])C2=O)C2=C(O1)C=CC(F)=C2,449157
1993,DB02102,Mozenavir,small molecule,experimental,,NC1=CC(CN2[C@H](CC3=CC=CC=C3)[C@H](O)[C@@H](O)[C@@H](CC3=CC=CC=C3)N(CC3=CC(N)=CC=C3)C2=O)=CC=C1,154044
1994,DB02103,2-Chlorodideoxyadenosine,small molecule,experimental,,[H][C@@]1(CO)CC[C@@]([H])(O1)N1C=NC2=C1N=C(Cl)N=C2N,72194
1995,DB02104,"2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine",small molecule,experimental,,COC1=CC(=CC(OC)=C1OC)N(C)CC1=C(C)C2=C(N)N=C(N)N=C2N=C1,447815
1996,DB02105,"3,5-Dinitrocatechol",small molecule,experimental,Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Benzene Derivatives|Central Nervous System Agents|COMT Inhibitors|Enzyme Inhibitors|Phenols,OC1=CC(=CC(=C1O)[N+]([O-])=O)[N+]([O-])=O,3870203
1997,DB02106,"[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid",small molecule,experimental,,OC(O)CC1=CC(Br)=C(OC2=CC(C(O)NCCC3=CC=CC=C3)=C(O)C=C2)C(Br)=C1,5287509
1998,DB02107,Leucine - Reduced Carbonyl,small molecule,experimental,,CC(C)C[C@@H](C)N,642324
1999,DB02108,2-Aminoethanimidic Acid,small molecule,experimental,,[H]N=C([H])CN,4471892
2000,DB02109,Hadacidin,small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins|Antibiotics, Antineoplastic|Antineoplastic Agents|Noxae|Teratogens|Toxic Actions",ON(CC(O)=O)C=O,12717
2001,DB02110,Protoporphyrin Ix Containing Co,small molecule,experimental,,CC1=C(CCC(O)=O)C2=CC3=C(CCC(O)=O)C(C)=C4C=C5N6C(=CC7=C(C=C)C(C)=C8C=C1N2[Co]6(N34)N78)C(C)=C5C=C,11967905
2002,DB02111,3-hydroxyisoxazole-4-carboxylic acid,small molecule,experimental,,OC(=O)C1=CON=C1O,448651
2003,DB02112,Zk-806450,small molecule,experimental,,CC(=N)N1CCC(CC1)OC1=CC=C2C(=C1)N(CC1=CC=C3C=CC(=CC3=C1)C(N)=N)C1=C2C=CC=C1,448062
2004,DB02113,6-Methylpurine,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring",CC1=C2NC=NC2=NC=N1,5287547
2005,DB02114,Cumidine,small molecule,experimental,Amines,CC(C)C1=CC=C(N)C=C1,7464
2006,DB02115,Daidzin,small molecule,experimental,"Alcohol Deterrents|BCRP/ABCG2 Inhibitors|Benzopyrans|Central Nervous System Agents|Chromones|Enzyme Inhibitors|Flavonoids|Heterocyclic Compounds, Fused-Ring|Pyrans",[H][C@]1(CO)O[C@@]([H])(OC2=CC=C3C(=O)C(=COC3=C2)C2=CC=C(O)C=C2)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O,107971
2007,DB02116,Olomoucine,small molecule,experimental,"Cyclin-Dependent Kinases, antagonists & inhibitors|Cytokinins|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Purines",CN1C=NC2=C1N=C(NCCO)N=C2NCC1=CC=CC=C1,4592
2008,DB02118,CP-271485,small molecule,experimental,,[H][C@@]1(CN(CC2=CC=CC=C2)C(=O)CO1)C1=CC2=C(C=C1)N(C)S(=O)(=O)C2,448940
2009,DB02119,"6-Hydroxymethyl-7,8-Dihydropterin",small molecule,experimental,"Biological Factors|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Pteridines",NC1=NC2=C(N=C(CO)CN2)C(=O)N1,218
2010,DB02120,"6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol",small molecule,experimental,,[H][C@]1(N)C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O,193758
2011,DB02121,Butyramide,small molecule,experimental,,CCCC(N)=O,10927
2012,DB02122,4-iodo-acetamido phenylboronic acid,small molecule,experimental,,OB(O)C1=CC=CC(NC(=O)CI)=C1,4634714
2013,DB02123,Glycochenodeoxycholic Acid,small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins|Bile Acids and Salts|BSEP/ABCB11 Inhibitors|BSEP/ABCB11 Substrates|Cholanes|Cholic Acids|Compounds used in a research, industrial, or household setting|Detergents|Fused-Ring Compounds|Glycodeoxycholic Acid|Household Products|N-substituted Glycines|Peptides|Peptoids|Steroids|Surface-Active Agents",C[C@H](CCC(=O)NCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,12544
2014,DB02124,"(2s,3s)-Trans-2,3-Dihydro-3-Hydroxyanthranilic Acid",small molecule,experimental,,[H][C@]1(O)C=CC=C(C(O)=O)[C@]1([H])N,448825
2015,DB02125,Adamantanone,small molecule,experimental,Cycloparaffins,O=C1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2,64151
2016,DB02126,4-Carboxycinnamic Acid,small molecule,experimental,,OC(=O)\C=C\C1=CC=C(C=C1)C(O)=O,697959
2017,DB02127,Diisopropyl methylphosphonate,small molecule,experimental,,CC(C)OP(C)(=O)OC(C)C,3073
2018,DB02128,[1-(3-hydroxy-2-oxo-1-phenethyl-propylcarbamoyl)2-phenyl-ethyl]-carbamic acid pyridin-4-ylmethyl ester,small molecule,experimental,,[H]N([C@@H](CC1=CC=CC=C1)C(=O)N([H])[C@@H](CCC1=CC=CC=C1)C(=O)CO)C(=O)OCC1=CN=CC=C1,5289091
2019,DB02129,Dihydroorotic Acid,small molecule,experimental,,OC(=O)[C@@H]1CC(=O)NC(=O)N1,439216
2020,DB02130,Vanillic acid,small molecule,experimental,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Ethers|Hydroxy Acids|Hydroxybenzoate Ethers|Hydroxybenzoates|Phenols|Phenyl Ethers",COC1=CC(=CC=C1O)C([O-])=O,54675858
2021,DB02131,N-1-methylheptylformamide,small molecule,experimental,,[H]N(C=O)[C@H](C)CCCCCC,5478865
2022,DB02132,Zenarestat,small molecule,experimental,"Aldehyde Reductase, antagonists & inhibitors|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring",OC(=O)CN1C(=O)N(CC2=C(F)C=C(Br)C=C2)C(=O)C2=C1C=C(Cl)C=C2,5724
2023,DB02133,Chlorophyll A,small molecule,experimental,"Biological Factors|Chlorophyll|Heterocyclic Compounds, Fused-Ring|Metalloporphyrins|Pigments, Biological|Porphyrins",[Mg++].CCC1=C(C)C2=N\C\1=C/C1=C(C)C3=C([N-]1)\C([C@@H](C(=O)OC)C3=O)=C1/N=C(/C=C3\[N-]/C(=C\2)C(C=C)=C3C)[C@@H](C)[C@@H]1CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C,12085802
2024,DB02134,Xanthine,small molecule,experimental,"Alkaloids|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Purines|Purinones|Xanthine derivatives",O=C1NC2=C(NC=N2)C(=O)N1,1188
2025,DB02135,"1-deoxy-1-{2,6,8-trioxo-7-[4-(phosphonooxy)butyl]-1,2,3,6,7,8-hexahydro-9H-purin-9-yl}-D-arabinitol",small molecule,experimental,,[H]N1C2=C(N(CCCCOP(O)(O)=O)C(=O)N2C[C@@H](O)[C@H](O)[C@H](O)CO)C(=O)N([H])C1=O,657027
2026,DB02136,Cephalosporin analog,small molecule,experimental,Agents that reduce seizure threshold,[H][C@]1(NC(C(O)=O)=C(CC[C@H](NC(=O)CC[C@@H](NC(C)=O)C(O)=O)C(=O)N[C@H](C)C(=O)N[C@H](C)C(O)=O)CS1)[C@H](NC(=O)CC1=CC=CC=C1)C(O)=O,17753890
2027,DB02137,Molybdenum cofactor,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Enzymes and Coenzymes|Heterocyclic Compounds, Fused-Ring|Proteins",O=[Mo++]=O.NC1=NC2=C(N[C@@H]3[C@H](N2)O[C@H](COP([O-])([O-])=O)C([S-])=C3[S-])C(=O)N1,131704190
2028,DB02138,Diethyl 4-Methylbenzylphosphonate,small molecule,experimental,Organophosphorus Compounds,CCOP(=O)(CC1=CC=C(C)C=C1)OCC,3050
2029,DB02139,(2e)-N-Allyl-4-{[3-(4-Bromophenyl)-5-Fluoro-1-Methyl-1h-Indazol-6-Yl]Oxy}-N-Methyl-2-Buten-1-Amine,small molecule,experimental,,CN(CC=C)C\C=C\COC1=CC2=C(C=C1F)C(=NN2C)C1=CC=C(Br)C=C1,445990
2030,DB02140,N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide,small molecule,experimental,,[H][C@@](CC1=CC=CC=C1)(NC(=O)C(=O)CC(=O)NCCC1=NC=CC=C1)C(=O)N(C)C,5287869
2031,DB02141,"S,S'-(1,4-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea",small molecule,experimental,,NC(=N)SCCC1=CC=C(CCSC(N)=N)C=C1,1337
2032,DB02142,Pyridoxamine-5'-Phosphate,small molecule,experimental,,CC1=NC=C(COP(O)(O)=O)C(CN)=C1O,1053
2033,DB02143,1-hydroxy-2-isopropylguanidine,small molecule,experimental,,CC(C)\N=C(/N)NO,447029
2034,DB02144,"1,2-diacyl-sn-glycero-3-phosphoinositol",small molecule,experimental,,[H]\C(CCCCCCCC)=C(\[H])CCCCCCCC(=O)O[C@]([H])(COC(=O)CCCCCCCCCCCCCCC)COP([O-])(=O)O[C@@]1([H])[C@]([H])(O)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O,49867502
2035,DB02145,Butyl alcohol,small molecule,experimental,,CCCCO,263
2036,DB02146,Glutathione S-atrazine,small molecule,experimental,,CCNC1=NC(SC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O)=NC(NC(C)C)=N1,5287712
2037,DB02147,Cyclo-Tetrametavanadate,small molecule,experimental,Vanadates,[O-][V]1(=O)O[V]([O-])(=O)O[V]([O-])(=O)O[V]([O-])(=O)O1,3393379
2038,DB02148,3-Amino-4-Oxybenzyl-2-Butanone,small molecule,experimental,,CC(=O)[C@@H](N)COCC1=CC=CC=C1,5289348
2039,DB02151,Methionine Phosphonate,small molecule,experimental,,CSCC[C@H](N)P(O)(O)=O,444719
2040,DB02152,K-252a,small molecule,experimental,"Alkaloids|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Indoles|Protein Kinase C, antagonists & inhibitors",[H][C@]12C[C@](O)(C(=O)OC)[C@](C)(O1)N1C3=C(C=CC=C3)C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13,3035817
2041,DB02153,3-sulfino-L-alanine,small molecule,experimental,,N[C@@H](C[S@@](O)=O)C(O)=O,1549098
2042,DB02154,"2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid",small molecule,experimental,,[H][C@@](CC1=CC=C2OCOC2=C1)(C(O)=O)[C@]([H])(CC1=CC=C2OCOC2=C1)C(O)=O,5496628
2043,DB02155,3-[(3-sec-butyl-4-hydroxybenzoyl)amino]azepan-4-yl 4-(2-hydroxy-5-methoxybenzoyl)benzoate,small molecule,experimental,,[H]N([C@@H]1CN([H])CCC[C@H]1OC(=O)C1=CC=C(C=C1)C(=O)C1=C(O)C=CC(OC)=C1)C(=O)C1=CC([C@@H](C)CC)=C(O)C=C1,448327
2044,DB02156,Sulfopyruvate,small molecule,experimental,,OC(=O)C(=O)CS(O)(=O)=O,440717
2045,DB02158,"(2S,3S,4R,5S)-2-(4-Amino-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-[(methylsulfanyl)methyl]-3,4-pyrrolidinediol",small molecule,experimental,,CSC[C@H]1N[C@H]([C@H](O)[C@@H]1O)C1=CNC2=C1N=CNC2N,131704191
2046,DB02159,(R)-Propylene glycol,small molecule,experimental,,C[C@@H](O)CO,259994
2047,DB02160,S-Butyryl-Cystein,small molecule,experimental,,[H][C@](N)(CSC(=O)CCC)C(O)=O,17753929
2048,DB02161,Hydroxy-Phenyl-Acetic Acid 8-Methyl-8-Aza-Bicyclo[3.2.1]Oct-3-Yl Ester,small molecule,experimental,,[H][C@](O)(C(=O)O[C@@]1([H])C[C@]2([H])CC[C@]([H])(C1)N2C)C1=CC=CC=C1,447234
2049,DB02162,5'-O-(N-Ethyl-Sulfamoyl)Adenosine,small molecule,experimental,,[H][C@]1(COS(=O)(=O)NCC)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,17753791
2050,DB02163,"2,5-Xylidine",small molecule,experimental,,CC1=CC=C(C)C(N)=C1,7259
2051,DB02164,N-sulfo-flavin mononucleotide,small molecule,experimental,,[H]N1C(=O)N=C2N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C3=C(C=C(C)C(C)=C3)[N+](=C2C1=O)S([O-])(=O)=O,5288230
2052,DB02165,Zinc trihydroxide,small molecule,experimental,Metal cations|Metal divalent cations|Zinc Compounds,[Zn].[H]O[H].[H]O[H].[H]O[H],445443
2053,DB02166,Propidium,small molecule,experimental,"Coloring Agents|Compounds used in a research, industrial, or household setting|Heterocyclic Compounds, Fused-Ring|Indicators and Reagents|Intercalating Agents|Laboratory Chemicals|Phenanthridines",CC[N+](C)(CC)CCC[N+]1=C(C2=CC=CC=C2)C2=C(C=CC(N)=C2)C2=C1C=C(N)C=C2,4939
2054,DB02167,"N,N-Dimethyl-L-Alanine",small molecule,experimental,,[H][C@@](C)(N(C)C)C(O)=O,5488191
2055,DB02168,6-bromopurine,small molecule,experimental,,BrC1=NC=NC2=C1NC=N2,5287830
2056,DB02169,"9,10-Deepithio-9,10-Didehydroacanthifolicin",small molecule,experimental,,[H]\C(=C(\[H])[C@@]1([H])CC[C@@]2(CC[C@@]3([H])O[C@@]([H])(C(=C)[C@@]([H])(O)[C@]3([H])O2)[C@@]([H])(O)C[C@]([H])(C)[C@@]2([H])O[C@@]3(CCCCO3)CC[C@@]2([H])C)O1)[C@@]([H])(C)[C@]1([H])CC(C)=C[C@@]2(O[C@]([H])(C[C@@](C)(O)C(O)=O)CC[C@@]2([H])O)O1,446512
2057,DB02170,"1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One",small molecule,experimental,,OC1=CC=C(C2=C1C(=O)C1=C(O)C=CC=C1O2)[N+]([O-])=O,5326637
2058,DB02172,"2,5-Dideoxy-2,5-Imino-D-Glucitol",small molecule,experimental,Alcohols|Carbohydrates|Sugar Alcohols,OC[C@@H]1N[C@@H](CO)[C@H](O)[C@H]1O,11073745
2059,DB02173,Co(III)-(Deuteroporphyrin IX),small molecule,experimental,,[Co+7].[H]\C-1=C2\[N-]\C(=C([H])/C3=N/C(=C([H])\C4=C(CCC([O-])=O)C(C)=C(N4)\C([H])=C4\C=C(C)C-1=N4)/C(CCC(O)=O)=C3C)C(C)=C2,131704192
2060,DB02174,D-Glutamine,small molecule,experimental,,N[C@H](CCC(N)=O)C(O)=O,145815
2061,DB02175,Malonic acid,small molecule,experimental,"Acids, Acyclic|Dicarboxylic Acids|Thallium",OC(=O)CC(O)=O,867
2062,DB02176,Mercury Acetate Ion,small molecule,experimental,,CC(=O)O[Hg+],16685160
2063,DB02177,1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine,small molecule,experimental,,CCOC1=CC=CC=C1SC1=C(C=C(C=C1)C1=CC(=NC=C1)N1CCN(CC1)C(C)=O)N(=O)=O,448317
2064,DB02178,Phenylacetaldehyde,small molecule,experimental,"Aldehydes|Oils, Volatile",O=CCC1=CC=CC=C1,998
2065,DB02179,O-Trifluoromethylphenyl Anthranilic Acid,small molecule,experimental,,OC(=O)C1=CC=CC=C1NC1=C(C=CC=C1)C(F)(F)F,445155
2066,DB02180,Myristoyl-Coa,small molecule,experimental,"Adenine Nucleotides|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides|Thioesters of coenzyme A",CCCCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N,11966124
2067,DB02181,2'-Deoxyguanosine-5'-Triphosphate,small molecule,experimental,,NC1=NC2=C(N=CN2[C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O2)C(=O)N1,65103
2068,DB02182,Hybrid Between B and C Type Hemes (Protoporphyrin Ixcontaining Fe),small molecule,experimental,,CCC1=C2C=C3N4C(=CC5=C(C)C(CCC(O)=O)=C6C=C7N8C(=CC(N2[Fe]48N56)=C1C)C(C)=C7CCC(O)=O)C(C=C)=C3C,131704193
2069,DB02183,Adenosine-5'-ditungstate,small molecule,experimental,,NC1=C2N=CN(C3OC(CO[W](O)(=O)O[W](O)(O)=O)C(O)C3O)C2=NC=N1,
2070,DB02184,"D-1,4-dithiothreitol",small molecule,experimental,,O[C@H](CS)[C@H](O)CS,446094
2071,DB02185,"2,4-Dihydroxy-7-(Methyloxy)-2h-1,4-Benzoxazin-3(4h)-One",small molecule,experimental,,[H][C@@]1(O)OC2=C(C=CC(OC)=C2)N(O)C1=O,445228
2072,DB02186,N-Acetyl-D-Galactosamine 6-Sulfate,small molecule,experimental,,CC(=O)N[C@H]1[C@H](O)O[C@H](COS(O)(=O)=O)[C@H](O)[C@@H]1O,440271
2073,DB02187,Equilin,small molecule,experimental,"17-Ketosteroids|Adrenal Cortex Hormones|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Estradiol Congeners|Estranes|Estrenes|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Steroids",[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC=C21)C=C(O)C=C3,223368
2074,DB02188,N-Methylmesoporphyrin Containing Copper,small molecule,experimental,,CCC1=C2C=C3N4C(=CC5=[N+]6C(=CC7=[N]8(C)C(=CC(N2[Cu-]468)=C1C)C(CC)=C7C)C(C)=C5CCC(O)=O)C(CCC(O)=O)=C3C,5288831
2075,DB02189,"2',3'-Dideoxyadenosine triphosphate",small molecule,experimental,"Adenine Nucleotides|Carbohydrates|Deoxyribonucleotides|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",NC1=C2N=CN([C@H]3CC[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O3)C2=NC=N1,65304
2076,DB02190,(S)-oxalosuccinic acid,small molecule,experimental,,[H][C@@](CC(O)=O)(C(O)=O)C(=O)C(O)=O,5496597
2077,DB02191,"(7as,12ar,12bs)-1,2,3,4,7a,12,12a,12b-Octahydroindolo[2,3-a]Quinolizin-7(6h)-One",small molecule,experimental,,[H][C@@]12CCCC[N@]1CC(=O)C1=C2NC2=C1C=CC=C2,11987779
2078,DB02192,Phenylethyl alcohol,small molecule,experimental,"Alcohols|Anti-Infective Agents|Anti-Infective Agents, Local|Compounds used in a research, industrial, or household setting|Disinfectants|Pharmaceutic Aids|Pharmaceutical Preparations|Preservatives, Pharmaceutical",OCCC1=CC=CC=C1,6054
2079,DB02194,"8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",small molecule,experimental,,OC1=CC=C(C[C@@]2(O)N=C3N(C=C(N=C3CC3=CC=CC=C3)C3=CC=C(O)C=C3)C2=O)C=C1,5287994
2080,DB02195,"3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine",small molecule,experimental,,ON1C2=CC=CN=C2C(=C1C1=CC=NC=C1)C1=CC=C(F)C=C1,5288238
2081,DB02196,Uridine-Diphosphate-N-Acetylgalactosamine,small molecule,experimental,,CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@](O)(=O)O[P@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O,23700
2082,DB02197,"4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide",small molecule,experimental,,NS(=O)(=O)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC=CN23)C=C1,5288527
2083,DB02198,2-Bromoacetyl Group,small molecule,experimental,,OC(=O)CBr,6227
2084,DB02199,"1,3-Dedimethyl-1,3-Divinyl Heme",small molecule,experimental,,CC1=C(CCC(O)=O)C2=CC3=C(CCC(O)=O)C(C)=C4C=C5N6C(=CC7=C(C=C)C(C=C)=C8C=C1N2[Fe]6(N34)N78)C(C=C)=C5C=C,131704194
2085,DB02200,3-[N-[benzyloxycarbonyl]-phenylalaninyl-amino]-5-phenyl-pentane-1-sulfonylmethylbenzene,small molecule,experimental,,[H]N([C@@H](CCC1=CC=CC=C1)CCS(=O)(=O)CC1=CC=CC=C1)C(=O)[C@H](CC1=CC=CC=C1)N([H])C(=O)OCC1=CC=CC=C1,5289560
2086,DB02201,Malonate Ion,small molecule,experimental,,[O-]C(=O)CC([O-])=O,9084
2087,DB02202,"(S)-butane-1,3-diol",small molecule,experimental,,C[C@H](O)CCO,446973
2088,DB02203,Acetone Cyanohydrin,small molecule,experimental,,CC(C)(O)C#N,6406
2089,DB02205,(+)-Rutamarin alcohol,small molecule,experimental,,CC(C)(O)[C@@H]1CC2=C(O1)C=C1OC(=O)C(=CC1=C2)C(C)(C)C=C,5287846
2090,DB02207,7-Nitroindazole,small molecule,experimental,"Analgesics|Anti-Anxiety Agents|Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Neuroprotective Agents|Nitric Oxide Synthase, antagonists & inhibitors|Peripheral Nervous System Agents|Protective Agents|Psychotropic Drugs|Pyrazoles|Sensory System Agents|Tranquilizing Agents",O=N(=O)C1=CC=CC2=CNN=C12,1893
2091,DB02209,Pyridoxine phosphate,small molecule,experimental,Coenzymes|Enzymes and Coenzymes|Picolines|Pyridines|Vitamin B Complex|Vitamins,CC1=NC=C(COP(O)(O)=O)C(CO)=C1O,1055
2092,DB02210,"Hexane-1,6-Diol",small molecule,experimental,,OCCCCCCO,12374
2093,DB02211,(R)-N-methyl-N-2-propynyl-1-indanamine,small molecule,experimental,,CN(CC#C)[C@@H]1CCC2=C1C=CC=C2,5289295
2094,DB02213,Metanitrophenyl-Alpha-D-Galactoside,small molecule,experimental,,[H][C@]1(CO)O[C@]([H])(OC2=CC=CC(=C2)N(=O)=O)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O,445328
2095,DB02214,"6,7-dioxo-5H-8-ribitylaminolumazine",small molecule,experimental,,[H]N1C(=O)N([H])C2=C(N([H])C(=O)C(=O)N2C[C@H](O)[C@H](O)[C@H](O)CO)C1=O,447426
2096,DB02215,Furoyl-Leucine,small molecule,experimental,,[H][C@@](CC(C)C)(NC(=O)C1=CC=CO1)C(O)=O,774282
2097,DB02216,S-Methylcysteine,small molecule,experimental,"Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Carbon Radioisotopes|Sulfhydryl Compounds|Sulfur Compounds",CSC[C@H](N)C(O)=O,24417
2098,DB02217,Dpb-T,small molecule,experimental,,[H][C@]1(C[C@]2([H])O[C@@](OC[C@]2([H])O1)(C1=CC=CC=C1)P(O)(O)=O)N1C=C(C)C(=O)NC1=O,5288101
2099,DB02218,"N-[4-hydroxymethyl-cyclohexan-6-yl-1,2,3-triol]-4,6-dideoxy-4-aminoglucopyranoside",small molecule,experimental,,[H][C@]1(C)O[C@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])N[C@@]1([H])C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O,444440
2100,DB02219,3-(cyclohexylamino)propanesulfonic acid,small molecule,experimental,"Acids|Acids, Noncarboxylic|Alkanes|Amines|Cyclohexanes|Cycloparaffins|Hydrocarbons, Acyclic|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",OS(=O)(=O)CCCNC1CCCCC1,70815
2101,DB02220,AL7089A,small molecule,experimental,,CN[C@H]1CN(C2=CC(OC)=CC=C2)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,3013848
2102,DB02221,"4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide",small molecule,experimental,,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=C(F)C=C(F)C=C1F,446241
2103,DB02222,"2,6-Diamino-(S)-9-[2-(Phosphonomethoxy)Propyl]Purine",small molecule,experimental,,C[C@@H](CN1C=NC2=C1N=C(N)N=C2N)OCP([O-])([O-])=O,5287571
2104,DB02223,LY231514 tetra glu,small molecule,experimental,,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)NC(CCC(O)=O)C(O)=O)C(O)=O)C(O)=O)C(O)=O)N1,131704196
2105,DB02224,Taxifolin,small molecule,experimental,"Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antirheumatic Agents|Benzopyrans|Central Nervous System Agents|Chromones|Flavonoids|Flavonols|Heterocyclic Compounds, Fused-Ring|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Pyrans|Sensory System Agents",O[C@@H]1[C@H](OC2=CC(O)=CC(O)=C2C1=O)C1=CC=C(O)C(O)=C1,439533
2106,DB02225,"1,2-Di-N-Pentanoyl-Sn-Glycero-3-Dithiophosphocholine",small molecule,experimental,,CCCCC(=O)OC[C@H](CO[P@@]([S-])(=S)OCC[N+](C)(C)C)OC(=O)CCCC,447776
2107,DB02226,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium",small molecule,experimental,,NC1=CC2=C(C=C1)C1=CC=C(N)C=C1C(C1=CC=CC=C1)=[N+]2CCCCCCC1=CN(CCNC2=C3CCCCC3=NC3=C2C=CC=C3)N=N1,5289507
2108,DB02227,"4,5-Dihydroxy-Tetrahydro-Pyran-2-Carboxylic Acid",small molecule,experimental,,O[C@H]1CO[C@@H](C[C@@H]1O)C(O)=O,448431
2109,DB02228,2-deoxy-2-fluoro-β-D-galactose,small molecule,experimental,,[H][C@@]1(O)O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]1([H])F,7191874
2110,DB02229,5'-O-[(L-methionyl)-sulphamoyl]adenosine,small molecule,experimental,,CSCC[C@H](N)C(=O)NS(=O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)NC=NC12,131704197
2111,DB02230,Immucillin-G,small molecule,experimental,"Purine-Nucleoside Phosphorylase, antagonists & inhibitors|Pyrimidines",NC1=NC2=C(NC=C2[C@@H]2N[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N1,444498
2112,DB02232,"1,2-Dihydroxybenzene",small molecule,experimental,Benzene Derivatives|Phenols,OC1=CC=CC=C1O,289
2113,DB02233,6-hydroxy-D-norleucine,small molecule,experimental,,[H][C@@](N)(CCCCO)C(O)=O,5288041
2114,DB02234,S-Ethylisothiourea,small molecule,experimental,"Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Enzyme Inhibitors|Hypnotics and Sedatives|Nitric Oxide Synthase, antagonists & inhibitors|Sulfur Compounds|Thiourea|Vasoconstrictor Agents",CCSC(N)=N,5139
2115,DB02235,L-methionine (R)-S-oxide,small molecule,experimental,"Amino Acids|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Sulfur Compounds",C[S@@](=O)CC[C@H](N)C(O)=O,10062737
2116,DB02236,Glycinamide Ribonucleotide,small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides",NCC(=O)NC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O,5459918
2117,DB02237,Maltotetraose,small molecule,experimental,"Anti-Bacterial Agents|Anti-Infective Agents|Biopolymers|Carbohydrates|Compounds used in a research, industrial, or household setting|Disaccharides|Glucans|Macromolecular Substances|Oligosaccharides|Polymers|Polysaccharides",OC[C@@H](O)[C@@H](O[C@H]1O[C@H](CO)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)[C@@H](O)C=O,123966
2118,DB02238,4-methylthio-2-oxobutanoic acid,small molecule,experimental,"Amino Acids|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Sulfur Compounds",CSCCC(=O)C(O)=O,473
2119,DB02239,Laevulinic Acid,small molecule,experimental,,CC(=O)CCC(O)=O,11579
2120,DB02240,Quinacrine mustard,small molecule,experimental,"Acridines|Aminoacridines|Coloring Agents|Compounds used in a research, industrial, or household setting|Fluorescent Dyes|Heterocyclic Compounds, Fused-Ring|Hydrocarbons, Halogenated|Indicators and Reagents|Laboratory Chemicals|Luminescent Agents|Mustard Compounds|Nitrogen Mustard Compounds",COC1=CC2=C(NC(C)CCCN(CCCl)CCCl)C3=CC=C(Cl)C=C3N=C2C=C1,20194
2121,DB02241,"8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",small molecule,experimental,,OO[C@]1(CC2=CC=C(O)C=C2)N=C2N(C=C(N=C2CC2=CC=CC=C2)C2=CC=C(O)C=C2)C1=O,5288011
2122,DB02242,Cyclohexanepropanoic acid,small molecule,experimental,,OC(=O)CCC1CCCCC1,69702
2123,DB02243,4-Morpholin-4-Yl-Piperidine-1-Carboxylic Acid [1-(3-Benzenesulfonyl-1-Propyl-Allylcarbamoyl)-2-Phenylethyl]-Amide,small molecule,experimental,,[H][C@](CCC)(C=CS(=O)(=O)C1=CC=CC=C1)N=C(O)[C@]([H])(CC1=CC=CC=C1)N=C(O)N1CCC(CC1)N1CCOCC1,5288869
2124,DB02245,7-Deazaguanine,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Purines|Purinones|Xanthine derivatives",NC1=NC2=C(CC=N2)C(=O)N1,4470573
2125,DB02247,Hydrolyzed Cephalothin,small molecule,experimental,Nephrotoxic agents,[H][C@@](NC(=O)CC1=CC=CS1)(C(O)=O)[C@@]1([H])NC(C(O)=O)=C(C)CS1,5288660
2126,DB02248,3-Methyl-5-Sulfo-Pyrrolidine-2-Carboxylic Acid,small molecule,experimental,,[H][C@@]1(C)C[C@@]([H])(N[C@@]1([H])C(O)=O)S(O)(=O)=O,5287761
2127,DB02249,2-Ethoxyethanol,small molecule,experimental,Alcohols|Glycols|Solvents,CCOCCO,8076
2128,DB02251,O-Succinylbenzoate,small molecule,experimental,"Acids, Carbocyclic",OC(=O)CCC(=O)C1=C(C=CC=C1)C(O)=O,955
2129,DB02252,Iodobenzene,small molecule,experimental,"Benzene Derivatives|Hydrocarbons, Halogenated|Hydrocarbons, Iodinated",IC1=CC=CC=C1,11575
2130,DB02253,"(1r)-4-[(1e,3e,5e,7z,9e,11z,13e,15e)-17-Hydroxy-3,7,12,16-Tetramethylheptadeca-1,3,5,7,9,11,13,15-Octaen-1-Yl]-3,5,5-Trimethylcyclohex-3-En-1-Ol",small molecule,experimental,,OC\C(C)=C\C=C\C(\C)=C/C=C/C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C,5287502
2131,DB02254,Trifluoro-thiamin phosphate,small molecule,experimental,,CC1=C(CCOP([O-])([O-])=O)SC=[N+]1CC1=CN=C(N=C1N)C(F)(F)F,4631605
2132,DB02255,Ilomastat,small molecule,experimental,"Amines|Amino Acids, Peptides, and Proteins|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Hydroxy Acids|Hydroxylamines|Matrix Metalloproteinase Inhibitors|Oligopeptides|Peptides|Protease Inhibitors",CNC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC(C)C)CC(=O)NO,132519
2133,DB02256,2'-Deoxyuridine,small molecule,experimental,,OC[C@H]1O[C@H](C[C@@H]1O)N1C=CC(=O)NC1=O,13712
2134,DB02257,N-Bromoacetyl-Aminoethyl Phosphate,small molecule,experimental,,CC(=O)N(Br)CCOP(O)(O)=O,4354
2135,DB02258,SR11254,small molecule,experimental,,CC1(C)CCC(C)(C)C2=CC(=CC=C12)C(=N/O)\C1=CC=C2C=C(C=CC2=C1)C(O)=O,9887303
2136,DB02259,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide",small molecule,experimental,,CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=C(C=C2)S(=O)(=O)NC1=CC=C(C=C1)S(N)(=O)=O,448661
2137,DB02260,4-Oxosebacic Acid,small molecule,experimental,"Fatty Acids|Lipids|Porphobilinogen Synthase, antagonists & inhibitors",OC(=O)CCCCCC(=O)CCC(O)=O,1755
2138,DB02261,Platelet Activating Factor,small molecule,experimental,"Adrenergic Agents|Alcohols|Amines|Amino Acids, Peptides, and Proteins|Amino Alcohols|Ammonium Compounds|Autacoids|Biological Factors|Blood Coagulation Factors|Blood Proteins|Carbohydrates|Cardiovascular Agents|Ethanolamines|Ethers|Glycerophosphates|Glycerophospholipids|Glyceryl Ethers|Inflammation Mediators|Lipids|Membrane Lipids|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|P-glycoprotein inducers|P-glycoprotein substrates|Phosphatidic Acids|Phospholipid Ethers|Phospholipids|Platelet Activating Factor, antagonists & inhibitors|Proteins|Quaternary Ammonium Compounds|Sugar Alcohols|Sugar Phosphates|Trimethyl Ammonium Compounds|Triose Sugar Alcohols",CCCCCCCCCCCCCCCCOC[C@H](CO[P@@]([O-])(=O)OCC[N+](C)(C)C)OC(C)=O,108156
2139,DB02262,Orotic acid,small molecule,investigational,Pyrimidines|Pyrimidinones,OC(=O)C1=CC(=O)NC(=O)N1,967
2140,DB02263,Glyceraldehyde-3-Phosphate,small molecule,experimental,,O[C@H](COP(O)(O)=O)C=O,439168
2141,DB02264,O2-Sulfo-Glucuronic Acid,small molecule,experimental,,[H][C@@]1(O)O[C@@]([H])(C(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])OS(O)(=O)=O,444390
2142,DB02265,Ethyl-Trimethyl-Silane,small molecule,experimental,,CC[Si](C)(C)C,137936
2143,DB02266,Flufenamic acid,small molecule,approved,"Acids, Carbocyclic|Amines|Aminobenzoates|Aniline Compounds|Anti-Inflammatory Agents|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Benzene Derivatives|Benzoates|Fenamates|Musculo-Skeletal System|OAT1/SLC22A6 inhibitors|ortho-Aminobenzoates",OC(=O)C1=CC=CC=C1NC1=CC(=CC=C1)C(F)(F)F,3371
2144,DB02267,Argininosuccinate,small molecule,experimental,,N[C@@H](CCC\N=C(/N)N[C@H](CC(O)=O)C(O)=O)C(O)=O,448718
2145,DB02268,4-(Acetylamino)-3-Amino Benzoic Acid,small molecule,experimental,,CC(=O)NC1=C(N)C=C(C=C1)C(O)=O,446367
2146,DB02269,[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium,small molecule,experimental,,C[N+](C)(C)C1=CC=C(CNC(=O)C2=CC3=C(C=CC(OCC4=CC=CC=C4)=C3)N2CC2=CC=CC(=C2)C(N)=N)C=C1,446978
2147,DB02270,Dimethylallyl S-Thiolodiphosphate,small molecule,experimental,,CC(C)CCS[P@](O)(=O)OP(O)(O)=O,5288123
2148,DB02271,S-(2-oxo)pentadecylcoa,small molecule,experimental,,[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@H](O)C(=O)N([H])CCC(=O)N([H])CCSCC(=O)CCCCCCCCCCCCC)[C@@H](OP(O)(O)=O)[C@H]3O)C2=NC=N1,449362
2149,DB02272,Porphobilinogen,small molecule,experimental,,NCC1=C(CC(O)=O)C(CCC(O)=O)=CN1,1021
2150,DB02273,"2,6-Dimethyl-7-Octen-2-Ol",small molecule,experimental,,C[C@@H](CCCC(C)(C)O)C=C,1712076
2151,DB02274,7-Keto-8-Aminopelargonic Acid,small molecule,experimental,"Amino Acids, Peptides, and Proteins",[H][C@@](C)(N)C(=O)CCCCCC(O)=O,448124
2152,DB02275,"[2-Aminomethyl-5-Oxo-4-(4-Oxo-Cyclohexa-2,5-Dienylmethyl)-4,5-Dihydro-Imidazol-1-Yl] -Acetaldehyde",small molecule,experimental,,[H][C@@]1(CC2C=CC(=O)C=C2)N=C(CN)N(CC=O)C1=O,17754118
2153,DB02276,(S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide,small molecule,experimental,,[H][C@@](CC(C)C)(NC(=O)[C@]([H])(CCCC)OP(O)(O)=O)C(=O)NC1=CC=C(C=C1)[N+]([O-])=O,17754079
2154,DB02277,1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea,small molecule,experimental,,CN1N=C(C=C1NC(=O)NC1=CC=C(Cl)C=C1)C(C)(C)C,446816
2155,DB02278,"7,8-dihydro-7,7-dimethyl-6-hydroxypterin",small molecule,experimental,,[H]N([H])C1=NC(=O)C2=C(N1[H])N([H])C(C)(C)C(=O)N2[H],3340355
2156,DB02279,Benzoylformic Acid,small molecule,experimental,"Acids, Aldehydic|Acids, Carbocyclic|Hydroxy Acids",OC(=O)C(=O)C1=CC=CC=C1,11915
2157,DB02280,(R)-Mandelic acid,small molecule,experimental,,O[C@@H](C(O)=O)C1=CC=CC=C1,11914
2158,DB02281,Formycin,small molecule,experimental,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",[H][C@]1(CO)O[C@@]([H])(C2=C3N=CN=C(N)C3=NN2)[C@]([H])(O)[C@]1([H])O,447199
2159,DB02282,5'-S-methyl-5'-thioadenosine,small molecule,experimental,"Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antineoplastic Agents|Antiparasitic Agents|Antiprotozoals|Carbohydrates|Deoxyribonucleosides|Enzyme Inhibitors|Folic Acid Antagonists|Glutamates|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Protein O-Methyltransferase, antagonists & inhibitors|Purine Nucleosides|Purines|Purinones|Ribonucleosides|Sulfur Compounds|Xanthine derivatives",CSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N,439176
2160,DB02283,2-Phenylamino-Ethanesulfonic Acid,small molecule,experimental,,OS(=O)(=O)CCNC1=CC=CC=C1,446854
2161,DB02285,Protoporphyrin,small molecule,experimental,"Biological Factors|Dermatologicals|Heterocyclic Compounds, Fused-Ring|Photosensitizing Agents|Pigments, Biological|Porphyrins|Radiation-Sensitizing Agents",CC1=C(CCC(O)=O)/C2=C/C3=N/C(=C\C4=C(C)C(C=C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C=C)=C4C)/C(C)=C3CCC(O)=O,4971
2162,DB02286,2-amino-3-(4-amino-1H-indol-3-yl)propanoic acid,small molecule,experimental,,[H][C@](N)(CC1=CNC2=CC=CC(N)=C12)C(O)=O,17753790
2163,DB02287,2-(2-hydroxy-phenyl)-3H-benzoimidazole-5-carboxamidine,small molecule,experimental,,NC(=[NH2+])C1=CC2=C(C=C1)N=C(N2)C1=CC=CC=C1O,5353306
2164,DB02288,CRA-9334,small molecule,experimental,,CC1=CC(Br)=C([O-])C(=C1)C1=NC2=CC(=CC=C2N1)C(N)=[NH2+],10904076
2165,DB02289,2-Aminopropanedioic Acid,small molecule,experimental,,NC(C(O)=O)C(O)=O,100714
2166,DB02290,"3-{2,6,8-trioxo-9-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",small molecule,experimental,,[H]N1C2=C(N(CCCOP(O)(O)=O)C(=O)N2C[C@H](O)[C@H](O)[C@H](O)CO)C(=O)N([H])C1=O,657025
2167,DB02292,Irosustat,small molecule,investigational,"Acids|Acids, Noncarboxylic|Steryl-Sulfatase, antagonists & inhibitors|Sulfur Acids|Sulfur Compounds",NS(=O)(=O)OC1=CC=C2C3=C(CCCCC3)C(=O)OC2=C1,5287541
2168,DB02293,"(2S)-2,3-bis{[(3R,7R)-3,7,11,15-tetramethylhexadecyl]oxy}propyl (2R)-2-hydroxy-3-[(hydroxyphosphinato)oxy]propyl phosphate",small molecule,experimental,,[H]C(C)(CCCC(C)C)CCC[C@@]([H])(C)CCC[C@@]([H])(C)CCOC[C@@]([H])(COP(O)(=O)OC[C@]([H])(O)COP([O-])([O-])=O)OCC[C@]([H])(C)CCC[C@]([H])(C)CCCC([H])(C)CCCC(C)C,131704198
2169,DB02294,"(5R,6S,7S,8S)-5-hydroxymethyl-6,7,8-trihydroxy-tetrazolo[1,5-A]piperidine",small molecule,experimental,,[H][C@]1(O)C2=NN=NN2[C@]([H])(CO)[C@]([H])(O)[C@]1([H])O,5288483
2170,DB02295,"N-[3-(Dimethylamino)Propyl]-2-({[4-({[4-(Formylamino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-5-Isopropyl-1,3-Thiazole-4-Carboxamide",small molecule,experimental,,CC(C)C1=C(N=C(NC(=O)C2=CC(NC(=O)C3=CC(NC=O)=CN3C)=CN2C)S1)C(=O)NCCCN(C)C,448379
2171,DB02296,Isoamyl alcohol,small molecule,experimental,Alcohols|Fatty Alcohols|Lipids,CC(C)CCO,31260
2172,DB02297,2-Amino-6-Chloropyrazine,small molecule,experimental,,NC1=CN=CC(Cl)=N1,118458
2173,DB02298,5-Hydroxyamino-3-Methyl-Pyrrolidine-2-Carboxylic Acid,small molecule,experimental,,[H][C@@]1(C)C[C@@]([H])(NO)N[C@@]1([H])C(O)=O,49866701
2174,DB02299,Arginineamide,small molecule,experimental,,N[C@@H](CCCNC(N)=[NH2+])C(N)=O,445032
2175,DB02300,Calcipotriol,small molecule,approved,Antipsoriatics|Antipsoriatics for Topical Use|Cholestanes|Cholestenes|Dermatologicals|Fused-Ring Compounds|Lipids|Membrane Lipids|Misc. Skin and Mucous Membrane Agents|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble),O[C@H](\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)C1CC1,5288783
2176,DB02301,"5,10-Methylene-6-Hydrofolic Acid",small molecule,experimental,,NC1=NC(=O)C2=C(N1)N=C[C@@H]1CN(CN21)C1=CC=C(C=C1)C(=O)N[C@H](CCC(O)=O)C(O)=O,6323520
2177,DB02302,Symmetric dimethylarginine,small molecule,experimental,"Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins",CN\C(NCCC[C@H](N)C(O)=O)=N\C,169148
2178,DB02303,"(5S)-5-Iododihydro-2,4(1H,3H)-pyrimidinedione",small molecule,experimental,,[H]N1C[C@H](I)C(=O)N([H])C1=O,5288605
2179,DB02304,Prostaglandin B2,small molecule,experimental,"Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Prostaglandins",CCCCC[C@H](O)\C=C\C1=C(C\C=C/CCCC(O)=O)C(=O)CC1,5280881
2180,DB02305,"4,5-Dehydro-D-Glucuronic Acid",small molecule,experimental,,[H][C@@]1(O)OC(=C[C@]([H])(O)[C@@]1([H])O)C(O)=O,445037
2181,DB02306,Palmitoyl-Linoleoyl Phosphatidylcholine,small molecule,experimental,,CCCCCCCCCCCCCCCC(=O)OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC,5287971
2182,DB02307,N-(1-carboxy-3-phenylpropyl)phenylalanyl-alpha-asparagine,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Oligopeptides|Peptides",[H]N([H])C(=O)[C@H](CC(O)=O)N([H])C(=O)[C@H](CC1=CC=CC=C1)N([H])[C@@H](CCC1=CC=CC=C1)C(O)=O,448836
2183,DB02308,"4-(1,3,2-Dioxaborolan-2-Yloxy)Butan-1-Aminium",small molecule,experimental,,[NH3+]CCCCOB1OCCO1,5288139
2184,DB02309,5-monophosphate-9-beta-D-ribofuranosyl xanthine,small molecule,experimental,,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)[N+]1=CNC2=C1NC(=O)NC2=O,6323540
2185,DB02310,"3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium",small molecule,experimental,,CC1=CN=C2C(=C1)C(C)=C(C)C1=C2[N+](C)=CC(C)=C1,168131
2186,DB02311,Methyl Methylsulfinylmethyl Sulfide,small molecule,experimental,,CSC[S@](C)=O,9543427
2187,DB02312,beta-D-galactose 6-phosphate,small molecule,experimental,,O[C@@H]1O[C@H](COP(O)(O)=O)[C@H](O)[C@H](O)[C@H]1O,449526
2188,DB02313,"Ethyl (4R)-4-{[(2R,5S)-2-(4-fluorobenzyl)-6-methyl-5-{[(5-methyl-1,2-oxazol-3-yl)carbonyl]amino}-4-oxoheptanoyl]amino}-5-[(3S)-2-oxo-3-pyrrolidinyl]pentanoate",small molecule,experimental,,[H]N([C@H](CCC(=O)OCC)C[C@@H]1CCN([H])C1=O)C(=O)[C@H](CC(=O)[C@@H](N([H])C(=O)C1=NOC(C)=C1)C(C)C)CC1=CC=C(F)C=C1,6323208
2189,DB02314,Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate,small molecule,experimental,,C[C@H](NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@H](OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@@H]1NC(C)=O)C(=O)N[C@H](CCC(O)=O)C(O)=O,449538
2190,DB02315,Cyclic GMP,small molecule,experimental,"Carbohydrates|Glycosides|Guanine Nucleotides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Nucleotides, Cyclic|Purine Nucleotides|Purines|Ribonucleotides",NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(O)(=O)O[C@H]3[C@H]2O)C(=O)N1,24316
2191,DB02316,"1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid",small molecule,experimental,,OC(=O)CCCCCN1C(=CC2=C1C=CC(OCC1=C(Cl)C=CC=C1Cl)=C2)C(O)=O,11113761
2192,DB02317,Alpha-D-Galactose-1-Phosphate,small molecule,experimental,,OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@H]1O,123912
2193,DB02318,2-deoxy-2-fluoro-alpha-D-mannosyl fluoride,small molecule,experimental,,[H][C@]1(O)[C@]([H])(O)[C@@]([H])(CO)OC([H])(F)[C@@]1([H])F,131704200
2194,DB02319,"5,6-dihydroxy-NADP",small molecule,experimental,,[H]N([H])C(=O)C1=CN([C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]3O[C@H]([C@H](OP(O)(O)=O)[C@@H]3O)N3C=NC4=C(N=CN=C34)N([H])[H])[C@@H](O)[C@H]2O)[C@@H](O)[C@@H](O)C1,447659
2195,DB02320,N-beta-D-glucopyranosylacetamide,small molecule,experimental,,[H]N([C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(C)=O,445382
2196,DB02321,"5-(3-Amino-4,4-Dihyroxy-Butylsulfanylmethyl)-Tetrahydro-Furan-2,3,4-Triol",small molecule,experimental,,N[C@@H](CCSC[C@H]1O[C@@H](O)[C@H](O)[C@@H]1O)C(O)=O,440041
2197,DB02322,Heparin Disaccharide I-S,small molecule,experimental,,[H][C@]1(O)O[C@]([H])(COS([O-])(=O)=O)[C@@]([H])(O[C@]2([H])OC(=C[C@]([H])(O)[C@@]2([H])OS([O-])(=O)=O)C([O-])=O)[C@]([H])(O)[C@@]1([H])NS([O-])(=O)=O,5288499
2198,DB02323,EM-1745,small molecule,experimental,"17-Hydroxysteroid Dehydrogenases, antagonists & inhibitors|Estradiol Congeners|Estranes|Estrenes|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids",[H][C@]1(CCCCCCCCC(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])O)C[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]2(C)[C@@]1([H])O,446201
2199,DB02324,5-Iodo-2'-Deoxyuridine-5'-Monophosphate,small molecule,experimental,,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(O)=O)N1C=C(I)C(=O)NC1=O,449489
2200,DB02325,Isopropyl alcohol,small molecule,approved|investigational,"Alcohols|Antiseptics and Disinfectants|Compounds used in a research, industrial, or household setting|Dermatologicals|Miscellaneous Local Anti-infectives|Propanols|Solvents",CC(C)O,3776
2201,DB02326,1-Hydroxyamine-2-Isobutylmalonic Acid,small molecule,experimental,,CC(C)C[C@@H](C(O)=O)C(=O)NO,6323374
2202,DB02327,Triethylene glycol,small molecule,experimental,"Alcohols|Compounds used in a research, industrial, or household setting|Ethylene Glycols|Glycols|Macromolecular Substances|Polymers",OCCOCCOCCO,8172
2203,DB02328,2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Imino]-5-Phosphono-Pent-3-Enoic Acid,small molecule,experimental,,[H]\C(CP(O)(O)=O)=C(\[H])/C(=N\CC1=C(COP(O)(O)=O)C=NC(C)=C1O)/C(O)=O,5288538
2204,DB02329,Carbenoxolone,small molecule,experimental,Alimentary Tract and Metabolism|Anti-Ulcer Agents|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Gastrointestinal Agents|Glycyrrhetinic Acid|Pentacyclic Triterpenes|Terpenes|Triterpenes,[H][C@@]1(CC[C@@]2(C)[C@@]([H])(CC[C@]3(C)[C@]2([H])C(=O)C=C2[C@]4([H])C[C@](C)(CC[C@]4(C)CC[C@@]32C)C(O)=O)C1(C)C)OC(=O)CCC(O)=O,636403
2205,DB02331,"(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid",small molecule,experimental,,[H][C@@](CC1=CC=CC=C1)(N(CC1=CC=C(S1)C1=CC2=CC=CC=C2O1)C(=O)C1=C(Cl)C=C(Cl)C=C1)C(O)=O,447369
2206,DB02332,Flavin-N7 protonated-adenine dinucleotide,small molecule,experimental,,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C([NH3+])N=CN=C13)C1=NC(=O)NC(=O)C1=N2,131704201
2207,DB02333,Deoxyuridine-5'-Triphosphate,small molecule,experimental,,O[C@H]1C[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O,65070
2208,DB02334,(R)-2-Hydroxy-3-Sulfopropanoic Acid,small molecule,experimental,,O[C@@H](CS(O)(=O)=O)C(O)=O,443250
2209,DB02335,2-Aminothiazoline,small molecule,experimental,Sulfur Compounds,NC1=NCCS1,15689
2210,DB02336,RU83876,small molecule,experimental,,CC(=O)N[C@@H](CC1=CC(=C(C=C1)P(O)(O)=O)P(O)(O)=O)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O,447527
2211,DB02337,S-(D-Carboxybutyl)-L-Homocysteine,small molecule,experimental,,N[C@@H](CCSCCCCC(O)=O)C(O)=O,446994
2212,DB02338,NADPH,small molecule,experimental,"Adenine Nucleotides|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](OP(O)(O)=O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O,5884
2213,DB02339,Allyl-{6-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-Hexyl-}-Methyl-Amin,small molecule,experimental,,CN(CCCCCCOC1=CC=C2C(OC=C2C2=CC=C(Br)C=C2)=C1)CC=C,447560
2214,DB02340,N-Acetyl-Serine,small molecule,experimental,,CC(=O)N[C@@H](CO)C(O)=O,65249
2215,DB02341,"Mdl 101,146",small molecule,experimental,"Amino Acids, Peptides, and Proteins|Oxazines|Pancreatic Elastase, antagonists & inhibitors|Peptides",CC(C)[C@@H](NC(=O)C1=CC=C(C=C1)C(=O)N1CCOCC1)C(=O)N1CCC[C@@H]1C(=O)N[C@H](C(C)C)C(=O)C(F)(F)C(F)(F)F,46936357
2216,DB02342,2-Methoxyestradiol,small molecule,investigational,"Antimitotic Agents|Antineoplastic Agents|Estradiol Congeners|Estranes|Estrenes|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Mitosis Modulators|Steroids|Tubulin Modulators",[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C(OC)=C3,16760554
2217,DB02343,"3,6,9,12,15-Pentaoxaheptadecane",small molecule,experimental,,CCOCCOCCOCCOCCOCC,78057
2218,DB02345,Selenocysteine,small molecule,experimental,"Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Cysteine|Organoselenium Compounds|Selenium Compounds|Sulfhydryl Compounds|Sulfur Compounds",N[C@@H](C[SeH])C(O)=O,6326983
2219,DB02346,3'-O-N-Octanoyl-a-D-Glucopyranosyl-B-D-Fructofuranoside,small molecule,experimental,,[H][C@]1(CO)O[C@@](CO)(O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(OC(=O)CCCCCCC)[C@@]2([H])O)[C@@]([H])(O)[C@]1([H])O,448657
2220,DB02347,2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid,small molecule,experimental,"Organophosphorus Compounds|Receptors, AMPA, antagonists & inhibitors",CC(C)(C)C1=C(C[C@H](N)C(O)=O)C(OCP(O)(O)=O)=NO1,447249
2221,DB02348,Monofluorophosphate ion,small molecule,experimental,"Acids|Acids, Noncarboxylic|Anions|Cariostatic Agents|Compounds used in a research, industrial, or household setting|Electrolytes|Fluorine Compounds|Hydrofluoric Acid|Ions|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Protective Agents|Toothpastes",[O-]P([O-])(F)=O,65241
2222,DB02349,Nicotinamide-adenine-dinucleotide-5-hydroxy-4-oxonorvaline,small molecule,experimental,,[H]N([H])[C@@H](CC(=O)[C@@H](O)C1=C(C=[N+](C=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N=CN=C23)N([H])[H])[C@@H](O)[C@H]1O)C(=O)N([H])[H])C(O)=O,5289029
2223,DB02350,"N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide",small molecule,experimental,,[H][C@@]1(N(CCCSC1(C)C)S(=O)(=O)C1=CC=C(OC)C=C1)C(=O)NO,5288814
2224,DB02352,3-(Benzyloxy)Pyridin-2-Amine,small molecule,experimental,,NC1=NC=CC=C1OCC1=CC=CC=C1,90334
2225,DB02353,Heparin Disaccharide Iii-S,small molecule,experimental,,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O[C@]2([H])OC(=C[C@]([H])(O)[C@@]2([H])OS([O-])(=O)=O)C([O-])=O)[C@]([H])(O)[C@@]1([H])NS([O-])(=O)=O,5288504
2226,DB02354,4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine,small molecule,experimental,,CN1C(CNC2=CC=C(C=C2)C(N)=N)=NC2=C1C=CC(CN1C(C)=NC3=C1C=CC=C3)=C2,445756
2227,DB02355,Adenosine-5'-Rp-Alpha-Thio-Triphosphate,small molecule,experimental,,[H][C@]1(CO[P@@](O)(=S)OP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,6858181
2228,DB02356,4-Imidazolmethylene-5-Imidazolone Chromophore,small molecule,experimental,,[H][C@](N)(CO)[C@@]1([H])N=C(CC2=CN=CN2)C(=O)N1CC(O)=O,49867147
2229,DB02357,Methyl-O3-(Alpha-D-Mannose)-Alpha-D-Mannose,small molecule,experimental,,[H][C@]1(O)[C@]([H])(O)[C@@]([H])(CO)O[C@]([H])(O[C@@]2([H])[C@]([H])(O)[C@@]([H])(CO)O[C@]([H])(OC)[C@@]2([H])O)[C@@]1([H])O,3080923
2230,DB02358,LY374571,small molecule,experimental,,[H]N([H])C1=NC(=O)C(N([H])[H])=C(N([H])C(=O)N([H])C2=CC=C(C=C2)C(=O)N([H])[C@@H](CCC(O)=O)C(O)=O)N1[H],445076
2231,DB02359,"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine",small molecule,experimental,,CCCCN1C(CC2=CC(OC)=CC=C2OC)=NC2=C(N)N=CN=C12,448969
2232,DB02360,Bis-Napthyl Beta-Ketophosphonic Acid,small molecule,experimental,,[H][C@](C(=O)C1=CC2=CC=CC=C2C=C1)(C1=CC=CC2=CC=CC=C12)P(O)(O)=O,446833
2233,DB02361,S-Methyl Thiocysteine Group,small molecule,experimental,,[H][C@](N)(CSSC)C(O)=O,3080775
2234,DB02362,Aminobenzoic acid,small molecule,approved|experimental,"4-Aminobenzoic Acid|Acids, Carbocyclic|Aminobenzoates|Benzene Derivatives|Benzoates|Dermatologicals|Emollients and Protectives|para-Aminobenzoates|Protectives Against UV-Radiation|Protectives Against UV-Radiation for Topical Use|Sunscreen Agents|Vitamin B Complex|Vitamins",NC1=CC=C(C=C1)C(O)=O,978
2235,DB02363,2'-Monophosphoadenosine-5'-Diphosphate,small molecule,experimental,,[H][C@]1(COP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O,165230
2236,DB02364,2-Amino-3-(Diethoxy-Phosphoryloxy)-Propionic Acid,small molecule,experimental,,[H][C@](N)(COP(=O)(OCC)OCC)C(O)=O,17754161
2237,DB02365,"1,10-Phenanthroline",small molecule,experimental,"Chelating Agents|Cholinergic Agents|Cholinesterase Inhibitors|Compounds used in a research, industrial, or household setting|Cross-Linking Reagents|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Indicators and Reagents|Intercalating Agents|Iron Chelating Agents|Laboratory Chemicals|Neurotransmitter Agents|Sequestering Agents",C1=CC2=CC=C3C=CC=NC3=C2N=C1,1318
2238,DB02366,CRA_10762,small molecule,experimental,,NC(=N)C1=CC2=C(NC(=N2)C2=CC=CC(C3=CC=CC=C3)=C2O)C=C1Cl,6102594
2239,DB02367,(1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine,small molecule,experimental,,CCCCOC1=CC=C(C=C1)S(=O)(=O)N1C[C@H](C[C@@H]1C(=O)NO)NS(C)(=O)=O,5287415
2240,DB02368,N-Acetyl-L-Citrulline,small molecule,experimental,,CC(=O)N[C@@H](CCCNC(N)=O)C(O)=O,656979
2241,DB02369,"3-Aza-2,3-Dihydrogeranyl Diphosphate",small molecule,experimental,Phosphate salts,CN(CCO[P@]([O-])(=O)OP([O-])([O-])=O)CCC=C(C)C,4469807
2242,DB02370,Nz-(1-Carboxyethyl)-Lysine,small molecule,experimental,,C[C@@H](NCCCC[C@H](N)C(O)=O)C(O)=O,17754073
2243,DB02371,"2-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Ethanesulfonic Acid",small molecule,experimental,,OCC(CO)(CO)NCCS(O)(=O)=O,81831
2244,DB02372,"2,5-Dimethylpyrimidin-4-Amine",small molecule,experimental,,CC1=CN=C(C)N=C1N,445779
2245,DB02373,Adenosine monotungstate,small molecule,experimental,,[H]N([H])C1=NC=NC2=C1N=CN2[C@]1([H])O[C@@]([H])(CO[W](O)(O)=O)[C@]([H])(O)[C@@]1([H])O,46936368
2246,DB02374,Xylose-Derived Imidazole,small molecule,experimental,,[H][C@@]1(O)CN2C=CN=C2[C@]([H])(O)[C@@]1([H])O,445615
2247,DB02375,Myricetin,small molecule,experimental,"Benzopyrans|Chromones|Heterocyclic Compounds, Fused-Ring|Pyrans",OC1=CC(O)=C2C(OC(=C(O)C2=O)C2=CC(O)=C(O)C(O)=C2)=C1,5281672
2248,DB02376,"D-gluconhydroximo-1,5-lactam",small molecule,experimental,,[H][C@]1(O)C(NO)=N[C@]([H])(CO)[C@@]([H])(O)[C@]1([H])O,445248
2249,DB02377,Guanine,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Purines|Purinones|Xanthine derivatives",NC1=NC(=O)C2=C(N1)N=CN2,764
2250,DB02378,MMI-175,small molecule,experimental,,CC(C)C[C@H](NC(=O)[C@@H]1CC(=O)NCCCCCCOC(=O)N[C@@H](C(C)C)C(=O)N1)[C@@H](O)C[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC1=CC=CC=C1,449218
2251,DB02379,Beta-D-Glucose,small molecule,experimental,,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,64689
2252,DB02380,Deoxyinosine,small molecule,experimental,"Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides",OC[C@H]1O[C@H](C[C@@H]1O)N1C=NC2=C1N=CNC2=O,65058
2253,DB02381,nor-NOHA,small molecule,investigational,,N[C@@H](CCNC(=N)NO)C(O)=O,446124
2254,DB02382,Namn,small molecule,experimental,,[H][C@]1(COP(O)([O-])=O)O[C@@]([H])([N+]2=CC=CC(=C2)C(O)=O)[C@]([H])(O)[C@]1([H])O,5288991
2255,DB02383,Tolrestat,small molecule,withdrawn,"Aldehyde Reductase, antagonists & inhibitors|Aldose Reductase Inhibitors|Alimentary Tract and Metabolism|Drugs Used in Diabetes|Enzyme Inhibitors",COC1=C(C2=CC=CC(C(=S)N(C)CC(O)=O)=C2C=C1)C(F)(F)F,53359
2256,DB02384,(E)-2-Fluoro-P-Hydroxycinnamate,small molecule,experimental,,[H]\C(=C(/F)C(O)=O)C1=CC=C([O-])C=C1,54708743
2257,DB02385,D-threo-neopterin,small molecule,experimental,"Biological Factors|Coenzymes|Enzymes and Coenzymes|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Pteridines|Pterins",NC1=NC2=NC=C(N=C2C(=O)N1)[C@@H](O)[C@H](O)CO,444632
2258,DB02386,Leucine Phosphonic Acid,small molecule,experimental,"Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Organophosphorus Compounds",CC(C)C[C@H](N)P(O)(O)=O,445715
2259,DB02388,"Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",small molecule,experimental,,CCCN1C(=NC(=C1C1=CC=NC(NC2CCCCC2)=N1)C1=CC=C(Cl)C(Cl)=C1)C1CCNCC1,447873
2260,DB02390,5-Bromo-N[2-(Dimethylamino)Ethyl]-9-Aminoacridine-4-Carboxamide,small molecule,experimental,,C[NH+](C)CCNC(=O)C1=CC=CC2=C(N)C3=C([NH+]=C12)C(Br)=CC=C3,447088
2261,DB02391,"2-Amino-7-[2-(2-Hydroxy-1-Hydroxymethyl-Ethylamino)-Ethyl]-1,7-Dihydro-Purin-6-One",small molecule,experimental,,NC1=NC2=C(N(CCNC(CO)CO)C=N2)C(=O)N1,445732
2262,DB02393,"D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate",small molecule,experimental,,[H][C@]1(O)[C@]([H])(O)[C@]([H])(CP(O)(O)=O)O[C@]1([H])COP(O)(O)=O,444761
2263,DB02394,Oxiranpseudoglucose,small molecule,experimental,,[H][C@@]12C[C@]([H])(O)[C@@]([H])(O)[C@]([H])(O)[C@]1(CO)O2,5289076
2264,DB02395,"3-Hydroxymethyl-5-Aziridinyl-1methyl-2-[1h-Indole-4,7-Dione]-Propanol",small molecule,experimental,,CN1C(CCCO)=C(CO)C2=C1C(=O)C=C(N1CC1)C2=O,1667
2265,DB02396,Methylethylamine,small molecule,experimental,,CCNC,12219
2266,DB02397,O-(N-acetyl-alpha-D-galactosaminyl)-L-serine,small molecule,experimental,"Antigens|Antigens, Neoplasm|Biological Factors|Biomarkers|Biomarkers, Tumor|Epitopes",CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@H](N)C(O)=O,447272
2267,DB02398,6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine,small molecule,experimental,,NCC1=CC=C(NC(=O)C2=CC=C3C=C(C=CC3=C2)C(N)=N)C=C1,447733
2268,DB02399,L-Rhamnitol,small molecule,experimental,,C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)CO,445052
2269,DB02400,ES-936,small molecule,experimental,,COC1=CC(=O)C2=C(C(COC3=CC=C(C=C3)[N+]([O-])=O)=C(C)N2C)C1=O,4470790
2270,DB02401,"4-Hydroxy-1,2,5-oxadiazole-3-carboxylic acid",small molecule,experimental,Oxazoles,OC(=O)C1=NON=C1O,448650
2271,DB02402,"5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine",small molecule,experimental,,COC1=CC=C(OC2=CC=CC3=NC(N)=NC(N)=C23)C=C1,447098
2272,DB02403,2-Fluoroaniline,small molecule,experimental,Amines,NC1=CC=CC=C1F,9584
2273,DB02404,1-Deoxy-1-Thio-Heptaethylene Glycol,small molecule,experimental,,OCCOCCOCCOCCOCCOCCOCCS,446506
2274,DB02405,12-Bromododecanoic Acid,small molecule,experimental,Fatty Acids|Lipids,OC(=O)CCCCCCCCCCCBr,175468
2275,DB02406,N-Valeric Acid,small molecule,experimental,,CCCCC(O)=O,7991
2276,DB02407,6-O-Cyclohexylmethyl Guanine,small molecule,experimental,,NC1=NC(OCC2CCCCC2)=C2N=CNC2=N1,4564
2277,DB02408,"(3s)-3-Amino-1-(Cyclopropylamino)Heptane-2,2-Diol",small molecule,experimental,,[H][C@](N)(CCCC)C(O)(O)CNC1CC1,448219
2278,DB02409,"(1r,4s)-2-Azabornane",small molecule,experimental,,[H][C@@]12CC[C@@](C)(NC1)C2(C)C,447260
2279,DB02410,"2-Acetyl-3-[(4-Amino-2-Methyl-5-Pyrimidinyl)Methyl]-4-Methyl-5-(4,6,6-Trihydroxy-3,5-Dioxa-4,6-Diphosphahex-1-Yl)Thiazolium Inner Salt P,P'-Dioxide",small molecule,experimental,,CC(=O)C1=[N+](CC2=CN=C(C)N=C2N)C(C)=C(CCOP(O)(=O)OP(O)(O)=O)S1,4369479
2280,DB02411,"2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2",small molecule,experimental,,CC(C)CCN(C[C@@H](O)[C@@H]1CC2=CC=C(OCCCC(=O)N[C@@H](CC(N)=O)C(=O)N1)C=C2)S(=O)(=O)C1=CC=CC=C1,466959
2281,DB02412,Tetrahydropyran,small molecule,experimental,,C1CCOCC1,8894
2282,DB02413,Hydroxyethylcysteine,small molecule,experimental,,N[C@@H](CSCCO)C(O)=O,119224
2283,DB02414,Cyclo(his-pro),small molecule,experimental,"Amino Acids, Peptides, and Proteins|Antioxidants|Compounds used in a research, industrial, or household setting|Membrane Transport Modulators|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Peptides|Protective Agents",[H][C@@]12CCCN1C(=O)[C@H](CC1=CN=CN1)NC2=O,449094
2284,DB02415,N-Octyl-2-Hydroxyethyl Sulfoxide,small molecule,experimental,,CCCCCCCC[S@@](=O)CCO,9543425
2285,DB02416,"2-Ribofuranosyl-3-Iodo-2,3-Dihydro-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",small molecule,experimental,,[H][C@]1(I)NN(C2=NC=NC(N)=C12)[C@]1([H])O[C@]([H])(CO)[C@@]([H])(O)[C@@]1([H])O,17754151
2286,DB02417,"2,4,6-Tribromophenol",small molecule,experimental,Benzene Derivatives,OC1=C(Br)C=C(Br)C=C1Br,1483
2287,DB02418,"(R,R)-2,3-Butanediol",small molecule,experimental,,C[C@@H](O)[C@H](C)O,220010
2288,DB02419,Ethyl Oxo(Piperidin-1-Yl)Acetate,small molecule,experimental,,CCOC(=O)C(=O)N1CCCCC1,104406
2289,DB02420,"[[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid,",small molecule,experimental,,NCC1=CC=C(NC(=O)C(O)=O)C=C1,449125
2290,DB02421,Uridine-5'-diphosphate-mannose,small molecule,experimental,,[H]N1C(=O)C=CN([C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)C1=O,448873
2291,DB02422,Methyl-2-S-(Alpha-D-Mannopyranosyl)-2-Thio-Alpha-D-Mannopyranoside,small molecule,experimental,,[H][C@]1(CO)O[C@]([H])(OC)[C@@]([H])(S[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@]2([H])O)[C@@]([H])(O)[C@]1([H])O,656957
2292,DB02423,Thiopyrophosphate,small molecule,experimental,"Acids|Acids, Noncarboxylic|Anions|Electrolytes|Ions|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Polyphosphates",OP(O)(=O)OP(O)([O-])=S,5289158
2293,DB02424,Geldanamycin,small molecule,experimental|investigational,"Amides|Anti-Infective Agents|Antibiotics, Antineoplastic|Antineoplastic Agents|Cysteine Proteinase Inhibitors|Enzyme Inhibitors|HSP90 Heat-Shock Proteins|Lactams|Protease Inhibitors|Quinones|Tyrosine Kinase Inhibitors",CO[C@H]1C[C@H](C)CC2=C(OC)C(=O)C=C(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O,5288382
2294,DB02425,Hexadecyl Octanoate,small molecule,experimental,,CCCCCCCCCCCCCCCOC(=O)CCCCCCC,589196
2295,DB02426,Carboxyatractyloside,small molecule,experimental,Carbohydrates|Diterpenes|Glycosides|Terpenes,CC(C)CC(=O)O[C@H]1[C@@H](O[C@@H]2C[C@]3(C)[C@H]4CC[C@@H]5C[C@@]4(CC[C@H]3C(C2)(C(O)=O)C(O)=O)[C@@H](O)C5=C)O[C@@H](COO)[C@H](OS(O)(=O)=O)[C@@H]1OS(O)(=O)=O,46936378
2296,DB02427,"2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline",small molecule,experimental,,COC1=CC(CN(C)C2=CC=C3N=C(N)N=C(N)C3=C2)=C(OC)C=C1,447021
2297,DB02428,Quinaldic Acid,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring",OC(=O)C1=NC2=C(C=CC=C2)C=C1,7124
2298,DB02429,4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide,small molecule,experimental,,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=CC=C(F)C=C1,446237
2299,DB02430,Trehalose-6-Phosphate,small molecule,experimental,"Biopolymers|Carbohydrates|Compounds used in a research, industrial, or household setting|Disaccharides|Enzyme Inhibitors|Glucans|Hexokinase, antagonists & inhibitors|Macromolecular Substances|Oligosaccharides|Polymers|Polysaccharides",OC[C@H]1O[C@H](O[C@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,122336
2300,DB02431,Cytidine-5'-Triphosphate,small molecule,experimental,,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O,6176
2301,DB02432,RU90395,small molecule,experimental,,COC(=O)C1=C(C=CC(C[C@H](NC(C)=O)C(=O)N[C@H]2CCCCN(CC3=CC=C(C=C3)C3=CC=CC=C3)C2=O)=C1)C(F)(C(O)=O)C(O)=O,447522
2302,DB02433,"{[(2,2-Dihydroxy-Ethyl)-(2,3,4,5-Tetrahydroxy-6-Phosphonooxy-Hexyl)-Amino]-Methyl}-Phosphonic Acid",small molecule,experimental,,[H][C@@](O)(COP(O)(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)CN(CC(O)O)CP(O)(O)=O,5289106
2303,DB02434,4-(2-Thienyl)Butyric Acid,small molecule,experimental,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids|Sulfur Compounds",OC(=O)CCCC1=CC=CS1,78386
2304,DB02435,Aminomethylcyclohexane,small molecule,experimental,,[NH3+]CC1CCCCC1,448748
2305,DB02436,{4-[(2S)-2-({[(1S)-1-Carboxy-2-phenylethyl]carbamoyl}amino)-3-oxo-3-(pentylamino)propyl]phenoxy}malonic acid,small molecule,experimental,,CCCCCNC(=O)[C@H](CC1=CC=C(OC(C(O)=O)C(O)=O)C=C1)NC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O,445784
2306,DB02437,(5r)-5-Amino-6-Hydroxyhexylcarbamic Acid,small molecule,experimental,,N[C@H](CO)CCCCNC(O)=O,17754062
2307,DB02438,3-O-Methylfructose in Linear Form,small molecule,experimental,,[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(OC)C(=O)CO,449225
2308,DB02441,"2-Butyl-5,6-Dihydro-1h-Imidazo[4,5-D]Pyridazine-4,7-Dione",small molecule,experimental,,CCCCC1=NC2=C(N1)C(=O)NNC2=O,3465283
2309,DB02442,Dioxyselenocysteine,small molecule,experimental,Selenium Compounds,[H][C@](N)(C[SeH](=O)=O)C(O)=O,17754171
2310,DB02443,Methicillin Acyl-Serine,small molecule,experimental,,[H][C@](N)(COC(=O)[C@@]([H])(N=C([O-])C1=C(OC)C=CC=C1OC)[C@]1([H])N[C@@]([H])(C(O)=O)C(C)(C)S1)C([O-])=O,131704202
2311,DB02445,2-Deoxy-2-Amino Glucitol-6-Phosphate,small molecule,experimental,,[H][C@](N)(CO)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)COP(O)(O)=O,446113
2312,DB02446,Glutamine hydroxamate,small molecule,experimental,"Amines|Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Aspartate Aminotransferases, antagonists & inhibitors|Hydroxy Acids|Hydroxylamines",N[C@@H](CCC(=O)NO)C(O)=O,449178
2313,DB02447,"3,8,9,10-tetrahydroxy-7-hydroxymethyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-dione",small molecule,experimental,,[H]N1C(=O)N(O)C(=O)[C@]11O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,445718
2314,DB02448,N-Tridecanoic Acid,small molecule,experimental,,CCCCCCCCCCCCC(O)=O,12530
2315,DB02449,3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid,small molecule,experimental,,[H][C@@](CC1=CNC2=CC=CC=C12)(NS(=O)(=O)C1=CC=C(C=C1)N1CCC(CC1)C1=CC=CC=C1)C(O)=O,444789
2316,DB02450,"2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid",small molecule,experimental,,[H][C@@](CC1=CC=CC=C1)(C(O)=O)[C@]([H])(CC1=CC2=C(OCO2)C=C1)C(O)=O,5496627
2317,DB02451,B-nonylglucoside,small molecule,experimental,,CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,155448
2318,DB02452,Thymidine 5'-triphosphate,small molecule,experimental,"Carbohydrates|Deoxyribonucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines",CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O2)C(=O)NC1=O,64968
2319,DB02453,Antimonous acid,small molecule,experimental,,[H]O[Sb](O[H])O[H],6338574
2320,DB02454,5-(6-Amino-9h-Purin-9-Yl)-4-Hydroxytetrahydrofuran-3-Yl Dihydrogen Phosphate,small molecule,experimental,,[H][C@@]1(CO[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]1([H])O)OP(O)(O)=O,17753975
2321,DB02455,Fluoresceinylthioureido,small molecule,experimental,,[H]N(CC)C(=S)N([H])C1=CC=C(C(=C1)C(O)=O)C1=C2C=CC(=O)C=C2OC2=C1C=CC(O)=C2,49866988
2322,DB02456,Aracytidine 5'-monophosphate,small molecule,experimental,,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O,65177
2323,DB02457,Undecyl-Phosphinic Acid Butyl Ester,small molecule,experimental,,[H][P@@](=O)(CCCCCCCCCCC)OCCCC,46936391
2324,DB02458,"S-(2,4-dinitrophenyl)glutathione",small molecule,experimental,"Amino Acids, Peptides, and Proteins|Haptens|Oligopeptides|Peptides",[H][C@](N)(CCC(=O)N[C@@]([H])(CSC1=C(C=C(C=C1)N(=O)=O)N(=O)=O)C(=O)NCC(O)=O)C(O)=O,97535
2325,DB02459,4-guanidinobenzoic acid,small molecule,experimental,"Acids, Carbocyclic|Amidines|Benzene Derivatives",NC(=N)NC1=CC=C(C=C1)C(O)=O,159772
2326,DB02460,Hydrogenobyrinic acid,small molecule,experimental,"Biological Factors|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Porphyrins",[H][C@]12N=C(\C(C)=C3/N=C(/C=C4\N=C(\C(\C)=C5/N[C@]1(C)[C@@](C)(CC(O)=O)[C@@H]5CCC(O)=O)[C@@](C)(CC(O)=O)[C@@H]4CCC(O)=O)C(C)(C)[C@@H]3CCC(O)=O)[C@](C)(CCC(O)=O)[C@H]2CC(O)=O,10396076
2327,DB02461,S-Methyl Phosphocysteine,small molecule,experimental,,N[C@@H](CSCP(O)(O)=O)C(O)=O,192579
2328,DB02462,Thiocoumarin,small molecule,experimental,,CN(C)CCCOC1=CC(=O)SC2=CC=CC=C12,657073
2329,DB02463,2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine,small molecule,experimental,,NC(=[NH2+])C1=CC2=C(NC(=C2)C2=CC=CC=C2O)C=C1,1507
2330,DB02464,Benzylamine,small molecule,experimental,Amines|Benzene Derivatives|Benzyl Compounds,NCC1=CC=CC=C1,7504
2331,DB02465,Methoxy arachidonyl fluorophosphonate,small molecule,experimental,"Autacoids|Biological Factors|Eicosanoids|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Essential|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Organophosphorus Compounds|Phospholipases A, antagonists & inhibitors",[H]\C(CCCCC)=C(/[H])C\C([H])=C(\[H])C\C([H])=C(\[H])C\C([H])=C(\[H])CCCC[P@](F)(=O)OC,92536013
2332,DB02466,BMS-181156,small molecule,experimental,,CC1(C)CCC(C)(C)C2=CC(=CC=C12)C(=O)\C=C\C1=CC=C(C=C1)C(O)=O,445576
2333,DB02467,L-methionine (S)-S-oxide,small molecule,experimental,,[H]C([H])([H])[S@](=O)C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],10909908
2334,DB02468,12-Phenylheme,small molecule,experimental,,CC1C(C=C)C2=CC3=C(C)C(CCC(O)=O)=C4C=C5N6C(=CC7=C(C)C(C=C)=C8N7[Fe++]6(N34)N2C1=C8C1=CC=CC=C1)C(C)=C5CCC(O)=O,131704203
2335,DB02469,"4,6-dideoxy-4-amino-beta-D-glucopyranoside",small molecule,experimental,,[H][C@]1(C)O[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])N,447845
2336,DB02470,D-Glycero-D-Mannopyranose-7-Phosphate,small molecule,experimental,,[H][C@@](O)(COP(O)(O)=O)[C@@]1([H])O[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(O)[C@]1([H])O,449154
2337,DB02471,Nojirimycine Tetrazole,small molecule,experimental,,[H][C@]1(O)C2=NN=NN2[C@]([H])(CO)[C@@]([H])(O)[C@]1([H])O,445245
2338,DB02472,"7,8-dihydroinosine",small molecule,experimental,,[H]N1CN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C2=C1C(=O)N=CN2[H],6323375
2339,DB02473,"6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",small molecule,experimental,,CC(C)C1=NCCC2=C1C=C(NC(=O)C1=CC=C3C=C(C=CC3=C1)C(N)=N)C=C2,447735
2340,DB02474,BMSC-0013,small molecule,experimental,,[H]N(CCCCCC(=O)N([H])[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)C(=O)OC,447137
2341,DB02475,Deoxyamidinoproclavaminic acid,small molecule,experimental,,NC(=N)NCCC[C@H](N1CCC1=O)C(O)=O,441123
2342,DB02477,N-({4-[4-(2-Methyl-1H-imidazol-1-yl)butyl]phenyl}acetyl)-L-seryl-N-(2-cyclohexylethyl)-L-lysinamide,small molecule,experimental,,CC1=NC=CN1CCCCC1=CC=C(CC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCCC2CCCCC2)C=C1,446385
2343,DB02479,(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,small molecule,experimental,,[H]N([H])S(=O)(=O)C1=CC=C(C=C1)C(=O)N([H])C[C@@H](C)CN1C=CC2=CC=CC=C12,446276
2344,DB02480,(S)-4-bromo-3-hydroxy-3-methylbutyl diphosphate,small molecule,experimental,,C[C@@](O)(CBr)CCOP(O)(=O)OP(O)(O)=O,17754158
2345,DB02481,N-Benzylformamide,small molecule,experimental,"Acids, Acyclic|Amides|Formates",O=CNCC1=CC=CC=C1,80654
2346,DB02482,Phosphonothreonine,small molecule,experimental,,C[C@H](OP(O)(O)=O)[C@@H](N)C(O)=O,10976469
2347,DB02483,Etheno-NAD,small molecule,experimental,,[H]N([H])C(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2N=CN2C=CN=C32)[C@@H](O)[C@H]1O,131675359
2348,DB02484,Cytidine 5'-diphosphoglycerol,small molecule,experimental,,[H]N([H])C1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@@H](O)CO)[C@@H](O)[C@H]1O,447253
2349,DB02485,Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid,small molecule,experimental,,[H][C@]1(O[C@](C[C@H](O)[C@H]1NC(C)=O)(OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(N)=NC1=O)C(O)=O)[C@H](O)[C@H](O)CO,448209
2350,DB02486,2-Hydroxyethyl Disulfide,small molecule,experimental,"Acids|Acids, Noncarboxylic|Alcohols|Anions|Electrolytes|Gases|Hydrogen Sulfide|Ions|Sulfides|Sulfur Compounds",OCCSSCCO,15906
2351,DB02488,1-(2-Ethanone)-2-Hydroxy-2-(1-Amino-2-Methyl-2-Ethanol)-4-(2-Dimethyl)Ethane-Imidazoline-5-One;Chromophore (Thr-Leu-Gly),small molecule,experimental,,[H][C@](C)(O)[C@]([H])(N)[C@@]1(O)N=C(CC(C)C)C(=O)N1CC=O,17753917
2352,DB02489,9-Methylguanine,small molecule,experimental,"Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Purines|Purinones|Xanthine derivatives",CN1C=NC2=C1N=C(N)NC2=O,79639
2353,DB02490,(Diaminomethyl-Methyl-Amino)-Acetic Acid,small molecule,experimental,,CN(CC(O)=O)C(N)N,4635864
2354,DB02491,4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine,small molecule,experimental,,CC(C)(N)C1=CC=C(C=C1)C1=NC(NC2=CC=C(CCN3CCOCC3)C=C2)=NC=C1Cl,447622
2355,DB02492,Ghavamiol,small molecule,experimental,"Alcohols|Amines|Ammonium Compounds|Carbohydrates|Glycoside Hydrolases, antagonists & inhibitors|Imines|Imino Sugars|Monosaccharides|Nitrogen Compounds|Onium Compounds|Pentoses|Pyrrolidines|Sugar Alcohols",[H][C@@](O)(CN1C[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])CO)C([H])(CO)OS([O-])([O-])[O-],131704205
2356,DB02493,Hydantocidin-5'-phosphate,small molecule,experimental,,[H]N1C(=O)N([H])[C@@]2(O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C1=O,446561
2357,DB02494,(S)-3-phenyllactic acid,small molecule,experimental,,O[C@@H](CC1=CC=CC=C1)C(O)=O,444718
2358,DB02495,9-(4-hydroxybutyl)-N2-phenylguanine,small molecule,experimental,,OCCCCN1C=NC2=C1N=C(NC1=CC=CC=C1)NC2=O,448110
2359,DB02496,1-Deoxy-D-xylulose 5-phosphate,small molecule,experimental,Carbohydrates|Sugar Phosphates,CC(=O)[C@@H](O)[C@H](O)COP(O)(O)=O,443201
2360,DB02497,L-Alpha-Glycerophosphorylserine,small molecule,experimental,,[H][C@@](O)(CO)COP(O)(=O)OC[C@]([H])(N)C(O)=O,444182
2361,DB02498,Carba-nicotinamide-adenine-dinucleotide,small molecule,experimental,,[H]N([H])C(=O)C1=C[N+](=CC=C1)[C@@H]1C[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N=CN=C23)N([H])[H])[C@@H](O)[C@H]1O,163884
2362,DB02499,Dinor-N(Omega)-Hydroxy-L-Arginine,small molecule,experimental,,N[C@@H](C\N=C(/N)NO)C(O)=O,657087
2363,DB02500,6-(Dihydroxy-Isobutyl)-Thymine,small molecule,experimental,,CC1=C(CC(CO)CO)NC(=O)NC1=O,1855
2364,DB02501,N(2)-succinyl-L-arginine,small molecule,experimental,,NC(=N)NCCC[C@H](NC(=O)CCC(O)=O)C(O)=O,439968
2365,DB02502,8-hydroxy-2'-deoxyguanosine,small molecule,experimental,"Adjuvants, Immunologic|Carbohydrates|Deoxyribonucleosides|Glycosides|Heterocyclic Compounds, Fused-Ring|Immunologic Factors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides",NC1=NC2=C(N=C(O)N2[C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)N1,73318
2366,DB02503,4-(Carboxyvin-2-Yl)Phenylboronic Acid,small molecule,experimental,,OB(O)C1=CC=C(\C=C\C(O)=O)C=C1,5288001
2367,DB02504,[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid,small molecule,experimental,,CC1=C(CC(N)=O)C2=C(C=CC(OCCCP(O)(O)=O)=C2)N1CC1=CC=CC=C1,3711
2368,DB02505,N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl),small molecule,experimental,,CCCCCC1=CC=C(C=C1)C(=O)N(CC1=CC=C(C=C1)C1=CC=C(CC(=O)OC)C=C1)C1CCN(CC2=NC=CN2)CC1,657149
2369,DB02506,"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",small molecule,experimental,,[H][C@@](C)(CC[C@]([H])(N)[C@]([H])(C)C(O)=O)C[C@]([H])(C)[C@]([H])(CC1=CC=CC=C1)OC,17753820
2370,DB02508,Isopentyl Pyrophosphate,small molecule,experimental,,CC(C)CCO[P@](O)(=O)OP(O)(O)=O,448400
2371,DB02509,Farnesol,small molecule,experimental,Alcohols|Fatty Alcohols|Lipids|Sesquiterpenes|Terpenes,CC(C)=CCC\C(C)=C/CC\C(C)=C/CO,1549107
2372,DB02510,5'-O-(L-Prolylsulfamoyl)adenosine,small molecule,experimental,,[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COS(=O)(=O)N([H])C(=O)[C@@H]4CCCN4[H])[C@@H](O)[C@H]3O)C2=NC=N1,447378
2373,DB02511,2-Hydroxy-5-({1-[(2-Naphthyloxy)Methyl]-3-Oxoprop-1-Enyl}Amino)Tyrosine,small molecule,experimental,,[H][C@](N)(CC1=C(O)C=C(O)C(N\C(COC2=CC=C3C=CC=CC3=C2)=C\C=O)=C1)C(O)=O,17754104
2374,DB02512,"1,6-Fructose Diphosphate (Linear Form)",small molecule,experimental,,O[C@H](COP(O)(O)=O)[C@H](O)[C@H](O)C(=O)COP(O)(O)=O,189150
2375,DB02513,Thymol,small molecule,approved,"Anti-Infective Agents|Anti-Infective Agents, Local|Antifungal Agents|Benzene Derivatives|Monoterpenes|Terpenes",CC(C)C1=CC=C(C)C=C1O,6989
2376,DB02514,(2Z)-3-{[Oxido(oxo)phosphoranyl]oxy}-2-phenylacrylate,small molecule,experimental,,[O-]C(=O)C(=C/OP(=O)=O)\C1=CC=CC=C1,16133778
2377,DB02515,sn-glycerol 3-phosphate,small molecule,experimental,,OC[C@@H](O)COP(O)(O)=O,439162
2378,DB02516,(R)-carnitinyl-CoA betaine,small molecule,experimental,,CC(C)(COP([O-])(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C[C@@H](O)C[N+](C)(C)C,5287894
2379,DB02517,D-Glutamic Acid,small molecule,experimental,,N[C@H](CCC(O)=O)C(O)=O,23327
2380,DB02518,N-Acetylalanine,small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins",C[C@H](NC(C)=O)C(O)=O,88064
2381,DB02519,Indirubin-5-sulphonate,small molecule,experimental,,[H]N1C(=O)\C(C2=C1C=CC(=C2)S(O)(=O)=O)=C1/N([H])C2=CC=CC=C2C1=O,5288641
2382,DB02520,Ditiocarb,small molecule,experimental,"Acids, Acyclic|Adjuvants, Immunologic|Anti-Infective Agents|Carbamates|Chelating Agents|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Immunologic Factors|Sequestering Agents|Sulfur Compounds|Thiocarbamates",CCN(CC)C(S)=S,8987
2383,DB02521,Flaviolin,small molecule,experimental,Naphthalenes|Quinones,OC1=CC2=C(C(O)=C1)C(=O)C=C(O)C2=O,160478
2384,DB02522,Phosphonopyruvate,small molecule,experimental,,OC(=O)C(=O)CP(O)(O)=O,439811
2385,DB02523,"2-aminooxyethyl-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl]-methyl-sulfonium",small molecule,experimental,,[H][C@@]1(C[S+](C)CCON)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,49866595
2386,DB02524,"2',3'-O-{4-[Hydroxy(oxido)-λ5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)",small molecule,experimental,,[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@]4([H])OC5(O[C@@]34[H])C(=CC(C=C5[N+]([O-])=O)=[N+](O)[O-])[N+]([O-])=O)C2=NC=N1,644358
2387,DB02525,"D-galactohydroximo-1,5-lactam",small molecule,experimental,,[H][C@]1(O)C(NO)=N[C@]([H])(CO)[C@]([H])(O)[C@]1([H])O,448963
2388,DB02526,CRA_10655,small molecule,experimental,,NC(=[NH2+])C1=CC=C2NC(=NC2=C1)C1=CC=CC(OC2CCCC2)=C1[O-],6119062
2389,DB02527,Cyclic adenosine monophosphate,small molecule,experimental,"Adenine Nucleotides|Carbohydrates|Cyclic AMP|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Nucleotides, Cyclic|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Substrates|Purine Nucleotides|Purines|Ribonucleotides",NC1=C2N=CN([C@@H]3O[C@@H]4COP(O)(=O)O[C@H]4[C@H]3O)C2=NC=N1,6076
2390,DB02528,Tetrazolyl Histidine,small molecule,experimental,,[H][C@](N)(CC1=CN(C=N1)C1=NNN=N1)C=O,17754111
2391,DB02529,"(2R,4S,5R,6R)-5-Acetamido-4-amino-6-(diethylcarbamoyl)oxane-2-carboxylic acid",small molecule,experimental,,CCN(CC)C(=O)[C@@H]1O[C@H](C[C@H](N)[C@H]1NC(C)=O)C(O)=O,17753990
2392,DB02530,gamma-Aminobutyric acid,small molecule,approved|investigational,"Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Aminobutyrates|Butyrates|Fatty Acids|Fatty Acids, Volatile|GABA Agents|Lipids|Neurotransmitter Agents",NCCCC(O)=O,119
2393,DB02531,Isobutyric acid,small molecule,experimental,"Acids, Acyclic|Butyrates|Fatty Acids|Fatty Acids, Volatile|Lipids",CC(C)C(O)=O,6590
2394,DB02532,"2,4,6-Triaminoquinazoline",small molecule,experimental,,NC1=CC=C2N=C(N)N=C(N)C2=C1,292661
2395,DB02534,2-Allylphenol,small molecule,experimental,Benzene Derivatives,OC1=CC=CC=C1CC=C,15624
2396,DB02535,Aminodi(Ethyloxy)Ethylaminocarbonylbenzenesulfonamide,small molecule,experimental,,NCCOCCOCCNC(=O)C1=CC=C(C=C1)S(N)(=O)=O,2144
2397,DB02536,D-glyceraldehyde,small molecule,experimental,,OC[C@@H](O)C=O,79014
2398,DB02537,2-Hydroxy-5-({1-[(4-Methylphenoxy)Methyl]-3-Oxoprop-1-Enyl}Amino)-L-Tyrosine,small molecule,experimental,,[H]\C(C=O)=C(\COC1=CC=C(C)C=C1)NC1=C(O)C=C(O)C(C[C@]([H])(N)C(O)=O)=C1,52941757
2399,DB02538,"N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide",small molecule,experimental,,CC(=O)NC1=NC(=CC=N1)C1=C(C)N=C2C=CC=CN12,447652
2400,DB02540,"10-formyl-5,8,10-trideazafolic acid",small molecule,experimental,,[H]N([H])C1=NC(=O)C2=C(C=CC(C[C@H](C(O)=O)C3=CC=C(C=C3)C(=O)N([H])[C@@H](CCC(O)=O)C(O)=O)=C2)N1[H],444725
2401,DB02541,4-Hydroxybutan-1-Aminium,small molecule,experimental,,[NH3+]CCCCO,448524
2402,DB02542,(4s)-5-Fluoro-L-Leucine,small molecule,experimental,,C[C@H](CF)C[C@H](N)C(O)=O,15227560
2403,DB02543,Pyrrole-2-Carboxylate,small molecule,experimental,"Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Imines|Imino Acids",OC(=O)C1=CC=CN1,12473
2404,DB02544,"N-(6-{[3-(4-Bromophenyl)-1,2-Benzisothiazol-6-Yl]Oxy}Hexyl)-N-Methylprop-2-En-1-Amine",small molecule,experimental,,CN(CCCCCCOC1=CC=C2C(SN=C2C2=CC=C(Br)C=C2)=C1)CC=C,445992
2405,DB02545,Fexaramine,small molecule,experimental,,COC(=O)\C=C\C1=CC(=CC=C1)N(CC1=CC=C(C=C1)C1=CC=C(C=C1)N(C)C)C(=O)C1CCCCC1,5326713
2406,DB02546,Vorinostat,small molecule,approved|investigational,Amides|Amines|Anilides|Aniline Compounds|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Enzyme Inhibitors|Histone Deacetylase Inhibitors|Hydroxamic Acids|Hydroxy Acids|Hydroxylamines|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Potential QTc-Prolonging Agents|QTc Prolonging Agents,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1,5311
2407,DB02547,Guanosine-5'-Diphosphate-Rhamnose,small molecule,experimental,,C[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2NC(N)=NC3=O)[C@@H](O)[C@@H](O)[C@@H]1O,439912
2408,DB02548,D-glucitol 6-phosphate,small molecule,experimental,Carbohydrates|Sugar Phosphates,OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)COP(O)(O)=O,152306
2409,DB02549,3'-O-Acetylthymidine-5'-diphosphate,small molecule,experimental,,[H]N1C(=O)N(C=C(C)C1=O)[C@H]1C[C@H](OC(C)=O)[C@@H](COP(O)(=O)OP(O)(O)=O)O1,445182
2410,DB02550,"8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine",small molecule,experimental,,COC1=C(OC)C(OC)=C(Cl)C(CC2=NC3=C(N)N=C(F)N=C3N2CCCC#C)=C1,448972
2411,DB02551,"6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",small molecule,experimental,,[H][C@]1(CC)CNCC2=C1C=C(NC(=O)C1=CC=C3C=C(C=CC3=C1)C(N)=N)C=C2,447731
2412,DB02552,Geranyl Diphosphate,small molecule,experimental,"Acids|Acids, Noncarboxylic|Anions|Electrolytes|Ions|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Polyphosphates|Terpenes",CC(C)=CCC\C(C)=C\CO[P@@](=O)(O)OP(=O)(O)O,445995
2413,DB02553,Glutathionylspermidine disulfide,small molecule,experimental,,[H]N([H])CCCCN([H])CCCN([H])C(=O)CN([H])C(=O)[C@H](CSSC[C@H](N([H])C(=O)CC[C@@H](N([H])[H])C(O)=O)C(=O)N([H])CC(=O)N([H])CCCN([H])CCCCN([H])[H])N([H])C(=O)CC[C@@H](N([H])[H])C(O)=O,449555
2414,DB02554,UDP-6-sulfoquinovose,small molecule,experimental,,O[C@@H]1[C@@H](COP(O)(=O)OP(O)(=O)O[C@H]2O[C@H](CS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]2O)O[C@H]([C@@H]1O)N1C=CC(=O)NC1=O,443244
2415,DB02555,SP4160,small molecule,experimental,,CC(C)C[C@@H](N=C(N)N)C(=O)NCC(=O)N1CCC(CC1)C1=CC(=NN1C)C1=C(Cl)C(Cl)=C(OCC2=CC=C(NC(C)=O)C=C2)C=C1,656989
2416,DB02556,D-Phenylalanine,small molecule,experimental,,N[C@H](CC1=CC=CC=C1)C(O)=O,71567
2417,DB02557,Phosphoramidon,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Carbohydrates|Enzyme Inhibitors|Glycoconjugates|Metalloendopeptidases, antagonists & inhibitors|Peptides|Protease Inhibitors",CC(C)C[C@H](NP(O)(=O)O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(O)=O,445114
2418,DB02558,N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine,small molecule,experimental,,[H][C@@](C)(NC(=O)[C@]([H])(CC1=CC=CC=C1)NC(=O)[C@]([H])(S)CC1=CC=CC=C1)C(O)=O,448249
2419,DB02559,"6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine",small molecule,experimental,,[H][C@@]12CCN(C[C@@]3([H])CC[C@]4([H])N[C@@]([H])(N)N[C@@]([H])(N)[C@]4([H])C3)[C@@]1([H])CCCC2,17754203
2420,DB02560,[(1S)-1-acetamido-2-(4-chlorophenyl)ethyl]-[(2S)-2-amino-3-hydroxy-3-oxo-propoxy]-dihydroxy-boron,small molecule,experimental,,CC(=O)N[C@H](CC1=CC=C(Cl)C=C1)[B-](O)(O)OC[C@H](N)C(O)=O,17753903
2421,DB02561,Beta-D-Fructopyranose,small molecule,experimental,,OC[C@]1(O)OC[C@H](O)[C@@H](O)[C@@H]1O,6992107
2422,DB02562,"Quinonoid 7,8-Tetrahydrobiopterin",small molecule,experimental,,[H][C@@]1(CN=C2NC(N)=NC(=O)C2=N1)[C@@H](O)[C@H](C)O,133246
2423,DB02563,Hexanoyl-CoA,small molecule,experimental,"Adenine Nucleotides|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides|Thioesters of coenzyme A",CCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N,449118
2424,DB02565,4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide,small molecule,experimental,Amides|Amines|Anilides|Aniline Compounds|Antineoplastic Agents|Enzyme Inhibitors|Histone Deacetylase Inhibitors|Hydroxamic Acids|Hydroxy Acids|Hydroxylamines,CN(C)C1=CC=C(C=C1)C(=O)NCCCCCCC(=O)NO,3994
2425,DB02566,8-Hydroxy-4-(1-Hydroxyethyl)Quinoline-2-Carboxylic Acid,small molecule,experimental,,[H][C@@](C)(O)C1=CC(=NC2=C1C=CC[C@]2([H])O)C(O)=O,5289243
2426,DB02567,PD173955,small molecule,experimental,Pyridines|Tyrosine Kinase Inhibitors,CSC1=CC=CC(NC2=NC=C3C=C(C(=O)N(C)C3=N2)C2=C(Cl)C=CC=C2Cl)=C1,447077
2427,DB02568,Peldesine,small molecule,investigational,"Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|N-Glycosyl Hydrolases, antagonists & inhibitors|Purines|Purinones|Xanthine derivatives",NC1=NC(=O)C2=C(N1)C(CC1=CN=CC=C1)=CN2,60817
2428,DB02569,"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate",small molecule,experimental,,CC1=CN([C@@H]2O[C@H](CO[P@@](O)(=O)OP(O)(O)=O)C=C2)C(=O)NC1=O,461279
2429,DB02570,PD150606,small molecule,experimental,"Acids, Acyclic",[H][C@](S)(CC1=CC=C(I)C=C1)C(O)=O,444306
2430,DB02571,Allysine,small molecule,experimental,"Acids, Acyclic|Adipates|Amino Acids|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Dicarboxylic Acids",[H]C(=O)CCC[C@H](N)C(O)=O,160603
2431,DB02572,"1,3-bis-([3-[3-[3-(4-{3-[3-nitro-5-(galactopyranosyloxy)-benzoylamino]-propyl}-piperazin-1-yl)-propylamino-3,4-dioxo-cyclobutenyl]-amino-propoxy-ethoxy-ethoxy]-propyl-]amino-carbonyloxy)-2-amino-propane",small molecule,experimental,,NC(CO\C(O)=N\CCCOCCOCCOCCCNC1=C(NCCCN2CCN(CCC\N=C(/O)C3=CC(=CC(OC4OC(CO)C(O)C(O)C4O)=C3)[N+]([O-])=O)CC2)C(=O)C1=O)CO\C(O)=N\CCCOCCOCCOCCCNC1=C(NCCCN2CCN(CCC\N=C(/O)C3=CC(=CC(O[C@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)=C3)[N+]([O-])=O)CC2)C(=O)C1=O,131704207
2432,DB02573,"2'-deoxycytidine-2'-deoxyadenosine-3',5'-monophosphate",small molecule,experimental,,[H]N([H])C1=NC(=O)N(C=C1)[C@H]1C[C@H](OP(O)(=O)OC[C@H]2O[C@H](C[C@@H]2O)N2C=NC3=C(N=CN=C23)N([H])[H])[C@@H](CO)O1,448286
2433,DB02574,BV2,small molecule,experimental,,NC(COC(=O)NCCCN1CCN(CCCNC(=O)C2=CC(=CC(OC3OC(CO)C(O)C(O)C3O)=C2)[N+]([O-])=O)CC1)COC(=O)NCCCN1CCN(CCCNC(=O)C2=CC(=CC(O[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)=C2)[N+]([O-])=O)CC1,131704208
2434,DB02576,F-Loop of Vitamin B12,small molecule,experimental,,C[C@H](O)C[NH3+],7311735
2435,DB02577,Mesoheme,small molecule,experimental,"Biological Factors|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Porphyrins",CC1=C(CCC(O)=O)C2=CC3=C(CCC(O)=O)C(C)=C4C=C5N6C(=CC7=C(C=C)C(C)=C8C=C1N2[Fe++]6(N34)N78)C(C)=C5C=C,131704209
2436,DB02578,N-[(6S)-6-Carboxy-6-(glycylamino)hexanoyl]-D-alanyl-D-alanine,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Peptides",[H]N([H])CC(=O)N([H])[C@@H](CCCCC(=O)N([H])[C@H](C)C(=O)N([H])[C@H](C)C(O)=O)C(O)=O,446306
2437,DB02579,Acrylic Acid,small molecule,experimental,"Acids, Acyclic|Compounds used in a research, industrial, or household setting|Equipment and Supplies|Surgical Equipment|Surgical Fixation Devices|Tissue Adhesives",OC(=O)C=C,6581
2438,DB02580,Pentaglyme,small molecule,experimental,,COCCOCCOCCOCCOCCOC,70931
2439,DB02581,"N(2)-carbamimidoyl-N-{2-[4-(3-{4-[(5-carboxyfuran-2-yl)methoxy]-2,3-dichlorophenyl}-1-methyl-1H-pyrazol-5-yl)piperidin-1-yl]-2-oxoethyl}-D-leucinamide",small molecule,experimental,,CC(C)C[C@@H](NC(N)=N)C(=O)NCC(=O)N1CCC(CC1)C1=CC(=NN1C)C1=CC=C(OCC2=CC=C(O2)C(O)=O)C(Cl)=C1Cl,5288251
2440,DB02582,(6Z)-6-{[(1Z)-1-{[(1R)-1-Carboxy-2-methyl-2-propen-1-yl]imino}-1-hydroxy-3-sulfanyl-2-propanyl]imino}-6-hydroxynorleucine,small molecule,experimental,,[H][C@@](N=C(O)C(CS)N=C(O)CCCC(N)C(O)=O)(C(C)=C)C(O)=O,131704210
2441,DB02583,"N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine",small molecule,experimental,,COC1=CC(CN(C)C2=CC3=C(N=C2)N=C(N)N=C3N)=C(OC)C=C1,444617
2442,DB02585,4-(Hydroxymethyl)Benzamidine,small molecule,experimental,,NC(=N)C1=CC=C(CO)C=C1,448513
2443,DB02586,"4,7-Dimethyl-[1,10]Phenanthroline",small molecule,experimental,,CC1=CC=NC2=C3N=CC=C(C)C3=CC=C12,72792
2444,DB02587,Colforsin,small molecule,experimental|investigational,"Adjuvants, Immunologic|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Diterpenes|Immunologic Factors|P-glycoprotein inhibitors|Peripheral Nervous System Agents|Protective Agents|Respiratory System Agents|Terpenes|Vasodilating Agents",[H][C@]1(O)CCC(C)(C)[C@]2([H])[C@]([H])(O)[C@]([H])(OC(C)=O)[C@@]3(C)O[C@](C)(CC(=O)[C@]3(O)[C@@]12C)C=C,47936
2445,DB02588,"(2R)-2-[(1R)-1-{[(2S)-2-Carboxy-2-(4-hydroxyphenyl)acetyl]amino}-1-methoxy-2-oxoethyl]-5-methylene-5,6-dihydro-2H-1,3-oxazine-4-carboxylic acid",small molecule,experimental,,COC(NC(=O)[C@@H](C(O)=O)C1=CC=C(O)C=C1)(C=O)[C@H]1OCC(=C)C(=N1)C(O)=O,131704211
2446,DB02589,Se-Ethyl-Isoselenourea,small molecule,experimental,Selenium Compounds,CC[Se]C(N)=N,449633
2447,DB02590,Abequose,small molecule,experimental,Carbohydrates|Monosaccharides,[H][C@@]1(O)C[C@@]([H])(O)[C@@]([H])(O)O[C@]1([H])C,447147
2448,DB02591,"5,6-Dimethylbenzimidazole",small molecule,experimental,"Heterocyclic Compounds, Fused-Ring",CC1=CC2=C(C=C1C)N=CN2,675
2449,DB02592,Carbaphosphonate,small molecule,experimental,,[H][C@@]1(O)C[C@@](O)(C[C@]([H])(CP(O)(O)=O)[C@@]1([H])O)C(O)=O,445131
2450,DB02593,"7,8-Dihydroxy-1-Methoxy-3-Methyl-10-Oxo-4,10-Dihydro-1h,3h-Pyrano[4,3-B]Chromene-9-Carboxylic Acid",small molecule,experimental,,[H][C@]1(C)CC2=C(C(=O)C3=C(O2)C=C(O)C(O)=C3C(O)=O)[C@]([H])(OC)O1,5287417
2451,DB02594,2'-Deoxycytidine,small molecule,experimental|investigational,,NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](CO)O1,13711
2452,DB02595,"(2R,3S,5S)-2-(Hydroxymethyl)-5-[(2-sulfoethyl)carbamoyl]-3-pyrrolidiniumyl 2-acetamido-2-deoxy-4-O-sulfo-beta-D-glucopyranoside",small molecule,experimental,,[H]N(CCS(O)(=O)=O)C(=O)[C@@H]1C[C@H](O[C@@H]2O[C@H](CO)[C@@H](OS(O)(=O)=O)[C@H](O)[C@H]2N([H])C(C)=O)[C@@H](CO)[N+]1([H])[H],101059193
2453,DB02596,"alpha,beta-Methyleneadenosine 5'-triphosphate",small molecule,experimental,"Adenine Nucleotides|Antineoplastic Agents|Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)CP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O,91557
2454,DB02597,"[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala",small molecule,experimental,,[H][C@@](C)(NC(=O)[C@]([H])(CC1=CC=CC=C1)NC(=O)[C@@]([H])(S)CCCCC)C(O)=O,5289469
2455,DB02598,"N-Alpha-Acetyl-3,5-Diiodotyrosylglycine",small molecule,experimental,,CC(=O)N[C@@H](CC1=CC(I)=C(O)C(I)=C1)C(=O)NCC(O)=O,447701
2456,DB02599,"2,6-Diamino-8-Propylsulfanylmethyl-3h-Quinazoline-4-One",small molecule,experimental,,CCCSCC1=CC(N)=CC2=C1N=C(N)NC2=O,446623
2457,DB02600,Oseltamivir acid,small molecule,experimental,"Acetamides|Acetates|Acids, Acyclic|Amides|Anti-Infective Agents|Antiviral Agents|Cyclohexanes|Cyclohexenes|Cycloparaffins|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids",CCC(CC)O[C@@H]1C=C(C[C@H](N)[C@H]1NC(C)=O)C(O)=O,449381
2458,DB02601,4-Hydroxyphenylglycine,small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins|Carnitine O-Palmitoyltransferase, antagonists & inhibitors|Enzyme Inhibitors",NC(C(O)=O)C1=CC=C(O)C=C1,92143
2459,DB02602,AL7182,small molecule,experimental,,COC1=CC(=CC=C1)N1CCC2=C(SC(=C2)S(N)(=O)=O)S1(=O)=O,1604
2460,DB02603,1-Amino-6-Cyclohex-3-Enylmethyloxypurine,small molecule,experimental,,NC1=NC(OCC2CCCCC2)=C2N=CNC2=C1,445967
2461,DB02604,2-Deoxy-Glucose-6-Phosphate,small molecule,experimental,,O[C@H]1C[C@@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1,46936435
2462,DB02606,2-Butanol,small molecule,experimental|investigational,Alcohols|Fatty Alcohols|Lipids,CC[C@@H](C)O,84682
2463,DB02607,Adenosine Phosphonoacetic Acid,small molecule,experimental,"Acetates|Acids, Acyclic|Adenine Nucleotides|Carbohydrates|Fatty Acids|Fatty Acids, Volatile|Glycosides|Heterocyclic Compounds, Fused-Ring|Lipids|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Organophosphonates|Organophosphorus Compounds|Purine Nucleotides|Purines|Ribonucleotides",[H][C@]1(COC(=O)CP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,448505
2464,DB02608,"N-[(1R,2R)-1,3-Dihydroxy-1-(4-nitrophenyl)-2-propanyl]acetamide",small molecule,experimental,,[H]N([C@H](CO)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O)C(C)=O,247978
2465,DB02609,4-Hydroxy-L-Threonine-5-Monophosphate,small molecule,experimental,,N[C@@H]([C@H](O)COP(O)(O)=O)C(O)=O,440901
2466,DB02610,"N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide",small molecule,experimental,,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=C(F)C(F)=C(F)C(F)=C1F,445770
2467,DB02611,Balanol Analog 1,small molecule,experimental,,[H][C@]1(CNCCC[C@@]1([H])OC(=O)C1=CC=C(O)C=C1)NC(=O)C1=CC=C(O)C=C1,448326
2468,DB02613,Capric dimethyl amine oxide,small molecule,experimental,,CCCCCCCCCC[N+](C)(C)[O-],62452
2469,DB02614,1(R)-1-Acetamido-2-(3-Carboxyphenyl)Ethyl Boronic Acid,small molecule,experimental,,[H][C@@](CC1=CC=CC(=C1)C(O)=O)(NC(C)=O)B(O)O,5287795
2470,DB02615,Compound 19,small molecule,experimental,,[H][C@@](C)(COC1=CC=C(C=C1)[C@]1([H])OC2=C(S[C@]1([H])C1=CC=C(O)C=C1)C=C(O)C=C2)N1CCCC1,449209
2471,DB02616,FR117016,small molecule,experimental,,NC(N)=NC1=NC(=CS1)C1=CC=C(CNC2=NC3=C(N2)C=CC=C3)S1,447339
2472,DB02617,"1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane",small molecule,experimental,,CCCCCC[C@](O)(CN1C=CN=C1)C1=CC=C(Cl)C=C1Cl,5289140
2473,DB02618,Ethyl Dimethyl Ammonio Propane Sulfonate,small molecule,experimental,,CC[N+](C)(C)CCCS([O-])(=O)=O,5221296
2474,DB02619,12-Bromo-1-dodecanol,small molecule,experimental,,[H]OCCCCCCCCCCCCBr,137895
2475,DB02620,3-(4-{2-[2-(2-bromo-acetylamino)-ethyldisulfanyl]-ethylcarbamoyl}-cyclohexylcarbamoyl)-pyrazine-2-carboxylic acid,small molecule,experimental,,CC(=O)NCCSSCCNC(=O)C1CCC(CC1)NC(=O)C1=NC=CN=C1C(O)=O,447450
2476,DB02621,Latrunculin A,small molecule,experimental,Marine Toxins|Porifera|Sulfur Compounds|Thiazoles,[H][C@]1(CSC(=O)N1)[C@@]1(O)C[C@H]2C[C@@H](CC[C@H](C)\C=C/C=C/CC\C(C)=C/C(=O)O2)O1,6437378
2477,DB02622,2-(Oxalyl-Amino)-Benzoic Acid,small molecule,experimental,,OC(=O)C(=O)NC1=C(C=CC=C1)C(O)=O,444764
2478,DB02623,Aminophosphonic acid-guanylate ester,small molecule,experimental,,[H]N([H])C1=NC(=O)C2=C(N1[H])N(C=N2)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)N([H])[H])[C@@H](O)[C@H]1O,444148
2479,DB02624,Homoserine Lactone,small molecule,experimental,Furans|Lactones|Luminescent Proteins|Quorum Sensing,N[C@@H]1CCOC1=O,7057884
2480,DB02625,(2r)-2-{[Formyl(Hydroxy)Amino]Methyl}Hexanoic Acid,small molecule,experimental,,[H][C@@](CCCC)(CN(O)C=O)C(O)=O,5287843
2481,DB02626,Phenylferricrocin-iron,small molecule,experimental,,[Fe].CC(=O)N(O)CCC[C@@H]1NC(=O)CNC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CNC(=O)[C@H](CCCN(O)C(C)=O)NC(=O)[C@H](CCCN(O)C(C)=O)NC1=O,131704212
2482,DB02627,"4,4'-Biphenyldiboronic Acid",small molecule,experimental,,OB(O)C1=CC=C(C=C1)C1=CC=C(C=C1)B(O)O,2734608
2483,DB02628,"1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide",small molecule,experimental,,[H][C@@](C)(NC)C(=O)N[C@]([H])(C(=O)N1CCC[C@@]1([H])C(=O)N[C@]1([H])CCCC2=C1C=CC=C2)C(C)(C)C,4369343
2484,DB02629,"N,N-[2,5-O-di-2-fluoro-benzyl-glucaryl]-di-[1-amino-indan-2-ol]",small molecule,experimental,,O[C@H]([C@@H](O)[C@@H](OCC1=C(F)C=CC=C1)C(=O)N[C@@H]1[C@H](O)CC2=CC=CC=C12)[C@@H](OCC1=CC=CC=C1F)C(=O)N[C@@H]1[C@H](O)CC2=C1C=CC=C2,445306
2485,DB02630,L-xylitol 5-phosphate,small molecule,experimental,Carbohydrates|Sugar Phosphates,OC[C@@H](O)[C@H](O)[C@@H](O)COP(O)(O)=O,448027
2486,DB02632,4-nitrophenyl-beta-D-galactoside,small molecule,experimental,"Affinity Labels|Carbohydrates|Compounds used in a research, industrial, or household setting|Galactosides|Glycosides|Indicators and Reagents|Laboratory Chemicals|Photoaffinity Labels",OC[C@H]1O[C@@H](OC2=CC=C(C=C2)[N+]([O-])=O)[C@H](O)[C@@H](O)[C@H]1O,65115
2487,DB02633,Cibacron Blue,small molecule,experimental,,NC1=C(C=C(NC2=CC=C(NC3=NC(Cl)=NC(NC4=CC=CC=C4S(O)(=O)=O)=N3)C(=C2)S(O)(=O)=O)C2=C1C(=O)C1=CC=CC=C1C2=O)S(O)(=O)=O,172469
2488,DB02635,N-[O-Phosphono-Pyridoxyl]-Isoleucine,small molecule,experimental,,[H][C@](C)(CC)[C@@]([H])(NCC1=C(COP(O)(O)=O)C=NC(C)=C1O)C(O)=O,92282619
2489,DB02636,"9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid",small molecule,experimental,,COC1=C(O)C=CC2=C1C=C(C1=C2C2=C(OCO2)C=C1C(O)=O)[N+]([O-])=O,1941
2490,DB02637,Oxaloacetate Ion,small molecule,experimental,,OC(=O)C(=O)CC([O-])=O,3260017
2491,DB02638,Terlipressin,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Cardiovascular Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Moderate Risk QTc-Prolonging Agents|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormones|Pituitary Hormones, Posterior|Posterior Pituitary Lobe Hormones|Proteins|QTc Prolonging Agents|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Vasoconstrictor Agents|Vasopressin and Analogues|Vasopressins",NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,72081
2492,DB02639,7-(alpha-D-Glucopyranosyloxy)-4-methyl-2H-1-benzopyran-2-one,small molecule,experimental,,CC1=CC(=O)OC2=C1C=CC(O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)=C2,87330
2493,DB02640,Fumagillin,small molecule,experimental,"Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Anti-Infective Agents|Antineoplastic Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Cycloparaffins|Fatty Acids|Growth Inhibitors|Growth Substances|Lipids|Terpenes",CO[C@@H]1[C@@H](CC[C@]2(CO2)[C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C)OC(=O)\C=C\C=C\C=C\C=C\C(O)=O,6917655
2494,DB02641,Heptanamide,small molecule,experimental,,CCCCCCC(N)=O,136449
2495,DB02642,[[N-(Benzyloxycarbonyl)Amino]Methyl]Phosphate,small molecule,experimental,,OP(O)(=O)CNC(=O)OCC1=CC=CC=C1,1950
2496,DB02643,"N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate",small molecule,experimental,"Amines|Ammonium Compounds|Compounds used in a research, industrial, or household setting|Detergents|Household Products|Nitrogen Compounds|Onium Compounds|Surface-Active Agents",CCCCCCCCCCCC[N+](C)(C)CCCS(O)(=O)=O,84704
2497,DB02644,N-omega-propyl-L-arginine,small molecule,experimental,,[H]N([H])[C@@H](CCCN([H])C(\N([H])[H])=[N+](/[H])CCC)C(O)=O,5287494
2498,DB02645,"3,4-Epoxybutyl-Alpha-D-Glucopyranoside",small molecule,experimental,,[H][C@]1(CCO[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]2([H])O)CO1,5288150
2499,DB02646,Nitrosoethane,small molecule,experimental,,CCN=O,79124
2500,DB02647,N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide,small molecule,experimental,,O=C(NC1=CC(=NN1)C1CC1)C1=CC=CC=C1,449088
2501,DB02648,(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium,small molecule,experimental,,C[N+](C)(C)C[C@H](O)CC(O)=O,10918
2502,DB02649,3-Amino-3-Oxopropanoic Acid,small molecule,experimental,,NC(=O)CC(O)=O,75367
2503,DB02650,Trichloroacetaldehyde,small molecule,experimental,Alcohols|Ethylene Glycols|Glycols,[H]C(=O)C(Cl)(Cl)Cl,6407
2504,DB02651,"{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)",small molecule,experimental,,OP(O)(=O)C(F)(F)C1=CC=C(CC(CC2=CC=C(C=C2)C(F)(F)P(O)(O)=O)(N2N=NC3=C2C=CC=C3)C2=CC=C(F)C(F)=C2)C=C1,448024
2505,DB02652,L-[(N-Hydroxyamino)Carbonyl]Phenylalanine,small molecule,experimental,,[H]N(O)C(=O)N([H])[C@@H](CC1=CC=CC=C1)C(O)=O,446056
2506,DB02654,6-hydroxy-FAD,small molecule,experimental,"Adenine Nucleotides|Biological Factors|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Flavins|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pigments, Biological|Pteridines|Purine Nucleotides|Purines|Ribonucleotides|Vitamin B Complex|Vitamins",CC1=CC2=C(N=C3C(=O)NC(=O)N=C3N2C[C@H](O)[C@H](O)[C@H](O)COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)C(O)=C1C,4369241
2507,DB02655,D-Aspartic Acid,small molecule,experimental,"Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Excitatory Amino Acids",N[C@H](CC(O)=O)C(O)=O,83887
2508,DB02656,LY-294002,small molecule,experimental,"Benzopyrans|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Oxazines|Phosphatidylinositol 3-Kinases, antagonists & inhibitors|Pyrans",O=C1C=C(OC2=C1C=CC=C2C1=CC=CC=C1)N1CCOCC1,3973
2509,DB02657,Glucosamine 6-Phosphate,small molecule,experimental,Amino Sugars|Carbohydrates|Glucosephosphates|Hexosamines|Hexosephosphates|Sugar Phosphates,N[C@H]1[C@@H](O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O,439217
2510,DB02658,"2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Allopyranoside",small molecule,experimental,,[H][C@]1(CO)O[C@@]([H])(OC2=C(C=C(C=C2)[N+]([O-])=O)[N+]([O-])=O)[C@]([H])(F)[C@@]([H])(O)[C@]1([H])O,445227
2511,DB02659,Cholic Acid,small molecule,approved,Alimentary Tract and Metabolism|Bile Acid Preparations|Bile acids and derivatives|Bile Acids and Salts|Bile and Liver Therapy|Bile Therapy|BSEP/ABCB11 inducers|BSEP/ABCB11 Inhibitors|BSEP/ABCB11 Substrates|Cholanes|Cholic Acids|Fused-Ring Compounds|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Inducers|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein inducers|Steroids,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C,221493
2512,DB02660,Filaminast,small molecule,experimental,Amines|Hydroxylamines,COC1=CC=C(C=C1OC1CCCC1)C(\C)=N\OC(N)=O,9578243
2513,DB02661,"Adenosine-5'-diphosphate-2',3'-vanadate",small molecule,experimental,Vanadates,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)OP(O)(O)=O)[C@H]2O[V](=O)(=O)O[C@H]12,46936447
2514,DB02662,Novo Nordisk a/S Compound,small molecule,experimental,,OC(=O)C(=O)NC1=C(C=C(I)C=C1)C(O)=O,1829
2515,DB02663,2-Amino-4-(Hydroxymethyl-Phosphinyl)Butanoic Acid,small molecule,experimental,,C[P@@](O)(=O)CC[C@@H](N)C(O)=O,6971307
2516,DB02664,1-Butane Boronic Acid,small molecule,experimental,,CCCCB(O)O,20479
2517,DB02665,"(1R,2S)-2-Phenylcyclopropanaminium",small molecule,experimental,,[NH3+][C@@H]1C[C@H]1C1=CC=CC=C1,11861988
2518,DB02666,(C8-R)-hydantocidin 5'-phosphate,small molecule,experimental,,[H]N1C(=O)N(CCC[C@@H](N(O)CO)C(O)=O)C(=O)[C@]11O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O,448088
2519,DB02667,Factor IIIm,small molecule,experimental,,COC1=CC=C2N(C=NC2=C1)[C@H]1O[C@H](CO)[C@@H](O[P@]([OH-])(=O)O[C@H](C)CNC(=O)CC[C@]2(C)[C@@H](CC(N)=O)C3=[N+]4C2=C(C)C2=[N+]5C(=CC6=[N+]7C(=C(C)C8=[N+]([C@]3(C)[C@@](C)(CC(N)=O)[C@@H]8CCC(N)=O)[Co]457)[C@@](C)(CC(N)=O)[C@@H]6CCC(N)=O)C(C)(C)[C@@H]2CCC(N)=O)[C@H]1O,6323227
2520,DB02668,JE-2147,small molecule,experimental,"Acids, Carbocyclic|Amino Acids, Peptides, and Proteins|Antiviral Agents|HIV Protease Inhibitors|Oligopeptides|Peptides|Sulfur Compounds",CC1=CC=CC=C1CNC(=O)[C@H]1N(CSC1(C)C)C(=O)[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CC=CC(O)=C1C,446837
2521,DB02669,RB106,small molecule,experimental,,[H][C@](S)(CC1=CC=CC=C1)C(=O)NCC(=O)N1[C@@]([H])(CC[C@]1([H])C1=CC=CC=C1)C(O)=O,448087
2522,DB02670,4-Deoxy-Alpha-D-Glucose,small molecule,experimental,,[H][C@]1(O)C[C@@]([H])(CO)O[C@]([H])(O)[C@]1([H])O,444914
2523,DB02671,1-Methylimidazole,small molecule,experimental,,CN1C=C[NH+]=C1,444235
2524,DB02673,"(4aS,6R,8aS)-11-[8-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)octyl]-6-hydroxy-3-methoxy-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11-ium",small molecule,experimental,,COC1=CC=C2C=[N+](CCCCCCCCN3C(=O)C4=C(C=CC=C4)C3=O)CC[C@@]34C=C[C@H](O)C[C@@H]3OC1=C24,5288394
2525,DB02674,"4-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Butyricacid",small molecule,experimental,,[H][C@]12CS[C@@]([H])(CCCC(O)=O)[C@@]1([H])NC(=O)N2,446903
2526,DB02675,(4-Hydroxymaltosephenyl)Glycine,small molecule,experimental,,[H][C@@](N)(C(O)=O)C1=CC=C(O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@]2([H])O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@]2([H])O)C=C1,17754164
2527,DB02676,"2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol",small molecule,experimental,,OCC(CO)(CO)NCCCNC(CO)(CO)CO,125132
2528,DB02677,D-naphthyl-1-acetamido boronic acid alanine,small molecule,experimental,,CC(=O)N[C@H](CC1=CC=CC2=C1C=CC=C2)[B-](O)(O)OC[C@H](N)C(O)=O,17754157
2529,DB02678,beta-D-Galactosamine,small molecule,experimental,,N[C@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1O,449462
2530,DB02679,Cyanamide,small molecule,experimental,"Acids|Acids, Noncarboxylic|Anions|Carbodiimides|Cyanides|Electrolytes|Hydrogen Cyanide|Imines|Ions|Nitrogen Compounds",NC#N,9864
2531,DB02680,"1,3-Dinitrobenzene",small molecule,experimental,Benzene Derivatives|Nitro Compounds|Nitrobenzenes,[O-][N+](=O)C1=CC(=CC=C1)[N+]([O-])=O,7452
2532,DB02681,"2,8-bis[oxido(oxo)vanadio]-1,1,1,3,5,5,7,7,9,9,9-undecaoxopentavanadoxane-2,8-diium",small molecule,experimental,,[O-][V](=O)[O+]([V](=O)O[V](=O)(=O)O[V](=O)(=O)[O+]([V]([O-])=O)[V](=O)(=O)=O)[V](=O)(=O)=O,
2533,DB02683,Inhibitor Bea428,small molecule,experimental,,[H][C@@](O)([C@@]([H])(O)[C@@]([H])(OCC1=CC=C(C=C1)C1=CN=CC=C1)C(O)=N[C@@]([H])(C(C)C)C(O)=NC)[C@@]([H])(OCC1=CC=C(C=C1)C1=CN=CC=C1)C(O)=N[C@@]([H])(C(C)C)C(O)=NC,445308
2534,DB02684,5'-O-(L-Cysteinylsulfamoyl)adenosine,small molecule,experimental,,[H]N([H])[C@@H](CS)C(=O)N([H])S(=O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N=CN=C12)N([H])[H],447377
2535,DB02685,3-Methylphenylalanine,small molecule,experimental,,CC1=CC=CC(C[C@H](N)C(O)=O)=C1,2761494
2536,DB02686,Undecyl-Beta-D-Maltopyranoside,small molecule,experimental,,[H][C@]1(O)[C@]([H])(O)[C@@]([H])(CO)O[C@]([H])(O[C@@]2([H])[C@]([H])(O)[C@@]([H])(O)[C@]([H])(OCCCCCCCCCCC)O[C@]2([H])CO)[C@]1([H])O,447793
2537,DB02688,"2,3-Didehydroalanine",small molecule,experimental,,NC(=C)C(O)=O,123991
2538,DB02689,S-{2-[Amino(Dihydroxy)-Lambda~4~-Sulfanyl]Ethyl}-D-Cysteine,small molecule,experimental,,[H][C@](N)(CSCCS(N)(=O)=O)C(O)=O,448254
2539,DB02690,NU1025,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring",CC1=NC2=C(C=CC=C2O)C(=O)N1,63306
2540,DB02691,Glycocholic acid,small molecule,experimental|investigational,"Amino Acids|Amino Acids, Peptides, and Proteins|Bile Acids and Salts|Cholagogues and Choleretics|Cholanes|Cholic Acids|Compounds used in a research, industrial, or household setting|Detergents|Fused-Ring Compounds|Gastrointestinal Agents|Household Products|N-substituted Glycines|Peptides|Peptoids|Steroids|Surface-Active Agents",[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCC([O-])=O,5460316
2541,DB02693,"(4S,5S)-1,2-dithiane-4,5-diol",small molecule,experimental,,[H][C@@]1(O)CSSC[C@@]1([H])O,445528
2542,DB02694,Pantoyl Adenylate,small molecule,experimental,,[H][C@](O)(C(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O)C(C)(C)CO,447261
2543,DB02695,O1-Pentyl-Mannose,small molecule,experimental,,[H][C@]1(O)[C@]([H])(O)[C@@]([H])(CO)O[C@]([H])(OCCCCC)[C@@]1([H])O,447084
2544,DB02696,"6-Aminohexyl-uridine-C1,5'-diphosphate",small molecule,experimental,,[H]N([H])CCCCCCOP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)N([H])C1=O,448803
2545,DB02697,Hydroxyaminovaline,small molecule,experimental,,CC(C)[C@@H](N)C(=O)NO,444599
2546,DB02698,"N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid",small molecule,experimental,,OC(=O)C1=CC=CC2=C1OC1=C(C=CC=C1C(O)=O)N2C1=CC(=CC=C1)C(F)(F)F,4310
2547,DB02699,4-Oxoretinol,small molecule,experimental,"Alkenes|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Retinoids|Terpenes",C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)CCC1(C)C,5289090
2548,DB02700,3-Deoxy-D-Glucosamine,small molecule,experimental,,[H][C@@]1(N)C[C@]([H])(O)[C@@]([H])(CO)O[C@]1([H])O,5288374
2549,DB02701,Nicotinamide,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Micronutrients|Nicotinic Acids|Physiological Phenomena|Pyridines|Vitamin B Complex|Vitamins",NC(=O)C1=CC=CN=C1,936
2550,DB02702,XV638,small molecule,experimental,,[H][C@]1(CC2=CC=CC=C2)N(CC2=CC(=CC=C2)C(=O)NC2=NC=CS2)C(=O)N(CC2=CC(=CC=C2)C(=O)NC2=NC=CS2)[C@]([H])(CC2=CC=CC=C2)[C@]([H])(O)[C@@]1([H])O,441046
2551,DB02703,Fusidic acid,small molecule,approved|investigational,Agents Causing Muscle Toxicity|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antibiotics for Topical Use|Antiinfectives for Systemic Use|BCRP/ABCG2 Inhibitors|BSEP/ABCB11 Inhibitors|Cholestadienes|Cholestadienols|Cholestanes|Cholestenes|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Enzyme Inhibitors|Fused-Ring Compounds|Lipids|Medicated Dressings|Medicated Dressings With Antiinfectives|Membrane Lipids|OATP1B1/SLCO1B1 Inhibitors|Ophthalmologicals|Other Miscellaneous Antibacterial Agents|Protein Synthesis Inhibitors|Sensory Organs|Steroid Antibacterials|Steroids|Sterols|UGT1A1 Substrates,[H][C@@]12C[C@@H](O)[C@@]3([H])[C@@]4(C)CC[C@@H](O)[C@@H](C)[C@]4([H])CC[C@]3(C)[C@@]1(C)C[C@H](OC(C)=O)\C2=C(\CCC=C(C)C)C(O)=O,3000226
2552,DB02704,"(2R,3R,4R,5R)-3,4-Dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis(2-phenylethyl)hexanediamide",small molecule,experimental,,O[C@@H]([C@H](O)[C@@H](CCC1=CC=CC=C1)C(=O)N[C@@H]1[C@H](O)CC2=C1C=CC=C2)[C@@H](CCC1=CC=CC=C1)C(=O)N[C@@H]1[C@H](O)CC2=C1C=CC=C2,449129
2553,DB02705,"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",small molecule,experimental,,[H][C@]1(NCCC2=C1C=C(NC(=O)C1=CC=C3C=C(C=CC3=C1)C(N)=N)C=C2)C(C)C,447736
2554,DB02706,Mercaptocarboxylate Inhibitor,small molecule,experimental,,[H][C@](CS)(CCC1=CC=CC=C1)C(=O)N=C(C(O)=O)C1=CC=C(CN2C=NN=N2)S1,5288784
2555,DB02707,Pentyl Trihydrogen Diphosphate,small molecule,experimental,,CCCCCO[P@](O)(=O)OP(O)(O)=O,448673
2556,DB02709,Resveratrol,small molecule,investigational,"Analgesics|Analgesics, Non-Narcotic|Angiogenesis Inhibitors|Anti-Inflammatory Agents|Anticarcinogenic Agents|Antimutagenic Agents|Antineoplastic Agents, Phytogenic|Antioxidants|Antiplatelet agents|Antirheumatic Agents|Benzene Derivatives|Benzopyrans|Benzylidene Compounds|Central Nervous System Agents|Chromones|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Flavones|Flavonoids|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|Peripheral Nervous System Agents|Phenols|Polyphenols|Protective Agents|Pyrans|Sensory System Agents|Stilbenes|Vasodilating Agents",OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1,445154
2557,DB02710,"2,3,-Dihydroxybenzoylserine",small molecule,experimental,,[H][C@@](CO)(NC(=O)C1=C(O)C(O)=CC=C1)C(O)=O,151483
2558,DB02711,"4-{2,6,8-Trioxo-9-[(2S,3R,4R)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate",small molecule,experimental,,OC[C@@H](O)[C@H](O)[C@@H](O)CN1C(=O)N(CCCCOP(O)(O)=O)C2=C1NC(=O)NC2=O,657028
2559,DB02712,Sorbinil,small molecule,experimental|investigational,"Aldehyde Reductase, antagonists & inhibitors|Imidazoles",FC1=CC=C2OCC[C@]3(NC(=O)NC3=O)C2=C1,337359
2560,DB02713,Acetylamino-Acetic Acid,small molecule,experimental,,CC(=O)NCC(O)=O,10972
2561,DB02714,3'-Uridinemonophosphate,small molecule,experimental,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides|Uracil Nucleotides",OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=CC(=O)NC1=O,101543
2562,DB02715,Compound 18,small molecule,experimental,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Iodobenzoates",[H][C@](C)(COC1=CC=C(C=C1)[C@]1([H])OC2=C(S[C@]1([H])C1=CC=C(O)C=C1)C=C(O)C=C2)N1CCCC1,449208
2563,DB02716,7-methyl-guanosine-5'-triphosphate,small molecule,experimental,,C[N+]1=CN([C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C2=C1C(=O)NC(N)=N2,444378
2564,DB02717,Cellotetraose,small molecule,experimental,"Biopolymers|Carbohydrates|Compounds used in a research, industrial, or household setting|Glucans|Macromolecular Substances|Monosaccharides|Polymers|Polysaccharides",[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(O[C@]2([H])O[C@]([H])(CO)[C@@]([H])(O[C@]3([H])O[C@]([H])(CO)[C@@]([H])(O[C@]4([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]4([H])O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O,5288428
2565,DB02719,C-(1-hydrogyl-beta-D-glucopyranosyl) formamide,small molecule,experimental,,[H]N([H])C(=O)[C@]1(O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,447771
2566,DB02720,alpha-D-glucopyranosyl-2-carboxylic acid amide,small molecule,experimental,,[H]N([H])C(=O)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,445825
2567,DB02721,4-Iodopyrazole,small molecule,experimental,,IC1=CNN=C1,77022
2568,DB02722,4-O-methyl-beta-D-glucuronic acid,small molecule,experimental,,CO[C@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@@H]1C(O)=O,446874
2569,DB02723,"4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide",small molecule,experimental,,O\N=C(/N)N1CCC(CC1)CNC(=O)[C@@H]1CC[C@H]2CN(CC(=O)N12)S(=O)(=O)CC1=CC=CC=C1,5326608
2570,DB02724,Delta-2-Albomycin A1,small molecule,experimental,,O1N2C(=[O+][Fe-3]1134ON(C(=[O+]1)C)CCC[C@](C(=O)N[C@@](C(=O)N[C@@](C(O)=O)([C@@]([C@]1(S[C@@](N5C=C\C(=N\C(N)=O)N(C5=O)C)([C@@]([C@]1([H])O)([H])O)[H])[H])([H])O)[H])([H])CO)([H])NC([C@@]([H])(CCCN(O3)C(=[O+]4)C)NC([C@]([H])(N)CCC2)=O)=O)C,131704215
2571,DB02725,"2-Amino-4-(4-Amino-Cyclohexa-2,5-Dienyl)-Butyric Acid",small molecule,experimental,,[H][C@](N)(CC[C@@]1([H])C=CC([H])(N)C=C1)C(O)=O,99594
2572,DB02726,2-Phosphoglycolic Acid,small molecule,experimental,,OC(=O)COP(O)(O)=O,529
2573,DB02727,2-butyl-1-hydroxyguanidine,small molecule,experimental,Amidines,CCCC\N=C(/N)NO,447030
2574,DB02728,7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester,small molecule,experimental,,CCOC(=O)C1=CC2=CC=C(O)C=C2OC1=O,5289613
2575,DB02729,SD146,small molecule,experimental,,O[C@@H]1[C@@H](O)[C@@H](CC2=CC=CC=C2)N(CC2=CC=CC(=C2)C(=O)NC2=NC3=C(N2)C=CC=C3)C(=O)N(CC2=CC(=CC=C2)C(=O)NC2=NC3=C(N2)C=CC=C3)[C@@H]1CC1=CC=CC=C1,444672
2576,DB02730,4-Methylthio-Alpha-D-Mannose,small molecule,experimental,,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(SC)[C@]([H])(O)[C@@]1([H])O,5288724
2577,DB02731,Ethylmercurithiosalicylic acid,small molecule,experimental,,CC[Hg]SC1=CC=CC=C1C(O)=O,67361
2578,DB02732,"[(2R,3S,4R,5R)-5-(4-acetonyl-3-carbamoyl-pyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] phosphate",small molecule,experimental,,[H]N([H])C(=O)C1=C(CC(C)=O)C=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N=CN=C23)N([H])[H])[C@@H](O)[C@H]1O,131704217
2579,DB02733,Purvalanol,small molecule,experimental,,[H][C@@](CO)(NC1=NC2=C(N=CN2C(C)C)C(NC2=CC=C(C(O)=O)C(Cl)=C2)=N1)C(C)C,448991
2580,DB02734,4-Deoxy-D-Mannuronic Acid,small molecule,experimental,,[H][C@@]1(O)OC(=C[C@]([H])(O)[C@]1([H])O)C(O)=O,446144
2581,DB02735,2-Amino-3-Oxo-4-Sulfo-Butyric Acid,small molecule,experimental,,[H][C@@](N)(C(O)=O)[C@@]([H])(O)OS(O)(=O)=O,131704218
2582,DB02736,Acetamide,small molecule,experimental,"Acetates|Acids, Acyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Lipids",CC(N)=O,178
2583,DB02738,Adenosine-5'-Pentaphosphate,small molecule,experimental,,NC1=C2N=CN([C@@H]3O[C@H](CO[P@@](O)(=O)O[P@](O)(=O)O[P@@](O)(=O)O[P@@](O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1,193491
2584,DB02740,3-Indolebutyric Acid,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring",OC(=O)CCCC1=CNC2=C1C=CC=C2,8617
2585,DB02741,CD564,small molecule,experimental,,CC1(C)CCC(C)(C)C2=C1C=CC(=C2)C(=O)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O,2605
2586,DB02742,Kifunensine,small molecule,experimental,Enzyme Inhibitors,[H][C@]12NC(=O)C(=O)N1[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@]2([H])O,130611
2587,DB02743,beta-D-galactopyranosyl-(1->4)-beta-D-galactopyranose,small molecule,experimental,Carbohydrates|Oligosaccharides|Polysaccharides,[H][C@@]1(O)O[C@]([H])(CO)[C@]([H])(O[C@]2([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O,448925
2588,DB02744,RPR131247,small molecule,experimental,,NC(=N)C1=CC=C(O)C(CN2CC[C@H](NS(=O)(=O)C3=CC4=C(S3)C=CC=N4)C2=O)=C1,5326514
2589,DB02745,Uridine,small molecule,experimental|investigational,"Analogs/Derivatives|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Analog|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O,6029
2590,DB02746,Phthalic Acid,small molecule,experimental,"Acids, Carbocyclic",OC(=O)C1=CC=CC=C1C(O)=O,1017
2591,DB02747,Diamino-N-[(4S)-5-anilino-4-{[(2S)-2-{[(1R)-1-carboxyethyl]amino}-4-phenylbutanoyl]amino}-5-oxopentyl]methaniminium,small molecule,experimental,,[H]N([H])C(N([H])[H])=[N+]([H])CCC[C@H](N([H])C(=O)[C@H](CCC1=CC=CC=C1)N([H])[C@H](C)C(O)=O)C(=O)N([H])C1=CC=CC=C1,5288637
2592,DB02749,Pyromellitic Acid,small molecule,experimental,"Acids, Carbocyclic|Benzene Derivatives",OC(=O)C1=CC(C(O)=O)=C(C=C1C(O)=O)C(O)=O,6961
2593,DB02750,S-(Methylmercury)-L-Cysteine,small molecule,experimental,,C[Hg]SC[C@@H](N)C(O)=O,46936479
2594,DB02751,Glycocyamine,small molecule,experimental,"Affinity Labels|Amino Acids|Amino Acids, Peptides, and Proteins|Compounds used in a research, industrial, or household setting|Indicators and Reagents|Laboratory Chemicals",NC(N)=NCC(O)=O,763
2595,DB02752,Tosyl-D-Proline,small molecule,experimental,,[H][C@@]1(CCCN1S(=O)(=O)C1=CC=C(C)C=C1)C(O)=O,445504
2596,DB02753,Selenoinosine,small molecule,experimental,Selenium Compounds,[H][C@]1(CO)O[C@@]([H])(N2C=NC3=C2N=CN=C3[SeH])[C@]([H])(O)[C@]1([H])O,6337677
2597,DB02754,"9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine",small molecule,experimental,,CCCCN1C(CC2=CC(OC)=C(OC)C(OC)=C2)=NC2=C(N)N=CN=C12,448965
2598,DB02755,1-3 Sugar Ring of Pentamannosyl 6-Phosphate,small molecule,experimental,,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O[C@@]3([H])O[C@]([H])(COP(O)(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@]3([H])O)[C@]2([H])O)[C@]1([H])O,444727
2599,DB02756,Pyroquilon,small molecule,experimental,"Antifungal Agents|Heterocyclic Compounds, Fused-Ring",O=C1CCC2=CC=CC3=C2N1CC3,91665
2600,DB02757,Pyrazole,small molecule,experimental,"Alcohol Dehydrogenase, antagonists & inhibitors|Enzyme Inhibitors",N1C=CC=N1,1048
2601,DB02758,Indolepropionic acid,small molecule,experimental,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Heterocyclic Compounds, Fused-Ring|Lipids",OC(=O)CCC1=CNC2=CC=CC=C12,3744
2602,DB02759,4-methyl-umbelliferyl-N-acetyl-chitobiose,small molecule,experimental,"Benzopyrans|Carbohydrates|Coumarins|Heterocyclic Compounds, Fused-Ring|Muramidase, antagonists & inhibitors|Polysaccharides|Pyrans|Umbelliferones",[H]N([C@H]1[C@H](O[C@@H]2[C@@H](CO)O[C@@H](OC3=CC4=C(C=C3)C(C)=CC(=O)O4)[C@H](N([H])C(C)=O)[C@H]2O)O[C@H](CO)[C@@H](O)[C@@H]1O)C(C)=O,171284
2603,DB02760,"1,6-Di-O-Phosphono-D-Allitol",small molecule,experimental,,[H][C@](O)(COP(O)(O)=O)[C@]([H])(O)[C@]([H])(O)[C@]([H])(O)COP(O)(O)=O,5288174
2604,DB02761,S-Mercaptocysteine,small molecule,experimental,,N[C@@H](CSS)C(O)=O,165331
2605,DB02762,RU79072,small molecule,experimental,,OP(O)(=O)OC1=CC=CC2=CC=C(N=C12)C#N,447532
2606,DB02763,5-Mercapto-2-Nitro-Benzoic Acid,small molecule,experimental,,OC(=O)C1=CC(S)=CC=C1[N+]([O-])=O,123648
2607,DB02765,R-9-(2-hydroxypropyl)adenine,small molecule,experimental,,C[C@@H](O)CN1C=NC2=C1N=CN=C2N,445211
2608,DB02766,N-[(2R)-4-diazonio-3-oxoniumylidene-1-phenylbutan-2-yl]-1-phenylmethoxymethanimidate,small molecule,experimental,,[O-]\C(OCC1=CC=CC=C1)=N/[C@H](CC1=CC=CC=C1)C(=[OH+])C[N+]#N,131704219
2609,DB02767,(R)-3-hydroxytetradecanoic acid,small molecule,experimental,,CCCCCCCCCCC[C@@H](O)CC(O)=O,5288266
2610,DB02768,Tert-Butyloxycarbonyl Group,small molecule,experimental,,CC(C)(C)OC=O,61207
2611,DB02770,7-alpha-D-Ribofuranosyl-2-aminopurine-5'-phosphate,small molecule,experimental,,[H]N([H])C1=NC=C2N(C=NC2=N1)[C@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O,446858
2612,DB02772,Sucrose,small molecule,approved|experimental|investigational,"Carbohydrates|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Disaccharides|Flavoring Agents|Food|Food Additives|Food and Beverages|Food Ingredients|Oligosaccharides|Pharmaceutic Aids|Pharmaceutical Preparations|Physiological Phenomena|Polysaccharides|Sweetening Agents",OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O,5988
2613,DB02773,(3-Chloro-4-Propoxy-Phenyl)-Acetic Acid,small molecule,experimental,,CCCOC1=CC=C(CC(O)=O)C=C1Cl,2084
2614,DB02774,"1,3-Propanediol",small molecule,experimental,Alcohols|Glycols,OCCCO,10442
2615,DB02776,1-Hexadecanosulfonic Acid,small molecule,experimental,,CCCCCCCCCCCCCCCCS(O)(=O)=O,14253
2616,DB02777,Diundecyl Phosphatidyl Choline,small molecule,experimental,,[H][C@@](COC(=O)CCCCCCCCCCC)(COP(O)(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCC,445355
2617,DB02778,"2,5-Anhydroglucitol-1,6-Biphosphate",small molecule,experimental,,[H][C@]1(O)[C@]([H])(O)[C@]([H])(COP(O)(O)=O)O[C@]1([H])COP(O)(O)=O,445555
2618,DB02779,Dodecyltrimethylammonium,small molecule,experimental,"Amines|Ammonium Compounds|Compounds used in a research, industrial, or household setting|Detergents|Household Products|Nitrogen Compounds|Onium Compounds|Surface-Active Agents",CCCCCCCCCCCC[N+](C)(C)C,8153
2619,DB02780,Beta-3-Cysteine,small molecule,experimental,,[H][C@](N)(CS)CC(O)=O,87087973
2620,DB02781,"4-{(Z)-[2-[3-(Methylsulfanyl)Propanoyl]-5-Oxo-1-(2-Oxoethyl)-1,5-Dihydro-4h-Imidazol-4-Ylidene]Methyl}Benzenolate",small molecule,experimental,,[H]\C(=C1/N=C(N(CC=O)C1=O)C(=O)CCSC)C1=CC=C([O-])C=C1,57484478
2621,DB02783,4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate,small molecule,experimental,,CC1=NC=C(COP(O)(O)=O)C(CNOCC(O)=O)=C1O,447742
2622,DB02784,N-(Bromoacetyl)-beta-alanyl-N-(2-{4-[(carboxycarbonyl)amino]phenyl}ethyl)-L-serinamide,small molecule,experimental,,[H]N(CCC(=O)N([H])[C@@]([H])(CO)C(=O)N([H])CCC1=CC=C(C=C1)N([H])C(=O)C(O)=O)C(=O)CBr,49866981
2623,DB02785,"(2S)-1-[(2S,4R)-4-Benzyl-2-hydroxy-5-{[(1S,2R,5S)-2-hydroxy-5-methylcyclopentyl]amino}-5-oxopentyl]-4-{[6-chloro-5-(4-methyl-1-piperazinyl)-2-pyrazinyl]carbonyl}-N-(2-methyl-2-propanyl)-2-piperazineca rboxamide",small molecule,experimental,,[H]N([C@H]1[C@@H](C)CC[C@H]1O)C(=O)[C@@H](C[C@H](O)CN1CCN(C[C@H]1C(=O)N([H])C(C)(C)C)C(=O)C1=CN=C(N2CCN(C)CC2)C(Cl)=N1)CC1=CC=CC=C1,444756
2624,DB02786,2-Anhydro-3-Fluoro-Quinic Acid,small molecule,experimental,,[H][C@@]1(O)C[C@@](O)(C=C(F)[C@@]1([H])O)C(O)=O,448993
2625,DB02787,N-Acetylmannosaminitol,small molecule,experimental,,[H][C@@](C)(O)N[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)CO,49867319
2626,DB02788,(S)-acetoin,small molecule,experimental,,C[C@H](O)C(C)=O,447765
2627,DB02789,Pregnenolone,small molecule,approved|experimental,"Adrenal Cortex Hormones|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Pregnanes|Pregnenes|Progesterone Congeners|Steroids",[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,8955
2628,DB02790,Phenyl-uridine-5'-diphosphate,small molecule,experimental,,[H]N1C(=O)C=CN([C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OC3=CC=CC=C3)[C@@H](O)[C@H]2O)C1=O,449409
2629,DB02792,Deglucobalhimycin,small molecule,experimental,,[H]N([H])C(=O)C[C@@H]1N([H])C(=O)[C@H](N([H])C(=O)[C@@H](CC(C)C)N([H])C)[C@H](O)C2=CC(Cl)=C(OC3=C(O)C4=CC(=C3)[C@@]([H])(N([H])C1=O)C(=O)N([H])[C@]1([H])C3=CC(=C(O)C=C3)C3=C(C=C(O)C=C3O)[C@H](N([H])C(=O)[C@@]([H])(N([H])C1=O)[C@H](O[C@H]1C[C@](C)(N([H])[H])C(O)(O)[C@H](C)O1)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C=C2,446082
2630,DB02793,Isochorismic Acid,small molecule,experimental,"Acids, Carbocyclic|Cyclohexanecarboxylic Acids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Isomerism",[H][C@]1(O)C(=CC=C[C@]1([H])OC(=C)C([O-])=O)C([O-])=O,5460580
2631,DB02794,"(2S)-2-({4-[(2S)-1-(2-Amino-4-oxo-1,4-dihydro-6-quinazolinyl)-3-{[2-({(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]tetrahydro-2-furanyl}amino)-2-oxoethyl]amino}-2-hydroxy-2-propanyl]benzoyl}ami no)pentanedioic acid",small molecule,experimental,,[H]N([H])C1=NC(=O)C2=C(C=CC(CC(O)(CN([H])CC(=O)N([H])[C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C3=CC=C(C=C3)C(=O)N([H])[C@@H](CCC(O)=O)C(O)=O)=C2)N1[H],446514
2632,DB02795,P-Anisic Acid,small molecule,experimental,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Ethers|Hydroxy Acids|Hydroxybenzoates|Phenols|Phenyl Ethers",COC1=CC=C(C=C1)C(O)=O,7478
2633,DB02796,9-deazainosine,small molecule,experimental,"Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides",[H]N1C=C([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C2=C1C(=O)N=CN2[H],122671
2634,DB02797,3-Nitrophenylboronic Acid,small molecule,experimental,"Acids|Acids, Noncarboxylic|Boron Compounds",OB(O)C1=CC=CC(=C1)[N+]([O-])=O,1677
2635,DB02798,Alpha-Methylene Adenosine Monophosphate,small molecule,experimental,,[H][C@]1(COP(C)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,445093
2636,DB02799,N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide,small molecule,experimental,,CCN(CC)C1=CC2=C(C=C1)C=C(C(=O)N\C=C/N1C(=O)CCC1=O)C(=O)O2,5288792
2637,DB02800,"5-hydroxymethyl-5,6-dihydrofolic acid",small molecule,experimental,,NC1=NC2=C(N(CO)[C@@H](CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=N2)C(=O)N1,6323516
2638,DB02801,"2,3-Anhydro-quinic acid",small molecule,experimental,,[H][C@@]1(O)C[C@@](O)(C=C[C@@]1([H])O)C(O)=O,445905
2639,DB02802,3-(alpha-D-Galactopyranosyloxy)-5-nitrobenzamide,small molecule,experimental,,[H]N([H])C(=O)C1=CC(=CC(O[C@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)=C1)[N+]([O-])=O,446958
2640,DB02803,"3-Phenyl-1,2-Propandiol",small molecule,experimental,,OC[C@@H](O)CC1=CC=CC=C1,446127
2641,DB02804,A-98881,small molecule,experimental,,[H][C@@]1(O)CN(CC2=CC=CC=C2)N(CC2=CC(OC)=C(O)C=C2)C(=O)N(CC2=CC(OC)=C(O)C=C2)[C@]1([H])CC1=CC=CC=C1,447923
2642,DB02805,Arabinouridine 3'-phosphate,small molecule,experimental,,[H]N1C(=O)C=CN([C@@H]2O[C@H](CO)[C@@H](OP(O)(O)=O)[C@@H]2O)C1=O,6915836
2643,DB02806,2-Methoxyethanol,small molecule,experimental,Alcohols|Glycols|Immunologic Factors|Immunosuppressive Agents|Noxae|Solvents|Teratogens|Toxic Actions,COCCO,8019
2644,DB02807,3-deoxy-D-lyxo-hexonic acid,small molecule,experimental,,[H][C@](O)(C[C@@]([H])(O)[C@]([H])(O)CO)C(O)=O,5289313
2645,DB02808,Trifluorofurnesyl Diphosphate,small molecule,experimental,,CC(C)=CCC\C(C)=C\CC\C(=C\CO[P@@](=O)(O)OP(O)(O)=O)C(F)(F)F,449547
2646,DB02809,"Brodimoprim-4,6-Dicarboxylate",small molecule,experimental,,COC1=CC(CC2=C[NH+]=C(N)N=C2N)=CC(OCCC[C@@H](CCC([O-])=O)C([O-])=O)=C1Br,5287754
2647,DB02810,N-(2-Acetamido)Iminodiacetic Acid,small molecule,experimental,"Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Imines",NC(=O)CN(CC(O)=O)CC(O)=O,117765
2648,DB02811,Diethyl phosphonate,small molecule,experimental,,[H]P(=O)(OCC)OCC,6327654
2649,DB02812,RWJ-56423,small molecule,experimental,,[H]N([H])C(=NCCC[C@H](N([H])C(=O)[C@@H]1C[C@@H](O)CN1C(C)=O)C(=O)C1=NC2=CC=CC=C2S1)N([H])[H],5287596
2650,DB02813,"2-Acetamido-2-Deoxy-D-Glucono-1,5-Lactone",small molecule,experimental,,CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1=O,87901
2651,DB02814,3'-Deazo-Thiamin Diphosphate,small molecule,experimental,,CC1=C(CCO[P@](O)(=O)O[P@](O)([O-])=O)SC=[N+]1CC1=C(N)C=C(C)N=C1,5180213
2652,DB02816,"7-(1-Methyl-1,2,3-Triazol-4-Yl)-6-Formyl-2,7-Dihydro-[1,4]Thiazepine-3-Carboxylic Acid, Brl42715, C6-(N1-Methyl-1,2,3-Triazolylmethylene)Penem",small molecule,experimental,,[H][C@@]1(SC=C(NC=C1C=O)C(O)=O)C1=CN(C)N=N1,5288206
2653,DB02817,5-Exo-Hydroxycamphor,small molecule,experimental,,[H][C@@]1(O)C[C@@]2(C)C(=O)C[C@]1([H])C2(C)C,447414
2654,DB02818,Iodo-Willardiine,small molecule,experimental,,N[C@@H](CN1C=C(I)C(=O)NC1=O)C(O)=O,447196
2655,DB02819,"Mono-[3,4-Dihydroxy-5-(5-Methyl-Benzoimidazol-1-Yl)-Tetrahydor-Furan-2-Ylmethyl] Ester",small molecule,experimental,,[H][C@]1(COP(O)(O)=O)O[C@]([H])(N2C=NC3=C2C=CC(C)=C3)[C@]([H])(O)[C@]1([H])O,446491
2656,DB02820,"1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct",small molecule,experimental,,[H][C@@](N1C=NC2=NN(C=C2C1=S)[C@@]1([H])C=CN(C=C1C([O-])=N)[C@]1([H])O[C@]([H])(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])([O-])[C@]2([H])[O-])[C@@]([H])(O)[C@@]1([H])O)(C(=O)N1CCCCCC1)C1=CC=CC=C1,131704220
2657,DB02821,Canaline,small molecule,experimental,"Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Butyrates|Fatty Acids|Fatty Acids, Volatile|Lipids",NOCC[C@H](N)C(O)=O,441443
2658,DB02822,Para-Bromobenzyl Alcohol,small molecule,experimental,Alcohols|Benzene Derivatives|Benzyl Compounds,OCC1=CC=C(Br)C=C1,70119
2659,DB02823,Phosphonoacetic Acid,small molecule,experimental,"Acetates|Acids, Acyclic|Anti-Infective Agents|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|Nucleic Acid Synthesis Inhibitors|Organophosphonates|Organophosphorus Compounds|Reverse Transcriptase Inhibitors",OC(=O)CP(O)(O)=O,546
2660,DB02824,N-Pyridoxyl-Glycine-5-Monophosphate,small molecule,experimental,,CC1=NC=C(COP(O)(O)=O)C(CNCC(O)=O)=C1O,445062
2661,DB02825,Methylphosphinate,small molecule,experimental,,CP([O-])=O,6369389
2662,DB02827,"7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",small molecule,experimental,,[H][C@@]1(COC2=NS(=O)(=O)C3=C2C=CC=C3)OCCC2=C1SC(NC(=O)C(O)=O)=C2C(O)=O,446871
2663,DB02828,5-Fluorolevulinic Acid,small molecule,experimental,Keto Acids,OC(=O)CCC(=O)CF,131153
2664,DB02829,4-(Acetylamino)-3-[(Aminoacetyl)Amino]Benzoic Acid,small molecule,experimental,,CC(=O)NC1=CC=C(C=C1NC(=O)C[NH3+])C(O)=O,446325
2665,DB02830,FR236913,small molecule,experimental,,[H][C@](CO)(CCN1C=CC2=C1C=C(NC(=O)NCC1=CC=CC=C1)C=C2)N1C=NC(=C1)C(N)=O,447546
2666,DB02831,Dihydrogenphosphate,small molecule,experimental,,[H]OP([O-])(=O)O[H],1003
2667,DB02832,Siroheme,small molecule,experimental,"Biological Factors|Heterocyclic Compounds, Fused-Ring|Metalloporphyrins|Pigments, Biological|Porphyrins",C[C@@]1(CC(O)=O)C2=CC3=C(CC(O)=O)C(CCC(O)=O)=C4C=C5N6C(=CC7=C(CCC(O)=O)[C@](C)(CC(O)=O)C8=CC(N2[Fe@]6(N34)N78)=C1CCC(O)=O)C(CC(O)=O)=C5CCC(O)=O,11968291
2668,DB02833,[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine,small molecule,experimental,,CC1=C(SC(N)=N1)C1=NC(NC2=CC=CC(=C2)[N+]([O-])=O)=NC=C1,447961
2669,DB02834,IDD552,small molecule,experimental,"Benzene Derivatives|Hydrocarbons, Fluorinated|Hydrocarbons, Halogenated|Sulfur Compounds",OC(=O)COC1=CC(F)=CC=C1C(=O)NCC1=NC2=C(S1)C(F)=CC(F)=C2F,448658
2670,DB02835,"Alpha-D-Glucose 1,6-Bisphosphate",small molecule,experimental,,O[C@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H](OP(O)(O)=O)[C@@H]1O,82400
2671,DB02836,Guanosine 5'-diphosphate 2':3'-cyclic monophosphate,small molecule,experimental,,[H]N([H])C1=NC(=O)C2=C(N1[H])N(C=N2)[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@]2([H])O[P@](O)(=O)O[C@@]12[H],444825
2672,DB02837,4-(Hydrogen sulfate)-beta-D-galactopyranose,small molecule,experimental,,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1OS(O)(=O)=O,446807
2673,DB02838,"3,4-Dihydro-2h-Pyrrolium-5-Carboxylate",small molecule,experimental,,[O-]C(=O)C1=[NH+]CCC1,440046
2674,DB02839,"2,4-Dihydroxybenzoic Acid",small molecule,experimental,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Hydroxy Acids|Phenols",OC(=O)C1=CC=C(O)C=C1O,1491
2675,DB02840,"4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid",small molecule,experimental,,CCC1=C(O)C=C(O)C(=C1)C1=NNC(C(O)=O)=C1C1=CC=C2OCOC2=C1,5326934
2676,DB02841,[(2-Ethoxy-1-Naphthoyl)Amino]Methylboronic Acid,small molecule,experimental,,CCOC1=C(C(=O)NCB(O)O)C2=C(C=CC=C2)C=C1,5288987
2677,DB02842,9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide,small molecule,experimental,,CN(C)CCCNC(=O)C1=CC=CC2=C(N)C3=C(C=CC=C3)N=C12,150238
2678,DB02843,alpha-D-glucose-1-phosphate,small molecule,experimental,Carbohydrates|Hexosephosphates|Sugar Phosphates,OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@@H]1O,65533
2679,DB02844,"S-Adenosyl-1,8-Diamino-3-Thiooctane",small molecule,experimental,"Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides",[H][C@]1(CSC(CCCCCN)=CCN)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,49866597
2680,DB02845,Methylphosphinic Acid,small molecule,experimental,"Acids|Acids, Noncarboxylic|Cholinesterase Inhibitors|Organophosphorus Compounds|Phosphorus Acids|Phosphorus Compounds",CP(O)=O,6369390
2681,DB02846,L-thioproline,small molecule,experimental,,[H][C@]1(CSCN1)C(O)=O,93176
2682,DB02847,"(2s,3r)-1-Amino-2-Methylbutane-2,3-Diol",small molecule,experimental,,[H][C@](C)(O)[C@@](C)(O)CN,445278
2683,DB02848,"{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol",small molecule,experimental,,CCOC1=C(OCC)C=C2C(NC3=CC=CC(=C3)C3=CSC(CO)=N3)=NC=NC2=C1,5740
2684,DB02849,N-Pyridoxyl-1-Amino-Cyclopropanecarboxylic Acid-5-Monophosphate,small molecule,experimental,,CC1=NC=C(COP(O)(O)=O)C(CNC2(CC2)C(O)=O)=C1O,4324
2685,DB02850,DAS869,small molecule,experimental,,COC1=CC=C(C=C1)C1=C(C)C(=CC=C1S(C)(=O)=O)C(=O)C1=C(O)N(N=C1)C(C)(C)C,5326813
2686,DB02851,Thiocamphor,small molecule,experimental,Bornanes|Ketones|Monoterpenes|Norbornanes|Terpenes,[H][C@@]12CC[C@@](C)(C(=S)C1)C2(C)C,1714210
2687,DB02852,Domoic Acid,small molecule,experimental,Central Nervous System Depressants|Marine Toxins|Neuromuscular Agents|Neurotoxins|Peripheral Nervous System Agents|Pyrrolidines,[H]\C(\C(\[H])=C(\C)[C@@]1([H])CN[C@]([H])(C(O)=O)[C@@]1([H])CC(O)=O)=C(\[H])[C@@]([H])(C)C(O)=O,5282253
2688,DB02853,D-Proline,small molecule,experimental,,OC(=O)[C@H]1CCCN1,8988
2689,DB02854,Aetiocholanolone,small molecule,experimental,,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@]([H])(O)CC[C@]12C,5880
2690,DB02855,N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Cathepsin B, antagonists & inhibitors|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Cysteine Proteinase Inhibitors|Enzyme Inhibitors|Neuroprotective Agents|Oligopeptides|Peptides|Protease Inhibitors|Protective Agents",[H][C@](O)(CC(=O)N[C@]([H])(C(=O)N1CCC[C@@]1([H])C(O)=O)[C@@]([H])(C)CC)C(=O)NCCC,5287408
2691,DB02856,Ethyl N-methylcarbamate,small molecule,experimental,"Acids, Acyclic|Carbamates",CCOC(=O)NC,7752
2692,DB02857,Guanosine,small molecule,experimental|investigational,"Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides",NC1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N1,6802
2693,DB02858,3-(4-Benzenesulfonyl-Thiophene-2-Sulfonylamino)-Phenylboronic Acid,small molecule,experimental,,OB(O)C1=CC(NS(=O)(=O)C2=CC(=CS2)S(=O)(=O)C2=CC=CC=C2)=CC=C1,1475
2694,DB02859,Soraphen A,small molecule,experimental,Lactones|Polyketides,[H]\C1=C([H])/[C@@]([H])(OC)[C@]([H])(CCCC[C@]([H])(OC(=O)[C@@]([H])(C)[C@@]2(O)O[C@]([H])([C@@]([H])(C)[C@]([H])(O)[C@@]2([H])OC)[C@@]1([H])C)C1=CC=CC=C1)OC,5281897
2695,DB02860,Calyculin A,small molecule,experimental,"Carcinogens|Cardiovascular Agents|Enzyme Inhibitors|Noxae|Phosphoprotein Phosphatases, antagonists & inhibitors|Toxic Actions|Vasoconstrictor Agents",[H][C@@]1(O[C@]2(C[C@@H](O)[C@H](C)[C@H](C\C=C\C3=COC(=N3)[C@@H](C)CCNC(=O)[C@@H](O)[C@@H](O)[C@H](COC)N(C)C)O2)C(C)(C)[C@H]1OP(O)(O)=O)[C@H](C[C@H](O)[C@H](C)[C@H](O)[C@H](C)\C=C(/C)\C(\C)=C\C=C\C(\C)=C/C#N)OC,5311365
2696,DB02861,"4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide",small molecule,experimental,,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=CC(F)=C(F)C(F)=C1,446242
2697,DB02862,Gluco-Phenylimidazole,small molecule,experimental,,[H][C@]1(CO)N2C=C(N=C2[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O)C1=CC=CC=C1,5288604
2698,DB02864,Biliverdin Ix Gamma Chromophore,small molecule,experimental,,[H]\C(=C1\N\C(=C(\[H])C2=NC(=O)C(CCC(O)=O)=C2C)C(C=C)=C1C)C1=C(C=C)C(C)=C(N1)C(\[H])=C1/N=C(O)C(CCC(O)=O)=C1C,5839041
2699,DB02865,Glucosamine 4-Phosphate,small molecule,experimental,Amino Sugars|Carbohydrates|Hexosamines|Hexosephosphates|Sugar Phosphates,N[C@H]1[C@H](O)O[C@H](CO)[C@@H](OP(O)(O)=O)[C@@H]1O,448057
2700,DB02866,Dansylamide,small molecule,experimental,"Coloring Agents|Compounds used in a research, industrial, or household setting|Fluorescent Dyes|Indicators and Reagents|Laboratory Chemicals|Luminescent Agents|Naphthalenes|Sulfones|Sulfur Compounds",CN(C)C1=C2C=CC=C(C2=CC=C1)S(N)(=O)=O,65077
2701,DB02867,D-Mannose 1-Phosphate,small molecule,experimental,,OC[C@H]1OC(OP(O)(O)=O)[C@@H](O)[C@@H](O)[C@@H]1O,644175
2702,DB02868,Deacetoxyvinzolidine,small molecule,experimental,"Alkaloids|Antineoplastic Agents|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|Secologanin Tryptamine Alkaloids|Vinca Alkaloids",[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)(C[C@@]22OC(=O)N(CCCl)C2=O)[C@@]13[H])[C@]1(C[C@H]2CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC,157684
2703,DB02869,3-amino-5-phenylpentane,small molecule,experimental,,[H][C@](N)(CCC1=CC=CC=C1)C=CS(=O)(=O)C1=CC=CC=C1,10086234
2704,DB02870,N-Allylaniline,small molecule,experimental,,C=CCNC1=CC=CC=C1,68525
2705,DB02871,3-Butylthiolane 1-Oxide,small molecule,experimental,"Alcohol Dehydrogenase, antagonists & inhibitors|Sulfur Compounds",[H][C@]1(CCCC)CC[S@](=O)C1,9543528
2706,DB02872,"Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone",small molecule,experimental,,[H][C@]1(N=C(N(C(=O)N2CCN(CCO)CC2)[C@]1([H])C1=CC=C(Br)C=C1)C1=C(OCC)C=C(OC)C=C1)C1=CC=C(Br)C=C1,5288631
2707,DB02873,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One",small molecule,experimental,,FC1=CC=C(C(F)=C1)C1=C2CNC(=O)N(C2=CC(=C1)N1CCNCC1)C1=C(Cl)C=CC=C1Cl,4630909
2708,DB02875,CRA_1802,small molecule,experimental,,NC(=[NH2+])C1=CC=C2NC(=NC2=C1)C1=CC(F)=CC=C1[O-],10869340
2709,DB02876,"3-(4-carbamoyl-1-carboxy-2-methylsulfonyl-buta-1,3-dienylamino)-indolizine-2-carboxylic acid",small molecule,experimental,,[H]C(=C([H])C(\CS(=O)=O)=C(\NC1=C(C=O)C=C2C=CC=CN12)C(O)=O)C(O)=N,6399008
2710,DB02877,Arotinoid acid,small molecule,experimental,"Acids, Carbocyclic|Alkenes|Benzene Derivatives|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Terpenes",C\C(=C/C1=CC=C(C=C1)C(O)=O)C1=CC=C2C(=C1)C(C)(C)CCC2(C)C,5289501
2711,DB02878,3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid,small molecule,experimental,,[H][C@](CN)(CCC(O)=O)[C@]([H])(CCN)CC(O)=O,5289108
2712,DB02879,"2,3-Di-O-Sulfo-Alpha-D-Glucopyranose",small molecule,experimental,,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(OS(O)(=O)=O)[C@@]1([H])OS(O)(=O)=O,447561
2713,DB02880,N-[(1R)-1-(4-Bromophenyl)ethyl]-5-fluoro-2-hydroxybenzamide,small molecule,experimental,,[H]N([C@H](C)C1=CC=C(Br)C=C1)C(=O)C1=C(O)C=CC(F)=C1,5496910
2714,DB02881,4-(4-Hydroxy-3-Isopropylphenylthio)-2-Isopropylphenol,small molecule,experimental,,CC(C)C1=CC(SC2=CC=C(O)C(=C2)C(C)C)=CC=C1O,448797
2715,DB02882,Cyanocinnoline,small molecule,experimental,,NCC1=C(N=CC=C(C2=CC=CC=C2)C2=CC=CC=C2)C2=CC=CC=C2N=N1,6323416
2716,DB02883,"2',3'-Dideoxycytidine-5'-Monophosphate",small molecule,experimental,,NC1=NC(=O)N(C=C1)[C@H]1CC[C@@H](COP(O)(O)=O)O1,446696
2717,DB02884,3-Cyclohexyl-L-alanine,small molecule,experimental,,N[C@@H](CC1CCCCC1)C(O)=O,712421
2718,DB02885,4-Imino-5-Methidyl-2-Trifluoromethylpyrimidine,small molecule,experimental,,FC(F)(F)C1=NC(=N)C(=C)C=N1,4635111
2719,DB02887,Stavudine triphosphate,small molecule,experimental,"Carbohydrates|Deoxyribonucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines",CC1=CN([C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C=C2)C(=O)NC1=O,65355
2720,DB02888,FKB-001,small molecule,experimental,,COC1=CC(=CC(OC)=C1OC)C(F)(F)C(=O)N1CCCC[C@H]1C(=O)O[C@@H](CCCC1=CC=CC=C1)CCCC1=CN=CC=C1,446414
2721,DB02889,"4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose",small molecule,experimental,,[H][C@]1(C)O[C@]([H])(O[C@]2([H])[C@@]([H])(CO)O[C@]([H])(O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])N[C@@]1([H])C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O,449164
2722,DB02890,6-hydroxyuridine-5'-phosphate,small molecule,experimental,,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)N1C(=O)NC(=O)C=C1O,161647
2723,DB02891,Tricyclazole,small molecule,experimental|investigational,Sulfur Compounds,CC1=C2N3C=NN=C3SC2=CC=C1,39040
2724,DB02892,L-2-Amino-6-Methylene-Pimelic Acid,small molecule,experimental,,N[C@@H](CCCC(=C)C(O)=O)C(O)=O,445478
2725,DB02893,D-Methionine,small molecule,approved|experimental|investigational,,CSCC[C@@H](N)C(O)=O,84815
2726,DB02894,"Sulfamic Acid 2,3-O-(1-Methylethylidene)-4,5-O-Sulfonyl-Beta-Fructopyranose Ester",small molecule,experimental,,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OS(=O)(=O)O2,445393
2727,DB02895,3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol,small molecule,experimental,,S\C=C\C[S@](=O)CC=C,9543424
2728,DB02896,Methylthioinosine,small molecule,experimental,"Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides|Sulfur Compounds|Thioinosine|Thionucleosides",CSC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,9570
2729,DB02897,Acetylphosphate,small molecule,experimental,,CC(=O)OP(O)(O)=O,186
2730,DB02898,(5R)-5-{[(2-Amino-3H-purin-6-yl)oxy]methyl}-2-pyrrolidinone,small molecule,experimental,,NC1=NC2=C(N=CN2)C(OC[C@H]2CCC(=O)N2)=N1,445966
2731,DB02899,N-Carboxymethionine,small molecule,experimental,,[H][C@@](CCSC)(NC(O)=O)C(O)=O,17753927
2732,DB02900,alpha-D-mannose 6-phosphate,small molecule,experimental,,O[C@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@@H]1O,447096
2733,DB02901,Stanolone,small molecule,illicit|investigational,"5-Androstanon (3) Derivatives|Alimentary Tract and Metabolism|Anabolic Agents for Systemic Use|Anabolic Steroids|Androgens|Androstan Derivatives|Androstanes|Androstanols|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|P-glycoprotein substrates|Sex Hormones and Modulators of the Genital System|Steroids|Testosterone and derivatives|Testosterone Congeners|Thyroxine-binding globulin inhibitors",[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C,10635
2734,DB02902,3'-phospho-5'-adenylyl sulfate,small molecule,experimental,,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OS(O)(=O)=O)[C@@H](OP(O)(O)=O)[C@H]1O,10214
2735,DB02903,"1,3-bis-([[3-(4-{3-[3-nitro-5-(galactopyranosyloxy)-benzoylamino]-propyl}-piperazin-1-yl)-propylamino-3,4-dioxo-cyclobutenyl]-amino-ethyl]-amino-carbonyloxy)-2-amino-propane",small molecule,experimental,,NC(CO\C(O)=N\CCNC1=C(NCCCN2CCN(CCC\N=C(/O)C3=CC(=CC(OC4OC(CO)C(O)C(O)C4O)=C3)[N+]([O-])=O)CC2)C(=O)C1=O)CO\C(O)=N\CCNC1=C(NCCCN2CCN(CCC\N=C(/O)C3=CC(=CC(O[C@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)=C3)[N+]([O-])=O)CC2)C(=O)C1=O,131704221
2736,DB02904,Beta-3-Serine,small molecule,experimental,,[H][C@](CN)(CO)C(O)=O,17753872
2737,DB02905,N7-(5'-Phospho-alpha-ribosyl)-2-hydroxypurine,small molecule,experimental,,O[C@@H]1[C@@H](COP(O)(O)=O)O[C@@H]([C@@H]1O)N1C=NC2=C1C=NC(=O)N2,446493
2738,DB02906,"(2s,4s)-Alpha-Campholinic Acid",small molecule,experimental,,[H][C@@]1(C)C(=O)C[C@@]([H])(CC(O)O)C1(C)C,5287884
2739,DB02907,2-Amino-Vinyl-Phosphate,small molecule,experimental,,N\C=C\OP(O)(O)=O,6120722
2740,DB02908,RU78783,small molecule,experimental,,OP(O)(=O)C(C1=CC=CC=C1)P(O)(O)=O,447537
2741,DB02909,5-(2-Chlorophenyl)Furan-2-Carboxylic Acid,small molecule,experimental,,OC(=O)C1=CC=C(O1)C1=CC=CC=C1Cl,784625
2742,DB02910,Octanoyl-Coenzyme A,small molecule,experimental,"Adenine Nucleotides|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides|Thioesters of coenzyme A",CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N,445344
2743,DB02911,"2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine",small molecule,experimental,,[H][C@]1(CNC2=C(N1)C(N)=NC(N)=N2)C1=CC=CC=C1,445109
2744,DB02912,Propanoyl-CoA,small molecule,experimental,"Adenine Nucleotides|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides|Thioesters of coenzyme A",CCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N,92753
2745,DB02914,Anhydrovitamin A,small molecule,experimental,"Alkenes|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Retinoids|Terpenes",C\C(C=C)=C/C=C/C(/C)=C/C=C1/C(C)=CCCC1(C)C,5287678
2746,DB02915,"4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine",small molecule,experimental,,CC1=NC(C)=C(S1)C1=CC=NC(NC2=CC=C(C=C2)C(F)(F)F)=N1,447958
2747,DB02916,"[(2r,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydro-2-Furanyl]Methyl Sulfamate",small molecule,experimental,,[H][C@]1(COS(N)(=O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,97576
2748,DB02917,N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide,small molecule,experimental,,CN(C1=CC=C(C=C1)C(=O)NO)S(=O)(=O)C1=CC=C(S1)C1=NC=CC=C1,449096
2749,DB02918,Zardaverine,small molecule,experimental,Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Enzyme Inhibitors|Peripheral Nervous System Agents|Phosphodiesterase Inhibitors|Respiratory System Agents,COC1=CC(=CC=C1OC(F)F)C1=NNC(=O)C=C1,5723
2750,DB02919,"2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",small molecule,experimental,,COC1=CC(CN(C)C2=CN=C3N=C(N)N=C(N)C3=C2)=CC(OC)=C1OC,447229
2751,DB02920,Zn(Ii)-(20-Oxo-Protoporphyrin Ix),small molecule,experimental,,CC1=C(CCC(O)=O)C2=CC3=C(CCC(O)=O)C(C)=C4N3[Zn]35N2C1=CC1=C(C=C)C(C)=C(C=C2N3C(C(C)=C2C=C)=C4O)N51,131704222
2752,DB02921,(South)-Methanocarba-Thymidine,small molecule,experimental,,CC1=CN(C(=O)NC1=O)[C@]12C[C@H]1[C@H](CO)[C@@H](O)C2,447628
2753,DB02922,Hexafluoroacetone Hydrate,small molecule,experimental,"Hydrocarbons, Fluorinated|Hydrocarbons, Halogenated|Ketones",OC(O)(C(F)(F)F)C(F)(F)F,69617
2754,DB02923,"Biphenyl-2,3-Diol",small molecule,experimental,,OC1=C(O)C(=CC=C1)C1=CC=CC=C1,254
2755,DB02924,"(4R)-limonene 1α,2α-epoxide",small molecule,experimental,,CC(=C)[C@@H]1CC[C@@]2(C)O[C@H]2C1,6857487
2756,DB02925,Piretanide,small molecule,approved,Amides|Cardiovascular Agents|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|High-Ceiling Diuretics|Membrane Transport Modulators|Natriuretic Agents|Sodium Potassium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds,NS(=O)(=O)C1=CC(=CC(N2CCCC2)=C1OC1=CC=CC=C1)C(O)=O,4849
2757,DB02927,"Mixed Carbamic Phosphoric Acid Anhydride of 7,8-Diaminononanic Acid",small molecule,experimental,,C[C@H](N)[C@@H](CCCCCC(O)=O)NC(=O)OP(O)(O)=O,445026
2758,DB02928,3-Amino-6-Hydroxy-Tyrosine,small molecule,experimental,,N[C@@H](CC1=CC(N)=C(O)C=C1O)C(O)=O,17754207
2759,DB02929,K201 free base,small molecule,experimental|investigational,,COC1=CC=C2SCCN(CC2=C1)C(=O)CCN1CCC(CC2=CC=CC=C2)CC1,1715
2760,DB02930,Adenosine 5'-[gamma-thio]triphosphate,small molecule,experimental,"Adenine Nucleotides|Affinity Labels|Carbohydrates|Compounds used in a research, industrial, or household setting|Glycosides|Heterocyclic Compounds, Fused-Ring|Indicators and Reagents|Laboratory Chemicals|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=S)[C@@H](O)[C@H]1O,440317
2761,DB02931,CoA-s-acetyl tryptamine,small molecule,experimental,,[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)N([H])CCC(=O)N([H])CCSCC(=O)N([H])CCC4=CN([H])C5=CC=CC=C45)[C@@H](OP(O)(O)=O)[C@H]3O)C2=NC=N1,444837
2762,DB02932,(R)-Bicalutamide,small molecule,experimental,,C[C@](O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC1=CC(=C(C=C1)C#N)C(F)(F)F,56069
2763,DB02933,5'-Deoxy-5'-(Methylthio)-Tubercidin,small molecule,experimental,,[H][C@]1(CSC)O[C@@]([H])(N2C=CC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,188350
2764,DB02934,9-(6-deoxy-alpha-L-talofuranosyl)-6-methylpurine,small molecule,experimental,,[H][C@@](C)(O)[C@@]1([H])O[C@@]([H])(N2C=NC3=C(C)N=CN=C23)[C@]([H])(O)[C@]1([H])O,447722
2765,DB02935,Diglyme,small molecule,experimental,Alcohols|Ethers|Glycols,COCCOCCOC,8150
2766,DB02936,4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid,small molecule,experimental,,CC1=C(CC(N)=O)C2=C(C=CC(OCCCC(O)=O)=C2)N1CC1=CC=CC=C1,3710
2767,DB02937,"Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate",small molecule,experimental,,[H][C@]1(COP(O)(=O)OP(O)(=O)C[As](O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,42626649
2768,DB02938,Heptanoic acid,small molecule,experimental|investigational,,CCCCCCC(O)=O,8094
2769,DB02940,"(4s)-2-[(1e)-1-Aminoprop-1-Enyl]-4,5-Dihydro-1,3-Thiazole-4-Carboxylic Acid",small molecule,experimental,,[H][C@@]1(CSC(=N1)C(\N)=C\C)C(O)=O,5289509
2770,DB02941,3-(1-Aminoethyl)Nonanedioic Acid,small molecule,experimental,,[H][C@@](C)(N)[C@@]([H])(CCCCCC(O)=O)CC(O)=O,5497016
2771,DB02942,"Inositol 1,3-Bisphosphate",small molecule,experimental,Alcohols|Carbohydrates|Sugar Alcohols|Sugar Phosphates,O[C@H]1[C@H](O)[C@@H](OP(O)(O)=O)[C@@H](O)[C@@H](OP(O)(O)=O)[C@@H]1O,128419
2772,DB02943,N-(4-Aminobutanoyl)-S-(4-methoxybenzyl)-L-cysteinylglycine,small molecule,experimental,,[H]N([H])CCCC(=O)N([H])[C@@H](CSCC1=CC=C(OC)C=C1)C(=O)N([H])CC(O)=O,447867
2773,DB02945,alpha-L-iduronic acid,small molecule,experimental,,[H][C@@]1(O)O[C@@]([H])(C(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O,446102
2774,DB02946,Carpropamide,small molecule,experimental,,CC[C@]1([C@@H](C)C1(Cl)Cl)C(=O)N[C@H](C)C1=CC=C(Cl)C=C1,449402
2775,DB02947,2-Fluoro-2'-Deoxyadenosine,small molecule,experimental,,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])CO)N1C=NC2=C(N)N=C(F)N=C12,447864
2776,DB02948,Fosmidomycin,small molecule,experimental|investigational,Anti-Bacterial Agents|Anti-Infective Agents|Organophosphonates|Organophosphorus Compounds,ON(CCCP(O)(O)=O)C=O,572
2777,DB02949,2-Acetyl-Protoporphyrin Ix,small molecule,experimental,,CC1=C2C=C3[C@@H](C(O)=C)C(C)=C4C=C5N6C(=CC7=C(CCC(O)=O)C(C)=C8C=C([C@@H]1C=C)N2[Fe@@]6(N34)N78)C(CCC(O)=O)=C5C,17754017
2778,DB02950,Hymenialdisine,small molecule,experimental,"Interleukin-8, antagonists & inhibitors",[H][C@@]12C=C(Br)N=C1C(=O)NCC[C@]2([H])C1=NC(N)=NC1=O,17754027
2779,DB02951,3-Hydroxypyruvic Acid,small molecule,experimental,Keto Acids,OCC(=O)C(O)=O,964
2780,DB02952,2-aminoisobutyric acid,small molecule,experimental,"Acids, Acyclic|Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Peptides, and Proteins|Aminobutyrates|Butyrates|Fatty Acids|Fatty Acids, Volatile|Isobutyrates|Lipids",CC(C)(N)C(O)=O,6119
2781,DB02953,2-Thiomethyl-3-Phenylpropanoic Acid,small molecule,experimental,,[H][C@](CS)(CC1=CC=CC=C1)C(O)=O,5287850
2782,DB02954,(Carboxyhydroxyamino)Ethanoic Acid,small molecule,experimental,,ON(CC(O)=O)C(O)=O,4633094
2783,DB02955,Ricinoleic Acid,small molecule,experimental,"Biological Products|Complex Mixtures|Fats|Fats, Unsaturated|Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Lipids|Oils|Oleic Acids|Plant Oils|Plant Preparations",[H]\C(CCCCCCCC(O)=O)=C(/[H])C[C@]([H])(O)CCCCCC,643684
2784,DB02956,Pentasulfide-Sulfur,small molecule,experimental,,[S-]SSS[S-],5289210
2785,DB02957,Orotidylic acid,small molecule,experimental,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides|Uracil Nucleotides",O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)N1C(=O)NC(=O)C=C1C(O)=O,160617
2786,DB02958,Selenomethionine Selenoxide,small molecule,experimental,Selenium Compounds,[H][C@](N)(CC[Se](C)=O)C(O)=O,17754089
2787,DB02959,Oxitriptan,small molecule,approved|investigational|nutraceutical,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Antidepressive Agents|Antidepressive Agents, Second-Generation|Central Nervous System Agents|Central Nervous System Depressants|Nervous System|Psychoanaleptics|Psychotropic Drugs|Tryptophan",N[C@@H](CC1=CNC2=C1C=C(O)C=C2)C(O)=O,439280
2788,DB02960,1-Carboxyethylaminomethyl-4-Aminomethylbenzene,small molecule,experimental,,[NH3+]CC1=CC=C(CNCCC(O)=O)C=C1,5158928
2789,DB02961,Rhamnose,small molecule,experimental,"Carbohydrates|Deoxy Sugars|Rhamnose, metabolism",[H][C@@](C)(O)[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(O)C=O,19233
2790,DB02962,Benzimidazole,small molecule,experimental|investigational,"Anthelmintics|Anti-Infective Agents|Antiparasitic Agents|Heterocyclic Compounds, Fused-Ring",N1C=NC2=CC=CC=C12,5798
2791,DB02963,"(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine",small molecule,experimental,,CS(=O)(=O)C1=CC=C(NC2=CC(Cl)=NC3=CC=NN23)C=C1,5287989
2792,DB02964,"8,9,10-Trihydroxy-7-hydroxymethyl-2-thioxo-6-oxa-1,3-diaza-spiro[4.5]decan-4-one",small molecule,experimental,,OC[C@H]1O[C@@]2(NC(=S)NC2=O)[C@H](O)[C@@H](O)[C@@H]1O,4369162
2793,DB02965,Ndelta-(N'-Sulphodiaminophosphinyl)-L-Ornithine,small molecule,experimental,,[H][C@](N)(CCCN[P@@](N)(=O)NS(O)(=O)=O)C(O)=O,9543429
2794,DB02966,Fluoro-Willardiine,small molecule,experimental,,N[C@@H](CN1C=C(F)C(=O)NC1=O)C(O)=O,126569
2795,DB02967,N-Ethylmaleimide,small molecule,experimental,"Compounds used in a research, industrial, or household setting",CCN1C(=O)C=CC1=O,4362
2796,DB02968,Penicillin G Acyl-Serine,small molecule,experimental,Agents causing hyperkalemia,[H][C@](N)(COC(=O)[C@@]([H])(N=C([O-])CC1=CC=CC=C1)[C@]1([H])N[C@@]([H])(C(O)=O)C(C)(C)S1)C([O-])=O,131704224
2797,DB02969,5-(2-hydroxyethyl)-4-methylthiazole,small molecule,experimental,Sulfur Compounds,CC1=C(CCO)SC=N1,1136
2798,DB02970,2-Propyl-Aniline,small molecule,experimental,,CCCC1=CC=CC=C1N,15759
2799,DB02971,2-Amino-4-(2-Amino-Ethoxy)-Butyric Acid,small molecule,experimental,,[H][C@](N)(CCOCCN)C(O)=O,446250
2800,DB02972,1-Benzyl-(R)-Propylamine,small molecule,experimental,,CC[C@H](N)CC1=CC=CC=C1,40472480
2801,DB02973,4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide,small molecule,experimental,,NS(=O)(=O)C1=CC=C(C=C1)\N=N\C1=C2C=C(Br)C=CC2=NC1=O,1707
2802,DB02974,4-(4-Chlorophenyl)Imidazole,small molecule,experimental,,ClC1=CC=C(C=C1)C1=CN=CN1,448632
2803,DB02975,GE-2270A,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Peptides|Sulfur Compounds",[H][C@]1(NC(=O)CNC(=O)C2=C(COC)SC(=N2)[C@@H](NC(=O)C2=C(C)SC(=N2)[C@H](CC(=O)NC)NC(=O)C2=CSC(=N2)C2=CC=C(N=C2C2=CSC(=N2)C2=CSC1=N2)C1=NC(=CS1)C1=N[C@@H](CO1)C(=O)N1CCC[C@H]1C(N)=O)C(C)C)[C@@H](O)C1=CC=CC=C1,16186054
2804,DB02976,Uridine-5'-diphosphate-2-deoxy-2-fluorogalactose,small molecule,experimental,,[H]N1C(=O)C=CN([C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)O[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@@]3([H])F)[C@@H](O)[C@H]2O)C1=O,445795
2805,DB02977,PNU177836,small molecule,experimental,,[H][C@@](O)(N[C@@]([H])(CC1=CC=CC=C1)[C@]([H])(O)N[C@@]([H])(CC1=CC(C(O)=O)=C(OCC(O)=O)C=C1)[C@@]([H])(O)NCCCCC)OC(C)(C)C,5289442
2806,DB02978,Beta-Hydroxyleucine,small molecule,experimental,"Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins",CC(C)[C@H](O)[C@H](N)C(O)=O,6994741
2807,DB02979,"N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane",small molecule,experimental,,CS\C(N)=N\CCCCCCCCCCCCCC\N=C(/N)SC,11740154
2808,DB02980,Thymidine-5'-(dithio)phosphate,small molecule,experimental,,[H]N1C(=O)N(C=C(C)C1=O)[C@H]1C[C@H](O)[C@@H](COP(O)(S)=S)O1,6858204
2809,DB02981,Vitamin B6 Complexed with 2-Amino-Hexanoic Acid,small molecule,experimental,,[H][C@@](CCCC)(NCC1=C(COP(O)(O)=O)C=NC(C)=C1O)C(O)=O,444862
2810,DB02982,Bombykol,small molecule,experimental,Alcohols|Lipids,[H]\C(CCC)=C(/[H])\C(\[H])=C(/[H])CCCCCCCCCO,445128
2811,DB02983,Para-Mercury-Benzenesulfonic Acid,small molecule,experimental,,OS(=O)(=O)C1=CC=C([Hg])C=C1,65258
2812,DB02984,"4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline",small molecule,experimental,,COC1=CC2=NC=NC(NC3=CC(SC)=CC=C3)=C2C=C1OC,1714
2813,DB02985,8-iodo-guanine,small molecule,experimental,,NC1=NC(=O)C2=C(N1)N=C(I)N2,444737
2814,DB02986,"N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide",small molecule,experimental,,NS(=O)(=O)C1=CC=C(S1)S(=O)(=O)NCC1=CC=CS1,4293
2815,DB02987,Cysteine-S-acetamide,small molecule,experimental,"Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Sulfhydryl Compounds|Sulfur Compounds",N[C@@H](CSCC(N)=O)C(O)=O,17754220
2816,DB02988,Imino-Tryptophan,small molecule,experimental,,[H]N=C(CC1=CNC2=CC=CC=C12)C(O)=O,5599
2817,DB02989,CRA_10972,small molecule,experimental,,CC(C)COC1=CC=CC(C2=NC3=C(N2)C=C(Cl)C(=C3)C(N)=N)=C1O,5326669
2818,DB02990,S-(2-Acetamidoethyl) hexadecanethioate,small molecule,experimental,,CCCCCCCCCCCCCCCC(=O)SCCNC(C)=O,3378216
2819,DB02991,S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea,small molecule,experimental,,CCS\C(N)=N\C1=CC=C(C=C1)C(F)(F)F,3311
2820,DB02992,1-Deoxy-6-O-Phosphono-1-[(Phosphonomethyl)Amino]-L-Threo-Hexitol,small molecule,experimental,,[H][C@@](O)(CNCP(O)(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)COP(O)(O)=O,447811
2821,DB02993,8-Methyl-9-Oxoguanine,small molecule,experimental,,CC1=NC2=C(O1)N=C(N)NC2=O,446312
2822,DB02994,Cacodylic acid,small molecule,experimental,"Agrochemicals|Arsenicals|Compounds used in a research, industrial, or household setting|Herbicides|Organometallic Compounds|Pesticides|Toxic Actions",C[As](C)(O)=O,2513
2823,DB02995,Cyclohexylammonium Ion,small molecule,experimental,,[NH3+]C1CCCCC1,1549093
2824,DB02996,2-(Thiomethylene)-4-Methylpentanoic Acid,small molecule,experimental,,[H][C@](CS)(CC(C)C)C(O)=O,17754166
2825,DB02998,Metribolone,small molecule,experimental,Estranes|Estrenes|Fused-Ring Compounds|Steroids,[H][C@@]12CC[C@](C)(O)[C@@]1(C)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H],261000
2826,DB02999,Quisqualic acid,small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins|Excitatory Amino Acid Agents|Excitatory Amino Acid Agonists|Neurotransmitter Agents|Oxadiazoles|Oxazoles",N[C@@H](CN1OC(=O)NC1=O)C(O)=O,40539
2827,DB03000,S-9-(2-hydroxypropyl)adenine,small molecule,experimental,,[H][C@@](C)(O)CN1C=NC2=C(N)N=CN=C12,445210
2828,DB03001,Peridinin,small molecule,experimental,"Alkenes|Biological Factors|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Terpenes",CC(=O)O[C@H]1CC(C)(C)C(=C=C\C(C)=C\C=C\C=C\C=C(/C)\C=C2/OC(=O)C(\C=C\[C@@]34O[C@]3(C)C[C@@H](O)CC4(C)C)=C2)[C@](C)(O)C1,5289155
2829,DB03002,p-Iodophenol,small molecule,experimental,"Benzene Derivatives|Hydrocarbons, Halogenated|Hydrocarbons, Iodinated",OC1=CC=C(I)C=C1,10894
2830,DB03003,Glutathione sulfonic acid,small molecule,experimental,,[H]N([H])[C@@H](CCC(=O)N([H])[C@@H](CS(O)(=O)=O)C(=O)N([H])CC(O)=O)C(O)=O,444104
2831,DB03004,"(2S)-2-amino-6-[[(3R,4R)-1-[(1S)-1-carboxy-2-[(S)-methylsulfinyl]ethyl]-2-oxo-4-sulfanylazetidin-3-yl]amino]-6-oxohexanoic acid",small molecule,experimental,,[H]N([H])[C@@H](CCCC(=O)N([H])[C@@H]1C(=O)N([C@H](C[S@](C)=O)C(O)=O)[C@]1([H])S)C(O)=O,9600398
2832,DB03005,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium",small molecule,experimental,,NC1=CC2=C(C=C1)C1=CC=C(N)C=C1C(C1=CC=CC=C1)=[N+]2CCCCCCC1=CN=NN1CCNC1=C2CCCCC2=NC2=C1C=CC=C2,5289508
2833,DB03006,Arsanilic acid,small molecule,experimental|vet_approved,"Adjuvants, Immunologic|Alkenes|Anti-Infective Agents|Arsenicals|Compounds used in a research, industrial, or household setting|Hydrocarbons, Acyclic|Immunologic Factors|Organometallic Compounds|Protective Agents|Radiation-Protective Agents|Tellurium",NC1=CC=C(C=C1)[As](O)(O)=O,7389
2834,DB03007,"9r,13r-Opda",small molecule,experimental,,[H][C@@]1(CCCCCCCC(O)=O)C=CC(=O)[C@]1([H])CC=CCC,49867442
2835,DB03008,5-fluoro-beta-L-gulosyl fluoride,small molecule,experimental,Carbohydrates|Monosaccharides,[H][C@]1(O)[C@@]([H])(O)[C@]([H])(O)[C@](F)(CO)OC1([H])F,131704225
2836,DB03009,2-{[2-Oxo-2-(1-piperidinyl)ethyl]sulfanyl}-6-(trifluoromethyl)-4(1H)-pyrimidinone,small molecule,experimental,,[H]N1C(SCC(=O)N2CCCCC2)=NC(=O)C=C1C(F)(F)F,448768
2837,DB03010,Patupilone,small molecule,experimental|investigational,Anti-Bacterial Agents|Antimitotic Agents|Antineoplastic Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Mitosis Modulators|Polyketides|Tubulin Modulators,[H]\C(=C(\C)[C@]1([H])C[C@]2([H])O[C@]2(C)CCC[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C(C)(C)[C@@]([H])(O)CC(=O)O1)C1=CSC(C)=N1,448013
2838,DB03011,Adenosine-5'-(Dithio)Phosphate,small molecule,experimental,,[H][C@]1(COP(O)(S)=S)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)C([H])(O)[C@]1([H])O,131704226
2839,DB03012,Phenylalanine-N-Sulfonamide,small molecule,experimental,,[H][C@@](CC1=CC=CC=C1)(NS(N)(=O)=O)C(O)=O,446382
2840,DB03013,N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine,small molecule,experimental,,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2NC(C)=O)[C@@H]1O,439326
2841,DB03015,"6-hydroxy-1,6-dihydro purine nucleoside",small molecule,experimental,,[H]N1C=[N+]([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C2=C1[C@H](O)N=CN2[H],5289205
2842,DB03016,CRA_1801,small molecule,experimental,,NC(=N)C1=CC2=C(C=C1)N=C(N2)C1=C(O)C=CC=N1,5326682
2843,DB03017,Lauric acid,small molecule,approved|experimental,Fatty Acids|Lipids,CCCCCCCCCCCC(O)=O,3893
2844,DB03018,"3,4-dimethylaniline",small molecule,experimental,Amines,CC1=CC=C(N)C=C1C,7248
2845,DB03019,"4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine",small molecule,experimental,,NC1=NC=CC(=N1)C1=C(Cl)SC(Cl)=C1,447955
2846,DB03020,5-beta-D-ribofuranosylnicotinamide adenine dinucleotide,small molecule,experimental,,NC(=O)C1=C[NH+]=CC(=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O,444215
2847,DB03021,Ulapualide A,small molecule,experimental,Ionophores,[H]C(=C([H])C([H])(C)C([H])(OC(C)=O)[C@]([H])(C)C(=O)CC[C@]([H])(C)[C@]([H])(C[C@]1([H])OC(=O)C[C@@]([H])(O)CCCC(=O)C[C@]([H])(C)C2=COC(=N2)C2=COC(=N2)C2=COC(=N2)\C([H])=C([H])\C[C@]([H])(OC)[C@@]1([H])C)OC)N(C)CO,131704227
2848,DB03022,"3-[2,6,8-Trioxo-9-[(2R,3S,4R)-2,3,4,5-tetrahydroxypentyl]-3H-purin-7-yl]propyl dihydrogen phosphate",small molecule,experimental,,[H]N1C2=C(N(CCCOP(O)(O)=O)C(=O)N2C[C@@H](O)[C@H](O)[C@H](O)CO)C(=O)N([H])C1=O,657023
2849,DB03023,"1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",small molecule,experimental,,CC(C)(C)N1[NH+]=C(C2=C1N=CN=C2N)C1=CC=C(Cl)C=C1,448171
2850,DB03024,2-Methyl-3-(2-Aminothiazolo)Propanal,small molecule,experimental,,[H][C@](C)(CC1=CSC(N)=N1)C=O,5288557
2851,DB03025,(S)-oct-1-en-3-ol,small molecule,experimental,,CCCCC[C@H](O)C=C,2724898
2852,DB03026,Phosphoglycolohydroxamic Acid,small molecule,experimental,,ONC(=O)COP(O)(O)=O,4797
2853,DB03028,1h-Benoximidazole-2-Carboxylic Acid,small molecule,experimental,,OC(=O)C1=NC2=CC=CC=C2N1,233240
2854,DB03030,4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole,small molecule,experimental,,CC1=CC=C(CN2C=NC(=C2)C2=CC=CS2)C=C1,446185
2855,DB03031,Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide,small molecule,experimental,,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NCCCCCCCCNC(=O)C12CC3CC(CC(C3)C1)C2,447015
2856,DB03032,S-octylglutathione,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Glutathione Transferase, antagonists & inhibitors|Oligopeptides|Peptides",CCCCCCCCSC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O,443115
2857,DB03033,4-methoxybenzenesulfinate,small molecule,experimental,,COC1=CC=C(C=C1)S([O-])=O,3952261
2858,DB03034,D-Levofloxacin,small molecule,experimental,OCT2 Inhibitors,C[C@@H]1COC2=C(N3CCN(C)CC3)C(F)=CC3=C2N1C=C(C(O)=O)C3=O,452723
2859,DB03035,"1,8-Di-Hydroxy-4-Nitro-Anthraquinone",small molecule,experimental,,OC1=CC=CC2=C1C(=O)C1=C(O)C=CC(=C1C2=O)[N+]([O-])=O,4634231
2860,DB03037,Oxidized Acetyl Dithranol,small molecule,experimental,,OC(=O)CC1=C(O)C2=C(C=C1)C(=O)C1=C(C(O)=CC=C1)C2=O,3266379
2861,DB03038,LY341770,small molecule,experimental,,[H]N([H])C1=NC(=O)C2=C(N([H])C=C2CCC2=CC=C(C=C2)C(=O)N([H])[C@@H](CCC2=NN([H])N=N2)C(O)=O)N1[H],446552
2862,DB03039,"4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide",small molecule,experimental,,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=CC(F)=CC=C1F,446239
2863,DB03040,Nitrilotriacetic acid,small molecule,experimental,"Acetates|Acids, Acyclic|Amino Acids, Peptides, and Proteins|Chelating Agents|Compounds used in a research, industrial, or household setting|Fatty Acids|Fatty Acids, Volatile|Lipids|Peptides|Sequestering Agents",OC(=O)CN(CC(O)=O)CC(O)=O,8758
2864,DB03041,UDP-alpha-D-glucuronic acid,small molecule,experimental,"Carbohydrates|Deoxyribonucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Diphosphate Sugars|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides|Uracil Nucleotides|Uridine Diphosphate|Uridine Diphosphate Sugars",O[C@@H]1[C@@H](COP(O)(=O)OP(O)(=O)O[C@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)O[C@H]([C@@H]1O)N1C=CC(=O)NC1=O,17473
2865,DB03042,5-Phosphoarabinonic Acid,small molecule,experimental,,[H][C@@](O)(COP(O)(O)=O)[C@@]([H])(O)[C@]([H])(O)C(O)=O,191445
2866,DB03043,"(S)-2-Amino-3-(6h-Selenolo[2,3-B]-Pyrrol-4-Yl)-Propionic Acid",small molecule,experimental,Selenium Compounds,[H][C@](N)(CC1=CNC2=C1C=C[Se]2)C(O)=O,15480321
2867,DB03044,Doramapimod,small molecule,investigational,Protein Kinase Inhibitors,CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NC1=CC=C(OCCN2CCOCC2)C2=C1C=CC=C2)C(C)(C)C,156422
2868,DB03045,Pantothenyl-Aminoethanol-Acetate Pivalic Acid,small molecule,experimental,,CC(=O)OCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COC(=O)C(C)(C)C,447720
2869,DB03046,7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide,small molecule,experimental,,COC1=CC=C2C=CC(=CC2=C1C1=CN(N=C1)S(C)(=O)=O)C(N)=N,5289529
2870,DB03047,L-Alpha-Phosphatidyl-Beta-Oleoyl-Gamma-Palmitoyl-Phosphatidylethanolamine,small molecule,experimental,,[H]\C(C)=C(\[H])CCC([H])=C([H])CC\C([H])=C(/[H])CCCCCCC(=O)OC[C@]([H])(COP(O)(=O)OCCN)OC(=O)CCCCCCC\C([H])=C(/[H])C\C([H])=C(/[H])CCC,5288167
2871,DB03048,6-Carboxymethyluracil,small molecule,experimental,,OC(=O)CC1=CC(=O)NC(=O)N1,73271
2872,DB03049,S-Selanyl Cysteine,small molecule,experimental,Selenium Compounds,N[C@@H](CS[SeH])C(O)=O,17753926
2873,DB03051,(S)-2-Tetrahydrofuroic acid,small molecule,experimental,,OC(=O)[C@H]1CCCO1,2734707
2874,DB03052,Dazoxiben,small molecule,experimental,"Enzyme Inhibitors|Thromboxane-A Synthase, antagonists & inhibitors",OC(=O)C1=CC=C(OCCN2C=CN=C2)C=C1,53001
2875,DB03053,1-Aminocyclopropylphosphonate,small molecule,experimental,,NC1(CC1)[P@](O)([O-])=O,194762
2876,DB03054,Bromoform,small molecule,experimental,"Carcinogens|Hydrocarbons, Halogenated|Noxae|Teratogens|Toxic Actions",BrC(Br)Br,5558
2877,DB03056,4-Piperidino-Piperidine,small molecule,experimental,,C1CCN(CC1)C1CCNCC1,78607
2878,DB03057,Malonaldehyde,small molecule,experimental,Aldehydes,[H]C(=O)CC([H])=O,10964
2879,DB03058,2-Aminobenzyl alcohol,small molecule,experimental,Alcohols|Benzene Derivatives|Benzyl Compounds,NC1=CC=CC=C1CO,21439
2880,DB03059,Acetoacetyl-CoA,small molecule,experimental,"Adenine Nucleotides|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides|Thioesters of coenzyme A",CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N,92153
2881,DB03060,Sri-9662,small molecule,experimental,,COC1=CC(\C=C/C2=C(C)C3=C(N)N=C(N)N=C3N=C2)=C(OC)C=C1,446753
2882,DB03061,(R)-N-(1-Methyl-Hexyl)-Formamide,small molecule,experimental,,CCCCC[C@H](C)NC=O,5289037
2883,DB03062,(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone,small molecule,experimental,Dietary Supplements|Supplements,CN1C=CN=C1C(=O)C1=C(C)C2=C(O1)C=CC=C2OCCCNCC1=CN=CC=C1,446386
2884,DB03063,"N-[(2S,3S)-4-[2-[(5S)-3a,4,5,6,7,7a-Hexahydro-1,3-benzodioxol-5-yl]ethyl-[3-(1,3-dioxoisoindol-2-yl)propanoyl]amino]-3-hydroxy-1-phenylbutan-2-yl]-3,5-dimethoxy-4-phenylmethoxybenzamide",small molecule,experimental,,COC1=CC(=CC(OC)=C1OCC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC[C@@H]1CCC2OCOC2C1)C(=O)CCN1C(=O)C2=CC=CC=C2C1=O,131704228
2885,DB03064,"3-Decyl-2,5-Dioxo-4-Hydroxy-3-Pyrroline",small molecule,experimental,,CCCCCCCCCCC1=C(O)C(=O)NC1=O,54676715
2886,DB03065,7-Nitroindazole-2-Carboxamidine,small molecule,experimental,,NC(=N)N1C=C2C=CC=C(C2=N1)[N+]([O-])=O,1894
2887,DB03066,D-Lactic acid,small molecule,experimental,,C[C@@H](O)C(O)=O,61503
2888,DB03067,"4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid",small molecule,experimental,,OC(=O)C1=C(C=C(OC2=C(NC(=O)C3=CC(=CC=C3)[N+]([O-])=O)C=C(NC(=O)C3=CC(=CC=C3)[N+]([O-])=O)C=C2)C=C1)C(O)=O,657141
2889,DB03068,Zebularine,small molecule,experimental,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC=NC1=O,100016
2890,DB03069,Cytidine-5'-diphospho-beta-D-xylose,small molecule,experimental,,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)O[C@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H]1O,449144
2891,DB03070,Selenazole-4-carboxyamide-adenine dinucleotide,small molecule,experimental,Selenium Compounds,[H]N([H])C(=O)C1=C[Se]C(=N1)[C@]1([H])O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N=CN=C23)N([H])[H])[C@@H](O)[C@H]1O,444451
2892,DB03071,4-Methylidene-5-One,small molecule,experimental,,C[C@H](N)C1=NC(C)=C(O)N1CC(O)=O,17754076
2893,DB03072,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",small molecule,experimental,,CC1=CC=CC2=C1N=C(CCCN1CCC(=CC1)C1=CC=C(F)C=C1)NC2=O,448889
2894,DB03073,3-Methoxybenzamide,small molecule,experimental,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors",COC1=CC(=CC=C1)C(N)=O,98487
2895,DB03074,7-cyano-7-deazaguanine,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Purines|Purinones|Xanthine derivatives",NC1=NC2=C(C(=CN2)C#N)C(=O)N1,446357
2896,DB03075,(Diphosphono)Aminophosphonic Acid,small molecule,experimental,,OP(O)(=O)N[P@](O)(=O)OP(O)(O)=O,447781
2897,DB03076,"3-[[(3R,4S,5S,6R)-7-Benzyl-4,5-dihydroxy-1,1-dioxo-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepan-2-yl]methyl]-N-methylbenzamide",small molecule,experimental,,CNC(=O)C1=CC=CC(CN2[C@H](COC3=CC=CC=C3)[C@H](O)[C@@H](O)[C@@H](COC3=CC=CC=C3)N(CC3=CC=CC=C3)S2(=O)=O)=C1,445754
2898,DB03077,"3-Amino-4-{3-[2-(2-Propoxy-Ethoxy)-Ethoxy]-Propylamino}-Cyclobut-3-Ene-1,2-Dione",small molecule,experimental,,CCCOCCOCCOCCCNC1=C(N)C(=O)C1=O,4476954
2899,DB03078,PASBN,small molecule,experimental,,O[P@@](=O)(OCC1=CC=CC=C1)OC1=C(C=O)C=CC=C1,5289215
2900,DB03079,Alpha-Ribazole-5'-Phosphate Derivative,small molecule,experimental,,[H][C@]1(COP(O)(O)=O)O[C@]([H])(N2C=NC3=CC=CC=C23)[C@]([H])(O)[C@]1([H])O,446856
2901,DB03081,"[N-[N-(4-Methoxy-2,3,6-trimethylphenylsulfonyl)-L-aspartyl]-D-(4-amidino-phenylalanyl)]-piperidine",small molecule,experimental,,COC1=C(C)C(C)=C(C(C)=C1)S(=O)(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](CC1=CC=C(C=C1)C(N)=N)C(=O)N1CCCCC1,177837
2902,DB03082,6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide,small molecule,experimental,,NCC1=CC=C(NC(=O)C2=CC(NC3=NC=CC=N3)=C3C=C(C=CC3=C2)C(N)=N)C=C1,448605
2903,DB03083,IC261,small molecule,experimental,"Benzene Derivatives|Heterocyclic Compounds, Fused-Ring|Phenols",COC1=CC(OC)=C(\C=C2\C(=O)NC3=CC=CC=C23)C(OC)=C1,5288600
2904,DB03084,"Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",small molecule,experimental,,CCCN1C(=NC(=C1C1=CC=NC(NC2CC2)=N1)C1=CC=C(Cl)C(Cl)=C1)C1CCN(C)CC1,447872
2905,DB03085,Glycolic acid,small molecule,approved|investigational,"Acetates|Acids, Acyclic|Dermatologicals|Fatty Acids|Fatty Acids, Volatile|Hydroxy Acids|Keratolytic Agents|Lipids",OCC(O)=O,757
2906,DB03086,"N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide",small molecule,experimental,,[H][C@@](N)(CC1CCCCC1)[C@]([H])(O)C(=O)NNC1=CC=C(C)C=C1,448288
2907,DB03087,2-(Sec-Butyl)Thiazole,small molecule,experimental,,CC[C@@H](C)C1=NC=CS1,5289510
2908,DB03088,Pidolic acid,small molecule,approved|investigational,"Acids, Acyclic|Alimentary Tract and Metabolism|Amino Acids|Amino Acids, Acidic|Amino Acids, Cyclic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Glutamates|Imines|Imino Acids|Mineral Supplements|Pyrrolidines|Pyrrolidinones",OC(=O)[C@@H]1CCC(=O)N1,7405
2909,DB03090,Ethylaminobenzylmethylcarbonyl Group,small molecule,experimental,,[H][C@@](CCCC)(N1CCN[C@]([H])(CC2=CC=CC=C2)C1=O)C(O)=O,131704229
2910,DB03091,Isoglutamine,small molecule,experimental,"Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins",N[C@@H](CCC(O)=O)C(N)=O,445883
2911,DB03092,5-Hydroxymethyl-Chonduritol,small molecule,experimental,,[H][C@]1(O)C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O,5288564
2912,DB03093,"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",small molecule,experimental,,COC1=CC(CC2=NC3=NC(F)=NC(N)=C3N2)=C(OC)C=C1,448973
2913,DB03094,"3,5-Dihydro-5-Methylidene-4h-Imidazol-4-On",small molecule,experimental,,[H][C@@](C)(N)[C@@]1([H])N[C@@]([H])(CN)C(=O)N1CC(O)=O,49866408
2914,DB03095,Tetramethylammonium,small molecule,experimental,Amines|Ammonium Compounds|Autonomic Agents|Ganglionic Stimulants|Nitrogen Compounds|Onium Compounds|Peripheral Nervous System Agents,C[N+](C)(C)C,6380
2915,DB03096,2-Morpholinoethylamine,small molecule,experimental,,NCCN1CCOCC1,408285
2916,DB03097,"PMP-hydroxyisoxazole, pyridoxamine-5-phosphate-hydroxyisoxazole",small molecule,experimental,,[H]N(CC1=C(O)C(C)=NC=C1COP(O)(O)=O)C1=CON([H])C1=O,445008
2917,DB03098,[Methylseleno]Acetate,small molecule,experimental,Selenium Compounds,C[Se]CC([O-])=O,1952
2918,DB03099,5-Amino 6-Nitro Uracil,small molecule,experimental,,NC1=C(NC(=O)NC1=O)[N+]([O-])=O,4369374
2919,DB03100,6-Nitroindazole,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Nitric Oxide Synthase, antagonists & inhibitors|Pyrazoles",O=N(=O)C1=CC2=NNC=C2C=C1,24239
2920,DB03101,Ribose-1-Phosphate,small molecule,experimental,,OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H]1O,439236
2921,DB03102,"2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",small molecule,experimental,,OC(=O)C(=O)NC1=C(C(O)=O)C2=C(COCC2)S1,444765
2922,DB03103,Thymidine-5'- Diphosphate,small molecule,experimental,,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O2)C(=O)NC1=O,164628
2923,DB03104,2-[4-[(Z)-2-Acetamido-3-oxo-3-[[(3S)-2-oxo-1-[(4-phenylphenyl)methyl]azepan-3-yl]amino]prop-1-enyl]-2-formylphenyl]acetic acid,small molecule,experimental,,CC(=O)N\C(=C/C1=CC=C(CC(O)=O)C(C=O)=C1)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O,5287555
2924,DB03105,L-Pentahomoserine,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Biomarkers",N[C@@H](CCCO)C(O)=O,5287587
2925,DB03106,scyllo-inositol,small molecule,investigational,Alcohols|Carbohydrates|Stereoisomerism|Sugar Alcohols,O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,892
2926,DB03107,beta-Alanine,small molecule,experimental,"Alanine|Amino Acids|Amino Acids, Peptides, and Proteins",NCCC(O)=O,239
2927,DB03108,4-phospho-D-erythronic acid,small molecule,experimental,"Acids, Acyclic|Carbohydrates|Hydroxy Acids",[H][C@@](O)(COP(O)(O)=O)[C@@]([H])(O)C(O)=O,449304
2928,DB03109,2-acetylamino-2-deoxy-b-D-allopyranose,small molecule,experimental,,[H]N([C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@H]1O)C(C)=O,445246
2929,DB03110,2-Chlorophenol,small molecule,experimental,"Benzene Derivatives|Chlorobenzenes|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Phenols",OC1=CC=CC=C1Cl,7245
2930,DB03111,Glucosamine 1-Phosphate,small molecule,experimental,Amino Sugars|Carbohydrates|Hexosamines|Hexosephosphates|Sugar Phosphates,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(O)=O,188960
2931,DB03112,"6-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Hexanoic Acid",small molecule,experimental,,[H][C@]12CS[C@@]([H])(CCCCCC(O)=O)[C@@]1([H])NC(=O)N2,446904
2932,DB03113,3-Fluoro-2-(Phosphonooxy)Propanoic Acid,small molecule,experimental,,[H][C@@](CF)(OP(O)(O)=O)C(O)=O,5288237
2933,DB03114,PAS219,small molecule,experimental,,O[P@@](=O)(OCC1CCCCC1)OC1=C(C=O)C=CC=C1,5287461
2934,DB03115,"5-Bromo-N-[(2S)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide",small molecule,experimental,,[H]N(OC[C@@H](O)CO)C(=O)C1=CC(Br)=C(F)C(F)=C1N([H])C1=C(F)C=C(I)C=C1,448535
2935,DB03116,5-(1-Carboxy-1-Phosphonooxy-Ethoxyl)-Shikimate-3-Phosphate,small molecule,experimental,,[H][C@]1(CC(=C[C@@]([H])(OP(O)(O)=O)[C@@]1([H])O)C(O)=O)O[C@@](C)(OP(O)(O)=O)C(O)=O,5289376
2936,DB03117,2-carboxypropyl-coenzyme A,small molecule,experimental,,[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)N([H])CCC(=O)N([H])CCSC[C@H](C)C(O)=O)[C@@H](OP(O)(O)=O)[C@H]3O)C2=NC=N1,449598
2937,DB03118,(2Z)-1-(5-Chloro-1H-indol-3-yl)-3-hydroxy-3-(1H-tetrazol-5-yl)-2-propen-1-one,small molecule,experimental,,O\C(=C/C(=O)C1=CNC2=CC=C(Cl)C=C12)C1=NN=NN1,5287411
2938,DB03120,p-Toluenesulfonic acid,small molecule,experimental,"Acids|Acids, Noncarboxylic|Arylsulfonates|Arylsulfonic Acids|Benzene Derivatives|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",CC1=CC=C(C=C1)S(O)(=O)=O,6101
2939,DB03121,(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid,small molecule,experimental,,COC1=CC2=C(C=C1)N(CC1=CC=CC=C1)C(C)=C2CC(O)=O,1372
2940,DB03124,5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid,small molecule,experimental,,[H][C@@](CC(O)=O)(NC(=O)C1=CC=C(CNS(=O)(=O)C2=CC(C(O)=O)=C(O)C=C2)C=C1)C(C)=O,5287429
2941,DB03125,"2,4-Diamino-5-(3,4,5-Trimethoxy-Benzyl)-Pyrimidin-1-Ium",small molecule,experimental,,COC1=CC(CC2=C[NH+]=C(N)N=C2N)=CC(OC)=C1OC,446998
2942,DB03126,Mant-Adp,small molecule,experimental,"Acids, Carbocyclic|Adenine Nucleotides|Aminobenzoates|Benzene Derivatives|Benzoates|Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",[H][C@@]1(C[C@]([H])(OC(=O)C2=CC=CC=C2NC)[C@@]([H])(COP(O)(=O)OP(O)(O)=O)O1)N1C=NC2=C(N)N=CN=C12,5288821
2943,DB03127,Benzamidine,small molecule,experimental,Amidines|Enzyme Inhibitors|Protease Inhibitors|Serine Protease Inhibitors,NC(=[NH2+])C1=CC=CC=C1,444655
2944,DB03128,Acetylcholine,small molecule,approved|investigational,Amines|Antiglaucoma Preparations and Miotics|Biogenic Amines|Cardiovascular Agents|Cholinergic Agents|Cholinergic Agonists|Cholinergic Receptor Agonist|Miotics|Neurotransmitter Agents|OCT1 substrates|Ophthalmologicals|Parasympathomimetics|Sensory Organs|Vasodilating Agents,CC(=O)OCC[N+](C)(C)C,187
2945,DB03129,"Diamino-N-[3-(1,3,2-dioxaborolan-2-yloxy)propyl]methaniminium",small molecule,experimental,,[H]N([H])C(N([H])[H])=[N+]([H])CCCOB1OCCO1,5289336
2946,DB03130,S-P-Nitrobenzyloxycarbonylglutathione,small molecule,experimental,,[H]N([H])[C@@H](CCC(=O)N([H])[C@@H](CSC(O)OCC1=CC=C(C=C1)[N+]([O-])=O)C(=O)N([H])CC(O)=O)C(O)=O,5288453
2947,DB03132,3-(2-Benzothiazolylthio)-1-Propanesulfonic Acid,small molecule,experimental,"Acids|Acids, Noncarboxylic|Alkanes|Heterocyclic Compounds, Fused-Ring|Hydrocarbons, Acyclic|Sulfonic Acids|Sulfur Acids|Sulfur Compounds|Thiazoles|Triose-Phosphate Isomerase, antagonists & inhibitors",OS(=O)(=O)CCCSC1=NC2=C(S1)C=CC=C2,162569
2948,DB03133,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole",small molecule,experimental,,[H][C@]1(CO)O[C@@]([H])(C2=NC3=C(N2)C=C(C)C=C3)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O,49867153
2949,DB03134,L-2-aminopimelic acid,small molecule,experimental,"Acids, Acyclic|Dicarboxylic Acids",N[C@@H](CCCCC(O)=O)C(O)=O,446719
2950,DB03135,[2(Formyl-Hydroxy-Amino)-Ethyl]-Phosphonic Acid,small molecule,experimental,,ON(CCP(O)(O)=O)C=O,446273
2951,DB03136,4-Iodobenzo[B]Thiophene-2-Carboxamidine,small molecule,experimental,,NC(=[NH2+])C1=CC2=C(S1)C=CC=C2I,1746
2952,DB03137,"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine",small molecule,experimental,,COC1=CC(CC2=NC3=C(N)N=C(F)N=C3N2CCCC#C)=C(OC)C=C1,5289232
2953,DB03138,Perchlorate,small molecule,experimental,"Acids|Acids, Noncarboxylic|Chlorine Compounds",[O-][Cl](=O)(=O)=O,123351
2954,DB03139,"6-[5-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Pentanoylamino]-Hexanoic Acid",small molecule,experimental,,[H][C@@]1(CCCCC(=O)NCCCCCC(O)=O)SC[C@]2([H])NC(=O)N[C@]12[H],446905
2955,DB03140,4-Carboxyphenylboronic Acid,small molecule,experimental,,OB(O)C1=CC=C(C=C1)C(O)=O,312183
2956,DB03141,"3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril",small molecule,experimental,,O[C@@H]1CN(N(CC2=CC=C(O)C=C2)C(=O)N(CC2=CC=C(O)C=C2)[C@@H]1CC1=CC=CC=C1)S(=O)(=O)C1=CC(=CC=C1)C#N,448667
2957,DB03142,Alpha-L-Arabinose,small molecule,experimental,,OC[C@@H]1O[C@@H](O)[C@H](O)[C@H]1O,445935
2958,DB03143,Nonan-1-Ol,small molecule,experimental,,CCCCCCCCCO,8914
2959,DB03144,N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine,small molecule,experimental,"Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins",N[C@@H](CCCNC(=N)NO)C(O)=O,123895
2960,DB03145,4-Methyl-5-Hydroxyethylthiazole Phosphate,small molecule,experimental,,CC1=C(CCOP(O)(O)=O)SC=N1,1137
2961,DB03146,2-deazo-6-thiophosphate guanosine-5'-monophosphate,small molecule,experimental,,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2[NH+]=CN=C3SP(O)(O)=O)[C@]([H])(O)[C@]1([H])O,446796
2962,DB03147,Flavin adenine dinucleotide,small molecule,approved,"Adenine Nucleotides|Biological Factors|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Flavins|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pigments, Biological|Pteridines|Purine Nucleotides|Purines|Ribonucleotides|Vitamin B Complex|Vitamins",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2,643975
2963,DB03148,Adenosine 5'-methylenediphosphate,small molecule,experimental,"5'-Nucleotidase, antagonists & inhibitors|Adenine Nucleotides|Carbohydrates|Enzyme Inhibitors|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)CP(O)(O)=O)[C@@H](O)[C@H]1O,92199
2964,DB03150,"2',3'-Dideoxythymidine-5'-Monophosphate",small molecule,experimental,,CC1=CN([C@H]2CC[C@@H](COP(O)(O)=O)O2)C(=O)NC1=O,165151
2965,DB03151,mu4-sulfido-quadro-tetracopper,small molecule,experimental,,[Cu]12[Cu]3[Cu]4[Cu]1S234,4628301
2966,DB03152,B-2-Octylglucoside,small molecule,experimental,,[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])OCCCCCCCC,445463
2967,DB03153,"3H-pyrazolo[4,3-d]pyrimidin-7-ol",small molecule,experimental,,OC1=NC=NC2=C1N=NC2,5791881
2968,DB03154,{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid,small molecule,experimental,,OP(O)(=O)C(F)(F)C1=CC2=CC(=CC=C2C=C1)C(F)(F)P(O)(O)=O,446662
2969,DB03155,2'-fluoro-2'-deoxyuridine 3'-monophosphate,small molecule,experimental,,[H]N1C(=O)C=CN([C@@H]2O[C@H](CO)[C@@H](OP(O)(O)=O)[C@@]2([H])F)C1=O,5289534
2970,DB03156,beta-D-glucuronic acid,small molecule,experimental,,O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O,441478
2971,DB03157,"N,O-Didansyl-L-Tyrosine",small molecule,experimental,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Naphthalenes|Sulfones|Sulfur Compounds|Thymidylate Synthase, antagonists & inhibitors",[H][C@@](CC1=CC=C(OS(=O)(=O)C2=CC=CC3=C2C=CC=C3N(C)C)C=C1)(NS(=O)(=O)C1=CC=CC2=C1C=CC=C2N(C)C)C(O)=O,446468
2972,DB03158,"D-Myo-Inositol-1,4-Bisphosphate",small molecule,experimental,,O[C@H]1[C@@H](O)[C@@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@@H]1OP(O)(O)=O,439444
2973,DB03159,CRA_8696,small molecule,experimental,,NC(=[NH2+])C1=CC=C2NC(=CC2=C1)C1=CC=CC(=C1[O-])C1=CC=CC=C1,447476
2974,DB03160,N-Pyridoxyl-7-Keto-8-Aminopelargonic Acid-5'-Monophosphate,small molecule,experimental,,[H][C@@](C)(NCC1=C(COP(O)(O)=O)C=NC(C)=C1O)C(=O)CCCCCC(O)=O,445085
2975,DB03161,Thymidine-5'-diphospho-beta-D-xylose,small molecule,experimental,,[H]N1C(=O)N(C=C(C)C1=O)[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)O[C@H]2OC[C@@H](O)[C@H](O)[C@H]2O)O1,447462
2976,DB03162,"4-oxo-4,5-dihydro-1,2,5-thiadiazole-3-carboxylic acid",small molecule,experimental,,OC(=O)C1=NSN=C1O,448652
2977,DB03163,2-oxopropyl-CoM,small molecule,experimental,,CC(=O)CSCCS(O)(=O)=O,443231
2978,DB03164,6-amino-1-methyl-7H-purin-1-ium,small molecule,experimental,,[H]N([H])C1=[N+](C)C=NC2=C1N([H])C=N2,444453
2979,DB03165,2-Dimethylamino-Ethyl-Diphosphate,small molecule,experimental,,CN(C)CCO[P@](O)(=O)OP(O)(O)=O,447358
2980,DB03166,Acetic acid,small molecule,approved,"Acetates|Acids, Acyclic|Anti-Bacterial Agents|Anti-Infective Agents|Compounds used in a research, industrial, or household setting|Fatty Acids|Fatty Acids, Volatile|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Indicators and Reagents|Laboratory Chemicals|Lipids|Organic Acids|Otologicals|Sensory Organs",CC(O)=O,176
2981,DB03167,Pentabromophenol,small molecule,experimental,Benzene Derivatives,OC1=C(Br)C(Br)=C(Br)C(Br)=C1Br,11852
2982,DB03168,Nicotinamide adenine dinucleotide cyclohexanone,small molecule,experimental,,[H]N([H])C(=O)C1=C(C=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N=CN=C23)N([H])[H])[C@@H](O)[C@H]1O)[C@@H]1CCCCC1=O,131704230
2983,DB03169,(S)-Hmg-Coa,small molecule,experimental,,[H][C@](O)(C([O-])=NCCC([O-])=NCCSC(=O)C[C@@](C)(O)CC([O-])=O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP([O-])([O-])=O,131704231
2984,DB03170,Dephospho Coenzyme A,small molecule,experimental,,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS,444485
2985,DB03171,Indole-3-Propanol Phosphate,small molecule,experimental,,OP(O)(=O)OCCCC1=CNC2=C1C=CC=C2,3713
2986,DB03172,Tubercidin,small molecule,experimental,"Antibiotics, Antineoplastic|Antimetabolites|Antineoplastic Agents|Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Noxae|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides|Toxic Actions",NC1=NC=NC2=C1C=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,6245
2987,DB03173,CRA_10433,small molecule,experimental,,NC(=[NH2+])C1=CC=C2NC(=CC2=C1)C1=CC=CC(OC2CCCC2)=C1[O-],447478
2988,DB03174,Phosphonoacetaldehyde,small molecule,experimental,Aldehydes,OP(O)(=O)CC=O,490
2989,DB03175,Propyl alcohol,small molecule,approved|experimental,Alcohols|Antiseptics and Disinfectants|Dermatologicals|Propanols,CCCO,1031
2990,DB03176,KB-141,small molecule,experimental,"Acids, Carbocyclic|Benzene Derivatives|Ethers|Ligands|Phenols|Receptors, Thyroid Hormone, agonists",CC(C)C1=CC(OC2=C(Cl)C=C(CC(O)=O)C=C2Cl)=CC=C1O,9863447
2991,DB03177,5-methylbenzimidazole,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring",CC1=CC2=C(C=C1)N=CN2,11979
2992,DB03178,"Guanosine-2',3'-cyclophosphorothioate",small molecule,experimental,,[H]N([H])C1=NC(=O)C2=C(N1[H])N(C=N2)[C@@H]1O[C@H](CO)[C@@]2([H])O[P@](O)(=S)O[C@@]12[H],6323502
2993,DB03179,Sinapoyl coenzyme A,small molecule,experimental,,COC1=CC(\C=C\C(=O)SCCNC(=O)CCNC(=O)C2(O)[C@H](OP(O)(=O)OP(O)(=O)OC[C@H]3O[C@H]([C@@H](O)[C@@H]3OP(O)(O)=O)N3C=NC4=C(N)N=CN=C34)C2(C)C)=CC(OC)=C1O,131704232
2994,DB03180,"4,5-Dimethyl-1,2-phenylenediamine",small molecule,experimental,Amines|Aniline Compounds|Diamines|Polyamines,CC1=CC(N)=C(N)C=C1C,76635
2995,DB03181,"2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione",small molecule,experimental,,CC(C)C1=CC(OC2=C(C)C=C(C=C2C)N2N=CC(=O)NC2=O)=CC=C1O,447271
2996,DB03182,alpha-Fluoro-carboxymethyldethia coenzyme A complex,small molecule,experimental,,[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)N([H])CCC(=O)N([H])CC[C@@H](F)C(O)=O)[C@@H](OP(O)(O)=O)[C@H]3O)C2=NC=N1,444883
2997,DB03183,"1-(4-Aminophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",small molecule,experimental,,CCOC(=O)C1=C(C)N(N=C1C)C1=CC=C(N)C=C1,656966
2998,DB03184,5-Amino-3-Methyl-Pyrrolidine-2-Carboxylic Acid,small molecule,experimental,,[H][C@]1(N)C[C@@]([H])(C)[C@@]([H])(N1)C(O)=O,5289579
2999,DB03185,"1-Beta-Ribofuranosyl-1,3-Diazepinone",small molecule,experimental,,[H][C@]1(CO)O[C@@]([H])(N2C=CC=CNC2=O)[C@]([H])(O)[C@]1([H])O,5287841
3000,DB03186,Adenylate-3'-phosphate-[[2'-deoxy-uridine-5'-phosphate]-3'-phosphate],small molecule,experimental,,[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)O[C@H]4C[C@@H](O[C@@H]4COP(O)(O)=O)N4C=CC(=O)N([H])C4=O)[C@@H](OP(O)(O)=O)[C@H]3O)C2=NC=N1,448108
3001,DB03187,6-(Hydroxyethyldithio)-8-(Aminomethylthio)Octanoic Acid,small molecule,experimental,,[H][C@](CCCCC(O)=O)(CCSCN)SSCCO,5289084
3002,DB03189,Cu-Cyclam,small molecule,experimental,,[Cu].C1CNCCNCCCNCCNC1,131704233
3003,DB03190,6-o-Capryloylsucrose,small molecule,experimental,,[H][C@]1(COC(=O)CCCCCCC)O[C@@](CO)(O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]2([H])O)[C@@]([H])(O)[C@]1([H])O,447970
3004,DB03191,3-Oxiran-2ylalanine,small molecule,experimental,,[H][C@](N)(C[C@@]1([H])CO1)C(O)=O,447569
3005,DB03192,(R)-3-hydroxydecanoyl-CoA,small molecule,experimental,,CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N,447877
3006,DB03193,Stearic acid,small molecule,approved|experimental,Fatty Acids|Lipids,CCCCCCCCCCCCCCCCCC(O)=O,5281
3007,DB03194,Methyl beta-L-fucopyranoside,small molecule,experimental,,CO[C@H]1O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]1O,7167925
3008,DB03195,3'-Fluoro-3'-deoxythymidine 5'-monophosphate,small molecule,experimental,,CC1=CN([C@H]2C[C@H](F)[C@@H](COP(O)(O)=O)O2)C(=O)NC1=O,447405
3009,DB03196,4-Nitrophenyl-Ara,small molecule,experimental,,[H][C@@]1(CO)O[C@@]([H])(OC2=CC=C(C=C2)[N+]([O-])=O)[C@]([H])(O)[C@@]1([H])O,151437
3010,DB03197,6-Hydroxymethylpterin,small molecule,experimental,"Biological Factors|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Pteridines",NC1=NC(=O)C2=NC(CO)=CN=C2N1,69736
3011,DB03198,Thio-Maltohexaose,small molecule,experimental,,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(S[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O[C@@]3([H])O[C@]([H])(CO)[C@@]([H])(S[C@@]4([H])O[C@]([H])(CO)[C@@]([H])(O[C@@]5([H])O[C@]([H])(CO)[C@@]([H])(S[C@@]6([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]6([H])O)[C@]([H])(O)[C@@]5([H])O)[C@]([H])(O)[C@@]4([H])O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O,449606
3012,DB03199,4-Methoxy-E-Rhodomycin T,small molecule,experimental,,[H][C@@]1(C[C@]([H])(N(C)C)[C@]([H])(O)[C@]([H])(C)O1)O[C@@]1([H])C[C@](O)(CC)[C@]([H])(C(=O)OC)C2=C(O)C3=C(C(O)=C12)C(=O)C1=C(C=CC=C1OC)C3=O,42627031
3013,DB03200,7-Alpha-D-Ribofuranosyl-Purine-5'-Phosphate,small molecule,experimental,,[H][C@]1(COP(O)(O)=O)O[C@]([H])(N2C=NC3=NC=NC=C23)[C@]([H])(O)[C@]1([H])O,446857
3014,DB03201,D-Cysteine,small molecule,experimental,,N[C@H](CS)C(O)=O,92851
3015,DB03202,"2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide",small molecule,experimental,,[H][C@](NC(=O)CN1C(=O)C(NS(C)(=O)=O)=CN=C1C1=CC=C(N)C=C1)(C(C)C)C(=O)C(F)(F)F,5289459
3016,DB03203,Sphingosine,small molecule,experimental,Alcohols|Amines|Amino Alcohols|Glycols|P-glycoprotein substrates,[H]\C(CCCCCCCCCCCCC)=C(\[H])[C@@]([H])(O)[C@@]([H])(N)CO,5280335
3017,DB03204,4-amino-5-aminomethyl-2-methylpyrimidine,small molecule,experimental,,CC1=NC=C(CN)C(N)=N1,66762
3018,DB03205,Pyrroloquinoline Quinone,small molecule,experimental,,OC(=O)C1=CC2=C(N1)C1=C(N=C(C=C1C(O)=O)C(O)=O)C(=O)C2=O,1024
3019,DB03206,Duvoglustat,small molecule,investigational,Alkaloids|Amino Sugars|Anti-Infective Agents|Carbohydrates|Enzyme Inhibitors|Hexosamines|Imines|Imino Pyranoses|Imino Sugars|Piperidines,OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O,29435
3020,DB03207,"2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid",small molecule,experimental,,[H][C@@]1(CC2=C(CN1S(=O)(=O)C1=CC=C(C=C1)C1=CC=CC=C1)C=CC=C2)C(O)=O,444698
3021,DB03208,"Beta-1,2,3,4,6-Penta-O-Galloyl-D-Glucopyranose",small molecule,experimental,,[H][C@@]1(COC(=O)C2=CC(O)=C(O)C(O)=C2)O[C@@]([H])(OC(=O)C2=CC(O)=C(O)C(O)=C2)[C@@]([H])(OC(=O)C2=CC(O)=C(O)C(O)=C2)[C@@]([H])(OC(=O)C2=CC(O)=C(O)C(O)=C2)[C@]1([H])OC(=O)C1=CC(O)=C(O)C(O)=C1,446509
3022,DB03209,Oteracil,small molecule,approved,Triazines,OC(=O)C1=NC(=O)NC(=O)N1,4604
3023,DB03210,4-Aminohydrocinnamic Acid,small molecule,experimental,,NC1=CC=C(CCC(O)=O)C=C1,75451
3024,DB03211,(3-Formyl-but-3-Enyl)-Phosphonic Acid,small molecule,experimental,,OP(O)(=O)CCC(=C)C=O,4628690
3025,DB03212,4-Deoxyglucarate,small molecule,experimental,,[H][C@](O)(C[C@]([H])(O)[C@@]([H])(O)C([O-])=O)C([O-])=O,5288136
3026,DB03213,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone,small molecule,experimental,,NC(=N)C1=CC2=C(C=C1)N=C(N2)C(=O)C1=NC2=C(N1)C=CC(=C2)C([NH3+])=[NH2+],131704234
3027,DB03214,Vinylglycine,small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins",N[C@@H](C=C)C(O)=O,156126
3028,DB03215,"(2s,5s)-5-Carboxymethylproline",small molecule,experimental,,[H][C@@]1(CC(O)=O)CC[C@]([H])(N1)C(O)=O,447989
3029,DB03216,"(1'R,2'S)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-yl)Adenine",small molecule,experimental,,NC1=NC=NC2=C1N=CN2[C@@H]1C=C[C@H](O)[C@H]1O,5287610
3030,DB03217,DPI59,small molecule,experimental,,[H][C@@](O)(C1=CC=CC2=CC=CC=C12)P(O)(O)=O,447531
3031,DB03218,N-acetyl-N'-beta-D-glucopyranosyl urea,small molecule,experimental,"Carbohydrates|Glycogen Phosphorylase, antagonists & inhibitors|Hexoses|Monosaccharides",CC(=O)NC(=O)N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,446801
3032,DB03219,11-Deoxy-Beta-Rhodomycin,small molecule,experimental,,[H][C@]1(O)C[C@]([H])(O[C@]2([H])[C@]([H])(C)O[C@]([H])(C[C@]2([H])N(C)C)O[C@@]2([H])C[C@](O)(CC)[C@]([H])(O)C3=C2C(O)=C2C(=O)C4=C(C=CC=C4O)C(=O)C2=C3)O[C@@]([H])(C)[C@]1([H])O[C@@]1([H])CCC(=O)[C@@]([H])(C)O1,5288114
3033,DB03220,FR-234938,small molecule,experimental,,C[C@H](O)[C@@H](CCC1=C2C=CC=CC2=CC=C1)N1C=NC(=C1)C(N)=O,449013
3034,DB03221,AL7099A,small molecule,experimental,,CN[C@@H]1CN(C2=CC(OC)=CC=C2)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,4369101
3035,DB03222,dATP,small molecule,experimental,"Adenine Nucleotides|Carbohydrates|Deoxyribonucleotides|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",NC1=NC=NC2=C1N=CN2[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1,15993
3036,DB03223,Diphthamide,small molecule,experimental,"Amino Acids|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins",C[N+](C)(C)[C@@H](CCC1=NC(C[C@H](N)C(O)=O)=CN1)C(N)=O,46936613
3037,DB03224,2-Formyl-Protoporphryn Ix,small molecule,experimental,,[Fe+4].[H]\C(O)=C1/C(C)=C2[N-]/C/1=C([H])\C1=C(C)[C@@]([H])(C=C)\C([N-]1)=C([H])\C1=C(C)C(CCC(O)=O)=C([N-]1)\C([H])=C1/[N-]/C(=C\2/[H])C(C)=C1CCC(O)=O,131704235
3038,DB03225,D-Tryptophan,small molecule,experimental,,N[C@H](CC1=CNC2=CC=CC=C12)C(O)=O,9060
3039,DB03226,Trifluoroethanol,small molecule,experimental,Alcohols,OCC(F)(F)F,6409
3040,DB03227,Nicotinamide Mononucleotide,small molecule,experimental,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Ribonucleotides",NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@@H](COP(O)(O)=O)[C@H](O)[C@H]1O,6093202
3041,DB03228,"5-[Bis-2(Chloro-Ethyl)-Amino]-2,4-Dintro-Benzamide",small molecule,experimental,,NC(=O)C1=C(C=C(C(=C1)N(CCCl)CCCl)[N+]([O-])=O)[N+]([O-])=O,126690
3042,DB03229,2-Oxo-4-Methylpentanoic Acid,small molecule,experimental,Caproates,CC(C)CC(=O)C(O)=O,70
3043,DB03230,Adenosine-5'-Propylphosphate,small molecule,experimental,,[H][C@]1(COP(O)(=O)OCCC)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,447832
3044,DB03231,"3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide",small molecule,experimental,,[H]N([H])C1=NC(=O)C2=NN(N([H])C2=N1)C1=CC=CC(=C1)C(=O)N([H])CC1=CC=CC=C1SC1=CC=CC=C1CO,448408
3045,DB03232,"2-[(2e,6e,10e,14e,18e,22e,26e)-3,7,11,15,19,23,27,31-Octamethyldotriaconta-2,6,10,14,18,22,26,30-Octaenyl]Phenol",small molecule,experimental,,CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC1=CC=CC=C1O,5280832
3046,DB03233,3'-deoxy-3'-aminothymidine monophosphate,small molecule,experimental,,[H]N([H])[C@H]1C[C@@H](O[C@@H]1COP(O)(O)=O)N1C=C(C)C(=O)N([H])C1=O,162501
3047,DB03234,"(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone",small molecule,experimental,,CN(CC=C)CC1=CC=C(C=C1)C1=CC=C(C=C1)C(=O)C1=CC=C(Br)C=C1,445986
3048,DB03235,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(alpha-D-galactopyranosyloxy)-5-nitrobenzamide,small molecule,experimental,,[H]N([H])CCCN1CCN(CCCN([H])C(=O)C2=CC(=CC(O[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)=C2)[N+]([O-])=O)CC1,447977
3049,DB03236,(2s)-4-(Beta-Alanylamino)-2-Aminobutanoic Acid,small molecule,experimental,,NCCC(=O)NCC[C@H](N)C(O)=O,46936619
3050,DB03237,"2,3-Dihydroxy-5-Oxo-Hexanedioate",small molecule,experimental,,O[C@@H](CC(=O)C([O-])=O)[C@@H](O)C([O-])=O,5288442
3051,DB03238,"3,5-Difluoroaniline",small molecule,experimental,Amines,NC1=CC(F)=CC(F)=C1,96595
3052,DB03239,"3',5'-Dinitro-N-Acetyl-L-Thyronine",small molecule,experimental,,[H][C@@](CC1=CC=C(OC2=CC(=C(O)C(=C2)[N+]([O-])=O)[N+]([O-])=O)C=C1)(NC(C)=O)C(O)=O,449394
3053,DB03240,"(S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid",small molecule,experimental,,N[C@@H](CN1C2=C(CCC2)C(=O)NC1=O)C(O)=O,657004
3054,DB03241,1-Amino-1-Carbonyl Pentane,small molecule,experimental,,[H][C@](N)(CCCC)C=O,5288719
3055,DB03242,P-Aminophenyl-Alpha-D-Galactopyranoside,small molecule,experimental,,[H][C@]1(CO)O[C@]([H])(OC2=CC=C(N)C=C2)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O,445340
3056,DB03243,4-Fluorobenzylamine,small molecule,experimental,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Fluorine Radioisotopes|Radioimmunodetection",[NH3+]CC1=CC=C(F)C=C1,448749
3057,DB03244,"(S)-2-[4-(Aminomethyl)-1h-1,2,3-Triazol-1-Yl]-4-Methylpentanoic Acid",small molecule,experimental,,[H][C@@](CC(C)C)(N1C=C(CN)N=N1)C(O)=O,49867722
3058,DB03245,S-4-Nitrobutyryl-CoA,small molecule,experimental,,[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)N([H])CCC(=O)N([H])CCSC(=O)CCC[N+]([O-])=O)[C@@H](OP(O)(O)=O)[C@H]3O)C2=NC=N1,448575
3059,DB03246,Beta-L-Arabinose,small molecule,experimental,,OC[C@@H]1O[C@H](O)[C@H](O)[C@H]1O,6857384
3060,DB03247,Flavin mononucleotide,small molecule,approved|investigational,"Biological Factors|Carbohydrates|Coenzymes|Diet, Food, and Nutrition|Enzymes and Coenzymes|Flavins|Food|Food and Beverages|Glycosides|Growth Substances|Heterocyclic Compounds, Fused-Ring|Micronutrients|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Physiological Phenomena|Pigments, Biological|Pteridines|Ribonucleotides|Vitamin B Complex|Vitamins",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2,643976
3061,DB03248,2-(Phosphonooxy)Butanoic Acid,small molecule,experimental,,CC[C@@H](OP(O)(O)=O)C(O)=O,17754119
3062,DB03249,2'-O-Methyl-3'-Methyl-3'-Deoxy-Arabinofuranosyl-Thymine-5'-Phosphate,small molecule,experimental,,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=C(C)C(=O)NC2=O)[C@]([H])(OC)[C@]1([H])C,17754189
3063,DB03250,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole",small molecule,experimental,,[H][C@]1(CO)O[C@@]([H])(C2=NC3=CC(C)=CC=C3S2)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O,22298966
3064,DB03251,RWJ-51084,small molecule,experimental,"Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Heterocyclic Compounds, Fused-Ring|Sulfur Compounds|Thiazoles",[H]N([H])C(=NCCC[C@H](N([H])C(=O)C1CCCC1)C(=O)C1=NC2=CC=CC=C2S1)N([H])[H],5289320
3065,DB03252,D-Lysine,small molecule,experimental,,[H][C@@](N)(CCCCN)C(O)=O,57449
3066,DB03253,(2s)-Pyrrolidin-2-Ylmethylamine,small molecule,experimental,,NC[C@@H]1CCCN1,2734054
3067,DB03254,4-Phenyl-1h-Imidazole,small molecule,experimental,,N1C=NC=C1C1=CC=CC=C1,69590
3068,DB03255,Phenol,small molecule,approved|experimental,"Anesthetics|Anesthetics, Local|Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Antivaricose Therapy|Benzene Derivatives|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Dermatologicals|Disinfectants|Histamine Antagonists|Miscellaneous Therapeutic Agents|Nervous System|Pharmaceutical Preparations|Pharmaceutical Solutions|Phenol and Derivatives|Phenols|Sclerosing Agents for Local Injection|Sclerosing Solutions|Solutions|Throat Preparations|Vasoprotectives",OC1=CC=CC=C1,996
3069,DB03256,(6R)-Folinic acid,small molecule,experimental,Folic Acid and Derivatives|Vitamin B Complex|Vitamins,[H]N([H])C1=NC(=O)C2=C(N([H])C[C@@H](CN([H])C3=CC=C(C=C3)C(=O)N([H])[C@@H](CCC(O)=O)C(O)=O)N2C=O)N1[H],135548
3070,DB03257,"5-[1-(Acetylamino)-3-Methylbutyl]-2,5-Anhydro-3,4-Dideoxy-4-(Methoxycarbonyl)Pentonic Acid",small molecule,experimental,,[H][C@@](CC(C)C)(NC(C)=O)[C@]1([H])O[C@]([H])(C[C@@]1([H])C(=O)OC)C(O)=O,449201
3071,DB03258,2'-Deoxycytidine 5'-triphosphate,small molecule,experimental,"Carbohydrates|Cytosine Nucleotides|Deoxyribonucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides",NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1,65091
3072,DB03259,"2',6'-Dichloro-Biphenyl-2,6-Diol",small molecule,experimental,,OC1=CC=CC(=C1O)C1=C(Cl)C=CC=C1Cl,446948
3073,DB03260,Hexamethylene diamine,small molecule,experimental,Amines|Amphetamines|Ethylamines|Phenethylamines|Polyamines|Sympathomimetics,NCCCCCCN,16402
3074,DB03262,"Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",small molecule,experimental,,NS(=O)(=O)C1=CC2=C(S1)S(=O)(=O)N(C(CN1CCOCC1)=C2)C1=CC(O)=CC=C1,4369172
3075,DB03263,Thiocellobiose,small molecule,experimental,Carbohydrates|Glycosides|Sulfur Compounds,[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(S[C@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O,446272
3076,DB03264,Dodecyl-Coa,small molecule,experimental,,CCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C(N)N=CN=C12,165436
3077,DB03266,Glutaral,small molecule,experimental,"Aldehydes|Anti-Infective Agents|Compounds used in a research, industrial, or household setting|Cross-Linking Reagents|Disinfectants|Fixatives|Indicators and Reagents|Laboratory Chemicals",O=CCCCC=O,3485
3078,DB03267,1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,small molecule,experimental,,CCCCN1C2=C(NC(CC3=CC=C(NC(C)=O)C=C3)=N2)C(=O)N(CC=C)C1=O,447076
3079,DB03268,RU82197,small molecule,experimental,,CC(=O)N[C@@H](CC1=CC(C=O)=C(C=C1)C(O)=O)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O,5287443
3080,DB03269,"4,6-Dideoxy-4-{[4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino}hexopyranose",small molecule,experimental,,[H][C@]1(C)O[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])N[C@@]1([H])C=C(CO)C([H])(O)[C@]([H])(O)[C@@]1([H])O,131704236
3081,DB03270,"2,6-Difluorobenzenesulfonamide",small molecule,experimental,,NS(=O)(=O)C1=C(F)C=CC=C1F,446274
3082,DB03272,4-Bromo-3-(5'-Carboxy-4'-Chloro-2'-Fluorophenyl)-1-Methyl-5-Trifluoromethyl-Pyrazol,small molecule,experimental,,CN1N=C(C(Br)=C1C(F)(F)F)C1=CC(C(O)=O)=C(Cl)C=C1F,448564
3083,DB03273,3'-Oxo-Adenosine,small molecule,experimental,,[H][C@]1(CO)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)C1=O,446824
3084,DB03274,"2',5'-Dideoxyuridine",small molecule,experimental,,[H]N1C(=O)C=CN([C@H]2C[C@H](O)[C@@H](C)O2)C1=O,444320
3085,DB03275,Cysteinamide,small molecule,experimental,,N[C@@H](CS)C(N)=O,6540253
3086,DB03276,"4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid",small molecule,experimental,,NC(=O)C[C@@H]1NC(=O)C2(CCCCC2)NC(=O)C[C@H](\C=C\C[C@H](CNC1=O)CC1=CC=CC2=CC=CC=C12)C1=CC=C(C=C1)CP(O)(O)=O,657098
3087,DB03277,alpha-maltotriose,small molecule,experimental,,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O[C@@]3([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O,192826
3088,DB03278,D-Treitol,small molecule,experimental,,OC[C@H](O)[C@@H](O)CO,445969
3089,DB03279,Dodecyl-Alpha-D-Maltoside,small molecule,experimental,,[H][C@]1(O)[C@]([H])(O)[C@@]([H])(CO)O[C@]([H])(O[C@@]2([H])[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(OCCCCCCCCCCCC)O[C@]2([H])CO)[C@]1([H])O,445456
3090,DB03280,p1-(5'-adenosyl)p5-(5'-thymidyl)pentaphosphate,small molecule,experimental,,[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]4O[C@H](C[C@@H]4O)N4C=C(C)C(=O)N([H])C4=O)[C@@H](O)[C@H]3O)C2=NC=N1,447202
3091,DB03281,2'-Deoxymaltose,small molecule,experimental,,[H][C@@]1(O)C[C@@]([H])(O)[C@]([H])(O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]2([H])O)[C@@]([H])(CO)O1,17753954
3092,DB03283,beta-L-fucose,small molecule,experimental,,C[C@@H]1O[C@H](O)[C@@H](O)[C@H](O)[C@@H]1O,444863
3093,DB03284,"2,6-Anhydro-3-Deoxy-D-Erythro-Hex-2-Enonic Acid",small molecule,experimental,,[H][C@]1(O)COC(=C[C@]1([H])O)C(O)=O,5288331
3094,DB03285,Isoliquiritigenin,small molecule,experimental,"Aldehyde Reductase, antagonists & inhibitors|Benzopyrans|Chromones|Enzyme Inhibitors|Flavonoids|Heterocyclic Compounds, Fused-Ring|Ketones|Plants|Propiophenones|Pyrans",OC1=CC=C(\C=C\C(=O)C2=C(O)C=C(O)C=C2)C=C1,638278
3095,DB03286,C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide,small molecule,experimental,,[H]C(N)(O)[C@]1(O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O)N=[N+]=[N-],131704237
3096,DB03287,4-(2-Amino-Ethoxy)-2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Amino]-but-3-Enoic Acid,small molecule,experimental,,[H]\C(OCCN)=C(\[H])/C(=N\CC1=C(COP(O)(O)=O)C=NC(C)=C1O)/C(O)=O,131704238
3097,DB03288,5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide,small molecule,experimental,,[H][C@@](O)(CNC(=O)C1=CC2=CC(Cl)=CC=C2N1)N(CCO)C1CCCC1,46936633
3098,DB03289,Thiarsa Dihydroxy Cysteine,small molecule,experimental,,[H][C@](N)(CS[As](O)O)C(O)=O,49866861
3099,DB03290,L-naphthyl-1-acetamido boronic acid alanine,small molecule,experimental,,CC(=O)N[C@@H](CC1=CC=CC2=CC=CC=C12)[B-](O)(O)OC[C@H](N)C(O)=O,17754159
3100,DB03291,4-Deoxy-4-Amino-Beta-D-Glucose,small molecule,experimental,,[H][C@]1(N)[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(O)O[C@]1([H])CO,17753995
3101,DB03292,3-Phosphono-D-alanine,small molecule,experimental,,[H][C@@](N)(CP(O)(O)=O)C(O)=O,446873
3102,DB03293,9-Methyl Uric Acid,small molecule,experimental,,CN1C(=O)NC2=C1NC(=O)NC2=O,108714
3103,DB03294,"1-Methyl-3-Oxo-1,3-Dihydro-Benzo[C]Isothiazole-5-Sulfonic Acid Amide",small molecule,experimental,,CN1SC(=O)C2=CC(=CC=C12)S(N)(=O)=O,1387
3104,DB03295,Glutathionylspermidine,small molecule,experimental,"Amines|Amino Acids, Peptides, and Proteins|Biogenic Amines|Biogenic Polyamines|Diamines|Oligopeptides|Peptides|Polyamines",NCCCCNCCCNC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@H](N)C(O)=O,440772
3105,DB03296,3'-beta-Sialyl-beta-lactose,small molecule,experimental,,[H]N([C@@H]1[C@@H](O)C[C@@](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](CO)O[C@H](O)[C@H](O)[C@H]3O)[C@@H]2O)(O[C@@]1([H])[C@H](O)[C@H](O)CO)C(O)=O)C(C)=O,448469
3106,DB03297,Benzylsulfonic acid,small molecule,experimental,"Acids|Acids, Noncarboxylic|Alkanes|Alkanesulfonates|Alkanesulfonic Acids|Hydrocarbons, Acyclic|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",OS(=O)(=O)CC1=CC=CC=C1,7532
3107,DB03298,Phenylphosphate,small molecule,experimental,Organophosphorus Compounds,OP(O)(=O)OC1=CC=CC=C1,12793
3108,DB03299,N-Succinyl Phenylglycine,small molecule,experimental,,[H][C@](NC(=O)CCC(O)=O)(C(O)=O)C1=CC=CC=C1,448582
3109,DB03300,Pterin Cytosine Dinucleotide,small molecule,experimental,,[H][C@]12NC3=C(N[C@@]1([H])C(S)=C(S)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(N)=NC1=O)O2)C(=O)NC(N)=N3,4369128
3110,DB03301,2-Allyl-6-Methyl-Phenol,small molecule,experimental,,CC1=CC=CC(CC=C)=C1O,76883
3111,DB03302,"4,5,6,7-Tetrachloro-3h-Isobenzofuran-1-One",small molecule,experimental,,ClC1=C2COC(=O)C2=C(Cl)C(Cl)=C1Cl,33791
3112,DB03303,3-deoxy-D-arabino-hexonic acid,small molecule,experimental,"Acids, Acyclic|Carbohydrates|Hydroxy Acids",OC[C@@H](O)[C@@H](O)C[C@H](O)C(O)=O,152990
3113,DB03304,7-Deaza-7-Aminomethyl-Guanine,small molecule,experimental,,NCC1=CNC2=C1C(=O)NC(N)=N2,171
3114,DB03305,N(G)-Iminoethylornithine,small molecule,experimental,"Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Peptides, and Proteins|Enzyme Inhibitors|Nitric Oxide Synthase, antagonists & inhibitors",CC(=N)NCCC[C@H](N)C(O)=O,107984
3115,DB03306,RU78300,small molecule,experimental,,COC1=CC=CC(C=O)=C1OP(O)(O)=O,5287488
3116,DB03307,4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide,small molecule,experimental,,NC1=NC=NC(NC2=CC=C(C=C2)S(N)(=O)=O)=C1,2608
3117,DB03308,L-Leucyl-Hydroxylamine,small molecule,experimental,,CC(C)C[C@H](N)C(=O)NO,3080766
3118,DB03309,N-cyclohexyltaurine,small molecule,experimental,"Acids|Acids, Noncarboxylic|Alkanes|Alkanesulfonic Acids|Buffers|Hydrocarbons, Acyclic|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",OS(=O)(=O)CCNC1CCCCC1,66898
3119,DB03310,Glutathione disulfide,small molecule,approved|experimental|investigational,"Amino Acids, Peptides, and Proteins|Oligopeptides|Peptides",N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O)C(=O)NCC(O)=O)C(O)=O,65359
3120,DB03311,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide",small molecule,experimental,,CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=C(C=C2)S(=O)(=O)NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CS1,448662
3121,DB03312,Brivudine,small molecule,approved|investigational,"Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Carbohydrates|Deoxyribonucleosides|Deoxyuridine|Direct Acting Antivirals|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(\C=C\Br)C(=O)NC1=O,446727
3122,DB03313,Cephalosporin C,small molecule,experimental,"Agents that reduce seizure threshold|Amides|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Sulfur Compounds|Thiazines",[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CCC[C@@H](N)C(O)=O)C(O)=O,65536
3123,DB03314,5-fluorotryptophan,small molecule,experimental,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Carbon Radioisotopes",N[C@@H](CC1=CNC2=C1C=C(F)C=C2)C(O)=O,688357
3124,DB03315,Guanosine 3'-monophosphate,small molecule,experimental,"Carbohydrates|Glycosides|Guanine Nucleotides|Heterocyclic Compounds, Fused-Ring|Isomerism|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",NC1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](OP(O)(O)=O)[C@H]2O)C(=O)N1,8339
3125,DB03316,"1,4-Dioxane",small molecule,experimental,,C1COCCO1,31275
3126,DB03317,Ferroheme C,small molecule,experimental,"Biological Factors|Heterocyclic Compounds, Fused-Ring|Metalloporphyrins|Pigments, Biological|Porphyrins",CC(S)C1=C2C=C3C(C)=C(C(C)S)C4=[N+]3[Fe--]35N6C(=C4)C(C)=C(CCC(O)=O)C6=CC4=[N+]3C(=CC(N25)=C1C)C(C)=C4CCC(O)=O,51351657
3127,DB03318,6-Hydro-1-Methyladenosine-5'-Monophosphate,small molecule,experimental,,[H]N=C1N(C)C=NC2=C1N=CN2[C@]1([H])O[C@]([H])(COP(O)(O)=O)[C@@]([H])(O)[C@@]1([H])O,49867280
3128,DB03319,"(2S)-2-Ammonio-3-[5-(2-methyl-2-propanyl)-3-oxido-1,2-oxazol-4-yl]propanoate",small molecule,experimental,,[H][C@](N)(CC1=C(ON=C1[O-])C(C)(C)C)C(O)=O,131704239
3129,DB03320,3-Amino-Alanine,small molecule,experimental,,N[C@@H](C[NH3+])C(O)=O,17753953
3130,DB03321,Des(carbamimidoyl) zanamivir,small molecule,experimental,,[H][C@]1(OC(=C[C@H](N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,445533
3131,DB03322,Dexpropranolol,small molecule,experimental,Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Cardiovascular Agents|Naphthalenes|Neurotransmitter Agents|Phenoxypropanolamines|Propanolamines|Propanols|Vasodilating Agents,CC(C)NC[C@@H](O)COC1=CC=CC2=C1C=CC=C2,21138
3132,DB03323,Maltose,small molecule,experimental|investigational,"Biopolymers|Carbohydrates|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Disaccharides|Flavoring Agents|Food|Food Additives|Food and Beverages|Food Ingredients|Glucans|Macromolecular Substances|Maltose, metabolism|Oligosaccharides|Pharmaceutic Aids|Pharmaceutical Preparations|Physiological Phenomena|Polymers|Polysaccharides|Sweetening Agents",OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O,439186
3133,DB03325,Tyrosyladenylate,small molecule,experimental,,[H]N([H])[C@@H](CC1=CC=C(O)C=C1)C(=O)N([H])S(=O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N=CN=C12)N([H])[H],449029
3134,DB03326,"Deoxycytidylyl-3',5'-guanosine",small molecule,experimental,"Carbohydrates|Cytosine Nucleotides|Deoxyribonucleotides|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Nucleotides|Purine Nucleosides|Purines|Pyrimidine Nucleotides|Pyrimidines|Ribonucleosides|Ribonucleotides",NC1=NC(=O)C2=C(N1)N(C=N2)[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OC2CC(OC2CO)N2C=CC(N)=NC2=O)O1,49866787
3135,DB03327,{1-[(3-Hydroxy-Methyl-5-Phosphonooxy-Methyl-Pyridin-4-Ylmethyl)-Amino]-Ethyl}-Phosphonic Acid,small molecule,experimental,,[H][C@@](C)(NCC1=C(COP(O)(O)=O)C=NC(C)=C1O)P(O)(O)=O,444528
3136,DB03328,Dioxo(sulfanyl)molybdenum,small molecule,experimental,,S[Mo](=O)=O,5162682
3137,DB03329,2-Pyridinethiol,small molecule,experimental,Sulfur Compounds,SC1=NC=CC=C1,2723698
3138,DB03330,S-(N-hydroxy-N-iodophenylcarbamoyl)glutathione,small molecule,experimental,,N[C@@H](CCC(=O)N[C@@H](CS[C@@H](O)N(O)C1=CC=C(I)C=C1)C(=O)NCC(O)=O)C(O)=O,17753999
3139,DB03331,"N-naphthalen-1-ylmethyl-2'-[3,5-dimethoxybenzamido]-2'-deoxy-adenosine",small molecule,experimental,,[H]N(CC1=CC=CC2=CC=CC=C12)C1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3N([H])C(=O)C3=CC(OC)=CC(OC)=C3)C2=NC=N1,446186
3140,DB03332,"5,6-Cyclic-Tetrahydropteridine",small molecule,experimental,,NC1=NC2=C(N3[C@@H](COC3=O)CN2)C(=O)N1,6323220
3141,DB03333,(4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester,small molecule,experimental,,NS(=O)(=O)C1=CC=C(NC(=S)OCCC2=CSC=C2)C=C1,17754181
3142,DB03335,(+)-1-bromo-2-propanol,small molecule,experimental,,C[C@H](O)CBr,641237
3143,DB03336,BIA,small molecule,experimental,,OC1=CC(=CC(=C1O)[N+]([O-])=O)C(=O)CCN1CCN(CC1)C1=CC(=CC=C1)C(F)(F)F,4369285
3144,DB03337,1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea,small molecule,experimental,,NC(=N)C1=CC=C(NC(=O)NC2=CC=C(OC3=CC=CC=C3)C=C2)C=C1,444581
3145,DB03338,Heptyl glucoside,small molecule,experimental,,CCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,448173
3146,DB03339,3-Iodo-Benzyl Alcohol,small molecule,experimental,,OCC1=CC=CC(I)=C1,42300
3147,DB03340,3-[(1-Amino-2-Carboxy-Ethyl)-Hydroxy-Phosphinoyl]-2-Methyl-Propionic Acid,small molecule,experimental,,[H][C@@](C)(CP(O)(=O)[C@@]([H])(N)CC(O)=O)C(O)=O,446920
3148,DB03341,CoA-S-acetyl 5-bromotryptamine,small molecule,experimental,,[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)N([H])CCC(=O)N([H])CCSCC(=O)N([H])CCC4=CN([H])C5=C4C=C(Br)C=C5)[C@@H](OP(O)(O)=O)[C@H]3O)C2=NC=N1,446811
3149,DB03342,4-(Acetylamino)-3-Guanidinobenzoic Acid,small molecule,experimental,,CC(=O)NC1=CC=C(C=C1NC(N)N)C(O)=O,3364666
3150,DB03343,Malate Like Intermediate,small molecule,experimental,,O[C@H](\C=C(/O)[O-])C([O-])=O,5289457
3151,DB03344,"Inositol-(1,3,4,5,6)-Pentakisphosphate",small molecule,experimental,,[H][C@]1(O)[C@]([H])(OP(O)(O)=O)[C@@]([H])(OP(O)(O)=O)[C@@]([H])(OP(O)(O)=O)[C@]([H])(OP(O)(O)=O)[C@@]1([H])OP(O)(O)=O,17754035
3152,DB03345,Mercaptoethanol,small molecule,experimental,Alcohols|Sulfhydryl Compounds|Sulfur Compounds,OCCS,1567
3153,DB03346,"3,3',5,5'-tetrachlorobiphenyl-4,4'-diol",small molecule,experimental,,OC1=C(Cl)C=C(C=C1Cl)C1=CC(Cl)=C(O)C(Cl)=C1,97032
3154,DB03347,Triethyl phosphate,small molecule,experimental,Organophosphorus Compounds,CCOP(=O)(OCC)OCC,6535
3155,DB03348,Huperzine B,small molecule,investigational,"Drugs, Chinese Herbal",[H][C@]12CCCN[C@]11CC(C)=C[C@H]2CC2=C1C=CC(=O)N2,5462442
3156,DB03349,8-Bromo-Adenosine-5'-Monophosphate,small molecule,experimental,,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C(Br)=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,168120
3157,DB03350,Cobalt hexammine ion,small molecule,experimental,,[NH3+][Co-3]([NH3+])([NH3+])([NH3+])([NH3+])[NH3+],453369
3158,DB03351,Sri-9439,small molecule,experimental,,CC1=C(CNC2=CC=CC3=NC=CC=C23)C=NC2=NC(N)=NC(N)=C12,446752
3159,DB03352,S-Arsonocysteine,small molecule,experimental,,N[C@@H](CS[As](O)(O)=O)C(O)=O,17753924
3160,DB03353,2-Iminobiotin,small molecule,experimental|investigational,Coenzymes|Enzymes and Coenzymes|Imidazoles,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])N=C(N)N2,128878
3161,DB03354,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole",small molecule,experimental,"Carbohydrates|Glycogen Phosphorylase, antagonists & inhibitors|Glycosides|Oxazoles",[H][C@]1(CO)O[C@@]([H])(C2=NN=C(C)O2)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O,657043
3162,DB03355,5'-O-(L-Threonylsulfamoyl)adenosine,small molecule,experimental,,[H]N([H])[C@@H]([C@@H](C)O)C(=O)N([H])S(=O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N=CN=C12)N([H])[H],445439
3163,DB03357,(S)-Mandelic acid,small molecule,experimental,,O[C@H](C(O)=O)C1=CC=CC=C1,439616
3164,DB03358,"7-Methyl-7,8-dihydroguanosine 5'-(tetrahydrogen triphosphate)",small molecule,experimental,,[H]N([H])C1=NC(=O)C2=C(N1[H])N(CN2C)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O,6323407
3165,DB03359,"M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene",small molecule,experimental,,C[N+](C)(C)C1=CC=CC(=C1)C(O)(O)C(F)(F)F,3991
3166,DB03360,N-Acetylproline,small molecule,experimental,"Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Imines|Imino Acids",[H][C@]1(CCCN1C(C)=O)C(O)=O,66141
3167,DB03361,"2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate",small molecule,experimental,,[H][C@@](C)(O)[C@]12NC3=NC(C)=NC=C3CN1C(C)=C(CCOP(O)(=O)OP(O)(O)=O)S2,447750
3168,DB03362,N-Dimethyl-Lysine,small molecule,experimental,,[H][C@](N)(CCCCN(C)C)C(O)=O,193344
3169,DB03363,3-Acetylpyridine Adenine Dinucleotide,small molecule,experimental,"Adenine Nucleotides|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(C)=O)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,131704240
3170,DB03364,N-Carbamyl-D-Methionine,small molecule,experimental,,CSCC[C@@H](NC(N)=O)C(O)=O,448878
3171,DB03365,"4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline",small molecule,experimental,,COC1=CC2=NC=NC(NC3=CC(O)=CC=C3)=C2C=C1OC,5687
3172,DB03366,Imidazole,small molecule,experimental|investigational,"Enzyme Inhibitors|Thromboxane-A Synthase, antagonists & inhibitors",N1C=CN=C1,795
3173,DB03367,PF-00356231,small molecule,experimental,,[H][C@](CC(O)=O)(NC(=O)C1=CC(=CS1)C1=CC=C(C=C1)C1=CC=NC=C1)C1=CC=CC=C1,448942
3174,DB03368,"5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione",small molecule,experimental,,CC1(C(=O)NC(=O)NC1=O)C1=CC=C(OC2=CC=CC=C2)C=C1,1836
3175,DB03369,9-Aminophenanthrene,small molecule,experimental,,NC1=CC2=CC=CC=C2C2=CC=CC=C12,13695
3176,DB03370,FR239087,small molecule,experimental,,[H][C@@](C)(O)[C@@]([H])(CCC1=CC=CC(Cl)=C1Cl)N1C=NC(=C1)C(N)=O,449014
3177,DB03371,Modified Ribosylated Glutamyl Ester,small molecule,experimental,,[H][C@](N)(CCC(=O)O[C@@]1([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]1(O)F)C(O)=O,131704241
3178,DB03372,"3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbolin-2-Yl)-Propan-1-One",small molecule,experimental,,SCCC(=O)N1CCC2=C(C1)NC1=C2C=CC=C1,447329
3179,DB03373,ZK-806711,small molecule,experimental,,[H]N=C(C)N1CCC(CC1)OC1=CC2=C(C=C1)N=C(C)N2CC1=CC2=C(C=C1)C=CC(=C2)C(N)=[NH2+],131704242
3180,DB03374,"3,5-Diiodotyrosine",small molecule,experimental,Antithyroid agents|Thyroid Products,[H][C@](N)(CC1=CC(I)=C(O)C(I)=C1)C(O)=O,9305
3181,DB03376,5'-O-(N-(Alanyl)sulfamoyl)adenosine,small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins|Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides",[H]N([H])[C@@H](C)C(=O)N([H])S(=O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N=CN=C12)N([H])[H],196672
3182,DB03378,"4-Amino-1-[(1s,3r,4r,7s)-7-Hydroxy-1-(Hydroxymethyl)-2,5-Dioxabicyclo[2.2.1]Hept-3-Yl]-5-Methylpyrimidin-2(1h)-One",small molecule,experimental,,,
3183,DB03379,2-Carboxyethylphosphonic Acid,small molecule,experimental,,OC(=O)CCP(O)(O)=O,1682
3184,DB03380,L-tyrosinamide,small molecule,experimental,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins",[H][C@](N)(CC1=CC=C(O)C=C1)C(N)=O,151243
3185,DB03381,Hexadecanal,small molecule,experimental,,CCCCCCCCCCCCCCCC=O,984
3186,DB03382,S-oxy-L-cysteine,small molecule,experimental,,[H][C@](N)(CS=O)C(O)=O,49866839
3187,DB03383,CP-320626,small molecule,experimental,"Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Phosphorylase b, antagonists & inhibitors",OC1CCN(CC1)C(=O)[C@H](CC1=CC=C(F)C=C1)NC(=O)C1=CC2=C(N1)C=CC(Cl)=C2,444746
3188,DB03384,Fica,small molecule,experimental,,FC1=CC2=C(NC(=C2)C(=O)NCCS)C=C1,448573
3189,DB03385,4-Methylimidazole,small molecule,experimental,,CC1=CNC=N1,13195
3190,DB03386,4-Fluorotryptophane,small molecule,experimental,,N[C@@H](CC1=CNC2=C1C(F)=CC=C2)C(O)=O,688475
3191,DB03387,N-Hydroxy-N-Isopropyloxamic Acid,small molecule,experimental,,CC(C)N(O)C(=O)C(O)=O,73284
3192,DB03388,"3-[(2,4-Dichlorobenzoyl)(Isopropyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid",small molecule,experimental,,CC(C)N(C(=O)C1=C(Cl)C=C(Cl)C=C1)C1=C(SC(=C1)C1=CC=CC=C1)C(O)=O,657065
3193,DB03389,alpha-D-Xylopyranose,small molecule,experimental,,O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O,6027
3194,DB03390,"(2R,3R)-2,3-Dihydroxy-4-oxo-4-(propylamino)butanoic acid",small molecule,experimental,,[H]N(CCC)C(=O)[C@H](O)[C@@H](O)C(O)=O,449346
3195,DB03391,Chromophore (Met-Tyr-Gly),small molecule,experimental,,[H]\C(=C1\N=C(N(CC(O)=O)C1=O)[C@@]([H])(N)CCSC)C1=CC=C(O)C=C1,49866789
3196,DB03392,"(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester",small molecule,experimental,,[H][C@]1(O)[C@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(NP(=O)(OC)OC)[C@]1([H])O,656959
3197,DB03393,Sanglifehrin A,small molecule,experimental,,[H][C@@]12CCCN(N1)C(=O)[C@H](CC1=CC(O)=CC=C1)NC(=O)[C@@H](NC(=O)[C@H](CCC(C)=O)[C@H](O)[C@@H](C)[C@@H](O)\C=C\C=C\C[C@H](OC2=O)C(\C)=C\C=C\CC[C@H](C)[C@@H](O)C[C@@H]1O[C@@]2(NC(=O)[C@@H](CC)C[C@@H]2C)[C@@H](C)[C@@H](O)[C@H]1C)C(C)C,5388925
3198,DB03394,Heptaethylene glycol,small molecule,experimental,Pegylated agents,OCCOCCOCCOCCOCCOCCOCCO,79718
3199,DB03395,Enalkiren,small molecule,experimental,"Agents Acting on the Renin-Angiotensin System|Amino Acids, Peptides, and Proteins|Enzyme Inhibitors|Oligopeptides|Peptides|Protease Inhibitors|Renin-Inhibitors",COC1=CC=C(C[C@H](NC(=O)CC(C)(C)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CC2CCCCC2)[C@@H](O)[C@@H](O)CC(C)C)C=C1,60594
3200,DB03396,"(2R,3R,4S,5R,6E)-3,4,5-Trihydroxy-N-[(3S,6R)-6-hydroxy-2-oxo-3-azepanyl]-2-methoxy-8,8-dimethyl-6-nonenamide",small molecule,experimental,,[H]N([C@H]1CC[C@@H](O)CN([H])C1=O)C(=O)[C@H](OC)[C@H](O)[C@@H](O)[C@H](O)\C=C\C(C)(C)C,448235
3201,DB03397,Uridine-Diphosphate-N-Acetylglucosamine,small molecule,experimental,,CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O,445675
3202,DB03399,Ethyl Isocyanide,small molecule,experimental,,CC[N+]#C,4474585
3203,DB03400,3-(P-Tolyl)Propionic Acid,small molecule,experimental,,CC1=CC=C(CCC(O)=O)C=C1,73927
3204,DB03401,"1D-myo-inositol 1,4,5-trisphosphate",small molecule,experimental,"Alcohols|Carbohydrates|Inositol 1,4,5-Trisphosphate|Inositol Phosphates|Sugar Alcohols|Sugar Phosphates",O[C@@H]1[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H](O)[C@@H]1OP(O)(O)=O,439456
3205,DB03402,"1,2-Di-1-(3,7,11,15-Tetramethyl-Hexadecane)-Sn-Glycero-3-Phosphate",small molecule,experimental,,[H][C@@](C)(CCCC(C)C)CCC[C@@]([H])(C)CCC[C@@]([H])(C)CCOC[C@@]([H])(COP(O)(O)=O)OCC[C@]([H])(C)CCC[C@]([H])(C)CCC[C@]([H])(C)CCCC(C)C,448151
3206,DB03403,Cytidine-5'-Monophosphate,small molecule,experimental,"Carbohydrates|Cytosine Nucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides",NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O,6131
3208,DB03405,N2-[(Benzyloxy)carbonyl]-N-[(3R)-1-{N-[(benzyloxy)carbonyl]-L-leucyl}-4-oxo-3-pyrrolidinyl]-L-leucinamide,small molecule,experimental,,[H]N([C@@H](CC(C)C)C(=O)N([H])[C@@H]1CN(CC1=O)C(=O)[C@H](CC(C)C)N([H])C(=O)OCC1=CC=CC=C1)C(=O)OCC1=CC=CC=C1,5289122
3209,DB03406,O1-Methyl-4-Deoxy-4-Thio-Alpha-D-Glucose,small molecule,experimental,,[H][C@@]1(O)[C@@]([H])(O)[C@@]([H])(OC)O[C@]([H])(CO)[C@@]1([H])S,446000
3210,DB03407,4-Nitrocatechol,small molecule,experimental,Benzene Derivatives|Phenols,OC1=CC=C(C=C1O)[N+]([O-])=O,3505109
3211,DB03408,gamma-Glutamylcysteine,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Oligopeptides|Peptides",N[C@@H](CCC(=O)N[C@@H](CS)C(O)=O)C(O)=O,123938
3212,DB03409,L-Octahydroindole-2-carboxylic acid,small molecule,experimental,,[H][C@]12C[C@H](N[C@@]1([H])CCCC2)C(O)=O,7408452
3213,DB03410,4-hydroxycoumarin,small molecule,experimental,"Anticoagulants|Benzopyrans|Coumarins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Narrow Therapeutic Index Drugs|Pyrans|Vitamin K Antagonists",OC1=CC(=O)OC2=CC=CC=C12,54682930
3214,DB03411,"2-Hydroxymethyl-Pyrrolidine-3,4-Diol",small molecule,experimental,,OC[C@@H]1NC[C@H](O)[C@H]1O,127716
3215,DB03412,6-hydroxynorleucine,small molecule,experimental,"Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Aminocaproates|Caproates|Fatty Acids|Fatty Acids, Volatile|Lipids",N[C@@H](CCCCO)C(O)=O,97725
3216,DB03413,Deoxyuridine-5'-Diphosphate,small molecule,experimental,,O[C@H]1C[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O,145729
3217,DB03414,5-Thio-a/B-D-Mannopyranosylamine,small molecule,experimental,,[H][C@]1(N)S[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@]1([H])O,448267
3218,DB03415,3-thiaoctanoyl-CoA,small molecule,experimental,,CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N,448875
3219,DB03416,Thiamine(1+) monophosphate,small molecule,experimental,,CC1=C(CCO[P@](O)([O-])=O)SC=[N+]1CC1=CN=C(C)N=C1N,3382778
3220,DB03417,"(2S,3R)-2-[[4-(Tert-butylcarbamoyl)piperazine-1-carbonyl]amino]-6-(diaminomethylideneamino)-3-formylhexanoic acid",small molecule,experimental,,[H]N([H])C(=NCCC[C@@H](C=O)[C@H](N([H])C(=O)N1CCN(CC1)C(=O)N([H])C(C)(C)C)C(O)=O)N([H])[H],6323182
3221,DB03418,Diacetyldeuteroheme,small molecule,experimental,"Biological Factors|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Porphyrins",CC(=O)C1=C(C)C2=CC3=C(C(O)=C)C(C)=C4C=C5N6C(=CC7=C(CCC(O)=O)C(C)=C8C=C1N2[Fe]6(N78)N34)C(CCC(O)=O)=C5C,131704243
3222,DB03419,Uracil,small molecule,experimental|investigational,Fluorouracil and prodrugs|Pyrimidines|Pyrimidinones,O=C1NC=CC(=O)N1,1174
3223,DB03420,"2,4-deoxy-4-guanidino-5-N-acetyl-neuraminic acid",small molecule,experimental,,[H][C@]1(O[C@H](C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,17754002
3224,DB03421,"2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione",small molecule,experimental,,O=C1NN(CCC2=CC=CC=C2)C(=O)C2=C1C=CC=C2,1584
3225,DB03422,"1,3-Thiazole-4-Carboxylic Acid",small molecule,experimental,,OC(=O)C1=CSC=N1,304271
3226,DB03423,S-Adenosyl-L-Homoselenocysteine,small molecule,experimental,Selenium Compounds,[H][C@](N)(CC[Se]C[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O)C(O)=O,446317
3227,DB03424,Ubenimex,small molecule,investigational,"Adjuvants, Immunologic|Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Aminopeptidases, antagonists & inhibitors|Anti-Bacterial Agents|Anti-HIV Agents|Anti-Infective Agents|Antibiotics, Antineoplastic|Enzyme Inhibitors|Immunologic Factors|Protease Inhibitors",CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1)C(O)=O,72172
3228,DB03425,"2s,4r-4-Methylglutamate",small molecule,experimental,"Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins",[H][C@@](C)(C[C@]([H])(N)C(O)=O)C([O-])=O,131704245
3229,DB03426,Digalactosyl Diacyl Glycerol (Dgdg),small molecule,experimental,,[H][C@@](COC(=O)CCCCCCCCCCCCCCCCC)(CO[C@]1([H])O[C@]([H])(CO[C@@]2([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@]([H])(O)[C@@]1([H])O)OC(=O)CCCCCCCCCCCCCCCCC,15991538
3230,DB03427,delta-(L-alpha-Aminoadipoyl)-L-cysteinyl-D-vinylglycine,small molecule,experimental,,[H]N([H])[C@@H](CCCC(=O)N([H])[C@@H](CS)C(=O)N([H])[C@H](C=C)C(O)=O)C(O)=O,6398414
3231,DB03428,SU9516,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring",COC1=CC=C2NC(=O)\C(=C/C3=CN=CN3)C2=C1,5289419
3232,DB03429,Tetrastearoyl cardiolipin,small molecule,experimental,,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCC(O)COP(O)(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC,449005
3233,DB03430,(S)-4-hydroxymandelonitrile,small molecule,experimental,,O[C@H](C#N)C1=CC=C(O)C=C1,440104
3234,DB03432,Beta-Amino Isobutyrate,small molecule,experimental,,C[C@H](CN)C([O-])=O,5287787
3235,DB03433,{3-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Amino]-2-Methyl-Propyl}-Phosphonic Acid,small molecule,experimental,,C[C@H](CNCC1=C(O)C(C)=NC=C1COP(O)(O)=O)OP(O)(O)=O,5496700
3236,DB03434,3-(N-morpholino)propanesulfonic acid,small molecule,experimental,Buffers|Oxazines,OS(=O)(=O)CCCN1CCOCC1,70807
3237,DB03435,Uridine-5'-Diphosphate,small molecule,experimental,,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O,6031
3238,DB03436,Gallichrome,small molecule,experimental,"Amines|Amino Acids, Peptides, and Proteins|Gallium|Hydroxamic Acids|Hydroxy Acids|Hydroxylamines|Peptides|Peptides, Cyclic",CC1=[O][Ga]2345ON1CCC[C@H]1NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCCN(O2)C(C)=[O]3)NC(=O)C(CCCN(O4)C(C)=[O]5)NC1=O,46936673
3239,DB03437,"(2R,4S)-2-[(1R)-1-{[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid",small molecule,experimental,,[H]N([H])C1=NC(=CS1)C(=N\OC)\C(=O)N([H])[C@H](C=O)[C@@]1([H])SC(C)(C)[C@@H](N1[H])C(O)=O,9600418
3240,DB03438,Lysophosphatidylglycerol,small molecule,experimental,Alcohols|Carbohydrates|Glycerophosphates|Lipids|Membrane Lipids|Phosphatidic Acids|Phospholipids|Sugar Alcohols|Sugar Phosphates|Triose Sugar Alcohols,[H][C@](O)(CO)COP([O-])(=O)OC[C@@]([H])(O)COC(=O)CCCCCCCCCCCCCCC,5289143
3241,DB03439,"4,6-dideoxy-4-amino-alpha-D-glucose",small molecule,experimental,,[H][C@]1(C)O[C@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])N,444139
3242,DB03440,N-hexadecanoylglycine,small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins|Fatty Acids|Lipids",CCCCCCCCCCCCCCCC(=O)NCC(O)=O,151008
3243,DB03441,2-Benzyl-3-Iodopropanoic Acid,small molecule,experimental,,[H][C@@](CI)(CC1=CC=CC=C1)C(O)=O,17753867
3244,DB03442,Acid yellow 54 free acid,small molecule,experimental,"Acids|Acids, Noncarboxylic|Arylsulfonates|Arylsulfonic Acids|Benzene Derivatives|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",CC1=NN(C(O)=C1\N=N\C1=CC(=CC=C1C(O)=O)S(O)(=O)=O)C1=C(C)C=C(C=C1)S(O)(=O)=O,5478860
3245,DB03443,bis(5-amidino-benzimidazolyl)methanone zinc,small molecule,experimental,,NC(N)C1=CC2=C(C=C1)[N+]1=C(N2)C(=O)C2=[N+]([Zn]1)C1=C(N2)C=C(C=C1)C(N)N,131704246
3246,DB03444,6-bromoindirubin-3'-oxime,small molecule,experimental,"Amines|Glycogen Synthase Kinase 3, antagonists & inhibitors|Heterocyclic Compounds, Fused-Ring|Hydroxylamines",O\N=C1\C(\NC2=C\1C=CC=C2)=C1\C(=O)NC2=CC(Br)=CC=C12,5287844
3247,DB03445,"(3S)-3-(dioxidosulfanyl)-N-[(1E)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine",small molecule,experimental,,CC(CN1C=CN=N1)([C@@H](N\C=C\C=O)C(O)=O)S(=O)=O,6419229
3248,DB03446,N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide,small molecule,experimental,,[H][C@]1(CO)O[C@]([H])(OC2=CC=CC(=C2)C(=O)NCC2=CC=CC=C2)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O,445579
3249,DB03447,Uridylyl-2'-5'-phospho-adenosine,small molecule,experimental,,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)O[C@@H]4[C@H](O)[C@@H](CO)O[C@H]4N4C=CC(=O)NC4=O)[C@@H](O)[C@H]3O)C2=NC=N1,444053
3250,DB03448,2'-Deoxyuridine 3'-Monophosphate,small molecule,experimental,,OC[C@H]1O[C@H](C[C@@H]1OP(O)(O)=O)N1C=CC(=O)NC1=O,449392
3251,DB03449,N-(4-{2-[(3-chlorobenzyl)amino]ethyl}phenyl)thiophene-2-carboximidamide,small molecule,experimental,,[H]N([H])C(=N/C1=CC=C(CCN([H])CC2=CC(Cl)=CC=C2)C=C1)\C1=CC=CS1,449021
3252,DB03450,Cephalothin Group,small molecule,experimental,Nephrotoxic agents,[H][C@@](NC(=O)CC1=CC=CS1)(C=O)[C@]1([H])NC(C(O)=O)=C(CC(=O)OC)CS1,46936680
3253,DB03451,Lexacalcitol,small molecule,experimental,Antineoplastic Agents|Cholestanes|Cholestenes|Fused-Ring Compounds|Immunologic Factors|Immunosuppressive Agents|Lipids|Membrane Lipids|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble),[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@@H](C)OCCCC(O)(CC)CC,73896915
3254,DB03452,3-Trimethylsilylsuccinic Acid,small molecule,experimental,,C[Si](C)(C)C(CC(O)=O)C(O)=O,3359381
3255,DB03453,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,small molecule,experimental,,[H]N=C(N([H])[H])N1CCC[C@H](CC(=O)N([H])[C@@H](CC2=CC=C(C=C2)C#CC2=CC=CC=C2)C(=O)OC)C1,5288250
3256,DB03454,"3-methyl-benzene-1,2-diol",small molecule,experimental,,CC1=CC=CC(O)=C1O,340
3257,DB03455,(1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid,small molecule,experimental,,[H][C@](NOCCS)(C(O)=O)C1=CNC2=C1C=CC=C2,447066
3258,DB03456,N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide,small molecule,experimental,,[H][C@@](CC(C)C)(NC(=O)OCC1=CC=CC=C1)C(=O)N[C@]1([H])CCN(C1)C#N,5288988
3259,DB03458,"N(4)-Adenosyl-N(4)-methyl-2,4-diaminobutanoic acid",small molecule,experimental,"Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Butyrates|Fatty Acids|Fatty Acids, Volatile|Lipids",CN(CC[C@H](N)C(O)=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12,188380
3260,DB03459,Sparfosic acid,small molecule,experimental,"Acetates|Acids, Acyclic|Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antimetabolites|Antineoplastic Agents|Enzyme Inhibitors|Excitatory Amino Acids|Fatty Acids|Fatty Acids, Volatile|Lipids|Noxae|Organophosphonates|Organophosphorus Compounds|Toxic Actions",[H]N([C@@H](CC(O)=O)C(O)=O)C(=O)CP(O)(O)=O,39981
3261,DB03460,Violaxanthin,small molecule,experimental,"Alkenes|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Terpenes",C\C(\C=C\C=C(/C)\C=C\[C@@]12O[C@]1(C)C[C@@H](O)CC2(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/[C@@]12O[C@]1(C)C[C@@H](O)CC2(C)C,448438
3262,DB03461,Nicotinamide adenine dinucleotide phosphate,small molecule,experimental,"Adenine Nucleotides|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](OP(O)(O)=O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O,57525501
3263,DB03462,Thymine,small molecule,experimental,Pyrimidines|Pyrimidinones,CC1=CNC(=O)NC1=O,1135
3264,DB03464,Formycin-5'-Monophosphate,small molecule,experimental,,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(C2=C3N=CN=C(N)C3=NN2)[C@]([H])(O)[C@]1([H])O,444260
3265,DB03466,BMS184394,small molecule,experimental,,CC1(C)CCC(C)(C)C2=C1C=CC(=C2)[C@@H](O)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O,445575
3266,DB03467,Naringenin,small molecule,experimental,"Anti-Ulcer Agents|BCRP/ABCG2 Inhibitors|Benzopyrans|Chromones|Estrogen Antagonists|Flavonoids|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Pyrans",[H][C@]1(CC(=O)C2=C(O1)C=C(O)C=C2O)C1=CC=C(O)C=C1,439246
3267,DB03468,"1,2,3,4-Tetrahydro-Isoquinoline-7-Sulfonic Acid Amide",small molecule,experimental,,NS(=O)(=O)C1=CC2=C(CCNC2)C=C1,5226
3268,DB03469,Heme D,small molecule,experimental,"Biological Factors|Heterocyclic Compounds, Fused-Ring|Metalloporphyrins|Pigments, Biological|Porphyrins",CC1=C(CCC(O)=O)C2=CC3=C(CCC(O)=O)C(C)=C4C=C5[N+]6=C(C=C7N8C(C=C1N2[Fe]68N34)=C([O-])[C@]7(C)CC(O)=O)C(=O)[C@]5(C)CC(O)=O,131704247
3269,DB03470,Trypanothione,small molecule,experimental,"Amines|Amino Acids, Peptides, and Proteins|Biogenic Amines|Biogenic Polyamines|Diamines|Oligopeptides|Peptides|Polyamines|Trypanosoma",N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(=O)NCCCCNCCCNC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@H](N)C(O)=O)C(O)=O,449517
3270,DB03471,6-phenyl-4(R)-(7-phenyl-heptanoylamino)-hexanoic acid,small molecule,experimental,,[H]N([C@@H](CCC(O)=O)CCC1=CC=CC=C1)C(=O)CCCCCCC1=CC=CC=C1,446783
3271,DB03472,Cyclohexyl-Hexyl-Beta-D-Maltoside,small molecule,experimental,,[H][C@]1(CO)O[C@]([H])(O[C@]2([H])[C@@]([H])(CO)O[C@@]([H])(OCCCCCCC3CCCCC3)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O,447688
3272,DB03473,N5-Methylglutamine,small molecule,experimental,,CNC(=O)CC[C@H](N)C(O)=O,439925
3273,DB03474,Reactive Red 1 Dye,small molecule,experimental,,NC1=NC(NC2=CC(=CC3=C2C(O)=C(\N=N\C2=CC=CC=C2S(O)(=O)=O)C(=C3)S(O)(=O)=O)S(O)(=O)=O)=NC(N)=N1,5326578
3274,DB03475,"1-[4-Carboxy-2-(3-Pentylamino)Phenyl]-5,5'-Di(Hydroxymethyl)Pyrrolidin-2-One",small molecule,experimental,,CCC(CC)NC1=CC(=CC=C1N1C(=O)CCC1(CO)CO)C(O)=O,444508
3275,DB03476,Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine,small molecule,experimental,,[H][C@]1(C[C@@]1([H])C1=CC2=CC=C(C=C2C=C1)C(N)=N)C1=CC=CC=C1,448841
3276,DB03477,1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole,small molecule,experimental,,NS(=O)(=O)C1=CC=C(C=C1)N1N=C(C=C1C1=CC=C(Br)C=C1)C(F)(F)F,1396
3277,DB03478,2'-O-Acetyl Adenosine-5-Diphosphoribose,small molecule,experimental,,[H][C@]1(O)O[C@]([H])(COP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])O)[C@@]([H])(O)[C@@]1([H])OC(C)=O,447049
3278,DB03479,"8,9,10-trihydroxy-7-hydroxymethyl-3-methyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-dione",small molecule,experimental,,CN1C(=O)N[C@@]2(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C1=O,445720
3279,DB03480,Brequinar Analog,small molecule,experimental,,CC1=C(N=C2C=CC(F)=CC2=C1C(O)=O)C1=CC=C(C=C1)C1=CC=CC=C1,1543
3280,DB03481,"5,10-Dimethylene Tetrahydromethanopterin",small molecule,experimental,,C[C@H]1[C@@H]2[C@@H](C)NC3=C(N2CN1C1=CC=C(C[C@@H](O)[C@@H](O)[C@H](O)CO[C@H]2O[C@H](CO[P@@](O)(=O)O[C@@H](CCC(O)=O)C(O)=O)[C@@H](O)[C@@H]2O)C=C1)C(=O)NC(N)=N3,46936694
3281,DB03482,8-demethyl-8-dimethylamino-flavin-adenine-dinucleotide,small molecule,experimental,,[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN4C5=C(C=C(C)C(=C5)N(C)C)N=C5C(=O)N([H])C(=O)N=C45)[C@@H](O)[C@H]3O)C2=NC=N1,5289282
3282,DB03483,(4S)-5-[[(2S)-1-[[(2S)-1-Amino-3-[4-[difluoro(phosphono)methyl]phenyl]-1-oxopropan-2-yl]amino]-3-[4-[difluoro(phosphono)methyl]phenyl]-1-oxopropan-2-yl]amino]-4-benzamido-5-oxopentanoic acid,small molecule,experimental,,[H]N([H])C(=O)[C@H](CC1=CC=C(C=C1)C(F)(F)P(O)(O)=O)N([H])C(=O)[C@H](CC1=CC=C(C=C1)C(F)(F)P(O)(O)=O)N([H])C(=O)[C@H](CCC(O)=O)N([H])C(=O)C1=CC=CC=C1,446986
3283,DB03484,sn-glycero-3-phosphoethanolamine,small molecule,experimental,Alcohols|Carbohydrates|Glycerophosphates|Glycerophospholipids|Lipids|Membrane Lipids|Phosphatidic Acids|Phospholipids|Sugar Alcohols|Sugar Phosphates|Triose Sugar Alcohols,[H][C@](O)(CO)COP(O)(=O)OCCN,5459861
3284,DB03485,alpha-D-Fucopyranose,small molecule,experimental,,C[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O,444200
3285,DB03486,Phosphomethylphosphonic acid guanosyl ester,small molecule,experimental,,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)CP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,448477
3286,DB03487,(S)-Aspartimide,small molecule,experimental,,[H]N1C(=O)C[C@H](N)C1=O,13373305
3287,DB03488,Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose,small molecule,experimental,,OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@H](F)[C@@H](O)[C@@H]1O,448923
3288,DB03489,2-Keto-3-Deoxygluconate,small molecule,experimental,"Acids, Acyclic|Carbohydrates|Hydroxy Acids|Sugar Acids",OC[C@H](O)[C@@H](O)CC(=O)C(O)=O,11309850
3289,DB03490,"3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole",small molecule,experimental,,C1C2=C(C=CC=C2)C2=NNC(=C12)C1=CC=NC=C1,314123
3290,DB03491,2'-Deoxyguanosine-5'-Diphosphate,small molecule,experimental,,NC1=NC2=C(N=CN2[C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O2)C(=O)N1,439220
3291,DB03492,"lambda-bis(2,2'-bipyridine)imidazole osmium (II)",small molecule,experimental,,C1=CN(C=N1)[Os++]123[N]4=CC=CC=C4C4=[N]1C=CC=C4.C1=CC(C4=CC=CC=[N]24)=[N]3C=C1,46936698
3292,DB03493,7-Methylguanosine,small molecule,experimental,"Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides|RNA Caps",CN1C=[N+]([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C2=C1C(=O)N=C(N)N2,445404
3293,DB03495,"4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1->4)-Alpha-D-Threo-Hexopyranosyl-(1->6)-Alpha-L-Threo-Hexopyranose",small molecule,experimental,,[H][C@]1(C)O[C@]([H])(O[C@]2([H])[C@@]([H])(CO)O[C@]([H])(OC[C@@]3([H])O[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])N[C@@]1([H])C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O,449165
3294,DB03496,Alvocidib,small molecule,experimental|investigational,"Antineoplastic Agents|BCRP/ABCG2 Substrates|Benzopyrans|Chromones|Cyclin-Dependent Kinases, antagonists & inhibitors|Enzyme Inhibitors|Growth Inhibitors|Growth Substances|Heterocyclic Compounds, Fused-Ring|Protein Kinase Inhibitors|Pyrans|UGT1A1 Substrates",CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl,5287969
3295,DB03497,L-serine O-sulfate,small molecule,experimental,"Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins",N[C@@H](COS(O)(=O)=O)C(O)=O,164701
3296,DB03498,Mercaptomethyl Phosphonate,small molecule,experimental,,[O-]P([O-])(=O)CS,5288817
3297,DB03499,D-Malic acid,small molecule,experimental,,O[C@H](CC(O)=O)C(O)=O,92824
3298,DB03500,Tricosanoic acid,small molecule,experimental,Fatty Acids|Lipids,CCCCCCCCCCCCCCCCCCCCCCC(O)=O,17085
3299,DB03501,Galactose-uridine-5'-diphosphate,small molecule,experimental,"Carbohydrates|Deoxyribonucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Diphosphate Sugars|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides|Uracil Nucleotides|Uridine Diphosphate|Uridine Diphosphate Sugars",OC[C@H]1O[C@H](O[P@@](O)(=O)O[P@@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@H](O)[C@@H](O)[C@H]1O,18068
3300,DB03502,(4s)-4-{[(2s)-2-Amino-3-Oxopropyl]Sulfanyl}-L-Homoserinate,small molecule,experimental,,[H][C@](O)(C[C@]([H])(N)C(O)=O)SC[C@]([H])(N)C(O)=O,49867129
3301,DB03503,"4-Acetyl-4-guanidino-6-methyl(propyl)carboxamide-4,5-dihydro-2H-pyran-2-carboxylic acid",small molecule,experimental,,CCCN(C)C(=O)[C@@H]1OC(=C[C@H](NC(N)=N)[C@H]1NC(C)=O)C(O)=O,449379
3302,DB03504,"9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine",small molecule,experimental,,CCCCN1C(CC2=CC(OC)=C(OC)C(OC)=C2Cl)=NC2=C(N)N=CN=C12,448970
3303,DB03505,"2,6-diaminoquinazolin-4-ol",small molecule,experimental,,NC1=CC2=C(O)N=C(N)N=C2C=C1,448010
3304,DB03506,9-Deazaadenine,small molecule,experimental,,[H]N([H])C1=NC=NC2=C1N([H])C=C2,5287565
3305,DB03507,"6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One",small molecule,experimental,,[O-][N+](=O)C1=CC(=CC=C1)C1=CC2=C(S1)C=C1N2C(=S)N(CCCN2CCOCC2)C1=O,4470566
3306,DB03508,Diethylene glycol ethyl methyl ether,small molecule,experimental,,CCOCCOCCOC,13847
3307,DB03509,2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,small molecule,experimental,"Antineoplastic Agents|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Poly(ADP-ribose) Polymerase Inhibitors",NC(=O)C1=CC=CC2=NC=C(N=C12)C1=CC=C(Cl)C=C1,657038
3308,DB03510,6-O-Phosphoryl Inosine Monophosphate,small molecule,experimental,,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=CN=C3OP(O)(O)=O)[C@]([H])(O)[C@]1([H])O,444818
3309,DB03511,alpha-D-galacturonic acid,small molecule,experimental,,O[C@H]1O[C@@H]([C@H](O)[C@H](O)[C@H]1O)C(O)=O,445929
3310,DB03512,"Uridine-2',3'-vanadate",small molecule,experimental,Vanadates,OC[C@@H]1O[C@H]([C@H]2O[V](O)(O)(=O)O[C@H]12)N1C=CC(=O)NC1=O,46936702
3311,DB03513,"(S)-2-Amino-3-(4h-Selenolo[3,2-B]-Pyrrol-6-Yl)-Propionic Acid",small molecule,experimental,Selenium Compounds,[H][C@](N)(CC1=CNC2=C1[Se]C=C2)C(O)=O,15480320
3312,DB03514,4-Vinylguaiacol,small molecule,experimental,"Alkenes|Benzene Derivatives|Catechols|Ethers|Hydrocarbons, Acyclic|Methyl Ethers|Phenols|Phenyl Ethers",COC1=C(O)C=CC(C=C)=C1,332
3313,DB03515,Equilenin,small molecule,experimental,"17-Ketosteroids|Adrenal Cortex Hormones|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Estradiol Congeners|Estranes|Estrenes|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Steroids",[H][C@@]12CCC(=O)[C@@]1(C)CCC1=C2C=CC2=C1C=CC(O)=C2,444865
3314,DB03516,Eniluracil,small molecule,investigational,Enzyme Inhibitors|Pyrimidines|Pyrimidinones,O=C1NC=C(C#C)C(=O)N1,43157
3315,DB03517,[Methylthio]Acetate,small molecule,experimental,,CSCC([O-])=O,5179950
3316,DB03518,Mevalonic acid,small molecule,experimental,Hydroxy Acids,C[C@@](O)(CCO)CC(O)=O,439230
3317,DB03520,6-Chloro-2-fluoropurine,small molecule,experimental,,FC1=NC2=C(N=CN2)C(Cl)=N1,5287914
3318,DB03522,Aspartic Acid-4-Carboxymethyl Ester,small molecule,experimental,,N[C@@H](CC(=O)OCC(O)=O)C(O)=O,17753844
3319,DB03523,Brequinar,small molecule,experimental,Antineoplastic Agents|Benzene Derivatives|Enzyme Inhibitors|Immunologic Factors|Immunosuppressive Agents|Oxidoreductases,CC1=C(N=C2C=CC(F)=CC2=C1C(O)=O)C1=CC=C(C=C1)C1=CC=CC=C1F,57030
3320,DB03524,"N-[3-[4-(3-aminopropyl)piperazin-1-yl]propyl]-3-[(2-thiophen-2-ylacetyl)amino]-5-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzamide",small molecule,experimental,,NCCCN1CCN(CCCNC(=O)C2=CC(NC(=O)CC3=CC=CS3)=CC(O[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)=C2)CC1,49867166
3321,DB03525,RU79073,small molecule,experimental,,OP(O)(=O)OC1=C2NCCCC2=CC=C1,5287550
3322,DB03526,AL5927,small molecule,experimental,,COC1=CC=C(CNS(=O)(=O)C2=CC=C(S2)S(N)(=O)=O)C=C1,4316
3323,DB03528,9-Beta-D-Xylofuranosyl-Adenine,small molecule,experimental,,[H][C@]1(CO)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@@]1([H])O,447916
3324,DB03530,Acylated ceftazidime,small molecule,experimental,,[H]N([H])C1=NC(=CS1)C(=N\OC(C)(C)C(O)=O)\C(=O)N([H])[C@H](C=O)[C@@]1([H])SCC(=C)C(=N1)C(O)=O,9600404
3325,DB03531,Flavin-adenine dinucleotide-N5-isobutyl ketone,small molecule,experimental,,CC(C)C(=O)N1C2=C(C=C(C)C(C)=C2)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)[N+]2=CN=C3C2=NC=NC3=N)C2=C1C([O-])=NC(=O)N2,131704249
3326,DB03532,Phosphomethylphosphonic acid guanylate ester,small molecule,experimental,,NC1=NC(=O)C2=C(N1)N(C=N2)[C@@H]1O[C@H](COP(O)(=O)CP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O,449108
3327,DB03533,Acetyleneurea,small molecule,experimental,"Hydrocarbons, Acyclic",[H][C@@]12NC(=O)N[C@]1([H])NC(=O)N2,62347
3328,DB03534,3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide,small molecule,experimental,,CN(CC1=C(N)C=CC(=C1)C(=O)N(C)CC1=CC2=C(C=CC=C2)N1C)C(C)=O,447018
3329,DB03535,Z-Pro-Prolinal,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Oligopeptides|Peptides",[H][C@]1(CCCN1C(=O)[C@]1([H])CCCN1C(=O)OCC1=CC=CC=C1)C=O,122623
3330,DB03536,Benzyl N-[(2S)-5-(diaminomethylamino)-1-[[(2S)-4-fluoro-3-oxobutan-2-yl]amino]-1-oxopentan-2-yl]carbamate,small molecule,experimental,,C[C@H](NC(=O)[C@H](CCCNC(N)N)NC(=O)OCC1=CC=CC=C1)C(=O)CF,131704251
3331,DB03537,[4-(4-Hydroxy-Benzyl)-2-(2-Hydroxy-1-Methyl-Ethyl)-5-Oxo-Imidazolidin-1-Yl]-Acetic Acid,small molecule,experimental,,[H]\C(=C1\N=C(N(CC(O)=O)C1=O)[C@@]([H])(N)CO)C1=CC=C(O)C=C1,49867069
3332,DB03539,2-(Acetylamino)-2-Deoxy-6-O-Methyl-Alpha-D-Allopyranose,small molecule,experimental,,[H][C@]1(O)[C@]([H])(O)[C@@]2([H])N=C(O[C@@]2([H])[C@]1([H])CO)N=C,5287668
3333,DB03540,Norcamphor,small molecule,experimental,Monoterpenes|Terpenes,[H][C@]12CC[C@]([H])(C1)C(=O)C2,449588
3334,DB03541,"10-Propargyl-5,8-Dideazafolic Acid",small molecule,experimental,,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(C=C1)N(CC#C)CC1=CC=C2NC(N)=NC(=O)C2=C1)C(O)=O,443388
3335,DB03542,L-Myo-Inositol-1-Phosphate,small molecule,experimental,,[H][C@]1(O)[C@]([H])(O)[C@]([H])(O)[C@]([H])(OP([O-])([O-])=O)[C@@]([H])(O)[C@]1([H])O,5288700
3336,DB03543,1-(O-Carboxy-Phenylamino)-1-Deoxy-D-Ribulose-5-Phosphate,small molecule,experimental,,[H][C@@](O)(CNC1=CC=CC=C1C(O)=O)[C@]([H])(O)[C@]([H])(O)COP(O)(O)=O,446446
3337,DB03544,S-Phosphocysteine,small molecule,experimental,"Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Sulfhydryl Compounds|Sulfur Compounds",N[C@@H](CSP(O)(O)=O)C(O)=O,3082729
3338,DB03546,"N-({4-[(1R)-4-[(2R,4S,5S)-2,4-diamino-6-oxohexahydropyrimidin-5-yl]-1-(2,2,2-trifluoro-1,1-dihydroxyethyl)butyl]phenyl}carbonyl)-L-glutamic acid",small molecule,experimental,,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(C=C1)[C@@]([H])(CCCC1C(O)=N[C@]([H])(N)N[C@]1([H])N)C(O)(O)C(F)(F)F)C(O)=O,131704252
3339,DB03548,3-deoxy-alpha-D-manno-oct-2-ulopyranosonic acid,small molecule,experimental,,[H][C@@]1(O[C@](O)(C[C@@H](O)[C@H]1O)C(O)=O)[C@H](O)CO,445569
3340,DB03549,Biotinyl P-Nitroaniline,small molecule,experimental,,[H][C@@]1(CCCCC(=O)NC2=CC=C(C=C2)[N+]([O-])=O)SC[C@]2([H])NC(=O)N[C@]12[H],446236
3341,DB03550,Isopenicillin N,small molecule,experimental,"Amides|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Sulfur Compounds",[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CCC[C@H](N)C(O)=O)C(O)=O,440723
3342,DB03551,"(3R,4R)-3-Hydroxy-4-(hydroxymethyl)-1-[(4-oxo-4,4a,5,7a-tetrahydro-3H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]pyrrolidinium",small molecule,experimental,,[H]N1C=C(C[N+]2([H])C[C@H](O)[C@@H](CO)C2)C2N=CN([H])C(=O)C12,131704253
3343,DB03552,3-Tyrosine,small molecule,experimental,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Isomerism",N[C@@H](CC1=CC=CC(O)=C1)C(O)=O,6950578
3344,DB03553,Glutaric Acid,small molecule,experimental,"Acids, Acyclic|Dicarboxylic Acids|OAT1/SLC22A6 inhibitors|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates",OC(=O)CCCC(O)=O,743
3345,DB03554,5-Iodouracil,small molecule,experimental,Pyrimidines|Pyrimidinones,IC1=CNC(=O)NC1=O,69672
3346,DB03555,CRA_11092,small molecule,experimental,,[H][C@]1(C)CCCC[C@]1([H])OC1=CC=CC(C2=NC3=C(N2)C=C(F)C(=C3)C(N)=N)=C1O,5326671
3347,DB03556,"2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400",small molecule,experimental,,CCOCCOCCOCCOCCOCCOCCOCCOCCO,657096
3348,DB03557,4-[[(2S)-1-[[6-[(1-Amino-1-oxo-3-sulfanylpropan-2-yl)amino]-6-oxohexyl]amino]-3-[4-[difluoro(phosphono)methyl]phenyl]-1-oxopropan-2-yl]amino]-3-[[2-[4-[difluoro(phosphono)methyl]phenyl]acetyl]amino]-4-oxobutanoic acid,small molecule,experimental,,NC(=O)C(CS)NC(=O)CCCCCNC(=O)[C@H](CC1=CC=C(C=C1)C(F)(F)P(O)(O)=O)NC(=O)C(CC(O)=O)NC(=O)CC1=CC=C(C=C1)C(F)(F)P(O)(O)=O,131704254
3349,DB03558,SP-876,small molecule,experimental,,OC(=O)CCNC(=O)[C@H]1CCCN1S(=O)(=O)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,445506
3350,DB03559,Cyclohexylformamide,small molecule,experimental,"Acids, Acyclic|Alcohol Dehydrogenase, antagonists & inhibitors|Amides|Formates",[H]C(=O)NC1CCCCC1,13017
3351,DB03560,P-Hydroxybenzaldehyde,small molecule,experimental,Aldehydes,OC1=CC=C(C=O)C=C1,126
3352,DB03562,Tetrahydrodeoxyuridine,small molecule,experimental,,[H]N1C(=O)CCN(C2C[C@H](O)[C@@H](CO)O2)C1=O,5289468
3353,DB03564,"(4r)-2-Methylpentane-2,4-Diol",small molecule,experimental,,C[C@H](O)CC(C)(C)O,5288834
3354,DB03565,1-O-Octyl-2-Heptylphosphonyl-Sn-Glycero-3-Phosphoethanolamine,small molecule,experimental,,[H][C@@](COCCCCCCCC)(COP(O)(=O)OCCN)OP(O)(=O)CCCCCCC,129148
3355,DB03566,Spermidine,small molecule,experimental,Amines|Biogenic Amines|Biogenic Polyamines|Diamines|OCT1 substrates|Polyamines,NCCCCNCCCN,1102
3356,DB03567,alpha-N-Acetyl-D-galactosamine,small molecule,experimental|investigational,,CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O,84265
3357,DB03568,Butyric Acid,small molecule,experimental|investigational,"Acids, Acyclic|Butyrates|Fatty Acids|Fatty Acids, Volatile|Histamine Agents|Lipids|Neurotransmitter Agents",CCCC(O)=O,264
3358,DB03569,"4,5-Dehydro-L-Iduronic Acid",small molecule,experimental,,[H][C@@]1(O)OC(C(O)=O)=C(O)[C@]([H])(O)[C@@]1([H])O,54688710
3359,DB03570,Tris-Hydroxymethyl-Methyl-Ammonium,small molecule,experimental,,C[N+](CO)(CO)CO,4468930
3360,DB03571,"3-(5-amino-7-hydroxy-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(3,5-dichlorobenzyl)-benzamide",small molecule,experimental,,NC1=NC2=NN(N=C2C(O)=N1)C1=CC(=CC=C1)C(=O)NCC1=CC(Cl)=CC(Cl)=C1,448407
3361,DB03572,FR230513,small molecule,experimental,,[H][C@](CO)(CCC1=CC=CC2=C1C=CC=C2)N1C=NC(=C1)C(N)=O,447341
3362,DB03573,WRR-99,small molecule,experimental,,[H][C@](O)(CC(O)=O)C(=O)N[C@]([H])(CCC1=CC=CC=C1)C(=O)NCCC(C)C,5289258
3363,DB03574,Ferricrocin-iron,small molecule,experimental,,[Fe].[H][C@@]1(CCCN(O)C(C)=[OH+])NC(=O)CNC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@]([H])(CCCN(O)C(C)=[OH+])NC(=O)[C@]([H])(CCCN(O)C(C)=[OH+])NC1=O,131704255
3364,DB03575,Phencyclidine,small molecule,illicit,"Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Hallucinogens|Neurotransmitter Agents|NMDA Receptor Antagonists|Phencyclidine, antagonists & inhibitors|Piperidines|Psychotropic Drugs",C1CCN(CC1)C1(CCCCC1)C1=CC=CC=C1,6468
3365,DB03576,N-Pyridoxyl-Threonine-5-Monophosphate,small molecule,experimental,,CC(O)C(NCC1=C(COP(O)(O)=O)C=NC(C)=C1O)C(O)=O,3378336
3366,DB03577,Alpha-Benzyl-Aminobenzyl-Phosphonic Acid,small molecule,experimental,,[H][C@](NCC1=CC=CC=C1)(C1=CC=CC=C1)P(O)(O)=O,447336
3367,DB03578,Pyruvamide,small molecule,experimental,Keto Acids,CC(=O)C(N)=O,79088
3368,DB03581,Glucose-6-Phosphate,small molecule,experimental,Carbohydrates|Glucosephosphates|Hexosephosphates|Sugar Phosphates,O[C@H](COP(O)(O)=O)[C@H](O)[C@H](O)[C@@H](O)C=O,3034794
3369,DB03582,N~2~-Succinylornithine,small molecule,experimental,,NCCC[C@H](NC(=O)CCC(O)=O)C(O)=O,127370
3370,DB03583,"(2E,3S)-3-hydroxy-5'-[(4-hydroxypiperidin-1-yl)sulfonyl]-3-methyl-1,3-dihydro-2,3'-biindol-2'(1'H)-one",small molecule,experimental,,[H]N1C(=O)\C(C2=C1C=CC(=C2)S(=O)(=O)N1CCC(O)CC1)=C1/N([H])C2=CC=CC=C2[C@]1(C)O,5289321
3371,DB03584,4-Thio-beta-D-glucopyranose,small molecule,experimental,,[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(S)[C@]([H])(O)[C@@]1([H])O,445564
3372,DB03585,Oxyphenbutazone,small molecule,approved|withdrawn,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antirheumatic Agents|Butylpyrazolidines|Central Nervous System Agents|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|OAT1/SLC22A6 inhibitors|Ophthalmologicals|Other Nonsteroidal Anti-inflammatory Agents|Peripheral Nervous System Agents|Pyrazoles|Pyrazolones|Sensory Organs|Sensory System Agents|Topical Products for Joint and Muscular Pain",CCCCC1C(=O)N(N(C1=O)C1=CC=C(O)C=C1)C1=CC=CC=C1,4641
3373,DB03586,"(3R,4R,5S,6R)-6-Fluoro-3,4,5-trihydroxytetrahydro-2H-pyran-2-olate",small molecule,experimental,,[H][C@]1(F)OC([O-])[C@H](O)[C@@H](O)[C@@H]1O,5289591
3374,DB03587,Pyruvaldehyde,small molecule,experimental,Aldehydes|Glyoxal,CC(=O)C=O,880
3375,DB03588,Diphenylacetic acid,small molecule,experimental,"Acids, Carbocyclic|Phenylacetates",OC(=O)C(C1=CC=CC=C1)C1=CC=CC=C1,8333
3376,DB03589,Mesoxalic acid,small molecule,experimental,"Acids, Acyclic|Dicarboxylic Acids",OC(=O)C(=O)C(O)=O,10132
3377,DB03590,"2,6-Diaminopimelic Acid",small molecule,experimental,,N[C@@H](CCC[C@H](N)C(O)=O)C(O)=O,439283
3378,DB03591,RU82209,small molecule,experimental,,CC(=O)N[C@@H](CC1=CC=C(C=C1)C(F)(F)P(O)(O)=O)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O,447523
3379,DB03592,Pterin-6-Yl-Methyl-Monophosphate,small molecule,experimental,,NC1=NC2=NC=C(COP(O)(O)=O)N=C2C(=O)N1,445462
3380,DB03593,7-methyl-5'-guanylic acid,small molecule,experimental,"Carbohydrates|Glycosides|Guanine Nucleotides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides|RNA|RNA Caps|RNA, Messenger",C[N+]1=CN([C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C2=C1C(=O)NC(N)=N2,440190
3381,DB03594,"1,2,4-Triazole",small molecule,experimental,,N1C=NC=N1,9257
3382,DB03595,CRA_9785,small molecule,experimental,,NC(=[NH2+])C1=CC=C2NC(=NC2=C1)C1=CC(OC(F)(F)F)=CC=C1[O-],22556917
3383,DB03596,N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide,small molecule,experimental,,[H][C@@](CC)(CNC(=O)C1=CC=C(C=C1)S(N)(=O)=O)C1=CC2=C(NC=C2)C=C1,5496599
3384,DB03597,gamma-Glutamyl[S-(2-iodobenzyl)cysteinyl]glycine,small molecule,experimental,,[H]N([H])[C@@H](CCC(=O)N([H])[C@@H](CSCC1=CC=CC=C1I)C(=O)N([H])CC(O)=O)C(O)=O,447108
3385,DB03598,"Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",small molecule,experimental,,COC1=CC=CC(=C1)N1C(CN2CCOCC2)=CC2=C(SC(=C2)S(N)(=O)=O)S1(=O)=O,4369171
3386,DB03600,Capric acid,small molecule,experimental,Anti-Infective Agents|Antifungal Agents|Fatty Acids|Lipids,CCCCCCCCCC(O)=O,2969
3387,DB03601,5-deoxyflavanone,small molecule,experimental,,OC1=CC=C(C=C1)[C@@H]1CC(=O)C2=CC=C(O)C=C2O1,114829
3388,DB03602,S-benzylglutathione,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Lactoylglutathione Lyase, antagonists & inhibitors|Oligopeptides|Peptides",[H]N([H])[C@@H](CCC(=O)N([H])[C@@H](CSCC1=CC=CC=C1)C(=O)N([H])CC(O)=O)C(O)=O,445707
3389,DB03603,Glucaric acid,small molecule,experimental,"Acids, Acyclic|Carbohydrates|Hydroxy Acids|Sugar Acids",O[C@@H]([C@H](O)[C@@H](O)C(O)=O)[C@H](O)C(O)=O,33037
3390,DB03604,Tiratricol,small molecule,investigational,"Agents used to treat hypothyroidism|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Dermatologicals|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thyroid Products|Thyronines",OC(=O)CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1,5803
3391,DB03605,"(2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid",small molecule,experimental,,[H][C@@](CC1=CC=CC=C1)(N(CC1=CC(=CC=C1)C(F)(F)F)C(=O)C1=C(Cl)C=C(Cl)C=C1)C(O)=O,447368
3392,DB03606,(S)-Rolipram,small molecule,experimental,,[H][C@@]1(CNC(=O)C1)C1=CC=C(OC)C(OC2CCCC2)=C1,158758
3393,DB03607,[(1R)-1-acetamido-2-(4-chlorophenyl)ethyl]-[(2S)-2-amino-3-hydroxy-3-oxo-propoxy]-dihydroxy-boron,small molecule,experimental,,CC(=O)N[C@@H](CC1=CC=C(Cl)C=C1)[B-](O)(O)OC[C@H](N)C(O)=O,17753902
3394,DB03608,Diminazene,small molecule,experimental,Amidines|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Benzamidines|Triazenes|Trypanocidal Agents,NC(=N)C1=CC=C(N\N=N\C2=CC=C(C=C2)C(N)=N)C=C1,2354
3395,DB03609,3'-deoxyguanosine,small molecule,experimental,,[H]N([H])C1=NC(=O)C2=C(N1[H])N(C=N2)[C@@H]1O[C@H](CO)C[C@H]1O,165138
3396,DB03610,4-(trifluoromethyl)phenol,small molecule,experimental,Benzene Derivatives,OC1=CC=C(C=C1)C(F)(F)F,67874
3397,DB03611,L-2-amino-4-methoxy-cis-but-3-enoic acid,small molecule,experimental,,[H]\C(OC)=C(/[H])[C@]([H])(N)C(O)=O,5287671
3398,DB03612,3-Hydroxybutyryl-Coenzyme A,small molecule,experimental,"Adenine Nucleotides|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides|Thioesters of coenzyme A",CC(O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N,644065
3399,DB03613,4-hydroxyphenacyl coenzyme A,small molecule,experimental,,[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)N([H])CCC(=O)N([H])CCSCC(=O)C4=CC=C(O)C=C4)[C@@H](OP(O)(O)=O)[C@H]3O)C2=NC=N1,446968
3400,DB03614,Mecobalamin,small molecule,approved|investigational,"Antianemic Preparations|Blood and Blood Forming Organs|Corrinoids|Heterocyclic Compounds, Fused-Ring|Vitamin B Complex|VITAMIN B12 AND FOLIC ACID|Vitamins",C1(CC[C@@]2([C@@H](CC(N)=O)[C@@]3([C@@]4([N+]5=C([C@H]([C@@]4(CC(N)=O)C)CCC(N)=O)C(C)=C4[N+]6=C(C=C7[N+]8=C([C@H](C7(C)C)CCC(N)=O)C(C)=C2N3[Co-3]568([N+]2=CN([C@H]3O[C@@H]([C@@H](OP(O[C@@H](CN1)C)([O-])=O)[C@H]3O)CO)C1=CC(C)=C(C=C21)C)C)[C@H]([C@@]4(CC(N)=O)C)CCC(N)=O)C)[H])C)=O,71306319
3401,DB03615,Ribostamycin,small molecule,approved|experimental,Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Carbohydrates|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Glycosides|Narrow Therapeutic Index Drugs|Nephrotoxic agents,[H][C@@]1(O[C@@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2N)O[C@H](CO)[C@@H](O)[C@H]1O,33042
3402,DB03616,Kabiramide C,small molecule,experimental,,[H]\C(=C(\[H])[C@@]([H])(C)[C@@]([H])(OC)[C@@]([H])(C)C(=O)CC[C@]([H])(C)[C@]([H])(C[C@]1([H])OC(=O)C[C@]([H])(C[C@]([H])(C)C[C@]([H])(O)[C@]([H])(C)[C@@]([H])(OC)C2=COC(=N2)C2=COC(=N2)C2=COC(=N2)\C([H])=C([H])\C[C@]([H])(OC)[C@@]1([H])C)O[C@]([H])(N)O)OC)N(C)CO,5288658
3403,DB03617,Modified Acarbose Hexasaccharide,small molecule,experimental,,[H][C@]1(C)O[C@]([H])(O[C@]2([H])[C@@]([H])(CO)O[C@]([H])(O[C@]3([H])C(CO)=C[C@]([H])(N[C@]4([H])[C@@]([H])(C)O[C@]([H])(O[C@]5([H])[C@@]([H])(CO)O[C@]([H])(O[C@]6([H])[C@@]([H])(C)O[C@@]([H])(O)[C@]([H])(O)[C@@]6([H])O)[C@]([H])(O)[C@@]5([H])O)[C@]([H])(O)[C@@]4([H])O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O,449600
3404,DB03618,2-(acetylamino)-2-deoxy-4-O-beta-D-galactopyranosyl-alpha-D-glucopyranose,small molecule,experimental,,[H]N([C@H]1[C@@H](O)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@@H]1O)C(C)=O,656944
3405,DB03619,Deoxycholic acid,small molecule,approved,Bile Acids and Salts|BSEP/ABCB11 inducers|Cholagogues and Choleretics|Cholanes|Cholic Acids|Cytolytic Agent|Decreased Cell Membrane Integrity|Dermatologicals|Fused-Ring Compounds|Gastrointestinal Agents|Other Miscellaneous Therapeutic Agents|Steroids,[H][C@@]12CC[C@H]([C@H](C)CCC(O)=O)[C@@]1(C)[C@@H](O)C[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@H](O)CC[C@]12C,222528
3406,DB03621,"L-709,587",small molecule,experimental,,[H]\C(=C(\C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@]([H])(C[C@@]2([H])C)OC)[C@]([H])(C[C@@]([H])(C)[C@]([H])(O)\C(C)=C([H])\[C@@]([H])(CC)C(=O)C[C@]([H])(O)[C@@]1([H])C)OC)[C@]1([H])CC[C@@]([H])(OC2=CC=C3N(C)C=CC3=C2)[C@@]([H])(C1)OC,5496872
3407,DB03622,"5-[4-(2-Hydroxyethyl)-1-piperidinyl]-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione",small molecule,experimental,,OCCC1CCN(CC1)[C@@]1(C(=O)NC(O)=NC1=O)C1=CC=CC=C1,446505
3408,DB03623,"9-(4-Hydroxyphenyl)-2,7-Phenanthroline",small molecule,experimental,,OC1=CC=C(C=C1)C1=CC2=C(C=CC3=C2C=NC=C3)N=C1,5326727
3409,DB03624,7-(Carboxyamino)-8-Amino-Nonanoic Acid,small molecule,experimental,,C[C@H](N)[C@@H](CCCCCC(O)=O)NC(O)=O,444640
3410,DB03626,"5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione",small molecule,experimental,,COC1=CC(=O)C2=C(C(COC3=CC=CC=C3)=C(C)N2C)C1=O,4469805
3411,DB03627,Adamantane,small molecule,experimental,Cycloparaffins,C1C2CC3CC1CC(C2)C3,9238
3412,DB03628,ISO24,small molecule,experimental,,CCC1=CC=C(NC(=O)P(O)(O)=O)C=C1,447534
3413,DB03629,Pyridoxal-5'-Phosphate-N-Oxide,small molecule,experimental,,CC1=C(O)C(C=O)=C(COP(O)(O)=O)C=[N+]1[O-],3253681
3414,DB03630,2-Iodobenzylthio Group,small molecule,experimental,,SCC1=CC=CC=C1I,444808
3415,DB03631,"3-(4-hydroxy-3-imino-6-oxo-cyclohexa-1,4-dienyl)-alanine",small molecule,experimental,,[H]N=C1C=C(C[C@H](N)C(O)=O)C(=O)C=C1O,17754209
3416,DB03632,Argifin,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Chitinases, antagonists & inhibitors|Peptides",CNC(=O)NC(=N)NCCC[C@@H]1NC(=O)[C@@H](C)NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](CC2=CC=CC=C2)N(C)C1=O)C(O)=O)C(O)=O,449124
3417,DB03633,Lpc-Ether,small molecule,experimental,,CCCCCCCCCCCCCCCCCCOC[C@@H](O)CO[P@@](O)(=O)OCC[N+](C)(C)C,446876
3418,DB03634,"1,3-DI(N-Propyloxy-A-mannopyranosyl)-carbomyl 5-methyazido-benzene",small molecule,experimental,,[H]N(CCCO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)C(=O)C1=CC(=CC(CN=[N+]=[N-])=C1)C(=O)N([H])CCCO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O,5288155
3419,DB03635,Ethanesulfonic acid,small molecule,experimental,"Acids|Acids, Noncarboxylic|Alkanes|Alkanesulfonic Acids|Hydrocarbons, Acyclic|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",CCS(O)(=O)=O,11668
3420,DB03636,Glycinamide,small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins",NCC(N)=O,69020
3421,DB03637,Guanidine-3-propanol,small molecule,experimental,,[H]N([H])C(N([H])[H])=[N+]([H])CCCO,448503
3422,DB03638,Cytidyl-2'-5'-phospho-guanosine,small molecule,experimental,,[H]N([H])C1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N([H])C(=NC2=O)N([H])[H],447657
3423,DB03639,1-Guanidinium-7-Aminoheptane,small molecule,experimental,,NCCCCCCCNC(N)N,5288371
3424,DB03640,Beta-Hydroxyaspartic Acid,small molecule,experimental,"Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Excitatory Amino Acids",N[C@@H]([C@@H](O)C(O)=O)C(O)=O,14463
3425,DB03641,"2'-deoxyuridine 5'-alpha,beta-imido-diphosphate",small molecule,experimental,,[H]N(P(O)(O)=O)P(O)(=O)OC[C@H]1O[C@H](C[C@@H]1O)N1C=CC(=O)N([H])C1=O,449098
3426,DB03642,N-[(2S)-4-Methyl-1-oxo-1-{[(4S)-3-oxo-1-(2-pyridinylsulfonyl)-4-azepanyl]amino}-2-pentanyl]-1-benzofuran-2-carboxamide,small molecule,experimental,,CC(C)C[C@H](NC(=O)C1=CC2=C(O1)C=CC=C2)C(=O)N[C@H]1CCCN(CC1=O)S(=O)(=O)C1=CC=CC=N1,5287468
3427,DB03643,CRA_1144,small molecule,experimental,,NC(=[NH2+])C1=CC=C2NC(=NC2=C1)C1=CC=CC=C1[O-],5353307
3428,DB03644,3-hydroxyanthranilic acid,small molecule,experimental,"Acids, Carbocyclic|Aminobenzoates|Antioxidants|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Free Radical Scavengers|Hydroxy Acids|Hydroxybenzoates|ortho-Aminobenzoates|Phenols|Protective Agents",NC1=C(O)C=CC=C1C(O)=O,86
3429,DB03645,Phosphonoacetohydroxamic Acid,small molecule,experimental,,ONC(=O)CP(O)(O)=O,445375
3430,DB03646,"2,3-di-O-phytanyl-sn-glycerol",small molecule,experimental,Alcohols|Carbohydrates|Ethers|Sugar Alcohols|Triose Sugar Alcohols,[H][C@@](C)(CCCC(C)C)CCC[C@@]([H])(C)CCC[C@@]([H])(C)CCOC[C@@]([H])(CO)OCC[C@]([H])(C)CCC[C@]([H])(C)CCC[C@]([H])(C)CCCC(C)C,446373
3431,DB03647,3-[Isopropyl(4-Methylbenzoyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid,small molecule,experimental,,CC(C)N(C(=O)C1=CC=C(C)C=C1)C1=C(SC(=C1)C1=CC=CC=C1)C(O)=O,503535
3432,DB03648,"(2S,2'S)-2,2'-(1,2-Hydrazinediylbis{methylene[(2S)-1-oxo-2,1-hexanediyl]imino})bis(6-amino-N-phenylhexanamide)",small molecule,experimental,,[H]N([H])CCCC[C@H](N([H])C(=O)[C@@H](CCCC)CN([H])N([H])C[C@@H](CCCC)C(=O)N([H])[C@@H](CCCCN([H])[H])C(=O)N([H])C1=CC=CC=C1)C(=O)N([H])C1=CC=CC=C1,5496887
3433,DB03649,"[{(5-Chloro-2-Pyridinyl)Amino} Methylene]-1,1-Bisphosphonate",small molecule,experimental,,OP(O)(=O)C(NC1=CC=C(Cl)C=N1)P(O)(O)=O,405389
3434,DB03650,(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One,small molecule,experimental,,OC1=CC=C(C=C1)\N=C1/C(=O)NC2=CC=CC=C12,611002
3435,DB03651,Picric acid,small molecule,experimental,"Benzene Derivatives|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Indicators and Reagents|Laboratory Chemicals|Nitro Compounds|Nitrophenols|Phenols|Uncoupling Agents",OC1=C(C=C(C=C1[N+]([O-])=O)[N+]([O-])=O)[N+]([O-])=O,6954
3436,DB03652,beta-D-Galactopyranuronic acid,small molecule,experimental,,O[C@@H]1O[C@@H]([C@H](O)[C@H](O)[C@H]1O)C(O)=O,441476
3437,DB03653,"5-{[Ethyl(Methyl)Amino]Methyl}-2-Methyl-5,6-Dihydropyrimidin-4-Amine",small molecule,experimental,,CCN(C)CC1=CN=C(C)N=C1N,448672
3438,DB03654,"S,S-Propylthiocysteine",small molecule,experimental,,[H][C@](N)(CSSCCC)C=O,17754128
3439,DB03656,Tribenuron Methyl,small molecule,experimental,"Acids|Acids, Noncarboxylic|Arylsulfonic Acids|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",COC(=O)C1=CC=CC=C1S(=O)(=O)NC(=O)N(C)C1=NC(C)=NC(OC)=N1,153909
3440,DB03657,1-deoxy-1-methoxycarbamido-beta-D-glucopyranose,small molecule,experimental,,COC(=O)N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,445722
3441,DB03658,"(2R,4S)-2-[(1R)-1-{[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid",small molecule,experimental,,[H]N([H])[C@@H](C(=O)N([H])[C@H](C=O)[C@@]1([H])SC(C)(C)[C@@H](N1[H])C(O)=O)C1=CC=C(O)C=C1,5287717
3442,DB03659,Butylamine,small molecule,experimental,"Alkanes|Amines|Butanes|Hydrocarbons, Acyclic",CCCCN,8007
3443,DB03660,4-Iodo-L-phenylalanine,small molecule,experimental,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins",[H][C@](N)(CC1=CC=C(I)C=C1)C(O)=O,134497
3444,DB03661,L-cysteic acid,small molecule,experimental,,N[C@@H](CS(O)(=O)=O)C(O)=O,72886
3445,DB03662,Vitamin B6 Complexed with 2-Amino-Pentanoic Acid,small molecule,experimental,,CCC[C@H](NCC1=C(O)C(C)=NC=C1COP(O)(O)=O)C(O)=O,444861
3446,DB03663,"1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol",small molecule,experimental,,CC(C)C(=O)COC1=NC(N)=NC2=C1NC=N2,445940
3447,DB03664,P1-(adenosine-5'-P5-(uridine-5')pentaphosphate,small molecule,experimental,,[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)N4C=CC(=O)N([H])C4=O)[C@@H](O)[C@H]3O)C2=NC=N1,448894
3448,DB03666,Zidovudine monophosphate,small molecule,experimental,"Carbohydrates|Deoxyribonucleosides|Deoxyribonucleotides|Dideoxynucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Nucleotides|Pyrimidine Nucleosides|Pyrimidine Nucleotides|Pyrimidines",CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COP(O)(O)=O)O2)C(=O)NC1=O,65374
3449,DB03667,Acetic Acid Salicyloyl-Amino-Ester,small molecule,experimental,,CC(=O)ONC(=O)C1=C(O)C=CC=C1,445302
3450,DB03668,6-oxouridine 5'-phosphate,small molecule,experimental,,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)N1C(=O)CC(=O)NC1=O,445132
3451,DB03669,4-Fluorophenethyl Alcohol,small molecule,experimental,,OCCC1=CC=C(F)C=C1,82068
3452,DB03670,"2-(Oxalyl-Amino)-4,5,6,7-Tetrahydro-Thieno[2,3-C]Pyridine-3-Carboxylic Acid",small molecule,experimental,,OC(=O)C(=O)NC1=C(C(O)=O)C2=C(CNCC2)S1,444766
3453,DB03671,Digoxigenin,small molecule,experimental,Carbohydrates|Cardanolides|Cardenolides|Cardiac Glycosides|Digitalis Glycosides|Digoxin and derivatives|Fused-Ring Compounds|Glycosides|Steroids,[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@@H](O)CC[C@]4(C)[C@@]3([H])C[C@@H](O)[C@]12C)C1=CC(=O)OC1,15478
3454,DB03672,9-N-Phenylmethylamino-Tacrine,small molecule,experimental,,C(NC1=C2C=CC=CC2=NC2=C1CCCC2)C1=CC=CC=C1,1933
3455,DB03673,beta-2-Thienyl-L-alanine,small molecule,experimental,,N[C@@H](CC1=CC=CS1)C(O)=O,146719
3456,DB03675,"2,3-Dihydroxy-Valerianic Acid",small molecule,experimental,,CC[C@@](C)(O)[C@@H](O)C(O)=O,448154
3457,DB03676,Cystein-S-Yl Cacodylate,small molecule,experimental,,[H][C@](N)(CS[As](C)(C)=O)C(O)=O,17753879
3458,DB03677,N-Cyclohexyl-N'-Decylurea,small molecule,experimental,,CCCCCCCCCCNC(=O)NC1CCCCC1,4359
3459,DB03678,"(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine",small molecule,experimental,,C[C@H](NC1=NC=NC2=C1C=C(F)C(F)=C2)C(C1=CC=CC=C1)C1=CC=CC=C1,5496989
3460,DB03679,2-Hydroxy-Tryptophan,small molecule,experimental,,[H][C@](N)(CC1=C(O)NC2=CC=CC=C12)C(O)=O,17754204
3461,DB03680,Tartronate,small molecule,experimental,,OC(C([O-])=O)C([O-])=O,44
3462,DB03682,"Dibenzofuran-4,6-Dicarboxylic Acid",small molecule,experimental,"Acids, Acyclic|Heterocyclic Compounds, Fused-Ring",OC(=O)C1=CC=CC2=C1OC1=C2C=CC=C1C(O)=O,3022
3463,DB03683,2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid,small molecule,experimental,,[H][C@@](CC(C)C)(CN(O)C=O)C(O)=O,5289415
3464,DB03685,Uridine monophosphate,small molecule,experimental,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides|Uracil Nucleotides",O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O,6030
3465,DB03686,S-(4-nitrobenzyl)glutathione,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Oligopeptides|Peptides",N[C@@H](CCC(=O)N[C@@H](CSCC1=CC=C(C=C1)[N+]([O-])=O)C(=O)NCC(O)=O)C(O)=O,97538
3466,DB03687,4-(Cytidine 5'-diphospho)-2-C-methyl-D-erythritol,small molecule,experimental,,C[C@](O)(CO)[C@H](O)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(N)=NC1=O,443199
3467,DB03688,Hydracrylic acid,small molecule,experimental,Hydroxy Acids|Isomerism|Lactates,OCCC(O)=O,68152
3468,DB03690,"(Z,Z)-4-Hydroxy-N,N,N-Trimethyl-10-Oxo-7-[(1-Oxo-9-Octadecenyl)Oxy]-3,5,9-Trioxa-4-Phosphaheptacos-18-En-1-Aminium-4-Oxide",small molecule,experimental,,CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC,448653
3469,DB03691,WRR-112,small molecule,experimental,,[H][C@](O)(CC(O)=O)C(=O)N[C@@]([H])(CCC1=CC=CC=C1)C(=O)NCCC(C)C,5289294
3470,DB03692,1-Hexadecanosulfonyl-O-L-Serine,small molecule,experimental,,[H][C@](N)(COS(=O)(=O)CCCCCCCCCCCCCCCC)C(O)=O,17754154
3471,DB03693,N-(2-Aminoethyl)-5-Chloroisoquinoline-8-Sulfonamide,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring",NCCNS(=O)(=O)C1=CC=C(Cl)C2=C1C=NC=C2,129236
3472,DB03694,N-phenylthiourea,small molecule,experimental,Sulfur Compounds|Thiourea,NC(=S)NC1=CC=CC=C1,676454
3473,DB03695,Piritrexim,small molecule,investigational,Antineoplastic Agents|Enzyme Inhibitors|Folic Acid Antagonists,COC1=CC(CC2=C(C)C3=C(N=C2)N=C(N)N=C3N)=C(OC)C=C1,54369
3474,DB03696,Lanosterol,small molecule,experimental,"Cholestadienes|Cholestadienols|Cholestanes|Cholestenes|Fused-Ring Compounds|Lanosterol, metabolism|Lipids|Membrane Lipids|Steroids|Sterols|Terpenes|Triterpenes",[H][C@@]1(CC[C@@]2(C)C3=C(CC[C@]12C)[C@@]1(C)CC[C@H](O)C(C)(C)[C@]1([H])CC3)[C@H](C)CCC=C(C)C,246983
3475,DB03697,4-Sulfonamide-[1-(4-Aminobutane)]Benzamide,small molecule,experimental,,NCCCCNC(=O)C1=CC=C(C=C1)S(N)(=O)=O,1758
3476,DB03698,5-Mercaptoethanol-2-decenoyl-coenzyme A,small molecule,experimental,,CCCCC[C@@H](C\C=C\C(=O)SCCNC(=O)CCN[C@H](O)C(=O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)[N+]1=CNC2=C(N)N=CN=C12)SCC=O,49867291
3477,DB03699,Succinyl-Coenzyme A,small molecule,experimental,"Adenine Nucleotides|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides|Thioesters of coenzyme A",CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC(O)=O,92133
3478,DB03700,D-Threonine,small molecule,experimental,,C[C@@H](O)[C@@H](N)C(O)=O,90624
3479,DB03701,Vanoxerine,small molecule,investigational,Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Uptake Inhibitors|Membrane Transport Modulators|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors,FC1=CC=C(C=C1)C(OCCN1CCN(CCCC2=CC=CC=C2)CC1)C1=CC=C(F)C=C1,3455
3480,DB03702,"N-{4-[(Carboxymethyl)carbamoyl]benzoyl}-L-valyl-N-[(3S)-1,1,1-trifluoro-4-methyl-2-oxo-3-pentanyl]-L-prolinamide",small molecule,experimental,,[H]N(CC(O)=O)C(=O)C1=CC=C(C=C1)C(=O)N([H])[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N([H])[C@@H](C(C)C)C(=O)C(F)(F)F,5288240
3481,DB03703,Cyclohexanol,small molecule,experimental,Alcohols|Cyclohexanes|Cycloparaffins|Fatty Alcohols|Hexanols|Lipids,OC1CCCCC1,7966
3482,DB03704,12-Hydroxydodecanoic Acid,small molecule,experimental,Fatty Acids|Lipids,OCCCCCCCCCCCC(O)=O,79034
3483,DB03705,6-Methylamino-5-Nitroisocytosine,small molecule,experimental,,CNC1=C(C(=O)NC(N)=N1)[N+]([O-])=O,448810
3484,DB03706,1-Hydroxy-2-S-glutathionyl-3-para-nitrophenoxy-propane,small molecule,experimental,,N[C@@H](CCC(=O)N[C@@H](CS[C@@H](CO)COC1=CC=C(C=C1)[N+]([O-])=O)C(=O)NCC(O)=O)C(O)=O,17753973
3485,DB03707,S-Ethyl-N-Phenyl-Isothiourea,small molecule,experimental,,CCS\C(N)=N\C1=CC=CC=C1,347590
3486,DB03708,Adenosine 5'-phosphosulfate,small molecule,experimental|investigational,"Adenine Nucleotides|Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OS(O)(=O)=O)[C@@H](O)[C@H]1O,10238
3487,DB03709,Bicine,small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins",OCCN(CCO)CC(O)=O,8761
3488,DB03710,[(1S)-4-(1-Aminobutylideneamino)-1-carboxybutyl]azanium,small molecule,experimental,,CCC\C(N)=N/CCC[C@H]([NH3+])C(O)=O,131704256
3489,DB03711,6-Hydroxy-6-Methyl-Heptan-3-One,small molecule,experimental,,CCC(=O)CCC(C)(C)O,129891
3490,DB03712,RU85053,small molecule,experimental,,CC(=O)N[C@@H](CC1=CC(C(O)=O)=C(CC(O)=O)C=C1)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O,447524
3491,DB03714,4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid,small molecule,experimental,,[H][C@@](CCC(O)=O)(NC(=O)C1=CC2=C(C=C1)C=C(C=C2)C(F)(F)P(O)(O)=O)C(N)=O,444695
3492,DB03716,5'-Fluoro-5'-Deoxyadenosine,small molecule,experimental,"Carbohydrates|Deoxyribonucleosides|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides",NC1=C2N=CN([C@@H]3O[C@H](CF)[C@@H](O)[C@H]3O)C2=NC=N1,448403
3493,DB03717,"3-Hydroxy-4-(3,4,5-trihydroxy-tetrahydro-pyran-2-yloxy)-piperidin-2-one",small molecule,experimental,,[H]N1CC[C@@H](O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)C1=O,446394
3494,DB03718,6-aza uridine 5'-monophosphate,small molecule,experimental,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides|Uracil Nucleotides",[H][C@@]1(O)[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)N1N=CC(=O)NC1=O,150959
3495,DB03719,N-Ethyl-5'-Carboxamido Adenosine,small molecule,experimental,,CCNC(=O)[C@@H]1O[C@H]([C@H](O)[C@H]1O)N1C=NC2=C1N=CN=C2N,6604901
3496,DB03720,"alpha,beta-Dehydroaminobutyric acid",small molecule,experimental,,C\C=C(/N)C(O)=O,6449989
3497,DB03721,N-acetyl-alpha-neuraminic acid,small molecule,experimental,,[H][C@]1(O[C@](O)(C[C@H](O)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,444885
3498,DB03722,"3,4-Dihydro-5-Methyl-Isoquinolinone",small molecule,experimental,,CC1=CC=CC2=C1CCNC2=O,148140
3499,DB03723,2'-Deoxy-Thymidine-Beta-L-Rhamnose,small molecule,experimental,,C[C@@H]1O[C@H](OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H](C[C@@H]2O)N2C=C(C)C(=O)NC2=O)[C@H](O)[C@H](O)[C@H]1O,121966
3500,DB03724,"(1s,2s)-1-Amino-1-(1,3-Thiazol-2-Yl)Propan-2-Ol",small molecule,experimental,,[H][C@](C)(O)[C@]([H])(N)C1=NC=CS1,445279
3501,DB03725,5'-Guanylylmethylenebisphosphonate,small molecule,experimental,"Anti-Infective Agents|Antiviral Agents|Carbohydrates|Glycosides|Guanine Nucleotides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)CP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,93082
3502,DB03726,Purine Riboside-5'-Monophosphate,small molecule,experimental,,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=CN=CN=C23)[C@]([H])(O)[C@]1([H])O,444450
3503,DB03727,Coproporphyrin I,small molecule,experimental,"Biological Factors|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Porphyrins",CC1=C(CCC(O)=O)/C2=C/C3=N/C(=C\C4=C(C)C(CCC(O)=O)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(CCC(O)=O)=C4C)/C(CCC(O)=O)=C3C,68271
3504,DB03728,p-Chlorobenzoic acid,small molecule,experimental,"Acids, Carbocyclic|Benzene Derivatives|Benzoates",OC(=O)C1=CC=C(Cl)C=C1,6318
3505,DB03729,2-Amino-1H-benzimidazol-5-ol,small molecule,experimental,,NC1=NC2=C(N1)C=C(O)C=C2,162636
3506,DB03730,"3,9-Dimethyladenine",small molecule,experimental,,CN1C=NC2=C1[N+](C)=CN=C2N,447936
3507,DB03731,S-2-(Boronoethyl)-L-Cysteine,small molecule,experimental,,[H][C@](N)(CSCC[B-](O)(O)O)C(O)=O,446122
3508,DB03732,Etheno-Nadp,small molecule,experimental,,[H][C@@]1(O)O[C@]([H])(COP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C3N=CN3C=CN=C43)[C@]([H])(OP(O)(O)=O)[C@]2([H])O)[C@@]([H])(O)[C@@]1([H])O,49866945
3509,DB03733,Ethylene Dichloride,small molecule,experimental,"Alkanes|Ethane|Hydrocarbons, Acyclic|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated",ClCCCl,11
3510,DB03734,Xylarohydroxamate,small molecule,experimental,"Acids, Acyclic|Amines|Carbohydrates|Hydroxy Acids|Hydroxylamines",ONC(=O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O,5289593
3511,DB03735,9-(2-Deoxy-Beta-D-Ribofuranosyl)-6-Methylpurine,small molecule,experimental,,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])CO)N1C=NC2=C(C)N=CN=C12,97184
3512,DB03736,2-Cyclopropylmethylenepropanal,small molecule,experimental,,[H][C@](C)(CC1CC1)C=O,5287974
3513,DB03737,"4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One",small molecule,experimental,,[H][C@](C)(O)[C@]([H])(N)[C@]([H])(O)C#CC1=C(F)C=CC2=C1\C(=C\C1=C(OC)C=CN1)C(=O)N2,5288222
3514,DB03738,Pantothenoylaminoethenethiol,small molecule,experimental,,[H]N(CCC(=O)N([H])\C=C/S)C(=O)[C@H](O)C(C)(C)CO,447227
3515,DB03739,3-Hydroxyimino Quinic Acid,small molecule,experimental,,[H][C@@]1(O)C[C@@](O)(C\C(=N/O)[C@@]1([H])O)C(O)=O,9584748
3516,DB03740,N-acetyl-alpha-D-glucosamine,small molecule,experimental,,CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O,82313
3517,DB03741,2-Methylbutanoic Acid,small molecule,experimental,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids",CC[C@@H](C)C(O)=O,6950479
3518,DB03742,Compound 4-D,small molecule,experimental,,[H][C@]1(OC2=C(S[C@]1([H])C1=CC=C(O)C=C1)C=C(O)C=C2)C1=CC=C(OCCN2CCCCC2)C=C1,448577
3519,DB03744,"Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate",small molecule,experimental,,[H][C@@](CC1=CC=CC=C1)(NC(=O)C1=CC2=C(N1)C=CC(Cl)=C2)C(=O)N1CC(C1)C(O)=O,445459
3520,DB03745,Arabinose-5-phosphate,small molecule,experimental,,[H][C@@](O)(CO)[C@]([H])(O)[C@]([H])(O)COP(O)(O)=O,5287584
3521,DB03746,"3-Amino-4,5-Dihydroxy-Cyclohex-1-Enecarboxylate",small molecule,experimental,,N[C@H]1C=C(C[C@@H](O)[C@@H]1O)C([O-])=O,17753950
3522,DB03747,N-Acetyl-glucosamine thiazoline,small molecule,experimental,Amino Sugars|Carbohydrates|Hexosamines|Sulfur Compounds,[H][C@]12O[C@H](CO)[C@@H](O)[C@H](O)[C@@]1([H])N=C(C)S2,5289024
3523,DB03748,Methyl-[4-(4-Piperidine-1-Ylmethyl-Phenyl)-Cyclohexyl]-Carbaminic Acid-(4-Chlorophenyl)-Ester,small molecule,experimental,,CN([C@H]1CC[C@@H](CC1)C1=CC=C(CN2CCCCC2)C=C1)C(=O)OC1=CC=C(Cl)C=C1,447562
3524,DB03749,"4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole",small molecule,experimental,,CCC1=C(O)C=C(O)C(=C1)C1=NNC=C1C1=CNC=N1,46936782
3525,DB03750,Isovaleric Acid,small molecule,experimental,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids|Valerates",CC(C)CC(O)=O,10430
3526,DB03751,2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,small molecule,experimental,,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)O2)C(=O)NC1=O,443210
3527,DB03752,P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid,small molecule,experimental,Sulfur Compounds,[H][C@@](C)(C(O)=O)C1=CC=C(C=C1)C(=O)C1=CC=C(I)S1,447834
3528,DB03753,Flurbiprofen Methyl Ester,small molecule,experimental,,COC(=O)[C@@H](C)C1=CC=C(C(F)=C1)C1=CC=CC=C1,446134
3529,DB03754,Tromethamine,small molecule,approved,"Alcohols|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Buffers|Compounds used in a research, industrial, or household setting|Drug Delivery Systems|Excipients|Glycols|I.V. Solution Additives|i.v. Solutions|Laboratory Chemicals|Pharmaceutic Aids|Pharmaceutical Preparations|Pharmaceutical Vehicles|Propylene Glycols|Solutions Affecting the Electrolyte Balance",NC(CO)(CO)CO,6503
3530,DB03755,"Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate",small molecule,experimental,,[H][C@]1(COP(O)(=O)OP(O)(=O)CP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,446443
3531,DB03756,Doconexent,small molecule,approved|investigational,"Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Diet, Food, and Nutrition|Dietary Fats|Dietary Fats, Unsaturated|Fats|Fatty Acids|Fatty Acids, Omega-3|Fatty Acids, Unsaturated|Fish Oils|Food|Food and Beverages|Lipids|Oils|Physiological Phenomena",CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O,445580
3532,DB03757,N-{[(2-Methyl-2-propanyl)oxy]carbonyl}-L-alanyl-L-alaninamide,small molecule,experimental,,[H]N([H])C(=O)[C@H](C)N([H])C(=O)[C@H](C)N([H])C(=O)OC(C)(C)C,5497045
3533,DB03758,Radicicol,small molecule,experimental,Anti-Infective Agents|Antifungal Agents|Antiparasitic Agents|Antiprotozoals|Enzyme Inhibitors|Lactones|Polyketides|Tyrosine Kinase Inhibitors,C[C@@H]1C[C@H]2O[C@@H]2\C=C/C=C/C(=O)CC2=C(Cl)C(O)=CC(O)=C2C(=O)O1,6323491
3534,DB03759,FG-9041,small molecule,experimental,"Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents",[O-][N+](=O)C1=C(C=C2NC(=O)C(=O)NC2=C1)[N+]([O-])=O,3899541
3535,DB03760,Dihydrolipoic Acid,small molecule,experimental,"Antioxidants|Coenzymes|Compounds used in a research, industrial, or household setting|Enzymes and Coenzymes|Fatty Acids|Lipids|Protective Agents|Sulfur Compounds|Thiophenes",[H][C@](S)(CCS)CCCCC(O)=O,9834298
3536,DB03761,5-fluoro-2'-deoxyuridine-5'-monophosphate,small molecule,experimental,,O[C@H]1C[C@@H](O[C@@H]1COP(O)(O)=O)N1C=C(F)C(=O)NC1=O,8642
3537,DB03763,5-methyl-2'-deoxypseudouridine,small molecule,experimental,,CN1C=C([C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)NC1=O,445537
3538,DB03764,4-Hydroperoxy-2-Methoxy-Phenol,small molecule,experimental,,COC1=CC(OO)=CC=C1O,446140
3539,DB03765,2'-cytidylic acid,small molecule,experimental,,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1OP(O)(O)=O,101544
3540,DB03766,Propanoic acid,small molecule,approved|vet_approved,"Acids, Acyclic|Anti-Infective Agents|Fatty Acids|Fatty Acids, Volatile|Lipids|Ophthalmologicals|Sensory Organs",CCC(O)=O,1032
3541,DB03767,Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide,small molecule,experimental,,[H][C@@](COCC1=CC=CC=C1)(NC(=O)[C@]([H])(CC(C)C)NC(=O)N1CCOCC1)C#N,5287799
3542,DB03768,"N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3",small molecule,experimental,,CC(C)CCN(C[C@@H](O)[C@@H]1CC2=CC=C(OCCCC(=O)N[C@@H](C(C)C)C(=O)N1)C=C2)S(=O)(=O)C1=CC=CC=C1,466960
3543,DB03769,D-Eritadenine,small molecule,experimental,"Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Purines",[H][C@@](O)(CN1C=NC2=C(N)N=CN=C12)[C@@]([H])(O)C(O)=O,159961
3544,DB03770,N-hydroxyguanidine,small molecule,experimental,Amidines|Anti-Infective Agents|Antineoplastic Agents|Antiviral Agents,NC(=N)NO,80668
3545,DB03771,Allyl-{4-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-but-2-Enyl}-Methyl-Amine,small molecule,experimental,,CN(CC=C)C\C=C\COC1=CC2=C(C=C1)C(=CO2)C1=CC=C(Br)C=C1,447559
3546,DB03772,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,5-Diol",small molecule,experimental,,[H][C@@]1(O)C[C@@]([H])(O)[C@]([H])(OCCCCCC)O[C@]1([H])CO,448294
3547,DB03773,alpha-D-quinovopyranose,small molecule,experimental,Carbohydrates|Deoxy Sugars,[H][C@]1(C)O[C@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O,441480
3548,DB03774,Glutamyl Group,small molecule,experimental,,[NH3+][C@@H](CCC=O)C(O)=O,5288620
3549,DB03775,Dethiobiotin,small molecule,experimental,Coenzymes|Enzymes and Coenzymes|Imidazoles|Immunologic Factors|Immunosuppressive Agents|Mitogens|Mitosis Modulators,C[C@@H]1NC(=O)N[C@@H]1CCCCCC(O)=O,445027
3550,DB03776,Lactaldehyde,small molecule,experimental,,[H]C(=O)[C@H](C)O,439231
3551,DB03777,Bisindolylmaleimide I,small molecule,experimental,"Acids, Acyclic|Anti-Inflammatory Agents|Dicarboxylic Acids|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Imides|Maleates|Protein Kinase C, antagonists & inhibitors",CN(C)CCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2,2396
3552,DB03779,Glucosaminyl-(Alpha-6)-D-Myo-Inositol,small molecule,experimental,,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)[C@H]1O,445937
3553,DB03780,2-Aminoquinazolin-4(3h)-One,small molecule,experimental,,NC1=NC2=CC=CC=C2C(=O)N1,242831
3554,DB03781,"2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid",small molecule,experimental,,[H][C@](C)(OC1=CC=C(OC2=CC=C(Cl)C=C2Cl)C=C1)C(O)=O,448978
3555,DB03782,N-(1-adamantyl)-N'-(4-guanidinobenzyl)urea,small molecule,experimental,,NC(N)=NC1=CC=C(CNC(=O)NC23CC4CC(CC(C4)C2)C3)C=C1,4286
3556,DB03783,Phenacetin,small molecule,withdrawn,"Acetanilides|Amides|Amines|Analgesics|Analgesics, Non-Narcotic|Anilides|Aniline Compounds|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Nervous System|OAT1/SLC22A6 inhibitors|Peripheral Nervous System Agents|Sensory System Agents",CCOC1=CC=C(NC(C)=O)C=C1,4754
3557,DB03784,Elaidamide,small molecule,experimental,,CCCCCCCC\C=C\CCCCCCCC(N)=O,5353370
3558,DB03785,Mevinolinic acid,small molecule,experimental,Naphthalenes,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,64727
3559,DB03787,"(5-Hydroxy-6-methyl-4-{[(E)-(3-oxo-1,2-oxazolidin-4-ylidene)amino]methyl}-3-pyridinyl)methyl dihydrogen phosphate",small molecule,experimental,,CC1=NC=C(COP(O)(O)=O)C(C\N=C2/CONC2=O)=C1O,131704257
3560,DB03788,GC-24,small molecule,experimental,,CC1=CC(OCC(O)=O)=CC(C)=C1CC1=CC=C(O)C(CC2=CC=CC=C2)=C1,448011
3561,DB03789,"2,3-Dimethylimidazolium Ion",small molecule,experimental,,CN1C=C[NH+]=C1C,444800
3562,DB03790,L-methionine sulfone,small molecule,experimental,"Amino Acids|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Sulfur Compounds",CS(=O)(=O)CC[C@H](N)C(O)=O,445282
3563,DB03791,GW-3965,small molecule,experimental,"Acids, Carbocyclic|Amines|Benzene Derivatives|Benzyl Compounds|Ligands",OC(=O)CC1=CC=CC(OCCCN(CC(C2=CC=CC=C2)C2=CC=CC=C2)CC2=CC=CC(=C2Cl)C(F)(F)F)=C1,447905
3564,DB03792,5-Aminouracil,small molecule,experimental,Pyrimidines|Pyrimidinones,NC1=CNC(=O)NC1=O,13611
3565,DB03793,Benzoic acid,small molecule,approved|investigational,"Acids, Carbocyclic|Alimentary Tract and Metabolism|Ammonium Ion Binding Activity|Anti-Infective Agents|Antifungal Agents|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Diagnostic Agents|Diet, Food, and Nutrition|Food|Food Additives|Food and Beverages|Food Ingredients|Food Preservatives|Nitrogen Binding Agent|OAT3/SLC22A8 Inhibitors|Physiological Phenomena|Tests for Gastric Secretion|Urea Cycle Disorder Agents|Various Alimentary Tract and Metabolism Products",OC(=O)C1=CC=CC=C1,243
3566,DB03794,Trifluoroalanine,small molecule,experimental,,[H][C@](N)(C(O)=O)C(F)(F)F,87123
3567,DB03795,2-Dehydropantoate,small molecule,experimental,,CC(C)(CO)C(=O)C(O)=O,38
3568,DB03796,Palmitic Acid,small molecule,approved,Enzyme Inhibitors|Fatty Acids|Lipids|Palmitic Acids,CCCCCCCCCCCCCCCC(O)=O,985
3569,DB03797,3-Aminomethyl-Pyridinium-Adenine-Dinucleotide,small molecule,experimental,,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(CN)=C3)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,131704258
3570,DB03798,2'-Deoxycytidine-5'-Monophosphate,small molecule,experimental,,NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1,13945
3571,DB03799,Trifluoromethionine,small molecule,experimental,"Amino Acids|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Sulfur Compounds",N[C@@H](CCSC(F)(F)F)C(O)=O,165196
3572,DB03800,Deoxyuridine monophosphate,small molecule,experimental,"Carbohydrates|Deoxyribonucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides|Uracil Nucleotides",O[C@H]1C[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O,65063
3573,DB03801,Lysine Nz-Carboxylic Acid,small molecule,experimental,,N[C@@H](CCCCNC(O)=O)C(O)=O,17754054
3574,DB03802,"1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",small molecule,experimental,,[H][C@@]12CCCCN1CCN(C2)C1=CC=C(C=C1)[C@@]1([H])N(CCC2=CC(O)=CC=C12)C1=CC=CC=C1,5287617
3575,DB03803,"N,N-[2,5-O-dibenzyl-glucaryl]-DI-[valinyl-aminomethanyl-pyridine]",small molecule,experimental,,CC(C)[C@H](NC(=O)[C@H](OCC1=CC=CC=C1)[C@H](O)[C@@H](O)[C@@H](OCC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)NCC1=NC=CC=C1)C(=O)NCC1=CC=CC=N1,445309
3576,DB03804,5-Bromothienyldeoxyuridine,small molecule,experimental,,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])CO)N1C=C(C2=CC=C(Br)S2)C(=O)NC1=O,446725
3577,DB03807,"1-(2-Chlorophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",small molecule,experimental,,CCOC(=O)C1=C(C)N(N=C1C)C1=C(Cl)C=CC=C1,656968
3578,DB03808,Hexamidine,small molecule,experimental,"Amidines|Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Biguanides and Amidines|Dermatologicals|Nasal Preparations|Ophthalmological and Otological Preparations|Ophthalmologicals|Sensory Organs|Throat Preparations",NC(=N)C1=CC=C(OCCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,65130
3579,DB03809,9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine,small molecule,experimental,,CCCCN1C(CC2=CC=CC(OC)=C2)=NC2=C(N)N=CN=C12,5289228
3580,DB03810,3-Methylglutamic acid,small molecule,experimental,"Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Excitatory Amino Acids|Glutamates",[H][C@@](C)(CC(O)=O)[C@]([H])(N)C(O)=O,11412540
3581,DB03811,Histidinol,small molecule,experimental,Alcohols|Amines|Amino Alcohols|Imidazoles|Propanolamines|Propanols,[H][C@@]([NH3+])(CO)CC1=CN=CN1,6950298
3582,DB03812,"3-{2,6,8-trioxo-9-[(2S,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",small molecule,experimental,,OC[C@@H](O)[C@H](O)[C@@H](O)CN1C(=O)N(CCCOP(O)(O)=O)C2=C1NC(=O)NC2=O,657024
3583,DB03813,2-Decenoyl N-Acetyl Cysteamine,small molecule,experimental,,CCCCCCC\C=C/C(=O)SCCNC(C)=O,5288022
3584,DB03814,2-(N-morpholino)ethanesulfonic acid,small molecule,experimental,"Acids|Acids, Noncarboxylic|Alkanes|Buffers|Hydrocarbons, Acyclic|Oxazines|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",OS(=O)(=O)CCN1CCOCC1,4478249
3585,DB03815,Fucitol,small molecule,experimental,Alcohols|Carbohydrates,[H][C@@](C)(O)[C@@]([H])(O)[C@@]([H])(O)[C@]([H])(O)CO,445724
3586,DB03816,Difluoromethionine,small molecule,experimental,,N[C@@H](CCSC(F)F)C(O)=O,447827
3587,DB03817,"L-2,4-diaminobutyric acid",small molecule,experimental,"Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Butyrates|Fatty Acids|Fatty Acids, Volatile|Lipids",NCC[C@H](N)C(O)=O,134490
3588,DB03818,N-[Tosyl-D-Prolinyl]Amino-Ethanethiol,small molecule,experimental,,[H][C@@]1(CCCN1S(=O)(=O)C1=CC=C(C)C=C1)C(=O)NCCS,445503
3589,DB03819,Salicylhydroxamic Acid,small molecule,experimental,Amides|Anti-Infective Agents|Antifungal Agents|Antiparasitic Agents|Antiprotozoals|Trypanocidal Agents,ONC(=O)C1=CC=CC=C1O,66644
3590,DB03820,"(2S,5R,6R)-6-({(6S)-6-[(Ammonioacetyl)amino]-6-carboxylatohexanoyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",small molecule,experimental,,[H]N([C@@H](CCCCC(=O)N([H])[C@@H]1C(=O)N2[C@@H](C([O-])=O)C(C)(C)S[C@]12[H])C([O-])=O)C(=O)C[N+]([H])([H])[H],131704259
3591,DB03821,2-Amino-3-Hydroxy-3-Phosphonooxy-Propionic Acid,small molecule,experimental,,[H][C@@](N)(C(O)=O)[C@@]([H])(O)OP(O)(O)=O,17753979
3592,DB03822,Ethyl dihydrogen phosphate,small molecule,experimental,"Acids|Acids, Noncarboxylic|Anions|Electrolytes|Ions|Organophosphorus Compounds|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds",CCOP(O)(O)=O,74190
3593,DB03823,Epigallocatechin,small molecule,experimental|investigational,"Benzopyrans|Chromans|Chromones|Flavonoids|Heterocyclic Compounds, Fused-Ring|Pyrans",O[C@@H]1CC2=C(O[C@@H]1C1=CC(O)=C(O)C(O)=C1)C=C(O)C=C2O,72277
3594,DB03824,"7-Iodo-1,2,3,4-Tetrahydro-Isoquinoline",small molecule,experimental,,IC1=CC2=C(CCNC2)C=C1,5288606
3595,DB03825,Rhodamine 6G,small molecule,experimental,"Antineoplastic Agents|Coloring Agents|Compounds used in a research, industrial, or household setting|Fluorescent Dyes|Heterocyclic Compounds, Fused-Ring|Indicators and Reagents|Laboratory Chemicals|Luminescent Agents|P-glycoprotein substrates|Xanthenes",[Cl-].CCNC1=CC2=[O+]C3=C(C=C(C)C(NCC)=C3)C(C3=CC=CC=C3C(=O)OCC)=C2C=C1C,13806
3596,DB03826,"5,6-Diaminouracil",small molecule,experimental,Pyrimidines|Pyrimidinones,NC1=C(N)C(=O)NC(=O)N1,76726
3597,DB03827,"(3s)-3,4-Di-N-Hexanoyloxybutyl-1-Phosphocholine",small molecule,experimental,,[H][C@](CCP([O-])(=O)OCC[N+](C)(C)C)(COC(=O)CCCCC)OC(=O)CCCCC,5287503
3598,DB03828,RU78299,small molecule,experimental,,CC1=CC(C=O)=C(OP(O)(O)=O)C(C=O)=C1,5287465
3599,DB03829,Pseudouridine-5'-Monophosphate,small molecule,experimental,,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)C1=CNC(=O)NC1=O,439424
3600,DB03830,Phosphorylated Dihydropteroate,small molecule,experimental,,NC1=NC2=NC=C(CNC3=CC=C(C=C3)C(=O)OP(O)(O)=O)N=C2C(=O)N1,656948
3601,DB03831,"[(Z)-octadec-9-enyl] (2R)-2,3-bis(oxidanyl)propanoate",small molecule,experimental,,[H]\C(CCCCCCCC)=C(/[H])CCCCCCCCOC(=O)[C@]([H])(O)CO,17754086
3602,DB03832,"3-Carboxy-N,N,N-Trimethyl-2-(Octanoyloxy)Propan-1-Aminium",small molecule,experimental,,[H][C@@](CC(O)=O)(C[N+](C)(C)C)OC(=O)CCCCCCC,449186
3603,DB03833,"2-Prolyl-5-Tert-Butyl-[1,3,4]Oxadiazole",small molecule,experimental,,[H][C@]1(CCCN1)C(=O)C1=NN=C(O1)C(C)(C)C,449137
3604,DB03834,"(3S)-3-(dioxidosulfanyl)-N-[(1Z)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine",small molecule,experimental,,CC(CN1C=CN=N1)([C@@H](N\C=C/C=O)C(O)=O)S([O-])=O,6419228
3605,DB03835,"N-[(5S,7R,8S,9S,10R)-8,9,10-Trihydroxy-7-(hydroxymethyl)-2,4-dioxo-6-oxa-1,3-diazaspiro[4.5]dec-3-yl]acetamide",small molecule,experimental,,CC(=O)NN1C(=O)N[C@@]2(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C1=O,5288395
3606,DB03836,"1,3,5-trichlorobenzene",small molecule,experimental,"Benzene Derivatives|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated",ClC1=CC(Cl)=CC(Cl)=C1,7950
3607,DB03837,Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide,small molecule,experimental,,C(C)(C)C[C@H](C(=O)N[C@H](CCC1=CC=CC=C1)\C=C\S(=O)(=O)C1=CC=CC=C1)NC(=O)N1CCOCC1,23648296
3608,DB03839,D-Tyrosine,small molecule,experimental,,N[C@H](CC1=CC=C(O)C=C1)C(O)=O,71098
3609,DB03840,Tetra(Imidazole)Diaquacopper (Ii),small molecule,experimental,,O.O.[Cu+4].[N-]1C=CN=C1.[N-]1C=CN=C1.[N-]1C=CN=C1.[N-]1C=CN=C1,49874334
3610,DB03841,Niraxostat,small molecule,experimental,,CC(C)(C)COC1=C(C=C(C=C1)N1C=C(C=N1)C(O)=O)C#N,449035
3611,DB03842,2-Chloro-6-Methyl-Aniline,small molecule,experimental,,CC1=CC=CC(=C)[C@H]1N,17753774
3612,DB03843,Formaldehyde,small molecule,approved|vet_approved,"Aldehydes|Anti-Infective Agents|Anti-Infective Agents, Local|Cell-mediated Immunity|Compounds used in a research, industrial, or household setting|Disinfectants|Fixatives|Increased Histamine Release|Macromolecular Substances|Standardized Chemical Allergen",[H]C([H])=O,712
3613,DB03844,"N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide",small molecule,experimental,,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=C(F)C=CC=C1F,4288
3614,DB03845,P1-(5'-Adenosyl)P5-(5'-(3'azido-3'-Deoxythymidyl))Pentaphosphate,small molecule,experimental,,[H][C@@]1(C[C@]([H])(N=[N+]=[N-])[C@@]([H])(COP([O-])(=O)OP([O-])(=O)OP(O)(=O)OP([O-])(=O)OP([O-])(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])O)O1)N1C=C(C)C([O-])=NC1=O,131704260
3615,DB03846,2'-deoxy-5-(hydroxymethyl)uridine 5'-(dihydrogen phosphate),small molecule,experimental,,[H]N1C(=O)N(C=C(CO)C1=O)[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1,447206
3616,DB03847,gamma-carboxy-L-glutamic acid,small molecule,experimental,,N[C@@H](CC(C(O)=O)C(O)=O)C(O)=O,104625
3617,DB03848,Benzenesulfinic acid,small molecule,experimental,"Acids|Acids, Noncarboxylic|Sulfur Acids|Sulfur Compounds",O[S@@](=O)C1=CC=CC=C1,12057
3618,DB03849,Cilomilast,small molecule,investigational,"Acids, Carbocyclic|Cyclohexanes|Cycloparaffins|Enzyme Inhibitors|Phosphodiesterase 4 Inhibitors|Phosphodiesterase Inhibitors",[H][C@@]1(CC[C@](CC1)(C#N)C1=CC(OC2CCCC2)=C(OC)C=C1)C(O)=O,151170
3619,DB03850,Jaspisamide A,small molecule,experimental,,[H]\C(C[C@@]([H])(OC)[C@@]([H])(C)C(=O)CC[C@]([H])(C)[C@]([H])(C[C@]1([H])OC(=O)C[C@@]([H])(O)C[C@]([H])(O)CC(=O)[C@]([H])(C)[C@]([H])(OC)C2=COC(=N2)C2=COC(=N2)C2=COC(=N2)\C([H])=C([H])\CC[C@@]1([H])C)OC)=C(\[H])N(C)CO,5288653
3620,DB03851,Carbazole Butanoic Acid,small molecule,experimental,,OC(=O)CCCN1C2=CC=CC=C2C2=C1C=CC=C2,448769
3621,DB03852,Eucalyptol,small molecule,experimental|nutraceutical,"Agrochemicals|Alcohols|Anti-Infective Agents|Antitussive Agents|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Cosmetics|Cough and Cold Preparations|Cyclohexanes|Cyclohexanols|Cycloparaffins|Diet, Food, and Nutrition|Expectorants|Fatty Alcohols|Flavoring Agents|Food|Food Additives|Food and Beverages|Food Ingredients|Hexanols|Household Products|Insect Repellents|Lipids|Monoterpenes|Mouthwashes|Pesticides|Pharmaceutic Aids|Pharmaceutical Preparations|Physiological Phenomena|Protective Agents|Respiratory System Agents|Solvents|Terpenes|Toxic Actions",C[C@@]12CC[C@@H](CC1)C(C)(C)O2,2758
3622,DB03853,Reactive Red 6 hapten,small molecule,experimental,,OC1=C(C=C(C=C1)S(O)(=O)=O)\N=N\C1=C(C=C2C(C=CC(NC3=NC(NC4=C(C5=CC(=C(\N=N\C6=C(O)C=CC(=C6)S(O)(=O)=O)C(O)=C5C=C4)S(O)(=O)=O)S(O)(=O)=O)=NC=N3)=C2S(O)(=O)=O)=C1O)S(O)(=O)=O,6400893
3623,DB03854,Cadaverine,small molecule,experimental,Alcohols|Amines|Biogenic Amines|Biogenic Polyamines|Carbohydrates|Diamines|Glycerophosphates|Glycerophospholipids|Lipids|Membrane Lipids|Phosphatidic Acids|Phospholipids|Polyamines|Sugar Alcohols|Sugar Phosphates|Triose Sugar Alcohols,NCCCCCN,273
3624,DB03855,L-Threonohydroxamate 4-Phosphate,small molecule,experimental,,[H][C@](O)(COP(O)(O)=O)[C@@]([H])(O)[C@]([H])(O)NO,49867766
3625,DB03856,L-Eflornithine,small molecule,experimental|investigational,,NCCC[C@@](N)(C(F)F)C(O)=O,6992039
3626,DB03857,"1,4-dithio-beta-D-glucopyranose",small molecule,experimental,,OC[C@H]1O[C@@H](S)[C@H](O)[C@@H](O)[C@@H]1S,445999
3627,DB03858,S-Acetonylcysteine,small molecule,experimental,,CC(=O)CSC[C@H](N)C(O)=O,17753922
3628,DB03859,1-thio-beta-D-glucopyranose,small molecule,experimental,Carbohydrates|Hexoses|Monosaccharides,OC[C@H]1O[C@@H](S)[C@H](O)[C@@H](O)[C@@H]1O,444809
3629,DB03860,ICI-164384,small molecule,experimental,"Alkenes|Alkynes|Amides|Estradiol Congeners|Estranes|Estrenes|Estrogen Antagonists|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormone Antagonists|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydrocarbons, Acyclic|Steroids",[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCCC(=O)N(C)CCCC)[C@@]21[H],104772
3630,DB03861,"(2R,3R,4S,5R)-2-acetamido-3,4-dihydroxy-5-hydroxymethyl-piperidine",small molecule,experimental,,[H]N([C@H]1N([H])C[C@H](CO)[C@H](O)[C@@H]1O)C(C)=O,446429
3631,DB03862,Tetrahydrooxazine,small molecule,experimental,,OC[C@H]1ONC[C@@H](O)[C@@H]1O,449101
3632,DB03863,2-O-Methyl-beta-L-fucopyranose,small molecule,experimental,,CO[C@@H]1[C@@H](O)O[C@@H](C)[C@@H](O)[C@H]1O,446103
3633,DB03864,Monothioglycerol,small molecule,experimental,Alcohols|Carbohydrates|Sugar Alcohols|Triose Sugar Alcohols,OC[C@@H](O)CS,447638
3634,DB03865,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,small molecule,experimental,,NC(=[NH2+])C1=CC2=C(NC(=C2)C2=CC=CC(=C2O)C2=CC=CC=C2)C=C1Cl,445843
3635,DB03866,Prostaglandin G2,small molecule,experimental,"Anions|Autacoids|Biological Factors|Eicosanoids|Electrolytes|Fatty Acids|Fatty Acids, Unsaturated|Free Radicals|Inflammation Mediators|Ions|Lipids|Oxides|Oxygen Compounds|Peroxides|Prostaglandin Endoperoxides|Prostaglandins|Reactive Oxygen Species",[H][C@@](CCCCC)(OO)\C=C\[C@@]1([H])[C@@]2([H])C[C@]([H])(OO2)[C@]1([H])C\C=C/CCCC(O)=O,5280883
3636,DB03867,3-nitro-L-tyrosine,small molecule,experimental,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins",N[C@@H](CC1=CC(=C(O)C=C1)[N+]([O-])=O)C(O)=O,65124
3637,DB03868,3-Dehydroquinic Acid,small molecule,experimental,"Acids, Carbocyclic|Cyclohexanecarboxylic Acids|Cyclohexanes|Cycloparaffins|Hydroxy Acids",O[C@@H]1C[C@@](O)(CC(=O)[C@H]1O)C(O)=O,439351
3638,DB03869,5'-O-(L-Serylsulfamoyl)adenosine,small molecule,experimental,,[H]N([H])[C@@H](CO)C(=O)N([H])S(=O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N=CN=C12)N([H])[H],445736
3639,DB03870,"Ara-Alpha(1,3)-Xyl",small molecule,experimental,,[H][C@@]1(CO)O[C@@]([H])(O[C@@]2([H])[C@]([H])(O)CO[C@@]([H])(O)[C@]2([H])O)[C@]([H])(O)[C@@]1([H])O,448208
3640,DB03871,"lambda-bis(2,2'-bipyridine)imidazole ruthenium (II)",small molecule,experimental,,[Ru+3].[N-]1C=CN=C1.C1=CC=C(N=C1)C1=CC=CC=N1.C1=CC=C(N=C1)C1=CC=CC=N1,46936282
3641,DB03872,"2,3-Dideoxyfucose",small molecule,experimental,,[H][C@]1(O)CC[C@]([H])(O)[C@@]([H])(C)O1,5287900
3642,DB03874,"(4e,8e,12z,16z)-N,N,4,8,13,17,21-Heptamethyldocosa-4,8,12,16,20-Pentaen-1-Amine",small molecule,experimental,,CN(C)CCC\C(C)=C\CC\C(C)=C\CC\C=C(/C)CC\C=C(/C)CCC=C(C)C,448904
3643,DB03876,"Thieno[2,3-B]Pyridine-2-Carboxamidine",small molecule,experimental,,NC(=[NH2+])C1=CC2=C(S1)N=CC=C2,5438
3644,DB03877,AL-4623,small molecule,experimental,,CCN[C@H]1CN(CCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,4369102
3645,DB03878,N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,small molecule,experimental,,CC1=CC=C(NC(=O)C2=CC=CN=C2)C=C1NC1=NC=CC(=N1)C1=CC=CN=C1,4327
3646,DB03879,alpha-L-methyl-fucose,small molecule,experimental,,CO[C@@H]1O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]1O,446578
3647,DB03880,Batimastat,small molecule,experimental,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Enzyme Inhibitors|Metalloendopeptidases, antagonists & inhibitors|Protease Inhibitors|Sulfur Compounds",[H][C@@](CC1=CC=CC=C1)(NC(=O)[C@]([H])(CC(C)C)[C@]([H])(CSC1=CC=CS1)C(=O)NO)C(=O)NC,5362422
3648,DB03881,"(2S,3R,4S,5S)-3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium",small molecule,experimental,,[H]N1C=C([C@H]2[C@H](O)[C@H](O)[C@@H](CSC)[N+]2([H])[H])C2=C1C(=O)N=CN2[H],131704261
3649,DB03882,"5-Alpha-Androstane-3-Beta,17beta-Diol",small molecule,experimental,,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@@]([H])(O)CC[C@]4(C)[C@@]3([H])CC[C@]12C,242332
3650,DB03883,Carboxyethyllumazine,small molecule,experimental,,[H]N1C(=O)N([H])C2=C(N=C(CCC(O)=O)C(=O)N2C[C@H](O)[C@H](O)[C@H](O)CO)C1=O,185679
3651,DB03884,Phenylpyruvic acid,small molecule,experimental,"Acids, Carbocyclic|Keto Acids|Pyruvates",OC(=O)C(=O)CC1=CC=CC=C1,997
3652,DB03885,L-gamma-glutamyl-S-(naphthalen-1-ylmethyl)-L-cysteinylglycine,small molecule,experimental,,[H]N([H])[C@@H](CCC(=O)N([H])[C@@H](CSCC1=CC=CC2=CC=CC=C12)C(=O)N([H])CC(O)=O)C(O)=O,449471
3653,DB03886,Biopterin,small molecule,experimental,"Biological Factors|Coenzymes|Enzymes and Coenzymes|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Pteridines|Pterins",C[C@@H](O)[C@@H](O)C1=CN=C2N=C(N)NC(=O)C2=N1,444475
3654,DB03887,Alpha-Adenosine Monophosphate,small molecule,experimental,,[H][C@]1(COP(O)(O)=O)O[C@]([H])(N2C=NC3=NC=NC(N)=C23)[C@]([H])(O)[C@]1([H])O,446488
3655,DB03888,N-Allyl-6-{[3-(4-bromophenyl)-1-methyl-1H-indazol-6-yl]oxy}-N-methyl-1-hexanamine,small molecule,experimental,,CN(CCCCCCOC1=CC2=C(C=C1)C(=NN2C)C1=CC=C(Br)C=C1)CC=C,445989
3656,DB03889,S-(N-hydroxy-N-bromophenylcarbamoyl)glutathione,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Oligopeptides|Peptides",N[C@@H](CCC(=O)N[C@@H](CS[C@H](O)N(O)C1=CC=C(Br)C=C1)C(=O)NCC(O)=O)C(O)=O,17753992
3657,DB03890,N-[2-(1-Formyl-2-Methyl-Propyl)-1-(4-Piperidin-1-Yl-but-2-Enoyl)-Pyrrolidin-3-Yl]-Methanesulfonamide,small molecule,experimental,,O=C[C@@]([H])(C(C)C)[C@]1([H])N(CC[C@@]1([H])NS(=O)(=O)C)C(=O)\C=C\CN1CCCCC1,6323197
3658,DB03891,"Dibenzyl (carbonylbis{2,1-hydrazinediyl[(2S)-4-methyl-1-oxo-1,2-pentanediyl]})biscarbamate",small molecule,experimental,,[H]N(N([H])C(=O)[C@H](CC(C)C)N([H])C(=O)OCC1=CC=CC=C1)C(=O)N([H])N([H])C(=O)[C@H](CC(C)C)N([H])C(=O)OCC1=CC=CC=C1,5288634
3659,DB03892,5-N-Allyl-arginine,small molecule,experimental,,N[C@@H](CCC\[NH+]=C(/N)NCC=C)C(O)=O,5287706
3660,DB03893,Thionicotinamide-Adenine-Dinucleotide,small molecule,experimental,,[H][C@]1(COP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C([S-])=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,131704262
3661,DB03894,N-Propargyl-1(S)-Aminoindan,small molecule,experimental,,[H][C@@]1(CCC2=C1C=CC=C2)NCC#C,5289310
3662,DB03895,Malachite Green,small molecule,experimental,"Agrochemicals|Amines|Aniline Compounds|Anti-Infective Agents|Anti-Infective Agents, Local|Coloring Agents|Compounds used in a research, industrial, or household setting|Fungicides, Industrial|Pesticides|Toxic Actions",CN(C)C1=CC=C(C=C1)C(C1=CC=CC=C1)=C1C=CC(C=C1)=[N+](C)C,11295
3663,DB03896,Triphosphoric acid,small molecule,experimental,"Acids|Acids, Noncarboxylic|Anions|Electrolytes|Ions|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds",OP(O)(=O)OP(O)(=O)OP(O)(O)=O,983
3664,DB03897,Phloretic acid,small molecule,experimental,"Acids, Carbocyclic",OC(=O)CCC1=CC=C(O)C=C1,10394
3665,DB03898,3-Chloro-4-Hydroxyphenylglycine,small molecule,experimental,,N[C@H](C(O)=O)C1=CC(Cl)=C(O)C=C1,11401421
3666,DB03899,9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine,small molecule,experimental,,CCCCN1C(CC2=CC=C(OC)C=C2)=NC2=C(N)N=CN=C12,5289227
3667,DB03900,tert-butanol,small molecule,experimental,Alcohols|Butanols|Fatty Alcohols|Lipids,CC(C)(C)O,6386
3668,DB03901,5-Oxoprolinal,small molecule,experimental,"Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Imines|Imino Acids|Pyroglutamyl-Peptidase I, antagonists & inhibitors",O=C[C@@H]1CCC(=O)N1,130336
3669,DB03902,Oxalic Acid,small molecule,experimental,"Acids, Acyclic|Compounds used in a research, industrial, or household setting|Dicarboxylic Acids|Indicators and Reagents|Laboratory Chemicals|OAT3/SLC22A8 Substrates|Oxalates|Reducing Agents",OC(=O)C(O)=O,971
3670,DB03903,Tmr,small molecule,experimental,,CN(C)C1=CCC2=C(C3=CC=C(C=C3OC2=C1)N(C)C)C1=CC=C(C=C1C(O)=O)N1C(=O)C=CC1=O,5289288
3671,DB03904,Urea,small molecule,approved|investigational,"Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Carbamide products|Dermatologicals|Diuretics, Osmotic|Emollients and Protectives|i.v. Solutions|Keratolytic Agents|Solutions Producing Osmotic Diuresis",NC(N)=O,1176
3672,DB03905,Succinamide-CoA,small molecule,experimental,,[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)N([H])CCC(=O)N([H])CCN([H])C(=O)CCC(O)=O)[C@@H](OP(O)(O)=O)[C@H]3O)C2=NC=N1,446720
3673,DB03906,2-Phenylheme,small molecule,experimental,,CC1=C(C=C)C2=CC3=[N+]4C(=CC5=C(C)C(CCC(O)=O)=C6N5[Fe]44N2C1=CC1=[N+]4C(C(CCC(O)=O)=C1C)=C6C1=CC=CC=C1)C(C=C)=C3C,17753777
3674,DB03907,"N-[(E)-3-[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]prop-2-enyl]-2,3-dihydroxy-5-nitrobenzamide",small molecule,experimental,,[H]N([H])C1=C2N=CN([C@@H]3O[C@H](\C=C\CN([H])C(=O)C4=C(O)C(O)=CC(=C4)[N+]([O-])=O)[C@@H](O)[C@H]3O)C2=NC=N1,4369234
3675,DB03908,"N,N-[2,5-O-[Dibenzyl]-glucaryl]-DI-[isoleucyl-amido-methane]",small molecule,experimental,,[H]N(C)C(=O)[C@@H](N([H])C(=O)[C@H](OCC1=CC=CC=C1)[C@H](O)[C@@H](O)[C@@H](OCC1=CC=CC=C1)C(=O)N([H])[C@@H]([C@@H](C)CC)C(=O)N([H])C)[C@@H](C)CC,445303
3676,DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",small molecule,experimental,,[H][C@]1(COP(O)(=O)OP(O)(=O)CP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,91532
3677,DB03910,"S,S'-(1,3-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea",small molecule,experimental,,NC(=N)SCCC1=CC(CCSC(N)=N)=CC=C1,1331
3678,DB03911,L-Xylopyranose,small molecule,experimental,,O[C@H]1COC(O)[C@@H](O)[C@@H]1O,439509
3679,DB03912,D-pantetheine 4'-phosphate,small molecule,experimental,Sulfhydryl Compounds|Sulfur Compounds,CC(C)(COP(O)(O)=O)[C@@H](O)C(=O)NCCC(=O)NCCS,115254
3680,DB03913,Coenzyme F420,small molecule,experimental,"Biological Factors|Coenzymes|Enzymes and Coenzymes|Flavins|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Pteridines",C[C@H](OP(O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=CC(O)=CC=C2C=C2C(=O)NC(=O)N=C12)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(O)=O)C(O)=O)C(O)=O,123996
3681,DB03914,"[2-(1-amino-2-hydroxy-propyl)-4-(1H-indol-3-ylmethylene)-5-oxo-4,5-dihydro-imidazol-1-yl]-acetaldehyde",small molecule,experimental,,[H]\C(C1=CNC2=CC=CC=C12)=C1\N=C(N(CC(O)=O)C1=O)[C@@]([H])(N)[C@@]([H])(C)O,49867414
3682,DB03915,2-Amino-3-Ketobutyric Acid,small molecule,experimental,,CC(=O)[C@H](N)C(O)=O,440033
3683,DB03916,4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine,small molecule,experimental,,CC1=C(Cl)C=C(NC2=NC(=CC=N2)C2=CC(=NC=C2)N2CCN(CCN)CC2)C=C1,656967
3684,DB03917,N-Ethylretinamide,small molecule,experimental,"Alkenes|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Retinoids|Terpenes|Vitamin A|Vitamins|Vitamins (Fat Soluble)",CCNC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,5288173
3685,DB03918,"6S-5,6,7,8-Tetrahydrobiopterin",small molecule,experimental,,[H][C@@]1(CNC2=C(N1)C(=O)N=C(N)N2)[C@H](O)[C@@H](C)O,6323235
3686,DB03919,Ethyl-Carbamic Acid Methyl Ester,small molecule,experimental,,CCNC(=O)OC,448166
3687,DB03920,N-Methyl-Alpha-Beta-Dehydroalanine,small molecule,experimental,,CNC(=C)C(O)=O,134856
3688,DB03921,4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline,small molecule,experimental,,N1C=C(C(=N1)C1=NC=CC=C1)C1=C2C=CC=CC2=NC=C1,447966
3689,DB03923,Feruloyl Coenzyme A,small molecule,experimental,,COC1=CC(\C=C\C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO[P@@](=O)(O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(O)(O)=O)N2C=NC3=C(N)N=CN=C23)=CC(O)=C1O,44229079
3690,DB03924,"5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone",small molecule,experimental,,NC1=CC=C(N)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O,85466
3691,DB03925,Freselestat,small molecule,experimental|investigational,"Leukocyte Elastase, antagonists & inhibitors|Oxazoles|Pyrimidines",CC(C)[C@@H](NC(=O)CN1C(=O)C(N)=CN=C1C1=CC=CC=C1)[C@@H](O)C1=NN=C(O1)C(C)(C)C,46936829
3692,DB03926,"5alpha-androstane-3beta,17alpha-diol",small molecule,experimental,,[H][C@@]12CC[C@@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@@H](O)CC[C@]12C,446934
3693,DB03927,Glycyl-L-alpha-amino-epsilon-pimelyl-D-alanine,small molecule,experimental,,[H]N([H])CC(=O)N([H])[C@@H](CCCCC(=O)N([H])[C@H](C)C(O)=O)C(O)=O,446307
3694,DB03928,"Carboxymethylthio-3-(3-Chlorophenyl)-1,2,4-Oxadiazol",small molecule,experimental,,OC(=O)CSC1=NC(=NO1)C1=CC=CC(Cl)=C1,446195
3695,DB03929,D-Serine,small molecule,approved|experimental,,N[C@H](CO)C(O)=O,71077
3696,DB03930,4-Methyl-Pyrroline-5-Carboxylic Acid,small molecule,experimental,,[H][C@@]1(C)C=CN[C@@]1([H])C(O)=O,5287781
3697,DB03931,Diguanosine-5'-Triphosphate,small molecule,experimental,,NC1=NC(=O)C2=C(N1)N(C=N2)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2NC(N)=NC3=O)[C@@H](O)[C@H]1O,444841
3698,DB03932,LFA703,small molecule,experimental,,[H][C@](C)(CC)C(=O)O[C@@]1([H])C[C@@]([H])(C)C=C2C=C[C@]([H])(C)[C@]([H])(CC[C@@]3([H])C[C@@]([H])(O)CC(=O)N3CC3=CC4=C(C=C3)C(CO)=C(OC)C=C4)[C@@]12[H],449169
3699,DB03933,C-1027 Aromatized chromophore,small molecule,experimental,,[H]N1C(=O)C(=C)OC2=CC(OC)=CC(C(=O)O[C@H]3COC(=O)C[C@@H](C4=CC(O)=C(O[C@]5([H])C6=C(C=C3C=C6)C3=CC=C[C@]53O[C@@H]3OC(C)(C)[C@H]([C@@H](O)[C@H]3O)N(C)C)C(Cl)=C4)[N+]([H])([H])[H])=C12,5289301
3700,DB03934,Protoporphyrin Ix Containing Zn,small molecule,experimental,,CC1=C(CCC(O)=O)C2=CC3=[N]4C(=CC5=C(C)C(C=C)=C6C=C7C(C)=C(C=C)C8=[N]7[Zn]4(N2C1=C8)N56)C(C)=C3CCC(O)=O,3802528
3701,DB03935,"1,4-Dideoxy-O2-Sulfo-Glucuronic Acid",small molecule,experimental,,[H][C@]1(O)O[C@@]([H])(C(O)=O)[C@]([H])(O)[C@]([H])(O)[C@@]1([H])OS(O)(=O)=O,49867144
3702,DB03936,1-Deoxy-Ribofuranose-5'-Phosphate,small molecule,experimental,,[H][C@]1(O)CO[C@]([H])(COP(O)(O)=O)[C@]1([H])O,5289299
3703,DB03937,D-erythrose 4-phosphate,small molecule,experimental,,[H]C(=O)[C@H](O)[C@H](O)COP(O)(O)=O,122357
3704,DB03938,Deacetoxycephalosporin C,small molecule,experimental,"Agents that reduce seizure threshold|Amides|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Sulfur Compounds|Thiazines",[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)CCC[C@@H](N)C(O)=O)C(O)=O,160139
3705,DB03939,"(4S)-4-hydroxy-3,4-dihydro-2(1H)-pyrimidinone",small molecule,experimental,,[H]N1C=C[C@H](O)N([H])C1=O,446637
3706,DB03940,Oxamic Acid,small molecule,experimental,"Acids, Aldehydic|Amino Acids|Amino Acids, Peptides, and Proteins|Glyoxylates",NC(=O)C(O)=O,974
3707,DB03941,p-Heptylphenol,small molecule,experimental,,CCCCCCCC1=CC=C(O)C=C1,16143
3708,DB03942,Carboxylic PRPP,small molecule,experimental,,[H][C@]1(O)[C@@]([H])(O)[C@]([H])(C[C@]1([H])COP(O)(O)=O)OP(O)(=O)OP(O)(O)=O,444189
3709,DB03943,D-Asparagine,small molecule,experimental,,N[C@H](CC(N)=O)C(O)=O,439600
3710,DB03944,"5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One",small molecule,experimental,,[H][C@]1(C)SC(=O)NN=C1C1=CC2=C(C=C1)N(CCC2)C(=O)C1=CC(OC)=C(OC)C=C1,446286
3711,DB03945,"N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium",small molecule,experimental,Alcohols|Amines|Amino Alcohols|Ammonium Compounds|Ethanolamines|Nitrogen Compounds|Onium Compounds|Phosphorylcholine|Quaternary Ammonium Compounds|Trimethyl Ammonium Compounds,C[N+](C)(C)CCOP(O)(O)=O,1014
3712,DB03946,"3,4-Dihydroxybenzoic Acid",small molecule,experimental,"Acids, Carbocyclic|Anticarcinogenic Agents|Antineoplastic Agents|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Drugs, Chinese Herbal|Hydroxy Acids|Phenols|Protective Agents",OC(=O)C1=CC=C(O)C(O)=C1,72
3713,DB03947,D-Xylulose,small molecule,experimental,,OC[C@H](O)[C@H](O)C(=O)CO,644111
3714,DB03948,"6-Chloropurine Riboside, 5'-Monophosphate",small molecule,experimental,,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(Cl)[NH+]=CN=C23)[C@]([H])(O)[C@]1([H])O,17753915
3715,DB03949,N-[(2S)-3-Phenyl-2-sulfanylpropanoyl]-L-phenylalanyl-L-tyrosine,small molecule,experimental,,[H]N([C@@H](CC1=CC=CC=C1)C(=O)N([H])[C@@H](CC1=CC=C(O)C=C1)C(O)=O)C(=O)[C@@H](S)CC1=CC=CC=C1,5289470
3716,DB03950,(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,small molecule,experimental,,[H]N([H])S(=O)(=O)C1=CC=C(C=C1)C(=O)N([H])C[C@H](C)CN1C=CC2=CC=CC=C12,446277
3717,DB03951,N-acetyl-D-glucosamine-6-phosphate,small molecule,experimental,,CC(=O)N[C@H]1C(O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O,440996
3718,DB03952,9-(6-deoxy-beta-D-allofuranosyl)-6-methylpurine,small molecule,experimental,,[H][C@](C)(O)[C@@]1([H])O[C@@]([H])(N2C=NC3=C(C)N=CN=C23)[C@]([H])(O)[C@]1([H])O,447724
3719,DB03953,Thiocitrulline,small molecule,experimental,"Amino Acids|Amino Acids, Diamino|Amino Acids, Peptides, and Proteins|Enzyme Inhibitors|Nitric Oxide Synthase, antagonists & inhibitors|Sulfur Compounds",[H]N([H])[C@@H](CCCN([H])C(=S)N([H])[H])C(O)=O,2733514
3720,DB03955,1-deoxymannojirimycin,small molecule,experimental,,[H][C@@]1(O)CN[C@]([H])(CO)[C@@]([H])(O)[C@]1([H])O,72258
3721,DB03956,"Inositol 2,4,5-trisphosphate",small molecule,experimental,Alcohols|Carbohydrates|Sugar Alcohols|Sugar Phosphates,O[C@H]1[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H](O)[C@H]1OP(O)(O)=O,122195
3722,DB03957,SP2456,small molecule,experimental,,[H]N([H])C(=N[C@H](C1CCCCC1)C(=O)N([H])CC(=O)N1CCC(CC1)C1=CC(=NN1[H])C1=C(Cl)C(Cl)=CC=C1)N([H])[H],447945
3723,DB03958,7-methyl-guanosine-5'-triphosphate-5'-guanosine,small molecule,experimental,,[H]N([H])C1=NC(=O)C2=C(N1[H])N(C=N2)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)[N+]2=CN(C)C3=C2N([H])C(=NC3=O)N([H])[H])[C@@H](O)[C@H]1O,121959
3724,DB03959,"N,O6-Disulfo-Glucosamine",small molecule,experimental,,[H][C@]1(O)O[C@]([H])(COS(O)(=O)=O)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])NS(O)(=O)=O,444389
3725,DB03960,Cp-Coeleneterazine,small molecule,experimental,,[H][C@@]1(CC2CCCC2)NC(=CN2C(=O)[C@](CC3=CC=C(O)C=C3)(OO)N=C12)C1=CC=C(O)C=C1,98454432
3726,DB03961,"2c-Methyl-D-Erythritol 2,4-Cyclodiphosphate",small molecule,experimental,,[H][C@@]1(O)COP(O)(=O)OP(O)(=O)O[C@@]1(C)CO,126747
3727,DB03962,Nicotinamide 8-bromo-adenine dinucleotide phosphate,small molecule,experimental,,[H]N([H])C(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](OP(O)(O)=O)[C@@H]2O)N2C(Br)=NC3=C(N=CN=C23)N([H])[H])[C@@H](O)[C@H]1O,131704263
3728,DB03963,S-(Dimethylarsenic)Cysteine,small molecule,experimental,,[H][C@](N)(CS[As](C)C)C(O)=O,17753880
3729,DB03964,4-Hydroxy-Aconitate Ion,small molecule,experimental,,[H]\C(C([O-])=O)=C(/C([O-])=O)[C@@]([H])(O)C([O-])=O,5287714
3730,DB03966,Clorobiocin,small molecule,experimental,"Aminocoumarins|Benzopyrans|Carbohydrates|Coumarins|Glycosides|Heterocyclic Compounds, Fused-Ring|Pyrans",CO[C@@H]1[C@@H](OC(=O)C2=CC=C(C)N2)[C@@H](O)[C@H](OC2=C(Cl)C3=C(C=C2)C(O)=C(NC(=O)C2=CC(CC=C(C)C)=C(O)C=C2)C(=O)O3)OC1(C)C,54706138
3731,DB03967,Dodecyl sulfate,small molecule,experimental,"Acids|Acids, Noncarboxylic|Alcohols|Alkanes|Alkanesulfonates|Alkanesulfonic Acids|Compounds used in a research, industrial, or household setting|Dodecanol|Fatty Alcohols|Hydrocarbons, Acyclic|Lipids|Sulfonic Acids|Sulfur Acids|Sulfur Compounds|Surface-Active Agents",CCCCCCCCCCCCOS(O)(=O)=O,8778
3732,DB03968,"1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine",small molecule,experimental,,CN1C(=O)CCC1(C)C,444570
3733,DB03970,"(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid",small molecule,experimental,,[H][C@]1(SCC(=NC=C1C(O)=O)C(O)=O)C1=CN2C(SC3=C2CCC3)=N1,447998
3734,DB03971,Acarbose Derived Hexasaccharide,small molecule,experimental,,[H][C@]1(C)O[C@]([H])(O[C@]2([H])[C@@]([H])(CO)O[C@]([H])(OC[C@@]3([H])O[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])N[C@@]1([H])C=C(CO)[C@@]([H])(O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O[C@@]3([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O,449167
3735,DB03972,"2-Amino-4h-1,3-Benzoxathiin-4-Ol",small molecule,experimental,,[H][C@]1(N)OC2=CC=CC=C2[C@]([H])(O)S1,49867689
3736,DB03973,"3-[2,6,8-Trioxo-9-[(2R,3R,4R)-2,3,4,5-tetrahydroxypentyl]-3H-purin-7-yl]propyl dihydrogen phosphate",small molecule,experimental,,[H]N1C2=C(N(CCCOP(O)(O)=O)C(=O)N2C[C@@H](O)[C@@H](O)[C@H](O)CO)C(=O)N([H])C1=O,657026
3737,DB03974,L-homoarginine,small molecule,experimental,"Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Arginine",N[C@@H](CCCCNC(N)=N)C(O)=O,9085
3738,DB03975,Mercuribenzoic Acid,small molecule,experimental,,OC(=O)C1=CC=C([Hg])C=C1,8747
3739,DB03976,Phosphorylisopropane,small molecule,experimental,,CC(C)OP(O)(O)=O,15391
3740,DB03977,Trimethyllysine,small molecule,experimental,"Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Mitogens|Mitosis Modulators",C[N+](C)(C)CCCC[C@H](N)C(O)=O,440121
3741,DB03978,Tyrosinal,small molecule,experimental,,[H][C@](N)(CC1=CC=C(O)C=C1)C=O,445993
3742,DB03979,1-[Glycerolylphosphonyl]-2-[8-(2-Hexyl-Cyclopropyl)-Octanal-1-Yl]-3-[Hexadecanal-1-Yl]-Glycerol,small molecule,experimental,,[H]C(O)(CO)COP(O)(=O)OC[C@@]([H])(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC[C@@]1([H])C[C@@]1([H])CCCCCC,131704264
3743,DB03980,4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole,small molecule,experimental,,NC1=NC(=CC=N1)C1=C(N=CN1CC1CC1)C1=CC=C(F)C=C1,5172
3744,DB03981,"1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid",small molecule,experimental,,[H][C@@]1(O)OC(=C[C@]([H])(O)[C@@]1([H])OS(O)(=O)=O)C(O)=O,444552
3745,DB03982,"Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid",small molecule,experimental,,OC(=O)C(=O)N(C1=CC=CC=C1C(O)=O)C1=CC=CC2=C1C=CC=C2,447411
3746,DB03983,"{[2-Amino-4-oxo-6,7-di(sulfanyl-κS)-3,5,5a,8,9a,10-hexahydro-4H-pyrano[3,2-g]pteridin-8-yl]methyl dihydrogenato(2-) phosphate}(dioxo)sulfanylmolybdenum",small molecule,experimental,,NC1=NC2=C(N[C@@H]3[C@H](N2)O[C@@H](COP(O)(O)=O)C2=C3S[Mo](S)(=O)(=O)S2)C(=O)N1,46936855
3747,DB03984,Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide,small molecule,experimental,,[H][C@@](CSCC1=CC=CC=C1)(NC(=O)[C@]([H])(CC1=CC=CC=C1)NC(=O)N1CCOCC1)C=O,5287870
3748,DB03985,R-azabisabolene,small molecule,experimental,,C[N@@H+](CCC=C(C)C)[C@H]1CCC(C)=CC1,5289266
3749,DB03986,6-methyl-formycin A,small molecule,experimental,,[H][C@]1(O[C@H](CO)[C@@H](O)[C@H]1O)C1=C2N=C[N+](C)=C(N)C2=NN1,446658
3750,DB03987,"2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",small molecule,experimental,,COC1=CC(OC)=CC(CN(C)C2=CN=C3N=C(N)N=C(N)C3=C2)=C1,447022
3751,DB03988,"2,6-Diamino-Hexanoic Acid Amide",small molecule,experimental,,N[C@@H](CCCC[NH3+])C(N)=O,17754068
3752,DB03989,D-Allopyranose,small molecule,experimental,,OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O,439507
3753,DB03990,4'-nitrophenyl-3i-thiolaminaritrioside,small molecule,experimental,,[H][C@]1(CO)O[C@@]([H])(S[C@@]2([H])[C@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OC3([H])C([H])(O)C([H])(CO)OC([H])(OC4=CC=C(C=C4)N(=O)=O)C3([H])O)[C@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O,131704265
3754,DB03991,"2-deoxy-2,3-dehydro-N-acetylneuraminic acid",small molecule,experimental,"Acids, Acyclic|Amino Sugars|Carbohydrates|Enzyme Inhibitors|Hydroxy Acids|Neuraminic Acids|Neuraminidase, antagonists & inhibitors|Sialic Acids|Sugar Acids",[H][C@]1(OC(=C[C@H](O)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,65309
3755,DB03992,3-(Benzoylamino)-L-Alanine,small molecule,experimental,,N[C@@H](CNC(=O)C1=CC=CC=C1)C(O)=O,14233317
3756,DB03993,Isocaproic acid,small molecule,experimental,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids",CC(C)CCC(O)=O,12587
3757,DB03994,Ethanolamine,small molecule,experimental,Alcohols|Amines|Amino Alcohols|Ethanolamines|Sclerosing Activity|Sclerosing Solutions|Vascular Sclerosing Activity,NCCO,700
3758,DB03995,Betadex,small molecule,experimental,"Biopolymers|Carbohydrates|Compounds used in a research, industrial, or household setting|Cyclodextrins|Dextrins|Diet, Food, and Nutrition|Dietary Carbohydrates|Food|Food Additives|Food and Beverages|Food Ingredients|Glucans|Macromolecular Substances|Physiological Phenomena|Polymers|Polysaccharides|Sequestering Agents|Starch",[H][C@]1(CO)O[C@]2([H])O[C@]3([H])[C@@]([H])(CO)O[C@]([H])(O[C@]4([H])[C@@]([H])(CO)O[C@]([H])(O[C@]5([H])[C@@]([H])(CO)O[C@]([H])(O[C@]6([H])[C@@]([H])(CO)O[C@]([H])(O[C@]7([H])[C@@]([H])(CO)O[C@]([H])(O[C@]8([H])[C@@]([H])(CO)O[C@]([H])(O[C@@]1([H])[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]8([H])O)[C@]([H])(O)[C@@]7([H])O)[C@]([H])(O)[C@@]6([H])O)[C@]([H])(O)[C@@]5([H])O)[C@]([H])(O)[C@@]4([H])O)[C@]([H])(O)[C@@]3([H])O,444041
3759,DB03996,"3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol",small molecule,experimental,,[H][C@]1(CC(=NN1C(C)=O)C1=C(Cl)C=CC=C1)C1=CC=CC(O)=C1,5288685
3760,DB03997,L-histidinol phosphate,small molecule,experimental,,N[C@H](COP(O)(O)=O)CC1=CNC=N1,439398
3761,DB03998,"[2-(Methyleneamine)-4-(4-Hydroxy-Benzylidine)-5-Oxo-4,5-Dihydro-Imidazol-1-Yl]-Acetaldehyde",small molecule,experimental,,[H]\C(=C1\N=C(CN)N(CC(O)=O)C1=O)C1=CC=C(O)C=C1,49866821
3762,DB03999,Butylphosphonate,small molecule,experimental,,CCCCP(O)(O)=O,76839
3763,DB04000,Bromo-Willardiine,small molecule,experimental,,N[C@@H](CN1C=C(Br)C(=O)NC1=O)C(O)=O,167842
3764,DB04001,6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid,small molecule,experimental,,OC(=O)C(=O)NC1=CC2=C(C=CN2)C=C1C(O)=O,444763
3765,DB04002,4-Sulfonamide-[4-(Thiomethylaminobutane)]Benzamide,small molecule,experimental,,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCCCCNCS,1759
3766,DB04003,{4-[(2S)-2-Acetamido-3-({(1S)-1-[3-carbamoyl-4-(cyclohexylmethoxy)phenyl]ethyl}amino)-3-oxopropyl]-2-phosphonophenoxy}acetic acid,small molecule,experimental,,[H]N([H])C(=O)C1=C(OCC2CCCCC2)C=CC(=C1)[C@H](C)N([H])C(=O)[C@H](CC1=CC(=C(OCC(O)=O)C=C1)P(O)(O)=O)N([H])C(C)=O,446300
3767,DB04004,"2,6-Diamino-8-(2-Dimethylaminoethylsulfanylmethyl)-3h-Quinazolin-4-One",small molecule,experimental,,CN(C)CCSCC1=C2N=C(N)NC(=O)C2=CC(N)=C1,448017
3768,DB04005,Uridine 5'-triphosphate,small molecule,experimental|investigational,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides|Uracil Nucleotides",O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O,6133
3769,DB04006,"[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone",small molecule,experimental,,NC1=C(N2C=C(C=CC2=N1)C(=O)C1=C(F)C=CC=C1F)C(=O)C1=CC=CC=C1,5289179
3770,DB04007,Bromo-WR99210,small molecule,experimental,,CC1(C)N=C(N)N=C(N)N1OCCCOC1=CC=C(Br)C=C1,2429
3771,DB04008,Zinc;[amino-[2-[[5-[amino(azaniumylidene)methyl]benzimidazol-1-id-2-yl]methyl]benzimidazol-1-id-5-yl]methylidene]azanium,small molecule,experimental,,[Zn++].NC(=[NH2+])C1=CC2=C([N-]C(CC3=NC4=C([N-]3)C=CC(=C4)C(N)=[NH2+])=N2)C=C1,131704266
3772,DB04009,Dimethyl Propionate Ester Heme,small molecule,experimental,,COC(=O)CCC1=C(C)C2=CC3=C(C=C)C(C)=C4C=C5N6C(=CC7=C(C)C(CCC(=O)OC)=C8C=C1N2[Fe@@]6(N78)N34)C(C)=C5C=C,11963944
3773,DB04010,2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,small molecule,experimental,,COC1=CC=CC(=C1)C1=NC2=C(N1)C=CC=C2C(N)=O,1511
3774,DB04011,"2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole",small molecule,experimental,,CN(C)C1=CC=C(C=C1)C1=NC2=C(N1)C=CC(=C2)C1=NC2=C(N1)C=C(C=C2)N1CCN(C)CC1,448202
3775,DB04012,"(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Leucine",small molecule,experimental,,[H][C@@](CC(C)C)(NC(=O)[C@]1([H])CSCCN1S(=O)(=O)C1=CC=C(C)C=C1)C(O)=O,446411
3776,DB04013,1-Deoxy-1-methoxycarbamido-beta-D-gluco-2-heptulopyranosonamide,small molecule,experimental,,[H]N([H])C(=O)[C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)N([H])C(=O)OC,444456
3777,DB04014,Alsterpaullone,small molecule,experimental,"CDC2 Protein Kinase|Cyclin B|Heterocyclic Compounds, Fused-Ring",[O-][N+](=O)C1=CC2=C(NC3=C2CC(=O)NC2=C3C=CC=C2)C=C1,5005498
3778,DB04015,Methionine Phosphinate,small molecule,experimental,,CSCC[C@H](N)P(O)=O,6398483
3779,DB04016,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,small molecule,experimental,,CN(C1CCN(CC1)C(=O)C1=CC2=CC=CC=C2C=C1)C(=O)C1=CC2=CC=CC=C2C=C1C(=O)[C@@H](C1=CC=CC2=CC=CC=C12)P(O)(O)=O,656932
3780,DB04017,Clorgiline,small molecule,experimental,Agents that produce hypertension|Amines|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Enzyme Inhibitors|Monoamine Oxidase A Inhibitors|Monoamine Oxidase Inhibitors|Propylamines|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,CN(CCCOC1=CC=C(Cl)C=C1Cl)CC#C,4380
3781,DB04018,S-Isopropyl-Isothiourea,small molecule,experimental,,CC(C)SC(N)=N,445319
3782,DB04020,"4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol",small molecule,experimental,,OC1=CC=C(CCNC2=NC(SCCCC3=CC=C(Cl)C=C3)=NC(=N2)N2CCNCC2)C=C1,9957008
3783,DB04021,MF268,small molecule,experimental,,[H][C@]1(C)CN(CCCCCCCCNC=O)C[C@@]([H])(C)O1,5288799
3784,DB04022,Guanosine tetraphosphate,small molecule,experimental,"Carbohydrates|Glycosides|Guanine Nucleotides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](OP(O)(=O)OP(O)(O)=O)[C@H]2O)C(=O)N1,439450
3785,DB04023,GDP-alpha-D-mannuronic acid,small molecule,experimental,,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)O[C@H]3O[C@@H]([C@@H](O)[C@H](O)[C@@H]3O)C(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,447152
3786,DB04024,Serine-3'-aminoadenosine,small molecule,experimental,,[H]N([H])[C@@H](CO)C(=O)N([H])[C@@H]1[C@@H](CO)O[C@H]([C@@H]1O)N1C=NC2=C(N=CN=C12)N([H])[H],448726
3787,DB04026,Pseudotropine,small molecule,experimental,Alkaloids|Aza Compounds|Azabicyclo Compounds,[H][C@]12CC[C@]([H])(C[C@@]([H])(O)C1)N2C,449293
3788,DB04027,D-arginine,small molecule,experimental,,N[C@H](CCCNC(N)=N)C(O)=O,71070
3789,DB04028,Tyvelose,small molecule,experimental,Carbohydrates|Monosaccharides,[H][C@]1(O)C[C@]([H])(O)[C@@]([H])(O)O[C@]1([H])C,448819
3790,DB04029,Phenylalanylamide,small molecule,experimental,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins",N[C@@H](CC1=CC=CC=C1)C(N)=O,445694
3791,DB04030,"1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole",small molecule,experimental,,OC1=CC=C(CN2C3=C(CCN(C3)C(=O)C3=CC=C(O)C=C3)C3=CC=CC=C23)C=C1,4470577
3792,DB04031,Serine vanadate,small molecule,experimental,Vanadates,N[C@@H](CO[V](O)([O-])([O-])[O-])C(O)=O,17754186
3793,DB04032,Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Butyl-Amide,small molecule,experimental,,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NCCCCNC(=O)C12CC3CC(CC(C3)C1)C2,448333
3794,DB04033,Z-Ala Prolinal,small molecule,experimental,,[H][C@@](C)(NC(=O)OCC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(O)=O,5388928
3795,DB04034,Ribulose-5-Phosphate,small molecule,experimental,,OCC(=O)[C@@H](O)[C@H](O)COP(O)(O)=O,439190
3796,DB04035,Ceftazidime BATSI,small molecule,experimental,,CC(C)(O\N=C(/C(=O)NCB(O)O)C1=CSC(N)=N1)C(O)=O,5849540
3797,DB04036,Coenzyme A persulfide,small molecule,experimental,"Adenine Nucleotides|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)N([H])CCC(=O)N([H])CCSS)[C@@H](OP(O)(O)=O)[C@H]3O)C2=NC=N1,174251
3798,DB04037,"N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine",small molecule,experimental,,ClC1=CC=C(CN(CC2=CC=C(Cl)C=C2)C2=NNN=N2)C=C1,447980
3799,DB04038,Ergosterol,small molecule,approved|experimental,"Cholestanes|Cholestenes|Diet, Food, and Nutrition|Food|Food and Beverages|Fused-Ring Compounds|Growth Substances|Micronutrients|Physiological Phenomena|Provitamins|Steroids|Vitamins",CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,444679
3800,DB04039,3-Oxo-Pentadecanoic Acid,small molecule,experimental,,CCCCCCCCCCCCC(=O)CC(O)=O,4476947
3801,DB04040,"N-[1,3-Di(4-morpholinyl)-2-propanyl]-3-(α-D-galactopyranosyloxy)-5-nitrobenzamide",small molecule,experimental,,[H]N(C(CN1CCOCC1)CN1CCOCC1)C(=O)C1=CC(=CC(O[C@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)=C1)[N+]([O-])=O,5287447
3802,DB04041,Nitrocefin Acyl-Serine,small molecule,experimental,,[H]\C(=C(\[H])C1=C(C=C(C=C1)N(=O)=O)N(=O)=O)C1=C(N[C@]([H])(SC1)[C@]([H])(N=C([O-])CC1=CC=CS1)C(=O)OC[C@]([H])(N)C([O-])=O)C(O)=O,131704267
3803,DB04042,"2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol",small molecule,experimental,,[H][C@](O)(OC)C1=CC=C(CN2[C@]([H])(COC3=CC=CC=C3)[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(COC3=CC=CC=C3)N(CC3=CC=C(CO)C=C3)S2(=O)=O)C=C1,17753826
3804,DB04043,Carboxymycobactin T,small molecule,experimental,,OC(=O)CCCCCC\C=C/[C@@H]1O[Fe@]23ON1CCCC[C@@H](NC(=O)[C@@H]1CO[C@H](N1)C1=CC=CC=C1O2)C(=O)OCCC(=O)N[C@@H]1CCCCN(O3)C1=O,46936871
3805,DB04044,4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid,small molecule,experimental,,OC(=O)C1=C(C=C(OC2=C(NC(=O)C3=CC(=CC=C3)[N+]([O-])=O)C=CC=C2)C=C1)C(O)=O,657140
3806,DB04045,(R)-methylmalonyl-CoA,small molecule,experimental,"Adenine Nucleotides|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides|Thioesters of coenzyme A",C[C@H](C(O)=O)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N,449534
3807,DB04046,Methyl beta-galactoside,small molecule,experimental,Carbohydrates|Galactosides|Glycosides|Methylglycosides,CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O,94214
3808,DB04047,6-hydroxymethylpterin diphosphate,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring",[H]N([H])C1=NC(=O)C2=NC(COP(O)(=O)OP(O)(O)=O)=CN=C2N1[H],151434
3809,DB04048,N-Carbamoyl-Alanine,small molecule,experimental,,C[C@@H](NC(N)=O)C(O)=O,1535935
3810,DB04049,Coelenteramide,small molecule,experimental,"Acetamides|Acetates|Acids, Acyclic|Amides|Benzene Derivatives|Fatty Acids|Fatty Acids, Volatile|Lipids",OC1=CC=C(CC(=O)NC2=NC=C(N=C2CC2=CC=CC=C2)C2=CC=C(O)C=C2)C=C1,5326781
3811,DB04050,N-Propyl Isocyanide,small molecule,experimental,,CCC[N+]#[C-],79084
3812,DB04051,5-phenylpentanoic acid,small molecule,experimental,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids|Valerates",OC(=O)CCCCC1=CC=CC=C1,16757
3813,DB04052,"3,4-Xylenol",small molecule,experimental,Agrochemicals|Benzene Derivatives,CC1=CC=C(O)C=C1C,7249
3814,DB04053,Hypophosphite,small molecule,experimental,,[O-]P=O,183145
3815,DB04054,"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",small molecule,experimental,,CCCCN1C(CC2=C(OC)C=CC(OC)=C2)=NC2=C(N)N=C(F)N=C12,448974
3816,DB04055,"2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium",small molecule,experimental,,CC[N+]1=C(C)C(C(=O)OC(C)C)=C(C2=CC=CC=C2Cl)C(C(O)=O)=C1C(O)=O,1478
3817,DB04057,"N-[4-([(2-Amino-4-oxo-1,4-dihydropyrido[3,2-d]pyrimidin-6-yl)methyl]{(2E)-3-[4-carbamoyl-1-(5-O-phosphono-beta-D-ribofuranosyl)-1H-imidazol-5-yl]-2-propenoyl}amino)benzoyl]-L-glutamic acid",small molecule,experimental,,[H]N([H])C(=O)C1=C(\C=C\C(=O)N(CC2=NC3=C(C=C2)N([H])C(=NC3=O)N([H])[H])C2=CC=C(C=C2)C(=O)N([H])[C@@H](CCC(O)=O)C(O)=O)N(C=N1)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O,6323417
3818,DB04058,N-Carbamoylphenylalanine,small molecule,experimental,,NC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O,446054
3819,DB04059,8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide,small molecule,experimental,,NC(=N)C1=CC2=C(C=CC=C2NC2=NC=CC=N2)C=C1,448610
3820,DB04060,"(5-methyl-6-oxo-1,6-dihydro-pyridin-3-yl)-1,2-dideoxy-ribofuranose-5-monophosphate",small molecule,experimental,,CC1=CC(=CNC1=O)[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1,17754095
3821,DB04061,Alpha-Amino-2-Indanacetic Acid,small molecule,experimental,,[H][C@@](N)(C1CC2=CC=CC=C2C1)C(O)=O,12192007
3822,DB04062,beta-D-fucose,small molecule,experimental,,C[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O,439650
3823,DB04063,alpha-Methylleucine,small molecule,experimental,,CC(C)C[C@](C)(N)C(O)=O,446181
3824,DB04064,Nogalaviketone,small molecule,experimental,,COC(=O)C1=C(C)CC(=O)C2=C(O)C3=C(C=C12)C(=O)C1=CC=CC(O)=C1C3=O,5289026
3825,DB04065,N-Cyclopentyl-N-Cyclobutylformamide,small molecule,experimental,,O=CN(C1CCC1)C1CCCC1,5287890
3826,DB04066,p-Coumaric acid,small molecule,experimental,"Acids, Acyclic|Adrenal Cortex Hormones|Anti-Infective Agents|Antioxidants|Compounds used in a research, industrial, or household setting|Contraceptive Agents, Male|Fatty Acids|Fatty Acids, Volatile|Free Radical Scavengers|Hormonal Contraceptives for Systemic Use|Lipids|Protective Agents|Reproductive Control Agents",OC(=O)\C=C\C1=CC=C(O)C=C1,637542
3827,DB04067,4-hydroxybenzyl coenzyme A,small molecule,experimental,,[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)N([H])CCC(=O)N([H])CCSCC4=CC=C(O)C=C4)[C@@H](OP(O)(O)=O)[C@H]3O)C2=NC=N1,446969
3828,DB04068,"2',3'-dideoxy-3'-fluoro-urididine-5'-diphosphate",small molecule,experimental,,[H]N1C(=O)C=CN([C@H]2C[C@]([H])(F)[C@@H](COP(O)(=O)OP(O)(O)=O)O2)C1=O,444503
3829,DB04069,"5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine",small molecule,experimental,,NC1=NN=C2C(CCC3=CC=CC=C23)=C1,5288116
3830,DB04070,6-Deoxyerythronolide B,small molecule,experimental,Anti-Bacterial Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Polyketides,[H][C@@]1(C)C[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)O[C@]([H])(CC)[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C1=O,121904
3831,DB04071,Cpad,small molecule,experimental,,NC(=O)C1=NC(=CC=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O,444170
3832,DB04072,Alpha-Methylisocitric Acid,small molecule,experimental,,C[C@@](O)([C@H](CC(O)=O)C(O)=O)C(O)=O,5459784
3833,DB04073,N-{3-[4-(3-amino-propyl)-piperazin-1-yl]-propyl}-3-nitro-5-(galactopyranosyl)-beta-benzamide,small molecule,experimental,,[H]N([H])CCCN1CCN(CCCN([H])C(=O)C2=CC(=CC(O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)=C2)[N+]([O-])=O)CC1,447976
3834,DB04074,alpha-Ketoisovalerate,small molecule,experimental,Pentanoic Acids|Valerates,CC(C)C(=O)C(O)=O,49
3835,DB04075,N-Acetyl-L-Glutamate,small molecule,experimental,,CC(=O)N[C@@H](CCC(O)=O)C(O)=O,70914
3836,DB04076,Hypoxanthine,small molecule,experimental,"Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Purines|Purinones|Xanthine derivatives",O=C1N=CNC2=C1NC=N2,790
3837,DB04079,"Heptane-1,2,3-Triol",small molecule,experimental,Alcohols|Lipids,[H][C@@](O)(CO)[C@]([H])(O)CCCC,444397
3838,DB04080,RU78191,small molecule,experimental,,OC(=O)C(C(O)=O)C1=CC=CC=C1,75791
3839,DB04081,"(4s-Trans)-4-(Methylamino)-5,6-Dihydro-6-Methyl-4h-Thieno(2,3-B)Thiopyran-2-Sulfonamide-7,7-Dioxide",small molecule,experimental,,[H][C@]1(C)C[C@]([H])(NC)C2=C(SC(=C2)S(N)(=O)=O)S1(=O)=O,5288859
3840,DB04082,Decyloxy-Methanol,small molecule,experimental,,CCCCCCCCCCOCO,4629337
3841,DB04083,N(6)-(pyridoxal phosphate)-L-lysine,small molecule,experimental,,CC1=NC=C(COP(O)(O)=O)C(\C=N\CCCC[C@H](N)C(O)=O)=C1O,10062732
3842,DB04084,2-deoxy-2-fluoro-α-D-mannose,small molecule,experimental,,OC[C@H]1O[C@H](O)[C@@H](F)[C@@H](O)[C@@H]1O,2758978
3843,DB04085,Bis(N-maleimidomethyl)ether,small molecule,experimental,"Acids, Acyclic|Dicarboxylic Acids|Imides|Maleates",O=C1C=CC(=O)N1COCN1C(=O)C=CC1=O,84836
3844,DB04086,"2',4'-Dinitrophenyl-2deoxy-2-Fluro-B-D-Cellobioside",small molecule,experimental,,[H][C@]1(CO)O[C@@]([H])(O[C@]2([H])[C@@]([H])(CO)O[C@@]([H])(OC3=C(C=C(C=C3)N(=O)=O)N(=O)=O)[C@]([H])(F)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O,445981
3845,DB04087,Open Form of 2'-Deoxy-Ribofuranose-5'-Phosphate,small molecule,experimental,,[H][C@](O)(CCO)[C@]([H])(O)COP(O)(O)=O,5288577
3846,DB04088,2-[{4-[(2S)-2-{[(Allyloxy)carbonyl]amino}-3-({4-[3-hydroxy-2-(methoxycarbonyl)phenoxy]butyl}amino)-3-oxopropyl]phenyl}(carboxycarbonyl)amino]benzoic acid,small molecule,experimental,,[H]N(CCCCOC1=CC=CC(O)=C1C(=O)OC)C(=O)[C@H](CC1=CC=C(C=C1)N(C(=O)C(O)=O)C1=CC=CC=C1C(O)=O)N([H])C(=O)OCC=C,10305301
3847,DB04089,AL5300,small molecule,experimental,,[H][C@]1(O)CN(CC2=CC=CS2)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,4369103
3848,DB04090,RH-1,small molecule,experimental|investigational,,CC1=C(N2CC2)C(=O)C(CO)=C(N2CC2)C1=O,394347
3849,DB04092,Apstatin,small molecule,experimental,"Amino Acids, Peptides, and Proteins",C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1)C(N)=O,447280
3850,DB04093,Undecanal,small molecule,experimental,,[H]C(=O)CCCCCCCCCC,8186
3851,DB04094,4-hydroxybutan-2-one,small molecule,experimental,Ketones,CC(=O)CCO,111509
3852,DB04095,9-Deazahypoxanthine,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Purines|Purinones",O=C1NC=NC2=C1NC=C2,446221
3853,DB04096,"(2R,3R,4R,5R)-4,5-Dihydroxy-2-(hydroxymethyl)-6-oxo-3-piperidinyl beta-D-glucopyranoside",small molecule,experimental,,[H]N1[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)C1=O,447325
3854,DB04097,Uridine-5'-diphosphate-4-deoxy-4-fluoro-alpha-D-galactose,small molecule,experimental,,[H]N1C(=O)C=CN([C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)O[C@H]3O[C@H](CO)[C@@]([H])(F)[C@H](O)[C@H]3O)[C@@H](O)[C@H]2O)C1=O,448872
3855,DB04098,Balanol,small molecule,experimental,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Cyclic AMP-Dependent Protein Kinases, antagonists & inhibitors|Hydroxy Acids|Phenols|Protein Kinase C, antagonists & inhibitors",OC(=O)C1=CC=CC(O)=C1C(=O)C1=C(O)C=C(C=C1O)C(=O)O[C@@H]1CCCNC[C@@H]1NC(=O)C1=CC=C(O)C=C1,44308490
3856,DB04099,Deamido-Nad+,small molecule,experimental,,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)[N+]4=CC=CC(=C4)C(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1,165491
3857,DB04100,"(1,10 Phenanthroline)-(Tri-Carbon Monoxide) Rhenium (I)",small molecule,experimental,,[O]#C[Re+]1(C#[O])(C#[O])[N]2=CC=CC3=C2C2=C(C=CC=[N]12)C=C3,446592
3858,DB04101,"N'-[4-(2,4-Dimethyl-1,3-thiazol-5-yl)-2-pyrimidinyl]-N-hydroxyimidoformamide",small molecule,experimental,,CC1=NC(C)=C(S1)C1=NC(\N=C\NO)=NC=C1,9547884
3859,DB04102,2-Amino-Adenosine,small molecule,experimental,,[H][C@]1(CO)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(N)[C@]1([H])O,447594
3860,DB04103,3-Methylcytosine,small molecule,experimental,Pyrimidines|Pyrimidinones,C[N+]1=C(N)C=CNC1=O,4469987
3861,DB04104,3-Methyladenine,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Purines",CN1C=NC(N)=C2N=CN=C12,1673
3862,DB04105,N-Heptylformamide,small molecule,experimental,,CCCCCCCNC=O,347402
3863,DB04106,Fotemustine,small molecule,investigational,Alkylating Drugs|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Nitroso Compounds|Nitrosoureas,CCOP(=O)(OCC)[C@@H](C)NC(=O)N(CCCl)N=O,46936889
3864,DB04107,[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester,small molecule,experimental,,CCOC(=O)CO\N=C(\C1=CC=CC=N1)C1(CC1)C1=CC=C2N(C)C(CNC3=CC=C(C=C3)C(N)=N)=NC2=C1,9600423
3865,DB04108,"(2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide",small molecule,experimental,,[H][C@](N)(CCSCC)[C@]([H])(O)C(=O)N[C@@]([H])(C)C1=C2C=CC=CC2=CC=C1,5287684
3866,DB04109,"[4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine",small molecule,experimental,,NC(=[NH2+])C1=CC=C(COB2OCCO2)C=C1,5289339
3867,DB04110,2-Nitro-4-cresol,small molecule,experimental,Benzene Derivatives|Phenols,CC1=CC=C(O)C(=C1)[N+]([O-])=O,8391
3868,DB04111,Balhimycin,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Carbohydrates|Glycoconjugates|Glycopeptides|Peptides",CNC(CC(C)C)C(=O)NC1C(O)C2=CC=C(OC3=C(OC4OC(CO)C(O)C(O)C4O)C4=CC(=C3)C(NC(=O)C(CC(N)=O)NC1=O)C(=O)NC1C3=CC=C(O)C(=C3)C3=C(C=C(O)C=C3O)C(NC(=O)C(NC1=O)C(OC1CC(C)(N)C(=O)C(C)O1)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,445877
3869,DB04112,(2R)-2-Acetamido-3-(octadecyloxy)propyl 2-(methylsulfanyl)ethyl hydrogen phosphate,small molecule,experimental,,[H]N([C@H](COCCCCCCCCCCCCCCCCCC)COP(O)(=O)OCCSC)C(C)=O,5288635
3870,DB04113,N-Formylpiperidine,small molecule,experimental,"Alcohol Dehydrogenase, antagonists & inhibitors",[H]C(=O)N1CCCCC1,17429
3871,DB04114,"3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine",small molecule,experimental,,[H][C@]12CC3=C(C(N)=C4C=CC(Cl)=CC4=N3)[C@]([H])(CC(CC)=C1)C2,5288588
3872,DB04115,Berberine,small molecule,approved|investigational,"Alkaloids|Benzylisoquinolines|Berberine Alkaloids|Heterocyclic Compounds, Fused-Ring|Isoquinolines",COC1=CC=C2C=C3C4=CC5=C(OCO5)C=C4CC[N+]3=CC2=C1OC,2353
3873,DB04116,Allolactose,small molecule,experimental,Carbohydrates|Disaccharides|Oligosaccharides|Polysaccharides,OC[C@H]1O[C@@H](OC[C@H]2OC(O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@H]1O,6454902
3874,DB04117,"4-(N,N-Dimethylamino)cinnamoyl-CoA",small molecule,experimental,,[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)N([H])CCC(=O)N([H])CCSC(=O)\C=C\C4=CC=C(C=C4)N(C)C)[C@@H](OP(O)(O)=O)[C@H]3O)C2=NC=N1,445461
3875,DB04118,N-Coeleneterazine,small molecule,experimental,,[H][C@@]1(CC2=CC=CC=C2)NC(=CN2C(=O)[C@](CC3=CC4=CC=CC=C4C=C3)(OO)N=C12)C1=CC=C(O)C=C1,49866868
3876,DB04119,Hexatantalum Dodecabromide,small molecule,experimental,,Br.Br.Br.Br.Br.Br.Br.Br.Br.Br.Br.[Br-].[Ta].[Ta].[Ta].[Ta].[Ta].[Ta+],131704268
3877,DB04120,"4-Methyl-1,2-Benzenediol",small molecule,experimental,,CC1=CC=C(O)C(O)=C1,9958
3878,DB04121,Guanosine-3'-monophosphate-5'-diphosphate,small molecule,experimental,,NC1=NC(=O)C2=C(N1)N(C=N2)[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H]1O,188347
3879,DB04122,beta-D-glucose 6-phosphate,small molecule,experimental,,O[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O,439427
3880,DB04123,(P-Iodophenylacetylamino)Methylphosphinic Acid,small molecule,experimental,,[H][P@](O)(=O)CNC(=O)CC1=CC=C(I)C=C1,1290
3881,DB04124,Aurodox,small molecule,experimental,"Alkenes|Anti-Bacterial Agents|Anti-Infective Agents|Hydrocarbons, Acyclic|Polyenes",[H][C@@]1(O[C@@]([H])([C@H](C)[C@H](OC)C(\C)=C\C=C\CNC(=O)[C@@H](CC)[C@@]2(O)O[C@@H](\C=C\C=C/C)C(C)(C)[C@@H](O)[C@H]2O)[C@@H](O)[C@H]1O)\C=C\C=C\C=C(/C)C(=O)C1=C(O)C=CN(C)C1=O,54688679
3882,DB04125,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine,small molecule,experimental,,CC(=O)N1CCN(CC1)C(=O)[C@H](CC1=CC=CC(=C1)C(N)=N)NS(=O)(=O)C1=CC=C2C=CC=CC2=C1,178051
3883,DB04126,N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane,small molecule,experimental,,[H][C@](O)(CC(O)=O)C(=O)N[C@@]([H])(CC(C)C)C(=O)NCCC(C)C,5288147
3884,DB04127,beta-D-arabinofuranose 5-phosphate,small molecule,experimental,,[H][C@@]1(O)O[C@]([H])(COP(O)(O)=O)[C@@]([H])(O)[C@]1([H])O,447568
3885,DB04128,"5-Nitroso-6-ribityl-amino-2,4(1H,3H)-pyrimidinedione",small molecule,experimental,,[H]N(C[C@H](O)[C@H](O)[C@H](O)CO)C1=C(N=O)C(=O)N([H])C(=O)N1[H],6323394
3886,DB04129,Willardiine,small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins|Pyrimidines|Pyrimidinones",NOC(=O)CCN1C=CC(=O)NC1=O,440053
3887,DB04130,5-Methoxybenzimidazole,small molecule,experimental,,COC1=CC2=C(C=C1)N=CN2,78598
3888,DB04131,"10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione",small molecule,experimental,,[H][C@@]1(C[C@]([H])(N(C)C)[C@]([H])(O)[C@]([H])(C)O1)O[C@@]1([H])C[C@](O)(CC)CC2=CC3=C(C(O)=C12)C(=O)C1=C(C=CC=C1O)C3=O,5287662
3889,DB04132,S-Hexylglutathione,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Enzyme Inhibitors|Lactoylglutathione Lyase, antagonists & inhibitors|Oligopeptides|Peptides",CCCCCCSC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O,97536
3890,DB04133,Degraded Cephaloridine,small molecule,experimental,,[H][C@@](NC(=O)CC1=CC=CS1)(C=O)[C@]1([H])NC(C(O)=O)=C(C)CS1,5287902
3891,DB04135,"(4S)-5-Fluoro-4-hydroxy-3,4-dihydro-2(1H)-pyrimidinone",small molecule,experimental,,[H]N1C=C(F)[C@H](O)N([H])C1=O,448302
3892,DB04136,Lysophosphotidylserine,small molecule,experimental,,[H][C@@](O)(CO[C@@]([H])(O)CCCCCCCCCCCCCC)COP(O)(=O)OC[C@]([H])(N)C(O)=O,17754066
3893,DB04137,Guanosine-5'-Triphosphate,small molecule,experimental,,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,6830
3894,DB04138,"5-[Bis(2-bromoethyl)amino]-N-(2,3-dioxopropyl)-2,4-dinitrobenzamide",small molecule,experimental,,[H]N(CC(=O)C=O)C(=O)C1=CC(N(CCBr)CCBr)=C(C=C1[N+]([O-])=O)[N+]([O-])=O,5287756
3895,DB04139,6-Hydroxypropylthymine,small molecule,experimental,,CC1=C(CCCO)NC(=O)NC1=O,1865
3896,DB04140,1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide,small molecule,experimental,,[H][C@@]1(CC(=O)N(CC2=CC=CC=C2)CN1S(=O)(=O)C1=CC=C(OC)C=C1)C(=O)NO,445018
3897,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",small molecule,experimental,,[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCC)[C@]1([H])O,447027
3898,DB04142,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide",small molecule,experimental,,CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=C(C=C2)S(=O)(=O)N(C)C,448660
3899,DB04143,Indole-3-Glycerol Phosphate,small molecule,experimental,"Alcohols|Carbohydrates|Compounds used in a research, industrial, or household setting|Indicators and Reagents|Laboratory Chemicals|Lipids|Membrane Lipids|Phospholipids|Sugar Alcohols|Sugar Phosphates|Triose Sugar Alcohols",[H][C@@](O)(COP(O)(O)=O)[C@@]([H])(O)C1=CNC2=C1C=CC=C2,444150
3900,DB04144,"Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone",small molecule,experimental,,[H][C@]1(N=C(N(C(=O)N2CCNCC2)[C@]1([H])C1=CC=C(Cl)C=C1)C1=C(OC(C)C)C=C(OC)C=C1)C1=CC=C(Cl)C=C1,49867154
3901,DB04145,Nicotinyl alcohol,small molecule,experimental,"Cardiovascular Agents|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Nicotinic Acid and Derivatives|Peripheral Vasodilators|Pyridines|Vasodilating Agents",OCC1=CC=CN=C1,7510
3902,DB04146,I-Coeleneterazine,small molecule,experimental,,[H][C@]1(CC2=CC=CC=C2)NC(=CN2C(=O)[C@](CC3=CC=C(I)C=C3)(OO)N=C12)C1=CC=C(O)C=C1,49866867
3903,DB04147,Dodecyldimethylamine N-oxide,small molecule,experimental,"Amines|Compounds used in a research, industrial, or household setting|Detergents|Household Products|Methylamines|Surface-Active Agents",CCCCCCCCCCCC[N+](C)(C)[O-],15433
3904,DB04149,(R)-Rolipram,small molecule,experimental,,[H][C@]1(CNC(=O)C1)C1=CC(OC2CCCC2)=C(OC)C=C1,448055
3905,DB04150,"N-alpha-Acetyl-3,5-diiodotyrosyl-D-threonine",small molecule,experimental,,[H]N([C@@H](CC1=CC(I)=C(O)C(I)=C1)C(=O)N([H])[C@H]([C@@H](C)O)C(O)=O)C(C)=O,5288651
3906,DB04151,1-Methylhistidine,small molecule,experimental,"Amino Acids|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins",CN1C=NC(C[C@H](N)C(O)=O)=C1,92105
3907,DB04152,"2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid",small molecule,experimental,,N[C@@H](CC1=CCCCC2=C1C(=O)NO2)C(O)=O,5288598
3908,DB04153,S-Hydroxymethyl Glutathione,small molecule,experimental,,N[C@@H](CCC(=O)N[C@@H](CSCO)C(=O)NCC(O)=O)C(O)=O,447123
3909,DB04154,"N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide",small molecule,experimental,,CN(C(C)=O)C1=CC=CC(=C1)C1=NN=C2C=CC(=NN12)C1=CC=CC=C1,5287936
3910,DB04155,2-Fluoro-2-Deoxy-Beta-D-Galactopyranosyl-Beta-D-Glucopyranose,small molecule,experimental,,[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(O[C@]2([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]2([H])F)[C@]([H])(O)[C@@]1([H])O,446584
3911,DB04156,Aspartate Beryllium Trifluoride,small molecule,experimental,,N[C@@H](C[C@H](O)O[Be](F)(F)F)C(O)=O,46936905
3912,DB04157,N-[(Aminooxy)Carbonyl]Aniline,small molecule,experimental,,NOC(=O)NC1=CC=CC=C1,448926
3913,DB04158,"6-(adenosine tetraphosphate-methyl)-7,8-dihydropterin",small molecule,experimental,,[H]N([H])C1=NC(=O)C2=C(N([H])CC(COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)N3C=NC4=C(N=CN=C34)N([H])[H])=N2)N1[H],6323200
3914,DB04159,Beta-Hydroxytryptophane,small molecule,experimental,,[H][C@@](N)(C(O)=O)[C@@]([H])(O)C1=CNC2=CC=CC=C12,6857734
3915,DB04160,Pyrophosphoric acid,small molecule,approved|experimental,"Acids|Acids, Noncarboxylic|Anions|Electrolytes|Ions|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Polyphosphates",OP(O)(=O)OP(O)(O)=O,1023
3916,DB04161,Propionamide,small molecule,experimental,,CCC(N)=O,6578
3917,DB04162,"5-Nitro-6-ribityl-amino-2,4(1H,3H)-pyrimidinedione",small molecule,experimental,,[H]N(C[C@H](O)[C@H](O)[C@H](O)CO)C1=C(C(=O)N([H])C(=O)N1[H])[N+]([O-])=O,446835
3918,DB04163,"5-Phenylsulfanyl-2,4-Quinazolinediamine",small molecule,experimental,,NC1=NC2=C(C(N)=N1)C(SC1=CC=CC=C1)=CC=C2,446244
3919,DB04164,"1,4-Deoxy-4-((5-Hydroxymethyl-2,3,4-Trihydroxycyclohex-5-Enyl)Amino)Fructose",small molecule,experimental,,[H][C@]1(O)OC(=C)[C@@]([H])(N[C@@]2([H])C=C(C=O)C(=O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O,129856752
3920,DB04165,Valpromide,small molecule,experimental,"Acids, Acyclic|Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Fatty Acid Derivatives|Fatty Acids|Fatty Acids, Volatile|Lipids|Nervous System|Pentanoic Acids|Valerates",CCCC(CCC)C(N)=O,71113
3921,DB04166,Anthranilic acid,small molecule,experimental,"Acids, Carbocyclic|Aminobenzoates|Benzene Derivatives|Benzoates|Central Nervous System Agents",NC1=CC=CC=C1C(O)=O,227
3922,DB04167,Aceglutamide,small molecule,experimental,"Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins",CC(=O)N[C@@H](CCC(N)=O)C(O)=O,182230
3923,DB04168,Bropirimine,small molecule,experimental,"Adjuvants, Immunologic|Antineoplastic Agents|Immunologic Factors|Interferon Inducers|Pyrimidines|Pyrimidinones",NC1=NC(=O)C(Br)=C(N1)C1=CC=CC=C1,65457
3924,DB04169,"3,5-Diaminophthalhydrazide",small molecule,experimental,,NC1=CC(N)=C2C(=O)NNC(=O)C2=C1,1616
3925,DB04170,4-bromo-3-hydroxy-3-methyl butyl diphosphate,small molecule,experimental,,C[C@](O)(CBr)CCO[P@](O)(=O)OP(O)(O)=O,448012
3926,DB04171,D-Isovaline,small molecule,experimental,,CC[C@@](C)(N)C(O)=O,2724877
3927,DB04172,"[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine",small molecule,experimental,,[H][C@@](CC1=CC(=CC=C1)C(N)=N)(NS(=O)(=O)C1=C(C=C(C=C1C(C)C)C(C)C)C(C)C)C(=O)N1CCN(CC1)C(=O)CCN,5289531
3928,DB04173,Fructose,small molecule,approved|experimental,"Carbohydrates|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Flavoring Agents|Food|Food Additives|Food and Beverages|Food Ingredients|Fructose|General Nutrients|Hexoses|Ketoses|Monosaccharides|Pharmaceutic Aids|Pharmaceutical Preparations|Physiological Phenomena|Sweetening Agents",OC[C@@H]1O[C@@](O)(CO)[C@H](O)[C@H]1O,439553
3929,DB04174,3'-1-carboxy-1-phosphonooxy-ethoxy-uridine-diphosphate-N-acetylglucosamine,small molecule,experimental,,[H]N([C@H]1[C@@H](OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)N([H])C2=O)O[C@H](CO)[C@@H](O)[C@@H]1OC(C)(OP(O)(O)=O)C(O)=O)C(C)=O,448003
3930,DB04175,Mdl-29951,small molecule,experimental,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Heterocyclic Compounds, Fused-Ring|Lipids",OC(=O)CCC1=C(NC2=C1C(Cl)=CC(Cl)=C2)C(O)=O,446916
3931,DB04176,"Phosporic Acid Mono-[3,4-Dihydroxy-5-(5-Methoxy-Benzoimidazol-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester",small molecule,experimental,,[H][C@]1(COP(O)(O)=O)O[C@]([H])(N2C=NC3=C2C=CC(OC)=C3)[C@]([H])(O)[C@]1([H])O,446492
3932,DB04177,Digitoxigenin,small molecule,experimental,Carbohydrates|Cardanolides|Cardenolides|Cardiac Glycosides|Digitalis Glycosides|Fused-Ring Compounds|Glycosides|Steroids,[H][C@]12CC[C@]3([H])[C@]([H])(CC[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@H](O)C2,4369270
3933,DB04178,Di-Stearoyl-3-Sn-Phosphatidylcholine,small molecule,experimental,,[H][C@@](COC(=O)CCCCCCCCCCCCCCCCC)(COP(O)(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,94191
3934,DB04179,Benzofuran,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring",O1C=CC2=CC=CC=C12,9223
3935,DB04180,"4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide",small molecule,experimental,,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=C(F)C=C(F)C=C1,446238
3936,DB04182,"(S)-2-Amino-4-[(2s,3r)-2,3,5-Trihydroxy-4-Oxo-Pentyl]Mercapto-Butyric Acid",small molecule,experimental,,[H][C@](N)(CCSC[C@@]([H])(O)[C@@]([H])(O)C(=O)CO)C(O)=O,5288675
3937,DB04183,Methylmalonic Acid,small molecule,experimental,"Acids, Acyclic|Dicarboxylic Acids|Malonates",CC(C(O)=O)C(O)=O,487
3938,DB04185,Norvaline,small molecule,experimental,"Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins",CCC[C@H](N)C(O)=O,65098
3939,DB04186,"N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea",small molecule,experimental,,[H][C@]12CCCN1C(=O)C1=C2C(NC(=O)NC2=CC=CC=N2)=CC=C1,445840
3940,DB04187,"(9S,10S)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene",small molecule,experimental,,[H]N([H])[C@@H](CCC(=O)N([H])[C@@H](CS[C@]1([H])[C@@H](O)C2=CC=CC=C2C2=CC=CC=C12)C(=O)N([H])CC(O)=O)C(O)=O,444461
3941,DB04188,MDL72527,small molecule,experimental,"Amines|Biogenic Amines|Biogenic Polyamines|Diamines|Oxidoreductases Acting on CH-NH Group Donors, antagonists & inhibitors|Polyamines",C=C=CCNCCCCNCC=C=C,4026
3942,DB04189,N(2)-(2-carboxyethyl)-L-arginine,small molecule,experimental,"Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins",NC(=N)NCCC[C@H](NCCC(O)=O)C(O)=O,446475
3943,DB04190,"2,5-dibenzyloxy-3-hydroxy-hexanedioic acid bis-[(2-hydroxy-indan-1-yl)-amide]",small molecule,experimental,,O[C@H](C[C@@H](OCC1=CC=CC=C1)C(=O)N[C@@H]1[C@H](O)CC2=CC=CC=C12)[C@@H](OCC1=CC=CC=C1)C(=O)N[C@@H]1[C@H](O)CC2=CC=CC=C12,444974
3944,DB04191,Skf 107457,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Peptides",[H][C@@](C)(N)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CC1=CC=CC=C1)[C@@]([H])(O)CCC(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(C(C)C)C(=O)OC,444196
3945,DB04193,L-Homoserine,small molecule,experimental,,N[C@@H](CCO)C(O)=O,12647
3946,DB04194,Triacetylchitotriose,small molecule,experimental,,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3NC(C)=O)[C@H](O)[C@H]2NC(C)=O)[C@@H]1O,444514
3947,DB04195,Heptulose-2-Phosphate,small molecule,experimental,,C[C@]1(OP(O)(O)=O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,124823
3948,DB04196,Pteroic acid,small molecule,experimental,"Biological Factors|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Pteridines",NC1=NC2=NC=C(CNC3=CC=C(C=C3)C(O)=O)N=C2C(=O)N1,95054
3949,DB04197,Descarboxy-nor-N(Omega)-Hydroxy-L-Arginine,small molecule,experimental,,N\C(NO)=N/CCC[NH3+],5287648
3950,DB04198,Formycin B,small molecule,experimental,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",[H][C@]1(CO)O[C@@]([H])(C2=C3N=CNC(=O)C3=NN2)[C@]([H])(O)[C@]1([H])O,72443
3951,DB04199,1-Monohexanoyl-2-Hydroxy-Sn-Glycero-3-Phosphate,small molecule,experimental,,[H][C@](O)(COC(=O)CCCCC)COP(O)(O)=O,657119
3952,DB04200,Matairesinol,small molecule,experimental,Benzene Derivatives|Benzyl Compounds|Plants,[H][C@]1(CC2=CC=C(O)C(OC)=C2)COC(=O)[C@]1([H])CC1=CC=C(O)C(OC)=C1,119205
3953,DB04201,Histidyl-Adenosine Monophosphate,small molecule,experimental,,[H][C@](N)(CC1=CN=CN1)C(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,444222
3954,DB04202,Isoformononetin,small molecule,experimental,,COC1=CC=C2C(=O)C(=COC2=C1)C1=CC=C(O)C=C1,3764
3955,DB04203,3-Mercuri-4-Aminobenzenesulfonamide,small molecule,experimental,,NC1=CC=C(C=C1[Hg])S(N)(=O)=O,193512
3956,DB04204,[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid,small molecule,experimental,,OP(O)(=O)C(F)(F)C1=CC=C(CCCCC2=CC=C(C=C2)C(F)(F)P(O)(O)=O)C=C1,446665
3957,DB04205,"Thymidine-3',5'-Diphosphate",small molecule,experimental,,[H][C@@]1(C[C@@]([H])(O[C@]1([H])COP(O)(O)=O)N1C=C(C)C(=O)NC1=O)OP(O)(O)=O,121976
3958,DB04206,7-Aza-L-tryptophan,small molecule,experimental,,N[C@@H](CC1=CNC2=NC=CC=C12)C(O)=O,7000165
3959,DB04207,L-Saccharopine,small molecule,experimental,"Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins",N[C@@H](CCCCN[C@@H](CCC(O)=O)C(O)=O)C(O)=O,160556
3960,DB04208,"3-(3,4-dimethoxyphenyl)propanoic acid",small molecule,experimental,,COC1=C(OC)C=C(CCC(O)=O)C=C1,75019
3961,DB04209,Dequalinium,small molecule,approved|investigational,"Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Heterocyclic Compounds, Fused-Ring|Miscellaneous Anti-infectives|Quinoline Derivatives|Quinolines|Quinolinium Compounds|Throat Preparations",CC1=CC(N)=C2C=CC=CC2=[N+]1CCCCCCCCCC[N+]1=C(C)C=C(N)C2=C1C=CC=C2,2993
3962,DB04210,"3-(alpha-D-galactopyranosyloxy)-N-(3-{4-[3-({2-[(3-{4-[3-({[3-(hexopyranosyloxy)-5-nitrophenyl]carbonyl}amino)propyl]piperazin-1-yl}propyl)amino]-3,4-dioxocyclobut-1-en-1-yl}amino)propyl]piperazin-1-yl}propyl)-5-nitrobenzamide",small molecule,experimental,,OCC1OC(OC2=CC(=CC(=C2)[N+]([O-])=O)C(=O)NCCCN2CCN(CCCNC3=C(NCCCN4CCN(CCCNC(=O)C5=CC(=CC(O[C@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)=C5)[N+]([O-])=O)CC4)C(=O)C3=O)CC2)C(O)C(O)C1O,131704269
3963,DB04211,"5-(acetylamino)-3,5-dideoxy-3-fluoro-D-erythro-alpha-L-manno-non-2-ulopyranosonic acid",small molecule,experimental,,[H][C@]1(O[C@@](O)([C@H](F)[C@H](O)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,448471
3964,DB04212,2-Iminiopropanoate,small molecule,experimental,,CC(=[NH2+])C([O-])=O,5288980
3965,DB04213,N-Cyclohexyl-N'-(Propyl)Phenyl Urea,small molecule,experimental,,O=C(NCCCC1=CC=CC=C1)NC1CCCCC1,4358
3966,DB04214,4-Nitrophenyl Phosphate,small molecule,experimental,"Benzene Derivatives|Chromogenic Compounds|Coloring Agents|Compounds used in a research, industrial, or household setting|Indicators and Reagents|Laboratory Chemicals|Nitro Compounds|Phenols",OP(O)(=O)OC1=CC=C(C=C1)[N+]([O-])=O,378
3967,DB04215,CRA_9076,small molecule,experimental,,CC1=CC(Br)=C([O-])C(=C1)C1=CC2=CC(=CC=C2N1)C(N)=[NH2+],447508
3968,DB04216,Quercetin,small molecule,experimental|investigational,"Antioxidants|BCRP/ABCG2 Inhibitors|Benzopyrans|Chromones|Compounds used in a research, industrial, or household setting|COMT Inhibitors|COMT Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Flavonoids|Flavonols|Heterocyclic Compounds, Fused-Ring|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein inhibitors|Protective Agents|Pyrans",OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1,5280343
3969,DB04217,L-2-amino-3-butynoic acid,small molecule,experimental,"Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Butyrates|Fatty Acids|Fatty Acids, Volatile|Lipids",N[C@@H](C#C)C(O)=O,175496
3970,DB04218,1-Deaza-Adenosine,small molecule,experimental,,[H][C@]1(CO)O[C@@]([H])(N2C=NC3=C(N)C=CN=C23)[C@]([H])(O)[C@]1([H])O,159738
3971,DB04219,Trivanadate,small molecule,experimental,Vanadates,O[V](=O)(O[V]([O-])=O)O[V](=O)=O,131704270
3972,DB04220,CGP 4832,small molecule,experimental,"Amides|Heterocyclic Compounds, Fused-Ring|Lactams|Lactams, Macrocyclic",CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(=O)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)CC(=O)OCC3CCCN(C)C3)[C@@H]1C)=C(N1CCOCC1)C2=O,131704272
3973,DB04221,Didecyldimethylammonium,small molecule,approved|experimental,Amines|Ammonium Compounds|Antiseptics and Disinfectants|Dermatologicals|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds,CCCCCCCCCC[N+](C)(C)CCCCCCCCCC,16958
3974,DB04222,Sparsomycin,small molecule,experimental,"Antibiotics, Antineoplastic|Antineoplastic Agents|Enzyme Inhibitors|Protein Synthesis Inhibitors|Pyrimidines|Pyrimidinones",CSC[S@+]([O-])C[C@H](CO)NC(=O)\C=C\C1=C(C)NC(=O)NC1=O,9543443
3975,DB04223,Nitroarginine,small molecule,experimental|investigational,"Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Arginine|Enzyme Inhibitors",N[C@@H](CCCNC(=N)N[N+]([O-])=O)C(O)=O,440005
3976,DB04224,Oleic Acid,small molecule,approved|investigational|vet_approved,"Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Lipids|Oleic Acids",CCCCCCCC\C=C\CCCCCCCC(O)=O,637517
3977,DB04225,N-Methyldehydrobutyrine,small molecule,experimental,,CN\C(=C/C)C(O)=O,17754075
3978,DB04226,Dihydro-Acarbose,small molecule,experimental,,[H][C@]1(CO)C[C@]([H])(N[C@]2([H])[C@@]([H])(C)O[C@]([H])(O[C@@]3([H])[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(O[C@@]4([H])[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(O)O[C@]4([H])CO)O[C@]3([H])CO)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O,4369025
3979,DB04227,"9-Amino-2-deoxy-2,3-dehydro-n-acetyl-neuraminic acid",small molecule,experimental,,[H]N([H])C[C@@H](O)[C@@H](O)[C@]1([H])OC(=C[C@H](O)[C@H]1N([H])C(C)=O)C(O)=O,445534
3980,DB04228,Dihydroxyphenylglycine,small molecule,experimental,Alcohols|Ethylene Glycols|Glycols,N[C@H](C(O)=O)C1=CC(O)=CC(O)=C1,443586
3981,DB04229,"7,10,13-Tri(Carboxymethyl)-5,15-Dioxo-4,7,10,13,16-Pentaaza-1,19-Dithianonadecane",small molecule,experimental,,OC(=O)CN(CCN(CC(O)=O)CC(=O)NCCS)CCN(CC(O)=O)CC(=O)NCCS,5289611
3982,DB04230,Nitromethyldethia coenzyme A,small molecule,experimental,,[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)N([H])CCC(=O)N([H])CCC[N+]([O-])=O)[C@@H](OP(O)(O)=O)[C@H]3O)C2=NC=N1,5289039
3983,DB04231,Tetra(Imidazole)Diaquacopper (I),small molecule,experimental,,[OH2+][Cu-4]([OH2+])([N]1=CNC=C1)([N+]1=CNC=C1)([N+]1=CNC=C1)[N+]1=CNC=C1,131704273
3984,DB04232,N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide,small molecule,experimental,,[H][C@@]1(CN(CCN1S(=O)(=O)C1=CC=C(OC)C=C1)C(=O)OCC1=CC=CC=C1)C(=O)NO,5289389
3985,DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,small molecule,experimental,,CCCCCCCCOCCOCCOCCOCCO,5414
3986,DB04234,N2-({[(4-Bromophenyl)Methyl]Oxy}Carbonyl)-N1-[(1s)-1-Formylpentyl]-L-Leucinamide,small molecule,experimental,,[H][C@@](CCCC)(NC(=O)[C@]([H])(CC(C)C)NC(=O)OCC1=CC=C(Br)C=C1)C=O,5288867
3987,DB04235,4-Amino Hexanoic Acid,small molecule,experimental,,[H][C@@](N)(CC)CCC(O)=O,5289553
3988,DB04236,2-Amino-3-(1h-Indol-3-Yl)-Propan-1-Ol,small molecule,experimental,,[H][C@@](N)(CO)CC1=CNC2=CC=CC=C12,6951149
3989,DB04237,Tris(Hydroxyethyl)Aminomethane,small molecule,experimental,,NC(CCO)(CCO)CCO,448009
3990,DB04238,N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid,small molecule,experimental,,[H][C@@](CC1=CC(=CC=C1)C(N)=N)(NS(=O)(=O)C1=CC2=CC=CC=C2C=C1)C(=O)N1CCCC[C@]1([H])C(O)=O,446604
3991,DB04239,2-Amino-6-Aminomethyl-8-Phenylsulfanylmethyl-3h-Quinazolin-4-One,small molecule,experimental,,NCC1=CC(CSC2=CC=CC=C2)=C2N=C(N)NC(=O)C2=C1,6323390
3992,DB04240,"(1S)-1-C-{(2R)-6-[(2R)-2-Butanyl]-5,10-dihydroxy-4-oxo-1,2,3,4-tetrahydro-2-anthracenyl}-5-deoxy-1-O-methyl-D-xylulose",small molecule,experimental,,CC[C@@H](C)C1=C(O)C2=C(O)C3=C(C[C@H](CC3=O)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)C=C2C=C1,5288133
3993,DB04241,N-Pyridoxyl-2-Methylalanine-5-Phosphate,small molecule,experimental,,CC1=NC=C(COP(O)(O)=O)C(CNC(C)(C)C(O)=O)=C1O,445009
3994,DB04242,4-hydroxybenzoic acid,small molecule,experimental,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Hydroxy Acids|Hydroxybenzoates|Phenols",OC(=O)C1=CC=C(O)C=C1,135
3995,DB04243,TMP,small molecule,experimental,"Carbohydrates|Deoxyribonucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Thymine Nucleotides",CC1=CN([C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)NC1=O,12803287
3996,DB04244,(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide,small molecule,experimental,,[H]N(C[C@@H](O)CN([H])S(=O)(=O)C1=CC=CC=N1)C(=O)[C@H](CC(C)C)C1=CC=CC(=C1)C1=CC=CC=C1,5288593
3997,DB04246,CRA_23653,small molecule,experimental,,NC(=N)C1=CC2=C(C=C1)N=C(N2)C1=CC(CC[NH3+])=CC(=C1O)C1=CC=CC=C1,17753797
3998,DB04248,beta-(1->4)-galactotriose,small molecule,experimental,,[H][C@@]1(O)O[C@]([H])(CO)[C@]([H])(O[C@]2([H])O[C@]([H])(CO)[C@]([H])(O[C@]3([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O,448924
3999,DB04249,Zinc Substituted Heme C,small molecule,experimental,Metal cations|Metal divalent cations|Zinc Compounds,[Zn+4].[H]\C(C)=C1\C(C)=C2[N-]\C\1=C([H])/C1=C(C)C(=C([H])C)\C([N-]1)=C([H])\C1=C(C)C(CCC(O)=O)=C([N-]1)\C([H])=C1/[N-]\C(=C/2\[H])C(C)=C1CCC(O)=O,131704274
4000,DB04250,Butyrylthiocholine,small molecule,experimental,Alcohols|Amines|Amino Alcohols|Ammonium Compounds|Cholinesterase substrates|Ethanolamines|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds|Sulfhydryl Compounds|Sulfur Compounds|Thiocholine|Trimethyl Ammonium Compounds,CCCC(=O)SCC[N+](C)(C)C,20689
4001,DB04252,N-Carbamoylaspartic acid,small molecule,experimental,"Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Excitatory Amino Acids",NC(=O)N[C@@H](CC(O)=O)C(O)=O,93072
4002,DB04253,Tretazicar,small molecule,investigational,Antineoplastic Agents|Azirines|Prodrugs|Radiation-Sensitizing Agents,NC(=O)C1=CC(N2CC2)=C(C=C1[N+]([O-])=O)[N+]([O-])=O,89105
4003,DB04254,"8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine",small molecule,experimental,,CCCCN1C(CC2=CC3=C(OCO3)C=C2)=NC2=C(N)N=C(F)N=C12,448976
4004,DB04255,Inhibitor BEA388,small molecule,experimental,,CNC(=O)[C@@H](NC(=O)[C@H](OCC1=CC=CC=C1)[C@H](O)[C@@H](O)[C@@H](OCC1=CC=CC=C1)C(=O)N[C@@H]1[C@H](O)CC2=CC=CC=C12)C(C)C,445305
4005,DB04256,(S)-alpha-methyl-4-carboxyphenylglycine,small molecule,experimental,,C[C@@](N)(C(O)=O)C1=CC=C(C=C1)C(O)=O,446355
4006,DB04257,Palmitoleic Acid,small molecule,experimental,"Fatty Acids|Fatty Acids, Unsaturated|Lipids",CCCCCC\C=C/CCCCCCCC(O)=O,445638
4007,DB04258,Seocalcitol,small molecule,investigational,Antineoplastic Agents|Cholestanes|Cholestenes|Fused-Ring Compounds|Immunologic Factors|Immunosuppressive Agents|Lipids|Membrane Lipids|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble),[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\C=C\C(O)(CC)CC,20055510
4008,DB04259,"7-Methyl-7,8-dihydroguanosine 5'-(dihydrogen phosphate)",small molecule,experimental,,[H]N([H])C1=NC(=O)C2=C(N1[H])N(CN2C)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O,165838
4009,DB04260,"9-(5,5-Difluoro-5-Phosphonopentyl)Guanine",small molecule,experimental,,NC1=NC2=C(N=CN2CCCCC(F)(F)P(O)(O)=O)C(=O)N1,448999
4010,DB04261,Carbamic Acid,small molecule,experimental,"Acids, Acyclic",NC(O)=O,277
4011,DB04262,3-(7-hydroxy-8-ribityllumazine-6-yl) propionic acid,small molecule,experimental,,[H][C@@](O)(CO)[C@@]([H])(O)[C@@]([H])(O)CN1C(O)=C(CCC(O)=O)N=C2C(O)=NC(=O)N=C12,
4012,DB04263,Geneticin,small molecule,experimental,Agents that produce neuromuscular block (indirect)|Amebicides|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Carbohydrates|Coccidiostats|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Glycosides|Narrow Therapeutic Index Drugs|Nephrotoxic agents,[H][C@](C)(O)[C@@]1([H])O[C@]([H])(O[C@]2([H])[C@@]([H])(N)C[C@@]([H])(N)[C@]([H])(O[C@@]3([H])OC[C@](C)(O)[C@]([H])(NC)[C@@]3([H])O)[C@@]2([H])O)[C@]([H])(N)[C@@]([H])(O)[C@]1([H])O,123865
4013,DB04264,"(10R)-10-formyl-5,8,10-trideazafolic acid",small molecule,experimental,,[H]N([H])C1=NC(=O)C2=C(C=CC(C[C@@H](C(O)=O)C3=CC=C(C=C3)C(=O)N([H])[C@@H](CCC(O)=O)C(O)=O)=C2)N1[H],444729
4014,DB04265,N-acetyl-beta-neuraminic acid,small molecule,experimental,,CC(=O)N[C@@H]1[C@@H](O)C[C@](O)(O[C@H]1[C@H](O)[C@H](O)CO)C(O)=O,445063
4015,DB04266,"5-(6-D-ribitylamino-2,4-dihydroxypyrimidin-5-yl)-1-pentyl-phosphonic acid",small molecule,experimental,,[H]N(C[C@H](O)[C@H](O)[C@H](O)CO)C1=C(CCCCCP(O)(O)=O)C(=O)N([H])C(=O)N1[H],445357
4016,DB04267,Dipicolinic acid,small molecule,experimental,"Chelating Agents|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Procollagen-Proline Dioxygenase, antagonists & inhibitors|Pyridines|Sequestering Agents",OC(=O)C1=CC=CC(=N1)C(O)=O,10367
4017,DB04268,Methylumbelliferyl chitotriose,small molecule,experimental,,[H]N([C@H]1[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](CO)O[C@H](OC4=CC5=C(C=C4)C(C)=CC(=O)O5)[C@H](N([H])C(C)=O)[C@H]3O)[C@H](N([H])C(C)=O)[C@H]2O)O[C@H](CO)[C@@H](O)[C@@H]1O)C(C)=O,5289535
4018,DB04269,Cyclotheonamide A,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Peptides|Thrombin, antagonists & inhibitors",[H][C@@]12CCCN1C(=O)[C@H](CNC(=O)\C=C\[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C(=O)[C@H](CCCNC(N)=N)NC2=O)NC=O,5287991
4019,DB04270,(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid,small molecule,experimental,,[H][C@@](CC1=CC=C(OCCN2C3=C(C=CC=C3)C3=C2C=CC=C3)C=C1)(OCC)C(O)=O,446758
4020,DB04271,"3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",small molecule,experimental,,CCOC(=O)C1=C(C)NN=C1C,215436
4021,DB04272,Citric acid,small molecule,approved|nutraceutical|vet_approved,"Acid Preparations|Acidifying Activity|Acids, Acyclic|Alimentary Tract and Metabolism|Calcium Chelating Activity|Calcium Chelating Agents|Calculi Dissolution Agent|Chelating Agents|Citrates|Compounds used in a research, industrial, or household setting|Decreased Coagulation Factor Activity|Digestives, Incl. Enzymes|Hematologic Agents|Sequestering Agents|Tricarboxylic Acids|Urinary Acidifying Agents|Urinary Alkalinisers",OC(=O)CC(O)(CC(O)=O)C(O)=O,311
4022,DB04273,"8,9-Dichloro-2,3,4,5-Tetrahydro-1h-Benzo[C]Azepine",small molecule,experimental,,ClC1=CC=C2CCCNCC2=C1Cl,121938
4023,DB04274,(2S)-7-hydroxyflavanone,small molecule,experimental,,OC1=CC2=C(C=C1)C(=O)C[C@H](O2)C1=CC=CC=C1,688857
4024,DB04275,N-acetylserotonin,small molecule,experimental,"Amines|Autacoids|Biogenic Amines|Biogenic Monoamines|Biological Factors|Heterocyclic Compounds, Fused-Ring|Indoles|Inflammation Mediators|Tryptamines",CC(=O)NCCC1=CNC2=C1C=C(O)C=C2,903
4025,DB04276,4-[[(2S)-2-[[(2S)-3-Carboxy-2-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]butyl-(diaminomethylidene)azanium,small molecule,experimental,,CC(C)C[C@H](NC(=O)[C@@H](O)CC(O)=O)C(=O)NCCCC[NH+]=C(N)N,5288145
4026,DB04277,Fructose -6-Phosphate,small molecule,experimental,,OCC(=O)[C@@H](O)[C@@H](O)[C@H](O)COP(O)(O)=O,5459952
4027,DB04278,2-[2-(2-Cyclohexyl-2-guanidino-acetylamino)-acetylamino]-N-(3-mercapto-propyl)-propionamide,small molecule,experimental,,[H]N([H])C(=N[C@H](C1CCCCC1)C(=O)N([H])CC(=O)N([H])[C@@H](C)C(=O)N([H])CCCS)N([H])[H],5496715
4028,DB04279,3-Isopropylmalic Acid,small molecule,experimental,,CC(C)C(C(O)C(O)=O)C(O)=O,36
4029,DB04280,"3,4-Dihydro-2'-deoxyuridine-5'-monophosphate",small molecule,experimental,,[H]N1[C@H](O)C=CN([C@H]2C[C@H](O)[C@@H](COP(O)(O)=O)O2)C1=O,449076
4030,DB04281,"2-[4-(4-Chlorophenyl)Cyclohexylidene]-3,4-Dihydroxy-1(2h)-Naphthalenone",small molecule,experimental,,[H]C1(CCC(CC1)=C1C(O)=C(O)C2=CC=CC=C2C1=O)C1=CC=C(Cl)C=C1,5287621
4031,DB04282,2-deoxy-2-fluoro-α-D-glucose,small molecule,experimental,,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])F,445226
4032,DB04283,2-Bromohypoxanthine,small molecule,experimental,,BrC1=NC2=C(NC=N2)C(=O)N1,447087
4033,DB04284,L-proline betaine,small molecule,experimental,"Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Imines|Imino Acids",C[N+]1(C)CCC[C@H]1C([O-])=O,115244
4034,DB04285,"{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid",small molecule,experimental,,[H]\C(C[C@](CC1=CC=C(C=C1)C(F)(F)P(O)(O)=O)(N1N=NC2=CC=CC=C12)C1=NC2=CC=CC=C2S1)=C(\[H])C1=CC=CC=C1,448025
4035,DB04286,beta-D-Ribopyranose,small molecule,experimental,,O[C@@H]1CO[C@@H](O)[C@H](O)[C@@H]1O,441481
4036,DB04287,KH064,small molecule,experimental,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids|Valerates",[H]N([C@@H](CCC(O)=O)CC1=CC=C(OCC2=CC=CC=C2)C=C1)C(=O)CCCCCCC1=CC=CC=C1,446400
4037,DB04288,2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine,small molecule,experimental,,[H][C@]1(N)CC[C@@]([H])(CC1)NC1=NC(NCC2=CC=CC=C2)=C2N=CN(C3CCCC3)C2=N1,3543
4038,DB04289,Genz-10850,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring",O=C(N1CCN(CC1)C1C2=CC=CC=C2C2=CC=CC=C12)C1=CC2=C(NC=C2)C=C1,447767
4039,DB04291,Oxfenicine,small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins|Carnitine O-Palmitoyltransferase, antagonists & inhibitors|Enzyme Inhibitors",N[C@H](C(O)=O)C1=CC=C(O)C=C1,36143
4040,DB04292,4-[(Isopropylamino)Methyl]Phenylalanine,small molecule,experimental,,CC(C)NCC1=CC=C(C[C@H](N)C(O)=O)C=C1,46936944
4041,DB04293,7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,small molecule,experimental,,N[C@@H](C(=O)N[C@@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1,12897341
4042,DB04294,5-Phosphoribosyl-1-(Beta-Methylene) Pyrophosphate,small molecule,experimental,,[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(OP(O)(=O)CP(O)(O)=O)O[C@]1([H])COP(O)(O)=O,448176
4043,DB04295,N-(Benzoylcarbamoyl)-beta-D-glucopyranosylamine,small molecule,experimental,"Carbohydrates|Glycogen Phosphorylase, antagonists & inhibitors|Hexoses|Monosaccharides",[H]N([C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(=O)N([H])C(=O)C1=CC=CC=C1,446600
4044,DB04296,5-Oxo-L-Norleucine,small molecule,experimental,,[H][C@](N)(CCC(C)=O)C(O)=O,5289072
4045,DB04297,Trichostatin A,small molecule,experimental,Amines|Anti-Infective Agents|Antifungal Agents|Antineoplastic Agents|Enzyme Inhibitors|Histone Deacetylase Inhibitors|Hydroxy Acids|Hydroxylamines|Protein Synthesis Inhibitors,C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)C1=CC=C(C=C1)N(C)C,444732
4046,DB04298,"3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One",small molecule,experimental,,CC1=CC(SC2=C(O)C[C@](CCC3=CC=C(O)C=C3)(OC2=O)C2CCCC2)=C(C=C1N)C(C)(C)C,54688711
4047,DB04299,Maleic Acid,small molecule,experimental,"Acid Etching, Dental|Acids, Acyclic|Aldehyde Reductase, antagonists & inhibitors|Dicarboxylic Acids|Enzyme Inhibitors",OC(=O)\C=C/C(O)=O,444266
4048,DB04300,"(1s,3r,4r,6s)-1,3,4,6-Tetrapkisphosphate",small molecule,experimental,,O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@@H](O)[C@@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O,121969
4049,DB04301,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate,small molecule,experimental,,NC(=N)C1=CC2=C(C=C1)N=C(N2)C(O)(O)C1=NC2=C(N1)C=C(C=C2)C([NH3+])=[NH2+],131704276
4050,DB04302,"4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One",small molecule,experimental,,C\C(C=C)=C/[C@@]1(C)SC(=O)C(C)=C1O,445629
4051,DB04303,4-O-methyl-alpha-D-glucuronic acid,small molecule,experimental,,[H][C@]1(O)O[C@]([H])(C(O)=O)[C@@]([H])(OC)[C@]([H])(O)[C@@]1([H])O,445994
4052,DB04304,L-Gluconic Acid,small molecule,experimental,,OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O,6857417
4053,DB04306,"5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine",small molecule,experimental,,CC1=CC=C(SC2=CC=CC3=C2C(N)=NC(N)=N3)C=C1,446245
4054,DB04307,5-Hydroxy-N-Propargyl-1(R)-Aminoindan,small molecule,experimental,,[H][C@]1(CCC2=CC=C(O)C=C12)NCC#C,5289289
4055,DB04308,D-4-hydroxyphenylglycine,small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins|Carnitine O-Palmitoyltransferase, antagonists & inhibitors|Enzyme Inhibitors",[H][C@](N)(C(O)=O)C1=CC=C(O)C=C1,89853
4056,DB04310,2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,small molecule,experimental,,[H][C@@](CCCCC)(CC(=O)NO)C(=O)N[C@@]([H])(C(C)C)C(=O)N1CCC[C@@]1([H])CO,443600
4057,DB04311,4-Phenylbutylamine,small molecule,experimental,"Alkanes|Amines|Butanes|Hydrocarbons, Acyclic",NCCCCC1=CC=CC=C1,83242
4058,DB04312,"2,3-Difluorobenzyl Alcohol",small molecule,experimental,,OCC1=CC=CC(F)=C1F,447153
4059,DB04313,(3S)-3-methyl-D-aspartic acid,small molecule,experimental|investigational,,C[C@@H]([C@@H](N)C(O)=O)C(O)=O,5287600
4060,DB04314,1-Methylcytosine,small molecule,experimental,Pyrimidines|Pyrimidinones,CN1C=CC(N)=NC1=O,79143
4061,DB04315,Guanosine-5'-Diphosphate,small molecule,experimental,,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,8977
4062,DB04316,D-[(N-Hydroxyamino)Carbonyl]Phenylalanine,small molecule,experimental,,[H]N(O)C(=O)N([H])[C@H](CC1=CC=CC=C1)C(O)=O,446049
4063,DB04317,"3,3-Dichloro-2-Phosphonomethyl-Acrylic Acid",small molecule,experimental,,OC(=O)C(CP(O)(O)=O)=C(Cl)Cl,367584
4064,DB04318,Nα-[(2S)-2-{[(S)-[(1S)-1-{[(Benzyloxy)carbonyl]amino}-2-phenylethyl](hydroxy)phosphoryl]methyl}-5-phenylpentanoyl]-L-tryptophanamide,small molecule,experimental,,[H]N([H])C(=O)[C@H](CC1=CN([H])C2=CC=CC=C12)N([H])C(=O)[C@H](CCCC1=CC=CC=C1)CP(O)(=O)[C@@H](CC1=CC=CC=C1)N([H])C(=O)OCC1=CC=CC=C1,446143
4065,DB04320,2-Bromo-2-Propene-1-Ol,small molecule,experimental,,OCC(Br)=C,446627
4066,DB04321,N-Hexylphosphonate Ethyl Ester,small molecule,experimental,,CCCCCC[P@@](O)(=O)OCC,446896
4067,DB04322,LY249543,small molecule,experimental,,[H]N([H])C1=NC(=O)C2=C(N([H])C[C@@H](CCC3=CC=C(C=C3)C(=O)N([H])[C@@H](CCC(O)=O)C(O)=O)C2)N1[H],445072
4068,DB04323,2-Amino-3-(Cystein-S-Yl)-Isoxazolidin-5-Yl-Acetic Acid,small molecule,experimental,,[H][C@](N)(CS[C@]1([H])C[C@@]([H])(ON1)[C@]([H])(N)C(O)=O)C(O)=O,17753793
4069,DB04324,Ovalicin,small molecule,experimental,Terpenes,[H][C@]1(CC=C(C)C)O[C@]1(C)[C@@]1(O)[C@]([H])(OC)C(=O)CC[C@@]1(C)O,5289086
4070,DB04325,Phenethylamine,small molecule,experimental,Amines|Central Nervous System Agents|Central Nervous System Depressants|Ethylamines|Psychotropic Drugs,NCCC1=CC=CC=C1,1001
4071,DB04326,Dihydroxyacetone phosphate,small molecule,investigational,Carbohydrates|Sugar Phosphates,OCC(=O)COP(O)(O)=O,668
4072,DB04327,Phosphatidylethanolamine,small molecule,experimental,Alcohols|Carbohydrates|Glycerophosphates|Glycerophospholipids|Lipids|Membrane Lipids|Phosphatidic Acids|Phospholipids|Sugar Alcohols|Sugar Phosphates|Triose Sugar Alcohols,CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](CO[P@](O)(=O)OCC[NH3+])OC(=O)CCCCCCCCCCCCCCCCC,17754130
4073,DB04328,Shikimate-3-Phosphate,small molecule,experimental,"Acids, Carbocyclic|Cyclohexanecarboxylic Acids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydroxy Acids",O[C@@H]1CC(=C[C@@H](OP(O)(O)=O)[C@H]1O)C(O)=O,121947
4074,DB04329,Isoquinoline,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring",C1=CC=C2C=NC=CC2=C1,8405
4075,DB04330,Bilh 434,small molecule,experimental,,[H][C@]1(O[C@@]2(C(=O)C3=C(C=C(C)C=C3)C2=O)[C@]([H])(C(O)=O)[C@]1([H])C(=O)NC1=CC=C(C=C1)C1=CSN=N1)C1=CC(Cl)=C(Cl)C=C1,5287508
4076,DB04331,Monastrol,small molecule,experimental,Antimitotic Agents|Antineoplastic Agents|Enzyme Inhibitors|Mitosis Modulators|Sulfur Compounds,CCOC(=O)C1=C(C)NC(=S)N[C@H]1C1=CC=CC(O)=C1,794323
4077,DB04332,2-{2-[2-2-(Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethanol,small molecule,experimental,,COCCOCCOCCOCCO,90263
4078,DB04333,Octamethylenediamine,small molecule,experimental,Amines|Polyamines,NCCCCCCCCN,24250
4079,DB04334,6-hydroxydopa quinone,small molecule,experimental,"Amines|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Benzene Derivatives|Catecholamines|Catechols|Phenols|Phenylalanine",N[C@@H](CC1=CC(=O)C(O)=CC1=O)C(O)=O,123871
4080,DB04335,Inosine,small molecule,experimental|investigational,"Carbohydrates|Dermatologicals|Genito Urinary System and Sex Hormones|Glycosides|Gynecological Antiinfectives and Antiseptics|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Ophthalmologicals|Purine Nucleosides|Purines|Ribonucleosides|Sensory Organs",OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1NC=NC2=O,6021
4081,DB04336,1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea,small molecule,experimental,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates",NC(=N)C1=CC=C(NC(=O)NC2=CC=C(Cl)C=C2)C=C1,2014
4082,DB04337,Isocyanomethane,small molecule,experimental,,C[N+]#[C-],11646
4083,DB04338,SB220025,small molecule,experimental,"Calcium-Calmodulin-Dependent Protein Kinases, antagonists & inhibitors",NC1=NC=CC(=N1)C1=C(N=CN1C1CCNCC1)C1=CC=C(F)C=C1,5164
4084,DB04339,Carbocisteine,small molecule,approved|investigational,Cough and Cold Preparations|Expectorants,N[C@@H](CSCC(O)=O)C(O)=O,193653
4085,DB04340,2-[(Dioxidophosphoranyl)oxy]benzoate,small molecule,experimental,,[O-]C(=O)C1=CC=CC=C1OP([O-])=O,6398365
4086,DB04341,S-(3-Iodobenzyl)glutathione,small molecule,experimental,,[H]N([H])[C@@H](CCC(=O)N([H])[C@@H](CSCC1=CC(I)=CC=C1)C(=O)N([H])CC(O)=O)C(O)=O,449342
4087,DB04342,7-((Carboxy(4-Hydroxyphenyl)Acetyl)Amino)-7-Methoxy-(3-((1-Methyl-1h-Tetrazol-5-Yl)Thio)Methyl)-8-Oxo-5-Oxa-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,small molecule,experimental,,CO[C@]1(NC(=O)[C@H](C(O)=O)C2=CC=C(O)C=C2)[C@H]2OCC(CSC3=NN=NN3C)=C(N2C1=O)C(O)=O,5488645
4088,DB04343,Glyoxylic acid,small molecule,experimental,"Acids, Aldehydic",OC(=O)C=O,760
4089,DB04345,Lumichrome,small molecule,experimental,"Biological Factors|Coenzymes|Enzymes and Coenzymes|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Pteridines",CC1=CC2=NC3=C(N=C2C=C1C)C(=O)NC(=O)N3,5326566
4090,DB04346,"(2r,4s)-2-Methyl-2,3,3,4-Tetrahydroxytetrahydrofuran",small molecule,experimental,,[H][C@]1(O)CO[C@@](C)(O)C1(O)O,448719
4091,DB04347,3-Dehydroshikimate,small molecule,experimental,"Acids, Carbocyclic|Cyclohexanecarboxylic Acids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydroxy Acids",O[C@@H]1CC(=CC(=O)[C@H]1O)C(O)=O,439774
4092,DB04348,Taurocholic acid,small molecule,approved|experimental,"Acids|Acids, Noncarboxylic|Alkanes|Alkanesulfonic Acids|BCRP/ABCG2 Inhibitors|Bile Acids and Salts|BSEP/ABCB11 inducers|BSEP/ABCB11 Substrates|Cholagogues and Choleretics|Cholanes|Cholic Acids|Compounds used in a research, industrial, or household setting|Detergents|Fused-Ring Compounds|Gastrointestinal Agents|Household Products|Hydrocarbons, Acyclic|OAT1/SLC22A6 inhibitors|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Inducers|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein inhibitors|P-glycoprotein substrates|Steroids|Sulfonic Acids|Sulfur Acids|Sulfur Compounds|Surface-Active Agents",[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCCS(O)(=O)=O,6675
4093,DB04349,"(S)-propane-1,2-diol",small molecule,experimental,,C[C@H](O)CO,439846
4094,DB04350,Argadin,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Peptides",CC(=O)NC(=N)NCCC[C@@H]1NC(=O)[C@H](CCCC(O)=O)NC(=O)[C@H](CC2=CNC=N2)N2[C@H](O)C[C@H](NC(=O)[C@H]3CCCN3C1=O)C2=O,449123
4095,DB04351,Aconitate Ion,small molecule,experimental,,[O-]C(=O)C\C(=C\C([O-])=O)C([O-])=O,5459816
4096,DB04352,beta-D-Ribose-5-phosphate,small molecule,experimental,,O[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O,447634
4097,DB04353,"Tert-butyl N-[(2S,5R)-6-[[(2S)-5-amino-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-benzyl-3,6-dioxo-1-phenylhexan-2-yl]carbamate",small molecule,experimental,,[H]N([H])C(=O)CC[C@H](N([H])C(=O)[C@H](CC(=O)[C@H](CC1=CC=CC=C1)N([H])C(=O)OC(C)(C)C)CC1=CC=CC=C1)C(=O)N([H])[C@@H](CC1=CC=CC=C1)C(=O)N([H])[H],6323486
4098,DB04356,9-Deazaguanine,small molecule,experimental,"Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Purines|Purinones|Xanthine derivatives",NC1=NC2=C(NC=C2)C(=O)N1,100684
4099,DB04357,Pteric acid,small molecule,experimental,,NC1=[NH+]C2=C(N=C(CNC3=CC=C(C=C3)C(O)=O)C=N2)C(O)=N1,4472713
4100,DB04359,Vinylsulfonic acid,small molecule,experimental,"Acids|Acids, Noncarboxylic|Alkenes|Hydrocarbons, Acyclic|Phosphogluconate Dehydrogenase, antagonists & inhibitors|Sulfur Acids|Sulfur Compounds",OS(=O)(=O)C=C,62474
4101,DB04360,Benzo[B]Thiophene-2-Boronic Acid,small molecule,experimental,,OB(O)C1=CC2=C(S1)C=CC=C2,2359
4102,DB04361,Methyldiazene,small molecule,experimental,,[H]N=NC,123421
4103,DB04362,Adenosine Diphosphate 5-(Beta-Ethyl)-4-Methyl-Thiazole-2-Carboxylic Acid,small molecule,experimental,,[H][C@]1(COP([O-])(=O)OP([O-])(=O)OCCC2=C(C)N=C(S2)C([O-])=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,5287651
4104,DB04363,Mesobiliverdin IV alpha,small molecule,experimental,,[H]N1C(=O)C(C)=C(CC)\C1=C\C1=N\C(=C/C2=C(C)C(CCC(O)=O)=C(\C=C3/N([H])C(=O)C(C)=C3CC)N2[H])\C(C)=C1CCC(O)=O,131704277
4105,DB04364,(R)-acetoin,small molecule,experimental,,C[C@@H](O)C(C)=O,439314
4106,DB04365,Arecoline,small molecule,experimental,Alkaloids|Cholinergic Agents|Cholinergic Agonists|Neurotransmitter Agents|Nicotinic Acids|Pyridines,COC(=O)C1=CCCN(C)C1,2230
4107,DB04366,3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate,small molecule,experimental,,[H][C@]1(COP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])N,446090
4108,DB04367,Debromohymenialdisine,small molecule,experimental,"Protein Kinase C, antagonists & inhibitors",NC1=NC(=O)\C(N1)=C1/CCNC(=O)C2=C1C=CN2,5288032
4109,DB04368,Bb-3497,small molecule,experimental,Amines|Hydroxy Acids|Hydroxylamines,[H][C@@](CCCC)(CN(O)C=O)C(=O)N[C@]([H])(C(=O)N(C)C)C(C)(C)C,159596
4110,DB04369,"1,3,2-Dioxaborolan-2-Ol",small molecule,experimental,,OB1OCCO1,5289333
4111,DB04370,S-sulphocysteine,small molecule,experimental,"Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Sulfhydryl Compounds|Sulfur Compounds",N[C@@H](CSS(O)(=O)=O)C(O)=O,115015
4112,DB04371,AL6528,small molecule,experimental,,COC1=CC(=CC=C1)N1C=CC2=C(SC(=C2)S(N)(=O)=O)S1(=O)=O,1514
4113,DB04372,L-Dilinoleoyllecithin,small molecule,experimental,Alcohols|Carbohydrates|Glycerophosphates|Glycerophospholipids|Lipids|Membrane Lipids|Phosphatidic Acids|Phospholipids|Sugar Alcohols|Sugar Phosphates|Triose Sugar Alcohols,CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC,5288075
4114,DB04373,"4-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",small molecule,experimental,,CC(C)C[C@@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)COC1=C(C)C=CC=C1C)NC(=O)C1=CC=CC(N)=C1,446912
4115,DB04374,"4-Carboxy-5-(1-Pentyl)Hexylsulfanyl-1,2,3-Triazole",small molecule,experimental,,CCCCCC(CCCCC)SC1=C(N=NN1)C(O)=O,444302
4116,DB04376,13-Acetylphorbol,small molecule,experimental,,[H][C@]12[C@]3([H])C=C(CO)C[C@]4(O)C(=O)C(C)=C[C@@]4([H])[C@@]3(O)[C@]([H])(C)[C@@]([H])(O)[C@@]1(OC(C)=O)C2(C)C,499953
4117,DB04377,Meglutol,small molecule,experimental,"Acids, Acyclic|Anticholesteremic Agents|Antimetabolites|Dicarboxylic Acids|Enzyme Inhibitors|Glutarates|Hypolipidemic Agents|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Noxae|Toxic Actions",CC(O)(CC(O)=O)CC(O)=O,1662
4118,DB04378,"3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",small molecule,experimental,,CC(C)C[C@@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)COC1=C(C)C=CC=C1C)NC(=O)C1=CC=C(N)C=C1,446917
4119,DB04379,N-Methyl-N-(Methylbenzyl)Formamide,small molecule,experimental,Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 Substrates,[H][C@@](C)(N(C)C=O)C1=CC=CC=C1,444567
4120,DB04380,Allantoate,small molecule,experimental,,NC(=O)NC(NC(N)=O)C([O-])=O,5287444
4121,DB04381,Crotonaldehyde,small molecule,experimental,,[H]C(=O)\C=C\C,447466
4122,DB04382,2-Deoxy-alpha-D-galactopyranose,small molecule,experimental,,OC[C@H]1O[C@H](O)C[C@@H](O)[C@H]1O,446586
4123,DB04383,L-valinol,small molecule,experimental,,CC(C)[C@H](N)CO,640993
4124,DB04384,Fe-Mesopone,small molecule,experimental,,CCC1=C2C=C3N4C(=CC5=C(C)C(CCC(O)=O)=C6C=C7N8C(=CC(N2[Fe]48N56)=C1C)C(C)=C7CCC(O)=O)C(=O)C3(C)CC,131704278
4125,DB04385,3-Deazacytidine,small molecule,experimental,"Carbohydrates|Cytidine Deaminase, antagonists & inhibitors|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",[H][C@]1(CO)O[C@@]([H])(N2C=CC(N)=CC2=O)[C@]([H])(O)[C@]1([H])O,97577
4126,DB04386,"4,6-O-(1-Carboxyethylidene)-Beta-D-Glucose",small molecule,experimental,,C[C@]1(OC[C@H]2O[C@@H](O)[C@H](O)[C@@H](O)[C@H]2O1)C(O)=O,46936963
4127,DB04387,1-Hydroxy-2-Amino-3-Cyclohexylpropane,small molecule,experimental,,N[C@H](CO)CC1CCCCC1,444569
4128,DB04388,4-Carboxy-4-Aminobutanal,small molecule,experimental,,N[C@@H](CCC=O)C(O)=O,193305
4129,DB04389,Ado-P-Ch2-P-Ps-Ado,small molecule,experimental,,[H][C@]1(COP(O)(=O)CP(O)(=O)O[P@](O)(=S)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,6858209
4130,DB04391,Aeruginosin 98-B,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Peptides",[H]N([H])C(=NCCCCN([H])C(=O)[C@@H]1C[C@]2([H])CC[C@H](C[C@]2([H])N1C(=O)[C@H](N([H])C(=O)[C@H](O)CC1=CC=C(O)C=C1)[C@H](C)CC)OS(O)(=O)=O)N([H])[H],444346
4131,DB04392,"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",small molecule,experimental,,[H][C@@]1(C[C@@]2([H])C(=O)OC3=C(C=CC=C3)C2=O)C(=O)OC2=CC=CC=C2C1=O,17753965
4132,DB04393,Soneclosan,small molecule,experimental,,OC1=C(OC2=CC=C(Cl)C=C2)C=CC(Cl)=C1,18807
4133,DB04394,3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide,small molecule,experimental,,NS(=O)(=O)C1=CC=C(N2CCCC2=O)C(=C1)[N+]([O-])=O,3092847
4134,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,small molecule,experimental,,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O,44462678
4135,DB04396,Thiodigalactoside,small molecule,experimental,Carbohydrates|Galactosides|Glycosides|Sulfur Compounds|Thioglycosides,[H][C@]1(CO)O[C@@]([H])(S[C@]2([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O,119138
4136,DB04397,Alpha-D-Glucose-1-Phosphate-6-Vanadate,small molecule,experimental,Vanadates,O[C@@H]1[C@@H](O)[C@H](CO[V](O)(=O)=O)O[C@H](OP(O)(O)=O)[C@H]1O,46936967
4137,DB04398,Lactic acid,small molecule,approved|vet_approved,Basic Ointments and Protectants|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hydroxy Acids|Lactates|Miscellaneous Local Anti-infectives|Organic Acids,CC(O)C(O)=O,612
4138,DB04400,"L-erythro-7,8-dihydrobiopterin",small molecule,experimental,"Biological Factors|Coenzymes|Enzymes and Coenzymes|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Pteridines|Pterins",C[C@H](O)[C@H](O)C1=NC2=C(NC1)NC(N)=NC2=O,119055
4139,DB04401,Betaine aldehyde,small molecule,experimental,Amines|Ammonium Compounds|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds|Trimethyl Ammonium Compounds,C[N+](C)(C)CC=O,249
4140,DB04404,Allosamizoline,small molecule,experimental,Amino Sugars|Carbohydrates|Chitinases|Hexosamines,[H][C@]1(O)[C@]([H])(O)[C@@]2([H])N=C(O[C@@]2([H])[C@]1([H])CO)N(C)C,5287673
4141,DB04405,"2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid",small molecule,experimental,,[H][C@](CCN1C(=O)C2=CC=CC=C2C1=O)(CC(=O)C1=CC=C(C=C1)C1=CC=C(OCC)C=C1)C(O)=O,448384
4142,DB04406,3-(Phosphonomethyl)Pyridine-2-Carboxylic Acid,small molecule,experimental,,OC(=O)C1=NC=CC=C1CP(O)(O)=O,1629
4143,DB04407,4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol,small molecule,experimental,,CNC1=NC(C)=C(S1)C1=CC=NC(NC2=CC=C(O)C=C2)=N1,447960
4144,DB04408,Ncs-Chromophore,small molecule,experimental,,[H]\C1=C2\C(=C[C@@]([H])(OC(=O)C3=C(O)C=CC4=C3C=C(OC)C=C4C)[C@]2([H])O[C@@]2([H])O[C@]([H])(C)[C@]([H])(O)[C@]([H])(O)[C@@]2([H])NC)C#C[C@@]2(O[C@]2([H])C#C1)[C@@]1([H])COC(=O)O1,447545
4145,DB04409,Naphthalene Trisulfonate,small molecule,experimental,,[O-]S(=O)(=O)C1=CC2=C(C=C1)C(=CC(=C2)S([O-])(=O)=O)S([O-])(=O)=O,4437
4146,DB04410,3-Phenylpropylamine,small molecule,experimental,Amines,NCCCC1=CC=CC=C1,16259
4147,DB04411,Alpha-N-Dichloroacetyl-P-Aminophenylserinol,small molecule,experimental,,[H][C@](CO)(NC(=O)C(Cl)Cl)[C@]([H])(O)C1=CC=C(N)C=C1,445896
4148,DB04414,Heptamolybdate,small molecule,experimental,,O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Mo].[Mo].[Mo].[Mo].[Mo].[Mo].[Mo],131704280
4149,DB04415,3-Amino-1-Chloro-4-Phenyl-Butanol-2-Yl,small molecule,experimental,,N[C@@H](CC1=CC=CC=C1)[C@@H](O)CCl,5289149
4150,DB04416,"R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid",small molecule,experimental,,[H][C@](CC#CCOC)(NS(=O)(=O)C1=CC=C(C=C1)C1=CC=C(OC)C=C1)C(O)=O,446165
4151,DB04417,P-Nitrophenol,small molecule,experimental,Benzene Derivatives|Nitro Compounds|Phenols,OC1=CC=C(C=C1)[N+]([O-])=O,980
4152,DB04418,Adenylosuccinic acid,small molecule,experimental,"Adenine Nucleotides|Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Carbohydrates|Excitatory Amino Acids|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",O[C@@H]1[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C(N[C@@H](CC(O)=O)C(O)=O)N=CN=C12,447145
4153,DB04419,D-norleucine,small molecule,experimental,,CCCC[C@@H](N)C(O)=O,456468
4154,DB04421,Nicotinamide adenine dinucleotide 3-pentanone adduct,small molecule,experimental,,CCC(=O)[C@@H](C)C1=C(C=[N+](C=C1)[C@@H]1O[C@H](COP(O)(=O)OP([O-])(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O)C(N)=O,131704281
4155,DB04422,Homocysteine,small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Sulfur Compounds",N[C@@H](CCS)C(O)=O,91552
4156,DB04423,Coproporphyrin I containing CO(III),small molecule,experimental,,CC1=C(CCC(O)=O)C2=CC3=C(C)C(CCC(O)=O)=C4C=C5N6C(=CC7=C(C)C(CCC(O)=O)=C8C=C1N2[Co]6(N78)N34)C(CCC(O)=O)=C5C,5476798
4157,DB04424,RPR128515,small molecule,experimental,,COC(=O)[C@H](CC1=CC=CC(=C1)C(N)=N)[C@@H](C)NC(=O)C1=CC=C(C=C1)C1=CC=CC(CN)=C1,5497056
4158,DB04425,"7,8-Dihydroneopterin",small molecule,experimental,"Biological Factors|Coenzymes|Enzymes and Coenzymes|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Pteridines|Pterins",NC1=NC2=C(N=C(CN2)[C@H](O)[C@H](O)CO)C(=O)N1,65074
4159,DB04426,Alpha-Methyl-N-Acetyl-D-Glucosamine,small molecule,experimental,,[H][C@]1(CO)O[C@@]([H])(OC)[C@]([H])(NC(C)=O)[C@@]([H])(O)[C@]1([H])O,445750
4160,DB04427,4-Methyl-N-[(2S)-1-oxo-3-phenyl-1-[[(3S)-1-phenyl-5-(phenylmethoxysulfamoyl)pentan-3-yl]amino]propan-2-yl]piperazine-1-carboxamide,small molecule,experimental,,[H]N(OCC1=CC=CC=C1)S(=O)(=O)CC[C@H](CCC1=CC=CC=C1)N([H])C(=O)[C@H](CC1=CC=CC=C1)N([H])C(=O)N1CCN(C)CC1,5289562
4161,DB04429,4'-Hydroxyflavanone,small molecule,experimental,"Benzopyrans|Chromones|Flavonoids|Heterocyclic Compounds, Fused-Ring|Pyrans",OC1=CC=C(C=C1)[C@@H]1CC(=O)C2=CC=CC=C2O1,688859
4162,DB04430,3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile,small molecule,experimental,,N#C\C(=C\NC1=CC=C(NC2=CC=CC=C2)C=C1)C1=NNN=N1,5288260
4163,DB04431,4-epi-vancosaminyl derivative of vancomycin,small molecule,experimental,,[H]N([H])C(=O)C[C@@H]1N([H])C(=O)[C@H](N([H])C(=O)[C@@H](CC(C)C)[N+]([H])([H])C)[C@H](O)C2=CC(Cl)=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@@](C)([C@@H](O)[C@H](C)O4)[N+]([H])([H])[H])C4=CC(=C3)[C@@]([H])(N([H])C1=O)C(=O)N([H])[C@]1([H])C3=CC(=C(O)C=C3)C3=C(C=C(O)C=C3O)[C@H](N([H])C(=O)[C@@]([H])(N([H])C1=O)[C@H](O[C@H]1C[C@@](C)([C@@H](O)[C@H](C)O1)[N+]([H])([H])[H])C1=CC(Cl)=C(O4)C=C1)C(O)=O)C=C2,131704282
4164,DB04432,ZK-805623,small molecule,experimental,,CC1=C(F)C(OC2=CC(=CC=C2)C(N)=N)=[NH+]C(OC2=CC=CC(=C2)C(N)=N)=C1F,4470378
4165,DB04433,Verpacamide A,small molecule,experimental,,[H][C@@]12CCCN1C(=O)[C@H](CCCNC(N)=N)NC2=O,449095
4166,DB04434,Naphthyridine Inhibitor,small molecule,experimental,,CC1=CC=CC(=N1)C1=C(CNN1)C1=CC=C2N=CC=CC2=N1,5287512
4167,DB04436,3-Fluoro-L-tyrosine,small molecule,experimental,,N[C@@H](CC1=CC(F)=C(O)C=C1)C(O)=O,643330
4168,DB04437,"Cysteine-Methylene-Carbamoyl-1,10-Phenanthroline",small molecule,experimental,,N[C@@H](CSCC(=O)NC1=CC2=C(N=CC=C2)C2=C1C=CC=N2)C(O)=O,17754108
4169,DB04438,Brivudine monophosphate,small molecule,experimental,,O[C@H]1C[C@@H](O[C@@H]1COP(O)(O)=O)N1C=C(\C=C\Br)C(=O)NC1=O,6505368
4170,DB04439,Modified Acarbose Pentasaccharide,small molecule,experimental,,[H][C@]1(C)O[C@]([H])(O[C@]2([H])C(CO)=C[C@]([H])(N[C@]3([H])[C@@]([H])(C)O[C@]([H])(O[C@]4([H])[C@@]([H])(CO)O[C@]([H])(O[C@]5([H])[C@@]([H])(CO)O[C@]([H])(O)[C@]([H])(O)[C@@]5([H])O)[C@]([H])(O)[C@@]4([H])O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O,447014
4171,DB04440,Nebularine,small molecule,experimental,"Anti-Infective Agents|Antineoplastic Agents|Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purines",[H][C@]1(CO)O[C@@]([H])(N2C=NC3=CN=CN=C23)[C@]([H])(O)[C@]1([H])O,68368
4172,DB04441,2-Fluoroadenosine,small molecule,experimental,"Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides",[H][C@]1(CO)O[C@@]([H])(N2C=NC3=C(N)N=C(F)N=C23)[C@]([H])(O)[C@]1([H])O,8975
4173,DB04442,"Imino[2-(2-oxo-1,2-dihydro-3-pyridinyl)-1H-benzimidazol-5-yl]methanaminium",small molecule,experimental,,NC(=[NH2+])C1=CC2=C(NC(=N2)C2=CC=CNC2=O)C=C1,5326542
4174,DB04444,Tetrafluoroaluminate Ion,small molecule,experimental,,F[Al](F)(F)[F-],5311325
4175,DB04445,Mercuric iodide,small molecule,experimental,Anions|Antiseptics and Disinfectants|Dermatologicals|Electrolytes|Iodine Compounds|Ions|Mercurial Products,I[Hg]I,24485
4176,DB04446,Benzo[B]Thiophene-2-Carboxamidine,small molecule,experimental,,NC(=[NH2+])C1=CC2=C(S1)C=CC=C2,444753
4177,DB04447,"1,4-Dithiothreitol",small molecule,experimental,,O[C@@H](CS)[C@@H](O)CS,439196
4178,DB04448,"2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene",small molecule,experimental,,OCC1=CC=C(F)C=C1F,91867
4179,DB04449,"5-(3,3-Dihydroxypropeny)-3-Methoxy-Benzene-1,2-Diol",small molecule,experimental,,COC1=CC(\C=C\C(O)O)=CC(O)=C1O,5288545
4180,DB04450,Heptyl 1-Thiohexopyranoside,small molecule,experimental,,[H][C@]1(CO)O[C@@]([H])(SCCCCCCC)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O,656917
4181,DB04451,4-Methylpiperazin-1-Yl Carbonyl Group,small molecule,experimental,,CN1CCN(CC1)C(O)=O,6453585
4182,DB04452,Aminoquinuride,small molecule,experimental,,CC1=NC2=CC=C(NC(=O)NC3=CC4=C(C=C3)N=C(C)C=C4N)C=C2C(N)=C1,71166
4183,DB04453,"4-O-(4,6-Dideoxy-4-{[4-[(4-O-Hexopyranosylhexopyranosyl)Oxy]-5,6-Dihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}Hexopyranosyl)Hexopyranose",small molecule,experimental,,[H][C@]1(C)O[C@]([H])(O[C@]2([H])[C@@]([H])(CO)O[C@]([H])(O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])N[C@@]1([H])C=C(CO)[C@@]([H])(O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O[C@@]3([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O,4369394
4184,DB04454,Alpha-Aminobutyric Acid,small molecule,experimental,"Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Butyrates|Fatty Acids|Fatty Acids, Volatile|Lipids",CC[C@@H](N)C(O)=O,439691
4185,DB04455,"N,N,N-trimethylglycinium",small molecule,experimental|investigational,,C[N+](C)(C)CC(O)=O,248
4186,DB04456,Arsenous acid,small molecule,experimental|investigational,Anions|Arsenicals|Electrolytes|Ions|Organometallic Compounds,O[As](O)O,545
4187,DB04457,2'-Deoxyguanosine-5'-Monophosphate,small molecule,experimental,,NC1=NC(=O)C2=C(N1)N(C=N2)[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1,65059
4188,DB04458,"2,2-Dichloro-1-methanesulfinyl-3-methyl-cyclopropanecarboxylic acid [1-(4-bromo-phenyl)-ethyl]-amide",small molecule,experimental,,CC(NC(=O)[C@@]1([C@@H](C)C1(Cl)Cl)[S@](C)=O)C1=CC=C(Br)C=C1,9543529
4189,DB04459,"3,4-Dichloroisocoumarin",small molecule,experimental,"Benzopyrans|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Pyrans|Serine Protease Inhibitors",ClC1=C(Cl)C2=CC=CC=C2C(=O)O1,1609
4190,DB04460,(C8-S)-Hydantocidin 5'-phosphate,small molecule,experimental,,[H]N1C(=O)N(CCC[C@H](N(O)CO)C(O)=O)C(=O)[C@]11O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O,5289306
4191,DB04461,Coproporphyrinogen III,small molecule,experimental,"Biological Factors|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Porphyrinogens|Porphyrins",CC1=C2CC3=C(C)C(CCC(O)=O)=C(CC4=C(CCC(O)=O)C(C)=C(CC5=C(CCC(O)=O)C(C)=C(CC(N2)=C1CCC(O)=O)N5)N4)N3,321
4192,DB04462,Tetrabromo-2-Benzotriazole,small molecule,experimental,,[H]N1N=C2C(=N1)C(Br)=C(Br)C(Br)=C2Br,1694
4193,DB04463,"3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol",small molecule,experimental,,CC(C)(C)N1N=C(C2=C(N)N=CN=C12)C1=CC=CC(O)=C1,657095
4194,DB04464,N-Formylmethionine,small molecule,experimental,"Amino Acids|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Sulfur Compounds",[H]C(=O)N[C@@H](CCSC)C(O)=O,439750
4195,DB04465,Lactose,small molecule,approved|experimental|investigational,"Carbohydrates|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Disaccharides|Flavoring Agents|Food|Food Additives|Food and Beverages|Food Ingredients|Oligosaccharides|Pharmaceutic Aids|Pharmaceutical Preparations|Physiological Phenomena|Polysaccharides|Sweetening Agents",OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O,440995
4196,DB04466,SR12813,small molecule,experimental,,CCOP(=O)(OCC)C(=CC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C)P(=O)(OCC)OCC,446313
4197,DB04467,N-(5'-phosphopyridoxyl)-L-alanine,small molecule,experimental,,[H][C@@](C)(NCC1=C(COP(O)(O)=O)C=NC(C)=C1O)C(O)=O,444773
4198,DB04468,Afimoxifene,small molecule,investigational,"Androstanes|Androstenes|Androstenols|Antineoplastic Agents|Benzene Derivatives|Benzylidene Compounds|Estrogen Antagonists|Estrogen Receptor Modulators|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormone Antagonists|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Receptors, Estrogen, agonists|Selective Estrogen Receptor Modulators|Steroids|Stilbenes",CC\C(=C(/C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,449459
4199,DB04469,"1-(4-Methoxyphenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",small molecule,experimental,,CCOC(=O)C1=C(C)N(N=C1C)C1=CC=C(OC)C=C1,656965
4200,DB04470,CRA_10656,small molecule,experimental,,CC(C)COC1=C([O-])C(=CC=C1)C1=NC2=CC(=CC=C2N1)C(N)=[NH2+],6119063
4201,DB04471,"2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",small molecule,experimental,,OC1=CC=C2[C@H](N(CCC2=C1)C1=CC=CC=C1)C1=CC=C(OCCN2CCCCC2)C=C1,448915
4202,DB04472,(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol,small molecule,experimental,,[H][C@](O)(CN=[N+]=[N-])C1=CC=C(C=C1)[N+]([O-])=O,11481186
4203,DB04473,alpha-L-fucose,small molecule,experimental,,C[C@@H]1O[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O,439554
4204,DB04474,8-anilinonaphthalene-1-sulfonic acid,small molecule,experimental,"Acids|Acids, Noncarboxylic|Amines|Aniline Compounds|Arylsulfonates|Arylsulfonic Acids|Coloring Agents|Compounds used in a research, industrial, or household setting|Fluorescent Dyes|Indicators and Reagents|Laboratory Chemicals|Luminescent Agents|Naphthalenes|Naphthalenesulfonates|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",OS(=O)(=O)C1=CC=CC2=CC=CC(NC3=CC=CC=C3)=C12,1369
4205,DB04476,"Trencam-3,2-Hopo",small molecule,experimental,,NC(=O)C1=CC=CC(O)=C1O,449146
4206,DB04477,"2'-Deoxy-2'-[(3,5-dimethoxybenzoyl)amino]-N-[(1R)-1,2,3,4-tetrahydro-1-naphthalenyl]adenosine",small molecule,experimental,,[H]N([C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C=NC2=C(N=CN=C12)N([H])[C@@H]1CCCC2=CC=CC=C12)C(=O)C1=CC(OC)=CC(OC)=C1,5289484
4207,DB04478,"Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine",small molecule,experimental,,CN(C)S(=O)(=O)N1CCN(CC1)C1=CC=NC(CO)=N1,132302
4208,DB04479,4-Nitro-Inden-1-One,small molecule,experimental,,[O-][N+](=O)C1=CC=CC2=C1C=CC2=O,1750
4209,DB04480,"3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole",small molecule,experimental,,CC1=NC(=CC=C1)C1=NN2CCCC2=C1C1=CC=C(F)C=C1,5287525
4210,DB04481,Erythritol,small molecule,experimental,Alcohols|Carbohydrates|Cardiovascular Agents|Sugar Alcohols|Vasodilating Agents,OC[C@H](O)[C@H](O)CO,222285
4211,DB04482,Cmp-2-Keto-3-Deoxy-Octulosonic Acid,small molecule,experimental,,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)O[C@]2(C[C@@H](O)[C@@H](O)[C@H](O2)[C@H](O)CO)C(O)=O)[C@@H](O)[C@H]1O,445888
4212,DB04483,2-deoxy-2-fluoro-β-D-mannose,small molecule,experimental,,OC[C@H]1O[C@@H](O)[C@@H](F)[C@@H](O)[C@@H]1O,445913
4213,DB04484,L-phenylalaninol,small molecule,experimental,,N[C@H](CO)CC1=CC=CC=C1,447213
4214,DB04485,Thymidine,small molecule,experimental|investigational,"Carbohydrates|Deoxyribonucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines",CC1=CN([C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)NC1=O,5789
4215,DB04486,"(2s)-2,8-Diaminooctanoic Acid",small molecule,experimental,,NCCCCCC[C@H](N)C(O)=O,46936985
4216,DB04487,N-Methylleucine,small molecule,experimental,,CN[C@H](CC(C)C)C(O)=O,6951123
4217,DB04488,"(6S)-N-[(2S,3R,6R,7R)-3-(Acetyloxymethyl)-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]octan-7-yl]-6-[(2-aminoacetyl)amino]-7-hydroxy-7-oxoheptanimidate",small molecule,experimental,,[H][C@]12SC[C@@H](COC(C)=O)[C@H](N1C(=O)[C@H]2\N=C(/[O-])CCCC[C@H](NC(=O)CN)C(O)=O)C(O)=O,131704283
4218,DB04489,Guanidinoethylmercaptosuccinic acid,small molecule,experimental,"Acids, Acyclic|Dicarboxylic Acids",[H]N([H])C(=NCCS[C@@H](CC(O)=O)C(O)=O)N([H])[H],446018
4219,DB04490,3-(Mercaptomethylene)Pyridine,small molecule,experimental,,SCC1=CC=CN=C1,205225
4220,DB04491,Diisopropylphosphono Group,small molecule,experimental,,CC(C)OP(=O)OC(C)C,6327350
4221,DB04492,2-(acetylamino)-2-deoxy-4-O-sulfo-alpha-D-galactopyranose,small molecule,experimental,,[H]N([C@H]1[C@@H](O)O[C@H](CO)[C@H](OS(O)(=O)=O)[C@@H]1O)C(C)=O,447406
4222,DB04493,Fructose-6-phosphate,small molecule,experimental,Carbohydrates|Hexosephosphates|Sugar Phosphates,OCC(=O)[C@@H](O)[C@H](O)[C@H](O)COP(O)(O)=O,69507
4223,DB04494,Dihydroxy(oxo)molybdenum(6+),small molecule,experimental,,O[Mo+6](O)=O,
4224,DB04495,Paratoulene phosphate,small molecule,experimental,"Amides|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Azepines|Lactams|Phosphoamino Acids",CC(=O)N[C@@H](CC1=CC=C(OP(O)(O)=O)C=C1)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O,447518
4225,DB04496,4-Phospho-D-erythronohydroxamic acid,small molecule,experimental,Amines|Carbohydrates|Hydroxy Acids|Hydroxylamines,[H]N(O)C(=O)[C@H](O)[C@H](O)COP(O)(O)=O,449303
4226,DB04497,2'-Monophosphoadenosine-5'-Diphosphoribose,small molecule,experimental,,[H][C@@]1(O)O[C@]([H])(COP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C3NCN[C@@]4([H])[NH3+])[C@]([H])(OP(O)(O)=O)[C@]2([H])O)[C@@]([H])(O)[C@@]1([H])O,131704284
4227,DB04498,Aspartate Semialdehyde,small molecule,experimental,"Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Excitatory Amino Acids",[H][C@@](N)(CC=O)C(O)=O,49866644
4228,DB04499,(R)-styrene oxide,small molecule,experimental,,C1O[C@@H]1C1=CC=CC=C1,114705
4229,DB04500,Acedoben,small molecule,experimental,"Acids, Carbocyclic|Aminobenzoates|Benzene Derivatives|Benzoates",CC(=O)NC1=CC=C(C=C1)C(O)=O,19266
4230,DB04501,Camphane,small molecule,experimental,Monoterpenes|Norbornanes|Terpenes,[H][C@]12CC[C@](C)(CC1)C2(C)C,92108
4231,DB04502,WRR-204,small molecule,experimental,,O=C(N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC1=CC=CC=C1)CCS(=O)(=O)OC1=CC=CC=C1)OCC1=CC=CC=C1,17754216
4232,DB04503,Sp-722,small molecule,experimental,,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(C=C1)S(=O)(=O)N1CCC[C@]1([H])C(O)=O)C(O)=O,445505
4233,DB04504,"(3s)-2,3,4,5-Tetrahydropyridin-3-Amine",small molecule,experimental,,[H][C@@]1(N)CCC=NC1,445281
4234,DB04505,"8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine",small molecule,experimental,,COC1=C(OC)C(OC)=C(Cl)C(CC2=NC3=C(N)N=CN=C3N2CCCC#C)=C1,448971
4235,DB04506,Chlorophyll B,small molecule,experimental,"Biological Factors|Heterocyclic Compounds, Fused-Ring|Metalloporphyrins|Pigments, Biological|Porphyrins",[Mg++].[H]C(=O)C1=C(CC)C2=N\C\1=C/C1=C(C=C)C(C)=C([N-]1)\C=C1/N=C([C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@@H]1C)C1=C3[N-]/C(=C\2)C(C)=C3C(=O)[C@@H]1C(=O)OC,6450186
4236,DB04508,"Methyl(6s)-1-Thio-L-Manno-Hexodialdo-6,2-Pyranoside",small molecule,experimental,,[H][C@@]1(O)[C@@]([H])(O)[C@]([H])(OC)O[C@]([H])(C=S)[C@]1([H])O,5289570
4237,DB04509,N-Methylnaloxonium,small molecule,experimental,,C[N@@+]1(CC=C)CC[C@]23[C@H]4OC5=C(O)C=CC(C[C@@H]1[C@]2(O)CCC4=O)=C35,6323452
4238,DB04510,3-phospho-D-glyceric acid,small molecule,experimental,"Acids, Acyclic|Carbohydrates|Hydroxy Acids|Sugar Acids",O[C@H](COP(O)(O)=O)C(O)=O,439183
4239,DB04511,N-Succinyl Methionine,small molecule,experimental,,[H][C@](CCSC)(NC(=O)CCC(O)=O)C(O)=O,448581
4240,DB04512,2-Isobutyl-3-methoxypyrazine,small molecule,experimental,Odorants,COC1=C(CC(C)C)N=CC=N1,32594
4241,DB04513,N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide,small molecule,experimental,"Amides|Calcium-Calmodulin-Dependent Protein Kinases, antagonists & inhibitors|Cardiovascular Agents|Enzyme Inhibitors|Sulfones|Sulfur Compounds|Vasodilating Agents",NCCCCCCNS(=O)(=O)C1=CC=CC2=C1C=CC=C2Cl,5681
4242,DB04514,Uridylyl-2'-5'-phospho-guanosine,small molecule,experimental,,[H]N([H])C1=NC(=O)C2=C(N1[H])N(C=N2)[C@@H]1O[C@H](COP(O)(=O)O[C@@H]2[C@H](O)[C@@H](CO)O[C@H]2N2C=CC(=O)N([H])C2=O)[C@@H](O)[C@H]1O,89950
4243,DB04515,2-O-methyl-alpha-L-fucopyranose,small molecule,experimental,,CO[C@@H]1[C@H](O)O[C@@H](C)[C@@H](O)[C@H]1O,444792
4244,DB04516,2-Deoxy-Glucitol-6-Phosphate,small molecule,experimental,,[H][C@@](O)(CCO)[C@]([H])(O)[C@]([H])(O)COP(O)(O)=O,49866901
4245,DB04517,Dipyrromethane Cofactor,small molecule,experimental,Coenzymes,CC1=C(CC(O)=O)C(CCC(O)=O)=C(CC2=C(CC(O)=O)C(CCC(O)=O)=CN2)N1,5460481
4246,DB04518,"3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol",small molecule,experimental,,CC1=NC(C)=C(S1)C1=NC(NC2=CC=CC(O)=C2)=NC=C1,447959
4247,DB04519,Caprylic acid,small molecule,investigational,"Acids, Acyclic|Fatty Acids|Lipids|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors",CCCCCCCC(O)=O,379
4248,DB04520,"(3s,8ar)-3-(4-Hydroxybenzyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione",small molecule,experimental,,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=C(O)C=C1)NC2=O,119404
4249,DB04521,4-S-Glutathionyl-5-pentyl-tetrahydro-furan-2-ol,small molecule,experimental,,[H]N([H])[C@@H](CCC(=O)N([H])[C@@H](CS[C@@]1([H])C[C@H](O)O[C@@H]1CCCCC)C(=O)N([H])CC(O)=O)C(O)=O,444455
4250,DB04522,Dexfosfoserine,small molecule,experimental,,N[C@@H](COP(O)(O)=O)C(O)=O,68841
4251,DB04523,Tert-Butyl(1s)-1-Cyclohexyl-2-Oxoethylcarbamate,small molecule,experimental,,[H][C@@](NC(=O)OC(C)(C)C)(C=O)C1CCCCC1,448022
4252,DB04524,Malonyl-CoA,small molecule,experimental,"Adenine Nucleotides|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides|Thioesters of coenzyme A",CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(O)=O,644066
4253,DB04525,N-(3-Carboxypropanoyl)-L-phenylalanyl-3-carboxy-O-(carboxymethyl)-N-pentyl-L-tyrosinamide,small molecule,experimental,,CCCCCNC(=O)[C@H](CC1=CC=C(OCC(O)=O)C(=C1)C(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CCC(O)=O,445785
4254,DB04526,L-Glycero-D-Manno-Heptopyranose,small molecule,experimental,Carbohydrates|Monosaccharides,[H][C@](O)(CO)[C@@]1([H])O[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(O)[C@]1([H])O,125414
4255,DB04527,beta-Hydroxyasparagine,small molecule,experimental,"Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins",N[C@@H]([C@H](O)C(N)=O)C(O)=O,15991574
4256,DB04528,"2,4-Dinitrophenol",small molecule,experimental,"Benzene Derivatives|Coloring Agents|Compounds used in a research, industrial, or household setting|Dinitrophenols|Enzyme Inhibitors|Nitro Compounds|Nitrophenols|Phenols|Uncoupling Agents",OC1=CC=C(C=C1[N+]([O-])=O)[N+]([O-])=O,1493
4257,DB04529,Desvancosaminyl vancomycin,small molecule,experimental,,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,447876
4258,DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",small molecule,experimental,,N[C@@H](CSSCCO)C(O)=O,170018
4259,DB04531,S-Benzylcysteine,small molecule,experimental,"Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Sulfhydryl Compounds|Sulfur Compounds",N[C@@H](CSCC1=CC=CC=C1)C(O)=O,193613
4260,DB04532,Indole,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring",N1C=CC2=C1C=CC=C2,798
4261,DB04533,2-Amino-4-methylphenol,small molecule,experimental,Benzene Derivatives|Phenols,CC1=CC=C(O)C(N)=C1,7264
4262,DB04534,5-Nitroindazole,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Pyrazoles",[O-][N+](=O)C1=CC=C2NN=CC2=C1,21501
4263,DB04537,Tryptophanamide,small molecule,experimental,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins",N[C@@H](CC1=CNC2=C1C=CC=C2)C(N)=O,439356
4264,DB04538,threo-3-methyl-L-aspartic acid,small molecule,experimental,,C[C@@H]([C@H](N)C(O)=O)C(O)=O,440064
4265,DB04539,Glyphosate,small molecule,experimental,"Agrochemicals|Amino Acids|Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Herbicides|Pesticides|Toxic Actions|Uncoupling Agents",OC(=O)C[NH2+]CP(O)(O)=O,5288464
4266,DB04540,Cholesterol,small molecule,approved|investigational,BCRP/ABCG2 Inducers|Cholestanes|Cholestenes|Fused-Ring Compounds|Lipids|Membrane Lipids|P-glycoprotein inhibitors|Steroids|Sterols,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C,5997
4267,DB04541,Cyclo(prolylglycyl),small molecule,experimental,"Amino Acids, Peptides, and Proteins|Peptides",[H][C@@]12CCCN1C(=O)CNC2=O,126154
4268,DB04542,Zidovudine diphosphate,small molecule,experimental,"Carbohydrates|Deoxyribonucleosides|Deoxyribonucleotides|Dideoxynucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Nucleotides|Pyrimidine Nucleosides|Pyrimidine Nucleotides|Pyrimidines",CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COP(O)(=O)OP(O)(O)=O)O2)C(=O)NC1=O,455742
4269,DB04543,"2,6-Diamino-8-(1h-Imidazol-2-Ylsulfanylmethyl)-3h-Quinazoline-4-One",small molecule,experimental,,NC1=NC2=C(C=C(N)C=C2CSC2=NC=CN2)C(=O)N1,446622
4270,DB04544,1-Deoxy-1-acetylamino-beta-D-gluco-2-heptulopyranosonamide,small molecule,experimental,,[H]N([H])C(=O)[C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)N([H])C(C)=O,445723
4271,DB04545,Afegostat,small molecule,experimental|investigational,"Carbohydrates|Glycoside Hydrolases, antagonists & inhibitors|Imines|Imino Sugars|Piperidines",OC[C@H]1CNC[C@@H](O)[C@@H]1O,447607
4272,DB04546,3-Deazaadenosine,small molecule,experimental,"Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Isomerism|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides",NC1=NC=CC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,23190
4273,DB04547,Inhibitor BEA409,small molecule,experimental,,CNC(=O)[C@@H](NC(=O)[C@H](OCC1=CC=C(C=C1)C1=CSC=C1)[C@H](O)[C@@H](O)[C@@H](OCC1=CC=C(C=C1)C1=CSC=C1)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,445307
4274,DB04548,4-Deoxy-D-Glucuronic Acid,small molecule,experimental,,O[C@H]1C[C@H](O[C@@H](O)[C@@H]1O)C(O)=O,446228
4275,DB04549,"4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide",small molecule,experimental,,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=C(F)C(F)=C(F)C=C1,446240
4276,DB04551,"beta-D-fructofuranose 1,6-bisphosphate",small molecule,experimental,,O[C@H]1[C@H](O)[C@@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O,10267
4277,DB04552,Niflumic acid,small molecule,experimental,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Amines|Aminobenzoates|Analgesics|Analgesics, Non-Narcotic|Aniline Compounds|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antirheumatic Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Fenamates|Musculo-Skeletal System|Nephrotoxic agents|Nicotinic Acids|Niflumic Acid and Prodrugs|ortho-Aminobenzoates|Peripheral Nervous System Agents|Pyridines|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory System Agents|Topical Products for Joint and Muscular Pain|UGT1A9 Inhibitors",OC(=O)C1=C(NC2=CC=CC(=C2)C(F)(F)F)N=CC=C1,4488
4278,DB04553,2-Oxobutanoic Acid,small molecule,experimental,,CCC(=O)C(O)=O,58
4279,DB04554,8-Bromoadenosine-5'-Diphosphate,small molecule,experimental,,[H][C@]1(COP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C(Br)=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,447236
4280,DB04555,Cytidine-5'-Diphosphate,small molecule,experimental,,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O,6132
4281,DB04556,NAP-226-90,small molecule,experimental,Amines|Benzene Derivatives|Ethylamines,C[C@H](N(C)C)C1=CC(O)=CC=C1,445892
4282,DB04557,Arachidonic Acid,small molecule,experimental,"Arachidonic Acids|Autacoids|Biological Factors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Eicosanoids|Fatty Acids|Fatty Acids, Essential|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids",CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O,444899
4283,DB04559,N-(Chlorophenyl)-N'-hydroxyguanidine,small molecule,experimental,,N\C(NO)=N/C1=CC=C(Cl)C=C1,181426
4284,DB04560,"4,7-Dioxosebacic Acid",small molecule,experimental,"Fatty Acids|Lipids|Porphobilinogen Synthase, antagonists & inhibitors",OC(=O)CCC(=O)CCC(=O)CCC(O)=O,1698
4285,DB04561,"4-acetamido-2,4-didexoy-D-glycero-beta-D-galacto-octopyranosylphosphonic acid",small molecule,experimental,,[H][C@]1(O[C@H](C[C@H](O)[C@H]1NC(C)=O)P(O)(O)=O)[C@H](O)[C@H](O)CO,445079
4286,DB04562,Tricarballylic acid,small molecule,experimental,"Acids, Acyclic",OC(=O)CC(CC(O)=O)C(O)=O,14925
4287,DB04563,CRA_9678,small molecule,experimental,,NC(=N)C1=CC2=C(NC(=C2)C2=C(O)C(Br)=CC(CC([O-])=O)=C2)C=C1,17753799
4288,DB04564,Gluconolactone,small molecule,approved|experimental,"Acids, Acyclic|Calculi Dissolution Agent|Carbohydrates|Hydroxy Acids|Irrigation|Sugar Acids",OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O,7027
4289,DB04565,4-(Acetylamino)-3-[(Hydroxyacetyl)Amino]Benzoic Acid,small molecule,experimental,,CC(=O)NC1=CC=C(C=C1NC(=O)CO)C(O)=O,446324
4290,DB04566,Inosinic Acid,small molecule,experimental,,O[C@@H]1[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=CNC2=O,8582
4291,DB04567,Chromophore (Gly-Tyr-Gly),small molecule,experimental,,[H]\C(=C1\N=C(N(CC(O)=O)C1=O)[C@@]([H])(N)[C@@]([H])(C)O)C1=CC=C(O)C=C1,49866829
4292,DB04568,5-Aminoimidazole Ribonucleoside,small molecule,experimental,,[H][C@]1(CO)O[C@@]([H])(N2C=NC=C2N)[C@]([H])(O)[C@]1([H])O,448820
4293,DB04569,Benzyl formate,small molecule,experimental,"Acids, Acyclic",O=COCC1=CC=CC=C1,7708
4294,DB04570,Latamoxef,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Amides|Anions|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|Electrolytes|Gases|Heterocyclic Compounds, Fused-Ring|Hydrogen Sulfide|Ions|Lactams|Nephrotoxic agents|Sulfides|Sulfur Compounds|Third-Generation Cephalosporins",[H][C@]12OCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)C(C(O)=O)C1=CC=C(O)C=C1)OC)C(O)=O,47499
4295,DB04571,Trioxsalen,small molecule,approved,"Antipsoriatics|Antipsoriatics for Systemic Use|Antipsoriatics for Topical Use|Benzopyrans|Coumarins|Dermatologicals|Furocoumarins|Heterocyclic Compounds, Fused-Ring|Photosensitizing Agents|Photosensitizing agents used for phototherapy|Psoralens for Systemic Use|Psoralens for Topical Use|Pyrans|Radiation-Sensitizing Agents",CC1=CC2=CC3=C(OC(=O)C=C3C)C(C)=C2O1,5585
4296,DB04572,Thiotepa,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Alkylating Activity|Alkylating Drugs|Anions|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Aziridines|Azirines|Cholinesterase Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Electrolytes|Ethylene Imines|Immunologic Factors|Immunosuppressive Agents|Ions|Myeloablative Agonists|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Noxae|Organophosphorus Compounds|Phosphoramides|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Toxic Actions|Triethylenephosphoramide",S=P(N1CC1)(N1CC1)N1CC1,5453
4297,DB04573,Estriol,small molecule,approved|investigational|vet_approved,"Estradiol Congeners|Estranes|Estrenes|Estrogens|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Natural and Semisynthetic Estrogens, Plain|P-glycoprotein inducers|P-glycoprotein substrates|Sex Hormones and Modulators of the Genital System|Steroids|Thyroxine-binding globulin inducers",[H][C@@]12C[C@@H](O)[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,5756
4298,DB04574,Estrone sulfate,small molecule,approved,"17-Ketosteroids|Adrenal Cortex Hormones|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Estradiol Congeners|Estranes|Estrenes|Estrogens|Estrogens, Conjugated (USP)|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Ketosteroids|MATE 1 Substrates|MATE 2 Substrates|MATE substrates|Reproductive Control Agents|Steroids|Thyroxine-binding globulin inducers",[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OS(O)(=O)=O)C=C3,3001028
4299,DB04575,Quinestrol,small molecule,approved,"Estradiol Congeners|Estrogenic Steroids, Alkylated|Estrogens|Ethinyl Estradiol|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Norpregnanes|Norpregnatrienes|Norsteroids|Steroids|Thyroxine-binding globulin inducers",[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC1CCCC1)C=C3,9046
4300,DB04576,Fleroxacin,small molecule,experimental,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antineoplastic Agents|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",CN1CCN(CC1)C1=C(F)C=C2C(=O)C(=CN(CCF)C2=C1F)C(O)=O,3357
4301,DB04577,1-(1-phenylcyclopentyl)methylamine,small molecule,experimental,,NCC1(CCCC1)C1=CC=CC=C1,205131
4302,DB04578,"(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",small molecule,experimental,,[H][C@](N)(CC(=O)N1CC2=CC=CC=C2C[C@@]1([H])C(N)=O)CC1=CC=CC=C1F,5494385
4303,DB04579,"N-{[(2S,3S)-3-(Ethoxycarbonyl)-2-oxiranyl]carbonyl}-L-threonyl-L-isoleucine",small molecule,experimental,,CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O,49866368
4304,DB04580,1-Methyl-2-quinolone,small molecule,experimental,,CN1C(=O)C=CC2=CC=CC=C12,11820
4305,DB04581,1-benzylimidazole,small molecule,experimental,Adrenergic Agents|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Neurotransmitter Agents,C(N1C=CN=C1)C1=CC=CC=C1,77918
4306,DB04582,Imazaquin,small molecule,experimental,"Agrochemicals|Compounds used in a research, industrial, or household setting|Herbicides|Heterocyclic Compounds, Fused-Ring|Pesticides|Toxic Actions",CC(C)[C@@]1(C)N=C(NC1=O)C1=NC2=CC=CC=C2C=C1C(O)=O,909781
4307,DB04583,"5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid",small molecule,experimental,,NC(=O)C1=CC(=CC(=C1)C1=CC=C(C=C1)C1=CC=CC=C1)C(O)=O,5287459
4308,DB04584,Phenyldehydroalanine,small molecule,experimental,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins",N\C(=C/C1=CC=CC=C1)C(O)=O,5702627
4309,DB04585,DEHYDRO-2(S)-AMINO-6-BORONOHEXANOIC ACID,small molecule,experimental,,N[C@@H](CC\C=C\[B-](O)(O)O)C(O)=O,657085
4310,DB04586,o-Bromophenol,small molecule,experimental,Benzene Derivatives,OC1=CC=CC=C1Br,7244
4311,DB04587,2'-O-butyl-5-methyluridine,small molecule,experimental,,CCCCO[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C=C(C)C(=O)NC1=O,49866449
4312,DB04588,"N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE",small molecule,experimental,,NS(=O)(=O)C1=CC=C(CNC(=O)C2=C(NN=C2)C2=CC(Cl)=C(O)C=C2O)C=C1,5327104
4313,DB04590,(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID,small molecule,experimental,,CCOC1=CC([C@@H](NC2=CC=C(C=C2)C(N)=N)C(O)=O)=C(F)C(O[C@@H]2CCOC2)=C1,6852220
4314,DB04591,"N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE",small molecule,experimental,,[H][C@@]1(CCCCN1)C(F)(F)CNC1=NC=CC2=C1N=C(CC1=CC=CC=C1N1C=NC=N1)O2,5287492
4315,DB04592,3-Bromo-3-buten-1-ol,small molecule,experimental,,OCCC(Br)=C,533975
4316,DB04593,3-({1-[3-CARBAMIMIDOYL-1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-PROPYLCARBAMOYL]-2-METHYL-BUTYLSULFAMOYL}-METHYL)-BENZOIC ACID,small molecule,experimental,,CC[C@@H](C)[C@@H](NS(=O)(=O)CC1=CC(=CC=C1)C(O)=O)C(=O)N[C@@H](CCC(N)=N)C(=O)NCC1=CC=C(C=C1)C(N)=N,5326876
4317,DB04594,3-hydroxyglutaric acid,small molecule,experimental,"Acids, Acyclic|Dicarboxylic Acids",OC(CC(O)=O)CC(O)=O,181976
4318,DB04595,"(E)-(4S,6S)-8-METHYL-6-((S)-3-METHYL-2-{(S)-2-[(5-METHYL-ISOXAZOLE-3-CARBONYL)-AMINO]-PROPIONYLAMINO}-BUTYRYLAMINO)-5-OXO-4-((R)-2-OXO-PYRROLIDIN-3-YLMETHYL)-NON-2-ENOIC ACID BENZYL ESTER",small molecule,experimental,,CC(C)C[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)C1=NOC(C)=C1)C(=O)N[C@H](\C=C\C(=O)OCC1=CC=CC=C1)C[C@@H]1CCNC1=O,6323191
4319,DB04596,"4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-β-D-mannopyranosyl}-D-glucopyranuronic acid",small molecule,experimental,,[H][C@@]12CO[C@@](C)(O[C@@]1([H])[C@H](O)[C@H](O)[C@H](O[C@H]1[C@H](O)[C@@H](O)C(O)O[C@@H]1C(O)=O)O2)C(O)=O,5287514
4320,DB04597,"[4,6-O-(1-CARBOXYETHYLIDENE)-BETA-D-MANNOSE]",small molecule,experimental,,C[C@@]1(OC[C@H]2O[C@@H](O)[C@@H](O)[C@@H](O)[C@@H]2O1)C(O)=O,4369553
4321,DB04598,2-AMINO-4-CHLORO-3-HYDROXYBENZOIC ACID,small molecule,experimental,,NC1=C(C=CC(Cl)=C1O)C(O)=O,114947
4322,DB04599,Aniracetam,small molecule,experimental,"Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Nervous System|Nootropic Agents|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Psychotropic Drugs|Pyrrolidines",COC1=CC=C(C=C1)C(=O)N1CCCC1=O,2196
4323,DB04600,"4-[(3-BROMO-4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",small molecule,experimental,,NS(=O)(=O)OC1=CC=C(CN(N2C=NN=C2)C2=CC=C(C=C2)C#N)C=C1Br,4369414
4324,DB04601,"4-[(4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",small molecule,experimental,,NS(=O)(=O)OC1=CC=C(CN(N2C=NN=C2)C2=CC=C(C=C2)C#N)C=C1,4369413
4325,DB04602,PUROMYCIN AMINONUCLEOSIDE-5'-MONOPHOSPHATE,small molecule,experimental,,CN(C)C1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](N)[C@H]1O,451597
4326,DB04603,5-Formyl-2'-deoxy-cytidine-5'-monophosphate,small molecule,experimental,,NC1=NC(=O)N(C=C1C=O)[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1,15081829
4327,DB04604,5-iodotubercidin,small molecule,experimental,"Adenosine Kinase, antagonists & inhibitors|Carbohydrates|Enzyme Inhibitors|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides",[H][C@]1(CO)O[C@@]([H])(N2C=C(I)C3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,97297
4328,DB04605,5-Aminoisoquinoline,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring",NC1=CC=CC2=C1C=CN=C2,70766
4329,DB04606,2-[2-ETHANESULFONYLAMINO-3-(5-PROPOXY-1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIMIDOYL-BENZYLAMIDE),small molecule,experimental,,CCCOC1=CC2=C(NC=C2C[C@@H](NS(=O)(=O)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC2=CC=C(C=C2)C(N)=N)C=C1,5326888
4330,DB04607,"PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE",small molecule,experimental,,NS(=O)(=O)C1=CC=C(NC2=CN3C=C(C=CC3=N2)C(=O)C2=C(Cl)C=CC=C2Cl)C=C1,5330608
4331,DB04608,"9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE",small molecule,experimental,,OC1=CC2=C(NC3=CC(=C4C(=O)NC(=O)C4=C23)C2=CC=CC=C2)C=C1,4369491
4332,DB04609,INHIBITOR Q8467 OF DUPONT MERCK,small molecule,experimental,,O[C@@H]1[C@@H](O)[C@@H](CC2=CC=CC=C2)N(CC2=CC(=CC=C2)C(=O)NC2=NC=CS2)C(=O)N(CC2CC2)[C@@H]1CC1=CC=CC=C1,448069
4333,DB04610,"7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin",small molecule,experimental,,C[C@@]1(CCC2=CC=CC=C2)NC2=C(N=C1CO)C(=O)NC(N)=N2,4369143
4334,DB04612,"N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE",small molecule,experimental,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@H](C[C@H]1C(=O)N[C@@H]1CCCC2=CC=CC=C12)OC1=CC=CC=C1)C(C)(C)C,5388929
4335,DB04613,"(E)-(4S,6S)-6-((S)-2-{(S)-2-[(FURAN-2-CARBONYL)-AMINO]-3-METHYL-BUTYRYLAMINO}-3-METHYL-BUTYRYLAMINO)-8-METHYL-5-OXO-4-((R)-2-OXO-PYRROLIDIN-3-YLMETHYL)-NON-2-ENOIC ACID ETHYL ESTER",small molecule,experimental,,CCOC(=O)\C=C\[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)C1=COC=C1,5287569
4336,DB04614,(R)-tacrine(10)-hupyridone,small molecule,experimental,,O=C1NC2=C(C=C1)[C@@H](CCC2)NCCCCCCCCCCNC1=C2CCCCC2=NC2=CC=CC=C12,5326966
4337,DB04615,(S)-tacrine(10)-hupyridone,small molecule,experimental,,O=C1NC2=C(C=C1)[C@H](CCC2)NCCCCCCCCCCNC1=C2CCCCC2=NC2=CC=CC=C12,5326967
4338,DB04616,TACRINE(8)-4-AMINOQUINOLINE,small molecule,experimental,,C(CCCCNC1=C2CCCCC2=NC2=CC=CC=C12)CCCNC1=CC=NC2=CC=CC=C12,656986
4339,DB04617,"(9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM",small molecule,experimental,,[NH3+]CCCCCCCCNC1=C2CCCCC2=[NH+]C2=CC=CC=C12,5287586
4340,DB04618,"4,6-DIDEOXY-4-{[4-[(4-O-HEXOPYRANOSYLHEXOPYRANOSYL)OXY]-5,6-DIHYDROXY-3-(HYDROXYMETHYL)CYCLOHEX-2-EN-1-YL]AMINO}HEXOPYRANOSYL-(1->4)HEXOPYRANOSYL-(1->4)HEXOPYRANOSE",small molecule,experimental,,C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O,4369393
4341,DB04619,Acetophenone,small molecule,experimental,Dermatologicals|Ketones|Photosensitizing Agents|Radiation-Sensitizing Agents,CC(=O)C1=CC=CC=C1,7410
4342,DB04620,Cycloleucine,small molecule,experimental,"Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Cycloparaffins|Cyclopentanes",NC1(CCCC1)C(O)=O,2901
4343,DB04622,N-acetylhistamine,small molecule,experimental,Amines|Autacoids|Biogenic Amines|Biogenic Monoamines|Biological Factors|Ethylamines|Imidazoles|Inflammation Mediators,CC(=O)NCCC1=CNC=N1,69602
4344,DB04623,"2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",small molecule,experimental,,CCOCCOC(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@]1(CC2=CC=CC=C2)NC=C([C@@H]2[C@@H]3OC(=O)N[C@@H]3C3=CC=CC=C23)C1=O,5459358
4345,DB04624,DERIVATIVE OF AKLANONIC ACID METHYL ESTER (AAME),small molecule,experimental,,[H][C@](O)(CC)C[C@@]([H])(O)C1=C(O)C2=C(C=C1CC(=O)OC)C(=O)C1=CC=CC(O)=C1C2=O,42627264
4346,DB04626,Apramycin,small molecule,experimental|vet_approved,Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Carbohydrates|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Glycosides|Narrow Therapeutic Index Drugs|Nephrotoxic agents,CN[C@H]1[C@@H](O)[C@H]2O[C@H](O[C@@H]3[C@@H](N)C[C@@H](N)[C@H](O)[C@H]3O)[C@H](N)C[C@@H]2O[C@@H]1O[C@H]1O[C@H](CO)[C@@H](N)[C@H](O)[C@H]1O,3081545
4347,DB04627,Cyclouridine,small molecule,experimental,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",OC[C@H]1O[C@@H]2[C@@H](OC3=NC(=O)C=CN23)[C@@H]1O,806138
4348,DB04628,Allosamidin,small molecule,experimental,"Agrochemicals|Amino Sugars|Carbohydrates|Chitinases, antagonists & inhibitors|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Hexosamines|Insecticides|Oligosaccharides|Pesticides|Polysaccharides|Toxic Actions",CN(C)C1=N[C@@H]2[C@@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@H]4NC(C)=O)[C@@H](O)[C@H]3NC(C)=O)[C@@H](CO)[C@@H]2O1,119339
4349,DB04629,Aplyronine A,small molecule,experimental,"Actins, antagonists & inhibitors|Lactones|Polyketides",COC[C@H](N(C)C)C(=O)O[C@@H]1C\C=C\C=C\C(=O)O[C@@H](C\C=C\[C@H](OC)C[C@H](C)C\C=C(C)\[C@@H](OC)CC[C@@H](C)[C@@H](O)[C@@H]1C)[C@@H](C)[C@@H](O)[C@@H](C)CC[C@@H](OC(=O)[C@H](C)N(C)C)[C@H](C)[C@H](OC(C)=O)[C@H](C)\C=C\N(C)C=O,11840920
4350,DB04630,Aldosterone,small molecule,experimental|investigational,"11-Hydroxycorticosteroids|Adrenal Cortex Hormones|Aldosterone, metabolism|Corticosteroids|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Immunosuppressive Agents|Mineralocorticoids|P-glycoprotein inducers|P-glycoprotein substrates|Pregnanes|Pregnenediones|Pregnenes|Steroids|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])[C@@H](O)C[C@]12C=O)C(=O)CO,5839
4351,DB04631,Atpenin A5,small molecule,experimental,Pyridines,[H][C@](C)(C[C@]([H])(C)[C@@]([H])(Cl)CCl)C(=O)C1=C(O)C(OC)=C(NC1=O)OC,54676868
4352,DB04632,4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE,small molecule,experimental,,OC1=C(CNC2CCN(CC2)S(=O)(=O)NC2=CC(OC3=CC=C(F)C=C3)=CC=C2)C=CC=C1,5287728
4353,DB04633,"N-ethyl-N-[3-(propylamino)propyl]propane-1,3-diamine",small molecule,experimental,,CCCNCCCNCCCNCC,5494411
4354,DB04634,N-BENZYLOXYCARBONYL-L-SERINE-BETALACTONE,small molecule,experimental,,[H][C@@](C)(NC(=O)OCC1=CC=CC=C1)C(O)=O,736104
4355,DB04636,Glutamine t-butyl ester,small molecule,experimental,,CC(C)(C)OC(=O)[C@@H](N)CCC(N)=O,5287779
4356,DB04637,6-Bromo-1-hexanol,small molecule,experimental,,OCCCCCCBr,77970
4357,DB04638,"2,5-di-tert-butylhydroquinone",small molecule,experimental,"Antioxidants|Benzene Derivatives|Calcium-Transporting ATPases, antagonists & inhibitors|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Phenols|Protective Agents",CC(C)(C)C1=CC(O)=C(C=C1O)C(C)(C)C,2374
4358,DB04639,Biphenylalanine,small molecule,experimental,,[H][C@](N)(CC1=CC=C(C=C1)C1=CC=CC=C1)C(O)=O,2761815
4359,DB04640,"Naphthalene-2,6-disulfonic acid",small molecule,experimental,"Acids|Acids, Noncarboxylic|Arylsulfonates|Arylsulfonic Acids|Naphthalenes|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",OS(=O)(=O)C1=CC2=CC=C(C=C2C=C1)S(O)(=O)=O,11390
4360,DB04641,"3,7-DIHYDROXYNAPHTHALENE-2-CARBOXYLIC ACID",small molecule,experimental,,OC(=O)C1=C(O)C=C2C=CC(O)=CC2=C1,736299
4361,DB04642,"7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID",small molecule,experimental,,OC(=O)CCCCCCOC1=C(Cl)C=C(NC(=O)NC(=O)C2=CC=CC=C2Cl)C=C1Cl,5326884
4362,DB04643,"4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID",small molecule,experimental,,OC(=O)CCCOC1=CC=C(NC(=O)NC(=O)C2=CC=C(Cl)C=C2Cl)C(Cl)=C1,5326885
4363,DB04644,"4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID",small molecule,experimental,,CC1=C(C)C(OCCCC(O)=O)=CC=C1NC(=O)NC(=O)C1=CC=C(Cl)C=C1Cl,5326886
4364,DB04645,"5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID",small molecule,experimental,,CC1=C(NC(=O)NC(=O)C2=CC=C(Cl)C=C2Cl)C=CC=C1OCCCCC(O)=O,5326887
4365,DB04646,Dibromothymoquinone,small molecule,experimental,Benzoquinones|Quinones,CC(C)C1=C(Br)C(=O)C(C)=C(Br)C1=O,34474
4366,DB04647,BOC-GAMMA-D-GLU-L-LYS(CBZ)-D-BOROALA,small molecule,experimental,,C[C@@H](NC(=O)[C@H](CCCCNC(=O)OCC1=CC=CC=C1)NC(=O)CC[C@H](NC(=O)OC(C)(C)C)C(O)=O)B(O)O,5287824
4367,DB04648,S-propylamine-L-cysteine,small molecule,experimental,,NCCCSC[C@H](N)CO,23644529
4368,DB04649,TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S,small molecule,experimental,,CN(CC[C@H](N)CC(=O)N[C@H]1C=C[C@@H](O[C@@H]1C(O)=O)N1C=C[C@@](N)(O)NC1=O)C(N)=N,5287847
4369,DB04650,"5-[(3AS,4R,6AR)-2-OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL]PENTANOIC ACID",small molecule,experimental,,[H][C@]12CS[C@]([H])(CCCCC(O)=O)[C@@]1([H])NC(=O)N2,638035
4370,DB04651,BIOTINOL-5-AMP,small molecule,experimental,,NC1=C2N=CN([C@@H]3O[C@H](CO[P@@](O)(=O)OCCCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)[C@@H](O)[C@H]3O)C2=NC=N1,6102809
4371,DB04652,Corticosterone,small molecule,experimental,"11-Hydroxycorticosteroids|Adrenal Cortex Hormones|Anti-Inflammatory Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Pregnanes|Pregnenediones|Pregnenes|Steroids",[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])[C@@]([H])(O)C[C@]12C)C(=O)CO,5753
4372,DB04653,N-[(benzyloxy)carbonyl]-L-leucyl-N-[(1S)-3-fluoro-1-(4-hydroxybenzyl)-2-oxopropyl]-L-leucinamide,small molecule,experimental,,[H]N([C@@H](CC(C)C)C(=O)N([H])[C@@H](CC(C)C)C(=O)N([H])[C@@H](CC1=CC=C(O)C=C1)C(=O)CF)C(=O)OCC1=CC=CC=C1,11505008
4373,DB04654,4-PIPERIDIN-4-YLBUTANAL,small molecule,experimental,,O=CCCCC1CCNCC1,11840929
4374,DB04655,Metoprine,small molecule,experimental,Antineoplastic Agents|Enzyme Inhibitors|Folic Acid Antagonists|Pyrimidines,CC1=C(C(N)=NC(N)=N1)C1=CC(Cl)=C(Cl)C=C1,24466
4375,DB04656,"1,3,4-TRIHYDROXY-5-(3-PHENOXYPROPYL)-CYCLOHEXANE-1-CARBOXYLIC A CID",small molecule,experimental,,[H][C@@]1(O)C[C@@](O)(C[C@]([H])(CCCOC2=CC=CC=C2)[C@@]1([H])O)C(O)=O,6102758
4376,DB04657,Carboxin,small molecule,approved|experimental,"Agrochemicals|Amides|Amines|Anilides|Aniline Compounds|Compounds used in a research, industrial, or household setting|Fungicides, Industrial|Oxathiins|Pesticides|Toxic Actions",CC1=C(SCCO1)C(=O)NC1=CC=CC=C1,21307
4377,DB04658,"(1S,2R,3S,4R,5S)-8-AZABICYCLO[3.2.1]OCTANE-1,2,3,4-TETROL",small molecule,experimental,,O[C@H]1[C@H]2CC[C@](O)(N2)[C@@H](O)[C@@H]1O,124434
4378,DB04659,"(1S,2S,3R,4S,5S)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL)CYCLOHEXYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE",small molecule,experimental,,OC[C@H]1C[C@@H](S\C(=N/OS(O)(=O)=O)CC2=CC=CC=C2)[C@H](O)[C@@H](O)[C@@H]1O,9600408
4379,DB04660,Choline alfoscerate,small molecule,experimental|investigational,Alcohols|Biological Products|Carbohydrates|Complex Mixtures|Glycerophosphates|Glycerophospholipids|Lecithins|Lipids|Membrane Lipids|Nervous System|Parasympathomimetics|Pharmaceutical Preparations|Phosphatidic Acids|Phosphatidylcholines|Phospholipids|Plant Extracts|Plant Preparations|Sugar Alcohols|Sugar Phosphates|Triose Sugar Alcohols,[H][C@@](O)(CO)COP([O-])(=O)OCC[N+](C)(C)C,657272
4380,DB04661,cis-tetracosenoyl sulfatide,small molecule,experimental,,CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OS(O)(=O)=O)[C@H]1O)NC(=O)CCCCCCCCCCCCC\C=C/CCCCCCCC,5459361
4381,DB04662,OLOMOUCINE II,small molecule,experimental,"Cyclin-Dependent Kinases, antagonists & inhibitors|Heterocyclic Compounds, Fused-Ring",[H][C@@](CC)(CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2O)=N1,5494414
4382,DB04663,"2-KETO-6-PHOSPHATE-D-GLUCONIC ACID, ALPHA-FURANOSE FORM",small molecule,experimental,,O[C@@H]1[C@@H](COP(O)(O)=O)O[C@](O)([C@@H]1O)C(O)=O,5494415
4383,DB04664,Cyclohexyl-pentyl-maltoside,small molecule,experimental,Carbohydrates|Glycosides|Surface-Active Agents,OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](OCCCCCC3CCCCC3)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O,5327073
4384,DB04665,Coumarin,small molecule,experimental,"Anticoagulants|Benzopyrans|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Edema, drug therapy|Heterocyclic Compounds, Fused-Ring|Pyrans|Vitamin K Antagonists",O=C1OC2=CC=CC=C2C=C1,323
4385,DB04666,CHROMOPHORE (LYS-TYR-GLY),small molecule,experimental,,[H]\C(=C1\N=C(N(CC(O)=O)C1=O)[C@@]([H])(N)CCCCN)C1=CC=C(O)C=C1,49866823
4386,DB04667,CHROMOPHORE (HIS-TYR-GLY),small molecule,experimental,,[H][C@](N)(CC1=CN=CN1)C1=NC(C=C2C=CC(=O)C=C2)=C(O)N1CC([O-])=O,131704285
4387,DB04668,CHROMOPHORE (GLU-TYR-GLY),small molecule,experimental,,[H]N=C(CCC(O)=O)C1=N\C(=C(/[H])C2=CC=C(O)C=C2)C(=O)N1CC(O)=O,131704287
4388,DB04669,TRIAZOLOPYRIMIDINE,small molecule,experimental,,BrC1=CC=CC(=C1)C1=NC2=[N+](NC=N2)C(NCC2=CC=NC=C2)=C1,5327131
4389,DB04671,[(1S)-4-[[Amino-[(2R)-2-amino-2-carboxyethyl]sulfanylmethylidene]amino]-1-carboxybutyl]azanium,small molecule,experimental,,N[C@@H](CS\C(N)=N\CCC[C@H]([NH3+])C(O)=O)C(O)=O,131704288
4390,DB04672,"Cyclic 3',5'-thymidine monophosphate",small molecule,experimental,"Carbohydrates|Deoxyribonucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Thymine Nucleotides",[H][C@]1(COP(O)(O)=O)O[C@]([H])(C=C1)N1C=C(C)C(=O)NC1=O,461278
4391,DB04673,4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE,small molecule,experimental,,[H][C@@]1(CC(C)C)CN(CCN1C(=O)C1=NC=C(C=N1)C1=CC=NC=C1)S(=O)(=O)C1=CC2=CC(Cl)=CC=C2N1,49866889
4392,DB04674,"2-HYDROXY-3,5-DIIODOBENZOIC ACID",small molecule,experimental,,OC(=O)C1=C(O)C(I)=CC(I)=C1,8631
4393,DB04676,Dansyllysine,small molecule,experimental,"Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins",CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NCCCC[C@H](N)C(O)=O,121945
4394,DB04677,N-METHYL-N-[(1R)-1-METHYL-2-PHENYLETHYL]PROP-2-EN-1-AMINE,small molecule,experimental,,[H][C@@](C)(CC1=CC=CC=C1)N(C)CC=C,5288103
4395,DB04678,H TYPE II TRISACCHARIDE,small molecule,experimental,,C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]2O[C@H]2[C@H](O)[C@@H](NC(C)=O)[C@H](O)O[C@@H]2CO)[C@@H](O)[C@H](O)[C@@H]1O,5288910
4396,DB04679,Human blood group H type 1 trisaccharide,small molecule,experimental,"Antigens|Antigens, Neoplasm|Biological Factors|Biomarkers|Biomarkers, Tumor|Epitopes",C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]2O[C@H]2[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]2NC(C)=O)[C@@H](O)[C@H](O)[C@@H]1O,5326971
4397,DB04680,GALACTOSE GREASE,small molecule,experimental,,[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCCCCC(=O)OC)[C@]1([H])O,5326972
4398,DB04681,BETA-METHYLLACTOSIDE,small molecule,experimental,,CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O,121942
4399,DB04682,Octylphenoxy polyethoxyethanol,small molecule,experimental,"Adrenal Cortex Hormones|Compounds used in a research, industrial, or household setting|Contraceptive Agents, Female|Contraceptive Agents, Male|Hormonal Contraceptives for Systemic Use|Spermatocidal Agents",CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)C=C1,14123494
4400,DB04683,"(2R)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(9E)-HEXADEC-9-ENOYLOXY]PROPYL (9E)-OCTADEC-9-ENOATE",small molecule,experimental,,CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](CO[P@](O)(=O)OC[C@H](O)CO)OC(=O)CCCCCCC\C=C/CCCCCC,5288113
4401,DB04684,Bis(6-aminohexyl)amine,small molecule,experimental,,NCCCCCCNCCCCCCN,8924
4402,DB04685,"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE",small molecule,experimental,,[H][C@]1(F)C[C@@]([H])(O[C@]1([H])COC(C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1)N1C=CC(=O)NC1=O,4369390
4403,DB04686,CHROMOPHORE (ASP-TYR-GLY),small molecule,experimental,,[H]\C(=C1\N=C(N(CC(O)=O)C1=O)[C@@]([H])(N)CC(O)=O)C1=CC=C(O)C=C1,49866928
4404,DB04687,DIMETHYL THIOPHOSPHATE,small molecule,experimental,,COP(O)(=S)OC,168140
4405,DB04688,Methylecgonine,small molecule,experimental,Alkaloids|Analgesics|Aza Compounds|Azabicyclo Compounds|Central Nervous System Agents|Narcotics|Peripheral Nervous System Agents|Sensory System Agents|Tropanes,[H][C@@]12CC[C@@]([H])(N1C)[C@@]([H])(C(=O)OC)[C@@]([H])(O)C2,104904
4406,DB04689,2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,small molecule,experimental,,CCCC1=C(OCCCOC2=CC3=C(C=C2)N(CC(O)=O)C=C3)C=CC2=C1C=CC(=C2)C(=O)C1=CC=CC=C1,6102812
4407,DB04690,Camptothecin,small molecule,experimental,"Alkaloids|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|BCRP/ABCG2 Substrates|Enzyme Inhibitors|P-glycoprotein substrates|Topoisomerase I Inhibitors|Topoisomerase Inhibitors",CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=CC=CC=C4N=C13)C2=O,24360
4408,DB04691,2'-O-[1-ethyl-1H-imidazol)] thymidine-5'-monophosphate,small molecule,experimental,,CC1=CN([C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2OCCN2C=CN=C2)C(=O)NC1=O,49866943
4409,DB04692,Ethyl (2E)-4-({(2S)-2-[(N-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-valyl)amino]-2-phenylacetyl}amino)-5-[(3S)-2-oxo-3-pyrrolidinyl]-2-pentenoate,small molecule,experimental,,[H]N([C@@H](C(C)C)C(=O)N([H])[C@H](C(=O)N([H])C(C[C@@H]1CCN([H])C1=O)\C=C\C(=O)OCC)C1=CC=CC=C1)C(=O)OC(C)(C)C,23304231
4410,DB04693,"Estrane-3,17-dione",small molecule,experimental,Fused-Ring Compounds|Steroids,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12[H],5288172
4411,DB04694,"2,6-anhydro-3-deoxy-3-fluoronononic acid",small molecule,experimental,,[H][C@]1(O[C@](O)(C(O)=O)[C@]([H])(F)[C@H](O)[C@H]1O)[C@H](O)[C@H](O)CO,5327010
4412,DB04695,Farnesyl thiopyrophosphate,small molecule,experimental,Organophosphates|Organophosphorus Compounds|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Terpenes,[H]\C(CC\C(C)=C(/[H])CSP(O)(=O)OP(O)(O)=O)=C(\C)CCC=C(C)C,657041
4413,DB04696,"4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN",small molecule,experimental,,OC1=C(Br)C=C(C=C1)C1(OC(=O)C2=C3C(C=CC=C13)=C(Cl)C=C2)C1=CC(Br)=C(O)C=C1,5288329
4414,DB04697,TRANS-4-(GUANIDINOMETHYL)-CYCLOHEXANE-L-YL-D-3-CYCLOHEXYLALANYL-L-AZETIDINE-2-YL-D-TYROSINYL-L-HOMOARGININAMIDE,small molecule,experimental,,NC(N)=NCCCC[C@H](NC(=O)[C@@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H]1CCN1C(=O)[C@@H](CC1CCCCC1)NC(=O)[C@@H]1CC[C@H](CN=C(N)N)CC1)C(N)=O,5288332
4415,DB04698,"N-(1,4-dihydro-5H-tetrazol-5-ylidene)-9-oxo-9H-xanthene-2-sulfonamide",small molecule,experimental,,[H]N(C1=NN([H])N=N1)S(=O)(=O)C1=CC2=C(OC3=CC=CC=C3C2=O)C=C1,6102777
4416,DB04699,gamma-butyrolactone,small molecule,experimental,"4-Butyrolactone|4-Butyrolactone, analogs & derivatives|Compounds used in a research, industrial, or household setting|Furans|Lactones|Solvents",O=C1CCCO1,7302
4417,DB04700,GLUTATHIONE SULFINATE,small molecule,experimental,,N[C@@H](CCC(=O)N[C@@H](C[S@](O)=O)C(=O)NCC(O)=O)C(O)=O,5326960
4418,DB04701,S-Methyl glutathione,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Oligopeptides|Peptides",CSC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O,115260
4419,DB04702,"S-[(2E)-3,7-DIMETHYLOCTA-2,6-DIENYL] TRIHYDROGENTHIODIPHOSPHATE",small molecule,experimental,,[H]\C(CSP(O)(=O)OP(O)(O)=O)=C(\C)CCC=C(C)C,5288476
4420,DB04703,Hesperidin,small molecule,approved|investigational,"Benzopyrans|Chromones|Flavanones|Flavonoids|Heterocyclic Compounds, Fused-Ring|Pyrans",COC1=CC=C(C=C1O)[C@@H]1CC(=O)C2=C(O1)C=C(O[C@@H]1O[C@H](CO[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]1O)C=C2O,10621
4421,DB04704,20-hydroxycholesterol,small molecule,experimental,Cholestanes|Cholestenes|Fused-Ring Compounds|Lipids|Membrane Lipids|Oxysterols|Steroids|Sterols,CC(C)CCC[C@@](C)(O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,440711
4422,DB04705,25-Hydroxycholesterol,small molecule,experimental,Cholestanes|Cholestenes|Fused-Ring Compounds|Lipids|Membrane Lipids|Oxysterols|Steroids|Sterols,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)(C)O,65094
4423,DB04706,7beta-hydroxycholesterol,small molecule,experimental,Cholestanes|Cholestenes|Fused-Ring Compounds|Lipids|Membrane Lipids|Oxysterols|Steroids|Sterols,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C,473141
4424,DB04707,Hydroxyfasudil,small molecule,experimental,"Amides|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Piperazines|Sulfonamides|Sulfones|Sulfur Compounds",O=C1NC=CC2=C(C=CC=C12)S(=O)(=O)N1CCCNCC1,3064778
4425,DB04708,"(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",small molecule,experimental,,NC(=O)C[C@H]1C[C@@H](C2=CN[C@](C[C@H](O)[C@H](CC3=CC=CC=C3)NC(=O)O[C@H]3CCOC3)(CC3=CC=CC=C3)C2=O)C2=CC=CC=C12,5459370
4426,DB04709,"(3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE",small molecule,experimental,,[H][C@]12C(=O)N(C(=O)[C@@]1([H])[C@]1([H])CC[C@@]2([H])CC1)C1=CC=C(C2=CC=CC=C12)[N+]([O-])=O,5326911
4427,DB04710,(E)-(S)-4-[(S)-4-METHYL-2-((S)-3-METHYL-2{(S)-2-[(5-METHYL-ISOXAZOLE-3- CARBONYL)-AMINO]-PROPIONYLAMINO}-BUTYRYLAMINO)-PENTANOYLAMINO]-5-((S)-2- OXO-PYRROLIDIN-3-YL)-PENT-2-ENOIC ACID ETHYL ESTER,small molecule,experimental,,CCOC(=O)\C=C\[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)C1=NOC(C)=C1,15959287
4428,DB04711,Iodipamide,small molecule,approved,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Iodinated Contrast Agents|Iodobenzoates|Radiographic Contrast Agent|Roentgenography|Triiodobenzoic Acids|Watersoluble, Hepatotropic X-Ray Contrast Media|X-Ray Contrast Activity|X-Ray Contrast Media, Iodinated",OC(=O)C1=C(I)C(NC(=O)CCCCC(=O)NC2=C(I)C=C(I)C(C(O)=O)=C2I)=C(I)C=C1I,3739
4429,DB04712,ANILINOMETHYL GLUCO-PHENYLIMIDAZOLE,small molecule,experimental,,OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C2=NC(CNC3=CC=CC=C3)=CN12,5459372
4430,DB04713,4-Iodo-D-phenylalanine,small molecule,experimental,,[H][C@@](N)(CC1=CC=C(I)C=C1)C(O)=O,2733279
4431,DB04714,ISOPENTENYL PYROPHOSPHATE,small molecule,experimental,Terpenes,CC(=C)CCO[P@](O)(=O)OP(O)(O)=O,1195
4432,DB04715,IMIDAZOPYRIDAZIN 1,small molecule,experimental,,CC(=O)C1=CC=CC(=C1)C1=CN=C2C=CC(NCC3CC3)=NN12,5459373
4433,DB04716,"2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one",small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Pyridines",CC(C)(C)C1=NC2=C3C=CNC(=O)C3=C3C=C(F)C=CC3=C2N1,5494425
4434,DB04717,2''-O-[N-(3-(aminopropyl)2-aminoethyl]paromomycin,small molecule,experimental,,NCCCNCCO[C@H]1[C@H](O[C@@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2N)O[C@H](CO)[C@H]1O[C@H]1O[C@@H](CN)[C@@H](O)[C@H](O)[C@H]1N,16658532
4435,DB04718,"(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-2-O-{2-[(piperidin-3-ylmethyl)amino]ethyl}-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-2-deoxy-alpha-D-glucopyranoside",small molecule,experimental,,NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2OCCNCC2CCCNC2)[C@H](N)[C@@H](O)[C@@H]1O,5459375
4436,DB04719,"DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE",small molecule,experimental,,CN(C)C1=NC2=C(Br)C(Br)=C(Br)C(Br)=C2N1,5326976
4437,DB04720,"S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE",small molecule,experimental,,CSC1=NC2=C(N1)C(Br)=C(Br)C(Br)=C2Br,5326977
4438,DB04721,"N1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE",small molecule,experimental,,CN1CCN2C1=NC1=C(Br)C(Br)=C(Br)C(Br)=C21,5326978
4439,DB04722,"2-[3-chloro-6-[2,2-difluoro-2-(1-oxidopyridin-1-ium-2-yl)ethyl]imino-1-hydroxypyridin-2-yl]-N-[(1R)-1-(3-chlorophenyl)ethyl]acetamide",small molecule,experimental,,C[C@@H](NC(=O)CC1=C(Cl)C=C\C(=N/CC(F)(F)C2=CC=CC=[N+]2[O-])N1O)C1=CC(Cl)=CC=C1,4369429
4440,DB04723,2-(3-GUANIDINOPHENYL)-3-MERCAPTOPROPANOIC ACID,small molecule,experimental,,NC(N)=NC1=CC=CC(=C1)[C@@H](CS)C(O)=O,4369579
4441,DB04724,"(S)-2-((S)-3-isobutyl-2,5-dioxo-4-quinolin-3-ylmethyl-[1,4]diazepan-1yl)-N-methyl-3-naphtalen-2-yl-propionamide",small molecule,experimental,,CNC(=O)[C@H](CC1=CC2=CC=CC=C2C=C1)N1CCC(=O)N(CC2=CC3=CC=CC=C3N=C2)[C@@H](CC(C)C)C1=O,5326914
4442,DB04725,Licofelone,small molecule,investigational,"Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antirheumatic Agents|Central Nervous System Agents|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Lipoxygenase Inhibitors|Peripheral Nervous System Agents|Sensory System Agents|UGT1A3 substrates",CC1(C)CN2C(CC(O)=O)=C(C(=C2C1)C1=CC=CC=C1)C1=CC=C(Cl)C=C1,133021
4443,DB04726,Lumiflavin,small molecule,experimental,"Biological Factors|Coenzymes|Enzymes and Coenzymes|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Pteridines",CN1C2=CC(C)=C(C)C=C2N=C2C(=O)NC(=O)N=C12,66184
4444,DB04727,"1-{4-[4-Amino-6-(4-methoxyphenyl)furo[2,3-d]pyrimidin-5-yl]phenyl}-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea",small molecule,experimental,,COC1=CC=C(C=C1)C1=C(C2=C(N)N=CN=C2O1)C1=CC=C(NC(=O)NC2=C(F)C=CC(=C2)C(F)(F)F)C=C1,5326956
4445,DB04728,Lividomycin A,small molecule,experimental,,NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)C[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O,72394
4446,DB04729,Gentamicin C1a,small molecule,experimental,Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Carbohydrates|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Glycosides|Narrow Therapeutic Index Drugs|Nephrotoxic agents,CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H]2O)OC[C@]1(C)O,72396
4447,DB04731,1-ACETYL-2-LYSO-SN-GLYCERO-3-PHOSPHOETHANOLAMINE,small molecule,experimental,,CC(=O)OC[C@H](O)CO[P@](O)(=O)OCC[NH3+],6102806
4448,DB04732,N-(4-MORPHOLINE)CARBONYL-B-(1-NAPHTHYL)-L-ALANINE-L-LEUCINE BORONIC ACID,small molecule,experimental,,[H][C@@](CC(C)C)(NC(=O)[C@@]([H])(CC1=C2C=CC=CC2=CC=C1)NC(=O)N1CCOCC1)B(O)O,387442
4449,DB04733,"1,6-DI-O-PHOSPHONO-D-MANNITOL",small molecule,experimental,,O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H](O)COP(O)(O)=O,4369446
4450,DB04734,Citraconic acid,small molecule,experimental,"Acids, Acyclic|Dermatologicals|Dicarboxylic Acids",C\C(=C\C(O)=O)C(O)=O,643798
4451,DB04735,MONOGALACTOSYL-DIACYLGLYCEROL,small molecule,experimental,,CCCCCCCCCCCCCCCC(=O)O[C@@H](CO[C@@H]1O[C@@H](CO)[C@H](O)[C@H](O)[C@@H]1O)COC(=O)CCCCCCCCCCCC,5327038
4452,DB04736,"2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE(BETA1-4)-2-ACETAMIDO-1,6-ANHYDRO-3-O-[(R)-1-CARBOXYETHYL]-2-DEOXY-BETA-D-GLUCOPYRANOSE-L-ALANYL-GAMMA-D-GLUTAMYL-MESO-DIAMINOPIMELYL-D-ALANINE",small molecule,experimental,,C[C@@H](NC(=O)[C@H](CCC[C@@H](N)C(O)=O)NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@@H]1[C@@H](NC(C)=O)[C@@H]2OC[C@@H](O2)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O)C(O)=O)C(O)=O,163626
4453,DB04737,(S)-mandelonitrile,small molecule,experimental,,O[C@H](C#N)C1=CC=CC=C1,439767
4454,DB04738,Motuporin,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Cytotoxins|Peptides",[H]N1[C@H](CCC(=O)N(C)\C(=C/C)C(=O)N([H])[C@H]([C@H](C)C(=O)N([H])[C@@H](C(C)C)C(=O)N([H])[C@@H](\C=C\C(\C)=C\[C@H](C)[C@H](CC2=CC=CC=C2)OC)[C@H](C)C1=O)C(O)=O)C(O)=O,4369034
4455,DB04739,4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE,small molecule,experimental,,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1,4369496
4456,DB04740,Moxalactam (hydrolyzed),small molecule,experimental,,[H]N(C(=O)[C@@H](C(O)=O)C1=CC=C(O)C=C1)C(OC)(C(O)=O)[C@@]1([H])OCC(=C)C(=N1)C(O)=O,5288864
4457,DB04741,Myxothiazol,small molecule,experimental,"Acids, Acyclic|Acrylates|Anti-Infective Agents|Antifungal Agents|Electron Transport Complex III, antagonists & inhibitors|Enzyme Inhibitors|Sulfur Compounds",CO[C@@H](\C=C\C1=CSC(=N1)C1=CSC(=N1)[C@@H](C)\C=C\C=C\C(C)C)[C@@H](C)C(\OC)=C/C(N)=O,10972974
4458,DB04742,"(2R)-2-{(1R)-2-oxo-1-[(2-thienylacetyl)amino]ethyl}-5,6-dihydro-2h-1,3-thiazine-4-carboxylic acid",small molecule,experimental,,[H][C@@](NC(=O)CC1=CC=CS1)(C=O)[C@@]1([H])SCCC(=N1)C(O)=O,5288990
4459,DB04743,Nimesulide,small molecule,approved|investigational|withdrawn,"Agents causing hyperkalemia|Agents that produce hypertension|Amides|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiarrhythmic agents|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antiplatelet agents|Antirheumatic Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Central Nervous System Agents|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory System Agents|Sulfones|Sulfur Compounds|Topical Products for Joint and Muscular Pain",CS(=O)(=O)NC1=C(OC2=CC=CC=C2)C=C(C=C1)[N+]([O-])=O,4495
4460,DB04744,Lawsone,small molecule,experimental,"Anti-Infective Agents|Antifungal Agents|Coloring Agents|Compounds used in a research, industrial, or household setting|Cosmetics|Dermatologicals|Enzyme Inhibitors|Household Products|Naphthalenes|Oxidoreductases|Protective Agents|Quinones|Radiation-Protective Agents|Sunscreen Agents",OC1=CC(=O)C2=CC=CC=C2C1=O,6755
4461,DB04745,2-Hydroxyquinoline,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Quinolines",O=C1NC2=C(C=CC=C2)C=C1,6038
4462,DB04746,"(10E,12Z)-octadecadienoic acid",small molecule,experimental,,CCCCC\C=C/C=C/CCCCCCCCC(O)=O,5282800
4463,DB04747,11-TRANS-13-TRANS-15-CIS-OCTADECATRIENOIC ACID,small molecule,experimental,,CC\C=C/C=C/C=C/CCCCCCCCCC(O)=O,5494436
4464,DB04748,OXIMINOARYLSULFONAMIDE,small molecule,experimental,,C(C)(C)CN(C[C@@H](O)[C@@H](NC(=O)[C@H](C(C)C)N1CCN(CC2=CSC(C)=N2)C1=O)CC1=CC=CC=C1)S(=O)(=O)C1=CC=C(C=C1)\C=N\O,9600417
4465,DB04749,2-(3-OXO-PROPYLSULFANYLCARBONYL)-ETHANETHIOLATE,small molecule,experimental,,[S-]CCC(=O)SCCC=O,5289078
4466,DB04750,OREGON GREEN 488 CARBOXYLATE,small molecule,experimental,,OC(=O)C1=CC(C(O)=O)=C(C=C1)C1=C2C=C(F)C(=O)C=C2OC2=CC(O)=C(F)C=C12,5289081
4467,DB04751,Purvalanol A,small molecule,experimental,"CDC2 Protein Kinase, antagonists & inhibitors|Heterocyclic Compounds, Fused-Ring",[H][C@@](CO)(NC1=NC(NC2=CC=CC(Cl)=C2)=C2N=CN(C(C)C)C2=N1)C(C)C,456214
4468,DB04752,Phosphatidyl ethanol,small molecule,experimental,,[H]\C(CCCCCC)=C(/[H])CCCCCCCC(=O)O[C@@]([H])(COC(=O)CCCCCCC\C([H])=C(\[H])CCCCCCCC)COP(O)(=O)OCCO,52946593
4469,DB04753,"9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",small molecule,experimental,,OC[C@H]1O[C@H]([C@@H]2O[C@H](CP(O)(O)=O)O[C@H]12)C1=CNC2=C1NC=NC2=O,5327013
4470,DB04754,"GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",small molecule,experimental,,NC1=NC(=O)C2=C(N1)N(C=N2)[C@@H]1O[C@H](CO)[C@H]2O[C@@H](CP(O)(O)=O)O[C@@H]12,5327012
4471,DB04755,PROPYL-1-PHOSPHATE,small molecule,experimental,,[O-]CCCOP(=O)=O,49867456
4472,DB04756,"2-[(3,5-Dichloro-4-trioxidanylphenyl)amino]benzoic acid",small molecule,experimental,,OOOC1=C(Cl)C=C(NC2=CC=CC=C2C(O)=O)C=C1Cl,4369477
4473,DB04757,"GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE",small molecule,experimental,,NC1=NC(=O)C2=C(N1)N(C=N2)[C@@H]1O[C@H](CO)[C@H]2O[C@@H](O[C@@H]12)P(O)(O)=O,5327014
4474,DB04758,2-[2-ETHANESULFONYLAMINO-3-(1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIM IDOYL-BENZYLAMIDE),small molecule,experimental,,CCS(=O)(=O)N[C@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC1=CC=C(C=C1)C(N)=N,5326883
4475,DB04759,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)",small molecule,experimental,,CC1=CC(CNC(=O)C2=CC(=NC=N2)C(=O)NCC2=CC=CC(C)=C2)=CC=C1,5289109
4476,DB04760,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)",small molecule,experimental,,CC1=C(F)C=CC(CNC(=O)C2=CC(=NC=N2)C(=O)NCC2=CC(C)=C(F)C=C2)=C1,5289110
4477,DB04761,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]",small molecule,experimental,,O=C(NCC1=CC=CN=C1)C1=CC(=NC=N1)C(=O)NCC1=CN=CC=C1,5289111
4478,DB04762,N-PYRIDOXYL-D-GLUTAMIC ACID-5'-MONOPHOSPHATE,small molecule,experimental,,CC1=NC=C(COP(O)(O)=O)C(CN[C@H](CCC(O)=O)C(O)=O)=C1O,4369489
4479,DB04763,"1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM",small molecule,experimental,,CC1=CC(C)=[N+](CCC2=CC=C(C=C2)S(N)(=O)=O)C(C)=C1,5289159
4480,DB04764,[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE,small molecule,experimental,,NCC1=CC=CC(=C1)C1CCN(CC1)C(=O)C1=CC(CCC2=CC=CC=C2)=CN=C1,657077
4481,DB04765,N-PYRIDOXYL-2-METHYL-L-GLUTAMIC ACID-5'-MONOPHOSPHATE,small molecule,experimental,,CC1=NC=C(COP(O)(O)=O)C(CN[C@@](C)(CCC(O)=O)C(O)=O)=C1O,4369488
4482,DB04767,N-[1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-3-METHYLSULFANYL-PROPYL]-3-HYDROXY-2-PROPOXYAMINO-BUTYRAMID,small molecule,experimental,,CCCS(=O)(=O)N[C@H]([C@H](C)O)C(=O)N[C@@H](CCSC)C(=O)NCC1=CC=C(C=C1)C(N)=N,5289214
4483,DB04768,Pyrithiamine Pyrophosphate,small molecule,experimental,,CC1=NC=C(C[N+]2=CC=CC(CCO[P@](O)(=O)OP(O)(O)=O)=C2C)C(N)=N1,5327150
4484,DB04769,"5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE",small molecule,experimental,,O=C1NC(=O)\C(S1)=C\C1=CC2=C(C=C1)N=CC=N2,5289247
4485,DB04770,"O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL",small molecule,experimental,,[H][C@@](CC)(CO)NC1=NC2=C(N=CN2C(C)C)C(OCC2=CC=CC=C2)=N1,4369502
4486,DB04771,1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE,small molecule,experimental,,CC(C)C[C@H](NC(=O)C1=CC=C(C=C1)[N+]([O-])=O)C(=O)N1CCC[C@H]1C(=O)NCCCCN=C(N)N,5494439
4487,DB04772,1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE,small molecule,experimental,,CC(C)C[C@H](NS(=O)(=O)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)NCCCCN=C(N)N,5494440
4488,DB04773,METHYL (3R)-3-{[(3R)-3-{[(3R)-3-HYDROXYBUTANOYL]OXY}BUTANOYL]OXY}BUTANOATE,small molecule,experimental,,[H][C@](C)(O)CC(=O)O[C@]([H])(C)CC(=O)O[C@]([H])(C)CC(=O)OC,49867580
4489,DB04774,Reidispongiolide A,small molecule,experimental,Lactones|Polyketides,CO[C@H](C\C=C\N(C)C=O)[C@@H](C)C(=O)CC[C@H](C)[C@H](OC)[C@H](C)[C@H]1OC(=O)\C=C\C=C(C)\C[C@H](CC2=CC(=O)O[C@H](C2)[C@H](C)[C@H](C[C@H](OC)\C=C\[C@H](C)[C@H](C[C@@H](OC)\C=C\[C@@H]1C)OC)OC)OC,5289284
4490,DB04775,Reidispongiolide C,small molecule,experimental,,[H]/C1=C([H])\C(=O)O[C@]([H])([C@@]([H])(C)[C@@]([H])(OC)[C@@]([H])(C)CCC(=O)[C@]([H])(C)[C@@]([H])(CCC(O)=O)OC)[C@@]([H])(C)\C([H])=C([H])\[C@@]([H])(C[C@]([H])(OC)[C@@]([H])(C)\C([H])=C([H])\[C@]([H])(C[C@]([H])(OC)[C@@]([H])(C)[C@@]2([H])CC(C[C@@]([H])(C\C(C)=C\1/[H])OC)=CC(=O)O2)OC)OC,52946592
4491,DB04776,(2R)-2-({6-[benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)butan-1-ol,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Purines",[H][C@@](CC)(CO)NC1=NC2=C(N=CN2C(C)C)C(=N1)N(C)CC1=CC=CC=C1,5289296
4492,DB04777,(R)-4-Nitrostyrene oxide,small molecule,experimental,,[O-][N+](=O)C1=CC=C(C=C1)[C@@H]1CO1,1237170
4493,DB04778,SC45647,small molecule,experimental,Amidines|Sweetening Agents,C[C@@H](N[C@@H](NCC(O)O)NC1=CC=C(CN)C=C1)C1=CC=CC=C1,21158881
4494,DB04779,ETHYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE,small molecule,experimental,,CCS\C(CC1=CC=CC=C1)=N/OS(O)(=O)=O,9600421
4495,DB04780,Sulfatide,small molecule,experimental,,CCCCCCCCCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OS(O)(=O)=O)[C@H]1O)[C@H](O)\C=C\CCCCCCCCCCCCC,5459389
4496,DB04781,5-hydroxyvaleric acid,small molecule,experimental,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids",OCCCCC(O)=O,25945
4497,DB04782,(S)-4-Nitrostyrene oxide,small molecule,experimental,,[O-][N+](=O)C1=CC=C(C=C1)[C@H]1CO1,1237169
4498,DB04783,Sphinxolide B,small molecule,experimental,,CO[C@H](C\C=C\N(C)C=O)[C@@H](C)C(=O)CC[C@H](C)[C@H](OC)[C@H](C)[C@H]1OC(=O)\C=C\C=C(C)/C[C@H](CC2=CC(=O)O[C@H]([C@H]2O)[C@H](C)[C@H](C[C@H](OC)\C=C\[C@H](C)[C@@H](O)C[C@@H](OC)\C=C\[C@@H]1C)OC)OC,46937020
4499,DB04784,(R)-1-phenylethanol,small molecule,experimental,,C[C@@H](O)C1=CC=CC=C1,637516
4500,DB04785,Streptolydigin,small molecule,experimental,Anti-Bacterial Agents|Anti-Infective Agents|Carbohydrates|Glycosides,[H][C@@]1([C@H](C)C(=O)NC)N([C@@H]2CC[C@H](O)[C@H](C)O2)C(=O)\C(=C(\O)/C=C/C(/C)=C/[C@@H](C)[C@@]2([H])O[C@@]3(C)O[C@H](C=C[C@@]33CO3)[C@@H]2C)C1=O,54708748
4501,DB04786,Suramin,small molecule,investigational,"Acids|Acids, Noncarboxylic|Agents Against Leishmaniasis and Trypanosomiasis|Anti-Infective Agents|Antinematodal Agents|Antineoplastic Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Arylsulfonates|Arylsulfonic Acids|Naphthalenes|Naphthalenesulfonates|Sulfonic Acids|Sulfur Acids|Sulfur Compounds|Trypanocidal Agents",CC1=C(NC(=O)C2=CC(NC(=O)NC3=CC=CC(=C3)C(=O)NC3=C(C)C=CC(=C3)C(=O)NC3=C4C(C=C(C=C4S(O)(=O)=O)S(O)(=O)=O)=C(C=C3)S(O)(=O)=O)=CC=C2)C=C(C=C1)C(=O)NC1=C2C(C=C(C=C2S(O)(=O)=O)S(O)(=O)=O)=C(C=C1)S(O)(=O)=O,5361
4502,DB04787,Tanaproget,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Oxazines|Receptors, Progesterone, agonists|Sulfur Compounds",CN1C(=CC=C1C1=CC=C2NC(=S)OC(C)(C)C2=C1)C#N,4369524
4503,DB04788,Tagetitoxin,small molecule,experimental,"Acids, Acyclic|Bacterial Toxins",[H]N([H])[C@H]1[C@@H](OC(C)=O)[C@@]2([H])O[C@](CS[C@@]2(O)C(=O)N([H])[H])([C@@H]1OP(O)(O)=O)C(O)=O,5327077
4504,DB04789,5-methyltetrahydrofolic acid,small molecule,investigational|nutraceutical,"Biological Factors|Coenzymes|Enzymes and Coenzymes|Folic Acid and Derivatives|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Pteridines|Pterins|Vitamin B Complex|Vitamins",CN1C(CNC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2=C1C(=O)N=C(N)N2,9825434
4505,DB04790,"2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol",small molecule,experimental,,[H][C@]1(CO[C@]2([H])[C@]([H])(CO[C@]12[H])OC1=CC=CC(=C1)C(N)=N)OC1=CC(=CC=C1)C(N)=N,5326924
4506,DB04791,"2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL",small molecule,experimental,,[H][C@@]1(CO[C@]2([H])[C@@]([H])(CO[C@]12[H])OC1=CC=CC(=C1)C(N)=N)OC1=CC=C(C=C1)C(N)=N,5326925
4507,DB04792,"2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL",small molecule,experimental,,[H][C@]1(CO[C@]2([H])[C@]([H])(CO[C@]12[H])OC1=CC=C(C=C1)C(N)=N)OC1=CC=C(C=C1)C(N)=N,5326926
4508,DB04793,"1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-glucitol",small molecule,experimental,,[H]N=C(N([H])[H])C1=CC=C(O[C@@H]2CO[C@]3([H])[C@H](CO[C@]23[H])OC2=CC=CC(=C2)C(=N[H])N([H])[H])C=C1,5326927
4509,DB04794,Bifonazole,small molecule,approved|investigational,Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Azole Antifungals|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Imidazole and Triazole Derivatives,C1=CN(C=N1)C(C1=CC=CC=C1)C1=CC=C(C=C1)C1=CC=CC=C1,2378
4510,DB04795,Thenoyltrifluoroacetone,small molecule,experimental,"Butanones|Chelating Agents|Compounds used in a research, industrial, or household setting|Ketones|Sequestering Agents|Sulfur Compounds|Thiophenes",FC(F)(F)C(=O)CC(=O)C1=CC=CS1,5601
4511,DB04796,Inecalcitol,small molecule,investigational,"Cholestanes|Cholestenes|Fused-Ring Compounds|Hydrocarbons, Acyclic|Lipids|Membrane Lipids|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)",[H][C@@]1(CC[C@]2([H])\C(CCC[C@]12C)=C\C=C1C[C@@H](O)C[C@H](O)C1)[C@H](C)CC#CC(C)(C)O,6915835
4512,DB04797,Triazolopyridine,small molecule,experimental,,CC(C)C1=NN=C2C=CC(=CN12)C1=C(N=CO1)C1=CC=C(F)C=C1,5289514
4513,DB04798,THIO-ATPA,small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins|Sulfur Compounds",[H][C@]([NH3+])(CC1=C(SN=C1[O-])C(C)(C)C)C(O)=O,5289517
4514,DB04799,"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",small molecule,experimental,Sulfur Compounds,CCCCCCCCCCCC1=C(O)C(=O)C2=C(N=CS2)C1=O,3016416
4515,DB04800,1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID,small molecule,experimental,,CN1N=C(C=C1NS(O)(=O)=O)C1=CC=CC=C1,5327154
4516,DB04801,cis-Vaccenic acid,small molecule,experimental,"Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Lipids",CCCCCC\C=C/CCCCCCCCCC(O)=O,5282761
4517,DB04802,"D-Erythro-2,3-diaminobutyric acid",small molecule,experimental,,C[C@@H](N)[C@@H](N)C(O)=O,14221359
4518,DB04803,Verdoheme,small molecule,experimental,"Biological Factors|Heterocyclic Compounds, Fused-Ring|Metalloporphyrins|Pigments, Biological|Porphyrins",CC1=CC2=CC3=[N+]4C(=CC5=C(C=C)C(C)=C6OC7=C(C=C)C(C)=C8C=C1N2[Fe]4(N56)N78)C(C)=C3CCC(O)=O,131704289
4519,DB04804,"(2S)-2,3-Diaminobutanoic acid",small molecule,experimental,,C[C@@H](N)[C@H](N)C(O)=O,11073394
4520,DB04805,Virginiamycin S1,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Peptides|Peptides, Cyclic|Streptogramins",[H][C@@]12CCCN1C(=O)[C@@H](CC)NC(=O)[C@@H](NC(=O)C1=NC=CC=C1O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@]1([H])CC(=O)CCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N(C)C2=O)C1=CC=CC=C1,5388936
4521,DB04806,(5-BROMO-4-CHLORO-3-INDOLYL)-A-D-MANNOSE,small molecule,experimental,,OC[C@H]1O[C@H](OC2=CNC3=C2C(Cl)=C(Br)C=C3)[C@@H](O)[C@@H](O)[C@@H]1O,5289587
4522,DB04807,4-NITROPHENYL-(6-S-ALPHA-D-XYLOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE,small molecule,experimental,,O[C@@H]1CO[C@H](SC[C@H]2O[C@@H](OC3=CC=C(C=C3)[N+]([O-])=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H]1O,6102810
4523,DB04808,Neamine,small molecule,experimental,Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Carbohydrates|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Glycosides|Narrow Therapeutic Index Drugs|Nephrotoxic agents,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O,72392
4524,DB04809,SALOPHEN-10-PROPIONATE IRON CHELATE,small molecule,experimental,,[Fe+4].[H]\C(=N/C1=C(C=C(CCC(O)=O)C=C1)/N=C(\[H])C1=CC=CC=C1[O-])C1=CC=CC=C1[O-],131704291
4525,DB04810,Salophen-10-carboxylate iron chelate,small molecule,experimental,,[Fe+4].[H]\C(=N/C1=C(C=C(C=C1)C(O)=O)/N=C(\[H])C1=CC=CC=C1[O-])C1=CC=CC=C1[O-],131704292
4526,DB04811,Salophen iron chelate,small molecule,experimental,,[Fe+4].[H]\C(=N/C1=CC=CC=C1\N=C(/[H])C1=CC=CC=C1[O-])C1=CC=CC=C1[O-],131704294
4527,DB04812,Benoxaprofen,small molecule,approved|withdrawn,"Acids, Acyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|Dermatologicals|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|Lipoxygenase Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Propionates|Sensory System Agents",CC(C(O)=O)C1=CC2=C(OC(=N2)C2=CC=C(Cl)C=C2)C=C1,39941
4528,DB04813,Bithionol,small molecule,approved|withdrawn,"Anthelmintics|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Infective Agents|Anti-Infective Agents, Local|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiplatyhelmintic Agents|Antitrematodals|Benzene Derivatives|Dermatologicals|Phenols|Preparations Containing Sulfur",OC1=C(SC2=C(O)C(Cl)=CC(Cl)=C2)C=C(Cl)C=C1Cl,2406
4529,DB04814,Bunamiodyl,small molecule,withdrawn,,CCCC(=O)NC1=C(I)C=C(I)C(\C=C(/CC)C(O)=O)=C1I,6436657
4530,DB04815,Clioquinol,small molecule,approved|vet_approved|withdrawn,"Anti-Infective Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Antiseptics and Disinfectants|Cell-mediated Immunity|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Heterocyclic Compounds, Fused-Ring|Hydroxyquinoline Derivatives|Hydroxyquinolines|Increased Histamine Release|Medicated Dressings|Medicated Dressings With Antiinfectives|Miscellaneous Antifungals|Otologicals|Quinoline Derivatives|Quinolines|Sensory Organs|Standardized Chemical Allergen",OC1=C(I)C=C(Cl)C2=C1N=CC=C2,2788
4531,DB04816,Dantron,small molecule,approved|investigational|withdrawn,Alimentary Tract and Metabolism|Anthracenes|Contact Laxatives|Drugs for Constipation|Enemas|Gastrointestinal Agents|Laxatives|Mutagens|Noxae|Quinones|Toxic Actions,OC1=CC=CC2=C1C(=O)C1=C(C=CC=C1O)C2=O,2950
4532,DB04817,Metamizole,small molecule,approved|investigational|withdrawn,"Agents causing hyperkalemia|Agents that produce hypertension|Aminopyrine|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antipyretics|Central Nervous System Agents|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Nephrotoxic agents|Nervous System|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Pyrazoles|Pyrazolones|Sensory System Agents",CN(CS(O)(=O)=O)C1=C(C)N(C)N(C1=O)C1=CC=CC=C1,522325
4533,DB04818,Iproniazid,small molecule,withdrawn,"Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Hydrazines|Isonicotinic Acids|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Monoamine Oxidase Inhibitors|Monoamine Oxidase Inhibitors, Non-Selective|Nervous System|Psychoanaleptics|Psychotropic Drugs|Pyridines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",CC(C)NNC(=O)C1=CC=NC=C1,3748
4534,DB04819,Methapyrilene,small molecule,withdrawn,Amines|Aminopyridines|Anti-Allergic Agents|Antihistamines for Systemic Use|Central Nervous System Agents|Central Nervous System Depressants|Diamines|Ethylenediamines|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Hypnotics and Sedatives|Neurotransmitter Agents|Polyamines|Pyridines|Substituted Ethylene Diamines,CN(C)CCN(CC1=CC=CS1)C1=NC=CC=C1,8667
4535,DB04820,Nialamide,small molecule,approved|withdrawn,"Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Enzyme Inhibitors|Isonicotinic Acids|Monoamine Oxidase Inhibitors|Monoamine Oxidase Inhibitors, Non-Selective|Nervous System|Psychoanaleptics|Psychotropic Drugs|Pyridines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",O=C(CCNNC(=O)C1=CC=NC=C1)NCC1=CC=CC=C1,4472
4536,DB04821,Nomifensine,small molecule,approved|withdrawn,"Antidepressive Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Uptake Inhibitors|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Psychoanaleptics",CN1CC(C2=CC=CC=C2)C2=C(C1)C(N)=CC=C2,4528
4537,DB04822,Oxeladin,small molecule,approved|withdrawn,"Acids, Carbocyclic|Antitussive Agents|Central Nervous System Agents|Cough and Cold Preparations|Respiratory System Agents",CCN(CC)CCOCCOC(=O)C(CC)(CC)C1=CC=CC=C1,4619
4538,DB04823,Oxyphenisatin,small molecule,investigational|withdrawn,"Alimentary Tract and Metabolism|Contact Laxatives|Drugs for Constipation|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Indoles|Laxatives",OC1=CC=C(C=C1)C1(C(=O)NC2=CC=CC=C12)C1=CC=C(O)C=C1,31315
4539,DB04824,Phenolphthalein,small molecule,approved|withdrawn,"Alimentary Tract and Metabolism|Benzene Derivatives|Compounds used in a research, industrial, or household setting|Contact Laxatives|Drugs for Constipation|Indicators and Reagents|Laboratory Chemicals|Laxatives|Phenolphthaleins|Phenols",OC1=CC=C(C=C1)C1(OC(=O)C2=CC=CC=C12)C1=CC=C(O)C=C1,4764
4540,DB04825,Prenylamine,small molecule,approved|withdrawn,"Adrenergic Agents|Agents causing hyperkalemia|Amines|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Calmodulin, antagonists & inhibitors|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Ethylamines|Hydroxy Acids|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|Phenethylamines|QTc Prolonging Agents|Vasodilating Agents|Vasodilators Used in Cardiac Diseases",CC(CC1=CC=CC=C1)NCCC(C1=CC=CC=C1)C1=CC=CC=C1,9801
4541,DB04826,Thenalidine,small molecule,approved|withdrawn,"Antihistamines for Systemic Use|Antihistamines for Topical Use|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Dermatologicals",CN1CCC(CC1)N(CC1=CC=CS1)C1=CC=CC=C1,27901
4542,DB04827,Urethane,small molecule,approved|withdrawn,"Acids, Acyclic|Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Antineoplastic Agents|Carbamates|Carcinogens|Central Nervous System Agents|Central Nervous System Depressants|Noxae|Toxic Actions",CCOC(N)=O,5641
4543,DB04828,Zomepirac,small molecule,withdrawn,"Acetic Acid Derivatives and Related Substances|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Sensory System Agents",CN1C(CC(O)=O)=CC(C)=C1C(=O)C1=CC=C(Cl)C=C1,5733
4544,DB04829,Lysergic acid diethylamide,small molecule,illicit|investigational|withdrawn,"Agents that produce hypertension|Alkaloids|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Ergolines|Ergot Alkaloids and Derivatives|Hallucinogens|Heterocyclic Compounds, Fused-Ring|Lysergic Acid|Neurotransmitter Agents|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists|Serotonin Receptor Antagonists",[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N(CC)CC,5761
4545,DB04830,Buformin,small molecule,investigational|withdrawn,Alimentary Tract and Metabolism|Amidines|Biguanides|Blood Glucose Lowering Agents|Drugs Used in Diabetes|Guanidines|OCT1 substrates,CCCC\N=C(/N)N=C(N)N,2468
4546,DB04831,Tienilic acid,small molecule,withdrawn,"Acetates|Acids, Acyclic|Antigout Preparations|Antihypertensive Agents|Antirheumatic Agents|Aryloxyacetic Acid Derivatives|Cardiovascular Agents|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Diuretics|Fatty Acids|Fatty Acids, Volatile|Glycolates|High-Ceiling Diuretics|Hydroxy Acids|Lipids|Natriuretic Agents|Phenoxyacetates|Renal Agents|Sulfur Compounds|Thiophenes|Uricosuric Agents",OC(=O)COC1=C(Cl)C(Cl)=C(C=C1)C(=O)C1=CC=CS1,38409
4547,DB04832,Zimelidine,small molecule,approved|withdrawn,Antidepressive Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|P-glycoprotein inhibitors|Psychoanaleptics|Pyridines|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators,CN(C)C\C=C(\C1=CC=C(Br)C=C1)C1=CC=CN=C1,41987
4548,DB04833,Methaqualone,small molecule,illicit|withdrawn,"Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Hypnotics and Sedatives|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Psycholeptics|Quinazolines|Quinazolinones",CC1=CC=CC=C1N1C(C)=NC2=CC=CC=C2C1=O,6292
4549,DB04834,Rapacuronium,small molecule,approved|withdrawn,Agents producing tachycardia|Androstanes|Androstanols|Anticholinergic Agents|Central Nervous System Depressants|Fused-Ring Compounds|Muscarinic Antagonists|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular-Blocking Agents (Nondepolarizing)|Peripheral Nervous System Agents|Steroids,[H][C@@]12C[C@@H]([C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(CC=C)CCCCC1,5311399
4550,DB04835,Maraviroc,small molecule,approved|investigational,Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|CCR5 Co-receptor Antagonist|CCR5 Receptor Antagonists|Cyclohexanes|Cycloparaffins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Direct Acting Antivirals|Hepatotoxic Agents|HIV Fusion Inhibitors|Triazoles|Viral Fusion Protein Inhibitors,CC(C)C1=NN=C(C)N1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)C1=CC=CC=C1,3002977
4551,DB04836,Amineptine,small molecule,illicit|withdrawn,"Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Antidepressive Agents, Tricyclic|Benzocycloheptenes|Central Nervous System Agents|Central Nervous System Depressants|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Non-Selective Monoamine Reuptake Inhibitors|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",OC(=O)CCCCCCNC1C2=CC=CC=C2CCC2=CC=CC=C12,34869
4552,DB04837,Clofedanol,small molecule,approved|withdrawn,Alcohols|Amines|Amino Alcohols|Antitussive Agents|Cough and Cold Preparations|Histamine Antagonists|Histamine H1 Antagonists|Propanols,CN(C)CCC(O)(C1=CC=CC=C1)C1=CC=CC=C1Cl,2795
4553,DB04838,Cyclandelate,small molecule,approved,"Acids, Carbocyclic|Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Hydroxy Acids|Mandelic Acids|Peripheral Vasodilators|Vasodilating Agents",CC1CC(CC(C)(C)C1)OC(=O)C(O)C1=CC=CC=C1,2893
4554,DB04839,Cyproterone acetate,small molecule,approved|investigational,"Adrenal Cortex Hormones|Antiandrogens|Antiandrogens and Estrogens|Antineoplastic Agents|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptive Agents, Male|Contraceptives, Oral|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Other Miscellaneous Therapeutic Agents|Pregnadienes|Pregnanes|Progestin Contraceptives|Progestins|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids|Steroids, Chlorinated",[H][C@@]12C[C@]1([H])[C@@]1(C)C(=CC2=O)C(Cl)=C[C@@]2([H])[C@]3([H])CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)CC[C@]12[H],9880
4555,DB04840,Debrisoquine,small molecule,approved|investigational,"Adrenergic Agents|Antiadrenergic Agents, Peripherally Acting|Antihypertensive Agents|Autonomic Agents|Cardiovascular Agents|Catecholamines|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Guanidine Derivatives|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Neurotransmitter Agents|P-glycoprotein substrates|Peripheral Nervous System Agents|Sympatholytics",NC(=N)N1CCC2=CC=CC=C2C1,2966
4556,DB04841,Flunarizine,small molecule,approved,"Agents causing hyperkalemia|Antiarrhythmic agents|Anticonvulsants|Antimigraine Agents, Miscellaneous|Antivertigo Preparations|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Piperazine Derivatives|Piperazines|Vasodilating Agents",FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1,941361
4557,DB04842,Fluspirilene,small molecule,approved|investigational,Agents causing hyperkalemia|Antiarrhythmic agents|Antidepressive Agents|Antipsychotic Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Diphenylbutylpiperidine Derivatives|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Imidazoles|Moderate Risk QTc-Prolonging Agents|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Piperidines|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Spiro Compounds|Tranquilizing Agents,FC1=CC=C(C=C1)C(CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1)C1=CC=C(F)C=C1,3396
4558,DB04843,Mepenzolate,small molecule,approved,"Acids, Carbocyclic|Agents producing tachycardia|Alimentary Tract and Metabolism|Anticholinergic Agents|Diphenylacetic Acids|Drugs for Functional Gastrointestinal Disorders|Hydroxy Acids|Muscarinic Antagonists|Phenylacetates|Synthetic Anticholinergics, Quaternary Ammonium Compounds",C[N+]1(C)CCCC(C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,4057
4559,DB04844,Tetrabenazine,small molecule,approved|investigational,"Adrenergic Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|Membrane Transport Modulators|Miscellaneous Central Nervous System Agents|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|QTc Prolonging Agents|Quinolizines|Vesicular Monoamine Transporter 2 Inhibitor|Vesicular Monoamine Transporter 2 Inhibitors",COC1=C(OC)C=C2C3CC(=O)C(CC(C)C)CN3CCC2=C1,6018
4560,DB04845,Ixabepilone,small molecule,approved|investigational,Anti-Bacterial Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Cytotoxic Antibiotics and Related Substances|Immunosuppressive Agents|Lactones|Macrolides|Microtubule Inhibition|Microtubule Inhibitors|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Polyketides|Tubulin Modulators,[H][C@]12C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC[C@@]1(C)O2)C(\C)=C\C1=CSC(C)=N1,6445540
4561,DB04846,Celiprolol,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic Agonists|Adrenergic Antagonists|Adrenergic beta-1 Receptor Antagonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-3 Receptor Agonists|Adrenergic beta-Agonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Autonomic Agents|Benzene Derivatives|Beta Blocking Agents, Selective|Beta-Blockers (Beta1 Selective)|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenoxypropanolamines|Phenylurea Compounds|Potential QTc-Prolonging Agents|Propanolamines|Propanols|QTc Prolonging Agents|Sympathomimetics|Vasodilating Agents",CCN(CC)C(=O)NC1=CC=C(OCC(O)CNC(C)(C)C)C(=C1)C(C)=O,2663
4562,DB04847,Roxadustat,small molecule,investigational,"Amino Acids|Amino Acids, Peptides, and Proteins|Antianemic Preparations|Blood and Blood Forming Organs|Heterocyclic Compounds, Fused-Ring|Hypoxia-Inducible Factor-Proline Dioxygenases, antagonists & inhibitors",CC1=NC(C(=O)NCC(O)=O)=C(O)C2=C1C=C(OC1=CC=CC=C1)C=C2,11256664
4563,DB04848,AZD0947,small molecule,investigational,,,
4564,DB04849,Cediranib,small molecule,investigational,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Protein Kinase Inhibitors|Tyrosine Kinase Inhibitors",COC1=CC2=C(C=C1OCCCN1CCCC1)N=CN=C2OC1=C(F)C2=C(NC(C)=C2)C=C1,9933475
4565,DB04850,Posizolid,small molecule,investigational,OATP1B1/SLCO1B1 Inhibitors|Oxazoles,OC[C@H](O)C(=O)N1CCC(=CC1)C1=C(F)C=C(C=C1F)N1C[C@H](COC2=NOC=C2)OC1=O,213049
4566,DB04851,Biricodar,small molecule,investigational,P-glycoprotein inhibitors,COC1=CC(=CC(OC)=C1OC)C(=O)C(=O)N1CCCC[C@H]1C(=O)OC(CCCC1=CN=CC=C1)CCCC1=CN=CC=C1,9963148
4567,DB04852,Implitapide,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CC1=NC2=C(C3=CC=CC=C3N2CC2=CC(=CC=C2)[C@H](C2CCCC2)C(=O)N[C@@H](CO)C2=CC=CC=C2)C(C)=C1,5745206
4568,DB04853,Binodenoson,small molecule,investigational,"Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purinergic Agents|Purinergic Agonists|Purinergic P1 Receptor Agonists|Purines|Ribonucleosides",OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=C(N\N=C\C3CCCCC3)N=C12,9576912
4569,DB04854,Febuxostat,small molecule,approved,Antigout Preparations|Antirheumatic Agents|Drugs causing inadvertant photosensitivity|Musculo-Skeletal System|Photosensitizing Agents|Preparations Inhibiting Uric Acid Production|Sulfur Compounds|Thiazoles|Xanthine Oxidase Inhibitors,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N,134018
4570,DB04855,Dronedarone,small molecule,approved,"Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antiarrhythmic agents|Antiarrhythmics, Class III|Benzofurans|Bradycardia-Causing Agents|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|OCT1 inhibitors|OCT2 Inhibitors|P-glycoprotein inhibitors|Photosensitizing Agents|QTc Prolonging Agents",CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,208898
4571,DB04856,Dexloxiglumide,small molecule,investigational,"Acids, Acyclic|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Fatty Acids|Fatty Acids, Volatile|Lipids|Valerates",CCCCCN(CCCOC)C(=O)[C@@H](CCC(O)=O)NC(=O)C1=CC(Cl)=C(Cl)C=C1,65937
4572,DB04857,Brasofensine,small molecule,investigational,"Amines|Heterocyclic Compounds, Fused-Ring|Hydroxylamines",[H][C@@]12CC[C@@]([H])(N1C)[C@]([H])(\C=N\OC)[C@H](C2)C1=CC(Cl)=C(Cl)C=C1,9614919
4573,DB04858,Tirapazamine,small molecule,investigational,Antineoplastic Agents|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 Substrates|Radiation-Sensitizing Agents|Triazines,NC1=[N+]([O-])C2=C(C=CC=C2)[N+]([O-])=N1,33776
4574,DB04859,Zanapezil,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",O=C(CCC1CCN(CC2=CC=CC=C2)CC1)C1=CC2=C(CCCCN2)C=C1,198752
4575,DB04860,Isatoribine,small molecule,investigational,"Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides",NC1=NC(=O)C2=C(N1)N([C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)C(=O)S2,72231
4576,DB04861,Nebivolol,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic Agonists|Adrenergic Antagonists|Adrenergic beta-1 Receptor Agonists|Adrenergic beta-Agonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Benzopyrans|Beta blocking agents and calcium channel blockers|Beta Blocking Agents and Thiazides|Beta Blocking Agents, Selective|Beta Blocking Agents, Selective, and Thiazides|Beta-Blockers (Beta1 Selective)|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Ethanolamines|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Neurotransmitter Agents|Pyrans|Vasodilating Agents",OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2,71301
4577,DB04862,Merimepodib,small molecule,investigational,"Acids, Acyclic|Benzene Derivatives|IMP Dehydrogenase, antagonists & inhibitors",COC1=C(C=CC(NC(=O)NC2=CC=CC(CNC(=O)O[C@H]3CCOC3)=C2)=C1)C1=CN=CO1,153241
4578,DB04863,Lefradafiban,small molecule,investigational,"Antianginal Agents|Benzene Derivatives|Platelet Glycoprotein GPIIb-IIIa Complex, antagonists & inhibitors|Vasodilating Agents",[H][C@@]1(COC2=CC=C(C=C2)C2=CC=C(C=C2)C(=N)NC(=O)OC)C[C@@H](CC(=O)OC)C(=O)N1,9576916
4579,DB04864,Huperzine A,small molecule,approved|experimental,"Central Nervous System Agents|Cholinergic Agents|Cholinesterase Inhibitors|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Neuroprotective Agents|Neurotransmitter Agents|Protective Agents|Terpenes",[H][C@@]12CC3=C(C=CC(=O)N3)[C@@](N)(CC(C)=C1)\C2=C\C,854026
4580,DB04865,Omacetaxine mepesuccinate,small molecule,approved|investigational,"Alkaloids|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Antineoplastic and Immunomodulating Agents|Benzazepines|Enzyme Inhibitors|Harringtonines|Heterocyclic Compounds, Fused-Ring|Narrow Therapeutic Index Drugs|Protein Synthesis Inhibitors",[H][C@@]1(OC(=O)[C@@](O)(CCCC(C)(C)O)CC(=O)OC)C(OC)=C[C@]23CCCN2CCC2=CC4=C(OCO4)C=C2[C@]13[H],285033
4581,DB04866,Halofuginone,small molecule,investigational|vet_approved,"Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Anti-Infective Agents|Antineoplastic Agents|Antiparasitic Agents|Antiprotozoals|Coccidiostats|Enzyme Inhibitors|Growth Inhibitors|Growth Substances|Heterocyclic Compounds, Fused-Ring|Protein Synthesis Inhibitors|Quinazolines",[H][C@]1(O)CCCN[C@]1([H])CC(=O)CN1C=NC2=C(C=C(Cl)C(Br)=C2)C1=O,456390
4582,DB04867,Lintitript,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Indoles|Sulfur Compounds",OC(=O)CN1C(=CC2=CC=CC=C12)C(=O)NC1=NC(=CS1)C1=CC=CC=C1Cl,122077
4583,DB04868,Nilotinib,small molecule,approved|investigational,Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Highest Risk QTc-Prolonging Agents|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Kinase Inhibitor|Myelosuppressive Agents|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Photosensitizing Agents|Protein Kinase Inhibitors|QTc Prolonging Agents|Tyrosine Kinase Inhibitors|UGT1A1 Inhibitors,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,644241
4584,DB04869,Olcegepant,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Calcitonin Gene-Related Peptide, analogs & derivatives|Heterocyclic Compounds, Fused-Ring|Oligopeptides|Peptides|Receptors, Calcitonin Gene-Related Peptide, antagonists & inhibitors",NCCCC[C@H](NC(=O)[C@@H](CC1=CC(Br)=C(O)C(Br)=C1)NC(=O)N1CCC(CC1)N1CC2=C(NC1=O)C=CC=C2)C(=O)N1CCN(CC1)C1=CC=NC=C1,6918509
4585,DB04870,Oleoyl-estrone,small molecule,investigational,"17-Ketosteroids|Adrenal Cortex Hormones|Anti-Obesity Agents|Drug Carriers|Estradiol Congeners|Estranes|Estrenes|Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Lipids|Steroids",[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC(=O)CCCCCCC\C=C/CCCCCCCC)C=C3,6918373
4586,DB04871,Lorcaserin,small molecule,approved,"Alimentary Tract and Metabolism|Antidepressive Agents|Antiobesity Preparations, Excl. Diet Products|Central Nervous System Depressants|Centrally Acting Antiobesity Products|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 2c Receptor Agonists|Serotonin 5-HT2 Receptor Agonists|Serotonin 5-HT2C Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists",C[C@H]1CNCCC2=CC=C(Cl)C=C12,11658860
4587,DB04872,Osanetant,small molecule,investigational,Antipsychotic Agents|Central Nervous System Agents|Central Nervous System Depressants|Neurotoxic agents|Psychotropic Drugs|Tranquilizing Agents,CN(C(C)=O)C1(CCN(CCC[C@@]2(CCCN(C2)C(=O)C2=CC=CC=C2)C2=CC(Cl)=C(Cl)C=C2)CC1)C1=CC=CC=C1,219077
4588,DB04873,Piboserod,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CCCCN1CCC(CNC(=O)C2=C3OCCCN3C3=CC=CC=C23)CC1,177336
4589,DB04874,Picoplatin,small molecule,investigational,Organometallic Compounds,N.[Cl-].[Cl-].[Pt++].CC1=CC=CC=N1,177358
4590,DB04875,Pralnacasan,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]1CCCN2N1C(=O)[C@H](CCC2=O)NC(=O)C1=NC=CC2=CC=CC=C12,153270
4591,DB04876,Vildagliptin,small molecule,approved|investigational,Agents causing angioedema|Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cycloparaffins|DPP-IV Inhibitors|Drugs Used in Diabetes|Enzyme Inhibitors|Glucagon-Like Peptide 1|Nitriles|Protease Inhibitors|Pyrrolidines,OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N1CCC[C@H]1C#N,6918537
4592,DB04877,Voacamine,small molecule,experimental,"Alkaloids|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|P-glycoprotein inhibitors|Secologanin Tryptamine Alkaloids",[H][C@@]12C[C@H](CC)[C@]3([H])N(C1)CCC1=C(NC4=CC(=C(OC)C=C14)[C@@]1([H])C[C@]4([H])C(C(=O)OC)[C@@]([H])(CC5=C1NC1=CC=CC=C51)N(C)C\C4=C\C)[C@@]3(C2)C(=O)OC,11953931
4593,DB04878,Voglibose,small molecule,investigational,Alcohols|Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Carbohydrates|Cyclohexanes|Cycloparaffins|Drugs Used in Diabetes|Enzyme Inhibitors|Fatty Alcohols|Glycoside Hydrolase Inhibitors|Hexanols|Lipids|Sugar Alcohols,OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O,444020
4594,DB04879,Vatalanib,small molecule,investigational,Enzyme Inhibitors|Protein Kinase Inhibitors|Pyridazines|Tyrosine Kinase Inhibitors,ClC1=CC=C(NC2=NN=C(CC3=CC=NC=C3)C3=CC=CC=C23)C=C1,151194
4595,DB04880,Enoximone,small molecule,approved|investigational,"Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Imidazoles|Phosphodiesterase 3 Inhibitors|Phosphodiesterase Inhibitors|Photosensitizing Agents|Protective Agents|Vasodilating Agents",CSC1=CC=C(C=C1)C(=O)C1=C(C)NC(=O)N1,53708
4596,DB04881,Elacridar,small molecule,investigational,"BCRP/ABCG2 Inhibitors|Benzocycloheptenes|Drug Resistance, Multiple|Heterocyclic Compounds, Fused-Ring|Isoquinolines|P-glycoprotein inhibitors",COC1=CC=CC2=C1NC1=C(C=CC=C1C(=O)NC1=CC=C(CCN3CCC4=CC(OC)=C(OC)C=C4C3)C=C1)C2=O,119373
4597,DB04882,Edotecarin,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Indoles",OCC(CO)NN1C(=O)C2=C3C(NC4=C3C=CC(O)=C4)=C3N([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C4=C(C=CC(O)=C4)C3=C2C1=O,9808998
4598,DB04883,Darusentan,small molecule,investigational,"Acids, Carbocyclic|Endothelin Receptor Antagonists",COC1=CC(OC)=NC(O[C@H](C(O)=O)C(OC)(C2=CC=CC=C2)C2=CC=CC=C2)=N1,177236
4599,DB04884,Dapoxetine,small molecule,investigational,Amines|Antidepressive Agents|Benzene Derivatives|Benzyl Compounds|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Genito Urinary System and Sex Hormones|Hypoglycemia-Associated Agents|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Urologicals,CN(C)[C@@H](CCOC1=CC=CC2=CC=CC=C12)C1=CC=CC=C1,71353
4600,DB04885,Cilansetron,small molecule,investigational,"Alimentary Tract and Metabolism|Antidepressive Agents|Central Nervous System Depressants|Drugs for Functional Gastrointestinal Disorders|Heterocyclic Compounds, Fused-Ring|Indoles|Serotonin Agents|Serotonin Receptor Antagonists",CC1=NC=CN1C[C@H]1CCC2=C(C3=CC=CC4=C3N2CCC4)C1=O,6918107
4601,DB04886,Calanolide A,small molecule,investigational,"Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Benzopyrans|Calophyllum|Coumarins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Plant Extracts|Pyrans",CCCC1=CC(=O)OC2=C1C1=C(C=CC(C)(C)O1)C1=C2[C@@H](O)[C@H](C)[C@@H](C)O1,64972
4602,DB04887,Brecanavir,small molecule,investigational,"Acids, Acyclic|Dioxoles|Heterocyclic Compounds, Fused-Ring",[H][C@]12OCC[C@@]1([H])[C@H](CO2)OC(=O)N[C@@H](CC1=CC=C(OCC2=CSC(C)=N2)C=C1)[C@H](O)CN(CC(C)C)S(=O)(=O)C1=CC2=C(OCO2)C=C1,5743186
4603,DB04888,Bifeprunox,small molecule,investigational,"Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Neurotoxic agents",O=C1NC2=C(O1)C(=CC=C2)N1CCN(CC2=CC(=CC=C2)C2=CC=CC=C2)CC1,208951
4604,DB04889,Bicifadine,small molecule,investigational,Analgesics|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Monoamine Oxidase A Substrates,CC1=CC=C(C=C1)C12CC1CNC2,47953
4605,DB04890,Bepotastine,small molecule,approved,Anti-Allergic Agents|Drugs that are Mainly Renally Excreted|Histamine Antagonists|Histamine H1 Antagonists|Mast Cell Stabilizers,OC(=O)CCCN1CCC(CC1)OC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1,2350
4606,DB04891,Becocalcidiol,small molecule,investigational,Cholestanes|Cholestenes|Fused-Ring Compounds|Lipids|Membrane Lipids|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble),CC[C@@](C)([H])[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1/C[C@](O)([H])C(=C)[C@]([H])(O)C1,5289547
4607,DB04892,Phenserine,small molecule,investigational,"Acids, Acyclic|Alkaloids|Carbamates|Cholinergic Agents|Cholinesterase Inhibitors|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|Neurotransmitter Agents|Phenylcarbamates|Stereoisomerism",[H][C@]12N(C)CC[C@@]1(C)C1=C(C=CC(OC(=O)NC3=CC=CC=C3)=C1)N2C,192706
4608,DB04893,AZD3409,small molecule,investigational,,,
4609,DB04894,Vapreotide,small molecule,experimental|investigational,"Amino Acids, Peptides, and Proteins|Analgesics|Antineoplastic Agents|Central Nervous System Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Pancreatic Hormones|Peptide Hormones|Peptides|Peripheral Nervous System Agents|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormone Release Inhibiting Hormones|Proteins|Sensory System Agents|Somatostatin and Analogues|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(N)=O)NC(=O)[C@H](N)CC1=CC=CC=C1,6918026
4611,DB04896,Milnacipran,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Analgesics|Analgesics, Non-Narcotic|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cyclopropanes|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Norepinephrine Uptake Inhibitors|Peripheral Nervous System Agents|Psychoanaleptics|Psychotropic Drugs|Selective Serotonin Reuptake Inhibitors|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin and Noradrenaline Reuptake Inhibitors|Serotonin Modulators",CCN(CC)C(=O)C1(CC1CN)C1=CC=CC=C1,65833
4613,DB04898,Ximelagatran,small molecule,approved|investigational|withdrawn,Amines|Anticoagulants|Antithrombins|Azetines|Benzene Derivatives|Benzyl Compounds|Blood and Blood Forming Organs|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Enzyme Inhibitors|Hematologic Agents|Protease Inhibitors|Serine Protease Inhibitors,CCOC(=O)CN[C@@H](C(=O)N1CC[C@H]1C(=O)NCC1=CC=C(C=C1)C(\N)=N\O)C1CCCCC1,9574101
4617,DB04903,Pagoclone,small molecule,investigational,"Central Nervous System Depressants|GABA Agents|Heterocyclic Compounds, Fused-Ring|Hypnotics (Nonbenzodiazepine)|Hypnotics and Sedatives",CC(C)CCC(=O)CC1N(C(=O)C2=CC=CC=C12)C1=NC2=C(C=CC(Cl)=N2)C=C1,131664
4619,DB04905,Tesmilifene,small molecule,investigational,Antiplatelet agents|Benzene Derivatives|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Ethers|Hematologic Agents|Histamine Agents|Neurotransmitter Agents|P-glycoprotein inducers|P-glycoprotein inhibitors|Phenols,CCN(CC)CCOC1=CC=C(CC2=CC=CC=C2)C=C1,108092
4621,DB04908,Flibanserin,small molecule,approved|investigational,"Agents that produce hypertension|Antidepressive Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Genito Urinary System and Sex Hormones|Heterocyclic Compounds, Fused-Ring|Miscellaneous Central Nervous System Agents|P-glycoprotein inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Agonists|Serotonin Receptor Antagonists",FC(F)(F)C1=CC(=CC=C1)N1CCN(CCN2C(=O)NC3=CC=CC=C23)CC1,6918248
4622,DB04909,Sitamaquine,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Quinolines",CCN(CC)CCCCCCNC1=CC(OC)=CC2=C(C)C=CN=C12,42548
4623,DB04910,Oxibendazole,small molecule,investigational|vet_approved,"Anthelmintics|Anti-Infective Agents|Antiparasitic Agents|Heterocyclic Compounds, Fused-Ring",CCCOC1=CC2=C(C=C1)N=C(NC(=O)OC)N2,4622
4624,DB04911,Oritavancin,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Carbohydrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Glycoconjugates|Glycopeptide Antibacterials|Glycopeptides|Lipids|Lipoglycopeptide Antibacterial|Lipopeptides|Peptides",CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(NCC5=CC=C(C=C5)C5=CC=C(Cl)C=C5)[C@@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O[C@H]1C[C@](C)(N)[C@@H](O)[C@H](C)O1)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,16136912
4625,DB04912,Stannsoporfin,small molecule,investigational,"Biological Factors|Enzyme Inhibitors|Heme Oxygenase (Decyclizing), antagonists & inhibitors|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Porphyrins",[Cl-].[Cl-].[Sn+4].CCC1=C2[N-]C(\C=C3/N=C(/C=C4\[N-]\C(=C/C5=N/C(=C\2)/C(C)=C5CC)C(C)=C4CCC(O)=O)C(CCC(O)=O)=C3C)=C1C,15978579
4627,DB04915,Idronoxil,small molecule,investigational,"Benzopyrans|Chromones|Flavonoids|Heterocyclic Compounds, Fused-Ring|Pyrans",OC1=CC=C(C=C1)C1=CC2=C(OC1)C=C(O)C=C2,219100
4628,DB04917,Renzapride,small molecule,investigational,"Acids, Carbocyclic|Amides|Antidepressive Agents|Benzene Derivatives|Benzoates|Central Nervous System Depressants|Neurotransmitter Agents|Serotonin 5-HT4 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists|Serotonin Receptor Antagonists",COC1=C(C=CC(N)=C1Cl)C(=O)NC1CCN2CCCC1C2,3052778
4629,DB04918,Ceftobiprole,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|beta-Lactams|Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines",[H][C@@]1(NC(=O)C(=N/O)\C2=NSC(N)=N2)C(=O)N2C(C(O)=O)=C(CS[C@]12[H])\C=C1/CCN(C1=O)[C@]1([H])CCNC1,12993649
4631,DB04920,Clevidipine,small molecule,approved|investigational,Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium Channel Blockers (Dihydropyridine)|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cholinesterase substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dihydropyridine Derivatives|Dihydropyridines|Drugs that are Mainly Renally Excreted|Hypotensive Agents|Membrane Transport Modulators|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC,153994
4634,DB04924,Itopride,small molecule,investigational,"Acids, Carbocyclic|Alimentary Tract and Metabolism|Amides|Benzene Derivatives|Benzoates|Drugs for Functional Gastrointestinal Disorders|Propulsives",COC1=CC=C(C=C1OC)C(=O)NCC1=CC=C(OCCN(C)C)C=C1,3792
4636,DB04926,Neramexane,small molecule,investigational,Cycloparaffins,CC1(C)CC(C)(C)CC(C)(N)C1,6433106
4637,DB04928,XP12B,small molecule,investigational,,,
4638,DB04929,DG031,small molecule,investigational,,,
4639,DB04930,Permethrin,small molecule,approved|investigational,"Agrochemicals|Antiparasitic Products, Insecticides and Repellents|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Ectoparasiticides, Incl. Scabicides|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Enzyme Inhibitors|Insecticides|Monoterpenes|Pesticides|Pyrethrines, Incl. Synthetic Compounds|Pyrethrins|Scabicides and Pediculicides|Terpenes|Toxic Actions",CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC(OC2=CC=CC=C2)=CC=C1,40326
4640,DB04931,Afamelanotide,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Compounds used in a research, industrial, or household setting|Dermatologicals|Hormones, Hormone Substitutes, and Hormone Antagonists|Indicators and Reagents|Laboratory Chemicals|Melanocyte-Stimulating Hormones|Peptide Hormones|Peptides|Protective Agents|Protectives Against UV-Radiation|Protectives Against UV-Radiation for Systemic Use|Proteins",CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O,16197727
4642,DB04933,Eritoran,small molecule,investigational,"Antigens|Antigens, Bacterial|Bacterial Toxins|Biological Factors|Carbohydrates|Endotoxins|Glycoconjugates|Lipids|Lipopolysaccharides|Lipopolysaccharides, antagonists & inhibitors|Oligosaccharides|Polysaccharides|Polysaccharides, Bacterial|Toll-Like Receptor 4, antagonists & inhibitors|Toxins, Biological",CCCCCCCCCCCC(=O)CC(=O)N[C@H]1[C@@H](OP(O)(O)=O)O[C@H](CO[C@@H]2O[C@H](COC)[C@@H](OP(O)(O)=O)[C@H](OCC[C@@H](CCCCCCC)OC)[C@H]2NC(=O)CCCCCCCCC\C=C/CCCCCC)[C@@H](O)[C@@H]1OCCCCCCCCCC,6912404
4643,DB04934,Rifalazil,small molecule,investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics, Antitubercular|Antituberculosis Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Lactams|Lactams, Macrocyclic|Leprostatic Agents",CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C)C(O)=C4C(=O)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C1OC5=CC(=CC(O)=C5N=C1C4=C3C2=O)N1CCN(CC(C)C)CC1,6540558
4644,DB04936,Tagatose,small molecule,investigational,"Carbohydrates|Chelating Agents|Compounds used in a research, industrial, or household setting|Iron Chelating Agents|Monosaccharides|Sequestering Agents",OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO,92092
4645,DB04938,Ospemifene,small molecule,approved|investigational,Benzene Derivatives|Benzylidene Compounds|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Estrogen Agonist/Antagonist|Genito Urinary System and Sex Hormones|Selective Estrogen Receptor Modulators|Sex Hormones and Modulators of the Genital System|Stilbenes,OCCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,3036505
4646,DB04941,Crofelemer,small molecule,approved,"Alimentary Tract and Metabolism|Antidiarrheals|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Benzopyrans|Biopolymers|Chromans|Chromones|Compounds used in a research, industrial, or household setting|Flavonoids|Heterocyclic Compounds, Fused-Ring|Macromolecular Substances|Polymers|Pyrans|Tannins",,
4647,DB04942,Tamibarotene,small molecule,investigational,"Acids, Carbocyclic|Benzene Derivatives|Naphthalenes",CC1(C)CCC(C)(C)C2=C1C=CC(NC(=O)C1=CC=C(C=C1)C(O)=O)=C2,108143
4648,DB04943,LX201,small molecule,investigational,,,
4649,DB04944,Acadesine,small molecule,investigational,"Carbohydrates|Cardiac Therapy|Glycosides|Imidazoles|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides",[H][C@]1(CO)O[C@]([H])([C@H](O)[C@@H]1O)N1C=NC(C(N)=O)=C1N,17513
4651,DB04946,Iloperidone,small molecule,approved,Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antidepressive Agents|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Substrates|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Highest Risk QTc-Prolonging Agents|Histamine Antagonists|Histamine H1 Antagonists|Hyperglycemia-Associated Agents|Nervous System|Neurotoxic agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Schizophrenia|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Tranquilizing Agents,COC1=C(OCCCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C=CC(=C1)C(C)=O,71360
4652,DB04947,Altropane,small molecule,investigational,Alkaloids|Aza Compounds|Azabicyclo Compounds|Iodine Radioisotopes|Tropanes,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)C1=CC=C(F)C=C1)C(=O)OC)N2C\C=C\I,6440180
4653,DB04948,Lofexidine,small molecule,approved|investigational,Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Antidepressive Agents|Antihypertensive Agents|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Drugs Used in Addictive Disorders|Drugs Used in Opioid Dependence|Hypotensive Agents|Imidazoles|Imidazolines|MATE 1 Inhibitors|MATE inhibitors|Moderate Risk QTc-Prolonging Agents|Nervous System|Neurotransmitter Agents|Peripheral Nervous System Agents|QTc Prolonging Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists,CC(OC1=C(Cl)C=CC=C1Cl)C1=NCCN1,30668
4656,DB04951,Pirfenidone,small molecule,approved|investigational,"Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antifibrotic Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Antirheumatic Agents|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Immunosuppressive Agents|Peripheral Nervous System Agents|Pyridines|Pyridones|Sensory System Agents",CC1=CN(C(=O)C=C1)C1=CC=CC=C1,40632
4657,DB04952,Ramoplanin,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Peptides|Peptides, Cyclic",NCCC[C@H]1NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H]([C@@H](O)C)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H]([C@@H](C)O)NC(=O)[C@@H](CCCN)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](CC(N)=O)NC(=O)\C=C/C=C\CC(C)C)[C@@H](OC(=O)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H]([C@@H](C)O)NC(=O)[C@@H](NC1=O)C1=CC=C(C=C1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)C1=CC=C(O)C=C1)C1=CC(Cl)=C(O)C=C1)C(N)=O)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1,73425378
4658,DB04953,Ezogabine,small molecule,approved|investigational,"Acids, Acyclic|Amines|Aniline Compounds|Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Diamines|Drugs that are Mainly Renally Excreted|Membrane Transport Modulators|Nervous System|Polyamines|Potassium Channel Opener|Potassium Channel Openers|Potential QTc-Prolonging Agents|QTc Prolonging Agents|UGT1A1 Substrates|UGT1A3 substrates|UGT1A4 substrates|UGT1A9 Substrates",CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1,121892
4659,DB04954,Tecadenoson,small molecule,investigational,"Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purinergic Agents|Purinergic Agonists|Purinergic P1 Receptor Agonists|Purines|Ribonucleosides",OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N[C@@H]3CCOC3)N=CN=C12,158795
4660,DB04955,Pumactant,small molecule,investigational,Lipids|Membrane Lipids|Pulmonary Surfactants,,
4662,DB04957,Azimilide,small molecule,investigational,"Antiarrhythmic agents|Antiarrhythmics, Class III|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Imidazoles|Imidazolidines|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|QTc Prolonging Agents",CN1CCN(CCCCN2C(=O)CN(N=CC3=CC=C(O3)C3=CC=C(Cl)C=C3)C2=O)CC1,9571004
4665,DB04960,Tipifarnib,small molecule,investigational,"Antineoplastic Agents|Heterocyclic Compounds, Fused-Ring|P-glycoprotein inhibitors|Quinolines",CN1C=NC=C1[C@@](N)(C1=CC=C(Cl)C=C1)C1=CC2=C(C=C1)N(C)C(=O)C=C2C1=CC(Cl)=CC=C1,159324
4666,DB04961,Troxacitabine,small molecule,investigational,Anti-HIV Agents|Anti-Infective Agents|Antineoplastic Agents|Dioxoles|Pyrimidines|Pyrimidinones,NC1=NC(=O)N(C=C1)[C@@H]1CO[C@H](CO)O1,454194
4670,DB04967,Lucanthone,small molecule,investigational,"Anthelmintics|Anti-Infective Agents|Antiparasitic Agents|Antiplatyhelmintic Agents|Heterocyclic Compounds, Fused-Ring|Schistosomicides|Sulfur Compounds|Thioxanthenes|Xanthenes|Xanthones",CCN(CC)CCNC1=C2C(=O)C3=CC=CC=C3SC2=C(C)C=C1,10180
4671,DB04968,PH94B,small molecule,investigational,,,
4673,DB04970,Lesopitron,small molecule,investigational,,ClC1=CN(CCCCN2CCN(CC2)C2=NC=CC=N2)N=C1,60813
4674,DB04971,Reglitazar,small molecule,investigational,,CC1=C(CCOC2=CC=C(CC3C(=O)NOC3=O)C=C2)N=C(O1)C1=CC=CC=C1,
4675,DB04972,Canfosfamide,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Cytotoxins|Oligopeptides|Peptides",N[C@@H](CCC(=O)N[C@@H](CS(=O)(=O)CCOP(=O)(N(CCCl)CCCl)N(CCCl)CCCl)C(=O)N[C@@H](C(O)=O)C1=CC=CC=C1)C(O)=O,5312109
4677,DB04974,Rimiducid,small molecule,investigational,Cross-Linking Reagents,CC[C@H](C(=O)N1CCCC[C@H]1C(=O)O[C@H](CCC1=CC=C(OC)C(OC)=C1)C1=CC(OCC(=O)NCCNC(=O)COC2=CC=CC(=C2)[C@@H](CCC2=CC=C(OC)C(OC)=C2)OC(=O)[C@@H]2CCCCN2C(=O)[C@@H](CC)C2=CC(OC)=C(OC)C(OC)=C2)=CC=C1)C1=CC(OC)=C(OC)C(OC)=C1,
4678,DB04975,Banoxantrone,small molecule,investigational,Anthracenes|Antineoplastic Agents|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Quinones,C[N+](C)([O-])CCNC1=CC=C(NCC[N+](C)(C)[O-])C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O,9955116
4680,DB04977,Plitidepsin,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Peptides|Peptides, Cyclic",[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)C(=O)[C@@H](OC(=O)C[C@H](O)[C@]([H])(NC(=O)[C@@H](NC(=O)[C@@H](CC(C)C)N(C)C(=O)[C@@H]1CCCN1C(=O)C(C)=O)[C@@H](C)OC(=O)[C@H](CC1=CC=C(OC)C=C1)N(C)C2=O)[C@@H](C)CC)C(C)C,9812534
4681,DB04978,SP1049C,small molecule,investigational,"Alcohols|Anthracyclines|Carbohydrates|Compounds used in a research, industrial, or household setting|Ethylene Glycols|Glycols|Glycosides|Macromolecular Substances|Naphthacenes|Polyethylene Glycols|Polymers",,
4683,DB04980,Lemuteporfin,small molecule,investigational,"Alcohols|Biological Factors|Glycols|Heterocyclic Compounds, Fused-Ring|Pigments, Biological",,
4685,DB04982,Talampanel,small molecule,investigational,"Benzazepines|Heterocyclic Compounds, Fused-Ring|Receptors, AMPA, antagonists & inhibitors",C[C@@H]1CC2=CC3=C(OCO3)C=C2C(=NN1C(C)=O)C1=CC=C(N)C=C1,164509
4686,DB04983,Denufosol,small molecule,investigational,"Carbohydrates|Cytosine Nucleotides|Deoxyribonucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Nucleotides|Pyrimidine Nucleosides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleosides|Ribonucleotides",[H]N([H])C1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)N([H])C2=O)O1,9875516
4692,DB04991,XL784,small molecule,investigational,,,
4693,DB04992,AP5346,small molecule,investigational,Organometallic Compounds,,
4694,DB04995,AT1022,small molecule,investigational,,,
4695,DB04996,Satraplatin,small molecule,investigational,Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Organometallic Compounds|Platinum Compounds,N.[Cl-].[Cl-].[Pt+4].CC([O-])=O.CC([O-])=O.NC1CCCCC1,123974
4696,DB04997,ATL1102,small molecule,investigational,,,
4697,DB04998,AGRO100,small molecule,investigational,"Aptamers, Nucleotide|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Oligonucleotides|Polynucleotides",[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)OC1([H])CC([H])(OC1([H])CO)N1C=NC2=C1NC(=N)N=C2O)N1C=NC2=C1NC(=N)N=C2O)N1C=C(C)C(O)=NC1=O)N1C=NC2=C1NC(=N)N=C2O)N1C=NC2=C1NC(=N)N=C2O)N1C=C(C)C(O)=NC1=O)N1C=NC2=C1NC(=N)N=C2O)N1C=NC2=C1NC(=N)N=C2O)N1C=C(C)C(O)=NC1=O)N1C=NC2=C1NC(=N)N=C2O)N1C=NC2=C1NC(=N)N=C2O)N1C=C(C)C(O)=NC1=O)N1C=C(C)C(O)=NC1=O)N1C=NC2=C1NC(=N)N=C2O)N1C=C(C)C(O)=NC1=O)N1C=NC2=C1NC(=N)N=C2O)N1C=NC2=C1NC(=N)N=C2O)N1C=C(C)C(O)=NC1=O)N1C=NC2=C1NC(=N)N=C2O)N1C=NC2=C1NC(=N)N=C2O)N1C=C(C)C(O)=NC1=O)N1C=NC2=C1NC(=N)N=C2O)N1C=NC2=C1NC(=N)N=C2O)N1C=C(C)C(O)=NC1=O)N1C=NC2=C1NC(=N)N=C2O)N1C=NC2=C1NC(=N)N=C2O,
4698,DB04999,MBO7133,small molecule,investigational,,,
4700,DB05001,PSN9301,small molecule,investigational,,,
4701,DB05003,Imexon,small molecule,investigational,Ketones,NC1=NC(=O)N2CC12,68791
4702,DB05004,Peptide YY (3-36),small molecule,investigational,"Amino Acids, Peptides, and Proteins|Gastrointestinal Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Peptide Hormones|Peptides",,
4704,DB05009,Apadenoson,small molecule,investigational,"Acids, Carbocyclic|Adenosine A2 Receptor Agonists|Carbohydrates|Cyclohexanes|Cycloparaffins|Glycosides|Heterocyclic Compounds, Fused-Ring|Hydrocarbons, Acyclic|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purines",CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=C(N=C2N)C#CC[C@H]1CC[C@@H](CC1)C(=O)OC,9805430
4705,DB05010,SGS-742,small molecule,investigational,"Central Nervous System Agents|Compounds used in a research, industrial, or household setting|GABA Agents|GABA Antagonists|Neuroprotective Agents|Neurotransmitter Agents|Protective Agents",CCCCP(O)(=O)CCCN,130021
4707,DB05012,XEN2174,small molecule,investigational,"Amino Acids, Peptides, and Proteins",,
4708,DB05013,Ingenol mebutate,small molecule,approved,Cell Death Inducer|Dermatologicals|Increased Cellular Death|Misc. Skin and Mucous Membrane Agents|Terpenes,[H][C@@]12C[C@@H](C)[C@]34C=C(C)[C@H](OC(=O)C(\C)=C/C)[C@@]3(O)[C@H](O)C(CO)=C[C@@]([H])(C4=O)[C@]1([H])C2(C)C,6918670
4709,DB05014,XL999,small molecule,investigational,,,
4710,DB05015,Belinostat,small molecule,approved|investigational,Amides|Amines|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (weak)|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2A6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Histone Deacetylase Inhibitors|Hydroxy Acids|Hydroxylamines|Immunosuppressive Agents|Myelosuppressive Agents|P-glycoprotein substrates|Sulfones|Sulfur Compounds|UGT1A1 Substrates|UGT1A1 substrates with narrow therapeutic index,ONC(=O)\C=C\C1=CC=CC(=C1)S(=O)(=O)NC1=CC=CC=C1,6918638
4711,DB05016,Ataluren,small molecule,approved|investigational,Musculo-Skeletal System|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|OATP1B3 inhibitors|Oxazoles|UGT1A9 Substrates,OC(=O)C1=CC=CC(=C1)C1=NOC(=N1)C1=CC=CC=C1F,11219835
4712,DB05017,YSIL6,small molecule,investigational,,,
4713,DB05018,Migalastat,small molecule,approved|investigational,Alimentary Tract and Metabolism|Alkaloids|Carbohydrates|Drugs that are Mainly Renally Excreted|Imines|Imino Pyranoses|Imino Sugars|Other Miscellaneous Therapeutic Agents|Piperidines|UGT1A1 Substrates|Various Alimentary Tract and Metabolism Products,OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O,176077
4715,DB05020,Besifovir dipivoxil,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Organophosphorus Compounds|Purines|Purinones|Xanthine derivatives",CC(C)(C)C(=O)OCOP(=O)(COC1(CN2C=NC3=CN=C(N)N=C23)CC1)OCOC(=O)C(C)(C)C,
4716,DB05021,EMZ702,small molecule,investigational,,,
4717,DB05022,Amonafide,small molecule,investigational,"Anti-Infective Agents|Antineoplastic Agents|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Imides|Indicators and Reagents|Intercalating Agents|Isoquinolines|Laboratory Chemicals|Naphthalenes|Piperidines|Piperidones",CN(C)CCN1C(=O)C2=CC=CC3=CC(N)=CC(C1=O)=C23,50515
4718,DB05023,ATL1101,small molecule,investigational,,,
4719,DB05024,CTA018,small molecule,investigational,,,
4720,DB05025,Arimoclomol,small molecule,investigational,Amines,O[C@@H](CON=C(Cl)C1=C[N+]([O-])=CC=C1)CN1CCCCC1,208924
4721,DB05027,DG041,small molecule,investigational,,,
4722,DB05029,Lancovutide,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Bacterial Proteins|Membrane Proteins|Peptides|Pore Forming Cytotoxic Proteins|Proteins",,
4723,DB05032,REV131,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Proteins",,
4724,DB05033,INCB7839,small molecule,investigational,,,
4725,DB05034,Ularitide,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cardiovascular Agents|Diuretics|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Natriuretic Agents|Natriuretic Peptides|Peptide Hormones|Peptides|Peripheral Nervous System Agents|Respiratory System Agents",CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)CNC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CSSC[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC1=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O,16132416
4726,DB05035,Eprotirome,small molecule,investigational,Amides|Amines|Aniline Compounds,CC(C)C1=C(O)C=CC(OC2=C(Br)C=C(NC(=O)CC(O)=O)C=C2Br)=C1,10299876
4727,DB05036,Grn163l,small molecule,investigational,,,
4728,DB05038,Anatibant,small molecule,investigational,"Bradykinin Receptor Antagonists|Heterocyclic Compounds, Fused-Ring",CC1=CC(C)=C2C=CC=C(OCC3=C(Cl)C=CC(=C3Cl)S(=O)(=O)N3CCC[C@H]3C(=O)NCCCNC(=O)C3=CC=C(C=C3)C(N)=N)C2=N1,9831652
4729,DB05039,Indacaterol,small molecule,approved,"Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs for Obstructive Airway Diseases|Heterocyclic Compounds, Fused-Ring|Indenes|P-glycoprotein substrates|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Selective Beta 2-adrenergic Agonists|UGT1A1 Substrates",CCC1=C(CC)C=C2CC(CC2=C1)NC[C@H](O)C1=C2C=CC(=O)NC2=C(O)C=C1,6918554
4731,DB05042,SGS518,small molecule,investigational,,,
4732,DB05043,GSK159797,small molecule,investigational,,,
4733,DB05044,PSN357,small molecule,investigational,,,
4734,DB05045,Obinepitide,small molecule,investigational,,CC[C@H](C)[C@H](N=C(O)[C@H](CC1=CC=C(O)C=C1)N=C(O)[C@H](CCCNC(N)=N)N=C(O)[C@H](CCCNC(N)=N)N=C(O)[C@H](CC(C)C)N=C(O)[C@H](CC(O)=O)N=C(O)[C@H](C)N=C(O)[C@H](C)N=C(O)[C@H](CC1=CC=C(O)C=C1)N=C(O)[C@H](CCC(O)=N)N=C(O)[C@H](C)N=C(O)[C@H](CCSC)N=C(O)[C@H](CCC(O)=N)N=C(O)[C@H](CCC(O)=O)N=C(O)[C@@H]1CCCN1C(=O)[C@@H](N=C(O)[C@H](C)N=C(O)[C@H](CC(O)=N)N=C(O)[C@H](CC(O)=O)N=C(O)CN=C(O)[C@@H]1CCCN1C(=O)[C@H](CC1=CC=C(O)C=C1)N=C(O)[C@@H](N=C(O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)N=C(O)[C@H](CC(C)C)N=C(O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(O)=N[C@@H](CC(O)=N)C(O)=N[C@@H](CCSC)C(O)=N[C@@H](CC(C)C)C(O)=N[C@@H]([C@@H](C)O)C(O)=N[C@@H](CCCNC(N)=N)C(O)=N[C@@H](CCC(O)=N)C(O)=N[C@@H](CCCNC(N)=N)C(O)=N[C@@H](CC1=CC=C(O)C=C1)C(O)=N,131704295
4735,DB05046,V1003,small molecule,investigational,,,
4736,DB05047,CX717,small molecule,illicit|investigational,,O=C(N1CCOCC1)C1=CC2=NON=C2C=C1,
4737,DB05048,Cannabinor,small molecule,investigational,Terpenes,[H][C@]12C[C@]([H])(C(=O)C[C@@H]1C1=C(O)C=C(C=C1OC(=O)\C=C\C(O)=O)C(C)(C)CCCCCC)C2(C)C,10174045
4738,DB05049,DDP733,small molecule,investigational,,,
4739,DB05050,ADL5859,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Heterocyclic Compounds, Fused-Ring|Pyrans|Receptors, Opioid, delta",,
4740,DB05051,BZL101,small molecule,investigational,Biological Products|Complex Mixtures|Pharmaceutical Preparations|Plant Preparations|Scutellaria,,
4741,DB05052,MF101,small molecule,investigational,,,
4742,DB05053,MB-07803,small molecule,investigational,,CCOC(=O)C(C)(C)NP(=O)(NC(C)(C)C(=O)OCC)C1=CC=C(O1)C1=C(SC(N)=N1)C(=O)C(C)(C)C,24770445
4743,DB05054,AN0128,small molecule,investigational,Boron Compounds,,
4744,DB05055,RG2417,small molecule,investigational,,,
4745,DB05056,EGS21,small molecule,investigational,,,
4746,DB05057,Erdosteine,small molecule,approved|investigational,"Acetates|Acids, Acyclic|Cough and Cold Preparations|Expectorants|Fatty Acids|Fatty Acids, Volatile|Lipids|Respiratory System Agents|Sulfhydryl Compounds|Sulfur Compounds",OC(=O)CSCC(=O)NC1CCSC1=O,65632
4747,DB05059,ILY101,small molecule,investigational,,,
4748,DB05060,R1626,small molecule,investigational,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides",,
4749,DB05061,GFT14,small molecule,investigational,,,
4750,DB05063,Mitoquinone,small molecule,investigational,Benzoquinones|Coenzymes|Enzymes and Coenzymes|Quinones,,
4751,DB05064,INCB13739,small molecule,investigational,"11-beta-Hydroxysteroid Dehydrogenase Type 1, antagonists & inhibitors|Amides|Sulfones|Sulfur Compounds",,
4752,DB05068,ATG002,small molecule,investigational,,,
4753,DB05069,ATG003,small molecule,investigational,,,
4754,DB05070,ADX10059,small molecule,investigational,,,
4755,DB05071,ACE393,small molecule,investigational,,,
4756,DB05072,AV608,small molecule,investigational,,,
4757,DB05075,TG-100801,small molecule,investigational,Benzene Derivatives,CC1=C2N=C(NC3=CC=C(OCCN4CCCC4)C=C3)N=NC2=CC(=C1)C1=CC(OC(=O)C2=CC=CC=C2)=CC=C1Cl,11973736
4758,DB05076,Fenretinide,small molecule,investigational,"Alkenes|Anticarcinogenic Agents|Antineoplastic Agents|Biological Factors|Carotenoids|Compounds used in a research, industrial, or household setting|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Protective Agents|Retinoids|Terpenes",C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(=O)NC1=CC=C(O)C=C1,5288209
4759,DB05077,SLV319,small molecule,investigational,"Agents producing tachycardia|Amides|Cannabinoid Receptor Antagonists|Cannabinoids and similars|Receptor, Cannabinoid, CB1, antagonists & inhibitors|Sulfones|Sulfur Compounds",,
4760,DB05078,AER001,small molecule,investigational,,,
4761,DB05079,HY10275,small molecule,investigational,,,
4762,DB05080,OBE101,small molecule,investigational,,,
4763,DB05081,JB991,small molecule,investigational,,,
4764,DB05082,ARX201,small molecule,investigational,,,
4766,DB05085,TM30339,small molecule,investigational,,,
4767,DB05087,Ganaxolone,small molecule,investigational,Fused-Ring Compounds|Pregnanes|Steroids,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@](C)(O)CC[C@]12C,6918305
4768,DB05088,Tetrathiomolybdate,small molecule,investigational,"Adenosine Triphosphatases, antagonists & inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Chelating Agents|Compounds used in a research, industrial, or household setting|Elements|Enzyme Inhibitors|Growth Inhibitors|Growth Substances|Metals|Metals, Heavy|Sequestering Agents|Transition Elements",[S-][Mo]([S-])(=S)=S,25199766
4770,DB05090,FP0011,small molecule,investigational,,,
4771,DB05091,M0002,small molecule,investigational,,,
4772,DB05092,CDP323,small molecule,investigational,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Integrin alpha4",,
4773,DB05093,AX200,small molecule,investigational,,,
4774,DB05095,Cimicoxib,small molecule,investigational,"Agents causing hyperkalemia|Agents that produce hypertension|Amides|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Nephrotoxic agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sulfones|Sulfur Compounds",COC1=C(F)C=C(C=C1)C1=C(Cl)N=CN1C1=CC=C(C=C1)S(N)(=O)=O,213053
4775,DB05096,LY2140023,small molecule,investigational,"Amino Acids, Peptides, and Proteins",,
4777,DB05098,Leptin,small molecule,investigational,"Adipokines|Amino Acids, Peptides, and Proteins|Biological Factors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Intercellular Signaling Peptides and Proteins|Peptide Hormones|Peptides|Proteins",,
4779,DB05100,Prinomastat,small molecule,investigational,Enzyme Inhibitors|Matrix Metalloproteinase Inhibitors|Protease Inhibitors,CC1(C)SCCN([C@H]1C(=O)NO)S(=O)(=O)C1=CC=C(OC2=CC=NC=C2)C=C1,466151
4781,DB05102,Rupintrivir,small molecule,investigational,Anti-Infective Agents|Antiviral Agents|Enzyme Inhibitors|Protease Inhibitors|Pyrrolidines,CCOC(=O)\C=C\[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H](CC(=O)[C@H](C(C)C)NC(=O)C1=NOC(C)=C1)CC1=CC=C(F)C=C1,6440352
4782,DB05103,AN-9,small molecule,investigational,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids",CCCC(=O)OCOC(=O)C(C)(C)C,60748
4783,DB05104,Asimadoline,small molecule,investigational,"Acetates|Acids, Acyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Lipids",CN([C@H](CN1CC[C@H](O)C1)C1=CC=CC=C1)C(=O)C(C1=CC=CC=C1)C1=CC=CC=C1,179340
4784,DB05105,Pleconaril,small molecule,investigational,"Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Common Cold, drug therapy|Direct Acting Antivirals|Oxazoles",CC1=NOC(CCCOC2=C(C)C=C(C=C2C)C2=NOC(=N2)C(F)(F)F)=C1,1684
4786,DB05107,16-Bromoepiandrosterone,small molecule,investigational,"17-Ketosteroids|Adrenal Cortex Hormones|Androstanes|Androstanols|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Steroids|Testosterone Congeners",[H][C@@]12C[C@@H](Br)C(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@@H](O)CC[C@]12C,71613
4787,DB05108,EHT899,small molecule,investigational,,,
4788,DB05109,Trabectedin,small molecule,approved|investigational,"Agents Causing Muscle Toxicity|Alkylating Activity|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Dioxoles|Heterocyclic Compounds, Fused-Ring|Immunosuppressive Agents|Isoquinolines|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Noxae|Tetrahydroisoquinolines|Toxic Actions",[H][C@@]12[C@@H]3SC[C@]4(NCCC5=C4C=C(OC)C(O)=C5)C(=O)OC[C@H](N1[C@@H](O)[C@@H]1CC4=CC(C)=C(OC)C(O)=C4[C@H]2N1C)C1=C2OCOC2=C(C)C(OC(C)=O)=C31,108150
4791,DB05112,AP5280,small molecule,investigational,"Acids, Acyclic|Acrylates|Amides|Drug Delivery Systems|Organometallic Compounds",,
4792,DB05113,105AD7,small molecule,investigational,,,
4793,DB05114,EHC18,small molecule,investigational,,,
4794,DB05115,NN344,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Insulin|Insulin, Long-Acting|Pancreatic Hormones|Peptide Hormones|Peptides|Protein Precursors|Proteins",,
4795,DB05116,Thymectacin,small molecule,investigational,"Carbohydrates|Deoxyribonucleosides|Deoxyuridine|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Nucleotides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",COC(=O)[C@H](C)NP(=O)(OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(\C=C\Br)C(=O)NC1=O)OC1=CC=CC=C1,6440764
4797,DB05118,R1204,small molecule,investigational,,,
4798,DB05119,Rilapladib,small molecule,investigational,"Acetates|Acids, Acyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Heterocyclic Compounds, Fused-Ring|Lipids|Quinolines",COCCN1CCC(CC1)N(CC1=CC=C(C=C1)C1=CC=C(C=C1)C(F)(F)F)C(=O)CN1C(SCC2=C(F)C(F)=CC=C2)=CC(=O)C2=C1C=CC=C2,9918381
4799,DB05120,AT1391,small molecule,investigational,,,
4801,DB05122,R1295,small molecule,investigational,,,
4802,DB05123,Gemcabene,small molecule,investigational,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids",CC(C)(CCCCOCCCCC(C)(C)C(O)=O)C(O)=O,157692
4803,DB05124,ARC183,small molecule,investigational,,,
4804,DB05125,SC12267,small molecule,investigational,,,
4805,DB05126,PYM50018,small molecule,investigational,,,
4806,DB05127,ANA971,small molecule,investigational,,,
4807,DB05128,Aminocandin,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Echinocandin Antifungal|Lipids|Peptides",CCCCCCCCOC1=CC=C(C=C1)C1=CC=C(C=C1)C(=O)N[C@H]1CC(CNC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)CC1=CC=C(O)C=C1)NCCN,16072305
4808,DB05129,Elsamitrucin,small molecule,investigational,"Antibiotics, Antineoplastic|Antineoplastic Agents|Carbohydrates|Glycosides",CO[C@@H]1[C@@H](N)[C@@H](O[C@H]2[C@H](OC3=CC=CC4=C3C3=C5C(C(=O)OC6=C5C(=C(C)C=C6)C(=O)O3)=C4O)O[C@H](C)[C@H](O)[C@]2(C)O)O[C@H](C)[C@@H]1O,5362259
4809,DB05130,INCB3284,small molecule,investigational,"Acids, Carbocyclic|Amides|Amino Acids|Amino Acids, Peptides, and Proteins|Benzene Derivatives|Benzoates",,
4810,DB05131,TTP889,small molecule,investigational,,,
4811,DB05132,ND1251,small molecule,investigational,,,
4812,DB05133,VP025,small molecule,investigational,,,
4813,DB05134,Tanespimycin,small molecule,investigational,"Amides|HSP90 Heat-Shock Proteins, antagonists & inhibitors|Lactams|Protein-Serine-Threonine Kinases, antagonists & inhibitors|Quinones",[H]/C1=C([H])/[C@]([H])(OC)[C@@]([H])(OC(O)=N)C(C)=C([H])[C@]([H])(C)[C@@]([H])(O)[C@]([H])(C[C@]([H])(C)CC2=C(NCC=C)C(=O)C=C(N=C(O)\C(C)=C\1/[H])C2=O)OC,6505803
4814,DB05135,Vibriolysin,small molecule,investigational,,,
4816,DB05137,Lobeline,small molecule,investigational,Alkaloids|Autonomic Agents|Cholinergic Agents|Cholinergic Agonists|Ganglionic Stimulants|Neurotransmitter Agents|Nicotinic Agonists|Peripheral Nervous System Agents|Piperidines|Respiratory System Agents,CN1[C@H](C[C@H](O)C2=CC=CC=C2)CCC[C@@H]1CC(=O)C1=CC=CC=C1,101616
4820,DB05141,LY2181308,small molecule,investigational,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Polynucleotides",,
4821,DB05142,ND7001,small molecule,investigational,,,
4822,DB05143,OXI-4503,small molecule,investigational,"Acids|Acids, Noncarboxylic|Anions|Benzene Derivatives|Benzylidene Compounds|Electrolytes|Ions|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Polyphosphates",[H]\C(=C(/[H])C1=C(OP(O)(O)=O)C(OP(O)(O)=O)=C(OC)C=C1)C1=CC(OC)=C(OC)C(OC)=C1,6918546
4825,DB05146,XL820,small molecule,investigational,,,
4826,DB05147,CYT997,small molecule,investigational,,,
4827,DB05148,CG0070,small molecule,investigational,,,
4828,DB05149,XL844,small molecule,investigational,,,
4829,DB05150,CAD106,small molecule,investigational,,,
4830,DB05151,TST10088,small molecule,investigational,,,
4831,DB05152,NGX267,small molecule,investigational,Cholinergic Agents|Cholinergic Agonists|Muscarinic Agonists|Neurotransmitter Agents|Sulfur Compounds,CC[C@@H]1SC2(CCN(C)CC2)NC1=O,
4832,DB05154,Pretomanid,small molecule,approved,Antituberculosis Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Imidazoles|Nitro Compounds|OAT3/SLC22A8 Inhibitors,[O-][N+](=O)C1=CN2C[C@@H](COC2=N1)OCC1=CC=C(OC(F)(F)F)C=C1,456199
4833,DB05155,CR665,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Nerve Tissue Proteins|Neuropeptides|Peptides|Proteins",CCCC[C@@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC1=CC=NC=C1,25030387
4834,DB05156,SL017,small molecule,investigational,,,
4835,DB05157,KC706,small molecule,investigational,,,
4836,DB05158,PM02734,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Peptides|Peptides, Cyclic",,
4837,DB05159,CCX915,small molecule,investigational,,,
4838,DB05160,Topsalysin,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Biological Factors|Membrane Proteins|Proteins|Toxins, Biological",,
4839,DB05161,Elafin,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Enzyme Inhibitors|Peptides|Protease Inhibitors|Proteinase Inhibitory Proteins, Secretory|Proteins",,
4840,DB05163,PV903,small molecule,investigational,,,
4842,DB05165,LY2275796,small molecule,investigational,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Polynucleotides",,
4843,DB05166,APD668,small molecule,investigational,,,
4845,DB05168,Vintafolide,small molecule,investigational,"Alkaloids|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Biological Factors|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|Pigments, Biological|Pteridines|Pterins|Secologanin Tryptamine Alkaloids|Vinca Alkaloids",[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C)[C@@]1([H])[C@](O)([C@H](O)[C@]2(CC)C=CC3)C(=O)NNC(=O)OCCSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)CC[C@H](NC(=O)C1=CC=C(NCC2=CNC3=NC(N)=NC(=O)C3=N2)C=C1)C(O)=O)C(O)=O)[C@]1(C[C@@]2([H])C[N@](C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC,122173811
4846,DB05169,AT9283,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Protein Kinase Inhibitors",,
4847,DB05170,Benzimate,small molecule,investigational,,,
4848,DB05171,E-2012,small molecule,investigational,Amyloid Precursor Protein Secretases,[H]\C(C1=CC(OC)=C(C=C1)N1C=NC(C)=C1)=C1\CCCN(C1=O)[C@@]([H])(C)C1=CC=C(F)C=C1,11560787
4849,DB05172,AT3022,small molecule,investigational,,,
4850,DB05173,PTC299,small molecule,investigational,"Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antirheumatic Agents|Central Nervous System Agents|Enzyme Inhibitors|Peripheral Nervous System Agents|Sensory System Agents|Sulfur Compounds",,
4851,DB05174,CX501,small molecule,investigational,,,
4852,DB05177,DG051,small molecule,investigational,,,
4853,DB05178,DLO6001,small molecule,investigational,,,
4854,DB05179,DLO6002,small molecule,investigational,,,
4855,DB05180,LX6171,small molecule,investigational,,,
4856,DB05181,BTA798,small molecule,investigational,,,
4857,DB05182,AS1409,small molecule,investigational,,,
4858,DB05183,MLN0415,small molecule,investigational,,,
4859,DB05184,XL228,small molecule,investigational,,,
4860,DB05185,TRO19622,small molecule,investigational,Cholestanes|Cholestenes|Fused-Ring Compounds|Steroids,,
4861,DB05186,SQ-109,small molecule,investigational,Amines|Cycloparaffins|Diamines|Polyamines,CC(C)=CCC\C(C)=C\CNCCNC1C2CC3CC(C2)CC1C3,5274428
4862,DB05187,Elafibranor,small molecule,investigational,"Acids, Acyclic|Benzopyrans|Chromones|Fatty Acids|Fatty Acids, Volatile|Flavonoids|Heterocyclic Compounds, Fused-Ring|Ketones|Lipids|PPAR alpha, agonists|PPAR delta, agonists|Propiophenones|Pyrans",CSC1=CC=C(C=C1)C(=O)\C=C\C1=CC(C)=C(OC(C)(C)C(O)=O)C(C)=C1,9864881
4863,DB05188,KD3010,small molecule,investigational,"Amides|PPAR delta, antagonists & inhibitors|Sulfones|Sulfur Compounds",CC1=CC=C(C=C1)S(O)(=O)=O.[H]C1(CC2=C(C1)C(=CC=C2)S(=O)(=O)N1[C@@]([H])(C)CN(C[C@@]1([H])C)C1=CC=C(OC(F)(F)F)C=C1)C(O)=O,
4864,DB05189,EPC2407,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Pyrans",,
4865,DB05190,XL281,small molecule,investigational,,,
4866,DB05191,Atl146e,small molecule,investigational,"Acids, Carbocyclic|Adenosine A2 Receptor Agonists|Cyclohexanes|Cycloparaffins|Heterocyclic Compounds, Fused-Ring",,
4867,DB05192,MB07811,small molecule,investigational,Organophosphorus Compounds,,
4868,DB05194,KB002,small molecule,investigational,,,
4869,DB05195,ADC4022,small molecule,investigational,,,
4870,DB05196,ACR325,small molecule,investigational,,,
4871,DB05197,Sofalcone,small molecule,investigational,"Anti-Ulcer Agents|Benzopyrans|Chromones|Flavonoids|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Ketones|Propiophenones|Pyrans",CC(C)=CCOC1=CC=C(\C=C\C(=O)C2=C(OCC(O)=O)C=C(OCC=C(C)C)C=C2)C=C1,5282219
4872,DB05198,CYC116,small molecule,investigational,Protein Kinase Inhibitors|Sulfur Compounds,,
4873,DB05199,LX1031,small molecule,investigational,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Benzene Derivatives|Tryptophan Hydroxylase, antagonists & inhibitors",,
4874,DB05200,AT2220,small molecule,investigational,,,
4875,DB05201,V24343,small molecule,investigational,,,
4877,DB05203,SPP1148,small molecule,investigational,,,
4878,DB05204,XL418,small molecule,investigational,,,
4879,DB05205,CX157,small molecule,investigational,,,
4880,DB05207,SD118,small molecule,investigational,,,
4882,DB05210,SF1126,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Benzopyrans|Heterocyclic Compounds, Fused-Ring|Peptides|Pyrans",,
4883,DB05211,PS386113,small molecule,investigational,,,
4884,DB05212,HE3286,small molecule,investigational,"17-Ketosteroids|Adrenal Cortex Hormones|Androstanes|Androstenes|Androstenols|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Steroids",[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](O)C=C2C[C@@H](O)CC[C@]12C,16739648
4885,DB05214,KD7040,small molecule,investigational,,,
4886,DB05217,GMX1777,small molecule,investigational,Amidines,,
4888,DB05219,Crisaborole,small molecule,approved|investigational,"Agents for Dermatitis, Excluding Corticosteroids|Anti-Inflammatory Agents|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (weak)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Phosphodiesterase 4 Inhibitors|Phosphodiesterase Inhibitors",OB1OCC2=C1C=CC(OC1=CC=C(C=C1)C#N)=C2,44591583
4889,DB05220,Alisertib,small molecule,investigational,Protein Kinase Inhibitors,COC1=CC(NC2=NC=C3CN=C(C4=CC(Cl)=CC=C4C3=N2)C2=C(OC)C=CC=C2F)=CC=C1C(O)=O,24771867
4891,DB05223,Pracinostat,small molecule,investigational,"Antineoplastic Agents|Heterocyclic Compounds, Fused-Ring|Histone Deacetylase Inhibitors|Moderate Risk QTc-Prolonging Agents|QTc Prolonging Agents",CCCCC1=NC2=C(C=CC(\C=C\C(=O)NO)=C2)N1CCN(CC)CC,49855250
4892,DB05224,REP8839,small molecule,investigational,Amines|Polyamines|Sulfur Compounds,,
4893,DB05225,AM103,small molecule,investigational,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Heterocyclic Compounds, Fused-Ring|Lipids",,
4894,DB05226,BTA9881,small molecule,investigational,,,
4895,DB05227,APD791,small molecule,investigational,"Acids, Carbocyclic|Amides|Antidepressive Agents|Benzene Derivatives|Benzoates|Central Nervous System Depressants|Neurotransmitter Agents|Oxazines|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists",,
4896,DB05228,RDEA806,small molecule,investigational,,,
4897,DB05229,Beraprost,small molecule,investigational,"Anticoagulants|Antiplatelet agents|Autacoids|Biological Factors|Blood and Blood Forming Organs|Cardiovascular Agents|Cryoprotective Agents|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 Substrates|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Hematologic Agents|Inflammation Mediators|Lipids|Platelet Aggregation Inhibitors Excl. Heparin|Prostaglandins|Prostaglandins I|Vasodilating Agents",[Na+].[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C1=CC=CC(CCCC([O-])=O)=C1O2,23663404
4898,DB05230,AC3056,small molecule,investigational,,,
4899,DB05232,Tetrodotoxin,small molecule,investigational,"Anesthetics|Anesthetics, Local|Biological Factors|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Compounds used in a research, industrial, or household setting|Heterocyclic Compounds, Fused-Ring|Marine Toxins|Membrane Transport Modulators|Noxae|Peripheral Nervous System Agents|Poisons|Quinazolines|Sensory System Agents|Sodium Channel Blockers|Toxic Actions|Toxins, Biological",[H][C@]12OC3([O-])OC(C4C(O)[NH+]=C(N)NC4(C1O)[C@@H]3O)C2(O)CO,21733122
4900,DB05233,AP1081,small molecule,investigational,,,
4901,DB05234,LGD2941,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Quinolines",C[C@@H]1CC[C@H]([C@@H](O)C(F)(F)F)N1C1=CC2=C(NC(=O)C=C2C(F)(F)F)C=C1,16750192
4902,DB05235,NRP409,small molecule,investigational,,,
4905,DB05239,Cobimetinib,small molecule,approved|investigational,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Azetines|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Kinase Inhibitor|MAP Kinase Kinase 1, antagonists & inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 inhibitors|OATP1B3 substrates|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Photosensitizing Agents|Protein Kinase Inhibitors",OC1(CN(C1)C(=O)C1=C(NC2=C(F)C=C(I)C=C2)C(F)=C(F)C=C1)[C@@H]1CCCCN1,16222096
4906,DB05241,XL765,small molecule,investigational,"Amides|Heterocyclic Compounds, Fused-Ring|Phosphatidylinositol 3-Kinase, antagonists & inhibitors|Sulfones|Sulfur Compounds",,
4908,DB05243,XL019,small molecule,investigational,,,
4909,DB05244,G4544,small molecule,investigational,,,
4910,DB05245,Silver sulfadiazine,small molecule,approved|vet_approved,"Amides|Amines|Aniline Compounds|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Local|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Miscellaneous Local Anti-infectives|Sulfanilamides|Sulfonamide Antibacterial|Sulfonamides|Sulfones|Sulfur Compounds",[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1,441244
4911,DB05246,Methsuximide,small molecule,approved,Agents causing hyperkalemia|Anti-epileptic Agent|Antiarrhythmic agents|Anticonvulsants|Bradycardia-Causing Agents|Calcium Channel Blockers|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Decreased Central Nervous System Disorganized Electrical Activity|Imides|Nervous System|Potential QTc-Prolonging Agents|Pyrrolidines|Pyrrolidinones|QTc Prolonging Agents|Succinimide Derivatives,CN1C(=O)CC(C)(C1=O)C1=CC=CC=C1,6476
4912,DB05249,FavId,small molecule,investigational,,,
4913,DB05252,Fenoxaprop-ethyl,small molecule,investigational,"Acids, Acyclic|Agrochemicals|Compounds used in a research, industrial, or household setting|Fatty Acids|Fatty Acids, Volatile|Herbicides|Lipids|Pesticides|Toxic Actions",CCOC(=O)C(C)OC1=CC=C(OC2=NC3=C(O2)C=C(Cl)C=C3)C=C1,47938
4914,DB05253,Telapristone acetate,small molecule,investigational,Fused-Ring Compounds|Norpregnanes|Norsteroids|Steroids,[H][C@@]12CC[C@](OC(C)=O)(C(=O)COC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H],
4916,DB05255,Ronacaleret,small molecule,investigational,"Acids, Carbocyclic|Indenes",CC(C)(CC1CC2=C(C1)C=CC=C2)NC[C@@H](O)COC1=CC(CCC(O)=O)=CC(F)=C1F,10345214
4920,DB05260,Gallium nitrate,small molecule,approved|investigational,"Antineoplastic Agents|Bone Resorption Inhibition|Calcium Resorption Inhibitor|Calcium-Regulating Hormones and Agents|Elements|Immunosuppressive Agents|Metals|Metals, Heavy",[Ga+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O,61635
4921,DB05262,Oxypurinol,small molecule,investigational,Enzyme Inhibitors|Pyrazoles|Pyrimidines|Xanthine Oxidase Inhibitors,O=C1NC2=C(C=NN2)C(=O)N1,4644
4922,DB05263,Caprospinol,small molecule,investigational,"Acids, Acyclic|Cholestanes|Fatty Acids|Fatty Acids, Volatile|Fused-Ring Compounds|Lipids|Steroids",[H][C@]12C[C@@]3([H])[C@]4([H])CC=C5C[C@H](CC[C@]5(C)[C@@]4([H])CC[C@]3(C)[C@@]1([H])[C@H](C)[C@@]1(CC[C@@H](C)CO1)O2)OC(=O)CCCCC,16394575
4923,DB05264,NPI 32101,small molecule,investigational,,,
4924,DB05265,Ecabet,small molecule,investigational,"Anti-Infective Agents|Anti-Ulcer Agents|Anticarcinogenic Agents|Antineoplastic Agents|Compounds used in a research, industrial, or household setting|Diterpenes|Enzyme Inhibitors|Gastrointestinal Agents|Pepsin A, antagonists & inhibitors|Phenanthrenes|Protease Inhibitors|Protective Agents|Terpenes",[H][C@@]12CCC3=CC(C(C)C)=C(C=C3[C@@]1(C)CCC[C@@]2(C)C(O)=O)S(O)(=O)=O,65781
4925,DB05266,Ibudilast,small molecule,investigational,Anti-Asthmatic Agents|Antiplatelet agents|Autonomic Agents|Bronchodilator Agents|Cardiovascular Agents|Drugs for Obstructive Airway Diseases|Enzyme Inhibitors|Hematologic Agents|Leukotriene Antagonists|Peripheral Nervous System Agents|Phosphodiesterase 5 Inhibitors|Phosphodiesterase Inhibitors|Respiratory System Agents|Vasodilating Agents,CC(C)C(=O)C1=C2C=CC=CN2N=C1C(C)C,3671
4926,DB05268,iCo-007,small molecule,investigational,,,
4927,DB05271,Rotigotine,small molecule,approved,Agents that produce hypertension|Anti-Parkinson Agents (Dopamine Agonist)|Anti-Parkinson Drugs|Antidepressive Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Agonists|Hypotensive Agents|Naphthalenes|Nervous System|Neurotransmitter Agents|Nonergot-derivative Dopamine Receptor Agonists|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists|Sulfur Compounds,CCCN(CCC1=CC=CS1)[C@H]1CCC2=C(O)C=CC=C2C1,59227
4928,DB05273,Samarium (153Sm) lexidronam,small molecule,approved|investigational,"Analgesics|Analgesics, Non-Narcotic|Central Nervous System Agents|Pain Palliation (Bone Seeking Agents)|Peripheral Nervous System Agents|Radioactive Therapeutic Agent|Radioisotopes|Radiopharmaceutical Activity|Sensory System Agents|Therapeutic Radiopharmaceuticals|Various Pain Palliation Radiopharmaceuticals",[153Sm+3].OP(O)(=O)CN(CCN(CP(O)([O-])=O)CP(O)([O-])=O)CP(O)([O-])=O,76962714
4930,DB05282,MCC,small molecule,investigational,,,
4931,DB05284,CA4P,small molecule,investigational,,COC1=CC(=CC(OC)=C1OC)[C@@H](O)CC1=CC(O)=C(OC)C=C1,100154
4932,DB05285,SB-249553,small molecule,investigational,,,
4933,DB05288,Anecortave acetate,small molecule,investigational,"11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Angiogenesis Inhibitors|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Pregnadienes|Pregnanes|Pregnenediones|Pregnenes|Steroids",[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC=C1[C@@]2([H])CCC2=CC(=O)CC[C@]12C,111332
4934,DB05289,Tarenflurbil,small molecule,investigational,"Acids, Acyclic|Benzene Derivatives|Biphenyl Compounds|Fatty Acids|Fatty Acids, Volatile|Lipids|Propionates",C[C@@H](C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1,92337
4935,DB05290,SPP 301,small molecule,investigational,,,
4936,DB05292,IDM-1,small molecule,investigational,,,
4937,DB05293,IDM-2,small molecule,investigational,,,
4938,DB05294,Vandetanib,small molecule,approved,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|Kinase Inhibitor|Narrow Therapeutic Index Drugs|OCT2 Inhibitors|P-glycoprotein inhibitors|Photosensitizing Agents|Protein Kinase Inhibitors|QTc Prolonging Agents|Tyrosine Kinase Inhibitors",COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,3081361
4939,DB05295,Eldecalcitol,small molecule,investigational,Bone Density Conservation Agents|Fused-Ring Compounds|Secosteroids|Steroids|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble),[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)[C@@H](OCCCO)[C@H](O)C1=C)[C@H](C)CCCC(C)(C)O,6918141
4940,DB05296,Motexafin lutetium,small molecule,investigational,"Biological Factors|Dermatologicals|Heterocyclic Compounds, Fused-Ring|Photosensitizing Agents|Pigments, Biological|Porphyrins|Radiation-Sensitizing Agents",[Lu+3].CC([O-])=O.CC([O-])=O.CCC1=C2[N-]C(\C=C3/N=C(/C=N/C4=CC(OCCOCCOCCOC)=C(OCCOCCOCCOC)C=C4\N=C\C4=N\C(=C/2)\C(CCCO)=C4C)C(C)=C3CCCO)=C1CC,3081907
4941,DB05297,Paclitaxel docosahexaenoic acid,small molecule,investigational,Cyclodecanes|Cycloparaffins|Diterpenes|Taxoids|Terpenes,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(=O)O[C@@H](C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@@]3([H])[C@@](C)([C@@H](O)C[C@@]4([H])OC[C@@]34OC(=O)C)C(=O)[C@H](OC(=O)C)C(=C1C)C2(C)C)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1,6918473
4942,DB05298,Tetomilast,small molecule,investigational,Sulfur Compounds,CCOC1=C(OCC)C=C(C=C1)C1=NC(=CS1)C1=NC(=CC=C1)C(O)=O,3025803
4944,DB05300,PTI-801,small molecule,investigational,,,
4945,DB05301,LAX-101,small molecule,investigational,,,
4946,DB05303,OMS-103HP,small molecule,investigational,"Acids, Carbocyclic|Benzocycloheptenes|Dibenzocycloheptenes|Imidazoles|Pharmaceutical Preparations|Phenylpropionates",,
4950,DB05308,ANX-510,small molecule,investigational,,,
4951,DB05309,TP-508,small molecule,investigational,,,
4952,DB05310,FP-1096,small molecule,investigational,,,
4954,DB05312,NVS antibody,small molecule,investigational,,,
4955,DB05313,MP4,small molecule,investigational,,,
4956,DB05315,MC-1,small molecule,investigational,,,
4957,DB05316,Pimavanserin,small molecule,approved|investigational,Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Antidepressive Agents|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Agents|Central Nervous System Depressants|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Tranquilizing Agents,CC(C)COC1=CC=C(CNC(=O)N(CC2=CC=C(F)C=C2)C2CCN(C)CC2)C=C1,10071196
4958,DB05317,TAK-475,small molecule,investigational,"Azepines|Farnesyl-Diphosphate Farnesyltransferase, antagonists & inhibitors",,
4960,DB05320,ATG-Fresenius S,small molecule,investigational,,,
4964,DB05326,INKP-102,small molecule,investigational,,,
4965,DB05327,Ranirestat,small molecule,investigational,"Aldehyde Reductase, antagonists & inhibitors|Enzyme Inhibitors|Stereoisomerism",FC1=C(CN2C(=O)C3=CC=CN3[C@@]3(CC(=O)NC3=O)C2=O)C=CC(Br)=C1,153948
4966,DB05328,VGV-1,small molecule,investigational,,,
4970,DB05333,TC-5231,small molecule,investigational,,,
4973,DB05339,MN-305,small molecule,investigational,,Cl.C(CNC[C@H]1COC2=CC=CC=C2O1)COC1=CC2=C(OCO2)C=C1,198746
4974,DB05340,ATL-2502,small molecule,investigational,,[Na+].CC12CC(O)C3C(CCC4=CC(=O)C=CC34C)C1CCC2(O)C(=O)COC(=O)C1=CC(=CC=C1)S([O-])(=O)=O,23691973
4975,DB05343,Arundic acid,small molecule,investigational,"Acids, Acyclic|Fatty Acids|Lipids",CCCCCC[C@@H](CCC)C(O)=O,208925
4977,DB05345,SO-101,small molecule,investigational,,,
4978,DB05346,WL-1002,small molecule,investigational,,,
4979,DB05351,Dexlansoprazole,small molecule,approved|investigational,"2-Pyridinylmethylsulfinylbenzimidazoles|Acid Reducers|Alimentary Tract and Metabolism|Anti-Ulcer Agents|Benzimidazoles|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Enzyme Inhibitors|Gastric Acid Lowering Agents|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Proton Pump Inhibitors|Proton-pump Inhibitors|Pyridines|Sulfoxides|Sulfur Compounds",CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C1=NC2=CC=CC=C2N1,9578005
4980,DB05352,Fx-1006A,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",,
4981,DB05353,CMC 001,small molecule,investigational,,,
4982,DB05361,SR-123781A,small molecule,investigational,,,
4983,DB05362,SSR-126517E,small molecule,investigational,,,
4984,DB05363,LIC-477,small molecule,investigational,,,
4985,DB05364,ROX-888,small molecule,investigational,,,
4986,DB05367,Actelion-1,small molecule,investigational,Amides|Endothelin A Receptor Antagonists|Endothelin B Receptor Antagonists|Endothelin Receptor Antagonists|Sulfones|Sulfur Compounds,,
4988,DB05369,HZT-501,small molecule,investigational,,,
4989,DB05371,ACR-16,small molecule,investigational,,,
4990,DB05374,Rindopepimut,small molecule,investigational,"Antineoplastic Agents|Antineoplastic Agents, Immunological|Biological Products|Complex Mixtures|Vaccines",,
4991,DB05377,Chlorfenson,small molecule,investigational,"Acids|Acids, Noncarboxylic|Arylsulfonates|Arylsulfonic Acids|Benzene Derivatives|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",ClC1=CC=C(OS(=O)(=O)C2=CC=C(Cl)C=C2)C=C1,6635
4992,DB05380,DOTMP HO-166,small molecule,investigational,,[166Ho++].OP(O)(=O)CN1CCN(CP(O)(O)=O)CCN(CP([O-])([O-])=O)CCN(CP(O)(O)=O)CC1,131704296
4993,DB05381,Histamine,small molecule,approved|investigational,"Adjuvants, Immunologic|Amines|Antineoplastic and Immunomodulating Agents|Autacoids|Biogenic Amines|Biogenic Monoamines|Biological Factors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Diagnostic Agents|Ethylamines|Gastric Function|Histamine Agents|Histamine Agonists|Imidazoles|Inflammation Mediators|Neurotransmitter Agents|OCT1 substrates|OCT2 Inhibitors|OCT2 Substrates|Other Diagnostics|Tests for Gastric Secretion",NCCC1=CNC=N1,774
4994,DB05382,Iodine,small molecule,approved|investigational,"Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Dermatologicals|Diet, Food, and Nutrition|Elements|Food|Food and Beverages|Growth Substances|Halogens|Herbs and Natural Products|Iodine Products|Micronutrients|Minerals|Miscellaneous Local Anti-infectives|Trace Elements",II,807
4995,DB05383,Pimagedine,small molecule,investigational,"Amidines|Enzyme Inhibitors|Nitric Oxide Synthase, antagonists & inhibitors|OCT2 Inhibitors",NNC(N)=N,2146
4996,DB05384,Carbopol 974P,small molecule,investigational,"Compounds used in a research, industrial, or household setting|Macromolecular Substances|Plastics|Polymers|Resins, Synthetic|Spermatocidal Agents",,
4997,DB05385,PRO 2000,small molecule,investigational,"Acids|Acids, Noncarboxylic|Arylsulfonates|Arylsulfonic Acids|Compounds used in a research, industrial, or household setting|Macromolecular Substances|Naphthalenes|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",,
4999,DB05387,AE-941,small molecule,investigational,Cartilage|Complex Mixtures,,
5000,DB05389,Tetrachlorodecaoxide,small molecule,approved|investigational,"Anions|Compounds used in a research, industrial, or household setting|Electrolytes|Elements|Gases|Halogens|Ions|Oxygen Compounds|Protective Agents|Radiation-Protective Agents",O.O=O.[O-][Cl]=O.[O-][Cl]=O.[O-][Cl]=O.[O-][Cl]=O,3000391
5001,DB05390,INS 316,small molecule,investigational,,,
5002,DB05391,liposomal prostaglandin E1,small molecule,investigational,,,
5003,DB05393,NOV-002,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Chlorine Compounds|Nitrogen Compounds|Oligopeptides|Peptides|Pharmaceutical Preparations",,
5004,DB05394,Corticorelin,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Corticotropin-Releasing Hormone|Corticotropin-Releasing Hormone, antagonists & inhibitors|Diagnostic Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Peptide Hormones|Peptides|Pituitary Hormone-Releasing Hormones|Proteins|Tests for Pituitary Function",,
5005,DB05395,Amibegron,small molecule,investigational,Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Antidepressive Agents|Central Nervous System Depressants|Naphthalenes|Neurotransmitter Agents,[H][C@](O)(CN[C@@]1([H])CCC2=C(C1)C=C(OCC(=O)OCC)C=C2)C1=CC(Cl)=CC=C1,3035442
5007,DB05398,C31G,small molecule,investigational,Amines|Ammonium Compounds|Fatty Acids|Lipids|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds|Trimethyl Ammonium Compounds,CCCCCCCCCCCC[N+](C)(C)[O-].CCCCCCCCCCCC[N+](C)(C)CC([O-])=O,456362
5008,DB05399,Succinobucol,small molecule,investigational,Benzene Derivatives|Phenols,CC(C)(C)C1=CC(SC(C)(C)SC2=CC(=C(OC(=O)CCC(O)=O)C(=C2)C(C)(C)C)C(C)(C)C)=CC(=C1O)C(C)(C)C,216325
5010,DB05403,CEP-1347,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Indoles",[H][C@@]12C[C@H](C(=O)OOC)[C@](C)(O1)N1C3=C(C=C(CSCC)C=C3)C3=C4CNC(=O)C4=C4C5=C(C=CC(CSCC)=C5)N2C4=C13,133005
5011,DB05404,AZD 3355,small molecule,investigational,"Acids|Acids, Noncarboxylic|Amines|GABA Agents|GABA Agonists|GABA-A Receptor Agonists|Gastrointestinal Agents|Neurotransmitter Agents|Organophosphorus Compounds|Phosphorus Acids|Phosphorus Compounds",,
5013,DB05406,GTI-2501,small molecule,investigational,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Polynucleotides",,
5014,DB05407,TBC-3711,small molecule,investigational,Endothelin A Receptor Antagonists|Endothelin Receptor Antagonists|Sulfur Compounds,,
5015,DB05408,Emricasan,small molecule,investigational,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids|Valerates",C[C@H](NC(=O)C(=O)NC1=C(C=CC=C1)C(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)COC1=C(F)C(F)=CC(F)=C1F,12000240
5016,DB05409,NCX 701,small molecule,investigational,"Acetanilides|Acids|Acids, Noncarboxylic|Amides|Amines|Anilides|Aniline Compounds|Anions|Electrolytes|Ions|Nitric Acid|Nitrogen Compounds",CC(=O)NC1=CC=C(OC(=O)CCCO[N+]([O-])=O)C=C1,6918532
5017,DB05410,NCX 1022,small molecule,investigational,"11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Adrenal Cortex Hormones|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Pregnanes|Pregnenediones|Pregnenes|Steroids",CC12CC(O)C3C(CCC4=CC(=O)CCC34C)C1CCC2(O)C(=O)COC(=O)C1=CC=CC(CON(=O)=O)=C1,
5019,DB05412,Talmapimod,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",[H][C@]1(C)CN(C(=O)C2=C(Cl)C=C3N(C)C=C(C(=O)C(=O)N(C)C)C3=C2)[C@]([H])(C)CN1CC1=CC=C(F)C=C1,9871074
5020,DB05413,Tifuvirtide,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Antigens|Antigens, Viral|Biological Factors|env Gene Products, Human Immunodeficiency Virus|Gene Products, env|HIV Antigens|Human Immunodeficiency Virus Proteins|Membrane Fusion Proteins|Membrane Proteins|Peptides|Polyproteins|Proteins|Retroviridae Proteins|Viral Envelope Proteins|Viral Fusion Proteins|Viral Proteins|Viral Structural Proteins",CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(C)=O)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,16130644
5021,DB05414,Pipendoxifene,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CC1=C(N(CC2=CC=C(OCCN3CCCCC3)C=C2)C2=C1C=C(O)C=C2)C1=CC=C(O)C=C1,6433099
5022,DB05415,OSI-461,small molecule,investigational,Indenes|Phosphodiesterase Inhibitors,,
5023,DB05416,Cardarine,small molecule,investigational,Sulfur Compounds,CC1=C(CSC2=CC(C)=C(OCC(O)=O)C=C2)SC(=N1)C1=CC=C(C=C1)C(F)(F)F,9803963
5024,DB05417,GW 468816,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Receptors, N-Methyl-D-Aspartate, antagonists & inhibitors",,
5025,DB05418,GW 597599,small molecule,investigational,,,
5026,DB05419,ADX-10061,small molecule,investigational,,,
5027,DB05420,Gallium maltolate,small molecule,investigational,Gallium|Pyrans,[Ga+3].CC1=C([O-])C(=O)C=CO1.CC1=C([O-])C(=O)C=CO1.CC1=C([O-])C(=O)C=CO1,9846339
5028,DB05421,CP-122721,small molecule,investigational,,COC1=CC=C(OC(F)(F)F)C=C1CN[C@H]1CCCN[C@H]1C1=CC=CC=C1,9821217
5029,DB05422,OPC-14523,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Quinolines",COC1=CC=CC2=C1CCC(=O)N2CCCN1CCN(CC1)C1=CC=CC(Cl)=C1,
5030,DB05423,ORG-34517,small molecule,investigational,"Dioxoles|Fused-Ring Compounds|Heterocyclic Compounds, Fused-Ring|Receptors, Glucocorticoid, antagonists & inhibitors",[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C3OCOC3=C1)C1=C3CCC(=O)C=C3CC[C@@]21[H],9867361
5031,DB05424,Canertinib,small molecule,investigational,"Acids, Acyclic|Anesthetics|Antineoplastic Agents|Cardiotonic Agents|Cardiovascular Agents|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Oxazines|Peripheral Nervous System Agents|Protective Agents|Sensory System Agents|Tyrosine Kinase Inhibitors",FC1=C(Cl)C=C(NC2=NC=NC3=CC(OCCCN4CCOCC4)=C(NC(=O)C=C)C=C23)C=C1,156414
5034,DB05428,Motexafin gadolinium,small molecule,investigational,"Antineoplastic Agents|Biological Factors|Compounds used in a research, industrial, or household setting|Contrast Media|Dermatologicals|Diagnostic Uses of Chemicals|Heterocyclic Compounds, Fused-Ring|Photosensitizing Agents|Pigments, Biological|Porphyrins|Radiation-Sensitizing Agents",[Gd+3].CC([O-])=O.CC([O-])=O.CCC1=C(CC)/C2=C/C3=N/C(=C\N=C4/C=C(OCCOCCOCCOC)C(OCCOCCOCCOC)=C/C/4=N\C=C4/N=C(/C=C\1\[N-]\2)C(CCCO)=C4C)/C(C)=C3CCCO,158385
5036,DB05430,VLTS-589,small molecule,investigational,,,
5037,DB05431,MLN-977,small molecule,investigational,,NC(=O)N(O)CCC#C[C@@H]1CC[C@@H](COC2=CC=C(F)C=C2)O1,
5038,DB05432,DAS-431 IV,small molecule,investigational,,,
5039,DB05433,rGLP-1,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Gastrointestinal Hormones|Glucagon-Like Peptides|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Pancreatic Hormones|Peptide Hormones|Peptides|Proglucagon|Protein Precursors|Proteins|Recombinant Fusion Proteins",,
5040,DB05434,ABT-510,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Peptides",CCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN(C)C(C)=O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC,6918562
5044,DB05440,SRP 299,small molecule,investigational,Biological Products|Complex Mixtures|Vaccines,,
5046,DB05442,Etiprednol dicloacetate,small molecule,investigational,"Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists",[H][C@@]12CC[C@](OC(=O)C(Cl)Cl)(C(=O)OCC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,9935073
5047,DB05443,ADL 10-0101,small molecule,investigational,,,
5048,DB05444,Iroxanadine,small molecule,investigational,,C(C1CONC(=N1)C1=CN=CC=C1)N1CCCCC1,6421776
5050,DB05446,LJP 1082,small molecule,investigational,"Alcohols|Amino Acids, Peptides, and Proteins|Carbohydrates|Compounds used in a research, industrial, or household setting|Ethylene Glycols|Glycoconjugates|Glycols|Macromolecular Substances|Polymers|Proteins",NC(CCC(=O)NC(CSCO)C(=O)NCC(O)=O)C(O)=O,1082
5051,DB05447,AVI-4557,small molecule,investigational,,,
5052,DB05448,PX-12,small molecule,investigational,"Acids|Acids, Noncarboxylic|Anions|Electrolytes|Gases|Hydrogen Sulfide|Ions|Sulfides|Sulfur Compounds",CCC(C)SSC1=NC=CN1,219104
5053,DB05449,FM-VP4,small molecule,investigational,,,
5054,DB05450,Smilagenin,small molecule,investigational,"Cholestanes|Drugs, Chinese Herbal|Fused-Ring Compounds|Sapogenins|Saponins|Steroids",[H][C@]12C[C@@]3([H])[C@]4([H])CC[C@]5([H])C[C@@H](O)CC[C@]5(C)[C@@]4([H])CC[C@]3(C)[C@@]1([H])[C@H](C)[C@@]1(CC[C@@H](C)CO1)O2,
5055,DB05451,P54,small molecule,investigational,,,
5056,DB05452,PH-284,small molecule,investigational,,,
5057,DB05454,Paliroden,small molecule,investigational,,FC(F)(F)C1=CC(=CC=C1)C1=CCN(CCC2=CC=C(C=C2)C2=CC=CC=C2)CC1,11567682
5058,DB05455,SR 121463,small molecule,investigational,,,
5059,DB05456,ETC-588,small molecule,investigational,Alcohols|Carbohydrates|Glycerophosphates|Glycerophospholipids|Lipids|Membrane Lipids|Phosphatidic Acids|Phospholipids|Sugar Alcohols|Sugar Phosphates|Triose Sugar Alcohols,CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC\C=C/CCCCCCCC)COP([O-])(=O)OCC[N+](C)(C)C,6449792
5060,DB05457,OSI-7904L,small molecule,investigational,"Acids, Acyclic|Dicarboxylic Acids|Heterocyclic Compounds, Fused-Ring",,
5061,DB05458,Pozanicline,small molecule,investigational,,CC1=C(OC[C@@H]2CCCN2)C=CC=N1,178052
5063,DB05460,Ezatiostat,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Oligopeptides|Peptides",CCOC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCC1=CC=CC=C1)C(=O)N[C@@H](C(=O)OCC)C1=CC=CC=C1,5310939
5064,DB05461,OPC-28326,small molecule,investigational,Amines,O.Cl.CCC(=O)NC1=C(C)C=C(C=C1C)C(=O)N1CCC(CC1)N(C)CCC1=CC=CC=C1,15942713
5065,DB05462,Chlorotoxin I-131,small molecule,investigational,"Arthropod Venoms|Biological Factors|Bodily Secretions|Complex Mixtures|Fluids and Secretions|Neurotoxins|Noxae|Toxic Actions|Toxins, Biological|Venoms",CCC(C(C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,4369566
5066,DB05463,ISS-1018,small molecule,investigational,"Adjuvants, Immunologic|Carbohydrates|Glycosides|Immunologic Factors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Oligonucleotides|Polynucleotides",,
5067,DB05464,NOX-700,small molecule,investigational,"Acids, Acyclic|Carbamates|Sulfur Compounds",,
5068,DB05465,Tandutinib,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Tyrosine Kinase Inhibitors",COC1=C(OCCCN2CCCCC2)C=C2N=CN=C(N3CCN(CC3)C(=O)NC3=CC=C(OC(C)C)C=C3)C2=C1,3038522
5069,DB05466,R673,small molecule,investigational,,,
5070,DB05467,R667,small molecule,investigational,,,
5071,DB05468,R411,small molecule,investigational,,,
5072,DB05469,R450,small molecule,investigational,,,
5073,DB05470,VX-702,small molecule,investigational,Benzene Derivatives,NC(=O)N(C1=CC=C(C(N)=O)C(=N1)C1=CC=C(F)C=C1F)C1=C(F)C=CC=C1F,10341154
5075,DB05472,omega interferon,small molecule,investigational,Immunosuppressive Agents|Myelosuppressive Agents,,
5076,DB05473,QR-334,small molecule,investigational,,,
5077,DB05474,T487,small molecule,investigational,,,
5078,DB05475,Golotimod,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Oligopeptides|Peptides",N[C@H](CCC(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(O)=O)C(O)=O,6992140
5079,DB05476,WX-UK1,small molecule,investigational,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins",Cl.CCOC(=O)N1CCN(CC1)C(=O)[C@H](CC1=CC=CC(=C1)C(N)=N)NS(=O)(=O)C1=C(C=C(C=C1C(C)C)C(C)C)C(C)C,9939426
5081,DB05478,Pradefovir mesylate,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Purines",CS(O)(=O)=O.NC1=C2N=CN(CCOC[P@@]3(=O)OCC[C@H](O3)C3=CC(Cl)=CC=C3)C2=NC=N1,9604653
5082,DB05479,CZEN 002,small molecule,investigational,,CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NC(CC1=CN=CN1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O,16129664
5083,DB05480,PBI-1402,small molecule,investigational,,,
5085,DB05482,7-ethyl-10-hydroxycamptothecin,small molecule,investigational,Alkaloids|Antineoplastic Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Topoisomerase I Inhibitors|Topoisomerase Inhibitors,CCC1=C2C=C(O)C=CC2=NC2=C1CN1C2=CC2=C(COC(=O)[C@]2(O)CC)C1=O,104842
5086,DB05483,PCL-016,small molecule,investigational,,,
5087,DB05484,MDX-018,small molecule,investigational,,,
5089,DB05487,Custirsen,small molecule,investigational,"Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Oligonucleotides, Antisense|Pyrans|Sulfur Compounds",COCCO[C@@H]1[C@H](O)[C@@H](COP(S)(=O)O[C@@H]2[C@@H](COP(S)(=O)O[C@@H]3[C@@H](COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@H]5C[C@@H](O[C@@H]5COP(S)(=O)O[C@H]5C[C@@H](O[C@@H]5COP(S)(=O)O[C@H]5C[C@@H](O[C@@H]5COP(S)(=O)O[C@H]5C[C@@H](O[C@@H]5COP(S)(=O)O[C@H]5C[C@@H](O[C@@H]5COP(S)(=O)O[C@H]5C[C@@H](O[C@@H]5COP(S)(=O)O[C@H]5C[C@@H](O[C@@H]5COP(S)(=O)O[C@H]5C[C@@H](O[C@@H]5COP(S)(=O)O[C@H]5C[C@@H](O[C@@H]5COP(S)(=O)O[C@H]5C[C@@H](O[C@@H]5COP(S)(=O)O[C@H]5C[C@@H](O[C@@H]5COP(S)(=O)O[C@H]5C[C@@H](O[C@@H]5COP(S)(=O)O[C@H]5C[C@@H](O[C@@H]5COP(S)(=O)O[C@@H]5[C@@H](COP(S)(=O)O[C@@H]6[C@@H](COP(S)(=O)O[C@@H]7[C@@H](COP(S)(=O)O[C@@H]8[C@@H](CO)O[C@H]([C@@H]8OCCOC)N8C=C(C)C(N)=NC8=O)O[C@H]([C@@H]7OCCOC)N7C=NC8=C7N=CN=C8N)O[C@H]([C@@H]6OCCOC)N6C=NC7=C6N=C(N)NC7=O)O[C@H]([C@@H]5OCCOC)N5C=C(C)C(N)=NC5=O)N5C=NC6=C5N=CN=C6N)N5C=NC6=C5N=C(N)NC6=O)N5C=CC(N)=NC5=O)N5C=NC6=C5N=CN=C6N)N5C=NC6=C5N=C(N)NC6=O)N5C=NC6=C5N=CN=C6N)N5C=NC6=C5N=C(N)NC6=O)N5C=C(C)C(=O)NC5=O)N5C=CC(N)=NC5=O)N5C=C(C)C(=O)NC5=O)N5C=C(C)C(=O)NC5=O)N5C=CC(N)=NC5=O)N5C=NC6=C5N=CN=C6N)O[C@H]([C@@H]4OCCOC)N4C=C(C)C(=O)NC4=O)O[C@H]([C@@H]3OCCOC)N3C=C(C)C(N)=NC3=O)O[C@H]([C@@H]2OCCOC)N2C=NC3=C2N=CN=C3N)O[C@H]1N1C=C(C)C(=O)NC1=O,
5090,DB05488,Technetium Tc-99m ciprofloxacin,small molecule,investigational,"Anti-Bacterial Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Moderate Risk QTc-Prolonging Agents|Organometallic Compounds|QTc Prolonging Agents|Quinolines|Quinolones",,
5091,DB05489,ACA 125,small molecule,investigational,,,
5092,DB05490,AMG-131,small molecule,investigational,"Amides|Heterocyclic Compounds, Fused-Ring|PPAR gamma, agonists|Sulfones|Sulfur Compounds",ClC1=CC=C(C(Cl)=C1)S(=O)(=O)NC1=CC(Cl)=C(OC2=CN=C3C=CC=CC3=C2)C(Cl)=C1,16145453
5093,DB05491,ATN-161,small molecule,investigational,,,
5094,DB05492,Epicept NP-1,small molecule,investigational,,CC1=CC(=C(NCCCN)C=C1)[N+]([O-])=O,5276854
5095,DB05493,NX-1207,small molecule,investigational,,,
5096,DB05494,Elacytarabine,small molecule,investigational,"Arabinonucleosides|Carbohydrates|Fatty Acids|Glycosides|Lipids|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",CCCCCCCC\C=C\CCCCCCCC(=O)OC[C@H]1O[C@H]([C@@H](O)[C@@H]1O)N1C=CC(N)=NC1=O,6438895
5097,DB05495,PG-530742,small molecule,investigational,,,
5099,DB05498,KW-7158,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Sulfur Compounds",C[C@](O)(C(=O)NC1=CC=CC2=C1C(=O)C1=C(CS2(=O)=O)C=CS1)C(F)(F)F,9844981
5100,DB05499,TAK-428,small molecule,investigational,,,
5102,DB05501,AMD-070,small molecule,investigational,"Receptors, CXCR4, antagonists & inhibitors",NCCCCN(CC1=NC2=CC=CC=C2N1)[C@H]1CCCC2=C1N=CC=C2,11256587
5104,DB05505,NM-702,small molecule,investigational,,,
5105,DB05506,ISIS 113715,small molecule,investigational,,,
5106,DB05507,VX-765,small molecule,investigational,"Acids, Carbocyclic|Amino Acids, Peptides, and Proteins|Aminobenzoates|Benzene Derivatives|Benzoates|Oligopeptides|Peptides",,
5107,DB05509,LI-301,small molecule,investigational,,,
5108,DB05511,Piclidenoson,small molecule,investigational,"Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides",CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(NCC3=CC(I)=CC=C3)N=CN=C12,123683
5110,DB05513,Atiprimod,small molecule,investigational,,CCCC1(CCC)CCC2(CCN(CCCN(CC)CC)C2)CC1,
5111,DB05514,Cobiprostone,small molecule,investigational,"Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids",CC[C@H](C)CC(F)(F)[C@@]1(O)CC[C@H]2[C@@H](CC(=O)[C@@H]2CCCCCCC(O)=O)O1,
5113,DB05518,Managlinat dialanetil,small molecule,investigational,"Amino Acids|Amino Acids, Peptides, and Proteins|Fructose-Bisphosphatase, antagonists & inhibitors|Organophosphorus Compounds",[H][C@@](C)(NP(=O)(N[C@@]([H])(C)C(=O)OCC)C1=CC=C(O1)C1=C(CC(C)C)SC(N)=N1)C(=O)OCC,
5114,DB05519,Budiodarone,small molecule,investigational,"Benzofurans|Heterocyclic Compounds, Fused-Ring",CC[C@H](C)OC(=O)CC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2,
5115,DB05520,Mimopezil,small molecule,investigational,,[H][C@@]12CC3=C(C=CC(=O)N3)[C@](CC(C)=C1)(\N=C\C1=CC(Cl)=CC(OC)=C1O)\C2=C\C,
5116,DB05521,Telaprevir,small molecule,approved|withdrawn,"Amino Acids, Peptides, and Proteins|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Antivirals for treatment of HCV infections|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Direct Acting Antivirals|HCV NS3/4A Protease Inhibitors|NS3/4A Protease Inhibitors|OATP1B1/SLCO1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporting Polypeptide 2B1 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Peptides|Protease Inhibitors",[H][C@@]12CCC[C@]1([H])[C@H](N(C2)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=NC=CN=C1)C1CCCCC1)C(C)(C)C)C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1,3010818
5117,DB05524,Pelitinib,small molecule,investigational,"Amines|Antineoplastic Agents|Enzyme Inhibitors|ErbB Receptors, antagonists & inhibitors|Heterocyclic Compounds, Fused-Ring|Protein Kinase Inhibitors|Quinolines",CCOC1=CC2=C(C=C1NC(=O)\C=C\CN(C)C)C(NC1=CC(Cl)=C(F)C=C1)=C(C=N2)C#N,
5119,DB05528,Mipomersen,small molecule,approved|investigational,"Anticholesteremic Agents|Antisense Elements (Genetics)|Apolipoprotein B-100 Synthesis Inhibitor|Carbohydrates|Compounds used in a research, industrial, or household setting|Decreased Protein Synthesis|Diagnostic Uses of Chemicals|DNA|DNA, Antisense|Glycosides|Hepatotoxic Agents|Hypolipidemic Agents|Hypolipidemic Agents Indicated for Hyperlipidemia|Laboratory Chemicals|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Molecular Probes|Noxae|Nucleic Acid Probes|Nucleic Acids|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Oligodeoxyribonucleotides, Antisense|Oligonucleotides|Oligonucleotides, Antisense|Polynucleotides|Toxic Actions",COCCO[C@@H]1[C@H](O)[C@@H](COP(S)(=O)O[C@@H]2[C@@H](COP(S)(=O)O[C@@H]3[C@@H](COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]5[C@@H](COP(S)(=O)O[C@H]6C[C@@H](O[C@@H]6COP(S)(=O)O[C@H]6C[C@@H](O[C@@H]6COP(S)(=O)O[C@H]6C[C@@H](O[C@@H]6COP(S)(=O)O[C@H]6C[C@@H](O[C@@H]6COP(S)(=O)O[C@H]6C[C@@H](O[C@@H]6COP(S)(=O)O[C@H]6C[C@@H](O[C@@H]6COP(S)(=O)O[C@H]6C[C@@H](O[C@@H]6COP(S)(=O)O[C@H]6C[C@@H](O[C@@H]6COP(S)(=O)O[C@H]6C[C@@H](O[C@@H]6COP(S)(=O)O[C@H]6C[C@@H](O[C@@H]6COP(S)(=O)O[C@@H]6[C@@H](COP(S)(=O)O[C@@H]7[C@@H](COP(S)(=O)O[C@@H]8[C@@H](COP(S)(=O)O[C@@H]9[C@@H](COP(S)(=O)O[C@@H]%10[C@@H](CO)O[C@H]([C@@H]%10OCCOC)N%10C=NC%11=C%10N=C(N)NC%11=O)O[C@H]([C@@H]9OCCOC)N9C=C(C)C(N)=NC9=O)O[C@H]([C@@H]8OCCOC)N8C=C(C)C(N)=NC8=O)O[C@H]([C@@H]7OCCOC)N7C=C(C)C(=O)NC7=O)O[C@H]([C@@H]6OCCOC)N6C=C(C)C(N)=NC6=O)N6C=NC7=C6N=CN=C7N)N6C=NC7=C6N=C(N)NC7=O)N6C=C(C)C(=O)NC6=O)N6C=C(C)C(N)=NC6=O)N6C=C(C)C(=O)NC6=O)N6C=NC7=C6N=C(N)NC7=O)N6C=C(C)C(N)=NC6=O)N6C=C(C)C(=O)NC6=O)N6C=C(C)C(=O)NC6=O)N6C=C(C)C(N)=NC6=O)O[C@H]([C@@H]5OCCOC)N5C=NC6=C5N=C(N)NC6=O)O[C@H]([C@@H]4OCCOC)N4C=C(C)C(N)=NC4=O)O[C@H]([C@@H]3OCCOC)N3C=NC4=C3N=CN=C4N)O[C@H]([C@@H]2OCCOC)N2C=C(C)C(N)=NC2=O)O[C@H]1N1C=C(C)C(N)=NC1=O,131704297
5121,DB05531,alpha-Pyrrolidinononanophenone,small molecule,investigational,,CCCCCCCC(N1CCCC1)C(=O)C1=CC=CC=C1,
5122,DB05532,BMS-488043,small molecule,investigational,Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|HIV Fusion Inhibitors|Viral Fusion Protein Inhibitors,COC1=C2C(NC=C2C(=O)C(=O)N2CCN(CC2)C(=O)C2=CC=CC=C2)=C(OC)N=C1,
5123,DB05533,QR-333,small molecule,investigational,,,
5124,DB05540,Alanosine,small molecule,investigational,"Amino Acids|Amino Acids, Peptides, and Proteins|Antibiotics, Antineoplastic|Antineoplastic Agents|Chelating Agents|Compounds used in a research, industrial, or household setting|Sequestering Agents",N[C@@H](CN(O)N=O)C(O)=O,22128
5125,DB05541,Brivaracetam,small molecule,approved|investigational,Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Epoxide Hydrolase Inhibitors|Miscellaneous Anticonvulsants|Nervous System|Pyrrolidines,CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1,9837243
5126,DB05542,Naronapride,small molecule,investigational,"Acids, Carbocyclic|Amides|Antidepressive Agents|Benzene Derivatives|Benzoates|Central Nervous System Depressants|Neurotransmitter Agents|Serotonin 5-HT4 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists",CO[C@H]1CN(CCCCCC(=O)O[C@H]2CN3CCC2CC3)CC[C@H]1NC(=O)C1=C(OC)C=C(N)C(Cl)=C1,
5128,DB05549,INO-1001,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Poly(ADP-ribose) Polymerases, antagonists & inhibitors",CS(O)(=O)=O.O=C1NC2=C(CC3=C2C=CC(=C3)S(=O)(=O)NCCCN2CCOCC2)C2=CC=CC=C12,
5130,DB05552,TG100-115,small molecule,investigational,"Benzene Derivatives|Heterocyclic Compounds, Fused-Ring|Phosphatidylinositol 3-Kinases, antagonists & inhibitors",NC1=NC(N)=C2N=C(C3=CC=CC(O)=C3)C(=NC2=N1)C1=CC(O)=CC=C1,
5131,DB05553,Regrelor,small molecule,investigational,"Adenine Nucleotides|Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purinergic Agents|Purinergic Antagonists|Purinergic P2 Receptor Antagonists|Purines|Ribonucleotides",[H][C@]12O[C@@H](O[C@@]1([H])[C@@H](O[C@@H]2COP(O)(O)=O)N1C=NC2=C1N=CN=C2NC(=O)NCC)\C=C\C1=CC=CC=C1,
5133,DB05559,NF-kappaB Decoy,small molecule,investigational,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Oligonucleotides|Polynucleotides",,
5134,DB05560,Delcasertib,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Protein Kinase C-delta, antagonists & inhibitors",[H][C@](N)(CSSC[C@]([H])(N)C(O)=N[C@@]([H])(CC1=CC=C(O)C=C1)C(O)=NCC(O)=N[C@@]([H])(CCCNC(N)=N)C(O)=N[C@@]([H])(CCCCN)C(O)=N[C@@]([H])(CCCCN)C(O)=N[C@@]([H])(CCCNC(N)=N)C(O)=N[C@@]([H])(CCCNC(N)=N)C(O)=N[C@@]([H])(CCC(O)=N)C(O)=N[C@@]([H])(CCCNC(N)=N)C(O)=N[C@@]([H])(CCCNC(N)=N)C(O)=N[C@@]([H])(CCCNC(N)=N)C(O)=O)C(O)=N[C@@]([H])(CO)C(O)=N[C@@]([H])(CC1=CC=CC=C1)C(O)=N[C@@]([H])(CC(O)=N)C(O)=N[C@@]([H])(CO)C(O)=N[C@@]([H])(CC1=CC=C(O)C=C1)C(O)=N[C@@]([H])(CCC(O)=O)C(O)=N[C@@]([H])(CC(C)C)C(O)=NCC(O)=N[C@@]([H])(CO)C(O)=N[C@@]([H])(CC(C)C)C(O)=O,
5135,DB05562,Naluzotan,small molecule,investigational,Agents that produce hypertension|Amides|Antidepressive Agents|Central Nervous System Depressants|Neurotransmitter Agents|Serotonin 5-HT1 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists|Sulfones|Sulfur Compounds,CC(=O)NC1=CC=CC(=C1)N1CCN(CCCCNS(=O)(=O)CC2CCCCC2)CC1,
5136,DB05565,PBT-1033,small molecule,investigational,,CN(C)CC1=CC=C2C(Cl)=CC(Cl)=C(O)C2=N1,
5137,DB05575,Motesanib,small molecule,investigational,"Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Nicotinic Acids|Protein Kinase Inhibitors|Pyridines|Tyrosine Kinase Inhibitors",CC1(C)CNC2=CC(NC(=O)C3=C(NCC4=CC=NC=C4)N=CC=C3)=CC=C12,
5139,DB05580,TRU-015,small molecule,investigational,,,
5141,DB05585,Verubulin,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",COC1=CC=C(C=C1)N(C)C1=NC(C)=NC2=C1C=CC=C2,
5142,DB05586,Facinicline,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Pyrazoles",[H]N([C@@H]1CN2CCC1CC2)C(=O)C1=NN([H])C2=CC=CC=C12,
5143,DB05590,Bedoradrine,small molecule,investigational,"Acetates|Acids, Acyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Lipids",CN(C)C(=O)COC1=CC=C2CC[C@@H](CC2=C1)NC[C@H](O)C1=CC=C(O)C(CCO)=C1,
5144,DB05592,Blarcamesine,small molecule,investigational,,CN(C)CC1CCOC1(C1=CC=CC=C1)C1=CC=CC=C1,
5147,DB05596,PRX-03140,small molecule,investigational,,CC(C)N1C2=C(C=CS2)C(O)=C(C(=O)NCCCN2CCCCC2)C1=O,
5149,DB05606,Beclanorsen,small molecule,investigational,,,
5150,DB05607,PRX-08066,small molecule,investigational,Antidepressive Agents|Central Nervous System Depressants|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds,OC(=O)\C=C\C(O)=O.FC1=C(C=C(CN2CCC(CC2)NC2=C3C=C(Cl)SC3=NC=N2)C=C1)C#N,
5151,DB05608,MKC-1,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Protein Kinase Inhibitors",CN1C=C(C2=CC=CC=C12)C1=C(C(=O)NC1=O)C1=CN(C)C2=CC(=CC=C12)[N+]([O-])=O,
5152,DB05611,Apilimod,small molecule,investigational,Oxazines,CC1=CC=CC(\C=N\NC2=CC(=NC(OCCC3=CC=CC=N3)=N2)N2CCOCC2)=C1,
5153,DB05616,"4'-Methylene-5,8,10-trideazaaminopterin",small molecule,investigational,"Biological Factors|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Pteridines|Pterins",NC1=NC2=CC=C(CCC3=CC=C(C=C3)C(=O)NC(CC(=C)C(O)=O)C(O)=O)C=C2C(N)=N1,
5154,DB05620,AVI-4065,small molecule,investigational,,,
5155,DB05624,Teverelix,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Peptides",CC(C)C[C@H](NC(=O)[C@@H](CCCCNC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=C(C=CC=C2)C=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,
5156,DB05625,CTCE-9908,small molecule,investigational,"Amino Acids, Peptides, and Proteins",,
5157,DB05626,Retaspimycin,small molecule,investigational,"Amides|HSP90 Heat-Shock Proteins, antagonists & inhibitors|Lactams|Protein-Serine-Threonine Kinases, antagonists & inhibitors|Quinones",CO[C@H]1C[C@H](C)CC2=C(NCC=C)C(O)=CC(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)=C2O,
5158,DB05630,Sodium stibogluconate,small molecule,approved|investigational,"Acids, Acyclic|Agents Against Leishmaniasis and Trypanosomiasis|Anti-Infective Agents|Antimony Compounds|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiplatyhelmintic Agents|Antiprotozoals|Carbohydrates|Gluconates|Hydroxy Acids|Organometallic Compounds|Schistosomicides|Sugar Acids",O.O.O.O.O.O.O.O.O.[Na+].[Na+].[Na+].[H][C@@]1(O[Sb]2(O)(O[Sb]34([O-])O[C@@H](C([O-])=O)[C@@]([H])(O3)[C@]([H])(O4)[C@H](O)CO)O[C@@H](C([O-])=O)[C@@]1([H])O2)[C@H](O)CO,56927674
5159,DB05631,ALT-2074,small molecule,investigational,Selenium Compounds,CC1(C)CN[Se]C2=CC=CC=C12,
5160,DB05633,Glypromate,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Peptides",[H]N([H])CC(=O)N1CCC[C@H]1C(=O)N([H])[C@@H](CCC(O)=O)C(O)=O,
5162,DB05642,DDP-225,small molecule,investigational,,O.Cl.CC1=CC2=C(N=C(N=C2S1)N1CCNCC1)C1=CC=CC=C1F,
5164,DB05644,KP-1461,small molecule,investigational,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides",CCCCCCCOC(=O)NC1=NC(=O)N(CN1)[C@H]1C[C@H](O)[C@@H](CO)O1,
5165,DB05645,Larazotide,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Peptides",CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O,
5167,DB05650,OT-551,small molecule,investigational,,CC1(C)CC(CC(C)(C)N1O)OC(=O)C1CC1,10131000
5168,DB05652,VTP-201227,small molecule,investigational,,,
5169,DB05653,IRX-5183,small molecule,investigational,"Alkenes|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Terpenes",CC1(C)CCC(C)(C)C2=C1C=C(C(=O)NC1=CC(F)=C(C(O)=O)C(F)=C1)C(O)=C2Cl,
5171,DB05659,Faropenem medoxomil,small molecule,investigational,"Amides|Heterocyclic Compounds, Fused-Ring|Lactams|Sulfur Compounds",[H][C@]12SC(=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(=O)OCC1=C(C)OC(=O)O1)[C@@]1([H])CCCO1,6918218
5172,DB05660,D-JNKI-1,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Neuroprotective Agents",,
5173,DB05662,NP-50301,small molecule,investigational,,,
5174,DB05667,Levoketoconazole,small molecule,investigational,,CC(=O)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=CN=C3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1,
5175,DB05668,Palifosfamide,small molecule,investigational,"Acids|Acids, Noncarboxylic|Alkylating Drugs|Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Anions|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Electrolytes|Hydrocarbons, Halogenated|Ions|Mustard Compounds|Nitrogen Mustard Compounds|Noxae|Organophosphorus Compounds|Oxazines|Phosphoramide Mustards|Phosphoramides|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Toxic Actions",OP(=O)(NCCCl)NCCCl,
5179,DB05676,Apremilast,small molecule,approved|investigational,"Agents reducing cytokine levels|Anti-Inflammatory Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Disease-modifying Antirheumatic Agents|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Immunosuppressive Agents|Isoindoles|P-glycoprotein substrates|Phosphodiesterase 4 Inhibitors|Phosphodiesterase Inhibitors|Phthalimides|Selective Immunosuppressants",CCOC1=CC(=CC=C1OC)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O,11561674
5180,DB05678,SLx-4090,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Heterocyclic Compounds, Fused-Ring",COC1=CC=CC(C(=O)NC2=CC3=C(CN(CC3)C(=O)OC3=CC=CC=C3)C=C2)=C1C1=CC=C(C=C1)C(F)(F)F,
5182,DB05680,Sotirimod,small molecule,investigational,,CC(C)CN1C(C)=NC2=C1C1=NC=CC=C1N=C2N,
5183,DB05683,Iodofiltic acid I-123,small molecule,investigational,"Benzene Derivatives|Hydrocarbons, Halogenated|Hydrocarbons, Iodinated|Iodine Radioisotopes|Lipids",CC(CCCCCCCCCCCCC1=CC=C([123I])C=C1)CC(O)=O,
5185,DB05686,Sivifene,small molecule,investigational,Benzene Derivatives|Hydrazines,OC1=CC=C(C=C1)C(=NNC1=CC=C(C=C1[N+]([O-])=O)[N+]([O-])=O)C1=CC=C(O)C=C1,
5186,DB05687,BL-1020,small molecule,investigational,"Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Aminobutyrates|Antipsychotic Agents|Butyrates|Central Nervous System Depressants|Fatty Acids|Fatty Acids, Volatile|Heterocyclic Compounds, Fused-Ring|Lipids|Neurotoxic agents|Phenothiazines|Sulfur Compounds",,
5187,DB05688,CRx-119,small molecule,investigational,,,
5188,DB05695,NPS-2143,small molecule,investigational,,CC(C)(CC1=CC=C2C=CC=CC2=C1)NC[C@@H](O)COC1=CC=CC(Cl)=C1C#N,
5190,DB05705,ALS-08,small molecule,investigational,,,
5191,DB05706,13-deoxydoxorubicin,small molecule,investigational,,COC1=C2C(=O)C3=C(O)C4=C(C[C@@](O)(CCO)C[C@@H]4O[C@H]4C[C@H](N)[C@H](O)[C@H](C)O4)C(O)=C3C(=O)C2=CC=C1,
5192,DB05708,GTS-21,small molecule,investigational,Benzene Derivatives|Cholinergic Agents|Cholinergic Agonists|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 Substrates|Neurotransmitter Agents|Nicotinic Agonists,[H]\C(=C1\CCCN=C1C1=CN=CC=C1)C1=C(OC)C=C(OC)C=C1,5310985
5193,DB05710,Gantacurium,small molecule,investigational,"Anticholinergic Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Nicotinic Antagonists",COC1=CC(C[C@@H]2C3=CC(OC)=C(OC)C=C3CC[N@@+]2(C)CCCOC(=O)C(\Cl)=C\C(=O)OCCC[N@@+]2(C)CCC3=CC(OC)=C(OC)C=C3[C@@H]2C2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OC,10772467
5194,DB05712,AZD-9684,small molecule,investigational,,,
5195,DB05713,LY-517717,small molecule,investigational,"Amino Acids|Amino Acids, Peptides, and Proteins",CN1CCC(CC1)N1CCN(CC1)C(=O)[C@H](NC(=O)C1=CC=C2C=CNC2=C1)C1=CC=CC=C1,9939865
5196,DB05714,Flovagatran,small molecule,investigational,"Acids|Acids, Noncarboxylic|Amino Acids, Peptides, and Proteins|Boron Compounds|Oligopeptides|Peptides",COCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CC1=CC=CC=C1)NC(=O)OCC1=CC=CC=C1)B(O)O,
5198,DB05719,Elesclomol,small molecule,investigational,Amides|Sulfur Compounds,CN(NC(=O)CC(=O)NN(C)C(=S)C1=CC=CC=C1)C(=S)C1=CC=CC=C1,300471
5199,DB05721,EVT 201,small molecule,investigational,"Benzazepines|Heterocyclic Compounds, Fused-Ring",,
5200,DB05722,CGC-11047,small molecule,investigational,Amines,,
5201,DB05723,ALKS 29,small molecule,investigational,,,
5202,DB05724,alpha-Conotoxin VC 1.1,small molecule,investigational,"Biological Factors|Bodily Secretions|Complex Mixtures|Fluids and Secretions|Marine Toxins|Mollusk Venoms|Toxins, Biological|Venoms",CC[C@H](C)[C@@H]1NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC2=CNC=N2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]2CSSC[C@H](NC(=O)CN)C(=O)N[C@@H](CSSC[C@H](NC1=O)C(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N2,
5203,DB05730,PMI-001,small molecule,investigational,,,
5204,DB05732,Strontium malonate,small molecule,investigational,,[Sr++].[O-]C(=O)CC([O-])=O,
5205,DB05735,Cefilavancin,small molecule,investigational,"Amides|Amino Acids, Peptides, and Proteins|beta-Lactams|Carbohydrates|Glycoconjugates|Heterocyclic Compounds, Fused-Ring|Lactams|Peptides|Sulfur Compounds|Thiazines",,
5206,DB05736,MIV-701,small molecule,investigational,,,
5207,DB05737,Varespladib methyl,small molecule,investigational,"Acids, Acyclic|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Heterocyclic Compounds, Fused-Ring|Lipids|Phospholipase A2 Inhibitors",CCC1=C(C(=O)C(N)=O)C2=C(OCC(=O)OC)C=CC=C2N1CC1=CC=CC=C1,9886917
5208,DB05738,Vapitadine,small molecule,investigational,,NC(=O)C1=CN=C2N1CCC1=C(C=CC=C1)C21CCNCC1,9842252
5210,DB05740,RPI-78M,small molecule,investigational,,,
5211,DB05741,AGS-005,small molecule,investigational,,,
5212,DB05742,AGS-004,small molecule,investigational,,,
5213,DB05744,CRx-139,small molecule,investigational,,,
5214,DB05746,PF-03187207,small molecule,investigational,,,
5215,DB05747,R-851,small molecule,investigational,,,
5216,DB05749,MPI-674,small molecule,investigational,,,
5217,DB05750,AVE-1625,small molecule,investigational,,,
5218,DB05751,RP01,small molecule,investigational,,,
5219,DB05752,ALKS 27,small molecule,investigational,,,
5220,DB05753,VSF-173,small molecule,investigational,,,
5221,DB05754,IPH 1101,small molecule,investigational,,,
5222,DB05755,BF-37,small molecule,investigational,,,
5223,DB05756,PAC-113,small molecule,investigational,,,
5224,DB05757,DNB-001,small molecule,investigational,,,
5226,DB05765,ATX-201,small molecule,investigational,,,
5227,DB05766,ACP-104,small molecule,investigational,,,
5228,DB05767,Andrographolide,small molecule,investigational,"Analgesics|Analgesics, Non-Narcotic|Anti-Infective Agents|Anti-Inflammatory Agents|Antiparasitic Agents|Antiplatelet agents|Antiprotozoals|Antirheumatic Agents|Biological Products|Central Nervous System Agents|Colitis, Ulcerative, drug therapy|Complex Mixtures|Hematologic Agents|Peripheral Nervous System Agents|Pharmaceutical Preparations|Plant Preparations|Sensory System Agents|Stereoisomerism|Terpenes",[H][C@]12CCC(=C)[C@@H](C\C=C3/[C@H](O)COC3=O)[C@]1(C)CC[C@@H](O)[C@@]2(C)CO,5318517
5229,DB05768,Alkaline Phosphatase,small molecule,investigational,"Alkaline Phosphatase, antagonists & inhibitors|Enzymes|Enzymes and Coenzymes|Esterases|Hydrolases|Phosphoric Monoester Hydrolases",,
5230,DB05769,LCP-AtorFen,small molecule,investigational,,,
5232,DB05772,Rabeximod,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CN(C)CCNC(=O)CN1C2=CC=C(Cl)C=C2C2=C1N=C1C=C(C)C(C)=CC1=N2,56841552
5234,DB05775,CRx-401,small molecule,investigational,,,
5237,DB05778,Col-118,small molecule,investigational,,,
5238,DB05779,Oglufanide,small molecule,investigational,"Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Angiogenesis Modulating Agents|Antidotes|Antineoplastic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Growth Inhibitors|Growth Substances|Immunologic Factors|Oligopeptides|Peptides|Protective Agents",N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O,100094
5239,DB05780,ATX-101,small molecule,investigational,,,
5240,DB05785,LGD-1550,small molecule,investigational,,,
5241,DB05786,Irofulven,small molecule,investigational,"Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Noxae|Radiation-Sensitizing Agents|Terpenes|Toxic Actions",CC1=C(CO)C2=C(C)C3(CC3)[C@@](C)(O)C(=O)C2=C1,148189
5243,DB05789,MX6,small molecule,investigational,,,
5244,DB05790,SR 140333,small molecule,investigational,Stereoisomerism,[Cl-].CC(C)OC1=CC=CC(CC(=O)N2CCC[C@](CC[N+]34CCC(CC3)(CC4)C3=CC=CC=C3)(C2)C2=CC(Cl)=C(Cl)C=C2)=C1,5311449
5245,DB05791,Perflubron,small molecule,investigational,"Anti-Obesity Agents|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Emulsions|Hydrocarbons, Fluorinated|Hydrocarbons, Halogenated|Magnetic Resonance Imaging Contrast Media|Radiation-Sensitizing Agents",FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)Br,9873
5246,DB05792,Arylacenamide,small molecule,investigational,"Cycloparaffins|Enzyme Inhibitors|Immunologic Factors|Receptors, sigma, antagonists & inhibitors",Cl.CCN(C\C=C/C1=CC(Cl)=C(C=C1)C1CCCCC1)C1CCCCC1,6439330
5249,DB05796,Daglutril,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Neprilysin, antagonists & inhibitors",CCOC(=O)[C@H](CCC1=CC=CC=C1)CC1(CCCC1)C(=O)N[C@H]1CCC2=CC=CC=C2N(CC(O)=O)C1=O,3038505
5252,DB05799,NOX-100,small molecule,investigational,,,
5253,DB05800,Alethine,small molecule,investigational,Amines|Ethylamines|Mercaptoethylamines|Sulfhydryl Compounds|Sulfur Compounds,NCCC(=O)NCCSSCCNC(=O)CCN,69532
5254,DB05801,GTI 2040,small molecule,investigational,,,
5255,DB05803,ISIS 14803,small molecule,investigational,,,
5256,DB05804,Prasterone sulfate,small molecule,investigational,"17-Ketosteroids|Adrenal Cortex Hormones|Androstanes|Androstenes|Androstenols|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP3A7 Substrates|Dehydroepiandrosterone|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Steroids|Testosterone Congeners",[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@H](CC[C@]12C)OS(O)(=O)=O,12594
5257,DB05805,NS-2359,small molecule,investigational,Alkaloids|Aza Compounds|Azabicyclo Compounds|Neurotransmitter Uptake Inhibitors,COC[C@H]1[C@H]2CC[C@@H](C[C@@H]1C1=CC(Cl)=C(Cl)C=C1)N2C,68470595
5258,DB05806,Cositecan,small molecule,investigational,Alkaloids,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C(CC[Si](C)(C)C)C4=CC=CC=C4N=C13)C2=O,148202
5260,DB05808,PI-88,small molecule,investigational,Carbohydrates|Polysaccharides,,
5262,DB05810,99mTc-glucarate,small molecule,investigational,,,
5264,DB05812,Abiraterone,small molecule,approved,"Androstanes|Androstenes|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Cytochrome P450 17A1 Inhibitors|Endocrine Therapy|Enzyme Inhibitors|Fused-Ring Compounds|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors|Steroids",[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,132971
5265,DB05814,GPI-1485,small molecule,investigational,Anti-Bacterial Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Lactones|Polyketides,CCC(C)(C)C(=O)C(=O)N1CCC[C@H]1C(O)=O,9837656
5267,DB05817,Laromustine,small molecule,investigational,Amides|Sulfones|Sulfur Compounds,CNC(=O)N(N(CCCl)S(C)(=O)=O)S(C)(=O)=O,3081349
5270,DB05820,DP-b99,small molecule,investigational,"Acetates|Acids, Acyclic|Amines|Diamines|Ethylenediamines|Fatty Acids|Fatty Acids, Volatile|Lipids|Polyamines",,
5271,DB05821,DP-VPA,small molecule,investigational,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids|Pentanoic Acids|Valerates",,
5272,DB05824,CNS-5161,small molecule,investigational,,CSC1=CC(\N=C(/N)N(C)C2=CC(SC)=CC=C2)=C(Cl)C=C1,192711
5273,DB05825,NCX 1015,small molecule,investigational,Fused-Ring Compounds|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids,,
5274,DB05826,Prolease-r-hFSH,small molecule,investigational,,,
5276,DB05828,LU-31130,small molecule,investigational,,,
5278,DB05830,Trestolone,small molecule,investigational,"Adrenal Cortex Hormones|Contraceptive Agents, Male|Estranes|Estrenes|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Reproductive Control Agents|Steroids|Testosterone Congeners",[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3C[C@@H](C)[C@@]21[H],19582
5279,DB05831,ING-1,small molecule,investigational,,,
5280,DB05832,PPI-1019,small molecule,investigational,,CN[C@H](CC(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@H](CC(C)C)C(N)=O,9830969
5281,DB05834,OC-1012,small molecule,investigational,,,
5282,DB05835,NS-3728,small molecule,investigational,,FC(F)(F)C1=CC(=CC(NC(=O)NC2=C(C=CC(Br)=C2)C2=NNN=N2)=C1)C(F)(F)F,71587684
5284,DB05837,OSI-7836,small molecule,investigational,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides",Cl.NC1=NC(=S)N(C=C1)[C@]1(O)O[C@H](CO)[C@@H](O)[C@@H]1O,3037115
5285,DB05838,OPC-51803,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Receptors, Vasopressin, agonists",CC(C)NC(=O)C[C@H]1CCCN(C(=O)C2=C(Cl)C=C(C=C2)N2CCCC2)C2=CC=CC=C12,3038506
5286,DB05839,BG-777,small molecule,investigational,,,
5287,DB05840,AGI-1096,small molecule,investigational,"Acids, Acyclic|Benzene Derivatives|Fatty Acids|Fatty Acids, Volatile|Lipids",,
5288,DB05841,AI-128,small molecule,investigational,,,
5289,DB05842,AI-850,small molecule,investigational,Cyclodecanes|Cycloparaffins|Diterpenes|Taxoids|Terpenes,,
5290,DB05843,trans NV-04,small molecule,investigational,,,
5291,DB05845,NV-07a,small molecule,investigational,,,
5292,DB05846,Mito-4509,small molecule,investigational,,,
5294,DB05849,NCX 950,small molecule,investigational,,,
5295,DB05851,Biomed 101,small molecule,investigational,,,
5297,DB05854,CLX-0921,small molecule,investigational,Sulfur Compounds,,
5298,DB05855,Rivanicline,small molecule,investigational,Alkaloids|Pyridines|Solanaceous Alkaloids,CNCC\C=C\C1=CN=CC=C1,5310967
5299,DB05856,CPD 923,small molecule,investigational,,,
5302,DB05859,PI-166,small molecule,investigational,,,
5304,DB05861,Tasquinimod,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Quinolines",COC1=CC=CC2=C1C(O)=C(C(=O)N(C)C1=CC=C(C=C1)C(F)(F)F)C(=O)N2C,54682876
5306,DB05864,PPI-2458,small molecule,investigational,"Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Ethers|Ethers, Cyclic",[H][C@@]1([C@H](OC)[C@@H](CC[C@]11CO1)OC(=O)N[C@H](C(C)C)C(N)=O)[C@@]1(C)O[C@@H]1CC=C(C)C,6918653
5307,DB05865,VIT-100,small molecule,investigational,,,
5308,DB05866,ETC-1001,small molecule,investigational,,,
5310,DB05868,Ciluprevir,small molecule,investigational,"Acids, Acyclic|Heterocyclic Compounds, Fused-Ring|Sulfur Compounds",COC1=CC2=C(C=C1)C(O[C@H]1CN3C(=O)[C@H](CCCCC\C=C/[C@]4([H])C[C@@]4(C(O)=O)NC(=O)[C@]3([H])C1)NC(=O)OC1CCCC1)=CC(=N2)C1=CSC(NC(C)C)=N1,9853710
5311,DB05869,Ethyl pyruvate,small molecule,investigational,Keto Acids,CCOC(=O)C(C)=O,12041
5313,DB05871,UC-781,small molecule,investigational,Amides|Amines|Aniline Compounds|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents,CC(C)=CCOC1=C(Cl)C=CC(NC(=S)C2=C(C)OC=C2)=C1,3000926
5314,DB05873,AVI-4020,small molecule,investigational,,,
5315,DB05874,AEOL 10150,small molecule,investigational,"Antioxidants|Biological Factors|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Porphyrins",,
5316,DB05875,"Sar9, Met (O2)11-Substance P",small molecule,investigational,"Amino Acids, Peptides, and Proteins|Autacoids|Biological Factors|Cholinesterase substrates|Inflammation Mediators|Intercellular Signaling Peptides and Proteins|Kinins|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptides|Proteins|Receptors, Neurokinin-3, antagonists & inhibitors|Tachykinins",CC(C)C[C@H](NC(=O)CN(C)C(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CCS(C)(=O)=O)C(N)=O,
5318,DB05880,MBT-0312,small molecule,investigational,,,
5319,DB05881,EHT 0202,small molecule,investigational,,,
5320,DB05882,CHF 4227,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Pyrans",,
5322,DB05884,HCV-086,small molecule,investigational,,CNC(=O)C1=C(OC2=CC(NS(C)(=O)=O)=C(OC(C)C)C=C12)C1=CC=C(F)C=C1,10409873
5323,DB05885,Seletracetam,small molecule,investigational,Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Pyrrolidines|Vasodilating Agents,CC[C@H](N1C[C@@H](CC1=O)C=C(F)F)C(N)=O,9942725
5324,DB05886,NV-18,small molecule,investigational,,,
5325,DB05887,TAFA-93,small molecule,investigational,,,
5326,DB05888,MEM 1414,small molecule,investigational,,,
5328,DB05890,Veglin,small molecule,investigational,,,
5330,DB05894,GT 389-255,small molecule,investigational,,,
5332,DB05896,Sirna-027,small molecule,investigational,,,
5333,DB05897,rhIGFBP-3,small molecule,investigational,,,
5334,DB05898,CERE-110,small molecule,investigational,,,
5335,DB05899,IT-101,small molecule,investigational,"Alkaloids|Biopolymers|Carbohydrates|Compounds used in a research, industrial, or household setting|Dextrins|Diet, Food, and Nutrition|Dietary Carbohydrates|Food|Food and Beverages|Glucans|Macromolecular Substances|Physiological Phenomena|Polymers|Polysaccharides|Starch",,
5336,DB05903,KOS-1584,small molecule,investigational,Anti-Bacterial Agents|Antineoplastic Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Polyketides,C[C@H]1\C=C\C\C(C)=C/C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(\C)=C\C1=CSC(C)=N1,6918835
5337,DB05904,BLX-883,small molecule,investigational,,,
5338,DB05905,TD-2749,small molecule,investigational,,,
5340,DB05911,RUS 3108,small molecule,investigational,,,
5341,DB05912,REN-850,small molecule,investigational,,,
5342,DB05913,OSI-930,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Sulfur Compounds",FC(F)(F)OC1=CC=C(NC(=O)C2=C(NCC3=CC=NC4=CC=CC=C34)C=CS2)C=C1,9868037
5345,DB05918,LS11,small molecule,investigational,,,
5346,DB05919,DDP-200,small molecule,investigational,,,
5347,DB05920,RTA 744,small molecule,investigational,,,
5348,DB05924,NLX-P101,small molecule,investigational,,,
5349,DB05928,Dovitinib,small molecule,investigational,"BCRP/ABCG2 Inducers|BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein inhibitors|Quinolines|Tyrosine Kinase Inhibitors|UGT1A3 Inhibitors|UGT2B7 Inhibitors",CN1CCN(CC1)C1=CC=C2N=C(NC2=C1)C1=C(N)C2=C(NC1=O)C=CC=C2F,9977819
5350,DB05929,GPI-0100,small molecule,investigational,Carbohydrates|Glycosides,,
5351,DB05930,SB-559448,small molecule,investigational,,,
5352,DB05931,Pegdinetanib,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Blood Proteins|Carbohydrates|Extracellular Matrix Proteins|Globulins|Glycoconjugates|Glycoproteins|Membrane Glycoproteins|Membrane Proteins|Peptides|Proteins|Scleroproteins|Serum Globulins|Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitors",,
5353,DB05932,Denibulin,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",COC(=O)NC1=NC2=C(N1)C=CC(SC1=CC=C(NC(=O)[C@H](C)N)C=C1)=C2,
5354,DB05934,CTCE-0214,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Anti-Inflammatory Agents|Biological Factors|Chemokines|Chemokines, CXC|Chemotactic Factors|Cytokines|Inflammation Mediators|Intercellular Signaling Peptides and Proteins|Peptides|Proteins",,
5355,DB05936,CVT-6883,small molecule,investigational,"Adenosine A2 Receptor Antagonists|Heterocyclic Compounds, Fused-Ring",CCCN1C(=O)N(CC)C2=C(NC(=N2)C2=CN(CC3=CC=CC(=C3)C(F)(F)F)N=C2)C1=O,
5356,DB05938,Edonerpic,small molecule,investigational,"Acids, Acyclic|Dicarboxylic Acids|Sulfur Compounds",OC1CN(CCCOCCC2=CC3=C(SC=C3)C=C2)C1,
5357,DB05939,MK-0354,small molecule,investigational,,C1CC2=C(C1)C(=NN2)C1=NNN=N1,
5360,DB05943,Resatorvid,small molecule,investigational,Amides|Sulfones|Sulfur Compounds,[H][C@]1(CCCC=C1C(=O)OCC)S(=O)(=O)NC1=C(Cl)C=C(F)C=C1,
5361,DB05944,Varlitinib,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Sulfur Compounds",C[C@@H]1COC(NC2=CC=C3N=CN=C(NC4=CC=C(OCC5=NC=CS5)C(Cl)=C4)C3=C2)=N1,42642648
5363,DB05950,Contulakin-G,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Carbohydrates|Glycoconjugates|Nerve Tissue Proteins|Peptides|Proteins",,
5364,DB05956,EVT-101,small molecule,investigational,,Cl.Cl.CC1=NC=CN1CC1=CC(=CN=N1)C1=CC=C(F)C(=C1)C(F)F,
5365,DB05959,ENMD-1198,small molecule,investigational,Estranes|Fused-Ring Compounds|Steroids,COC1=C(C=C2CC[C@H]3[C@@H]4CC=C[C@@]4(C)CC[C@@H]3C2=C1)C(N)=O,
5366,DB05961,PPL-100,small molecule,investigational,,COC(=O)N[C@@H](C(C1=CC=CC=C1)C1=CC=CC=C1)C(=O)NCCCC[C@@H](CO)N(CC(C)C)S(=O)(=O)C1=CC=C(N)C=C1,
5367,DB05964,Amitifadine,small molecule,investigational,Stereoisomerism,[H][C@]12C[C@]1(CNC2)C1=CC(Cl)=C(Cl)C=C1,
5368,DB05966,TAS-108,small molecule,investigational,,OC(=O)CC(O)(CC(O)=O)C(O)=O.CCN(CC)CC1=CC=C(OCC[C@H]2CC[C@H]3[C@@H]4[C@H](C)CC5=C(C=CC(O)=C5)[C@H]4CC[C@]23C)C(OC)=C1,
5369,DB05967,ANZ-100,small molecule,investigational,,,
5370,DB05968,PR-104,small molecule,investigational,"Hydrocarbons, Halogenated|Mustard Compounds",CS(=O)(=O)OCCN(CCBr)C1=C(C=C(C=C1[N+]([O-])=O)[N+]([O-])=O)C(=O)NCCOP(O)(O)=O,
5371,DB05969,SNS-032,small molecule,investigational,Sulfur Compounds,CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1,
5372,DB05971,Archexin,small molecule,investigational,,,
5373,DB05973,Inosine 5'-sulfate,small molecule,investigational,,O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=CNC2=O,
5374,DB05974,Transcrocetinate,small molecule,investigational,"Alkenes|Anticarcinogenic Agents|Antineoplastic Agents|Antioxidants|Biological Factors|Compounds used in a research, industrial, or household setting|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Protective Agents|Terpenes",C\C(\C=C\C=C(/C)C(O)=O)=C/C=C/C=C(\C)/C=C/C=C(\C)C(O)=O,
5375,DB05983,Bardoxolone methyl,small molecule,investigational,Fused-Ring Compounds|Pentacyclic Triterpenes|Sapogenins|Steroids|Terpenes|Triterpenes,COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@]4(C)C=C(C#N)C(=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2,
5376,DB05984,RAF-265,small molecule,investigational,,CN1C(NC2=CC=C(C=C2)C(F)(F)F)=NC2=CC(OC3=CC=NC(=C3)C3=NC=C(N3)C(F)(F)F)=CC=C12,
5377,DB05990,Obeticholic acid,small molecule,approved,Alimentary Tract and Metabolism|Bile Acid Preparations|Bile acids and derivatives|Bile Acids and Salts|Bile and Liver Therapy|Bile Therapy|BSEP/ABCB11 inducers|BSEP/ABCB11 Inhibitors|Cholanes|Cholic Acids|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Farnesoid X Receptor Agonist|Farnesoid X Receptor Agonists|Fused-Ring Compounds|Miscellaneous GI Drugs,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)[C@H](CC)[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,447715
5378,DB05992,Plinabulin,small molecule,investigational,Deuterium|Piperazines,CC(C)(C)C1=C(\C=C2/NC(=O)\C(NC2=O)=C\C2=CC=CC=C2)N=CN1,
5379,DB05993,PRX-07034,small molecule,investigational,,Cl.COC1=C(OC)C(=CC(Cl)=C1)C(C)NC1=CC(=CC=C1S(C)(=O)=O)N1CCNCC1,
5381,DB06005,Adomiparin,small molecule,investigational,,,
5382,DB06011,AMG-222,small molecule,investigational,Agents causing angioedema|Benzocycloheptenes|Blood Glucose Lowering Agents|DPP-IV Inhibitors,[H][C@](C)(CC1(C2=NNN=N2)C2=CC=C(C=C2CCC2=CC(=CC=C12)C(=O)N(C)C)C(=O)N(C)C)NCC(=O)N1CCC[C@@]1([H])C#N,
5383,DB06013,Aldoxorubicin,small molecule,investigational,Anthracyclines|Antineoplastic Agents|Carbohydrates|Cardiotoxic antineoplastic agents|Glycosides|Hydrazines|Naphthacenes,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]4C[C@H](N)[C@H](O)[C@H](C)O4)C(\CO)=N\NC(=O)CCCCCN4C(=O)C=CC4=O)C(O)=C3C(=O)C2=CC=C1,
5385,DB06016,Cariprazine,small molecule,approved|investigational,Agents that produce hypertension|Antidepressive Agents|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Histamine Antagonists|Histamine H1 Antagonists|Nervous System|Neurotoxic agents|Psycholeptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Agonists|Serotonin Receptor Antagonists|Tranquilizing Agents,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1,11154555
5386,DB06021,AV-412,small molecule,investigational,"Antineoplastic Agents|Enzyme Inhibitors|ErbB Receptors, antagonists & inhibitors|Heterocyclic Compounds, Fused-Ring|Protein Kinase Inhibitors|Receptor, ErbB-2, antagonists & inhibitors",CC1=CC=C(C=C1)S(O)(=O)=O.CC1=CC=C(C=C1)S(O)(=O)=O.CN1CCN(CC1)C(C)(C)C#CC1=C(NC(=O)C=C)C=C2C(NC3=CC=C(F)C(Cl)=C3)=NC=NC2=C1,
5388,DB06039,PA-1050040,small molecule,investigational,,,
5389,DB06040,Filanesib,small molecule,investigational,Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Sulfur Compounds|Thiazoles,CON(C)C(=O)N1N=C(S[C@@]1(CCCN)C1=CC=CC=C1)C1=CC(F)=CC=C1F,
5390,DB06042,ZEN-012,small molecule,investigational,,,
5392,DB06045,Trofinetide,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Peptides",C[C@]1(CCCN1C(=O)CN)C(=O)N[C@@H](CCC(O)=O)C(O)=O,
5395,DB06058,XTL-6865,small molecule,investigational,,,
5396,DB06061,AZD-8330,small molecule,investigational,Protein Kinase Inhibitors|Pyridines,CN1C(=O)C(C)=CC(C(=O)NOCCO)=C1NC1=CC=C(I)C=C1F,16666708
5397,DB06063,CAM-2029,small molecule,investigational,,,
5398,DB06064,KAI-1455,small molecule,investigational,,,
5399,DB06069,XMT-1001,small molecule,investigational,"Acetals|Alkaloids|Compounds used in a research, industrial, or household setting|Macromolecular Substances",,
5400,DB06070,SNX-5422,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Heterocyclic Compounds, Fused-Ring|Pyrazoles",CC1(C)CC2=C(C(=NN2C2=CC(N[C@H]3CC[C@@H](CC3)OC(=O)CN)=C(C=C2)C(N)=O)C(F)(F)F)C(=O)C1,44195571
5401,DB06071,DTS-201,small molecule,investigational,Anthracyclines|Carbohydrates|Glycosides|Naphthacenes,,
5402,DB06073,CTS-21166,small molecule,investigational,,,
5403,DB06075,Linsitinib,small molecule,investigational,,C[C@@]1(O)C[C@@H](C1)C1=NC(=C2N1C=CN=C2N)C1=CC=C2C=CC(=NC2=C1)C1=CC=CC=C1,
5404,DB06077,Lumateperone,small molecule,approved|investigational,Antidepressive Agents|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dopamine Agonists|Dopamine Antagonists|Dopamine D2 Receptor Agonists|Neurotoxic agents|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists|UGT1A1 Substrates|UGT1A4 substrates,[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=CC=CC3=C1N2CCN3C,21302490
5405,DB06080,ABT-869,small molecule,investigational,"Benzene Derivatives|Heterocyclic Compounds, Fused-Ring|Pyrazoles|Receptor Protein-Tyrosine Kinases, antagonists & inhibitors",,
5407,DB06082,PX-478,small molecule,investigational,"Acids, Carbocyclic|Hydrocarbons, Halogenated",Cl.Cl.N[C@@H](CC1=CC=C(C=C1)[N+]([O-])(CCCl)CCCl)C(O)=O,
5408,DB06083,Tapinarof,small molecule,investigational,Benzene Derivatives|Benzylidene Compounds|Phenols,CC(C)C1=C(O)C=C(\C=C\C2=CC=CC=C2)C=C1O,
5409,DB06087,Friulimicin B,small molecule,investigational,"Amino Acids, Peptides, and Proteins",CC(C)CCCCCCC\C=C/CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]1[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H]2CCCCN2C1=O)[C@H](C)C(O)=O)[C@@H](C)N)C(C)C,
5410,DB06089,ICA-105665,small molecule,investigational,,,
5411,DB06090,Bradanicline,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Receptors, Nicotinic",[H][C@@]1(CC2=CC=CN=C2)N2CCC(CC2)[C@@]1([H])NC(=O)C1=CC2=C(O1)C=CC=C2,25147644
5412,DB06091,Evofosfamide,small molecule,investigational,"Acids|Acids, Noncarboxylic|Anions|Electrolytes|Hydrocarbons, Halogenated|Imidazoles|Ions|Mustard Compounds|Nitro Compounds|Nitrogen Mustard Compounds|Organophosphorus Compounds|Phosphoramides|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds",CN1C(COP(=O)(NCCBr)NCCBr)=CN=C1[N+]([O-])=O,
5413,DB06093,ABT-560,small molecule,investigational,,,
5414,DB06094,Apatorsen,small molecule,investigational,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Polynucleotides",COCCOC1C(O)C(COP(O)(=S)OC2C(COP(O)(=S)OC3C(COP(O)(=S)OC4C(COP(O)(=S)OC5CC(OC5COP(O)(=S)OC5CC(OC5COP(O)(=S)OC5CC(OC5COP(O)(=S)OC5CC(OC5COP(O)(=S)OC5CC(OC5COP(O)(=S)OC5CC(OC5COP(O)(=S)OC5CC(OC5COP(O)(=S)OC5CC(OC5COP(O)(=S)OC5CC(OC5COP(O)(=S)OC5CC(OC5COP(O)(=S)OC5CC(OC5COP(O)(=S)OC5CC(OC5COP(O)(=S)OC5C(COP(O)(=S)OC6C(COP(O)(=S)OC7C(COP(O)(=S)OC8C(CO)OC(C8OCCOC)N8C=NC9=C8NC(=N)N=C9O)OC(C7OCCOC)N7C=NC8=C7NC(=N)N=C8O)OC(C6OCCOC)N6C=NC7=C6NC(=N)N=C7O)OC(C5OCCOC)N5C=NC6=C(N)N=CN=C56)N5C=C(C)C(=N)N=C5O)N5C=NC6=C5NC(=N)N=C6O)N5C=C(C)C(=N)N=C5O)N5C=NC6=C5NC(=N)N=C6O)N5C=NC6=C5NC(=N)N=C6O)N5C=C(C)C(=N)N=C5O)N5C=NC6=C5NC(=N)N=C6O)N5C=C(C)C(=N)N=C5O)N5C=C(C)C(O)=NC5=O)N5C=C(C)C(=N)N=C5O)N5C=NC6=C5NC(=N)N=C6O)N5C=NC6=C5NC(=N)N=C6O)OC(C4OCCOC)N4C=C(C)C(O)=NC4=O)OC(C3OCCOC)N3C=C(C)C(=N)N=C3O)OC(C2OCCOC)N2C=NC3=C(N)N=CN=C23)OC1N1C=C(C)C(O)=NC1=O,131704298
5415,DB06096,NXN-188,small molecule,investigational,,,
5416,DB06097,GSK-923295,small molecule,investigational,,,
5417,DB06098,PRLX 93936,small molecule,investigational,,,
5419,DB06103,VX-148,small molecule,investigational,Benzene Derivatives,,
5420,DB06106,AIT-034,small molecule,investigational,,O=C(CCN1C=NC2=C1NC=NC2=O)NCCCN1CCCC1=O,
5421,DB06109,YKP-1358,small molecule,investigational,Antidepressive Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Neurotransmitter Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists,,
5422,DB06111,AB192,small molecule,experimental,"Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Dipeptidyl-Peptidases and Tripeptidyl-Peptidases, antagonists & inhibitors|Imines|Imino Acids|Organophosphorus Compounds",,
5423,DB06112,"3,4-Methylenedioxy-N-isopropylamphetamine",small molecule,investigational,,CC(C)NC(C)CC1=CC2=C(OCO2)C=C1,
5425,DB06117,"1alpha,24S-Dihydroxyvitamin D2",small molecule,investigational,Cholestanes|Cholestenes|Fused-Ring Compounds|Lipids|Membrane Lipids|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble),CC(C)[C@](C)(O)\C=C\[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C,
5426,DB06119,Cenobamate,small molecule,approved|investigational,Anticonvulsants|Central Nervous System Depressants|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|GABA Modulators|UGT2B7 substrates|Voltage-Gated Sodium Channel Blockers,NC(=O)O[C@@H](CN1N=CN=N1)C1=C(Cl)C=CC=C1,
5427,DB06124,L-aminocarnityl-succinyl-leucyl-argininal-diethylacetal,small molecule,investigational,,CCOC(OCC)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)CCC(=O)N[C@H](CC([O-])=O)C[N+](C)(C)C,
5428,DB06127,Bisegliptin,small molecule,investigational,Agents causing angioedema|Blood Glucose Lowering Agents|DPP-IV Inhibitors,[H][C@@]1(F)CN(C(=O)CNC23CCC(CC2)(CC3)C(=O)OCC)[C@@]([H])(C1)C#N,
5429,DB06129,SVV-001,small molecule,investigational,,,
5431,DB06133,Dimethylcurcumin,small molecule,investigational,,COC1=CC=C(\C=C\C(\O)=C\C(=O)\C=C\C2=CC(OC)=C(OC)C=C2)C=C1OC,
5432,DB06134,SNS-314,small molecule,investigational,Benzene Derivatives|Protein Kinase Inhibitors|Sulfur Compounds,ClC1=CC=CC(NC(=O)NC2=NC=C(CCNC3=C4SC=CC4=NC=N3)S2)=C1,
5433,DB06137,KX-01,small molecule,investigational,"Acetates|Acids, Acyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Lipids",O=C(CC1=CC=C(C=N1)C1=CC=C(OCCN2CCOCC2)C=C1)NCC1=CC=CC=C1,
5434,DB06138,IRL-1620,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Biological Factors|Intercellular Signaling Peptides and Proteins|Peptides|Proteins",,
5435,DB06140,SUVN-502,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents",COC1=CC=C2N(C=C(CN3CCN(C)CC3)C2=C1)S(=O)(=O)C1=CC=CC=C1Br,
5436,DB06144,Sertindole,small molecule,approved|investigational|withdrawn,"Antidepressive Agents|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Heterocyclic Compounds, Fused-Ring|Indole Derivatives|Nervous System|Neurotoxic agents|Psycholeptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Tranquilizing Agents",FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2,60149
5437,DB06145,Spiramycin,small molecule,approved,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antiparasitic Agents|Antiprotozoals|Carbohydrates|Coccidiostats|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Glycosides|Lactones|Leucomycins|Macrolides|Macrolides, Lincosamides and Streptogramins|Polyketides",CO[C@H]1[C@H](O)CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O[C@H]2CC[C@@H]([C@H](C)O2)N(C)C)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]1O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(O)[C@@H](O)[C@H](C)O2)[C@@H]([C@H]1O)N(C)C,6440717
5438,DB06147,Sulfathiazole,small molecule,approved|vet_approved,Amides|Amines|Aniline Compounds|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Short-Acting Sulfonamides|Sulfanilamides|Sulfathiazoles|Sulfonamides|SULFONAMIDES AND TRIMETHOPRIM|Sulfones|Sulfur Compounds|Thiazoles,NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CS1,5340
5439,DB06148,Mianserin,small molecule,approved|investigational,"Adrenergic Agents|Agents that produce hypertension|Antidepressive Agents|Antidepressive Agents, Second-Generation|Antidepressive Agents, Tetracyclic|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dibenzazepines|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Heterocyclic Compounds, Fused-Ring|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Nervous System|Neurotransmitter Agents|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists",CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,4184
5440,DB06149,Teicoplanin,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Carbohydrates|Glycoconjugates|Glycopeptide Antibacterials|Glycopeptides|Lipids|Lipoglycopeptides|Lipopeptides|Peptides",,
5441,DB06150,Sulfadimethoxine,small molecule,approved|vet_approved,Amides|Amines|Aniline Compounds|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Long-Acting Sulfonamides|Sulfanilamides|Sulfonamides|SULFONAMIDES AND TRIMETHOPRIM|Sulfones|Sulfur Compounds,COC1=NC(OC)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1,5323
5442,DB06151,Acetylcysteine,small molecule,approved|investigational,"Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Anti-Infective Agents|Antidote for Acetaminophen Overdose|Antidotes|Antioxidants|Compounds used in a research, industrial, or household setting|Cough and Cold Preparations|Cysteine|Decreased Respiratory Secretion Viscosity|Expectorants|Free Radical Scavengers|Increased Glutathione Concentration|OATP1B1/SLCO1B1 Inhibitors|Ophthalmologicals|Protective Agents|Reduction Activity|Respiratory System Agents|Sensory Organs|Sulfhydryl Compounds|Sulfur Compounds",CC(=O)N[C@@H](CS)C(O)=O,12035
5443,DB06152,Nylidrin,small molecule,approved,"2-Amino-1-Phenylethanol Derivatives|Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-Agonists|Agents causing hyperkalemia|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Autonomic Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Ethylamines|Genito Urinary System and Sex Hormones|Miscellaneous Vasodilatating Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Peripheral Vasodilators|Phenethylamines|Propanolamines|Propanols|Reproductive Control Agents|Sympathomimetics|Sympathomimetics, Labour Repressants|Tocolytic Agents|Vasodilating Agents",CC(CCC1=CC=CC=C1)NC(C)C(O)C1=CC=C(O)C=C1,4567
5444,DB06153,Pizotifen,small molecule,approved,"Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anticholinergic Agents|Antidepressive Agents|Antimigraine Agents, Miscellaneous|Antimigraine Preparations|Central Nervous System Agents|Central Nervous System Depressants|Histamine Antagonists|Histamine H1 Antagonists|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|Peripheral Nervous System Agents|Psychotropic Drugs|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Thiophenes",CN1CCC(CC1)=C1C2=C(CCC3=CC=CC=C13)SC=C2,27400
5445,DB06154,Pentaerythritol tetranitrate,small molecule,approved,Alcohols|Antianginal Agents|Carbohydrates|Cardiac Therapy|Cardiovascular Agents|Drugs that are Mainly Renally Excreted|Fibrin Modulating Agents|Glycols|Hematologic Agents|Organic Nitrates|Polysaccharides|Propylene Glycols|Vasodilating Agents|Vasodilators Used in Cardiac Diseases,[O-][N+](=O)OCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O,6518
5446,DB06155,Rimonabant,small molecule,approved|investigational,"Agents producing tachycardia|Alimentary Tract and Metabolism|Anti-Obesity Agents|Antiobesity Preparations, Excl. Diet Products|Cannabinoid Receptor Antagonists|Cannabinoids and similars|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Neurotransmitter Agents|Piperidines|Pyrazoles|Receptor, Cannabinoid, CB1, antagonists & inhibitors",CC1=C(N(N=C1C(=O)NN1CCCCC1)C1=C(Cl)C=C(Cl)C=C1)C1=CC=C(Cl)C=C1,104850
5447,DB06156,Tesofensine,small molecule,investigational,"Biogenic Monoamines, antagonists & inhibitors",CCOC[C@H]1[C@H]2CC[C@@H](C[C@@H]1C1=CC(Cl)=C(Cl)C=C1)N2C,
5448,DB06157,Istaroxime,small molecule,investigational,"17-Ketosteroids|Adrenal Cortex Hormones|Androstanes|Androstanols|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Sodium-Potassium-Exchanging ATPase, antagonists & inhibitors|Steroids",C[C@]12CC[C@H]3[C@@H](CC(=O)[C@H]4C\C(CC[C@]34C)=N\OCCN)[C@@H]1CCC2=O,
5449,DB06159,Rubitecan,small molecule,investigational,Alkaloids|Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase I Inhibitors|Topoisomerase Inhibitors,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=CC=C(C1=C3)[N+]([O-])=O)C2=O,11954380
5450,DB06160,Garenoxacin,small molecule,investigational,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antineoplastic Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Moderate Risk QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",C[C@H]1NCC2=CC(=CC=C12)C1=CC=C2C(=O)C(=CN(C3CC3)C2=C1OC(F)F)C(O)=O,
5451,DB06161,Opebacan,small molecule,investigational,,,
5453,DB06163,Plevitrexed,small molecule,investigational,"Antineoplastic Agents|Heterocyclic Compounds, Fused-Ring",CC1=NC(=O)C2=CC(CN(CC#C)C3=CC=C(C(=O)N[C@@H](CCC4=NN=NN4)C(O)=O)C(F)=C3)=C(C)C=C2N1,
5454,DB06166,Fosdevirine,small molecule,investigational,"Acids|Acids, Noncarboxylic|Heterocyclic Compounds, Fused-Ring|Organophosphorus Compounds|Phosphorus Acids|Phosphorus Compounds",CO[P@](=O)(C1=C(NC2=CC=C(Cl)C=C12)C(N)=O)C1=CC(C)=CC(\C=C\C#N)=C1,
5456,DB06169,Indibulin,small molecule,investigational,"Acetates|Acids, Acyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Heterocyclic Compounds, Fused-Ring|Lipids",ClC1=CC=C(CN2C=C(C(=O)C(=O)NC3=CC=NC=C3)C3=CC=CC=C23)C=C1,
5458,DB06174,Noscapine,small molecule,approved|investigational,"Alkaloids|Antitussive Agents|Central Nervous System Agents|Cough and Cold Preparations|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Opiate Alkaloids|Opium Alkaloids and Derivatives|Respiratory System Agents",[H][C@@]1(OC(=O)C2=C1C=CC(OC)=C2OC)[C@]1([H])N(C)CCC2=CC3=C(OCO3)C(OC)=C12,
5459,DB06176,Romidepsin,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Highest Risk QTc-Prolonging Agents|Histone Deacetylase Inhibitors|Narrow Therapeutic Index Drugs|OATP1B3 substrates|P-glycoprotein substrates|Peptides|Peptides, Cyclic|QTc Prolonging Agents",C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C,57515973
5460,DB06177,Glufosfamide,small molecule,investigational,"Acids|Acids, Noncarboxylic|Anions|Carbohydrates|Electrolytes|Hexoses|Hydrocarbons, Halogenated|Ions|Monosaccharides|Mustard Compounds|Nitrogen Mustard Compounds|Organophosphorus Compounds|Oxazines|Phosphoramide Mustards|Phosphoramides|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds",OC[C@H]1O[C@@H](OP(=O)(NCCCl)NCCCl)[C@H](O)[C@@H](O)[C@@H]1O,
5461,DB06178,Talotrexin,small molecule,investigational,"Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Peptides, and Proteins|Biological Factors|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Pteridines",NC1=NC(N)=C2N=C(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCCNC(=O)C3=CC=CC=C3C(O)=O)C(O)=O)C=NC2=N1,
5462,DB06179,Darinaparsin,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Oligopeptides|Organometallic Compounds|Peptides",C[As](C)SC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O,
5464,DB06181,IMO-2055,small molecule,investigational,"Antineoplastic Agents|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Polynucleotides|Toll-Like Receptor 9, agonists",,
5465,DB06182,Talabostat,small molecule,investigational,"Acids|Acids, Noncarboxylic|Amino Acids, Peptides, and Proteins|Boron Compounds|Dipeptidyl-Peptidases and Tripeptidyl-Peptidases, antagonists & inhibitors|Oligopeptides|Peptides",CC(C)[C@H](N)C(=O)N1CCC[C@H]1B(O)O,
5466,DB06184,AEG35156,small molecule,investigational,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Polynucleotides",,
5467,DB06185,Forodesine,small molecule,investigational,"Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine-Nucleoside Phosphorylase, antagonists & inhibitors|Purines|Pyrimidines",OC[C@H]1N[C@H]([C@H](O)[C@@H]1O)C1=CNC2=C1N=CNC2=O,444499
5469,DB06187,Valtorcitabine,small molecule,investigational,,CC(C)[C@H](N)C(=O)O[C@@H]1C[C@H](O[C@H]1CO)N1C=CC(N)=NC1=O,
5470,DB06188,Ispinesib,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Heterocyclic Compounds, Fused-Ring",CC(C)[C@@H](N(CCCN)C(=O)C1=CC=C(C)C=C1)C1=NC2=CC(Cl)=CC=C2C(=O)N1CC1=CC=CC=C1,
5471,DB06190,Solabegron,small molecule,investigational,"Acids, Carbocyclic|Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-3 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Amines|Benzene Derivatives|Neurotransmitter Agents",[H][C@](O)(CNCCNC1=CC(=CC=C1)C1=CC(=CC=C1)C(O)=O)C1=CC=CC(Cl)=C1,9887812
5472,DB06191,Zosuquidar,small molecule,investigational,"Benzocycloheptenes|Drug Resistance, Multiple|Heterocyclic Compounds, Fused-Ring|P-glycoprotein inhibitors",[H][C@]12C3=CC=CC=C3[C@H](N3CCN(C[C@@H](O)COC4=CC=CC5=C4C=CC=N5)CC3)C3=CC=CC=C3[C@@]1([H])C2(F)F,153997
5474,DB06193,Pixantrone,small molecule,approved|investigational,"Anthracyclines and Related Substances|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytotoxic Antibiotics and Related Substances|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Narrow Therapeutic Index Drugs|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",NCCNC1=CC=C(NCCN)C2=C1C(=O)C1=C(C=NC=C1)C2=O,134019
5475,DB06194,Elocalcitol,small molecule,investigational,Cholestanes|Cholestenes|Fused-Ring Compounds|Lipids|Membrane Lipids|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble),CCC(O)(CC)\C=C\C[C@H](C)C1=CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@@](F)([H])C1=C,11396600
5476,DB06195,Seliciclib,small molecule,investigational,"Anti-Infective Agents|Antineoplastic Agents|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Protein Kinase Inhibitors|Purines",CC[C@H](CO)NC1=NC(NCC2=CC=CC=C2)=C2N=CN(C(C)C)C2=N1,160355
5477,DB06196,Icatibant,small molecule,approved|investigational,"Agents causing angioedema|Amino Acids, Peptides, and Proteins|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antirheumatic Agents|Autacoids|Biological Factors|Blood and Blood Forming Organs|Bradykinin B2 Receptor Antagonists|Bradykinin Receptor Antagonists|Central Nervous System Agents|Complement Inactivating Agents|Drugs that are Mainly Renally Excreted|Drugs Used in Hereditary Angioedema|Immunologic Factors|Inflammation Mediators|Intercellular Signaling Peptides and Proteins|Kinins|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptides|Peripheral Nervous System Agents|Proteins|Sensory System Agents",[H][C@]12C[C@]([H])(N(C(=O)[C@@]3([H])CC4=C(CN3C(=O)[C@H](CO)NC(=O)[C@H](CC3=CC=CS3)NC(=O)CNC(=O)[C@]3([H])C[C@@H](O)CN3C(=O)[C@@H]3CCCN3C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](N)CCCNC(N)=N)C=CC=C4)[C@@]1([H])CCCC2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O,71364
5478,DB06197,Bimosiamose,small molecule,investigational,"Alkanes|Benzene Derivatives|Carbohydrates|Hexoses|Hydrocarbons, Acyclic|Monosaccharides",[H][C@]1(CO)O[C@]([H])(OC2=C(C=C(CCCCCCC3=CC(=C(O[C@@]4([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@]4([H])O)C=C3)C3=CC=CC(CC(O)=O)=C3)C=C2)C2=CC=CC(CC(O)=O)=C2)[C@@]([H])(O)[C@@]([H])(O)[C@]1([H])O,
5479,DB06198,Alovudine,small molecule,investigational,"Anti-Infective Agents|Antiviral Agents|Carbohydrates|Deoxyribonucleosides|Fluorine Radioisotopes|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides",CC1=CN([C@H]2C[C@H](F)[C@@H](CO)O2)C(=O)NC1=O,
5480,DB06199,Atrasentan,small molecule,investigational,"Antineoplastic Agents|Benzodioxoles|Dioxoles|Endothelin A Receptor Antagonists|Endothelin Receptor Antagonists|Heterocyclic Compounds, Fused-Ring|OATP1B1/SLCO1B1 Substrates|Pyrrolidines",CCCCN(CCCC)C(=O)CN1C[C@@H]([C@H]([C@@H]1C1=CC=C(OC)C=C1)C(O)=O)C1=CC2=C(OCO2)C=C1,159594
5481,DB06200,Tedisamil,small molecule,investigational,"Antiarrhythmic agents|Antiarrhythmics, Class III|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Cycloparaffins|Moderate Risk QTc-Prolonging Agents|Protective Agents|QTc Prolonging Agents",C(C1CC1)N1CC2CN(CC3CC3)CC(C1)C21CCCC1,65825
5482,DB06201,Rufinamide,small molecule,approved,Anticonvulsants|Carboxamide Derivatives|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (weak)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Membrane Transport Modulators|Miscellaneous Anticonvulsants|Nervous System|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers,NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1,129228
5483,DB06202,Lasofoxifene,small molecule,approved|investigational,Genito Urinary System and Sex Hormones|Naphthalenes|Selective Estrogen Receptor Modulators|Sex Hormones and Modulators of the Genital System,[H][C@@]1(CCC2=CC(O)=CC=C2[C@@]1([H])C1=CC=C(OCCN2CCCC2)C=C1)C1=CC=CC=C1,216416
5484,DB06203,Alogliptin,small molecule,approved,"Agents causing angioedema|Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|DPP-IV Inhibitors|Drugs that are Mainly Renally Excreted|Drugs Used in Diabetes|Enzyme Inhibitors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Incretins|Protease Inhibitors|Pyrimidines|Pyrimidinones",CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC2=C(C=CC=C2)C#N)C1=O,11450633
5485,DB06204,Tapentadol,small molecule,approved,Adrenergic Agents|Adrenergic Uptake Inhibitors|Analgesics|Antidepressive Agents|Benzene Derivatives|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Membrane Transport Modulators|Narcotics|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Opiate Agonists|Opioid Agonist|Opioids|Peripheral Nervous System Agents|Phenols|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|UGT1A9 Substrates|UGT2B7 substrates,CC[C@H]([C@@H](C)CN(C)C)C1=CC(O)=CC=C1,9838022
5487,DB06206,Sugammadex,small molecule,approved,"Antidotes|Biopolymers|Carbohydrates|Compounds used in a research, industrial, or household setting|Cyclodextrins|Dextrins|Diet, Food, and Nutrition|Dietary Carbohydrates|Food|Food and Beverages|gamma-Cyclodextrins|Glucans|Macromolecular Substances|Physiological Phenomena|Polymers|Polysaccharides|Starch",O[C@@H]1[C@@H](O)[C@@H]2O[C@H]3O[C@H](CSCCC(O)=O)[C@@H](O[C@H]4O[C@H](CSCCC(O)=O)[C@@H](O[C@H]5O[C@H](CSCCC(O)=O)[C@@H](O[C@H]6O[C@H](CSCCC(O)=O)[C@@H](O[C@H]7O[C@H](CSCCC(O)=O)[C@@H](O[C@H]8O[C@H](CSCCC(O)=O)[C@@H](O[C@H]9O[C@H](CSCCC(O)=O)[C@@H](O[C@H]1O[C@@H]2CSCCC(O)=O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O,6918585
5488,DB06207,Silodosin,small molecule,approved,"Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs Used in Benign Prostatic Hypertrophy|Genito Urinary System and Sex Hormones|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|P-glycoprotein substrates|Peripheral alpha-1 blockers|Selective Alfa-1-adrenergic Blocking Agents|UGT2B7 substrates|Urological Agents|Urologicals",C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F,5312125
5489,DB06209,Prasugrel,small molecule,approved,Anticoagulants|Antiplatelet agents|Blood and Blood Forming Organs|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Decreased Platelet Aggregation|Drugs that are Mainly Renally Excreted|Hematologic Agents|P2Y12 Platelet Inhibitor|Piperazines|Platelet Aggregation Inhibitors Excl. Heparin|Purinergic P2Y Receptor Antagonists|Sulfur Compounds|Thiophenes,CC(=O)OC1=CC2=C(CCN(C2)C(C(=O)C2CC2)C2=CC=CC=C2F)S1,6918456
5490,DB06210,Eltrombopag,small molecule,approved,"Acids, Carbocyclic|BCRP/ABCG2 Inhibitors|Benzene Derivatives|Blood and Blood Forming Organs|Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Hematinics|Hemostatics|Increased Megakaryocyte Maturation|Increased Platelet Production|OATP1B1/SLCO1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Thrombopoietin Receptor Agonist|Thrombopoietin Receptor Agonists|UGT1A1 Inhibitors|UGT1A1 Substrates|UGT1A3 Inhibitors|UGT1A3 substrates|UGT1A4 Inhibitors|UGT1A6 Inhibitors|UGT1A9 Inhibitors|UGT2B15 Inhibitors|UGT2B7 Inhibitors",CC1=NN(C(=O)\C1=N/NC1=CC=CC(C2=CC=CC(=C2)C(O)=O)=C1O)C1=CC=C(C)C(C)=C1,9846180
5491,DB06211,Doripenem,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Carbapenems|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Lactams|OAT3/SLC22A8 Substrates|Penem Antibacterial|Sulfur Compounds",[H][C@]12[C@@H](C)C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,73303
5492,DB06212,Tolvaptan,small molecule,approved,"Agents causing hyperkalemia|Antidiuretic Hormone Receptor Antagonists|Benzazepines|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Diuretics|Heterocyclic Compounds, Fused-Ring|Natriuretic Agents|P-glycoprotein inhibitors|P-glycoprotein substrates|Vasopressin V2 Receptor Antagonist|Vasopressin V2 Receptor Antagonists",CC1=CC=CC=C1C(=O)NC1=CC(C)=C(C=C1)C(=O)N1CCC[C@@H](O)C2=C1C=CC(Cl)=C2,443894
5493,DB06213,Regadenoson,small molecule,approved|investigational,"Adenosine A2 Receptor Agonists|Cardiac Therapy|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|Purinergic Agents|Purinergic Agonists|Purinergic P1 Receptor Agonists",CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1,219024
5494,DB06215,Ferumoxytol,small molecule,approved|investigational,"Compounds used in a research, industrial, or household setting|Ferric Compounds|Ferrous Compounds|Hematinics|Hematologic Agents|Iron Compounds|Magnetic Resonance Contrast Activity|Minerals|Organometallic Compounds|Paramagnetic Contrast Agent|Parenteral Iron Replacement|Parenteral Nutrition Solutions|Pharmaceutical Preparations|Pharmaceutical Solutions|Solutions",[O--].[O--].[O--].[O--].[Fe++].[Fe+3].[Fe+3],16211978
5495,DB06216,Asenapine,small molecule,approved,"Acid Reducers|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antidepressive Agents|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Diazepines, Oxazepines, Thiazepines and Oxepines|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H2 Antagonists|Hyperglycemia-Associated Agents|Nervous System|Neurotoxic agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Agonists|Tranquilizing Agents|UGT1A4 substrates",OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,11954293
5496,DB06217,Vernakalant,small molecule,approved|investigational,"Antiarrhythmic agents|Antiarrhythmics, Class III|Benzene Derivatives|Cardiac Therapy|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Ethers|Methyl Ethers|Phenols|Phenyl Ethers|Potential QTc-Prolonging Agents|QTc Prolonging Agents",COC1=C(OC)C=C(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)C=C1,9930049
5497,DB06218,Lacosamide,small molecule,approved,"Acetamides|Acetates|Acids, Acyclic|Alkanes|Amides|Anti-epileptic Agent|Anticonvulsants|Bradycardia-Causing Agents|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Decreased Central Nervous System Disorganized Electrical Activity|Fatty Acids|Fatty Acids, Volatile|Hydrocarbons, Acyclic|Lipids|Membrane Transport Modulators|Miscellaneous Anticonvulsants|Nervous System|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers",COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,219078
5498,DB06219,Dalbavancin,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Carbohydrates|Glycoconjugates|Glycopeptide Antibacterials|Glycopeptides|Lipids|Lipoglycopeptide Antibacterial|Lipoglycopeptides|Lipopeptides|Peptides",,23724878
5499,DB06224,Alicaforsen,small molecule,investigational,"Carbohydrates|Gastrointestinal Agents|Glycosides|Immunologic Factors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Oligonucleotides|Polynucleotides",,
5500,DB06225,HMR4011,small molecule,investigational,,,
5502,DB06228,Rivaroxaban,small molecule,approved,Anticoagulants|Antithrombins|BCRP/ABCG2 Substrates|Blood and Blood Forming Organs|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Factor Xa Inhibitors|Hematologic Agents|Morpholines|Oxazines|P-glycoprotein substrates|Protease Inhibitors|Serine Protease Inhibitors|Sulfur Compounds|Thiophenes,ClC1=CC=C(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O,9875401
5503,DB06229,Ocaperidone,small molecule,investigational,Pyrimidines,CC1=CC=CN2C(=O)C(CCN3CCC(CC3)C3=NOC4=CC(F)=CC=C34)=C(C)N=C12,
5504,DB06230,Nalmefene,small molecule,approved|investigational|withdrawn,"Alkaloids|Antipruritics|Appetite Depressants|Central Nervous System Agents|Drugs that are Mainly Renally Excreted|Drugs Used in Addictive Disorders|Drugs Used in Alcohol Dependence|Heterocyclic Compounds, Fused-Ring|Morphinans|Nervous System|Neuroprotective Agents|Opiate Alkaloids|Opioid Antagonists|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents|UGT1A3 substrates|UGT2B7 substrates",[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,
5505,DB06231,Caldaret,small molecule,investigational,"Acids|Acids, Noncarboxylic|Arylsulfonates|Arylsulfonic Acids|Benzene Derivatives|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",CC1=CC=C(N2CCNCC2)C(=C1)S(O)(=O)=O,
5506,DB06233,Ridaforolimus,small molecule,investigational,Anti-Bacterial Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Polyketides|Protein Kinase Inhibitors,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OP(C)(C)=O,
5507,DB06234,Maribavir,small molecule,investigational,"Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Carbohydrates|Direct Acting Antivirals|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides",CC(C)NC1=NC2=CC(Cl)=C(Cl)C=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O,
5508,DB06235,Vadimezan,small molecule,investigational,"Antineoplastic Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|UGT1A9 Substrates|UGT2B7 substrates|Xanthenes",CC1=C(C)C2=C(C=C1)C(=O)C1=CC=CC(CC(O)=O)=C1O2,123964
5509,DB06236,Elvucitabine,small molecule,investigational,"Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Carbohydrates|Deoxycytidine|Deoxyribonucleosides|Dideoxynucleosides|Enzyme Inhibitors|Glycosides|HIV Reverse Transcriptase|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Reverse Transcriptase Inhibitors|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Reverse Transcriptase Inhibitors|Ribonucleosides",NC1=NC(=O)N(C=C1F)[C@H]1O[C@@H](CO)C=C1,
5510,DB06237,Avanafil,small molecule,approved,"Cyclic Nucleotide Phosphodiesterases, Type 5|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs Used in Erectile Dysfunction|Genito Urinary System and Sex Hormones|Phosphodiesterase 5 Inhibitors|Urologicals|Vasodilating Agents",COC1=C(Cl)C=C(CNC2=C(C=NC(=N2)N2CCC[C@H]2CO)C(=O)NCC2=NC=CC=N2)C=C1,9869929
5512,DB06240,Tariquidar,small molecule,investigational,"Drug Resistance, Multiple|Heterocyclic Compounds, Fused-Ring|P-glycoprotein inhibitors",COC1=CC2=C(CN(CCC3=CC=C(NC(=O)C4=CC(OC)=C(OC)C=C4NC(=O)C4=CN=C5C=CC=CC5=C4)C=C3)CC2)C=C1OC,
5514,DB06243,Eflornithine,small molecule,approved|withdrawn,"Agents Against Leishmaniasis and Trypanosomiasis|Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antineoplastic Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Decarboxylase Inhibitor|Decarboxylase Inhibitors|Dermatologicals|Enzyme Inhibitors|Misc. Skin and Mucous Membrane Agents|Ornithine Decarboxylase Inhibitors|Trypanocidal Agents",NCCCC(N)(C(F)F)C(O)=O,3009
5517,DB06246,Exisulind,small molecule,investigational,"Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anticarcinogenic Agents|Antineoplastic Agents|Antirheumatic Agents|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Indenes|Peripheral Nervous System Agents|Protective Agents|Sensory System Agents",CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)(=O)=O,
5518,DB06247,CX516,small molecule,investigational,"Receptors, AMPA",O=C(N1CCCCC1)C1=CC2=C(C=C1)N=CC=N2,
5519,DB06248,Amelubant,small molecule,investigational,"Acids, Acyclic|Receptors, Leukotriene B4, antagonists & inhibitors",CCOC(=O)NC(=N)C1=CC=C(OCC2=CC=CC(COC3=CC=C(C=C3)C(C)(C)C3=CC=C(O)C=C3)=C2)C=C1,
5520,DB06249,Arzoxifene,small molecule,approved|investigational,Sulfur Compounds,COC1=CC=C(C=C1)C1=C(OC2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2,
5521,DB06250,Fluasterone,small molecule,investigational,"17-Ketosteroids|Adrenal Cortex Hormones|Androstanes|Androstenes|Androstenols|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Steroids|Testosterone Congeners",C[C@]12CC[C@H]3[C@@H](CC=C4CCCC[C@]34C)[C@@H]1C[C@@H](F)C2=O,
5522,DB06251,Dersalazine,small molecule,investigational,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Hydroxy Acids|Hydroxybenzoates|Phenols|Platelet Activating Factor, antagonists & inhibitors|Salicylates",CC1=NC2=CN=CC=C2N1CC1CCN(CC1)C(=O)\C=C(\C1=CC=CC=C1)C1=CC=C(C=C1)\N=N\C1=CC(C(O)=O)=C(O)C=C1,
5523,DB06253,Thioctic acid tromethamine,small molecule,investigational,,NC(CO)(CO)CO.OC(=O)CCCC[C@@H]1CCSS1,
5524,DB06255,Incadronic acid,small molecule,experimental,Antineoplastic Agents|Bisphosphonates|Bone Density Conservation Agents|Organophosphonates|Organophosphorus Compounds,OP(O)(=O)C(NC1CCCCCC1)P(O)(O)=O,3699
5526,DB06257,HE-2200,small molecule,investigational,Androstanes|Androstenes|Fused-Ring Compounds|Steroids,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](O)C=C2C[C@@H](O)CC[C@]12C,
5527,DB06258,Bimoclomol,small molecule,investigational,,OC(CO\N=C(/Cl)C1=CN=CC=C1)CN1CCCCC1,9576891
5528,DB06260,Aviptadil,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Erectile Dysfunction|Gastrointestinal Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Imidazoles|Nerve Tissue Proteins|Neuropeptides|Peptide Hormones|Peptides|Pharmaceutical Preparations|Proteins",CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CN=CN1)C(C)C)[C@@H](C)O)[C@H](O)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O,
5529,DB06261,Hexaminolevulinate,small molecule,approved,"Amino Acids|Amino Acids, Peptides, and Proteins|Carbon Radioisotopes|Keto Acids|Levulinic Acids|Other Diagnostics|Photosensitizing Agents",[H]N([H])CC(=O)CCC(=O)OCCCCCC,6433083
5530,DB06262,Droxidopa,small molecule,approved|investigational,"Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Adrenergic beta-1 Receptor Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-3 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Alcohols|Anti-Dyskinesia Agents|Benzene Derivatives|Biogenic Amines|Biogenic Monoamines|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Catecholamines|Catechols|Central Nervous System Agents|Drugs that are Mainly Renally Excreted|Epinephrine and similars|Ethanolamines|Increased Blood Pressure|Phenols",N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O,92974
5531,DB06263,Amrubicin,small molecule,investigational,Anthracyclines and Related Substances|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Cytotoxic Antibiotics and Related Substances|Glycosides|Naphthacenes,[H][C@@]1(C[C@@](N)(CC2=C1C(O)=C1C(=O)C3=CC=CC=C3C(=O)C1=C2O)C(C)=O)O[C@H]1C[C@H](O)[C@H](O)CO1,3035016
5532,DB06264,Tolperisone,small molecule,investigational,"Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Ketones|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Peripheral Nervous System Agents|Propiophenones|Pyridines|Topical Products for Joint and Muscular Pain",CC(CN1CCCCC1)C(=O)C1=CC=C(C)C=C1,
5533,DB06266,Lonidamine,small molecule,investigational,"Adrenal Cortex Hormones|Anti-Infective Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Antiparasitic Agents|Antiprotozoals|Antispermatogenic Agents|Contraceptive Agents, Male|Heterocyclic Compounds, Fused-Ring|Hormonal Contraceptives for Systemic Use|Noxae|Pyrazoles|Radiation-Sensitizing Agents|Reproductive Control Agents|Toxic Actions|Trypanocidal Agents",OC(=O)C1=NN(CC2=C(Cl)C=C(Cl)C=C2)C2=C1C=CC=C2,39562
5534,DB06267,Udenafil,small molecule,approved|investigational,Amides|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Drugs Used in Erectile Dysfunction|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Phosphodiesterase 5 Inhibitors|Phosphodiesterase Inhibitors|Sulfones|Sulfur Compounds|Urologicals|Vasodilating Agents,CCCOC1=C(C=C(C=C1)S(=O)(=O)NCCC1CCCN1C)C1=NC(=O)C2=C(N1)C(CCC)=NN2C,6918523
5535,DB06268,Sitaxentan,small molecule,approved|investigational|withdrawn,Antihypertensive Agents|Antihypertensives for Pulmonary Arterial Hypertension|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Endothelin Receptor Antagonists|Sulfur Compounds,CC1=NOC(NS(=O)(=O)C2=C(SC=C2)C(=O)CC2=CC3=C(OCO3)C=C2C)=C1Cl,216235
5536,DB06270,MAHDL01,small molecule,investigational,,,
5538,DB06272,Maxacalcitol,small molecule,investigational,"Anticarcinogenic Agents|Antineoplastic Agents|Cholestanes|Cholestenes|Compounds used in a research, industrial, or household setting|Dermatologicals|Fused-Ring Compounds|Lipids|Membrane Lipids|Protective Agents|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)",[H]\C(\C(\[H])=C1/CCC[C@@]2(C)[C@@]1([H])CC[C@]2([H])[C@]([H])(C)OCCC(C)(C)O)=C1/C[C@@]([H])(O)C[C@]([H])(O)C1=C,
5540,DB06274,Alvimopan,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Drugs for Constipation|Gastrointestinal Agents|Opioid Antagonists|Peripheral Opioid Receptor Antagonists|Receptors, Opioid, mu, antagonists & inhibitors",C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(O)=O)CC[C@@]1(C)C1=CC(O)=CC=C1,5488548
5541,DB06276,Tanomastat,small molecule,investigational,"Acids, Carbocyclic|Benzene Derivatives|Matrix Metalloproteinases",OC(=O)[C@@H](CSC1=CC=CC=C1)CC(=O)C1=CC=C(C=C1)C1=CC=C(Cl)C=C1,
5542,DB06280,Senicapoc,small molecule,investigational,"Acetates|Acids, Acyclic|Amides|Benzene Derivatives|Fatty Acids|Fatty Acids, Volatile|Lipids",NC(=O)C(C1=CC=CC=C1)(C1=CC=C(F)C=C1)C1=CC=C(F)C=C1,
5543,DB06281,Torcetrapib,small molecule,investigational,"Anticholesteremic Agents|Blood Pressure|Cholesterol Ester Transfer Proteins|Heterocyclic Compounds, Fused-Ring|Hypolipidemic Agents|Lipid Regulating Agents|Noxae|Toxic Actions",CCOC(=O)N1[C@H](CC)C[C@H](N(CC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)C(=O)OC)C2=C1C=CC(=C2)C(F)(F)F,159325
5544,DB06282,Levocetirizine,small molecule,approved,"Antihistamines for Systemic Use|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Neurotransmitter Agents|Piperazine Derivatives|Piperazines|Potential QTc-Prolonging Agents|QTc Prolonging Agents",OC(=O)COCCN1CCN(CC1)[C@H](C1=CC=CC=C1)C1=CC=C(Cl)C=C1,1549000
5545,DB06283,Ziconotide,small molecule,approved,"Analgesics|Analgesics, Non-Narcotic|Antiarrhythmic agents|Calcium Channel Blockers|Calcium Channels, N-Type|Calcium-Regulating Hormones and Agents|Central Nervous System Agents|Central Nervous System Depressants|Complex Mixtures|Compounds used in a research, industrial, or household setting|Conotoxins|Fluids and Secretions|Marine Toxins|Membrane Transport Modulators|Mollusk Venoms|N-Calcium Channel Receptor Antagonists|Narrow Therapeutic Index Drugs|Nervous System|Neuroprotective Agents|Peripheral Nervous System Agents|Protective Agents|Sensory System Agents|Toxins, Biological|Vasodilating Agents|Venoms",,
5547,DB06287,Temsirolimus,small molecule,approved,Agents causing angioedema|Anti-Bacterial Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Kinase Inhibitor|Lactones|Macrolides|mTOR Inhibitors|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Polyketides|Protein Kinase Inhibitors|Sirolimus and Prodrugs,OCC(C)(CO)C(=O)O[C@@H]1CC[C@@H](C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@@H](OC)C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)C[C@H]1OC,23724530
5548,DB06288,Amisulpride,small molecule,approved|investigational,"Acids, Carbocyclic|Amides|Antidepressive Agents|Antidepressive Agents, Second-Generation|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Potential QTc-Prolonging Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Tranquilizing Agents",CCN1CCCC1CNC(=O)C1=CC(=C(N)C=C1OC)S(=O)(=O)CC,2159
5549,DB06290,Simeprevir,small molecule,approved,"Amides|Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Antivirals for treatment of HCV infections|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|BSEP/ABCB11 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Direct Acting Antivirals|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|HCV NS3/4A Protease Inhibitors|HCV Protease Inhibitors|Heterocyclic Compounds, Fused-Ring|NS3/4A Protease Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 inhibitors|OATP1B3 substrates|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Photosensitizing Agents|Protease Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds",[H][C@]12C[C@]1(NC(=O)[C@]1([H])C[C@H](C[C@@]1([H])C(=O)N(C)CCCC\C=C/2)OC1=CC(=NC2=C1C=CC(OC)=C2C)C1=NC(=CS1)C(C)C)C(=O)NS(=O)(=O)C1CC1,24873435
5550,DB06292,Dapagliflozin,small molecule,approved,"Alimentary Tract and Metabolism|Benzene Derivatives|Blood Glucose Lowering Agents|Carbohydrates|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Diuretics|Drugs Used in Diabetes|Glycosides|Hypotensive Agents|P-glycoprotein substrates|Sodium-glucose co-transporter 2 (SGLT2) inhibitors|Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors|Sodium-Glucose Transport Proteins, antagonists & inhibitors|Sodium-Glucose Transporter 2 Inhibitors|UGT1A9 Substrates|UGT2B7 substrates",CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C1,9887712
5551,DB06293,Pegnivacogin,small molecule,investigational,"Carbohydrates|Factor IXa, antagonists & inhibitors|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Oligonucleotides|Pegylated agents|Polynucleotides",COCCOC(=O)NCCCCC(NC(=O)OCCOC)C(=O)NCCCCCCOP(O)(O)=O,
5552,DB06294,Semuloparin,small molecule,investigational,Anticoagulants|Carbohydrates|Cardiovascular Agents|Fibrin Modulating Agents|Glycosaminoglycans|Hematologic Agents|Heparin and similars|Polysaccharides,,
5553,DB06295,Pramiconazole,small molecule,investigational,,CC(C)N1CCN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2OC[C@@](CN3C=NC=N3)(O2)C2=CC=C(F)C=C2F)C=C1,
5554,DB06297,LX-2931,small molecule,investigational,Amines|Hydroxylamines,C\C(=N/O)C1=NC=C(N1)[C@@H](O)[C@H](O)[C@H](O)CO,
5555,DB06299,Hydronidone,small molecule,investigational,Pyridines,CC1=CN(C(=O)C=C1)C1=CC=C(O)C=C1,
5556,DB06302,Glesatinib,small molecule,investigational,"Acetamides|Acetates|Acids, Acyclic|Amides|Benzene Derivatives|Fatty Acids|Fatty Acids, Volatile|Lipids|Tyrosine Kinase Inhibitors",COCCNCC1=CC=C(N=C1)C1=CC2=NC=CC(OC3=CC=C(NC(=S)NC(=O)CC4=CC=C(F)C=C4)C=C3F)=C2S1,
5560,DB06306,Onalespib,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Heterocyclic Compounds, Fused-Ring|HSP90 Heat-Shock Proteins, antagonists & inhibitors",CC(C)C1=CC(C(=O)N2CC3=CC=C(CN4CCN(C)CC4)C=C3C2)=C(O)C=C1O,
5561,DB06307,Apoptone,small molecule,investigational,Androstanes|Fused-Ring Compounds|Steroids,C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@]34C)[C@@H]1CC[C@@]2(O)C#C,
5562,DB06309,Refametinib,small molecule,investigational,Amides|Amines|Aniline Compounds|Sulfones|Sulfur Compounds,[H][C@@](O)(CO)CC1(CC1)S(=O)(=O)NC1=C(OC)C=C(F)C(F)=C1NC1=C(F)C=C(I)C=C1,
5564,DB06311,Darapladib,small molecule,investigational,Amines|Enzyme Inhibitors|Hydroxylamines|Phospholipase A2 Inhibitors|Pyrimidines,CCN(CC)CCN(CC1=CC=C(C=C1)C1=CC=C(C=C1)C(F)(F)F)C(=O)CN1C2=C(CCC2)C(=O)N=C1SCC1=CC=C(F)C=C1,
5565,DB06313,BNC105,small molecule,investigational,"Benzene Derivatives|Ethers|Heterocyclic Compounds, Fused-Ring|Methyl Ethers|Phenols|Phenyl Ethers",COC1=CC(=CC(OC)=C1OC)C(=O)C1=C(C)OC2=C1C=CC(OC)=C2OP(O)(O)=O,
5566,DB06314,SGX-523,small molecule,investigational,,CN1C=C(C=N1)C1=NN2C(SC3=CC=C4N=CC=CC4=C3)=NN=C2C=C1,
5569,DB06321,R-348,small molecule,investigational,,CCC(=O)NS(=O)(=O)C1=CC(NC2=NC=C(F)C(NC3=CC=C(OCC#C)C=C3)=N2)=CC=C1C,
5573,DB06325,Pegpleranib,small molecule,investigational,Pegylated agents,,
5575,DB06328,Methoxyamine,small molecule,investigational,Amines,CON,
5576,DB06331,4-O-Demethylpenclomedine,small molecule,investigational,Pyridines,[H]N1C(OC)=C(Cl)C(=O)C(Cl)=C1C(Cl)(Cl)Cl,
5577,DB06333,Trodusquemine,small molecule,investigational,Amines|Biogenic Amines|Biogenic Polyamines|Diamines|Fused-Ring Compounds|Polyamines|Steroids,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)NCCCNCCCCNCCCN)[C@H](C)CC[C@@H](OS(O)(=O)=O)C(C)C,
5578,DB06334,Tucidinostat,small molecule,investigational,"Acids, Carbocyclic|Amides|Amines|Antineoplastic Agents|Benzene Derivatives|Benzoates|Histone Deacetylase Inhibitors|Moderate Risk QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents",NC1=CC(F)=CC=C1NC(=O)C1=CC=C(CNC(=O)\C=C\C2=CN=CC=C2)C=C1,
5579,DB06335,Saxagliptin,small molecule,approved,"Agents causing angioedema|Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Cycloparaffins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|DPP-IV Inhibitors|Drugs that are Mainly Renally Excreted|Drugs Used in Diabetes|Enzyme Inhibitors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypoglycemia-Associated Agents|Incretins|OAT3/SLC22A8 Substrates|Oligopeptides|Peptides|Protease Inhibitors",[H][C@@]12C[C@]1([H])N([C@@H](C2)C#N)C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2,11243969
5580,DB06336,Elsiglutide,small molecule,investigational,,,
5583,DB06345,AR-9281,small molecule,investigational,"Cycloparaffins|Epoxide Hydrolases, antagonists & inhibitors",CC(=O)N1CCC(CC1)NC(=O)NC12CC3CC(CC(C3)C1)C2,
5584,DB06346,Fiboflapon,small molecule,investigational,"Acids, Acyclic|Asthma, drug therapy|Fatty Acids|Fatty Acids, Volatile|Heterocyclic Compounds, Fused-Ring|Lipids|Valerates",CCOC1=CC=C(C=N1)C1=CC=C(CN2C(CC(C)(C)C(O)=O)=C(SC(C)(C)C)C3=CC(OCC4=CC=C(C)C=N4)=CC=C23)C=C1,
5585,DB06347,Cenisertib,small molecule,investigational,Monoterpenes|Terpenes,[H][C@@]12C[C@@]([H])(C=C1)[C@@H]([C@@H]2NC1=C(F)C=NC(NC2=CC=C(N3CCN(C)CC3)C(C)=C2)=N1)C(N)=O,
5586,DB06350,Elinogrel,small molecule,investigational,"Amides|Heterocyclic Compounds, Fused-Ring|Quinazolines|Sulfones|Sulfur Compounds",CNC1=C(F)C=C2C(NC(=O)N(C2=O)C2=CC=C(NC(=O)NS(=O)(=O)C3=CC=C(Cl)S3)C=C2)=C1,
5587,DB06354,Tezampanel,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Receptors, AMPA, antagonists & inhibitors",[H][C@]1(CCC2=NN=NN2)CC[C@@]2([H])CN[C@@]([H])(C[C@@]2([H])C1)C(O)=O,
5590,DB06358,Iclaprim,small molecule,investigational,Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Enzyme Inhibitors|Folic Acid Antagonists|SULFONAMIDES AND TRIMETHOPRIM|Trimethoprim and Derivatives,COC1=CC(CC2=CN=C(N)N=C2N)=C2C=CC(OC2=C1OC)C1CC1,
5593,DB06362,Becatecarin,small molecule,investigational,"Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Indoles",CCN(CC)CCN1C(=O)C2=C(C1=O)C1=C(N([C@@H]3O[C@H](CO)[C@@H](OC)[C@H](O)[C@H]3O)C3=C(Cl)C=CC=C13)C1=C2C2=C(N1)C(Cl)=CC=C2,
5594,DB06364,XR5944,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",[H]N(CCN([H])CCN([H])C(=O)C1=CC=CC2=NC3=CC=CC(C)=C3N=C12)CCN([H])C(=O)C1=CC=CC2=NC3=CC=CC(C)=C3N=C12,
5595,DB06365,Sapacitabine,small molecule,investigational,"Antineoplastic Agents|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidines|Pyrimidinones",CCCCCCCCCCCCCCCC(=O)NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1C#N,
5597,DB06367,Relacatib,small molecule,investigational,Sulfur Compounds,CC(C)C[C@H](NC(=O)C1=CC2=CC=CC=C2O1)C(=O)N[C@H]1CC[C@@H](C)N(CC1=O)S(=O)(=O)C1=CC=CC=N1,
5598,DB06368,Alamifovir,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",COC1=CC=C(SC2=C3N=CN(CCOCP(=O)(OCC(F)(F)F)OCC(F)(F)F)C3=NC(N)=N2)C=C1,213052
5599,DB06370,Indisulam,small molecule,investigational,Amides|Antineoplastic Agents|Carbonic Anhydrase Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Diuretics|Enzyme Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds,NS(=O)(=O)C1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC2=C1NC=C2Cl,216468
5602,DB06374,Elacestrant,small molecule,investigational,Naphthalenes,CCNCCC1=CC=C(CN(CC)C2=C(C=CC(OC)=C2)[C@@H]2CCC3=CC(O)=CC=C3C2)C=C1,
5603,DB06376,CHGN111,small molecule,investigational,,,
5605,DB06393,Xaliproden,small molecule,investigational,Nervous System|Neurotransmitter Agents,FC(F)(F)C1=CC(=CC=C1)C1=CCN(CCC2=CC3=CC=CC=C3C=C2)CC1,
5607,DB06395,Abafungin,small molecule,investigational,Antifungal Agents|Azole Antifungals|Sulfur Compounds,CC1=CC(C)=C(OC2=CC=CC=C2C2=CSC(N=C3NCCCN3)=N2)C=C1,159326
5608,DB06397,Nicaraven,small molecule,investigational,"Antioxidants|Compounds used in a research, industrial, or household setting|Nicotinic Acids|Protective Agents|Pyridines",CC(CNC(=O)C1=CC=CN=C1)NC(=O)C1=CC=CN=C1,
5611,DB06401,Bazedoxifene,small molecule,approved|investigational,"Bone Density Conservation Agents|Estrogen Agonist/Antagonist|Estrogen Receptor Modulators|Genito Urinary System and Sex Hormones|Heterocyclic Compounds, Fused-Ring|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Selective Estrogen Receptor Modulators|Sex Hormones and Modulators of the Genital System|UGT1A1 Substrates",CC1=C(N(CC2=CC=C(OCCN3CCCCCC3)C=C2)C2=C1C=C(O)C=C2)C1=CC=C(O)C=C1,154257
5612,DB06402,Telavancin,small molecule,approved,"Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Carbohydrates|Drugs that are Mainly Renally Excreted|Glycoconjugates|Glycopeptide Antibacterials|Glycopeptides|Glycosides|Lipids|Lipoglycopeptide Antibacterial|Lipopeptides|Moderate Risk QTc-Prolonging Agents|Peptides|QTc Prolonging Agents",CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2OC2=C3OC4=CC=C(C=C4Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]4C(C=C2OC2=C(Cl)C=C(C=C2)[C@@H](O)[C@@H]2NC(=O)[C@H](NC4=O)C4=CC(=C(O)C=C4)C4=C(O)C(CNCP(O)(O)=O)=C(O)C=C4[C@H](NC2=O)C(O)=O)=C3)O[C@@H](C)[C@H]1O,3081362
5613,DB06403,Ambrisentan,small molecule,approved|investigational,"Acids, Carbocyclic|Antihypertensive Agents|Antihypertensives for Pulmonary Arterial Hypertension|Cardiovascular Agents|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Endothelin Receptor Antagonists|Hypertension, Pulmonary|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein substrates|UGT1A3 substrates|UGT1A9 Substrates|UGT2B7 substrates|Vasodilating Agents",COC([C@H](OC1=NC(C)=CC(C)=N1)C(O)=O)(C1=CC=CC=C1)C1=CC=CC=C1,6918493
5615,DB06405,Eprodisate,small molecule,investigational,"Acids|Acids, Noncarboxylic|Alkanes|Hydrocarbons, Acyclic|Sulfur Acids|Sulfur Compounds",OS(=O)(=O)CCCS(O)(=O)=O,
5616,DB06406,Idraparinux,small molecule,investigational,Anticoagulants|Antithrombins|Carbohydrates|Enzyme Inhibitors|Factor Xa Inhibitors|Hematologic Agents|Polysaccharides|Protease Inhibitors|Serine Protease Inhibitors,,
5617,DB06408,Taribavirin,small molecule,investigational,"Anti-Infective Agents|Antiviral Agents|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine-Nucleoside Phosphorylase, antagonists & inhibitors|Ribonucleosides",NC(=N)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,
5618,DB06409,Morphine glucuronide,small molecule,investigational,"Alkaloids|Heterocyclic Compounds, Fused-Ring|Morphinans|Opiate Alkaloids|Phenanthrenes",[H][C@]12C=C[C@H](O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4O,
5619,DB06410,Doxercalciferol,small molecule,approved,"Anti-Parathyroid Agents|Bone Density Conservation Agents|Calcium Homeostasis|Cholestanes|Cholestenes|Diet, Food, and Nutrition|Food|Food and Beverages|Fused-Ring Compounds|Growth Substances|Lipids|Membrane Lipids|Micronutrients|Physiological Phenomena|Secosteroids|Steroids|Sterols|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)",[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C,46705423
5620,DB06412,Oxymetholone,small molecule,approved|illicit,"Alimentary Tract and Metabolism|Anabolic Agents|Anabolic Agents for Systemic Use|Anabolic Steroids|Androgens|Androstan Derivatives|Androstanes|Androstanols|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Thyroxine-binding globulin inhibitors",[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)\C(C[C@]12C)=C/O,5281034
5621,DB06413,Armodafinil,small molecule,approved|investigational,"Benzene Derivatives|Benzhydryl Compounds|Central Nervous System Agents|Central Nervous System Stimulants|Centrally Acting Sympathomimetics|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Nervous System|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Wakefulness-Promoting Agents",NC(=O)C[S@@](=O)C(C1=CC=CC=C1)C1=CC=CC=C1,9690109
5622,DB06414,Etravirine,small molecule,approved,Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Direct Acting Antivirals|Enzyme Inhibitors|Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor|Non-Nucleoside Reverse Transcriptase Inhibitors|Nonnucleoside Reverse Transcriptase Inhibitors|Nucleic Acid Synthesis Inhibitors|P-glycoprotein inducers|Reverse Transcriptase Inhibitors,CC1=CC(=CC(C)=C1OC1=C(Br)C(N)=NC(NC2=CC=C(C=C2)C#N)=N1)C#N,193962
5623,DB06415,Calfactant,small molecule,approved,Alveolar Surface Tension Reduction|Bradycardia-Causing Agents|Complex Mixtures|Pulmonary Surfactants|Respiratory System Agents|Surface-Active Agents|Surfactant Activity,,
5624,DB06419,Cethromycin,small molecule,investigational,"Anti-Bacterial Agents|Anti-Infective Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Erythromycin and similars|Lactones|Macrolides|P-glycoprotein inhibitors|P-glycoprotein substrates|Polyketides|Protein Synthesis Inhibitors|RNA, Ribosomal, 23S",[H]C(CO[C@]1(C)C[C@@H](C)C(=O)[C@H](C)[C@H]2NC(=O)O[C@]2(C)[C@@H](CC)OC(=O)[C@H](C)C(=O)[C@H](C)[C@H]1O[C@@H]1O[C@H](C)C[C@@H]([C@H]1O)N(C)C)=C([H])C1=CC2=C(C=CC=C2)N=C1,447451
5625,DB06420,Annamycin,small molecule,investigational,"Anthracyclines|Antibiotics, Antineoplastic|Antineoplastic Agents|Carbohydrates|Glycosides|Naphthacenes|P-glycoprotein inhibitors",C[C@@H]1O[C@@H](O[C@H]2C[C@@](O)(CC3=C2C(O)=C2C(=O)C4=CC=CC=C4C(=O)C2=C3O)C(=O)CO)[C@H](I)[C@H](O)[C@H]1O,
5626,DB06421,Declopramide,small molecule,investigational,"Acids, Carbocyclic|Amides|Aminobenzoates|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|para-Aminobenzoates",CCN(CC)CCNC(=O)C1=CC=C(N)C(Cl)=C1,
5627,DB06422,Ticalopride,small molecule,investigational,"Acids, Carbocyclic|Amides|Aminobenzoates|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Chlorobenzoates|para-Aminobenzoates|Piperidines",CO[C@H]1CNCC[C@H]1NC(=O)C1=CC(Cl)=C(N)C=C1OC,
5629,DB06429,Talnetant,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Receptors, Neurokinin-3, antagonists & inhibitors",CCC(NC(=O)C1=C(O)C(=NC2=CC=CC=C12)C1=CC=CC=C1)C1=CC=CC=C1,133090
5630,DB06431,Evernimicin,small molecule,investigational,Carbohydrates|Glycosides,,
5631,DB06433,Tezacitabine,small molecule,investigational,"Antineoplastic Agents|Carbohydrates|Deoxyribonucleosides|Enzyme Inhibitors|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Radiation-Sensitizing Agents|Ribonucleoside Diphosphate Reductase, antagonists & inhibitors|Ribonucleosides",NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)\C1=C/F,6435808
5632,DB06434,Repifermin,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Biological Factors|Fibroblast Growth Factors|Intercellular Signaling Peptides and Proteins|Peptides|Proteins",,
5633,DB06435,Tarazepide,small molecule,investigational,"Benzazepines|Heterocyclic Compounds, Fused-Ring",CN1C2=CC=CC=C2C(=N[C@H](NC(=O)C2=CC3=CC=CC4=C3N2CCC4)C1=O)C1=CC=CC=C1,
5634,DB06436,Semaxanib,small molecule,investigational,"Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Enzyme Inhibitors|Growth Inhibitors|Growth Substances|Heterocyclic Compounds, Fused-Ring|Protein Kinase Inhibitors",CC1=CC(C)=C(N1)\C=C1/C(=O)NC2=CC=CC=C12,5329098
5635,DB06437,Tifacogin,small molecule,investigational,"Amino Acids, Peptides, and Proteins",,
5636,DB06439,Tyloxapol,small molecule,approved|investigational,"Alcohols|Compounds used in a research, industrial, or household setting|Cough and Cold Preparations|Detergents|Ethylene Glycols|Expectorants|Glycols|Household Products|Macromolecular Substances|Polymers|Surface-Active Agents",,
5637,DB06440,Ravuconazole,small molecule,investigational,Antifungal Agents|Azole Antifungals|Sulfur Compounds,C[C@@H](C1=NC(=CS1)C1=CC=C(C=C1)C#N)[C@](O)(CN1C=NC=N1)C1=CC=C(F)C=C1F,467825
5638,DB06441,Cangrelor,small molecule,approved,"Adenine Nucleotides|Anticoagulants|Antiplatelet agents|Blood and Blood Forming Organs|Carbohydrates|Decreased Platelet Aggregation|Glycosides|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|P2Y12 Platelet Inhibitor|Platelet Aggregation Inhibitors Excl. Heparin|Purine Nucleotides|Purinergic Agents|Purinergic Antagonists|Purinergic P2 Receptor Antagonists|Purinergic P2Y Receptor Antagonists|Purines|Ribonucleotides",CSCCNC1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)C(Cl)(Cl)P(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC(SCCC(F)(F)F)=N1,9854012
5639,DB06442,Avasimibe,small molecule,investigational,"Acids|Acids, Acyclic|Acids, Noncarboxylic|Arteriosclerosis|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (moderate)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|Sulfur Acids|Sulfur Compounds",CC(C)C1=CC(C(C)C)=C(CC(=O)NS(=O)(=O)OC2=C(C=CC=C2C(C)C)C(C)C)C(=C1)C(C)C,
5640,DB06444,Dexanabinol,small molecule,investigational,"Antiemetics|Autonomic Agents|Cannabinoids and similars|Cardiovascular Agents|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Gastrointestinal Agents|Neuroprotective Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Protective Agents|Terpenes",CCCCCCC(C)(C)C1=CC(O)=C2[C@H]3CC(CO)=CC[C@@H]3C(C)(C)OC2=C1,107778
5641,DB06445,Diethylnorspermine,small molecule,investigational,Amines|Antihypertensive Agents|Antineoplastic Agents|Biogenic Amines|Biogenic Polyamines|Cardiovascular Agents|Diamines|Polyamines,CCNCCCNCCCNCCCNCC,
5642,DB06446,Dotarizine,small molecule,investigational,Agents causing hyperkalemia|Antiarrhythmic agents|Antidepressive Agents|Benzene Derivatives|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Membrane Transport Modulators|Neurotransmitter Agents|Serotonin Agents|Serotonin Receptor Antagonists|Vasodilating Agents,C(CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1)CC1(OCCO1)C1=CC=CC=C1,55285
5643,DB06447,E5531,small molecule,investigational,"Antigens|Antigens, Bacterial|Bacterial Toxins|Biological Factors|Carbohydrates|Endotoxins|Glycoconjugates|Lipids|Lipopolysaccharides|Polysaccharides|Polysaccharides, Bacterial|Toxins, Biological",[H]N([C@H]1[C@@H](OP(O)(O)=O)O[C@H](CO[C@@H]2O[C@H](COC)[C@@H](OP(O)(O)=O)[C@H](OCC[C@@H](CCCCCCC)OC(=O)CCC\C=C/CCCCCC)[C@H]2N([H])C(=O)CC(=O)CCCCCCCCCCC)[C@@H](O)[C@@H]1OCC[C@H](O)CCCCCCC)C(=O)CC(=O)CCCCCCCCCCC,
5644,DB06448,Lonafarnib,small molecule,investigational,Enzyme Inhibitors|P-glycoprotein inhibitors,NC(=O)N1CCC(CC(=O)N2CCC(CC2)[C@H]2C3=C(CCC4=C2C(Br)=CC(Cl)=C4)C=C(Br)C=N3)CC1,148195
5645,DB06449,Ilodecakin,small molecule,investigational,,,
5646,DB06451,Aprinocarsen,small molecule,investigational,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Oligonucleotides|Polynucleotides|Protein Kinase C, antagonists & inhibitors|Sulfur Compounds",[H]C1(O)CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])CO)N1C=NC2=C1NC(=N)N=C2O)N1C=C(C)C(O)=NC1=O)N1C=C(C)C(O)=NC1=O)N1C=CC(=N)N=C1O)N1C=C(C)C(O)=NC1=O)N1C=CC(=N)N=C1O)N1C=NC2=C1NC(=N)N=C2O)N1C=CC(=N)N=C1O)N1C=C(C)C(O)=NC1=O)N1C=NC2=C1NC(=N)N=C2O)N1C=NC2=C1NC(=N)N=C2O)N1C=C(C)C(O)=NC1=O)N1C=NC2=C1NC(=N)N=C2O)N1C=NC2=C(N)N=CN=C12)N1C=NC2=C1NC(=N)N=C2O)N1C=C(C)C(O)=NC1=O)N1C=C(C)C(O)=NC1=O)N1C=C(C)C(O)=NC1=O)N1C=CC(=N)N=C1O)N1C=NC2=C(N)N=CN=C12,
5647,DB06453,Mirostipen,small molecule,investigational,,,
5648,DB06454,Sarizotan,small molecule,investigational,,FC1=CC=C(C=C1)C1=CN=CC(CNC[C@H]2CCC3=CC=CC=C3O2)=C1,
5649,DB06455,Meclinertant,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Receptors, Neurotensin, antagonists & inhibitors",COC1=CC=CC(OC)=C1C1=CC(=NN1C1=C2C=CC(Cl)=CC2=NC=C1)C(=O)NC1(C2CC3CC(C2)CC1C3)C(O)=O,
5650,DB06457,Tecastemizole,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",FC1=CC=C(CN2C(NC3CCNCC3)=NC3=CC=CC=C23)C=C1,
5651,DB06458,Remacemide,small molecule,investigational,"Acetates|Acids, Acyclic|Amides|Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|Neuroprotective Agents|Protective Agents",CC(CC1=CC=CC=C1)(NC(=O)CN)C1=CC=CC=C1,
5652,DB06460,Enrasentan,small molecule,investigational,Endothelin Receptor Antagonists|Indenes,CCCOC1=CC=C2[C@@H]([C@H]([C@@H](C2=C1)C1=CC=C(OC)C=C1OCCO)C(O)=O)C1=CC=C2OCOC2=C1,
5653,DB06461,Squalamine,small molecule,investigational,"Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Anti-Bacterial Agents|Anti-Infective Agents|Anticarcinogenic Agents|Antineoplastic Agents|Cholestanes|Compounds used in a research, industrial, or household setting|Fused-Ring Compounds|Growth Inhibitors|Growth Substances|Hydroxy Acids|Protective Agents|Steroids",CC(C)[C@@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@H]4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)NCCCNCCCCN)OS(O)(=O)=O,
5657,DB06465,FK-960,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates",CC(=O)N1CCN(CC1)NC(=O)C1=CC=C(F)C=C1,
5659,DB06468,Cariporide,small molecule,investigational,Amidines|Antiarrhythmic agents|Cardiovascular Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sulfur Compounds,CC(C)C1=CC=C(C=C1S(C)(=O)=O)C(=O)NC(N)=N,
5660,DB06469,Lestaurtinib,small molecule,investigational,"Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Indoles|Tyrosine Kinase Inhibitors",C[C@]12O[C@H](C[C@]1(O)CO)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C3C(=O)NC4)C3=CC=CC=C3N21,
5661,DB06470,Clomethiazole,small molecule,investigational,"Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Nervous System|Neuroprotective Agents|Neurotransmitter Agents|Protective Agents|Psycholeptics|Sulfur Compounds|Thiazoles",CC1=C(CCCl)SC=N1,10783
5662,DB06471,Naxifylline,small molecule,investigational,"Adenosine A1 Receptor Antagonists|Alkaloids|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|Purinergic Agents|Purinergic Antagonists|Purinergic P1 Receptor Antagonists|Purines|Purinones",[H][C@]12O[C@@]1([H])[C@@]1([H])C[C@]2([H])C[C@@H]1C1=NC2=C(N1)N(CCC)C(=O)C(CCC)C2=O,70691449
5663,DB06472,Fradafiban,small molecule,investigational,"Benzene Derivatives|Platelet Glycoprotein GPIIb-IIIa Complex, antagonists & inhibitors",NC(=N)C1=CC=C(C=C1)C1=CC=C(OC[C@@H]2C[C@@H](CC(O)=O)C(=O)N2)C=C1,
5666,DB06477,Sumanirole,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CN[C@H]1CN2C(=O)NC3=CC=CC(C1)=C23,
5667,DB06478,Porfiromycin,small molecule,investigational,"Antibiotics, Antineoplastic|Antineoplastic Agents|Azirines|Heterocyclic Compounds, Fused-Ring|Indolequinones|Indoles|Mitomycins|Quinones",CO[C@]12[C@@H]3[C@H](CN1C1=C([C@H]2COC(N)=O)C(=O)C(N)=C(C)C1=O)N3C,
5668,DB06479,Propentofylline,small molecule,investigational,"Alkaloids|Anti-Ulcer Agents|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Nervous System|Neuroprotective Agents|Protective Agents|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Purines|Purinones|Xanthine derivatives",CCCN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C,
5669,DB06480,Prucalopride,small molecule,approved,"Alimentary Tract and Metabolism|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Drugs for Constipation|Drugs that are Mainly Renally Excreted|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Laxatives|Miscellaneous GI Drugs|Neurotransmitter Agents|P-glycoprotein substrates",COCCCN1CCC(CC1)NC(=O)C1=C2OCCC2=C(N)C(Cl)=C1,3052762
5670,DB06481,Manitimus,small molecule,investigational,"Hydrocarbons, Acyclic",O\C(CCC#C)=C(\C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,
5671,DB06482,ALGRX 1207,small molecule,investigational,,,
5672,DB06485,Ropidoxuridine,small molecule,investigational,,OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(I)C=NC1=O,
5673,DB06486,Enzastaurin,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CN1C=C(C2=CC=CC=C12)C1=C(C(=O)NC1=O)C1=CN(C2CCN(CC3=CC=CC=N3)CC2)C2=CC=CC=C12,
5674,DB06489,Liatermin,small molecule,investigational,,,
5676,DB06493,Velafermin,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Biological Factors|Intercellular Signaling Peptides and Proteins|Peptides|Proteins",,
5677,DB06494,Sufugolix,small molecule,investigational,,CONC(=O)NC1=CC=C(C=C1)C1=C(CN(C)CC2=CC=CC=C2)C2=C(S1)N(CC1=C(F)C=CC=C1F)C(=O)N(C2=O)C1=CC=CC=C1,
5679,DB06496,Dextrin 2-sulfate,small molecule,investigational,"Biopolymers|Carbohydrates|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Dietary Carbohydrates|Food|Food and Beverages|Glucans|Macromolecular Substances|Physiological Phenomena|Polymers|Polysaccharides|Starch",,
5680,DB06497,Aplaviroc,small molecule,investigational,"Acids, Carbocyclic|Benzene Derivatives|HIV Fusion Inhibitors",[H][C@@]1(NC(=O)C2(CCN(CC3=CC=C(OC4=CC=C(C=C4)C(O)=O)C=C3)CC2)N(CCCC)C1=O)[C@H](O)C1CCCCC1,
5682,DB06499,Furaprofen,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CC(C(O)=O)C1=CC=CC2=C1OC=C2C1=CC=CC=C1,
5684,DB06504,S-8510,small molecule,investigational,"Benzazepines|Heterocyclic Compounds, Fused-Ring",C1CC2=C(CO1)C1=C(NC(=N1)C1=NOC=C1)C=N2,
5685,DB06506,Repinotan,small molecule,investigational,"Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|Pyrans|Sulfur Compounds",O=C1N(CCCCNC[C@H]2CCC3=CC=CC=C3O2)S(=O)(=O)C2=CC=CC=C12,
5686,DB06508,GW-559090,small molecule,investigational,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins",CC(C)C[C@H](NC(=O)COC1=CC=CC=C1C)C(=O)N[C@@H](CC1=CC=C(OC(=O)N2CCC(CC2)C(N)=O)C=C1)C(O)=O,
5687,DB06510,Muraglitazar,small molecule,investigational,"Amino Acids|Amino Acids, Peptides, and Proteins|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 Substrates|PPAR alpha, agonists|PPAR gamma, agonists|UGT1A1 Substrates|UGT1A3 substrates",COC1=CC=C(OC(=O)N(CC(O)=O)CC2=CC=C(OCCC3=C(C)OC(=N3)C3=CC=CC=C3)C=C2)C=C1,
5689,DB06512,Deramciclane,small molecule,investigational,Anti-Anxiety Agents|Anticonvulsants|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Monoterpenes|Neurotransmitter Agents|Norbornanes|Psychotropic Drugs|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Terpenes|Tranquilizing Agents,[H][C@]12CC[C@](C)(C1(C)C)[C@@](C2)(OCCN(C)C)C1=CC=CC=C1,119590
5690,DB06515,Resiniferatoxin,small molecule,investigational,Neurotoxins|Terpenes|TRPV Cation Channels,[H][C@]12O[C@]3(CC4=CC=CC=C4)O[C@]1(C[C@@]([H])(C)[C@]1(O3)[C@]3([H])C=C(C)C(=O)[C@@]3(O)CC(COC(=O)CC3=CC(OC)=C(O)C=C3)=C[C@@]21[H])C(C)=C,104826
5691,DB06518,R-1487,small molecule,investigational,"Mitogen-Activated Protein Kinase 14, antagonists & inhibitors|Pyridines",CN1C(=O)C(OC2=CC=C(F)C=C2F)=CC2=C1N=C(NC1CCOCC1)N=C2,
5692,DB06519,Edaglitazone,small molecule,investigational,Sulfur Compounds,CC1=C(CCOC2=C3C=CSC3=C(CC3SC(=O)NC3=O)C=C2)N=C(O1)C1=CC=CC=C1,
5693,DB06521,Ertiprotafib,small molecule,investigational,"Acids, Carbocyclic|Sulfur Compounds",CC1=C(C)C2=C(C3=CC(C)=C(O[C@H](CC4=CC=CC=C4)C(O)=O)C(C)=C3)C3=CC=CC=C3C(Br)=C2S1,
5694,DB06523,Levovirin,small molecule,investigational,,NC(=O)C1=NN(C=N1)[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O,
5695,DB06525,Ganstigmine,small molecule,investigational,"Acids, Acyclic|Carbamates",CCC1=C(NC(=O)OC2=CC3=C(C=C2)N(C)[C@H]2ON(C)CC[C@@]32C)C=CC=C1,
5696,DB06527,Tramiprosate,small molecule,investigational,"Acids|Acids, Noncarboxylic|Alkanes|Alkanesulfonic Acids|Anticonvulsants|Carbohydrates|Central Nervous System Agents|Central Nervous System Depressants|GABA Agents|GABA Agonists|Hydrocarbons, Acyclic|Neurotransmitter Agents|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",NCCCS(O)(=O)=O,
5697,DB06529,Ocinaplon,small molecule,investigational,Central Nervous System Depressants|Hypnotics (Nonbenzodiazepine)|Hypnotics and Sedatives,O=C(C1=C2N=CC=C(N2N=C1)C1=CC=NC=C1)C1=CC=CC=N1,
5698,DB06530,Resiquimod,small molecule,investigational,,CCOCC1=NC2=C(N)N=C3C=CC=CC3=C2N1CC(C)(C)O,
5699,DB06532,Pafuramidine,small molecule,investigational,Amidines|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Trypanocidal Agents,CONC(=N)C1=CC=C(C=C1)C1=CC=C(O1)C1=CC=C(C=C1)C(=N)NOC,
5700,DB06533,Ragaglitazar,small molecule,investigational,"Acids, Carbocyclic",CCO[C@H](CC1=CC=C(OCCN2C3=CC=CC=C3OC3=C2C=CC=C3)C=C1)C(O)=O,
5702,DB06535,Etilevodopa,small molecule,investigational,"Amines|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Anti-Parkinson Drugs|Benzene Derivatives|Catecholamines|Catechols|Dihydroxyphenylalanine|Dopa and Dopa Derivatives|Dopamine Agents|Nervous System|Phenols|Phenylalanine",CCOC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1,
5703,DB06536,Tesaglitazar,small molecule,investigational,"Acids|Acids, Carbocyclic|Acids, Noncarboxylic|Alkanes|Alkanesulfonic Acids|Hydrocarbons, Acyclic|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",CCO[C@@H](CC1=CC=C(OCCC2=CC=C(OS(C)(=O)=O)C=C2)C=C1)C(O)=O,208901
5704,DB06538,Robalzotan,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Pyrans",NC(=O)C1=C2C[C@H](COC2=C(F)C=C1)N(C1CCC1)C1CCC1,
5705,DB06543,Astaxanthin,small molecule,investigational,"Alkenes|Anticoagulants|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Fibrinolytic Agents|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Terpenes",C\C(\C=C\C=C(/C)\C=C\C1=C(C)C(=O)[C@@H](O)CC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)C(=O)[C@@H](O)CC1(C)C,5281224
5707,DB06548,Minodronic acid,small molecule,investigational,Organophosphonates|Organophosphorus Compounds,OC(CC1=CN=C2C=CC=CN12)(P(O)(O)=O)P(O)(O)=O,
5708,DB06549,Labradimil,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Autacoids|Biological Factors|Inflammation Mediators|Intercellular Signaling Peptides and Proteins|Kinins|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptides|Proteins",COC1=CC=C(C[C@@H](CN[C@@H](CCCN=C(N)N)C(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)[C@H](CC2=CC=CS2)NC(=O)CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CCCN=C(N)N)C=C1,
5711,DB06554,Gaboxadol,small molecule,investigational,Analgesics|Anesthetics|Anticonvulsants|Appetite Depressants|Central Nervous System Agents|Central Nervous System Depressants|GABA Agents|GABA Agonists|Neurotransmitter Agents|Peripheral Nervous System Agents|Sensory System Agents,O=C1NOC2=C1CCNC2,3448
5712,DB06555,Siramesine,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",FC1=CC=C(C=C1)N1C=C(CCCCN2CCC3(CC2)OCC2=CC=CC=C32)C2=CC=CC=C12,
5715,DB06558,Tezosentan,small molecule,investigational,"Cardiovascular Agents|Receptors, Endothelin|Vasodilating Agents",COC1=CC=CC=C1OC1=C(NS(=O)(=O)C2=NC=C(C=C2)C(C)C)N=C(N=C1OCCO)C1=CC(=NC=C1)C1=NNN=N1,151174
5716,DB06559,Lanimostim,small molecule,investigational,,,
5718,DB06562,Emfilermin,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Biological Factors|Cytokines|Intercellular Signaling Peptides and Proteins|Peptides|Proteins",,
5719,DB06568,alpha-Hydroxy glycineamide,small molecule,investigational,,,
5720,DB06569,P-57AS3,small molecule,investigational,,[H][C@@]12CC=C3C[C@H](CC[C@]3(C)[C@@]1([H])C[C@@H](OC(=O)C(\C)=C\C)[C@]1(C)[C@H](CC[C@]21O)C(C)=O)O[C@H]1C[C@H](OC)[C@H](O[C@H]2C[C@H](OC)[C@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](OC)[C@H]3O)[C@@H](C)O2)[C@@H](C)O1,
5721,DB06573,Rebimastat,small molecule,investigational,Matrix Metalloproteinases,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](S)CCN1C(=O)N(C)C(C)(C)C1=O)C(C)(C)C,
5722,DB06575,Valomaciclovir,small molecule,investigational,"Antiviral Agents|Herpes Zoster|Heterocyclic Compounds, Fused-Ring|Purines|Purinones|Varicellovirus|Xanthine derivatives",CC(C)[C@H](N)C(=O)OCC[C@@H](CO)CN1C=NC2=C1N=C(N)NC2=O,
5724,DB06578,Tonabersat,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Heterocyclic Compounds, Fused-Ring|Pyrans",CC(=O)C1=CC=C2OC(C)(C)[C@@H](O)[C@@H](NC(=O)C3=CC=C(F)C(Cl)=C3)C2=C1,
5725,DB06579,Adipiplon,small molecule,investigational,Anti-Anxiety Agents|Central Nervous System Agents|Central Nervous System Depressants|GABA Agents|GABA Agonists|Neurotransmitter Agents|Psychotropic Drugs|Tranquilizing Agents,CCCC1=C(CN2C=CN=C2C2=C(F)C=CC=N2)N=CN2N=C(C)N=C12,11198924
5726,DB06580,Celgosivir,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CCCC(=O)O[C@H]1CN2CC[C@H](O)[C@@H]2[C@@H](O)[C@@H]1O,
5727,DB06581,Bevirimat,small molecule,investigational,"Acids, Acyclic|Anti-HIV Agents|Dicarboxylic Acids|Terpenes",[H][C@]12[C@@H](CC[C@@]1(CC[C@]1(C)[C@]2([H])CC[C@]2([H])[C@@]3(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O)C(C)=C,457928
5728,DB06582,Dextofisopam,small molecule,investigational,"Antidepressive Agents|Benzazepines|Central Nervous System Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Psychotropic Drugs|Stereoisomerism",CC[C@@H]1C2=CC(OC)=C(OC)C=C2C(=NN=C1C)C1=CC=C(OC)C(OC)=C1,
5730,DB06585,Fipamezole,small molecule,investigational,Indenes,CCC1(CC2=CC=C(F)C=C2C1)C1=CNC=N1,
5731,DB06586,Cetilistat,small molecule,investigational,"Anti-Obesity Agents|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Lipid Regulating Agents|Oxazines",CCCCCCCCCCCCCCCCOC1=NC2=C(C=C(C)C=C2)C(=O)O1,9952916
5732,DB06587,Mitemcinal,small molecule,investigational,Anti-Bacterial Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Polyketides,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C(C)C)[C@@]2(C)CC(C)=C(O2)[C@H](C)C(=O)[C@]1(C)OC,
5733,DB06588,Triphendiol,small molecule,investigational,"Benzopyrans|Chromones|Flavonoids|Heterocyclic Compounds, Fused-Ring|Pyrans",COC1=CC=C(C=C1)[C@@H]1[C@@H](COC2=CC(O)=CC=C12)C1=CC=C(O)C=C1,
5734,DB06589,Pazopanib,small molecule,approved,"Amides|Angiogenesis Inhibitors|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Hepatotoxic Agents|Immunosuppressive Agents|Kinase Inhibitor|Moderate Risk QTc-Prolonging Agents|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein substrates|Protein Kinase Inhibitors|QTc Prolonging Agents|Receptors, Vascular Endothelial Growth Factor, antagonists & inhibitors|Sulfones|Sulfur Compounds|Tyrosine Kinase Inhibitors|UGT1A1 Inhibitors",CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1,10113978
5735,DB06590,Ceftaroline fosamil,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines",[H][C@]12SCC(SC3=NC(=CS3)C3=CC=[N+](C)C=C3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OCC)\C1=NSC(NP(O)(O)=O)=N1)C([O-])=O,9852981
5736,DB06592,Pegargiminase,small molecule,investigational,"Alcohols|Compounds used in a research, industrial, or household setting|Enzymes|Enzymes and Coenzymes|Ethylene Glycols|Glycols|Macromolecular Substances|Polymers",,
5737,DB06594,Agomelatine,small molecule,approved|investigational,"Acetates|Acids, Acyclic|Amides|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Fatty Acids|Fatty Acids, Volatile|Lipids|Melatonin, agonists|Nervous System|Psychoanaleptics|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists",COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1,82148
5738,DB06595,Midostaurin,small molecule,approved|investigational,"Alkaloids|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbazoles|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strong)|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strong)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 CYP3A7 Inducers|Cytochrome P-450 CYP3A7 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|Kinase Inhibitor|Protein Kinase C, antagonists & inhibitors|Protein Kinase Inhibitors|Receptor Tyrosine Kinase Inhibitors|Tyrosine Kinase Inhibitors",CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O)N(C)C(=O)C1=CC=CC=C1,9829523
5739,DB06597,Estradiol sulfamate,small molecule,investigational,"Amides|Estradiol Congeners|Estranes|Estrenes|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Steryl-Sulfatase, antagonists & inhibitors|Sulfones|Sulfur Compounds",[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OS(N)(=O)=O)C=C3CC[C@@]21[H],
5740,DB06598,Brostallicin,small molecule,investigational,Amidines,CN1C=C(NC(=O)C2=CC(NC(=O)C3=CC(NC(=O)C4=CC(NC(=O)C(Br)=C)=CN4C)=CN3C)=CN2C)C=C1C(=O)NCCN=C(N)N,
5742,DB06600,Nemonoxacin,small molecule,investigational,"Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Moderate Risk QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines",COC1=C2N(C=C(C(O)=O)C(=O)C2=CC=C1N1C[C@@H](C)C[C@H](N)C1)C1CC1,
5744,DB06603,Panobinostat,small molecule,approved|investigational,"Amines|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Histone Deacetylase Inhibitors|Hydroxamic Acids|Hydroxy Acids|Hydroxylamines|Immunosuppressive Agents|Indoles|Moderate Risk QTc-Prolonging Agents|P-glycoprotein substrates|QTc Prolonging Agents",CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1,6918837
5745,DB06604,Ilepatril,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Prodrugs",[H][C@]12CCC[C@H](N1C(=O)[C@H](CC1=C2C=CC=C1)NC(=O)[C@@H](SC(C)=O)C(C)C)C(O)=O,
5746,DB06605,Apixaban,small molecule,approved,Anticoagulants|Antithrombins|BCRP/ABCG2 Substrates|Blood and Blood Forming Organs|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Enzyme Inhibitors|Factor Xa Inhibitors|Hematologic Agents|P-glycoprotein substrates|Protease Inhibitors|Pyridines|Serine Protease Inhibitors,COC1=CC=C(C=C1)N1N=C(C(N)=O)C2=C1C(=O)N(CC2)C1=CC=C(C=C1)N1CCCCC1=O,10182969
5749,DB06608,Tafenoquine,small molecule,approved|investigational,"Aminoquinolines|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiprotozoals|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|MATE 1 Inhibitors|MATE 2 Inhibitors|MATE inhibitors|OCT2 Inhibitors|Quinolines",COC1=CC(C)=C2C(OC3=CC=CC(=C3)C(F)(F)F)=C(OC)C=C(NC(C)CCCN)C2=N1,
5750,DB06609,Odiparcil,small molecule,investigational,Carbohydrates,[H][C@@]1(O)CS[C@@]([H])(OC2=CC3=C(C=C2)C(C)=CC(=O)O3)[C@]([H])(O)[C@@]1([H])O,
5751,DB06610,Omiganan,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Membrane Proteins|Peptides|Pore Forming Cytotoxic Proteins|Proteins",[H]N=C(N([H])[H])N([H])CCC[C@H](N([H])C(=O)[C@H](CCCN([H])C(=N[H])N([H])[H])N([H])C(=O)[C@H](CC1=CN([H])C2=CC=CC=C12)N([H])C(=O)[C@@H]1CCCN1C(=O)[C@H](CC1=CN([H])C2=CC=CC=C12)N([H])C(=O)[C@H](CC1=CN([H])C2=CC=CC=C12)N([H])C(=O)[C@@H]1CCCN1C(=O)[C@H](CC1=CN([H])C2=CC=CC=C12)N([H])C(=O)[C@H](CCCN([H])C(=N[H])N([H])[H])N([H])C(=O)[C@H](CC(C)C)N([H])C(=O)[C@@H](N([H])[H])[C@@H](C)CC)C(=O)N([H])[C@@H](CCCCN([H])[H])C(=O)N([H])[H],
5754,DB06614,Peramivir,small molecule,approved|investigational,"Amidines|Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cycloparaffins|Direct Acting Antivirals|Enzyme Inhibitors|Neuraminidase Inhibitors|Neuraminidase, antagonists & inhibitors",[H][C@@]1([C@@H](NC(C)=O)C(CC)CC)[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O,154234
5755,DB06616,Bosutinib,small molecule,approved,"Amines|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Immunosuppressive Agents|Kinase Inhibitor|Myelosuppressive Agents|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Protein Kinase Inhibitors|Tyrosine Kinase Inhibitors",COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl,5328940
5756,DB06618,Cutamesine,small molecule,investigational,"Carbon Radioisotopes|Central Nervous System Agents|Nootropic Agents|Receptors, sigma, agonists",COC1=C(OC)C=C(CCN2CCN(CCCC3=CC=CC=C3)CC2)C=C1,
5757,DB06619,Amdoxovir,small molecule,investigational,"Carbohydrates|Dioxoles|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purines",NC1=NC(N)=C2N=CN([C@H]3CO[C@@H](CO)O3)C2=N1,
5758,DB06620,Aplindore,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",O=C1CC2=C3O[C@@H](CNCC4=CC=CC=C4)COC3=CC=C2N1,
5759,DB06622,7-beta-Hydroxyepiandrosterone,small molecule,investigational,,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](O)C[C@@]2([H])C[C@@H](O)CC[C@]12C,
5760,DB06623,Flupirtine,small molecule,investigational,Amines|Analgesics|Central Nervous System Agents|Drugs that are Mainly Renally Excreted|Nervous System|Peripheral Nervous System Agents|Pyridines|Sensory System Agents,CCOC(=O)NC1=C(N)N=C(NCC2=CC=C(F)C=C2)C=C1,53276
5761,DB06624,Taranabant,small molecule,investigational,"Cannabinoid Receptor Agonists|Cannabinoids and similars|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Neurotransmitter Agents",C[C@H](NC(=O)C(C)(C)OC1=CC=C(C=N1)C(F)(F)F)[C@@H](CC1=CC=C(Cl)C=C1)C1=CC=CC(=C1)C#N,
5762,DB06625,Vipadenant,small molecule,investigational,Adenosine A2 Receptor Antagonists|Neurotransmitter Agents|Purinergic Agents|Purinergic Antagonists|Purinergic P1 Receptor Antagonists,CC1=CC(CN2N=NC3=C(N=C(N)N=C23)C2=CC=CO2)=CC=C1N,
5763,DB06626,Axitinib,small molecule,approved|investigational,"Acids, Carbocyclic|Amides|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Indazoles|Kinase Inhibitor|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|P-glycoprotein inhibitors|P-glycoprotein substrates|Protein Kinase Inhibitors|Pyrazoles|Receptor Tyrosine Kinase Inhibitors|Tyrosine Kinase Inhibitors|UGT1A1 Substrates",CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,6450551
5764,DB06629,Zibotentan,small molecule,investigational,,COC1=NC(C)=CN=C1NS(=O)(=O)C1=CC=CN=C1C1=CC=C(C=C1)C1=NN=CO1,
5765,DB06630,Anacetrapib,small molecule,investigational,"Anticholesteremic Agents|Cholesterol Ester Transfer Proteins, antagonists & inhibitors|Hypolipidemic Agents|Lipid Regulating Agents|Noxae|Oxazoles|Toxic Actions",COC1=CC(F)=C(C=C1C1=CC=C(C=C1CN1[C@@H](C)[C@H](OC1=O)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C(F)(F)F)C(C)C,
5766,DB06633,N-chlorotaurine,small molecule,investigational,"Acids|Acids, Noncarboxylic|Alkanes|Alkanesulfonic Acids|Anti-Infective Agents|Enzyme Inhibitors|Hydrocarbons, Acyclic|Inflammation Mediators|Nitric Oxide Synthase, antagonists & inhibitors|Protein-Serine-Threonine Kinases, antagonists & inhibitors|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",OS(=O)(=O)CCNCl,
5767,DB06634,Casopitant,small molecule,investigational,Alimentary Tract and Metabolism|Antiemetics|Antiemetics and Antinauseants|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Neurokinin-1 Receptor Antagonists|Neurotransmitter Agents|Peripheral Nervous System Agents,C[C@@H](N(C)C(=O)N1CC[C@@H](C[C@@H]1C1=CC=C(F)C=C1C)N1CCN(CC1)C(C)=O)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,
5768,DB06635,Otamixaban,small molecule,investigational,Anticoagulants|Antithrombins|Enzyme Inhibitors|Factor Xa Inhibitors|Hematologic Agents|Protease Inhibitors|Serine Protease Inhibitors,COC(=O)[C@H](CC1=CC(=CC=C1)C(N)=N)[C@@H](C)NC(=O)C1=CC=C(C=C1)C1=CC=[N+]([O-])C=C1,5496659
5769,DB06636,Isavuconazonium,small molecule,approved|investigational,Anti-Infective Agents|Antifungal Agents|Azole Antifungals|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Isavuconazole and Prodrugs|P-glycoprotein inhibitors,[H]C(C)(OC(=O)N(C)C1=C(COC(=O)CNC)C=CC=N1)[N+]1=CN(C[C@](O)(C2=C(F)C=CC(F)=C2)[C@@]([H])(C)C2=NC(=CS2)C2=CC=C(C=C2)C#N)N=C1,6918606
5770,DB06637,Dalfampridine,small molecule,approved,Amines|Aminopyridines|Cardiovascular Agents|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Membrane Transport Modulators|Nervous System|OCT2 Substrates|OCT2 substrates with narrow therapeutic index|Other Miscellaneous Therapeutic Agents|Potassium Channel Antagonists|Potassium Channel Blockers|Pyridines,NC1=CC=NC=C1,1727
5771,DB06638,Quarfloxin,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Oxazines|Quinolines",CN1CCC[C@H]1CCNC(=O)C1=CN2C3=C(OC4=C2C(=CC(F)=C4N2CCC(C2)C2=CN=CC=N2)C1=O)C=C1C=CC=CC1=C3,
5772,DB06640,Fispemifene,small molecule,investigational,Benzene Derivatives|Benzylidene Compounds|Stilbenes,OCCOCCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,
5773,DB06641,Perifosine,small molecule,investigational,Alcohols|Amines|Amino Alcohols|Ammonium Compounds|Ethanolamines|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds|Trimethyl Ammonium Compounds,CCCCCCCCCCCCCCCCCCOP([O-])(=O)OC1CC[N+](C)(C)CC1,
5776,DB06645,Anamorelin,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Peptide Hormones|Peptides",CN(C)N(C)C(=O)[C@@]1(CC2=CC=CC=C2)CCCN(C1)C(=O)[C@@H](CC1=CNC2=CC=CC=C12)NC(=O)C(C)(C)N,
5778,DB06649,Priralfinamide,small molecule,investigational,"Acids, Acyclic|Benzene Derivatives|Fatty Acids|Fatty Acids, Volatile|Hydrocarbons, Fluorinated|Hydrocarbons, Halogenated|Lipids",C[C@H](NCC1=CC=C(OCC2=CC=CC=C2F)C=C1)C(N)=O,
5780,DB06651,DiaPep 277,small molecule,investigational,"Acid Anhydride Hydrolases|Adenosine Triphosphatases|Amino Acids, Peptides, and Proteins|Chaperonins|Diabetes Mellitus, Type 1|Enzymes|Enzymes and Coenzymes|Group I Chaperonins|Heat-Shock Proteins|Hydrolases|Molecular Chaperones|Peptides|Proteins",[H][C@](C)(O)[C@]([H])(N=C(O)[C@]([H])(CC(C)C)N=C(O)[C@]([H])(CO)N=C(O)[C@]([H])(CC(O)=O)N=C(O)[C@]([H])(CC(C)C)N=C(O)[C@]([H])(C)N=C(O)[C@]1([H])CCCN1C(=O)[C@@]([H])(N=C(O)[C@@]([H])(N=C(O)[C@]([H])(CCCNC(N)=N)N=C(O)[C@]([H])(CC(C)C)N=C(O)[C@]([H])(CC(C)C)N=C(O)[C@]([H])(C)N=C(O)[C@@]([H])(N=C(O)CN=C(O)CN=C(O)CN=C(O)[C@]([H])(CC(C)C)N=C(O)[C@@]([H])(N)C(C)C)C(C)C)C(C)C)[C@@]([H])(C)CC)C(=O)N1CCC[C@@]1([H])C(O)=N[C@@]([H])(C)C(O)=N[C@@]([H])(CC(O)=N)C(O)=N[C@@]([H])(CCC(O)=O)C(O)=N[C@@]([H])(CC(O)=O)C(O)=O,
5781,DB06652,Vicriviroc,small molecule,investigational,Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates,COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)C1=C(C)N=CN=C1C)C1=CC=C(C=C1)C(F)(F)F,
5782,DB06654,Safinamide,small molecule,approved|investigational,"Agents that produce hypertension|Agents that reduce seizure threshold|Amines|Amino Acids|Amino Acids, Peptides, and Proteins|Anti-Parkinson Drugs|Antidepressive Agents|BCRP/ABCG2 Inhibitors|Benzene Derivatives|Benzyl Compounds|Breast Cancer Resistance Protein Inhibitors|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dopamine Agents|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Monoamine Oxidase B Inhibitors|Monoamine Oxidase Inhibitors|Nervous System|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",C[C@H](NCC1=CC=C(OCC2=CC(F)=CC=C2)C=C1)C(N)=O,131682
5784,DB06656,TAS-106,small molecule,investigational,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@](O)(C#C)[C@H]1O,
5785,DB06657,Valrocemide,small molecule,investigational,"Amino Acids|Amino Acids, Peptides, and Proteins",CCCC(CCC)C(=O)NCC(N)=O,
5786,DB06659,Rostaporfin,small molecule,investigational,"Biological Factors|Dermatologicals|Heterocyclic Compounds, Fused-Ring|Photosensitizing Agents|Pigments, Biological|Radiation-Sensitizing Agents",[Cl-].[Sn+4].CCOC(=O)C1=CC2=C3[N-]\C(=C/C4=N/C(=C\C5=C(CC)C(C)=C([N-]5)\C=C5/N=C2C(C)=C5CC)/C(C)=C4CC)[C@@H](C)[C@]13CC,
5787,DB06660,Saredutant,small molecule,investigational,"Acids, Carbocyclic|Amides|Antidepressive Agents|Benzene Derivatives|Benzoates|Central Nervous System Depressants|Receptors, Neurokinin-2, antagonists & inhibitors",CN(C[C@@H](CCN1CCC(CC1)(NC(C)=O)C1=CC=CC=C1)C1=CC=C(Cl)C(Cl)=C1)C(=O)C1=CC=CC=C1,
5789,DB06663,Pasireotide,small molecule,approved,"Amino Acids, Peptides, and Proteins|Bradycardia-Causing Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Hypoglycemia-Associated Agents|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Pancreatic Hormones|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormone Release Inhibiting Hormones|Potential QTc-Prolonging Agents|Proteins|QTc Prolonging Agents|Somatostatin Agonists|Somatostatin and Analogues|Somatostatin Receptor Agonists|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1,9941444
5790,DB06666,Lixivaptan,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates",CC1=CC=C(F)C=C1C(=O)NC1=CC=C(C(=O)N2CC3=CC=CN3CC3=C2C=CC=C3)C(Cl)=C1,
5791,DB06669,Arverapamil,small molecule,investigational,,COC1=CC=C(CCNCCC[C@@](C#N)(C(C)C)C2=CC=C(OC)C(OC)=C2)C=C1OC,
5792,DB06670,Odanacatib,small molecule,investigational,Benzene Derivatives|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|P-glycoprotein substrates,CC(C)(F)C[C@H](N[C@@H](C1=CC=C(C=C1)C1=CC=C(C=C1)S(C)(=O)=O)C(F)(F)F)C(=O)NC1(CC1)C#N,10152654
5793,DB06673,Almorexant,small molecule,investigational,"Acetates|Acids, Acyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Heterocyclic Compounds, Fused-Ring|Lipids",CNC(=O)[C@H](N1CCC2=CC(OC)=C(OC)C=C2[C@@H]1CCC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,
5795,DB06677,Clazosentan,small molecule,investigational,"Amides|Receptor, Endothelin A|Sulfones|Sulfur Compounds|Vasospasm, Intracranial",COC1=CC=CC=C1OC1=C(NS(=O)(=O)C2=CC=C(C)C=N2)N=C(N=C1OCCO)C1=CC=NC(=C1)C1=NN=NN1,
5796,DB06678,Esmirtazapine,small molecule,investigational,"Adrenergic Agents|Adrenergic alpha-2 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Anti-Anxiety Agents|Antidepressive Agents|Antidepressive Agents, Tetracyclic|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Dibenzazepines|Heterocyclic Compounds, Fused-Ring|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Psychotropic Drugs|Serotonin 5-HT2 Receptor Antagonists|Serotonin 5-HT3 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Tranquilizing Agents",[H][C@]12CN(C)CCN1C1=C(CC3=CC=CC=C23)C=CC=N1,3085218
5798,DB06680,Asoprisnil,small molecule,investigational,Amines|Estranes|Fused-Ring Compounds|Hydroxylamines|Steroids,[H]\C(=N/O)C1=CC=C(C=C1)[C@@]1([H])C[C@@]2(C)[C@@]([H])(CC[C@]2(COC)OC)[C@]2([H])CCC3=CC(=O)CCC3=C12,
5800,DB06682,Naproxcinod,small molecule,investigational,"Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Cardiovascular Agents|Musculo-Skeletal System|Naphthaleneacetic Acids|Naphthalenes|Nitric Oxide Donors|Propionates",COC1=CC2=CC=C(C=C2C=C1)[C@H](C)C(=O)OCCCCO[N+]([O-])=O,
5801,DB06683,Clevudine,small molecule,investigational,"Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Arabinonucleosides|Carbohydrates|Direct Acting Antivirals|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",CC1=CN([C@H]2O[C@@H](CO)[C@H](O)[C@H]2F)C(=O)NC1=O,
5802,DB06684,Vilazodone,small molecule,approved,"Agents that produce hypertension|Antidepressive Agents|Benzofurans|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Indoles|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Piperazines|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists",NC(=O)C1=CC2=CC(=CC=C2O1)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1,6918314
5803,DB06685,Laquinimod,small molecule,investigational,"Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Nervous System|Quinolines",CCN(C(=O)C1=C(O)C2=C(C=CC=C2Cl)N(C)C1=O)C1=CC=CC=C1,54677946
5805,DB06689,Ethanolamine oleate,small molecule,approved,"Antivaricose Therapy|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Lipids|Pharmaceutical Preparations|Pharmaceutical Solutions|Sclerosing Agents for Local Injection|Sclerosing Solutions|Solutions|Vasoprotectives",NCCO.CCCCCCCC\C=C/CCCCCCCC(O)=O,5282489
5806,DB06690,Nitrous oxide,small molecule,approved|vet_approved,"Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anesthetics|Anesthetics, General|Anesthetics, Inhalation|Anions|Central Nervous System Agents|Central Nervous System Depressants|Electrolytes|Gases|Ions|Methemoglobinemia Associated Agents|Nervous System|Nitrogen Compounds|Nitrogen Oxides|Oxides|Oxygen Compounds|Peripheral Nervous System Agents|Sensory System Agents",[N-]=[N+]=O,948
5807,DB06691,Mepyramine,small molecule,approved|vet_approved,"Amines|Aminopyridines|Anti-Allergic Agents|Antihistamines for Systemic Use|Antihistamines for Topical Use|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Hypnotics and Sedatives|Neurotransmitter Agents|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Sleep Aids, Pharmaceutical|Substituted Ethylene Diamines",COC1=CC=C(CN(CCN(C)C)C2=NC=CC=C2)C=C1,4992
5809,DB06693,Mevastatin,small molecule,experimental,Agents Causing Muscle Toxicity|Anti-Infective Agents|Anticholesteremic Agents|Antifungal Agents|Enzyme Inhibitors|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Hypolipidemic Agents|Lipid Regulating Agents|Naphthalenes|Noxae|Toxic Actions,[H][C@]12[C@H](CCC=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC,64715
5810,DB06694,Xylometazoline,small molecule,approved|investigational,"Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Antiarrhythmic agents|Antihistamine Drugs|Calcium Channel Blockers|Cardiovascular Agents|Decongestants and Antiallergics|Nasal Decongestants|Nasal Preparations|Ophthalmologicals|Respiratory System Agents|Sensory Organs|Sympathomimetics Used as Decongestants|Sympathomimetics, Plain|Vasoconstrictor Agents|Vasodilating Agents",CC1=CC(=CC(C)=C1CC1=NCCN1)C(C)(C)C,5709
5811,DB06695,Dabigatran etexilate,small molecule,approved,"Anticoagulants|Antithrombins|Benzimidazoles|Blood and Blood Forming Organs|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|P-glycoprotein substrates|Protease Inhibitors|Pyridines|Serine Protease Inhibitors|UGT1A9 Substrates|UGT2B7 substrates",CCCCCCOC(=O)\N=C(\N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C3=NC=CC=C3)N2C)C=C1,6445226
5812,DB06696,Arbekacin,small molecule,experimental|investigational,Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Carbohydrates|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Glycosides|Narrow Therapeutic Index Drugs|Nephrotoxic agents,NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O,68682
5813,DB06697,Artemether,small molecule,approved,"Anions|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Artemisinin and Derivatives, Plain|Artemisinins|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (weak)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Electrolytes|Free Radicals|Highest Risk QTc-Prolonging Agents|Ions|Oxides|Oxygen Compounds|Peroxides|QTc Prolonging Agents|Reactive Oxygen Species|Sesquiterpenes|Terpenes",[H][C@@]12CC[C@@H](C)[C@]3([H])CC[C@@]4(C)OO[C@@]13[C@]([H])(O[C@H](OC)[C@@H]2C)O4,68911
5814,DB06698,Betahistine,small molecule,approved|investigational,Antivertigo Preparations|Cardiovascular Agents|Histamine Agents|Histamine Agonists|Histamine Antagonists|Miscellaneous Central Nervous System Agents|Miscellaneous Therapeutic Agents|Nervous System|Neurotransmitter Agents|Pyridines|Vasodilating Agents,CNCCC1=CC=CC=N1,2366
5815,DB06699,Degarelix,small molecule,approved,"Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Endocrine Therapy|Gonadotropin-releasing Hormone Antagonists|Gonadotropin-Releasing Hormone, antagonists & inhibitors|Hormone Antagonists and Related Agents|Peptides|Potential QTc-Prolonging Agents|QTc Prolonging Agents",CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=C(NC(N)=O)C=C1)NC(=O)[C@H](CC1=CC=C(NC(=O)[C@@H]2CC(=O)NC(=O)N2)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC=C2C=CC=CC2=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,16136245
5816,DB06700,Desvenlafaxine,small molecule,approved|investigational,Agents producing tachycardia|Agents that reduce seizure threshold|Alcohols|Antidepressive Agents|Benzene Derivatives|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cyclohexanes|Cyclohexanols|Cycloparaffins|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Fatty Alcohols|Hexanols|Hypoglycemia-Associated Agents|Lipids|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Norepinephrine Uptake Inhibitors|Phenols|Psychoanaleptics|Psychotropic Drugs|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin and Noradrenaline Reuptake Inhibitors|Serotonin Modulators,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,125017
5817,DB06701,Dexmethylphenidate,small molecule,approved|investigational,"Agents that produce hypertension|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Stimulants|Central Nervous System Stimulation|Centrally Acting Sympathomimetics|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Dopamine Agents|Dopamine Uptake Inhibitors|Membrane Transport Modulators|Methylphenidate and isomer|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Phenylacetates|Piperidines|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators",[H][C@@](C(=O)OC)(C1=CC=CC=C1)[C@@]1([H])CCCCN1,154101
5818,DB06702,Fesoterodine,small molecule,approved,Agents producing tachycardia|Anticholinergic Agents|Benzene Derivatives|Cholinergic Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs for Urinary Frequency and Incontinence|Drugs that are Mainly Renally Excreted|Genito Urinary System and Sex Hormones|Muscarinic Antagonists|Neurotransmitter Agents|P-glycoprotein substrates|Urological Agents|Urologicals,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C,6918558
5819,DB06703,Gadobutrol,small molecule,approved,"Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Gadolinium-based Contrast Agent|Magnetic Resonance Contrast Activity|Magnetic Resonance Imaging Contrast Media|Other Diagnostics|Paramagnetic Contrast Media",OC[C@H](O)[C@H](CO)[N+]12CC[N+]3(CC([O-])=O)CC[N+]4(CC([O-])=O)CC[N+](CC([O-])=O)(CC1)[Gd-]234,70678987
5820,DB06704,Iobenguane,small molecule,approved|investigational,"Amidines|Benzene Derivatives|Compounds used in a research, industrial, or household setting|Diagnostic Radiopharmaceuticals|Diagnostic Uses of Chemicals|Enzyme Inhibitors|Guanidines|Hydrocarbons, Halogenated|Hydrocarbons, Iodinated|Indicators and Reagents|Iodine (131I) Compounds|Iodobenzenes|Laboratory Chemicals|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Radiopharmaceuticals|Therapeutic Radiopharmaceuticals|Tumour Detection",NC(N)=NCC1=CC(I)=CC=C1,60860
5821,DB06705,Gadofosveset trisodium,small molecule,approved,"Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Drugs that are Mainly Renally Excreted|Elements|Gadolinium-based Contrast Agent|Lanthanoid Series Elements|Magnetic Resonance Angiography|Magnetic Resonance Contrast Activity|Magnetic Resonance Imaging Contrast Media|Metals|Metals, Rare Earth|Paramagnetic Contrast Agent|Paramagnetic Contrast Media",[Na+].[Na+].[Na+].[Gd+3].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC(COP([O-])(=O)OC1CCC(CC1)(C1=CC=CC=C1)C1=CC=CC=C1)N(CC([O-])=O)CC([O-])=O,73049652
5822,DB06706,Isometheptene,small molecule,approved,Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alimentary Tract and Metabolism|Amines|Drugs for Functional Gastrointestinal Disorders|Methemoglobinemia Associated Agents,CNC(C)CCC=C(C)C,22297
5823,DB06707,Levonordefrin,small molecule,approved,Adrenergic Agonists|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Benzene Derivatives|Biogenic Amines|Biogenic Monoamines|Cardiovascular Agents|Catecholamines|Catechols|Epinephrine and similars|Ethanolamines|Phenols|Vasoconstrictor Agents,C[C@H](N)[C@H](O)C1=CC(O)=C(O)C=C1,164739
5824,DB06708,Lumefantrine,small molecule,approved,"Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Fluorenes|Highest Risk QTc-Prolonging Agents|QTc Prolonging Agents",CCCCN(CCCC)CC(O)C1=C2C(=CC(Cl)=C1)\C(=C/C1=CC=C(Cl)C=C1)C1=C2C=CC(Cl)=C1,6437380
5825,DB06709,Methacholine,small molecule,approved|investigational,Amines|Ammonium Compounds|Autonomic Agents|Bronchoconstrictor Agents|Cholinergic Agents|Cholinergic Agonists|Cholinergic Receptor Agonist|Methacholine Compounds|Miotics|Muscarinic Agonists|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Other Diagnostics|Parasympathomimetics|Peripheral Nervous System Agents|Quaternary Ammonium Compounds|Respiratory System Agents|Trimethyl Ammonium Compounds,CC(C[N+](C)(C)C)OC(C)=O,1993
5826,DB06710,Methyltestosterone,small molecule,approved,"3-Oxoandrosten (4) Derivatives|Anabolic Agents|Androgens|Androgens and Estrogens|Androstanes|Androstenes|Androstenols|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|OAT3/SLC22A8 Inducers|Sex Hormones and Modulators of the Genital System|Steroids|Testosterone Congeners|Thyroxine-binding globulin inhibitors",[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,6010
5827,DB06711,Naphazoline,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Cardiovascular Agents|Decongestants and Antiallergics|Imidazoles|Nasal Decongestants|Nasal Preparations|Neurotransmitter Agents|Ophthalmologicals|Respiratory System Agents|Sensory Organs|Sympathomimetics Used as Decongestants|Sympathomimetics, Plain|Vasoconstrictor Agents",C(C1=NCCN1)C1=CC=CC2=CC=CC=C12,4436
5828,DB06712,Nilvadipine,small molecule,approved|investigational,Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dihydropyridine Derivatives|Dihydropyridines|Hypotensive Agents|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents,COC(=O)C1=C(NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C)C#N,4494
5829,DB06713,Norelgestromin,small molecule,approved|investigational,"Adrenal Cortex Hormones|Amines|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hydroxylamines|Norpregnanes|Norpregnenes|Norsteroids|Pharmaceutical Preparations|Progestins|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids",[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(C=C3CC[C@@]21[H])=NO,62930
5830,DB06714,Propylhexedrine,small molecule,approved,Amines,CNC(C)CC1CCCCC1,7558
5831,DB06715,Potassium Iodide,small molecule,approved,Anions|Antidotes|Antithyroid agents|Cough and Cold Preparations|Electrolytes|Expectorants|Iodides|Iodine Compounds|Ions|Minerals|Ophthalmologicals|Potassium Compounds|Potassium Salt|Sensory Organs|Thyroid Products,[K+].[I-],4875
5832,DB06716,Fospropofol,small molecule,approved|illicit|investigational,"Agents that reduce seizure threshold|Anesthetics|Anesthetics, General|Benzene Derivatives|Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives|Phenols",CC(C)C1=CC=CC(C(C)C)=C1OCOP(O)(O)=O,3038498
5833,DB06717,Fosaprepitant,small molecule,approved,Antiemetics|Aprepitant and Prodrugs|Autonomic Agents|Central Nervous System Agents|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Gastrointestinal Agents|Miscellaneous Antiemetics|Morpholines|Neurokinin 1 Antagonists|Neurokinin-1 Receptor Antagonists|Neurotransmitter Agents|Oxazines|Peripheral Nervous System Agents|Substance P/Neurokinin-1 Receptor Antagonist,C[C@@H](O[C@H]1OCCN(CC2=NC(=O)N(N2)P(O)(O)=O)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,219090
5834,DB06718,Stanozolol,small molecule,approved|vet_approved,"Alimentary Tract and Metabolism|Anabolic Agents|Anabolic Agents for Systemic Use|Anabolic Steroids|Androgens|Androstan Derivatives|Androstanes|Androstanols|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Thyroxine-binding globulin inhibitors",[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC3=NNC=C3C[C@]12C,25249
5837,DB06721,Gimatecan,small molecule,investigational,Alkaloids|OATP1B1/SLCO1B1 Substrates,[H]\C(=N/OC(C)(C)C)C1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=CC=C12,
5838,DB06723,Aluminum hydroxide,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Adjuvants, Immunologic|Alimentary Tract and Metabolism|Alkalies|Aluminium Compounds|Aluminum and magnesium containing antacids|Anions|Antacids|Antacids and Adsorbents|Carbon Compounds, Inorganic|Carbonic Acid|Drugs for Acid Related Disorders|Electrolytes|Gastric Acid Lowering Agents|Gastrointestinal Agents|Hydroxides|Immunologic Factors|Ions|Metal cations|Metal divalent cations|Miscellaneous Local Anti-infectives",[OH-].[OH-].[OH-].[Al+3],10176082
5839,DB06724,Calcium carbonate,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Alkalies|Anions|Antacids|Antacids and Adsorbents|Blood Coagulation Factors|Calcium Compounds|Calcium Salts|Carbon Compounds, Inorganic|Carbonates|Carbonic Acid|Drugs for Acid Related Disorders|Electrolytes|Gastric Acid Lowering Agents|Gastrointestinal Agents|Ions|Mineral Supplements|Minerals|Phosphate Binder|Polyvalent cation containing laxatives, antacids, oral supplements|Replacement Preparations",[Ca++].[O-]C([O-])=O,10112
5840,DB06725,Lornoxicam,small molecule,approved|investigational,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Oxicams|Peripheral Nervous System Agents|Sensory System Agents|Sulfur Compounds|Thiazines",CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O,54690031
5841,DB06726,Bufuralol,small molecule,experimental,Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Bradycardia-Causing Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Neurotransmitter Agents,CCC1=CC=CC2=C1OC(=C2)C(O)CNC(C)(C)C,71733
5842,DB06727,Sparteine,small molecule,experimental,"Alkaloids|Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ia|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Quinolizidines|Quinolizines|Reproductive Control Agents",[H][C@@]12CCCCN1C[C@@H]1C[C@H]2CN2CCCC[C@]12[H],168213
5843,DB06728,Aniline,small molecule,experimental,Amines|Carcinogens|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 Substrates|Noxae|Toxic Actions,NC1=CC=CC=C1,6115
5844,DB06729,Sulfaphenazole,small molecule,approved,Amides|Amines|Aniline Compounds|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Intermediate-Acting Sulfonamides|Long-Acting Sulfonamides|Ophthalmologicals|Pyrazoles|Sensory Organs|Sulfanilamides|Sulfonamides|SULFONAMIDES AND TRIMETHOPRIM|Sulfones|Sulfur Compounds,NC1=CC=C(C=C1)S(=O)(=O)NC1=CC=NN1C1=CC=CC=C1,5335
5845,DB06730,Gestodene,small molecule,investigational,"Adrenal Cortex Hormones|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Norpregnanes|Norsteroids|Progestin Contraceptives|Progestins|Progestogens and Estrogens, Sequential Preparations|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids",CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1C=C[C@@]2(O)C#C,3033968
5846,DB06731,Seproxetine,small molecule,investigational,Antidepressive Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Selective Serotonin Reuptake Inhibitors|Serotonin Agents|Serotonin Modulators,NCC[C@H](OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,3058751
5847,DB06732,beta-Naphthoflavone,small molecule,experimental,"Benzoflavones|Benzopyrans|Chromones|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Enzyme Inhibitors|Flavonoids|Heterocyclic Compounds, Fused-Ring|Pyrans",O=C1C=C(OC2=C1C1=CC=CC=C1C=C2)C1=CC=CC=C1,2361
5848,DB06733,Bafilomycin A1,small molecule,experimental,"Anti-Infective Agents|Antifungal Agents|Enzyme Inhibitors|Lactones|Polyketides|Proton-Translocating ATPases, antagonists & inhibitors",CO[C@H]1\C=C\C=C(C)\C[C@H](C)[C@H](O)[C@H](C)\C=C(/C)\C=C(OC)\C(=O)O[C@@H]1[C@@H](C)[C@@H](O)[C@H](C)[C@@]1(O)C[C@@H](O)[C@H](C)[C@H](O1)C(C)C,6436223
5849,DB06734,Bafilomycin B1,small molecule,experimental,Lactones|Polyketides,CO[C@H]1\C=C/C=C(C)\C[C@H](C)[C@H](O)[C@H](C)\C=C(\C)/C=C(OC)\C(=O)OC1[C@@H](C)[C@@H](O)[C@H](C)[C@@]1(O)C[C@@H](OC(=O)\C=C\C(=O)NC2=C(O)CCC2=O)[C@H](C)[C@H](O1)C(C)C,
5850,DB06735,Enclomiphene,small molecule,investigational,"Benzene Derivatives|Benzylidene Compounds|Clomiphene|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Estrogen Antagonists|Estrogen Receptor Modulators|Fertility Agents|Fertility Agents, Female|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Reproductive Control Agents|Selective Estrogen Receptor Modulators|Stilbenes",CCN(CC)CCOC1=CC=C(C=C1)C(=C(\Cl)C1=CC=CC=C1)\C1=CC=CC=C1,1548953
5851,DB06736,Aceclofenac,small molecule,approved|investigational,"Acetic Acid Derivatives and Related Substances|Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antirheumatic Agents|Central Nervous System Agents|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Phenylacetates|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory System Agents|Topical Products for Joint and Muscular Pain",OC(=O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,71771
5852,DB06737,Zaltoprofen,small molecule,experimental,"Acids, Acyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antigout Preparations|Antirheumatic Agents|Central Nervous System Agents|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Fatty Acids|Fatty Acids, Volatile|Heterocyclic Compounds, Fused-Ring|Lipids|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Pyrans|Sensory System Agents|Sulfur Compounds|UGT2B7 substrates",CC(C(O)=O)C1=CC=C2SC3=C(C=CC=C3)C(=O)CC2=C1,5720
5853,DB06738,Ketobemidone,small molecule,investigational,Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Isonipecotic Acids|Narcotics|Nervous System|Neurotransmitter Agents|Opioids|Peripheral Nervous System Agents|Phenylpiperidine opioids|Piperidines|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|UGT1A9 Substrates,CCC(=O)C1(CCN(C)CC1)C1=CC(O)=CC=C1,10101
5854,DB06739,Seratrodast,small molecule,experimental,"Analgesics|Analgesics, Non-Narcotic|Anti-Asthmatic Agents|Anti-Inflammatory Agents|Antirheumatic Agents|Central Nervous System Agents|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs for Obstructive Airway Diseases|Fatty Acids|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Lipids|Peripheral Nervous System Agents|Prostaglandin Antagonists|Quinones|Respiratory System Agents|Sensory System Agents|UGT1A9 Substrates",CC1=C(C)C(=O)C(C(CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O,2449
5855,DB06740,BW-A 58C,small molecule,experimental,Naphthalenes|Quinones,CC(C)(C)C1CCC(CC1)C1=C(O)C(=O)C2=CC=CC=C2C1=O,146797
5856,DB06741,Gavestinel,small molecule,investigational,"Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Glycine Agents|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|UGT1A1 Substrates|UGT1A3 substrates|UGT1A9 Substrates",OC(=O)C1=C(\C=C\C(=O)NC2=CC=CC=C2)C2=C(Cl)C=C(Cl)C=C2N1,6450546
5857,DB06742,Ambroxol,small molecule,approved|investigational,Adrenergics for Systemic Use|Amines|Aniline Compounds|Cough and Cold Preparations|Cyclohexanes|Cyclohexylamines|Cycloparaffins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs for Obstructive Airway Diseases|Expectorants|Respiratory System Agents|Selective Beta 2-adrenergic Agonists,NC1=C(Br)C=C(Br)C=C1CN[C@H]1CC[C@H](O)CC1,2132
5858,DB06743,Ginkgolide A,small molecule,nutraceutical,Diterpenes|Terpenes,C[C@@H]1C(=O)O[C@H]2C[C@@]34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@@]4(C(=O)O5)[C@@]12O,9909368
5859,DB06744,ginkgolide-B,small molecule,nutraceutical,,C[C@@H]1C(=O)O[C@H]2[C@H](O)[C@@]34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@@]4(C(=O)O5)[C@@]12O,6324617
5860,DB06745,ginkgolide-C,small molecule,nutraceutical,Diterpenes|Terpenes,C[C@@H]1C(=O)O[C@H]2[C@H](O)[C@]34[C@@H]5OC(=O)[C@]3(O[C@@H]3OC(=O)[C@H](O)[C@]43[C@@H]([C@H]5O)C(C)(C)C)[C@@]12O,9867869
5861,DB06746,ginkgolide-J,small molecule,nutraceutical,Diterpenes|Terpenes,C[C@@H]1C(=O)O[C@H]2C[C@]34[C@@H]5OC(=O)[C@]3(O[C@@H]3OC(=O)[C@H](O)[C@]43[C@@H]([C@H]5O)C(C)(C)C)[C@@]12O,11154476
5862,DB06747,ginkgolide-M,small molecule,nutraceutical,,C[C@H]1C2[C@@H](OC1=O)[C@H](O)[C@]13[C@@H]4OC(=O)[C@]21O[C@@H]1OC(=O)[C@H](O)[C@]31[C@@H]([C@H]4O)C(C)(C)C,46937025
5863,DB06748,Ginsenoside C,small molecule,nutraceutical,Antineoplastic Agents|Carbohydrates|Glycosides|Hypolipidemic Agents|Lipid Regulating Agents|Noxae|Panax|Saponins|Terpenes|Toxic Actions|Triterpenes,[H][C@@]1(CC[C@]2(C)[C@]1([H])[C@H](O)C[C@]1([H])[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@]3([H])CC[C@@]21C)[C@](C)(CCC=C(C)C)O[C@@H]1O[C@H](CO[C@@H]2OC[C@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O,6917976
5864,DB06749,Ginsenoside Rb1,small molecule,nutraceutical,Carbohydrates|Glycosides|OATP1B3 inhibitors|Panax|Saponins|Terpenes|Triterpenes,[H][C@@]1(CC[C@]2(C)[C@]1([H])[C@H](O)C[C@]1([H])[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@]3([H])CC[C@@]21C)C(C)(CCC=C(C)C)O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O,46937026
5865,DB06750,Ginsenoside Rg1,small molecule,nutraceutical,"Carbohydrates|Central Nervous System Agents|Drugs, Chinese Herbal|Glycosides|Panax|Saponins|Terpenes|Triterpenes",CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@H](C[C@@]21C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,441923
5866,DB06751,Drotaverine,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Alkaloids|Analgesics|Autonomic Agents|Benzylisoquinolines|Cardiovascular Agents|Central Nervous System Agents|Drugs for Functional Gastrointestinal Disorders|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Opiate Alkaloids|Papaverine and Derivatives|Parasympatholytics|Peripheral Nervous System Agents|Sensory System Agents|Vasodilating Agents",CCOC1=C(OCC)C=C(\C=C2/NCCC3=CC(OCC)=C(OCC)C=C23)C=C1,1712095
5868,DB06753,Triclofos,small molecule,approved|withdrawn,Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Organophosphorus Compounds|Psycholeptics,OP(O)(=O)OCC(Cl)(Cl)Cl,
5869,DB06754,Danaparoid,small molecule,approved|withdrawn,Agents causing hyperkalemia|Anticoagulants|Blood and Blood Forming Organs|Carbohydrates|Cardiovascular Agents|Chondroitin|Fibrin Modulating Agents|Fibrinolytic Agents|Glycosaminoglycans|Hematologic Agents|Heparin and similars|Heparinoids|Polysaccharides,,
5870,DB06755,Beta carotene,small molecule,approved|nutraceutical,"Alimentary Tract and Metabolism|Alkenes|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Dermatologicals|Diet, Food, and Nutrition|Emollients and Protectives|Food|Food and Beverages|Growth Substances|Hydrocarbons, Acyclic|Micronutrients|Physiological Phenomena|Pigments, Biological|Polyenes|Protectives Against UV-Radiation|Protectives Against UV-Radiation for Systemic Use|Provitamins|Terpenes|Vitamin A|Vitamins|Vitamins (Fat Soluble)",C\C(\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)CCCC1(C)C,5280489
5871,DB06756,Glycine betaine,small molecule,approved|nutraceutical,"Acid Preparations|Alimentary Tract and Metabolism|Amines|Amino Acids and Derivatives|Ammonium Compounds|Cholinesterase Inhibitors|Digestives, Incl. Enzymes|Gastrointestinal Agents|Hypolipidemic Agents|Lipid Regulating Agents|Lipotropic Agents|Methylating Activity|Methylating Agent|Nitrogen Compounds|Noxae|Onium Compounds|Other Miscellaneous Therapeutic Agents|Quaternary Ammonium Compounds|Toxic Actions|Trimethyl Ammonium Compounds",C[N+](C)(C)CC([O-])=O,247
5872,DB06757,Manganese,small molecule,approved|nutraceutical,"Acids|Acids, Noncarboxylic|Anions|Chlorine Compounds|Diet, Food, and Nutrition|Electrolytes|Elements|Food|Food and Beverages|Growth Substances|Ions|Magnetic Resonance Contrast Activity|Metals|Metals, Heavy|Micronutrients|Minerals|Paramagnetic Contrast Agent|Physiological Phenomena|Replacement Preparations|Sulfur Acids|Sulfur Compounds|Sulfuric Acids|Trace Elements|Transition Elements",[Mn++],27854
5876,DB06762,Pinacidil,small molecule,approved,"Amidines|Antihypertensive Agents|Arteriolar Smooth Muscle, Agents Acting On|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Guanidine Derivatives|Guanidines|Membrane Transport Modulators|Vasodilating Agents",CC(N\C(NC#N)=N\C1=CC=NC=C1)C(C)(C)C,
5877,DB06763,Saralasin,small molecule,investigational,"Agents Acting on the Renin-Angiotensin System|Agents causing hyperkalemia|Agents that produce hypertension|Amino Acids, Peptides, and Proteins|Angiotensin Receptor Antagonists|Angiotensins|Autacoids|Biological Factors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Inflammation Mediators|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Proteins",[H]N([H])C(=NCCC[C@H](N([H])C(=O)CN([H])C)C(=O)N([H])[C@@H](C(C)C)C(=O)N([H])[C@@H](CC1=CC=C(O)C=C1)C(=O)N([H])[C@@H](C(C)C)C(=O)N([H])[C@@H](CC1=CN=CN1[H])C(=O)N1CCC[C@H]1C(=O)N([H])[C@@H](C)C(O)=O)N([H])[H],
5878,DB06764,Tetryzoline,small molecule,approved,"Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Autonomic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Decongestants and Antiallergics|Nasal Decongestants|Nasal Preparations|Ophthalmic Solutions|Ophthalmologicals|Peripheral Nervous System Agents|Pharmaceutical Preparations|Pharmaceutical Solutions|Respiratory System Agents|Sensory Organs|Solutions|Sympathomimetics|Sympathomimetics Used as Decongestants|Sympathomimetics, Plain|Vasoconstrictor Agents",C1CN=C(N1)C1CCCC2=CC=CC=C12,5419
5879,DB06766,Alcaftadine,small molecule,approved,"Decongestants and Antiallergics|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Ophthalmologicals|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sensory Organs",CN1CCC(CC1)=C1C2=NC=C(C=O)N2CCC2=CC=CC=C12,19371515
5880,DB06767,Ammonium chloride,small molecule,approved|investigational|vet_approved,"Acidifiers|Acidifying Agents|Acids|Acids, Noncarboxylic|Agents causing hyperkalemia|Ammonium Compounds|Anions|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Chlorides|Chlorine Compounds|Drugs that are Mainly Renally Excreted|Electrolyte Solutions|Electrolytes|Genito Urinary System and Sex Hormones|I.V. Solution Additives|Ions|Nitrogen Compounds|Urinary Acidifying Agents|Urologicals",[NH4+].[Cl-],25517
5881,DB06768,Ammonium lactate,small molecule,approved,alpha-Hydroxy Acid,[NH4+].CC(O)C([O-])=O,62358
5882,DB06769,Bendamustine,small molecule,approved|investigational,"Acids, Acyclic|Alkylating Activity|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Benzimidazoles|Butyrates|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Fatty Acids|Fatty Acids, Volatile|Heterocyclic Compounds, Fused-Ring|Hydrocarbons, Halogenated|Immunosuppressive Agents|Lipids|Mustard Compounds|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Nitrogen Mustard Analogues|Nitrogen Mustard Compounds|Noxae|P-glycoprotein substrates with narrow therapeutic index|Toxic Actions",CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,65628
5883,DB06770,Benzyl alcohol,small molecule,approved,"Alcohols|Anesthetics|Anesthetics, Local|Antiparasitic Products, Insecticides and Repellents|Benzene Derivatives|Benzyl Alcohols|Benzyl Compounds|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 Substrates|Ectoparasiticides, Incl. Scabicides|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Pediculicides|Peripheral Nervous System Agents|Sensory System Agents",OCC1=CC=CC=C1,244
5884,DB06771,Besifloxacin,small molecule,approved,"Anti-Bacterial Agents|Anti-Infective Agents|Antineoplastic Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Moderate Risk QTc-Prolonging Agents|Ophthalmologicals|QTc Prolonging Agents|Quinolines|Quinolone Antimicrobial|Quinolones|Sensory Organs|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",N[C@@H]1CCCCN(C1)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1Cl)C(O)=O,10178705
5885,DB06772,Cabazitaxel,small molecule,approved,Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|Cardiotoxic antineoplastic agents|Cyclodecanes|Cycloparaffins|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Diterpenes|Immunosuppressive Agents|Microtubule Inhibition|Microtubule Inhibitors|Myelosuppressive Agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Taxane Derivatives|Taxoids|Terpenes,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C4=CC=CC=C4)C(C)=C([C@@H](OC)C(=O)[C@]1(C)[C@H](C[C@H]1OC[C@@]21OC(C)=O)OC)C3(C)C,9854073
5887,DB06774,Capsaicin,small molecule,approved,"Alkaloids|Alkenes|Alkynes|Amides|Anesthetics|Anesthetics, Local|Antipruritics|Basic Lotions and Liniments|Benzene Derivatives|Capsaicin and Similar Agents|Capsaicin, antagonists & inhibitors|Catechols|Cholinesterase Inhibitors|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Hydrocarbons, Acyclic|Lipids|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Musculo-Skeletal System|Nervous System|Peripheral Nervous System Agents|Phenols|Polyunsaturated Alkamides|Sensory System Agents|Solanaceous Alkaloids|Topical Products for Joint and Muscular Pain",COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1,1548943
5888,DB06775,Carglumic acid,small molecule,approved,"Alimentary Tract and Metabolism|Amino Acids|Amino Acids and Derivatives|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Ammonia Detoxicants|Carbamoyl Phosphate Synthetase 1 Activator|Carbamoyl Phosphate Synthetase 1 Activators",NC(=O)N[C@@H](CCC(O)=O)C(O)=O,121396
5889,DB06776,Sodium cellulose phosphate,small molecule,approved,"Biopolymers|Calcium Binder|Calcium Chelating Activity|Carbohydrates|Cation Exchange Resins|Compounds used in a research, industrial, or household setting|Drugs for Treatment of Hypercalcemia|Glucans|Macromolecular Substances|Polymers|Polysaccharides",,
5890,DB06777,Chenodeoxycholic acid,small molecule,approved,Alimentary Tract and Metabolism|Bile Acid Preparations|Bile acids and derivatives|Bile Acids and Salts|Bile and Liver Therapy|Bile Therapy|Cholanes|Cholic Acids|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Gastrointestinal Agents|Steroids|UGT2B7 Inhibitors,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,10133
5891,DB06778,Cupric sulfate,small molecule,approved,"Acids|Acids, Noncarboxylic|Anions|Antidotes|Autonomic Agents|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Copper-containing Intrauterine Device|Electrolytes|Emetics|Gastrointestinal Agents|Ions|Peripheral Nervous System Agents|Protective Agents|Sulfates|Sulfur Acids|Sulfur Compounds|Sulfuric Acids",[Cu++].[O-]S([O-])(=O)=O,24462
5892,DB06779,Dalteparin,small molecule,approved,Agents causing hyperkalemia|Anticoagulants|Blood and Blood Forming Organs|Carbohydrates|Cardiovascular Agents|Fibrin Modulating Agents|Fibrinolytic Agents|Glycosaminoglycans|Hematologic Agents|Heparin (Low Molecular Weight)|Heparin and similars|Polysaccharides,,
5893,DB06780,Desoxycorticosterone acetate,small molecule,approved,"Adrenal Cortex Hormones|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Desoxycorticosterone|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Mineralocorticoids|Pregnanes|Pregnenediones|Pregnenes|Steroids",[H][C@@]12CC[C@H](C(=O)COC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
5894,DB06781,Difluprednate,small molecule,approved,"Adrenal Cortex Hormones|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dermatologicals|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated",[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,443936
5895,DB06782,Dimercaprol,small molecule,approved,"Antidotes|Chelating Agents|Compounds used in a research, industrial, or household setting|Drugs that are Mainly Renally Excreted|Heavy Metal Antagonists|Metal Chelating Activity|Metal Chelator|Sequestering Agents|Sulfhydryl Compounds|Sulfur Compounds",OCC(S)CS,3080
5896,DB06783,Prussian blue,small molecule,approved,"Acids|Acids, Noncarboxylic|Anions|Antidotes|Chelating Activity|Coloring Agents|Compounds used in a research, industrial, or household setting|Cyanides|Decorporation Agent|Electrolytes|Ferrous Compounds|Hydrogen Cyanide|Ion Exchange Activity|Ions|Iron Compounds|Nitrogen Compounds|Organometallic Compounds|Protective Agents",[Fe+3].[Fe+3].[Fe+3].[Fe+3].N#C[Fe-4](C#N)(C#N)(C#N)(C#N)C#N.N#C[Fe-4](C#N)(C#N)(C#N)(C#N)C#N.N#C[Fe-4](C#N)(C#N)(C#N)(C#N)C#N,2724251
5897,DB06784,Gallium citrate Ga-67,small molecule,approved,Gallium|Gallium Radioisotopes|Radioactive Diagnostic Agent|Radiopharmaceutical Activity,[67Ga+3].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,65430
5898,DB06785,Ganirelix,small molecule,approved,"Amino Acids, Peptides, and Proteins|Anti-Gonadotropin-Releasing Hormones|Decreased GnRH Secretion|Gonadotropin Releasing Hormone Receptor Antagonists|Gonadotropin-releasing Hormone Antagonists|Gonadotropin-Releasing Hormone, antagonists & inhibitors|Hormone Antagonists|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormone-Releasing Hormones|Proteins|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",CCNC(NCC)=NCCCC[C@@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN=C(NCC)NCC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,16130957
5899,DB06786,Halcinonide,small molecule,approved|investigational|withdrawn,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Very Potent (Group IV)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dermatologicals|Fused-Ring Compounds|Immunosuppressive Agents|Pregnanes|Pregnenediones|Pregnenes|Steroids",[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,443943
5900,DB06787,Hexocyclium,small molecule,approved,"Agents producing tachycardia|Alimentary Tract and Metabolism|Anticholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Synthetic Anticholinergics, Quaternary Ammonium Compounds",C[N+]1(C)CCN(CC(O)(C2CCCCC2)C2=CC=CC=C2)CC1,24199
5901,DB06788,Histrelin,small molecule,approved,"Adrenal Cortex Hormones|Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Endocrine Therapy|Gonadotropin Releasing Hormone Receptor Agonist|Gonadotropin Releasing Hormone Receptor Agonists|Gonadotropin-releasing hormone agonist|Hormones|Hormones and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary Hormone-Releasing Hormones|Potential QTc-Prolonging Agents|Proteins|QTc Prolonging Agents",CC(O)=O.CC(O)=O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC1=CN(CC2=CC=CC=C2)C=N1)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,56927879
5902,DB06789,Hydroxyprogesterone caproate,small molecule,approved|investigational,"Adrenal Cortex Hormones|Antineoplastic Agents|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Corpus Luteum Hormones|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Estrogen Antagonists|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormone Antagonists|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxyprogesterones|Hyperglycemia-Associated Agents|Pregnanes|Pregnenediones|Pregnenes|Progesterone and Derivatives|Progesterone Congeners|Progestin Contraceptives|Progestins|Steroids",[H][C@@]12CC[C@](OC(=O)CCCCC)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,169870
5903,DB06791,Lanreotide,small molecule,approved,"Acromegaly|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Bradycardia-Causing Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Hypoglycemia-Associated Agents|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Other Miscellaneous Therapeutic Agents|Pancreatic Hormones|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormone Release Inhibiting Hormones|Proteins|Somatostatin and Analogues|Somatostatin Receptor Agonists|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",[H]N([H])CCCCC1N([H])C(=O)C(CC2=CN([H])C3=CC=CC=C23)N([H])C(=O)C(CC2=CC=C(O)C=C2)N([H])C(=O)C(CSSCC(N([H])C(=O)C(N([H])C1=O)C(C)C)C(=O)N([H])C(C(C)O)C(=O)N([H])[H])N([H])C(=O)C(CC1=CC2=CC=CC=C2C=C1)N([H])[H],71349
5904,DB06792,Lanthanum carbonate,small molecule,approved,"Drugs for Treatment of Hyperkalemia and Hyperphosphatemia|Elements|Kidney Failure, Chronic|Lanthanoid Series Elements|Metal cations|Metals|Metals, Rare Earth|Phosphate Binder|Phosphate-removing Agents",[La+3].[La+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O,168924
5905,DB06793,Levopropoxyphene,small molecule,withdrawn,"Acids, Acyclic|Agents that reduce seizure threshold|Antitussive Agents|Central Nervous System Agents|Fatty Acids|Fatty Acids, Volatile|Lipids|Propionates|Respiratory System Agents",[H][C@](C)(CN(C)C)[C@@](CC1=CC=CC=C1)(OC(=O)CC)C1=CC=CC=C1,200742
5906,DB06794,Lodoxamide,small molecule,approved,"Acids, Aldehydic|Alcohols|Amino Acids|Amino Acids, Peptides, and Proteins|Anti-Allergic Agents|Antioxidants|Decongestants and Antiallergics|Decreased Histamine Release|Glycols|Glyoxylates|Histamine Agents|Mast Cell Stabilizers|Neurotransmitter Agents|Ophthalmologicals|Propylene Glycols|Sensory Organs",OC(=O)C(=O)NC1=CC(=CC(NC(=O)C(O)=O)=C1Cl)C#N,44564
5907,DB06795,Mafenide,small molecule,approved|vet_approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Local|Dermatologicals|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Methemoglobinemia Associated Agents|Sulfonamide Antibacterial|Sulfonamides|Sulfones|Sulfur Compounds",NCC1=CC=C(C=C1)S(N)(=O)=O,3998
5908,DB06796,Mangafodipir,small molecule,approved|investigational|withdrawn,"Acetates|Acids, Acyclic|Amines|Coenzymes|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Diamines|Drugs that are Mainly Renally Excreted|Enzymes and Coenzymes|Ethylenediamines|Fatty Acids|Fatty Acids, Volatile|Lipids|Magnetic Resonance Contrast Activity|Magnetic Resonance Imaging Contrast Media|Paramagnetic Contrast Agent|Paramagnetic Contrast Media|Picolines|Polyamines|Pyridines",[Mn++].CC1=C(O)C(CN(CCN(CC([O-])=O)CC2=CC(COP(O)(O)=O)=NC(C)=C2O)CC([O-])=O)=CC(COP(O)(O)=O)=N1,131704299
5909,DB06797,Mebutamate,small molecule,approved,Anti-Anxiety Agents|Carbamates|Central Nervous System Depressants|Nervous System|Psycholeptics,CCC(C)C(C)(COC(N)=O)COC(N)=O,
5910,DB06799,Methenamine,small molecule,approved|vet_approved,"Acids, Carbocyclic|Amides|Amines|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Benzene Derivatives|Benzoates|Cycloparaffins|Hydroxy Acids|Keto Acids|Polyamines|Renal Agents|Urinary Acidifying Agents",C1N2CN3CN1CN(C2)C3,4101
5911,DB06800,Methylnaltrexone,small molecule,approved,"Alimentary Tract and Metabolism|Alkaloids|Amines|Ammonium Compounds|Central Nervous System Agents|Drugs for Constipation|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Miscellaneous GI Drugs|Morphinans|Narcotics|Nitrogen Compounds|Onium Compounds|Opiate Alkaloids|Opioid Antagonists|Peripheral Nervous System Agents|Peripheral Opioid Receptor Antagonists|Phenanthrenes|Sensory System Agents",C[N@+]1(CC2CC2)CC[C@]23[C@H]4OC5=C(O)C=CC(C[C@@H]1[C@]2(O)CCC4=O)=C35,16089915
5912,DB06801,Monoctanoin,small molecule,experimental,"Acids, Acyclic|Fatty Acids|Lipids|Solvents",CCCCCCCC(=O)OCC(O)CO,
5913,DB06802,Nepafenac,small molecule,approved|investigational,"Acetamides|Acetates|Acids, Acyclic|Acids, Carbocyclic|Agents causing hyperkalemia|Amides|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antirheumatic Agents|Benzene Derivatives|Central Nervous System Agents|Cyclooxygenase Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|Nephrotoxic agents|Ophthalmologicals|Peripheral Nervous System Agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory Organs|Sensory System Agents",NC(=O)CC1=CC=CC(C(=O)C2=CC=CC=C2)=C1N,151075
5914,DB06803,Niclosamide,small molecule,approved|investigational|vet_approved,"Agrochemicals|Amides|Amines|Anilides|Aniline Compounds|Anthelmintics|Anti-Infective Agents|Anticestodal Agents|Anticestodals|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiplatyhelmintic Agents|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Molluscacides|Pesticides|Salicylamides|Salicylanilides|Salicylic Acid Derivatives|Toxic Actions",OC1=C(C=C(Cl)C=C1)C(=O)NC1=C(Cl)C=C(C=C1)[N+]([O-])=O,4477
5915,DB06804,Nonoxynol-9,small molecule,approved|withdrawn,"Adrenal Cortex Hormones|Alcohols|Antispermatogenic Agents|Compounds used in a research, industrial, or household setting|Contraceptive Agents, Female|Contraceptive Agents, Male|Ethylene Glycols|Glycols|Hormonal Contraceptives for Systemic Use|Macromolecular Substances|Noxae|Polyethylene Glycols|Polymers|Reproductive Control Agents|Spermatocidal Agents|Surface-Active Agents|Toxic Actions",CCCCCCCCCC1=CC=C(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)C=C1,72385
5916,DB06807,Phenyl aminosalicylate,small molecule,approved,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Hydroxy Acids|Hydroxybenzoates|Phenols|Salicylates",NC1=CC(O)=C(C=C1)C(=O)OC1=CC=CC=C1,
5917,DB06809,Plerixafor,small molecule,approved,"Adjuvants, Immunologic|Anti-HIV Agents|Anti-Infective Agents|Antineoplastic and Immunomodulating Agents|Drugs that are Mainly Renally Excreted|Hematinics|Hematopoietic Stem Cell Mobilizer|Increased Hematopoietic Stem Cell Mobilization",C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,65015
5918,DB06810,Plicamycin,small molecule,approved|investigational|withdrawn,"Anthracyclines|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Calcium-Regulating Hormones and Agents|Carbohydrates|Coloring Agents|Compounds used in a research, industrial, or household setting|Cytotoxic Antibiotics and Related Substances|Enzyme Inhibitors|Fluorescent Dyes|Glycosides|Indicators and Reagents|Laboratory Chemicals|Luminescent Agents|Naphthacenes|Nucleic Acid Synthesis Inhibitors|Protein Synthesis Inhibitors",CO[C@@H]([C@@H]1CC2=CC3=CC(O[C@H]4C[C@@H](O[C@H]5C[C@@H](O)[C@H](O)[C@@H](C)O5)[C@H](O)[C@@H](C)O4)=C(C)C(O)=C3C(O)=C2C(=O)[C@H]1O[C@H]1C[C@@H](O[C@H]2C[C@@H](O[C@H]3C[C@](C)(O)[C@H](O)[C@@H](C)O3)[C@@H](O)[C@@H](C)O2)[C@H](O)[C@@H](C)O1)C(=O)[C@@H](O)[C@@H](C)O,163659
5919,DB06811,Polidocanol,small molecule,approved,"Alcohols|Antivaricose Therapy|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Detergents|Ethylene Glycols|Glycols|Household Products|Macromolecular Substances|Pegylated agents|Pharmaceutical Preparations|Pharmaceutical Solutions|Polyethylene Glycols|Polymers|Sclerosing Activity|Sclerosing Agents for Local Injection|Sclerosing Solutions|Solutions|Surface-Active Agents|Vascular Sclerosing Activity|Vasoprotectives",CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,656641
5920,DB06812,Povidone-iodine,small molecule,approved,"Alkenes|Anti-Infective Agents|Anti-Infective Agents, Local|Antifungal Agents (Vaginal)|Antiseptics and Disinfectants|Compounds used in a research, industrial, or household setting|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hydrocarbons, Acyclic|Iodine Compounds|Iodine Products|Iodophors|Irrigating Solutions|Macromolecular Substances|Medicated Dressings|Medicated Dressings With Antiinfectives|Medicated Shampoos|Miscellaneous Local Anti-infectives|Ophthalmologicals|Plastics|Polyenes|Polymers|Polyvinyls|Pyrrolidines|Pyrrolidinones|Sensory Organs|Throat Preparations|Vinyl Compounds",,
5921,DB06813,Pralatrexate,small molecule,approved|investigational,"Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Biological Factors|Drugs that are Mainly Renally Excreted|Folic Acid Analogues|Folic Acid Antagonists|Heterocyclic Compounds, Fused-Ring|Immunosuppressive Agents|Narrow Therapeutic Index Drugs|Pigments, Biological|Pteridines|Pterins",NC1=NC2=NC=C(CC(CC#C)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N=C2C(N)=N1,148121
5922,DB06814,Protokylol,small molecule,approved|vet_approved,Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents to Treat Airway Disease|Alcohols|Amines|Amino Alcohols|Benzene Derivatives|Biogenic Amines|Biogenic Monoamines|Catecholamines|Catechols|Dioxoles|Epinephrine and similars|Ethanolamines|Phenols,CC(CC1=CC=C2OCOC2=C1)NCC(O)C1=CC=C(O)C(O)=C1,
5923,DB06815,Pyrithione,small molecule,approved,Anti-Infective Agents|Antifungal Agents|Dermatologicals|Drugs that are Mainly Renally Excreted|Gallium Radioisotopes|Indium Radioisotopes|Keratolytic Agents|Miscellaneous Local Anti-infectives|Radiopharmaceuticals|Sulfur Compounds,[O-][N+]1=C(S)C=CC=C1,26041
5924,DB06816,Pyrvinium,small molecule,approved,"Anthelmintics|Anti-Infective Agents|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Heterocyclic Compounds, Fused-Ring|Quinolines|Quinolinium Compounds",CN(C)C1=CC2=C(C=C1)[N+](C)=C(\C=C\C1=C(C)N(C(C)=C1)C1=CC=CC=C1)C=C2,5281035
5925,DB06817,Raltegravir,small molecule,approved,Agents Causing Muscle Toxicity|Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Direct Acting Antivirals|Enzyme Inhibitors|HIV Integrase Inhibitors|Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor|Integrase Inhibitors|Pyrrolidines|Pyrrolidinones|UGT1A1 Substrates,CN1C(=O)C(O)=C(N=C1C(C)(C)NC(=O)C1=NN=C(C)O1)C(=O)NCC1=CC=C(F)C=C1,54671008
5926,DB06819,Phenylbutyric acid,small molecule,approved|investigational,"Acids, Carbocyclic|Alimentary Tract and Metabolism|Ammonium Ion Binding Activity|Antineoplastic Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Nitrogen Binding Agent|Urea Cycle Disorder Agents|Various Alimentary Tract and Metabolism Products",OC(=O)CCCC1=CC=CC=C1,4775
5927,DB06820,Sulconazole,small molecule,approved,Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Azole Antifungals|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Imidazole and Triazole Derivatives,ClC1=CC=C(CSC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1,5318
5928,DB06821,Sulfameter,small molecule,approved,"Amides|Amines|Aniline Compounds|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Leprostatic Agents|Long-Acting Sulfonamides|Renal Agents|Sulfanilamides|Sulfonamide Antibacterial|Sulfonamides|SULFONAMIDES AND TRIMETHOPRIM|Sulfones|Sulfur Compounds",COC1=CN=C(NS(=O)(=O)C2=CC=C(N)C=C2)N=C1,
5929,DB06822,Tinzaparin,small molecule,approved,Agents causing hyperkalemia|Anticoagulants|Blood and Blood Forming Organs|Carbohydrates|Cardiovascular Agents|Fibrin Modulating Agents|Fibrinolytic Agents|Glycosaminoglycans|Hematologic Agents|Heparin (Low Molecular Weight)|Heparin and similars|Polysaccharides,,
5930,DB06823,Tiopronin,small molecule,approved|investigational,"Amino Acids|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Cystine Disulfide Reduction|Drugs that are Mainly Renally Excreted|Genito Urinary System and Sex Hormones|N-substituted Glycines|Peptides|Peptoids|Reducing and Complexing Thiol|Sulfur Compounds|Urologicals",CC(S)C(=O)NCC(O)=O,5483
5931,DB06824,Triethylenetetramine,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Amines|Chelating Agents|Compounds used in a research, industrial, or household setting|Diamines|Drugs that are Mainly Renally Excreted|Ethylenediamines|Metal Chelating Activity|Metal Chelator|Polyamines|Sequestering Agents|Various Alimentary Tract and Metabolism Products",NCCNCCNCCN,5565
5932,DB06825,Triptorelin,small molecule,approved|vet_approved,"Adrenal Cortex Hormones|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|Endocrine Therapy|Gonadotropin Releasing Hormone Receptor Agonist|Gonadotropin Releasing Hormone Receptor Agonists|Gonadotropin-releasing hormone agonist|Hormones|Hormones and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Hypothalamic Hormones|Luteolytic Agents|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary Hormone-Releasing Hormones|Potential QTc-Prolonging Agents|Proteins|QTc Prolonging Agents|Reproductive Control Agents",CC(C)C[C@H](NC(=O)[C@@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,25074470
5933,DB06826,Unoprostone,small molecule,approved|investigational,"Antiglaucoma Preparations and Miotics|Antihypertensive Agents|Autacoids|Biological Factors|Cardiovascular Agents|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Ophthalmologicals|Prostaglandins|Prostaglandins F|Prostaglandins, Synthetic|Sensory Organs",CCCCCCCC(=O)CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O,5311236
5934,DB06827,Viomycin,small molecule,approved,"Agents that produce neuromuscular block (indirect)|Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics, Antitubercular|Antituberculosis Agents|Enzyme Inhibitors|Neurotoxic agents|Peptides|Peptides, Cyclic|Protein Synthesis Inhibitors",[H][C@@]1(C[C@H](O)NC(=N)N1)[C@]1([H])NC(=O)\C(NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CNC1=O)NC(=O)C[C@@H](N)CCCN)=C\NC(N)=O,3037981
5935,DB06828,5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole,small molecule,experimental,,C(CN1C=CC=C1)OC1=CC2=C(NC=C2)C=C1,44129621
5936,DB06829,4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID,small molecule,experimental,,OC(=O)COC1=C(SC(=C1Br)C1=CC=CC(NC2CCCCC2)=C1)C(O)=O,17759780
5937,DB06830,"(1-HYDROXYHEPTANE-1,1-DIYL)BIS(PHOSPHONIC ACID)",small molecule,experimental,,CCCCCCC(O)(P(O)(O)=O)P(O)(O)=O,5276520
5938,DB06831,2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE,small molecule,experimental,,COC1=CC=CC=C1N1C(=O)C2=C(Cl)C=CC=C2N=C1CSC1=C2N=CNC2=NC=N1,6852165
5939,DB06832,Prinaberel,small molecule,investigational,"Receptors, Estrogen, agonists",OC1=CC2=C(OC(=N2)C2=CC=C(O)C(F)=C2)C(C=C)=C1,5388909
5940,DB06833,1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE,small molecule,experimental,,CC1=CC=C(C=C1)N1C=C(CNCC2CCCCC2)C2=CC=CC=C12,16122612
5941,DB06834,"N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide",small molecule,experimental,,CN1C=C(C2=CC3=CC=CN=C3N2)C2=CC(=CC=C12)C(=O)NC(C)(C)CO,9968957
5942,DB06835,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(S)-HYDROXY[(1R)-2-METHYL-1-{[(2-PHENYLETHYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID,small molecule,experimental,,[H][C@@](C[P@@](O)(=O)[C@@]([H])(NS(=O)(=O)CCC1=CC=CC=C1)C(C)C)(C(O)=O)C1=CC=CC(CN)=C1,23653507
5943,DB06836,"N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide",small molecule,experimental,,[H]N(CCO)S(=O)(=O)C1=C(Cl)C=CC(=C1)C1=C(C)N=C(S1)N([H])C(C)=O,6852167
5944,DB06837,"(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide",small molecule,experimental,,[H][C@](CC(=O)NO)(CC1=CC(O)=CC=C1)C(=O)N[C@@]1([H])C2=C(C[C@@]1([H])O)C=CC=C2,11143173
5945,DB06838,methyl L-phenylalaninate,small molecule,experimental,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins",COC(=O)[C@@H](N)CC1=CC=CC=C1,736234
5946,DB06839,N-(ethoxycarbonyl)-L-leucine,small molecule,experimental,,[H][C@@](CC(C)C)(NC(=O)OCC)C(O)=O,10631973
5947,DB06840,"diethyl [(1R)-1,5-diaminopentyl]boronate",small molecule,experimental,,[H][C@](N)(CCCCN)B(OCC)OCC,46937028
5948,DB06841,"[(2R)-1-[(2S)-2-[[(2S,3S)-1-Chloro-6-(diaminomethylideneamino)-2-hydroxyhexan-3-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]azanium",small molecule,experimental,,NC(N)=NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]([NH3+])CC1=CC=CC=C1)[C@H](O)CCl,131704300
5949,DB06842,(4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one,small molecule,experimental,,[H][C@@]1(CC2=CC(OCCCC)=C(OC)C=C2)CNC(=O)N1,6603746
5950,DB06843,"2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE",small molecule,experimental,,[H][C@]1(C)O[C@]([H])(C[C@]1([H])OP(O)(O)=O)N1C=NC2=C1N=CN=C2N,444894
5951,DB06844,"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",small molecule,experimental,,O=C1N=C2C=CC3=C(SC=N3)C2=C1CNC1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1,1712
5952,DB06845,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,small molecule,experimental,,[H][C@]1(CCCN1C(=O)CNC1CCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N,23629654
5953,DB06847,"5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",small molecule,experimental,,[H][C@@](C)(C#CC1=C(N)N=C(N)N=C1C)C1=CC(OC)=C(C=C1)C1=CC=CC=C1,25195365
5954,DB06848,"1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine",small molecule,experimental,,CSC1=C2C=CC=CC2=C(S1)C(=O)N1CCC2(COC3=C2C=C(CN)C=C3)CC1,25113123
5955,DB06849,"1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine",small molecule,experimental,,NCC1=CC2=C(OCC22CCN(CC2)C(=O)\C=C\C2=CC=CC=C2)C=C1,25113124
5956,DB06850,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide,small molecule,experimental,,[H][C@]1(CCCN1C(=O)CNC1CCCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N,44141860
5957,DB06851,N-(pyridin-3-ylmethyl)aniline,small molecule,experimental,,C(NC1=CC=CC=C1)C1=CC=CN=C1,1082702
5958,DB06852,CHIR-124,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring",ClC1=CC2=C(NC(=O)C(C3=NC4=CC=CC=C4N3)=C2N[C@@H]2CN3CCC2CC3)C=C1,11502647
5959,DB06853,N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,small molecule,experimental,,[H][C@]1(CCCN1C(=O)CNC1CCCCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N,25113614
5960,DB06855,6-fluoro-2-(2-hydroxy-3-isobutoxy-phenyl)-1H-benzoimidazole-5-carboxamidine,small molecule,experimental,,CC(C)COC1=C(O)C(=CC=C1)C1=NC2=CC(C(N)=N)=C(F)C=C2N1,6102526
5961,DB06856,6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE,small molecule,experimental,,[H][C@]1(C)CCCC[C@]1([H])OC1=C(O)C(=CC=C1)C1=CC2=CC(C(N)=N)=C(F)C=C2N1,445849
5962,DB06857,N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE,small molecule,experimental,,CC1=CC(I)=C(O)C(=C1)C(=O)NC1=CC(Cl)=C(C=C1)C(N)=N,4300
5963,DB06858,N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,small molecule,experimental,,[H][C@]1(CCCN1C(=O)CNC1CCCCCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N,46937030
5964,DB06859,N-ALLYL-5-AMIDINOAMINOOXY-PROPYLOXY-3-CHLORO-N-CYCLOPENTYLBENZAMIDE,small molecule,experimental,,NC(=N)NOCCCOC1=CC(Cl)=CC(=C1)C(=O)N(CC=C)C1CCCC1,657007
5965,DB06860,"2-(2-chloropyridin-4-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",small molecule,experimental,,CC1=C2C(=O)N(C(=O)C2=CC=C1)C1=CC=NC(Cl)=C1,25134265
5966,DB06861,6-(2-HYDROXY-CYCLOPENTYL)-7-OXO-HEPTANAMIDINE,small molecule,experimental,,[H][C@](CCCCC(N)=N)(C=O)[C@@]1([H])CCC[C@]1([H])O,6323178
5967,DB06862,2-HYDROXY-5-(2-MERCAPTO-ETHYLSULFAMOYL)-BENZOIC ACID,small molecule,experimental,,OC(=O)C1=C(O)C=CC(=C1)S(=O)(=O)NCCS,447400
5968,DB06864,"2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID",small molecule,experimental,,[H][C@@]1(O)C=CC=C(C(=O)CCC(O)=O)[C@@]1([H])C(O)=O,5287432
5969,DB06865,6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,small molecule,experimental,,[H][C@](CCCCC(N)=N)(C(O)=O)[C@@]1([H])C2=C(C[C@]1([H])O)C=CC(=C2)C1=CC=C(O)C=C1,448123
5970,DB06866,6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,small molecule,experimental,,[H][C@](CCCCC(N)=N)(C(O)=O)[C@@]1([H])C2=C(C[C@]1([H])O)C=C(C=C2)C1=CC(OC)=CC=C1,5496862
5971,DB06867,"3,6,9,12,15,18-HEXAOXAICOSANE",small molecule,experimental,,CCOCCOCCOCCOCCOCCOCC,90206
5972,DB06868,N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide,small molecule,experimental,,[H][C@]1(CCCN1C(=O)CCC(C)C)C(=O)NCC1=CC(Cl)=CC=C1,42615253
5973,DB06869,1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE,small molecule,experimental,,[H][C@@](N)(C1CCCCC1)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=C(OCC(=O)NCC)C=CC(Cl)=C1,448677
5974,DB06870,Tetrahydrogestrinone,small molecule,experimental,"Anabolic Agents|Androgens|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Norpregnanes|Norpregnatrienes|Norsteroids|Steroids",[H][C@@]12CC[C@@](O)(CC)[C@@]1(CC)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H],6857686
5975,DB06871,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,small molecule,experimental,,[H][C@@]12CC[C@@](C)(O)[C@@]1(C)CCC1=C2C=CC2=CC(O)=CC=C12,9549180
5976,DB06872,"1-((2-HYDROXYETHOXY)METHYL)-5-(PHENYLTHIO)PYRIMIDINE-2,4(1H,3H)-DIONE",small molecule,experimental,,OCCOCN1C=C(SC2=CC=CC=C2)C(=O)NC1=O,4369475
5977,DB06873,"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)PYRIMIDINE-2,4(1H,3H)-DIONE",small molecule,experimental,,OCCOCN1C=C(CC2=CC=CC(OCC3=CC=CC=C3)=C2)C(=O)NC1=O,134111
5978,DB06874,"(6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4-(AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL)METHANOL",small molecule,experimental,,CC1=CC(=CC(C)=C1OC1=C(Br)C(CO)=NC(NC2=CC=C(C=C2)C#N)=N1)C#N,505461
5979,DB06875,ERB-196,small molecule,experimental,"Estrogen Receptor beta, agonists|Naphthalenes",OC1=CC=C2C=C(C=C(C#N)C2=C1)C1=CC=C(O)C(F)=C1,6102691
5980,DB06876,"N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE",small molecule,experimental,,CN1CCN(CC1)C1=CC=C(C=C1)C1=CC2=C(NC=C2NC(=O)C2=CN=CC=C2)N=C1,6914568
5981,DB06877,"N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE",small molecule,experimental,,CN(C)C(=O)C1=CC(=CN1)C1=NNC=C1C1=CC=CC=C1,6096886
5982,DB06878,1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide,small molecule,experimental,,[H][C@@](N)(CC)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC=CC(Cl)=C1,25113126
5983,DB06879,"5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE",small molecule,experimental,,CCN1C2=C(F)C=CC(F)=C2C(N)=NC11CCN(CC1)C(=O)C1=CN=C(CC1)C#N,46937031
5984,DB06880,"(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-PROP-1-YN-1-YLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE",small molecule,experimental,,[H][C@](N)(C1CCCC1)C(=O)N1[C@]([H])(CN)CC[C@]1([H])C#CC,11840904
5985,DB06881,(1Z)-2-HYDROXY-3-OXOHEX-1-EN-1-YL DIHYDROGEN PHOSPHATE,small molecule,experimental,,CCCC(=O)C(\O)=C\OP(O)(O)=O,46937032
5986,DB06882,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,small molecule,experimental,,CC(C)(C)C1=NN(C(NC(=O)NC2=C3C=CC=CC3=CC=C2)=C1)C1=CC=CC(N)=C1,25174101
5987,DB06883,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea,small molecule,experimental,,CC(C)(C)C1=NN(C(NC(=O)NC2=CC=CC=C2)=C1)C1=CC=CC(N)=C1,10915062
5988,DB06884,4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,small molecule,experimental,,CC(C)C1=CC=C(CNNC(=O)C2=CC=C(O)C=C2)C=C1,9549223
5989,DB06885,3-[({(1E)-[2-(trifluoromethyl)phenyl]methylidene}amino)oxy]propanoic acid,small molecule,experimental,,OC(=O)CCO\N=C\C1=C(C=CC=C1)C(F)(F)F,10400412
5990,DB06886,N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL,small molecule,experimental,,[H][C@](C)(O)[C@]([H])(CC1=CC=CC=C1)NC(=O)[C@]1([H])CCCN1C(=O)[C@]([H])(C)NC(=O)OCC1=CC=CC=C1,6323185
5991,DB06887,"[(3S)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",small molecule,experimental,,CNC(=O)[C@@H]1CC2=CC=C(NS(O)(=O)=O)C=C2CN1C(=O)OC(C)(C)C,5327152
5992,DB06888,"(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE",small molecule,experimental,,[H][C@]12CN(CCN3NC4=C(C=CC=C4C3=O)C3=NC4=C(NC3=O)C=CC=C4O1)[C@]([H])(C)C2,16046126
5993,DB06889,"3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one",small molecule,experimental,,O=C1N(CC2=NN=NN2)C=NC2=C1C1=C(CCCC1)S2,6458152
5994,DB06890,(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE,small molecule,experimental,,[H][C@](CC)(C(=O)NC1=CC=NC=C1)C1=CC=CC=C1,670006
5995,DB06891,"5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE",small molecule,experimental,,NC1=C(F)C=C(C=C1Cl)S(=O)(=O)NC1=NN=C(S1)S(N)(=O)=O,11069133
5996,DB06892,"(5S)-4,5-difluoro-6-[(2-fluoro-4-iodophenyl)imino]-N-(2-hydroxyethoxy)cyclohexa-1,3-diene-1-carboxamide",small molecule,experimental,,[H][C@@]1(F)C(F)=CC=C(C(=O)NOCCO)\C1=N\C1=C(F)C=C(I)C=C1,46937033
5997,DB06893,Decylsulfonic acid,small molecule,experimental,,CCCCCCCCCCS(O)(=O)=O,49957
5998,DB06894,1-Dodecanol,small molecule,experimental,Alcohols|Fatty Alcohols|Lipids,CCCCCCCCCCCCO,8193
5999,DB06896,"1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide",small molecule,experimental,,FC1=CC=C(C=C1)N1C=CC=C(C(=O)NC2=CC=C(OC3=CC=NC4=C3C=CN4)C(F)=C2)C1=O,21081761
6000,DB06897,"3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol",small molecule,experimental,,[H][C@@](C)(NC1=CC2=C(ON=C2C2=CC(Cl)=CC(CCCO)=C2)C=N1)C1=CC=CC=C1,24941248
6001,DB06898,"4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",small molecule,experimental,,CN1C(N)=NC2=C1C=C(C=N2)C1=CC=C(O)C=C1,15897928
6002,DB06899,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE",small molecule,experimental,,CCC1=NC(N)=NC(N)=C1C1=CC=C2SC(C)(C)C(=O)N(CCNC(C)=O)C2=C1,6914625
6003,DB06900,1-[4-(hydroxymethyl)phenyl]guanidine,small molecule,experimental,,NC(=N)NC1=CC=C(CO)C=C1,17975425
6004,DB06901,2-(2-HYDROXY-CYCLOPENTYL)-PENT-4-ENAL,small molecule,experimental,,[H][C@](CC=C)(C=O)[C@@]1([H])CCC[C@]1([H])O,5287452
6005,DB06902,p-Cumylphenol,small molecule,experimental,Benzene Derivatives,CC(C)(C1=CC=CC=C1)C1=CC=C(O)C=C1,11742
6006,DB06903,"(1S,3aS,5aR,8aS)-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylic acid",small molecule,experimental,,[H][C@]1(C)CC[C@]2([H])C(=C[C@@]3([H])CC(C)(C)C[C@@]123)C(O)=O,46937034
6007,DB06904,"(5S,6S)-6-[(R)ACETOXYETH-2-YL]-PENEM-3-CARBOXYLATEPROPANE",small molecule,experimental,,[H][C@](C)(OC(C)=O)[C@@]([H])(C=O)[C@@]1([H])NC(=CS1)C(=O)OCC=C,131704302
6008,DB06905,"(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid",small molecule,experimental,,[H][C@](C)(\C=C(/C)\C=C\[C@]([H])(N)[C@]([H])(C)C(O)=O)[C@]([H])(CC1=CC=CC=C1)OC,14205264
6009,DB06906,ethyl 2-amino-4-hydroxypyrimidine-5-carboxylate,small molecule,experimental,,CCOC(=O)C1=CN=C(N)N=C1O,84894
6010,DB06907,"2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID",small molecule,experimental,,OC(=O)C1=CC2=C(C=C1)N=C(O2)C1=C(Cl)C=CC=C1Cl,5327160
6011,DB06908,"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",small molecule,experimental,,[H][C@@](CC1=CC2=C(C=C1)N(CC1=C(C)OC(=N1)C1=C(Cl)C=CC=C1)C=C2)(OCC)C(O)=O,9549225
6012,DB06909,"1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide",small molecule,experimental,,CCN1N=CC2=C1N=CC(C(=O)NCC1=CC=CC=C1)=C2NC1CCOCC1,9821178
6013,DB06910,"[4-R-(4-ALPHA,6-BETA,7-BETA]-HEXAHYDRO-5,6-DI(HYDROXY)-1,3-DI(ALLYL)-4,7-BISPHENYLMETHYL)-2H-1,3-DIAZEPINONE",small molecule,experimental,,[H][C@]1(CC2=CC=CC=C2)N(CC=C)C(=O)N(CC=C)[C@]([H])(CC2=CC=CC=C2)[C@]([H])(O)[C@@]1([H])O,446158
6014,DB06911,D-leucyl-N-(3-chlorobenzyl)-L-prolinamide,small molecule,experimental,,[H][C@@](N)(CC(C)C)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC(Cl)=CC=C1,25113127
6015,DB06912,"UNDECA-3,7-DIENE-1,3,7,11-TETRACARBALDEHYDE",small molecule,experimental,,O=CCCCC=C(CCC=C(CCC=O)C=O)C=O,21363450
6016,DB06913,"(3R)-3-[3,5-Bis(trifluoromethyl)anilino]-2-cyano-3-sulfanylpropanamide",small molecule,experimental,,[H]S[C@@H](N([H])C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C(C#N)C(=O)N([H])[H],131704303
6017,DB06914,"1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE",small molecule,experimental,,ClC1=CC=C(CCC2(CN3C=CN=C3)OCCO2)C=C1,11500273
6018,DB06915,"naphthalene-1,2,4,5,7-pentol",small molecule,experimental,,OC1=CC(O)=C2C(O)=CC(O)=C(O)C2=C1,448669
6019,DB06916,"N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE",small molecule,experimental,,[H][C@@]1(CCCN1C1=NC(=NC(C)=C1)N1C=CN=C1)C(=O)NCCC1=CC2=C(OCO2)C=C1,16115747
6020,DB06917,(4-fluorophenyl)(pyridin-4-yl)methanone,small molecule,experimental,,FC1=CC=C(C=C1)C(=O)C1=CC=NC=C1,7023019
6021,DB06918,2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE,small molecule,experimental,,CC1=CC=CC=C1C1=CC2=C(N1)C=C(C=C2)C(N)=N,9547940
6022,DB06919,D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide,small molecule,experimental,,[H][C@@](N)(CC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC(Cl)=CC=C1,25011732
6023,DB06920,Eribaxaban,small molecule,experimental,,[H][C@@]1(CN(C(=O)NC2=CC=C(Cl)C=C2)[C@]([H])(C1)C(=O)NC1=CC=C(C=C1F)N1C=CC=CC1=O)OC,11634458
6024,DB06921,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID,small molecule,experimental,,[H][C@@](C[P@](O)(=O)[C@@]([H])(NS(=O)(=O)C1=CC=CC=C1)C(C)C)(C(O)=O)C1=CC(CN)=CC=C1,23653508
6025,DB06922,"2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",small molecule,experimental,,[H][C@](CC1=CC=CC2=CC=CC=C12)(N1C(=O)C2=CC=C(C=C2C1=O)C(O)=O)C(O)=O,16752640
6026,DB06923,2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,small molecule,experimental,,CC1=CC=CC(=C1)C1=CC2=C(N1)C=CC(=C2)C(N)=N,9547939
6027,DB06924,(2R)-2-benzyl-3-nitropropanoic acid,small molecule,experimental,,[H][C@@](CC1=CC=CC=C1)(C[N+]([O-])=O)C(O)=O,24768537
6028,DB06925,3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE,small molecule,experimental,,CC1=CC=C(C=C1C1=CC=C2N=C(N)N=CC2=C1)C(=O)NC1=CC=CC(=C1)C(F)(F)F,15991573
6029,DB06926,"(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid",small molecule,experimental,,[H][C@](O)(CCCCC)\C=C\C=C/CCCCCCCC(O)=O,6443013
6030,DB06927,[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,small molecule,experimental,,OC1=CC=C(C=C1)C1=CC2=C(O1)C(CC#N)=CC(O)=C2,656953
6031,DB06928,(2S)-2-{[HYDROXY(4-IODOBENZYL)PHOSPHORYL]METHYL}PENTANEDIOIC ACID,small molecule,experimental,,[H][C@@](CCC(O)=O)(C[P@](O)(=O)CC1=CC=C(I)C=C1)C(O)=O,6102781
6032,DB06929,1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,small molecule,experimental,,[H][C@]1(CCCN1C(=O)CCC)C(=O)NCC1=CC=C(C=C1)C(N)=N,25113616
6033,DB06930,"N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide",small molecule,experimental,,NC(=N)NC(=O)CN1C(=CC=C1C1=CC=CC=C1)C1=CC=CC=C1,11290116
6034,DB06931,"(1-HYDROXYNONANE-1,1-DIYL)BIS(PHOSPHONIC ACID)",small molecule,experimental,,CCCCCCCCC(O)(P(O)(O)=O)P(O)(O)=O,5276507
6035,DB06932,"10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine",small molecule,experimental,,COC1=CC2=NC=C3C(N)=NC4=C(C)C(N)=CC=C4C3=C2C=C1OC,17754396
6036,DB06933,N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide,small molecule,experimental,,CC(C)(C)NS(=O)(=O)C1=CC=C(C=C1)C1=CN=C2C=CC=C(NC3=CC=CC=N3)C2=C1,16750106
6037,DB06934,(1R)-3-chloro-1-phenylpropan-1-ol,small molecule,experimental,,[H][C@@](O)(CCCl)C1=CC=CC=C1,642409
6038,DB06935,"2',6'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID",small molecule,experimental,,OC(=O)C1=CC=C(C=C1)C1=C(F)C=CC=C1F,5327159
6039,DB06936,N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide,small molecule,experimental,,[H][C@]1(CCCN1C(=O)CCC(C)C)C(=O)NCC1=CC=C(C=C1)C(N)=N,25113617
6040,DB06937,"4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL",small molecule,experimental,,OC1=CC2=C(C=C1)C(=NO2)C1=C(O)C=C(O)C=C1,5326826
6041,DB06938,4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide,small molecule,experimental,,CNC(=O)C1=NC=CC(OC2=CC3=C(C=C2)N=C(NC2=CC(=C(Cl)C=C2)C(F)(F)F)N3)=C1,11167118
6042,DB06939,"N-(TRANS-4-{(1S,2S)-2-AMINO-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-1-METHYL-3-OXOPROPYL}CYCLOHEXYL)-N-METHYLACETAMIDE",small molecule,experimental,,[H][C@@](N)(C(=O)N1CC[C@]([H])(F)C1)[C@@]([H])(C)[C@@]1([H])CC[C@@]([H])(CC1)N(C)C(C)=O,16122596
6043,DB06940,"N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",small molecule,experimental,,CCNC(=O)C1=CN2N=CN=C(NC3=CC(=CC=C3C)C(=O)NOC)C2=C1C,10134493
6044,DB06941,(Z)-2-[2-(4-methylpiperazin-1-yl)benzyl]diazenecarbothioamide,small molecule,experimental,,CN1CCN(CC1)C1=C(C\N=N/C(N)=S)C=CC=C1,42608445
6045,DB06942,N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide,small molecule,experimental,,[H][C@]1(CCCN1C(=O)CCC1=CC=CC=C1)C(=O)NCC1=CC=C(C=C1)C(N)=N,25113615
6046,DB06943,(3S)-1-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}pyrrolidine-3-thiol,small molecule,experimental,,[H][C@]1(S)CCN(C1)S(=O)(=O)C1=CC=C(OCC#CC)C=C1,9861547
6047,DB06944,N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,small molecule,experimental,,O=C(CC1=CC2=C(C=CC=C2)C=C1)NC1=CC(=NN1)C1CC1,449087
6048,DB06945,N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide,small molecule,experimental,,ONC(=O)C1(CCOCC1)S(=O)(=O)C1=CC=C(OC2=CC=C(C=C2)C(F)(F)F)C=C1,9933197
6049,DB06946,"(2S,3S)-3-(4-fluorophenyl)-2,3-dihydroxypropanoic acid",small molecule,experimental,,[H][C@@](O)(C(O)=O)[C@@]([H])(O)C1=CC=C(F)C=C1,23644579
6050,DB06947,1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide,small molecule,experimental,,[H][C@@](N)(CC)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC=C(C=C1)C(N)=N,25113128
6051,DB06948,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,small molecule,experimental,,C(OC1=C2NC=NC2=NC(NC2=CC=CC=C2)=N1)C1CCCCC1,1540
6052,DB06949,"N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]naphthalene-2-carbohydrazide",small molecule,experimental,,OC1=C(Br)C=C(\C=N\NC(=O)C2=CC=C3C=CC=CC3=C2)C(O)=C1Br,46937037
6053,DB06950,"4-chloro-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide",small molecule,experimental,,OC1=C(Br)C=C(\C=N\NC(=O)C2=CC=C(Cl)C=C2)C(O)=C1Br,46937038
6054,DB06951,(3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid,small molecule,experimental,,[H][C@](CC)(C(O)=O)[C@]([H])(NS(=O)(=O)C1=CC=C(C)C=C1)C(O)=O,444650
6055,DB06952,(2S)-2-HYDROXY-2H-CHROMENE-2-CARBOXYLIC ACID,small molecule,experimental,,OC(=O)[C@@]1(O)OC2=CC=CC=C2C=C1,16122570
6056,DB06953,2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE,small molecule,experimental,,[H][C@](OCC1=NC(Cl)=C(C=C1C1=CC(Cl)=CC=C1)C#N)(C1=CN=CN1C)C1=CC=C(C=C1)C#N,5287467
6057,DB06954,"2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate",small molecule,experimental,,NS(=O)(=O)OC1=CC=C2C=C(CC3CCCCCC3)S(=O)(=O)C2=C1,11245700
6058,DB06955,"3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid",small molecule,experimental,,OC(=O)C1=C(C2=CNC3=C(Cl)C=CC=C23)C(=C(N1)C(O)=O)C1=CNC2=C(Cl)C=CC=C12,25246329
6059,DB06956,"N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE",small molecule,experimental,,CC(=O)C1=CC=C(NC(=O)C2=C(NN=C2)C2=CC(Cl)=C(O)C=C2O)C=C1,5327103
6060,DB06957,"4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL",small molecule,experimental,,CS(=O)(=O)C1=CC=C(CN2CCN(CC2)C2=C(NN=C2)C2=CC(Cl)=C(O)C=C2O)C=C1,10095904
6061,DB06958,"5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE",small molecule,experimental,,CCNC(=O)C1=NNC(=C1N1CCNCC1)C1=CC(Cl)=C(O)C=C1O,6102788
6062,DB06959,(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine,small molecule,experimental,,[H]N([H])[C@H](COC1=CN=CC(=C1)C1=CC2=C(C=C1)C=NC=C2)CC1C=NC2=CC=CC=C12,11840906
6063,DB06960,"N-[(1R,2R,3E)-2-hydroxy-1-(hydroxymethyl)heptadec-3-en-1-yl]acetamide",small molecule,experimental,,[H][C@@](O)(\C=C\CCCCCCCCCCCCC)[C@@]([H])(CO)NC(C)=O,12302745
6064,DB06961,"5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide",small molecule,experimental,,CCNC(=O)C1=NOC(=C1C1=CC=C(CN2CCOCC2)C=C1)C1=C(O)C=C(O)C(Cl)=C1,10456828
6065,DB06962,JNJ-27390467,small molecule,experimental,,NCC1=CC=C2OCC3(CCN(CC3)C(=O)C3=CC=C(O3)C#CC3=CC=CC=C3)C2=C1,24180717
6066,DB06963,"3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide",small molecule,experimental,,[H][C@@](C)(NC1=CC2=C(C=N1)C(C)=NN2C1=CC=CC(CCC(N)=O)=C1)C1=CC=CC=C1,24941249
6067,DB06964,"5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE",small molecule,experimental,,CCNC(=O)C1=NOC(=C1C1=CC=C(OC)C=C1)C1=C(O)C=C(O)C(Cl)=C1,16058668
6068,DB06965,Hexylphosphonic acid (R)-2-methyl-3-phenylpropyl ester,small molecule,experimental,,CCCCCCP(O)(=O)OC[C@H](C)CC1=CC=CC=C1,4369425
6069,DB06966,Hexylphosphonic acid (S)-2-methyl-3-phenylpropyl ester,small molecule,experimental,,CCCCCCP(O)(=O)OC[C@@H](C)CC1=CC=CC=C1,4369426
6070,DB06967,"6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE",small molecule,experimental,,CCC1=NC(N)=NC(N)=C1C1=CC2=C(C=C1)C1=CC=CC=C1N2CCCOC,6914626
6071,DB06968,"1,1'-HEXANE-1,6-DIYLBIS(1H-IMIDAZOLE)",small molecule,experimental,,C(CCCN1C=CN=C1)CCN1C=CN=C1,16122577
6072,DB06969,"2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide",small molecule,experimental,,CCNC(=O)C1=CC2=C(N=C(N)N=C2S1)C1=C(Cl)C=C(Cl)C(OCCN2CCCC2)=C1,25210273
6073,DB06970,"2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE",small molecule,experimental,,CCN(CC)S(=O)(=O)C1=CC=C(Cl)C(=C1)C(=O)NC1=C(C#N)C2=C(CCC2)S1,1117937
6074,DB06971,"N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA",small molecule,experimental,,CN(CCOC1=CC=C(C=C1)C1=CC=C(C=C1)C#N)C(=O)NO,5326979
6075,DB06972,"7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile",small molecule,experimental,,ClC1=CC(=CC(Cl)=C1)C1=C(C#N)[C@@]2(CC3=CC=C(C=C3)C#N)CCCN2C1=O,16040268
6076,DB06973,Bisphenol A,small molecule,experimental,"Air Pollutants|Air Pollutants, Occupational|Antioxidants|Benzene Derivatives|Benzopyrans|Compounds used in a research, industrial, or household setting|Environmental Pollutants|Estrogens|Estrogens, Non-Steroidal|Free Radical Scavengers|Heterocyclic Compounds, Fused-Ring|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Protective Agents|Pyrans|Toxic Actions",CC(C)(C1=CC=C(O)C=C1)C1=CC=C(O)C=C1,6623
6077,DB06974,"5-hydroxy-4-(7-methoxy-1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-2-(3-methylbutyl)-6-phenylpyridazin-3(2H)-one",small molecule,experimental,,COC1=CC=C2N=C(NS(=O)(=O)C2=C1)C1=C(O)C(=NN(CCC(C)C)C1=O)C1=CC=CC=C1,44143696
6078,DB06976,"1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA",small molecule,experimental,,[H][C@]1(CCCN1)C1=CC(NC(=O)NC2=CC=CC3=C2[C@]2([H])CCCN2C3=O)=NN1,445841
6079,DB06977,(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine,small molecule,experimental,,[H][C@@](N)(COC1=CN=CC(=C1)C1=CC2=CNN=C2C=C1)CC1=C2C=CC=CC2([H])N=C1,49866474
6080,DB06978,"N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]-4-methoxybenzohydrazide",small molecule,experimental,,COC1=CC=C(C=C1)C(=O)N\N=C\C1=CC(Br)=C(O)C(Br)=C1O,16475583
6081,DB06979,"5-(dodecylthio)-1H-1,2,3-triazole-4-carboxylic acid",small molecule,experimental,,CCCCCCCCCCCCSC1=C(N=NN1)C(O)=O,24180714
6082,DB06980,(2S)-2-(1H-indol-3-yl)hexanoic acid,small molecule,experimental,,[H][C@@](CCCC)(C(O)=O)C1=CNC2=C1C=CC=C2,24768549
6083,DB06981,(2S)-2-(1H-indol-3-yl)pentanoic acid,small molecule,experimental,,[H][C@@](CCC)(C(O)=O)C1=CNC2=CC=CC=C12,24768551
6084,DB06982,(2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid,small molecule,experimental,,[H][C@@](CCCCCCNC(=O)OC(C)(C)C)(C(O)=O)C1=CNC2=C1C=CC=C2,24768548
6085,DB06983,"(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol",small molecule,experimental,,OCC1=C2N=C(C=C(NCC3=CN=CC=C3)N2N=C1)C1=CC=CC=C1,21066379
6086,DB06984,"(1R,2R,3R,4S,5R)-4-(BENZYLAMINO)-5-(METHYLTHIO)CYCLOPENTANE-1,2,3-TRIOL",small molecule,experimental,,[H][C@@]1(O)[C@]([H])(O)[C@]([H])(NCC2=CC=CC=C2)[C@@]([H])(SC)[C@]1([H])O,6914612
6087,DB06985,2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid,small molecule,experimental,,OC(=O)C1=C(NC(=O)N2CCC(CC2)C2=C(C=CC=C2)C(F)(F)F)C=CC=C1,25138295
6088,DB06986,"2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",small molecule,experimental,,[H][C@]1(CC2=C(C=CC=C2)[C@@]1([H])O)NC(=O)C1=CC2=C(N1)SC(Cl)=C2,15991546
6089,DB06987,(R)-Atenolol,small molecule,experimental,,CC(C)NC[C@@H](O)COC1=CC=C(CC(N)=O)C=C1,180559
6090,DB06988,2-HYDROXY-5-{[(1E)-2-PHENYLETHYLIDENE]AMINO}-L-TYROSINE,small molecule,experimental,,[H][C@](N)(CC1=CC(\N=C\CC2=CC=CC=C2)=C(O)C=C1O)C(O)=O,46937041
6091,DB06989,{4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID,small molecule,experimental,,COC(=O)C(CC1=CC=CC=C1)(CC1=CC=C(NS(O)(=O)=O)C=C1)C(=O)OC,6914659
6092,DB06990,"4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID",small molecule,experimental,,OC(=O)C1=CC=C(\C=N\OCCO\N=C\C2=CC(=O)NC(=O)N2)C=C1,11987861
6093,DB06991,"N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide",small molecule,experimental,,[H][C@@](C)(CC)NC1=NC=C(S1)C(=O)NC1=C(C)C=CC(=C1)C(=O)NC,11427975
6094,DB06992,"(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone",small molecule,experimental,,CC1=CC=C(C=C1F)C1=NC(=CC=C1)C(=O)N1CCCC(C)(C)C1,24808495
6095,DB06993,"(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine",small molecule,experimental,,[H][C@@](N)(C(=O)N1CC[C@]([H])(F)C1)[C@]([H])(CC1CC1)C1([H])N[C@]([H])(NO1)C1=C(F)C=C(C=C1)S(C)(=O)=O,60206636
6096,DB06994,"(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine",small molecule,experimental,,[H][C@@](N)(C(F)=C1CCCC1)[C@]([H])(CC1CC1)C1=NC(=NO1)C1=CC=C(C=C1Cl)S(C)(=O)=O,24768547
6097,DB06995,N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide,small molecule,experimental,,NC1=NC=CC(OC2=C(F)C=C(NC(=O)NC(=O)CC3=CC=C(F)C=C3)C=C2)=C1,17748441
6098,DB06996,D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,small molecule,experimental,,[H][C@@](N)(CC(C)C)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC=C(C=C1)C(N)=N,25220914
6099,DB06997,"2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide",small molecule,experimental,,FC1=CC=C(CC(=O)NC(=O)NC2=CC(F)=C(OC3=CC=NC4=C3C=CN4)C=C2)C=C1,11560856
6100,DB06998,"[(5R)-5-(2,3-dibromo-5-ethoxy-4-hydroxybenzyl)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid",small molecule,experimental,,[H][C@]1(CC2=C(Br)C(Br)=C(O)C(OCC)=C2)SC(=S)N(CC(O)=O)C1=O,24860533
6101,DB06999,PLX-4720,small molecule,experimental,"Amides|Heterocyclic Compounds, Fused-Ring|Sulfones|Sulfur Compounds",CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,24180719
6102,DB07000,"N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide",small molecule,experimental,,CCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CN=CC=C2)=C1F,24180720
6103,DB07001,"(3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f][1,4]oxazepin-5(2H)-imine",small molecule,experimental,,CCC[C@H]1COC2=C(SC=C2)C(N)=N1,24941263
6104,DB07002,4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile,small molecule,experimental,,COC1=CC=NC(NC2CCN(CC2)C(=O)C2=CC=C(C=C2)C#N)=C1,9797857
6105,DB07003,"(2S)-2-methyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine",small molecule,experimental,,[H][C@]1(C)CN=C(N)C2=C(O1)C=CS2,24894153
6106,DB07004,2-[(5-hex-1-yn-1-ylfuran-2-yl)carbonyl]-N-methylhydrazinecarbothioamide,small molecule,experimental,,CCCCC#CC1=CC=C(O1)C(=O)NNC(=S)NC,2823014
6107,DB07005,D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide,small molecule,experimental,,[H][C@@](N)(CC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC=C(C=C1)C(N)=[NH2+],46937043
6108,DB07006,"9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",small molecule,experimental,,COC1=CC=CC=C1C1=CC2=C(C3=C(C=CC(O)=C3)N2CCCO)C2=C1C(=O)NC2=O,10364585
6109,DB07007,"(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine",small molecule,experimental,,[H][C@@]1(COC2=CC=C3CCNCC3=C2)COC2=C(SC=C2)C(N)=N1,24894155
6110,DB07008,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE",small molecule,experimental,,C1OC2=C(O1)C=C(OC1=CC=NC(OC3=CC=C(C=C3)N3C=CN=C3)=N1)C=C2,9969613
6111,DB07009,"2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL",small molecule,experimental,,OC1=CC2=C(C=C1)N=C(O2)C1=C2C=CC=C(O)C2=CC=C1,5326827
6112,DB07010,N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE,small molecule,experimental,,ClC1=CC(=CC=C1)C1=CNN=C1C1=CNC(=C1)C(=O)NCC1=CC=CC=C1,10134160
6113,DB07011,"(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE",small molecule,experimental,,[H][C@@]1(CCCN(CC2=CC3=C(OCO3)C=C2)C1)OC1=CC=C(C=C1)N1C=CN=C1,11740318
6114,DB07012,"6-AMINO-3,7-DIHYDRO-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",small molecule,experimental,,NC1=NC2=CC3=C(C=C2C(=O)N1)N=CN3,11287125
6115,DB07013,TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE,small molecule,experimental,,CC#CCNC1=CC=C(C=C1)S(=O)(=O)CC1(CCN(CC1)C(=O)OC(C)(C)C)C(=O)NO,24768528
6116,DB07014,"2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole",small molecule,experimental,,COC1=C(F)C=C(CSC2=NN=C(O2)C2=CC3=C(OCO3)C=C2)C=C1,2079916
6117,DB07015,"(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine",small molecule,experimental,,[H][C@]1(N)CN(C[C@@]1([H])C(=O)N1CCCC1)C(=O)C1=CN=C2C=CC=CC2=N1,24752844
6118,DB07016,"(3R)-8-(dioxidosulfanyl)-3-methyl-1,2,3,4-tetrahydroquinoline",small molecule,experimental,,[H][C@]1(C)CNC2=C(C1)C=CC=C2S(=O)=O,52942975
6119,DB07017,"(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one",small molecule,experimental,,C[C@H](NC1=NC(=O)[C@@](C)(S1)C(C)(C)O)C1=CC=C(F)C=C1,25023710
6120,DB07018,5-ETHYL-3-[(2-METHOXYETHYL)METHYLAMINO]-6-METHYL-4-(3-METHYLBENZYL)PYRIDIN-2(1H)-ONE,small molecule,experimental,,CCC1=C(C)NC(=O)C(N(C)CCOC)=C1CC1=CC=CC(C)=C1,486953
6121,DB07019,"N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1~7,11~]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE",small molecule,experimental,,[H][C@@]1(C)CCC2=CC(C[C@@](C)(N)C(=O)OCC3=CC(CC1)=NC(=C3)N(C)S(C)(=O)=O)=CC=C2,24768527
6122,DB07020,"N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide",small molecule,experimental,,O=C(NC1=CC(=CC=C1)C1=NNC2=CC=C(C=C12)C1=NNC=N1)C1=CC=CO1,22479942
6123,DB07021,"(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine",small molecule,experimental,,[H][C@]1(N)CN2C(C[C@]1([H])C1=CC(F)=C(F)C=C1F)=NC1=C2C=CN=C1,15953860
6124,DB07022,3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate,small molecule,experimental,,NC(=N)C1=CC2=C(NC(=O)C3=CC=CC(=C3)S(=O)(=O)OCCCO)C=CC=C2C=C1,11304895
6125,DB07023,"(1R)-2-[(Diaminomethylene)amino]-1-{4-[(4R)-4-(hydroxymethyl)-1,3,2-dioxaborolan-2-yl]phenyl}ethyl nicotinate",small molecule,experimental,,[H]N([H])C(=NC[C@H](OC(=O)C1=CN=CC=C1)C1=CC=C(C=C1)B1OC[C@@H](CO)O1)N([H])[H],6857688
6126,DB07024,"2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE",small molecule,experimental,,CC1=CC(N2CCCS2(=O)=O)=C2OC(=C(O)C(=O)C2=C1)C1=CC=C(O)C(O)=C1,15942652
6127,DB07025,3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,small molecule,experimental,,NCC1CCN(CC2=CC3=C(NC(=C3)C3=CC4=CC=CC=C4NC3=O)C=C2)CC1,10156987
6128,DB07026,"(1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE",small molecule,experimental,,[H][C@]12CN(C[C@]([H])(O1)[C@@]([H])(O2)C(=O)NCC1=CC=C(C=C1)C1=CC=CC=C1)C(=O)NO,11987860
6129,DB07027,D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide,small molecule,experimental,,[H][C@@](N)(CC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC=CC(F)=C1,25011733
6130,DB07028,(2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID,small molecule,experimental,,OC(=O)COC1=CC(Cl)=CC=C1C(=O)NCC1=C(F)C=C(Br)C=C1,16058629
6131,DB07029,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE",small molecule,experimental,,CC1=NC(OC2=CC=C(C=C2)N2C=CN=C2)=NC(OC2=CC3=C(OCO3)C=C2)=C1,10157080
6132,DB07030,(5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID,small molecule,experimental,,OC(=O)COC1=CC(Cl)=CC=C1C(=O)NCC1=CC(=CC=C1)[N+]([O-])=O,16058630
6133,DB07031,"3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid",small molecule,experimental,"Alkenes|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Terpenes",CC1(C)CCC(C)(C)C2=C1C=CC(=C2)[C@@H](O)C(=O)NC1=C(F)C=C(C=C1)C(O)=O,445455
6134,DB07032,2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL,small molecule,experimental,,OC1=CC=C(C=C1)C1=CC2=C(O1)C=CC(O)=C2,656936
6135,DB07033,5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE,small molecule,experimental,,[H][C@](C)(C1=CC=CN1)C1=C2C=C(O)C=CC2=NC1=O,46937045
6136,DB07034,"2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID",small molecule,experimental,,ON=C1C2=CC(OCC(O)=O)=CC=C2C2=C1C=C(OCC(O)=O)C=C2,3506204
6137,DB07035,"(2E)-3-{3-[(5-ETHYL-3-IODO-6-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-4-YL)OXY]PHENYL}ACRYLONITRILE",small molecule,experimental,,CCC1=C(C)NC(=O)C(I)=C1OC1=CC=CC(\C=C\C#N)=C1,5459348
6138,DB07036,"(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol",small molecule,experimental,,[H][C@@]12CC(F)(F)C[C@]1([H])[C@@]([H])(OC1=C2C=C(O)C=C1COC)C1=CC=C(O)C=C1,16758226
6139,DB07037,(2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL,small molecule,experimental,,[H][C@](O)(CN)CNC1=C2N=CC=CC2=C(C=C1)[N+]([O-])=O,6540273
6140,DB07038,2-(cyclohexylamino)benzoic acid,small molecule,experimental,,OC(=O)C1=CC=CC=C1NC1CCCCC1,19826721
6141,DB07039,(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide,small molecule,experimental,,C[C@](O)(COC1=CC=C(C=C1)C#N)C(=O)NC1=CC=C(C#N)C(I)=C1,24892823
6142,DB07040,"2-amino-7-fluoro-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxamide",small molecule,experimental,,NC(=O)C1=C(N)N=C2OC3=C(C=C(F)C=C3)C(=O)C2=C1,10038928
6143,DB07041,"N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide",small molecule,experimental,,CC(C)(CNC(=O)C1=CC=C(OC2=CC=CC=C2)C=C1)C1=NC2=NC(N)=NC(N)=C2C=C1,25023705
6144,DB07042,"7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide",small molecule,experimental,,CC(C)(C)C1=NC2=NC(N)=C(C=C2C(NCCC2=CNC=N2)=N1)C(N)=O,25023706
6145,DB07043,"7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide",small molecule,experimental,,CC(C)(C)C1=NC(N2CCN(CC2)C2=NC=CC=N2)=C2C=C(C(N)=O)C(N)=NC2=N1,25023707
6146,DB07044,"3-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide",small molecule,experimental,,OC1=C(Br)C=C(\C=N\NC(=O)C2=CC=CC(Br)=C2)C(O)=C1Br,16478818
6147,DB07045,"(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",small molecule,experimental,,[H][C@]1(CO)O[C@@]([H])(N2C(NCC3=CC=C(Cl)C(Cl)=C3)=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,25195347
6148,DB07046,"2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide",small molecule,experimental,,[H][C@@](O)(CO)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl,25163987
6149,DB07047,"2',4'-DICHLORO-4-HYDROXY-1,1'-BIPHENYL-3-CARBOXYLIC ACID",small molecule,experimental,,OC(=O)C1=CC(=CC=C1O)C1=C(Cl)C=C(Cl)C=C1,5287495
6150,DB07048,"N-[(2R)-5-(aminosulfonyl)-2,3-dihydro-1H-inden-2-yl]-2-propylpentanamide",small molecule,experimental,,[H][C@]1(CC2=C(C1)C=C(C=C2)S(N)(=O)=O)NC(=O)C(CCC)CCC,23653514
6151,DB07049,(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine,small molecule,experimental,,[H][C@@]1(C)CN(CCN1S(=O)(=O)C1=CC=C(C=C1)C(C)(C)C)C1=CC=C(C=C1)[N+]([O-])=O,24812720
6152,DB07050,"5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide",small molecule,experimental,,NS(=O)(=O)C1=NN=C(NS(=O)(=O)C2=CC=CC=C2)S1,18794
6153,DB07051,"3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER",small molecule,experimental,,CCOC(=O)C1=C(C)N([NH+]=C1C)C1=CC=CC=C1,46937046
6154,DB07052,5'-S-ethyl-5'-thioadenosine,small molecule,experimental,,[H][C@]1(CSCC)O[C@@]([H])(N2C=NC3=C2N=CN=C3N)[C@]([H])(O)[C@]1([H])O,10041129
6155,DB07053,2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,small molecule,experimental,,CCCC1=C2ON=C(C2=CC=C1OCCCOC1=CC2=C(C=C1)N(CC(O)=O)C=C2)C(F)(F)F,9547900
6156,DB07054,(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL,small molecule,experimental,,[H][C@](O)(COC1=CC=C(NC2=NC=NC(NC3=C(F)C=CC(=C3)C(F)(F)F)=C2)C=C1)CN(C)C,448994
6157,DB07055,"2-[2-(1H-tetrazol-5-yl)ethyl]-1H-isoindole-1,3(2H)-dione",small molecule,experimental,,O=C1N(CCC2=NN=NN2)C(=O)C2=CC=CC=C12,1289593
6158,DB07056,"2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide",small molecule,experimental,,CCN(CC)C(=O)CC1=CC=CC(NS(=O)(=O)C2=C(C)C(Cl)=CC=C2)=N1,11545694
6159,DB07057,(3S)-1-(2-hydroxyphenyl)-5-oxopyrrolidine-3-carboxylic acid,small molecule,experimental,,[H][C@]1(CN(C(=O)C1)C1=C(O)C=CC=C1)C(O)=O,756618
6160,DB07058,"5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione",small molecule,experimental,,COC1=CC=C(C=C1)N1C=NC2=C1C=C(C=C2)C1=NNC(=S)O1,25181321
6161,DB07059,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE",small molecule,experimental,,CCC1=NC(N)=NC(N)=C1C1=CC2=C(OC(C)(C)C(=O)N2CCNC(C)=O)C=C1,6914627
6162,DB07060,3-(INDOL-3-YL) LACTATE,small molecule,experimental,,[H][C@](O)(CC1=CNC2=C1C=CC=C2)C(O)=O,676157
6163,DB07061,"1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL",small molecule,experimental,,[H][C@](O)(CNC1CCCCC1)CN1C2=C(CCCC2)C2=C1C=CC(C)=C2,961704
6164,DB07062,"N-{3-[4-Hydroxy-1-(3-methylbutyl)-2-oxo-1,2-dihydropyrrolo[1,2-b]pyridazin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl}methanesulfonamide",small molecule,experimental,,CC(C)CCN1N2C=CC=C2C(O)=C(C1=O)C1=NC2=C(C=C(NS(C)(=O)=O)C=C2)S(=O)(=O)N1,46937047
6165,DB07063,Lidorestat,small molecule,investigational,"Aldehyde Reductase, antagonists & inhibitors|Heterocyclic Compounds, Fused-Ring|Indoles|Sulfur Compounds",OC(=O)CN1C=C(CC2=NC3=C(F)C(F)=CC(F)=C3S2)C2=C1C=CC=C2,157839
6166,DB07064,"(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE",small molecule,experimental,,[H][C@@]1(CN(CC2=C1C=CC(C)=C2C)C(=O)N(C)C)C1=CC(O)=CC=C1,6857690
6167,DB07065,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine",small molecule,experimental,,ClC1=C(Cl)C(=CC=C1)C1=NC2=C(SC#N)C=NN2C(NCC2=CC=NC=C2)=C1,44629555
6168,DB07066,"2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",small molecule,experimental,,[H][C@]1(CC2=C(NC1=O)C=CC=C2)NC(=O)C1=CC2=C(N1)SC(Cl)=C2,15991547
6169,DB07067,"(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE",small molecule,experimental,,[H][C@@](N)(C(=O)N1CCCC1)[C@]([H])(C)C1=NC(=NO1)C1=CC=C(C=C1)S(C)(=O)=O,23645698
6170,DB07068,"(4-{4-[(TERT-BUTOXYCARBONYL)AMINO]-2,2-BIS(ETHOXYCARBONYL)BUTYL}PHENYL)SULFAMIC ACID",small molecule,experimental,,CCOC(=O)C(CCNC(=O)OC(C)(C)C)(CC1=CC=C(NS(O)(=O)=O)C=C1)C(=O)OCC,6914660
6171,DB07069,m-Hydroxyhippuric acid,small molecule,experimental,"Acids, Carbocyclic|Amides|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Keto Acids",OC(=O)CNC(=O)C1=CC(O)=CC=C1,450268
6172,DB07070,(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid,small molecule,experimental,,[H][C@](CC)(CC1=CC(CNC(=O)C2=C(F)C=C(C=C2)C(F)(F)F)=C(OC)C=C1)C(O)=O,11711595
6173,DB07071,"(R)-1-(4-(4-(Hydroxymethyl)-1,3,2-dioxaborolan-2-YL)phenethyl)guanidine",small molecule,experimental,,NC(N)=NCCC1=CC=C(C=C1)B1OC[C@@H](CO)O1,6857691
6174,DB07072,"(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE",small molecule,experimental,,[H][C@@]1(CC[C@]([H])(C2=C(F)C=C(F)C(F)=C2)[C@@]([H])(N)C1)N1CCN2C(C1)=NN=C2C(F)(F)F,11538992
6175,DB07073,"5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one",small molecule,experimental,,CC1(C)CC2=C(SC(=N2)N2CCOCC2)C(=O)C1,622262
6176,DB07074,6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER,small molecule,experimental,,COC(=O)C1=CC2=CC=C(C=C2C(NC(=O)C2=CC=CC(O)=C2C)=C1)C(N)=N,6852141
6177,DB07075,3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE,small molecule,experimental,,NCC1CCN(CC2=CC3=C(NC(=C3)C3=NNC4=C3C=CC(=C4)C#N)C=C2)CC1,16129574
6178,DB07076,6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE,small molecule,experimental,,NC(=N)C1=CC2=CC=C(C=C2C=C1)C(=O)NC1=CC=CC(OC2CCCC2)=C1,447734
6179,DB07077,"(R)-1-(4-(4-(Hydroxymethyl)-1,3,2-dioxaborolan-2-YL)phenyl)guanidine",small molecule,experimental,,NC(N)=NC1=CC=C(C=C1)B1OC[C@@H](CO)O1,6857692
6180,DB07078,"(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE",small molecule,experimental,,COC1=CC(=CC=C1O)C1=CC2=C(C=C1)\C(=C\C1=CC=CN1)C(=O)N2,10125830
6181,DB07079,3-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}propane-1-thiol,small molecule,experimental,,CC#CCOC1=CC=C(C=C1)S(=O)(=O)CCCS,23627203
6182,DB07080,TO-901317,small molecule,experimental,"Amides|Hydrocarbons, Halogenated|Sulfones|Sulfur Compounds",OC(C1=CC=C(C=C1)N(CC(F)(F)F)S(=O)(=O)C1=CC=CC=C1)(C(F)(F)F)C(F)(F)F,447912
6183,DB07081,"(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",small molecule,experimental,,[H][C@](N)(CC(=O)N1CCN2N=C(N=C2[C@@]1([H])C)C(F)(F)F)CC1=C(F)C=C(F)C(F)=C1,23661697
6184,DB07082,"1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL",small molecule,experimental,,OC(C1=CC=C(NCC(F)(F)F)C=C1)(C(F)(F)F)C(F)(F)F,447911
6185,DB07083,beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide,small molecule,experimental,,[H][C@@](N)(C(C1=CC=CC=C1)C1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(=O)NCCC,25271577
6186,DB07084,"N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide",small molecule,experimental,,CC(=O)NC1=CC=C2OCCOCCOC3=C(OCCOCCOC2=C1)C=CC=C3,3943211
6187,DB07085,2-{[N-(2-ACETYL-5-CHLORO-4-FLUOROPHENYL)GLYCYL]AMINO}BENZOIC ACID,small molecule,experimental,,CC(=O)C1=CC(F)=C(Cl)C=C1NCC(=O)NC1=CC=CC=C1C(O)=O,16221501
6188,DB07086,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",small molecule,experimental,,[H][C@@]12C[C@@](CO)(CO[C@]1([H])C1=CC=C(O)C=C1)CC=C2C,6852154
6189,DB07087,"4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",small molecule,experimental,,[H][C@]1(C)CC[C@]2(CO)CO[C@]([H])(C3=CC=C(O)C=C3)[C@@]1([H])[C@@]2([H])C,46937048
6190,DB07088,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide,small molecule,experimental,,[H][C@]1(CCCN1C(=O)COC1CCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N,24963035
6191,DB07089,N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide,small molecule,experimental,,CCCOC1=CC=C(C=C1)C1=CSC(=C1CC(=O)NC(N)=N)C1=CC=CC=C1Cl,11995761
6192,DB07090,(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,small molecule,experimental,,[H][C@]1(CN(C2CCCCC2)C(=O)C1)C(=O)NC1=C(C)C(Cl)=CC=C1,40636608
6193,DB07091,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,small molecule,experimental,,[H][C@]1(CCCN1C(=O)COC1CCCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N,24963036
6194,DB07092,"(2S,3S)-3-AMINO-4-(3,3-DIFLUOROPYRROLIDIN-1-YL)-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YLCYCLOHEXYL)BUTANAMIDE",small molecule,experimental,,[H][C@@](N)(C(=O)N1CCC(F)(F)C1)[C@@]([H])(C(=O)N(C)C)[C@@]1([H])CC[C@@]([H])(CC1)C1=CN2N=CN=C2C=C1,11554165
6195,DB07093,"{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID",small molecule,experimental,,OC(=O)CN1C=CC(=O)N(CC2=NC3=CC(Cl)=CC=C3S2)C1=O,10450624
6196,DB07094,"1-(2,2'-bithiophen-5-yl)methanamine",small molecule,experimental,,NCC1=CC=C(S1)C1=CC=CS1,2776424
6197,DB07095,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide,small molecule,experimental,,[H][C@]1(CCCN1C(=O)CCC1CCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N,24963037
6198,DB07096,"6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE",small molecule,experimental,,NC1=CC=C2C(=O)NC(=O)C3=CC=CC1=C23,1720
6199,DB07097,"4-tert-butyl-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide",small molecule,experimental,,CC(C)(C)C1=CC=C(C=C1)C(=O)N\N=C\C1=CC(Br)=C(O)C(Br)=C1O,46937049
6200,DB07098,"4-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide",small molecule,experimental,,OC1=C(Br)C=C(\C=N\NC(=O)C2=CC=C(Br)C=C2)C(O)=C1Br,46937050
6201,DB07099,N-[4-(benzyloxy)phenyl]glycinamide,small molecule,experimental,,NCC(=O)NC1=CC=C(OCC2=CC=CC=C2)C=C1,22690393
6202,DB07100,"4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL",small molecule,experimental,,OC1=CC(O)=C(Cl)C=C1C1=C(C=NN1)N1CCNCC1,9796161
6203,DB07101,PD-0325901,small molecule,investigational,"Acids, Carbocyclic|Amides|Amines|Aniline Compounds|Benzene Derivatives|Benzoates",[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,9826528
6204,DB07102,(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid,small molecule,experimental,,[H][C@](N)(CCC(=O)NC1=CC=C(OCC2=CC=CC=C2)C=C1)C(O)=O,24768560
6205,DB07103,2-(4-METHYLPHENOXY)ETHYLPHOSPHINATE,small molecule,experimental,,[H][P@]([O-])(=O)CCOC1=CC=C(C)C=C1,5287517
6206,DB07104,4-amino-N-[4-(benzyloxy)phenyl]butanamide,small molecule,experimental,,NCCCC(=O)NC1=CC=C(OCC2=CC=CC=C2)C=C1,22692237
6207,DB07105,2-[2-(4-Chloro-Phenylsulfanyl)-Acetylamino]-3-(4-Guanidino-Phenyl)-Propionamide,small molecule,experimental,,NC(N)=NC1=CC=C(CC(NC(=O)CSC2=CC=C(Cl)C=C2)C(N)=O)C=C1,11957380
6208,DB07106,SKF-91488,small molecule,experimental,"Histamine Agents|Histamine Agonists|Histamine N-Methyltransferase, antagonists & inhibitors|Neurotransmitter Agents|Sulfur Compounds|Thiourea",CN(C)CCCCSC(N)=N,5227
6209,DB07107,(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE,small molecule,experimental,,[H][C@@](N)(COC1=CN=CC(\C=C\C2=CC=NC=C2)=C1)CC1=CNC2=C1C=CC=C2,6914613
6210,DB07108,"4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID",small molecule,experimental,,OC(=O)C1=CC=C(C=C1)C1=CC=C(F)C=C1,2782689
6211,DB07109,Isoferulic acid,small molecule,experimental,"Acids, Carbocyclic",COC1=C(O)C=C(\C=C\C(O)=O)C=C1,736186
6212,DB07110,4-(4-FLUOROBENZYL)PIPERIDINE,small molecule,experimental,,FC1=CC=C(CC2CCNCC2)C=C1,3699841
6213,DB07111,"(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid",small molecule,experimental,,[H][C@](O)(CCC(O)=O)\C=C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,24875301
6214,DB07112,N-[(4-HYDROXY-8-IODOISOQUINOLIN-3-YL)CARBONYL]GLYCINE,small molecule,experimental,,OC(=O)CNC(=O)C1=C(O)C2=CC=CC(I)=C2C=N1,6914624
6215,DB07113,"(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE",small molecule,experimental,,[H][C@]1(OC2=C(C=C(C=C2)C2=C(N)N=C(N)N=C2CC)N(CCCOC)C1=O)C1=CC(F)=CC(F)=C1,20843156
6216,DB07114,4-[(METHYLSULFONYL)AMINO]BENZOIC ACID,small molecule,experimental,,CS(=O)(=O)NC1=CC=C(C=C1)C(O)=O,250653
6217,DB07115,"N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide",small molecule,experimental,,CN(CC1=CC=C(Cl)C=C1)S(=O)(=O)C1=CC=C(C=C1)S(N)(=O)=O,17414308
6218,DB07116,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE,small molecule,experimental,,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(O)=O)N1C=CC2=C(C)C=CC=C12,46937051
6219,DB07117,"5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE",small molecule,experimental,,O=C1NC(=O)C(N2CCN(CC2)C2=NC=CC=N2)(C(=O)N1)C1=CC=C(OC2=CC=CC=C2)C=C1,10072851
6220,DB07118,Hymecromone,small molecule,experimental|investigational,"Alimentary Tract and Metabolism|Benzopyrans|Bile and Liver Therapy|Bile Therapy|Compounds used in a research, industrial, or household setting|Coumarins|Heterocyclic Compounds, Fused-Ring|Indicators and Reagents|Laboratory Chemicals|Narrow Therapeutic Index Drugs|Pyrans|Umbelliferones",CC1=CC(=O)OC2=C1C=CC(O)=C2,5280567
6221,DB07119,1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,small molecule,experimental,,OC1=CC=C(C=C1)C1=CC=C2C(C=CC(O)=C2Cl)=C1,6102690
6222,DB07120,"3-Carbamimidamido-1,1-diphenylurea",small molecule,experimental,,NC(N)=NNC(=O)N(C1=CC=CC=C1)C1=CC=CC=C1,4073054
6223,DB07121,"4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE",small molecule,experimental,,[H][C@]1(N(CCSC1(C)C)S(=O)(=O)C1=CC=C(OCC#CCN)C=C1)C(=O)NO,6102708
6224,DB07122,1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine,small molecule,experimental,,NC(N)=NC1=CC=C(CC(=O)C2=CC=CC=C2)C=C1,16758228
6225,DB07123,N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE,small molecule,experimental,,CC1=CC=C(C=C1)C(=O)N1CCC(CC2=CC=CC=C2)CC1,1415427
6226,DB07124,"(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE",small molecule,experimental,,[H][C@@](N)(COC1=CN=CC(=C1)C1=NCC2=NN=CC2=C1)CC1=C2C=CCC=C2N=C1,46937052
6227,DB07125,"4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid",small molecule,experimental,,[H][C@@](CC)(CO)NC1=NN2C(C=C1)=NC=C2C1=CC=C(C=C1)C(O)=O,24180718
6228,DB07126,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,small molecule,experimental,,NS(=O)(=O)C1=CC=C(NC2=NC(OCC3CCCCC3)=C3N=CNC3=N2)C=C1,4566
6229,DB07127,"{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID",small molecule,experimental,,CC1=NC(=NO1)C(CC1=CC=CC=C1)(CC1=CC=C(NS(O)(=O)=O)C=C1)C1=NOC(C)=N1,6914661
6230,DB07128,"N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE",small molecule,experimental,,CCCCNC1=CC(C)=NC2=NC(NC3=CC(Cl)=CC=C3C)=NN12,5287523
6231,DB07129,"(2R)-1-(2,6-dimethylphenoxy)propan-2-amine",small molecule,experimental,,[H][C@](C)(N)COC1=C(C)C=CC=C1C,180621
6232,DB07130,4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID,small molecule,experimental,,OC(=O)COC1=C(SC(=C1Br)C1=CC=CC=C1)C(O)=O,9547959
6233,DB07131,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,small molecule,experimental,,[H][C@]1(CCCN1C(=O)CCC1CCCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N,25134248
6234,DB07132,1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA,small molecule,experimental,,[H][C@](C)(C1=CC=CN1)C1=C2C=C(NC(N)=O)C=CC2=NC1=O,46937053
6235,DB07133,D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide,small molecule,experimental,,[H][C@@](N)(CC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC(C)=CC=C1,25021183
6236,DB07134,"5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",small molecule,experimental,,ClC1=C(SC=C1N1CC(=O)NS1(=O)=O)C1=CC=CC=C1,16058639
6237,DB07135,"(2S,3S)-3-AMINO-4-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-5-YLCYCLOHEXYL)BUTANAMIDE",small molecule,experimental,,[H][C@@](N)(C(=O)N1CC[C@]([H])(F)C1)[C@@]([H])(C(=O)N(C)C)[C@@]1([H])CC[C@@]([H])(CC1)C1=CC=CC2=NC=NN12,11495704
6238,DB07136,BX-528,small molecule,experimental,,CC(C)[C@H](NS(=O)(=O)CCCC1=CC=CC=C1)P(O)(=O)C[C@H](C(O)=O)C1=CC=CC(CN)=C1,11705956
6239,DB07137,(2S)-N-[(3E)-5-Cyclopropyl-3H-pyrazol-3-ylidene]-2-[4-(2-oxo-1-imidazolidinyl)phenyl]propanamide,small molecule,experimental,,C[C@H](C(=O)\N=C1/C=C(N=N1)C1CC1)C1=CC=C(C=C1)N1CCNC1=O,9601217
6240,DB07138,Neflamapimod,small molecule,investigational,,FC1=CC(F)=C(SC2=NN3C=NC(=O)C(=C3C=C2)C2=C(Cl)C=CC=C2Cl)C=C1,3038525
6241,DB07139,3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid,small molecule,experimental,,OC(=O)CCC1=CC=C(S1)C1=CC(=CC=C1)[N+]([O-])=O,25210476
6242,DB07140,"5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",small molecule,experimental,,[H][C@](C)(C#CC1=C(C)N=C(N)N=C1N)C1=CC(OC)=CC(=C1)C1=CC=CC=C1,25093369
6243,DB07141,"5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",small molecule,experimental,,[H][C@](C)(C#CC1=C(C)N=C(N)N=C1N)C1=CC(OC)=CC(=C1)C1=CC=C(C)C=C1,44144378
6244,DB07142,"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",small molecule,experimental,,[H][C@](C)(C#CC1=C(C)N=C(N)N=C1N)C1=CC(OC)=CC(=C1)C1=CC(C)=CC(C)=C1,44144379
6245,DB07143,D-phenylalanyl-N-benzyl-L-prolinamide,small molecule,experimental,,[H][C@@](N)(CC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC=CC=C1,25113125
6246,DB07144,"5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",small molecule,experimental,,[H][C@](C)(C#CC1=C(N)N=C(N)N=C1C)C1=CC(OC)=CC(=C1)C1=C(C)C=CC=C1C,44144380
6247,DB07145,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,small molecule,experimental,,[H][C@](C)(N1CC[C@](C)(C1=O)C1=CC=C(OCC2=CC(C)=NC3=CC=CC=C23)C=C1)C(=O)NO,6914621
6248,DB07146,"2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE",small molecule,experimental,,C(CN1CCNCC1)NC1=CC=NC2=C1C(=C(O2)C1=CC=CC=C1)C1=CC=CC=C1,11553058
6249,DB07147,"methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate",small molecule,experimental,,[H][C@@]1(C[C@]1(CC1=CC=C(OCC2=CC(C)=NC3=C2C=CC=C3)C=C1)C(=O)OC)C(=O)NO,24800833
6250,DB07148,"(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one",small molecule,experimental,,[H][C@]1(C=CC2=C(Cl)N=C(OCC3=CC=C(F)C=C3)C(=O)N12)C(=O)N1CCCC1,46937054
6251,DB07149,"(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one",small molecule,experimental,,[H][C@]1(CCF)CNC(=O)C2=C1NC(=C2)C1=NC(N)=NC=C1,16757525
6252,DB07150,4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME,small molecule,experimental,,O\N=C\C1=C2C=CC=CC2=C(C=C1)C1=CC=C(O)C=C1,11357504
6253,DB07151,4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one,small molecule,experimental,,CC1=CC(=CC=C1O)C1=NC(=O)N=C(C1)C1=CC=CC=C1,46937055
6254,DB07152,N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide,small molecule,experimental,,CC(=O)NC1=NC(=C(N1)C1=CC=C2N=CC=NC2=C1)C1=NC(C)=C(F)C=C1,25138294
6255,DB07153,"6-methyl-5-[3-methyl-3-(3,4,5-trimethoxyphenyl)but-1-yn-1-yl]pyrimidine-2,4-diamine",small molecule,experimental,,COC1=CC(=CC(OC)=C1OC)C(C)(C)C#CC1=C(C)N=C(N)N=C1N,25187896
6256,DB07154,"(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE",small molecule,experimental,,[H][C@](N)(CC(=O)N1CCCNC(=O)[C@@]1([H])C)CC1=C(F)C=C(F)C(F)=C1,10450114
6257,DB07155,(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE,small molecule,experimental,,[H][C@]1(CN(C2CCCCC2)C(=O)C1)C(=O)NC1=CC=CC=C1,2266114
6258,DB07156,"(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione",small molecule,experimental,,BrC1=CC=C2C(=O)NC(=O)\C(=C/NC3=CC=C(CN4CCCC4)C=C3)C2=C1,24808489
6259,DB07157,"(5R,6S,8S)-8-[3-(AMINOMETHYL)PHENYL]-6-HYDROXY-5-ISOPROPYL-3-OXO-1-PHENYL-2,7-DIOXA-4-AZA-6-PHOSPHANONAN-9-OIC ACID 6-OXIDE",small molecule,experimental,,[H][C@](NC(=O)OCC1=CC=CC=C1)(C(C)C)[P@@](O)(=O)O[C@]([H])(C(O)=O)C1=CC(CN)=CC=C1,23653502
6260,DB07158,"5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE",small molecule,experimental,,CCN1C(=O)C2=C(NN=C2C)C2=C1C=CC=C2,708346
6261,DB07159,Tamatinib,small molecule,experimental|investigational,,COC1=CC(NC2=NC=C(F)C(NC3=CC=C4OC(C)(C)C(=O)NC4=N3)=N2)=CC(OC)=C1OC,11213558
6262,DB07160,"N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE",small molecule,experimental,,[H][C@](C)(CC)[C@]([H])(NC(=O)[C@@]1([H])O[C@]1([H])C(=O)OCC)C(O)=O,23647357
6263,DB07161,5-phenyl-1H-indazol-3-amine,small molecule,experimental,,NC1=NNC2=CC=C(C=C12)C1=CC=CC=C1,11492186
6264,DB07162,4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide,small molecule,experimental,,CC(C)(C)NS(=O)(=O)C1=CC=C(C=C1)C1=CC2=C(NN=C2N)C=C1,24963047
6265,DB07163,5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE,small molecule,experimental,,NCCNC1=CC(C2=CC=CN2)=C2C(=O)NC3=CC=C(F)C1=C23,447766
6266,DB07164,"N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",small molecule,experimental,,C1CC1NC1=NC(=CC=N1)C1=C2C=CC=NN2N=C1,6918710
6267,DB07165,N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE,small molecule,experimental,,[H][C@@]1(Cl)CN=C(NCCC2=NC=CC=C2)[C@]([H])(O)N1CC(=O)NCC1=CSC2=CC=C(Cl)C=C12,46937056
6268,DB07167,5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE,small molecule,experimental,,CC1CCN(CC1)C1=CC=C(CO)C=C1NC(=O)C1=CC=C(O1)C#N,9884318
6269,DB07168,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile,small molecule,experimental,,CNC1=NC(NC2=CC=C(CC#N)C=C2)=NC(NC2=NNC(=C2)C2CC2)=C1,23624249
6270,DB07169,"5R-(3,4-DICHLOROPHENYLMETHYL)-3-(2-THIOPHENESULFONYLAMINO)-4-OXO-2-THIONOTHIAZOLIDINE",small molecule,experimental,,[H][C@]1(CC2=CC=C(Cl)C(Cl)=C2)SC(=S)N(NS(=O)(=O)C2=CC=CS2)C1=O,46937057
6271,DB07170,"5'-FLUORO-2',5'-DIDEOXYADENOSINE",small molecule,experimental,,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])CF)N1C=NC2=C1N=CN=C2N,15991535
6272,DB07171,"5-(2-hydroxyethyl)nonane-1,9-diol",small molecule,experimental,,OCCCCC(CCO)CCCCO,25058136
6273,DB07172,"(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid",small molecule,experimental,,[H][C@@](O)(CCCC(O)=O)\C=C\C=C/C\C=C/C\C=C/C\C=C/CC,24875302
6274,DB07173,"7-(5-DEOXY-BETA-D-RIBOFURANOSYL)-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE",small molecule,experimental,,[H][C@]1(C)O[C@@]([H])(N2C=C(I)C3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,9842606
6275,DB07174,"6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE",small molecule,experimental,,CCC1=C(C(N)=NC(N)=N1)C1=CC=C2OC(C)(C)C(=O)N(CCCOC)C2=C1,6914629
6276,DB07175,N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide,small molecule,experimental,,CC1=CC=C(NC2=CC(=NC=N2)C2=CC=CC=C2)C=C1NS(C)(=O)=O,25138203
6277,DB07176,1-Naphthylamine-5-sulfonic acid,small molecule,experimental,"Acids|Acids, Noncarboxylic|Arylsulfonates|Arylsulfonic Acids|Naphthalenes|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",NC1=C2C=CC=C(C2=CC=C1)S(O)(=O)=O,6793
6278,DB07177,"(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID",small molecule,experimental,,[H]C(CCCC(O)=O)=C([H])CC1C(\C([H])=C(/[H])C(=O)CCCCC)C(O)CC1=O,5353288
6279,DB07178,5-PENTYL-2-PHENOXYPHENOL,small molecule,experimental,,CCCCCC1=CC(O)=C(OC2=CC=CC=C2)C=C1,5274976
6280,DB07179,"3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide",small molecule,experimental,,CC1=C(C=CC=C1)C1=NC2=C(Br)C=NN2C(NCC2=C[N+]([O-])=CC=C2)=C1,11304412
6281,DB07180,"5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide",small molecule,experimental,,[H]N(C)C(=O)C1=C(C)N([H])C(\C=C2/C(=O)N([H])C3=C2C=C(Cl)C=C3)=C1C,11840911
6282,DB07181,"4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide",small molecule,experimental,,[H][C@@](N)(CC1=CC(F)=CC=C1F)C1=CC=C(C=C1)C1=CC=CC(=C1)C(N)=O,24832041
6283,DB07182,(2S)-2-(3-Carbamimidamidophenyl)-3-[hydroxy(3-phenylpropyl)phosphoryl]propanoic acid,small molecule,experimental,,NC(N)=NC1=CC=CC(=C1)C(CP(O)(=O)CCCC1=CC=CC=C1)C(O)=O,23653500
6284,DB07183,N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide,small molecule,experimental,,O=C(NC1=CC=C(OC2=CC=CC=C2)C=C1)C1=C(NCC2=CC=NC=C2)N=CC=C1,16040289
6285,DB07184,"6-(cyclohexylsulfanyl)-1-(ethoxymethyl)-5-(1-methylethyl)pyrimidine-2,4(1H,3H)-dione",small molecule,experimental,,CCOCN1C(=O)NC(=O)C(C(C)C)=C1SC1CCCCC1,444706
6286,DB07185,2-{[(4-CHLOROPHENOXY)ACETYL]AMINO}BENZOIC ACID,small molecule,experimental,,OC(=O)C1=C(NC(=O)COC2=CC=C(Cl)C=C2)C=CC=C1,708990
6287,DB07186,"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",small molecule,experimental,,CN1CCN(CC1)C1=CC=C(C=C1)C(=O)NC1=NNC2=CN(C=C12)C(=O)CC1=CC=CS1,11963557
6288,DB07187,CP-744809,small molecule,experimental,,CC1=C(OC2=CC=C(Cl)C=C12)S(=O)(=O)C1=NNC(=O)C=C1,6420118
6289,DB07188,"(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE",small molecule,experimental,,[H][C@]1(CN(C2CCCCC2)C(=O)C1)C(=O)NC1=CC(Cl)=CC(Cl)=C1,1283969
6290,DB07189,"(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid",small molecule,experimental,,[H][C@@]1(C[C@@]11C[C@]([H])(NC1=O)C1=CC=C(OCC2=CC(=NC3=C2C=CC=C3)C2=CC=CC=C2)C=C1)C(O)=O,25049750
6291,DB07190,3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide,small molecule,experimental,,[H][C@@](N)(CC1CCCCC1)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC(Cl)=CC=C1,42615254
6292,DB07192,(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,small molecule,experimental,,[H][C@]1(CN(C2CCCCC2)C(=O)C1)C(=O)NC1=CC=CC(Br)=C1,1116191
6293,DB07193,"(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine",small molecule,experimental,,[H][C@]1(N)CN2C(C[C@]1([H])C1=C(F)C=C(F)C(F)=C1)=NC1=CC(=CC=C21)S(C)(=O)=O,11710963
6294,DB07194,"2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide",small molecule,experimental,,[H][C@](C)(CO)NC(=O)C1=C(C)N=C(S1)C1=NC(NC2=CC(C)=CC(C)=C2)=NC=C1,25113172
6295,DB07195,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",small molecule,experimental,,[H][C@]1(C)C=C(C)[C@]2([H])[C@]([H])(C)[C@@]1(CO)CO[C@]2([H])C1=CC=C(O)C=C1,6857699
6296,DB07196,N-methyl-1-(2-thiophen-2-ylphenyl)methanamine,small molecule,experimental,,CNCC1=CC=CC=C1C1=CC=CS1,7060565
6297,DB07197,4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID,small molecule,experimental,,OC(=O)COC1=C(SC(=C1Br)C1=CC=C(O)C=C1)C(O)=O,9547958
6298,DB07198,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,small molecule,experimental,,OC1=CC=C(C=C1)C1=CC2=C(O1)C(=CC(O)=C2)C#N,656952
6299,DB07199,"(2S,4S,5R)-1-(4-TERT-BUTYLBENZOYL)-2-ISOBUTYL-5-(1,3-THIAZOL-2-YL)PYRROLIDINE-2,4-DICARBOXYLIC ACID",small molecule,experimental,,[H][C@@]1(C[C@](CC(C)C)(N(C(=O)C2=CC=C(C=C2)C(C)(C)C)[C@@]1([H])C1=NC=CS1)C(O)=O)C(O)=O,15991559
6300,DB07200,"(2S,4S,5R)-2-ISOBUTYL-5-(2-THIENYL)-1-[4-(TRIFLUOROMETHYL)BENZOYL]PYRROLIDINE-2,4-DICARBOXYLIC ACID",small molecule,experimental,,[H][C@@]1(C[C@](CC(C)C)(N(C(=O)C2=CC=C(C=C2)C(F)(F)F)[C@@]1([H])C1=CC=CS1)C(O)=O)C(O)=O,5275422
6301,DB07201,(2S)-3-[(9H-fluoren-9-ylideneamino)oxy]-2-methylpropanoic acid,small molecule,experimental,,[H][C@](C)(CON=C1C2=C(C=CC=C2)C2=C1C=CC=C2)C(O)=O,46937059
6302,DB07202,6-CHLORO-3-(3-METHYLISOXAZOL-5-YL)-4-PHENYLQUINOLIN-2(1H)-ONE,small molecule,experimental,,CC1=NOC(=C1)C1=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2,11221386
6303,DB07203,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,small molecule,experimental,,ClC1=CC=CC(NC2=NC(OCC3CCCCC3)=C3NC=NC3=N2)=C1,4565
6304,DB07204,"(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE",small molecule,experimental,,[H][C@@](N)(COC1=C2C=CC(=NC2=CN=C1)C1=CC=NC=C1)CC1=CNC2=C1C=CC=C2,6914614
6305,DB07205,N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,small molecule,experimental,,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=CN=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O,10180201
6306,DB07206,6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE,small molecule,experimental,,NC1=NC(CCC2=CC=C3C=CNC3=C2)=CC=C1,11586735
6307,DB07207,2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,small molecule,experimental,,NC(=N)C1=CC=C2NC(=NC2=C1)C1=NNC(=C1O)C1=CC=CC=C1,6420178
6308,DB07208,"(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid",small molecule,experimental,,[H][C@](O)(C\C=C/CCCCC)\C=C\CC(=O)CCCCC(O)=O,46937060
6309,DB07209,"(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid",small molecule,experimental,,[H][C@@](O)(CC(=O)CCCCC(O)=O)\C=C/C\C=C/CCCCC,46937061
6310,DB07210,"3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",small molecule,experimental,,BrC1=C2N=C(C=C(NCC3=CC=NC=C3)N2N=C1)C1=CC=CC=C1,10339710
6311,DB07211,(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE,small molecule,experimental,,C\C(=C/S(=O)(=O)N[C@@]1([H])CCN([C@](C)([H])C(=O)N2CCOCC2)C1=O)C1=CC=C(Cl)S1,10095865
6312,DB07212,N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE,small molecule,experimental,,CC1=C(O)C=CC=C1C(=O)NC1=C2C=C(C=CC2=CC=C1)C(N)=N,6852140
6313,DB07213,"(5-{3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL",small molecule,experimental,,OCC1=NNN=C1C1=CC2=C(C=C1)C(=NN2)C1=CC2=C(N1)C=CC(CN1CCCCC1)=C2,16058617
6314,DB07215,GW-590735,small molecule,investigational,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids|Sulfur Compounds",CC1=C(SC(=N1)C1=CC=C(C=C1)C(F)(F)F)C(=O)NCC1=CC=C(OC(C)(C)C(O)=O)C=C1,9956726
6315,DB07216,"(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",small molecule,experimental,,[H][C@]1(C2CCN(CC2)S(C)(=O)=O)C2=C(C=C(Cl)C=C2)C(=CC2=C1N=CC=C2)N1CCNCC1,9547909
6316,DB07217,"N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide",small molecule,experimental,,FC1=CC=CC=C1C(=O)NC1=C(C#N)C2=C(CCCC2)S1,766948
6317,DB07218,"6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE",small molecule,experimental,,CN1N=C(C)C2=C1N(O)C1=C(C=C(Cl)C=C1)C2=O,6540289
6318,DB07219,"BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",small molecule,experimental,,[H][C@](C)(CC)[C@]([H])(NC(=O)[C@@]1([H])O[C@]1([H])C(=O)NCCC)C(=O)N1CCC[C@@]1([H])C(=O)OCC1=CC=CC=C1,22850133
6319,DB07220,"N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE",small molecule,experimental,,O=C(CC1=CC=C(C=C1)N1CCCCC1)NC1=NNC2=C1C=C(C=C2)N1CCCS1(=O)=O,10138993
6320,DB07221,"(2,2-DIPHOSPHONOETHYL)(DODECYL)DIMETHYLPHOSPHONIUM",small molecule,experimental,,CCCCCCCCCCCC[P+](C)(C)CC(P(O)(O)=O)P(O)(O)=O,24836815
6321,DB07222,(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,small molecule,experimental,,[H][C@]1(CN(C2CCCCC2)C(=O)C1)C(=O)NC1=C(C)C=CC(Cl)=C1,6920596
6322,DB07223,"METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",small molecule,experimental,,[H][C@](C)(CC)[C@]([H])(NC(=O)[C@@]1([H])O[C@]1([H])C(=O)NCCC)C(=O)N1CCC[C@@]1([H])C(=O)OC,6610318
6323,DB07224,"N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE",small molecule,experimental,,[H][C@@](C)(NC(=O)[C@@]([H])(NC(=O)[C@@]1([H])O[C@]1([H])C(=O)OCC)[C@@]([H])(C)CC)C(O)=O,23647358
6324,DB07225,"N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE",small molecule,experimental,,[H][C@](C)(CC)[C@]([H])(NC(=O)[C@@]([H])(NC(=O)[C@@]1([H])O[C@]1([H])C(=O)OCC)[C@@]([H])(C)CC)C(O)=O,46937062
6325,DB07226,"N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE",small molecule,experimental,,ClC1=CC=CC=C1C1=CC2=C(C3=C(N2)C=CC(NC=O)=C3)C2=C1C(=O)NC2=O,24778473
6326,DB07227,L-778123,small molecule,experimental,,ClC1=CC(=CC=C1)N1CCN(CC2=CN=CN2CC2=CC=C(C=C2)C#N)CC1=O,216454
6327,DB07228,1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA,small molecule,experimental,,[H][C@](C)(CN(C)C)OC1=CN=CC(NC(=O)NC2=C(OC)C=CC(Cl)=C2)=N1,23657800
6328,DB07229,"3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE",small molecule,experimental,,COC1=CC(=C([O-])C(=C1)C1=CC2=CC(=CC=C2N1)C(N)=[NH2+])C1=CC=CC=C1,447492
6329,DB07230,3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE,small molecule,experimental,,OC1=CC=C(C=C1)C1=C(Br)C2=C(C=C(O)C=C2)C1=O,10286462
6330,DB07231,"N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE",small molecule,experimental,,[H][C@](C)(CC)[C@]([H])(NC(=O)[C@@]1([H])O[C@]1([H])C(=O)NCC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(O)=O,23647361
6331,DB07232,Veliparib,small molecule,investigational,"Antineoplastic Agents|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Poly(ADP-ribose) Polymerase Inhibitors",C[C@@]1(CCCN1)C1=NC2=CC=CC(C(N)=O)=C2N1,11960529
6332,DB07233,N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan,small molecule,experimental,,[H][C@](CC1=CNC2=C1C=C(C)C=C2)(NS(=O)(=O)C1=CC=C(OCC#CC)C=C1)C(O)=O,42627769
6333,DB07234,"3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione",small molecule,experimental,,[H][C@](C)(NC1=C(NC2=CC=NC=C2)C(=O)C1=O)C1=CC=CC=C1,15295578
6334,DB07235,"N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE",small molecule,experimental,,[H][C@@](CN)(CC1=C(Cl)C=C(Cl)C=C1)NC(=O)C1=CC=C(S1)C1=CC=NC(NC)=N1,16043304
6335,DB07236,3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL,small molecule,experimental,,OC1=CC2=C(C=C1)C(=NO2)C1=CC2=C(C=C1)C=C(O)C=C2,4369551
6336,DB07237,{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone,small molecule,experimental,,[H][C@]1(COC2=CC=C(C=C2)C(=O)C2=CC=C(C=C2)C2=CSC=C2)CCCN1,44129624
6337,DB07238,Nesbuvir,small molecule,investigational,"Amides|Heterocyclic Compounds, Fused-Ring|Sulfones|Sulfur Compounds",CNC(=O)C1=C(OC2=CC(N(CCO)S(C)(=O)=O)=C(C=C12)C1CC1)C1=CC=C(F)C=C1,11561383
6338,DB07239,7-(aminomethyl)-6-(2-chlorophenyl)-1-methyl-1H-benzimidazole-5-carbonitrile,small molecule,experimental,,CN1C=NC2=CC(C#N)=C(C(CN)=C12)C1=C(Cl)C=CC=C1,11572962
6339,DB07240,3-[(9H-fluoren-9-ylideneamino)oxy]propanoic acid,small molecule,experimental,,OC(=O)CCON=C1C2=C(C=CC=C2)C2=C1C=CC=C2,15627868
6340,DB07241,"7-carboxy-5-hydroxy-12,13-dihydro-6H-indolo[2,3-a]pyrrolo[3,4-c]carbazole",small molecule,experimental,,OC(=O)C1=C2C(=C(O)N1)C1=C(NC3=C1C=CC=C3)C1=C2C2=C(N1)C=CC=C2,46937063
6341,DB07242,"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",small molecule,experimental,,[H][C@@]1(C#N)C2=C(N(C)C3=C(Cl)C(Cl)=CC=C23)C(=O)NC11CCN(C)CC1,24851688
6342,DB07243,"(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLATE",small molecule,experimental,,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C1=CNC3=C1C=CC=N3)N2C,24752838
6343,DB07244,"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE",small molecule,experimental,,CCC1=C(C(N)=NC(N)=N1)C1=CC=C(NCC2=CC(F)=CC(F)=C2)C=C1,6914633
6344,DB07245,6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE,small molecule,experimental,,COC1=CC=CC(=C1)C1=CC(CCC2=CC=CC(N)=N2)=CC=C1,11659487
6345,DB07246,"(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE",small molecule,experimental,,N[C@](CS(=O)(=O)C1=CC=C(OC2=CC=CC=C2)C=C1)(C(=O)NO)C(F)(F)F,16129579
6346,DB07247,"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",small molecule,experimental,,NC(=O)NCC1=CC(=CC=C1)C1=C(O)C(=CC=C1)C1=CC2=C(N1)C=CN=C2,15942655
6347,DB07248,"7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE",small molecule,experimental,,COC1=CC(NC2=NC=C3C=CN(C3=N2)C2=CC=CC=N2)=CC(OC)=C1OC,11957393
6348,DB07249,"N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine",small molecule,experimental,,COC1=C(OCCCN2CCCCC2)C=C2N=CN=C(NC3=C(Cl)C=CC4=C3OCO4)C2=C1,5330197
6349,DB07250,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE",small molecule,experimental,,COC1=CC(NC2=NC(NC3=C(Cl)C=CC4=C3OCO4)=CC=N2)=CC(OC)=C1OC,24836813
6350,DB07251,"N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE",small molecule,experimental,,COC1=CC(NC2=NC=NC(NC3=CC(Cl)=C(OC)C=C3)=N2)=CC(OC)=C1OC,24836812
6351,DB07252,"3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide",small molecule,experimental,,NS(=O)(=O)C1=CC(NC2=NC(NC3=C(Cl)C=CC4=C3OCO4)=CC=N2)=CC=C1,25011728
6352,DB07253,"N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine",small molecule,experimental,,CS(=O)(=O)C1=CC(NC2=NC(NC3=C(Cl)C=CC4=C3OCO4)=CC=N2)=CC=C1,25011729
6353,DB07254,"N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE",small molecule,experimental,,CS(=O)(=O)NC1=CC(NC2=NC(NC3=C(Cl)C=CC4=C3OCO4)=CC=N2)=CC=C1,25011730
6354,DB07255,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE",small molecule,experimental,,ClC1=C(NC2=NC(NC3=CC(=CC=C3)N3CCOCC3)=NC=C2)C2=C(OCO2)C=C1,25011731
6355,DB07256,"3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE",small molecule,experimental,,NC(=O)C1=CC(NC2=NC(NC3=C(Cl)C=CC4=C3OCO4)=CC=N2)=CC=C1,24861080
6356,DB07257,"4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione",small molecule,experimental,,CN1C=C(CCO)C2=C1C=C(C1=C2C(=O)NC1=O)C1=CC=CC=C1Cl,11602832
6357,DB07258,(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol,small molecule,experimental,,[H][C@](O)(C1=CC=NC=C1)C1=CC=C(OCCN2CCCC2)C=C1,44129623
6358,DB07259,1-(4-thiophen-2-ylphenyl)methanamine,small molecule,experimental,,NCC1=CC=C(C=C1)C1=CC=CS1,2776332
6359,DB07260,N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline,small molecule,experimental,,[H][C@]1(COC2=CC=C(NCC3=CC=CC=C3)C=C2)CCCN1,44129620
6360,DB07261,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE",small molecule,experimental,,[H][C@@]1(CCN(CC2=CC3=C(C=CN=C3N)C=C2)C1=O)NS(=O)(=O)C1=CC2=C(S1)C=CC=N2,445480
6361,DB07262,1-{[N-(1-Imino-guanidino-methyl)]sulfanylmethyl}-3-trifluoromethyl-benzene,small molecule,experimental,,NC(=N)NC(=N)SCC1=CC=CC(=C1)C(F)(F)F,9543472
6362,DB07263,"[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid",small molecule,experimental,,[H][C@](CC1=CC(Br)=C(C=C1)C(F)(F)P(O)(O)=O)(C(=O)C1=CC=CC=C1)C1=CC=CC=C1,24808499
6363,DB07264,(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE,small molecule,experimental,,[H][C@](CO)(NC(=O)C1=CC(=CN1)C1=NNC=C1C1=CC=CC(Cl)=C1)C1=CC(Cl)=C(F)C=C1,16115004
6364,DB07265,"3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID",small molecule,experimental,,OC(=O)CCN1C2=C(C=C(O)C=C2)C2=C1C=C(C1=C2C(=O)NC1=O)C1=CC=CC=C1,9978312
6365,DB07266,AKI-001,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Protein Kinase Inhibitors",CCN1C(=O)C(C)(C)C2=CC3=C(C=C12)C1=C(N3)C2=NNC(C)=C2CCC1,24894130
6366,DB07267,2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine,small molecule,experimental,,CC1=CC=CC(=N1)C1=NC(NC2=CC=NC=C2)=C2C=CC=CC2=N1,10267580
6367,DB07268,2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE,small molecule,experimental,,NC(=O)C1=CC=CC=C1NC1=NC(NC2=CC(O)=CC=C2)=NC=C1,16058637
6368,DB07269,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID,small molecule,experimental,,[H][C@@](C[P@](O)(=O)[C@@]([H])(NC(=O)OCC1=CC=CC=C1)C(C)C)(C(O)=O)C1=CC(CN)=CC=C1,23653503
6369,DB07270,"N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE",small molecule,experimental,,COC1=CC2=C(OC(NS(=O)(=O)C3=CC(Cl)=CC=C3Cl)=N2)C(=C1)C1=CC(N)=CC=C1,6102822
6370,DB07271,"4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",small molecule,experimental,,N[C@@H](CC(=O)N1CCCNC(=O)C1CC(F)(F)F)CC1=C(F)C=C(F)C(F)=C1,10024590
6371,DB07272,"N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE",small molecule,experimental,,CCOC1=NC(NC(=O)CC2=CC(OC)=C(Br)C=C2OC)=CC(N)=C1C#N,6852206
6372,DB07273,1-[(2-AMINO-4-CHLORO-5-METHYLPHENYL)SULFONYL]-L-PROLINE,small molecule,experimental,,[H][C@]1(CCCN1S(=O)(=O)C1=C(N)C=C(Cl)C(C)=C1)C(O)=O,6914644
6373,DB07274,"N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide",small molecule,experimental,,COC1=C(OC)C=C2C(OC3=CC4=CC=CC(C(=O)NC5CC5)=C4C=C3)=CC=NC2=C1,11441375
6374,DB07275,"3-(1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1-(3-methylbutyl)quinolin-2(1H)-one",small molecule,experimental,,CC(C)CCN1C(=O)C(C2=NS(=O)(=O)C3=CC=CC=C3N2)=C(O)C2=CC=CC=C12,16001653
6375,DB07276,"5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE",small molecule,experimental,,CCOC1=NC(=CC=C1C#N)C(=O)NCC1=CC(OC)=CC=C1OC,9543521
6376,DB07277,2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE,small molecule,experimental,,[H][C@@](C)(N1CC[C@]([H])(NS(=O)(=O)CCC2=CC=C(Cl)S2)C1=O)C(=O)N1CCOCC1,10343728
6377,DB07278,GW-813893,small molecule,experimental,Amides|Anticoagulants|Antithrombins|Enzyme Inhibitors|Factor Xa Inhibitors|Hematologic Agents|Protease Inhibitors|Pyrrolidines|Serine Protease Inhibitors|Sulfones|Sulfur Compounds,C[C@H](N1CC[C@H](NS(=O)(=O)\C=C\C2=CC=C(Cl)S2)C1=O)C(=O)N1CCOCC1,9911502
6378,DB07279,N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE,small molecule,experimental,,[H][C@](C)(COC1=CC(=CC(C)=C1)C(=O)N(CC)C(C)C)NC1=CC=NC=C1,9820034
6379,DB07280,5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE,small molecule,experimental,,CN(C)C1=CC=C(C=C1)C1=C(N=CN=C1N)C#CC1=CC=C(N=C1)N1CCOCC1,11987868
6380,DB07281,"N~3~-BENZYLPYRIDINE-2,3-DIAMINE",small molecule,experimental,,NC1=NC=CC=C1NCC1=CC=CC=C1,10397869
6381,DB07282,3-({[(1Z)-(2-methoxyphenyl)methylidene]amino}oxy)propanoic acid,small molecule,experimental,,COC1=CC=CC=C1\C=N/OCCC(O)=O,44129627
6382,DB07283,"9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid",small molecule,experimental,,OC(=O)C1=C2N(CC3=CC=CC=C3)C3=C(CCCC3)C2=CC=C1,10017976
6383,DB07284,"N~3~-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE",small molecule,experimental,,NC1=NC=CC=C1NCC1=CC=CC(=C1)C1=CN=CC=C1,11701820
6384,DB07285,"(3R)-4,4-DIFLUORO-3-[(4-METHOXYPHENYL)SULFONYL]BUTANOIC ACID",small molecule,experimental,,[H][C@@](CC(O)=O)(C(F)F)S(=O)(=O)C1=CC=C(OC)C=C1,16129580
6385,DB07286,BMS-564929,small molecule,experimental,,[H][C@@]1(O)CCN2C(=O)N(C(=O)[C@]12[H])C1=C(C)C(Cl)=C(C=C1)C#N,9882972
6386,DB07287,"2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL",small molecule,experimental,,OC1=CC(CC2=CC=CC=N2)=CC=C1OC1=CC=C(Cl)C=C1Cl,16220130
6387,DB07288,N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide,small molecule,experimental,,ClC1=CC=C(NC(=O)C2=C(NCC3=CC=NC=C3)C=CC=C2)C=C1,9797919
6388,DB07289,5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID,small molecule,experimental,,OC(=O)COC1=C(SC(=C1Br)C1=CC=CC(NCC2=CC=CC=C2)=C1)C(O)=O,17758920
6389,DB07290,(2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE,small molecule,experimental,,[H][C@@](NS(=O)(=O)C1=CC(C)=C(F)C=C1)(C1CCOCC1)C(=O)NO,4369384
6390,DB07291,5-amino-1-(4-chlorophenyl)-1H-pyrazole-4-carbonitrile,small molecule,experimental,,NC1=C(C=NN1C1=CC=C(Cl)C=C1)C#N,639097
6391,DB07292,"4-(2-amino-1,3-thiazol-4-yl)phenol",small molecule,experimental,,NC1=NC(=CS1)C1=CC=C(O)C=C1,346926
6392,DB07293,benzyl (2-oxopropyl)carbamate,small molecule,experimental,,CC(=O)CNC(=O)OCC1=CC=CC=C1,22747857
6393,DB07294,"3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid",small molecule,experimental,,CC1(C)CCC(C)(C)C2=C1C=CC(=C2)[C@H](O)C(=O)NC1=C(F)C=C(C=C1)C(O)=O,445460
6394,DB07295,2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID,small molecule,experimental,,OC(=O)C(=O)N(C1=CC=CC=C1C(O)=O)C1=CC=CC2=CC=C(O)C=C12,447695
6395,DB07296,(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE,small molecule,experimental,,OC1=C(C(=O)O\C1=C/C1=CC=CC2=CC=CC=C12)C1=CC=C(Cl)C=C1,54682555
6396,DB07297,"5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE",small molecule,experimental,,C(CN1CCNCC1)NC1=C2C(OC(=C2C2=CC=CC=C2)C2=CC=CC=C2)=NC=N1,17756743
6397,DB07298,"3-(CARBOXYMETHOXY)THIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID",small molecule,experimental,,OC(=O)COC1=C(SC2=NC=CC=C12)C(O)=O,5327045
6398,DB07299,4-METHYL-PENTANOIC ACID {1-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYLCARBAMOYL]-2-METHYL-PROPYL}-AMIDE,small molecule,experimental,,[H][C@@](CCCNC(N)N)(NC(=O)[C@@]([H])(NC(=O)CCC(C)C)C(C)C)C(=O)C1=NC=CS1,6857702
6399,DB07300,"2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine",small molecule,experimental,,COCCOC1=C(OC)C=C2C(=C1)N=CC1=C(N)N=C(C=C21)N1C=CN=C1,44176356
6400,DB07301,Carbazole,small molecule,experimental,"Carcinogens|Heterocyclic Compounds, Fused-Ring|Indoles|Noxae|Toxic Actions",N1C2=CC=CC=C2C2=CC=CC=C12,6854
6401,DB07302,9(S)-HODE,small molecule,experimental,,CCCCC\C=C/C=C/[C@@H](O)CCCCCCCC(O)=O,5312830
6402,DB07303,"N~3~-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE",small molecule,experimental,,COC1=CN=CC(=C1)C1=CC(CNC2=CC=CN=C2N)=CC=C1,11500493
6403,DB07304,5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FUROIC ACID,small molecule,experimental,,OC(=O)C1=CC=C(O1)C1=C(OC(F)(F)F)C=CC=C1,834826
6404,DB07305,5-(2-CHLORO-4-NITROPHENYL)-2-FUROIC ACID,small molecule,experimental,,OC(=O)C1=CC=C(O1)C1=CC=C(C=C1Cl)[N+]([O-])=O,763808
6405,DB07306,ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE,small molecule,experimental,,CCOC(=O)N1CCC(CC1)NC1=NC=CC(Cl)=C1,24894151
6406,DB07307,N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide,small molecule,experimental,,CC1=CC=CC=C1C1=NN=CC2=C1C=CC(=C2)C1=C(C)C=CC(=C1)C(=O)NC1CC1,24941253
6407,DB07308,5-(2-CHLOROBENZYL)-2-FUROIC ACID,small molecule,experimental,,OC(=O)C1=CC=C(CC2=CC=CC=C2Cl)O1,14163672
6408,DB07309,5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID,small molecule,experimental,,OC(=O)C1=C(NS(=O)(=O)C2=CC=C(Cl)C=C2)C=CC(Br)=C1,1069140
6409,DB07310,"(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one",small molecule,experimental,,C[C@H](NC1=NC(=O)[C@](C)(S1)C(F)(F)F)C1=C(F)C=CC=C1,16105493
6410,DB07311,"18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE",small molecule,experimental,,ClC1=CC2=C(OCCCCCOC3=CN=CC(NC(=O)N2)=N3)C=C1,11348631
6411,DB07312,"2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE",small molecule,experimental,,ClC1=CC=C2OC(NS(=O)(=O)C3=CC(Cl)=CC=C3Cl)=NC2=C1,6102820
6412,DB07313,5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID,small molecule,experimental,,CC1=CC=C(NS(=O)(=O)C2=CC=CC=C2)C(=C1)C(O)=O,6102684
6413,DB07314,"1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA",small molecule,experimental,,COC1=CC(OC)=C(NC(=O)NC2=NC=C(N=C2)C#N)C=C1Cl,16122643
6414,DB07315,"5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide",small molecule,experimental,,[H][C@](O)(CO)C1=CC=C(NC(=O)C2=CC3=CC(Cl)=CC=C3N2)C=C1,24883477
6415,DB07316,"N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide",small molecule,experimental,,C[C@](O)(C1=CC=C(C=C1)C(=O)N(C1CC1)C1CCN(CC2(CC2)C(N)=O)CC1)C(F)(F)F,25263223
6416,DB07317,(3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one,small molecule,experimental,,O=C1OCC\C1=C/NC1=CC=CC=C1,44585557
6417,DB07318,"N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE",small molecule,experimental,,[H][C@@]1(CCNC(=O)C2=COC=C2)NC2=C(F)C=CC(F)=C2C(N)=N1,24941258
6418,DB07319,"6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE",small molecule,experimental,,NC1=NC(=NC(N)=N1)C1=CC2=CC=CC=C2C=C1Br,13373715
6419,DB07320,"4-(6-{[(4-METHYLCYCLOHEXYL)AMINO]METHYL}-1,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)BENZOIC ACID",small molecule,experimental,,[H][C@]1(C)CC[C@]([H])(CC1)NCC1=CC2=C(C=C1)C1=C(C2)C(=NN1)C1=CC=C(C=C1)C(O)=O,9844011
6420,DB07321,"2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE",small molecule,experimental,,COC1=CC2=C(OC(NS(=O)(=O)C3=CC(Cl)=CC=C3Cl)=N2)C(=C1)C1=CN=C(OC)C=C1,6102821
6421,DB07322,"2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",small molecule,experimental,,OC(=O)C1=C2CCCCC2=CC=C1NS(=O)(=O)C1=CC=CC=C1,6102685
6422,DB07323,"2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",small molecule,experimental,,CN(C)C\C=C/C1=CC(F)=CC=C1S(=O)(=O)NC1=CC=C2CCCCC2=C1C(O)=O,6102686
6423,DB07324,"3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE",small molecule,experimental,,CC1=CC(=NC(N)=N1)C#CC1=C(CNN2C=COC2=O)C=CC=C1,24832022
6424,DB07325,N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE,small molecule,experimental,,CC1=NC(N)=NC(CNS(=O)(=O)C2=CC(N\C=C3/CCOC3=O)=CC=C2)=C1,17755582
6425,DB07326,"6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide",small molecule,experimental,,FC(F)(F)C1=CC(NC2=NOC3=C(C(=O)NC4=CN=CN=C4)C(Cl)=CC=C23)=CC=C1,23658582
6426,DB07327,R-95845,small molecule,experimental,"Acetates|Acids, Acyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Ketones|Lipids",CC(=O)C1=C(N[C@H](C(N)=O)C2=C(Br)C=CC=C2Br)C=C(C)C=C1,446106
6427,DB07328,"METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE",small molecule,experimental,,[H][C@]1(CNC(=O)NC2=CC=C(C=C2)C(=O)OC)CC[C@]([H])(N1)C(=O)N1CCC[C@@]1([H])CN,11840913
6428,DB07329,1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO]METHYLPHOSPHONIC ACID,small molecule,experimental,,OC(=O)CCCCN(CC1=CC=C(C=C1)[N+]([O-])=O)CP(O)(O)=O,445651
6429,DB07330,A-620223,small molecule,experimental,,CCCN1CCC(CC1)C1=NC2=CC=CC(C(N)=O)=C2N1,9925908
6430,DB07331,p-Nitrophenylacetic acid,small molecule,experimental,"Acids, Carbocyclic",OC(=O)CC1=CC=C(C=C1)[N+]([O-])=O,4661
6431,DB07332,"ALPHA-(2,6-DICHLOROPHENYL)-ALPHA-(2-ACETYL-5-METHYLANILINO)ACETAMIDE",small molecule,experimental,,[H][C@@](NC1=C(C=CC(C)=C1)C(C)=O)(C(N)=O)C1=C(Cl)C=CC=C1Cl,449080
6432,DB07333,"N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE",small molecule,experimental,,COC1=CC=C(C=C1NC1=NC=C(O1)C1=CC(=CC=C1)C1=CN=CC=C1)S(=O)(=O)NCC1CC1,4369498
6433,DB07334,"N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE",small molecule,experimental,,CCS(=O)(=O)C1=CC=C(OC)C(NC2=NC=C(O2)C2=CC=CC(=C2)C2=CC=CC=N2)=C1,4369497
6434,DB07335,"3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL",small molecule,experimental,,CC(C)N1N=C(C2=C1N=CN=C2N)C1=CC=CC(O)=C1,24905143
6435,DB07336,4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-2-METHOXYPHENOL,small molecule,experimental,,COC1=CC(=CC=C1O)C1=CC2=C(C=C1)C(=NN2)C1=NC2=CC=CC=C2N1,5327122
6436,DB07337,"4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",small molecule,experimental,,NC1=NC(CC2=C3C=CNC3=CC=C2Cl)=NC(NC2=CC=C(C=C2)C#N)=N1,448533
6437,DB07338,Acifluorfen,small molecule,experimental,"Acids, Carbocyclic|Agrochemicals|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Herbicides|Pesticides|Toxic Actions",OC(=O)C1=C(C=CC(OC2=CC=C(C=C2Cl)C(F)(F)F)=C1)[N+]([O-])=O,44073
6438,DB07339,"(3S)-3-hydroxy-1-methyl-2,3-dihydro-1H-indole-5,6-dione",small molecule,experimental,,[H][C@@]1(O)CN(C)C2=CC(=O)C(=O)C=C12,23270857
6439,DB07340,Reversine,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Oxazines|Protein Kinase Inhibitors",C1CCC(CC1)NC1=NC(NC2=CC=C(C=C2)N2CCOCC2)=NC2=C1N=CN2,210332
6440,DB07341,"octyl 3-amino-3-deoxy-2-O-(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)-beta-D-galactopyranoside",small molecule,experimental,,[H][C@]1(O)C[C@]([H])(O[C@]2([H])[C@@]([H])(N)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]2([H])OCCCCCCCC)O[C@@]([H])(C)[C@@]1([H])O,46937064
6441,DB07342,1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone,small molecule,experimental,"Cycloparaffins|Heme Oxygenase-1, antagonists & inhibitors",[H]C12CC3([H])CC([H])(C1)CC(C2)(C3)C(=O)CN1C=CN=C1,20541332
6442,DB07343,"4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",small molecule,experimental,,NC1=NC(OC2=C(Cl)C=CC=C2Cl)=NC(NC2=CC=C(C=C2)C#N)=N1,448532
6443,DB07344,"3,6,9,12,15-PENTAOXAHEPTADECAN-1-OL",small molecule,experimental,,CCOCCOCCOCCOCCOCCO,78058
6444,DB07345,4-(2-aminoethyl)-2-cyclohexylphenol,small molecule,experimental,,NCCC1=CC=C(O)C(=C1)C1CCCCC1,24748051
6445,DB07346,4-(2-aminoethyl)-2-ethylphenol,small molecule,experimental,,CCC1=CC(CCN)=CC=C1O,24748050
6446,DB07347,4-(2-Aminoethyl)Benzenesulfonyl Fluoride,small molecule,experimental,Enzyme Inhibitors|Serine Protease Inhibitors|Sulfur Compounds|Trypsin Inhibitors,NCCC1=CC=C(C=C1)S(F)(=O)=O,1701
6447,DB07348,Brefeldin A,small molecule,experimental,Anti-Bacterial Agents|Anti-Infective Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Lactones|Macrolides|P-glycoprotein inhibitors|Polyketides|Protein Synthesis Inhibitors,[H][C@]1(O)C[C@@]2([H])\C=C\CCC[C@]([H])(C)OC(=O)\C=C\[C@@]([H])(O)[C@]2([H])C1,5287620
6448,DB07349,"(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE",small molecule,experimental,,[H][C@](O)(CO)CO[P@@]([O-])(=O)OC[C@@]([H])(COC(=O)CCCC)OC(=O)CCCCCCC,5287637
6449,DB07350,(2E)-N-hydroxy-3-[1-methyl-4-(phenylacetyl)-1H-pyrrol-2-yl]prop-2-enamide,small molecule,experimental,,CN1C=C(C=C1\C=C\C(=O)NO)C(=O)CC1=CC=CC=C1,10379137
6450,DB07351,O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)-ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3-L-PHENYLLACTATE,small molecule,experimental,,[H][C@@](C)(NC(=O)OCC1=CC=CC=C1)C(=O)NC[P@](O)(=O)O[C@@]([H])(CC1=CC=CC=C1)C(O)=O,16741275
6451,DB07352,Apigenin,small molecule,experimental,"Benzopyrans|Chromones|Flavones|Flavonoids|Heterocyclic Compounds, Fused-Ring|Pyrans",OC1=CC=C(C=C1)C1=CC(=O)C2=C(O1)C=C(O)C=C2O,5280443
6452,DB07353,"4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL",small molecule,experimental,,[H][C@](N)(O)CC[C@@]([H])(N)CC1=CC=C(O)C=C1,46937065
6453,DB07354,"2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM",small molecule,experimental,,COC1=C(OC)C=C2C3=C([NH+]=CC2=C1)C1=C(C3)C=C2OCOC2=C1,5287652
6454,DB07355,3-(heptyloxy)benzoic acid,small molecule,experimental,,CCCCCCCOC1=CC=CC(=C1)C(O)=O,14368760
6455,DB07356,"(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE",small molecule,experimental,,[H][C@](N)(C1CCCC1)C(=O)N1[C@]([H])(CN)CC[C@]1([H])C#C,11840917
6456,DB07357,"4-AMINO-2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL",small molecule,experimental,,[H][C@]1(N)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCC)[C@]1([H])O,448295
6457,DB07358,"2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",small molecule,experimental,,CN1C=NN=C1SC1=CC=C(N)C(=C1)C(=O)NC1=NC(C)=CS1,9819610
6458,DB07359,"3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide",small molecule,experimental,,CN1C=NN=C1SC1=NC(C(=O)NC2=NC(C)=CS2)=C(SC2=CC=C(F)C=C2)C=C1,10411846
6459,DB07360,"1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea",small molecule,experimental,,FC(F)(F)C1=CC=CC(NC(=O)NC2=NC=C(CCNC3=NC=NC4=C3SC=C4)S2)=C1,24880024
6460,DB07362,"1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea",small molecule,experimental,,CN1N=CC2=C1C(NCCC1=CN=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)S1)=NC=N2,15602701
6461,DB07363,"THIOPHENE-2,5-DISULFONIC ACID 2-AMIDE-5-(4-METHYL-BENZYLAMIDE)",small molecule,experimental,,CC1=CC=C(CNS(=O)(=O)C2=CC=C(S2)S(N)(=O)=O)C=C1,444607
6462,DB07364,"6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE",small molecule,experimental,,CCCCC1=C(NC2=NC=CN=C12)C1=CC=C(O)C=C1,5326843
6463,DB07365,1-Naphthyl-L-alanine,small molecule,experimental,,N[C@@H](CC1=CC=CC2=C1C=CC=C2)C(O)=O,2724883
6464,DB07366,2-[N'-(4-AMINO-BUTYL)-HYDRAZINOCARBONYL]-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER,small molecule,experimental,,[H][C@]1(CCCN1C(=O)OCC1=CC=CC=C1)C(=O)NNCCCCN,444238
6465,DB07367,"(3Z,5S,6R,7S,8S,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol",small molecule,experimental,,[H][C@]12CO\C(=N/CCCCCCCC)N1[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@@]2([H])O,46937066
6466,DB07368,4-(METHYLSULFONYL)BENZENECARBOXIMIDAMIDE,small molecule,experimental,,CS(=O)(=O)C1=CC=C(C=C1)C(N)=N,199994
6467,DB07369,"N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide",small molecule,experimental,,CN(C1=CC(Cl)=CC=C1)S(=O)(=O)C1=CC2=C(CC3=C(C)C(C)=C(C)N3)C(=O)N=C2C=C1,17749728
6468,DB07370,"(3Z,5S,6R,7S,8R,8aS)-3-(octylimino)hexahydro[1,3]thiazolo[3,4-a]pyridine-5,6,7,8-tetrol",small molecule,experimental,,[H][C@]12CS\C(=N/CCCCCCCC)N1[C@@H](O)[C@H](O)[C@@H](O)[C@@H]2O,46937067
6469,DB07371,3-(10-methyl-9-anthryl)propanoic acid,small molecule,experimental,,CC1=C2C=CC=CC2=C(CCC(O)=O)C2=C1C=CC=C2,446967
6470,DB07373,Boldione,small molecule,experimental,Androstanes|Androstenes|Fused-Ring Compounds|Steroids,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,13472
6471,DB07374,Anisomycin,small molecule,experimental,Anti-Bacterial Agents|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Enzyme Inhibitors|Nucleic Acid Synthesis Inhibitors|Protein Synthesis Inhibitors|Pyrrolidines,[H][C@]1(O)CN[C@]([H])(CC2=CC=C(OC)C=C2)[C@]1([H])OC(C)=O,253602
6472,DB07375,Etiocholanedione,small molecule,experimental,,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])CC(=O)CC[C@]12C,440114
6473,DB07376,5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID),small molecule,experimental,,CN(C)C1=C2C=CC=C(C2=CC=C1)S(O)(=O)=O,1792
6474,DB07377,"N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE",small molecule,experimental,,[H][C@@](N)(CCSC(C)C)[C@]([H])(O)C(=O)NNC(=O)C1=CC(Cl)=CC=C1,448285
6475,DB07378,"4-AMINO-2-OCTYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL",small molecule,experimental,,[H][C@]1(N)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCCCC)[C@]1([H])O,448297
6476,DB07379,(2S)-2-({6-[(3-Amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methyl-1-butanol,small molecule,experimental,,[H][C@](CO)(NC1=NC2=C(N=CN2C(C)C)C(NC2=CC(Cl)=CC(N)=C2)=N1)C(C)C,6914609
6477,DB07380,"1,1,1-TRIFLUORO-3-ACETAMIDO-4-PHENYL BUTAN-2-ONE(N-ACETYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)",small molecule,experimental,,[H][C@@](CC1=CC=CC=C1)(NC(C)=O)C(=O)C(F)(F)F,124969
6478,DB07381,(S)-atrolactic acid,small molecule,experimental,,CC(O)(C(O)=O)C1=CC=CC=C1,445144
6479,DB07382,"N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine",small molecule,experimental,,C1CC1C1=NNC(NC2=CC=NC(NC3=CC4=C(NC=N4)C=C3)=N2)=C1,42627755
6480,DB07383,"N-(1-BENZYL-3,3,3-TRIFLUORO-2,2-DIHYDROXY-PROPYL)-ACETAMIDE",small molecule,experimental,,[H][C@@](CC1=CC=CC=C1)(NC(C)=O)C(O)(O)C(F)(F)F,445824
6481,DB07384,1-ACETYL-2-CARBOXYPIPERIDINE,small molecule,experimental,,[H][C@]1(CCCCN1C(C)=O)C(O)=O,5287692
6482,DB07385,"3-(HYDROXYMETHYL)-1-METHYL-5-(2-METHYLAZIRIDIN-1-YL)-2-PHENYL-1H-INDOLE-4,7-DIONE",small molecule,experimental,,[H][C@@]1(C)C[N@@]1C1=CC(=O)C2=C(C(CO)=C(N2C)C2=CC=CC=C2)C1=O,5287703
6483,DB07387,3-(BUTYLSULPHONYL)-PROPANOIC ACID,small molecule,experimental,,CCCCS(=O)(=O)CCC(O)=O,4290313
6484,DB07388,ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE,small molecule,experimental,,CCOC(=O)N1CCC(CC1)NC1=NC=CC(C)=C1,11149707
6485,DB07389,N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE,small molecule,experimental,,CC1=CC(N)=NC(CCNC(=O)C2=CC=C(C=C2)C#N)=C1,10221335
6486,DB07390,"2-[3-(5-Mercapto-[1,3,4]thiadiazol-2-yl)-ureido]-N-methyl-3-phenyl-propionamide",small molecule,experimental,Enzyme Inhibitors|Matrix Metalloproteinase Inhibitors|Protease Inhibitors|Sulfur Compounds|Thiazoles,CNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)NC1=NNC(=S)S1,4369084
6487,DB07391,"(2S)-2-AMINO-1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)PROPAN-1-ONE",small molecule,experimental,,[H][C@@](C)(N)C(=O)C1=NN=C(O1)C(C)(C)C,6852125
6488,DB07392,Atrazine,small molecule,experimental,"Agrochemicals|Compounds used in a research, industrial, or household setting|Herbicides|Pesticides|Toxic Actions|Triazines",CCNC1=NC(NC(C)C)=NC(Cl)=N1,2256
6489,DB07393,"2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE",small molecule,experimental,,C1CCC2=C(P(C(=C2C1)C1=NC=CC=C1)C1=CC=CC=C1)C1=NC=CC=C1,11505541
6490,DB07394,AUROVERTIN B,small molecule,experimental,Pyrans,[H][C@]1(CC)O[C@]2(C)[C@]([H])(OC(C)=O)[C@@]1(C)O[C@@]([H])(\C=C\C=C\C=C\C1=C(C)C(OC)=CC(=O)O1)[C@]2([H])O,444853
6491,DB07395,"4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid",small molecule,experimental,,OC(=O)C1=CC=C(NC(=O)NC(=O)C2=CC(F)=C(F)C=C2Cl)C(OC(F)(F)F)=C1,16070039
6492,DB07396,AVE-2865,small molecule,experimental,,OC(=O)C1CCN(CC1)C1=C(NC(=O)NC(=O)C2=CC(F)=C(F)C=C2Cl)C=C(F)C=C1,12148754
6493,DB07397,"(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide",small molecule,experimental,,[H][C@@]1(CC(N)=O)CCCC2=C1C1=C(S2)N=C(NC1=O)C(=O)NCC1=CC=C2OCC(=O)NC2=C1,25174099
6494,DB07398,"2-[(CYCLOPROPYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",small molecule,experimental,,NC(=O)C1=C(NC(=O)C2CC2)SC2=C1CCCC2,673481
6495,DB07400,1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE,small molecule,experimental,,[H][C@](CC1=CC=CC=C1)(NC(=O)OCC)C(=O)N1CCC[C@@]1([H])C(=O)NNCCCCN,444224
6496,DB07401,Azoxystrobin,small molecule,experimental,"Acids, Acyclic|Acrylates|Electron Transport Complex III|Fungicides, Industrial|Methacrylates",CO\C=C(\C(=O)OC)C1=C(OC2=NC=NC(OC3=CC=CC=C3C#N)=C2)C=CC=C1,3034285
6497,DB07402,Azapropazone,small molecule,withdrawn,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antigout Preparations|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Renal Agents|Sensory System Agents|Triazines|Uricosuric Agents",[H][C@@]1(CC=C)C(=O)N2N(C1=O)C1=CC(C)=CC=C1N=C2N(C)C,46937068
6498,DB07403,"4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE",small molecule,experimental,,CN(C)C(=O)C1=CC=C(C=C1)S(=O)(=O)C1=CC=C(NC(=O)[C@@](C)(O)C(F)(F)F)C(Cl)=C1,16741245
6499,DB07404,BPH-608,small molecule,experimental,,OC(CC1=CC=CC(=C1)C1=CC(=CC=C1)C1=CC=CC=C1)(P(O)(O)=O)P(O)(O)=O,16086422
6500,DB07405,"1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE",small molecule,experimental,,NC1=NC2(CCN(CC2)C(=O)C2=CC=C(N=C2)C#N)NC2=C(F)C=CC(F)=C12,9886249
6501,DB07406,"(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE",small molecule,experimental,,[H][C@]1(C)CNC(=O)C2=C1C1=CC(=CC=C1N2)C(=O)NC1=NC(=CS1)C(=O)NCCN(C)C,16741237
6502,DB07407,5-(2-METHOXYPHENYL)-2-FUROIC ACID,small molecule,experimental,,COC1=C(C=CC=C1)C1=CC=C(O1)C(O)=O,776315
6503,DB07408,5-(2-NITROPHENYL)-2-FUROIC ACID,small molecule,experimental,,OC(=O)C1=CC=C(O1)C1=C(C=CC=C1)[N+]([O-])=O,736027
6504,DB07409,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",small molecule,experimental,,OC(CC1=CC=CC(=C1)C1=CC=C(C=C1)C1=CC=CC=C1)(P(O)(O)=O)P(O)(O)=O,16122554
6505,DB07410,[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,small molecule,experimental,,OC(CC1=CC(=CC=C1)C1=CC=CC2=C1OC1=C2C=CC=C1)(P(O)(O)=O)P(O)(O)=O,16122553
6506,DB07411,PHENYLALANINE BORONIC ACID,small molecule,experimental,,[H][C@](N)(CC1=CC=CC=C1)B(O)O,46937069
6507,DB07412,1-biphenyl-2-ylmethanamine,small molecule,experimental,,NCC1=C(C=CC=C1)C1=CC=CC=C1,263366
6508,DB07413,5'-S-[2-(decylamino)ethyl]-5'-thioadenosine,small molecule,experimental,,[H][C@]1(CSCCNCCCCCCCCCC)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,12000133
6509,DB07414,"(5S)-1-benzyl-3-(1,1-dioxido-1,2-benzisothiazol-3-yl)-4-hydroxy-5-(1-methylethyl)-1,5-dihydro-2H-pyrrol-2-one",small molecule,experimental,,[H][C@@]1(C(C)C)N(CC2=CC=CC=C2)C(=O)C(=C1O)C1=NS(=O)(=O)C2=C1C=CC=C2,46937070
6510,DB07415,4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine,small molecule,experimental,,[H][C@@](CC1=CC(=CC=C1OC)[N+]([O-])=O)(C1=CNC(N)=N1)C1=CC=C(OC)C(F)=C1,42628075
6511,DB07416,(2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE,small molecule,experimental,,[H][C@](CO)(COC(=O)CCCCCCCC)OC(=O)CCC,448271
6512,DB07418,bis(4-nitrophenyl) hydrogen phosphate,small molecule,experimental,,OP(=O)(OC1=CC=C(C=C1)[N+]([O-])=O)OC1=CC=C(C=C1)[N+]([O-])=O,255
6513,DB07419,S-23,small molecule,experimental,"Amides|Amines|Aniline Compounds|Heterocyclic Compounds, Fused-Ring|Isoquinolines",C[C@](O)(COC1=CC=C(Cl)C(F)=C1)C(=O)NC1=CC(=C(C=C1)C#N)C(F)(F)F,24892822
6514,DB07420,(1R)-4-(3-phenoxyphenyl)-1-phosphonobutane-1-sulfonic acid,small molecule,experimental,,[H][C@@](CCCC1=CC=CC(OC2=CC=CC=C2)=C1)(P(O)(O)=O)S(O)(=O)=O,24748047
6515,DB07421,"4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile",small molecule,experimental,,[H][C@](O)(NC1=CC(=C(C=C1)C#N)C(F)(F)F)[C@@](C)(O)COC1=CC=C(C=C1)[N+]([O-])=O,46937071
6516,DB07422,(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide,small molecule,experimental,,C[C@](O)(COC1=C(F)C(F)=C(F)C(F)=C1F)C(=O)NC1=CC=C(C(=C1)C(F)(F)F)[N+]([O-])=O,10174090
6517,DB07423,Andarine,small molecule,experimental,"Acetates|Acids, Acyclic|Amides|Amines|Aniline Compounds|Benzene Derivatives|Fatty Acids|Fatty Acids, Volatile|Lipids|Phenols",CC(=O)NC1=CC=C(OC[C@](C)(O)C(=O)NC2=CC=C(C(=C2)C(F)(F)F)[N+]([O-])=O)C=C1,9824562
6518,DB07424,Tripotassium (1R)-4-biphenyl-4-yl-1-phosphonatobutane-1-sulfonate,small molecule,experimental,,[K+].[K+].[K+].[O-]P([O-])(=O)[C@@H](CCCC1=CC=C(C=C1)C1=CC=CC=C1)S([O-])(=O)=O,46937072
6519,DB07425,Sobetirome,small molecule,investigational,"Acids, Acyclic|Benzene Derivatives|Fatty Acids|Fatty Acids, Volatile|Lipids",CC(C)C1=C(O)C=CC(CC2=C(C)C=C(OCC(O)=O)C=C2C)=C1,9862248
6520,DB07426,"[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)",small molecule,experimental,,OC(COC1=CC=CC(=C1)C1=CC=CC(=C1)C1=CC=CC=C1)(P(O)(O)=O)P(O)(O)=O,16122556
6521,DB07427,2-[(2-methoxy-5-methylphenoxy)methyl]pyridine,small molecule,experimental,,COC1=C(OCC2=NC=CC=C2)C=C(C)C=C1,44129642
6522,DB07428,4-[(5-methoxy-2-methylphenoxy)methyl]pyridine,small molecule,experimental,,COC1=CC(OCC2=CC=NC=C2)=C(C)C=C1,46937073
6523,DB07429,2-({[4-bromo-3-(diethylsulfamoyl)phenyl]carbonyl}amino)benzoic acid,small molecule,experimental,,CCN(CC)S(=O)(=O)C1=CC(=CC=C1Br)C(=O)NC1=CC=CC=C1C(O)=O,1121782
6524,DB07430,"(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one",small molecule,experimental,,[H][C@@]1(C)CNC2=C(SC3=C2C2=C(C=C3)N=C(C=C2)C2=CN=C(C)C=C2)C(=O)N1,44631903
6525,DB07431,"(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one",small molecule,experimental,,[H][C@@]1(CN)CNC2=C(SC3=C2C=C(OC)C=C3)C(=O)N1,45273683
6526,DB07432,"[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate",small molecule,experimental,,[H][C@]1(CO)O\C(=N/OC(=O)NC2=CC=CC=C2)[C@]([H])(NC(=O)CCC)[C@@]([H])(O)[C@]1([H])O,11509180
6527,DB07433,(TERT-BUTYLOXYCARBONYL)-ALANYL-AMINO ETHYL-FORMAMIDE,small molecule,experimental,,[H][C@](C)(NC=O)NC(=O)[C@]([H])(C)NC(=O)OC(C)(C)C,5287737
6528,DB07434,HONH-BENZYLMALONYL-L-ALANYLGLYCINE-P-NITROANILIDE,small molecule,experimental,,[H][C@@](C)(NC(=O)[C@]([H])(CC1=CC=CC=C1)C(=O)NO)C(=O)NCC(=O)NC1=CC=C(C=C1)[N+]([O-])=O,46937074
6529,DB07435,"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",small molecule,experimental,,[H][C@@]1(O)CC2=C3C=CC4=CC=CC5=CC=C(C=C2[C@@]([H])(O)[C@]1([H])O)C3=C45,5287739
6530,DB07436,N-(1-PHENYL-PROPYL)-FORMAMIDE,small molecule,experimental,,[H][C@](CC)(NC=O)C1=CC=CC=C1,446532
6531,DB07437,5-Benzylacyclouridine,small molecule,experimental,"Enzyme Inhibitors|Pyrimidines|Pyrimidinones|Uridine Phosphorylase, antagonists & inhibitors",OCCOCN1C=C(CC2=CC=CC=C2)C(=O)NC1=O,54929
6532,DB07439,"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE",small molecule,experimental,,OCCOCN1C(=O)NC(=O)C(CC2=CC=CC(OCC3=CC=CC=C3)=C2)=C1O,5287741
6533,DB07440,4-TERT-BUTYLBENZENESULFONIC ACID,small molecule,experimental,,CC(C)(C)C1=CC=C(C=C1)S(O)(=O)=O,324690
6534,DB07441,"3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID",small molecule,experimental,,CN1C2=CC=CC=C2C(C#N)(C(=O)NCCC(O)=O)C2=C1C=CC=C2,446965
6535,DB07443,(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide,small molecule,experimental,,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C1=CC=CC=C1,54727972
6536,DB07444,"6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",small molecule,experimental,,CC1=CC2=C(C=C1)N(CCCN)C1=C2C2=C(C(=O)NC2=O)C(C)=C1,6540255
6537,DB07445,"N'-[(1E)-(3,5-DIBROMO-2,4-DIHYDROXYPHENYL)METHYLENE]NICOTINOHYDRAZIDE",small molecule,experimental,,OC1=C(Br)C=C(\C=N\NC(=O)C2=CN=CC=C2)C(O)=C1Br,6248837
6538,DB07446,N-(biphenyl-4-ylsulfonyl)-D-leucine,small molecule,experimental,,[H][C@](CC(C)C)(NS(=O)(=O)C1=CC=C(C=C1)C1=CC=CC=C1)C(O)=O,25271580
6539,DB07447,5beta-dihydrotestosterone,small molecule,experimental,Testosterone and derivatives,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CC[C@]4([H])CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C,11302
6540,DB07448,(2S)-3-[(R)-[(1S)-1-amino-3-phenylpropyl](hydroxy)phosphoryl]-2-benzylpropanoic acid,small molecule,experimental,,[H][C@@](CC1=CC=CC=C1)(C[P@](O)(=O)[C@]([H])(N)CCC1=CC=CC=C1)C(O)=O,25138289
6541,DB07449,N-[(1S)-1-(aminocarbonyl)-4-(ethanimidoylamino)butyl]benzamide,small molecule,experimental,,C\C(N)=N/CCC[C@H](NC(=O)C1=CC=CC=C1)C(N)=O,46937075
6542,DB07450,(R)-minalrestat,small molecule,experimental,,[H]N1C(=O)C[C@@]2(C1=O)C(=O)N(CC1=C(F)C=C(Br)C=C1)C(=O)C1=C2C=C(F)C=C1,447950
6543,DB07451,1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6-FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)-CYCLOPROPYL]-UREA,small molecule,experimental,,[H][C@@]1(C[C@@]1([H])C1=C(F)C=CC(C(=O)CC)=C1O)NC(=O)NC1=NC=C(Br)C=C1,445332
6544,DB07452,"2,6-diamino-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",small molecule,experimental,,NC1=NC2=C(N1)C=C1C(=O)NC(N)=NC1=C2,24741806
6545,DB07453,alpha-Naphthoflavone,small molecule,experimental,"Benzopyrans|Chromones|Flavonoids|Heterocyclic Compounds, Fused-Ring|Pyrans",O=C1C=C(OC2=C1C=CC1=C2C=CC=C1)C1=CC=CC=C1,11790
6546,DB07454,(R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,small molecule,experimental,,C[C@](O)(CBr)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F,5287785
6547,DB07455,"N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide",small molecule,experimental,,[H][C@](C)(CNS(C)(=O)=O)C1=CC=C(C=C1)C1=CC=C(C=C1)[C@@]([H])(C)CNS(C)(=O)=O,22489160
6548,DB07456,"3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione",small molecule,experimental,,[H]N1C=C(C2=CC=CC=C12)C1=C(C(=O)N([H])C1=O)C1=CN(CC[C@H]2CCCN2C)C2=CC=CC=C12,448943
6549,DB07457,"3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE",small molecule,experimental,,NCCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2,2398
6550,DB07458,"3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione",small molecule,experimental,,[H]N1C=C(C2=CC=CC=C12)C1=C(C(=O)N([H])C1=O)C1=CN(CC[C@@H]2CCCN2C)C2=CC=CC=C12,448642
6551,DB07459,4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE,small molecule,experimental,,O=C(NCC1=NC=CC=C1)C1=CC=C(OC2=CC=CC=C2)C=C1,2352168
6552,DB07460,2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE,small molecule,experimental,,CNC(=O)C1=C(NC2=NC(NC3=CC=C(C=C3OC)N3CCOCC3)=NC=C2Cl)C=CC=C1,9934347
6553,DB07461,"3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",small molecule,experimental,,[H][C@]1(CCN2CC[C@@](N)(CC3=CC=CC=C3)C(=O)N12)C=O,5287789
6554,DB07462,"(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE",small molecule,experimental,,OC1=CC=C(C(=O)C2=CC=CC=C2)C(=C1O)[N+]([O-])=O,6914595
6555,DB07463,"(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(butylsulfanyl)methyl]pyrrolidin-3-ol",small molecule,experimental,,[H][C@]1(O)CN(CC2=CNC3=C2N=CN=C3N)C[C@]1([H])CSCCCC,11393519
6556,DB07464,1(R)-1-ACETAMIDO-2-(3-CARBOXY-2-HYDROXYPHENYL)ETHYL BORONIC ACID,small molecule,experimental,,[H][C@@](CC1=CC=CC(C(O)=O)=C1O)(NC(C)=O)B(O)O,5287794
6557,DB07465,"(1S,3S,5S)-2-{(2S)-2-amino-2-[(1R,3S,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrile",small molecule,experimental,,[H][C@@](N)(C(=O)N1[C@@]2([H])C[C@@]2([H])C[C@@]1([H])C#N)[C@]12C[C@@]3([H])C[C@]([H])(C[C@](O)(C3)C1)C2,11235729
6558,DB07466,(1R)-2-PHENYLACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID,small molecule,experimental,,[H][C@@](CC1=CC=CC(=C1)C(O)=O)(NC(=O)CC1=CC=CC=C1)B(O)O,5287796
6559,DB07467,(S)-Indapamide,small molecule,experimental,,C[C@H]1CC2=C(C=CC=C2)N1NC(=O)C1=CC=C(Cl)C(=C1)S(N)(=O)=O,12598931
6560,DB07468,"(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",small molecule,experimental,,CC1=C2C(=CC=C1)N=C1N(CC[C@@]1(O)C2=O)C1=CC=CC=C1,24178119
6561,DB07469,"(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",small molecule,experimental,,CC1=CC=C2C(=C1)N=C1N(CC[C@@]1(O)C2=O)C1=CC=CC=C1,24178120
6562,DB07470,"(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",small molecule,experimental,,O[C@@]12CCN(C1=NC1=C(C=CC=C1)C2=O)C1=CC=CC=C1,24178121
6563,DB07471,"5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE",small molecule,experimental,,[H][C@](C)(OC1=C(SC(=C1)N1C=NC2=CC(OC)=C(OC)C=C12)C(N)=O)C1=CC=CC=C1Cl,11957417
6564,DB07472,"(R)-(+)9B-(3-METHYL)PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-5(9BH)-ONE",small molecule,experimental,,CC1=CC(=CC=C1)[C@]12SCCN1C(=O)C1=CC=CC=C21,444703
6565,DB07473,"(R)-(+) 5(9BH)-OXO-9B-PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-3-CARBOXYLIC ACID METHYL ESTER",small molecule,experimental,,COC(=O)[C@@H]1CS[C@]2(N1C(=O)C1=CC=CC=C21)C1=CC=CC=C1,444704
6566,DB07474,3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE,small molecule,experimental,,CC1=CC(=CC2=C1N=C(N2)C1=C(NCC2=NC=CC=C2)C=CNC1=O)N1C=CN=C1,22021390
6567,DB07476,N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE,small molecule,experimental,,NS(=O)(=O)C1=CC=C(NC(=O)C2=CC=CC=C2S)C=C1,462919
6568,DB07477,Felbinac,small molecule,experimental,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antirheumatic Agents|Central Nervous System Agents|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Sensory System Agents|Topical Products for Joint and Muscular Pain",OC(=O)CC1=CC=C(C=C1)C1=CC=CC=C1,3332
6569,DB07478,"3,4-Biphenyldiol",small molecule,experimental,,OC1=C(O)C=C(C=C1)C1=CC=CC=C1,7075
6570,DB07479,"(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL",small molecule,experimental,,[H][C@@]1(O)CC2=C(C=CC3=C2C2=C(C=CC=C2)C=C3)[C@@]([H])(O)[C@]1([H])O,5287834
6571,DB07480,4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN,small molecule,experimental,,OP(O)(=O)OC1=CC=C(CC2=CC=C(OP(O)(O)=O)C=C2)C=C1,1757
6572,DB07481,"tert-butyl [(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl]carbamate",small molecule,experimental,,CC(C)(C)OC(=O)NCC1=CNC2=C1C(=O)NC(N)=N2,25113137
6573,DB07482,(2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDE,small molecule,experimental,,[H][C@]1(CCCN1C(=O)[C@]1([H])CCCN1)B(O)O,10198228
6574,DB07483,"1,1'-BIPHENYL-2-SULFINIC ACID",small molecule,experimental,,O[S@@](=O)C1=CC=CC=C1C1=CC=CC=C1,9543498
6575,DB07484,"(2R)-4,4-dihydroxy-5-nitro-2-(phenylmethyl)pentanoic acid",small molecule,experimental,,[H][C@@](CC1=CC=CC=C1)(CC(O)(O)C[N+]([O-])=O)C(O)=O,44176354
6576,DB07485,Bisphenol Z,small molecule,experimental,Benzene Derivatives|Cycloparaffins,OC1=CC=C(C=C1)C1(CCCCC1)C1=CC=C(O)C=C1,232446
6577,DB07486,"3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline",small molecule,experimental,,NC1=CC=CC(SC2=CC=C(\C=C\C(=O)N3CCOCC3)C(=C2C(F)(F)F)C(F)(F)F)=C1,11712628
6578,DB07487,"(6-METHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL)METHYLPHOSPHINATE",small molecule,experimental,,[H][C@@]1(C[P@@]([H])([O-])=O)CCC2=CC(C)=CC=C2O1,5287837
6579,DB07488,"{4-Amino-2-[(4-methoxyphenyl)amino]-1,3-thiazol-5-yl}(4-methoxyphenyl)methanone",small molecule,experimental,,COC1=CC=C(C=C1)\N=C1\NC(N)=C(S1)C(=O)C1=CC=C(OC)C=C1,399618
6580,DB07489,"4-Amino-2-[(3-chlorophenyl)amino]-5-(4-fluorobenzoyl)-1,3-thiazol-3-ium",small molecule,experimental,,[H]N([H])C1=C(SC(N([H])C2=CC(Cl)=CC=C2)=[N+]1[H])C(=O)C1=CC=C(F)C=C1,10062702
6581,DB07490,"2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL",small molecule,experimental,,[H][C@@](C)(C1=CC=C(Cl)C=C1)C1=CC(=CC(=C1O)[N+]([O-])=O)[N+]([O-])=O,446716
6582,DB07491,"5-amino-2,4,6-tribromobenzene-1,3-dicarboxylic acid",small molecule,experimental,,NC1=C(Br)C(C(O)=O)=C(Br)C(C(O)=O)=C1Br,18432427
6583,DB07492,Bromamphenicol,small molecule,experimental,Alcohols|Benzene Derivatives|Glycols|Nitro Compounds|Nitrobenzenes|Propylene Glycols,[H][C@](CO)(NC(=O)C(Br)Br)[C@]([H])(O)C1=CC=C(C=C1)[N+]([O-])=O,25113101
6584,DB07493,5-Bromoindirubin,small molecule,experimental,,[H]N1C(=O)\C(C2=C1C=CC(Br)=C2)=C1/N([H])C2=CC=CC=C2C1=O,5287845
6585,DB07494,"(3-EXO)-3-(10,11-DIHYDRO-5H-DIBENZO[A,D][7]ANNULEN-5-YLOXY)-8,8-DIMETHYL-8-AZONIABICYCLO[3.2.1]OCTANE",small molecule,experimental,,[H][C@]12CC[C@]([H])(C[C@]([H])(C1)OC1C3=CC=CC=C3CCC3=C1C=CC=C3)[N+]2(C)C,21124461
6586,DB07495,"5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE",small molecule,experimental,,CCNC(=O)C1=NNC(=C1C1=CC=C(OC)C=C1)C1=CC(Cl)=C(O)C=C1O,5327095
6587,DB07496,"1,3-diphenylurea",small molecule,experimental,,O=C(NC1=CC=CC=C1)NC1=CC=CC=C1,7595
6588,DB07497,"5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL",small molecule,experimental,,[H][C@@]1(CCCCC=O)SC[C@]2([H])NC(=O)N[C@]12[H],11840927
6589,DB07498,"4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID",small molecule,experimental,,OC(=O)CCCC1=NC(=NO1)C1=CC(=CC=C1)[N+]([O-])=O,2797541
6590,DB07499,"N-(4-{[amino(imino)methyl]amino}butyl)-2,4'-bi-1,3-thiazole-4-carboxamide",small molecule,experimental,,NC(N)=NCCCCNC(=O)C1=CSC(=N1)C1=CSC=N1,24856354
6591,DB07500,(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one,small molecule,experimental,,COC1=CC(O)=C(C=C1CC=C(C)C)C(=O)\C=C\C1=CC=C(O)C=C1,5321765
6592,DB07501,(2S)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,small molecule,experimental,,[H]N(C1=CC=C(OC[C@@H](O)CN(C)C)C=C1)C1=NC=C(Br)C(=N1)N([H])C1=CC=CC=C1,445958
6593,DB07502,"4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol",small molecule,experimental,,OC1=CC2=C(C=C1)C(=NO2)C1=CC(Br)=C(O)C=C1O,10403821
6594,DB07503,"(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE",small molecule,experimental,,FC1(F)OC2=C(O1)C=C(\C=C1/SC(=O)NC1=O)C=C2,5287855
6595,DB07504,(2R)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,small molecule,experimental,,[H]N(C1=CC=C(OC[C@H](O)CN(C)C)C=C1)C1=NC=C(Br)C(=N1)N([H])C1=CC=CC=C1,445957
6596,DB07505,"N-({(3R,4R)-4-[(benzyloxy)methyl]pyrrolidin-3-yl}methyl)-N-(2-methylpropyl)benzenesulfonamide",small molecule,experimental,,[H][C@]1(COCC2=CC=CC=C2)CNC[C@]1([H])CN(CC(C)C)S(=O)(=O)C1=CC=CC=C1,25113136
6597,DB07506,L-BENZYLSUCCINIC ACID,small molecule,experimental,,[H][C@](CC(O)=O)(CC1=CC=CC=C1)C(O)=O,444797
6598,DB07507,"2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",small molecule,experimental,,CC1=C2C(=O)N(C(=O)C2=CC=C1)C1=CC(=CC=C1O)C1=CC=CC=C1,25134257
6599,DB07508,4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE,small molecule,experimental,,CN1C(CC2=CC=C(C=C2)C(N)=N)=NC2=C1C=CC(NS(=O)(=O)C1=CC=CC=C1)=C2,446805
6600,DB07509,difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron,small molecule,experimental,,CCCCCCCCC1=CC=C2C=C3C=CC(CCCCC(O)=O)=[N+]3[B-](F)(F)N12,46937076
6601,DB07510,"3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid",small molecule,experimental,,OC(=O)C(\O)=C(\F)/C=C/C(=O)C1=CC=C(F)C=C1,23636976
6602,DB07511,"4-(4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzonitrile",small molecule,experimental,,CC1=C2C(=O)N(C(=O)C2=CC=C1)C1=CC=C(C=C1)C#N,25113145
6603,DB07512,7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE,small molecule,experimental,,ClC1=CC=CC(COC2=CC=C3C(OC(=O)C=C3C=O)=C2)=C1,16750123
6604,DB07513,7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE,small molecule,experimental,,CNCC1=CC(=O)OC2=C1C=CC(OCC1=CC=CC(Cl)=C1)=C2,11616886
6605,DB07514,"3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one",small molecule,experimental,,CC1=C(C(=O)N(C=C1)C1=CC=C2C(NCC2(C)C)=C1)C1=CC2=CN=C(N)N=C2C=C1,24812717
6606,DB07515,"1-(2-{[(6-amino-2-methylpyridin-3-yl)methyl]amino}ethyl)-6-chloro-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-1,4-dihydropyrazin-2-ol",small molecule,experimental,,CC1N[C@@H](N)CCC1CNCCN1C(O)C(NCC(F)(F)C2=CC=CC=N2)=NC=C1Cl,131704304
6607,DB07516,"(2Z,4E)-3-chloro-2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid",small molecule,experimental,,OC(=O)C(\O)=C(\Cl)/C=C/C(=O)C1=CC=CC=C1,17749729
6608,DB07517,3-CARBOXY-4-METHYL-5-PROPYL-2-FURANPROPIONIC,small molecule,experimental,,CCCC1=C(C)C(C(O)=O)=C(CCC(O)=O)O1,123979
6609,DB07518,(2R)-2-ETHYL-1-HEXANESULFONIC ACID,small molecule,experimental,,[H][C@@](CC)(CCCC)COS(O)(=O)=O,5496779
6610,DB07519,"(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",small molecule,experimental,,COC1=CC(=CC=C1)C1=CC(CC[C@]2(C)CC(=O)N(C)C(N)=N2)=CC=C1,16040323
6611,DB07520,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",small molecule,experimental,,[H][C@@](CS(=O)(=O)N1CCOCC1)(N[C@@]([H])(C1=CC=C(F)C=C1)C(F)(F)F)C(=O)NC1(CN)CC1,11840930
6612,DB07521,"(3Z,6S)-6-Chloro-1-(2-{[(5-chloro-1-benzothiophen-3-yl)methyl]amino}ethyl)-3-({2-[(2R)-2-piperidinyl]ethyl}imino)-2-piperazinol",small molecule,experimental,,[H][C@]1(CC\N=C2/NC[C@]([H])(Cl)N(CCNCC3=CSC4=CC=C(Cl)C=C34)C2O)CCCCN1,131704305
6613,DB07522,"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]NAPHTHALENE-2-SULFONAMIDE",small molecule,experimental,,[H][C@](N)(CC1=CC=CC=C1)[C@]([H])(O)CNS(=O)(=O)C1=CC=C2C=CC=CC2=C1,9543486
6614,DB07524,"N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine",small molecule,experimental,,N(C1=CNC2=NC=CC=C12)C1=CC=CC=C1,24180721
6615,DB07525,"3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine",small molecule,experimental,,COC1=CC=CC(CC2=CNC3=C2C=CC=N3)=C1,24180722
6616,DB07526,N-[4-({[5-(DIMETHYLAMINO)-1-NAPHTHYL]SULFONYL}AMINO)BUTYL]-3-SULFANYLPROPANAMIDE,small molecule,experimental,,CN(C)C1=C2C=CC=C(C2=CC=C1)S(=O)(=O)NCCCCNC(=O)CCS,11963499
6617,DB07527,"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE",small molecule,experimental,,[H][C@](N)(CC1=CC=CC=C1)[C@]([H])(O)CNS(=O)(=O)C1=C(C)C=C(OC)C(C)=C1C,9543487
6618,DB07528,3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one,small molecule,experimental,,CC1=C(C2=CC3=C(C=C2)N=C(N)N=C3)C(=O)N(C=C1)C1=CC(=CC=C1)C(F)(F)F,24812719
6619,DB07529,"(5E)-2-Amino-5-(2-pyridinylmethylene)-1,3-thiazol-4(5H)-one",small molecule,experimental,,N=C1NC(=O)\C(S1)=C/C1=CC=CC=N1,46937079
6620,DB07530,"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",small molecule,experimental,,[H][C@]1(CC[C@](C)(CCC#CC(O)(C(F)(F)F)C(F)(F)F)C1(C)C)\C=C\C=C1C[C@](O)([H])C[C@@](O)([H])C1,10457944
6621,DB07531,"4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",small molecule,experimental,,NS(=O)(=O)C1=CC=C(C=C1)C1=CC=C(O1)\C=C1/SC(=O)NC1=O,5828196
6622,DB07532,N-hexanoyl-L-homoserine,small molecule,experimental,,[H][C@@](CCO)(NC(=O)CCCCC)C(O)=O,24860535
6623,DB07533,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE",small molecule,experimental,,CNS(=O)(=O)C1=CC=C(C=C1)C1=CC=C(O1)\C=C1/SC(=N)NC1=O,23647652
6624,DB07534,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",small molecule,experimental,,NS(=O)(=O)C1=CC=C(C=C1)C1=CC=C(O1)\C=C1/SC(=N)NC1=O,5729339
6625,DB07535,2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one,small molecule,experimental,,NC1=NC(CCC2=CC3=C(C=CN3)C=C2)=CC(=O)N1,11651760
6626,DB07536,"N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide",small molecule,experimental,,[H][C@](C)(O)[C@]([H])(NC(=O)C1=CC=C(C=C1)C#CC1=CC=C(CN2CCOCC2)C=C1)C(=O)NO,11546620
6627,DB07537,"N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide",small molecule,experimental,,CC1=CC=C(C=C1C(=O)NC1=CN=C(N)C=C1)C(=O)NCCC1CCCC1,24812718
6628,DB07538,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE",small molecule,experimental,,NS(=O)(=O)C1=CC=C(C=C1C(F)(F)F)C1=CC=C(O1)\C=C1/SC(=N)NC1=O,23647657
6629,DB07539,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID",small molecule,experimental,,OC(=O)C1=CC=C(C=C1)C1=CC=C(O1)\C=C1/SC(=N)NC1=O,5951796
6630,DB07540,"4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE",small molecule,experimental,,C\C(C1=CC=C(O1)C1=CC=C(C=C1)S(N)(=O)=O)=C1\SC(=N)NC1=O,23647659
6631,DB07541,4-(dihydroxyboranyl)-2-({[4-(phenylsulfonyl)thiophen-2-yl]sulfonyl}amino)benzoic acid,small molecule,experimental,,OB(O)C1=CC(NS(=O)(=O)C2=CC(=CS2)S(=O)(=O)C2=CC=CC=C2)=C(C=C1)C(O)=O,46890069
6632,DB07542,5-AMINO-6-CYCLOHEXYL-4-HYDROXY-2-ISOBUTYL-HEXANOIC ACID,small molecule,experimental,,[H][C@](N)(CC1CCCCC1)[C@@]([H])(O)C[C@@]([H])(CC(C)C)C(O)=O,6323244
6633,DB07543,(S)-carazolol,small molecule,experimental,,CC(C)NC[C@H](O)COC1=CC=CC2=C1C1=CC=CC=C1N2,13023332
6634,DB07544,N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE,small molecule,experimental,,FC(F)(F)C1=CC=CC=C1S(=O)(=O)NNC(=O)C1=CC2=CC(Cl)=CC=C2O1,6914573
6635,DB07545,N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE,small molecule,experimental,,FC(F)(F)C1=CC=CC(NC2=NC(NC3=CC(NC(=O)C4CC4)=CC=C3)=NC=C2)=C1,9549303
6636,DB07546,[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid,small molecule,experimental,,CC(C)NC1=CC2=C(C=NN2C2=NC(=CN=C2)N2C=CC(CC(O)=O)=C2)C=C1,16224058
6637,DB07547,5-(4-CYANOPHENYL)-3-{[(2-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,small molecule,experimental,,CC1=CC=CC=C1S(=O)(=O)NC1=C(SC(=C1)C1=CC=C(C=C1)C#N)C(O)=O,9543494
6638,DB07548,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE",small molecule,experimental,,CC1=CN=C(NCC(F)(F)C2=CC=CC=N2)C(=O)N1CC(=O)NCC1=C(F)C=CC=N1,447219
6639,DB07549,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE",small molecule,experimental,,CC1=C[NH+]=C(NCC(F)(F)C2=[NH+]C=CC=C2)C(=O)N1CC(=O)NCC1=C(F)C(C)=CC=N1,6323250
6640,DB07550,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE",small molecule,experimental,,[O-][N+]1=CC=CC=C1C(F)(F)CNC1=NC=C(Cl)N(CC(=O)NCC2=C(F)C=CC=C2)C1=O,656913
6641,DB07551,"(2S)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile",small molecule,experimental,,CCNC1=NC(Cl)=NC(NC(C)(CC)C#N)=N1,449582
6642,DB07552,"(2R)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile",small molecule,experimental,,CCNC1=NC(Cl)=NC(NC(C)(CC)C#N)=N1,449597
6643,DB07553,"9,9,9-TRIFLUORO-8-OXO-N-PHENYLNONANAMIDE",small molecule,experimental,,FC(F)(F)C(=O)CCCCCCC(=O)NC1=CC=CC=C1,9882812
6644,DB07555,"Hydroxy(oxo)(2-{(1S)-2,2,2-trifluoro-1-[2-(trimethylarsonio)ethoxy]ethyl}phenyl)ammonium",small molecule,experimental,,[H][C@](OCC[As+](C)(C)C)(C1=CC=CC=C1[N+](O)=O)C(F)(F)F,46937080
6645,DB07556,CGS-27023,small molecule,experimental,"Amides|Amines|Enzyme Inhibitors|Hydroxy Acids|Hydroxylamines|Matrix Metalloproteinase Inhibitors|Metalloendopeptidases, antagonists & inhibitors|Protease Inhibitors|Serine Protease Inhibitors|Sulfones|Sulfur Compounds",COC1=CC=C(C=C1)S(=O)(=O)N(CC1=CC=CN=C1)[C@H](C(C)C)C(=O)NO,446504
6646,DB07557,"3,20-Pregnanedione",small molecule,experimental,,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])CC(=O)CC[C@]12C,92745
6647,DB07558,acetylleucyl-leucyl-norleucinal,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Calpain, antagonists & inhibitors|Cysteine Proteinase Inhibitors|Enzyme Inhibitors|NF-kappa B, antagonists & inhibitors|Oligopeptides|Peptides|Protease Inhibitors",[H]C(=O)[C@H](CCCC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O,443118
6648,DB07559,"(2Z)-2-cyano-N-(2,2'-dichlorobiphenyl-4-yl)-3-hydroxybut-2-enamide",small molecule,experimental,,C\C(O)=C(/C#N)C(=O)NC1=CC(Cl)=C(C=C1)C1=CC=CC=C1Cl,54727980
6649,DB07560,N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide,small molecule,experimental,,[H][C@](NC(=O)C1CCCCC1)(C(C)C)C(=O)NC1=CC=NC=C1,25134246
6650,DB07561,(2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide,small molecule,experimental,,CCOC1=CC(=CC=C1)C1=CC=C(NC(=O)C(\C#N)=C(\C)O)C=C1,54727985
6651,DB07562,"N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE",small molecule,experimental,,CN(C)C1=CC=C(NC2=NC(=CC=N2)C2=C(C)N=C(C)S2)C=C1,447962
6652,DB07563,"1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine",small molecule,experimental,,CN1CCN(CC1)C1=CC=C(CC2=CC3=CN=C(CN)N=C3N2C2CCCCC2)C=C1,46937081
6653,DB07564,"6-amino-2-[(2-morpholin-4-ylethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",small molecule,experimental,,NC1=NC2=C(C=C3N=C(NCCN4CCOCC4)NC3=C2)C(=O)N1,23643565
6654,DB07565,Chloramphenicol succinate,small molecule,approved,Alcohols|Anti-Bacterial Agents|Anti-Infective Agents|Benzene Derivatives|Glycols|Narrow Therapeutic Index Drugs|Nitro Compounds|Nitrobenzenes|P-glycoprotein substrates|Propylene Glycols,O[C@@H]([C@@H](COC(=O)CCC(O)=O)NC(=O)C(Cl)Cl)C1=CC=C(C=C1)[N+]([O-])=O,656580
6655,DB07567,"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL",small molecule,experimental,,[H][C@@]1(C)C2=CC(O)=CC=C2O[C@@]([H])(C2=CC=C(OCCN3CCCC3)C=C2)[C@@]1([H])C1=CC=C(O)C=C1,4369568
6656,DB07568,"(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE",small molecule,experimental,,[H][C@@](NS(=O)(=O)C1=CC=CC2=NSN=C12)(C(=O)NC1=CC=NC=C1)C1=CC=CC=C1,16214776
6657,DB07569,CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE,small molecule,experimental,,[H][C@@](CCSC)(NC(=O)[C@]1([H])CC[C@]([H])(C)CC1)C(=O)NC1=CC=NC=C1,25134245
6658,DB07570,3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID,small molecule,experimental,,OC(=O)C1=CC=C2C(=C1)N(CC(=O)N1CCOCC1)C(=C2C1CCCCC1)C1=CC=CC=C1,4369534
6659,DB07571,"N~2~-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE",small molecule,experimental,,[H][C@@](C)(O)[C@]([H])(CC1=CC=C(O)C=C1)NC(=O)[C@]([H])(CC(C)C)NC(=O)OCC1=CC=CC=C1,6857710
6660,DB07572,3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate,small molecule,experimental,,CC1=CC=C(C=C1)S(=O)(=O)NCCCOC(=O)NC1=CC=NC=C1,3236724
6661,DB07573,"(2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol",small molecule,experimental,,[H][C@@](O)(COC1=C(C)C=CC(C)=C1)CN1CCOCC1,831616
6662,DB07574,"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",small molecule,experimental,,[H][C@@]1(CCC2=C(C(OC)=C(OC)C(OC)=C2)C2=CC=C(OC)C(=O)C=C12)NC(=O)CS,5287955
6663,DB07575,"2,4-DIAMINO-1,5-DIPHENYL-3-HYDROXYPENTANE",small molecule,experimental,,[H][C@](N)(CC1=CC=CC=C1)C(O)[C@@]([H])(N)CC1=CC=CC=C1,452307
6664,DB07577,"2,4-Diamino-5-phenyl-6-ethylpyrimidine",small molecule,experimental,,CCC1=C(C(N)=NC(N)=N1)C1=CC=CC=C1,93114
6665,DB07578,CP-94707,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|HIV Reverse Transcriptase, antagonists & inhibitors|Sulfur Compounds|Thiazoles",CC1=NC2=C(C=CN=C2)N1C1=CC=C(CN2C(=O)SC3=CC=CC=C23)C=C1,448793
6666,DB07579,"Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane",small molecule,experimental,,CC1(OCC(CO1)OC(=O)NCCNC(=O)OC1COC(C)(OC1)C(O)=O)C(O)=O,4369593
6667,DB07580,"BIS-1,2-{[(Z)-2CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBONYL}-PIPERAZINE",small molecule,experimental,,[H][C@@]1(CO[C@](C)(OC1)C(O)=O)OC(=O)N1CCN(CC1)C(=O)O[C@@]1([H])CO[C@](C)(OC1)C(O)=O,4369594
6668,DB07581,5-AMINO-6-CYCLOHEXYL-4-HYDROXY-2-ISOPROPYL-HEXANOIC ACID,small molecule,experimental,,[H][C@](N)(CC1CCCCC1)[C@@]([H])(O)C[C@@]([H])(C(C)C)C(O)=O,5287976
6669,DB07582,"N-[(2R,3S)-1-((2S)-2-{[(CYCLOPENTYLAMINO)CARBONYL]AMINO}-3-METHYLBUTANOYL)-2-(1-FORMYL-1-CYCLOBUTYL)PYRROLIDINYL]CYCLOPROPANECARBOXAMIDE",small molecule,experimental,,[H][C@](NC(=O)NC1CCCC1)(C(C)C)C(=O)N1CC[C@]([H])(NC(=O)C2CC2)[C@@]1([H])C1(CCC1)C=O,5287977
6670,DB07583,"(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",small molecule,experimental,,[H][C@@]1(CNS(=O)(=O)C2=CC=CC3=CN=CC=C23)C[C@]([H])(CN1)OCC1=CC=C(Cl)C=C1,5327110
6671,DB07584,"N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",small molecule,experimental,,CC1=NN=C(N1)C1=CC=CC=C1NC1=NC=NC2=C1C=CN2,24798741
6672,DB07585,"5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine",small molecule,experimental,,ClC1=CNC2=C1C(=NC=N2)N1CCC2=C(C1)N=CN2,24798742
6673,DB07586,"5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE",small molecule,experimental,,CN(C)C(=O)C1=CC(=CC(NC(=O)C2=CC=C(C)C=C2)=C1)C1=CC=C(C=C1)C(=O)NO,5287979
6674,DB07587,"N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",small molecule,experimental,,[H][C@@](CS(=O)(=O)C[C@]1([H])CCC(=O)N1)(N[C@@]([H])(C1=CC=C(F)C=C1)C(F)(F)F)C(=O)NC1(CC1)C#N,11840933
6675,DB07588,"3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID",small molecule,experimental,,OC(=O)C1=C(C2=CNC3=CC=CC=C23)C(=C(N1)C(O)=O)C1=CNC2=C1C=CC=C2,11326613
6676,DB07589,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE",small molecule,experimental,,[H][C@@](CS(=O)(=O)CC1=CC=CC=C1)(N[C@@]([H])(C1=CC=C(O)C=C1)C(F)(F)F)C(=O)NC1(CN)CC1,11840934
6677,DB07590,"S-[3-(3,4-DICHLOROPHENYL)-3-OXOPROPYL]-L-CYSTEINE",small molecule,experimental,,[H][C@](N)(CSCCC(=O)C1=CC=C(Cl)C(Cl)=C1)C(O)=O,46937082
6678,DB07591,N1-CYCLOPENTYL-N2-(THIAZOL-2-YL)OXALAMIDE,small molecule,experimental,,O=C(NC1CCCC1)C(=O)NC1=NC=CS1,2255489
6679,DB07592,(2R)-3-Methyl-1-phenyl-2-butanyl [(2S)-1-oxo-2-hexanyl]carbamate,small molecule,experimental,,[H][C@@](CCCC)(NC(=O)O[C@]([H])(CC1=CC=CC=C1)C(C)C)C=O,10062713
6680,DB07593,1-(PHENYLMETHYL)CYCLOPENTYL[(1S)-1-FORMYLPENTYL]CARBAMATE,small molecule,experimental,,[H][C@@](CCCC)(NC(=O)OC1(CC2=CC=CC=C2)CCCC1)C=O,10062714
6681,DB07594,CCT-018159,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring",CCC1=C(O)C=C(O)C(=C1)C1=C(C(C)=NN1)C1=CC2=C(OCCO2)C=C1,5327091
6682,DB07595,"(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE",small molecule,experimental,,BrC1=CC=CC(=C1)C1=NC2=[N+](NC=C2)C(NCC2=CC=NC=C2)=C1,5327130
6683,DB07596,"(17beta)-17-(cyanomethyl)-2-methoxyestra-1(10),2,4-trien-3-yl sulfamate",small molecule,experimental,,[H][C@]1(CC#N)CC[C@@]2([H])[C@]3([H])CCC4=CC(OS(N)(=O)=O)=C(OC)C=C4[C@@]3([H])CC[C@]12C,11188898
6684,DB07597,"CIS-(1R,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL",small molecule,experimental,,[H][C@]1(N)CCC2=CC=CC=C2[C@@]1([H])O,6420129
6685,DB07598,"2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE",small molecule,experimental,,[H][C@@]12CCCN1C(=O)C1=C(O2)C=C2OCCOC2=C1,5288002
6686,DB07599,[(2-AMINO-ALPHA-METHOXYIMINO-4-THIAZOLYLACETYL)AMINO]METHYLBORONIC ACID,small molecule,experimental,,CO\N=C(/C(=O)NCB(O)O)C1=CSC(N)=N1,9600412
6687,DB07601,"4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol",small molecule,experimental,,OC1=CC(O)=C(Cl)C=C1C1=NOC2=C1C=C(NCCN1CCOCC1)C=C2,24836816
6688,DB07602,S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE,small molecule,experimental,,[H][C@](N)(CSCCC(=O)NC1=CC2=C(C=C1)N=CN=C2NC1=CC=CC=C1)C(O)=O,46937083
6689,DB07603,N-hexanoyl-L-homocysteine,small molecule,experimental,,[H][C@@](CCS)(NC(=O)CCCCC)C(O)=O,24860536
6690,DB07604,"(6AR,11AS,11BR)-10-ACETYL-9-HYDROXY-7,7-DIMETHYL-2,6,6A,7,11A,11B-HEXAHYDRO-11H-PYRROLO[1',2':2,3]ISOINDOLO[4,5,6-CD]INDOL-11-ONE",small molecule,experimental,,[H][C@@]12CC3=C4C(NC=C4[C@]1([H])[C@]1([H])N(C(O)=C(C(C)=O)C1=O)C2(C)C)=CC=C3,54682463
6691,DB07605,"2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE",small molecule,experimental,,[O-][N+]1=CC=CC2=C1C=C(S2)C(=O)N1CCN(CC1)S(=O)(=O)C1=CC2=CC(Cl)=CC=C2N1,9547923
6692,DB07606,"6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE",small molecule,experimental,,CCC1=NN(C2=C1C(=O)NC(CC1=CC(O)=C(O)C=C1)=N2)C1=C(Cl)C=C(Cl)C=C1Cl,5327057
6693,DB07607,4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE,small molecule,experimental,,C[S@@](=O)C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC(I)=CC=C1)C1=CC=NC=C1,9543437
6694,DB07608,N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide,small molecule,experimental,,[H][C@@](CCN)(C(=O)NC1=CC=C2NN=C(NC(=O)C3=CC=CC=C3)C2=C1)C1=CC(Cl)=CC=C1,24894158
6695,DB07609,"N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE",small molecule,experimental,,CN(C)CC1=CC=C(O1)C1=CC=CN=C1,11171679
6696,DB07610,"1,2-Dihydroxynaphthalene",small molecule,experimental,Naphthalenes,OC1=C(O)C2=CC=CC=C2C=C1,11318
6697,DB07611,DECANE-1-THIOL,small molecule,experimental,,CCCCCCCCCCS,8917
6698,DB07612,6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE,small molecule,experimental,,CC(C)(C)NC1=NC(=NC2=C1C=C(C=C2)C1=CC=CC(N)=C1)C(F)(F)F,5288016
6699,DB07613,3-phenyl-5-(1H-pyrazol-3-yl)isoxazole,small molecule,experimental,,N1C=CC(=N1)C1=CC(=NO1)C1=CC=CC=C1,24764436
6700,DB07614,"PHENYL-5-(1H-PYRAZOL-3-YL)-1,3-THIAZOLE",small molecule,experimental,,N1C=CC(=N1)C1=CN=C(S1)C1=CC=CC=C1,2763788
6701,DB07615,Tranilast,small molecule,investigational,"Acids, Carbocyclic|Agents causing hyperkalemia|Aminobenzoates|Analgesics|Analgesics, Non-Narcotic|Anti-Allergic Agents|Anti-Inflammatory Agents|Antiarrhythmic agents|Antiplatelet agents|Antirheumatic Agents|Benzene Derivatives|Benzoates|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Central Nervous System Agents|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Hematologic Agents|Histamine Agents|Membrane Transport Modulators|Neurotransmitter Agents|Peripheral Nervous System Agents|Sensory System Agents",COC1=CC=C(\C=C\C(=O)NC2=CC=CC=C2C(O)=O)C=C1OC,5282230
6702,DB07616,"4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid",small molecule,experimental,,CC1=CC(=CC=C1F)C1=CSC(NC2=CC=C(C(O)=O)C(O)=C2)=N1,695906
6703,DB07617,N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE,small molecule,experimental,,CNCC1=CC=C(O1)C1=CC=CN=C1,11229234
6704,DB07618,"2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE",small molecule,experimental,,NCC1CCN(CC(=O)NC2=CC=CC3=C2C(=O)C2=C(NN=C32)C2CCCCC2)CC1,5288017
6705,DB07619,"N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide",small molecule,experimental,,[H][C@@]1(CC[C@@]([H])(CC1)C1=CC=CN=C1)N(C1CC1)C(=O)C1=CC=C(C=C1)[C@](C)(O)C(F)(F)F,16726072
6706,DB07620,"2-[(2,4-DICHLORO-5-METHYLPHENYL)SULFONYL]-1,3-DINITRO-5-(TRIFLUOROMETHYL)BENZENE",small molecule,experimental,,CC1=CC(=C(Cl)C=C1Cl)S(=O)(=O)C1=C(C=C(C=C1[N+]([O-])=O)C(F)(F)F)[N+]([O-])=O,2799606
6707,DB07621,(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE,small molecule,experimental,,NCC1=CC=C(O1)C1=CC=CN=C1,11332763
6708,DB07622,"1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA",small molecule,experimental,,CN1CCN(CC1)NC(=O)NC1=CC=CC2=C1C(=O)C1=C(NN=C21)C1=C(C)N=C(C)S1,5288018
6709,DB07623,"4,4'-DIPYRIDYL DISULFIDE",small molecule,experimental,"Acids|Acids, Noncarboxylic|Anions|Electrolytes|Gases|Hydrogen Sulfide|Ions|Sulfhydryl Reagents|Sulfides|Sulfur Compounds",S(SC1=CC=NC=C1)C1=CC=NC=C1,75846
6710,DB07624,"1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide",small molecule,experimental,,[H][C@@]1(C)CN(CC2(CC2)C(N)=O)CCN1S(=O)(=O)C1=CC=C(C=C1)[C@](C)(O)C(F)(F)F,24856362
6711,DB07625,"4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide",small molecule,experimental,,CCOC1=CC=C(OCC)C(NC(=O)C2=CC(C)=C(OCCN)C(C)=C2)=C1,23653531
6712,DB07626,"4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",small molecule,experimental,,CCOC1=C(NC(=O)C2=CC(C)=C(OCCN)C(C)=C2)C=C(C=C1Cl)N1CCCCC1,23653533
6713,DB07627,(2S)-4-METHYL-2-(3-PHENYLTHIOUREIDO)-N-((3S)-TETRAHYDRO-2-HYDROXY-3-FURANYL)PENTANAMIDE,small molecule,experimental,,[H][C@@](CC(C)C)(NC(=S)NC1=CC=CC=C1)C(=O)N[C@]1([H])CO[C@]([H])(O)C1,6857711
6714,DB07628,"6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one",small molecule,experimental,,CN1C2=C(SC(C)=C2)C2=C1C(=O)N(CC1=CC=CC=C1F)N=C2,654376
6715,DB07629,"N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",small molecule,experimental,,[H][C@@]1(CCCC[C@@]1([H])NC(=O)C1=NC2=C(CN(C)CC2)S1)NC(=O)C1=CC2=C(N1)C=CC(Cl)=C2,24752832
6716,DB07630,"N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",small molecule,experimental,,[H][C@]1(CCCC[C@@]1([H])NC(=O)C1=NC2=C(CN(C)CC2)S1)NC(=O)C1=CC2=C(N1)C=CC(Cl)=C2,24752833
6717,DB07631,Lauryldimethylbetaine,small molecule,experimental,Amines|Ammonium Compounds|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds|Trimethyl Ammonium Compounds,CCCCCCCCCCCC[N+](C)(C)CC([O-])=O,4292413
6718,DB07632,"5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide",small molecule,experimental,,NS(=O)(=O)C1=NN=C(S1)C1=CC=CC=C1Cl,165323
6719,DB07633,octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside,small molecule,experimental,,[H][C@@]1(O)C[C@@]([H])(O[C@]2([H])O[C@@]([H])(C)[C@@]([H])(O)[C@@]([H])(O)[C@]2([H])O)[C@]([H])(OCCCCCCCC)O[C@]1([H])CO,46937084
6720,DB07634,"(2,6-Dimethylphenoxy)acetic acid",small molecule,experimental,,CC1=CC=CC(C)=C1OCC(O)=O,101369
6721,DB07635,"4,4'-Dihydroxybenzophenone",small molecule,experimental,,OC1=CC=C(C=C1)C(=O)C1=CC=C(O)C=C1,69150
6722,DB07636,"5-Heptyl-6-hydroxy-1,3-benzothiazole-4,7-dione",small molecule,experimental,,CCCCCCCC1=C(O)C2=C(SC=N2)C(=O)C1=O,5288033
6723,DB07637,Dibromotyrosine,small molecule,experimental,"Antithyroid agents|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thyroid Products",[H][C@](N)(CC1=CC(Br)=C(O)C(Br)=C1)C(O)=O,67532
6724,DB07638,"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",small molecule,experimental,,[H][C@@]12CC(F)(F)C[C@]1([H])[C@@]([H])(OC1=C2C=C(O)C=C1)C1=CC=C(O)C=C1,11197931
6725,DB07639,3-(7-DIAMINOMETHYL-NAPHTHALEN-2-YL)-PROPIONIC ACID ETHYL ESTER,small molecule,experimental,,CCOC(=O)C(CC1=CC2=C(C=C1)C=CC(=C2)C(N)N)C1=CC=C(OC2CCNC2)C=C1,75243795
6726,DB07640,"2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione",small molecule,experimental,,CCCCCCCCCCC1=C(C)C(=O)C(OC)=C(OC)C1=O,2971
6727,DB07641,Decyl(dimethyl)phosphine oxide,small molecule,experimental,Organophosphorus Compounds|Phosphorus Compounds,CCCCCCCCCCP(C)(C)=O,3492020
6728,DB07642,"5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",small molecule,experimental,,NC1=NC2=CC=CC(OCC3CCN(CC4=CC=CC=C4F)CC3)=C2C(N)=N1,23729147
6729,DB07643,"5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",small molecule,experimental,,NC1=NC2=C(C(N)=N1)C(OCC1CCN(CC3=C(Cl)C(Cl)=CC=C3)CC1)=CC=C2,24978486
6730,DB07644,"5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine",small molecule,experimental,,[H][C@@](C)(OC1=C2C(N)=NC(N)=NC2=CC=C1)C1=CC(Cl)=CC=C1,24778299
6731,DB07645,Sebacic acid,small molecule,experimental,"Acids, Acyclic|Fatty Acids|Lipids",OC(=O)CCCCCCCCC(O)=O,5192
6732,DB07646,"UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE",small molecule,experimental,,CCCCCCCCCCC[N+](C)(C)[O-],4112111
6733,DB07647,"(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL",small molecule,experimental,,[H][C@](C)(O)CNC1=C2C(NC(=C2C2=CC=CC=C2)C2=CC=CC=C2)=NC=N1,4369434
6734,DB07648,"(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL",small molecule,experimental,,[H][C@](O)(CO)CNC1=C2C(NC(=C2C2=CC=CC=C2)C2=CC=CC=C2)=NC=N1,4369435
6735,DB07649,"(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin-3-ol",small molecule,experimental,,[H][C@]1(O)CN(CC2=CNC3=C2N=CN=C3N)C[C@]1([H])CSCC1=CC=CC=C1,10067695
6736,DB07650,Decyl formate,small molecule,experimental,,CCCCCCCCCCOC=O,79541
6737,DB07651,N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE,small molecule,experimental,,[H][C@@](CC1=CC=C(C=C1)C(F)(F)P(O)(O)=O)(NC(=O)[C@]([H])(CC1=CC=CC=C1)NC(C)=O)C(N)=O,9547919
6738,DB07652,"1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE",small molecule,experimental,,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(O)=O)C1=CC(C)=C(F)C=C1F,46937086
6739,DB07653,"N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE",small molecule,experimental,,OC(=O)CNC1=NC=NC2=C1C(=C(O2)C1=CC=CC=C1)C1=CC=CC=C1,848641
6740,DB07654,"(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC",small molecule,experimental,,CN(CCO)C1=NC=NC2=C1C(=C(O2)C1=CC=CC=C1)C1=CC=CC=C1,4369432
6741,DB07655,"3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",small molecule,experimental,,OCCNC1=NC=NC2=C1C(=C(N2)C1=CC=CC=C1)C1=CC=CC=C1,4369433
6742,DB07657,PHOSPHONIC ACID 2-DODECANOYLAMINO-HEXYL ESTER PROPYL ESTER,small molecule,experimental,,[H][C@@](CCCC)(CO[P@](O)(=O)OCCO)NC(=O)CCCCCCCCCCC,131505
6743,DB07658,AC-(D)Phe-pro-borolys-OH,small molecule,experimental,,CC(=O)N[C@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)B(O)O,5288064
6744,DB07659,AC-(D)PHE-PRO-BOROHOMOLYS-OH,small molecule,experimental,,[H][C@@](CCCCCN)(NC(=O)[C@]1([H])CCCN1C(=O)[C@@]([H])(CC1=CC=CC=C1)NC(C)=O)B(O)O,5288066
6745,DB07660,AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH,small molecule,experimental,,[H][C@@](CCCN)(NC(=O)[C@]1([H])CCCN1C(=O)[C@@]([H])(CC1=CC=CC=C1)NC(C)=O)B(O)O,5288067
6746,DB07661,"1,6-Naphthalenediol",small molecule,experimental,Naphthalenes,OC1=CC=C2C(O)=CC=CC2=C1,68463
6747,DB07662,PD-168393,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring",BrC1=CC(NC2=C3C=C(NC(=O)C=C)C=CC3=NC=N2)=CC=C1,4708
6748,DB07663,"2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID",small molecule,experimental,,[H][C@](CC1=CC=C(O)C=C1)(N1C(=O)C2=C(C=C(C=C2)C(O)=O)C1=O)C(O)=O,7013169
6749,DB07664,K-00546,small molecule,experimental,,NC1=NC(NC2=CC=C(C=C2)S(N)(=O)=O)=NN1C(=S)NC1=C(F)C=CC=C1F,5330812
6750,DB07665,"N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide",small molecule,experimental,,[H]N([H])C(=NOCCN([H])C(=O)CC1=C(C=CC(N([H])CC(F)(F)C2=CC=CC=N2)=C1F)C#N)N([H])[H],9867609
6751,DB07666,"(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",small molecule,experimental,,[H][C@]1(N)CN(C[C@]1([H])C1=CC(F)=C(F)C=C1F)C1=CC(=NC=N1)C1=CC(=CC=C1)S(C)(=O)=O,16750059
6752,DB07667,"2-((3',5'-DIMETHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID",small molecule,experimental,,CC1=CC(=CC(C)=C1O)\N=N\C1=CC=CC=C1C(O)=O,5326799
6753,DB07668,3-(4-DIETHYLAMINO-2-HYDROXY-PHENYL)-2-METHYL-PROPIONIC ACID,small molecule,experimental,,CCN(CC)C1=CC(O)=C(\C=C(/C)C(O)=O)C=C1,5288082
6754,DB07669,"2,3-Dimethyl-1,4-naphthoquinone",small molecule,experimental,Naphthalenes|Quinones,CC1=C(C)C(=O)C2=CC=CC=C2C1=O,16615
6755,DB07670,"N,4-Dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide",small molecule,experimental,,CN(C1=CC=NN1C1=CC=CC=C1)S(=O)(=O)C1=CC=C(C)C=C1,447297
6756,DB07671,"2-[1-METHYLHEXYL]-4,6-DINITROPHENOL",small molecule,experimental,,CCCCCC(C)C1=C(O)C(=CC(=C1)N(=O)=O)N(=O)=O,4630702
6757,DB07672,TRANS-2-(DIMETHYLPHENYLSILYL)-PIPERIDINE-N-OXIDE,small molecule,experimental,,[H][C@@]1(CC[N@@+](C)([O-])CC1)[Si](C)(C)C1=CC=CC=C1,45480634
6758,DB07673,(2S)-2-Methyl-3-phenylpropanoic acid,small molecule,experimental,,C[C@@H](CC1=CC=CC=C1)C(O)=O,5288102
6759,DB07674,"O,O-DIETHYL HYDROGEN THIOPHOSPHATE",small molecule,experimental,,CCOP(O)(=S)OCC,655
6760,DB07675,(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID,small molecule,experimental,,[H][C@@](CC1=CC=C(OCCN2C3=C(OC4=C2C=CC=C4)C=CC=C3)C=C1)(OCC)C(O)=O,447458
6761,DB07676,"3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one",small molecule,experimental,,OC[C@@H](O)CCONC1=C(NC2=CC=CC=C12)C1=C2C=CC=CC2=NC1=O,24894167
6762,DB07677,"2-methyl-3,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one",small molecule,experimental,,CC1=NC2=C(CSCC2)C(=O)N1,10219702
6763,DB07678,"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",small molecule,experimental,,[H]\C(CC)=C(/[H])C1=C(O)C=C2CC[C@@]3([H])[C@]4([H])CC[C@]([H])(O)[C@@]4(C)CC[C@]3([H])C2=C1,42627296
6764,DB07679,"(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid",small molecule,experimental,,[H][C@]1(CC2=CC=C(OCCCCC(=O)N[C@@]([H])(C(C)C)C(=O)N1)C=C2)C(O)=O,10713671
6765,DB07680,[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID,small molecule,experimental,,[H][C@@](C(=O)NC1=CC=C2C=CC=CC2=C1)(C1=CSC2=C1C=C(Cl)C=C2)P(O)(O)=O,16122567
6766,DB07681,DODECANESULFONATE ION,small molecule,experimental,,CCCCCCCCCCCCS([O-])(=O)=O,3383616
6767,DB07683,"N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine",small molecule,experimental,,[H][C@](NS(=O)(=O)C1=CC2=C(C=C1)C1=CC=CC=C1S2)(C(C)C)C(O)=O,24794392
6768,DB07684,5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID,small molecule,experimental,,CN(C)C1=C2C=CC(=CC2=CC=C1)S(O)(=O)=O,4474224
6769,DB07685,"4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",small molecule,experimental,,NS(=O)(=O)C1=CC=C(NC2=CC(OCC3CCCCC3)=NC3=NC=NN23)C=C1,23586145
6770,DB07686,"4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",small molecule,experimental,,NS(=O)(=O)C1=CC=C(NC2=CC(NC3CCCCC3)=NC3=NC=NN23)C=C1,23586146
6771,DB07687,"4-({5-[(4-AMINOCYCLOHEXYL)AMINO][1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE",small molecule,experimental,,[H][C@]1(N)CC[C@@]([H])(CC1)NC1=NC2=NC=NN2C(NC2=CC=C(C=C2)S(N)(=O)=O)=C1,23645578
6772,DB07688,"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",small molecule,experimental,,NS(=O)(=O)C1=CC=C(NC2=CC(OC3CCCCC3)=NC3=NC=NN23)C=C1,11574606
6773,DB07689,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",small molecule,experimental,,COC(=O)C1CCN(CC1)C(=O)C1=CC=C(NCC2=NC3=C(N=C2)N=C(N)N=C3N)C=C1,25243853
6774,DB07691,"2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid",small molecule,experimental,,OC(=O)C1=C(NC(=O)C2=CC=CC(=C2)S(=O)(=O)N2CCC3=CC=CC=C3C2)C=CC=C1,24941254
6775,DB07692,"1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine",small molecule,experimental,,FC1=CC=CC(F)=C1S(=O)(=O)N1CCN(CC1)S(=O)(=O)C1=CC=C2OCCOC2=C1,25210493
6776,DB07693,"N-(3,5-dibromo-4-hydroxyphenyl)-2,6-dimethylbenzamide",small molecule,experimental,,CC1=CC=CC(C)=C1C(=O)NC1=CC(Br)=C(O)C(Br)=C1,25210478
6777,DB07694,"2,5-dichloro-N-(3,5-dibromo-4-hydroxyphenyl)benzamide",small molecule,experimental,,OC1=C(Br)C=C(NC(=O)C2=CC(Cl)=CC=C2Cl)C=C1Br,5119267
6778,DB07695,"N-(3,5-dibromo-4-hydroxyphenyl)-4-hydroxy-3,5-dimethylbenzamide",small molecule,experimental,,CC1=CC(=CC(C)=C1O)C(=O)NC1=CC(Br)=C(O)C(Br)=C1,25210479
6779,DB07696,methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate,small molecule,experimental,,[H][C@@](CC(=O)OC)(NC(=O)OC(C)(C)C)C(C)=O,46937089
6780,DB07697,"1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine",small molecule,experimental,,COC1=CC=C(C=C1)S(=O)(=O)N1CCN(CC1)S(=O)(=O)C1=CC=C2OCCOC2=C1,650361
6781,DB07698,"3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine",small molecule,experimental,,NC1=CC=CC(=C1)C1=C2N=C(NC3=CC=CC(Cl)=C3)C=CN2N=C1,6419789
6782,DB07700,"3-carboxamido-1,3,5(10)-estratrien-17(R)-spiro-2'(5',5'-dimethyl-6'oxo)tetrahydropyran",small molecule,experimental,,[H][C@@]12CC[C@@]3(CCC(C)(C)C(=O)O3)[C@@]1(C)CC[C@]1([H])C3=CC=C(C=C3CC[C@@]21[H])C(N)=O,11987804
6783,DB07701,"1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE",small molecule,experimental,,[H][C@@]1(CC2CCN(CC3=CC=CC=C3)CC2)CC2=CC(OC)=C(OC)C=C2C1=O,1150567
6784,DB07702,17alpha-Estriol,small molecule,experimental,,[H][C@@]12C[C@@H](O)[C@@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,256737
6785,DB07703,"(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE",small molecule,experimental,,[H][C@@]1(C)C[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)O[C@]([H])(CC)[C@]([H])(C)\C=C\C1=O,5282031
6786,DB07704,"6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",small molecule,experimental,,COC1=CC=C(CCC2=C3N=CNC3=CC3=C2N=C(N)NC3=O)C=C1,5326930
6787,DB07705,(S)-econazole,small molecule,experimental,,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1,12773795
6788,DB07706,2-Hydroxyestradiol,small molecule,experimental,"COMT Substrates|Estradiol Congeners|Estranes|Estrenes|Estrogens, Catechol|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids",[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=C(C=C(O)C(O)=C4)[C@@]3([H])CC[C@]12C,247304
6789,DB07707,"(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL",small molecule,experimental,,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])[C@@]([H])(COC)C[C@]12C,23728517
6790,DB07708,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,small molecule,experimental,,OC1=CC=C(C=C1)N1N=C2C=CC(O)=CC2=C1Cl,11368987
6791,DB07710,PHENYLALANYLAMINODI(ETHYLOXY)ETHYL BENZENESULFONAMIDEAMINOCARBONYLBENZENESULFONAMIDE,small molecule,experimental,,[H][C@](N)(CC1=CC=CC=C1)C(=O)NCCOCCOCCNC(=O)C1=CC=C(C=C1)S(N)(=O)=O,444849
6792,DB07711,"(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol",small molecule,experimental,,[H][C@@](C)(O)[C@@]([H])(CCCCCC)N1C=NC2=C(N)N=CN=C12,149790
6793,DB07712,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,small molecule,experimental,,CCC1=C2C=C(O)C=CC2=NN1C1=CC=C(O)C=C1,11149479
6794,DB07713,"(1S)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",small molecule,experimental,,COC1=CC=C(C=C1)C1=CC=C(C=C1)S(=O)(=O)N[C@H](C(C)C)P(O)(O)=O,6540261
6795,DB07714,"6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID",small molecule,experimental,,CC1=C(CCCCCC(O)=O)C(=O)C2=CC=CC=C2C1=O,10708341
6796,DB07715,Emodin,small molecule,investigational,Anthracenes|Anthraquinones|Biological Products|Cascara|Complex Mixtures|Enzyme Inhibitors|Gastrointestinal Agents|Laxatives|Pharmaceutical Preparations|Plant Extracts|Plant Preparations|Protein Kinase Inhibitors|Quinones,CC1=CC(O)=C2C(=O)C3=C(C=C(O)C=C3O)C(=O)C2=C1,3220
6797,DB07716,"(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL",small molecule,experimental,,[H][C@@]12C[C@]3([H])O[C@]4([H])C\C=C/[C@]([H])(O)[C@@]([H])(CO)O[C@@]4([H])C=C[C@@]3([H])O[C@@]1([H])[C@]([H])(O)[C@@]1([H])OCC=CC[C@]1([H])O2,45480632
6798,DB07717,"(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE",small molecule,experimental,,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12CCOCC1=CC(F)=CC(F)=C1,16750073
6799,DB07718,4-Hydroxyphenylpyruvic acid,small molecule,experimental,"Acids, Carbocyclic|Keto Acids|Pyruvates",OC(=O)C(=O)CC1=CC=C(O)C=C1,979
6800,DB07719,"[(3R)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",small molecule,experimental,,[H]N(C)C(=O)[C@H]1CC2=C(CN1C(=O)OC(C)(C)C)C=C(C=C2)N([H])S(O)(=O)=O,5327155
6801,DB07720,Epibatidine,small molecule,experimental,"Analgesics|Analgesics, Non-Narcotic|Central Nervous System Agents|Cholinergic Agents|Cholinergic Agonists|Neurotransmitter Agents|Nicotinic Agonists|Peripheral Nervous System Agents|Sensory System Agents",[H][C@@]12CC[C@@]([H])(N1)[C@]([H])(C2)C1=CC=C(Cl)N=C1,854023
6802,DB07721,DIETHYL 4-METHOXYPHENYL PHOSPHATE,small molecule,experimental,,CCOP(=O)(OCC)OC1=CC=C(OC)C=C1,11207678
6803,DB07722,3-(4-NITRO-PHENOXY)-PROPAN-1-OL,small molecule,experimental,,OCCCOC1=CC=C(C=C1)[N+]([O-])=O,4474777
6804,DB07723,3-(5-methoxy-1H-indol-3-yl)propanoic acid,small molecule,experimental,,COC1=CC=C2NC=C(CCC(O)=O)C2=C1,181137
6805,DB07724,Indeglitazar,small molecule,experimental,,COC1=CC=C(C=C1)S(=O)(=O)N1C=C(CCC(O)=O)C2=CC(OC)=CC=C12,11395145
6806,DB07726,t-Butylhydroquinone,small molecule,experimental,"Antioxidants|Benzene Derivatives|Calcium-Transporting ATPases, antagonists & inhibitors|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Phenols|Protective Agents",CC(C)(C)C1=C(O)C=CC(O)=C1,16043
6807,DB07728,"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",small molecule,experimental,,FC1=C(C=CC=C1)C1=CC(=CC=N1)C1=CC2=C(CCNC2=O)N1,11992146
6808,DB07729,3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide,small molecule,experimental,,FC1=CC(=CC=C1)C(=O)NC1=CC=CC(=C1)C1=NN=NN1,6470990
6809,DB07730,"5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE",small molecule,experimental,,OC1=CC(=CC=C1)C1=CC(=O)NS1(=O)=O,10062718
6810,DB07731,CAN-508,small molecule,experimental,"Cyclin-Dependent Kinase 9, antagonists & inhibitors",NC1=C(\N=N\C2=CC=C(O)C=C2)C(N)=NN1,9859248
6811,DB07732,2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE,small molecule,experimental,,OP(O)(=O)OCCNS(=O)(=O)C1=CC2=C(C=CC=C2)C=C1,11473003
6812,DB07733,"1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE",small molecule,experimental,,CN1N=C(C2=C1SC(=C2)C(=O)NCCS)C(F)(F)F,6852193
6813,DB07734,N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide,small molecule,experimental,,SCCCC(=O)NC1CCN(CC2=CC=CC=C2)CC1,25134249
6814,DB07735,"N-[1-(2,6-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide",small molecule,experimental,,COC1=CC=CC(OC)=C1CN1CCC(CC1)NC(=O)CCCS,25134250
6815,DB07736,(2S)-4-(4-fluorobenzyl)-N-(2-sulfanylethyl)piperazine-2-carboxamide,small molecule,experimental,,[H][C@]1(CN(CC2=CC=C(F)C=C2)CCN1)C(=O)NCCS,25134251
6816,DB07737,(2S)-4-(4-fluorobenzyl)-N-(3-sulfanylpropyl)piperazine-2-carboxamide,small molecule,experimental,,[H][C@]1(CN(CC2=CC=C(F)C=C2)CCN1)C(=O)NCCCS,25134252
6817,DB07738,"N-[1-(5-bromo-2,3-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide",small molecule,experimental,,COC1=C(OC)C(CN2CCC(CC2)NC(=O)CCCS)=CC(Br)=C1,25134253
6818,DB07739,"(3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN-4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE",small molecule,experimental,,[H][C@]1(CF)CC2=CC=C(C=C2CN1)S(=O)(=O)N1CCSCC1,11485425
6819,DB07740,"(7R,12R,13R)-13-formyl-12,14-dihydroxy-3,5,7-trimethyltetradeca-2,4-dienoic acid",small molecule,experimental,,[H]C(C(O)=O)=C(C)C(\[H])=C(/C)C[C@]([H])(C)CCCC[C@@]([H])(O)[C@@]([H])(CO)C=O,131704306
6820,DB07741,"4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE",small molecule,experimental,,[H][C@@]12CCC[N@@]1[C@@]([H])(C1=CC=C(C=C1)C(N)N)[C@@]1([H])C(=O)N(CC3=CC=C(F)C=C3)[C@]([H])(C(F)F)[C@@]21[H],46937090
6821,DB07742,"N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE",small molecule,experimental,,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=CC=CC(F)=C1F,1700
6822,DB07743,"S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE",small molecule,experimental,,FC(F)(F)C1=NN=C(N1)SC(=O)C1=CC=C(O1)C#CC1=CC=CC=C1,2822496
6823,DB07744,Z-Val-Ala-Asp fluoromethyl ketone,small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins|Caspase Inhibitors|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Cysteine Proteinase Inhibitors|Enzyme Inhibitors|Neuroprotective Agents|Protease Inhibitors|Protective Agents",CC(C)[C@H](NC(=O)OCC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)CF,5497171
6824,DB07745,2-{[4-(TRIFLUOROMETHOXY)BENZOYL]AMINO}ETHYL DIHYDROGEN PHOSPHATE,small molecule,experimental,,OP(O)(=O)OCCNC(=O)C1=CC=C(OC(F)(F)F)C=C1,16122525
6825,DB07746,3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID,small molecule,experimental,,CCC1=CC=C(NS(=O)(=O)C2=CC=C(F)C=C2)C(C(O)=O)=C1C,23647763
6826,DB07747,"(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",small molecule,experimental,,[H][C@]1(CO)CC2=CC=C(C=C2CN1)S(=O)(=O)NC1=CC=C(Cl)C=C1,9549217
6827,DB07748,2-({[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}AMINO)ETHYL DIHYDROGEN PHOSPHATE,small molecule,experimental,,OP(O)(=O)OCCNS(=O)(=O)C1=CC=C(OC(F)(F)F)C=C1,16122526
6828,DB07749,2-ACETYLAMINO-4-METHYL-PENTANOIC ACID (1-FORMYL-2-PHENYL-ETHYL)-AMIDE,small molecule,experimental,,[H][C@@](CC1=CC=CC=C1)(NC(=O)[C@]([H])(CC(C)C)NC(C)=O)C=O,5288190
6829,DB07750,"(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",small molecule,experimental,,[H]N(C1=CC=C(OC[C@H](O)CN(C)C)C=C1)C1=NC=CC(=N1)N([H])C1=C(Cl)C=CC(Cl)=C1,445952
6830,DB07751,"(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",small molecule,experimental,,[H]N(C1=CC=C(OC[C@@H](O)CN(C)C)C=C1)C1=CC(=NC=N1)N([H])C1=C(F)C=CC=C1F,445950
6831,DB07753,"3',5'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID",small molecule,experimental,,OC(=O)C1=CC=C(C=C1)C1=CC(F)=CC(F)=C1,5288193
6832,DB07754,DCFBC,small molecule,experimental,,OC(=O)CC[C@H](NC(=O)N[C@@H](CSCC1=CC=C(F)C=C1)C(O)=O)C(O)=O,25113157
6833,DB07755,"(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",small molecule,experimental,,[H]N(C1=CC=C(OC[C@@H](O)CN(C)C)C=C1)C1=NC=CC(=N1)N([H])C1=C(Cl)C=CC(Cl)=C1,445953
6834,DB07756,"1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL",small molecule,experimental,,CC1=C(CSCC2=CC(=CC=C2)C(O)(O)C(F)(F)F)C(N)=C2C(F)=CC=CC2=N1,1723
6835,DB07757,"(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one",small molecule,experimental,,CCCC[C@]12CC3=CC(O)=CC=C3C1=C(Br)C(=O)CC2,11987846
6836,DB07758,"5-(2,5-DICHLOROPHENYL)-2-FUROIC ACID",small molecule,experimental,,OC(=O)C1=CC=C(O1)C1=CC(Cl)=CC=C1Cl,736259
6837,DB07759,5-[2-(TRIFLUOROMETHYL)PHENYL]-2-FUROIC ACID,small molecule,experimental,,OC(=O)C1=CC=C(O1)C1=CC=CC=C1C(F)(F)F,647499
6838,DB07760,"3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid",small molecule,experimental,,OC(=O)C1=CC=CC(\C=N\OCCO\N=C\C2=CC(=O)NC(=O)N2)=C1,25210531
6839,DB07761,"(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",small molecule,experimental,,[H]N(C1=CC=C(OC[C@H](O)CN(C)C)C=C1)C1=CC(=NC=N1)N([H])C1=C(F)C=CC=C1F,445951
6840,DB07762,4-(N-ACETYLAMINO)-3-[N-(2-ETHYLBUTANOYLAMINO)]BENZOIC ACID,small molecule,experimental,,CCC(CC)C(=O)NC1=CC(=CC=C1NC(C)=O)C(O)=O,1708
6841,DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",small molecule,experimental,,C[C@]1(OC(=O)N(NC2=CC=CC=C2)C1=O)C1=CC=C(F)C=C1F,9547935
6842,DB07764,Fluorescin,small molecule,experimental,,OC(=O)C1=C(C=CC=C1)C1C2=CC=C(O)C=C2OC2=CC(O)=CC=C12,68205
6843,DB07765,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",small molecule,experimental,,COC(=O)C1CCN(CC1)C(=O)C1=CC=C(C=C1)N(C)CC1=NC2=C(N)N=C(N)N=C2N=C1,23629645
6844,DB07766,"(2Z,3E)-2,3'-biindole-2',3(1H,1'H)-dione 3-{O-[(3R)-3,4-dihydroxybutyl]oxime}",small molecule,experimental,,[H]N1C(=O)\C(C2=C1C=CC=C2)=C1/N([H])C2=CC=CC=C2/C/1=N\OCC[C@@]([H])(O)CO,24880018
6845,DB07767,Ferulic acid,small molecule,experimental,"Acids, Carbocyclic|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anticoagulants|Antihypertensive Agents|Antioxidants|Antirheumatic Agents|Cardiovascular Agents|Central Nervous System Agents|Cholagogues and Choleretics|Cinnamates|Compounds used in a research, industrial, or household setting|Free Radical Scavengers|Gastrointestinal Agents|Hematologic Agents|Indicators and Reagents|Laboratory Chemicals|Peripheral Nervous System Agents|Plants|Protective Agents|Sensory System Agents",COC1=CC(\C=C\C(O)=O)=CC=C1O,445858
6846,DB07768,Epitestosterone,small molecule,experimental,"Androstanes|Androstenes|Androstenols|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone Congeners",[H][C@@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C,10204
6847,DB07769,S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,small molecule,experimental,,C[C@](O)(COC1=CC=C(F)C=C1)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F,5288215
6848,DB07770,5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,small molecule,experimental,,CC1=CC=C(C=C1)S(=O)(=O)NC1=C(SC(=C1)C1=CC=C(F)C=C1)C(O)=O,9543495
6849,DB07771,"[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID",small molecule,experimental,,CC(C)=CCC\C(C)=C\CC\C(C)=C\CONC(=O)CP(O)(O)=O,445015
6850,DB07772,"(1R)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",small molecule,experimental,,COC1=CC=C(C=C1)C1=CC=C(C=C1)S(=O)(=O)N[C@@H](C(C)C)P(O)(O)=O,6852147
6851,DB07773,5-FLUOROINDOLE PROPANOL PHOSPHATE,small molecule,experimental,,OP(O)(=O)OCCCC1=CNC2=C1C=C(F)C=C2,1819
6852,DB07775,"3',5'-DIBROMO-2',4,4',6'-TETRAHYDROXY AURONE",small molecule,experimental,,OC1=CC(O)=C2C(=O)\C(OC2=C1)=C\C1=C(O)C(Br)=C(O)C(Br)=C1,5288217
6853,DB07776,Flavone,small molecule,approved|experimental,"Benzopyrans|Chromones|Flavones|Flavonoids|Heterocyclic Compounds, Fused-Ring|Pyrans",O=C1C=C(OC2=CC=CC=C12)C1=CC=CC=C1,10680
6854,DB07778,(S)-famoxadone,small molecule,experimental,,C[C@]1(OC(=O)N(NC2=CC=CC=C2)C1=O)C1=CC=C(OC2=CC=CC=C2)C=C1,446845
6855,DB07779,N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE,small molecule,experimental,,[H][C@](N)(CC(=O)N1CCC[C@@]1([H])CNC(=O)C1=CC=CC=C1)CC1=C(F)C=CC=C1,5494422
6856,DB07780,Farnesyl diphosphate,small molecule,experimental,Organophosphates|Organophosphorus Compounds|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Terpenes,CC(C)=CCC\C(C)=C\CC\C(C)=C\COP(O)(=O)OP(O)(O)=O,445713
6857,DB07781,N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-NITRILOMETHYL-PYRIDYL]-THIOUREA,small molecule,experimental,,CCOC1=C(F)C(CCNC(=S)NC2=NC=C(C=C2)C#N)=NC=C1,3000505
6858,DB07782,4-AMINO-2-TRIFLUOROMETHYL-5-HYDROXYMETHYLPYRIMIDINE PYROPHOSPHATE,small molecule,experimental,,NC1=NC(=NC=C1CO[P@@](O)(=O)OP(O)(O)=O)C(F)(F)F,1722
6859,DB07783,1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE,small molecule,experimental,,[H][C@](CO)(CCN1C=CC2=C1C=C(NC(=O)CCC1=CC=CC=C1)C=C2)N1C=NC(=C1)C(N)=O,448903
6860,DB07784,"[4-(4-ACETYLAMINO-PHENYL)-3,5-DIOXO-4-AZA-TRICYCLO[5.2.2.0 2,6]UNDEC-1-YLCARBAMOYLOXY]-ACETIC ACID",small molecule,experimental,,[H][C@]12C(=O)N(C(=O)[C@@]1([H])[C@@]1(CC[C@@]2([H])CC1)NC(=O)OCC(O)=O)C1=CC=C(NC(C)=O)C=C1,444144
6861,DB07785,"1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE",small molecule,experimental,,[H][C@@](C)(O)[C@@]([H])(CCOC1=CC2=C(C=CC=C2)C=C1)N1C=NC(=C1)C(N)=O,449015
6862,DB07786,"1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE",small molecule,experimental,,[H][C@@](C)(O)[C@]([H])(CCC1=CC=CC2=C1OC(=N2)C1=CC=C(Cl)C=C1)N1C=NC(=C1)C(N)=O,46937091
6863,DB07787,"5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE",small molecule,experimental,,FC1=C2C(=O)NC(=O)N(CCCCN3CCC(=CC3)C3=CC=CC=C3)C2=CC=C1,448890
6864,DB07788,"(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE",small molecule,experimental,,[H]\C1=C([H])/C2=CC(OC)=CC(O)=C2C(=O)O[C@]([H])(C)C\C([H])=C([H])/C(=O)[C@@]([H])(O)[C@@]([H])(O)C1,46882177
6865,DB07789,"1-[5-Methyl-2-(trifluoromethyl)furan-3-yl]-3-[5-[2-[[6-(1H-1,2,4-triazol-5-ylamino)pyrimidin-4-yl]amino]ethyl]-1,3-thiazol-2-yl]urea",small molecule,experimental,,CC1=CC(NC(=O)NC2=NC=C(CCNC3=CC(NC4=NC=NN4)=NC=N3)S2)=C(O1)C(F)(F)F,24875313
6866,DB07790,N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE,small molecule,experimental,,COCCNS(=O)(=O)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C(C)N2C(C)C)C=C1,24963033
6867,DB07791,4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE,small molecule,experimental,,CNS(=O)(=O)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C(C)N2C2CC2)C=C1,24901723
6868,DB07792,"(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",small molecule,experimental,,[H][C@@]1(CC2=C(C=CC=C2)N(CC(=O)NCCO)C1=O)NC(=O)C1=CC2=C(N1)SC(Cl)=C2,11987874
6869,DB07793,"(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",small molecule,experimental,,[H][C@@]1(Cl)SC2=NC(=CC2=C1)C(=O)N[C@@]1([H])CC2=C(C=CC=C2)N(CC(N)=O)C1=O,46937093
6870,DB07794,"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",small molecule,experimental,,NC1=NNC2=C1C=C(N=N2)C1=C2C=CC=CN2N=C1C1=CC=CC=C1,11493598
6871,DB07795,Fisetin,small molecule,experimental,"Benzopyrans|Chromones|Heterocyclic Compounds, Fused-Ring|Pyrans",OC1=CC2=C(C=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1,5281614
6872,DB07796,"(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE",small molecule,experimental,,[H][C@@]12CCC[N@@]1[C@@]([H])(C1=CC=C(C=C1)C(N)=[NH2+])[C@@]1([H])C(=O)N(CC3=CC=C(F)C=C3)C(=O)[C@@]21[H],5288257
6873,DB07797,N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-CHLORO-PYRIDYL]-THIOUREA,small molecule,experimental,,CCOC1=C(F)C(CCNC(=S)NC2=NC=C(Cl)C=C2)=NC=C1,3000541
6874,DB07798,"(3R)-3-(FLUOROMETHYL)-N-(3,3,3-TRIFLUOROPROPYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",small molecule,experimental,,[H][C@]1(CF)CC2=CC=C(C=C2CN1)S(=O)(=O)NCCC(F)(F)F,11349402
6875,DB07800,N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE,small molecule,experimental,,ClC1=CN=C(NS(=O)(=O)C2=C(NC(=O)C3=CC=C(C=C3)N3C=CC=CC3=O)C=CC=C2)C=C1,24794406
6876,DB07801,N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide,small molecule,experimental,,CCCCNC(=O)C1=CC=CC(NC(=O)CCCCCNC2=C3N=CNC3=NC=N2)=C1,24893974
6877,DB07802,"3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE",small molecule,experimental,,CC1=C(Br)C(=O)OC2=C(Br)C(O)=CC=C12,5795340
6878,DB07803,2-phenyl-1H-imidazole-4-carboxylic acid,small molecule,experimental,,OC(=O)C1=CNC(=N1)C1=CC=CC=C1,2738139
6879,DB07804,"5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE",small molecule,experimental,,[H][C@@](C)(N1CC[C@]([H])(NS(=O)(=O)C2=NNC(=N2)C2=CC=C(Cl)S2)C1=O)C(=O)N1CCOCC1,16040261
6880,DB07805,"3-CHLORO-2,2-DIMETHYL-N-[4-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE",small molecule,experimental,,CC(C)(CCl)C(=O)NC1=CC=C(C=C1)C(F)(F)F,3783853
6881,DB07806,"(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID",small molecule,experimental,,[H][C@@](NC(=O)CC1=CC=CC=C1)(C(=O)NCC1=CC=CC=C1)[C@]1([H])N[C@@]([H])(C(O)=O)C(C)(C)S1,446136
6882,DB07807,"(3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL",small molecule,experimental,,[H][C@@]1(O)CN(CCCC2=CC=CC=C2)C[C@]([H])(CO)[C@@]1([H])O,9860102
6883,DB07808,"(1S,2R)-2-[(2,5-difluorophenyl)carbamoyl]cyclopropanecarboxylic acid",small molecule,experimental,,[H][C@@]1(C[C@@]1([H])C(=O)NC1=CC(F)=CC=C1F)C(O)=O,7100107
6884,DB07809,4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE,small molecule,experimental,,CC1=CC=CC(=C1)C(=O)C1=CC=NC(NCC2=CC=C(C=C2)C(N)=N)=C1,17758361
6885,DB07810,Phloretin,small molecule,experimental,"Benzene Derivatives|Benzopyrans|Chromones|Flavonoids|Heterocyclic Compounds, Fused-Ring|Hydroxypropiophenone|Ketones|Phenols|Phloroglucinol|Propiophenones|Pyrans",OC1=CC=C(CCC(=O)C2=C(O)C=C(O)C=C2O)C=C1,4788
6886,DB07811,"N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide",small molecule,experimental,,CC1=NN=C(O1)C1=CC=C(C(C)=C1)C1=CC(=CC=C1C)C(=O)NC1CC1,10089048
6887,DB07812,"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide",small molecule,experimental,,[H][C@](CN)(NC(=O)C1=CC=C(S1)C1=C2C=CNC2=NC=C1)C1=CC=CC=C1,24963048
6888,DB07813,GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE,small molecule,experimental,,[H][C@@](C)(NC(=O)CN)C(=O)N1CCC[C@@]1([H])C(=O)NC1=CC=C2C=CC=CC2=C1,46937094
6889,DB07814,Gibberellic acid,small molecule,experimental,"Diterpenes|Diterpenes, Kaurane|Growth Substances|Plant Growth Regulators|Terpenes",[H][C@@]12CC[C@]3(O)C[C@]1(CC3=C)[C@@H](C(O)=O)[C@]1([H])[C@@]3(C)[C@@H](O)C=C[C@@]21OC3=O,439551
6890,DB07815,Gibberellin A4,small molecule,experimental,"Diterpenes|Diterpenes, Kaurane|Terpenes",[H][C@@]12C[C@]3(CC1=C)[C@@H](C(O)=O)[C@]1([H])[C@@]4(C)[C@@H](O)CC[C@@]1(OC4=O)[C@]3([H])CC2,92109
6891,DB07816,N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID,small molecule,experimental,,OC(=O)C\N=C(\NC(C1=CC=CC=C1)C1=CC=CC=C1)NC1=CC=C(C=C1)C#N,4447
6892,DB07817,"1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea",small molecule,experimental,,O=C(NC1=NC=CS1)NC1=CC(=CC=C1)S(=O)(=O)N1CCN(CC1)C1=CC=CC=N1,12087505
6893,DB07818,"(2E)-3-(2,4-DICHLOROPHENYL)-N-HYDROXYACRYLAMIDE",small molecule,experimental,,ONC(=O)\C=C\C1=CC=C(Cl)C=C1Cl,11708451
6894,DB07819,(2E)-3-(4-CHLOROPHENYL)-N-HYDROXYACRYLAMIDE,small molecule,experimental,,ONC(=O)\C=C\C1=CC=C(Cl)C=C1,11694089
6895,DB07820,"6-(3',5'-DIMETHYLBENZYL)-1-ETHOXYMETHYL-5-ISOPROPYLURACIL",small molecule,experimental,,CCOCN1C(=O)NC(=O)C(C(C)C)=C1CC1=CC(C)=CC(C)=C1,3457
6896,DB07821,"(1R)-1,2,2-trimethylpropyl (R)-methylphosphinate",small molecule,experimental,,[H][C@](C)(O[P@]([H])(C)=O)C(C)(C)C,46937095
6897,DB07823,"(2S)-2-[(3aR,4R,7S,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl]propanoic acid",small molecule,experimental,,[H][C@@](C)(N1C(=O)[C@@]2([H])[C@@]3([H])CC[C@]([H])(C3)[C@@]2([H])C1=O)C(O)=O,1933963
6898,DB07824,"4-ethyl-5-methyl-2-(1H-tetrazol-5-yl)-1,2-dihydro-3H-pyrazol-3-one",small molecule,experimental,,CCC1=C(C)NN(C1=O)C1=NN=NN1,5305969
6899,DB07825,(3S)-1-(4-acetylphenyl)-5-oxopyrrolidine-3-carboxylic acid,small molecule,experimental,,[H][C@]1(CN(C(=O)C1)C1=CC=C(C=C1)C(C)=O)C(O)=O,2376771
6900,DB07826,2-[4-chloro-2-(phenylcarbonyl)phenoxy]-N-phenylacetamide,small molecule,experimental,,ClC1=CC=C(OCC(=O)NC2=CC=CC=C2)C(=C1)C(=O)C1=CC=CC=C1,465669
6901,DB07827,"4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID",small molecule,experimental,,CN1C(=O)N(CC2=CC=C(C=C2)C(O)=O)C(=O)C2=C1C=CC(=C2)C#CCC1=CC=CC=C1,10224181
6902,DB07829,4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE,small molecule,experimental,,FC1=CC=C(C=C1)C1=NNC=C1C1=CC=NC=C1,12106168
6903,DB07830,"(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE",small molecule,experimental,,[H][C@]1(N)CN(CCC2=CC=C3OCOC3=C2)C(=O)C[C@]1([H])C1=CC(F)=C(F)C=C1F,16040279
6904,DB07831,"2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE",small molecule,experimental,,CCCC1=CC=C(NC(=O)C2=CC=CC=C2NCC2=CNC(=O)C=C2)C=C1C(F)(F)F,10477723
6905,DB07832,"4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde",small molecule,experimental,,CC1=C(NC2=CC=NC3=CC(=CC=C23)C2=CSC(C=O)=N2)C=C(O)C=C1,23644582
6906,DB07833,"N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide",small molecule,experimental,,CC1=NN=C(O1)C1=CC=C(C)C(=C1)C1=CC=C(C=C1)C(=O)NC1=CC(=CC=C1)C#N,10200651
6907,DB07834,"N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide",small molecule,experimental,,CC1=NN=C(O1)C1=CC=C(C)C(=C1)C1=CC=C(C=C1)C(=O)NCC1CC1,21078798
6908,DB07835,"N~3~-cyclopropyl-N~4~'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide",small molecule,experimental,,CC1=CC=C(C=C1C1=CC=C(C=C1)C(=O)NCC1CC1)C(=O)NC1CC1,24856363
6909,DB07836,1-DECYL-3-TRIFLUORO ETHYL-SN-GLYCERO-2-PHOSPHOMETHANOL,small molecule,experimental,,[H][C@](COCCCCCCCCCC)(COCC(F)(F)F)O[P@](O)(=O)OC,46937097
6910,DB07837,"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid",small molecule,experimental,,OC(=O)CC1=CC=C(C=C1)C1=CNC2=NC=C(C=C12)C1=CC=C2C=CC=CC2=C1,11952989
6911,DB07838,(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE,small molecule,experimental,,OC1=C(\C=C2/SC(=S)N(CC3=CC=CC=C3)C2=O)C=CC=C1[N+]([O-])=O,5726921
6912,DB07839,"N~2~-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE",small molecule,experimental,,[H][C@@](CC1CCCCC1)(NC1=NC2=CC=CC=C2O1)C(=O)NCCNC1=CC=C(OC)C=C1,6420159
6913,DB07840,"(E)-[4-(3,5-Difluorophenyl)-3H-pyrrolo[2,3-b]pyridin-3-ylidene](3-methoxyphenyl)methanol",small molecule,experimental,,COC1=CC=CC(=C1)C(=O)C1=CNC2=NC=CC(=C12)C1=CC(F)=CC(F)=C1,11674979
6914,DB07841,Geranylgeranyl diphosphate,small molecule,experimental,Organophosphates|Organophosphorus Compounds|Phosphate salts|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Terpenes,CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O,447277
6915,DB07842,(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid,small molecule,experimental,,[H][C@@](CC1=CC=CC=C1)(OC1=CC=C(CC)C=C1)C(O)=O,11149906
6916,DB07843,5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,small molecule,experimental,,[H][C@@](C)(N1CC[C@]([H])(NS(=O)(=O)C2=CC3=C(S2)C=CC(Cl)=C3)C1=O)C(=O)N1CCOCC1,9549259
6917,DB07844,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,small molecule,experimental,,[H][C@@](C)(N1CC[C@]([H])(NS(=O)(=O)C2=CC3=C(S2)C=C(Cl)C=C3)C1=O)C(=O)N1CCOCC1,9549258
6918,DB07845,"2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",small molecule,experimental,,COC1=C(NC2=NC3=C(C=CN3)C(NC3=CC=CC(F)=C3C(N)=O)=N2)C=CC(CS(C)(=O)=O)=C1,25113171
6919,DB07846,"(3,4,8b-Trimethyl-3-oxido-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-3-ium-7-yl) N-(2-ethylphenyl)carbamate",small molecule,experimental,,CCC1=CC=CC=C1NC(=O)OC1=CC2=C(C=C1)N(C)C1C2(C)CC[N+]1(C)[O-],74077203
6920,DB07847,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE,small molecule,experimental,,[H][C@@](C)(N1CC[C@]([H])(NS(=O)(=O)C2=CC3=CC=C(Cl)C=C3C=C2)C1=O)C(=O)N1CCOCC1,6852168
6921,DB07848,5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide,small molecule,experimental,,C[C@H](N1CC[C@H](NS(=O)(=O)C2=CC3=C(N2)C=CC(Cl)=C3)C1=O)C(=O)N1CCOCC1,9549257
6922,DB07849,S-NONYL-CYSTEINE,small molecule,experimental,,[H][C@](N)(CSCCCCCCCCC)C(O)=O,46937099
6923,DB07850,"(1R,2S)-2-(5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)cyclohexanecarboxylic acid",small molecule,experimental,,[H][C@]1(CCCC[C@]1([H])C1=NNC(=S)N1)C(O)=O,976666
6924,DB07851,"(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE",small molecule,experimental,,[H][C@]1(N)CCN(C[C@@]1([H])C1=CC(C)=CC=C1)C1=CC(OC)=C(OC)C=C1,24798721
6925,DB07852,"1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID",small molecule,experimental,,CC1=NC(=NN1C1=CC(Cl)=CC(Cl)=C1)C(O)=O,2763754
6926,DB07853,"2-[4-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]iminocyclohexa-2,5-dien-1-yl]acetonitrile",small molecule,experimental,,N#CCC1C=CC(C=C1)=NC1=NC2=CC=CC=C2C(NC2=NNC(=C2)C2CC2)=N1,46937100
6927,DB07854,N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,small molecule,experimental,,CNCC1=CC=C(C=C1)C1=NC=NC2=C1N=CN2,11608401
6928,DB07855,(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,small molecule,experimental,,[H][C@](N)(C1=CC=CC=C1)C1=CC=C(C=C1)C1=C2N=CNC2=NC=N1,16122632
6929,DB07856,6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,small molecule,experimental,,ClC1=CC=C(C=C1)C1(CCNCC1)C1=CC=C(C=C1)C1=C2N=CNC2=NC=N1,16122633
6930,DB07857,(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,small molecule,experimental,,NC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=C(C=C1)C1=CNN=C1,15602983
6931,DB07858,(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,small molecule,experimental,,NC[C@H](C1=CC=C(Cl)C=C1)C1=CC=C(C=C1)C1=CNN=C1,15602982
6932,DB07859,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,small molecule,experimental,,ClC1=CC=C(C=C1)C1(CCNCC1)C1=CC=C(C=C1)C1=CNN=C1,11175137
6933,DB07860,(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE,small molecule,experimental,,[H][C@@](CN)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,16122635
6934,DB07861,(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide,small molecule,experimental,,[H][C@](CC1=CC2=C(C=CC=C2)C=C1)(NS(=O)(=O)C1=CC2=C(C=CC=C2)C=C1)C(=O)NO,9823454
6935,DB07862,"7-(1-ETHYL-PROPYL)-7H-PYRROLO-[3,2-F]QUINAZOLINE-1,3-DIAMINE",small molecule,experimental,,CCC(CC)N1C=CC2=C1C=CC1=C2C(N)=NC(N)=N1,1881
6936,DB07863,2-chloro-5-nitro-N-phenylbenzamide,small molecule,experimental,,[O-][N+](=O)C1=CC=C(Cl)C(=C1)C(=O)NC1=CC=CC=C1,644213
6937,DB07864,4-[(CYCLOPROPYLETHYNYL)OXY]-6-FLUORO-3-ISOPROPYLQUINOLIN-2(1H)-ONE,small molecule,experimental,,CC(C)C1=C(OC#CC2CC2)C2=CC(F)=CC=C2NC1=O,448725
6938,DB07865,3-(1H-tetrazol-5-ylamino)cyclohex-2-en-1-one,small molecule,experimental,,O=C1CCCC(NC2=NN=NN2)=C1,1503946
6939,DB07866,"(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one",small molecule,experimental,,CCC[C@]1(C)SC(NC2CCCCCCC2)=NC1=O,24866443
6940,DB07867,6-CHLORO-4-(CYCLOHEXYLOXY)-3-PROPYLQUINOLIN-2(1H)-ONE,small molecule,experimental,,CCCC1=C(OC2CCCCC2)C2=CC(Cl)=CC=C2NC1=O,448724
6941,DB07868,6-CHLORO-4-(CYCLOHEXYLSULFANYL)-3-PROPYLQUINOLIN-2(1H)-ONE,small molecule,experimental,,CCCC1=C(SC2CCCCC2)C2=CC(Cl)=CC=C2NC1=O,448727
6942,DB07869,6-Chloro-4-[(R)-cyclohexylsulfinyl]-3-propyl-2(1H)-quinolinone,small molecule,experimental,,[H]N1C(=O)C(CCC)=C(C2=C1C=CC(Cl)=C2)[S@](=O)C1CCCCC1,9600414
6943,DB07870,Haloxyfop-P,small molecule,experimental,,C[C@@H](OC1=CC=C(OC2=C(Cl)C=C(C=N2)C(F)(F)F)C=C1)C(O)=O,448979
6944,DB07871,6-CHLORO-4-(CYCLOHEXYLOXY)-3-ISOPROPYLQUINOLIN-2(1H)-ONE,small molecule,experimental,,CC(C)C1=C(OC2CCCCC2)C2=CC(Cl)=CC=C2NC1=O,448729
6945,DB07872,5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide,small molecule,experimental,,[H][C@]1(CCN(CC(=O)NC2=C(F)C=C(C=C2)N2C=CC=CC2=O)C1)NC(=O)C1=CC=C(Cl)S1,42628060
6946,DB07873,Lauryl alcohol diphosphonic acid,small molecule,experimental,,CCCCCCCCCCCC(O)(P(O)(O)=O)P(O)(O)=O,4395717
6947,DB07874,"(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",small molecule,experimental,,COC1=CC(=CC=C1)C1=CC(=CC=C1)[C@]1(C)CC(=O)N(C)C(N)=N1,17749735
6948,DB07875,"5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide",small molecule,experimental,,[H][C@]1(O)CN(CC(=O)NC2=C(F)C=C(C=C2)N2C=CC=CC2=O)C[C@]1([H])NC(=O)C1=CC=C(Cl)S1,11979006
6949,DB07876,(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE,small molecule,experimental,,[H][C@]1(C)CNCCCN1S(=O)(=O)C1=C2C(C)=CN=CC2=CC=C1,448043
6950,DB07877,"8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE",small molecule,experimental,,CC(C)NCCCN1C(SC2=C(Br)C=C3OCOC3=C2)=NC2=C1N=CN=C2N,6914564
6951,DB07878,"N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE",small molecule,experimental,,C\C=C\C[C@]([H])(C(C)=O)N1N=NC(=C1)[C@](C)(C(C)C)NC(=O)C1=CC=CC=C1,46937102
6952,DB07879,"N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide",small molecule,experimental,,ONC(=O)C1=CC=C(S1)C(=O)N1CCN2C(C1)=NC=C2C1=CC=CC=C1,24836811
6953,DB07880,2-((4'-HYDROXYPHENYL)-AZO)BENZOIC ACID,small molecule,experimental,,OC(=O)C1=CC=CC=C1\N=N\C1=CC=C(O)C=C1,5357439
6954,DB07881,N-{[2-({[1-(4-CARBOXYBUTANOYL)AMINO]-2-PHENYLETHYL}-HYDROXYPHOSPHINYL)OXY]ACETYL}-2-PHENYLETHYLAMINE,small molecule,experimental,,[H][C@](CC1=CC=CC=C1)(NC(=O)CCCC(O)=O)[P@](O)(=O)OCC(=O)NCCC1=CC=CC=C1,447154
6955,DB07882,"4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID",small molecule,experimental,,[H][C@@]12O[C@]1(C)CC[C@]1([H])[C@]2(C)CCC[N@+]1([O-])CC(=O)NC1=CC=C(NC(=O)CCCC(O)=O)C=C1,5288514
6956,DB07883,(2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE,small molecule,experimental,,[H][C@]12CC[C@]([H])(C1)[C@](N)(C(=O)C1=CC=CC=C1)[C@]2([H])C1=CC=CC=C1,446476
6957,DB07884,Opaviraline,small molecule,experimental,"Antiviral Agents|Heterocyclic Compounds, Fused-Ring|Non-Nucleoside Reverse Transcriptase Inhibitors",CC[C@@H]1N(C(=O)OC(C)C)C2=C(NC1=O)C=CC(F)=C2,154048
6958,DB07885,Talviraline,small molecule,investigational,"Acquired Immunodeficiency Syndrome|Heterocyclic Compounds, Fused-Ring",[H][C@@]1(CSC)N(C(=O)OC(C)C)C2=C(NC1=S)C=CC(OC)=C2,3000493
6959,DB07887,"(R)-1-(4-(4-(hydroxymethyl)-1,3,2-dioxaborolan-2-yl)benzyl)guanidine",small molecule,experimental,,[H]N([H])C(=NCC1=CC=C(C=C1)B1OC[C@@H](CO)O1)N([H])[H],6857719
6960,DB07888,"3-(4-HYDROXYPHENYL)-4,5-DIHYDRO-5-ISOXAZOLE-ACETIC ACID METHYL ESTER",small molecule,experimental,,[H][C@]1(CC(=O)OC)CC(=NO1)C1=CC=C(O)C=C1,6323362
6961,DB07889,"(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol",small molecule,experimental,,[H]N(C1=CC=C(OC[C@@H](O)CN(C)C)C=C1)C1=NC=CC(=N1)C1=C(C)N=C2C=CC=CN12,447653
6962,DB07890,4-(2-HYDROXYPHENYLTHIO)-1-BUTENYLPHOSPHONIC ACID,small molecule,experimental,,OC1=C(SCC\C=C\P(O)(O)=O)C=CC=C1,444721
6963,DB07891,Estradiol hemisuccinate,small molecule,experimental,,[H][C@@]12CC[C@H](OC(=O)CCC(O)=O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3CC[C@@]21[H],66440
6964,DB07892,1-(2-HYDROXYETHYLOXYMETHYL)-6-PHENYL THIOTHYMINE,small molecule,experimental,,CC1=C(SC2=CC=CC=C2)N(COCCO)C(=O)NC1=O,64993
6965,DB07893,PHENYL[1-(N-SUCCINYLAMINO)PENTYL]PHOSPHONATE,small molecule,experimental,,[H][C@@](CCCC)(NC(=O)CCC(O)=O)[P@](O)(=O)OC1=CC=CC=C1,444107
6966,DB07894,4-(2-HYDROXY-4-FLUOROPHENYLTHIO)-BUTYLPHOSPHONIC ACID,small molecule,experimental,,OC1=CC=C(F)C=C1SCC\C=C\P(O)(O)=O,5288544
6967,DB07895,ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID,small molecule,experimental,Alcohols|Fatty Alcohols|Lipids|Organophosphorus Compounds|Sesquiterpenes|Terpenes,[H][C@@](C)(CCCC(C)C)CCC[C@@]([H])(C)C[C@@]([H])(O)P(O)(O)=O,46937103
6968,DB07896,(2S)-hydroxy(4-hydroxyphenyl)ethanoic acid,small molecule,experimental,,[H][C@@](O)(C(O)=O)C1=CC=C(O)C=C1,439940
6969,DB07897,1-(HYDROXYMETHYLENEAMINO)-8-HYDROXY-OCTANE,small molecule,experimental,,OCCCCCCCCNCO,4634038
6970,DB07898,"(2R)-3-[(tetrahydroxyphosphoranyl)oxy]-1,2-propanediyl dibutanoate",small molecule,experimental,,[H][C@@](COC(=O)CCC)(COP(O)(O)(O)O)OC(=O)CCC,5288553
6971,DB07899,(2S) N-acetyl-L-alanyl-αL-phenylalanyl-chloroethylketone,small molecule,experimental,,[H][C@@](C)(NC(C)=O)C(=O)N[C@@]([H])(CC1=CC=CC=C1)C(=O)CCCl,46937104
6972,DB07900,3-FORMYL-2-HYDROXY-5-METHYL-HEXANOIC ACID HYDROXYAMIDE,small molecule,experimental,,[H][C@@](O)(C(=O)NO)[C@@]([H])(CC(C)C)C=O,5288561
6973,DB07901,5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE,small molecule,experimental,,CC1=C(Cl)C(NCCC2=CC=CC=C2)=NC(=N1)C1=NC=CC=C1,2740174
6974,DB07902,"TERT-BUTYL {2-[(1,3-THIAZOL-2-YLAMINO)CARBONYL]PYRIDIN-3-YL}CARBAMATE",small molecule,experimental,,CC(C)(C)OC(=O)NC1=C(N=CC=C1)C(=O)NC1=NC=CS1,11809364
6975,DB07903,"3-[(2,2-DIMETHYLPROPANOYL)AMINO]-N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE",small molecule,experimental,,CC(C)(C)C(=O)NC1=C(N=CC=C1)C(=O)NC1=NC=CS1,11120251
6976,DB07905,"(1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione",small molecule,experimental,,[H][C@@]12C[C@]([H])(O)[C@]([H])(O)C(=O)C=CC[C@]([H])(C)OC(=O)C3=C(C=C(OC)C=C3O)[C@@]1([H])O2,9929643
6977,DB07906,"[(3R)-7-NITRO-1,2,3,4-TETRAHYDROISOQUINOLIN-3-YL]METHANOL",small molecule,experimental,,[H][C@]1(CO)CC2=CC=C(C=C2CN1)[N+]([O-])=O,10822243
6978,DB07907,(2S)-2-HYDROXYOCTANOIC ACID,small molecule,experimental,,[H][C@](O)(CCCCCC)C(O)=O,6995013
6979,DB07908,7-HYDROXY-4-METHYL-3-(2-HYDROXY-ETHYL)COUMARIN,small molecule,experimental,,CC1=C(CCO)C(=O)OC2=CC(O)=CC=C12,5288573
6980,DB07909,"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",small molecule,experimental,,[H][C@]1(O)C[C@]([H])(CC[C@]1([H])C1=CC=C(C=C1)C(=O)NCCCC(O)=O)C1=CC=CC=C1,444394
6981,DB07910,"(2S)-2-amino-3-phenylpropane-1,1-diol",small molecule,experimental,,[H][C@](N)(CC1=CC=CC=C1)C(O)O,445494
6982,DB07911,"(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE",small molecule,experimental,,[O-]C(=O)C(=O)\C=C\CC(=O)C1=CC=CC=C1,23615309
6983,DB07912,2-OXOHEPTYLPHOSPHONIC ACID,small molecule,experimental,,CCCCCC(=O)CP(O)(O)=O,4369424
6984,DB07913,HOMOPHENYLALANINYLMETHANE,small molecule,experimental,,[H][C@](N)(CCC1=CC=CC=C1)C(C)=O,46937105
6985,DB07914,"2-hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid",small molecule,experimental,Fatty Acids|Lipids,OC(=O)C(\O)=C\C=C\C(=O)C1=CC=CC=C1,
6986,DB07915,"(2E,4E)-2-Hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid",small molecule,experimental,,OC(=O)C(\O)=C/C=C/C(=O)C1=CC=CC=C1,
6987,DB07916,3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID,small molecule,experimental,,[H][C@@](CC(O)=O)(NC(=O)[C@@]([H])(CCCCNC(=O)C1=NC2=C(C=CC=C2O)C=C1)C1=CC=CS1)C=O,5288581
6988,DB07917,4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE,small molecule,experimental,,C(CN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1)CC1=NN=NN1,6540277
6989,DB07918,2-heptyl-4-hydroxyquinoline N-oxide,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Quinolines",CCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1,1561
6990,DB07919,Harmine,small molecule,experimental,"Alkaloids|Antidepressive Agents|Carbolines|Central Nervous System Agents|Central Nervous System Depressants|Enzyme Inhibitors|Hallucinogens|Harmala Alkaloids|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|Monoamine Oxidase Inhibitors|Psychotropic Drugs|Pyridines",COC1=CC2=C(C=C1)C1=C(N2)C(C)=NC=C1,5280953
6991,DB07920,N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide,small molecule,experimental,,O=NC(=O)CNS(=O)(=O)C1=CC=C(C=C1)C1=CC=CC=C1,46937106
6992,DB07921,2-[(4-fluorophenyl)sulfonylamino]-N-oxo-ethanamide,small molecule,experimental,,FC1=CC=C(C=C1)S(=O)(=O)NCC(=O)N=O,46937107
6993,DB07922,N-oxo-2-(phenylsulfonylamino)ethanamide,small molecule,experimental,,O=NC(=O)CNS(=O)(=O)C1=CC=CC=C1,46937108
6994,DB07923,octyl alpha-L-altropyranoside,small molecule,experimental,,[H][C@]1(O)[C@@]([H])(O)[C@]([H])(CO)O[C@@]([H])(OCCCCCCCC)[C@]1([H])O,46937109
6995,DB07924,octyl beta-D-galactopyranoside,small molecule,experimental,Carbohydrates|Glycosides,[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCCCC)[C@]1([H])O,9549264
6996,DB07925,4-(2-HYDROXYPHENYLSULFINYL)-BUTYLPHOSPHONIC ACID,small molecule,experimental,,OC1=CC=CC=C1[S@](=O)CCCCP(O)(O)=O,9543426
6997,DB07926,N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE,small molecule,experimental,,[H][C@@](CC(C)C)(CC(=O)NO)C(=O)N[C@@]([H])(CC1=CC=C(OC)C=C1)C(=O)NC,128564
6998,DB07927,3-[(4-Carboxy-2-hydroxyphenyl)sulfamoyl]-2-thiophenecarboxylic acid,small molecule,experimental,,OC(=O)C1=C(C=CS1)S(=O)(=O)NC1=C(O)C=C(C=C1)C(O)=O,657106
6999,DB07928,N-(2-OXOTETRAHYDROFURAN-3-YL)OCTANAMIDE,small molecule,experimental,,[H][C@@]1(CCOC1=O)NC(=O)CCCCCCC,6914579
7000,DB07929,"N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE",small molecule,experimental,,CC1=CC(=CC(C)=C1)C(=O)N(NC(=O)C1=C(C)C2=C(OCCO2)C=C1)C(C)(C)C,448258
7001,DB07930,(3R)-3-HYDROXYDODECANOIC ACID,small molecule,experimental,,[H][C@@](O)(CCCCCCCCC)CC(O)=O,5312804
7002,DB07931,Hexestrol,small molecule,withdrawn,"Antineoplastic Agents|Antineoplastic Agents, Hormonal|Benzene Derivatives|Benzylidene Compounds|Estrogens|Estrogens, Non-Steroidal|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Stilbenes|Thyroxine-binding globulin inducers",[H][C@](CC)(C1=CC=C(O)C=C1)[C@]([H])(CC)C1=CC=C(O)C=C1,192197
7003,DB07932,"dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate",small molecule,experimental,,[H][C@]12O[C@]([H])(C(C(=O)OC)=C1C(=O)OC)C(=C2C1=CC=C(O)C=C1)C1=CC=C(O)C=C1,11531308
7004,DB07933,Erteberel,small molecule,experimental|investigational,"Heterocyclic Compounds, Fused-Ring|Pyrans",[H][C@@]12CCC[C@]1([H])[C@@]([H])(OC1=C2C=C(O)C=C1)C1=CC=C(O)C=C1,10286159
7005,DB07934,[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE,small molecule,experimental,,[H][C@](CCNC1=CC=[NH+]C=C1)(NC(=O)CNS(=O)(=O)C1CCCCC1)C(=O)N1CCCCC1,448953
7006,DB07935,"5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile",small molecule,experimental,,CC1=NNC2=C1C(OC1=CC(=CC(=C1)C#N)C#N)=C(F)C=C2,25218427
7007,DB07936,N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine,small molecule,experimental,,[H][C@@]1(CCN(C1)C(=O)C1=CC=C(NC2=NC(C3=CN=C(C)N3C(C)C)=C(F)C=N2)C=C1)N(C)C,16113377
7008,DB07937,"2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine",small molecule,experimental,,CCCCOC1=NC(NCCN2CCOCC2)=C2N=CN(CC3=C(F)C=CC=C3F)C2=N1,16744441
7009,DB07938,(S)-iclaprim,small molecule,experimental,,[H][C@]1(OC2=C(C=C1)C(CC1=CN=C(N)N=C1N)=CC(OC)=C2OC)C1CC1,44141864
7010,DB07939,N-(3-MERCAPTOPROPANOYL)-D-ALANINE,small molecule,experimental,,[H][C@](C)(NC(=O)CCS)C(O)=O,16750083
7011,DB07940,"9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE",small molecule,experimental,,IC1=CC=CC(CNC2=C3CCCCC3=NC3=C2C=CC=C3)=C1,448167
7012,DB07941,PH-797804,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|p38 Mitogen-Activated Protein Kinases, antagonists & inhibitors|Pyridines",CNC(=O)C1=CC=C(C)C(=C1)N1C(C)=CC(OCC2=C(F)C=C(F)C=C2)=C(Br)C1=O,22049997
7013,DB07942,2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine,small molecule,experimental,,FC1=CC=C(C=C1)C1=CNN=C1C1=CC(F)=NC=C1,42647299
7014,DB07943,SD-0006,small molecule,investigational,,OCC(=O)N1CCC(CC1)C1=NNC(=C1C1=CC=NC=N1)C1=CC=C(Cl)C=C1,9865587
7015,DB07944,N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE,small molecule,experimental,,CC1=CC(OCCNC2=CC=[NH+]C=C2)=CC(NS(=O)(=O)C2=CC=CC=C2)=C1,448955
7016,DB07945,"5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid",small molecule,experimental,,NC(=O)C1=CC=CC(CN2C3=C(CCCCC3)C3=CC=CC(C(O)=O)=C23)=C1,9863791
7017,DB07946,"N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide",small molecule,experimental,,[H]N([H])C(=NOCCN([H])C(=O)CC1=C(Cl)C=CC(N([H])CC(F)(F)C2=CC=CC=C2)=C1F)N([H])[H],10114365
7018,DB07947,ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,small molecule,experimental,,ClC1=CC=C(COCCNCCNS(=O)(=O)C2=CC=CC3=CN=CC=C23)C=C1,5327109
7019,DB07949,"({[(3E)-2'-Oxo-2',7'-dihydro-2,3'-biindol-3(7H)-ylidene]amino}oxy)acetic acid",small molecule,experimental,,OC(=O)CO\N=C1/C2=CC=CCC2=N/C/1=C1\C(=O)N=C2CC=CC=C12,11840955
7020,DB07950,Indoleacetic acid,small molecule,experimental,"Growth Substances|Heterocyclic Compounds, Fused-Ring|Indoles|Plant Growth Regulators",OC(=O)CC1=CNC2=CC=CC=C12,802
7021,DB07951,N-(indole-3-acetyl)-L-aspartic acid,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Indoles",OC(=O)C[C@H](NC(=O)CC1=CNC2=CC=CC=C12)C(O)=O,446620
7022,DB07952,N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID,small molecule,experimental,,OC(=O)CNC(=O)CC1=CNC2=C1C=CC=C2,446640
7023,DB07953,N-[1H-INDOL-3-YL-ACETYL]VALINE ACID,small molecule,experimental,,[H][C@](NC(=O)CC1=CNC2=CC=CC=C12)(C(C)C)C(O)=O,446641
7024,DB07954,3-isobutyl-1-methyl-7H-xanthine,small molecule,experimental,"Alkaloids|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Phosphodiesterase Inhibitors|Purines|Purinones|Xanthine derivatives",CC(C)CN1C2=C(N=CN2)C(=O)N(C)C1=O,3758
7025,DB07955,(2-BROMOETHYL)(2-'FORMYL-4'-AMINOPHENYL) ACETATE,small molecule,experimental,,NC1=CC(C=O)=C(CC(=O)OCCBr)C=C1,4634717
7026,DB07956,[1-(3-CHLORO-2-FORMYL-PHENYLCARBAMOYL)-2-METHYL-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER,small molecule,experimental,,[H][C@](NC(=O)OC(C)(C)C)(C(C)C)C(=O)NC1=CC=CC(Cl)=C1C=O,5288602
7027,DB07957,METHYL(2-ACETOXY-2-(2-CARBOXY-4-AMINO-PHENYL))ACETATE,small molecule,experimental,,[H][C@](OC(C)=O)(C(=O)OC)C1=CC=C(N)C=C1C(O)=O,446501
7028,DB07958,(2-CARBAMOYLMETHYL-5-PROPYL-OCTAHYDRO-INDOL-7-YL)ACETIC ACID,small molecule,experimental,,CCCC1=CC2=C(NC(CC(N)=O)=C2)C(CC(O)=O)=C1,447739
7029,DB07959,3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE,small molecule,experimental,,N1N=C(C2=NC3=CC=CC=C3N2)C2=C1C=CC=C2,5327123
7030,DB07960,"5-ACETAMIDO-5,6-DIHYDRO-4-HYDROXY-6-ISOBUTOXY-4H-PYRAN-2-CARBOXYLIC ACID",small molecule,experimental,,[H][C@]1(O)C=C(O[C@@]([H])(OCC(C)C)[C@]1([H])NC(C)=O)C(O)=O,46937111
7031,DB07961,"1-(4-Cyano-phenyl)-3-[2-(2,6-dichloro-phenyl)-1-imino-ethyl]-thiourea",small molecule,experimental,,[H]N([H])C(\CC1=C(Cl)C=CC=C1Cl)=N/C(=S)N([H])C1=CC=C(C=C1)C#N,5496892
7032,DB07962,"METHYL N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINATE",small molecule,experimental,,COC(=O)CCNC(=O)C1=C(O)C(I)=CC(=C1)C1=C(F)C=C(F)C=C1,25150855
7033,DB07963,"N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINE",small molecule,experimental,,OC(=O)CCNC(=O)C1=C(O)C(I)=CC(=C1)C1=C(F)C=C(F)C=C1,25150856
7034,DB07964,"(3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE",small molecule,experimental,,[H][C@]1(N(CCSC1(C)C)S(=O)(=O)C1=CC=C(OCC#CC)C=C1)C(=O)NO,5288615
7035,DB07965,6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile,small molecule,experimental,,CN1CCN(CCN2C=NC3=C(NC4CCCCC4)N=C(N=C23)C#N)CC1,5288616
7036,DB07966,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile,small molecule,experimental,,N#CCC1=CC=C(NC2=NC3=CC=CC=C3C(NC3=NNC(=C3)C3CC3)=N2)C=C1,16040294
7037,DB07967,9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE,small molecule,experimental,,N#CC1=NC2=C(N=CN2C2CCCC2)C(NC2=CC=CC=C2OCCCN2C=CN=C2)=N1,11464526
7038,DB07968,N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA,small molecule,experimental,,COC1=CC=C(O)C=C1NC(=O)NC(=O)C1=CC=C(F)C=C1Cl,9547901
7039,DB07969,3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol,small molecule,experimental,,CN1CCN(CC1)C1=NC2=C(C=C(C=C2N=C1)C(F)(F)F)C1=CC(O)=CC=C1,25113181
7040,DB07970,5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide,small molecule,experimental,,CC1=C(NC2=CC(=CN=C2)C(N)=O)C=C(C=C1)C(=O)NC1=CC=CC(=C1)C(F)(F)F,24875320
7041,DB07971,"5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE",small molecule,experimental,,NC1=CC=C(SC2=CC=C(C=C2)N2C(=O)C3=C(C=C(N)C=C3)C2=O)C=C1,1202104
7042,DB07972,1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE,small molecule,experimental,,CC1=CC=CC(=C1)N1C=NC2=CC(N)=CC=C12,1510981
7043,DB07973,N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE,small molecule,experimental,,COC1=CC(CN2C(=CC3=C2C=CC=C3)C(=O)NC2CCN(CC2)C(C)C)=CC=C1,6540267
7044,DB07974,1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE,small molecule,experimental,,CC(C)N1CCC(CC1)NC(=O)C1=CC2=C(C=CC=C2)N1CC(=O)NC1=CC=C(Cl)C=C1,6540268
7045,DB07975,"2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID",small molecule,experimental,,OC(=O)C1=C(CCC1)C(=O)NC1=C(F)C=C(C=C1F)C1=CC=CC(OC(F)(F)F)=C1,10342449
7046,DB07976,3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID,small molecule,experimental,,COC1=CC=CC(=C1)C1=CC=C(NC(=O)C2=C(SC=C2)C(O)=O)C(F)=C1,15942657
7047,DB07977,"3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID",small molecule,experimental,,OC(=O)C1=C(C=CS1)C(=O)NC1=C(F)C=C(C=C1F)C1=CC(OC(F)(F)F)=CC=C1,15942658
7048,DB07978,"2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID",small molecule,experimental,,OC(=O)C1=C(C=CC1)C(=O)NC1=C(F)C(F)=C(C(F)=C1F)C1=CC(OC(F)(F)F)=CC=C1,46937112
7049,DB07979,"(2E)-3-(3,4-DIHYDROXYPHENYL)-2-IMINOPROPANOIC ACID",small molecule,experimental,,[H]N=C(CC1=CC(O)=C(O)C=C1)C(O)=O,46937113
7050,DB07981,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1R)-1-(hydroxymethyl)propyl]acetamide,small molecule,experimental,,CC[C@H](CO)NC(=O)CC1=C(C)N(C(=O)C2=CC=C(Cl)C=C2)C2=CC=C(OC)C=C12,16741227
7051,DB07982,2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol,small molecule,experimental,,CC(C)N1C(C)=NC=C1C1=NC(NC2=CC=C(C=C2)N2CCN(CC2)C(=O)CO)=NC=C1,11270500
7052,DB07983,1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID,small molecule,experimental,,COC1=CC=C2N(C(=O)C3=CC=C(I)C=C3)C(C)=C(CC(O)=O)C2=C1,447835
7053,DB07984,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1S)-1-(hydroxymethyl)propyl]acetamide,small molecule,experimental,,CC[C@@H](CO)NC(=O)CC1=C(C)N(C(=O)C2=CC=C(Cl)C=C2)C2=C1C=C(OC)C=C2,16741228
7054,DB07985,+/-METHYL 4-(AMINOIMINOMETHYL)-BETA-[3- INH (AMINOIMINO)PHENYL]BENZENE PENTANOATE,small molecule,experimental,,[H][C@](CCC1=CC=C(C=C1)C(N)=N)(CC(=O)OC)C1=CC=CC(=C1)C(N)=N,444406
7055,DB07986,[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID,small molecule,experimental,,OC(=O)CNS(=O)(=O)C1=CC=C(C=C1)N1CCC(CC1)C1=CC=CC=C1,1948
7056,DB07987,"[2-(5-Mercapto-[1,3,4]thiadiazol-2-ylcarbamoyl)-1-phenyl-ethyl]-carbamic acid benzyl ester",small molecule,experimental,,[H]N([C@H](CC(=O)N([H])C1=NN([H])C(=S)S1)C1=CC=CC=C1)C(=O)OCC1=CC=CC=C1,4369082
7057,DB07988,"2-[3-(5-Mercapto-[1,3,4]thiadiazol-2yl)-ureido]-N-methyl-3-pentafluorophenyl-propionamide",small molecule,experimental,Enzyme Inhibitors|Matrix Metalloproteinase Inhibitors|Protease Inhibitors|Sulfur Compounds|Thiazoles,CNC(=O)[C@H](CC1=C(F)C(F)=C(F)C(F)=C1F)NC(=O)NC1=NN=C(S)S1,4369080
7058,DB07989,2-(ACETYL-HYDROXY-AMINO)-4-METHYL-PENTANOIC ACID METHYL ESTER,small molecule,experimental,,[H][C@](CC(C)C)(N(O)C(C)=O)C(=O)OC,5288636
7059,DB07990,"(RP,SP)-O-(2R)-(1-PHENOXYBUT-2-YL)-METHYLPHOSPHONIC ACID CHLORIDE",small molecule,experimental,,[H][C@@](CC)(COC1=CC=CC=C1)O[P@](C)(Cl)=O,46937114
7060,DB07991,N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,small molecule,experimental,,[H][C@@](C)(CCC1=CC=C(O)C=C1)NC(=O)CC1=C(NC2=C1C=CC=C2)C1=CC=CC=C1,16750040
7061,DB07992,Indoxyl sulfate,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Indoles",OS(=O)(=O)OC1=CNC2=CC=CC=C12,10258
7062,DB07993,"N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE",small molecule,experimental,,NC1=NC=CC=C1NCC1=CC=CC(=C1)C1=CC2=C(C=CN2)C=C1,11507920
7063,DB07994,"N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE",small molecule,experimental,,NC1=NC=CC=C1NCC1=C(OCC2=NC=CC=C2)C=CC(=C1)C1=CC2=C(C=CN2)C=C1,11633167
7064,DB07995,H-89,small molecule,experimental,"Amides|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Protein Kinase Inhibitors|Sulfones|Sulfur Compounds",BrC1=CC=C(\C=C\CNCCNS(=O)(=O)C2=CC=CC3=C2C=CN=C3)C=C1,449241
7065,DB07996,5-(2-methylpiperazine-1-sulfonyl)isoquinoline,small molecule,experimental,"Amides|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Piperazines|Sulfonamides|Sulfones|Sulfur Compounds",CC1CNCCN1S(=O)(=O)C1=C2C=CN=CC2=CC=C1,3542
7066,DB07997,N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE,small molecule,experimental,,CNCCNS(=O)(=O)C1=CC=CC2=C1C=CN=C2,3540
7067,DB07999,"{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID",small molecule,experimental,,OC(=O)COC(=O)C1=C2C(C(=O)N(CC(O)=O)S2(=O)=O)=C2C=CC=CC2=C1,11494891
7068,DB08000,"2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE",small molecule,experimental,,OC(=O)CN1C(=O)C2=C(C(=CC3=CC=CC=C23)C(O)=O)S1(=O)=O,11660035
7069,DB08001,5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID,small molecule,experimental,,COC(=O)C1=C(O)C=CC=C1OC\C=C\C1=CC(=CC=C1)C1=C(CO)C(=NO1)C(O)=O,449162
7070,DB08003,ISOTHIAZOLIDINONE ANALOG,small molecule,experimental,,[H][C@@](CC1=CC=C(C=C1)[C@]1([H])CC(=O)NS1(=O)=O)(NC(=O)[C@]([H])(CC1=CC=CC=C1)NC(C)=O)C(N)=O,9547915
7071,DB08004,"(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol",small molecule,experimental,,[H][C@](CO)(NC1=NN2C(C=C1)=NC=C2C1=CC(N)=CC=C1)C(C)C,46937115
7072,DB08005,4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide,small molecule,experimental,,CCNC(=O)N1CCC(CC1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1,16129582
7073,DB08006,"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",small molecule,experimental,,CC1=NC2=NC=NN2C(NC2=CC3=CC4=CC=CC=C4C=C3C=C2)=C1,24882195
7074,DB08007,(2R)-3-{[(BENZYLAMINO)CARBONYL]AMINO}-2-HYDROXYPROPANOIC ACID,small molecule,experimental,,[H][C@@](O)(CNC(=O)NCC1=CC=CC=C1)C(O)=O,24820112
7075,DB08008,"5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine",small molecule,experimental,,CC1=NC2=NC=NN2C(NC2=CC=C(C=C2)C(F)(F)F)=C1,25263414
7076,DB08009,SU-11652,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring",CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(Cl)C=C3)=C1C,5329103
7077,DB08010,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime",small molecule,experimental,,O\N=C1/C(=O)N(CC2=C3OCOCC3=CC(F)=C2)C2=CC=CC(\C=C\C3=CC=CC=C3)=C12,45268539
7078,DB08011,"(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime",small molecule,experimental,,O\N=C1\C(=O)N(CC2=CC(F)=CC3=C2OCOC3)C2=C1C=C(F)C=C2,46937116
7079,DB08012,Pirodavir,small molecule,experimental,Antiviral Agents,CCOC(=O)C1=CC=C(OCCC2CCN(CC2)C2=CC=C(C)N=N2)C=C1,71345
7080,DB08013,(METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE,small molecule,experimental,,CCOC(=O)C1=CC=C(OCCCC2CCN(CC2)C2=NN=C(C)C=C2)C=C1,130188
7081,DB08014,(METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE,small molecule,experimental,,CCOC(=O)C1=CC=C(OCCCCC2CCN(CC2)C2=NN=C(C)C=C2)C=C1,449026
7082,DB08015,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime",small molecule,experimental,,O\N=C1/C(=O)N(CC2=CC(F)=CC3=C2OCOC3)C2=CC=CC(=C12)C1=CC=CC=C1,45270264
7083,DB08016,"4-(6-CHLORO-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL) BUTYL PHOSPHATE",small molecule,experimental,,OP(O)(=O)OCCCCC1=C(Cl)NC(=O)NC1=O,11987823
7084,DB08017,3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE,small molecule,experimental,,COC1=NN=C(C=C1)N1CCN(CC1)C1=CC(C)=CC=C1,127504
7085,DB08018,"N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE",small molecule,experimental,,[H][C@]1(CC2=NC(N)=CC(C)=C2)CNC[C@@]1([H])NCCNCC1=CC=C(Cl)C=C1,24798097
7086,DB08019,"N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine",small molecule,experimental,,[H][C@]1(CC2=NC(N)=CC(C)=C2)CNC[C@]1([H])NCCNCC1=CC(Cl)=CC=C1,25021186
7087,DB08020,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",small molecule,experimental,,[H][C@@]12CCC[C@]1([H])[C@@]([H])(OC1=C2C=C(O)C=C1COC)C1=CC=C(O)C=C1,9927355
7088,DB08021,5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide,small molecule,experimental,,ClC1=C(N2CCN(CC#C)CC2)C(NC(=O)C2=CC=C(Br)O2)=CC=C1,44224261
7089,DB08022,"(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile",small molecule,experimental,,[H][C@](C#N)(C1=NC2=C(S1)C=CC=C2)C1=NC(NCCC2=CC=CN=C2)=NC=C1,46937117
7090,DB08023,"N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine",small molecule,experimental,,CN(C1CCCCC1)C1=NC(=CC=N1)C1=CN=C2C=CC=CN12,24801862
7091,DB08024,1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE,small molecule,experimental,,[H][C@](N)(CC1=CC=C(C=C1)C1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])CN,5459374
7092,DB08025,"N-{2'-[(4-FLUOROPHENYL)AMINO]-4,4'-BIPYRIDIN-2-YL}-4-METHOXYCYCLOHEXANECARBOXAMIDE",small molecule,experimental,,[H][C@@]1(CC[C@@]([H])(CC1)C(=O)NC1=CC(=CC=N1)C1=CC(NC2=CC=C(F)C=C2)=NC=C1)OC,10364826
7093,DB08026,"2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide",small molecule,experimental,,CNC(=O)CN1CCC(CC1)NC1=NC(=CC=N1)C1=CN=C2C=CC=CN12,24801863
7094,DB08027,CAP-1,small molecule,experimental,,CN(C)CC1=CC=C(CSCCNC(=O)NC2=CC=C(C)C(Cl)=C2)O1,5082818
7095,DB08028,"BUT-3-ENYL-[5-(4-CHLORO-PHENYL)-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-YLIDENE]-AMINE",small molecule,experimental,,ClC1=CC=C(C=C1)C1=NN\C(SC1)=N\CCC=C,4636204
7096,DB08029,N~2~-(biphenyl-4-ylsulfonyl)-N-hydroxy-N~2~-(2-hydroxyethyl)glycinamide,small molecule,experimental,,OCCN(CC(=O)NO)S(=O)(=O)C1=CC=C(C=C1)C1=CC=CC=C1,24178109
7097,DB08030,3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide,small molecule,experimental,,ONC(=O)CCOC1=CC=C(C=C1)C1=CC=C(C=C1)C#N,10039403
7098,DB08031,"N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE",small molecule,experimental,,CC(C)(NC(=O)C1=CC=C2C(=C1)N1CCOC3=C(C=CC=C3)C1=C2C1CCCCC1)C(O)=O,11987832
7099,DB08032,"N,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",small molecule,experimental,,CCN(CC)C(=O)C1=C(NC(=O)C2=CC=CS2)SC2=C1CCCC2,1190625
7100,DB08033,"(5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",small molecule,experimental,,[H][C@@]1(C)CCC2=C(C1)C(C(=O)N(CC)CC)=C(NC(=O)C1=CC=CS1)S2,16122638
7101,DB08034,"(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE",small molecule,experimental,,COC1=C(\C=N\NC(=O)C2=CC(O)=C(O)C=C2)C2=CC=CC=C2C=C1,9562794
7102,DB08035,"1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE",small molecule,experimental,,CC1=CC=C(C)C(CC2=NN(C3=C2C(N)=NC=N3)C(C)(C)C)=C1,11522441
7103,DB08036,"6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one",small molecule,experimental,,O=C1NCC2=C3C(NC4=CC=CC=C34)=C3NC4=C(C=CC=C4)C3=C12,3815
7104,DB08037,MK-0731,small molecule,experimental,,CN([C@H]1CCN(C)C[C@H]1F)C(=O)N1CC(=C[C@@]1(CO)C1=CC=CC=C1)C1=C(F)C=CC(F)=C1,11655511
7105,DB08038,"L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide",small molecule,experimental,,[H][C@@](C)(N)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CC1=CC=CC=C1)[C@@]([H])(C)O,46937118
7106,DB08039,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",small molecule,experimental,,CN(C)S(=O)(=O)C1=CC=C2NC(=O)\C(=C/C3=CC4=C(CCCC4)N3)C2=C1,5312137
7107,DB08040,Kelatorphan,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Analgesics|Central Nervous System Agents|Oligopeptides|Peptides|Peripheral Nervous System Agents|Sensory System Agents",C[C@H](NC(=O)[C@@H](CC(=O)NO)CC1=CC=CC=C1)C(O)=O,123982
7108,DB08041,3-BENZYLOXYCARBONYLAMINO-2-HYDROXY-4-PHENYL-BUTYRIC ACID,small molecule,experimental,,[H][C@@](CC1=CC=CC=C1)(NC(=O)OCC1=CC=CC=C1)[C@@]([H])(O)C(O)=O,10958449
7109,DB08042,"N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",small molecule,experimental,,COC1=CC(NC2=NC(=CC=N2)N(C)C2=CC3=C(C=C2)C(C)=NN3)=CC(OC)=C1OC,24941243
7110,DB08043,1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA,small molecule,experimental,,FC(F)(F)C1=CC(NC(=O)NC2=CC=C(OC3=CC=NC=C3)C=C2)=CC=C1,15942672
7111,DB08044,ABT-341,small molecule,experimental,Benzene Derivatives|Enzyme Inhibitors|Protease Inhibitors,[H][C@]1(N)CC(=CC[C@]1([H])C1=CC(F)=C(F)C=C1F)C(=O)N1CCN2C(C1)=NN=C2C(F)(F)F,11974440
7112,DB08045,"4-{4-[4-(3-AMINOPROPOXY)PHENYL]-1H-PYRAZOL-5-YL}-6-CHLOROBENZENE-1,3-DIOL",small molecule,experimental,,NCCCOC1=CC=C(C=C1)C1=C(NN=C1)C1=CC(Cl)=C(O)C=C1O,5327092
7113,DB08046,2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide,small molecule,experimental,,NS(=O)(=O)C1=C(Cl)C=CC(=C1)[C@@]1(O)NC(=O)C2=C1C=CC=C2,688424
7114,DB08047,"4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol",small molecule,experimental,,OC1=CC(O)=C(C=C1)C1=NN(CC=C)C2=C1C=CC=C2C(F)(F)F,46870043
7115,DB08048,"4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL",small molecule,experimental,,OC1=CC=C2C(NN=C2C2=CC=C(O)C=C2O)=C1,14086997
7116,DB08049,"7,8-dihydroxy-4-phenyl-2H-chromen-2-one",small molecule,experimental,,OC1=CC=C2C(OC(=O)C=C2C2=CC=CC=C2)=C1O,5413034
7117,DB08050,5-phenyl-2-keto-valeric acid,small molecule,experimental,,OC(=O)C(=O)CCCC1=CC=CC=C1,13294447
7118,DB08051,"(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",small molecule,experimental,,[H][C@](N)(CC(=O)N1CCCCCN1C(=O)C1=CC=CC=C1)CC1=C(F)C=C(F)C(F)=C1,16739331
7119,DB08052,PP-121,small molecule,experimental,,NC1=NC=NC2=C1C(=NN2C1CCCC1)C1=CC2=C(NC=C2)N=C1,24905142
7120,DB08053,"1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",small molecule,experimental,,COC1=C(OC)C=C(C=C1)C1=NN(C2CCC2)C2=NC=NC(N)=C12,24905153
7121,DB08054,"1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",small molecule,experimental,,CC(C)N1N=C(C2=C(N)N=CN=C12)C1=CC2=CC=CN=C2C=C1,24905152
7122,DB08055,"N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",small molecule,experimental,,ClC1=C(NC2=NC=C(N3C=NC=C23)C2=CC=CC=C2)C=CC=C1,44563262
7123,DB08056,"N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",small molecule,experimental,,CC1=CC=CC(C)=C1NC1=NC=C(N2C=NC=C12)C1=CC=CC=C1,44422489
7124,DB08057,"N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine",small molecule,experimental,,[H][C@]1(C)CN(CCN1)C1=CC=C2N=C(NC3=C(C)C=CC=C3Cl)C3=CN=CN3C2=C1,46937119
7125,DB08058,"4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one",small molecule,experimental,,FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCCNCC1,11291932
7126,DB08059,Wortmannin,small molecule,experimental,"Androstadienes|Androstanes|Androstenes|Anti-Infective Agents|Antidepressive Agents|Antifungal Agents|Central Nervous System Depressants|Enzyme Inhibitors|Fused-Ring Compounds|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunologic Factors|Immunosuppressive Agents|Insulin Antagonists|Protein Kinase Inhibitors|Radiation-Sensitizing Agents|Serotonin Agents|Serotonin Receptor Antagonists|Steroids",[H][C@@]12CCC(=O)[C@@]1(C)C[C@@H](OC(C)=O)C1=C2C(=O)C2=C3C(=CO2)C(=O)O[C@H](COC)[C@]13C,312145
7127,DB08060,4-(2-AMINOPHENYL)-4-OXOBUTANOIC ACID,small molecule,experimental,,NC1=CC=CC=C1C(=O)CCC(O)=O,6420149
7128,DB08061,4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE,small molecule,experimental,,ClC1=CC=C(C=C1)C1=NNC(=C1)C1CCNCC1,449126
7129,DB08062,"3-(4-CHLOROPHENYL)-5-(METHYLTHIO)-4H-1,2,4-TRIAZOLE",small molecule,experimental,,CSC1=NN=C(N1)C1=CC=C(Cl)C=C1,449127
7130,DB08063,"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",small molecule,experimental,,COC1=CC=C(NC2=C(C(=O)N(CC3=CC=CC=C3)C2=O)C2=CC=CC=C2)C=C1,5288679
7131,DB08064,N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA,small molecule,experimental,,CC(C)(C)C1=NNC(NC(=O)NC2=CC=C(Cl)C(COC3=CC=CN=C3)=C2)=C1,5326866
7132,DB08065,2-(1H-pyrazol-3-yl)-1H-benzimidazole,small molecule,experimental,,N1C=CC(=N1)C1=NC2=CC=CC=C2N1,5403336
7133,DB08066,N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE,small molecule,experimental,,O=C(NC1=CNN=C1C1=NC2=C(N1)C=CC=C2)C1=CC=CC=C1,25138278
7134,DB08067,4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM,small molecule,experimental,,O=C(NC1CC1)NC1=CNN=C1C1=NC2=CC=C(C[NH+]3CCOCC3)C=C2N1,25138280
7135,DB08068,N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-,small molecule,experimental,,[H][C@@]1(F)C[C@]([H])(CC(=C1)C(=O)NC1=CC=C(Cl)C(COC2=CN=CC=C2)=C1)N1CCOCC1,46937120
7136,DB08069,"4-AMINO-5-(2-METHYLPHENYL)-2,4-DIHYDRO-3H-1,2,4-TRIAZOLE-3-THIONE",small molecule,experimental,,CC1=CC=CC=C1C1=NNC(=S)N1N,2405215
7137,DB08070,2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE,small molecule,experimental,,CC1=NNC=C1C1=CC=C(CCN)C=C1,16122634
7138,DB08071,"(2S)-1-methyl-2-[(2S,4R)-2-methyl-4-phenylpentyl]piperidine",small molecule,experimental,,[H][C@](C)(C[C@@]([H])(C)C1=CC=CC=C1)C[C@]1([H])CCCCN1C,46937121
7139,DB08072,"4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE",small molecule,experimental,,CC(C)OC1=CC(NC(=O)C2=CC(Cl)=C(OCCN)C(Cl)=C2)=CC=C1,23653530
7140,DB08073,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,small molecule,experimental,,[H][C@@](N)(COC1=CN=CC(=C1)C1=CC=C2NN=C(C)C2=C1)CC1=CNC2=CC=CC=C12,10172943
7141,DB08074,3-(3-Methyl-2-buten-1-yl)-3H-purin-6-amine,small molecule,experimental,,CC(C)=CCN1C=NC(N)=C2N=CN=C12,45070
7142,DB08075,"4-(2-amino-1,3-thiazol-4-yl)pyrimidin-2-amine",small molecule,experimental,,NC1=NC(=CS1)C1=NC(N)=NC=C1,13582275
7143,DB08076,"4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine",small molecule,experimental,,CC1=NC(=CN1CC1=C(Cl)C=CC=C1Cl)C1=NC(N)=NC=C1,2766552
7144,DB08077,"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",small molecule,experimental,,CC(C)(OC1=CC=C(NC(=O)NC2=CC(Cl)=CC(Cl)=C2)C=C1)C(O)=O,195347
7145,DB08078,{4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid,small molecule,experimental,,CCCC1=C(OCCCOC2=CC=C(OCC(O)=O)C=C2)C=CC(C(C)=O)=C1O,6603901
7146,DB08079,AMG-208,small molecule,investigational,,COC1=CC2=NC=CC(OCC3=NN=C4C=CC(=NN34)C3=CC=CC=C3)=C2C=C1,24864821
7147,DB08080,Latrunculin B,small molecule,experimental,Marine Toxins|Porifera|Sulfur Compounds|Thiazoles,[H][C@]1(CSC(=O)N1)[C@@]1(O)C[C@H]2C[C@@H](CC[C@H](C)\C=C/CC\C(C)=C/C(=O)O2)O1,6436219
7148,DB08081,3-OXO-OCTANOIC ACID (2-OXO-TETRAHYDRO-FURAN-3-YL)-AMIDE,small molecule,experimental,,[H][C@@]1(CCOC1=O)NC(=O)CC(=O)CCCCC,127293
7149,DB08082,N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE,small molecule,experimental,,OCCNC(=O)C1=CC=C(Cl)C=C1,233979
7150,DB08083,"2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide",small molecule,experimental,,NS(=O)(=O)C1=CC=C2NC(=NC2=C1)C1=CSC=N1,44144383
7151,DB08084,IDD594,small molecule,experimental,"Acids, Acyclic|Aldehyde Reductase, antagonists & inhibitors|Amides|Fatty Acids|Fatty Acids, Volatile|Lipids|Sulfur Compounds",OC(=O)COC1=CC(F)=CC=C1C(=S)NCC1=CC=C(Br)C=C1F,4369325
7152,DB08085,1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE,small molecule,experimental,,CCCCCCC1=CC=C(C=C1)C(=O)C=C,14899645
7153,DB08086,N-[12-(1H-imidazol-1-yl)dodecanoyl]-L-leucine,small molecule,experimental,,[H][C@@](CC(C)C)(NC(=O)CCCCCCCCCCCN1C=CN=C1)C(O)=O,46937122
7154,DB08087,"4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE",small molecule,experimental,,[H][C@@]1(O)CCN2C(=O)N(C(=O)[C@]12[H])C1=CC=C(C#N)C2=CC=CC=C12,9944398
7155,DB08088,"2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile",small molecule,experimental,,N#CC1=CC=C(\N=C2/O[C@@]([H])(C(F)(F)F)[C@]3([H])[C@](O)([H])CCN23)C(C)=C1Cl,11428356
7156,DB08089,LGD-2226,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Quinolines",FC(F)(F)CN(CC(F)(F)F)C1=CC2=C(NC(=O)C=C2C(F)(F)F)C=C1,11560224
7157,DB08090,"(3Z,5S,6R,7S,8R,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol",small molecule,experimental,,[H][C@]12CO\C(=N/CCCCCCCC)N1[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@]2([H])O,46937123
7158,DB08091,3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE,small molecule,experimental,,FC1=CC(=CC(=C1)C(=O)NC1=CC=C2NC=C(CCC3=CC=NC=C3)C2=C1)N1CCOCC1,5326868
7159,DB08092,3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide,small molecule,experimental,,FC1=CC(=CC(=C1)C(=O)NC1=CC=C2NC=CC2=C1)N1CCOCC1,5326870
7160,DB08093,3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE,small molecule,experimental,,NC1=C(OCC2=CC=CC3=CC=CC=C23)C=CC=N1,5326871
7161,DB08094,RO-4584820,small molecule,investigational,,COC1=CC=C(F)C(F)=C1C(=O)C1=CN=C(NC2CCN(CC2)S(C)(=O)=O)N=C1N,6918852
7162,DB08095,"3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA",small molecule,experimental,,[H][C@@](C)(NC1=NC=CC(=N1)N(C(=O)NC1=CC=CC=C1Cl)C1=CC=C(OC)C=C1)C(C)(C)O,6540299
7163,DB08096,"8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM",small molecule,experimental,,CCN1C(NC2=CC=CC=C2Cl)=NC2=C1N=C(NC1=C(F)C=CC=C1F)N=C2,6852209
7164,DB08097,"2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE",small molecule,experimental,,CC(C)N1C(NC2=CC=CC=C2F)=NC2=CN=C(OC3=C(F)C=CC=C3F)N=C12,9543517
7165,DB08098,"{[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid",small molecule,experimental,,OC(=O)CSC1=NN=C(O1)C1=CC=C(O1)[N+]([O-])=O,2817424
7166,DB08099,"6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine",small molecule,experimental,,[H][C@]1(CCC2=CC=C(C=C2N1CCCOC)C1=C(N)N=C(N)N=C1CC)C1=CC=CC=C1,11963546
7167,DB08100,"2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol",small molecule,experimental,,CC1=CC(\C=C\C2=CC=CC=C2)=CC(C)=C1O,6365297
7168,DB08101,"2,6-dibromo-4-[(E)-2-phenylethenyl]phenol",small molecule,experimental,,OC1=C(Br)C=C(\C=C\C2=CC=CC=C2)C=C1Br,25129137
7169,DB08102,"3,5-dibromobiphenyl-4-ol",small molecule,experimental,,OC1=C(Br)C=C(C=C1Br)C1=CC=CC=C1,243556
7170,DB08103,"2,6-dibromo-4-phenoxyphenol",small molecule,experimental,,OC1=C(Br)C=C(OC2=CC=CC=C2)C=C1Br,10831270
7171,DB08104,"N-(3,5-dibromo-4-hydroxyphenyl)benzamide",small molecule,experimental,,OC1=C(Br)C=C(NC(=O)C2=CC=CC=C2)C=C1Br,1184681
7172,DB08105,N-[(6-butoxynaphthalen-2-yl)sulfonyl]-L-glutamic acid,small molecule,experimental,,CCCCOC1=CC2=CC=C(C=C2C=C1)S(=O)(=O)N[C@@H](CCC(O)=O)C(O)=O,16122581
7173,DB08106,N-[(6-butoxynaphthalen-2-yl)sulfonyl]-D-glutamic acid,small molecule,experimental,,CCCCOC1=CC2=CC=C(C=C2C=C1)S(=O)(=O)N[C@H](CCC(O)=O)C(O)=O,16122580
7174,DB08107,N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID,small molecule,experimental,,[H][C@](CCC(O)=O)(NS(=O)(=O)C1=CC2=C(C=C1)C=C(OCCCCC)C=C2)C(O)=O,24755470
7175,DB08108,N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,small molecule,experimental,,[H][C@](CCC(O)=O)(NS(=O)(=O)C1=CC2=C(C=C1)C=C(OCC1=CC=C(C=C1)C#N)C=C2)C(O)=O,24755471
7176,DB08109,"(1S,4R,7AR)-4-BUTOXY-1-[(1R)-1-FORMYLPROPYL]-2,4,5,6,7,7A-HEXAHYDRO-1H-ISOINDOLE-3-CARBOXYLIC ACID",small molecule,experimental,,[H][C@](CC)(C=O)[C@@]1([H])NC(C(O)=O)=C2[C@@]1([H])CCC[C@@]2([H])OCCCC,46937124
7177,DB08110,"(1R,4S,7AS)-1-(1-FORMYLPROP-1-EN-1-YL)-4-METHOXY-2,4,5,6,7,7A-HEXAHYDRO-1H-ISOINDOLE-3-CARBOXYLIC ACID",small molecule,experimental,,[H][C@]1(NC(C(O)=O)=C2[C@]1([H])CCC[C@]2([H])OC)C(=C/C)\C=O,46937125
7178,DB08111,"4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol",small molecule,experimental,,OC1=CC=C(CC2=NN=C3C=CC(=NN23)C2=CC=CC=C2)C=C1,24901696
7179,DB08112,N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,small molecule,experimental,,[H][C@](CCC(O)=O)(NS(=O)(=O)C1=CC2=C(C=C1)C=C(OCC1=C(F)C=C(C=C1)C#N)C=C2)C(O)=O,25058128
7180,DB08113,3-pyridin-4-yl-1H-indazole,small molecule,experimental,,N1N=C(C2=C1C=CC=C2)C1=CC=NC=C1,12412578
7181,DB08114,"5-benzyl-1,3-thiazol-2-amine",small molecule,experimental,,NC1=NC=C(CC2=CC=CC=C2)S1,691952
7182,DB08115,2-aminoethyl naphthalen-1-ylacetate,small molecule,experimental,,NCCOC(=O)CC1=C2C=CC=CC2=CC=C1,24883481
7183,DB08116,"(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine",small molecule,experimental,,[H][C@](NC1=C(C=O)C=C2C=CC=CN12)(C(O)=O)[C@](C)(COC(=O)CC1=CC(O)=C(O)C=C1)[S@](O)=O,46937126
7184,DB08118,"2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",small molecule,experimental,,CNC1=C(C=C(SC2=NN=CN2C)C=C1)C(=O)NC1=NC(C)=CS1,25229552
7185,DB08119,"1,1,1-TRIFLUORO-3-((N-ACETYL)-L-LEUCYLAMIDO)-4-PHENYL-BUTAN-2-ONE(N-ACETYL-L-LEUCYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)",small molecule,experimental,,[H][C@@](CC(C)C)(NC(C)=O)C(=O)N[C@@]([H])(CC1=CC=CC=C1)C(=O)C(F)(F)F,3082654
7186,DB08120,"6,8-DIMERCAPTO-OCTANOIC ACID AMIDE",small molecule,experimental,,[H][C@](S)(CCS)CCCCC(N)=O,445160
7187,DB08121,(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid,small molecule,experimental,,[H][C@@](CC1=CC=CC=C1)(OC1=CC=C(C=C1)C1=CC=CC=C1)C(O)=O,11483970
7188,DB08122,"N-Methyl-4-{[(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]amino}benzenesulfonamide",small molecule,experimental,,[H]\C(NC1=CC=C(C=C1)S(=O)(=O)NC)=C1\C(=O)NC2=CC=CC=C12,5288708
7189,DB08123,"N-methyl-{4-[2-(7-oxo-6,7-dihydro-8H-[1,3]thiazolo[5,4-e]indol-8-ylidene)hydrazino]phenyl}methanesulfonamide",small molecule,experimental,,CNS(=O)(=O)CC1=CC=C(N\N=C2/C(=O)NC3=C2C2=C(C=C3)N=CS2)C=C1,5288709
7190,DB08124,"3-{[(2,2-dioxido-1,3-dihydro-2-benzothien-5-yl)amino]methylene}-5-(1,3-oxazol-5-yl)-1,3-dihydro-2H-indol-2-one",small molecule,experimental,,O=C1NC2=CC=C(C=C2\C1=C\NC1=CC2=C(CS(=O)(=O)C2)C=C1)C1=CN=CO1,5288710
7191,DB08125,"4-{[(2-Oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]amino}-N-(1,3-thiazol-2-yl)benzenesulfonamide",small molecule,experimental,,O=C1NC2=CC=CC=C2\C1=C\NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CS1,5288711
7192,DB08126,"3-{[4-([amino(imino)methyl]aminosulfonyl)anilino]methylene}-2-oxo-2,3-dihydro-1H-indole",small molecule,experimental,,NC(=N)NS(=O)(=O)C1=CC=C(N\C=C2/C(=O)NC3=C2C=CC=C3)C=C1,5288712
7193,DB08127,"1,3,3-trimethyl-2-[(1E,3E)-3-methylpenta-1,3-dien-1-yl]cyclohexene",small molecule,experimental,,C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,15143646
7194,DB08128,"(1S,4R,9S)-5-(trifluoromethyl)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-9-amine",small molecule,experimental,,[H][C@]12CC[C@]([H])(C3=C(C=CC=C13)C(F)(F)F)[C@@]2([H])N,46937127
7195,DB08129,(1R)-2-amino-1-[3-(trifluoromethyl)phenyl]ethanol,small molecule,experimental,,[H][C@](O)(CN)C1=CC=CC(=C1)C(F)(F)F,36688409
7196,DB08130,"N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine",small molecule,experimental,,NCCNC1=NN=C(O1)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,25023709
7197,DB08131,"2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-3-METHYL-BUTYRIC ACID",small molecule,experimental,,[H][C@](NC(=O)C1=CC=C(CCC2=CNC3=C2C(=O)NC(N)=N3)C=C1)(C(C)C)C(O)=O,446560
7198,DB08132,5-hydroxynaphthalene-1-sulfonamide,small molecule,experimental,,NS(=O)(=O)C1=C2C=CC=C(O)C2=CC=C1,87031
7199,DB08133,N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide,small molecule,experimental,,NS(=O)(=O)C1=CC=C(NC(=O)C2=NNC3=C2C=CC=C3)C=C1,9926933
7200,DB08134,4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide,small molecule,experimental,,NS(=O)(=O)C1=CC=C(NC2=NC(Cl)=CN=C2)C=C1,9994066
7201,DB08135,N-phenyl-1H-pyrazole-3-carboxamide,small molecule,experimental,,O=C(NC1=CC=CC=C1)C1=NNC=C1,680935
7202,DB08136,4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide,small molecule,experimental,,CC(=O)NC1=CNN=C1C(=O)NC1=CC=C(F)C=C1,24864077
7203,DB08137,(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide,small molecule,experimental,,FC1=CC=C(NC(=O)C2=NNC=C2NC(=O)C2=CC=CC=C2)C=C1,24864078
7204,DB08138,"{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide",small molecule,experimental,,FC1=CC=C(NC(=O)C2=NNC=C2NC(=O)C2=C(F)C=CC=C2F)C=C1,24864079
7205,DB08139,"5-chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile",small molecule,experimental,,CC(C)NC1=CC(Cl)=NC2=C(C=NN12)C#N,24971312
7206,DB08140,"5-[(4-AMINOCYCLOHEXYL)AMINO]-7-(PROPAN-2-YLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBONITRILE",small molecule,experimental,,[H][C@]1(N)CC[C@@]([H])(CC1)NC1=NC2=C(C=NN2C(NC(C)C)=C1)C#N,24971313
7207,DB08141,"4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide",small molecule,experimental,,[H][C@@]1(CCCNC1)NC(=O)C1=NNC=C1NC(=O)C1=C(F)C=CC=C1F,24864082
7208,DB08142,AT-7519,small molecule,investigational,"Cyclin-Dependent Kinases, antagonists & inhibitors",ClC1=CC=CC(Cl)=C1C(=O)NC1=CNN=C1C(=O)NC1CCNCC1,11338033
7209,DB08143,"5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE",small molecule,experimental,,[H][C@]1(F)CN(CC(=O)NC2=CC=C(C=C2F)N2C=CC=CC2=O)C[C@]1([H])NC(=O)C1=CC=C(Cl)S1,42628063
7210,DB08144,"6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine",small molecule,experimental,,NC1=NC2=NC(N)=C(C=C2C=N1)C1=C(Br)C=CC=C1Br,5328120
7211,DB08145,"6-(2,6-DIMETHOXYPHENYL)PYRIDO[2,3-D]PYRIMIDINE-2,7-DIAMINE",small molecule,experimental,,COC1=CC=CC(OC)=C1C1=CC2=CN=C(N)N=C2N=C1N,21850055
7212,DB08146,"7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine",small molecule,experimental,,NC1=NC2=C(C=N1)C=C(C1=CC=CC=C1)C(=N2)N1CC=CC1,46937128
7213,DB08147,"4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid",small molecule,experimental,,OC(=O)C(=O)CC(=O)C1=CC=CC(=C1)N(CC1=CC=CC=C1)CC1=CC=CC=C1,510684
7214,DB08148,"1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",small molecule,experimental,,NCC1(CCN(CC1)C1=C2C=CNC2=NC=N1)C1=CC=C(Cl)C=C1,24762195
7215,DB08149,"1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",small molecule,experimental,,NCC1(CC2=CC=C(Cl)C=C2)CCN(CC1)C1=C2C=CNC2=NC=N1,11696113
7216,DB08150,"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",small molecule,experimental,,[NH3+]C1(CC2=CC=C(Cl)C=C2)CCN(CC1)C1=C2C=CNC2=NC=N1,42627562
7217,DB08151,"(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol",small molecule,experimental,,[H][C@]1(CO)O[C@@]2(CC(=NO2)C2=CC=CC=C2)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O,44263483
7218,DB08152,{(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate,small molecule,experimental,,[H][C@@]1(COC(=O)CC2=CC(Cl)=CC=C2)CCCN1C(=O)CNC(=O)OC(C)(C)C,24754814
7219,DB08153,"(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE",small molecule,experimental,,OC1=CC(O)=C2C(CC(=O)CCCCC\C=C\CCOC2=O)=C1Cl,11987878
7220,DB08154,3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile,small molecule,experimental,,ClC1=CC(=CC(OC2=C(Cl)C=CC(OCC3=NNC4=C3C=CC=C4)=C2)=C1)C#N,16045336
7221,DB08155,N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE,small molecule,experimental,,CC(=O)NCCC1=CC=C(C=C1)S(N)(=O)=O,745994
7222,DB08156,3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID,small molecule,experimental,,NS(=O)(=O)C1=CC=C(CCC(O)=O)C=C1,3161908
7223,DB08157,ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE,small molecule,experimental,,CCOC(=O)CCC1=CC=C(C=C1)S(N)(=O)=O,16122582
7224,DB08158,"2,4-DINITROPHENYL 2-DEOXY-2-FLUORO-BETA-D-MANNOPYRANOSIDE",small molecule,experimental,,[H][C@]1(CO)O[C@@]([H])(OC2=C(C=C(C=C2)[N+]([O-])=O)[N+]([O-])=O)[C@@]([H])(F)[C@@]([H])(O)[C@]1([H])O,25195339
7225,DB08159,"4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE",small molecule,experimental,,OC(=O)CCCN1C2=C(C(=O)C3=CC=CC=C23)C2=CC=CC=C2C1=O,5288720
7226,DB08160,"(2S)-2-AMINO-4-(METHYLSULFANYL)-1-(1,3-THIAZOL-2-YL)BUTANE-1,1-DIOL",small molecule,experimental,,[H][C@](N)(CCSC)C(O)(O)C1=NC=CS1,5288721
7227,DB08161,(S)-2-(MERCAPTOMETHYL)-5-PHENYLPENTANOIC ACID,small molecule,experimental,,[H][C@](CS)(CCCC1=CC=CC=C1)C(O)=O,24748045
7228,DB08162,Fasudil,small molecule,investigational,"Amides|Antiarrhythmic agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Membrane Transport Modulators|Peripheral Vasodilators|Piperazines|Protein Kinase Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds|Vasodilating Agents",O=S(=O)(N1CCCNCC1)C1=CC=CC2=C1C=CN=C2,3547
7229,DB08163,5'-{[4-(aminooxy)butyl](methyl)amino}-5'-deoxy-8-ethenyladenosine,small molecule,experimental,,[H][C@]1(CN(C)CCCCON)O[C@@]([H])(N2C(C=C)=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,25181315
7230,DB08164,"(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE",small molecule,experimental,,[H][C@]1(N)CN(CC[C@]1([H])C1=CC(F)=C(F)C=C1F)C1=NC=NC(=C1)C1=CC=CC(=C1)S(C)(=O)=O,16058650
7231,DB08165,indane-5-sulfonamide,small molecule,experimental,,NS(=O)(=O)C1=CC=C2CCCC2=C1,96876
7232,DB08166,"(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",small molecule,experimental,,[H][C@@]1(C#N)C2=C(N(C)C3=CC(Cl)=CC=C23)C(=O)NC11CCNCC1,24851689
7233,DB08167,Methylthioninium,small molecule,experimental|investigational,Oxidation-Reduction Activity|Oxidation-Reduction Agent|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,CN(C)C1=CC2=[S+]C3=CC(=CC=C3N=C2C=C1)N(C)C,4139
7234,DB08168,Coumarin 120,small molecule,experimental,"Benzopyrans|Compounds used in a research, industrial, or household setting|Heterocyclic Compounds, Fused-Ring|Indicators and Reagents|Laboratory Chemicals|Pyrans",CC1=CC(=O)OC2=C1C=CC(N)=C2,92249
7235,DB08169,(2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide,small molecule,experimental,,O\C(C1CC1)=C(\C#N)C(=O)NC1=CC=C(C=C1)C1=CC=CC=C1,54723327
7236,DB08170,"(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE",small molecule,experimental,,[H][C@]1(N(CCC2=CC(O)=C(OC)C=C12)S(=O)(=O)C1=CC=C(OC)C=C1)C(=O)NO,15942651
7237,DB08171,11-MERCAPTOUNDECANOIC ACID,small molecule,experimental,Lipids|Sulfur Compounds,OC(=O)CCCCCCCCCCS,543502
7238,DB08172,(2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide,small molecule,experimental,,COC1=CC=CC=C1C1=CC(Cl)=C(NC(=O)C(\C#N)=C(\C)O)C=C1,54727975
7239,DB08173,5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE,small molecule,experimental,,ClC1=CC=C(S1)C(=O)NCCNC(=O)C1=CC=C(C=C1)N1C=CC=CC1=O,10250490
7240,DB08174,"5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE",small molecule,experimental,,[H][C@]1(CCC[C@]1([H])NC(=O)C1=CC=C(C=C1)N1C=CC=CC1=O)NC(=O)C1=CC=C(Cl)S1,9954980
7241,DB08175,"(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID",small molecule,experimental,,COC(C)(C)CCC[C@@](C)([H])C\C=C\C(\C)=C\C(O)=O,5288795
7242,DB08176,(1Z)-4-(4-FLUOROPHENYL)-2-METHYLIDENEBUTAN-1-IMINE,small molecule,experimental,,[H]N=C([H])C(=C)CCC1=CC=C(F)C=C1,46937129
7243,DB08177,(E)-3-(5((5-(4-CHLOROPHENYL)FURAN-2-YL)METHYLENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)PROPANOIC ACID,small molecule,experimental,,[H]\C(C1=CC=C(O1)C1=CC=C(Cl)C=C1)=C1/SC(=S)N(CCC(O)=O)C1=O,1286536
7244,DB08178,"4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",small molecule,experimental,,COC1=C2C(NC=C2C2=NC(N)=NC=C2)=NC=C1,23727981
7245,DB08179,"methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate",small molecule,experimental,,COC(=O)C1=C(C)C=C(OC2=C(O)C(O)=CC(C)=C2)C=C1O,11779786
7246,DB08180,2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE,small molecule,experimental,,CN(CCO[P@@](O)(=O)OP(O)(O)=O)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C,447278
7247,DB08181,2-((3'-METHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID,small molecule,experimental,,CC1=CC(=CC=C1O)\N=N\C1=CC=CC=C1C(O)=O,5326798
7248,DB08182,"4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",small molecule,experimental,,CCCOC1=C2C(NC=C2C2=NC(N)=NC=C2)=NC=C1,23727982
7249,DB08184,2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,small molecule,experimental,,CC1=C(C=CC=C1)C1=CC2=C(N1)C=CC(=C2)C(N)=N,9547945
7250,DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,small molecule,experimental,,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O,46937130
7251,DB08186,(3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE,small molecule,experimental,,CN1C=C(\C=C\C(C)=O)C2=CC=CC=C12,736407
7252,DB08187,N-Methylphenylalanyl-N-[(trans-4-aminocyclohexyl)methyl]-L-prolinamide,small molecule,experimental,,CN[C@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)NC[C@H]1CC[C@H](N)CC1,448763
7253,DB08188,Emivirine,small molecule,investigational,Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Enzyme Inhibitors|Nucleic Acid Synthesis Inhibitors|Pyrimidines|Pyrimidinones|Reverse Transcriptase Inhibitors,CCOCN1C(=O)NC(=O)C(C(C)C)=C1CC1=CC=CC=C1,65013
7254,DB08190,N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide,small molecule,experimental,,COC1=CC=C2NC(I)=C(CCNC(C)=O)C2=C1,115348
7255,DB08191,"4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid",small molecule,experimental,,OC(=O)C1=CC=C(C=C1)C1=CNC2=C1C=C(C=N2)C1=CC=CC=C1,11544170
7256,DB08192,2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,small molecule,experimental,,[H][C@]1(CC2=C(CN1)C=CC=C2)C1=NC(C(O)=O)=C(S1)C(C)C,46937131
7257,DB08193,2-(3-NITROPHENYL)ACETIC ACID,small molecule,experimental,,OC(=O)CC1=CC(=CC=C1)[N+]([O-])=O,15876
7258,DB08194,"4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine",small molecule,experimental,,CC1=NC(N)=NC2=C1CSCC2,2726820
7259,DB08195,(1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE,small molecule,experimental,,[H][C@@](CS(=O)(=O)CC1=C(OC(F)F)C=CC=C1)(OC(=O)N1CCOCC1)C(=O)NCC#N,9547943
7260,DB08196,"2-((3',5'-DIMETHOXY-4'-HYDROXYPHENYL)AZO)BENZOIC ACID",small molecule,experimental,,COC1=CC(=CC(OC)=C1O)\N=N\C1=CC=CC=C1C(O)=O,6288148
7261,DB08197,"(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime",small molecule,experimental,,[H][C@]1(C\C(=N/O)C2=C(C1)N=C(N)N=C2C)C1=CC=C(F)C=C1C1=CC=CN=C1,46937132
7262,DB08198,"[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE",small molecule,experimental,,[H][C@@]1(NC(=S)N(C)C(C)=C1C(=O)C1=CC=CC=C1)C1=CC(O)=CC=C1,15942673
7263,DB08199,N-[(BENZYLOXY)CARBONYL]-L-CYSTEINYLGLYCINE,small molecule,experimental,,[H][C@@](CS)(NC(=O)OCC1=CC=CC=C1)C(=O)NCC(O)=O,15942661
7264,DB08200,(1R)-menthyl hexyl phosphonate group,small molecule,experimental,,CCCCCCP(O)(=O)O[C@@H]1C[C@H](C)CC[C@H]1C(C)C,446980
7265,DB08201,(1S)-menthyl hexyl phosphonate group,small molecule,experimental,,CCCCCCP(O)(=O)O[C@H]1C[C@@H](C)CC[C@@H]1C(C)C,446981
7266,DB08202,4-({[(4-METHYLPIPERAZIN-1-YL)AMINO]CARBONOTHIOYL}AMINO)BENZENESULFONAMIDE,small molecule,experimental,,CN1CCN(CC1)NC(=S)NC1=CC=C(C=C1)S(N)(=O)=O,891831
7267,DB08203,"7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]-7H-PYRROLO[3,2-F] QUINAZOLINE-1,3-DIAMINE",small molecule,experimental,,COCC(COC)N1C=CC2=C1C=CC1=NC(N)=NC(N)=C21,447099
7268,DB08204,3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE,small molecule,experimental,,OC1=CC=C(C=C1)C1(OC(=O)C2=CC=CC3=C(C=CC1=C23)[N+]([O-])=O)C1=CC=C(O)C=C1,448781
7269,DB08205,"4-(1,3-BENZOXAZOL-2-YL)-2,6-DIMETHYLPHENOL",small molecule,experimental,,CC1=CC(=CC(C)=C1O)C1=NC2=CC=CC=C2O1,20284644
7270,DB08206,"4-(1,3-BENZOXAZOL-2-YL)-2,6-DIBROMOPHENOL",small molecule,experimental,,OC1=C(Br)C=C(C=C1Br)C1=NC2=C(O1)C=CC=C2,23722943
7271,DB08207,"2-(3,5-DIMETHYLPHENYL)-1,3-BENZOXAZOLE",small molecule,experimental,,CC1=CC(=CC(C)=C1)C1=NC2=C(O1)C=CC=C2,23722944
7272,DB08208,"2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE",small molecule,experimental,,OCCONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(C=C1F)C#C,10150081
7273,DB08209,Methyl red,small molecule,experimental,"Coloring Agents|Compounds used in a research, industrial, or household setting",CN(C)C1=CC=C(C=C1)\N=N\C1=CC=CC=C1C(O)=O,10303
7274,DB08210,"2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE",small molecule,experimental,,CN1C=CN=C1SC1=CC(C(=O)NC2=NC=CS2)=C(N)C=C1F,449003
7275,DB08211,5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide,small molecule,experimental,,NC(=O)C1=C(C2=CC(Br)=CC=C2N1)S(=O)(=O)N1CCCC1,11984575
7276,DB08212,1-[2-(3-ACETYL-2-HYDROXY-6-METHOXY-PHENYL)-CYCLOPROPYL]-3-(5-CYANO-PYRIDIN-2-YL)-THIOUREA,small molecule,experimental,,[H][C@]1(C[C@]1([H])C1=C(OC)C=CC(C(C)=O)=C1O)NC(=S)NC1=NC=C(C=C1)C#N,3000663
7277,DB08213,"1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE",small molecule,experimental,,[H][C@@]1(COC2=CC=CC=C2)CCCN1S(=O)(=O)C1=CC2=C(C=C1)N(C)C(=O)C2=O,5288850
7278,DB08214,4-(1H-IMIDAZOL-1-YL)PHENOL,small molecule,experimental,,OC1=CC=C(C=C1)N1C=CN=C1,82315
7279,DB08215,Terbutryn,small molecule,experimental,"Agrochemicals|Compounds used in a research, industrial, or household setting|Herbicides|Pesticides|Toxic Actions",CCNC1=NC(SC)=NC(NC(C)(C)C)=N1,13450
7280,DB08216,2-((3'-TERTBUTYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID,small molecule,experimental,,CC(C)(C)C1=CC(=CC=C1O)\N=N\C1=CC=CC=C1C(O)=O,6323420
7281,DB08217,"S-[(1-Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate",small molecule,experimental,,CC1(C)C=C(CSS(C)(=O)=O)C(C)(C)N1O,40428878
7282,DB08218,"HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM",small molecule,experimental,,O=N(=O)C1=CC=CC(=C1)\N=C1\N=CCC(=N1)C1=CC=CC(CN2C=NC=N2)=C1,11987556
7283,DB08219,"4-Methyl-5-[(2Z)-2-{[4-(4-morpholinyl)phenyl]imino}-2,5-dihydro-4-pyrimidinyl]-1,3-thiazol-2-amine",small molecule,experimental,,CC1=C(SC(N)=N1)C1=N\C(=N/C2=CC=C(C=C2)N2CCOCC2)N=CC1,11840966
7284,DB08220,"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",small molecule,experimental,,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C=C(CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(O)=O)C(=O)C1=CC=C(O)C=C1,9845059
7285,DB08221,N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE,small molecule,experimental,,CC1=CC=C(NC(=O)C2=CC=CC(=C2)C(F)(F)F)C=C1NC1=NC=CC=C1C1=CC=NC=N1,16040281
7286,DB08222,METHOXYUNDECYLPHOSPHINIC ACID,small molecule,experimental,,CCCCCCCCCCC[P@@](O)(=O)OC,446977
7287,DB08223,"N-{(1S,2R)-1-BENZYL-3-[(CYCLOPROPYLMETHYL)(2-FURYLSULFONYL)AMINO]-2-HYDROXYPROPYL}-N'-METHYLSUCCINAMIDE",small molecule,experimental,,[H][C@@](O)(CN(CC1CC1)S(=O)(=O)C1=CC=CO1)[C@]([H])(CC1=CC=CC=C1)NC(=O)CCC(=O)NC,15947913
7288,DB08224,"(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL",small molecule,experimental,,[H][C@]1(O)CC(=O)O[C@@]([H])(CC[C@@]2([H])[C@@]([H])(C)C=CC3=CCC[C@]([H])(O)[C@]23[H])C1,4369567
7289,DB08226,Myxopyronin B,small molecule,experimental,"DNA-Directed RNA Polymerases, antagonists & inhibitors",CCCC\C(C)=C\C=C(/C)C(=O)C1=C(O)C=C(CCC\C=C\NC(=O)OC)OC1=O,54699009
7290,DB08227,"1-(1-HYDROXY-2,2,6,6-TETRAMETHYLPIPERIDIN-4-YL)PYRROLIDINE-2,5-DIONE",small molecule,experimental,,CC1(C)CC(CC(C)(C)N1O)N1C(=O)CCC1=O,19989057
7291,DB08228,"5,8-dimethoxy-1,4-dimethylquinolin-2(1H)-one",small molecule,experimental,,COC1=C2N(C)C(=O)C=C(C)C2=C(OC)C=C1,1504717
7292,DB08229,[N-(3-dibenzylcarbamoyl-oxiranecarbonyl)-hydrazino]-acetic acid,small molecule,experimental,,[H]N([H])N(CC(O)=O)C(=O)CC([H])(O)C(=O)N(CC1=CC=CC=C1)CC1=CC=CC=C1,46937133
7293,DB08230,Tricetin,small molecule,experimental,"Antioxidants|Benzopyrans|Biological Factors|Carbohydrates|Chromones|Compounds used in a research, industrial, or household setting|Flavonoids|Glycosides|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Protective Agents|Pyrans",OC1=CC(O)=C2C(=O)C=C(OC2=C1)C1=CC(O)=C(O)C(O)=C1,5281701
7294,DB08231,Myristic acid,small molecule,experimental,Fatty Acids|Lipids|Myristic Acids,CCCCCCCCCCCCCC(O)=O,11005
7295,DB08232,"[5-(5-Amino-1H-pyrrolo[3,2-b]pyridin-2-yl)-6-hydroxy-3'-nitro-3-biphenylyl]acetic acid",small molecule,experimental,,NC1=CC=C2NC(=CC2=N1)C1=CC(CC(O)=O)=CC(=C1O)C1=CC=CC(=C1)[N+]([O-])=O,10135836
7296,DB08233,6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,small molecule,experimental,,OC1=CC=C(NC2=NC(OCC3CCCCC3)=C3N=CNC3=N2)C=C1,447649
7297,DB08234,"5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine",small molecule,experimental,,CCC1=NC(N)=NC(N)=C1C#CCC1=CC(OC)=CC=C1OC,25058133
7298,DB08235,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,small molecule,experimental,,CC1=C(CCNC(=O)C2=CC=CS2)C2=CC=CC=C2N1,588963
7299,DB08236,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",small molecule,experimental,,[H][C@]1(SCC(=O)N1C1=CC(Cl)=CC=C1O)C1=CC=CC(Br)=C1,44129612
7300,DB08237,2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate),small molecule,experimental,,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(O)=O)N1C=NC2=C1N=C(NCC1=CC=CC3=C1C=CC=C3)NC2=O,46937134
7301,DB08238,5-aminonaphthalene-2-sulfonic acid,small molecule,experimental,,NC1=C2C=CC(=CC2=CC=C1)S(O)(=O)=O,8408
7302,DB08239,"(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",small molecule,experimental,,[H][C@]1(C=C(CN1C(=O)N(C)C1CCNCC1)C1=CC(F)=CC=C1F)C1=CC=CC=C1,11675645
7303,DB08240,N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE,small molecule,experimental,,OP(O)(=O)OC1=C(C=C2C=CC=CC2=C1)C(=O)NC1=CC=C(Cl)C=C1,87517
7304,DB08241,4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,small molecule,experimental,,NC(=O)C1=CC=C(NC2=NC(OCC3CCCCC3)=C3N=CNC3=N2)C=C1,447656
7305,DB08242,"N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide",small molecule,experimental,,CNC(=O)C1=CC(NC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)=C(C)C=C1,23400214
7306,DB08244,"(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE",small molecule,experimental,,[H][C@](N)(C1CC1)C(=O)N1CC(=C[C@@]1([H])C1=CC=CC=C1)C1=CC(F)=CC=C1F,6102824
7307,DB08245,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-5-NITRO-1H-INDOLE,small molecule,experimental,,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(O)=O)N1C=CC2=CC(=CC=C12)[N+]([O-])=O,46937135
7308,DB08246,"(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",small molecule,experimental,,[H][C@]1(C=C(CN1C(=O)N(C)C)C1=CC(F)=CC=C1F)C1=CC=CC=C1,11840968
7309,DB08247,6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE,small molecule,experimental,,CC(C)C1=NC2=C(OCC3CCCCC3)N=C(N)N=C2N1,9547890
7310,DB08248,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,small molecule,experimental,,NS(=O)(=O)C1=CC=CC(NC2=NC(OCC3CCCCC3)=C3N=CNC3=N2)=C1,447655
7311,DB08249,"3,6,9,12,15-PENTAOXATRICOSAN-1-OL",small molecule,experimental,,CCCCCCCCOCCOCCOCCOCCOCCO,159866
7312,DB08250,"(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE",small molecule,experimental,,CCNC(=O)N1N=C(C[C@@]1(CCCN)C1=CC=CC=C1)C1=C(F)C=CC(F)=C1,23586165
7313,DB08251,4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID,small molecule,experimental,,[H][C@@](CC(O)=O)(NC(=O)C1=CN=CC(=C1)C1=CC=C(C=C1)C(O)=O)C=O,5288878
7314,DB08252,2-((4'-HYDROXYNAPHTHYL)-AZO)BENZOIC ACID,small molecule,experimental,,OC(=O)C1=CC=CC=C1\N=N\C1=C2C=CC=CC2=C(O)C=C1,5326800
7315,DB08253,NAM NAPTHYLAMINOALANINE,small molecule,experimental,,[H][C@](N)(CC1=CC=CC2=C1C=CC=C2)C(N)=O,5288981
7316,DB08254,2-Naphthalenesulfonic acid,small molecule,experimental,"Acids|Acids, Noncarboxylic|Arylsulfonates|Arylsulfonic Acids|Naphthalenes|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",OS(=O)(=O)C1=CC2=CC=CC=C2C=C1,8420
7317,DB08255,"(3AR,5R,6S,7R,7AR)-5-(HYDROXYMETHYL)-2-PROPYL-5,6,7,7A-TETRAHYDRO-3AH-PYRANO[3,2-D][1,3]THIAZOLE-6,7-DIOL",small molecule,experimental,,[H][C@]12O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])N=C(CCC)S2,11507040
7318,DB08256,N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE,small molecule,experimental,,OC(=O)CNC(=O)NC1CCCCC1,4149241
7319,DB08257,4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID,small molecule,experimental,,OC(=O)CCCNC(=O)NC1CCCCC1,6420119
7320,DB08258,6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID,small molecule,experimental,,OC(=O)CCCCCNC(=O)NC1CCCCC1,6420120
7321,DB08259,7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID,small molecule,experimental,,OC(=O)CCCCCCNC(=O)NC1CCCCC1,6420121
7322,DB08260,"(1S,2R,3S,4R,5R)-2,3,4-trihydroxy-N-octyl-6-oxa-8-azabicyclo[3.2.1]octane-8-carbothioamide",small molecule,experimental,,[H][C@@]12CO[C@@]([H])(N1C(=S)NCCCCCCCC)[C@]([H])(O)[C@@]([H])(O)[C@]2([H])O,24963032
7323,DB08261,"2-hydroxy-7-methoxy-5-methyl-naphthalene-1-carboxylic acid meso-2,5-dihydroxy-cyclopent-3-enyl ester",small molecule,experimental,,[H][C@]1(O)C=C[C@@]([H])(O)[C@]1([H])OC(=O)C1=C(O)C=CC2=C(C)C=C(OC)C=C12,446415
7324,DB08262,"2,6-dicarboxynaphthalene",small molecule,experimental,,OC(=O)C1=CC2=CC=C(C=C2C=C1)C(O)=O,14357
7325,DB08263,N-(carboxycarbonyl)-D-phenylalanine,small molecule,experimental,,[H][C@](CC1=CC=CC=C1)(NC(=O)C(O)=O)C(O)=O,5288998
7326,DB08264,"(1R, 2S)-cis 1,2 dihydroxy-1,2-dihydronaphthalene",small molecule,experimental,,[H][C@]1(O)C=CC2=C(C=CC=C2)[C@@]1([H])O,440294
7327,DB08265,"2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL",small molecule,experimental,,CC1=CC=C(C=C1)S(=O)(=O)N1N=CC2=C(C=CC=C2)B1O,481709
7328,DB08266,"Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate",small molecule,experimental,,[H]\C(CCC[C@@]([H])(C)C1=CC(=O)C([H])(C(=O)C(\C)=C(/[H])\C(\[H])=C(/C)CCC)C(=O)O1)=N/C(=O)OC,131704307
7329,DB08267,"6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",small molecule,experimental,,NC1=NC2=C(C=C3NC=NC3=C2CCC2=CC=CC=C2)C(=O)N1,5326928
7330,DB08268,"6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",small molecule,experimental,,CC1=CC=C(CCC2=C3N=CNC3=CC3=C2N=C(N)NC3=O)C=C1,5326929
7331,DB08270,"N-(2-AMINOETHYL)-N~2~-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE",small molecule,experimental,,[H][C@@](CC(C)C)(N[C@@]([H])(C1=CC=C(C=C1)C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F)C(=O)NCCN,46937137
7332,DB08271,N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID,small molecule,experimental,,COC1=CC=C(C=C1)S(=O)(=O)N(CC(C)C)CC(=O)NO,448002
7333,DB08272,(4S)-4-(2-NAPHTHYLMETHYL)-D-GLUTAMIC ACID,small molecule,experimental,,[H][C@@](N)(C[C@]([H])(CC1=CC2=CC=CC=C2C=C1)C(O)=O)C(O)=O,9817372
7334,DB08273,4-HYDROXY-5-IODO-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,small molecule,experimental,,OC1=C(C=C(CC(=O)NCCCCCC([O-])=O)C=C1I)[N+]([O-])=O,46937138
7335,DB08274,"6,7,8,9-TETRAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOHEPTA[B]PYRAN-2-ONE",small molecule,experimental,,[H][C@](CC)(C1=CC=CC=C1)C1=C(O)C2=C(CCCCC2)OC1=O,54708746
7336,DB08275,N-DODECANOYL-L-TYROSINE,small molecule,experimental,,[H][C@@](CC1=CC=C(O)C=C1)(NC(=O)CCCCCCCCCCC)C(O)=O,6710104
7337,DB08276,trifluoro-[hydroxy-[hydroxy-[2-(N-methyl-2-nitro-anilino)ethoxy]phosphoryl]oxy-phosphoryl]oxy-beryllium(1-),small molecule,experimental,,CN(CCO[P@](O)(=O)O[P@@](O)(=O)O[Be-](F)(F)F)C1=CC=CC=C1[N+]([O-])=O,
7338,DB08277,"2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE",small molecule,experimental,,[H][C@@]12C[C@@]3([H])C[C@@](C1)(C[C@@]([H])(C2)[C@@]3([H])NC(=O)C(C)(C)OC1=C(Cl)C=C(F)C=C1)S(C)(=O)=O,16040257
7339,DB08278,"1-(2-cyclopropylethyl)-3-(1,1-dioxo-2H-1,2,4-benzothiadiazin-3-yl)-6-fluoro-4-hydroxy-2(1H)-quinolinone",small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Quinolines|RNA Replicase, antagonists & inhibitors|Sulfur Compounds|Thiazines",OC1=C(C(=O)N(CCC2CC2)C2=C1C=C(F)C=C2)C1=NS(=O)(=O)C2=C(N1)C=CC=C2,5273394
7340,DB08279,3-{ISOPROPYL[(TRANS-4-METHYLCYCLOHEXYL)CARBONYL]AMINO}-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID,small molecule,experimental,,[H][C@]1(C)CC[C@@]([H])(CC1)C(=O)N(C(C)C)C1=C(SC(=C1)C1=CC=CC=C1)C(O)=O,503536
7341,DB08280,"(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE",small molecule,experimental,,[H][C@@]12C[C@@]3([H])C[C@@](C1)(C[C@@]([H])(C2)[C@@]3([H])NC(=O)C(C)(C)OC1=CC=C(OC)C=C1)C(N)=O,15942677
7342,DB08281,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-bromophenyl)thiocarbamate",small molecule,experimental,,BrC1=CC=C(NC(=S)OCCN2C(=O)C3=C(C=CC=C3)C2=O)C=C1,5278689
7343,DB08282,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-chlorophenyl)thiocarbamate",small molecule,experimental,,ClC1=CC=C(NC(=S)OCCN2C(=O)C3=C(C=CC=C3)C2=O)C=C1,5278688
7344,DB08283,"(2R,3R,4R,5S)-2-(HYDROXYMETHYL)-1-NONYLPIPERIDINE-3,4,5-TRIOL",small molecule,experimental,,[H][C@]1(O)CN(CCCCCCCCC)[C@]([H])(CO)[C@@]([H])(O)[C@]1([H])O,501640
7345,DB08284,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-iodophenyl)thiocarbamate",small molecule,experimental,,IC1=CC=C(NC(=S)OCCN2C(=O)C3=C(C=CC=C3)C2=O)C=C1,5278690
7346,DB08285,"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",small molecule,experimental,,[H][C@@](CC)(CO)NC1=NC2=C(C=NN2C(NCC2=CC=CC=C2)=N1)C(C)C,25190761
7347,DB08286,1-Naphthoxyacetic acid,small molecule,experimental,"Acetates|Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Hydroxy Acids|Lipids",OC(=O)COC1=CC=CC2=CC=CC=C12,76313
7348,DB08287,"(1R,2R)-N-(2-Aminoethyl)-2-{[(4-methoxyphenyl)sulfonyl]methyl}cyclohexanecarboxamide",small molecule,experimental,,[H][C@@]1(CS(=O)(=O)C2=CC=C(OC)C=C2)CCCC[C@@]1([H])C(=O)NCCN,11840970
7349,DB08288,CYCLOHEXYL-NORSTATINE,small molecule,experimental,,[H][C@](N)(CC1CCCCC1)[C@@]([H])(O)C(=O)OC(C)C,5289045
7350,DB08289,N-(PARA-GLUTARAMIDOPHENYL-ETHYL)-PIPERIDINIUM-N-OXIDE,small molecule,experimental,,OC(=O)CCCC(=O)NC1=CC=C(CC[N+]2([O-])CCCCC2)C=C1,3256857
7351,DB08291,N-(3-AMINOPROPYL)-2-NITROBENZENAMINE,small molecule,experimental,,NCCCNC1=CC=CC=C1[N+]([O-])=O,3581192
7352,DB08292,"(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",small molecule,experimental,,OC1=CC(O)=C2C(CC(=O)CCC\C=C/CCOC2=O)=C1Cl,11963551
7353,DB08293,"(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",small molecule,experimental,,OC1=CC(O)=C2C(CC(=O)CCC\C=C\CCOC2=O)=C1Cl,11963552
7354,DB08294,2-(4-HYDROXY-3-NITROPHENYL)ACETIC ACID,small molecule,experimental,,OC(=O)CC1=CC(=C(O)C=C1)[N+]([O-])=O,447364
7355,DB08295,4-HYDROXY-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,small molecule,experimental,,OC1=C(C=C(CC(=O)NCCCCCC([O-])=O)C=C1)[N+]([O-])=O,3256859
7356,DB08296,5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID,small molecule,experimental,,OC(=O)CCCC[P@]([O-])(=O)OC1=CC=C(C=C1)[N+]([O-])=O,3256861
7357,DB08297,ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE,small molecule,experimental,,[H][C@]1(C)O[C@@]([H])(OC2=CC=CC=C2[N+]([O-])=O)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O,150889
7358,DB08299,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",small molecule,experimental,,OC(=O)C1=CC=C(C=C1)C1=NC(C2=CC=CC(=C2)[N+]([O-])=O)=C2N=CC=CC2=C1,9999276
7359,DB08300,"1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",small molecule,experimental,,CN1N=C(C2=C(N)N=CN=C12)C1=CC2=CC=CC=C2C=C1,24905144
7360,DB08301,N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE,small molecule,experimental,,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1=CC=C(C=C1)S(N)(=O)=O,6852128
7361,DB08302,3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid,small molecule,experimental,,CCC\C(=C\C1=CC=C(O1)C1=CC(=CC=C1)C(O)=O)[N+]([O-])=O,6006216
7362,DB08303,"(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide",small molecule,experimental,,[H][C@@]1(NC2=CC(C)=C(C=C2S(=O)(=O)N1)S(=O)(=O)N1CCN(C)CC1)C1CCCC1,44129629
7363,DB08304,"(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",small molecule,experimental,,[H][C@@]1(CC2=C(C=C(C=C2)S(=O)(=O)N2CCN(C)CC2)S(=O)(=O)N1)C1CCCC1,44129630
7364,DB08305,"(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",small molecule,experimental,,[H][C@@]1(CC2=CC(C)=C(C=C2S(=O)(=O)N1)S(=O)(=O)N1CCN(C)CC1)C1CCCC1,44129631
7365,DB08306,3-[(3-Nitrophenyl)sulfamoyl]-2-thiophenecarboxylic acid,small molecule,experimental,,[H]N(C1=CC(=CC=C1)[N+]([O-])=O)S(=O)(=O)C1=C(SC=C1)C(O)=O,657105
7366,DB08307,"2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE",small molecule,experimental,,OC(C1=CC=C(C=C1[N+]([O-])=O)C(F)(F)F)=C1C(=O)CCCC1=O,5289053
7367,DB08308,"SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER",small molecule,experimental,,[H][C@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4([H])[C@@]3([H])CC[C@]12C)OC(=O)CCC(O)=O,5289054
7368,DB08309,3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL,small molecule,experimental,,OCCCNCCS(=O)(=O)C1=CC=C(NC2=NC(OCC3CCCCC3)=C3N=CNC3=N2)C=C1,6852201
7369,DB08310,"N-[(2R)-2-{[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl}hexyl]-N-hydroxyformamide",small molecule,experimental,,[H][C@@](CCCC)(CN(O)C=O)C(=O)N1CCC[C@@]1([H])C1=NC2=C(O1)C=CC=C2,25134267
7370,DB08312,"6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE",small molecule,experimental,,NC1=NC(N)=C(N=O)C(OCC2CCCCC2)=N1,398148
7371,DB08313,Nocodazole,small molecule,experimental,"Antimitotic Agents|Antineoplastic Agents|Benzimidazoles|Heterocyclic Compounds, Fused-Ring|Mitosis Modulators|Tubulin Modulators",COC(=O)NC1=NC2=CC(=CC=C2N1)C(=O)C1=CC=CS1,4122
7372,DB08314,"(2-AMINO-1,3-OXAZOL-5-YL)-(3-BROMOPHENYL)METHANONE",small molecule,experimental,,NC1=NC=C(O1)C(=O)C1=CC(Br)=CC=C1,25271554
7373,DB08315,"2-AMINO-N,N-BIS(PHENYLMETHYL)-1,3-OXAZOLE-5-CARBOXAMIDE",small molecule,experimental,,NC1=NC=C(O1)C(=O)N(CC1=CC=CC=C1)CC1=CC=CC=C1,25271555
7374,DB08316,"4-amino-7,7-dimethyl-7,8-dihydroquinazolin-5(6H)-one",small molecule,experimental,,CC1(C)CC(=O)C2=C(N)N=CN=C2C1,3137930
7375,DB08317,"5-methyl-6-phenylquinazoline-2,4-diamine",small molecule,experimental,,CC1=C(C=CC2=NC(N)=NC(N)=C12)C1=CC=CC=C1,25271556
7376,DB08318,"6-(2-phenoxyethoxy)-1,3,5-triazine-2,4-diamine",small molecule,experimental,,NC1=NC(OCCOC2=CC=CC=C2)=NC(N)=N1,25271557
7377,DB08319,"2'-HYDROXY-1,1'-BIPHENYL-2-SULFINIC ACID",small molecule,experimental,,OC1=CC=CC=C1C1=CC=CC=C1[S@@](O)=O,441161
7378,DB08320,"DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE",small molecule,experimental,,[H][C@]12O[C@]([H])(C(=C1C1=CC=C(O)C=C1)C1=CC=C(O)C=C1)[C@]([H])(C(=O)OCC)[C@]2([H])C(=O)OCC,24752837
7379,DB08321,"(1S,2S,3R,6R)-4-(hydroxymethyl)-6-(octylamino)cyclohex-4-ene-1,2,3-triol",small molecule,experimental,,[H][C@@]1(O)C(CO)=C[C@@]([H])(NCCCCCCCC)[C@]([H])(O)[C@@]1([H])O,9817381
7380,DB08322,"2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID",small molecule,experimental,,[H][C@@](CC(O)=O)(OC(=O)\C=C\C1=CC=C(O)C=C1)[C@@]([H])(OC(=O)\C=C\C1=CC=C(O)C=C1)C(O)=O,11669698
7381,DB08323,3-OXO-N-[(3S)-2-OXOPYRROLIDIN-3-YL]DODECANAMIDE,small molecule,experimental,,[H][C@@]1(CCNC1=O)NC(=O)CC(=O)CCCCCCCCC,16122585
7382,DB08324,N-3-OXO-DODECANOYL-L-HOMOSERINE LACTONE,small molecule,experimental,,[H][C@@]1(CCOC1=O)NC(=O)CC(=O)CCCCCCCCC,3246941
7383,DB08325,2-({6-[(3-Chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)ethanol,small molecule,experimental,,[H]N(CCO)C1=NC(N([H])C2=CC(Cl)=CC=C2)=C2N=CN(C(C)C)C2=N1,2856
7384,DB08326,"2-(6-HYDROXY-1,3-BENZOTHIAZOL-2-YL)-1,3-THIAZOL-4(5H)-ONE",small molecule,experimental,,OC1=CC2=C(C=C1)N=C(S2)C1=NC(=O)CS1,6420152
7385,DB08327,Homogentisic acid,small molecule,experimental,"Acids, Carbocyclic|Phenylacetates",OC(=O)CC1=CC(O)=CC=C1O,780
7386,DB08328,PANTOTHENYL-AMINOETHANOL-11-PIVALIC ACID,small molecule,experimental,,[H][C@](O)(C(=O)NCCC(=O)NCCO)C(C)(C)COC(=O)C(C)(C)C,25011726
7387,DB08329,Sulthiame,small molecule,experimental,Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Nervous System|Sulfur Compounds,NS(=O)(=O)C1=CC=C(C=C1)N1CCCCS1(=O)=O,5356
7388,DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,small molecule,experimental,,CO\C=C(\C(=O)OC)C1=C(\C=C\C2=CC=CC=C2)C=CC=C1,5289085
7389,DB08331,"N-1H-imidazol-2-yl-N'-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine",small molecule,experimental,,N(C1=NC=CN1)C1=CC=C(NC2=CC=C(NC3=NC=CN3)C=C2)C=C1,11370952
7390,DB08332,9-(2-carboxyethyl)-10-methylanthracene endoperoxide,small molecule,experimental,,C[C@@]12OO[C@@](CCC(O)=O)(C3=C1C=CC=C3)C1=C2C=CC=C1,446966
7391,DB08333,4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME,small molecule,experimental,,OC1=CC=C(\C=N\OC(=O)C2CCCCC2)C=C1,16122594
7392,DB08334,3-FLUORO-4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME,small molecule,experimental,,OC1=CC=C(\C=N\OC(=O)C2CCCCC2)C=C1F,23655000
7393,DB08335,"4-HYDROXYBENZALDEHYDE O-(3,3-DIMETHYLBUTANOYL)OXIME",small molecule,experimental,,CC(C)(C)CC(=O)O\N=C\C1=CC=C(O)C=C1,44602427
7394,DB08336,"2-Methyl-2-propanyl [(1R)-2-methyl-1-(1,3,4-oxadiazol-2-yl)propyl]carbamate",small molecule,experimental,,[H]N(C(=O)OC(C)(C)C)[C@]([H])(C(C)C)C1=NN=CO1,46937140
7395,DB08337,"2-Methyl-2-propanyl [(1S)-2-methyl-1-(1,3,4-oxadiazol-2-yl)propyl]carbamate",small molecule,experimental,,[H]N(C(=O)OC(C)(C)C)[C@@]([H])(C(C)C)C1=NN=CO1,46937141
7396,DB08338,"19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one",small molecule,experimental,,O=C1CCCCC2=C3N=C(NC4=CC(N1)=CC=C4)N=C(NC1CC1)N3N=C2,24756824
7397,DB08339,PD-166326,small molecule,experimental,,CN1C(=O)C(=CC2=CN=C(NC3=CC=CC(CO)=C3)N=C12)C1=C(Cl)C=CC=C1Cl,447700
7398,DB08340,"N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE",small molecule,experimental,,N(C1=CC=CC=C1)C1=NC2=CC=NN2C(NC2=CC=CC=C2)=N1,24779674
7399,DB08341,"4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide",small molecule,experimental,,[H][C@]1(CCC[C@@]1([H])N(C)C)NC1=NC(NC2=CC=C(C=C2)S(=O)(=O)NC)=NC=C1C(F)(F)F,25920890
7400,DB08342,S-palmitoyl-L-cysteine,small molecule,experimental,,CCCCCCCCCCCCCCCC(=O)SC[C@H](N)C(O)=O,46937142
7401,DB08344,4-chloro-N-(3-methoxypropyl)-N-[(3S)-1-(2-phenylethyl)piperidin-3-yl]benzamide,small molecule,experimental,,[H][C@@]1(CCCN(CCC2=CC=CC=C2)C1)N(CCCOC)C(=O)C1=CC=C(Cl)C=C1,23644580
7402,DB08345,"4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",small molecule,experimental,,N#CC1=C2N=C(NC3=CC=CC=C3)N=C(NCCC3=CN=CN3)N2N=C1,24779678
7403,DB08346,"(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE",small molecule,experimental,,OC1=CC(O)=C2C(CC(=O)CCCC\C=C\CCOC2=O)=C1Cl,24916788
7404,DB08347,4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile,small molecule,experimental,,CC(C)(C)NC[C@H](O)COC1=CC=CC2=C1CC(=N2)C#N,46937143
7405,DB08348,"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",small molecule,experimental,,CN(C)CC(=O)NC1=CC2=C(NC(=O)C3=CC=CC=C23)C=C1,4858
7406,DB08349,"N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide",small molecule,experimental,,CN1C2=C(C=NN2C2=C(F)C=C(F)C=C2)C(NC2=C(C)C=CC(=C2)C(=O)NC2CC2)=CC1=O,42647297
7407,DB08350,"5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE",small molecule,experimental,,COC1=CC=CC=C1C1=CNC2=C1C=C(C=N2)C1=CC(=CN=C1)C(=O)N(C)C,16750094
7408,DB08351,N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide,small molecule,experimental,,CC1=CC=C(C=C1C1=CC2=C(C=C1)N=C(NCCN1CCOCC1)N=C2)C(=O)NC1CC1,24963046
7409,DB08352,"6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine",small molecule,experimental,,CC(C)NC1=NC2=C(S1)C=C(C=C2)C1=C(N=CO1)C1=CC=CC=C1F,24755476
7410,DB08353,"2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",small molecule,experimental,,N#CC1=C2N=C(NCC3CCCCC3)N=C(NC3=CC=CC=C3)N2N=C1,24779675
7411,DB08354,"2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",small molecule,experimental,,ClC1=CC=C(CNC2=NC3=C(C=NN3C(NC3=CC=CC=C3)=N2)C#N)C=C1,24779676
7412,DB08355,"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",small molecule,experimental,,CN1N=C(C(O)=O)C2=C1C1=NC(NC3=CC=CC=C3)=NC=C1CC2,44129603
7413,DB08356,"4-[4-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]benzene-1,3-diol",small molecule,experimental,,COC1=CC=C(C=C1)C1=C(C)NN=C1C1=C(O)C=C(O)C=C1,5403427
7414,DB08357,Diethylene glycol diethyl ether,small molecule,experimental,,CCOCCOCCOCC,8179
7415,DB08358,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",small molecule,experimental,,O=C1NCCC2=C1C=C(N2)C1=CC(=NC=C1)C1=CC2=C(C=CC=C2)N=C1,10389239
7416,DB08359,2-PHENYLAMINO-4-METHYL-5-ACETYL THIAZOLE,small molecule,experimental,,CC(=O)C1=C(C)N=C(NC2=CC=CC=C2)S1,735838
7417,DB08360,"2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",small molecule,experimental,,CCN1CCN(CC1)C1=NC2=C(C=NN2C(NC2=CC=CC=C2)=N1)C#N,24779677
7418,DB08361,"2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide",small molecule,experimental,,[H][C@]1(N)CCCC[C@@]1([H])NC1=NC(NC2=CC=CC(C)=C2)=C(C=N1)C(N)=O,11493841
7419,DB08362,"N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE",small molecule,experimental,,CC(=O)NC1=CC=CC(NC2=NC3=C(C=NN3C(NC3=CC=CC=C3)=N2)C#N)=C1,23656870
7420,DB08363,1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine,small molecule,experimental,,CCN1C2=CC=C(CNC)C=C2C2=C1C=CC=C2,4722579
7421,DB08364,1-{[(1E)-(3-HYDROXY-2-METHYL-5-{[(TRIHYDROXY-LAMBDA^5^-PHOSPHANYL)OXY]METHYL}PYRIDIN-4-YL)METHYLIDENE]AMINO}UNDECAN-2-ONE,small molecule,experimental,,CCCCCCCCCC(=O)C\N=C\C1=C(COP(O)(O)O)C=NC(C)=C1O,46937144
7422,DB08365,"8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide",small molecule,experimental,,CN1C2=C(C(Br)=C1C(=O)NCCO)C1=C(C(=O)NC1=O)C(=C2)C1=C(Cl)C=CC=C1,11691442
7423,DB08366,"3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid",small molecule,experimental,,[H][C@]12C[C@]3([H])O[C@@]1(C)C[C@@]1(C2)CCC(=O)[C@@](C)(CCC(=O)NC2=C(O)C=CC(C(O)=O)=C2O)[C@]31[H],16086836
7424,DB08367,(R)-2-(FORMYLOXY)-3-(PHOSPHONOOXY)PROPYL PENTANOATE,small molecule,experimental,,[H][C@@](COC(=O)CCCC)(COP(O)(O)=O)OC=O,11963565
7425,DB08368,"OCTANE-1,3,5,7-TETRACARBOXYLIC ACID",small molecule,experimental,,[H][C@](C)(C[C@]([H])(C[C@@]([H])(CCC(O)=O)C(O)=O)C(O)=O)C(O)=O,24832027
7426,DB08369,1-(biphenyl-4-ylmethyl)-1H-imidazole,small molecule,experimental,,C(N1C=CN=C1)C1=CC=C(C=C1)C1=CC=CC=C1,12229396
7427,DB08370,S-(4-BROMOBENZYL)CYSTEINE,small molecule,experimental,,[H][C@](N)(CSCC1=CC=C(Br)C=C1)C(O)=O,5289112
7428,DB08371,p-Benzoyl-L-phenylalanine,small molecule,experimental,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Benzene Derivatives|Ketones",N[C@@H](CC1=CC=C(C=C1)C(=O)C1=CC=CC=C1)C(O)=O,7020128
7429,DB08372,1-[2-(4-ETHOXY-3-FLUOROPYRIDIN-2-YL)ETHYL]-3-(5-METHYLPYRIDIN-2-YL)THIOUREA,small molecule,experimental,,CCOC1=C(F)C(CCNC(=S)NC2=CC=C(C)C=N2)=NC=C1,9547984
7430,DB08373,"4,4'-BIS([H]METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL",small molecule,experimental,,CS(=O)(=O)C1=CC(Cl)=C(C=C1Cl)C1=C(Cl)C=C(C(Cl)=C1)S(C)(=O)=O,115069
7431,DB08374,Phenylalanylmethylchloride,small molecule,experimental,,[H][C@](N)(CC1=CC=CC=C1)C(=O)CCl,4369560
7432,DB08375,"(2R)-2-[(1R)-1-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-2-oxoethyl]-5-methylidene-2H-1,3-thiazine-4-carboxylic acid",small molecule,experimental,,[H][C@@]1(SCC(=C)C(=N1)C(O)=O)[C@H](NC(=O)C(=N/OC)\C1=CSC(N)=N1)C=O,131704308
7433,DB08376,"(2R)-3-(phosphonooxy)propane-1,2-diyl diheptanoate",small molecule,experimental,,[H][C@@](COC(=O)CCCCCC)(COP(O)(O)=O)OC(=O)CCCCCC,23629653
7434,DB08377,N-[4-(4-nitrophenylphospho)butanoyl]-D-alanine,small molecule,experimental,,C[C@@H](NC(=O)CCCP(O)(=O)OC1=CC=C(C=C1)[N+]([O-])=O)C(O)=O,446756
7435,DB08378,"4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID",small molecule,experimental,,[H][C@](O)(CCC(O)=O)NC1=CC=C(C=C1)N1C(=O)CCC1=O,46937145
7436,DB08379,6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one,small molecule,experimental,,FC1=C(CC2=NNC(=O)C=C2)C=CC(Cl)=C1OC1=CC=CC=C1,24875319
7437,DB08382,Gosogliptin,small molecule,investigational,"Agents causing angioedema|Blood Glucose Lowering Agents|Diabetes Mellitus, Type 2, drug therapy|DPP-IV Inhibitors",[H][C@]1(CN[C@@]([H])(C1)C(=O)N1CCC(F)(F)C1)N1CCN(CC1)C1=NC=CC=N1,11516136
7438,DB08383,"4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole",small molecule,experimental,,COC1=CC=C(C=C1)C1=C(N=C(N1)C1=CC=CS1)C1=CC=C(OC)C=C1,1122713
7439,DB08384,2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline,small molecule,experimental,,C(OC1=CC=C(C=C1)C1=NNC=C1CC1=CC=NC=C1)C1=NC2=CC=CC=C2C=C1,44141871
7440,DB08385,4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid,small molecule,experimental,,OC(=O)N1CCC(CC2=CN=C3C=CC=CC3=C2)CC1,24892821
7441,DB08386,2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,small molecule,experimental,,C(OC1=CC=C(C=C1)C1=NNC=C1C1=CC=NC=C1)C1=CC=C2C=CC=CC2=N1,11610553
7442,DB08387,Mardepodect,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CN1C=C(C(=N1)C1=CC=C(OCC2=NC3=CC=CC=C3C=C2)C=C1)C1=CC=NC=C1,11581936
7443,DB08388,"5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE",small molecule,experimental,,CCOCCC1(OC2=CC=C(OC3=CC=C(F)C=C3)C=C2)C(=O)NC(=O)NC1=O,657061
7444,DB08389,"6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",small molecule,experimental,,[H][C@]1(CCN(C1)C1=NC=NC2=CC(OC)=C(OC)C=C12)OC1=CC2=CC=CC=C2C=C1,15991588
7445,DB08390,"(6S)-6-CYCLOPENTYL-6-[2-(3-FLUORO-4-ISOPROPOXYPHENYL)ETHYL]-4-HYDROXY-5,6-DIHYDRO-2H-PYRAN-2-ONE",small molecule,experimental,,CC(C)OC1=CC=C(CC[C@]2(CC(O)=CC(=O)O2)C2CCCC2)C=C1F,54688400
7446,DB08391,PQ-10,small molecule,experimental,,COC1=CC2=NC=NC(N3CC[C@H](C3)OC3=NC4=CC=CC=C4N=C3)=C2C=C1OC,11955614
7447,DB08392,"2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL",small molecule,experimental,,COC1=CC=C(C=C1)C1=C(C2=C(NCCO)N=CN=C2O1)C1=CC=C(OC)C=C1,2059510
7448,DB08393,"2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL",small molecule,experimental,,OCCNC1=NC=NC2=C1C(=C(O2)C1=CC=CC=C1)C1=CC=CC=C1,1587957
7449,DB08394,PARA-NITROPHENYLPHOSPHONOBUTANOYL-GLYCINE,small molecule,experimental,,OC(=O)CNC(=O)CCC[P@](O)(=O)OC1=CC=C(C=C1)[N+]([O-])=O,449244
7450,DB08395,2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE,small molecule,experimental,,CCOCN1OC(=O)C(=C1C1=CC=NC(OC2=CC=CC=C2O)=N1)C1=CC=C(F)C=C1,4369443
7451,DB08396,"4-{[(Z)-(5-oxo-2-phenyl-1,3-oxazol-4(5H)-ylidene)methyl]amino}butanoic acid",small molecule,experimental,,OC(=O)CCCNC=C1N=C(OC1=O)C1=CC=CC=C1,11967789
7452,DB08397,6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID,small molecule,experimental,,OC(=O)C1=CC2=C(C=C1)C=C(C=C2)C(F)(F)P(O)(O)=O,1854
7453,DB08398,"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",small molecule,investigational,Carcinogens|Mutagens|Noxae|Toxic Actions,CN1C(N)=NC2=NC=C(C=C12)C1=CC=CC=C1,1530
7454,DB08399,Piceatannol,small molecule,experimental,Benzene Derivatives|Benzylidene Compounds|Tyrosine Kinase Inhibitors,OC1=CC(\C=C\C2=CC=C(O)C(O)=C2)=CC(O)=C1,667639
7455,DB08400,4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid,small molecule,experimental,,OC(=O)N1CCC(CC2=CC(OC3=NC=C(C=C3)C(F)(F)F)=CC=C2)CC1,25243828
7456,DB08401,(2E)-2-({(2S)-2-CARBOXY-2-[(PHENOXYACETYL)AMINO]ETHOXY}IMINO)PENTANEDIOIC ACID,small molecule,experimental,,[H][C@@](CO\N=C(/CCC(O)=O)C(O)=O)(NC(=O)COC1=CC=CC=C1)C(O)=O,16741209
7457,DB08402,"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",small molecule,experimental,,OC(=O)C1=C(NC(=O)C2=C(Cl)C=C(Cl)C=C2)C=CC(OC2=NC=CC=N2)=C1,5289162
7458,DB08403,METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID,small molecule,experimental,,[H][C@@](CC(C)C)(CC(=O)NO)C(=O)N[C@@]([H])(CC1=CC=CC=C1)C(=O)NC,194777
7459,DB08404,"S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEXANETHIOATE",small molecule,experimental,,[H][C@](O)(C(=O)NCCC(=O)NCCSC(=O)CCCCC)C(C)(C)CO[P@]([H])(O)=O,46937147
7460,DB08405,"S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEPTANETHIOATE",small molecule,experimental,,[H][C@](O)(C(=O)NCCC(=O)NCCSC(=O)CCCCCC)C(C)(C)CO[P@]([H])(O)=O,46937148
7461,DB08406,"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",small molecule,experimental,,NC1=NC2=C(N=C(CN3C4=CC=CC=C4C=CC4=CC=CC=C34)C=N2)C(N)=N1,446744
7462,DB08407,Platensimycin,small molecule,experimental,"3-Oxoacyl-(Acyl-Carrier-Protein) Synthase|Acids, Carbocyclic|Amides|Amines|Aniline Compounds|Anti-Infective Agents|Antimetabolites|Benzene Derivatives|Benzoates|Cycloparaffins|Fatty Acid Synthesis Inhibitors|Hypolipidemic Agents|Lipid Regulating Agents|Noxae|Toxic Actions",[H][C@]12C[C@@H]3O[C@@]1(C)C[C@@]1(C2)C=CC(=O)[C@@](C)(CCC(=O)NC2=C(O)C(=CC=C2O)C(O)=O)[C@]31[H],6857724
7463,DB08408,"(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl 2,2-dimethylpropanoate",small molecule,experimental,,[H][C@](O)(C(=O)NCCC(=O)NCCS)C(C)(C)COC(=O)C(C)(C)C,25011727
7464,DB08409,4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE,small molecule,experimental,,OC(=O)CNC(=O)CCC[P@@](O)(=O)OCC1=CC=C(C=C1)[N+]([O-])=O,449242
7465,DB08410,PARA-NITROBENZYL GLUTARYL GLYCINIC ACID,small molecule,experimental,,OC(=O)CNC(=O)CCCC(=O)NCC1=CC=C(C=C1)[N+]([O-])=O,449243
7466,DB08411,N-[4-(4-nitrophenylphospho)butanoyl]-L-alanine,small molecule,experimental,,[H][C@@](C)(NC(=O)CCC[P@](O)(=O)OC1=CC=C(C=C1)[N+]([O-])=O)C(O)=O,5496653
7467,DB08412,6-{4-[HYDROXY-(4-NITRO-PHENOXY)-PHOSPHORYL]-BUTYRYLAMINO}-HEXANOIC ACID,small molecule,experimental,,OC(=O)CCCCCNC(=O)CCC[P@](O)(=O)OC1=CC=C(C=C1)[N+]([O-])=O,449245
7468,DB08413,METHYL-PHOSPHONIC ACID MONO-(4-NITRO-PHENYL) ESTER,small molecule,experimental,,C[P@](O)(=O)OC1=CC=C(C=C1)[N+]([O-])=O,446757
7469,DB08414,PNU-142721,small molecule,experimental,,C[C@H](SC1=NC(Cl)=CC(N)=N1)C1=CC2=C(OC=C2)C=N1,446309
7470,DB08416,"(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE",small molecule,experimental,,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=C(C=C(OC)C(OS(N)(=O)=O)=C4)[C@@]3([H])CC[C@]12C)OS(N)(=O)=O,9804302
7471,DB08418,"(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate",small molecule,experimental,,[H][C@]12CC[C@]3(C)C(=O)N(CC4=CC=CN=C4)C(=O)C[C@@]3([H])[C@]1([H])CCC1=C2C=CC(OS(N)(=O)=O)=C1,9912519
7472,DB08419,(1S)-1-(PHENOXYMETHYL)PROPYL METHYLPHOSPHONOCHLORIDOATE,small molecule,experimental,,[H][C@](CC)(COC1=CC=CC=C1)O[P@](C)(Cl)=O,46937149
7473,DB08420,1-{[1-(2-AMINO-3-PHENYL-PROPIONYL)-PYRROLIDINE-2-CARBONYL]-AMINO}-2-(3-CYANO-PHENYL)-ETHANEBORONIC ACID,small molecule,experimental,,[H][C@@](N)(CC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(=O)N[C@@]([H])(CC1=CC(=CC=C1)C#N)B(O)O,5289192
7474,DB08421,PIPERIDINE-2-CARBOXYLIC ACID TERT-BUTYLAMIDE,small molecule,experimental,,[H][C@]1(CCCCN1)C(=O)NC(C)(C)C,5289197
7475,DB08422,[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE,small molecule,experimental,,[H][C@@](N)(CC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(=O)NCCNC1=CC=NC=C1,23586040
7476,DB08423,[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE,small molecule,experimental,,NC1=C(C=NN1C1=CC=C(F)C=C1)C(=O)C1=CC(OC2CCNCC2)=CC=C1,5327066
7477,DB08424,"[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE",small molecule,experimental,,[H][C@](O)(CO)COC1=CC(=CC=C1)C(=O)C1=C(N)N(N=C1)C1=CC=C(F)C=C1,5327067
7478,DB08426,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE",small molecule,experimental,,[H][C@@]1(CCN(CC2=CC3=C(N2)C=NC=C3)C1=O)NS(=O)(=O)C1=CC2=C(S1)C=CC=N2,445481
7479,DB08427,Prephenic acid,small molecule,experimental,"Acids, Carbocyclic|Cyclohexanes|Cycloparaffins",[H][C@]1(O)C=C[C@](CC(=O)C(O)=O)(C=C1)C(O)=O,1028
7480,DB08428,3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL,small molecule,experimental,,[H][C@@](C)(O)[C@@]([H])(N)CC1=CC=CC=C1,13949633
7481,DB08429,N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide,small molecule,experimental,,[H][C@](N)(CC(=O)N1CCC[C@@]1([H])CNC(=O)C1=CC=CC(=C1)S(C)(=O)=O)CC1=CC(Cl)=CC=C1,42608447
7482,DB08430,PARA-NITROPHENYL 1-THIO-BETA-D-GLUCOPYRANOSIDE,small molecule,experimental,,[H][C@]1(CO)O[C@@]([H])(SC2=CC=C(C=C2)[N+]([O-])=O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O,656902
7483,DB08431,"[(3R,4S)-4-HYDROXY-3-METHYL-2-OXOHEXYL]PHOSPHONIC ACID",small molecule,experimental,,[H][C@](C)(C(=O)C[P@]([H])(O)=O)[C@@]([H])(O)CC,46937150
7484,DB08432,THYMIDINE-5'-THIOPHOSPHATE,small molecule,experimental,,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(O)=S)N1C=C(C)C(=O)NC1=O,10019998
7485,DB08433,phenyl ethenesulfonate,small molecule,experimental,,C=CS(=O)(=O)OC1=CC=CC=C1,564920
7486,DB08434,2-METHYLCARBAMOYL-3-(4-PHOSPHONOOXY-PHENYL)-CYCLOPROPANECARBOXYLIC ACID,small molecule,experimental,,[H][C@]1(C(O)=O)[C@]([H])(C(=O)NC)[C@]1([H])C1=CC=C(OP(O)(O)=O)C=C1,5289221
7487,DB08435,"(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid",small molecule,experimental,,[H][C@]1(C\C=C\CCCC(O)=O)C=CC(=O)\C1=C/C=C/CCCCC,23654841
7488,DB08436,"8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-",small molecule,experimental,,CCCCN1C(CC2=CC3=C(OCO3)C=C2)=NC2=C(N)N=CN=C12,448968
7489,DB08437,Puromycin,small molecule,experimental,"Acids, Carbocyclic|Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antimetabolites|Antineoplastic Agents|Antiparasitic Agents|Antiprotozoals|Carbohydrates|Cinnamates|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Enzyme Inhibitors|Glycosides|Heterocyclic Compounds, Fused-Ring|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Noxae|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Protein Synthesis Inhibitors|Purine Nucleosides|Purines|Ribonucleosides|Toxic Actions|Trypanocidal Agents",[H][C@](N)(CC1=CC=C(OC)C=C1)C(=O)N[C@]1([H])[C@@]([H])(CO)O[C@@]([H])(N2C=NC3=C(N=CN=C23)N(C)C)[C@]1([H])O,439530
7490,DB08438,"(2E,4R,5S)-2,3,4,5-TETRAHYDROXY-6-(PALMITOYLOXY)HEX-2-ENOIC ACID",small molecule,experimental,,[H][C@](O)(COC(=O)CCCCCCCCCCCCCCC)[C@@]([H])(O)C(\O)=C(\O)C(O)=O,54736482
7491,DB08439,Parecoxib,small molecule,approved,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|COX-2 Inhibitors|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory System Agents",CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C1=C(C)ON=C1C1=CC=CC=C1,119828
7492,DB08440,"N-1,10-phenanthrolin-5-ylacetamide",small molecule,experimental,,CC(=O)NC1=C2C=CC=NC2=C2N=CC=CC2=C1,18719622
7493,DB08441,"6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE",small molecule,experimental,,BrC1=C2NCCCNS(=O)(=O)C3=CC=CC(NC(N=C1)=N2)=C3,9952008
7494,DB08442,"4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol",small molecule,experimental,,[H][C@@]1(CCCN1C(=O)C1=C(O)C=C(O)C=C1)C1=CC=CC=C1C,25058141
7495,DB08443,"2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol",small molecule,experimental,,OC1=CC(O)=C(C(=O)N2C=CC=C2)C(O)=C1,11160307
7496,DB08444,"3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile",small molecule,experimental,,CC1=CC(=CC(OC2=C(Br)C=C(CC3=NNC4=NN=CC=C34)C=C2)=C1)C#N,25058138
7497,DB08445,"(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",small molecule,experimental,,[H][C@]1(N)CN(C[C@]1([H])C1=C(F)C=C(F)C(F)=C1)C1=CC(=NC=N1)C1=CC=C(OC)N=C1,24180585
7498,DB08446,"3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile",small molecule,experimental,,FC1=C(CC2=NNC3=NN=CC=C23)C=CC(Br)=C1OC1=CC(=CC(Cl)=C1)C#N,25058137
7499,DB08447,3-{3-[(DIMETHYLAMINO)METHYL]-1H-INDOL-7-YL}PROPAN-1-OL,small molecule,experimental,,CN(C)CC1=CNC2=C1C=CC=C2CCCO,23640750
7500,DB08448,"(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol",small molecule,experimental,,[H][C@]12C=CCC=C1C=CC1=CC(O)=CC=C1N2CC1=NC2=C(N)N=C(N)N=C2N=C1,46937152
7501,DB08449,"2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid",small molecule,experimental,,OC(=O)CN1C=C(CC2=NC3=C(S2)C(F)=CC(F)=C3F)C2=CC=CN=C12,10150441
7502,DB08450,N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine,small molecule,experimental,,CC1=CC=CC(=N1)C1=NC(NC2=CC=C3NN=CC3=C2)=C2C=CC=CC2=N1,9998128
7503,DB08451,N-(QUINOLIN-8-YL)METHANESULFONAMIDE,small molecule,experimental,,CS(=O)(=O)NC1=CC=CC2=C1N=CC=C2,151506
7504,DB08453,2-Nonyl-4-quinolinol 1-oxide,small molecule,experimental,,CCCCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1,130804
7505,DB08454,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,small molecule,experimental,,CC1=CC(NC2=C3C=CC=CC3=NC(=N2)C2=CC=CC=C2)=NN1,6419766
7506,DB08455,Ro 12-7310,small molecule,experimental,"Alkenes|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Retinoids|Terpenes",[H]/C(=C(/[H])\C(\C)=C(/[H])C(O)=O)/C(/[H])=C(\C)/C(/[H])=C(\[H])C1=C(C)C=C(O)C(C)=C1C,6438583
7507,DB08456,"S-[(1-Hydroxy-2,2,5,5-tetramethyl-4-phenyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate",small molecule,experimental,,CC1(C)N(O)C(C)(C)C(=C1CSS(C)(=O)=O)C1=CC=CC=C1,131704309
7508,DB08457,"4-(3,5-DIMETHYLPHENOXY)-5-(FURAN-2-YLMETHYLSULFANYLMETHYL)-3-IODO-6-METHYLPYRIDIN-2(1H)-ONE",small molecule,experimental,,CC1=C(CSCC2=CC=CO2)C(OC2=CC(C)=CC(C)=C2)=C(I)C(=O)N1,5327076
7509,DB08458,(4-BROMOPHENYL)[4-({(2E)-4-[CYCLOPROPYL(METHYL)AMINO]BUT-2-ENYL}OXY)PHENYL]METHANONE,small molecule,experimental,,CN(C\C=C\COC1=CC=C(C=C1)C(=O)C1=CC=C(Br)C=C1)C1CC1,445987
7510,DB08459,"3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile",small molecule,experimental,,ClC1=CC(OC2=C(Cl)C=CC(OCC3=NNC4=NC=CC=C34)=C2)=CC(=C1)C#N,16045340
7511,DB08460,MK-4965,small molecule,experimental,"HIV Reverse Transcriptase, antagonists & inhibitors",NC1=CC=C2C(COC3=CC=C(Cl)C(OC4=CC(=CC(Cl)=C4)C#N)=C3)=NNC2=N1,16045418
7512,DB08461,"3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL",small molecule,experimental,,CC(C)(C)N1N=C(CC2=CC(O)=CC=C2)C2=C1N=CN=C2N,16750071
7513,DB08462,N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,small molecule,experimental,,C=CC(=O)NC1=CC=C2N=CN=C(NC3=CC=CC=C3)C2=C1,10401956
7514,DB08463,(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,small molecule,experimental,,[H][C@@](CC)(CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=C(C=C2)C2=CC=CC=N2)=N1,10224714
7515,DB08464,"METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE",small molecule,experimental,,COC(=O)C1=C(CCC(=O)NC2=C(O)C=C(OC)C(O)=C2)C(Cl)=C(O)C=C1O,11373270
7516,DB08465,"2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE",small molecule,experimental,,COC1=CC(N)=C(OC)C(CCOC(=O)C2=C(O)C=C(O)C(Cl)=C2)=C1OC,11840979
7517,DB08466,"5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol",small molecule,experimental,,OC1=CC=C(CCC2=CC(O)=CC(O)=C2)C=C1,185914
7518,DB08467,"6-(2,3,4,5,6,7-HEXAHYDRO-2,4,4-TRIMETHYL-1-METYLENEINDEN-2-YL)-3-METHYLHEXA-2,4-DIENOIC ACID",small molecule,experimental,,O=C(O)\C=C(/C)\C=C\C[C@]1(C)CC2=C(CCCC2(C)C)C1=C,5289278
7519,DB08469,"tert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate",small molecule,experimental,,CC(C)(C)OC(=O)N1CCC(CC1)C1=NC(=NO1)C1=CC=CS1,18690028
7520,DB08470,"3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole",small molecule,experimental,,FC1=CC=C(C=C1)C1=NN=C(N1)C1=CC=CC=C1,12195517
7521,DB08471,"1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine",small molecule,experimental,,O=C(CC1=CC=CS1)N1CCC(CC1)C1=NC(=NO1)C1=CC=CS1,1453694
7522,DB08472,(R)-Fluoxetine,small molecule,experimental,,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,1548970
7523,DB08473,Dichlororibofuranosylbenzimidazole,small molecule,experimental,"Carbohydrates|Enzyme Inhibitors|Glycosides|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Ribonucleosides",OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=CC(Cl)=C(Cl)C=C12,5894
7524,DB08474,3-(CARBOXYAMIDE(2-CARBOXYAMIDE-2-TERTBUTYLETHYL))PENTAN,small molecule,experimental,,[H][C@](CC(=O)NC(CC)CC)(C(N)=O)C(C)(C)C,5289290
7525,DB08475,"[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl hydrogen hex-5-enylphosphonate",small molecule,experimental,,CC1(C)OC[C@@H](COP(O)(=O)CCCCC=C)O1,5289293
7526,DB08476,3-AMINO-AZACYCLOTRIDECAN-2-ONE,small molecule,experimental,,[H][C@]1(N)CCCCCCCCCCNC1=O,446676
7527,DB08478,N-[2-Chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide,small molecule,experimental,,[H]N([H])C(\N=C(N([H])[H])N([H])[H])=N/C1=C(Cl)C=CC(=C1)C(F)(F)F,425841
7528,DB08479,"N-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide",small molecule,experimental,,COC1=CC(OC)=CC(NC(=N)NC(N)=N)=C1,2730282
7529,DB08480,4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN,small molecule,experimental,,[H][C@]1(CCC2=C1C=CC=C2O)\N=C\C=C,5494443
7530,DB08481,4-Methyl-N-[5-(5-methyl-furan-2-ylmethylene)-4-oxo-thiazolidin-2-ylidene]-benzenesulfonamide,small molecule,experimental,,[H]N(C1=NC(=O)\C(S1)=C\C1=CC=C(C)O1)S(=O)(=O)C1=CC=C(C)C=C1,7297549
7531,DB08482,[[1-[N-HYDROXY-ACETAMIDYL]-3-METHYL-BUTYL]-CARBONYL-LEUCINYL]-ALANINE ETHYL ESTER,small molecule,experimental,,[H][C@@](C)(NC(=O)[C@]([H])(CC(C)C)NC(=O)[C@]([H])(CC(C)C)CC(=O)NO)C(=O)OCC,5487313
7532,DB08484,4-AMINO-N-[(2-SULFANYLETHYL)CARBAMOYL]BENZENESULFONAMIDE,small molecule,experimental,,NC1=CC=C(C=C1)S(=O)(=O)NC(=O)NCCS,24856357
7533,DB08485,"(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID",small molecule,experimental,,[H][C@@]1(O)C[C@@](O)(C=C(C2=CC=CC(SC3=CC=CC=C3)=C2)[C@@]1([H])O)C(O)=O,16058682
7534,DB08486,Efaproxiral,small molecule,investigational,"Acids, Acyclic|Amines|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Antisickling Agents|Fatty Acids|Fatty Acids, Volatile|Hematologic Agents|Lipids|Photosensitizing Agents|Radiation-Sensitizing Agents|Sensitizers Used in Photodynamic/radiation Therapy",CC1=CC(NC(=O)CC2=CC=C(OC(C)(C)C(O)=O)C=C2)=CC(C)=C1,122335
7535,DB08487,3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,small molecule,experimental,,NC(=N)C1=CC(CN2CCN(CC2=O)S(=O)(=O)C2=CC3=C(S2)C=C(Cl)C=C3)=CC=C1,447359
7536,DB08488,"4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE",small molecule,experimental,,ClC1=CC=C(S1)\C=C\S(=O)(=O)N1CCN(CC2=CC3=C(N2)C=CN=C3)C(=O)C1,447360
7537,DB08489,"N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE",small molecule,experimental,,[H][C@@](CC(C)C)(CC(=O)NO)C(=O)N[C@@]1([H])CC2=CN(CCCCCCNC1=O)C1=C2C=CC=C1,478379
7538,DB08490,CTS-1027,small molecule,experimental|investigational,Amines|Hydroxy Acids|Hydroxylamines,ONC(=O)C1(CS(=O)(=O)C2=CC=C(OC3=CC=C(Cl)C=C3)C=C2)CCOCC1,3342298
7539,DB08491,N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE,small molecule,experimental,,ONC(=O)CC1(CCOCC1)S(=O)(=O)C1=CC=C(OC2=CC=CC=C2)C=C1,4369
7540,DB08492,(2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID,small molecule,experimental,,CCCCCCC#CC1=CC=CC=C1\C=C\C(O)=O,10308106
7541,DB08493,"5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID",small molecule,experimental,,[H][C@@](CC(C)C)(CC(O)=O)C(=O)N[C@@]1([H])CC2=CN(CCCCCCNC1=O)C1=C2C=CC=C1,5289314
7542,DB08494,"S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate",small molecule,experimental,,CC1=CC2=C(C=C1)N(CCC2)C(=O)SCC(=O)NC1=C(Cl)C=C(C=C1)S(N)(=O)=O,24878044
7543,DB08495,4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,small molecule,experimental,,NC(=N)C1=CC=C(CN2CCN(CC2=O)S(=O)(=O)C2=CC3=C(S2)C=C(Cl)C=C3)C=C1,447362
7544,DB08496,(R)-warfarin,small molecule,experimental,Anticoagulants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Vitamin K Antagonists,CC(=O)C[C@H](C1=CC=CC=C1)C1=C(O)C2=C(OC1=O)C=CC=C2,91546
7545,DB08497,"(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",small molecule,experimental,,[H][C@@](OC(C)=O)(C(=O)NC1=CC=CC2=C1C(=O)C(=O)NC2=O)C1=CC=CC=C1,24883486
7546,DB08498,"(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",small molecule,experimental,,[H][C@@](OC(C)=O)(C(=O)NC1=CC=CC2=C1C(=O)C(=O)NC2=O)C1=CC=CC(Cl)=C1,46937155
7547,DB08499,"N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide",small molecule,experimental,,FCCOC1=CC=CC(NC(=O)CCC(=O)NC2=CC=C3C(=O)NC(=O)C(=O)C3=C2)=C1,24883488
7548,DB08500,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",small molecule,experimental,,[H][C@]1(C[C@]2(ON1)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]2([H])O)C1=CC2=CC=CC=C2C=C1,46937156
7549,DB08501,"DIETHYL PROPANE-1,3-DIYLBISCARBAMATE",small molecule,experimental,,CCOC(=O)NCCCNC(=O)OCC,295941
7550,DB08502,Capravirine,small molecule,investigational,Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Enzyme Inhibitors|Non-Nucleoside Reverse Transcriptase Inhibitors|Nucleic Acid Synthesis Inhibitors|Reverse Transcriptase Inhibitors,CC(C)C1=C(SC2=CC(Cl)=CC(Cl)=C2)N(CC2=CC=NC=C2)C(COC(N)=O)=N1,1783
7551,DB08503,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",small molecule,experimental,,[H][C@]1(C[C@]2(ON1)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]2([H])O)C1=CC=C(C)C=C1,46937157
7552,DB08504,"6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM",small molecule,experimental,,[H][C@@](N)(C(=O)N1CC[C@]([H])(F)C1)[C@@]([H])(C(=O)N(C)C)C1=CC=C(C=C1)C1=CN2N=CN=C2C=C1,10320144
7553,DB08505,methyl 4-bromo-N-[8-(hydroxyamino)-8-oxooctanoyl]-L-phenylalaninate,small molecule,experimental,,[H][C@@](CC1=CC=C(Br)C=C1)(NC(=O)CCCCCCC(=O)NO)C(=O)OC,23640756
7554,DB08506,N-{(2S)-3-[(1R)-1-aminoethyl](hydroxy)phosphoryl-2-benzylpropanoyl}-L-phenylalanine,small molecule,experimental,,[H][C@@](C)(N)[P@@](O)(=O)C[C@@]([H])(CC1=CC=CC=C1)C(=O)N[C@@]([H])(CC1=CC=CC=C1)C(O)=O,10601417
7555,DB08507,N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID,small molecule,experimental,,[H][C@](CC(C)C)(N(CC1=CC=CC=C1)[P@](C)(=O)C1=CC=CC=C1)C(=O)NO,9543420
7556,DB08508,N-BENZOYL-D-ALANINE,small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins",[H][C@](C)(NC(=O)C1=CC=CC=C1)C(O)=O,91514
7557,DB08509,1-[6-(2-CHLORO-4-METHYXYPHENOXY)-HEXYL]-IMIDAZOLE,small molecule,experimental,,COC1=CC(Cl)=C(OCCCCCCN2C=CN=C2)C=C1,1360
7558,DB08510,5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE,small molecule,experimental,,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@]([H])(CC[C@]4(C)[C@@]3([H])CC[C@]12C)OC(=O)CCC(O)=O)C(C)=O,5289324
7559,DB08511,"6-amino-2-methyl-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",small molecule,experimental,,CC1=NC2=C(N1)C=C1C(=O)NC(N)=NC1=C2,24741805
7560,DB08512,"6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",small molecule,experimental,,NC1=NC2=CC3=C(C=C2C(=O)N1)N=C(NCC1=CC=CC2=CC=CC=C12)N3,16750097
7561,DB08513,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,small molecule,experimental,,CC1=CC(NC2=NC(NC3=CC=C(CC(O)=O)C=C3)=NC=C2C(N)=O)=CC=C1,24871491
7562,DB08514,"6-amino-2-[(thiophen-2-ylmethyl)amino]-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",small molecule,experimental,,NC1=NC2=CC3=C(NC(NCC4=CC=CS4)=N3)C=C2C(=O)N1,24741808
7563,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",small molecule,experimental,,[H][C@](O)([C@@]1([H])CCCC=C1)[C@]1(NC(=O)[C@]2([H])CCO[C@]12C)C=O,11840981
7564,DB08516,(S)-(+)-2-[4-(FLUOROBENZYLOXY-BENZYLAMINO)PROPIONAMIDE],small molecule,experimental,,[H][C@@](C)(\N=C\C1=CC=C(OCC2=CC(F)=CC=C2)C=C1)C(N)=O,23659732
7565,DB08517,Sakuranetin,small molecule,experimental,"Benzopyrans|Chromones|Heterocyclic Compounds, Fused-Ring|Pyrans",COC1=CC(O)=C2C(=O)C[C@H](OC2=C1)C1=CC=C(O)C=C1,73571
7566,DB08519,"N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",small molecule,experimental,,COC1=CC(NC2=NC=CC(NC3=CC=C4C(C)=NNC4=C3)=N2)=CC(OC)=C1OC,9822610
7567,DB08520,"(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE",small molecule,experimental,,[H][C@@]12CCCCN1C(=O)C(=O)C(C)(C)COC(=O)CCCCCCCCCCCOC2=O,445646
7568,DB08521,4-[4-(4-Fluorophenyl)-2-[4-[(R)-methylsulfinyl]phenyl]-1H-imidazol-5-yl]pyridine,small molecule,experimental,,C[S@@](=O)C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC=NC=C1)C1=CC=C(F)C=C1,40467016
7569,DB08522,4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE,small molecule,experimental,,FC1=CC=C(C=C1)C1=C(N(CC2CC2)C=N1)C1=CC=NC=C1,5171
7570,DB08523,[HYDROXY(3-PHENYLPROPYL)AMINO]METHANOL,small molecule,experimental,,OCN(O)CCCC1=CC=CC=C1,5289329
7571,DB08524,2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE,small molecule,experimental,,ON(CCOC1=CC=CC(=C1)C(=O)C1=CC=CC=C1)C=O,5289330
7572,DB08525,HYDROXY[3-(6-METHYLPYRIDIN-2-YL)PROPYL]FORMAMIDE,small molecule,experimental,,CC1=NC(CCCN(O)C=O)=CC=C1,5289331
7573,DB08526,CARBOBENZYLOXY-(L)-LEUCINYL-(L)LEUCINYL METHOXYMETHYLKETONE,small molecule,experimental,,[H][C@@](O)(COC)[C@]([H])(CC(C)C)NC(=O)[C@]([H])(CC(C)C)NC(=O)OCC1=CC=CC=C1,5289332
7574,DB08527,"1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE",small molecule,experimental,,NC(=O)C1=NN(C2=C1C=CC1=C2C=NN1)C1=CC=C(C=C1)S(N)(=O)=O,5331010
7575,DB08528,"2-AMINO-6-(3,5-DIMETHYLPHENYL)SULFONYLBENZONITRILE",small molecule,experimental,,CC1=CC(=CC(C)=C1)S(=O)(=O)C1=C(C#N)C(N)=CC=C1,1536
7576,DB08529,"(6E,11E)-HEPTADECA-6,11-DIENE-9,9-DIYLBIS(PHOSPHONIC ACID)",small molecule,experimental,,CCCCC\C=C\CC(C\C=C\CCCCC)(P(O)(O)=O)P(O)(O)=O,25023881
7577,DB08530,"7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE",small molecule,experimental,,CN1C2=C(N(CC3=CC=CC=C3)C(=N2)N2CC[NH2+]CC2)C(=O)N(C)C1=O,4747355
7578,DB08531,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",small molecule,experimental,,ClC1=CC=CC(=C1Cl)C1=NC2=CC=NN2C(NCC2=CC=NC=C2)=C1,21066087
7579,DB08532,"6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",small molecule,experimental,,FC1=CC=CC=C1C1=CN2C=CN=C2C(NCC2=CC=CN=C2)=N1,46937158
7580,DB08533,"3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",small molecule,experimental,,CC1=CN=C2N1C=CN=C2NCC1=CC=NC=C1,9991833
7581,DB08534,"5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",small molecule,experimental,,FC1=CC=CC=C1C1=NC2=CC=NN2C(NCC2=CC=NC=C2)=C1,21066096
7582,DB08535,"3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",small molecule,experimental,,BrC1=C2N=C(C=C(NCC3=CC=CN=C3)N2N=C1)C1=CC=CC=C1,10249180
7583,DB08536,"3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine",small molecule,experimental,,BrC1=C2C=C(C=C(NCC3=CN=CN=C3)N2N=C1)C1=CC=CC=C1,10317619
7584,DB08537,"3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine",small molecule,experimental,,BrC1=CN=C2N1C=C(C=C2NCC1=CN=CN=C1)C1=CC=CC=C1,10249182
7585,DB08538,"N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine",small molecule,experimental,,CCC1=C2N=C(C=C(NCC3=CN=C(N)N=C3)N2N=C1)C1=C(F)C=CC=C1F,44629554
7586,DB08539,"3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",small molecule,experimental,,C(NC1=CC(=NC2=C(C=NN12)C1CC1)C1=CC=CC=C1)C1=CN=CC=C1,10042950
7587,DB08540,"2-[4-(2H-1,4-BENZOTHIAZINE-3-YL)-PIPERAZINE-1-LY]-1,3-THIAZOLE-4-CARBOXYLIC ACID ETHYLESTER",small molecule,experimental,,CCOC(=O)C1=CSC(=N1)N1CCN(CC1)C1=NC2=CC=CC=C2SC1,5189
7588,DB08541,"[(3S)-9-hydroxy-1-methyl-10-oxo-4,10-dihydro-3H-benzo[g]isochromen-3-yl]acetic acid",small molecule,experimental,,[H][C@@]1(CC(O)=O)CC2=CC3=C(C(O)=CC=C3)C(=O)C2=C(C)O1,443833
7589,DB08542,"3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione",small molecule,experimental,,[H][C@@]12CCC(=O)[C@@]1(C)CCC(=O)[C@@]2([H])CCC1=C(O)C(O)=CC=C1C,440483
7590,DB08543,1-[2-HYDROXY-3-(4-CYCLOHEXYL-PHENOXY)-PROPYL]-4-(2-PYRIDYL)-PIPERAZINE,small molecule,experimental,,[H][C@@](O)(COC1=CC=C(C=C1)C1CCCCC1)CN1CCN(CC1)C1=CC=CC=N1,446129
7591,DB08544,(S)-Fluoxetine,small molecule,experimental,,CNCC[C@H](OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,1548968
7592,DB08545,(1S)-1-Phenylethyl (4-acetamidobenzyl)phosphonate,small molecule,experimental,,[H]N(C(C)=O)C1=CC=C(CP([O-])(=O)O[C@@H](C)C2=CC=CC=C2)C=C1,131704310
7593,DB08546,"4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE",small molecule,experimental,,[H][C@]1(O)C[N@]2[C@@]([H])(C1)[C@]1([H])C(=O)N(CC3=CC=C4OCOC4=C3)C(=O)[C@]1([H])[C@]2([H])C1=CC=C(C=C1)C(N)=N,4369485
7594,DB08547,PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE,small molecule,experimental,,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])[C@@]([H])(C[C@]12C)OC(=O)CCC(O)=O)C(C)=O,5289373
7595,DB08548,"[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl hydrogen hex-5-enylphosphonate",small molecule,experimental,,CC1(C)OC[C@H](COP(O)(=O)CCCCC=C)O1,5289374
7596,DB08549,"(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER",small molecule,experimental,,[H][C@]1(CC2=C(CN1C(=O)OCC1=CC=CC=C1)C=C(NS(O)(=O)=O)C=C2)C(=O)NC,5327153
7597,DB08550,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",small molecule,experimental,"Antidepressive Agents|Central Nervous System Depressants|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Monoamine Oxidase Inhibitors|Phenylethanolamine N-Methyltransferase, antagonists & inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",ClC1=CC=C2CCNCC2=C1Cl,123920
7598,DB08551,3-{(R)-(Dihydroxyboryl)[(2-thienylacetyl)amino]methyl}benzoic acid,small molecule,experimental,,[H][C@@](NC(=O)CC1=CC=CS1)(B(O)O)C1=CC(=CC=C1)C(O)=O,5289377
7599,DB08552,(1R)-1-(2-thienylacetylamino)-1-phenylmethylboronic acid,small molecule,experimental,,[H][C@@](NC(=O)CC1=CC=CS1)(B(O)O)C1=CC=CC=C1,5289378
7600,DB08553,"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",small molecule,experimental,,O\N=C1/CCC2=CC(=CC=C12)C1=CN(N=C1C1=CC=NC=C1)C1CCNCC1,11653652
7601,DB08554,N-(3-carboxypropanoyl)-L-norvaline,small molecule,experimental,,[H][C@@](CCC)(NC(=O)CCC(O)=O)C(O)=O,6852189
7602,DB08555,"1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline",small molecule,experimental,,COC1=CC2=C(C=C1Cl)C(=NCC2)C1=CC=CC(Br)=C1,25203945
7603,DB08556,"5'-ACETYL-4-{[(2,4-DIMETHYLPHENYL)SULFONYL]AMINO}-2,2'-BITHIOPHENE-5-CARBOXYLIC ACID",small molecule,experimental,,CC(=O)C1=CC=C(S1)C1=CC(NS(=O)(=O)C2=CC=C(C)C=C2C)=C(S1)C(O)=O,9543496
7604,DB08557,"2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide",small molecule,experimental,,COCCNC1=CC(=CC=C1C(N)=O)N1C2=C(C3=CC=CC=C13)C(=O)CCC2,24812721
7605,DB08558,"2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL",small molecule,experimental,,[H][C@]1(CO)O[C@@]([H])(SCCCCCCCC)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O,656909
7606,DB08559,"N-[(2S,4S,6R)-2-(dihydroxymethyl)-4-hydroxy-3,3-dimethyl-7-oxo-4lambda~4~-thia-1-azabicyclo[3.2.0]hept-6-yl]-2-phenylacetamide",small molecule,experimental,,[H][C@@]1(NC(=O)CC2=CC=CC=C2)C(=O)[N@]2[C@]1([H])[S@@]([H])(O)C(C)(C)[C@]2([H])C(O)=O,5289386
7607,DB08560,3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE,small molecule,experimental,,FC1=CC=C(C=C1)N1N=C(C=C1NS(=O)(=O)C1=CC=CC(F)=C1)C1=CC=CS1,2742752
7608,DB08561,"BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE",small molecule,experimental,,O=C(OCC1=CC=CC=C1)C1=CN2C(S1)=CC(=O)N(CC1=CC=CC=C1)C2=O,9896504
7609,DB08562,4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,small molecule,experimental,,OC(=O)CCCC(=O)NC1=CC=C(\C=C\C2=CC=CC=C2)C=C1,445650
7610,DB08564,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide,small molecule,experimental,,CN(C)C\C=C\C(=O)NC1=CC=C2N=CN=C(NC3=CC(Br)=CC=C3)C2=C1,5328969
7611,DB08565,L-1-naphthyl-2-acetamido-ethane boronic acid,small molecule,experimental,,[H]N([C@@H](CC1=CC=CC2=CC=CC=C12)[B-](O)(O)O)C(C)=O,449487
7612,DB08566,D-1-naphthyl-2-acetamido-ethane boronic acid,small molecule,experimental,,[H]N(C(C)=O)[C@]([H])(CC1=C2C=CC=CC2=CC=C1)[B-](O)(O)O,46937161
7613,DB08568,A-674563,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Pyrazoles",CC1=NNC2=C1C=C(C=C2)C1=CC(OC[C@@H](N)CC2=CC=CC=C2)=CN=C1,11314340
7614,DB08569,"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",small molecule,experimental,,[H][C@@](N)(COC1=CN=CC(=C1)C1=CC2=C(NN=C2C)C=C1)CC1=CC=C(Br)C=C1,16122642
7615,DB08570,4-(ACETYLAMINO)-3-HYDROXY-5-NITROBENZOIC ACID,small molecule,experimental,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Neuraminidase, antagonists & inhibitors",CC(=O)NC1=C(O)C=C(C=C1[N+]([O-])=O)C(O)=O,3364665
7616,DB08571,4-(ACETYLAMINO)-5-AMINO-3-HYDROXYBENZOIC ACID,small molecule,experimental,,CC(=O)NC1=C(N)C=C(C=C1O)C(O)=O,446366
7617,DB08572,4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE,small molecule,experimental,,NC(=O)C1=CC=C(NC2=NC(OCC3CCCCC3)=C(N=O)C(N)=N2)C=C1,5289411
7618,DB08573,3-[(4-CHLOROANILINO)SULFONYL]THIOPHENE-2-CARBOXYLIC ACID,small molecule,experimental,,OC(=O)C1=C(C=CS1)S(=O)(=O)NC1=CC=C(Cl)C=C1,446853
7619,DB08574,"(5R)-2-sulfanyl-5-[4-(trifluoromethyl)benzyl]-1,3-thiazol-4(5H)-one",small molecule,experimental,,FC(F)(F)C1=CC=C(C[C@H]2SC(=S)NC2=O)C=C1,23586154
7620,DB08575,"2-[(1S)-1-BENZYL-2-SULFANYLETHYL]-1H-IMIDAZO[4,5-C]PYRIDIN-5-IUM",small molecule,experimental,,[H][C@](CS)(CC1=CC=CC=C1)C1=NC2=C(N1)C=C[NH+]=C2,5289417
7621,DB08576,"1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)-2-(METHYLAMINO)ETHANONE",small molecule,experimental,,CNCC(=O)C1=NN=C(O1)C(C)(C)C,6852124
7622,DB08577,3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE,small molecule,experimental,,CC1=CNC(\C=C2/C(=O)NC3=CC=CC=C23)=C1CCC(O)=O,5289418
7623,DB08578,4-[(5-bromopyridin-2-yl)amino]-4-oxobutanoic acid,small molecule,experimental,,OC(=O)CCC(=O)NC1=CC=C(Br)C=N1,647833
7624,DB08579,"4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}aniline",small molecule,experimental,,[H][C@]1(C)CN(C[C@@]([H])(C)C1)C(=O)C1=CC(Br)=CC=C1N,24764440
7625,DB08580,4-bromo-2-{[(2R)-2-(2-chlorobenzyl)pyrrolidin-1-yl]carbonyl}aniline,small molecule,experimental,,[H][C@]1(CC2=C(Cl)C=CC=C2)CCCN1C(=O)C1=CC(Br)=CC=C1N,24764441
7626,DB08581,"4-[(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)amino]-4-oxobutanoic acid",small molecule,experimental,,[H][C@]1(C)CN(C[C@@]([H])(C)C1)C(=O)C1=CC(Br)=CC=C1NC(=O)CCC(O)=O,24764442
7627,DB08582,"N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide",small molecule,experimental,,[H][C@]1(C)CN(C[C@@]([H])(C)C1)C(=O)C1=C(NC(=O)CCC(=O)N2CCOCC2)C=CC(Br)=C1,24764443
7628,DB08583,"2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide",small molecule,experimental,,CCN1N=CC=C1C1=CNC2=NC=C(C=C12)C1=CC(C(=O)N(C)C)=C(N)C=C1,46937162
7629,DB08585,"S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] hexanethioate",small molecule,experimental,,[H][C@@](O)(C(=O)NCCC(=O)NCCSC(=O)CCCCC)C(C)(C)COP(O)(O)=O,25220903
7630,DB08586,"S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] octanethioate",small molecule,experimental,,[H][C@@](O)(C(=O)NCCC(=O)NCCSC(=O)CCCCCCC)C(C)(C)COP(O)(O)=O,25220904
7631,DB08587,Sinapic acid,small molecule,experimental,"Acids, Carbocyclic|Cinnamates|Compounds used in a research, industrial, or household setting|Indicators and Reagents|Laboratory Chemicals",COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O,637775
7632,DB08588,2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE,small molecule,experimental,,[H][C@@]1(N)CCCN(C1)C1=NC2=C(C=CC=C2)C(=O)N1CC1=C(C=CC=C1)C#N,23647311
7633,DB08589,SYRINGATE,small molecule,experimental,,COC(=O)C1=CC(OC)=C(O)C(OC)=C1,70164
7634,DB08590,1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE,small molecule,experimental,,CC(C)(C)C(=O)OC1=CC=C2N(CCCO)C(NC(=O)C3=CC(=CC=C3)[N+]([O-])=O)=NC2=C1,11987888
7635,DB08591,"5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",small molecule,experimental,,COC1=CC=C(C=C1N1CC(=O)NS1(=O)=O)C1=CC=CC=C1,4369451
7636,DB08593,"1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE",small molecule,experimental,,O=C1CN(C2=CC=CC=C2)S(=O)(=O)N1,4369452
7637,DB08594,TERT-BUTYL 2-CYANO-2-METHYLHYDRAZINECARBOXYLATE,small molecule,experimental,,CN(NC(=O)OC(C)(C)C)C#N,5289428
7638,DB08595,"4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",small molecule,experimental,,[H][C@]12CC=C(C)[C@]([H])(C1)[C@@]([H])(OC2(C)C)C1=CC=C(O)C=C1,15942662
7639,DB08596,5'-deoxy-5'-piperidin-1-ylthymidine,small molecule,experimental,,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])CN1CCCCC1)N1C=C(C)C(=O)NC1=O,25147494
7640,DB08597,Dorsomorphin,small molecule,experimental,"AMP-Activated Protein Kinases, antagonists & inhibitors|Enzyme Inhibitors|Protein Kinase Inhibitors",C(CN1CCCCC1)OC1=CC=C(C=C1)C1=CN2N=CC(=C2N=C1)C1=CC=NC=C1,11524144
7641,DB08598,R-82913,small molecule,experimental,"Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Benzazepines|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|HIV Reverse Transcriptase, antagonists & inhibitors|Nucleic Acid Synthesis Inhibitors|Reverse Transcriptase Inhibitors",C[C@H]1CN2C(=S)NC3=CC(Cl)=CC(CN1CC=C(C)C)=C23,3000237
7642,DB08599,N-[(4-methoxyphenyl)sulfonyl]-D-alanine,small molecule,experimental,,[H][C@](C)(NS(=O)(=O)C1=CC=C(OC)C=C1)C(O)=O,705712
7643,DB08600,Tivirapine,small molecule,experimental,,[H]N1C(=S)N2C[C@H](C)N(CC=C(C)C)CC3=C(Cl)C=CC1=C23,3000323
7644,DB08601,Tributyltin,small molecule,experimental,Organometallic Compounds|Organotin Compounds,[H][Sn](CCCC)(CCCC)CCCC,3032732
7645,DB08602,"3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one",small molecule,experimental,,CSC1=NC2=CC=CC=C2C(=O)N1C1=C(F)C=CC=C1F,25229546
7646,DB08603,N-[(1S)-5-amino-1-(chloroacetyl)pentyl]-4-methylbenzenesulfonamide,small molecule,experimental,,[H][C@@](CCCCN)(NS(=O)(=O)C1=CC=C(C)C=C1)C(=O)CCl,73094
7647,DB08604,Triclosan,small molecule,approved|investigational,"Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Benzene Derivatives|Dermatologicals|Ethers|Fatty Acid Synthesis Inhibitors|Hypolipidemic Agents|Lipid Regulating Agents|Medicated Dressings|Medicated Dressings With Antiinfectives|Miscellaneous Local Anti-infectives|Noxae|Phenol and Derivatives|Phenols|Phenyl Ethers|Toxic Actions",OC1=CC(Cl)=CC=C1OC1=C(Cl)C=C(Cl)C=C1,5564
7648,DB08605,"6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL",small molecule,experimental,,CCCS(=O)(=O)N1N=CC2=C(C=C(C)S2)B1O,171833
7649,DB08606,"(3R,4S)-1-[(4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)METHYL]-4-[(METHYLSULFANYL)METHYL]PYRROLIDIN-3-OL",small molecule,experimental,,[H][C@]1(O)CN(CC2=CNC3=C(N)N=CN=C23)C[C@]1([H])CSC,656970
7650,DB08607,"(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE",small molecule,experimental,,[H][C@]1(CC2=CC=C(OC[C@@]3(C)CCC4=C(C)C(O)=C(C)C(C)=C4O3)C=C2)SC(=O)NC1=O,9824580
7651,DB08608,"4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE",small molecule,experimental,,[H][C@@]1(C)CN(C(=O)[C@@](C)(O)C(F)(F)F)[C@@]([H])(C)CN1C(=O)C1=CC=C(C=C1)C#N,6102761
7652,DB08609,"(2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide",small molecule,experimental,,[H]N(C(=O)C(C)(O)C(F)(F)F)C1=C(C)C=C(C=C1)S(=O)(=O)N(CC)C1=CC=CC=C1,6102762
7653,DB08610,N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE,small molecule,experimental,,CC(C)C1=CC=C(COC2=C(Cl)C=C(CC(=O)NCCN)C=C2)C=C1,6102763
7654,DB08611,"2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL",small molecule,experimental,,OCCOC1=C(C=CC=C1)C1=C(F)C(F)=C(F)C=C1,46937163
7655,DB08612,"1,1,1-TRIFLUORO-3-(OCTYLTHIO)ACETONE",small molecule,experimental,,CCCCCCCCSCC(=O)C(F)(F)F,146089
7656,DB08613,"2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL",small molecule,experimental,,OC(O)(C1=CC=C(S1)C(=O)N1CCN2C(C1)=NC=C2C1=CC=CC=C1)C(F)(F)F,24836810
7657,DB08614,"3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE",small molecule,experimental,,[H][C@](NC(=O)CN1C(=O)C(NS(=O)(=O)NC)=CC=C1C1=CC=CC=C1)(C(C)C)C(=O)C(F)(F)F,5289460
7658,DB08615,"2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM",small molecule,experimental,,CN(C)C1=CC=C(C=C1)C1=[N+](C)C2=CC=C(O)C=C2S1,24832019
7659,DB08617,"4-(2,2,2-TRIFLUOROETHYL)-L-PHENYLALANINE",small molecule,experimental,,[H][C@](N)(CC1=CC=C(CC(F)(F)F)C=C1)C(O)=O,24764430
7660,DB08618,3-(HYDROXY-PHENYL-PHOSPHINOYLOXY)-8-METHYL-8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID METHYL ESTER,small molecule,experimental,,[H][C@@]12CC[C@@]([H])(N1C)[C@@]([H])(C(=O)OC)[C@]([H])(C2)O[P@](O)(=O)C1=CC=CC=C1,644013
7661,DB08619,Testosterone succinate,small molecule,experimental,"Androstanes|Androstenes|Androstenols|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone and derivatives|Testosterone Congeners|Thyroxine-binding globulin inhibitors",[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)OC(=O)CCC(O)=O,119202
7662,DB08620,Thiacloprid,small molecule,experimental,"Agrochemicals|Compounds used in a research, industrial, or household setting|Insecticides|Pesticides|Sulfur Compounds|Toxic Actions",ClC1=CC=C(CN2CCS\C2=N/C#N)C=N1,115224
7663,DB08621,Thiamphenicol,small molecule,experimental|investigational,Alcohols|Amphenicols|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Benzene Derivatives|Glycols|Nitro Compounds|Nitrobenzenes|Propylene Glycols,[H][C@](CO)(NC(=O)C(Cl)Cl)[C@]([H])(O)C1=CC=C(C=C1)S(C)(=O)=O,27200
7664,DB08622,"4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL",small molecule,experimental,,OC1(CCN(CCCC2(SCCS2)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,127702
7665,DB08623,"2-[CARBOXY-(2-THIOPHEN-2-YL-ACETYLAMINO)-METHYL]-5-METHYLENE-5,6-DIHYDRO-2H-[1,3]THIAZINE-4-CARBOXYLIC ACID",small molecule,experimental,,[H][C@@](NC(=O)CC1=CC=CS1)(C(O)=O)C1=N[C@]([H])(C(O)=O)C(=C)CS1,46937164
7666,DB08624,"1-[(4S)-4-amino-5-(1,3-benzothiazol-2-yl)-5-oxopentyl]guanidine",small molecule,experimental,,N[C@@H](CCCNC(N)=N)C(=O)C1=NC2=CC=CC=C2S1,46937165
7667,DB08626,Thiorphan,small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Enzyme Inhibitors|N-substituted Glycines|Peptides|Peptoids|Protease Inhibitors|Sulfur Compounds",[H][C@](CS)(CC1=CC=CC=C1)C(=O)NCC(O)=O,4369380
7668,DB08627,"(5R)-4-HYDROXY-3,5-DIMETHYL-5-[(1E,3E)-2-METHYLPENTA-1,3-DIENYL]THIOPHEN-2(5H)-ONE",small molecule,experimental,,C\C=C\C(\C)=C\[C@@]1(C)SC(=O)C(C)=C1O,5494446
7669,DB08628,"(5R)-5-[(1E)-BUTA-1,3-DIENYL]-4-HYDROXY-3,5-DIMETHYLTHIOPHEN-2(5H)-ONE",small molecule,experimental,,CC1=C(O)[C@](C)(SC1=O)\C=C\C=C,5494447
7670,DB08629,"N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE",small molecule,experimental,,[H][C@](N)(CC(C)C)CN1CCC[N@@]2CCC[C@@]12[H],5289474
7671,DB08631,"N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",small molecule,experimental,,ClC1=CC=C(NS(=O)(=O)C2=CC=C3CCNCC3=C2)C=C1,12606920
7672,DB08632,Trimesic acid,small molecule,experimental,"Acids, Acyclic",OC(=O)C1=CC(=CC(=C1)C(O)=O)C(O)=O,11138
7673,DB08633,TNP-470,small molecule,investigational,"Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antibiotics, Antineoplastic|Antineoplastic Agents|Cyclohexanes|Cycloparaffins|Growth Inhibitors|Growth Substances|Sesquiterpenes|Terpenes",[H][C@]1(CC=C(C)C)O[C@]1(C)[C@@]1([H])[C@]([H])(OC)[C@@]([H])(CC[C@]11CO1)OC(=O)NC(=O)CCl,369976
7674,DB08634,6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL,small molecule,experimental,,CC(C)C1=C(CC2=CC=CC=C2)N(COCC2=CC=CC=C2)C(=O)NC1=O,446515
7675,DB08635,N-(TRANS-4'-NITRO-4-STILBENYL)-N-METHYL-5-AMINO-PENTANOIC ACID,small molecule,experimental,,CN(CCCCC(O)=O)C1=CC=C(\C=C\C2=CC=C(C=C2)[N+]([O-])=O)C=C1,11963512
7676,DB08636,2-Hydroxybenzalpyruvate,small molecule,experimental,"Acids, Carbocyclic",OC(=O)C(=O)\C=C\C1=CC=CC=C1O,5280911
7677,DB08637,4-(2-METHOXYPHENYL)-2-OXOBUT-3-ENOIC ACID,small molecule,experimental,,[H]\C(=C(/[H])C1=CC=CC=C1OC)C(=O)C(O)=O,131704311
7678,DB08638,1-hydroperoxy-L-tryptophan,small molecule,experimental,,N[C@@H](CC1=CN(OO)C2=CC=CC=C12)C(O)=O,131704312
7679,DB08639,Dapivirine,small molecule,investigational,Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|HIV Reverse Transcriptase,CC1=CC(C)=C(NC2=NC(NC3=CC=C(C=C3)C#N)=NC=C2)C(C)=C1,214347
7680,DB08640,"(2S,3S)-3-FORMYL-2-({[(4-METHYLPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID",small molecule,experimental,,[H][C@@](CC)(C=O)[C@@]([H])(CNS(=O)(=O)C1=CC=C(C)C=C1)C(O)=O,6323526
7681,DB08641,"(2S,3S)-3-FORMYL-2-({[(4-NITROPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID",small molecule,experimental,,[H][C@@](CC)(C=O)[C@@]([H])(CNS(=O)(=O)C1=CC=C(C=C1)[N+]([O-])=O)C(O)=O,6323527
7682,DB08642,"(2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine",small molecule,experimental,,[H][C@]1(CN(C)C2=CC(OC)=C(OC)C(OC)=C2)CCC2=C(C1)C(N)=N[C@]([H])(N)N2,46937168
7683,DB08643,2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER,small molecule,experimental,,[H][C@@](CS)(NCC1=CC=C(C=C1)C1=CC=CC=C1)C(=O)NCC(=O)N[C@@]([H])(C(C)C)C(=O)OC,4369141
7684,DB08644,{1-[2-(1-FORMYL-PROPYL)-3-METHANESULFONYLAMINO-PYRROLIDINE-1-CARBONYL]-2-METHYL-PROPYL}-CARBAMIC ACID TERT-BUTYL ESTER,small molecule,experimental,,[H][C@@](CC)(C=O)[C@@]1([H])N(CC[C@]1([H])NS(C)(=O)=O)C(=O)[C@@]([H])(NC(=O)OC(C)(C)C)C(C)C,6323528
7685,DB08645,"6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE",small molecule,experimental,,[H][C@]1(NC2=CC(Cl)=C(C=C2S(=O)(=O)N1)S(N)(=O)=O)C(Cl)Cl,6604229
7686,DB08646,TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,small molecule,experimental,,[H][C@](N)(CC1=CNC2=C1C=CC(NNC1=CC=CC=C1)=C2O)C=O,46937169
7687,DB08647,TRAZEOLIDE,small molecule,experimental,,[H][C@]1(C)[C@]([H])(C(C)C)C2=C(C=C(C)C(=C2)C(=O)CCC(O)=O)C1(C)C,444705
7688,DB08648,"(1R,3S,5S,8R)-8-Hydroxy-2-oxabicyclo[3.3.1]non-6-ene-3,5-dicarboxylic acid",small molecule,experimental,,[H][C@@]1(O)C=C[C@]2(C[C@]([H])(O[C@]1([H])C2)C(O)=O)C(O)=O,445314
7689,DB08649,(1S)-1-AMINO-2-(1H-INDOL-3-YL)ETHANOL,small molecule,experimental,,[H][C@](N)(O)CC1=CNC2=CC=CC=C12,20846113
7690,DB08651,3'-THIO-THYMIDINE-5'-PHOSPHATE,small molecule,experimental,,[H][C@]1(S)C[C@@]([H])(O[C@]1([H])COP(O)(O)=O)N1C=C(C)C(=O)NC1=O,46937170
7691,DB08652,Indoleacetamide,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Indoles",NC(=O)CC1=CNC2=CC=CC=C12,397
7692,DB08653,Tryptamine,small molecule,experimental,"Amines|Biogenic Amines|Biogenic Monoamines|Heterocyclic Compounds, Fused-Ring|Indoles",NCCC1=CNC2=CC=CC=C12,1150
7693,DB08654,"TRANS-(1S,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL",small molecule,experimental,,[H][C@]1(N)CCC2=CC=CC=C2[C@]1([H])O,6420130
7694,DB08655,"9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE",small molecule,experimental,,CC(=O)N1C2=CC=CC=C2C2=C1C(=O)CCC2,853608
7695,DB08656,5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide,small molecule,experimental,,[H][C@](C)(NC(=O)C1=C(C)C=CC(N)=C1)C1=CC=CC2=C1C=CC=C2,24941262
7696,DB08657,2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID,small molecule,experimental,Sulfur Compounds,OC(=O)COC1=CC=C(C=C1)C1=CNC(CNC(=O)NC2=NC=C(SC3=NC=CC=C3)S2)=N1,17758816
7697,DB08658,ETHYL HYDROGEN DIETHYLAMIDOPHOSPHATE,small molecule,experimental,,CCO[P@](O)(=O)N(CC)CC,15083623
7698,DB08659,2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide,small molecule,experimental,,NNC(=O)C1=C(C2=C(N1)C=CC(=C2)S(N)(=O)=O)C1=CC=CC=C1,14611919
7699,DB08660,Quinalizarin,small molecule,experimental,Anthracenes|Quinones,OC1=CC=C(O)C2=C1C(=O)C1=C(C(O)=C(O)C=C1)C2=O,5004
7700,DB08661,"1-(2,5-dideoxy-5-pyrrolidin-1-yl-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",small molecule,experimental,,[H][C@@]1(O)C[C@]([H])(O[C@@]1([H])CN1CCCC1)N1C=C(C)C(=O)NC1=O,25147495
7701,DB08662,3-[1-(4-BROMO-PHENYL)-2-METHYL-PROPYL]-4-HYDROXY-CHROMEN-2-ONE,small molecule,experimental,,[H][C@](C(C)C)(C1=CC=C(Br)C=C1)C1=C(O)C2=C(OC1=O)C=CC=C2,54693872
7702,DB08663,4-HYDROXY-7-METHOXY-3-(1-PHENYL-PROPYL)-CHROMEN-2-ONE,small molecule,experimental,,[H][C@](CC)(C1=CC=CC=C1)C1=C(O)C2=C(OC1=O)C=C(OC)C=C2,54736485
7703,DB08664,({3-[1-(4-Hydroxy-2-oxo-2H-chromen-3-yl)-propyl]-phenylcarbamoyl}-methyl)-carbamic acid tert-butyl ester,small molecule,experimental,,CC[C@@H](C1=CC(NC(=O)CNC(=O)OC(C)(C)C)=CC=C1)C1=C(O)C2=CC=CC=C2OC1=O,54689025
7704,DB08665,"6,11-DIHYDRO-11-ETHYL-6-METHYL-9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN-5-ONE",small molecule,experimental,,CCN1C2=CC(=CC=C2N(C)C(=O)C2=C1N=CC=C2)[N+]([O-])=O,447012
7705,DB08666,5-imino-4-(3-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine,small molecule,experimental,,FC(F)(F)C1=CC(NN=C2C(=N)N=NC2=N)=CC=C1,11840988
7706,DB08667,4-(4-fluoro-phenylazo)-5-imino-5H-pyrazol-3-ylamine,small molecule,experimental,,FC1=CC=C(NN=C2C(=N)N=NC2=N)C=C1,11840989
7707,DB08668,3-(5-Amino-3-imino-3H-pyrazol-4-ylazo)-benzoic acid,small molecule,experimental,,OC(=O)C1=CC(NN=C2C(=N)N=NC2=N)=CC=C1,11840990
7708,DB08669,"METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-METHYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE",small molecule,experimental,,[H][C@@](C)(NC(=O)[C@@]([H])(O)[C@]([H])(N)C1=CC=C(C)C=C1)C(=O)N[C@]([H])(CC(C)C)C(=O)OC,6914647
7709,DB08670,"METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-ISOPROPYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE",small molecule,experimental,,[H][C@@](C)(NC(=O)[C@@]([H])(O)[C@]([H])(N)C1=CC=C(C=C1)C(C)C)C(=O)N[C@]([H])(CC(C)C)C(=O)OC,6914648
7710,DB08671,5-Imino-4-(2-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine,small molecule,experimental,,FC(F)(F)C1=CC=CC=C1NN=C1C(=N)N=NC1=N,11840992
7711,DB08672,4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE,small molecule,experimental,,[H][C@@](C)(CCC1=CC=C(C=C1)C(N)=O)NCC(=O)C1=CC=C(F)C=C1,15991577
7712,DB08673,"4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE",small molecule,experimental,,CC(C)C1=CN=C(NC2=CC=C(C=C2)S(N)(=O)=O)S1,5327097
7713,DB08674,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",small molecule,experimental,,[H][C@@]12CCN(C1=O)C1=C3C=C(OC4=C(C=CC(CN5C=NC=C5CN2)=C4)C#N)C=CC3=CC=C1,23646577
7714,DB08675,"(5Z)-7-{(1R,4S,5R,6R)-6-[(1E)-1-Octen-1-yl]-2,3-diazabicyclo[2.2.1]hept-2-en-5-yl}-5-heptenoic acid",small molecule,experimental,,[H]\C(CCCC(O)=O)=C(/[H])C[C@@]1([H])[C@]2([H])C[C@@]([H])(N=N2)[C@]1([H])C(\[H])=C(/[H])CCCCCC,94286438
7715,DB08676,"(20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE",small molecule,experimental,,[H][C@]12CCN(C1=O)C1=CC=CC3=C1C=C(OC1([H])CC(CN4C=NC=C4CCN2)=CC[C@]1([H])C#N)C=C3,131704313
7716,DB08677,N-(5-Isopropyl-thiazol-2-YL)-2-pyridin-3-YL-acetamide,small molecule,experimental,,[H]N(C(=O)CC1=CN=CC=C1)C1=NC=C(S1)C(C)C,5327096
7717,DB08678,(4-ETHYLPHENYL)SULFAMIC ACID,small molecule,experimental,,CCC1=CC=C(NS(O)(=O)=O)C=C1,9547998
7718,DB08680,N-{3-[(E)-(tert-butoxyimino)methyl]-4-chlorophenyl}-2-methylfuran-3-carbimidothioic acid,small molecule,experimental,,CC1=C(C=CO1)C(=S)NC1=CC(\C=N\OC(C)(C)C)=C(Cl)C=C1,9554696
7719,DB08681,1-METHYL ETHYL 2-CHLORO-5-[[[(1-METHYLETHOXY)THIOOXO]METHYL]AMINO]-BENZOATE,small molecule,experimental,,CC(C)OC(=S)NC1=CC(C(=O)OC(C)C)=C(Cl)C=C1,3000477
7720,DB08682,"1-METHYL ETHYL 1-CHLORO-5-[[(5,6DIHYDRO-2-METHYL-1,4-OXATHIIN-3-YL)CARBONYL]AMINO]BENZOATE",small molecule,experimental,,CC(C)OC(=O)C1=C(Cl)C=CC(NC(=O)C2=C(C)OCCS2)=C1,1385
7721,DB08683,"REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE",small molecule,experimental,,[H][C@]12CC[C@]([H])(O1)N1C3=C(C=CC=C3)C3=C4C(=O)NC(=O)C4=C4C5=C(C=CC=C5)N2C4=C13,447446
7722,DB08684,O-Decyl Hydrogen Thiocarbonate,small molecule,experimental,,CCCCCCCCCCOC(S)=O,14812933
7723,DB08685,"1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine",small molecule,experimental,,CN1CCN(C)C2=CC(CN)=CC=C12,7127816
7724,DB08686,"5,6,7,8,9,10-HEXAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOOCTA[B]PYRAN-2-ONE",small molecule,experimental,,[H][C@](CC)(C1=CC=CC=C1)C1=C(O)C2=C(CCCCCC2)OC1=O,54685311
7725,DB08687,FG-2216,small molecule,investigational,,OC(=O)CNC(=O)C1=C(O)C2=CC=CC=C2C(Cl)=N1,6914666
7726,DB08688,2-Undecanone,small molecule,experimental,,CCCCCCCCCC(C)=O,8163
7727,DB08689,Ubiquinone Q1,small molecule,experimental,Benzoquinones|Coenzymes|Enzymes and Coenzymes|Quinones,COC1=C(OC)C(=O)C(CC=C(C)C)=C(C)C1=O,4462
7728,DB08690,Ubiquinone Q2,small molecule,experimental,"Antidotes|Benzoquinones|Coenzymes|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Electron Transport Chain Complex Proteins|Enzymes and Coenzymes|Food|Food and Beverages|Growth Substances|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Lipid Regulating Agents|Micronutrients|Physiological Phenomena|Protective Agents|Quinones|Vitamins",COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O,5280346
7729,DB08691,"ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate",small molecule,experimental,,CCOC(=O)C1=C(\C(=C/N)C#N)C2=C(N1C)C(Cl)=C(Cl)C=C2,44237094
7730,DB08692,D-1-(4-chlorophenyl)-2-(acetamido)ethane boronic acid,small molecule,experimental,,[H]N(C(C)=O)[C@]([H])(CC1=CC=C(Cl)C=C1)[B-](O)(O)O,46937174
7731,DB08693,L-1-(4-chlorophenyl)-2-(acetamido)ethane boronic acid,small molecule,experimental,,[H]N([C@@H](CC1=CC=C(Cl)C=C1)[B-](O)(O)O)C(C)=O,449042
7732,DB08694,Variolin B,small molecule,experimental,Alkaloids,NC1=NC=CC(=N1)C1=C2C=CN=C(N)N2C2=NC=CC(O)=C12,9817550
7733,DB08695,3-(4-nitrophenyl)-1H-pyrazole,small molecule,experimental,,[O-][N+](=O)C1=CC=C(C=C1)C1=NNC=C1,2737071
7734,DB08697,"4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",small molecule,experimental,,CC1=CC(=CC(C)=C1OCCN)C(=O)NC1=CC(Cl)=CC(=C1)N1CCCCC1,23653532
7735,DB08698,"1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL",small molecule,experimental,,[H][C@@]1(N=C(C2=CC=CC=C2)C2=CC=CC=C2N=C1N1CC(O)C1)C1=CC=CS1,25113120
7736,DB08699,"1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",small molecule,experimental,,CC1=CC(CC2=NN(C3=C2C(N)=NC=N3)C(C)(C)C)=CC=C1,24865390
7737,DB08701,"2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE",small molecule,experimental,,OCCNC1=CC=C2C(=O)N(C(=O)C3=CC=CC1=C23)C1=CC(Br)=CC=C1,4177750
7738,DB08702,"2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID",small molecule,experimental,,OC(=O)C1=C(OC(=C1C(O)=O)C1=CC=CC=C1)C1=CC=CC=C1,220535
7739,DB08703,"12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one",small molecule,experimental,,CC(C)OC1=CC=C2C(CCC3=C2C2=C(C=NC2=O)C2=C3N(CCO)C3=CC=CC=C23)=C1,25203955
7740,DB08704,"[[(3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(pentanoylamino)oxan-2-ylidene]amino] N-phenylcarbamate",small molecule,experimental,,[H][C@]1(CO)O\C(=N/OC(=O)NC2=CC=CC=C2)[C@]([H])(NC(=O)CCCC)[C@@]([H])(O)[C@]1([H])O,11582002
7741,DB08705,"6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE",small molecule,experimental,,OC1=C(C=C(Br)C=C1)C1=CC(C2=CC=CC=C2)=C(C#N)C(=O)N1,1235170
7742,DB08706,"(2S)-({(5Z)-5-[(5-Ethyl-2-furyl)methylene]-4-oxo-4,5-dihydro-1,3-thiazol-2-yl}amino)(4-fluorophenyl)acetic acid",small molecule,experimental,,CCC1=CC=C(O1)\C=C1/SC(N[C@H](C(O)=O)C2=CC=C(F)C=C2)=NC1=O,16049839
7743,DB08707,"4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine",small molecule,experimental,,NC1=NC=CC(=N1)C1=CC2=C(ON=C2C=C1)C1=CC=C(Cl)C=C1,2765355
7744,DB08708,"N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine",small molecule,experimental,,FC(F)(F)C1=CC=CC(=C1)C1=NN=C2C=CC(NC3CCCCC3)=NN12,10361208
7745,DB08709,"2,3-diphenyl-1H-indole-7-carboxylic acid",small molecule,experimental,,OC(=O)C1=CC=CC2=C1NC(=C2C1=CC=CC=C1)C1=CC=CC=C1,5003498
7746,DB08710,"(5Z)-5-[(5-ethylfuran-2-yl)methylidene]-2-[[(S)-(4-fluorophenyl)-(2H-tetrazol-5-yl)methyl]amino]-1,3-thiazol-4-one",small molecule,experimental,,CCC1=CC=C(O1)\C=C1/SC(N[C@H](C2=NN=NN2)C2=CC=C(F)C=C2)=NC1=O,23586178
7747,DB08711,Methyl vanillate,small molecule,experimental,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Ethers|Hydroxy Acids|Hydroxybenzoate Ethers|Hydroxybenzoates|Phenols|Phenyl Ethers",COC(=O)C1=CC(OC)=C(O)C=C1,19844
7748,DB08712,11-[(MERCAPTOCARBONYL)OXY]UNDECANOIC ACID,small molecule,experimental,,OC(=O)CCCCCCCCCCOC(S)=O,24778468
7749,DB08713,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2N-METHYL-2H-TETRAZOL-5-YL]-PHENOL",small molecule,experimental,,CN1N=NC(=N1)C1=CC(C)=C(OCCCC2=CC(C)=NO2)C(C)=C1,1498
7750,DB08714,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[4-METHYL-2H-TETRAZOL-2-YL]-PHENOL",small molecule,experimental,,CC1=NOC(CCCOC2=C(C)C=C(C=C2C)N2N=NC(C)=N2)=C1,448137
7751,DB08715,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]-PHENOL",small molecule,experimental,,CC1=NC(=CO1)C1=CC(C)=C(OCCCC2=CC(C)=NO2)C(C)=C1,448138
7752,DB08717,"[(2S)-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-2-yl]acetic acid",small molecule,experimental,,[H][C@@]1(CC(O)=O)NC2=CC=CC=C2CN(C)C1=O,11117974
7753,DB08718,"4-(3-ethylthiophen-2-yl)benzene-1,2-diol",small molecule,experimental,,CCC1=C(SC=C1)C1=CC(O)=C(O)C=C1,24875311
7754,DB08719,"5-(5-(6-CHLORO-4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE",small molecule,experimental,,CC1=NOC(CCCCCOC2=CC=C(C=C2Cl)C2=NCCO2)=C1,1788
7755,DB08720,"5-(5-(4-(4,5-dihydro-2-oxazoly)phenoxy)pentyl)-3-methyl osoxazole",small molecule,experimental,,CC1=NOC(CCCCCOC2=CC=C(C=C2)C2=NCCO2)=C1,1786
7756,DB08721,"5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole",small molecule,experimental,,OCCOCOCC1=NOC(CCCCCOC2=C(Cl)C=C(C=C2Cl)C2=NCCO2)=C1,441047
7757,DB08722,5-(7-(6-chloro-4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole,small molecule,experimental,,[H][C@]1(C)COC(=N1)C1=CC=C(OCCCCCCCC2=CC(C)=NO2)C(Cl)=C1,5289564
7758,DB08723,WIN-54954,small molecule,experimental,,CC1=NOC(CCCCCOC2=C(Cl)C=C(C=C2Cl)C2=NCCO2)=C1,441048
7759,DB08724,5-(5-(4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)pentyl)-3-methyl isoxazole,small molecule,experimental,,[H][C@]1(C)COC(=N1)C1=CC=C(OCCCCCC2=CC(C)=NO2)C=C1,5289566
7760,DB08725,"(S)-5-(7-(4-(4-Ethyl-4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methylisoxazole",small molecule,experimental,,CC[C@H]1COC(=N1)C1=CC=C(OCCCCCCCC2=CC(C)=NO2)C=C1,3082640
7761,DB08726,"5-(7-(4-(4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole",small molecule,experimental,,CC1=NOC(CCCCCCCOC2=CC=C(C=C2)C2=NCCO2)=C1,55717
7762,DB08727,"3-Methyl-5-(7-{4-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]phenoxy}heptyl)-1,2-oxazole",small molecule,experimental,,C[C@@H]1COC(=N1)C1=CC=C(OCCCCCCCC2=CC(C)=NO2)C=C1,5272139
7763,DB08728,"5-(3-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)propyl)-3-methyl isoxazole",small molecule,experimental,,CC1=NOC(CCCOC2=C(Cl)C=C(C=C2Cl)C2=NCCO2)=C1,129539
7764,DB08729,"5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide",small molecule,experimental,,CCCC1=NN(C)C2=C1N=C(NC2=O)C1=C(OCC)SC(=C1)S(N)(=O)=O,24771758
7765,DB08730,3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE,small molecule,experimental,,FC1=CC(=CC(=C1)C(=O)NC1=CC=C2C=CN(CCC3=CC=NC=C3)C2=C1)N1CCOCC1,5326869
7766,DB08731,"2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",small molecule,experimental,,[H][C@](CC(O)=O)(CC1=CC=CC2=CC=CC=C12)N1C(=O)C2=CC=C(C=C2C1=O)C(O)=O,24764434
7767,DB08732,NALPHA-[(BENZYLOXY)CARBONYL]-N-[(1R)-4-HYDROXY-1-METHYL-2-OXOBUTYL]-L-PHENYLALANINAMIDE,small molecule,experimental,,[H][C@](C)(NC(=O)[C@]([H])(CC1=CC=CC=C1)NC(=O)OCC1=CC=CC=C1)C(=O)CCO,16220131
7768,DB08733,"(2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE",small molecule,experimental,,[H][C@@](CNC(=O)C1=NC=CS1)(C(=O)NO)[C@@]([H])(CC(C)C)C(=O)N[C@]([H])(C(=O)NC)C(C)(C)C,42609673
7769,DB08734,"6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE",small molecule,experimental,,CC1(C)N=C(N)N=C(N)N1OCCCOC1=CC(Cl)=C(Cl)C=C1Cl,121750
7770,DB08735,"R,S-Warfarin alcohol",small molecule,experimental,,[H][C@@](C)(O)C[C@]([H])(C1=CC=CC=C1)C1=C(O)C2=CC=CC=C2OC1=O,54736486
7771,DB08736,"S,R-Warfarin alcohol",small molecule,experimental,,[H][C@](C)(O)C[C@@]([H])(C1=CC=CC=C1)C1=C(O)C2=CC=CC=C2OC1=O,54723704
7772,DB08737,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL",small molecule,experimental,,[H][C@@]12CCC[C@]1([H])[C@@]([H])(OC1=CC=CC(O)=C21)C1=CC=C(O)C=C1,16750074
7773,DB08738,1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one,small molecule,experimental,,[H][C@]1(CCCN1C(=O)CCN1C(=O)C(=NC2=CC=CC=C12)C1=CC=CC=C1)C(=O)N1CCCC1,25155578
7774,DB08739,"2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione",small molecule,experimental,,[H][C@]1(CC(F)(F)CN1C(=O)CCN1C(=O)C2=C(C=CC=C2)C1=O)C(=O)N1CCCC1,25102845
7775,DB08740,"CYCLOHEXYLMETHYL-2,3-DIHYDROXY-5-METHYL-HEXYLAMIDE",small molecule,experimental,,[H][C@](N)(CC1CCCCC1)[C@@]([H])(O)[C@@]([H])(O)CC(C)C,5288373
7776,DB08741,"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine",small molecule,experimental,,[H][C@@]1(OC2=C(OC)C(OC)=CC(CC3=C(N)N=C(N)N=C3)=C2C=C1)C1CC1,10247560
7777,DB08742,"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",small molecule,experimental,,C=C1\C(=C/C=C2\CCC[C@]3(C)[C@]([H])(CC[C@@]23[H])C#CC#CC(C)(O)C)C[C@](O)([H])C[C@@]1(O)[H],11269429
7778,DB08743,"2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE",small molecule,experimental,,[H][C@@]1(N)CCCN(C1)C1=NC2=C(N1CC1=CC=CC=C1C#N)C(=O)N(C)C(=O)N2C,6914643
7779,DB08744,Casimiroin,small molecule,experimental,"Aromatase|Dioxoles|Heterocyclic Compounds, Fused-Ring|Quinolines|Quinone Reductases, antagonists & inhibitors",COC1=CC(=O)N(C)C2=C3OCOC3=CC=C12,124075
7780,DB08745,4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE,small molecule,experimental,,ClC1=CC=C(\C=C\S(=O)(=O)N2CCN(CC3CCN(CC3)C3=CC=NC=C3)C(=O)C2)C=C1,446345
7781,DB08746,1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE,small molecule,experimental,,ClC1=CC=C(\C=C\S(=O)(=O)N2CCN(CC3CCN(CC3)C3=CC=NC=C3)CC2)C=C1,446346
7782,DB08747,"(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one",small molecule,experimental,,[H][C@]1(N(C(C)=O)C2=CC=CC(O)=C2NC2=C1C(=O)CC(C)(C)C2)C1=C(Cl)C=C(Cl)C=C1,44574544
7783,DB08748,4-(Dimethylamino)benzoic acid,small molecule,experimental,"Acids, Carbocyclic|Aminobenzoates|Benzene Derivatives|Benzoates",CN(C)C1=CC=C(C=C1)C(O)=O,12092
7784,DB08749,3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE,small molecule,experimental,,CN(C1CCCCC1)C(=O)CCN1CC2=CC(=CC=C2N=C1N)C(=O)C1=CC=CC=C1,16741238
7785,DB08750,"1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE",small molecule,experimental,,NCC1=CC=C(C=C1)C(=O)N1CCC2(CC1)NC1=CC=CC(F)=C1C(N)=N2,24894149
7786,DB08751,"N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE",small molecule,experimental,,CN(CCN(C)C1=CC=C(C2=NON=C12)[N+]([O-])=O)C(C)=O,6857727
7787,DB08752,N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,small molecule,experimental,,[H][C@@](CC1CCCCC1)(NC(=O)N1CCOCC1)C(=O)NC1(CCN(C)CC1)C#N,9887557
7788,DB08753,"4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE",small molecule,experimental,,CC(=O)OC1=CC=C(\C=C\C(=O)NCCC2=CC=CC=C2)C=C1OC(C)=O,11957394
7789,DB08754,N-Caffeoyltyramine,small molecule,experimental,"Acids, Carbocyclic|Amines|Biogenic Amines|Biogenic Monoamines|Cinnamates",OC1=CC=C(CCNC(=O)\C=C\C2=CC(O)=C(O)C=C2)C=C1,9994897
7790,DB08755,N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,small molecule,experimental,,[H][C@@](CC1CCCCC1)(NC(=O)N1CCOCC1)C(=O)N[C@@](C)(COCC1=CC=CC=C1)C#N,46937176
7791,DB08756,Y-27632,small molecule,experimental,"Antihypertensive Agents|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Enzyme Inhibitors|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Neuromuscular Agents|Peripheral Nervous System Agents",[H][C@@]1(CC[C@@H](CC1)C(=O)NC1=CC=NC=C1)[C@@H](C)N,448042
7792,DB08757,5-(2-chlorophenyl)furan-2-carbohydrazide,small molecule,experimental,,NNC(=O)C1=CC=C(O1)C1=CC=CC=C1Cl,4697633
7793,DB08758,"IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE",small molecule,experimental,,NNC(=O)C1=CN2C=CC3=C(C=CC=C3)C2=N1,869249
7794,DB08759,"[(3R,4S,5S,7R)-4,8-DIHYDROXY-3,5,7-TRIMETHYL-2-OXOOCTYL]PHOSPHONIC ACID",small molecule,experimental,,[H][C@](C)(CO)C[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C[P@@]([H])(O)=O,46937177
7795,DB08760,(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid,small molecule,experimental,,[H][C@@](CC1=CC=CC=C1)(OC1=CC=C(Cl)C=C1)C(O)=O,11460087
7796,DB08761,"(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione",small molecule,experimental,,[H][C@@]1(CC2=CC=C(O)C=C2)NC(=O)[C@]([H])(CC2=CC=C(O)C=C2)NC1=O,11267350
7797,DB08762,O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)-L-BENZYLACETIC ACID,small molecule,experimental,,[H][C@@](C)(NC(=O)OCC1=CC=CC=C1)C(=O)N[C@@]([H])(C)[P@](O)(=O)O[C@@]([H])(CC1=CC=CC=C1)C(O)=O,5492457
7798,DB08763,[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE,small molecule,experimental,,[H][C@](NC(=O)OCC1=CC=CC=C1)(C1=CC=C(C=C1)C(N)=N)P(O)(O)=O,447110
7799,DB08765,"6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE",small molecule,experimental,,NS(=O)(=O)C1=NC2=C(S1)C=C(O)C=C2,6852129
7800,DB08766,Zofenoprilat,small molecule,experimental,"Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Imines|Imino Acids",C[C@H](CS)C(=O)N1C[C@H](C[C@H]1C(O)=O)SC1=CC=CC=C1,3034048
7801,DB08767,2-(4-METHOXYPHENYL)ACETAMIDE,small molecule,experimental,,COC1=CC=C(CC(N)=O)C=C1,241868
7802,DB08768,N(6)-dimethylallyladenine,small molecule,experimental,"Carbohydrates|Cytokinins|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides|Vitamin B Complex|Vitamins",CC(C)=CCNC1=NC=NC2=C1N=CN2,92180
7803,DB08770,"4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",small molecule,experimental,,NC1=NC(NCCC2=CC=C(O)C=C2)=NC2=NC(=NN12)C1=CC=CO1,176407
7804,DB08771,"(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one",small molecule,experimental,,CC(C)[C@H]1SC(NC2=C(F)C=CC=C2)=NC1=O,23644575
7805,DB08772,Zopolrestat,small molecule,experimental,"Aldehyde Reductase, antagonists & inhibitors|Aldose Reductase Inhibitors|Blood Glucose Lowering Agents|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Pyridazines|Sulfur Compounds|Thiazoles",OC(=O)CC1=NN(CC2=NC3=C(S2)C=CC(=C3)C(F)(F)F)C(=O)C2=C1C=CC=C2,1613
7806,DB08773,2-(4-hydroxyphenyl)benzo[b]thiophen-6-ol,small molecule,experimental,,OC1=CC=C(C=C1)C1=CC2=C(S1)C=C(O)C=C2,445920
7807,DB08774,"1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine",small molecule,experimental,,[H][C@]1(CN)CN(CCO1)C1=C(C=NC2=C1C=NN2)C1=CC=CC=C1,44129608
7808,DB08775,Benzoyl-tyrosine-alanine-fluoro-methyl ketone,small molecule,experimental,,C[C@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)OCC1=CC=CC=C1)C(=O)CF,15118984
7809,DB08776,"N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-[1,3]THIAZOLO[5,4-C]AZEPIN-2-YL)ACETAMIDE",small molecule,experimental,,CC(=O)NC1=NC2=C(S1)C(=O)NCCC2,739358
7810,DB08777,"5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE",small molecule,experimental,,O=C1NC=NC2=C1C1=C(CCCC1)S2,98614
7811,DB08778,"[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone",small molecule,experimental,,CC(C)(C)NC1=NC(N)=C(S1)C(=O)C1=CC=CC=C1,1484819
7812,DB08779,2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol,small molecule,experimental,,CSC1=NC(O)=C(CC2=CC=CS2)N1,46937179
7813,DB08780,6-MORPHOLIN-4-YL-9H-PURINE,small molecule,experimental,,C1CN(CCO1)C1=C2N=CNC2=NC=N1,76098
7814,DB08781,"1-[(2S)-4-(5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL]METHANAMINE",small molecule,experimental,,[H][C@]1(CN)CN(CCO1)C1=C(Br)C=NC2=C1C=NN2,44141939
7815,DB08782,4-(2-AMINOETHYL)BENZENESULFONAMIDE,small molecule,experimental,Amides|Sulfones|Sulfur Compounds,NCCC1=CC=C(C=C1)S(N)(=O)=O,169682
7816,DB08783,(4-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-methoxy-3-oxopropyl}phenyl)methaneseleninic acid,small molecule,experimental,Selenium Compounds,[H][C@@](CC1=CC=C(C[Se](O)=O)C=C1)(NC(=O)OC(C)(C)C)C(=O)OC,25111933
7817,DB08784,2-(4-CHLORO-PHENYLAMINO)-NICOTINIC ACID,small molecule,experimental,,OC(=O)C1=C(NC2=CC=C(Cl)C=C2)N=CC=C1,1432578
7818,DB08785,4-Methylcoumarin,small molecule,experimental,,CC1=CC(=O)OC2=CC=CC=C12,11833
7819,DB08786,4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine,small molecule,experimental,,COCCOC1=NC(N)=NC(C)=C1,3777900
7820,DB08787,"4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine",small molecule,experimental,,NC1=NC(=C(C=N1)\N=N\C1=CC=CC=C1)C1=C(Cl)C=C(Cl)C=C1,3695754
7821,DB08788,"3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE",small molecule,experimental,,CCOC1=CC=C(C=C1)C1=C(C#N)C(N)=NC2=C1C(N)=C(S2)C(N)=O,1916699
7822,DB08789,"2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE",small molecule,experimental,,CCNC(=O)C1=CC2=C(N=C(N)N=C2S1)C1=C(Cl)C=C(Cl)C=C1,44129601
7823,DB08790,1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID,small molecule,experimental,,OC(=O)C1=CN(N=C1)C1=CC=CC=C1,121026
7824,DB08791,"1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE",small molecule,experimental,,NC(=O)C1=CN=C2C=CN(C2=C1)S(=O)(=O)C1=CC=CC=C1[N+]([O-])=O,25229537
7825,DB08792,Diloxanide,small molecule,experimental,"Amebicides|Anti-Infective Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Dichloroacetamide Derivatives",CN(C(=O)C(Cl)Cl)C1=CC=C(O)C=C1,11367
7826,DB08794,Ethyl biscoumacetate,small molecule,withdrawn,"4-Hydroxycoumarins|Anticoagulants|Benzopyrans|Blood and Blood Forming Organs|Coumarins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|Pyrans|Vitamin K Antagonists",CCOC(=O)C(C1=C(O)C2=CC=CC=C2OC1=O)C1=C(O)C2=CC=CC=C2OC1=O,54685524
7827,DB08795,Azidocillin,small molecule,experimental,"Amides|Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|Beta-Lactamase Sensitive Penicillins|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Penicillins|Sulfur Compounds",[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N=[N+]=[N-])C1=CC=CC=C1)C(O)=O,15574941
7828,DB08796,Pipazethate,small molecule,experimental,"Amides|Antitussive Agents|Central Nervous System Agents|Cough and Cold Preparations|Heterocyclic Compounds, Fused-Ring|Respiratory System Agents|Sulfones|Sulfur Compounds",O=C(OCCOCCN1CCCCC1)N1C2=CC=CC=C2SC2=C1N=CC=C2,22425
7829,DB08797,Salicylamide,small molecule,approved,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Amides|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antirheumatic Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Cyclooxygenase Inhibitors|Ligands|Nephrotoxic agents|Nervous System|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Salicylic Acid and Derivatives|Sensory System Agents",NC(=O)C1=CC=CC=C1O,5147
7830,DB08798,Sulfamoxole,small molecule,experimental,Amides|Amines|Aniline Compounds|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Intermediate-Acting Sulfonamides|Sulfanilamides|Sulfonamides|SULFONAMIDES AND TRIMETHOPRIM|Sulfones|Sulfur Compounds,CC1=C(C)N=C(NS(=O)(=O)C2=CC=C(N)C=C2)O1,12894
7831,DB08799,Antazoline,small molecule,approved,"Anti-Allergic Agents|Antiallergic Agents, Excl. Corticosteroids|Antihistamines for Systemic Use|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Imidazoles|Moderate Risk QTc-Prolonging Agents|Nasal Preparations|Neurotransmitter Agents|QTc Prolonging Agents",C(N(CC1=CC=CC=C1)C1=CC=CC=C1)C1=NCCN1,2200
7832,DB08800,Chloropyramine,small molecule,experimental,"Amines|Antihistamines for Systemic Use|Antihistamines for Topical Use|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Dermatologicals|Diamines|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Polyamines|Substituted Ethylene Diamines",CN(C)CCN(CC1=CC=C(Cl)C=C1)C1=CC=CC=N1,25295
7833,DB08801,Dimetindene,small molecule,approved|investigational,"Agents producing tachycardia|Anti-Allergic Agents|Anticholinergic Agents|Antihistamines for Systemic Use|Antihistamines for Topical Use|Antipruritics|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Dermatologicals|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Indenes|Muscarinic Antagonists|Neurotransmitter Agents|Pyridines|Substituted Alkylamines",CC(C1=C(CCN(C)C)CC2=CC=CC=C12)C1=CC=CC=N1,21855
7834,DB08802,Isothipendyl,small molecule,experimental,"Antihistamines for Systemic Use|Antihistamines for Topical Use|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Dermatologicals|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Phenothiazine Derivatives|Sulfur Compounds",CC(CN1C2=CC=CC=C2SC2=C1N=CC=C2)N(C)C,3781
7835,DB08803,Tymazoline,small molecule,experimental,"Nasal Preparations|Sympathomimetics, Plain",CC(C)C1=C(OCC2=NCCN2)C=C(C)C=C1,34154
7836,DB08804,Nandrolone decanoate,small molecule,approved|illicit,"Anabolic Agents|Androgens|Bone Density Conservation Agents|Estranes|Estrenes|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Nandrolone and esters|Steroids|Testosterone Congeners|Thyroxine-binding globulin inhibitors",[H][C@@]12CC[C@H](OC(=O)CCCCCCCCC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],9677
7837,DB08805,Metiamide,small molecule,experimental,Acid Reducers|Anti-Ulcer Agents|Gastric Acid Lowering Agents|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Histamine H2 Antagonists|Neurotransmitter Agents|Sulfur Compounds|Thiourea,CNC(=S)NCCSCC1=C(C)NC=N1,1548992
7838,DB08806,Roxatidine acetate,small molecule,experimental,Acid Reducers|Alimentary Tract and Metabolism|Anti-Ulcer Agents|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Gastric Acid Lowering Agents|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Histamine H2 Antagonists|Neurotransmitter Agents,CC(=O)OCC(=O)NCCCOC1=CC=CC(CN2CCCCC2)=C1,5105
7839,DB08807,Bopindolol,small molecule,experimental,"Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Beta Blocking Agents, Non-Selective|Bradycardia-Causing Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Neurotransmitter Agents|Phenoxypropanolamines|Propanolamines|Propanols",CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C1=CC=CC=C1,44112
7840,DB08808,Bupranolol,small molecule,experimental,"Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Beta Blocking Agents, Non-Selective|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Neurotransmitter Agents|Phenoxypropanolamines|Potential QTc-Prolonging Agents|Propanolamines|Propanols|QTc Prolonging Agents",CC1=CC(OCC(O)CNC(C)(C)C)=C(Cl)C=C1,2475
7841,DB08809,Dichloroacetic acid,small molecule,approved|investigational,"Acetates|Acids, Acyclic|Chloroacetates|Fatty Acids|Fatty Acids, Volatile|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Lipids",OC(=O)C(Cl)Cl,6597
7842,DB08810,Cinitapride,small molecule,investigational,"Acids, Carbocyclic|Agents that produce hypertension|Alimentary Tract and Metabolism|Amides|Anti-Ulcer Agents|Antidepressive Agents|Benzene Derivatives|Benzoates|Central Nervous System Depressants|Drugs for Functional Gastrointestinal Disorders|Gastrointestinal Agents|Propulsives|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Agonists|Serotonin Receptor Antagonists",CCOC1=CC(N)=C(C=C1C(=O)NC1CCN(CC2CCC=CC2)CC1)[N+]([O-])=O,68867
7843,DB08811,Tofisopam,small molecule,experimental,"Anti-Anxiety Agents|Antidepressive Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Nervous System|Psycholeptics|Psychotropic Drugs|Stereoisomerism",CCC1C2=CC(OC)=C(OC)C=C2C(=NN=C1C)C1=CC(OC)=C(OC)C=C1,5502
7844,DB08813,Nadroparin,small molecule,approved|investigational,Agents causing hyperkalemia|Anticoagulants|Blood and Blood Forming Organs|Carbohydrates|Cardiovascular Agents|Fibrin Modulating Agents|Glycosaminoglycans|Hematologic Agents|Heparin (Low Molecular Weight)|Heparin and similars|Polysaccharides,,
7845,DB08814,Triflusal,small molecule,approved|investigational,"Acids, Carbocyclic|Anticoagulants|Antiplatelet agents|Benzene Derivatives|Benzoates|Blood and Blood Forming Organs|Hematologic Agents|Hydroxy Acids|Hydroxybenzoates|Phenols|Platelet Aggregation Inhibitors Excl. Heparin",CC(=O)OC1=C(C=CC(=C1)C(F)(F)F)C(O)=O,9458
7846,DB08815,Lurasidone,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic alpha-2 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antidepressive Agents|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Heterocyclic Compounds, Fused-Ring|Hyperglycemia-Associated Agents|Indole Derivatives|Isoindoles|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Potential QTc-Prolonging Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Thiazoles|Tranquilizing Agents",[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,213046
7847,DB08816,Ticagrelor,small molecule,approved,"Anticoagulants|Antiplatelet agents|Blood and Blood Forming Organs|Carbohydrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Decreased Platelet Aggregation|Glycosides|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|P-glycoprotein inhibitors|P-glycoprotein substrates|P2Y12 Platelet Inhibitor|Phenylalanine Hydroxylase Activators|Platelet Aggregation Inhibitors Excl. Heparin|Purine Nucleosides|Purinergic Agents|Purinergic Antagonists|Purinergic P2 Receptor Antagonists|Purinergic P2Y Receptor Antagonists|Purines|Ribonucleosides",CCCSC1=NC2=C(N=NN2[C@@H]2C[C@H](OCCO)[C@@H](O)[C@H]2O)C(N[C@@H]2C[C@H]2C2=CC(F)=C(F)C=C2)=N1,9871419
7848,DB08818,Hyaluronic acid,small molecule,approved|vet_approved,"Adjuvants, Immunologic|Carbohydrates|Cicatrizants|Compounds used in a research, industrial, or household setting|Dermatologicals|Glycosaminoglycans|Immunologic Factors|Lubricants|Musculo-Skeletal System|Nasal Preparations|Ophthalmologicals|Polysaccharides|Preparations for Treatment of Wounds and Ulcers|Protective Agents|Sensory Organs|Surgical Aids|Viscoelastic Substances|Viscosupplements",CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O,24759
7849,DB08819,Tafluprost,small molecule,approved,"Antiglaucoma Preparations and Miotics|Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Increased Prostaglandin Activity|Inflammation Mediators|Lipids|Ophthalmics|Ophthalmologicals|Prostaglandin analogs reducing intraocular pressure (IOP)|Prostaglandin Receptor Agonists|Prostaglandins|Prostaglandins, Synthetic|Sensory Organs",CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1,9868491
7850,DB08820,Ivacaftor,small molecule,approved,"Amines|Aniline Compounds|Benzene Derivatives|Chloride Channel Activation Potentiators|Chloride Channel Agonists|Cystic Fibrosis Transmembrane Conductance Regulator Potentiators|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Membrane Transport Modulators|P-glycoprotein inhibitors|Phenols|Quinolines",CC(C)(C)C1=CC(=C(O)C=C1NC(=O)C1=CNC2=CC=CC=C2C1=O)C(C)(C)C,16220172
7851,DB08822,Azilsartan medoxomil,small molecule,approved|investigational,"Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Angiotensin 2 Receptor Blocker|Angiotensin II receptor blockers (ARBs) and diuretics|Angiotensin II receptor blockers (ARBs), plain|Angiotensin II Type 1 Receptor Blockers|Angiotensin Receptor Antagonists|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Decreased Blood Pressure|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Oxazoles",CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NOC(=O)N1)C(=CC=C2)C(=O)OCC1=C(C)OC(=O)O1,11238823
7852,DB08823,Spinosad,small molecule,approved|investigational|vet_approved,"Agrochemicals|Compounds used in a research, industrial, or household setting|Insecticides|Lactones|Pediculicides|Pesticides|Pharmaceutical Preparations|Polyketides|Toxic Actions",[H][C@]1(C[C@@]2([H])C=C[C@@]3([H])[C@]4([H])CC(=O)O[C@@]([H])(CC)CCC[C@]([H])(O[C@@]5([H])CC[C@]([H])(N(C)C)[C@@]([H])(C)O5)[C@@]([H])(C)C(=O)C4=C[C@@]3([H])[C@]2([H])C1)O[C@]1([H])O[C@@]([H])(C)[C@]([H])(OC)[C@@]([H])(OC)[C@@]1([H])OC.[H][C@]1(C[C@@]2([H])C(C)=C[C@@]3([H])[C@]4([H])CC(=O)O[C@@]([H])(CC)CCC[C@]([H])(O[C@@]5([H])CC[C@]([H])(N(C)C)[C@@]([H])(C)O5)[C@@]([H])(C)C(=O)C4=C[C@@]3([H])[C@]2([H])C1)O[C@]1([H])O[C@@]([H])(C)[C@]([H])(OC)[C@@]([H])(OC)[C@@]1([H])OC,17754356
7853,DB08824,Ioflupane I-123,small molecule,approved,Alkaloids|Aza Compounds|Azabicyclo Compounds|Carbon Radioisotopes|Central Nervous System|Diagnostic Radiopharmaceuticals|Diagnostic Uses of Chemicals|Drugs that are Mainly Renally Excreted|Fluorine Radioisotopes|Iodine (123I) Compounds|Iodine Radioisotopes|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Tropanes,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)C1=CC=C([123I])C=C1)C(=O)OC)N2CCCF,3086674
7854,DB08826,Deferiprone,small molecule,approved,"Chelating Agents|Compounds used in a research, industrial, or household setting|Drugs that are Mainly Renally Excreted|Heavy Metal Antagonists|Iron Chelating Activity|Iron Chelating Agents|Pyridines|Pyridones|Sequestering Agents|UGT1A6 substrate",CN1C=CC(=O)C(O)=C1C,2972
7855,DB08827,Lomitapide,small molecule,approved|investigational,"Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Hepatotoxic Agents|Heterocyclic Compounds, Fused-Ring|Hypolipidemic Agents|Hypolipidemic Agents Indicated for Hyperlipidemia|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Microsomal Triglyceride Transfer Protein Inhibitor|Microsomal Triglyceride Transfer Protein Inhibitors|Miscellaneous Antilipemic Agents|P-glycoprotein inhibitors",FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)C2=C(C=CC=C2)C2=CC=C(C=C2)C(F)(F)F)C2=CC=CC=C2C2=CC=CC=C12,9853053
7856,DB08828,Vismodegib,small molecule,approved|investigational,Amides|Amines|Aniline Compounds|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Hedgehog Pathway Inhibitor|P-glycoprotein substrates|Smoothened Receptor Antagonists,CS(=O)(=O)C1=CC(Cl)=C(C=C1)C(=O)NC1=CC=C(Cl)C(=C1)C1=CC=CC=N1,24776445
7857,DB08830,Dehydroascorbic acid,small molecule,experimental,"Acids, Acyclic|Carbohydrates|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Hydroxy Acids|Lactones|Micronutrients|Physiological Phenomena|Sugar Acids|Urinary Acidifying Agents|Vitamin C and analogues|Vitamins",[H][C@](O)(CO)[C@@]1([H])OC(=O)C(=O)C1=O,440667
7858,DB08831,2-deoxyglucose,small molecule,experimental|investigational,Antimetabolites,[H]C([H])(C=O)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)CO,108223
7859,DB08833,Taurochenodeoxycholic acid,small molecule,experimental,"Acids|Acids, Noncarboxylic|Alkanes|Alkanesulfonic Acids|Bile Acids and Salts|Cholagogues and Choleretics|Cholanes|Cholic Acids|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Detergents|Fused-Ring Compounds|Gastrointestinal Agents|Household Products|Hydrocarbons, Acyclic|Steroids|Sulfonic Acids|Sulfur Acids|Sulfur Compounds|Surface-Active Agents|Taurodeoxycholic Acid",[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(=O)NCCS(O)(=O)=O,
7860,DB08834,Tauroursodeoxycholic acid,small molecule,experimental|investigational,"Acids|Acids, Noncarboxylic|Alkanes|Alkanesulfonic Acids|Anti-Infective Agents|Bile Acids and Salts|Cholagogues and Choleretics|Cholanes|Cholic Acids|Fused-Ring Compounds|Gastrointestinal Agents|Hydrocarbons, Acyclic|Isomerism|Steroids|Sulfonic Acids|Sulfur Acids|Sulfur Compounds|Taurodeoxycholic Acid",[H][C@@]12CC[C@H]([C@H](C)CCC(=O)NCCS(O)(=O)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](O)C[C@]2([H])C[C@H](O)CC[C@]12C,9848818
7861,DB08835,Spaglumic Acid,small molecule,experimental,"Antiallergic Agents, Excl. Corticosteroids|Decongestants and Antiallergics|Mast Cell Stabilizers|Nasal Preparations|Ophthalmologicals|Sensory Organs",CC(=O)N[C@@H](CC(=O)N[C@@H](CCC(O)=O)C(O)=O)C(O)=O,210320
7862,DB08836,Temocapril,small molecule,experimental|investigational,Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Azepines|Cardiovascular Agents|Enzyme Inhibitors|OATP1B1/SLCO1B1 Substrates|Protease Inhibitors|Sulfur Compounds|Thiepins,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]1CS[C@@H](CN(CC(O)=O)C1=O)C1=CC=CS1,443874
7863,DB08837,Tetraethylammonium,small molecule,experimental|investigational,Amines|Ammonium Compounds|Cardiovascular Agents|Ganglion Blockers|MATE 1 Substrates|MATE 2 Substrates|MATE substrates|Membrane Transport Modulators|Nitrogen Compounds|OCT2 Substrates|Onium Compounds|Potassium Channel Blockers|Quaternary Ammonium Compounds|Tetraethylammonium Compounds,CC[N+](CC)(CC)CC,5413
7864,DB08838,Agmatine,small molecule,experimental,Agents causing hyperkalemia|Amidines|Antiarrhythmic agents|Anticholinergic Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Guanidines|Nicotinic Antagonists|NMDA Receptor Antagonists|OCT1 substrates|OCT2 Substrates|Vasodilating Agents,NCCCCNC(N)=N,199
7865,DB08839,Serotonin,small molecule,investigational|nutraceutical,"Amines|Antidepressive Agents|Autacoids|Biogenic Amines|Biogenic Monoamines|Biological Factors|Bodily Secretions|Central Nervous System Depressants|Complex Mixtures|Endopeptidases|Enzymes|Enzymes and Coenzymes|Fluids and Secretions|Heterocyclic Compounds, Fused-Ring|Hydrolases|Indoles|Inflammation Mediators|Neurotransmitter Agents|Peptide Hydrolases|Serine Proteases|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Agonists|Snake Venoms|Toxins, Biological|Tryptamines|Venoms|Viper Venoms",NCCC1=CNC2=CC=C(O)C=C12,
7866,DB08840,N-methylnicotinamide,small molecule,experimental,Alimentary Tract and Metabolism|Bile and Liver Therapy|Bile Therapy|Drugs that are Mainly Renally Excreted|MATE 1 Substrates|MATE 2 Substrates|MATE substrates|Nicotinic Acids|Preparations for Biliary Tract Therapy|Pyridines,CNC(=O)C1=CC=CN=C1,
7867,DB08841,Tyramine,small molecule,investigational|nutraceutical,Adrenergic Agents|Agents producing tachycardia|Agents that produce hypertension|Amines|Autonomic Agents|Biogenic Amines|Biogenic Monoamines|Membrane Transport Modulators|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Peripheral Nervous System Agents|Sympathomimetics,NCCC1=CC=C(O)C=C1,5610
7868,DB08842,Acetylcarnitine,small molecule,approved|investigational,"Amines|Ammonium Compounds|Central Nervous System Agents|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Micronutrients|Nervous System|Nitrogen Compounds|Nootropic Agents|Onium Compounds|Physiological Phenomena|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Quaternary Ammonium Compounds|Trimethyl Ammonium Compounds",CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C,7045767
7869,DB08843,GS 0573,small molecule,investigational,"Anti-Infective Agents|Heterocyclic Compounds, Fused-Ring|Immunologic Factors|Purines",NC1=NC(N)=C2N=CN(CCOCP(O)(O)=O)C2=N1,
7870,DB08844,Uric acid,small molecule,investigational,"Alkaloids|Antioxidants|Compounds used in a research, industrial, or household setting|Heterocyclic Compounds, Fused-Ring|Protective Agents|Purines|Purinones|Xanthine derivatives",O=C1NC2=C(N1)C(=O)NC(=O)N2,1175
7871,DB08845,Oxogluric acid,small molecule,experimental|investigational|nutraceutical,"Acids, Acyclic|Dicarboxylic Acids|Glutarates|Keto Acids|Ketoglutaric Acids",OC(=O)CCC(=O)C(O)=O,
7872,DB08846,Ellagic acid,small molecule,investigational,"Benzopyrans|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|OAT1/SLC22A6 inhibitors|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Substrates|Pyrans",OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2,5281855
7873,DB08847,Hydroxyproline,small molecule,experimental,"Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Imines|Imino Acids",O[C@H]1CN[C@@H](C1)C(O)=O,5810
7874,DB08848,Guvacine,small molecule,experimental,Pyridines,OC(=O)C1=CCCNC1,3532
7875,DB08849,Nipecotic acid,small molecule,experimental,Piperidines,,
7876,DB08855,Leukotriene C4,small molecule,experimental|investigational,"Arachidonic Acids|Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Essential|Fatty Acids, Unsaturated|Inflammation Mediators|Leukotrienes|Lipids|SRS-A",CCCCC\C=C/C\C=C/C=C/C=C/[C@@H](SC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O)[C@@H](O)CCCC(O)=O,
7877,DB08856,DADLE,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Enkephalin, Leucine|Enkephalins|Nerve Tissue Proteins|Neuropeptides|Opioid Peptides|Peptides|Proteins",CC(C)C[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1)C(O)=O,
7878,DB08857,Bamet-UD2,small molecule,experimental,Bile Acids and Salts|Cholanes|Cholic Acids|Fused-Ring Compounds|Organometallic Compounds|Steroids,,
7879,DB08858,cis-Diamminechlorocholylglycinateplatinum(II),small molecule,experimental,Bile Acids and Salts|Cholanes|Fused-Ring Compounds|Organometallic Compounds|Steroids,N.N.Cl.[Pt++].CC(CCC([O-])=NCC([O-])=O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C,
7880,DB08860,Pitavastatin,small molecule,approved,"Agents Causing Muscle Toxicity|Anticholesteremic Agents|BCRP/ABCG2 Substrates|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Hypolipidemic Agents|Hypolipidemic Agents Indicated for Hyperlipidemia|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein substrates|Toxic Actions|UGT1A3 substrates|UGT2B7 substrates",O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O,5282452
7881,DB08861,DPDPE,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Enkephalins|Narcotics|Nerve Tissue Proteins|Neuropeptides|Neurotransmitter Agents|Opioid Peptides|Opioids|Peptides|Peripheral Nervous System Agents|Proteins|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",CC1(C)SSC(C)(C)[C@@H](NC(=O)[C@@H](N)CC2=CC=C(O)C=C2)C(=O)NCC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@H]1C(O)=O,
7882,DB08862,Cholecystokinin,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Cholagogues and Choleretics|Cholecystokinin, agonists|Cholecystokinin, antagonists & inhibitors|Diagnostic Agents|Gastrointestinal Agents|Gastrointestinal Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|Peptides|Tests for Pancreatic Function",,
7883,DB08864,Rilpivirine,small molecule,approved,Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Direct Acting Antivirals|Enzyme Inhibitors|Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor|Nitriles|Non-Nucleoside Reverse Transcriptase Inhibitors|Nonnucleoside Reverse Transcriptase Inhibitors|Nucleic Acid Synthesis Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein inhibitors|Potential QTc-Prolonging Agents|Pyrimidines|QTc Prolonging Agents|Reverse Transcriptase Inhibitors,CC1=CC(\C=C\C#N)=CC(C)=C1NC1=CC=NC(NC2=CC=C(C=C2)C#N)=N1,6451164
7884,DB08865,Crizotinib,small molecule,approved,Amines|Aminopyridines|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Bradycardia-Causing Agents|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Kinase Inhibitor|Moderate Risk QTc-Prolonging Agents|OCT2 Inhibitors|Organic Cation Transporter 1 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Piperidines|Protein Kinase Inhibitors|Pyridines|QTc Prolonging Agents|Receptor Tyrosine Kinase Inhibitors|Tyrosine Kinase Inhibitors,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,11626560
7885,DB08867,Ulipristal,small molecule,approved,"Adrenal Cortex Hormones|Contraceptive Agents, Female|Contraceptives, Postcoital|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Norpregnanes|Norsteroids|Progesterone Agonist/Antagonist|Progesterone Receptor Modulators|Reproductive Control Agents|Selective Progesterone Receptor Modulators|Sex Hormones and Modulators of the Genital System|Steroids",CN(C)C1=CC=C(C=C1)[C@H]1C[C@@]2(C)[C@@H](CC[C@]2(O)C(C)=O)[C@@H]2CCC3=CC(=O)CCC3=C12,13559281
7886,DB08868,Fingolimod,small molecule,approved|investigational,Alcohols|Amines|Amino Alcohols|Antineoplastic and Immunomodulating Agents|Bradycardia-Causing Agents|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 Substrates|Experimental Unapproved Treatments for COVID-19|Glycols|Immunologic Factors|Immunomodulatory Agents|Immunosuppressive Agents|P-glycoprotein inducers|P-glycoprotein inhibitors|Propylene Glycols|QTc Prolonging Agents|Selective Immunosuppressants|Sphingosine 1-phosphate Receptor Modulator,CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1,107970
7887,DB08869,Tesamorelin,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Anterior Pituitary Lobe Hormones and Analogues|Growth Hormone Releasing Factor Analog|Growth Hormone-Releasing Hormone|Growth Substances|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Increased GHRH Activity|Lipodystrophy|Nerve Tissue Proteins|Neuropeptides|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormone-Releasing Hormones|Proteins|Somatotropin Agonists|Somatropin and Somatropin Agonists|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",CC\C=C\CC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(N)=O,56928011
7889,DB08871,Eribulin,small molecule,approved|investigational,Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Immunosuppressive Agents|Microtubule Inhibition|Microtubule Inhibitors|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Potential QTc-Prolonging Agents|QTc Prolonging Agents,[H][C@@]12CC(=C)[C@]([H])(CC[C@@]3([H])C[C@@H](C)C(=C)[C@@]([H])(C[C@]4([H])O[C@H](C[C@H](O)CN)[C@H](OC)[C@@]4([H])CC(=O)C[C@@]4([H])CC[C@]5([H])O[C@@]6([H])[C@H]7O[C@@]8(C[C@]7([H])O[C@@]6([H])[C@@]([H])(O8)[C@@]5([H])O4)CC1)O3)O2,73425383
7890,DB08872,Gabapentin enacarbil,small molecule,approved|investigational,"Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Aminobutyrates|Anti-epileptic Agent|Butyrates|Central Nervous System Depressants|Drugs that are Mainly Renally Excreted|Fatty Acids|Fatty Acids, Volatile|Gabapentin and Prodrugs|Lipids",CC(C)C(=O)OC(C)OC(=O)NCC1(CC(O)=O)CCCCC1,9883933
7891,DB08873,Boceprevir,small molecule,approved|withdrawn,"Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Antivirals for treatment of HCV infections|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strong)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Direct Acting Antivirals|HCV NS3/4A Protease Inhibitors|Imines|Imino Acids|NS3/4A Protease Inhibitors|P-glycoprotein inhibitors|Protease Inhibitors",[H][C@]12CN([C@H](C(=O)NC(CC3CCC3)C(=O)C(N)=O)[C@@]1([H])C2(C)C)C(=O)[C@@H](NC(=O)NC(C)(C)C)C(C)(C)C,10324367
7892,DB08874,Fidaxomicin,small molecule,approved,"Alimentary Tract and Metabolism|Anti-Bacterial Agents|Anti-Infective Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Carbohydrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Intestinal Antiinfectives|Lactones|Macrolide Antibacterial|Macrolides|Other Macrolides|P-glycoprotein substrates|Polyketides",[H][C@@]1(O[C@@H]2[C@@H](CC)\C=C(C)\[C@@H](O)C\C=C\C=C(CO[C@@H]3O[C@H](C)[C@@H](OC(=O)C4=C(CC)C(Cl)=C(O)C(Cl)=C4O)[C@H](O)[C@@H]3OC)\C(=O)O[C@@H](C\C=C(/C)\C=C2/C)[C@@H](C)O)OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]1O,70678896
7893,DB08875,Cabozantinib,small molecule,approved|investigational,"Amides|Amines|Aniline Compounds|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Kinase Inhibitor|Protein Kinase Inhibitors|Receptor Protein-Tyrosine Kinases, antagonists & inhibitors|Tyrosine Kinase Inhibitors",COC1=CC2=C(C=C1OC)C(OC1=CC=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2,25102847
7895,DB08877,Ruxolitinib,small molecule,approved,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Immunosuppressive Agents|Janus Kinases, antagonists & inhibitors|Kinase Inhibitor|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Protein Kinase Inhibitors|Tyrosine Kinase Inhibitors",N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,25126798
7896,DB08878,Aminopterin,small molecule,investigational|withdrawn,"Biological Factors|Enzyme Inhibitors|Folic Acid Antagonists|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Pteridines|Pterins",NC1=NC2=C(N=C(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=N2)C(N)=N1,169371
7898,DB08880,Teriflunomide,small molecule,approved,"Acids, Acyclic|Amines|Analgesics|Analgesics, Non-Narcotic|Aniline Compounds|Anti-Inflammatory Agents|Antineoplastic and Immunomodulating Agents|Antirheumatic Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Benzene Derivatives|Butyrates|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 CYP1A2 Inducers (weak)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Dihydroorotate Dehydrogenase Inhibitors|Fatty Acids|Fatty Acids, Volatile|Hepatotoxic Agents|Hydroxy Acids|Immunologic Factors|Immunomodulatory Agents|Immunosuppressive Agents|Lipids|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|Peripheral Nervous System Agents|Pyrimidine Synthesis Inhibitor|Selective Immunosuppressants|Sensory System Agents",C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,54684141
7899,DB08881,Vemurafenib,small molecule,approved,"Amides|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|Indoles|Kinase Inhibitor|Narrow Therapeutic Index Drugs|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Photosensitizing Agents|Protein Kinase Inhibitors|QTc Prolonging Agents|Sulfonamides|Sulfones|Sulfur Compounds|Tyrosine Kinase Inhibitors",CCCS(=O)(=O)NC1=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CC=C(Cl)C=C2)=C(F)C=C1,42611257
7900,DB08882,Linagliptin,small molecule,approved,"Agents causing angioedema|Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|DPP-IV Inhibitors|Drugs Used in Diabetes|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Incretins|OCT1 inhibitors|OCT2 Inhibitors|OCT2 Substrates|P-glycoprotein inhibitors|P-glycoprotein substrates|Protease Inhibitors|Purines|Quinazolines",CC#CCN1C(=NC2=C1C(=O)N(CC1=NC3=C(C=CC=C3)C(C)=N1)C(=O)N2C)N1CCC[C@@H](N)C1,10096344
7901,DB08883,Perampanel,small molecule,approved,"AMPA Receptor Antagonists|Anticonvulsants|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (weak)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Miscellaneous Anticonvulsants|Nervous System|Noncompetitive AMPA Glutamate Receptor Antagonist|Pyridines|Receptors, AMPA, antagonists & inhibitors",O=C1N(C=C(C=C1C1=CC=CC=C1C#N)C1=NC=CC=C1)C1=CC=CC=C1,9924495
7902,DB08884,Gadoxetic acid,small molecule,approved,"Acetates|Acids, Acyclic|Amines|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Fatty Acids|Fatty Acids, Volatile|Gadolinium-based Contrast Agent|Lipids|Magnetic Resonance Contrast Activity|Magnetic Resonance Imaging Contrast Media|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|Organometallic Compounds|Other Diagnostics|Paramagnetic Contrast Agent|Paramagnetic Contrast Media|Polyamines",[Gd+3].[H][C@@](CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)(CC1=CC=C(OCC)C=C1)N(CC(O)=O)CC(O)=O,131704314
7905,DB08887,Icosapent ethyl,small molecule,approved|investigational|nutraceutical,"Antiplatelet agents|Autacoids|Biological Factors|Diet, Food, and Nutrition|Dietary Fats|Dietary Fats, Unsaturated|Eicosanoids|Fats|Fatty Acids|Fatty Acids, Omega-3|Fatty Acids, Unsaturated|Fish Oils|Food|Food and Beverages|Hematologic Agents|Hypolipidemic Agents|Inflammation Mediators|Lipids|Miscellaneous Antilipemic Agents|Oils|Physiological Phenomena",CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,9831415
7907,DB08889,Carfilzomib,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Immunosuppressive Agents|Myelosuppressive Agents|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Peptides|Proteasome Inhibitors",CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,11556711
7908,DB08890,Linaclotide,small molecule,approved,"Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Drugs for Constipation|Enzyme Activators|Gastrointestinal Agents|Guanylate Cyclase Activators|Guanylate Cyclase-C Agonist|Guanylyl Cyclase C Agonists|Laxatives|Miscellaneous GI Drugs",[H][C@]1(CSSC[C@]2([H])NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CSSC[C@H](N)C(=O)N3)NC2=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)NCC(=O)N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O,16158208
7909,DB08891,Arbaclofen,small molecule,investigational,,[H][C@@](CN)(CC(O)=O)C1=CC=C(Cl)C=C1,44602
7910,DB08892,Arbaclofen Placarbil,small molecule,investigational,"Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Aminobutyrates|Butyrates|Central Nervous System Agents|Central Nervous System Depressants|Fatty Acids|Fatty Acids, Volatile|GABA Agents|GABA Agonists|GABA-B Receptor Agonists|Lipids|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Neuromuscular Agents|Neurotransmitter Agents|Peripheral Nervous System Agents",CC(C)[C@H](OC(=O)NC[C@H](CC(O)=O)C1=CC=C(Cl)C=C1)OC(=O)C(C)C,11281011
7911,DB08893,Mirabegron,small molecule,approved,Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-3 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Amides|Amines|Anilides|Aniline Compounds|Cholinesterase substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs for Urinary Frequency and Incontinence|Drugs that are Mainly Renally Excreted|Genito Urinary System and Sex Hormones|Neurotransmitter Agents|P-glycoprotein inhibitors|P-glycoprotein substrates|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Selective Beta 3-adrenergic Agonists|Sulfur Compounds|Urological Agents|Urologicals,NC1=NC(CC(=O)NC2=CC=C(CCNC[C@H](O)C3=CC=CC=C3)C=C2)=CS1,9865528
7913,DB08895,Tofacitinib,small molecule,approved|investigational,"Antineoplastic and Immunomodulating Agents|Antirheumatic Agents|Biologics for Rheumatoid Arthritis Treatment|Bradycardia-Causing Agents|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Disease-modifying Antirheumatic Agents|Enzyme Inhibitors|Immunosuppressive Agents|Janus Kinase 3, antagonists & inhibitors|Janus Kinase Inhibitor|Janus Kinase Inhibitors|Myelosuppressive Agents|Protein Kinase Inhibitors|Selective Immunosuppressants",[H][C@@]1(C)CCN(C[C@]1([H])N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N,9926791
7914,DB08896,Regorafenib,small molecule,approved,Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|Benzene Derivatives|Bradycardia-Causing Agents|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Hepatotoxic Agents|Kinase Inhibitor|P-glycoprotein inhibitors|P-glycoprotein substrates|Protein Kinase Inhibitors|Tyrosine Kinase Inhibitors|UGT1A1 Inhibitors|UGT1A9 Inhibitors|UGT1A9 Substrates,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,11167602
7915,DB08897,Aclidinium,small molecule,approved,"Adrenergics, Inhalants|Agents producing tachycardia|Agents to Treat Airway Disease|Alkaloids|Anticholinergic Agents|Antimuscarinics Antispasmodics|Aza Compounds|Azabicyclo Compounds|Cholinesterase substrates|Drugs for Obstructive Airway Diseases|Drugs that are Mainly Renally Excreted|Muscarinic Antagonists",OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C1=CC=CS1)C1=CC=CS1,11434515
7917,DB08899,Enzalutamide,small molecule,approved,"Androgen Receptor Antagonists|Androgen Receptor Inhibitor|Antiandrogens|Antiandrogens, non-steroidal|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (moderate)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (moderate)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strong)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Endocrine Therapy|Hormone Antagonists and Related Agents|Hydantoins|Imidazoles|Imidazolidines|P-glycoprotein inhibitors|Thyroxine-binding globulin substrates",CNC(=O)C1=C(F)C=C(C=C1)N1C(=S)N(C(=O)C1(C)C)C1=CC=C(C#N)C(=C1)C(F)(F)F,15951529
7919,DB08901,Ponatinib,small molecule,approved|investigational,Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Hepatotoxic Agents|Immunosuppressive Agents|Kinase Inhibitor|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|P-glycoprotein inhibitors|P-glycoprotein substrates|Protein Kinase Inhibitors|Tyrosine Kinase Inhibitors,CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1,24826799
7921,DB08903,Bedaquiline,small molecule,approved,"Anti-Bacterial Agents|Anti-Infective Agents|Antiinfectives for Systemic Use|Antimycobacterials|Antituberculosis Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Diarylquinoline Antimycobacterial|Drugs for Treatment of Tuberculosis|Heterocyclic Compounds, Fused-Ring|Moderate Risk QTc-Prolonging Agents|Mycobacterium tuberculosis|QTc Prolonging Agents|Quinolines",COC1=NC2=C(C=C(Br)C=C2)C=C1[C@@H](C1=CC=CC=C1)[C@@](O)(CCN(C)C)C1=CC=CC2=C1C=CC=C2,5388906
7923,DB08905,Formestane,small molecule,approved|investigational|withdrawn,"17-Ketosteroids|Adrenal Cortex Hormones|Androstanes|Androstenes|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Aromatase Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Drugs that are Mainly Renally Excreted|Endocrine Therapy|Enzyme Inhibitors|Estrogen Antagonists|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Steroid Synthesis Inhibitors|Steroids|Testosterone Congeners",[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=C(O)C(=O)CC[C@]12C,11273
7924,DB08906,Fluticasone furoate,small molecule,approved,Adrenal Cortex Hormones|Agents to Treat Airway Disease|Androstanes|Androstenes|Corticosteroids|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs for Obstructive Airway Diseases|Fused-Ring Compounds|Glucocorticoids|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Nasal Preparations|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein substrates|Steroids|Thyroxine-binding globulin inhibitors,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,9854489
7925,DB08907,Canagliflozin,small molecule,approved,Agents causing hyperkalemia|Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Diuretics|Drugs that are Mainly Renally Excreted|Drugs Used in Diabetes|Glucosides|Hypotensive Agents|P-glycoprotein inhibitors|P-glycoprotein substrates|Sodium-glucose co-transporter 2 (SGLT2) inhibitors|Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors|Sulfur Compounds|Thiophenes|UGT1A9 Substrates,[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C1=CC=C(C)C(CC2=CC=C(S2)C2=CC=C(F)C=C2)=C1,24812758
7926,DB08908,Dimethyl fumarate,small molecule,approved|investigational,"Acids, Acyclic|Antineoplastic and Immunomodulating Agents|Dermatologicals|Dicarboxylic Acids|Fumarates|Immunologic Factors|Immunosuppressive Agents|Miscellaneous Central Nervous System Agents|Radiation-Sensitizing Agents",[H]\C(=C(\[H])C(=O)OC)C(=O)OC,637568
7927,DB08909,Glycerol phenylbutyrate,small molecule,approved,"Acids, Carbocyclic|Alcohols|Alimentary Tract and Metabolism|Carbohydrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Drugs that are Mainly Renally Excreted|Nitrogen Binding Agent|Sugar Alcohols|Triose Sugar Alcohols|Urea Cycle Disorder Agents|Various Alimentary Tract and Metabolism Products",O=C(CCCC1=CC=CC=C1)OCC(COC(=O)CCCC1=CC=CC=C1)OC(=O)CCCC1=CC=CC=C1,10482134
7928,DB08910,Pomalidomide,small molecule,approved,"Acids, Carbocyclic|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Growth Inhibitors|Growth Substances|Heterocyclic Compounds, Fused-Ring|Imides|Immunologic Factors|Immunosuppressive Agents|Isoindoles|Myelosuppressive Agents|P-glycoprotein substrates|Phthalic Acids|Phthalimides|Piperidines|Piperidones|Thalidomide Analog",NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,134780
7929,DB08911,Trametinib,small molecule,approved,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Kinase Inhibitor|MAP Kinase Kinase 1, antagonists & inhibitors|MAP Kinase Kinase 2, antagonists & inhibitors|Narrow Therapeutic Index Drugs|Protein Kinase Inhibitors|Pyridines|Pyrimidines",CN1C(=O)C(C)=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC1=CC=C(I)C=C1F)C1=CC(NC(C)=O)=CC=C1,11707110
7930,DB08912,Dabrafenib,small molecule,approved|investigational,"Amines|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (weak)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strong)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (moderate)|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Enzyme Inhibitors|Hydroxylamines|Hyperglycemia-Associated Agents|Kinase Inhibitor|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Organic Anion Transporter 1 Inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Photosensitizing Agents|Potential QTc-Prolonging Agents|Protein Kinase Inhibitors|Proto-Oncogene Proteins B-raf, antagonists & inhibitors|QTc Prolonging Agents",CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1,44462760
7931,DB08913,Radium Ra 223 dichloride,small molecule,approved|investigational,"Antineoplastic Agents|Elements|Elements, Radioactive|Isotopes|Metals|Metals, Alkaline Earth|Metals, Heavy|Radioactive alpha-Particle Emitting Therapeutic Agent|Radioisotopes",[Cl-].[Cl-].[223Ra++],
7932,DB08915,Aleglitazar,small molecule,investigational,Sulfur Compounds,CO[C@@H](CC1=CC=C(OCCC2=C(C)OC(=N2)C2=CC=CC=C2)C2=C1SC=C2)C(O)=O,10274777
7933,DB08916,Afatinib,small molecule,approved,"Amides|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Kinase Inhibitor|P-glycoprotein inhibitors|P-glycoprotein substrates|Protein Kinase Inhibitors|Quinazolines|Tyrosine Kinase Inhibitors",CN(C)C\C=C\C(=O)NC1=C(O[C@H]2CCOC2)C=C2N=CN=C(NC3=CC(Cl)=C(F)C=C3)C2=C1,10184653
7934,DB08917,Ferric carboxymaltose,small molecule,approved,"Biopolymers|Carbohydrates|Compounds used in a research, industrial, or household setting|Disaccharides|Glucans|Iron Compounds|Macromolecular Substances|Oligosaccharides|Organometallic Compounds|Parenteral Iron Replacement|Phosphate Binder|Polymers|Polysaccharides",,
7935,DB08918,Levomilnacipran,small molecule,approved|investigational,Adrenergic Uptake Inhibitors|Agents producing tachycardia|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cycloparaffins|Cyclopropanes|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Miscellaneous Antidepressants|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Norepinephrine Uptake Inhibitors|P-glycoprotein substrates|Psychotropic Drugs|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin and Noradrenaline Reuptake Inhibitors|Serotonin Modulators,CCN(CC)C(=O)[C@]1(C[C@H]1CN)C1=CC=CC=C1,6917779
7936,DB08921,(4R)-limonene,small molecule,investigational,Cyclohexanes|Cyclohexenes|Cycloparaffins|Monoterpenes|Terpenes,CC(=C)[C@@H]1CCC(C)=CC1,
7937,DB08922,Perospirone,small molecule,experimental,"Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Heterocyclic Compounds, Fused-Ring|Neurotoxic agents|Psychotropic Drugs|Sulfur Compounds|Tranquilizing Agents",[H][C@@]12CCCC[C@]1([H])C(=O)N(CCCCN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,115368
7938,DB08924,Amfecloral,small molecule,experimental,,CC(CC1=CC=CC=C1)\N=C\C(Cl)(Cl)Cl,21759
7939,DB08925,Adrafinil,small molecule,withdrawn,"Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Amines|Hydroxy Acids|Hydroxylamines|Nervous System|Neurotransmitter Agents|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Sympathomimetic-like Agent",,
7940,DB08926,Acediasulfone,small molecule,experimental,Sulfur Compounds,[H]N([H])C1=CC=C(C=C1)S(=O)(=O)C1=CC=C(C=C1)N([H])CC(O)=O,66451
7941,DB08927,Amperozide,small molecule,experimental,Antidepressive Agents|Antipsychotic Agents|Central Nervous System Agents|Central Nervous System Depressants|Neurotoxic agents|Neurotransmitter Agents|Psychotropic Drugs|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Tranquilizing Agents,[H]N(CC)C(=O)N1CCN(CCCC(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)CC1,73333
7942,DB08928,Arsthinol,small molecule,experimental,"Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Arsenicals|Organometallic Compounds",CC(=O)NC1=CC(=CC=C1O)[As]1SCC(CO)S1,8414
7943,DB08930,Dolutegravir,small molecule,approved,"Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BCRP/ABCG2 Substrates|Direct Acting Antivirals|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|HIV Integrase Inhibitors|Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor|Integrase Inhibitors|Miscellaneous Antiretrovirals*|Multidrug and Toxin Extrusion Transporter 1 Inhibitors|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|OCT2 Inhibitors|P-glycoprotein substrates|UGT1A1 Substrates|UGT1A3 substrates|UGT1A9 Substrates",[H][C@]12CN3C=C(C(=O)NCC4=CC=C(F)C=C4F)C(=O)C(O)=C3C(=O)N1[C@H](C)CCO2,54726191
7944,DB08931,Riociguat,small molecule,approved,Antihypertensive Agents|Antihypertensives for Pulmonary Arterial Hypertension|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Enzyme Activators|Guanylate Cyclase|Guanylate Cyclase Stimulators|Hypotensive Agents|Soluble Guanylate Cyclase Stimulator|Vasodilating Agents,COC(=O)N(C)C1=C(N)N=C(N=C1N)C1=NN(CC2=C(F)C=CC=C2)C2=C1C=CC=N2,11304743
7945,DB08932,Macitentan,small molecule,approved,Amides|Antihypertensive Agents|Antihypertensives for Pulmonary Arterial Hypertension|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Endothelin A Receptor Antagonists|Endothelin B Receptor Antagonists|Endothelin Receptor Antagonists|Sulfones|Sulfur Compounds|Vasodilating Agents,CCCNS(=O)(=O)NC1=C(C(OCCOC2=NC=C(Br)C=N2)=NC=N1)C1=CC=C(Br)C=C1,16004692
7946,DB08933,Luliconazole,small molecule,approved,Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Azole Antifungals|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Imidazole and Triazole Derivatives,ClC1=CC(Cl)=C(C=C1)[C@@H]1CS\C(S1)=C(\C#N)N1C=CN=C1,3003141
7947,DB08934,Sofosbuvir,small molecule,approved,"Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Antivirals for treatment of HCV infections|BCRP/ABCG2 Substrates|Carbohydrates|Direct Acting Antivirals|Drugs that are Mainly Renally Excreted|Glycosides|Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Nucleotides|P-glycoprotein substrates|Pyrimidine Nucleosides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleosides|Ribonucleotides|RNA Replicase Inhibitors|Uracil Nucleotides",CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1,45375808
7949,DB08936,Chlorcyclizine,small molecule,approved,Antihistamines for Systemic Use|Histamine Antagonists|Histamine H1 Antagonists|Piperazine Derivatives|Potential QTc-Prolonging Agents|QTc Prolonging Agents,CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,2710
7950,DB08937,TAS-102,small molecule,investigational,"Carbohydrates|Deoxyribonucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pharmaceutical Preparations|Pyrimidine Nucleosides|Pyrimidines",,
7951,DB08938,Magaldrate,small molecule,approved|withdrawn,Alimentary Tract and Metabolism|Alkalies|Aluminium Compounds|Aluminum and magnesium containing antacids|Anions|Antacids|Antacids With Antiflatulents|Drugs for Acid Related Disorders|Electrolytes|Gastric Acid Lowering Agents|Gastrointestinal Agents|Hydroxides|Ions|Magnesium Compounds|Metal cations|Metal divalent cations,O.[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Mg++].[Mg++].[Mg++].[Mg++].[Mg++].[Mg++].[Mg++].[Mg++].[Mg++].[Mg++].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O,3086011
7952,DB08939,Letosteine,small molecule,experimental,Cough and Cold Preparations|Expectorants|Respiratory System Agents|Sulfur Compounds|Thiazoles,CCOC(=O)CSCCC1NC(CS1)C(O)=O,68707
7953,DB08940,Kebuzone,small molecule,experimental,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Butylpyrazolidines|Central Nervous System Agents|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Pyrazoles|Pyrazolones|Sensory System Agents",CC(=O)CCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C1,3824
7954,DB08941,Isoxsuprine,small molecule,approved|withdrawn,2-Amino-1-Phenylethanol Derivatives|Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Autonomic Agents|Cardiovascular Agents|Ethylamines|Hypotensive Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Peripheral Vasodilators|Phenethylamines|Propanolamines|Propanols|Reproductive Control Agents|Sympathomimetics|Tocolytic Agents|Vasodilating Agents,C[C@H](COC1=CC=CC=C1)N[C@H](C)[C@@H](O)C1=CC=C(O)C=C1,11779629
7955,DB08942,Isoxicam,small molecule,approved|withdrawn,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antirheumatic Agents|Central Nervous System Agents|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Sensory System Agents|Sulfur Compounds|Thiazines",CN1C(C(=O)NC2=NOC(C)=C2)=C(O)C2=C(C=CC=C2)S1(=O)=O,54677972
7956,DB08943,Isoconazole,small molecule,approved,Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Azole Antifungals|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Imidazole and Triazole Derivatives|Imidazole Derivatives|Imidazoles|Ointments,ClC1=CC(Cl)=C(C=C1)C(CN1C=CN=C1)OCC1=C(Cl)C=CC=C1Cl,3760
7957,DB08944,Isoaminile,small molecule,approved|withdrawn,Antitussive Agents|Central Nervous System Agents|Cough and Cold Preparations|Nitriles|Respiratory System Agents,CC(C)[C@@](C[C@H](C)N(C)C)(C#N)C1=CC=CC=C1,12162152
7958,DB08945,Iotroxic acid,small molecule,experimental|withdrawn,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Iodobenzoates|Triiodobenzoic Acids|Watersoluble, Hepatotropic X-Ray Contrast Media|X-Ray Contrast Media, Iodinated",OC(=O)C1=C(I)C(NC(=O)COCCOCCOCC(=O)NC2=C(I)C(C(O)=O)=C(I)C=C2I)=C(I)C=C1I,
7959,DB08946,Iopanoic acid,small molecule,approved|withdrawn,"Benzene Derivatives|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Hydrocarbons, Halogenated|Hydrocarbons, Iodinated|Iodobenzenes|Watersoluble, Hepatotropic X-Ray Contrast Media|X-Ray Contrast Media, Iodinated",CCC(CC1=C(I)C(N)=C(I)C=C1I)C(O)=O,3735
7960,DB08947,Iopamidol,small molecule,approved,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Iodinated Contrast Agents|Iodobenzoates|Radiographic Contrast Agent|Roentgenography|Triiodobenzoic Acids|Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media|X-Ray Contrast Activity|X-Ray Contrast Media, Iodinated",C[C@H](O)C(=O)NC1=C(I)C(C(=O)NC(CO)CO)=C(I)C(C(=O)NC(CO)CO)=C1I,65492
7961,DB08948,Iodamide,small molecule,withdrawn,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Iodobenzoates|Triiodobenzoic Acids|Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media|X-Ray Contrast Media, Iodinated",CC(=O)NCC1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I,3723
7962,DB08949,Inositol nicotinate,small molecule,approved|withdrawn,Cardiovascular Agents|Nicotinic Acid and Derivatives|Other Nutritional Agents|Peripheral Vasodilators|Pyridines|Vasodilating Agents|Vitamin B Complex|Vitamins,O=C(O[C@H]1[C@H](OC(=O)C2=CC=CN=C2)[C@@H](OC(=O)C2=CC=CN=C2)[C@H](OC(=O)C2=CC=CN=C2)[C@H](OC(=O)C2=CC=CN=C2)[C@@H]1OC(=O)C1=CC=CN=C1)C1=CC=CN=C1,3720
7963,DB08950,Indoramin,small molecule,approved|withdrawn,"Acids, Carbocyclic|Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Amides|Antiadrenergic Agents, Peripherally Acting|Antihypertensive Agents|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Cardiovascular Agents|Heterocyclic Compounds, Fused-Ring|Hypotensive Agents|Indoles|Neurotransmitter Agents|Peripheral alpha-1 blockers|Piperidines",O=C(NC1CCN(CCC2=CNC3=C2C=CC=C3)CC1)C1=CC=CC=C1,33625
7964,DB08951,Indoprofen,small molecule,withdrawn,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Isoindoles|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Phenylpropionates|Propionates|Sensory System Agents",CC(C(O)=O)C1=CC=C(C=C1)N1CC2=CC=CC=C2C1=O,3718
7965,DB08952,Indenolol,small molecule,withdrawn,Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|Potential QTc-Prolonging Agents|Propanols|QTc Prolonging Agents|Vasodilating Agents,CC(C)NCC(O)COC1=CC=CC2=C1C=CC2,71955
7966,DB08953,Indalpine,small molecule,investigational|withdrawn,Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Psychotropic Drugs|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators,C(CC1=CNC2=CC=CC=C12)C1CCNCC1,44668
7967,DB08954,Ifenprodil,small molecule,approved|investigational|withdrawn,"Adrenergic Agents|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Anti-Parkinson Drugs|Anticonvulsants|Cardiovascular Agents|Central Nervous System Depressants|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Neurotransmitter Agents|NMDA Receptor Antagonists|Peripheral Vasodilators|Receptors, N-Methyl-D-Aspartate|Vasodilating Agents",CC(C(O)C1=CC=C(O)C=C1)N1CCC(CC2=CC=CC=C2)CC1,3689
7968,DB08955,Ibuproxam,small molecule,withdrawn,"Acetamides|Acetates|Acids, Acyclic|Agents causing hyperkalemia|Agents that produce hypertension|Amides|Amines|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Benzene Derivatives|Central Nervous System Agents|Fatty Acids|Fatty Acids, Volatile|Hydroxy Acids|Hydroxylamines|Lipids|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Propionates|Sensory System Agents",CC(C)CC1=CC=C(C=C1)C(C)C(=O)NO,68704
7969,DB08956,Hydroxydione,small molecule,investigational|withdrawn,Fused-Ring Compounds|Pregnanes|Steroids,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@]4([H])CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(=O)CO,257630
7970,DB08957,Hexoprenaline,small molecule,experimental|withdrawn,"Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Amines|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Drugs for Obstructive Airway Diseases|Ethylamines|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenethylamines|Reproductive Control Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists|Tocolytic Agents",OC(CNCCCCCCNCC(O)C1=CC(O)=C(O)C=C1)C1=CC(O)=C(O)C=C1,3609
7971,DB08958,Hexetidine,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Anti-Infective Agents|Anti-Infective Agents, Local|Antifungal Agents|Antiinfectives and Antiseptics for Local Oral Treatment|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Pyrimidines|Stomatological Preparations",CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1,3607
7972,DB08960,Hexamethonium,small molecule,experimental,"Amines|Ammonium Compounds|Anticholinergic Agents|Antihypertensive Agents|Autonomic Agents|Bis-Trimethylammonium Compounds|Cardiovascular Agents|Central Nervous System Depressants|Cholinergic Agents|Ganglion Blockers|Hexamethonium Compounds|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Neurotransmitter Agents|Nicotinic Antagonists|Nitrogen Compounds|Onium Compounds|Peripheral Nervous System Agents|Quaternary Ammonium Compounds",C[N+](C)(C)CCCCCC[N+](C)(C)C,3604
7973,DB08961,Azosemide,small molecule,investigational,Amides|Amines|Aniline Compounds|Cardiovascular Agents|Diuretics|Natriuretic Agents|Sodium Potassium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds,NS(=O)(=O)C1=C(Cl)C=C(NCC2=CC=CS2)C(=C1)C1=NNN=N1,2273
7974,DB08962,Glibornuride,small molecule,investigational|withdrawn,Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Drugs Used in Diabetes|Sulfones|Sulfonylureas|Sulfur Compounds,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)N[C@@H]1[C@H](O)[C@]2(C)CC[C@H]1C2(C)C,12818200
7975,DB08964,Gemeprost,small molecule,approved|withdrawn,"Abortifacient Agents|Abortifacient Agents, Nonsteroidal|Autacoids|Biological Factors|Drugs that are Mainly Renally Excreted|Eicosanoids|Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Genito Urinary System and Sex Hormones|Inflammation Mediators|Lipids|Prostaglandins|Prostaglandins E|Prostaglandins E, Synthetic|Reproductive Control Agents|Uterotonic agents",CCCCC(C)(C)[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(=O)OC,5282237
7976,DB08965,Fusafungine,small molecule,approved|withdrawn,"Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Peptides|Peptides, Cyclic|Throat Preparations",[H]C1(OC(=O)[C@]([H])(C(C)C)N(C)C(=O)C([H])(OC(=O)[C@]([H])(C(C)C)N(C)C(=O)C([H])(OC(=O)[C@]([H])(C(C)C)N(C)C1=O)C(C)C)C(C)C)C(C)C,3084092
7977,DB08966,Fursultiamine,small molecule,approved,"Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Micronutrients|Physiological Phenomena|Pyrimidines|Sulfur Compounds|Thiazoles|Vitamin B Complex|Vitamins",C\C(N(CC1=C(N)N=C(C)N=C1)C=O)=C(\CCO)SSCC1CCCO1,3002119
7978,DB08967,Dimetotiazine,small molecule,approved,"Analgesics|Antimigraine Preparations|Heterocyclic Compounds, Fused-Ring|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Nervous System|Neurotransmitter Agents|Sulfur Compounds",CC(CN1C2=CC=CC=C2SC2=C1C=C(C=C2)S(=O)(=O)N(C)C)N(C)C,3089
7979,DB08968,Fominoben,small molecule,experimental|withdrawn,Antitussive Agents|Central Nervous System Agents|Oxazines|Respiratory System Agents,CN(CC(=O)N1CCOCC1)CC1=C(Cl)C=CC=C1NC(=O)C1=CC=CC=C1,3407
7980,DB08969,Flurothyl,small molecule,withdrawn,Central Nervous System Agents|Central Nervous System Stimulants|Convulsants|Ethers|Ethyl Ethers,FC(F)(F)COCC(F)(F)F,9528
7981,DB08970,Fluprednidene,small molecule,experimental,"Adrenal Cortex Hormones|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Moderately Potent (Group II)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Dermatologicals|Glucocorticoids|Hyperglycemia-Associated Agents|Immunosuppressive Agents",[H][C@@]12CC(=C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,11794741
7982,DB08971,Fluocortolone,small molecule,approved|withdrawn,"Adrenal Cortex Hormones|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Anti-Inflammatory Agents|Corticosteroids|Corticosteroids for Systemic Use, Plain|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Dermatologicals|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Ophthalmologicals|Pregnadienediols|Pregnadienes|Pregnanes|Sensory Organs|Steroids|Steroids, Fluorinated|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Vasoprotectives",[H][C@@]1(C)C[C@@]2([H])[C@]3([H])C[C@]([H])(F)C4=CC(=O)C=C[C@]4(C)[C@@]3([H])[C@@]([H])(O)C[C@]2(C)[C@@]1([H])C(=O)CO,9053
7983,DB08972,Flumequine,small molecule,withdrawn,"Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antineoplastic Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones|Renal Agents|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",CC1CCC2=CC(F)=CC3=C2N1C=C(C(O)=O)C3=O,3374
7984,DB08973,Fluclorolone acetonide,small molecule,approved|withdrawn,Fused-Ring Compounds|Pregnadienes|Pregnanes|Steroids,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(Cl)[C@@H](Cl)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,20054914
7985,DB08974,Flubendazole,small molecule,experimental|withdrawn,"Acids, Acyclic|Anthelmintics|Anti-Infective Agents|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Benzimidazole Derivatives|Benzimidazoles|Carbamates|Heterocyclic Compounds, Fused-Ring",COC(=O)NC1=NC2=C(N1)C=CC(=C2)C(=O)C1=CC=C(F)C=C1,35802
7986,DB08975,Florantyrone,small molecule,withdrawn,,OC(=O)CCC(=O)C1=CC2=C(C=C1)C1=C3C2=CC=CC3=CC=C1,10617
7987,DB08976,Floctafenine,small molecule,approved|withdrawn,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Aminobenzoates|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antirheumatic Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Miscellaneous Analgesics and Antipyretics|Nephrotoxic agents|Nervous System|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Sensory System Agents",OCC(O)COC(=O)C1=CC=CC=C1NC1=CC=NC2=C(C=CC=C12)C(F)(F)F,76958517
7988,DB08978,Fentonium,small molecule,withdrawn,"Alimentary Tract and Metabolism|Alkaloids|Aza Compounds|Azabicyclo Compounds|Belladonna Alkaloids|Belladonna Alkaloids, Semisynthetic, Quaternary Ammonium Compounds|Belladonna and Derivatives, Plain|Drugs for Functional Gastrointestinal Disorders|Solanaceous Alkaloids|Tropanes",[H][C@](CO)(C(=O)O[C@]1([H])C[C@]2([H])CC[C@]([H])(C1)[N+]2(C)CC(=O)C1=CC=C(C=C1)C1=CC=CC=C1)C1=CC=CC=C1,10347880
7989,DB08979,Fenspiride,small molecule,experimental,Anti-Asthmatic Agents|Asthma|Autonomic Agents|Bronchodilator Agents|Drugs for Obstructive Airway Diseases|Peripheral Nervous System Agents|Respiratory System Agents,O=C1NCC2(CCN(CCC3=CC=CC=C3)CC2)O1,3344
7990,DB08980,Fendiline,small molecule,withdrawn,Agents causing hyperkalemia|Amines|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Ethylamines|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Non-Selective Calcium Channel Blockers|Phenethylamines|Phenylalkylamine Derivatives|QTc Prolonging Agents|Vasodilating Agents,CC(NCCC(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=CC=C1,3336
7991,DB08981,Fenbufen,small molecule,approved,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Propionates|Sensory System Agents",OC(=O)CCC(=O)C1=CC=C(C=C1)C1=CC=CC=C1,3335
7992,DB08982,Etozoline,small molecule,experimental,,[H]\C(C(=O)OCC)=C1\SC(N2CCCCC2)C(=O)N1C,5743585
7993,DB08983,Etofibrate,small molecule,experimental,"Acids, Acyclic|Agents Causing Muscle Toxicity|Anticholesteremic Agents|Benzene Derivatives|Butyrates|Ethers|Fatty Acids|Fatty Acids, Volatile|Fibric Acids|Hypolipidemic Agents|Isobutyrates|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Lipids|Noxae|Phenols|Phenyl Ethers|Toxic Actions",CC(C)(OC1=CC=C(Cl)C=C1)C(=O)OCCOC(=O)C1=CN=CC=C1,65777
7994,DB08984,Etofenamate,small molecule,experimental,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Amines|Aminobenzoates|Analgesics|Analgesics, Non-Narcotic|Aniline Compounds|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antirheumatic Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Fenamates|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|ortho-Aminobenzoates|Peripheral Nervous System Agents|Sensory System Agents|Thyroxine-binding globulin substrates|Topical Products for Joint and Muscular Pain",OCCOCCOC(=O)C1=CC=CC=C1NC1=CC=CC(=C1)C(F)(F)F,35375
7995,DB08985,Etilefrine,small molecule,withdrawn,"Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Adrenergic beta-1 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Autonomic Agents|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Ethanolamines|Neurotransmitter Agents|Peripheral Nervous System Agents|Protective Agents|Sympathomimetics|Vasoconstrictor Agents",CCNCC(O)C1=CC(O)=CC=C1,3306
7996,DB08986,Etifoxine,small molecule,investigational|withdrawn,Anti-Anxiety Agents|Central Nervous System Agents|Central Nervous System Depressants|Nervous System|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents,CCNC1=NC2=CC=C(Cl)C=C2C(C)(O1)C1=CC=CC=C1,30768
7997,DB08987,Etidocaine,small molecule,approved,"Acetanilides|Amides|Amines|Anesthetics|Anesthetics, Local|Anilides|Aniline Compounds|Central Nervous System Agents|Nervous System|Peripheral Nervous System Agents|Sensory System Agents",CCCN(CC)C(CC)C(=O)NC1=C(C)C=CC=C1C,37497
7998,DB08988,Ethoheptazine,small molecule,approved|withdrawn,,CCOC(=O)C1(CCCN(C)CC1)C1=CC=CC=C1,6469
7999,DB08989,Etamivan,small molecule,withdrawn,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Respiratory System Agents",CCN(CC)C(=O)C1=CC(OC)=C(O)C=C1,9363
8000,DB08990,Eprazinone,small molecule,experimental|withdrawn,Cough and Cold Preparations|Expectorants|Ketones|Respiratory System Agents,CCOC(CN1CCN(CC(C)C(=O)C2=CC=CC=C2)CC1)C1=CC=CC=C1,3245
8001,DB08991,Epirizole,small molecule,experimental,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antirheumatic Agents|Central Nervous System Agents|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Pyrazoles|Pyrimidines|Sensory System Agents",COC1=CC(C)=NN1C1=NC(C)=CC(OC)=N1,3242
8002,DB08992,Eperisone,small molecule,investigational,"Agents causing hyperkalemia|Antiarrhythmic agents|Autonomic Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Ketones|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Parasympatholytics|Peripheral Nervous System Agents|QTc Prolonging Agents|Vasodilating Agents",CCC1=CC=C(C=C1)C(=O)C(C)CN1CCCCC1,3236
8003,DB08993,Enviomycin,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics, Antitubercular|Antituberculosis Agents|Peptides|Peptides, Cyclic",[H][C@@]1(CCN=C(N)N1)[C@]1([H])NC(=O)\C(NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CNC1=O)NC(=O)C[C@@H](N)[C@H](O)CCN)=C\NC(N)=O,20055267
8004,DB08994,Ditazole,small molecule,experimental|withdrawn,Anticoagulants|Blood and Blood Forming Organs|Platelet Aggregation Inhibitors Excl. Heparin,OCCN(CCO)C1=NC(=C(O1)C1=CC=CC=C1)C1=CC=CC=C1,29088
8005,DB08995,Diosmin,small molecule,approved|investigational,"Benzopyrans|Capillary Stabilizing Agents|Chromones|Flavones|Flavonoids|Heterocyclic Compounds, Fused-Ring|Pyrans|Vasoprotectives",COC1=C(O)C=C(C=C1)C1=CC(=O)C2=C(O)C=C(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)C=C2O1,5281613
8006,DB08996,Dimetacrine,small molecule,experimental|withdrawn,"Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Antidepressive Agents, Tricyclic|Central Nervous System Depressants|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotoxic agents|Non-Selective Monoamine Reuptake Inhibitors|Psychoanaleptics|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",CN(C)CCCN1C2=CC=CC=C2C(C)(C)C2=CC=CC=C12,94280
8007,DB08997,Dexetimide,small molecule,withdrawn,Agents producing tachycardia|Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Anticholinergic Agents|Autonomic Agents|Central Nervous System Agents|Cholinergic Agents|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|Parasympatholytics|Peripheral Nervous System Agents|Piperidines|Piperidones|Tertiary Amines,O=C1CC[C@@](C2CCN(CC3=CC=CC=C3)CC2)(C(=O)N1)C1=CC=CC=C1,30843
8008,DB08998,Demexiptiline,small molecule,experimental,Benzocycloheptenes,CNCCON=C1C2=CC=CC=C2C=CC2=CC=CC=C12,28876
8009,DB08999,Cyclopentamine,small molecule,withdrawn,"Cycloparaffins|Ganglion Blockers|Nasal Preparations|Sympathomimetics, Plain",CNC(C)CC1CCCC1,7608
8010,DB09000,Cyamemazine,small molecule,experimental,"Anti-Anxiety Agents|Antipsychotic Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotoxic agents|Phenothiazines|Phenothiazines With Aliphatic Side-Chain|Photosensitizing Agents|Psycholeptics|Sulfur Compounds",CC(CN(C)C)CN1C2=CC=CC=C2SC2=C1C=C(C=C2)C#N,62865
8011,DB09001,Barbexaclone,small molecule,experimental,Anticonvulsants|Barbiturates|Barbiturates and Derivatives|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Nervous System|Pyrimidines|Pyrimidinones,CN[C@@H](C)CC1CCCCC1.CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1,71196
8012,DB09002,Cloperastine,small molecule,experimental,Cough and Cold Preparations,ClC1=CC=C(C=C1)C(OCCN1CCCCC1)C1=CC=CC=C1,2805
8013,DB09003,Clocapramine,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring",OC(=N)C1(CCN(CCCN2C3=CC=CC=C3CCC3=C2C=C(Cl)C=C3)CC1)N1CCCCC1,2793
8014,DB09004,Clobutinol,small molecule,withdrawn,Alcohols|Amines|Antitussive Agents|Central Nervous System Agents|Cough and Cold Preparations|Respiratory System Agents,CC(CN(C)C)C(C)(O)CC1=CC=C(Cl)C=C1,26937
8016,DB09006,Clinofibrate,small molecule,experimental,"Acetates|Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Glycolates|Hydroxy Acids|Lipids",CCC(C)(OC1=CC=C(C=C1)C1(CCCCC1)C1=CC=C(OC(C)(CC)C(O)=O)C=C1)C(O)=O,2787
8017,DB09007,Chlorphenoxamine,small molecule,withdrawn,"Agents producing tachycardia|Amines|Aminoalkyl Ethers|Anticholinergic Agents|Antihistamines for Systemic Use|Antihistamines for Topical Use|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Cholinergic Agents|Dermatologicals|Histamine Agents|Histamine Antagonists|Muscarinic Antagonists|Neurotransmitter Agents",CN(C)CCOC(C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,6475
8018,DB09008,Cefaloridine,small molecule,experimental|withdrawn,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|First-Generation Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Sulfur Compounds|Thiazines",[H][C@]12SCC(C[N+]3=CC=CC=C3)=C(N1C(=O)[C@H]2NC(=O)CC1=CC=CS1)C([O-])=O,5773
8019,DB09009,Articaine,small molecule,approved,"Amide Local Anesthetic|Amides|Anesthetics|Anesthetics, Local|Central Nervous System Agents|Hyperglycemia-Associated Agents|Local Anesthesia|Nervous System|Peripheral Nervous System Agents|Sensory System Agents|Sulfur Compounds|Thiophenes",CCCNC(C)C(=O)NC1=C(SC=C1C)C(=O)OC,32170
8020,DB09010,Carmofur,small molecule,withdrawn,Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Fluoropyrimidines|Pyrimidine Analogues|Pyrimidines|Pyrimidinones,CCCCCCNC(=O)N1C=C(F)C(=O)NC1=O,2577
8021,DB09011,Beclamide,small molecule,experimental,"Acids, Acyclic|Anticonvulsants|Central Nervous System Depressants|Fatty Acids|Fatty Acids, Volatile|Lipids|Nervous System",ClCCC(=O)NCC1=CC=CC=C1,10391
8022,DB09012,Carbazochrome,small molecule,experimental|withdrawn,"Biological Factors|Blood and Blood Forming Organs|Coagulants|Hematologic Agents|Hemostatics|Heterocyclic Compounds, Fused-Ring|Indoles|Pigments, Biological",CN1CC(O)C2=C\C(=N\NC(N)=O)C(=O)C=C12,5360410
8023,DB09013,Befunolol,small molecule,experimental,Adrenergic Agents|Adrenergic Agonists|Adrenergic Antagonists|Adrenergic beta-Agonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antiglaucoma Preparations and Miotics|Bradycardia-Causing Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Neurotransmitter Agents|Ophthalmologicals|Propanols|Sensory Organs,CC(C)NCC(O)COC1=CC=CC2=C1OC(=C2)C(C)=O,2309
8024,DB09014,Captodiame,small molecule,experimental,Anti-Anxiety Agents|Antidepressive Agents|Central Nervous System Depressants|Diphenylmethane Derivatives|Nervous System|Psycholeptics|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists,CCCCSC1=CC=C(C=C1)C(SCCN(C)C)C1=CC=CC=C1,10240
8025,DB09015,Canrenoic acid,small molecule,approved|withdrawn,"Agents causing hyperkalemia|Cardiovascular Agents|Diuretics|Fused-Ring Compounds|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Mineralocorticoid Receptor Antagonists|Natriuretic Agents|Potassium-Sparing Diuretics|Pregnadienes|Pregnanes|Steroids",[H][C@@]12CC[C@@](O)(CCC(O)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@]12C,656615
8026,DB09016,Butriptyline,small molecule,approved,"Agents that produce hypertension|Agents that reduce seizure threshold|Anti-Anxiety Agents|Antidepressive Agents|Antidepressive Agents, Tricyclic|Benzocycloheptenes|Central Nervous System Agents|Central Nervous System Depressants|Histamine Antagonists|Histamine H1 Antagonists|Moderate Risk QTc-Prolonging Agents|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Non-Selective Monoamine Reuptake Inhibitors|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Tertiary amine tricyclic antidepressants|Tranquilizing Agents",,21772
8027,DB09017,Brotizolam,small molecule,investigational|withdrawn,Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Hypnotics and Sedatives|Nervous System|Psycholeptics,CC1=NN=C2CN=C(C3=C(SC(Br)=C3)N12)C1=CC=CC=C1Cl,2451
8028,DB09018,Bromopride,small molecule,investigational,"Acids, Carbocyclic|Alimentary Tract and Metabolism|Amides|Aminobenzoates|Antiemetics|Autonomic Agents|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Central Nervous System Agents|Chlorobenzoates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs for Functional Gastrointestinal Disorders|Ethers|Gastrointestinal Agents|Hydroxy Acids|Hydroxybenzoate Ethers|Hydroxybenzoates|Neurotransmitter Agents|para-Aminobenzoates|Peripheral Nervous System Agents|Phenols|Phenyl Ethers|Propulsives",CCN(CC)CCNC(=O)C1=CC(Br)=C(N)C=C1OC,2446
8029,DB09019,Bromhexine,small molecule,approved,Amines|Aniline Compounds|Cough and Cold Preparations|Cyclohexanes|Cyclohexylamines|Cycloparaffins|Expectorants|Respiratory System Agents,CN(CC1=CC(Br)=CC(Br)=C1N)C1CCCCC1,2442
8030,DB09020,Bisacodyl,small molecule,approved,Alimentary Tract and Metabolism|Benzene Derivatives|Contact Laxatives|Cresols|Drugs for Constipation|Enemas|Gastrointestinal Agents|Increased Large Intestinal Motility|Laxatives|Phenols|Stimulation Large Intestine Fluid/Electrolyte Secretion,CC(=O)OC1=CC=C(C=C1)C(C1=CC=C(OC(C)=O)C=C1)C1=CC=CC=N1,2391
8031,DB09021,Benzoctamine,small molecule,experimental,Anti-Anxiety Agents|Central Nervous System Depressants|Dibenzo-Bicyclo-Octadiene Derivatives|Nervous System|Psycholeptics,CNCC12CCC(C3=CC=CC=C13)C1=CC=CC=C21,28425
8032,DB09022,Benfluorex,small molecule,investigational|withdrawn,Alimentary Tract and Metabolism|Amines|Anti-Obesity Agents|Appetite Depressants|Blood Glucose Lowering Agents|Drugs Used in Diabetes|Ethylamines|Hypolipidemic Agents|Lipid Regulating Agents|Noxae|Phenethylamines|Toxic Actions,CC(CC1=CC(=CC=C1)C(F)(F)F)NCCOC(=O)C1=CC=CC=C1,2318
8033,DB09023,Benactyzine,small molecule,withdrawn,"Acids, Carbocyclic|Agents producing tachycardia|Anticholinergic Agents|Antidepressive Agents|Autonomic Agents|Benzilates|Central Nervous System Agents|Central Nervous System Depressants|Cholinergic Agents|Diphenylacetic Acids|Hydroxy Acids|Muscarinic Antagonists|Neurotransmitter Agents|Parasympatholytics|Peripheral Nervous System Agents|Phenylacetates|Psychotropic Drugs",CCN(CC)CCOC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,9330
8034,DB09026,Aliskiren,small molecule,approved|investigational,"Acids, Acyclic|Agents Acting on the Renin-Angiotensin System|Agents causing hyperkalemia|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Benzene Derivatives|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dicarboxylic Acids|Ethers|Hypotensive Agents|Methyl Ethers|P-glycoprotein substrates|Renin-Inhibitors",COCCCOC1=C(OC)C=CC(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)=C1,5493444
8035,DB09027,Ledipasvir,small molecule,approved,"Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Antivirals for treatment of HCV infections|Breast Cancer Resistance Protein Inhibitors|Direct Acting Antivirals|Drugs that are Mainly Renally Excreted|Hepatitis C Virus NS5A Inhibitor|Heterocyclic Compounds, Fused-Ring|P-glycoprotein inhibitors|P-glycoprotein substrates",COC(=O)N[C@@H](C(C)C)C(=O)N1CC2(CC2)C[C@H]1C1=NC(=CN1)C1=CC=C2C3=CC=C(C=C3C(F)(F)C2=C1)C1=CC=C2NC(=NC2=C1)[C@@H]1[C@H]2CC[C@H](C2)N1C(=O)[C@@H](NC(=O)OC)C(C)C,67505836
8036,DB09028,Cytisine,small molecule,experimental,"Drugs Used in Addictive Disorders|Drugs Used in Nicotine Dependence|Heterocyclic Compounds, Fused-Ring|Nervous System|Nicotine, antagonists & inhibitors",O=C1C=CC=C2[C@H]3CNC[C@H](C3)CN12,10235
8038,DB09030,Vorapaxar,small molecule,approved,"Anticoagulants|Antiplatelet agents|Blood and Blood Forming Organs|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Hematologic Agents|P-glycoprotein inhibitors|Platelet Aggregation Inhibitors Excl. Heparin|Protease-activated Receptor-1 Antagonist|Protease-activated Receptor-1 Antagonists|Receptor, PAR-1, antagonists & inhibitors|Receptors, Thrombin, antagonists & inhibitors",[H][C@@]12C[C@]3([H])C[C@@H](CC[C@@]3([H])[C@H](\C=C\C3=CC=C(C=N3)C3=CC(F)=CC=C3)[C@]1([H])[C@@H](C)OC2=O)NC(=O)OCC,10077130
8039,DB09031,Miltefosine,small molecule,approved|investigational,Alcohols|Amines|Amino Alcohols|Ammonium Compounds|Anti-Infective Agents|Antifungal Agents|Antileishmanial|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Antiparasitic Agents|Antiprotozoals|Ethanolamines|Narrow Therapeutic Index Drugs|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds|Trimethyl Ammonium Compounds,CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C,3599
8041,DB09034,Suvorexant,small molecule,approved|investigational,"Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Hypnotics and Sedatives|Miscellaneous Anxiolytics Sedatives and Hypnotics|Nervous System|Neurotransmitter Agents|Orexin Receptor Antagonists|P-glycoprotein inhibitors|Psycholeptics|Sleep Aids, Pharmaceutical",[H][C@@]1(C)CCN(CCN1C(=O)C1=C(C=CC(C)=C1)N1N=CC=N1)C1=NC2=C(O1)C=CC(Cl)=C2,24965990
8045,DB09038,Empagliflozin,small molecule,approved,Alimentary Tract and Metabolism|BCRP/ABCG2 Substrates|Benzene Derivatives|Blood Glucose Lowering Agents|Drugs that are Mainly Renally Excreted|Drugs Used in Diabetes|Glycosides|Hypotensive Agents|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein substrates|Sodium-glucose co-transporter 2 (SGLT2) inhibitors|Sodium-Glucose Transporter 2 Inhibitors|UGT1A3 substrates|UGT1A9 Substrates|UGT2B7 substrates,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC=C(Cl)C(CC2=CC=C(O[C@H]3CCOC3)C=C2)=C1,11949646
8046,DB09039,Eliglustat,small molecule,approved,Alimentary Tract and Metabolism|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Gaucher Disease|Glucosylceramide Synthase Inhibitor|Glucosylceramide Synthase Inhibitors|Highest Risk QTc-Prolonging Agents|Other Miscellaneous Therapeutic Agents|P-glycoprotein inhibitors|P-glycoprotein substrates|QTc Prolonging Agents|Various Alimentary Tract and Metabolism Products,CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)C1=CC=C2OCCOC2=C1,23652731
8047,DB09040,Efinaconazole,small molecule,approved,Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Azole Antifungals|Dermatologicals|Imidazole and Triazole Derivatives,C[C@@H](N1CCC(=C)CC1)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,489181
8048,DB09041,Tavaborole,small molecule,approved|investigational,Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Dermatologicals|Oxaborole Antifungal|Protein Synthesis Inhibitors,OB1OCC2=CC(F)=CC=C12,11499245
8049,DB09042,Tedizolid phosphate,small molecule,approved,Anti-Bacterial Agents|Anti-Infective Agents|Antidepressive Agents|Central Nervous System Depressants|Immunosuppressive Agents|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Myelosuppressive Agents|Organophosphorus Compounds|Oxazolidinone Antibacterial|Oxazolidinones|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators,CN1N=NC(=N1)C1=CC=C(C=N1)C1=CC=C(C=C1F)N1C[C@H](COP(O)(O)=O)OC1=O,11476460
8053,DB09047,Finafloxacin,small molecule,approved|investigational,"Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antineoplastic Agents|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Quinolines|Quinolone Antimicrobial|Quinolones|Renal Agents|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",[H][C@]12CN(C[C@]1([H])OCCN2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1C#N)C(O)=O,11567473
8054,DB09048,Netupitant,small molecule,approved|investigational,Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Netupitant and prodrug|Neurokinin 1 Antagonists|P-glycoprotein inhibitors|Substance P/Neurokinin-1 Receptor Antagonist,CN(C(=O)C(C)(C)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C1=CN=C(C=C1C1=CC=CC=C1C)N1CCN(C)CC1,6451149
8055,DB09049,Naloxegol,small molecule,approved,"Alcohols|Alimentary Tract and Metabolism|Alkaloids|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs for Constipation|Ethylene Glycols|Glycols|Heterocyclic Compounds, Fused-Ring|Macromolecular Substances|Miscellaneous GI Drugs|Narcotics|Opiate Alkaloids|Opioid Antagonists|Peripheral Nervous System Agents|Peripheral Opioid Receptor Antagonists|Phenanthrenes|Polymers|Sensory System Agents",COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC=C)[C@H]1O5,56959087
8056,DB09050,Ceftolozane,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Sulfur Compounds|Thiazines",CN1C(N)=C(NC(=O)NCCN)C=[N+]1CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=NSC(N)=N1)C2=O)C([O-])=O,53234134
8059,DB09053,Ibrutinib,small molecule,approved,Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Immunosuppressive Agents|Kinase Inhibitor|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Protein Kinase Inhibitors|Tyrosine Kinase Inhibitors,NC1=NC=NC2=C1C(=NN2[C@@H]1CCCN(C1)C(=O)C=C)C1=CC=C(OC2=CC=CC=C2)C=C1,24821094
8060,DB09054,Idelalisib,small molecule,approved,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Class Ia Phosphatidylinositol 3-Kinase, antagonists & inhibitors|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Hepatotoxic Agents|Heterocyclic Compounds, Fused-Ring|Immunosuppressive Agents|Kinase Inhibitor|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Quinazolines|UGT1A4 Inhibitors|UGT1A4 substrates",[H][C@@](CC)(NC1=NC=NC2=C1N=CN2)C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1,11625818
8061,DB09055,Acipimox,small molecule,approved|investigational,"Agents Causing Muscle Toxicity|Hypolipidemic Agents|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Nicotinic Acid and Derivatives|Noxae|Toxic Actions",CC1=[N+]([O-])C=C(N=C1)C(O)=O,5310993
8062,DB09056,Amorolfine,small molecule,approved|investigational,Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Dermatologicals|Oxazines,[H]C(C)(CN1C[C@]([H])(C)O[C@]([H])(C)C1)CC1=CC=C(C=C1)C(C)(C)CC,
8064,DB09059,Atosiban,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Genito Urinary System and Sex Hormones|Hormone Antagonists|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Peptide Hormones|Peptides|Pituitary Hormones|Pituitary Hormones, Posterior|Reproductive Control Agents|Tocolytic Agents",[H][C@]1(NC(=O)[C@@]([H])(NC(=O)[C@@H](CC2=CC=C(OCC)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)[C@@H](C)CC)[C@@H](C)O,
8065,DB09060,Avibactam,small molecule,approved,Anti-Infective Agents|Aza Compounds|beta-Lactamase Inhibitors|Enzyme Inhibitors|OAT3/SLC22A8 Substrates,NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(O)(=O)=O,9835049
8066,DB09061,Cannabidiol,small molecule,approved|investigational,Agents producing tachycardia|Agents that produce hypertension|Anticonvulsants|Antidepressive Agents|BCRP/ABCG2 Inhibitors|Cannabinoids and similars|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Nervous System|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists|Terpenes,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1,644019
8067,DB09062,Cefminox,small molecule,experimental,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Second-Generation Cephalosporins|Sulfur Compounds|Thiazines",[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)CSC[C@@H](N)C(O)=O)OC)C(O)=O,
8068,DB09063,Ceritinib,small molecule,approved,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Bradycardia-Causing Agents|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Hyperglycemia-Associated Agents|Kinase Inhibitor|Moderate Risk QTc-Prolonging Agents|Narrow Therapeutic Index Drugs|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Protein Kinase Inhibitors|QTc Prolonging Agents|Receptor Protein-Tyrosine Kinases, antagonists & inhibitors|Sulfur Compounds|Tyrosine Kinase Inhibitors",CC(C)OC1=C(NC2=NC=C(Cl)C(N2)=NC2=CC=CC=C2S(=O)(=O)C(C)C)C=C(C)C(=C1)C1CCNCC1,57379345
8069,DB09064,Ciprofibrate,small molecule,approved|investigational,"Acids, Acyclic|Agents Causing Muscle Toxicity|Benzene Derivatives|Butyrates|Carcinogens|Ethers|Fatty Acids|Fatty Acids, Volatile|Fibric Acids|Hypolipidemic Agents|Isobutyrates|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Lipids|Noxae|Peroxisome Proliferators|Phenols|Phenyl Ethers|Toxic Actions",CC(C)(OC1=CC=C(C=C1)C1CC1(Cl)Cl)C(O)=O,
8070,DB09065,Cobicistat,small molecule,approved,"Acids, Acyclic|Anti-HIV Agents|Anti-Infective Agents|Antiinfectives for Systemic Use|BCRP/ABCG2 Inhibitors|Breast Cancer Resistance Protein Inhibitors|Carbamates|Chemically-Induced Disorders|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strong)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strong)|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|Other Miscellaneous Therapeutic Agents|P-glycoprotein inhibitors|Sulfur Compounds|Thiazoles",CC(C)C1=NC(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)CC2=CC=CC=C2)=CS1,25151504
8072,DB09067,Corticorelin ovine triflutate,small molecule,approved,"Amino Acids, Peptides, and Proteins|Diagnostic Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Peptide Hormones|Peptides|Pituitary Hormone-Releasing Hormones|Proteins|Tests for Pituitary Function",CC[C@H](C)[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)[C@@H](C)CC)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(N)=O,16132344
8073,DB09068,Vortioxetine,small molecule,approved|investigational,Agents that produce hypertension|Anti-Anxiety Agents|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Piperazines|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT3 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists|Serotonin Receptor Antagonists|Tranquilizing Agents,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,71768094
8074,DB09069,Trimetazidine,small molecule,approved|investigational,Cardiac Therapy|Cardiovascular Agents|Piperazines|Vasodilating Agents,COC1=C(OC)C(OC)=C(CN2CCNCC2)C=C1,21109
8075,DB09070,Tibolone,small molecule,approved|investigational,"Anabolic Agents|Antineoplastic Agents, Hormonal|Cardiovascular Agents|Estrogen Receptor Modulators|Estrogens|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormone Antagonists|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Norpregnanes|Norsteroids|Sex Hormones and Modulators of the Genital System|Steroids",[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC(=O)CC3)C[C@@]([H])(C)[C@@]21[H],444008
8076,DB09071,Tasimelteon,small molecule,approved|investigational,"Central Nervous System Depressants|Cycloparaffins|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Hypnotics and Sedatives|Melatonin Receptor Agonists|Nervous System|Psycholeptics|Receptors, Melatonin, agonists",CCC(=O)NC[C@@H]1C[C@H]1C1=CC=CC2=C1CCO2,10220503
8077,DB09072,Sodium oxybate,small molecule,approved,"Acids, Acyclic|Adjuvants, Anesthesia|Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Butyrates|Central Nervous System Agents|Central Nervous System Depressants|Fatty Acids|Fatty Acids, Volatile|Hydroxy Acids|Hydroxybutyrates|Lipids|Miscellaneous Central Nervous System Agents|Nervous System",[Na+].OCCCC([O-])=O,23663870
8078,DB09073,Palbociclib,small molecule,approved|investigational,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cyclin-Dependent Kinases, antagonists & inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Immunosuppressive Agents|Kinase Inhibitor|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|OCT1 inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Protein Kinase Inhibitors",CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,5330286
8079,DB09074,Olaparib,small molecule,approved,Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Immunosuppressive Agents|Myelosuppressive Agents|P-glycoprotein inhibitors|P-glycoprotein substrates|Poly(ADP-ribose) Polymerase Inhibitors|Pyridazines,FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1,
8080,DB09075,Edoxaban,small molecule,approved,Anticoagulants|Antithrombins|Blood and Blood Forming Organs|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Factor Xa Inhibitors|Fibrinolytic Agents|Hematologic Agents|P-glycoprotein substrates|Protease Inhibitors|Serine Protease Inhibitors|Sulfur Compounds,CN(C)C(=O)[C@H]1CC[C@H](NC(=O)C(=O)NC2=NC=C(Cl)C=C2)[C@@H](C1)NC(=O)C1=NC2=C(CN(C)CC2)S1,10280735
8081,DB09076,Umeclidinium,small molecule,approved,"Adrenergics, Inhalants|Agents producing tachycardia|Agents to Treat Airway Disease|Anticholinergic Agents|Antimuscarinics Antispasmodics|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Drugs for Obstructive Airway Diseases|Muscarinic Antagonists|P-glycoprotein substrates|Pulmonary Disease, Chronic Obstructive, drug therapy",OC(C1=CC=CC=C1)(C1=CC=CC=C1)C12CC[N+](CCOCC3=CC=CC=C3)(CC1)CC2,11519070
8083,DB09078,Lenvatinib,small molecule,approved|investigational,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Benzene Derivatives|BSEP/ABCB11 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Kinase Inhibitor|Moderate Risk QTc-Prolonging Agents|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OCT2 Inhibitors|P-glycoprotein substrates|Protein Kinase Inhibitors|QTc Prolonging Agents|Receptor Tyrosine Kinase Inhibitors|Tyrosine Kinase Inhibitors",COC1=C(C=C2C(OC3=CC=C(NC(=O)NC4CC4)C(Cl)=C3)=CC=NC2=C1)C(N)=O,9823820
8084,DB09079,Nintedanib,small molecule,approved,"Antifibrotic Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Kinase Inhibitor|OCT1 inhibitors|OCT1 substrates|P-glycoprotein inhibitors|P-glycoprotein substrates|Protein Kinase Inhibitors|Tyrosine Kinase Inhibitors|UGT1A1 Substrates",COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1,9809715
8085,DB09080,Olodaterol,small molecule,approved,"Adrenergic Agonists|Adrenergic beta-1 Receptor Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Drugs for Obstructive Airway Diseases|Heterocyclic Compounds, Fused-Ring|Oxazines|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists",COC1=CC=C(CC(C)(C)NC[C@H](O)C2=C3OCC(=O)NC3=CC(O)=C2)C=C1,11504295
8086,DB09081,Idebenone,small molecule,approved|investigational,"Antioxidants|Benzoquinones|Coenzymes|Compounds used in a research, industrial, or household setting|Drugs that are Mainly Renally Excreted|Enzymes and Coenzymes|Nervous System|Protective Agents|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Quinones",COC1=C(OC)C(=O)C(CCCCCCCCCCCCO)=C(C)C1=O,12881464
8087,DB09082,Vilanterol,small molecule,approved,"Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Alcohols|Benzene Derivatives|Benzyl Compounds|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs for Obstructive Airway Diseases|Drugs that are Mainly Renally Excreted|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Immunosuppressive Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents",OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCOCC1=C(Cl)C=CC=C1Cl,10184665
8088,DB09083,Ivabradine,small molecule,approved,"Benzazepines|Bradycardia-Causing Agents|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists|Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker|Miscellaneous Cardiac Drugs|QTc Prolonging Agents",COC1=C(OC)C=C2[C@@H](CN(C)CCCN3CCC4=CC(OC)=C(OC)C=C4CC3=O)CC2=C1,132999
8089,DB09084,Benzydamine,small molecule,approved,"Agents causing hyperkalemia|Agents that produce hypertension|Alimentary Tract and Metabolism|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antiinflammatory Products for Vaginal Administration|Drugs that are Mainly Renally Excreted|Genito Urinary System and Sex Hormones|Heterocyclic Compounds, Fused-Ring|Indazoles|Mouthwashes and Gargles|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Pyrazoles|Stomatological Preparations|Throat Preparations|Topical Products for Joint and Muscular Pain",CN(C)CCCOC1=NN(CC2=CC=CC=C2)C2=CC=CC=C12,12555
8090,DB09085,Tetracaine,small molecule,approved|vet_approved,"Acids, Carbocyclic|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Aminobenzoates|Anesthetics|Anesthetics for Topical Use|Anesthetics, General|Anesthetics, Local|Antipruritics and Local Anesthetics|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Benzene Derivatives|Benzoates|Central Nervous System Agents|Dental Agents|Dermatologicals|Ester Local Anesthetic|Esters of Aminobenzoic Acid|Local Anesthesia|Nervous System|Ophthalmologicals|para-Aminobenzoates|Peripheral Nervous System Agents|Sensory Organs|Sensory System Agents|Vasoprotectives",CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,5411
8091,DB09086,Eugenol,small molecule,approved,"Acids, Carbocyclic|Anti-Infective Agents|Caffeic Acids|Cell-mediated Immunity|Cinnamates|Compounds used in a research, industrial, or household setting|Increased Histamine Release|Solvents|Standardized Chemical Allergen",COC1=C(O)C=CC(CC=C)=C1,3314
8092,DB09087,Potassium alum,small molecule,approved,"Acids|Acids, Noncarboxylic|Adjuvants, Immunologic|Aluminium Compounds|Anions|Electrolytes|Immunologic Factors|Ions|Metal cations|Metal divalent cations|Potassium Salt|Sulfates|Sulfur Acids|Sulfur Compounds|Sulfuric Acids",[Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O,24856
8093,DB09088,Amylocaine,small molecule,approved|withdrawn,"Acids, Carbocyclic|Benzene Derivatives",CCC(C)(CN(C)C)OC(=O)C1=CC=CC=C1,10767
8094,DB09089,Trimebutine,small molecule,approved,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents producing tachycardia|Alimentary Tract and Metabolism|Antiarrhythmic agents|Anticholinergic Agents|Antimuscarinics Antispasmodics|Autonomic Agents|Benzene Derivatives|Benzoates|Bradycardia-Causing Agents|Calcium Channel Blockers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs for Functional Gastrointestinal Disorders|Drugs that are Mainly Renally Excreted|Ethers|Gastrointestinal Agents|Hydroxy Acids|Hydroxybenzoate Ethers|Hydroxybenzoates|Muscarinic Antagonists|Parasympatholytics|Peripheral Nervous System Agents|Phenols|Phenyl Ethers|Potential QTc-Prolonging Agents|Prokinetic Agents|QTc Prolonging Agents|Synthetic Anticholinergics, Esters With Tertiary Amino Group",CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1,5573
8095,DB09090,Pinaverium,small molecule,approved,Agents causing hyperkalemia|Alimentary Tract and Metabolism|Antiarrhythmic agents|Autonomic Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs for Functional Gastrointestinal Disorders|Membrane Transport Modulators|Miscellaneous GI Drugs|Oxazines|Parasympatholytics|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Vasodilating Agents,COC1=C(OC)C=C(C[N+]2(CCOCCC3CCC4CC3C4(C)C)CCOCC2)C(Br)=C1,40704
8096,DB09091,Tixocortol,small molecule,approved|withdrawn,"11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Adrenal Cortex Hormones|Alimentary Tract and Metabolism|Anti-Allergic Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Cell-mediated Immunity|Corticosteroids|Corticosteroids Acting Locally|Drugs that are Mainly Renally Excreted|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Immunosuppressive Agents|Increased Histamine Release|Intestinal Antiinflammatory Agents|Nasal Preparations|Pregnanes|Pregnenediones|Pregnenes|Standardized Chemical Allergen|Steroids",[H][C@@]12CC[C@](O)(C(=O)CS)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,162955
8097,DB09092,Xanthinol,small molecule,approved|withdrawn,"Alkaloids|Cardiovascular Agents|Heterocyclic Compounds, Fused-Ring|Nicotinic Acids|Peripheral Vasodilators|Purine Derivatives|Purines|Purinones|Pyridines|Vasodilating Agents",CN(CCO)CC(O)CN1C=NC2=C1C(=O)N(C)C(=O)N2C,9913
8098,DB09093,Chlortetracycline,small molecule,approved|investigational|vet_approved,Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antibiotics for Topical Use|Antiinfectives and Antiseptics for Local Oral Treatment|Antiinfectives for Systemic Use|Antiparasitic Agents|Antiprotozoals|Dermatologicals|Enzyme Inhibitors|Naphthacenes|Ophthalmologicals|Protein Synthesis Inhibitors|Sensory Organs|Stomatological Preparations|Tetracyclines,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC(Cl)=C1[C@@]3(C)O,54708735
8099,DB09094,Podophyllin,small molecule,approved,"Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Biological Products|Caustics|Complex Mixtures|Compounds used in a research, industrial, or household setting|Dermatologicals|Keratolytic Agents|Misc. Skin and Mucous Membrane Agents|Noxae|Pharmaceutical Preparations|Plant Extracts|Plant Preparations|Toxic Actions",COC1=CC(=CC(OC)=C1OC)C1C2C(COC2=O)C(O)C2=CC3=C(OCO3)C=C12.COC1=CC(=CC(OC)=C1OC)C1C2C(COC2=O)C(O)C2=CC3=C(OCO3)C=C12.COC1=CC(=CC(OC)=C1OC)C1C(C(CO)C(O)C2=CC3=C(OCO3)C=C12)C(O)=O.COC1=CC(=CC(OC)=C1OC)C1C(C(CO)C(O)C2=CC3=C(OCO3)C=C12)C(O)=O,11979494
8100,DB09095,Difluocortolone,small molecule,approved|investigational|withdrawn,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Dermatologicals|Drugs that are Mainly Renally Excreted|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Pregnadienediols|Pregnadienes|Pregnanes|Steroids|Steroids, Fluorinated",[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,11954369
8101,DB09096,Benzoyl peroxide,small molecule,approved,"Acids, Carbocyclic|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Benzene Derivatives|Benzoates|Dermatologicals|Keratolytic Agents|Nitrogen Binding Agent|Peroxides",O=C(OOC(=O)C1=CC=CC=C1)C1=CC=CC=C1,7187
8102,DB09097,Quinagolide,small molecule,approved|investigational,"Dopamine Agents|Dopamine Agonists|Dopamine D2 Receptor Agonists|Genito Urinary System and Sex Hormones|Heterocyclic Compounds, Fused-Ring|Miscellaneous Therapeutic Agents|Neurotransmitter Agents|Prolactine Inhibitors|Quinolines",[H][C@]12C[C@@H](CN(CCC)[C@]1([H])CC1=CC=CC(O)=C1C2)NS(=O)(=O)N(CC)CC,3086401
8104,DB09099,Somatostatin,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|P-glycoprotein substrates|Pancreatic Hormones|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormone Release Inhibiting Hormones|Proteins|Somatostatin and Analogues|Somatostatin, agonists|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",C[C@@H](O)[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC1=O)C(O)=O)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)O,16129681
8106,DB09101,Elvitegravir,small molecule,approved,"Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Direct Acting Antivirals|Heterocyclic Compounds, Fused-Ring|HIV Integrase|HIV Integrase Inhibitors|Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor|Quinolines|UGT1A1 Substrates",[H][C@@](CO)(C(C)C)N1C=C(C(O)=O)C(=O)C2=C1C=C(OC)C(CC1=C(F)C(Cl)=CC=C1)=C2,5277135
8107,DB09102,Daclatasvir,small molecule,approved|investigational,Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Antivirals for treatment of HCV infections|BCRP/ABCG2 Inhibitors|Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Substrates|Direct Acting Antivirals|HCV Replication Complex Inhibitors|Hepatitis C Virus NS5A Inhibitor|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates,COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C1=NC=C(N1)C1=CC=C(C=C1)C1=CC=C(C=C1)C1=CN=C(N1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C,25154714
8109,DB09104,Magnesium hydroxide,small molecule,approved|investigational,"Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Alkalies|Aluminum and magnesium containing antacids|Anions|Antacids|Antacids and Adsorbents|Basic Ointments and Protectants|Calculi Dissolution Agent|Drugs for Acid Related Disorders|Drugs that are Mainly Renally Excreted|Electrolytes|Emollients Demulcents and Protectants|Gastric Acid Lowering Agents|Gastrointestinal Agents|Genito Urinary System and Sex Hormones|Hydroxides|Ions|Laxatives|Laxatives, magnesium containing|Magnesium Compounds|Magnesium Salts|Metal cations|Metal divalent cations|Osmotic Laxatives|Urologicals",[OH-].[OH-].[Mg++],73981
8111,DB09106,Hydroxyethyl Starch,small molecule,approved,"Biomimetic Materials|Biopolymers|Blood and Blood Forming Organs|Blood and Related Products|Blood Substitutes|Blood Substitutes and Perfusion Solutions|Blood Substitutes and Plasma Protein Fractions|Carbohydrates|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Dietary Carbohydrates|Drugs that are Mainly Renally Excreted|Food|Food and Beverages|Glucans|Hematologic Agents|Increased Intravascular Volume|Macromolecular Substances|Osmotic Activity|Physiological Phenomena|Plasma Substitutes|Polymers|Polysaccharides|Replacement Preparations|Starch",,
8115,DB09110,Coenzyme M,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Alkanes|Alkanesulfonates|Alkanesulfonic Acids|Compounds used in a research, industrial, or household setting|Cough and Cold Preparations|Cytoprotective Agent|Detoxifying Agents for Antineoplastic Treatment|Expectorants|Hydrocarbons, Acyclic|Mesna|Protective Agents|Sulfhydryl Compounds|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",OS(=O)(=O)CCS,598
8116,DB09111,Pentastarch,small molecule,approved|investigational,"Biomimetic Materials|Biopolymers|Blood Substitutes|Carbohydrates|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Dietary Carbohydrates|Drugs that are Mainly Renally Excreted|Food|Food and Beverages|Glucans|Hematologic Agents|Increased Intravascular Volume|Macromolecular Substances|Osmotic Activity|Physiological Phenomena|Plasma Substitutes|Polymers|Polysaccharides|Starch",,
8117,DB09112,Nitrous acid,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Anions|Antidotes|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Electrolytes|Food|Food Additives|Food and Beverages|Food Ingredients|Food Preservatives|Hypotensive Agents|Indicators and Reagents|Ions|Laboratory Chemicals|Nitrites|Nitrogen Compounds|Physiological Phenomena|Sodium Compounds",ON=O,23668193
8119,DB09114,Colfosceril palmitate,small molecule,approved|investigational|withdrawn,Alcohols|Carbohydrates|Glycerophosphates|Glycerophospholipids|Lipids|Lung Surfactants|Membrane Lipids|Phosphatidic Acids|Phosphatidylcholines|Phospholipids|Pulmonary Surfactants|Sugar Alcohols|Sugar Phosphates|Triose Sugar Alcohols,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC,452110
8120,DB09115,Diiodohydroxyquinoline,small molecule,approved,"Amebicides|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Heterocyclic Compounds, Fused-Ring|Hydroxyquinolines|Quinoline Derivatives|Quinolines",OC1=C2N=CC=CC2=C(I)C=C1I,3728
8121,DB09116,Calcium carbimide,small molecule,approved|withdrawn,Drugs Used in Addictive Disorders|Drugs Used in Alcohol Dependence|Nervous System,[Ca++].[N-]=C=[N-],56955933
8122,DB09117,Paraldehyde,small molecule,approved|investigational,Acetaldehyde|Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Psycholeptics,CC1OC(C)OC(C)O1,31264
8123,DB09118,Stiripentol,small molecule,approved,Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dioxoles|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Miscellaneous Anticonvulsants|Nervous System|Photosensitizing Agents,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1,5311454
8124,DB09119,Eslicarbazepine acetate,small molecule,approved,"Anticonvulsants|Carboxamide Derivatives|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Eslicarbazepine and prodrugs|Heterocyclic Compounds, Fused-Ring|Membrane Transport Modulators|Nervous System|Sodium Channel Blockers|UGT1A1 Substrates|Voltage-Gated Sodium Channel Blockers",CC(=O)O[C@H]1CC2=CC=CC=C2N(C(N)=O)C2=CC=CC=C12,179344
8125,DB09120,Zucapsaicin,small molecule,approved|investigational,"Alkaloids|Alkenes|Alkynes|Amides|Benzene Derivatives|Capsaicin and Similar Agents|Catechols|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Hydrocarbons, Acyclic|Lipids|Musculo-Skeletal System|Other Nonsteroidal Anti-inflammatory Agents|Phenols|Polyunsaturated Alkamides|Solanaceous Alkaloids|Topical Products for Joint and Muscular Pain",COC1=C(O)C=CC(CNC(=O)CCCC\C=C/C(C)C)=C1,1548942
8126,DB09121,Aurothioglucose,small molecule,approved|withdrawn,Antiinflammatory and Antirheumatic Products|Antirheumatic Agents|Drugs that are Mainly Renally Excreted|Gold Preparations|Musculo-Skeletal System|Organogold Compounds|Organometallic Compounds|Specific Antirheumatic Agents,OC[C@H]1O[C@H](S[Au])[C@H](O)[C@@H](O)[C@@H]1O,6104
8128,DB09123,Dienogest,small molecule,approved,"Adrenal Cortex Hormones|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptive Agents, Male|Contraceptives, Oral|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Estranes|Estrenes|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormone Antagonists|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Pregnadien Derivatives|Progestin Contraceptives|Progestins|Progestogens and Estrogens, Sequential Preparations|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids|Testosterone Congeners",[H][C@@]12CC[C@@](O)(CC#N)[C@@]1(C)CCC1=C3CCC(=O)C=C3CC[C@@]21[H],68861
8129,DB09124,Medrogestone,small molecule,approved|withdrawn,"Adrenal Cortex Hormones|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Pregnadien Derivatives|Pregnadienes|Pregnanes|Progestins|Progestogens and Estrogens, Sequential Preparations|Sex Hormones and Modulators of the Genital System|Steroids",[H][C@@]12CC[C@](C)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=C(C)C2=CC(=O)CC[C@]12C,9949848
8130,DB09125,Potassium citrate,small molecule,approved|investigational|vet_approved,"Acids, Acyclic|Agents causing hyperkalemia|Alimentary Tract and Metabolism|Alkalinizing Activity|Anticoagulants|Calculi Dissolution Agent|Cardiovascular Agents|Citrates|Citric Acid Derivatives|Diuretics|Expectorants|Metabolic Alkalinizer|Mineral Supplements|Natriuretic Agents|Potassium Salt|Replacement Preparations|Respiratory System Agents|Tricarboxylic Acids|Urinary Alkalinisers",[K+].[K+].[K+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,13344
8132,DB09128,Brexpiprazole,small molecule,approved|investigational,"Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antidepressive Agents|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Agonists|Dopamine D2 Receptor Agonists|Heterocyclic Compounds, Fused-Ring|Hyperglycemia-Associated Agents|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Psycholeptics|Quinolines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Agonists|Serotonin Receptor Antagonists|Sulfur Compounds",O=C1NC2=CC(OCCCCN3CCN(CC3)C3=C4C=CSC4=CC=C3)=CC=C2C=C1,11978813
8133,DB09129,Chromic chloride,small molecule,approved,"Acids|Acids, Noncarboxylic|Anions|Antioxidants|Chlorine Compounds|Compounds used in a research, industrial, or household setting|Drugs that are Mainly Renally Excreted|Electrolytes|Ions|Minerals|Protective Agents|Replacement Preparations",[Cl-].[Cl-].[Cl-].[Cr+3],6452300
8134,DB09130,Copper,small molecule,approved|investigational,"Copper-containing Intrauterine Device|Decreased Embryonic Implantation|Decreased Sperm Motility|Diet, Food, and Nutrition|Elements|Food|Food and Beverages|Growth Substances|Inhibit Ovum Fertilization|Metals|Metals, Heavy|Micronutrients|Minerals|Physiological Phenomena|Replacement Preparations|Trace Elements|Transition Elements",[Cu],23978
8135,DB09131,Cupric Chloride,small molecule,approved|investigational,"Elements|Metals|Metals, Heavy|Transition Elements",Cl[Cu]Cl,24014
8136,DB09132,Gadoteric acid,small molecule,approved,"Alcohols|Amino Sugars|Carbohydrates|Chelating Agents|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Drugs that are Mainly Renally Excreted|Gadolinium-based Contrast Agent|Hexosamines|Magnetic Resonance Imaging Contrast Media|Paramagnetic Contrast Media|Roentgenography|Sequestering Agents|Sugar Alcohols",[Gd+3].OC(=O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1,158536
8137,DB09133,Iothalamic acid,small molecule,approved,"Acids, Carbocyclic|Alcohols|Amino Sugars|Benzene Derivatives|Benzoates|Carbohydrates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Drugs that are Mainly Renally Excreted|Hexosamines|Iodobenzoates|Radiographic Contrast Agent|Roentgenography|Sugar Alcohols|Triiodobenzoic Acids|Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media|X-Ray Contrast Activity|X-Ray Contrast Media, Iodinated",CNC(=O)C1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I,3737
8138,DB09134,Ioversol,small molecule,approved,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Drugs that are Mainly Renally Excreted|Iodinated Contrast Agents|Iodobenzoates|Radiographic Contrast Agent|Roentgenography|Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media|X-Ray Contrast Activity|X-Ray Contrast Media, Iodinated",OCCN(C(=O)CO)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I,3741
8139,DB09135,Ioxilan,small molecule,approved,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Drugs that are Mainly Renally Excreted|Iodinated Contrast Agents|Iodobenzoates|Radiographic Contrast Agent|Triiodobenzoic Acids|Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media|X-Ray Contrast Activity|X-Ray Contrast Media, Iodinated",CC(=O)N(CC(O)CO)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCCO)=C1I,3743
8140,DB09136,Isosulfan blue,small molecule,approved,"Amines|Aniline Compounds|Coloring Agents|Compounds used in a research, industrial, or household setting|Drugs that are Mainly Renally Excreted",CCN(CC)C1=CC=C(C=C1)C(=C1C=CC(C=C1)=[N+](CC)CC)C1=CC(=CC=C1S(O)(=O)=O)S(O)(=O)=O,50108
8141,DB09137,Technetium Tc-99m mebrofenin,small molecule,approved,"Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Compounds used in a research, industrial, or household setting|Diagnostic Radiopharmaceuticals|Diagnostic Uses of Chemicals|Drugs that are Mainly Renally Excreted|Hepatic and Reticulo Endothelial System|Imines|Indicators and Reagents|Laboratory Chemicals|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|Organometallic Compounds|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Radiopharmaceuticals|Technetium (99Mtc) Compounds",[99Tc].[H]OC(=O)C([H])([H])N(C([H])([H])C(=O)O[H])C([H])([H])C(=O)N([H])C1=C(C(Br)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H],11431716
8142,DB09138,Technetium Tc-99m medronate,small molecule,approved,"Compounds used in a research, industrial, or household setting|Diagnostic Radiopharmaceuticals|Diagnostic Uses of Chemicals|Indicators and Reagents|Laboratory Chemicals|Organometallic Compounds|Organophosphonates|Organophosphorus Compounds|Organotechnetium Compounds|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Radiopharmaceuticals|Skeleton|Technetium (99Mtc) Compounds",O.O.[98Tc+4].[O-]P([O-])(=O)CP([O-])([O-])=O,131704315
8143,DB09139,Technetium Tc-99m oxidronate,small molecule,approved,Diagnostic Radiopharmaceuticals|Drugs that are Mainly Renally Excreted|Organometallic Compounds|Organophosphonates|Organophosphorus Compounds|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Skeleton|Technetium (99Mtc) Compounds,[99Tc].OC(P(O)(O)=O)P(O)(O)=O,123801
8144,DB09140,Oxygen,small molecule,approved|vet_approved,Chalcogens|Elements|Gases|Medical Gases|Miscellaneous Therapeutic Agents|Other Miscellaneous Therapeutic Agents,O=O,977
8146,DB09142,Sincalide,small molecule,approved,"Amino Acids, Peptides, and Proteins|Cholecystokinin Analog|Diagnostic Agents|Gallbladder Function|Gastrointestinal Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|OATP1B3 substrates|Peptides|Tests for Bile Duct Patency",CSCC[C@H](NC(=O)[C@H](CC1=CC=C(OS(O)(=O)=O)C=C1)NC(=O)[C@@H](N)CC(O)=O)C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,9833444
8147,DB09143,Sonidegib,small molecule,approved|investigational,Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Benzene Derivatives|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Hedgehog Pathway Inhibitor|Narrow Therapeutic Index Drugs|Smoothened Receptor Antagonists,[H][C@]1(C)CN(C[C@@]([H])(C)O1)C1=CC=C(NC(=O)C2=CC=CC(=C2C)C2=CC=C(OC(F)(F)F)C=C2)C=N1,24775005
8148,DB09144,Uridine triacetate,small molecule,approved|investigational,"Acids, Acyclic|Alimentary Tract and Metabolism|Carbohydrates|Fatty Acids|Fatty Acids, Volatile|Glycosides|Lipids|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Analog|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides|Various Alimentary Tract and Metabolism Products",CC(=O)OC[C@H]1O[C@H]([C@H](OC(C)=O)[C@@H]1OC(C)=O)N1C=CC(=O)NC1=O,20058
8149,DB09145,Water,small molecule,approved,"Diluents|EENT Drugs, Miscellaneous|Irrigating Solutions|Other Miscellaneous Therapeutic Agents|Oxygen Compounds",O,962
8150,DB09146,Iron sucrose,small molecule,approved,"Acids, Acyclic|Carbohydrates|Disaccharides|Drugs for Treatment of Hyperkalemia and Hyperphosphatemia|Ferric Compounds|Hydroxy Acids|Iron Compounds|Iron Preparations|Iron Trivalent, Oral Preparations|Oligosaccharides|Organometallic Compounds|Pharmaceutical Preparations|Phosphate Binder|Phosphate-removing Agents|Polysaccharides|Sugar Acids",O.O.O.[OH-].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[Na+].[Na+].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O,91663255
8151,DB09147,Ferric pyrophosphate,small molecule,experimental,"Acids|Acids, Noncarboxylic|Anions|Electrolytes|Elements|Ions|Iron Compounds|Metals|Metals, Heavy|Parenteral Iron Replacement|Phosphate Binder|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Polyphosphates|Transition Elements",[Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O,24877
8152,DB09148,Florbetaben (18F),small molecule,approved,Amines|Benzene Derivatives|Benzylidene Compounds|Central Nervous System|Diagnostic Radiopharmaceuticals|Drugs that are Mainly Renally Excreted|Fluorine Radioisotopes|Positron Emitting Activity|Radioactive Diagnostic Agent,CNC1=CC=C(\C=C\C2=CC=C(OCCOCCOCC[18F])C=C2)C=C1,11501341
8153,DB09149,Florbetapir (18F),small molecule,approved|investigational,Alcohols|Amines|Central Nervous System|Diagnostic Radiopharmaceuticals|Drugs that are Mainly Renally Excreted|Fluorine Radioisotopes|Glycols|Positron Emitting Activity|Radioactive Diagnostic Agent,[H]N(C1=C([H])C([H])=C(\C([H])=C(/[H])C2=C([H])N=C(OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])[18F])C([H])=C2[H])C([H])=C1[H])C([H])([H])[H],24822371
8154,DB09151,Flutemetamol (18F),small molecule,approved|investigational,"Amines|Central Nervous System|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Radiopharmaceuticals|Diagnostic Uses of Chemicals|Heterocyclic Compounds, Fused-Ring|Indicators and Reagents|Laboratory Chemicals|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Radiopharmaceuticals|Sulfur Compounds|Thiazoles",CNC1=C([18F])C=C(C=C1)C1=NC2=CC=C(O)C=C2S1,15950376
8155,DB09152,Nitrogen,small molecule,approved|vet_approved,Elements|Gases|Medical Gases|Miscellaneous Therapeutic Agents|Other Miscellaneous Therapeutic Agents,N#N,947
8156,DB09153,Sodium chloride,small molecule,approved|vet_approved,"Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Anions|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Chlorides|Chlorine Compounds|Diluents|EENT Drugs, Miscellaneous|Electrolyte Solutions|Electrolytes|I.V. Solution Additives|Ions|Irrigating Solutions|Mineral Supplements|Miscellaneous Therapeutic Agents|Other Miscellaneous Therapeutic Agents|Replacement Preparations|Respiratory Agents, Miscellaneous|Salt Solutions|Sodium|Sodium Compounds",[Na+].[Cl-],5234
8157,DB09154,Sodium citrate,small molecule,approved|investigational,"Acids, Acyclic|Antacids and Adsorbents|Anticoagulants|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Buffers|Calculi Dissolution Agent|Citrates|Citric Acid Derivatives|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Food|Food Additives|Food and Beverages|Food Ingredients|Food Preservatives|Hematologic Agents|Irrigating Solutions|Laboratory Chemicals|Miscellaneous Anticoagulants|Miscellaneous GI Drugs|Neurotoxic agents|Physiological Phenomena|Salt Solutions|Tricarboxylic Acids|Urinary Alkalinisers",[Na+].[Na+].[Na+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,6224
8158,DB09155,Helium,small molecule,approved|investigational|vet_approved,Elements|Gases|Medical Gases|Miscellaneous Therapeutic Agents|Noble Gases|Other Miscellaneous Therapeutic Agents,[He],23987
8159,DB09156,Iopromide,small molecule,approved,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Drugs that are Mainly Renally Excreted|Iodinated Contrast Agents|Iodobenzoates|Radiographic Contrast Agent|Roentgenography|Triiodobenzoic Acids|Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media|X-Ray Contrast Activity|X-Ray Contrast Media, Iodinated",COCC(=O)NC1=C(I)C(C(=O)N(C)CC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I,3736
8160,DB09157,Carbon dioxide,small molecule,approved|investigational|vet_approved,"Anions|Carbon Compounds, Inorganic|Electrolytes|Gases|Ions|Medical Gases|Miscellaneous Therapeutic Agents|Other Diagnostics|Other Miscellaneous Therapeutic Agents|Oxides|Oxygen Compounds|Radiographic Contrast Agent|X-Ray Contrast Activity",O=C=O,280
8161,DB09158,Trypan blue free acid,small molecule,approved,"Acids|Acids, Noncarboxylic|Arylsulfonates|Arylsulfonic Acids|Azo Compounds|Coloring Agents|Compounds used in a research, industrial, or household setting|Diagnostic Dye|Naphthalenes|Naphthalenesulfonates|Ocular Disorders|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",CC1=CC(=CC=C1\N=N\C1=C(C=C2C=C(C=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C=C(C=C2C=C1S(O)(=O)=O)S(O)(=O)=O,9562061
8162,DB09160,Technetium Tc-99m tetrofosmin,small molecule,approved,"Compounds used in a research, industrial, or household setting|Diagnostic Radiopharmaceuticals|Diagnostic Uses of Chemicals|Indicators and Reagents|Laboratory Chemicals|Organometallic Compounds|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Radiopharmaceuticals|Technetium (99Mtc) Compounds",O.O.[98Tc].CCOCCP(CCOCC)CCP(CCOCC)CCOCC.CCOCCP(CCOCC)CCP(CCOCC)CCOCC,131704316
8163,DB09161,Technetium Tc-99m sestamibi,small molecule,approved|investigational,"Compounds used in a research, industrial, or household setting|Diagnostic Radiopharmaceuticals|Diagnostic Uses of Chemicals|Indicators and Reagents|Laboratory Chemicals|Nitriles|Organometallic Compounds|Organotechnetium Compounds|P-glycoprotein substrates|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Radiopharmaceuticals|Technetium (99Mtc) Compounds",[Tc+].COC(C)(C)C[N+]#[C-].COC(C)(C)C[N+]#[C-].COC(C)(C)C[N+]#[C-].COC(C)(C)C[N+]#[C-].COC(C)(C)C[N+]#[C-].COC(C)(C)C[N+]#[C-],22617237
8164,DB09163,Technetium Tc-99m exametazime,small molecule,approved,"Amines|Central Nervous System|Compounds used in a research, industrial, or household setting|Diagnostic Radiopharmaceuticals|Diagnostic Uses of Chemicals|Drugs that are Mainly Renally Excreted|Hydroxylamines|Indicators and Reagents|Laboratory Chemicals|Organometallic Compounds|Organotechnetium Compounds|Oximes|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Radiopharmaceuticals|Technetium (99Mtc) Compounds",,
8165,DB09164,Technetium Tc-99m disofenin,small molecule,approved,"Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Compounds used in a research, industrial, or household setting|Diagnostic Radiopharmaceuticals|Diagnostic Uses of Chemicals|Drugs that are Mainly Renally Excreted|Hepatic and Reticulo Endothelial System|Imines|Imino Acids|Indicators and Reagents|Laboratory Chemicals|Organometallic Compounds|Organotechnetium Compounds|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Radiopharmaceuticals|Technetium (99Mtc) Compounds",[99Tc].CC(C)C1=CC=CC(C(C)C)=C1NC(=O)CN(CC(O)=O)CC(O)=O,11430828
8166,DB09165,Technetium Tc-99m pyrophosphate,small molecule,approved,"Acids|Acids, Noncarboxylic|Anions|Compounds used in a research, industrial, or household setting|Diagnostic Radiopharmaceuticals|Diagnostic Uses of Chemicals|Diphosphates|Drugs that are Mainly Renally Excreted|Electrolytes|Indicators and Reagents|Ions|Laboratory Chemicals|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Polyphosphates|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Radiopharmaceuticals|Skeleton|Technetium (99Mtc) Compounds|Technetium Compounds",[99Tc+4].[O-]P([O-])(=O)OP([O-])([O-])=O,6452753
8167,DB09166,Etizolam,small molecule,experimental,"Anti-Anxiety Agents|Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Hypnotics and Sedatives|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents",CCC1=CC2=C(S1)N1C(C)=NN=C1CN=C2C1=CC=CC=C1Cl,3307
8168,DB09167,Dosulepin,small molecule,approved,"Adrenergic Agents|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that produce hypertension|Agents that reduce seizure threshold|Anticholinergic Agents|Antidepressive Agents|Antidepressive Agents, Tricyclic|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dibenzothiepins|Heterocyclic Compounds, Fused-Ring|Histamine Antagonists|Histamine H1 Antagonists|Membrane Transport Modulators|Muscarinic Antagonists|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Non-Selective Monoamine Reuptake Inhibitors|Potential QTc-Prolonging Agents|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists|Sulfur Compounds|Tertiary amine tricyclic antidepressants|Thiepins",CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12,5284550
8169,DB09168,4-Phenylfentanyl,small molecule,illicit,,CCC(=O)N(C1=CC=CC=C1)C1(CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,10319503
8170,DB09169,3-Allylfentanyl,small molecule,illicit,Piperidines,CCC(=O)N([C@@H]1CCN(CCC2=CC=CC=C2)C[C@@H]1CC=C)C1=CC=CC=C1,133866
8171,DB09170,β-Hydroxythiofentanyl,small molecule,illicit,,CCC(=O)N(C1CCN(CC(O)C2=CC=CS2)CC1)C1=CC=CC=C1,117072582
8172,DB09171,β-Methylfentanyl,small molecule,illicit,,CCC(=O)N(C1CCN(CC(C)C2=CC=CC=C2)CC1)C1=CC=CC=C1,6425761
8173,DB09172,Brifentanil,small molecule,illicit,Piperidines,CCN1N=NN(CCN2CC[C@@H]([C@H](C)C2)N(C(=O)COC)C2=CC=CC=C2F)C1=O,60672
8174,DB09173,Butyrfentanyl,small molecule,illicit,Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Piperidines|Street Drugs,CCCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,621174
8175,DB09174,Lofentanil,small molecule,illicit,Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Narcotics|Opioids|Peripheral Nervous System Agents|Piperidines|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,CCC(=O)N(C1=CC=CC=C1)[C@]1(CCN(CCC2=CC=CC=C2)C[C@H]1C)C(=O)OC,10070040
8176,DB09175,Mirfentanil,small molecule,experimental,Piperidines,O=C(N(C1CCN(CCC2=CC=CC=C2)CC1)C1=NC=CN=C1)C1=CC=CO1,60698
8177,DB09177,p-Fluorofentanyl,small molecule,illicit,,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=C(F)C=C1,62300
8178,DB09178,Phenaridine,small molecule,illicit,Amines|Aminopyridines|Pyridines,CCC(=O)N(C1CC(C)N(CCC2=CC=CC=C2)CC1C)C1=CC=CC=C1,162056
8179,DB09179,R-30490,small molecule,experimental,Piperidines,CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCC2=CC=CC=C2)CC1,124716
8180,DB09180,Thienylfentanyl,small molecule,illicit,,CCC(=O)N(C1CCN(CCC2=CC=CS2)CC1)C1=CC=CC=C1,62380
8181,DB09181,Trefentanil,small molecule,experimental,,CCN1N=NN(CCN2CCC(CC2)(N(C(=O)CC)C2=CC=CC=C2F)C2=CC=CC=C2)C1=O,60728
8182,DB09182,Benzylfentanyl,small molecule,illicit,Piperidines,CCC(=O)N(C1CCN(CC2=CC=CC=C2)CC1)C1=CC=CC=C1,252141
8183,DB09183,Dasabuvir,small molecule,approved,Amides|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Antivirals for treatment of HCV infections|BCRP/ABCG2 Inhibitors|Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Direct Acting Antivirals|Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor|P-glycoprotein substrates|Pyrimidines|Pyrimidinones|RNA Replicase Inhibitors|Sulfones|Sulfur Compounds|UGT1A1 Inhibitors,COC1=C(C=C(C=C1C1=CC2=CC=C(NS(C)(=O)=O)C=C2C=C1)N1C=CC(=O)NC1=O)C(C)(C)C,56640146
8184,DB09184,Edivoxetine,small molecule,investigational,Adrenergic Uptake Inhibitors|Alcohols|Antidepressive Agents|Central Nervous System Depressants|Oxazines,[H][C@]1(CNCCO1)[C@@](O)(CC1=C(OC)C=CC(F)=C1)C1CCOCC1,11186829
8185,DB09185,Viloxazine,small molecule,approved|investigational|withdrawn,"Adrenergic Agents|Adrenergic Uptake Inhibitors|Antidepressive Agents|Antidepressive Agents, Second-Generation|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Drugs that are Mainly Renally Excreted|Membrane Transport Modulators|Morpholines|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Oxazines|Psychoanaleptics|Psychotropic Drugs",CCOC1=CC=CC=C1OCC1CNCCO1,5666
8186,DB09186,Nisoxetine,small molecule,experimental,"Adrenergic Uptake Inhibitors|Amines|Antidepressive Agents|Central Nervous System Depressants|Norepinephrine, antagonists & inhibitors|Propylamines",CNCCC(OC1=CC=CC=C1OC)C1=CC=CC=C1,4500
8187,DB09187,Lortalamine,small molecule,experimental,"Adrenergic Uptake Inhibitors|Antidepressive Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Pyrans",CN1CCC23NC(=O)CC(C2C1)C1=CC(Cl)=CC=C1O3,3053755
8188,DB09188,Amedalin,small molecule,experimental,,CNCCC[C@]1(C)C(=O)N(C2=CC=CC=C12)C1=CC=CC=C1,76961482
8189,DB09189,Daledalin,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring",[H]N(C)CCCC1(C)CN(C2=CC=CC=C12)C1=CC=CC=C1,31707
8190,DB09190,Talopram,small molecule,experimental,"Adrenergic Uptake Inhibitors|Amines|Antidepressive Agents|Carbon Radioisotopes|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring",[H]N(C)CCCC1(OC(C)(C)C2=CC=CC=C12)C1=CC=CC=C1,23573
8191,DB09191,Talsupram,small molecule,experimental,Sulfur Compounds,[H]N(C)CCCC1(SC(C)(C)C2=CC=CC=C12)C1=CC=CC=C1,33014
8192,DB09192,Tandamine,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring",CCN1C2=CC=CC=C2C2=C1C(C)(CCN(C)C)SCC2,39187
8193,DB09193,"CP-39,332",small molecule,experimental,,CNC1CC(C2=CC=CC=C2)C2=CC=CC=C2C1,15657209
8194,DB09194,Etoperidone,small molecule,withdrawn,Antidepressive Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Drugs that are Mainly Renally Excreted|Nervous System|Piperazines|Psychoanaleptics|Pyridines|Pyridones|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists,CCN1C(=O)N(CCCN2CCN(CC2)C2=CC=CC(Cl)=C2)N=C1CC,40589
8195,DB09195,Lorpiprazole,small molecule,approved,Antidepressive Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Serotonin Agents|Serotonin Modulators,[H][C@@]12CCC[C@]1([H])C1=NN=C(CCN3CCN(CC3)C3=CC=CC(=C3)C(F)(F)F)N1C2,20055414
8196,DB09196,Lubazodone,small molecule,experimental,Oxazines,[H]N1CCO[C@H](COC2=C3CCCC3=C(F)C=C2)C1,157919
8197,DB09197,Mepiprazole,small molecule,experimental,,[H]N1N=C(CCN2CCN(CC2)C2=CC(Cl)=CC=C2)C=C1C,71897
8198,DB09198,Lobeglitazone,small molecule,experimental,"Blood Glucose Lowering Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|OATP1B1/SLCO1B1 Inhibitors|PPAR alpha, agonists|PPAR gamma, agonists|Sulfur Compounds|Thiazoles|Thiazolidinediones",COC1=CC=C(OC2=NC=NC(=C2)N(C)CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,9826451
8199,DB09199,Netoglitazone,small molecule,experimental,Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Sulfur Compounds|Thiazoles|Thiazolidinediones,FC1=C(COC2=CC=C3C=C(CC4SC(=O)NC4=O)C=CC3=C2)C=CC=C1,204109
8200,DB09200,Rivoglitazone,small molecule,experimental|investigational,Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Sulfur Compounds|Thiazoles|Thiazolidinediones,COC1=CC=C2N=C(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)N(C)C2=C1,3055168
8201,DB09201,Ciglitazone,small molecule,experimental,Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Sulfur Compounds|Thiazoles|Thiazolidinediones,CC1(COC2=CC=C(CC3SC(=O)NC3=O)C=C2)CCCCC1,2750
8202,DB09202,Cirazoline,small molecule,experimental,Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Cardiovascular Agents|Nasal Decongestants|Neurotransmitter Agents|Respiratory System Agents|Vasoconstrictor Agents,[H]N1CCN=C1COC1=CC=CC=C1C1CC1,2765
8203,DB09203,Synephrine,small molecule,experimental,Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Autonomic Agents|Biogenic Amines|Biogenic Monoamines|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Decongestants and Antiallergics|Ethanolamines|Nasal Decongestants|Neurotransmitter Agents|Ophthalmologicals|Peripheral Nervous System Agents|Respiratory System Agents|Sensory Organs|Sympathomimetics|Sympathomimetics Used as Decongestants|Vasoconstrictor Agents,CNCC(O)C1=CC=C(O)C=C1,7172
8204,DB09204,Arotinolol,small molecule,investigational,Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Bradycardia-Causing Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Hypotensive Agents|Neurotransmitter Agents|Propanols,CC(C)(C)NCC(O)CSC1=NC(=CS1)C1=CC=C(S1)C(N)=O,2239
8205,DB09205,Moxisylyte,small molecule,approved|investigational,Adrenergic Agents|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Amines|Autonomic Agents|Cardiovascular Agents|Cholinesterase substrates|Dimethylamines|Drugs that are Mainly Renally Excreted|Drugs Used in Erectile Dysfunction|Genito Urinary System and Sex Hormones|Methylamines|Miotics|Neurotransmitter Agents|Peripheral Nervous System Agents|Peripheral Vasodilators|Sympatholytics|Urologicals|Vasodilating Agents,CC(C)C1=C(OCCN(C)C)C=C(C)C(OC(C)=O)=C1,4260
8206,DB09206,Trimazosin,small molecule,experimental,"Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Antiadrenergic Agents, Peripherally Acting|Antihypertensive Agents|Cardiovascular Agents|Neurotransmitter Agents|Peripheral alpha-1 blockers|Vasodilating Agents",COC1=CC2=C(N=C(N=C2N)N2CCN(CC2)C(=O)OCC(C)(C)O)C(OC)=C1OC,37264
8207,DB09207,AS-8112,small molecule,experimental,Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Neurotransmitter Agents,[H]N(C)C1=C(Br)C=C(C(=O)N([H])[C@@H]2CN(C)CCN(CC)C2)C(OC)=C1,10993014
8209,DB09209,Pholcodine,small molecule,approved|illicit,"Alkaloids|Analgesics|Antitussive Agents|Central Nervous System Agents|Cough and Cold Preparations|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Morphinans|Morphine Derivatives|Opiate Alkaloids|Opium Alkaloids and Derivatives|Oxazines|Peripheral Nervous System Agents|Phenanthrenes|Respiratory System Agents|Sensory System Agents",[H][C@@]12OC3=C(OCCN4CCOCC4)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,5311356
8210,DB09210,Piracetam,small molecule,approved|investigational,"Acetamides|Acetates|Acids, Acyclic|Amides|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Drugs that are Mainly Renally Excreted|Fatty Acids|Fatty Acids, Volatile|Lipids|Nervous System|Neuroprotective Agents|Nootropic Agents|Protective Agents|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Pyrrolidines|Pyrrolidinones",NC(=O)CN1CCCC1=O,
8211,DB09211,Limaprost,small molecule,investigational,"Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Prostaglandins|Prostaglandins E",CCCC[C@H](C)C[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(O)=O,6438378
8212,DB09212,Loxoprofen,small molecule,approved,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antirheumatic Agents|Central Nervous System Agents|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Sensory System Agents|UGT2B7 substrates",CC(C(O)=O)C1=CC=C(CC2CCCC2=O)C=C1,3965
8213,DB09213,Dexibuprofen,small molecule,approved|investigational,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Phenylpropionates|Propionates|UGT1A1 Substrates|UGT1A3 substrates|UGT1A9 Substrates|UGT2B7 substrates",CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O,39912
8214,DB09214,Dexketoprofen,small molecule,approved|investigational,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antirheumatic Agents|Central Nervous System Agents|Drugs that are Mainly Renally Excreted|Glycols|Musculo-Skeletal System|Nephrotoxic agents|Nervous System|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Phenylpropionates|Propionates|Propylene Glycols|Sensory System Agents|Topical Products for Joint and Muscular Pain",[H][C@@](C)(C(O)=O)C1=CC(=CC=C1)C(=O)C1=CC=CC=C1,667550
8215,DB09215,Droxicam,small molecule,withdrawn,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Oxicams|Peripheral Nervous System Agents|Sensory System Agents",CN1C2=C(OC(=O)N(C2=O)C2=CC=CC=N2)C2=CC=CC=C2S1(=O)=O,65679
8216,DB09216,Tolfenamic acid,small molecule,approved|investigational,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Aminobenzoates|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiarrhythmic agents|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Benzene Derivatives|Benzoates|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Central Nervous System Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fenamates|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Membrane Transport Modulators|Migraine Disorders, drug therapy|Musculo-Skeletal System|Nephrotoxic agents|Neurotransmitter Agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Prostaglandin Antagonists|Sensory System Agents",CC1=C(Cl)C=CC=C1NC1=CC=CC=C1C(O)=O,610479
8217,DB09217,Firocoxib,small molecule,experimental|vet_approved,"Agents causing hyperkalemia|Agents that produce hypertension|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Furans|Lactones|Nephrotoxic agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sulfur Compounds",CC1(C)OC(=O)C(OCC2CC2)=C1C1=CC=C(C=C1)S(C)(=O)=O,208910
8218,DB09218,Clonixin,small molecule,experimental,"Agents causing hyperkalemia|Agents that produce hypertension|Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antirheumatic Agents|Central Nervous System Agents|Nephrotoxic agents|Nicotinic Acids|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Pyridines|Sensory System Agents",CC1=C(NC2=C(C=CC=N2)C(O)=O)C=CC=C1Cl,28718
8219,DB09219,Bisoxatin,small molecule,approved,Alimentary Tract and Metabolism|Contact Laxatives|Drugs for Constipation|Drugs that are Mainly Renally Excreted|Laxatives,OC1=CC=C(C=C1)C1(OC2=CC=CC=C2NC1=O)C1=CC=C(O)C=C1,28689
8220,DB09220,Nicorandil,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Agents causing hyperkalemia|Anions|Antiarrhythmic agents|Antihypertensive Agents|Cardiac Therapy|Cardiovascular Agents|Diet, Food, and Nutrition|Drugs that are Mainly Renally Excreted|Electrolytes|Food|Food and Beverages|Growth Substances|Ions|Micronutrients|Nicotinic Acids|Nitrates|Nitric Acid|Nitrogen Compounds|Physiological Phenomena|Pyridines|Vasodilating Agents|Vasodilators Used in Cardiac Diseases",[O-][N+](=O)OCCNC(=O)C1=CC=CN=C1,47528
8221,DB09221,Polaprezinc,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Anti-Ulcer Agents|Dipeptides|Gastrointestinal Agents|Metal cations|Metal divalent cations|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptides|Proteins|Zinc Compounds",NCCC(=O)N1[Zn]OC(=O)[C@@H]1CC1=CN=CN1,6918055
8223,DB09223,Blonanserin,small molecule,investigational,Antidepressive Agents|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs that are Mainly Renally Excreted|Neurotoxic agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists,CCN1CCN(CC1)C1=NC2=C(CCCCCC2)C(=C1)C1=CC=C(F)C=C1,125564
8224,DB09224,Melperone,small molecule,investigational,Antiarrhythmic agents|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Butyrophenone Derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs that are Mainly Renally Excreted|Ketones|Moderate Risk QTc-Prolonging Agents|Nervous System|Neurotoxic agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Tranquilizing Agents,CC1CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1,15387
8225,DB09225,Zotepine,small molecule,approved|investigational|withdrawn,"Antidepressive Agents|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotoxic agents|Psycholeptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Thiepins|Tranquilizing Agents",CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12,5736
8226,DB09226,Brilaroxazine,small molecule,investigational,Antidepressive Agents|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Agents|Central Nervous System Depressants|Neurotoxic agents|Neurotransmitter Agents|Psychotropic Drugs|Serotonin Agents|Tranquilizing Agents,ClC1=C(Cl)C(=CC=C1)N1CCN(CCCCOC2=CC=C3OCC(=O)NC3=C2)CC1,
8227,DB09227,Barnidipine,small molecule,experimental,Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dihydropyridine Derivatives|Dihydropyridines|Hypotensive Agents|Membrane Transport Modulators|Pyridines|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents,COC(=O)C1=C(C)NC(C)=C([C@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)O[C@H]1CCN(CC2=CC=CC=C2)C1,443869
8229,DB09229,Aranidipine,small molecule,experimental,Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Vasodilating Agents,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)=O,2225
8230,DB09230,Azelnidipine,small molecule,investigational,"Acids, Acyclic|Agents causing hyperkalemia|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Antiarrhythmic agents|Azetidines|Azetines|Bradycardia-Causing Agents|Calcium Channel Blockers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Imines|Imino Acids|Pyridines|Vasodilating Agents",CC(C)OC(=O)C1=C(C)NC(N)=C(C1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)OC1CN(C1)C(C1=CC=CC=C1)C1=CC=CC=C1,65948
8231,DB09231,Benidipine,small molecule,experimental,Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dihydropyridine Derivatives|Dihydropyridines|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents,COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(CC2=CC=CC=C2)C1,656668
8232,DB09232,Cilnidipine,small molecule,investigational,Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dihydropyridine Derivatives|Hypotensive Agents|Membrane Transport Modulators|Pyridines|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)OC\C=C\C1=CC=CC=C1,5282138
8233,DB09233,Cronidipine,small molecule,experimental,,[H]N1C(C)=C(C(C2=CC(=CC=C2)[N+]([O-])=O)C(C(=O)OCC2COC3(CCN(CC3)C3=CC=C(Cl)C=C3)O2)=C1C)C(=O)OC,65918
8234,DB09234,Darodipine,small molecule,experimental,Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dihydropyridines|Membrane Transport Modulators|Pyridines|Vasodilating Agents,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OCC,51701
8235,DB09235,Efonidipine,small molecule,experimental,Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Benzene Derivatives|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Diuretics|Hypotensive Agents|Membrane Transport Modulators|Natriuretic Agents|Nitro Compounds|Phenols|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Vasodilating Agents,CC1=C(C(C2=CC=CC(=C2)[N+]([O-])=O)C(=C(C)N1)P1(=O)OCC(C)(C)CO1)C(=O)OCCN(CC1=CC=CC=C1)C1=CC=CC=C1,119171
8236,DB09236,Lacidipine,small molecule,approved|investigational,Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dihydropyridine Derivatives|Hypotensive Agents|Membrane Transport Modulators|Mutagens|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1\C=C\C(=O)OC(C)(C)C)C(=O)OCC,5311217
8237,DB09237,Levamlodipine,small molecule,approved|investigational,Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Substrates|Nicotinic Acids|P-glycoprotein substrates|Pyridines,CCOC(=O)C1=C(COCCN)NC(C)=C([C@@H]1C1=CC=CC=C1Cl)C(=O)OC,9822750
8238,DB09238,Manidipine,small molecule,approved|investigational,ACE Inhibitors and Calcium Channel Blockers|Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dihydropyridine Derivatives|Membrane Transport Modulators|Pyridines|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)N(=O)=O)C(=O)OCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,4008
8239,DB09239,Niguldipine,small molecule,experimental,Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Antineoplastic Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Membrane Transport Modulators|P-glycoprotein inhibitors|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Vasodilating Agents,[H]N1C(C)=C([C@H](C2=CC(=CC=C2)[N+]([O-])=O)C(C(=O)OCCCN2CCC(CC2)(C2=CC=CC=C2)C2=CC=CC=C2)=C1C)C(=O)OC,60602
8240,DB09240,Niludipine,small molecule,experimental,Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dihydropyridines|Membrane Transport Modulators|Pyridines|Vasodilating Agents,[H]N1C(C)=C(C(C2=CC(=CC=C2)[N+]([O-])=O)C(C(=O)OCCOCCC)=C1C)C(=O)OCCOCCC,89767
8241,DB09241,Methylene blue,small molecule,approved|investigational,"Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Antidotes|Antipsychotic Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Diagnostic Agents|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Gastric Function|Heterocyclic Compounds, Fused-Ring|MATE 1 Inhibitors|MATE 2 Inhibitors|MATE inhibitors|Miscellaneous Therapeutic Agents|Monoamine Oxidase Inhibitors|Neurotoxic agents|OCT2 Inhibitors|Oxidation-Reduction Agent|P-glycoprotein inhibitors|P-glycoprotein substrates|Phenothiazines|Photosensitizing Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sulfur Compounds|Tests for Gastric Secretion|UGT1A4 Inhibitors|UGT1A9 Inhibitors",[Cl-].CN(C)C1=CC2=[S+]C3=C(C=CC(=C3)N(C)C)N=C2C=C1,6099
8242,DB09242,Moxonidine,small molecule,approved|investigational,"Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Antiadrenergic Agents, Centrally Acting|Antihypertensive Agents|Cardiovascular Agents|Hypotensive Agents|Imidazoline Receptor Agonists|Sympatholytics",COC1=NC(C)=NC(Cl)=C1NC1=NCCN1,4810
8243,DB09243,Hydracarbazine,small molecule,experimental,Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Central Nervous System Depressants|Monoamine Oxidase Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,[H]N([H])N([H])C1=NN=C(C=C1)C(=O)N([H])[H],71653
8244,DB09244,Pirlindole,small molecule,experimental,"Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Indoles|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Monoamine Oxidase Inhibitors|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists",CC1=CC=C2N3CCNC4CCCC(=C34)C2=C1,68802
8245,DB09245,Toloxatone,small molecule,experimental,Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Monoamine Oxidase A Inhibitors|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Monoamine Oxidase Inhibitors|Nervous System|Oxazoles|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,CC1=CC(=CC=C1)N1CC(CO)OC1=O,34521
8246,DB09246,Benmoxin,small molecule,withdrawn,Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Central Nervous System Depressants|Monoamine Oxidase Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,CC(NNC(=O)C1=CC=CC=C1)C1=CC=CC=C1,71671
8247,DB09247,Iproclozide,small molecule,withdrawn,"Acetates|Acids, Acyclic|Antidepressive Agents|Central Nervous System Depressants|Fatty Acids|Fatty Acids, Volatile|Hydroxy Acids|Lipids|Nervous System|Psychoanaleptics",CC(C)NNC(=O)COC1=CC=C(Cl)C=C1,19063
8248,DB09248,Mebanazine,small molecule,withdrawn,Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Central Nervous System Depressants|Monoamine Oxidase Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,CC(NN)C1=CC=CC=C1,6179
8249,DB09249,Octamoxin,small molecule,withdrawn,Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Central Nervous System Depressants|Monoamine Oxidase Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,CCCCCCC(C)NN,20811
8250,DB09250,Pheniprazine,small molecule,withdrawn,Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Central Nervous System Depressants|Monoamine Oxidase Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,CC(CC1=CC=CC=C1)NN,5929
8251,DB09251,Phenoxypropazine,small molecule,withdrawn,Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Central Nervous System Depressants|Monoamine Oxidase Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,[H]N([H])N([H])C(C)COC1=CC=CC=C1,71467
8252,DB09252,Pivhydrazine,small molecule,withdrawn,"Acids, Acyclic|Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Central Nervous System Depressants|Fatty Acids|Fatty Acids, Volatile|Lipids|Monoamine Oxidase Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",[H]N(CC1=CC=CC=C1)N([H])C(=O)C(C)(C)C,9375
8253,DB09253,Safrazine,small molecule,withdrawn,"Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Central Nervous System Depressants|Monoamine Oxidase Inhibitors|Monoamine Oxidase Inhibitors, Non-Selective|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",CC(CCC1=CC2=C(OCO2)C=C1)NN,34042
8254,DB09254,Caroxazone,small molecule,withdrawn,"Acetamides|Acetates|Acids, Acyclic|Agents that produce hypertension|Agents that reduce seizure threshold|Amides|Antidepressive Agents|Benzene Derivatives|Central Nervous System Depressants|Fatty Acids|Fatty Acids, Volatile|Lipids|Monoamine Oxidase Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",NC(=O)CN1CC2=CC=CC=C2OC1=O,29083
8255,DB09255,Dextran,small molecule,approved|investigational|vet_approved,"Anticoagulants|Biomimetic Materials|Biopolymers|Blood and Blood Forming Organs|Blood and Related Products|Blood Substitutes|Blood Substitutes and Perfusion Solutions|Blood Substitutes and Plasma Protein Fractions|Carbohydrates|Compounds used in a research, industrial, or household setting|Dextrans|Drugs that are Mainly Renally Excreted|Glucans|Hematologic Agents|Increased Intravascular Volume|Macromolecular Substances|Osmotic Activity|Plasma Substitutes|Polymers|Polysaccharides",,
8256,DB09256,Tegafur,small molecule,approved|investigational,Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2A6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Fluoropyrimidines|Fluorouracil and prodrugs|Narrow Therapeutic Index Drugs|Noxae|Pyrimidine Analogues|Pyrimidines|Pyrimidinones|Thyroxine-binding globulin inducers|Toxic Actions,FC1=CN(C2CCCO2)C(=O)NC1=O,5386
8257,DB09257,Gimeracil,small molecule,approved,Drugs that are Mainly Renally Excreted,OC1=CC(=O)NC=C1Cl,54679224
8258,DB09258,Bemiparin,small molecule,approved|investigational,Agents causing hyperkalemia|Anticoagulants|Blood and Blood Forming Organs|Carbohydrates|Glycosaminoglycans|Hematologic Agents|Heparin (Low Molecular Weight)|Heparin and similars|Polysaccharides,,
8259,DB09259,Reviparin,small molecule,approved|investigational,Agents causing hyperkalemia|Anticoagulants|Blood and Blood Forming Organs|Carbohydrates|Cardiovascular Agents|Fibrin Modulating Agents|Glycosaminoglycans|Hematologic Agents|Heparin (Low Molecular Weight)|Heparin and similars|Polysaccharides,,
8260,DB09260,Parnaparin,small molecule,approved|investigational,Agents causing hyperkalemia|Anticoagulants|Blood and Blood Forming Organs|Carbohydrates|Cardiovascular Agents|Fibrin Modulating Agents|Glycosaminoglycans|Hematologic Agents|Heparin (Low Molecular Weight)|Heparin and similars|Polysaccharides,,
8261,DB09261,Certoparin,small molecule,approved|investigational,Agents causing hyperkalemia|Anticoagulants|Carbohydrates|Glycosaminoglycans|Hematologic Agents|Heparin (Low Molecular Weight)|Heparin and similars|Polysaccharides,,
8262,DB09262,Imidafenacin,small molecule,investigational,Agents producing tachycardia|Anticholinergic Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Muscarinic Antagonists|UGT1A4 substrates,CC1=NC=CN1CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=C1,6433090
8263,DB09263,Patiromer,small molecule,approved|investigational,"Compounds used in a research, industrial, or household setting|Macromolecular Substances|Potassium Binder|Potassium Ion Binding Activity|Potassium-removing Agents",,
8265,DB09265,Lixisenatide,small molecule,approved,"Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Drugs that are Mainly Renally Excreted|Drugs Used in Diabetes|GLP-1 Agonists|Glucagon-like Peptide-1 (GLP-1) Agonists|Glucagon-like peptide-1 (GLP-1) analogues|Incretin Mimetics",CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CNC=N1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O,131704317
8266,DB09266,Technetium Tc-99m tilmanocept,small molecule,approved|investigational,Diagnostic Radiopharmaceuticals|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Technetium (99Mtc) Compounds|Tumour Detection,,
8267,DB09267,Strontium ranelate,small molecule,approved|withdrawn,Bone Density Conservation Agents|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Musculo-Skeletal System|Strontium|Sulfur Compounds,[Sr++].[Sr++].[O-]C(=O)CN(CC([O-])=O)C1=C(C#N)C(CC([O-])=O)=C(S1)C([O-])=O,6918182
8268,DB09268,Picosulfuric acid,small molecule,approved,"Acids, Acyclic|Alimentary Tract and Metabolism|Contact Laxatives|Drugs for Constipation|Drugs that are Mainly Renally Excreted|Gastrointestinal Agents|Laxatives|Pyridines|Tricarboxylic Acids",OS(=O)(=O)OC1=CC=C(C=C1)C(C1=CC=C(OS(O)(=O)=O)C=C1)C1=CC=CC=N1,5243
8269,DB09269,Phenylacetic acid,small molecule,approved,"Acids, Carbocyclic|Ammonium Ion Binding Activity|Nitrogen Binding Agent|Noxae|Toxic Actions|Urea Cycle Disorder Agents",OC(=O)CC1=CC=CC=C1,999
8270,DB09270,Ubidecarenone,small molecule,approved|investigational|nutraceutical,"Agents Causing Muscle Toxicity|Benzoquinones|Cardiac Therapy|Coenzymes|Diet, Food, and Nutrition|Electron Transport Chain Complex Proteins|Enzymes and Coenzymes|Food|Food and Beverages|Growth Substances|Hypoglycemia-Associated Agents|Micronutrients|Other Nutritional Agents|P-glycoprotein substrates|Physiological Phenomena|Quinones|Vitamins",COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O,5281915
8271,DB09271,Cimetropium,small molecule,experimental|investigational,"Alimentary Tract and Metabolism|Alkaloids|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Belladonna Alkaloids, Semisynthetic, Quaternary Ammonium Compounds|Belladonna and Derivatives, Plain|Drugs for Functional Gastrointestinal Disorders|Parasympatholytics|Peripheral Nervous System Agents|Tropanes",[H][C@](CO)(C(=O)O[C@@]1([H])C[C@@]2([H])[C@]3([H])O[C@]3([H])[C@@]([H])(C1)[N+]2(C)CC1CC1)C1=CC=CC=C1,20054871
8272,DB09272,Eluxadoline,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antipropulsives|Gastrointestinal Agents|Miscellaneous GI Drugs|Mixed Agonist / Antagonist Opioids|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|Opioid Antagonists|Opioids|Receptors, Opioid, delta, antagonists & inhibitors|Receptors, Opioid, mu, agonists|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",COC1=CC=C(CN([C@@H](C)C2=NC(=CN2)C2=CC=CC=C2)C(=O)[C@@H](N)CC2=C(C)C=C(C=C2C)C(N)=O)C=C1C(O)=O,11250029
8273,DB09273,Doxofylline,small molecule,experimental,"Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alkaloids|Anti-Asthmatic Agents|Antitussive Agents|Autonomic Agents|Bronchodilator Agents|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Drugs for Obstructive Airway Diseases|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Peripheral Nervous System Agents|Phosphodiesterase 5 Inhibitors|Phosphodiesterase Inhibitors|Purines|Purinones|Respiratory System Agents|Vasodilating Agents|Xanthine derivatives",CN1C2=C(N(CC3OCCO3)C=N2)C(=O)N(C)C1=O,50942
8274,DB09274,Artesunate,small molecule,approved|investigational,"Acids, Acyclic|Anions|Anthelmintics|Anti-Infective Agents|Antimalarials|Antineoplastic Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiplatyhelmintic Agents|Antiprotozoals|Antiviral Agents|Artemisinin and Derivatives, Plain|Artemisinins|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 Substrates|Dicarboxylic Acids|Electrolytes|Free Radicals|Ions|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|Oxides|Oxygen Compounds|P-glycoprotein substrates|Peroxides|Reactive Oxygen Species|Schistosomicides|Terpenes|UGT1A9 Substrates|UGT2B7 substrates",[H][C@@]12CC[C@@H](C)[C@]3([H])CC[C@@]4(C)OO[C@@]13[C@]([H])(O[C@@H](OC(=O)CCC(O)=O)[C@@H]2C)O4,6917864
8275,DB09275,Bismuth subcitrate potassium,small molecule,approved|investigational,Bismuth containing drugs|Neurotoxic agents,[K+].[K+].[K+].[K+].[K+].[Bi+3].[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O,118987133
8276,DB09276,Sodium aurothiomalate,small molecule,approved|investigational,"Acids, Acyclic|Antiinflammatory and Antirheumatic Products|Antirheumatic Agents|Dicarboxylic Acids|Drugs that are Mainly Renally Excreted|Gold Compounds|Gold Preparations|Hydroxy Acids|Malates|Musculo-Skeletal System|Organogold Compounds|Organometallic Compounds|Specific Antirheumatic Agents|Sulfhydryl Compounds|Sulfur Compounds|Thiomalates|UGT1A1 Inhibitors",[Na+].[Na+].[O-]C(=O)CC(S[Au])C([O-])=O,16760302
8277,DB09277,Choline C 11,small molecule,approved|investigational,Drugs that are Mainly Renally Excreted,[Cl-].C[N+](C)([11CH3])CCO,14989482
8278,DB09278,Activated charcoal,small molecule,approved,"Adsorption|Alimentary Tract and Metabolism|Anions|Antacids and Adsorbents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antidotes|Antifoaming Agents|Carbon|Charcoal Preparations|Compounds used in a research, industrial, or household setting|Electrolytes|Elements|Intestinal Adsorbents|Ions|Microspheres|Oxygen Compounds|Protective Agents",[C],297
8279,DB09279,Fimasartan,small molecule,investigational,"Agents Acting on the Renin-Angiotensin System|Agents causing hyperkalemia|Angiotensin II receptor blockers (ARBs) and diuretics|Angiotensin II receptor blockers (ARBs), plain|Angiotensin Receptor Antagonists|BCRP/ABCG2 Substrates|Benzene Derivatives|Hypotensive Agents|OATP1B1/SLCO1B1 Substrates",CCCCC1=NC(C)=C(CC(=S)N(C)C)C(=O)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1,9870652
8280,DB09280,Lumacaftor,small molecule,approved,"Amines|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Dioxoles|Heterocyclic Compounds, Fused-Ring|P-glycoprotein inducers|P-glycoprotein inhibitors|Pyridines",CC1=CC=C(NC(=O)C2(CC2)C2=CC=C3OC(F)(F)OC3=C2)N=C1C1=CC(=CC=C1)C(O)=O,16678941
8281,DB09281,Magnesium trisilicate,small molecule,approved,"Acids|Acids, Noncarboxylic|Agents that produce neuromuscular block (indirect)|Aluminum and magnesium containing antacids|Anions|Antacids|Calculi Dissolution Agent|Drugs that are Mainly Renally Excreted|Electrolytes|Gastric Acid Lowering Agents|Gastrointestinal Agents|Ions|Laxatives|Magnesium Compounds|Metal cations|Metal divalent cations|Minerals|Osmotic Laxatives|Oxides|Oxygen Compounds|Silicates|Silicon Compounds",[Mg++].[Mg++].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O,5311266
8282,DB09282,Molsidomine,small molecule,approved|investigational,Cardiac Therapy|Cardiovascular Agents|Morpholines|Nitric Oxide Donors|Oxadiazoles|Oxazines|Oxazoles|Sydnones|Vasodilating Agents|Vasodilators Used in Cardiac Diseases,CCOC(=O)[N-]C1=C[N+](=NO1)N1CCOCC1,5353788
8283,DB09283,Trapidil,small molecule,experimental,Antiplatelet agents|Cardiac Therapy|Cardiovascular Agents|Enzyme Inhibitors|Hematologic Agents|Phosphodiesterase Inhibitors|Pyrimidines|Triazoles|Vasodilating Agents|Vasodilators Used in Cardiac Diseases,CCN(CC)C1=CC(C)=NC2=NC=NN12,5531
8284,DB09284,Imolamine,small molecule,investigational,Cardiac Therapy|Cardiovascular Agents|Oxazoles|Vasodilating Agents|Vasodilators Used in Cardiac Diseases,CCN(CC)CCN1C(=N)ON=C1C1=CC=CC=C1,27501
8285,DB09285,Morniflumate,small molecule,experimental,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Amines|Aminobenzoates|Aniline Compounds|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Benzene Derivatives|Benzoates|Fenamates|Musculo-Skeletal System|Nephrotoxic agents|Nicotinic Acids|ortho-Aminobenzoates|Pyridines|UGT1A9 Inhibitors",FC(F)(F)C1=CC(NC2=C(C=CC=N2)C(=O)OCCN2CCOCC2)=CC=C1,72106
8286,DB09286,Pipamperone,small molecule,investigational,Antidepressive Agents|Antipsychotic Agents|Butyrophenone Derivatives|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Hypotensive Agents|Ketones|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Antagonists|Tranquilizing Agents,NC(=O)C1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N1CCCCC1,4830
8287,DB09287,Polyethylene glycol,small molecule,approved|vet_approved,"Alcohols|Alimentary Tract and Metabolism|Compounds used in a research, industrial, or household setting|Drug Delivery Systems|Drugs for Constipation|Electrolytes|Ethylene Glycols|Excipients|Gastrointestinal Agents|Glycols|Laxatives|Macromolecular Substances|Osmotic Activity|Osmotic Laxatives|P-glycoprotein inhibitors|Pegylated agents|Pharmaceutic Aids|Pharmaceutical Preparations|Pharmaceutical Vehicles|Polyethylene Glycols|Polymers|Solvents|Stimulation Large Intestine Fluid/Electrolyte Secretion|Surface-Active Agents",,
8288,DB09288,Propacetamol,small molecule,experimental,"Acetaminophen and Prodrugs|Acetanilides|Agents causing hyperkalemia|Agents that produce hypertension|Amides|Amines|Analgesics|Analgesics, Non-Narcotic|Anilides|Aniline Compounds|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antirheumatic Agents|Central Nervous System Agents|Cholinesterase substrates|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Nephrotoxic agents|Nervous System|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Prodrugs|Sensory System Agents|UGT1A1 Substrates|UGT1A6 substrate|UGT1A9 Substrates",CCN(CC)CC(=O)OC1=CC=C(NC(C)=O)C=C1,68865
8289,DB09289,Tianeptine,small molecule,investigational,"Agents Causing Muscle Toxicity|Agents that produce hypertension|Agents that reduce seizure threshold|Analgesics|Antidepressive Agents|Antidepressive Agents, Tricyclic|Azepines|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Sulfur Compounds|Thiepins",CN1C2=CC=CC=C2C(NCCCCCCC(O)=O)C2=C(C=C(Cl)C=C2)S1(=O)=O,68870
8290,DB09290,Ramosetron,small molecule,investigational,"Antidepressive Agents|Antiemetics|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|Peripheral Nervous System Agents|Serotonin Agents|Serotonin Receptor Antagonists",CN1C=C(C(=O)[C@@H]2CCC3=C(C2)N=CN3)C2=C1C=CC=C2,108000
8291,DB09291,Rolapitant,small molecule,approved|investigational,Alimentary Tract and Metabolism|Antiemetics and Antinauseants|BCRP/ABCG2 Inhibitors|Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Neurokinin 1 Antagonists|Neurokinin-1 Receptor Antagonists|Neurotransmitter Agents|P-glycoprotein inhibitors|Substance P/Neurokinin-1 Receptor Antagonist,C[C@@H](OC[C@]1(CC[C@]2(CCC(=O)N2)CN1)C1=CC=CC=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,10311306
8292,DB09292,Sacubitril,small molecule,approved,"Acids, Acyclic|Agents causing angioedema|Amino Acids|Amino Acids, Peptides, and Proteins|Butyrates|Drugs that are Mainly Renally Excreted|Fatty Acids|Fatty Acids, Volatile|Hypotensive Agents|Lipids|Neprilysin Inhibitor|Neprilysin, antagonists & inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors",CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C1=CC=CC=C1)NC(=O)CCC(O)=O,9811834
8293,DB09293,Iodide I-131,small molecule,approved|investigational,Diagnostic Radiopharmaceuticals|Iodine (131I) Compounds|Radioactive Therapeutic Agent|Radiopharmaceutical Activity|Therapeutic Radiopharmaceuticals|Thyroid Diagnostic Radiopharmaceuticals,[131I-],167195
8294,DB09295,Talniflumate,small molecule,experimental,"Agents causing hyperkalemia|Agents that produce hypertension|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Heterocyclic Compounds, Fused-Ring|Nephrotoxic agents|Niflumic Acid and Prodrugs|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)",FC(F)(F)C1=CC(NC2=C(C=CC=N2)C(=O)OC2OC(=O)C3=CC=CC=C23)=CC=C1,48229
8295,DB09296,Ombitasvir,small molecule,approved|investigational,"Acids, Acyclic|Amides|Amines|Aniline Compounds|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Antivirals for treatment of HCV infections|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 Substrates|Direct Acting Antivirals|Hepatitis C Virus NS5A Inhibitor|P-glycoprotein substrates|UGT1A1 Inhibitors",COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C(C=C1)[C@@H]1CC[C@H](N1C1=CC=C(C=C1)C(C)(C)C)C1=CC=C(NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)OC)C(C)C)C=C1,54767916
8296,DB09297,Paritaprevir,small molecule,approved|investigational,Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Antivirals for treatment of HCV infections|BCRP/ABCG2 Inhibitors|Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Direct Acting Antivirals|HCV NS3/4A Protease Inhibitors|NS3/4A Protease Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 inhibitors|OATP1B3 substrates|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|UGT1A1 Inhibitors,[H][C@@]12C[C@]1(NC(=O)[C@]1([H])C[C@H](CN1C(=O)[C@H](CCCCC\C=C/2)NC(=O)C1=CN=C(C)C=N1)OC1=NC2=C(C=CC=C2)C2=C1C=CC=C2)C(=O)NS(=O)(=O)C1CC1,68498031
8297,DB09298,Silibinin,small molecule,experimental|investigational,"Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Benzene Derivatives|Benzopyrans|Benzyl Compounds|Chromones|Compounds used in a research, industrial, or household setting|Flavonoids|Flavonolignans|Heterocyclic Compounds, Fused-Ring|Lignans|OAT1/SLC22A6 inhibitors|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Protective Agents|Pyrans|UGT1A1 Inhibitors",[H][C@@]1(OC2=C(O[C@@H]1CO)C=CC(=C2)[C@@]1([H])OC2=C(C(O)=CC(O)=C2)C(=O)[C@@H]1O)C1=CC(OC)=C(O)C=C1,31553
8298,DB09299,Tenofovir alafenamide,small molecule,approved,"Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Direct Acting Antivirals|Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Heterocyclic Compounds, Fused-Ring|Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Nephrotoxic agents|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein substrates|Purines|Tenofovir and prodrugs",CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)CN1C=NC2=C(N)N=CN=C12)OC1=CC=CC=C1,9574768
8299,DB09300,Butylscopolamine,small molecule,approved|investigational|vet_approved,"Agents producing tachycardia|Alimentary Tract and Metabolism|Alkaloids|Amines|Ammonium Compounds|Anticholinergic Agents|Antimuscarinics Antispasmodics|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Belladonna Alkaloids, Semisynthetic, Quaternary Ammonium Compounds|Belladonna and Derivatives, Plain|Cholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Parasympatholytics|Peripheral Nervous System Agents|Quaternary Ammonium Compounds|Scopolamine Derivatives|Tropanes",CCCC[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1,6852391
8300,DB09301,Chondroitin sulfate,small molecule,approved|investigational|nutraceutical,"Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Carbohydrates|Chondroitin|Drugs that are Mainly Renally Excreted|Glycosaminoglycans|Musculo-Skeletal System|Polysaccharides",,
8303,DB09304,Setiptiline,small molecule,experimental,"Antidepressive Agents, Tetracyclic|Dibenzazepines|Heterocyclic Compounds, Fused-Ring",CN1CCC2=C(C1)C1=CC=CC=C1CC1=CC=CC=C21,5205
8304,DB09305,Aptazapine,small molecule,experimental,"Antidepressive Agents, Tetracyclic|Benzazepines|Heterocyclic Compounds, Fused-Ring",CN1CCN2C(C1)C1=CC=CN1CC1=C2C=CC=C1,51355
8305,DB09306,Metralindole,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Indoles|Pyridines",COC1=CC2=C(C=C1)N1CCN(C)C3=NCCC2=C13,68713
8306,DB09307,Oxaprotiline,small molecule,experimental,"Agents that produce hypertension|Agents that reduce seizure threshold|Anthracenes|Antidepressive Agents|Antidepressive Agents, Tetracyclic|Antidepressive Agents, Tricyclic|Central Nervous System Agents|Central Nervous System Depressants|Narrow Therapeutic Index Drugs|Neurotoxic agents|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",,
8307,DB09308,Solithromycin,small molecule,investigational,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Ketolides|Lactones|Macrolides|Macrolides, Lincosamides and Streptogramins|Polyketides",[H][C@]12N(CCCCN3C=C(N=N3)C3=CC(N)=CC=C3)C(=O)O[C@]1(C)[C@@]([H])(CC)OC(=O)[C@@](C)(F)C(=O)[C@]([H])(C)[C@@]([H])(O[C@]1([H])O[C@]([H])(C)C[C@]([H])(N(C)C)[C@@]1([H])O)[C@@](C)(C[C@@]([H])(C)C(=O)[C@]2([H])C)OC,25242512
8308,DB09309,Kitasamycin,small molecule,experimental,Anti-Bacterial Agents|Anti-Infective Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Lactones|Leucomycins|Macrolides|Polyketides,CO[C@H]1[C@H](O)CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]1O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O2)[C@@H]([C@H]1O)N(C)C,5282322
8310,DB09311,Polycarbophil,small molecule,experimental,"Antidiarrheals|Bulk-Forming Laxatives|Compounds used in a research, industrial, or household setting|Dental Materials|Drug Carriers|Gastrointestinal Agents|Laxatives|Macromolecular Substances|Plastics|Polymers|Resins, Synthetic",,
8312,DB09313,Ioxaglic acid,small molecule,approved|investigational,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Iodobenzoates|Radiographic Contrast Agent|Triiodobenzoic Acids|Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media|X-Ray Contrast Activity|X-Ray Contrast Media, Iodinated",CNC(=O)C1=C(I)C(C(=O)NCC(=O)NC2=C(I)C(C(O)=O)=C(I)C(C(=O)NCCO)=C2I)=C(I)C(N(C)C(C)=O)=C1I,3742
8313,DB09314,Technetium Tc-99m pertechnetate,small molecule,approved|investigational,"Compounds used in a research, industrial, or household setting|Diagnostic Radiopharmaceuticals|Diagnostic Uses of Chemicals|Indicators and Reagents|Laboratory Chemicals|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Radiopharmaceuticals|Technetium Compounds|Thyroid Diagnostic Radiopharmaceuticals",O.O.O.O.[98Tc-],131709156
8314,DB09315,Xenon-133,small molecule,approved,Diagnostic Radiopharmaceuticals|Elements|Gases|Inhalation Diagnostic Agent|Isotopes|Noble Gases|Radioisotopes|Radiopharmaceutical Activity|Xenon|Xenon Isotopes,[133Xe],66376
8315,DB09316,Thallous Chloride,small molecule,approved,"Elements|Metals|Metals, Heavy|Radioactive Diagnostic Agent",[Cl-].[Tl+],24642
8316,DB09317,"Synthetic Conjugated Estrogens, A",small molecule,approved,"Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Estrogens|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Thyroxine-binding globulin inducers",,
8317,DB09318,"Synthetic Conjugated Estrogens, B",small molecule,approved,"Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Estrogens|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Thyroxine-binding globulin inducers",,
8318,DB09319,Carindacillin,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Penicillin G|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds",[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C(C(=O)OC1=CC2=C(CCC2)C=C1)C1=CC=CC=C1)C(O)=O,
8319,DB09320,Procaine benzylpenicillin,small molecule,approved|vet_approved,"Acids, Carbocyclic|Amides|Aminobenzoates|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Benzene Derivatives|Benzoates|Beta-Lactam Antibacterials|Beta-Lactamase Sensitive Penicillins|beta-Lactams|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Lactams|para-Aminobenzoates|Penicillin G|Penicillins|Sulfur Compounds",CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O,5903
8320,DB09321,Zinc oxide,small molecule,approved,"Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Anions|Basic Ointments and Protectants|Basic Powders and Demulcents|Compounds used in a research, industrial, or household setting|Copper Absorption Inhibitor|Cosmetics|Dermatologicals|Electrolytes|Household Products|Ions|Metal cations|Metal divalent cations|Oxides|Oxygen Compounds|Protective Agents|Radiation-Protective Agents|Sunscreen Agents|Vasoprotectives|Zinc Compounds",O=[Zn],14806
8321,DB09322,Zinc sulfate,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Alimentary Tract and Metabolism|Anions|Astringents|Copper Absorption Inhibitor|Dermatologicals|Electrolytes|Ions|Metal cations|Metal divalent cations|Mineral Supplements|Minerals|Misc. Skin and Mucous Membrane Agents|Sulfates|Sulfur Acids|Sulfur Compounds|Sulfuric Acids|Vasoprotectives|Zinc Compounds",[Zn++].[O-]S([O-])(=O)=O,24424
8322,DB09324,Sulbactam,small molecule,approved,"Amides|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|beta-Lactamase Inhibitors|beta-Lactams|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Lactams|Sulfur Compounds",[H][C@@]12CC(=O)N1[C@@]([H])(C(O)=O)C(C)(C)S2(=O)=O,130313
8323,DB09325,Sodium fluoride,small molecule,approved,"Alimentary Tract and Metabolism|Anions|Caries Prophylactic Agents|Cariostatic Agents|Compounds used in a research, industrial, or household setting|Dental Agents|Drugs that are Mainly Renally Excreted|Fluorides|Fluorine Compounds|Ions|Mineral Supplements|Miscellaneous Therapeutic Agents|Mouthwashes and Gargles|Protective Agents|Sodium Compounds|Stomatological Preparations",[F-].[Na+],5235
8324,DB09326,Ammonia N-13,small molecule,approved,Radioactive Diagnostic Agent|Radiopharmaceutical Activity,[13NH3],119432
8325,DB09327,Tegafur-uracil,small molecule,approved|investigational,Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 Substrates,O=C1NC=CC(=O)N1.FC1=CN(C2CCCO2)C(=O)NC1=O,104747
8328,DB09330,Osimertinib,small molecule,approved,"Acids, Acyclic|Acrylates|Amides|Amines|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Kinase Inhibitor|Narrow Therapeutic Index Drugs|P-glycoprotein substrates|Protein Kinase Inhibitors|Tyrosine Kinase Inhibitors",COC1=C(NC2=NC=CC(=N2)C2=CN(C)C3=C2C=CC=C3)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C,71496458
8330,DB09332,Kappadione,small molecule,approved,,[Na+].[Na+].[Na+].[Na+].CC1=C(OP([O-])([O-])=O)C2=CC=CC=C2C(OP([O-])([O-])=O)=C1,8555
8331,DB09333,Iopodic acid,small molecule,approved|investigational|withdrawn,"Benzene Derivatives|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Hydrocarbons, Halogenated|Hydrocarbons, Iodinated|Iodobenzenes|Watersoluble, Hepatotropic X-Ray Contrast Media|X-Ray Contrast Media, Iodinated",CN(C)C=NC1=C(I)C=C(I)C(CCC(O)=O)=C1I,5241
8333,DB09335,Alatrofloxacin,small molecule,approved|withdrawn,"Anti-Infective Agents|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",[H][C@@]12CN(C[C@]1([H])[C@H]2NC(=O)[C@H](C)NC(=O)[C@H](C)N)C1=NC2=C(C=C1F)C(=O)C(=CN2C1=CC=C(F)C=C1F)C(O)=O,3086677
8334,DB09336,Technetium Tc-99m nofetumomab merpentan,small molecule,approved|withdrawn,,,
8335,DB09337,Medical air,small molecule,approved|vet_approved,Medical Gases|Other Miscellaneous Therapeutic Agents,,
8336,DB09338,Mersalyl,small molecule,experimental,"Alkylmercury Compounds|Diuretics|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Low-Ceiling Diuretics, Excl. Thiazides|Mercurial Diuretics|Organomercury Compounds|Organometallic Compounds",COC(CNC(=O)C1=CC=CC=C1OCC(O)=O)C[Hg]O,443130
8338,DB09340,Tyropanoic acid,small molecule,approved,"Compounds used in a research, industrial, or household setting|Contrast Media|Watersoluble, Hepatotropic X-Ray Contrast Media|X-Ray Contrast Media, Iodinated",CCCC(=O)NC1=C(I)C=C(I)C(CC(CC)C(O)=O)=C1I,5611
8339,DB09341,"Dextrose, unspecified form",small molecule,approved|vet_approved,"Caloric Agents|Cardiac Function|Compounds used in a research, industrial, or household setting|Diabetes Mellitus|Hemodialysis Solution|Miscellaneous Therapeutic Agents",,
8340,DB09342,Propoxycaine,small molecule,approved,"Acids, Carbocyclic|Aminobenzoates|Anesthetics|Anesthetics, Local|Benzene Derivatives|Benzoates|Central Nervous System Agents|Ethers|Hydroxy Acids|Hydroxybenzoate Ethers|Hydroxybenzoates|para-Aminobenzoates|Peripheral Nervous System Agents|Phenols|Phenyl Ethers|Sensory System Agents",CCCOC1=CC(N)=CC=C1C(=O)OCCN(CC)CC,6843
8341,DB09343,Tipiracil,small molecule,approved|investigational,MATE 1 Substrates|MATE substrates|OCT2 Substrates|OCT2 substrates with narrow therapeutic index|Pyrimidines|Pyrimidinones|Thymidine Phosphorylase Inhibitor,ClC1=C(CN2CCCC2=N)NC(=O)NC1=O,6323266
8342,DB09344,Invert sugar,small molecule,experimental,"Antivaricose Therapy|Carbohydrates|Cariogenic Agents|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Drugs that are Mainly Renally Excreted|Flavoring Agents|Food|Food Additives|Food and Beverages|Food Ingredients|Hexoses|Ketoses|Monosaccharides|Pharmaceutic Aids|Pharmaceutical Preparations|Physiological Phenomena|Sclerosing Agents for Local Injection|Sweetening Agents|Vasoprotectives",,
8343,DB09345,Pramocaine,small molecule,approved,"Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Anesthetics|Anesthetics for Topical Use|Anesthetics, Local|Antipruritics and Local Anesthetics|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Central Nervous System Agents|Dermatologicals|Oxazines|Peripheral Nervous System Agents|Sensory System Agents|Vasoprotectives",CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,4886
8344,DB09346,Metrizoic acid,small molecule,approved,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Iodobenzoates|Radiographic Contrast Agent|Triiodobenzoic Acids|Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media|X-Ray Contrast Activity|X-Ray Contrast Media, Iodinated",CN(C(C)=O)C1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I,2528
8345,DB09347,Acetrizoic acid,small molecule,withdrawn,"Acids, Carbocyclic|Aminobenzoates|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Iodobenzoates|meta-Aminobenzoates|Triiodobenzoic Acids|Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media|X-Ray Contrast Media, Iodinated",CC(=O)NC1=C(I)C(C(O)=O)=C(I)C=C1I,6806
8346,DB09348,Propiolactone,small molecule,approved|withdrawn,"Anti-Infective Agents|Compounds used in a research, industrial, or household setting|Disinfectants|Lactones",O=C1CCO1,2365
8348,DB09350,Piperonyl butoxide,small molecule,approved|vet_approved,"Agrochemicals|Benzodioxoles|Compounds used in a research, industrial, or household setting|Dioxoles|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Pesticide Synergists|Pesticides|Toxic Actions",CCCCOCCOCCOCC1=CC2=C(OCO2)C=C1CCC,5794
8349,DB09351,Levobetaxolol,small molecule,approved|investigational,Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Bradycardia-Causing Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates,CC(C)NC[C@H](O)COC1=CC=C(CCOCC2CC2)C=C1,60657
8350,DB09352,Hydroxyamphetamine,small molecule,approved,Adrenergic Agonists|Amines|Amphetamines|Autonomic Agents|Ethylamines|Mydriatics|Peripheral Nervous System Agents|Phenethylamines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetics,CC(N)CC1=CC=C(O)C=C1,3651
8351,DB09353,Octasulfur,small molecule,approved,Chalcogens|Elements|Keratolytic Agents,S1SSSSSSS1,66348
8352,DB09355,Sulfabenzamide,small molecule,approved,Amides|Sulfones|Sulfur Compounds,NC1=CC=C(C=C1)S(=O)(=O)NC(=O)C1=CC=CC=C1,
8353,DB09357,Dexpanthenol,small molecule,approved,"Alanine|Alimentary Tract and Metabolism|Amino Acids|Amino Acids, Peptides, and Proteins|Cicatrizants|Dermatologicals|Drugs that are Mainly Renally Excreted|Imides|Ophthalmologicals|Preparations for Treatment of Wounds and Ulcers|Sensory Organs|Vitamin B Complex|Vitamins|Wound Healing",CC(C)(CO)[C@@H](O)C(=O)NCCCO,131204
8354,DB09363,Rauwolfia serpentina root,small molecule,investigational,"Alkaloids|Antiadrenergic Agents, Centrally Acting|Antihypertensive Agents|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|Secologanin Tryptamine Alkaloids",,
8355,DB09364,Procaine merethoxylline,small molecule,approved,,O.[Hg+].CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.[CH2]C(CN=C(O)C1=CC=CC=C1OCC([O-])=O)OCCOC,
8356,DB09366,Propyliodone,small molecule,approved,"Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Iodopyridones|Non-Watersoluble X-Ray Contrast Media|Pyridines|Pyridones|X-Ray Contrast Media, Iodinated",CCCOC(=O)CN1C=C(I)C(=O)C(I)=C1,
8357,DB09369,Polyestradiol phosphate,small molecule,approved,"Antineoplastic and Immunomodulating Agents|Endocrine Therapy|Estradiol Congeners|Estranes|Estrenes|Estrogens|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids",,
8358,DB09370,Sodium phosphate P 32,small molecule,approved,Antineoplastic Agents|Diagnostic Agents|Narrow Therapeutic Index Drugs|Radioactive Diagnostic Agent|Therapeutic Radiopharmaceuticals|Various Therapeutic Radiopharmaceuticals,[Na+].[Na+].O[32P]([O-])([O-])=O,
8359,DB09371,Norethynodrel,small molecule,approved,"Adrenal Cortex Hormones|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Norpregnanes|Norpregnenes|Norsteroids|Progestin Contraceptives|Progestins|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids",[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])CC(=O)CC3,
8360,DB09372,Tannic acid,small molecule,approved,"Compounds used in a research, industrial, or household setting",OC1=CC(=CC(O)=C1O)C(=O)OC1=C(O)C(O)=CC(=C1)C(=O)OC[C@H]1OC(OC(=O)C2=CC(OC(=O)C3=CC(O)=C(O)C(O)=C3)=C(O)C(O)=C2)[C@H](OC(=O)C2=CC(OC(=O)C3=CC(O)=C(O)C(O)=C3)=C(O)C(O)=C2)[C@@H](OC(=O)C2=CC(OC(=O)C3=CC(O)=C(O)C(O)=C3)=C(O)C(O)=C2)[C@@H]1OC(=O)C1=CC(OC(=O)C2=CC(O)=C(O)C(O)=C2)=C(O)C(O)=C1,
8361,DB09373,Trolamine polypeptide oleate condensate,small molecule,approved|vet_approved,,,
8362,DB09374,Indocyanine green acid form,small molecule,approved|investigational,"BSEP/ABCB11 Substrates|Cardiac Function|Coloring Agents|Compounds used in a research, industrial, or household setting|Diagnostic Dye|Liver Function|Roentgenography",CC1(C)\C(=C\C=C\C=C\C=C\C2=[N+](CCCCS(O)(=O)=O)C3=C(C4=CC=CC=C4C=C3)C2(C)C)N(CCCCS(O)(=O)=O)C2=C1C1=CC=CC=C1C=C2,11967809
8363,DB09375,Chymotrypsin,small molecule,approved|vet_approved,"Blood and Blood Forming Organs|Chymotrypsin, antagonists & inhibitors|Endopeptidases|Enzymes|Enzymes and Coenzymes|Hydrolases|Ophthalmologicals|Peptide Hydrolases|Sensory Organs|Serine Endopeptidases|Serine Proteases|Surgical Aids",,
8364,DB09376,Lapyrium,small molecule,approved,Pyridines,CCCCCCCCCCCC(=O)OCCNC(=O)C[N+]1=CC=CC=C1,22660
8365,DB09377,Undecoylium chloride iodine complex,small molecule,approved,,[Cl-].CCC(=O)OCCNC(=O)C[N+]1=CC=CC=C1,
8366,DB09378,Fluprednisolone,small molecule,approved,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Corticosteroids for Systemic Use|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated",[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,
8368,DB09380,Sodium chromate Cr-51,small molecule,approved,Radioactive Diagnostic Agent,[Na+].[Na+].[O-][51Cr]([O-])(=O)=O,
8369,DB09381,Esterified estrogens,small molecule,approved,Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Estrogens|Thyroxine-binding globulin inducers,,
8370,DB09382,Iodohippurate sodium I-131,small molecule,approved,Diagnostic Radiopharmaceuticals|Renal System,[Na+].[O-]C(=O)CNC(=O)C1=C([131I])C=CC=C1,
8371,DB09383,Meprednisone,small molecule,approved|investigational,"Adrenal Cortex Hormones|Corticosteroids|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Fused-Ring Compounds|Glucocorticoids|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Pregnadienediols|Pregnadienes|Pregnanes|Steroids|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thyroxine-binding globulin inhibitors",[H][C@]1(C)C[C@@]2([H])[C@]3([H])CCC4=CC(=O)C=C[C@]4(C)[C@@]3([H])C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO,
8372,DB09385,Cyanocobalamin Co-57,small molecule,approved,Radioactive Diagnostic Agent|Radiopharmaceutical Activity,[57Co+3].[C-]#N.C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)C2[N-]\C1=C(C)/C1=N/C(=C\C3=N\C(=C(C)/C4=N[C@]2(C)[C@@](C)(CC(N)=O)[C@@H]4CCC(N)=O)\[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)/C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=[NH]C2=C1C=C(C)C(C)=C2,
8373,DB09389,Norgestrel,small molecule,approved,"Adrenal Cortex Hormones|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Contraceptives, Postcoital|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Norpregnanes|Norpregnenes|Norsteroids|Progestin Contraceptives|Progestins|Progestogens and Estrogens, Sequential Preparations|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids",CCC12CCC3C(CCC4=CC(=O)CCC34)C1CCC2(O)C#C,4542
8374,DB09393,Amino acids,small molecule,investigational,"Amino Acid Hypertonic Solution|Amino Acids|Amino Acids, Peptides, and Proteins|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|i.v. Solutions|Solutions for Parenteral Nutrition",,
8375,DB09394,Phosphoric acid,small molecule,approved,"Acid Etching, Dental|Acids|Acids, Noncarboxylic|Compounds used in a research, industrial, or household setting|Dental Materials|Drugs that are Mainly Renally Excreted|Phosphorus Acids|Phosphorus Compounds",OP(O)(O)=O,1004
8376,DB09395,Sodium acetate,small molecule,approved|investigational,"Acetates|Acids, Acyclic|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Drugs that are Mainly Renally Excreted|Electrolyte Solutions|Fatty Acids|Fatty Acids, Volatile|I.V. Solution Additives|Lipids|Replacement Preparations",[Na+].CC([O-])=O,517045
8377,DB09397,Technetium Tc-99m sulfur colloid,small molecule,approved|investigational,"Compounds used in a research, industrial, or household setting|Diagnostic Radiopharmaceuticals|Diagnostic Uses of Chemicals|Hepatic and Reticulo Endothelial System|Indicators and Reagents|Laboratory Chemicals|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Radiopharmaceuticals|Sulfur Compounds|Technetium (99Mtc), Particles and Colloids|Technetium Compounds",[99Tc].S1SSSSSSS1,76957057
8378,DB09398,Fluoride ion F-18,small molecule,approved,Diagnostic Radiopharmaceuticals|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Tumour Detection,[18F-],23690531
8379,DB09400,Selenomethionine Se-75,small molecule,approved,Selenium Compounds,C[75Se]CC[C@H](N)C(O)=O,
8380,DB09401,Isosorbide,small molecule,approved|investigational,"Adrenal Cortex Hormones|Alcohols|Antianginal Agents|Carbohydrates|Cardiovascular Agents|Contraceptive Agents, Male|Diuretics|Diuretics, Osmotic|Hormonal Contraceptives for Systemic Use|Natriuretic Agents|Noxae|Organic Nitrates|Reproductive Control Agents|Sesquiterpenes|Sugar Alcohols|Terpenes|Toxic Actions|Vasodilating Agents",[H][C@]1(O)CO[C@]2([H])[C@]([H])(O)CO[C@]12[H],
8381,DB09403,Iocetamic acid,small molecule,approved,"Benzene Derivatives|Contrast Media|Hydrocarbons, Halogenated|Hydrocarbons, Iodinated|Watersoluble, Hepatotropic X-Ray Contrast Media|X-Ray Contrast Media, Iodinated",CC(CN(C(C)=O)C1=C(I)C=C(I)C(N)=C1I)C(O)=O,
8382,DB09407,Magnesium chloride,small molecule,approved,"Acids|Acids, Noncarboxylic|Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Anions|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Calculi Dissolution Agent|Chlorides|Chlorine Compounds|Drugs that are Mainly Renally Excreted|Electrolyte Solutions|Electrolytes|Hemodialysis Solution|I.V. Solution Additives|Ions|Magnesium Compounds|Metal cations|Metal divalent cations|Mineral Supplements|Minerals",[Mg++].[Cl-].[Cl-],5360315
8383,DB09409,Magnesium acetate tetrahydrate,small molecule,approved,Agents that produce neuromuscular block (indirect)|Calculi Dissolution Agent|Laxatives|Osmotic Laxatives,O.O.O.O.[Mg++].CC([O-])=O.CC([O-])=O,134717
8384,DB09413,Monopotassium phosphate,small molecule,approved|investigational|vet_approved,"Acids|Acids, Noncarboxylic|Anions|Buffers|Cariostatic Agents|Compounds used in a research, industrial, or household setting|Dental Materials|Electrolytes|Ions|Laboratory Chemicals|Laxatives|Osmotic Laxatives|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Potassium Salt|Protective Agents|Replacement Preparations",[K+].OP(O)([O-])=O,516951
8385,DB09414,Dipotassium phosphate,small molecule,approved,"Acids|Acids, Noncarboxylic|Anions|Buffers|Cariostatic Agents|Compounds used in a research, industrial, or household setting|Dental Materials|Electrolytes|Ions|Laboratory Chemicals|Laxatives|Osmotic Laxatives|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Potassium Salt|Protective Agents",[K+].[K+].OP([O-])([O-])=O,24450
8386,DB09418,Potassium perchlorate,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Antithyroid agents|Chlorine Compounds|Drugs that are Mainly Renally Excreted|Perchlorates|Potassium Salt|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thyroid Products",[K+].[O-][Cl](=O)(=O)=O,516900
8387,DB09419,Xylose,small molecule,approved,Carbohydrates|Monosaccharides|Pentoses,OC[C@@H](O)[C@H](O)[C@@H](O)C=O,644160
8388,DB09420,Iodide I-123,small molecule,approved,Diagnostic Radiopharmaceuticals|Elements|Halogens|Iodine Isotopes|Isotopes|Radioactive Diagnostic Agent|Radioisotopes|Radiopharmaceutical Activity|Thyroid Diagnostic Radiopharmaceuticals,[123I-],135300
8389,DB09421,Protirelin,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Diagnostic Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary Hormone-Releasing Hormones|Proteins|Tests for Thyreoidea Function|Thyroid Products|Thyrotropin-Releasing Hormone",[H][C@@](CC1=CN=CN1)(NC(=O)[C@]1([H])CCC(=O)N1)C(=O)N1CCC[C@@]1([H])C(N)=O,638678
8391,DB09423,Technetium Tc-99m polyphosphate,small molecule,approved,"Acids|Acids, Noncarboxylic|Anions|Electrolytes|Ions|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds",,
8392,DB09425,Indium In-111 pentetate,small molecule,approved,Central Nervous System|Diagnostic Radiopharmaceuticals|Lead Chelator|Radioactive Diagnostic Agent|Radiopharmaceutical Activity,[111In+3].OC(=O)CN(CCN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)CC(O)=O,131704319
8395,DB09443,Krypton Kr 81m,small molecule,approved,Diagnostic Radiopharmaceuticals,[81Kr],
8398,DB09449,"Sodium phosphate, monobasic",small molecule,approved,"Acids|Acids, Noncarboxylic|Agents that reduce seizure threshold|Anions|Electrolytes|Ions|Laxatives|Osmotic Laxatives|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Potassium Salt|Urinary Acidifying Agents",[Na+].OP(O)([O-])=O,23672064
8400,DB09459,L-tartaric acid,small molecule,experimental,"Acids, Acyclic|Carbohydrates|Chelating Agents|Dicarboxylic Acids|Hydroxy Acids|Sugar Acids|Urinary Alkalinisers",O[C@H]([C@@H](O)C(O)=O)C(O)=O,444305
8401,DB09460,Sodium carbonate,small molecule,approved,"Acids|Acids, Noncarboxylic|Alkalies|Anions|Carbon Compounds, Inorganic|Carbonic Acid|Electrolytes|Ions",[Na+].[Na+].[O-]C([O-])=O,10340
8402,DB09461,Xenon Xe-127,small molecule,approved,Elements|Gases|Inhalation Diagnostic Agent|Isotopes|Noble Gases|Radioactive Diagnostic Agent|Radioisotopes|Radiopharmaceutical Activity|Xenon|Xenon Isotopes,[127Xe],
8403,DB09462,Glycerin,small molecule,approved|investigational,"Alcohols|Alimentary Tract and Metabolism|Basic Ointments and Protectants|Carbohydrates|Cell-mediated Immunity|Compounds used in a research, industrial, or household setting|Cryoprotective Agents|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP2E1 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Drugs for Constipation|Enemas|Increased Histamine Release|Increased IgG Production|Irrigating Solutions|Laxatives|Non-Standardized Chemical Allergen|Osmotic Laxatives|Other Cold and Cough Preparations|Other Diagnostics|Protective Agents|Solvents|Sugar Alcohols|Triose Sugar Alcohols",OCC(O)CO,753
8404,DB09472,Sodium sulfate,small molecule,approved|vet_approved,"Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Anions|Drugs for Constipation|Drugs that are Mainly Renally Excreted|Electrolytes|Gastrointestinal Agents|Ions|Laxatives|Mineral Supplements|Osmotic Laxatives|Sodium|Sulfur Acids|Sulfur Compounds|Sulfuric Acids",[Na+].[Na+].[O-]S([O-])(=O)=O,24436
8405,DB09473,Indium In-111 oxyquinoline,small molecule,approved,Radioactive Diagnostic Agent|Radiopharmaceutical Activity,[111In+3].[O-]C1=CC=CC2=C1N=CC=C2.[O-]C1=CC=CC2=C1N=CC=C2.[O-]C1=CC=CC2=C1N=CC=C2,119117
8406,DB09477,Enalaprilat,small molecule,approved,"Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Amino Acids, Peptides, and Proteins|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Antihypertensive Agents Indicated for Hypertension|Cardiovascular Agents|Decreased Blood Pressure|Dipeptides|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Hypotensive Agents|Oligopeptides|Peptides|Photosensitizing Agents|Protease Inhibitors",[H][C@@](C)(N[C@@]([H])(CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@@]1([H])C(O)=O,5462501
8407,DB09479,Rubidium Rb-82,small molecule,approved|investigational,Radioactive Diagnostic Agent|Radiopharmaceutical Activity,[82Rb+],71357
8408,DB09480,Iofetamine I-123,small molecule,approved,"Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Central Nervous System|Compounds used in a research, industrial, or household setting|Diagnostic Radiopharmaceuticals|Diagnostic Uses of Chemicals|Ethylamines|Indicators and Reagents|Iodine (123I) Compounds|Laboratory Chemicals|Phenethylamines|Radiopharmaceuticals|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetics",CC(C)NC(C)CC1=CC=C([123I])C=C1,
8409,DB09481,Magnesium carbonate,small molecule,approved|investigational,"Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Aluminum and magnesium containing antacids|Antacids|Bleaching Agents|Calculi Dissolution Agent|Compounds used in a research, industrial, or household setting|Drugs for Acid Related Disorders|Drugs for Constipation|Drugs for Treatment of Hyperkalemia and Hyperphosphatemia|Drugs that are Mainly Renally Excreted|Elements|Gastric Acid Lowering Agents|Hygroscopic Agents|Laxatives|Laxatives, magnesium containing|Magnesium Compounds|Metal cations|Metal divalent cations|Metals|Metals, Alkaline Earth|Metals, Light|Noxae|Osmotic Laxatives|Oxidants|Toxic Actions",[Mg++].[O-]C([O-])=O,11029
8410,DB09483,Potassium lactate,small molecule,approved,Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Electrolyte Solutions|I.V. Solution Additives|Laxatives|Potassium Salt,[K+].CC(O)C([O-])=O,
8411,DB09484,Sodium fluorophosphate,small molecule,approved,"Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Anions|Caries Prophylactic Agents|Cariostatic Agents|Compounds used in a research, industrial, or household setting|Dental Agents|Electrolytes|Fluorides|Fluorine Compounds|Hydrofluoric Acid|Ions|Laxatives|Mineral Supplements|Osmotic Laxatives|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Protective Agents|Stomatological Preparations|Toothpastes",[Na+].[Na+].[O-]P([O-])(F)=O,
8412,DB09487,Iotrolan,small molecule,approved,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Iodobenzoates|Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media|X-Ray Contrast Media, Iodinated",CN(C(=O)CC(=O)N(C)C1=C(I)C(C(=O)NC(CO)C(O)CO)=C(I)C(C(=O)NC(CO)C(O)CO)=C1I)C1=C(I)C(C(=O)NC(CO)C(O)CO)=C(I)C(C(=O)NC(CO)C(O)CO)=C1I,
8413,DB09488,Acrivastine,small molecule,approved,"Antihistamines for Systemic Use|Drugs that are Mainly Renally Excreted|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Neurotransmitter Agents|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents",[H]\C(CN1CCCC1)=C(\C1=CC=C(C)C=C1)C1=CC=CC(=N1)C(\[H])=C(/[H])C(O)=O,5284514
8414,DB09490,Indium In-111 chloride,small molecule,approved,Radioactive Diagnostic Agent|Radiopharmaceutical Activity,Cl[111In](Cl)Cl,49800058
8416,DB09494,Cetyl alcohol,small molecule,approved,Alcohols|Drugs that are Mainly Renally Excreted|Lipids,CCCCCCCCCCCCCCCCO,2682
8417,DB09495,Avobenzone,small molecule,approved|investigational,"Compounds used in a research, industrial, or household setting|Cosmetics|Dermatologicals|Household Products|Ketones|Protective Agents|Radiation-Protective Agents|Sunscreen Agents",COC1=CC=C(C=C1)C(=O)CC(=O)C1=CC=C(C=C1)C(C)(C)C,51040
8418,DB09496,Octinoxate,small molecule,approved|investigational,"Acids, Carbocyclic|Compounds used in a research, industrial, or household setting|Cosmetics|Dermatologicals|Drugs that are Mainly Renally Excreted|Emollients and Protectives|Household Products|Protective Agents|Protectives Against UV-Radiation|Protectives Against UV-Radiation for Topical Use|Radiation-Protective Agents|Sunscreen Agents",[H]\C(=C(\[H])C1=CC=C(OC)C=C1)C(=O)OCC(CC)CCCC,5355130
8419,DB09498,Strontium chloride Sr-89,small molecule,approved|investigational,"Elements|Metals|Metals, Alkaline Earth|Metals, Heavy|Pain Palliation (Bone Seeking Agents)|Radioactive Therapeutic Agent|Strontium Radioisotopes|Therapeutic Radiopharmaceuticals|Various Pain Palliation Radiopharmaceuticals",[Cl-].[Cl-].[89Sr++],5362485
8420,DB09499,Thiosulfuric acid,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Anions|Anti-Infective Agents|Antidotes|Antioxidants|Antituberculosis Agents|Chelating Agents|Compounds used in a research, industrial, or household setting|Electrolytes|Ions|Minerals|Protective Agents|Sequestering Agents|Sulfates|Sulfur Acids|Sulfur Compounds|Sulfuric Acids",OS(O)(=O)=S,24478
8421,DB09501,Ferric ammonium citrate,small molecule,approved|experimental,Amines|Ammonium Compounds|Contrast Media|Iron Compounds|Magnetic Resonance Imaging Contrast Media|Nitrogen Compounds|Onium Compounds|Organometallic Compounds|Paramagnetic Contrast Media,N.[Fe+3].OC(=O)CC(O)(CC(O)=O)C(O)=O,
8422,DB09502,Fludeoxyglucose (18F),small molecule,approved|investigational,"Carbohydrates|Compounds used in a research, industrial, or household setting|Deoxy Sugars|Deoxyglucose|Diagnostic Radiopharmaceuticals|Diagnostic Uses of Chemicals|Drugs that are Mainly Renally Excreted|Indicators and Reagents|Laboratory Chemicals|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Radiopharmaceuticals|Tumour Detection",[H]C(=O)[C@H]([18F])[C@@H](O)[C@H](O)[C@H](O)CO,68614
8423,DB09507,Ferumoxsil,small molecule,approved|experimental,"Colloids|Complex Mixtures|Compounds used in a research, industrial, or household setting|Contrast Media|Ferric Compounds|Ferrosoferric Oxide|Ferrous Compounds|Investigative Techniques|Iron Compounds|Macromolecular Substances|Magnetic Resonance Imaging Contrast Media|Magnets|Metal Nanoparticles|Minerals|Nanoparticles|Nanostructures|Organometallic Compounds|Organosilicon Compounds|Pharmaceutical Preparations|Polymers|Silicon Compounds|Superparamagnetic Contrast Media",,
8424,DB09508,Ferumoxides,small molecule,approved,"Biopolymers|Carbohydrates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Ferric Compounds|Ferrosoferric Oxide|Ferrous Compounds|Glucans|Iron Compounds|Macromolecular Substances|Magnets|Metal Nanoparticles|Minerals|Nanoparticles|Nanostructures|Organometallic Compounds|Polymers|Polysaccharides|Suspensions",,
8425,DB09510,Urea C-13,small molecule,approved,Helicobacter pylori Diagnostic,N[13C](N)=O,636363
8426,DB09511,Talc,small molecule,approved,"Acids|Acids, Noncarboxylic|Anions|Antiperspirants|Compounds used in a research, industrial, or household setting|Cosmetics|Electrolytes|Household Products|Ions|Magnesium Compounds|Metal cations|Metal divalent cations|Minerals|Oxides|Oxygen Compounds|Silicates|Silicon Compounds",,
8427,DB09512,Simethicone,small molecule,approved,"Antifoaming Agents|Compounds used in a research, industrial, or household setting|Dermatologicals|Dimethylpolysiloxanes|Emollients|Macromolecular Substances|Organosilicon Compounds|Polymers|Silicon Compounds|Silicones|Siloxanes|Surface-Active Agents",O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C,
8428,DB09513,Urea C-14,small molecule,approved,,N[14C](N)=O,11457650
8429,DB09516,Mequinol,small molecule,approved,"Antioxidants|Benzene Derivatives|Compounds used in a research, industrial, or household setting|Depigmenting Activity|Dermatologicals|Ethers|Lentigo|Melanin Synthesis Inhibitors|Methyl Ethers|Phenols|Phenyl Ethers|Protective Agents|Skin Lightening Agent",COC1=CC=C(O)C=C1,9015
8430,DB09517,Sodium ferric gluconate complex,small molecule,approved,Iron Preparations|Parenteral Iron Replacement|Phosphate Binder,[O--].[O--].[O--].[Na+].[Fe+3].[Fe+3].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O,76968835
8431,DB09526,Hydroquinone,small molecule,approved|investigational,"Antioxidants|Benzene Derivatives|Compounds used in a research, industrial, or household setting|Depigmenting Activity|Depigmenting Agents|Dermatologicals|Melanin Synthesis Inhibitor|Melanin Synthesis Inhibitors|Mutagens|Noxae|Phenols|Protective Agents|Radiation-Protective Agents|Toxic Actions",OC1=CC=C(O)C=C1,785
8433,DB09531,Perflexane,small molecule,approved,"Diagnostic Agents|Hydrocarbons, Fluorinated|Hydrocarbons, Halogenated|Ultrasound Contrast Activity|Ultrasound Contrast Media",FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,
8435,DB09534,Ecamsule,small molecule,approved,"Acids|Acids, Noncarboxylic|Compounds used in a research, industrial, or household setting|Cosmetics|Dermatologicals|Household Products|Monoterpenes|Norbornanes|Protective Agents|Radiation-Protective Agents|Sulfur Acids|Sulfur Compounds|Sunscreen Agents|Terpenes",CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)C2=CC1=CC=C(C=C2C3CCC(CS(O)(=O)=O)(C2=O)C3(C)C)C=C1,9915879
8436,DB09535,Octocrylene,small molecule,approved|investigational,"Acids, Acyclic|Sunscreen Agents",,
8437,DB09536,Titanium dioxide,small molecule,approved,"Astringents and Deodorants|Biocompatible Materials|Coloring Agents|Compounds used in a research, industrial, or household setting|Cosmetics|Dermatologicals|Elements|Household Products|Metals|Metals, Light|Photosensitizing Agents|Protective Agents|Radiation-Protective Agents|Radiation-Sensitizing Agents|Sunscreen Agents|Transition Elements|Water Pollutants, Chemical",O=[Ti]=O,26042
8438,DB09537,Iodine povacrylex,small molecule,approved,,,
8439,DB09539,Omega-3-acid ethyl esters,small molecule,approved|investigational,"Autacoids|Biological Factors|Diet, Food, and Nutrition|Dietary Fats|Dietary Fats, Unsaturated|Eicosanoids|Fats|Fatty Acids|Fatty Acids, Omega-3|Fatty Acids, Unsaturated|Fish Oils|Food|Food and Beverages|Inflammation Mediators|Lipids|Nootropic Agents|Oils|Pharmaceutical Preparations|Physiological Phenomena",,
8440,DB09543,Methyl salicylate,small molecule,approved|vet_approved,"Acids, Carbocyclic|Antirheumatic Agents|Benzene Derivatives|Benzoates|Betula|Biological Products|Complex Mixtures|Compounds used in a research, industrial, or household setting|Fixatives|Gaultheria|Hydroxy Acids|Hydroxybenzoates|Lipids|Oils|Pharmaceutical Preparations|Phenols|Plant Preparations|Salicylates",COC(=O)C1=CC=CC=C1O,4133
8441,DB09546,Iobenguane sulfate I-123,small molecule,approved|investigational,Drugs that are Mainly Renally Excreted|Radioactive Diagnostic Agent|Radiopharmaceutical Activity,OS(O)(=O)=O.NC(=N)NCC1=CC([123I])=CC=C1.NC(=N)NCC1=CC([123I])=CC=C1,56840904
8443,DB09552,Thonzonium,small molecule,approved,Amines|Ammonium Compounds|Nitrogen Compounds|Onium Compounds,CCCCCCCCCCCCCCCC[N+](C)(C)CCN(CC1=CC=C(OC)C=C1)C1=NC=CC=N1,5456
8444,DB09555,Dexchlorpheniramine maleate,small molecule,approved,Agents that reduce seizure threshold|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|OCT1 inhibitors|OCT1 substrates|OCT2 Inhibitors|Pyridines|QTc Prolonging Agents|Stereoisomerism,OC(=O)\C=C/C(O)=O.CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1,5281070
8446,DB09561,Sodium glycerophosphate,small molecule,approved,Alcohols|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Carbohydrates|Electrolyte Solutions|I.V. Solution Additives|Lipids|Membrane Lipids|Phosphate salts|Phospholipids|Sugar Alcohols|Sugar Phosphates|Triose Sugar Alcohols,[Na+].[Na+].OCC(O)COP([O-])([O-])=O,22251426
8447,DB09563,Choline C-11,small molecule,approved,Radioactive Diagnostic Agent|Radiopharmaceutical Activity,C[N+](C)([11CH3])CCO,449688
8449,DB09567,Olive oil,small molecule,approved,"Biological Products|Complex Mixtures|Diet, Food, and Nutrition|Dietary Fats|Dietary Fats, Unsaturated|Fats|Fats, Unsaturated|Food|Food and Beverages|Lipid Emulsion|Lipids|Oils|Physiological Phenomena|Plant Oils|Plant Preparations",,
8450,DB09568,Omega-3-carboxylic acids,small molecule,approved|investigational,"Fatty Acids, Omega-3",,
8451,DB09570,Ixazomib,small molecule,approved|investigational,"Amino Acids|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Protease Inhibitors|Proteasome Inhibitors",CC(C)C[C@H](NC(=O)CNC(=O)C1=CC(Cl)=CC=C1Cl)B(O)O,25183872
8452,DB09571,Levmetamfetamine,small molecule,approved,,CN[C@H](C)CC1=CC=CC=C1,36604
9170,DB11056,Stannous chloride,small molecule,approved,,[Cl-].[Cl-].[Sn++],
9171,DB11057,Mineral oil,small molecule,approved|vet_approved,"Alimentary Tract and Metabolism|Basic Ointments and Protectants|Dermatologicals|Drugs for Constipation|Emollients|Laxatives|Softener and Emollient Laxatives|Softeners, Emollients",,
9172,DB11058,Petrolatum,small molecule,approved|investigational,"Basic Ointments and Protectants|Compounds used in a research, industrial, or household setting|Dermatologicals|Emollients|Ointment Bases|Pharmaceutic Aids|Pharmaceutical Preparations",,
9173,DB11059,Carboxymethylcellulose,small molecule,approved|investigational,"Anorexigenic Agents & Respiratory and CNS Stimulants|Artificial Tears|Biopolymers|Bulk-Forming Laxatives|Carbohydrates|Carboxymethylcellulose Sodium|Cellulose|Compounds used in a research, industrial, or household setting|EENT Drugs, Miscellaneous|Gastrointestinal Agents|Glucans|Laxatives|Macromolecular Substances|Polymers|Polysaccharides",,
9174,DB11060,Polyvinyl alcohol,small molecule,approved,"Alcohols|Alkenes|Artificial Tears|Compounds used in a research, industrial, or household setting|EENT Drugs, Miscellaneous|Hydrocarbons, Acyclic|Macromolecular Substances|Plastics|Polyenes|Polymers|Polyvinyls|Vinyl Compounds",,
9175,DB11061,Povidone,small molecule,approved,"Alkenes|Artificial Tears|Biomimetic Materials|Blood Substitutes|Compounds used in a research, industrial, or household setting|Hematologic Agents|Hydrocarbons, Acyclic|Macromolecular Substances|Pharmaceutic Aids|Pharmaceutical Preparations|Plasma Substitutes|Plastics|Polyenes|Polymers|Polyvinyls|Pyrrolidines|Pyrrolidinones|Vinyl Compounds",,
9176,DB11062,Octisalate,small molecule,approved|investigational,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Cosmetics|Dermatologicals|Household Products|Hydroxy Acids|Hydroxybenzoates|Phenols|Protective Agents|Radiation-Protective Agents|Sunscreen Agents",CCCCC(CC)COC(=O)C1=C(O)C=CC=C1,
9177,DB11063,Polysorbate 80,small molecule,approved,"Alcohols|Artificial Tears|Compounds used in a research, industrial, or household setting|Drug Delivery Systems|Ethylene Glycols|Excipients|Glycols|Macromolecular Substances|Pharmaceutic Aids|Pharmaceutical Preparations|Pharmaceutical Vehicles|Polyethylene Glycols|Polymers|Surface-Active Agents",,
9178,DB11064,Homosalate,small molecule,approved|investigational,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Cosmetics|Dermatologicals|Household Products|Hydroxy Acids|Hydroxybenzoates|Phenols|Protective Agents|Radiation-Protective Agents|Sunscreen Agents",CC1CC(CC(C)(C)C1)OC(=O)C1=C(O)C=CC=C1,
9181,DB11067,Heme iron polypeptide,small molecule,investigational,,,
9182,DB11068,Selenic acid,small molecule,approved,"Alimentary Tract and Metabolism|Antioxidants|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Micronutrients|Mineral Supplements|Physiological Phenomena|Protective Agents|Selenium Compounds|Trace Elements",O[Se](O)(=O)=O,1089
9184,DB11071,Phenyl salicylate,small molecule,approved,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Genito Urinary System and Sex Hormones|Hydroxy Acids|Hydroxybenzoates|Phenols|Urologicals",OC1=CC=CC=C1C(=O)OC1=CC=CC=C1,8361
9185,DB11072,Hydrogen fluoride,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Dental Agents|Fluorine Compounds",F,14917
9186,DB11073,Cetylpyridinium,small molecule,approved,"Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Compounds used in a research, industrial, or household setting|Dermatologicals|Detergents|Household Products|Irrigating Solutions|Medicated Dressings|Medicated Dressings With Antiinfectives|Miscellaneous Anti-infectives|Mouthwashes and Gargles|Pyridines|Pyridinium Compounds|Quaternary Ammonium Compounds|Surface-Active Agents|Throat Preparations",CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1,2683
9187,DB11074,Dimethicone,small molecule,approved,"Antifoaming Agents|Basic Ointments and Protectants|Compounds used in a research, industrial, or household setting|Macromolecular Substances|Misc. Skin and Mucous Membrane Agents|Organosilicon Compounds|Polymers|Scabicides and Pediculicides|Silicon Compounds|Silicones|Siloxanes|Skin Barrier Activity",,
9188,DB11075,Hypromellose,small molecule,approved,"Artificial Tears|Biopolymers|Carbohydrates|Cellulose|Compounds used in a research, industrial, or household setting|EENT Drugs, Miscellaneous|Glucans|Macromolecular Substances|Ophthalmologicals|Other Diagnostics|Polymers|Polysaccharides|Sensory Organs|Surgical Aids|Viscoelastic Substances",,
9189,DB11077,Polyethylene glycol 400,small molecule,approved,"Alcohols|Compounds used in a research, industrial, or household setting|Drugs that are Mainly Renally Excreted|EENT Drugs, Miscellaneous|Ethylene Glycols|Glycols|Macromolecular Substances|P-glycoprotein inhibitors|Pegylated agents|Polymers",,
9190,DB11079,Trolamine salicylate,small molecule,approved,"Acids, Carbocyclic|Agents causing hyperkalemia|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Benzene Derivatives|Benzoates|Hydroxy Acids|Hydroxybenzoates|Nephrotoxic agents|Non COX-2 selective NSAIDS|Phenols|Salicylates|Sunscreen Agents",OCCN(CCO)CCO.OC(=O)C1=CC=CC=C1O,25213
9191,DB11080,Silver nitrate,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Anions|Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Dermatologicals|Electrolytes|Ions|Nitrates|Nitric Acid|Nitrogen Compounds|Silver Compounds",[Ag+].[O-]N(=O)=O,516904
9192,DB11081,Aluminum chloride,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Aluminium Compounds|Anions|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Antiperspirants|Astringents and Deodorants|Chlorides|Chlorine Compounds|Compounds used in a research, industrial, or household setting|Cosmetics|Dental Agents|Dermatologicals|Electrolytes|Household Products|Ions|Metal cations|Metal divalent cations",Cl[Al](Cl)Cl,24012
9193,DB11082,Coal tar,small molecule,approved,Complex Mixtures|Dermatologicals|Keratolytic Agents|Keratoplastic Agents|Tars,,
9194,DB11085,Resorcinol,small molecule,approved,Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Infective Agents|Benzene Derivatives|Dermatologicals|Drugs that are Mainly Renally Excreted|Ophthalmologicals|Phenols|Root Canal Filling Materials|Sensory Organs,OC1=CC(O)=CC=C1,5054
9198,DB11089,Docusate,small molecule,approved,"Alimentary Tract and Metabolism|Drugs for Constipation|Enemas|Laxatives|Softener and Emollient Laxatives|Softeners, Emollients|Succinates|Surface-Active Agents",CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(O)(=O)=O,
9199,DB11090,Potassium nitrate,small molecule,approved,"Acids|Acids, Noncarboxylic|Anions|Compounds used in a research, industrial, or household setting|Drugs that are Mainly Renally Excreted|Electrolytes|Explosive Agents|Ions|Nitric Acid|Nitrogen Compounds|Potassium Salt",[K+].[O-][N+]([O-])=O,24434
9200,DB11091,Hydrogen peroxide,small molecule,approved|vet_approved,"Alimentary Tract and Metabolism|Anions|Anti-Infective Agents|Anti-Infective Agents, Local|Antifibrinolytic Agents|Antiinfectives and Antiseptics for Local Oral Treatment|Antiseptics and Disinfectants|Compounds used in a research, industrial, or household setting|Dermatologicals|Electrolytes|Free Radicals|Ions|Noxae|Otologicals|Oxidants|Oxides|Oxygen Compounds|Peroxides|Reactive Oxygen Species|Sensory Organs|Stomatological Preparations|Toxic Actions",OO,784
9201,DB11092,Stannous fluoride,small molecule,approved,"Alimentary Tract and Metabolism|Caries Prophylactic Agents|Compounds used in a research, industrial, or household setting|Stomatological Preparations",F[Sn]F,24550
9202,DB11093,Calcium citrate,small molecule,approved|investigational,"Acids, Acyclic|Alimentary Tract and Metabolism|Blood Coagulation Factors|Calcium Compounds|Calcium Salts|Citrates|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Food|Food Additives|Food and Beverages|Food Ingredients|Mineral Supplements|Phosphate Binder|Physiological Phenomena|Polyvalent cation containing laxatives, antacids, oral supplements|Tricarboxylic Acids",[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,13136
9203,DB11094,Vitamin D,small molecule,approved|nutraceutical|vet_approved,"Bone Density Conservation Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Diet, Food, and Nutrition|Food|Food and Beverages|Fused-Ring Compounds|Growth Substances|Micronutrients|Physiological Phenomena|Secosteroids|Steroids|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)",,
9205,DB11096,Meradimate,small molecule,approved,"Acids, Carbocyclic|Aminobenzoates|Benzene Derivatives|Benzoates|Sunscreen Agents",CC(C)C1CCC(C)CC1OC(=O)C1=CC=CC=C1N,
9207,DB11098,Potassium bicarbonate,small molecule,approved,"Acids|Acids, Noncarboxylic|Agents causing hyperkalemia|Alimentary Tract and Metabolism|Alkalies|Anions|Carbon Compounds, Inorganic|Carbonates|Carbonic Acid|Drugs that are Mainly Renally Excreted|Electrolytes|Ions|Mineral Supplements|Potassium Salt",[K+].OC([O-])=O,516893
9209,DB11100,Allantoin,small molecule,approved,Basic Ointments and Protectants|Dermatologicals|Herbs and Natural Products|Hydantoins|Imidazoles|Imidazolidines|Thyroxine-binding globulin substrates,NC(=O)NC1NC(=O)NC1=O,
9210,DB11102,N-acetyltyrosine,small molecule,approved,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Drugs that are Mainly Renally Excreted",CC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O,68310
9211,DB11104,Sulfur hexafluoride,small molecule,approved,"Acids|Acids, Noncarboxylic|Anions|Contrast Media|Electrolytes|Fluorides|Fluorine Compounds|Gases|Hydrofluoric Acid|Ions|Other Diagnostics|Sulfur Compounds|Ultrasound Contrast Activity|Ultrasound Contrast Media",FS(F)(F)(F)(F)F,17358
9212,DB11105,Benzalkonium,small molecule,approved|investigational,"Amines|Ammonium Compounds|Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Benzalkonium Compounds|Benzylammonium Compounds|Compounds used in a research, industrial, or household setting|Dermatologicals|Detergents|Household Products|Medicated Dressings|Medicated Dressings With Antiinfectives|Miscellaneous Local Anti-infectives|Nitrogen Compounds|Onium Compounds|Pharmaceutic Aids|Pharmaceutical Preparations|Preservatives, Pharmaceutical|Quaternary Ammonium Compounds|Surface-Active Agents|Throat Preparations",,
9213,DB11107,Potassium bitartrate,small molecule,experimental,Potassium Salt|Radiographic Contrast Agent,[K+].O[C@H]([C@@H](O)C([O-])=O)C(O)=O,23681127
9214,DB11108,Aluminum sesquichlorohydrate,small molecule,approved,"Acids|Acids, Noncarboxylic|Alkalies|Aluminium Compounds|Anions|Chlorine Compounds|Electrolytes|Hydroxides|Ions|Metal cations|Metal divalent cations",,
9215,DB11109,Chlorine,small molecule,experimental,"Compounds used in a research, industrial, or household setting|Elements|Gases|Halogens|Noxae|Poisons|Toxic Actions",ClCl,24526
9216,DB11110,Magnesium citrate,small molecule,approved,"Acids, Acyclic|Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Calculi Dissolution Agent|Citrates|Drugs for Constipation|Gastrointestinal Agents|Irrigating Solutions|Laxatives|Laxatives, magnesium containing|Magnesium Compounds|Metal cations|Metal divalent cations|Mineral Supplements|Osmotic Laxatives|Salt Solutions|Tricarboxylic Acids",[Mg++].[Mg++].[Mg++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,6099959
9218,DB11112,Lanolin,small molecule,approved,"Basic Ointments and Protectants|Compounds used in a research, industrial, or household setting|Cosmetics|Household Products|Lipids|Waxes",,
9220,DB11114,Eucalyptus oil,small molecule,approved,Biological Products|Complex Mixtures|Drugs that are Mainly Renally Excreted|Lipids|Oils|Other Cold and Cough Preparations|Plant Oils|Plant Preparations,,
9221,DB11115,Ensulizole,small molecule,approved,"Acids|Acids, Noncarboxylic|Heterocyclic Compounds, Fused-Ring|Sulfur Acids|Sulfur Compounds|Sunscreen Agents",OS(=O)(=O)C1=CC2=C(C=C1)N=C(N2)C1=CC=CC=C1,33919
9222,DB11116,Aluminum zirconium trichlorohydrex gly,small molecule,approved|experimental,,,
9223,DB11117,Undecylenic acid,small molecule,approved|investigational,"Antifungals for Dermatological Use|Antifungals for Topical Use|Dermatologicals|Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Lipids",OC(=O)CCCCCCCCC=C,
9224,DB11118,Ammonia,small molecule,approved,Gases|Nitrogen Compounds,,
9225,DB11119,Sodium iodide,small molecule,approved,Anions|Electrolytes|Iodides|Iodine Compounds|Ions|Replacement Preparations|Sodium Compounds|Thyroid Diagnostic Radiopharmaceuticals,[Na+].[I-],5238
9226,DB11120,Turpentine,small molecule,approved|experimental,"Biological Products|Biopolymers|Complex Mixtures|Compounds used in a research, industrial, or household setting|Irritants|Lipids|Macromolecular Substances|Noxae|Oils|Oils, Volatile|Plant Exudates|Polymers|Resins, Plant|Solvents|Toxic Actions",,
9227,DB11121,Chloroxylenol,small molecule,approved,"Anti-Infective Agents|Anti-Infective Agents, Local|Antiparasitic Agents|Antiplatyhelmintic Agents|Antiseptics and Disinfectants|Benzene Derivatives|Compounds used in a research, industrial, or household setting|Dermatologicals|Disinfectants|Drugs that are Mainly Renally Excreted|Miscellaneous Local Anti-infectives|Phenol and Derivatives|Schistosomicides",CC1=CC(O)=CC(C)=C1Cl,2723
9228,DB11123,Hypochlorite,small molecule,approved,"Acids|Acids, Noncarboxylic|Anions|Anti-Infective Agents|Antiseptics and Disinfectants|Chlorine Compounds|Compounds used in a research, industrial, or household setting|Dermatologicals|Disinfectants|Electrolytes|Free Radicals|Ions|Miscellaneous Local Anti-infectives|Noxae|Oxidants|Oxides|Oxygen Compounds|Reactive Oxygen Species|Sodium Compounds|Toxic Actions",[O-]Cl,61739
9229,DB11124,Racepinephrine,small molecule,approved,Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic beta-1 Receptor Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-3 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Alpha-and Beta-adrenergic Agonists|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Benzene Derivatives|Biogenic Amines|Biogenic Monoamines|Bronchodilator Agents|Cardiovascular Agents|Catecholamines|Catechols|Epinephrine and similars|Ethanolamines|Mydriatics|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenols|Respiratory System Agents|Sympathomimetics|Vasoconstrictor Agents,,
9230,DB11125,Benzethonium,small molecule,approved,"Amines|Ammonium Compounds|Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Benzylammonium Compounds|Dermatologicals|Miscellaneous Local Anti-infectives|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds|Throat Preparations",CC(C)(C)CC(C)(C)C1=CC=C(OCCOCC[N+](C)(C)CC2=CC=CC=C2)C=C1,2335
9231,DB11126,Calcium gluconate,small molecule,approved|vet_approved,"Acids, Acyclic|Alimentary Tract and Metabolism|Blood Coagulation Factors|Calcium Salts|Carbohydrates|Dermatologicals|Gluconates|Hydroxy Acids|Mineral Supplements|Minerals|Phosphate Binder|Replacement Preparations|Sugar Acids",[Ca++].[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O.[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O,9290
9232,DB11127,Selenious acid,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Diet, Food, and Nutrition|Drugs that are Mainly Renally Excreted|Food|Food and Beverages|Growth Substances|Micronutrients|Mineral Supplements|Minerals|Physiological Phenomena|Replacement Preparations|Selenium Compounds|Sodium Compounds|Trace Elements",O[Se](O)=O,1091
9233,DB11128,Ammonium molybdate,small molecule,experimental,"Coloring Agents|Compounds used in a research, industrial, or household setting|Elements|Metals|Metals, Heavy|Transition Elements",[NH4+].[NH4+].[NH4+].[NH4+].[NH4+].[NH4+].O.O.O.O.[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[Mo+6].[Mo+6].[Mo+6].[Mo+6].[Mo+6].[Mo+6].[Mo+6],485454
9234,DB11129,Carbamide peroxide,small molecule,approved,"Anions|Anti-Infective Agents|Anti-Infective Agents, Local|Bleaching Agents|Compounds used in a research, industrial, or household setting|Electrolytes|Free Radicals|Ions|Noxae|Oxidants|Oxides|Oxygen Compounds|Peroxides|Reactive Oxygen Species|Tooth Bleaching Agents|Toxic Actions",OO.NC(N)=O,31294
9235,DB11130,Opium,small molecule,approved|illicit,"Alimentary Tract and Metabolism|Analgesics|Antidiarrheals|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antipropulsives|Antitussive Agents|Biological Products|Central Nervous System Agents|Central Nervous System Depressants|Complex Mixtures|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Gastrointestinal Agents|Narcotics|Natural Opium Alkaloids|Nervous System|Opiate Agonists|Opioids|Peripheral Nervous System Agents|Pharmaceutical Preparations|Plant Extracts|Plant Preparations|Respiratory System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",,
9237,DB11132,Silicon dioxide,small molecule,approved,"Acids|Acids, Noncarboxylic|Anions|Colloids|Complex Mixtures|Compounds used in a research, industrial, or household setting|Dental Casting Investment|Electrolytes|Hygroscopic Agents|Investigative Techniques|Ions|Minerals|Oxides|Oxygen Compounds|Pharmaceutical Preparations|Silicon Compounds",O=[Si]=O,22644374
9238,DB11133,Omega-3 fatty acids,small molecule,approved|nutraceutical,"Diet, Food, and Nutrition|Dietary Fats|Dietary Fats, Unsaturated|Fats|Fatty Acids|Fatty Acids, Omega-3|Fatty Acids, Unsaturated|Fish Oils|Food|Food and Beverages|Lipids|Membrane Lipids|Oils|Phospholipids|Physiological Phenomena",,
9239,DB11134,Cupric oxide,small molecule,approved,"Copper-containing Intrauterine Device|Diet, Food, and Nutrition|Elements|Food|Food and Beverages|Growth Substances|Metals|Metals, Heavy|Micronutrients|Physiological Phenomena|Trace Elements|Transition Elements",[O--].[Cu++],164827
9240,DB11135,Selenium,small molecule,approved|investigational|vet_approved,"Alimentary Tract and Metabolism|Antioxidants|Chalcogens|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Drugs that are Mainly Renally Excreted|Elements|Food|Food and Beverages|Growth Substances|Micronutrients|Mineral Supplements|Minerals|Physiological Phenomena|Polyvalent cation containing laxatives, antacids, oral supplements|Protective Agents|Selenium Compounds|Trace Elements",[Se],6326970
9241,DB11136,Chromium,small molecule,approved,"Cell-mediated Immunity|Chromium|Diet, Food, and Nutrition|Drugs that are Mainly Renally Excreted|Elements|Food|Food and Beverages|Growth Substances|Increased Histamine Release|Metals|Metals, Heavy|Micronutrients|Minerals|Physiological Phenomena|Standardized Chemical Allergen|Trace Elements|Transition Elements",[Cr],23976
9242,DB11137,Molybdenum,small molecule,approved,"Diet, Food, and Nutrition|Elements|Food|Food and Beverages|Growth Substances|Metals|Metals, Heavy|Micronutrients|Physiological Phenomena|Trace Elements|Transition Elements",[Mo],23932
9243,DB11140,Chromium Cr-51,small molecule,approved,"Chromium|Chromium Isotopes|Elements|Isotopes|Metals|Metals, Heavy|Radioisotopes|Transition Elements",[51Cr],104786
9244,DB11141,Manganese gluconate,small molecule,approved,"Acids, Acyclic|Carbohydrates|Hydroxy Acids|Paramagnetic Contrast Agent|Sugar Acids",[Mn++].[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O.[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O,
9245,DB11142,Selenomethionine,small molecule,approved|investigational,"Amino Acids|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Organoselenium Compounds|Selenium Compounds|Sulfur Compounds",C[Se]CC[C@H](N)C(O)=O,105024
9246,DB11143,Cresol,small molecule,approved,Benzene Derivatives|Drugs that are Mainly Renally Excreted|Phenols|Standardized Chemical Allergen,,
9248,DB11145,Oxyquinoline,small molecule,approved|vet_approved,"Alimentary Tract and Metabolism|Anti-Infective Agents, Local|Antiinfectives and Antiseptics for Local Oral Treatment|Antiseptics and Disinfectants|Dermatologicals|Drugs that are Mainly Renally Excreted|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Heterocyclic Compounds, Fused-Ring|Hydroxyquinolines|Quinoline Derivatives|Quinolines|Stomatological Preparations|Throat Preparations",OC1=CC=CC2=C1N=CC=C2,1923
9249,DB11147,Aluminum zirconium pentachlorohydrate,small molecule,approved,,,
9250,DB11148,Butamben,small molecule,approved|withdrawn,"Acids, Carbocyclic|Aminobenzoates|Anesthetics|Anesthetics, Local|Benzene Derivatives|Benzoates|Central Nervous System Agents|Cholinesterase substrates|Drugs that are Mainly Renally Excreted|para-Aminobenzoates|Peripheral Nervous System Agents|Sensory System Agents",CCCCOC(=O)C1=CC=C(N)C=C1,2482
9251,DB11149,Aluminum zirconium tetrachlorohydrex gly,small molecule,approved,,,
9252,DB11150,Barium sulfate,small molecule,approved,"Acids|Acids, Noncarboxylic|Anions|Barium Compounds|Barium Sulfate Containing X-Ray Contrast Media|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Electrolytes|Ions|Radiographic Contrast Agent|Sulfates|Sulfur Acids|Sulfur Compounds|Sulfuric Acids|X-Ray Contrast Activity|X-Ray Contrast Media, Non-Iodinated",[Ba++].[O-]S([O-])(=O)=O,24414
9253,DB11151,Sodium hydroxide,small molecule,approved,"Alkalies|Anions|Caustics|Compounds used in a research, industrial, or household setting|Electrolytes|Hydroxides|Ions|Noxae|Sodium Compounds|Toxic Actions",[OH-].[Na+],14798
9254,DB11152,Trichloroacetate,small molecule,approved,"Acetates|Acids, Acyclic|Caustics|Chloroacetates|Compounds used in a research, industrial, or household setting|Fatty Acids|Fatty Acids, Volatile|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Lipids|Noxae|Toxic Actions|Trichloroacetic Acid",,
9255,DB11153,Potassium hydroxide,small molecule,approved,"Alkalies|Anions|Compounds used in a research, industrial, or household setting|Electrolytes|Indicators and Reagents|Ions|Laboratory Chemicals|Potassium Salt",[OH-].[K+],14797
9256,DB11154,Zinc citrate,small molecule,investigational,Anticoagulants|Calculi Dissolution Agent|Copper Absorption Inhibitor|Metal cations|Metal divalent cations|Zinc Compounds,[Zn++].[Zn++].[Zn++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,11023
9257,DB11155,Triclocarban,small molecule,approved,"Amides|Amines|Anilides|Aniline Compounds|Anti-Infective Agents|Anti-Infective Agents, Local|Benzene Derivatives|Environmental Pollutants|Miscellaneous Local Anti-infectives|Phenylurea Compounds|Toxic Actions|Water Pollutants|Water Pollutants, Chemical",ClC1=CC=C(NC(=O)NC2=CC(Cl)=C(Cl)C=C2)C=C1,7547
9258,DB11156,Pyrantel,small molecule,approved|vet_approved,"Anthelmintics|Anti-Infective Agents|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Central Nervous System Depressants|Drugs that are Mainly Renally Excreted|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular Depolarizing Agents|Peripheral Nervous System Agents|Pyrimidines|Sulfur Compounds|Tetrahydropyrimidine Derivatives|Thiophenes",[H]\C(=C(\[H])C1=NCCCN1C)C1=CC=CS1,708857
9259,DB11157,Anthralin,small molecule,approved,Anthracenes|Antipsoriatics|Antipsoriatics for Topical Use|Antracen Derivatives|Dermatologicals,OC1=CC=CC2=C1C(=O)C1=C(O)C=CC=C1C2,2202
9260,DB11158,Pectin,small molecule,approved|investigational|vet_approved,"Alimentary Tract and Metabolism|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Biological Products|Biopolymers|Carbohydrates|Complex Mixtures|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Food|Food Additives|Food and Beverages|Food Ingredients|Intestinal Adsorbents|Macromolecular Substances|Pharmaceutical Preparations|Physiological Phenomena|Plant Extracts|Plant Preparations|Polymers|Polysaccharides",,
9261,DB11159,Sodium sulfide,small molecule,approved,"Acids|Acids, Noncarboxylic|Anions|Electrolytes|Gases|Hydrogen Sulfide|Ions|Sulfur Compounds",[Na+].[Na+].[S--],14804
9262,DB11160,Phenyltoloxamine,small molecule,approved,Benzene Derivatives,CN(C)CCOC1=CC=CC=C1CC1=CC=CC=C1,7077
9263,DB11161,Polyethylene glycol 300,small molecule,approved,"Alcohols|Compounds used in a research, industrial, or household setting|Ethylene Glycols|Glycols|Macromolecular Substances|Polymers",,
9264,DB11164,Bicisate,small molecule,approved|investigational,Diagnostic Agents|Drugs that are Mainly Renally Excreted,CCOC(=O)[C@H](CS)NCCN[C@@H](CS)C(=O)OCC,72048
9267,DB11168,Calcium threonate,small molecule,approved,"Acids, Acyclic|Blood Coagulation Factors|Fatty Acids|Fatty Acids, Volatile|Lipids",[Ca++].OC[C@H](O)[C@@H](O)C([O-])=O.OC[C@H](O)[C@@H](O)C([O-])=O,13388558
9268,DB11169,Ferrous asparto glycinate,small molecule,approved,,,
9269,DB11171,Ferric sulfate,small molecule,approved,Hematinics|Iron Compounds|Organometallic Compounds|Parenteral Iron Replacement|Phosphate Binder,O.O.O.O.O.[Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O,23443659
9271,DB11174,2-(l-menthoxy)ethanol,small molecule,experimental,,[H][C@@]1(C)CC[C@@]([H])(C(C)C)[C@@]([H])(C1)OCCO,
9272,DB11175,Zinc picolinate,small molecule,investigational,"Compounds used in a research, industrial, or household setting|Copper Absorption Inhibitor|Iron Chelating Agents|Metal cations|Metal divalent cations|Pyridines|Sequestering Agents|Zinc Compounds",[Zn++].[O-]C(=O)C1=CC=CC=N1.[O-]C(=O)C1=CC=CC=N1,9904746
9273,DB11176,Zeaxanthin,small molecule,approved|investigational,"Alkenes|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Terpenes|Xanthophylls",C\C(\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C,5280899
9274,DB11178,Polysorbate 20,small molecule,approved,"Alcohols|Compounds used in a research, industrial, or household setting|Drug Delivery Systems|Ethylene Glycols|Excipients|Glycols|Macromolecular Substances|Pharmaceutic Aids|Pharmaceutical Preparations|Pharmaceutical Vehicles|Polyethylene Glycols|Polymers|Surface-Active Agents",,
9275,DB11179,Exametazime,small molecule,approved,Ketones,,
9276,DB11180,Tetrofosmin,small molecule,approved,,CCOCCP(CCOCC)CCP(CCOCC)CCOCC,4274
9277,DB11181,Homatropine,small molecule,approved,Alkaloids|Anticholinergic Agents|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Muscarinic Agonists|Muscarinic Antagonists|Mydriatics and Cycloplegics|Ophthalmologicals|Parasympatholytics|Peripheral Nervous System Agents|Sensory Organs,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)C1=CC=CC=C1)N2C,
9278,DB11182,Rose bengal,small molecule,approved|investigational,"Coloring Agents|Colouring Agents|Compounds used in a research, industrial, or household setting|Diagnostic Agents|Fluoresceins|Fluorescent Dyes|Heterocyclic Compounds, Fused-Ring|Indicators and Reagents|Laboratory Chemicals|Luminescent Agents|Ophthalmologicals|Other Diagnostics|Sensory Organs|Spiro Compounds|Xanthenes",OC(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C(O)=C(I)C=C12,
9279,DB11183,Light green SF yellowish,small molecule,approved|experimental,"Acids|Acids, Noncarboxylic|Amines|Ammonium Compounds|Arylsulfonates|Arylsulfonic Acids|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",[Na+].[Na+].CCN(CC1=CC(=CC=C1)S([O-])(=O)=O)C1=CC=C(C=C1)C(C1=CC=C(C=C1)S([O-])(=O)=O)=C1C=CC(C=C1)=[N+](CC)CC1=CC(=CC=C1)S([O-])(=O)=O,21223
9280,DB11184,Oftasceine,small molecule,approved,,OC(=O)CN(CC(O)=O)CC1=CC2=C(OC3=CC(O)=C(CN(CC(O)=O)CC(O)=O)C=C3C22OC(=O)C3=CC=CC=C23)C=C1O,65079
9281,DB11185,Sulisobenzone,small molecule,experimental,Benzene Derivatives|Drugs that are Mainly Renally Excreted|Ketones|Sunscreen Agents,COC1=C(C=C(C(=O)C2=CC=CC=C2)C(O)=C1)S(O)(=O)=O,19988
9282,DB11186,Pentoxyverine,small molecule,approved|investigational,Antitussive Agents|Central Nervous System Agents|Cough and Cold Preparations|Cycloparaffins|Respiratory System Agents,CCN(CC)CCOCCOC(=O)C1(CCCC1)C1=CC=CC=C1,2562
9283,DB11187,1-(c14-c18 esteroyl)-2-docosahexanoyl-sn-glycero-3-phosphocholine,small molecule,experimental,,,
9284,DB11188,1-(c14-c18 esteroyl)-2-docosahexanoyl-sn-glycero-3-phosphoethanolamine,small molecule,experimental,,,
9285,DB11189,Magnesium glycinate,small molecule,approved,Agents that produce neuromuscular block (indirect)|Calculi Dissolution Agent|Laxatives|Osmotic Laxatives,[Mg++].NCC([O-])=O.NCC([O-])=O,84645
9286,DB11190,Pantethine,small molecule,approved|investigational,Alimentary Tract and Metabolism|Sulfhydryl Compounds|Sulfur Compounds|Vitamin B Complex|Vitamins,CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO,452306
9287,DB11191,Cobamamide,small molecule,approved,"Antianemic Preparations|Blood and Blood Forming Organs|Coenzymes|Corrinoids|Enzymes and Coenzymes|Heterocyclic Compounds, Fused-Ring|Vitamin B Complex|VITAMIN B12 AND FOLIC ACID|Vitamins",[C@H]1(C[Co-3]2345[N+]6=C7C(C)=C8N2[C@]([H])([C@H](CC(=O)N)[C@]8(CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@@H]2[C@@H](CO)O[C@H](N8C=[N+]3C3=CC(C)=C(C)C=C83)[C@@H]2O)C)[C@@]2(C)[C@@](CC(=O)N)([C@H](CCC(=O)N)C(C(C)=C3[N+]4=C(C=C6C([C@@H]7CCC(=O)N)(C)C)[C@@H](CCC(=O)N)[C@@]3(CC(=O)N)C)=[N+]52)C)O[C@@H](N2C3=C(N=C2)C(=NC=N3)N)[C@H](O)[C@@H]1O,
9288,DB11192,L-threonic acid,small molecule,experimental,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids",[H][C@](O)(CO)[C@@]([H])(O)C(O)=O,
9289,DB11193,Papain,small molecule,approved,"Cysteine Endopeptidases|Cysteine Proteases|Endopeptidases|Enzymes|Enzymes and Coenzymes|Gastrointestinal Agents|Hydrolases|Papain, antagonists & inhibitors|Peptide Hydrolases",,
9290,DB11195,Xylitol,small molecule,experimental|investigational,"Alcohols|Carbohydrates|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Flavoring Agents|Food|Food Additives|Food and Beverages|Food Ingredients|Pharmaceutic Aids|Pharmaceutical Preparations|Physiological Phenomena|Sugar Alcohols|Sweetening Agents",OC[C@H](O)[C@@H](O)[C@H](O)CO,
9291,DB11197,Ferrous cysteine glycinate,small molecule,approved,,[Fe++].NCC(O)=O.[H][C@](N)(CS)C(O)=O.[H][C@](N)(C[S-])C([O-])=O,
9294,DB11200,Aluminum zirconium octachlorohydrex gly,small molecule,approved,,O.O.[Al+3].[Cl-].[Zr+4].NCC([O-])=O,
9295,DB11201,Menthyl salicylate,small molecule,approved,,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O,
9296,DB11202,N-alkyl ethylbenzyl dimethyl ammonium (C12-C14),small molecule,approved,,,
9297,DB11203,Boron,small molecule,experimental,"Diet, Food, and Nutrition|Elements|Food|Food and Beverages|Growth Substances|Metalloids|Micronutrients|Physiological Phenomena|Trace Elements",[B],5462311
9298,DB11204,Panthenol,small molecule,approved,"Alanine|Amino Acids|Amino Acids, Peptides, and Proteins|Imides|Vitamin B Complex|Vitamins|Wound Healing",,
9299,DB11205,Alcloxa,small molecule,approved,,[OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Cl-].NC(=O)NC1NC(=O)[N-]C1=O,
9300,DB11206,Bemotrizinol,small molecule,approved,Benzene Derivatives|Sunscreen Agents,CCCCC(CC)COC1=CC(O)=C(C=C1)C1=NC(=NC(=N1)C1=CC=C(OC)C=C1)C1=C(O)C=C(OCC(CC)CCCC)C=C1,
9301,DB11207,Amiloxate,small molecule,approved,"Acids, Carbocyclic|Sunscreen Agents",COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1,
9302,DB11208,Aluminum chlorohydrex propylene glycol,small molecule,approved,,,
9303,DB11209,Iron protein succinylate,small molecule,approved|investigational,"Acids, Acyclic|Amino Acids, Peptides, and Proteins|Anemia, Hypochromic, drug therapy|Dicarboxylic Acids|Ferric Compounds|Hematinics|Hematologic Agents|Proteins",,
9304,DB11210,Ferrous bisglycinate,small molecule,approved,"Amino Acids|Amino Acids, Peptides, and Proteins|Iron Compounds|Organometallic Compounds",[Fe++].NCC([O-])=O.NCC([O-])=O,9837124
9305,DB11211,Calcium sulfide,small molecule,experimental,"Acids|Acids, Noncarboxylic|Anions|Anti-Infective Agents|Electrolytes|Gases|Hydrogen Sulfide|Ions|Sulfur Compounds",[S--].[Ca++],
9306,DB11217,Arbutin,small molecule,approved,Carbohydrates|Glucosides|Glycosides,OC[C@H]1O[C@@H](OC2=CC=C(O)C=C2)[C@H](O)[C@@H](O)[C@@H]1O,440936
9308,DB11219,Enzacamene,small molecule,approved,Bornanes|Ketones|Monoterpenes|Norbornanes|Sunscreen Agents|Terpenes,CC1=CC=C(\C=C2/C3CCC(C)(C2=O)C3(C)C)C=C1,7019255
9309,DB11220,Octacosanol,small molecule,nutraceutical,Alcohols|Lipids,CCCCCCCCCCCCCCCCCCCCCCCCCCCCO,68406
9310,DB11221,Dioxybenzone,small molecule,approved,Benzene Derivatives|Ketones|Sunscreen Agents,COC1=CC(O)=C(C=C1)C(=O)C1=CC=CC=C1O,
9312,DB11223,Tolu balsam,small molecule,experimental,"Biological Products|Biopolymers|Complex Mixtures|Compounds used in a research, industrial, or household setting|Macromolecular Substances|Plant Exudates|Polymers|Resins, Plant|Standardized Chemical Allergen",,
9314,DB11225,Peg-100 stearate,small molecule,approved,Pegylated agents,,
9315,DB11226,Ethylhexyl methoxycrylene,small molecule,approved|experimental,,CCCCC(CC)COC(=O)C(C#N)=C(C1=CC=CC=C1)C1=CC=C(OC)C=C1,
9317,DB11228,Methylcellulose,small molecule,approved,"Alimentary Tract and Metabolism|Biopolymers|Bulk-Forming Laxatives|Carbohydrates|Cellulose|Compounds used in a research, industrial, or household setting|Drugs for Constipation|EENT Drugs, Miscellaneous|Glucans|Laxatives|Macromolecular Substances|Polymers|Polysaccharides",,
9318,DB11229,Padimate A,small molecule,experimental|withdrawn,"Acids, Carbocyclic|Aminobenzoates|Benzene Derivatives|Benzoates",,
9319,DB11230,Magnesium Aluminum Silicate,small molecule,approved,"Acids|Acids, Noncarboxylic|Agents that produce neuromuscular block (indirect)|Anions|Electrolytes|Ions|Minerals|Oxides|Oxygen Compounds|Pharmaceutic Aids|Silicon Compounds",,
9320,DB11231,Lycopene,small molecule,approved|investigational,"Alkenes|Anti-Inflammatory Agents|Anticarcinogenic Agents|Antioxidants|Biological Factors|Carotenoids|Compounds used in a research, industrial, or household setting|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Protective Agents|Radiation-Protective Agents|Terpenes",CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C,446925
9321,DB11232,Saccharide isomerate,small molecule,approved,,,
9322,DB11233,Silver citrate,small molecule,experimental,,[Ag+].[Ag+].[Ag+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,
9323,DB11234,Poliglusam,small molecule,experimental,"Anticholesteremic Agents|Biocompatible Materials|Biopolymers|Carbohydrates|Chelating Agents|Chitin|Chitosan|Coagulants|Compounds used in a research, industrial, or household setting|Hematologic Agents|Hemostatics|Hypolipidemic Agents|Lipid Regulating Agents|Macromolecular Substances|Noxae|Polymers|Polysaccharides|Sequestering Agents|Toxic Actions",,
9324,DB11235,Thonzylamine,small molecule,approved,"Agents producing tachycardia|Antiallergic Agents, Excl. Corticosteroids|Anticholinergic Agents|Antihistamines for Systemic Use|Antihistamines for Topical Use|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Dermatologicals|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Muscarinic Antagonists|Nasal Preparations|Neurotransmitter Agents|Substituted Ethylene Diamines",COC1=CC=C(CN(CCN(C)C)C2=NC=CC=N2)C=C1,5457
9325,DB11236,Polyethylene glycol 3500,small molecule,experimental,,,
9326,DB11237,Trypsin,small molecule,approved|vet_approved,Blood and Blood Forming Organs|Dermatologicals|Endopeptidases|Enzymes|Enzymes and Coenzymes|Hydrolases|Musculo-Skeletal System|Peptide Hydrolases|Preparations for Treatment of Wounds and Ulcers|Serine Endopeptidases|Serine Proteases,,
9327,DB11238,Borage oil,small molecule,approved|investigational,"Agents that reduce seizure threshold|Antirheumatic Agents|Biological Products|Complex Mixtures|Dietary Fats, Unsaturated|Fatty Acids|Fatty Acids, Essential|Fatty Acids, Omega-6|Fatty Acids, Unsaturated|Linolenic Acids|Lipids|Oils|Plant Preparations",,
9328,DB11239,Aluminum sulfate,small molecule,approved,"Acids|Acids, Noncarboxylic|Adjuvants, Immunologic|Aluminium Compounds|Anions|Electrolytes|Immunologic Factors|Ions|Metal cations|Metal divalent cations|Sulfates|Sulfur Acids|Sulfur Compounds|Sulfuric Acids",[Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O,24850
9329,DB11242,Gelatin,small molecule,approved|vet_approved,"Amino Acids, Peptides, and Proteins|Proteins|Scleroproteins",,
9330,DB11243,Ethyl macadamiate,small molecule,approved,,,
9331,DB11244,Cyclomethicone 5,small molecule,experimental,"Compounds used in a research, industrial, or household setting|Macromolecular Substances|Organosilicon Compounds|Polymers|Silicon Compounds",C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1,10913
9332,DB11246,Copper gluconate,small molecule,approved|investigational,Copper-containing Intrauterine Device,[Cu++].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O,10692
9334,DB11248,Zinc gluconate,small molecule,approved|vet_approved,"Acids, Acyclic|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Alimentary Tract and Metabolism|Carbohydrates|Copper Absorption Inhibitor|Hydroxy Acids|Metal cations|Metal divalent cations|Mineral Supplements|Sugar Acids|Vasoprotectives|Zinc Compounds",[Zn++].[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O.[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O,443445
9335,DB11250,Glyceryl monostearate,small molecule,experimental,Lipids,CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO,
9336,DB11251,Tocopherol,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Antioxidants|Benzopyrans|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Diet, Food, and Nutrition|Drugs that are Mainly Renally Excreted|Food|Food and Beverages|Growth Substances|Heterocyclic Compounds, Fused-Ring|Micronutrients|Physiological Phenomena|Protective Agents|Pyrans|Vitamin E|Vitamins|Vitamins (Fat Soluble)",,
9337,DB11252,Poloxamer 407,small molecule,investigational,"Alcohols|Compounds used in a research, industrial, or household setting|Drug Delivery Systems|Ethylene Glycols|Excipients|Glycols|Macromolecular Substances|Pharmaceutic Aids|Pharmaceutical Preparations|Pharmaceutical Vehicles|Polyethylene Glycols|Polymers|Surface-Active Agents",,
9338,DB11253,Xanthan gum,small molecule,approved,"Antigens|Antigens, Bacterial|Biological Factors|Carbohydrates|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Drug Carriers|Food|Food Additives|Food and Beverages|Food Ingredients|Physiological Phenomena|Polysaccharides",,
9339,DB11254,Hexylresorcinol,small molecule,approved,"Anthelmintics|Anti-Infective Agents|Anti-Infective Agents, Local|Antiparasitic Agents|Benzene Derivatives|Miscellaneous Anti-infectives|Phenols|Resorcinols|Throat Preparations",CCCCCCC1=C(O)C=C(O)C=C1,3610
9340,DB11255,Chromium picolinate,small molecule,approved,"Compounds used in a research, industrial, or household setting|Iron Chelating Agents|Pyridines|Sequestering Agents|Standardized Chemical Allergen",[Cr+3].[O-]C(=O)C1=NC=CC=C1.[O-]C(=O)C1=NC=CC=C1.[O-]C(=O)C1=NC=CC=C1,625469
9341,DB11256,Levomefolic acid,small molecule,approved|investigational,"Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Biological Factors|Coenzymes|Enzymes and Coenzymes|Folic Acid and Derivatives|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Pteridines|Pterins|Vitamin B Complex|Vitamins",CN1[C@@H](CNC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2=C1C(=O)N=C(N)N2,444412
9342,DB11257,Fluoride ion,small molecule,approved,,[F-],28179
9343,DB11259,Diosmetin,small molecule,experimental,"Benzopyrans|Chromones|Heterocyclic Compounds, Fused-Ring|Pyrans",COC1=C(O)C=C(C=C1)C1=CC(=O)C2=C(O1)C=C(O)C=C2O,5281612
9344,DB11260,Diacetyl benzoyl lathyrol,small molecule,approved,,C[C@H]1C[C@@]2(OC(C)=O)[C@H]([C@H]1OC(=O)C1=CC=CC=C1)[C@@H](OC(C)=O)C(=C)CC[C@H]1[C@@H](\C=C(C)\C2=O)C1(C)C,10577938
9345,DB11261,Atractylodes japonica root,small molecule,approved,,,
9346,DB11262,Bisoctrizole,small molecule,approved,Sunscreen Agents,CC(C)(C)CC(C)(C)C1=CC(CC2=C(O)C(=CC(=C2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)=C(O)C(=C1)N1N=C2C=CC=CC2=N1,
9347,DB11263,Polydatin,small molecule,approved,"Benzene Derivatives|Benzylidene Compounds|Carbohydrates|Drugs, Chinese Herbal|Glycosides",OC[C@H]1O[C@@H](OC2=CC(\C=C\C3=CC=C(O)C=C3)=CC(O)=C2)[C@H](O)[C@@H](O)[C@@H]1O,5281718
9348,DB11264,Calcium glycerophosphate,small molecule,approved,,[Ca++].OCC(CO)OP([O-])([O-])=O,
9350,DB11266,Sea salt,small molecule,approved,,,
9351,DB11267,Triethoxycaprylylsilane,small molecule,experimental,Naphthalenes|Organosilicon Compounds|Quinones|Silicon Compounds,CCCCCCCC[Si](OCC)(OCC)OCC,
9352,DB11268,Protocatechualdehyde,small molecule,experimental,Aldehydes|Anticoagulants|Benzene Derivatives|Hematologic Agents|Phenols,[H]C(=O)C1=CC(O)=C(O)C=C1,8768
9353,DB11269,Diethylamino hydroxybenzoyl hexyl benzoate,small molecule,approved,Amines|Aniline Compounds|Benzene Derivatives|Ketones|Phenols|Sunscreen Agents,CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(C=C1O)N(CC)CC,
9354,DB11270,Atractylodes japonica root oil,small molecule,approved,,,
9355,DB11271,Polysilicone-15,small molecule,approved,Sunscreen Agents,,
9356,DB11272,Methyl undecenoyl leucinate,small molecule,experimental,,COC(=O)[C@H](CC(C)C)NC(=O)CCCCCCCCC=C,56843908
9357,DB11273,Dihydroergocornine,small molecule,approved,"Agents that produce hypertension|Alkaloids|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Agonists|Ergot Alkaloids and Derivatives|Ergot-derivative Dopamine Receptor Agonists|Ergotamines|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents",[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C,
9358,DB11274,Dihydro-alpha-ergocryptine,small molecule,approved,Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C,
9359,DB11275,Epicriptine,small molecule,approved,Alkaloids,[H][C@@]12CCCN1C(=O)[C@]([H])([C@H](C)CC)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C,
9361,DB11277,Aluminum zirconium pentachlorohydrex gly,small molecule,approved,,,
9362,DB11278,DL-Methylephedrine,small molecule,approved,Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Drugs that are Mainly Renally Excreted,C[C@@H]([C@H](O)C1=CC=CC=C1)N(C)C,
9363,DB11279,Brilliant green cation,small molecule,approved|vet_approved,"Amines|Ammonium Compounds|Anti-Infective Agents|Anti-Infective Agents, Local|Coloring Agents|Compounds used in a research, industrial, or household setting|Nitrogen Compounds|Onium Compounds",CCN(CC)C1=CC=C(C=C1)C(C1=CC=CC=C1)=C1C=CC(C=C1)=[N+](CC)CC,12449
9364,DB11281,Bismuth subcarbonate,small molecule,experimental|vet_approved,"Acids|Acids, Noncarboxylic|Alkalies|Anions|Bismuth containing drugs|Carbon Compounds, Inorganic|Carbonic Acid|Electrolytes|Elements|Elements, Radioactive|Ions|Isotopes|Metals|Metals, Heavy|Neurotoxic agents|Radioisotopes",[O--].[O--].[Bi+3].[Bi+3].[O-]C([O-])=O,
9365,DB11282,Diethyltoluamide,small molecule,approved,"Acids, Carbocyclic|Agrochemicals|Amides|Antiparasitic Products, Insecticides and Repellents|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Insect Repellents|Insecticides and Repellents|Pesticides|Protective Agents|Toxic Actions",CCN(CC)C(=O)C1=CC(C)=CC=C1,
9366,DB11283,DL-dimyristoylphosphatidylcholine,small molecule,approved,"Alcohols|Carbohydrates|Compounds used in a research, industrial, or household setting|Glycerophosphates|Glycerophospholipids|Indicators and Reagents|Laboratory Chemicals|Lipids|Membrane Lipids|Phosphatidic Acids|Phosphatidylcholines|Phospholipids|Sugar Alcohols|Sugar Phosphates|Triose Sugar Alcohols",CCCCCCCCCCCCCC(=O)OCC(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC,
9367,DB11284,DL-dimyristoylphosphatidylglycerol,small molecule,approved,Alcohols|Carbohydrates|Glycerophosphates|Glycerophospholipids|Lipids|Membrane Lipids|Phosphatidic Acids|Phospholipids|Sugar Alcohols|Sugar Phosphates|Triose Sugar Alcohols,CCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCCCCCCCC,
9368,DB11285,Ethyl ferulate,small molecule,approved|experimental,"Acids, Carbocyclic|Cinnamates",[H]\C(=C(\[H])C1=CC(OC)=C(O)C=C1)C(=O)OCC,
9370,DB11288,Borneol,small molecule,experimental,Monoterpenes|Norbornanes|Perfume|Terpenes,CC1(C)C2CCC1(C)C(O)C2,
9371,DB11289,Methicone (20 CST),small molecule,experimental,,,
9372,DB11290,Aluminium tristearate,small molecule,experimental|vet_approved,,[Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O,
9373,DB11291,2-ethylhexyl benzoate,small molecule,experimental,,CCCCC(CC)COC(=O)C1=CC=CC=C1,
9374,DB11293,Rice bran oil,small molecule,approved,Biological Products|Complex Mixtures|Lipids|Oils|Plant Oils|Plant Preparations,,
9376,DB11295,Trichophyton verrucosum,small molecule,approved,,,
9377,DB11296,Prezatide,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Growth Substances|Peptides",NCCCC[C@H](NC(=O)[C@H](CC1=CNC=N1)NC(=O)CN)C(O)=O,73587
9378,DB11297,Palmitoyl oligopeptide,small molecule,experimental,,CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCCN)C(O)=O,
9379,DB11298,Thioredoxin,small molecule,approved,"Amino Acids, Peptides, and Proteins|Proteins|Thioredoxins|Thioredoxins, antagonists & inhibitors",,
9380,DB11299,Vanillyl butyl ether,small molecule,approved,,CCCCOCC1=CC(OC)=C(O)C=C1,5084146
9382,DB11301,Curcuma aromatica root oil,small molecule,approved,,,
9384,DB11304,Phenoxyethanol,small molecule,approved,"Alcohols|Anesthetics|Anti-Infective Agents|Anti-Infective Agents, Local|Central Nervous System Agents|Drugs that are Mainly Renally Excreted|Glycols",,31236
9385,DB11305,Quaternium-18,small molecule,experimental,,,
9386,DB11306,Bentonite,small molecule,approved,"Acids|Acids, Noncarboxylic|Aluminium Compounds|Aluminum Silicates|Anions|Antidotes|Compounds used in a research, industrial, or household setting|Electrolytes|Ions|Metal cations|Metal divalent cations|Minerals|Oxides|Oxygen Compounds|Protective Agents|Silicates|Silicon Compounds",,
9387,DB11309,Sulfuric acid,small molecule,experimental,"Acids|Acids, Noncarboxylic|Sulfur Acids|Sulfur Compounds",OS(O)(=O)=O,
9390,DB11313,Phenyl trimethicone,small molecule,experimental,"Compounds used in a research, industrial, or household setting|Macromolecular Substances|Organosilicon Compounds|Polymers|Silicon Compounds",,
9391,DB11315,Methscopolamine,small molecule,approved,"Agents producing tachycardia|Alimentary Tract and Metabolism|Alkaloids|Anticholinergic Agents|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Belladonna Alkaloids, Semisynthetic, Quaternary Ammonium Compounds|Belladonna and Derivatives, Plain|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Mydriatics and Cycloplegics|Ophthalmologicals|Parasympatholytics|Peripheral Nervous System Agents|Scopolamine Derivatives|Sensory Organs|Synthetic Anticholinergics, Quaternary Ammonium Compounds|Tropanes",C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1,71183
9392,DB11318,"1,2-Docosahexanoyl-sn-glycero-3-phosphoserine",small molecule,experimental,,[H]C(CC)=C([H])C\C([H])=C(\[H])C\C([H])=C(\[H])C\C([H])=C(\[H])C\C([H])=C(\[H])C\C([H])=C(\[H])CCC(=O)OC[C@]([H])(COP(O)(=O)OC[C@]([H])(N)C(O)=O)OC(=O)CC\C([H])=C(\[H])C\C([H])=C(\[H])C\C([H])=C(\[H])CC([H])=C([H])C\C([H])=C(\[H])C\C([H])=C(\[H])CC,
9393,DB11321,Cod liver oil,small molecule,nutraceutical|vet_approved,"Diet, Food, and Nutrition|Dietary Fats|Dietary Fats, Unsaturated|Fats|Fats, Unsaturated|Fish Oils|Food|Food and Beverages|Growth Substances|Lipids|Micronutrients|Oils|Physiological Phenomena",,
9394,DB11323,Glycol salicylate,small molecule,approved,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Hydroxy Acids|Hydroxybenzoates|Phenols",OCCOC(=O)C1=CC=CC=C1O,6880
9395,DB11324,Nonivamide,small molecule,investigational,"Acids, Carbocyclic|Alkaloids|Alkenes|Alkynes|Amides|Benzene Derivatives|Benzoates|Catechols|Ethers|Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Hydrocarbons, Acyclic|Hydroxy Acids|Hydroxybenzoate Ethers|Hydroxybenzoates|Lipids|Nitric Oxide Synthase, antagonists & inhibitors|Peripheral Nervous System Agents|Phenols|Phenyl Ethers|Polyunsaturated Alkamides|Sensory System Agents|Solanaceous Alkaloids",CCCCCCCCC(=O)NCC1=CC(OC)=C(O)C=C1,
9397,DB11326,Boric acid,small molecule,approved,"Acids|Acids, Noncarboxylic|Agrochemicals|Anti-Infective Agents|Boron Compounds|Compounds used in a research, industrial, or household setting|Insecticides|Otologicals|Pesticides|Sensory Organs|Toxic Actions",OB(O)O,7628
9398,DB11327,Dipyrithione,small molecule,approved,,[O-][N+]1=CC=CC=C1SSC1=CC=CC=[N+]1[O-],
9399,DB11328,Tetradecyl hydrogen sulfate (ester),small molecule,approved,Drugs that are Mainly Renally Excreted,CCCCC(CC)CCC(CC(C)C)OS(O)(=O)=O,
9400,DB11329,C11-12 isoparaffin,small molecule,approved,,,
9402,DB11331,1-Palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)),small molecule,approved|experimental,,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C/CCCCCCCC,
9403,DB11332,Sinapultide,small molecule,approved,"Amino Acids, Peptides, and Proteins|Pulmonary Surfactants",CC(C)C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O,
9404,DB11333,Poloxamer 188,small molecule,approved|investigational,"Alcohols|Compounds used in a research, industrial, or household setting|Drug Delivery Systems|Ethylene Glycols|Excipients|Glycols|Macromolecular Substances|Pharmaceutic Aids|Pharmaceutical Preparations|Pharmaceutical Vehicles|Polyethylene Glycols|Polymers|Surface-Active Agents",,
9405,DB11335,Ascorbyl glucoside,small molecule,experimental,"Acids, Acyclic|Carbohydrates|Hydroxy Acids|Sugar Acids",OC[C@H](O)[C@H]1OC(=O)C(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)=C1O,
9406,DB11336,Kinetin,small molecule,approved,"Cytokinins|Growth Substances|Heterocyclic Compounds, Fused-Ring|Plant Growth Regulators|Purines",C(NC1=NC=NC2=C1NC=N2)C1=CC=CO1,3830
9407,DB11337,Zeatin,small molecule,experimental,"Cytokinins|Growth Substances|Heterocyclic Compounds, Fused-Ring|Plant Growth Regulators|Purines",C\C(CO)=C/CNC1=C2N=CNC2=NC=N1,
9409,DB11340,Ubiquinol,small molecule,approved|investigational,Benzoquinones|Coenzymes|Enzymes and Coenzymes|Quinones,COC1=C(OC)C(O)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(C)=C1O,9962735
9410,DB11341,Ichthammol,small molecule,approved,Amines|Ammonium Compounds|Dermatologicals|Nitrogen Compounds|Onium Compounds,,
9411,DB11342,Aluminum oxide,small molecule,approved,Aluminium Compounds|Aluminum Oxides|Anions|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Dermatologicals|Electrolytes|Ions|Metal cations|Metal divalent cations|Oxides|Oxygen Compounds,[O--].[O--].[O--].[Al+3].[Al+3],9989226
9412,DB11343,Silanol,small molecule,approved,Organosilicon Compounds|Silicon Compounds,O[SiH3],6327522
9413,DB11344,(+)-menthol,small molecule,experimental,,CC(C)[C@H]1CC[C@H](C)C[C@@H]1O,
9414,DB11345,(S)-camphor,small molecule,experimental,,CC1(C)[C@H]2CC[C@]1(C)C(=O)C2,
9415,DB11346,Rubidium,small molecule,approved|investigational,"Elements|Metals|Metals, Alkali|Metals, Heavy",[Rb],
9417,DB11348,Calcium Phosphate,small molecule,approved,"Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Anions|Biocompatible Materials|Blood Coagulation Factors|Calcium Compounds|Calcium Salts|Ceramics|Compounds used in a research, industrial, or household setting|Electrolytes|Ions|Mineral Supplements|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds",[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O,24456
9418,DB11349,Cetyl ethylhexanoate,small molecule,experimental,,CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC,
9419,DB11350,Cocamidopropyl betaine,small molecule,experimental,"Amines|Ammonium Compounds|Compounds used in a research, industrial, or household setting|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds|Surface-Active Agents|Trimethyl Ammonium Compounds",,
9420,DB11352,Ascorbyl phosphate,small molecule,approved,Vitamin C and analogues|Vitamins,,
9421,DB11355,Propolis wax,small molecule,approved,,,
9422,DB11356,Polyquaternium-10 (400 cps at 2%),small molecule,approved,,,
9423,DB11357,Linseed oil,small molecule,approved|investigational,"Biological Products|Complex Mixtures|Fats|Fats, Unsaturated|Lipids|Oils|Plant Oils|Plant Preparations",,
9425,DB11359,Guaiacol,small molecule,approved,Benzene Derivatives|Catechols|Ethers|Methyl Ethers|Phenols|Phenyl Ethers,COC1=C(O)C=CC=C1,460
9426,DB11360,Lactobacillus plantarum,small molecule,approved|investigational,,,
9427,DB11361,Betula pendula tar oil,small molecule,nutraceutical,,,
9428,DB11362,Selexipag,small molecule,approved,"Acetates|Acids, Acyclic|Amides|Antihypertensive Agents|Blood and Blood Forming Organs|Cardiovascular Agents|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fatty Acids|Fatty Acids, Volatile|Lipids|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein substrates|Platelet Aggregation Inhibitors Excl. Heparin|Prodrugs|Prostacyclin Receptor Agonist|Prostacyclin Receptor Agonists|Receptors, Prostaglandin, agonists|Vasodilating Agents",CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)C1=NC(C2=CC=CC=C2)=C(N=C1)C1=CC=CC=C1,9913767
9429,DB11363,Alectinib,small molecule,approved|investigational,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Indoles|Kinase Inhibitor|P-glycoprotein inhibitors|P-glycoprotein substrates|Protein Kinase Inhibitors|Tyrosine Kinase Inhibitors",CCC1=CC2=C(C=C1N1CCC(CC1)N1CCOCC1)C(C)(C)C1=C(C3=CC=C(C=C3N1)C#N)C2=O,49806720
9430,DB11364,Pidotimod,small molecule,experimental,"Acids, Acyclic|Adjuvants, Immunologic|Amino Acids|Amino Acids, Acidic|Amino Acids, Cyclic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Drugs that are Mainly Renally Excreted|Glutamates|Imines|Imino Acids|Immunologic Factors|Pyrrolidines|Pyrrolidinones|Sulfur Compounds|Thiazoles",OC(=O)[C@@H]1CSCN1C(=O)[C@@H]1CCC(=O)N1,65944
9431,DB11365,Sennosides,small molecule,experimental,Alimentary Tract and Metabolism|Anthracenes|Anthraquinones|Biological Products|Complex Mixtures|Contact Laxatives|Drugs for Constipation|Gastrointestinal Agents|Herbs and Natural Products|Laxatives|Pharmaceutical Preparations|Plant Extracts|Plant Preparations|Quinones,OCC1OC(OC2=C3C(=O)C4=C(C=C(C=C4O)C(O)=O)C(C4C5=CC=CC(OC6OC(CO)C(O)C(O)C6O)=C5C(=O)C5=C4C=C(C=C5O)C(O)=O)C3=CC=C2)C(O)C(O)C1O,
9432,DB11366,Roquinimex,small molecule,investigational,"Adjuvants, Immunologic|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Growth Inhibitors|Growth Substances|Heterocyclic Compounds, Fused-Ring|Immunologic Factors|Quinolines",CN(C(=O)C1=C(O)C2=C(C=CC=C2)N(C)C1=O)C1=CC=CC=C1,54676478
9433,DB11367,Cefroxadine,small molecule,withdrawn,"Amides|Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|Drugs that are Mainly Renally Excreted|First-Generation Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines",[H][C@]12SCC(OC)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CCC=CC1)C(O)=O,5284529
9434,DB11368,Chlorophetanol,small molecule,experimental,Antifungals for Dermatological Use|Antifungals for Topical Use|Dermatologicals,OCCOC1=CC=C(Cl)C=C1,
9435,DB11371,Alfaxalone,small molecule,vet_approved,"Anesthetics|Anesthetics, General|Central Nervous System Agents|Central Nervous System Depressants|Fused-Ring Compounds|Nervous System|Pregnanes|Steroids",[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C(=O)C[C@]12C)C(C)=O,104845
9436,DB11372,Altrenogest,small molecule,vet_approved,"Adrenal Cortex Hormones|Estranes|Estrenes|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Progesterone Congeners|Progestins|Steroids",[H][C@@]12CC[C@@](O)(CC=C)[C@@]1(C)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H],
9437,DB11373,Amitraz,small molecule,experimental|vet_approved,"Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Agrochemicals|Amines|Aniline Compounds|Benzene Derivatives|Compounds used in a research, industrial, or household setting|Insect Repellents|Insecticides|Neurotransmitter Agents|Pesticide Synergists|Pesticides|Protective Agents|Toxic Actions",CN(\C=N\C1=C(C)C=C(C)C=C1)\C=N\C1=C(C)C=C(C)C=C1,
9438,DB11375,Avilamycin,small molecule,vet_approved,Anti-Bacterial Agents|Anti-Infective Agents|Carbohydrates|Growth Substances|Polysaccharides,[H][C@]12COC(O[C@@H]3O[C@H](COC)[C@@H](O[C@@H]4O[C@H](C)[C@H](OC)[C@H](O[C@H]5C[C@@]6(C)OC7(C[C@@H](O)[C@H](O[C@H]8C[C@@H](O)[C@H](OC(=O)C9=C(C)C(Cl)=C(O)C(Cl)=C9OC)[C@@H](C)O8)[C@@H](C)O7)O[C@]6([H])[C@@H](C)O5)[C@H]4O)[C@H](O)[C@@H]3OC)[C@H](OC(=O)C(C)C)[C@]1([H])O[C@@]1(O2)O[C@H](C)[C@@](O)(C(C)=O)[C@]2([H])OCO[C@@]12[H],
9439,DB11376,Azaperone,small molecule,investigational|vet_approved,Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Butyrophenones|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Hypnotics and Sedatives|Ketones|Neurotoxic agents|Neurotransmitter Agents|Psychotropic Drugs|Tranquilizing Agents,FC1=CC=C(C=C1)C(=O)CCCN1CCN(CC1)C1=CC=CC=N1,
9440,DB11377,Bambermycins,small molecule,vet_approved,"Anti-Bacterial Agents|Anti-Infective Agents|Antigens|Antigens, Bacterial|Biological Factors|Carbohydrates|Polysaccharides|Polysaccharides, Bacterial",C[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](NC(C)=O)[C@H](O[C@H]3[C@@H](OP(O)(=O)OC[C@@H](O)C(=O)OCC\C=C(/C)CC\C=C\C(C)(C)CCC(=C)C\C=C(/C)CCC=C(C)C)O[C@H](C(O)=O)[C@@](C)(O)[C@@H]3OC(N)=O)O[C@@H]2CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](NC(C)=O)[C@@H](O)[C@@H]1O[C@@H]1O[C@@H]([C@H](O)[C@H](O)[C@H]1O)C(=O)NC1=C(O)CCC1=O,
9441,DB11378,Buquinolate,small molecule,experimental|vet_approved,"Heterocyclic Compounds, Fused-Ring|Quinolines",CCOC(=O)C1=CNC2=CC(OCC(C)C)=C(OCC(C)C)C=C2C1=O,
9442,DB11379,Butonate,small molecule,experimental|vet_approved,Organophosphorus Compounds,CCCC(=O)OC(C(Cl)(Cl)Cl)P(=O)(OC)OC,
9443,DB11380,Cambendazole,small molecule,experimental|vet_approved,"Anthelmintics|Anti-Infective Agents|Antinematodal Agents|Antiparasitic Agents|Benzimidazoles|Heterocyclic Compounds, Fused-Ring",CC(C)OC(=O)NC1=CC2=C(NC(=N2)C2=CSC=N2)C=C1,
9444,DB11382,Carbarsone,small molecule,vet_approved,Arsenicals|Organometallic Compounds,NC(=O)NC1=CC=C(C=C1)[As](O)(O)=O,
9445,DB11383,Carbomycin,small molecule,vet_approved,Anti-Bacterial Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Polyketides,[H][C@@]1(C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O1)O[C@@H]1[C@@H](C)O[C@@]([H])(O[C@H]2[C@@H](CC=O)C[C@@H](C)C(=O)\C=C\[C@@H]3O[C@H]3C[C@@H](C)OC(=O)C[C@@H](OC(C)=O)[C@@H]2OC)[C@H](O)[C@H]1N(C)C,
9446,DB11385,Cefalonium,small molecule,experimental|vet_approved,"Amides|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Sulfur Compounds|Thiazines",[H][C@]12SCC(C[N+]3=CC=C(C=C3)C(N)=O)=C(N1C(=O)[C@H]2NC(=O)CC1=CC=CS1)C([O-])=O,
9447,DB11386,Chlorobutanol,small molecule,approved|investigational|vet_approved,"Alcohols|Alimentary Tract and Metabolism|Antiemetics and Antinauseants|Butanols|Chlorohydrins|Compounds used in a research, industrial, or household setting|Fatty Alcohols|Lipids|Pharmaceutic Aids|Pharmaceutical Preparations|Preservatives, Pharmaceutical",CC(C)(O)C(Cl)(Cl)Cl,5977
9448,DB11387,Chloroform,small molecule,approved|vet_approved,"Anesthetics|Anesthetics, General|Compounds used in a research, industrial, or household setting|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Nervous System|Solvents|Trihalomethanes",ClC(Cl)Cl,
9449,DB11389,Clorsulon,small molecule,vet_approved,Amides|Amines|Aniline Compounds|Anthelmintics|Anti-Infective Agents|Antiparasitic Agents|Antiplatyhelmintic Agents|Sulfonamides|Sulfones|Sulfur Compounds,NC1=C(C=C(C(=C1)C(Cl)=C(Cl)Cl)S(N)(=O)=O)S(N)(=O)=O,
9450,DB11390,Coumaphos,small molecule,vet_approved,"Agrochemicals|Anthelmintics|Anti-Infective Agents|Antinematodal Agents|Antiparasitic Agents|Benzopyrans|Cholinergic Agents|Cholinesterase Inhibitors|Compounds used in a research, industrial, or household setting|Coumarins|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Insecticides|Narrow Therapeutic Index Drugs|Neurotransmitter Agents|Organophosphates|Organophosphorus Compounds|Organothiophosphates|Organothiophosphorus Compounds|Pesticides|Potential QTc-Prolonging Agents|Pyrans|QTc Prolonging Agents|Sulfur Compounds|Toxic Actions|Umbelliferones",CCOP(=S)(OCC)OC1=CC2=C(C=C1)C(C)=C(Cl)C(=O)O2,
9451,DB11392,Cythioate,small molecule,vet_approved,"Agrochemicals|Compounds used in a research, industrial, or household setting|Insecticides|Organophosphorus Compounds|Pesticides|Sulfur Compounds|Toxic Actions",COP(=S)(OC)OC1=CC=C(C=C1)S(N)(=O)=O,
9452,DB11393,Danofloxacin,small molecule,experimental|vet_approved,"Anti-Infective Agents|Heterocyclic Compounds, Fused-Ring|Quinolines|Quinolones",[H][C@]12CN(C3=C(F)C=C4C(=O)C(=CN(C5CC5)C4=C3)C(O)=O)[C@]([H])(CN1C)C2,
9453,DB11394,Decoquinate,small molecule,experimental|vet_approved,"Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Coccidiostats|Heterocyclic Compounds, Fused-Ring|Hydroxyquinolines|Quinolines",CCCCCCCCCCOC1=C(OCC)C=C2NC=C(C(=O)OCC)C(=O)C2=C1,
9454,DB11395,Deracoxib,small molecule,vet_approved,Amides|Sulfones|Sulfur Compounds,COC1=C(F)C=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)F,
9455,DB11396,Dichlorophen,small molecule,experimental|vet_approved,"Anthelmintics|Anti-Infective Agents|Anticestodal Agents|Anticestodals|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiplatyhelmintic Agents|Antiprotozoals|Benzene Derivatives|Chlorobenzenes|Chlorophenols|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Phenols",OC1=CC=C(Cl)C=C1CC1=CC(Cl)=CC=C1O,
9456,DB11397,Dichlorvos,small molecule,vet_approved,"Agrochemicals|Anthelmintics|Anti-Infective Agents|Antiparasitic Agents|Cholinergic Agents|Cholinesterase Inhibitors|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Insecticides|Neurotransmitter Agents|Organophosphates|Organophosphorus Compounds|Pesticides|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Toxic Actions",COP(=O)(OC)OC=C(Cl)Cl,
9457,DB11398,Diclazuril,small molecule,investigational|vet_approved,Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Coccidiostats,ClC1=CC=C(C=C1)C(C#N)C1=C(Cl)C=C(C=C1Cl)N1N=CC(=O)NC1=O,
9458,DB11399,Dirlotapide,small molecule,investigational|vet_approved,"Acids, Acyclic|Heterocyclic Compounds, Fused-Ring",CN(CC1=CC=CC=C1)C(=O)[C@@H](NC(=O)C1=CC2=C(C=CC(NC(=O)C3=CC=CC=C3C3=CC=C(C=C3)C(F)(F)F)=C2)N1C)C1=CC=CC=C1,
9459,DB11400,Doramectin,small molecule,vet_approved,"Agrochemicals|Anthelmintics|Anti-Anxiety Agents|Anti-Bacterial Agents|Anti-Infective Agents|Anticonvulsants|Antiparasitic Agents|Central Nervous System Agents|Central Nervous System Depressants|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Insecticides|Lactones|Macrolides|Pesticides|Polyketides|Toxic Actions|Tranquilizing Agents",[H][C@@]12OC\C3=C/C=C/[C@H](C)[C@H](O[C@@]4([H])C[C@H](OC)[C@@H](O[C@@]5([H])C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)\C(C)=C\C[C@@H]4C[C@@H](C[C@]5(O4)O[C@H](C4CCCCC4)[C@@H](C)C=C5)OC(=O)[C@]([H])(C=C(C)[C@H]1O)[C@@]23O,
9460,DB11401,Efrotomycin,small molecule,vet_approved,Anti-Bacterial Agents|Anti-Infective Agents|Pyridines,[H]\C(C)=C(\[H])/C(/[H])=C(\[H])C1OC(O)(C(CC)C(O)=NC\C([H])=C(/[H])\C(\[H])=C(/C)C(OC)C(C)C2OC(\C([H])=C(/[H])\C(\[H])=C(/[H])C([H])=C(C)C(\O)=C3\C(=O)C=CN(C)C3=O)C(O)C2O)C(O)C(OC2OC(C)C(OC3OC(C)C(OC)C(O)C3OC)C(OC)C2O)C1(C)C,
9461,DB11403,Emodepside,small molecule,investigational|vet_approved,"Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antiparasitic Agents|Peptides|Peptides, Cyclic",[H][C@]1(C)OC(=O)[C@]([H])(CC(C)C)N(C)C(=O)[C@@]([H])(CC2=CC=C(C=C2)N2CCOCC2)OC(=O)[C@]([H])(CC(C)C)N(C)C(=O)[C@@]([H])(C)OC(=O)[C@]([H])(CC(C)C)N(C)C(=O)[C@@]([H])(CC2=CC=C(C=C2)N2CCOCC2)OC(=O)[C@]([H])(CC(C)C)N(C)C1=O,
9462,DB11404,Enrofloxacin,small molecule,vet_approved,"Anti-Bacterial Agents|Anti-Infective Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Quinolines|Quinolones",CCN1CCN(CC1)C1=CC2=C(C=C1F)C(=O)C(=CN2C1CC1)C(O)=O,
9463,DB11405,Eprinomectin,small molecule,vet_approved,"Agrochemicals|Anthelmintics|Anti-Bacterial Agents|Anti-Infective Agents|Antiparasitic Agents|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Insecticides|Lactones|Macrolides|Pesticides|Polyketides|Toxic Actions",[H]O[C@@H]1C(C)=C[C@@]2([H])C(=O)O[C@@]3([H])C[C@@]([H])(C\C=C(C)/[C@@H](O[C@H]4C[C@H](OC)[C@H](O[C@H]5C[C@@H](OC)[C@H](N([H])C(C)=O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C/C=C4/CO[C@@]1([H])[C@]24O[H])O[C@@]1(C3)O[C@H](C(C)C)[C@@H](C)C=C1,
9464,DB11408,Famphur,small molecule,vet_approved,"Agrochemicals|Compounds used in a research, industrial, or household setting|Insecticides|Organophosphates|Organophosphorus Compounds|Organothiophosphorus Compounds|Pesticides|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sulfur Compounds|Toxic Actions",COP(=S)(OC)OC1=CC=C(C=C1)S(=O)(=O)N(C)C,
9465,DB11409,Febantel,small molecule,experimental|vet_approved,Amidines|Anthelmintics|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals,COCC(=O)NC1=C(C=CC(SC2=CC=CC=C2)=C1)N=C(NC(=O)OC)NC(=O)OC,
9466,DB11410,Fenbendazole,small molecule,vet_approved,"Acids, Acyclic|Anthelmintics|Anti-Infective Agents|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Benzimidazole Derivatives|Benzimidazoles|Carbamates|Heterocyclic Compounds, Fused-Ring",COC(=O)NC1=NC2=C(N1)C=CC(SC1=CC=CC=C1)=C2,
9467,DB11411,Fenprostalene,small molecule,vet_approved,"Abortifacient Agents|Abortifacient Agents, Nonsteroidal|Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Prostaglandins|Prostaglandins, Synthetic|Reproductive Control Agents",COC(=O)CCC=C=CC[C@@H]1[C@H](O)C[C@H](O)[C@H]1\C=C\[C@H](O)COC1=CC=CC=C1,
9468,DB11412,Fenthion,small molecule,vet_approved,"Agrochemicals|Cholinergic Agents|Cholinesterase Inhibitors|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Insecticides|Neurotransmitter Agents|Organophosphates|Organophosphorus Compounds|Organothiophosphates|Organothiophosphorus Compounds|Pesticides|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sulfur Compounds|Toxic Actions",COP(=S)(OC)OC1=CC=C(SC)C(C)=C1,
9469,DB11413,Florfenicol,small molecule,experimental|vet_approved,Alcohols|Anti-Bacterial Agents|Anti-Infective Agents|Benzene Derivatives|Glycols|Nitro Compounds|Nitrobenzenes|Propylene Glycols,CS(=O)(=O)C1=CC=C(C=C1)[C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl,
9470,DB11416,Gamithromycin,small molecule,vet_approved,Anti-Bacterial Agents|Anti-Infective Agents|Lactones|Polyketides,[H][C@@]1(C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)O[C@H]1[C@H](C)[C@@H](O[C@]2([H])O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)N(CCC)C[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@@H]1C,
9471,DB11417,Gleptoferron,small molecule,vet_approved,"Acids, Acyclic|Biopolymers|Carbohydrates|Compounds used in a research, industrial, or household setting|Dextrans|Ferric Compounds|Glucans|Hydroxy Acids|Iron Compounds|Macromolecular Substances|Organometallic Compounds|Pharmaceutical Preparations|Polymers|Polysaccharides",[Fe+].OO.[H]C(O)(CO[C@@]1([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O)C([H])(O)C([H])(O)C([H])(O)C([H])(O)C([O-])=O,
9472,DB11419,Haloxon,small molecule,vet_approved,"Benzopyrans|Coumarins|Heterocyclic Compounds, Fused-Ring|Pyrans",CC1=C(Cl)C(=O)OC2=C1C=CC(OP(=O)(OCCCl)OCCCl)=C2,
9473,DB11420,Squalane,small molecule,experimental|vet_approved,"Alkenes|Hydrocarbons, Acyclic|Polyenes|Terpenes|Triterpenes",CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C,
9474,DB11421,Imidacloprid,small molecule,vet_approved,"Agrochemicals|Cholinergic Agents|Compounds used in a research, industrial, or household setting|Insecticides|Neurotransmitter Agents|Pesticides|Toxic Actions",[O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1,86418
9475,DB11423,Lasalocid,small molecule,vet_approved,"Anti-Bacterial Agents|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Coccidiostats|Compounds used in a research, industrial, or household setting|Furans|Ionophores|Membrane Transport Modulators",[H][C@@](C)(CCC1=C(C(O)=O)C(O)=C(C)C=C1)[C@]([H])(O)[C@]([H])(C)C(=O)[C@]([H])(CC)[C@@]1([H])O[C@@](CC)(C[C@]1([H])C)[C@@]1([H])CC[C@](O)(CC)[C@]([H])(C)O1,
9476,DB11424,Lufenuron,small molecule,experimental|vet_approved,"Acids, Carbocyclic|Agrochemicals|Amides|Benzene Derivatives|Benzoates|Chitin, antagonists & inhibitors|Compounds used in a research, industrial, or household setting|Insecticides|Pesticides|Toxic Actions",FC(C(F)(F)F)C(F)(F)OC1=C(Cl)C=C(NC(=O)NC(=O)C2=C(F)C=CC=C2F)C(Cl)=C1,
9477,DB11425,Luprostiol,small molecule,experimental|vet_approved,"Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Prostaglandins|Prostaglandins, Synthetic",O[C@H](COC1=CC(Cl)=CC=C1)CS[C@@H]1[C@@H](O)C[C@@H](O)[C@H]1C\C=C/CCCC(O)=O,
9478,DB11426,Marbofloxacin,small molecule,vet_approved,"Anti-Bacterial Agents|Anti-Infective Agents|Heterocyclic Compounds, Fused-Ring|Quinolines|Quinolones",CN1CCN(CC1)C1=C(F)C=C2C(=O)C(=CN3N(C)COC1=C23)C(O)=O,
9479,DB11427,Maropitant,small molecule,vet_approved,Antiemetics|Autonomic Agents|Benzene Derivatives|Central Nervous System Agents|Gastrointestinal Agents|Peripheral Nervous System Agents,[H][C@]1(NCC2=CC(=CC=C2OC)C(C)(C)C)C2CCN(CC2)[C@@]1([H])C(C1=CC=CC=C1)C1=CC=CC=C1,
9480,DB11428,Medetomidine,small molecule,experimental|vet_approved,"Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives|Imidazoles|Neurotransmitter Agents|Peripheral Nervous System Agents|Sensory System Agents",CC(C1=CN=CN1)C1=CC=CC(C)=C1C,
9481,DB11429,Mibolerone,small molecule,vet_approved,"Estranes|Estrenes|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone and derivatives|Testosterone Congeners",[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3C[C@@H](C)[C@@]21[H],
9482,DB11430,Monensin,small molecule,experimental|vet_approved,"Acids, Acyclic|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Coccidiostats|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Furans|Ionophores|Lipids|Membrane Transport Modulators|P-glycoprotein inhibitors|P-glycoprotein substrates|Proton Ionophores|Sodium Ionophores|Uncoupling Agents|Valerates",[H][C@@]1(C[C@H](C)[C@@]([H])(O1)[C@]1(CC)CC[C@@]([H])(O1)[C@]1(C)CC[C@]2(C[C@H](O)[C@@H](C)[C@]([H])(O2)[C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O1)[C@@]1([H])O[C@@](O)(CO)[C@H](C)C[C@@H]1C,
9483,DB11431,Moxidectin,small molecule,approved|investigational|vet_approved,"Agrochemicals|Anthelmintics|Anti-Infective Agents|Antinematodal Agents|Antiparasitic Agents|Compounds used in a research, industrial, or household setting|Insecticides|Lactones|Pesticides|Polyketides|Toxic Actions",[H][C@@]12OC\C3=C/C=C/[C@H](C)C\C(C)=C\C[C@]4([H])C[C@@]([H])(C[C@]5(C\C(=N/OC)[C@H](C)[C@H](O5)C(\C)=C\C(C)C)O4)OC(=O)[C@]([H])(C=C(C)[C@H]1O)[C@@]23O,
9484,DB11432,Narasin,small molecule,experimental|vet_approved,Anti-Bacterial Agents|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Coccidiostats|Ionophores,[H][C@@]1(CC[C@](O)(CC)[C@H](C)O1)[C@]1(C)CC[C@]2(O1)O[C@@]1(O[C@]([H])([C@@H](CC)C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@]3([H])O[C@@]([H])([C@@H](CC)C(O)=O)[C@@H](C)C[C@@H]3C)[C@@H](C)C[C@H]1C)C=C[C@H]2O,
9485,DB11433,Nequinate,small molecule,vet_approved,"Heterocyclic Compounds, Fused-Ring|Quinolines",CCCCC1=CC2=C(NC=C(C(=O)OC)C2=O)C=C1OCC1=CC=CC=C1,
9486,DB11436,Nifurpirinol,small molecule,experimental|vet_approved,Furans|Nitro Compounds,[H]\C(=C(\[H])C1=NC(CO)=CC=C1)C1=CC=C(O1)[N+]([O-])=O,
9487,DB11437,Nitarsone,small molecule,vet_approved,Organometallic Compounds,O[As](O)(=O)C1=CC=C(C=C1)N(=O)=O,
9488,DB11438,Nitenpyram,small molecule,experimental|vet_approved,"Agrochemicals|Compounds used in a research, industrial, or household setting|Insecticides|Pesticides|Toxic Actions",[H]C(=C(NC)N(CC)CC1=CN=C(Cl)C=C1)N(=O)=O,
9489,DB11440,Norgestomet,small molecule,vet_approved,Fused-Ring Compounds|Pregnanes|Pregnenes|Progesterone Congeners|Steroids,[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)C[C@H](C)[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],
9490,DB11442,Oleandomycin,small molecule,vet_approved,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Macrolides, Lincosamides and Streptogramins|Polyketides",CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@H](C)C[C@@]3(CO3)C(=O)[C@H](C)[C@@H](O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1O,
9491,DB11443,Orbifloxacin,small molecule,vet_approved,"Anti-Bacterial Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones",[H][C@]1(C)CN(C[C@@]([H])(C)N1)C1=C(F)C(F)=C2C(=O)C(=CN(C3CC3)C2=C1F)C(O)=O,
9492,DB11446,Oxfendazole,small molecule,investigational|vet_approved,"Anthelmintics|Anti-Infective Agents|Antinematodal Agents|Antiparasitic Agents|Benzimidazoles|Heterocyclic Compounds, Fused-Ring",COC(=O)NC1=NC2=CC(=CC=C2N1)S(=O)C1=CC=CC=C1,
9493,DB11447,Phenothiazine,small molecule,experimental|vet_approved,"Agents that reduce seizure threshold|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Heterocyclic Compounds, Fused-Ring|Sulfur Compounds",N1C2=CC=CC=C2SC2=CC=CC=C12,
9494,DB11448,Phosmet,small molecule,vet_approved,"Acids, Carbocyclic|Agrochemicals|Compounds used in a research, industrial, or household setting|Heterocyclic Compounds, Fused-Ring|Imides|Insecticides|Isoindoles|Organophosphates|Organophosphorus Compounds|Organothiophosphates|Organothiophosphorus Compounds|Pesticides|Phthalic Acids|Phthalimides|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sulfur Compounds|Toxic Actions",COP(=S)(OC)SCN1C(=O)C2=CC=CC=C2C1=O,
9495,DB11449,Phthalofyne,small molecule,experimental|vet_approved,,CCC(C)(OC(=O)C1=CC=CC=C1C(O)=O)C#C,
9496,DB11450,Pimobendan,small molecule,vet_approved,"Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Enzyme Inhibitors|Phosphodiesterase Inhibitors|Protective Agents|Vasodilating Agents",COC1=CC=C(C=C1)C1=NC2=CC(=CC=C2N1)C1=NNC(=O)CC1C,
9497,DB11451,Poloxalene,small molecule,investigational|vet_approved,"Alcohols|Anti-Infective Agents|Compounds used in a research, industrial, or household setting|Disinfectants|Ethylene Glycols|Gastrointestinal Agents|Glycols|Macromolecular Substances|Polyethylene Glycols|Polymers|Surface-Active Agents",C1CO1.CC1CO1,
9498,DB11452,Ponazuril,small molecule,vet_approved,,CN1C(=O)NC(=O)N(C1=O)C1=CC=C(OC2=CC=C(C=C2)S(=O)(=O)C(F)(F)F)C(C)=C1,
9499,DB11453,Pradofloxacin,small molecule,vet_approved,"Anti-Bacterial Agents|Fluoroquinolone Antibacterial|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Quinolines|Quinolones",[H][C@]12CN(C[C@@]1([H])NCCC2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1C#N)C(O)=O,
9500,DB11454,Prostalene,small molecule,vet_approved,"Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Prostaglandins|Prostaglandins F, Synthetic|Prostaglandins, Synthetic",CCCCC[C@@](C)(O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=C=CCCC(=O)OC,
9501,DB11455,Robenacoxib,small molecule,experimental|vet_approved,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Amines|Aniline Compounds|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Nephrotoxic agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)",CCC1=CC(CC(O)=O)=C(NC2=C(F)C(F)=CC(F)=C2F)C=C1,
9502,DB11456,Ronnel,small molecule,experimental|vet_approved,Organophosphorus Compounds|Sulfur Compounds,COP(=S)(OC)OC1=CC(Cl)=C(Cl)C=C1Cl,
9503,DB11457,Rotenone,small molecule,vet_approved,"Agrochemicals|Benzopyrans|Chromones|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Flavonoids|Heterocyclic Compounds, Fused-Ring|Insecticides|Isoflavones|Pesticides|Pyrans|Toxic Actions|Uncoupling Agents",[H][C@@]12COC3=C(C=C(OC)C(OC)=C3)[C@]1([H])C(=O)C1=CC=C3O[C@H](CC3=C1O2)C(C)=C,6758
9504,DB11458,Roxarsone,small molecule,vet_approved,Anti-Bacterial Agents|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Arsenicals|Coccidiostats|Organometallic Compounds,OC1=C(C=C(C=C1)[As](O)(O)=O)N(=O)=O,
9505,DB11459,Selamectin,small molecule,vet_approved,Anti-Bacterial Agents|Anti-Infective Agents|Antiparasitic Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Polyketides,[H][C@@]12OC\C3=C/C=C/[C@H](C)[C@H](O[C@@]4([H])C[C@H](OC)[C@@H](O)[C@H](C)O4)\C(C)=C\C[C@]4([H])C[C@@]([H])(C[C@]5(CC[C@H](C)[C@]([H])(O5)C5CCCCC5)O4)OC(=O)[C@]([H])(C=C(C)\C1=N\O)[C@@]23O,
9506,DB11460,Squalene,small molecule,vet_approved,"Alkenes|Hydrocarbons, Acyclic|Polyenes|Terpenes|Triterpenes",CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C=C(/C)CC\C=C(/C)CCC=C(C)C,638072
9507,DB11461,Sulfachlorpyridazine,small molecule,vet_approved,"Amides|Amines|Aniline Compounds|Anti-Infective Agents|Anti-Infective Agents, Urinary|Renal Agents|Sulfanilamides|Sulfonamides|Sulfones|Sulfur Compounds",NC1=CC=C(C=C1)S(=O)(=O)NC1=NN=C(Cl)C=C1,
9508,DB11462,Sulfaethoxypyridazine,small molecule,vet_approved,Amides|Amines|Aniline Compounds|Sulfanilamides|Sulfonamides|Sulfones|Sulfur Compounds,CCOC1=CC=C(NS(=O)(=O)C2=CC=C(N)C=C2)N=N1,
9509,DB11463,Sulfanitran,small molecule,vet_approved,Amides|Amines|Aniline Compounds|Sulfonamides|Sulfones|Sulfur Compounds,CC(=O)NC1=CC=C(C=C1)S(=O)(=O)NC1=CC=C(C=C1)[N+]([O-])=O,
9510,DB11464,Sulfaquinoxaline,small molecule,vet_approved,Amides|Amines|Aniline Compounds|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Sulfanilamides|Sulfonamides|Sulfones|Sulfur Compounds,NC1=CC=C(C=C1)S(=O)(=O)NC1=NC2=C(C=CC=C2)N=C1,
9511,DB11466,Tepoxalin,small molecule,vet_approved,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antirheumatic Agents|Central Nervous System Agents|Immunologic Factors|Immunosuppressive Agents|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Sensory System Agents",COC1=CC=C(C=C1)N1N=C(CCC(=O)N(C)O)C=C1C1=CC=C(Cl)C=C1,
9512,DB11467,Thiostrepton,small molecule,vet_approved,"Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Peptides|Peptides, Cyclic",[H]\C(C)=C1/N=C(O)C(N=C(O)C2=CSC(=N2)C23CCC(=NC2C2=CSC(=N2)C(N=C(O)C2=CSC(=N2)C(N=C(O)C2CSC1=N2)C(C)(O)C(C)O)C(C)OC(=O)C1=NC2=C(C=CC(NC(C(C)CC)C(O)=NC(C)C(O)=NC(=C)C(O)=NC(C)C(O)=N3)C2O)C(=C1)C(C)O)C1=NC(=CS1)C(O)=NC(=C)C(O)=NC(=C)C(O)=N)C(C)O,
9513,DB11468,Tiamulin,small molecule,vet_approved,Anti-Bacterial Agents|Anti-Infective Agents|Terpenes,[H][C@@]12C(=O)CC[C@]11CC[C@@]([H])(C)[C@@]2(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]1C)OC(=O)CSCCN(CC)CC,
9514,DB11470,Tildipirosin,small molecule,vet_approved,Anti-Bacterial Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Polyketides,[H][C@@]1(O[C@H]2[C@@H](CCN3CCCCC3)C[C@@H](C)C(=O)\C=C\C(\C)=C\[C@H](CN3CCCCC3)[C@@H](CC)OC(=O)C[C@@H](O)[C@@H]2C)O[C@H](C)[C@@H](O)[C@@H]([C@H]1O)N(C)C,
9515,DB11471,Tilmicosin,small molecule,investigational|vet_approved,Anti-Bacterial Agents|Anti-Infective Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Polyketides,CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@@H]([C@H]2O)N(C)C)[C@@H](CCN2C[C@@H](C)C[C@@H](C)C2)C[C@@H](C)C(=O)\C=C\C(\C)=C\[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC,
9516,DB11472,Tioxidazole,small molecule,vet_approved,Sulfur Compounds,CCCOC1=CC=C2N=C(NC(=O)OC)SC2=C1,
9517,DB11473,Metrifonate,small molecule,vet_approved,"Agrochemicals|Anthelmintics|Anti-Infective Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antitrematodals|Cholinergic Agents|Cholinesterase Inhibitors|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Insecticides|Neurotransmitter Agents|Organophosphonates|Organophosphorous Compounds|Organophosphorus Compounds|Pesticides|Toxic Actions",COP(=O)(OC)C(O)C(Cl)(Cl)Cl,
9518,DB11474,Tulathromycin A,small molecule,vet_approved,Anti-Bacterial Agents|Anti-Infective Agents|Carbohydrates|Oligosaccharides|Polysaccharides,[H][C@@]1(C[C@@](C)(OC)[C@](O)(CNCCC)[C@H](C)O1)O[C@H]1[C@H](C)[C@@H](O[C@]2([H])O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@@H]1C,
9519,DB11475,Tylosin,small molecule,vet_approved,Anti-Bacterial Agents|Anti-Infective Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Polyketides,CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H](CC=O)C[C@@H](C)C(=O)\C=C\C(\C)=C\[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC,
9520,DB11476,Virginiamycin,small molecule,vet_approved,"Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics for Topical Use|Dermatologicals|Enzyme Inhibitors|Peptides|Peptides, Cyclic|Protein Synthesis Inhibitors|Streptogramins",CC(C)[C@H]1OC(=O)C2=CCCN2C(=O)C2=COC(CC(=O)C[C@H](O)\C=C(/C)\C=C\CNC(=O)\C=C\[C@H]1C)=N2.[H][C@@]12CCCN1C(=O)[C@@H](CC)NC(=O)[C@@H](NC(=O)C1=C(O)C=CC=N1)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@]1([H])CC(=O)CCN1C(=O)[C@H](CC1=CC=CC=C1)N(C)C2=O)C1=CC=CC=C1,
9521,DB11477,Xylazine,small molecule,vet_approved,"Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Neuromuscular Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Sensory System Agents|Sulfur Compounds|Thiazines",CC1=CC=CC(C)=C1NC1=NCCCS1,
9522,DB11478,Zeranol,small molecule,experimental|vet_approved,"Benzene Derivatives|Biological Factors|Estrogens|Estrogens, Non-Steroidal|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Lactones|Mycotoxins|Phenols|Resorcinols|Toxins, Biological|Zearalenone",C[C@H]1CCC[C@H](O)CCCCCC2=CC(O)=CC(O)=C2C(=O)O1,
9523,DB11479,Zilpaterol,small molecule,vet_approved,"Heterocyclic Compounds, Fused-Ring|Organosilicon Compounds|Receptors, Adrenergic, beta",CC(C)N[C@@H]1CCN2C(=O)NC3=CC=CC([C@H]1O)=C23,
9524,DB11480,Zoalene,small molecule,experimental|vet_approved,"Acids, Carbocyclic|Amides|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Coccidiostats",CC1=C(C=C(C=C1C(N)=O)[N+]([O-])=O)[N+]([O-])=O,
9525,DB11481,Atipamezole,small molecule,investigational|vet_approved,Adrenergic Agents|Adrenergic alpha-2 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Neurotransmitter Agents,CCC1(CC2=CC=CC=C2C1)C1=CN=CN1,
9526,DB11482,Balsam of Peru,small molecule,nutraceutical|vet_approved,"Biological Products|Biopolymers|Cell-mediated Immunity|Complex Mixtures|Compounds used in a research, industrial, or household setting|Increased Histamine Release|Macromolecular Substances|Plant Exudates|Polymers|Resins, Plant|Standardized Chemical Allergen",,
9527,DB11485,Ceftiofur,small molecule,vet_approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Sulfur Compounds|Thiazines",[H][C@]12SCC(CSC(=O)C3=CC=CO3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,
9528,DB11487,Dexamethasone isonicotinate,small molecule,vet_approved,"Adrenal Cortex Hormones|Anti-Allergic Agents|Anti-Inflammatory Agents|Corticosteroids|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated",[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COC(=O)C3=CC=NC=C3)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,
9529,DB11490,Nalorphine,small molecule,experimental|vet_approved,"Alkaloids|Antidotes|Central Nervous System Agents|Heterocyclic Compounds, Fused-Ring|Morphinans|Opiate Alkaloids|Opioid Antagonists|Peripheral Nervous System Agents|Phenanthrenes|Semi-synthetic Opioids|Sensory System Agents",[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC=C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,
9530,DB11491,Sarafloxacin,small molecule,vet_approved|withdrawn,"Anti-Bacterial Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones",OC(=O)C1=CN(C2=CC=C(F)C=C2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O,56208
9531,DB11493,Sodium tripolyphosphate,small molecule,vet_approved,"Acids|Acids, Noncarboxylic|Anions|Electrolytes|Ions|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds",[Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O,
9532,DB11495,(S)-methoprene,small molecule,vet_approved,,[H]\C(C[C@@]([H])(C)CCCC(C)(C)OC)=C(\[H])/C(/C)=C(\[H])C(=O)OC(C)C,
9533,DB11496,2-mercaptobenzothiazole,small molecule,approved|experimental|vet_approved,"Anti-Infective Agents|Cell-mediated Immunity|Heterocyclic Compounds, Fused-Ring|Increased Histamine Release|Standardized Chemical Allergen|Sulfur Compounds|Thiazoles",S=C1NC2=C(S1)C=CC=C2,
9534,DB11497,Sulfotep,small molecule,experimental|vet_approved,Organophosphorus Compounds|Sulfur Compounds,CCOP(=S)(OCC)OP(=S)(OCC)OCC,
9535,DB11499,Amphomycin,small molecule,vet_approved,"Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Lipids|Peptides",[H]N([C@@H](CC(O)=O)C(=O)NCC(=O)N[C@H]([C@H](C)N)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@]1([H])C(=O)N[C@@H](C)[C@]1([H])NC(=O)[C@@]2([H])CCCCN2C1=O)C(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)C\C=C\CCCCCC(C)CC)[C@@H](C)C(O)=O,
9536,DB11501,Bunamidine,small molecule,vet_approved,Anthelmintics|Anti-Infective Agents|Antiparasitic Agents,CCCCCCOC1=C2C=CC=CC2=C(C=C1)C(=N)N(CCCC)CCCC,
9537,DB11502,Butacaine,small molecule,vet_approved,"Acids, Carbocyclic|Anesthetics|Anesthetics, Local|Benzene Derivatives|Benzoates|Central Nervous System Agents|Peripheral Nervous System Agents|Sensory System Agents",CCCCN(CCCC)CCCOC(=O)C1=CC=C(N)C=C1,
9538,DB11504,Caramiphen,small molecule,experimental|vet_approved,Cycloparaffins,CCN(CC)CCOC(=O)C1(CCCC1)C1=CC=CC=C1,
9539,DB11507,Cloprostenol,small molecule,vet_approved,"Abortifacient Agents|Adrenal Cortex Hormones|Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Hormonal Contraceptives for Systemic Use|Inflammation Mediators|Lipids|Luteolytic Agents|Prostaglandins|Prostaglandins F, Synthetic|Prostaglandins, Synthetic|Reproductive Control Agents",[H]\C(CCCC(O)=O)=C(/[H])C[C@@]1([H])[C@@]([H])(O)C[C@@]([H])(O)[C@]1([H])C(\[H])=C(/[H])[C@@]([H])(O)COC1=CC=CC(Cl)=C1,
9540,DB11509,Cupric glycinate,small molecule,vet_approved,"Amino Acids|Amino Acids, Peptides, and Proteins",[Cu++].NCC([O-])=O.NCC([O-])=O,
9541,DB11510,Deslorelin,small molecule,investigational|vet_approved,"Adrenal Cortex Hormones|Alcohol Dehydrogenase, antagonists & inhibitors|Amino Acids, Peptides, and Proteins|Enzyme Inhibitors|Gonadotropin-releasing hormone agonist|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary Hormone-Releasing Hormones|Proteins",[H][C@]1(CCC(=O)N1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC,
9542,DB11511,Difloxacin,small molecule,vet_approved,"Anti-Bacterial Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones",CN1CCN(CC1)C1=C(F)C=C2C(=C1)N(C=C(C(O)=O)C2=O)C1=CC=C(F)C=C1,
9543,DB11512,Dihydrostreptomycin,small molecule,approved|investigational|vet_approved|withdrawn,Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Carbohydrates|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Glycosides|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Ophthalmologicals|Sensory Organs,CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]2NC(N)=N)O[C@@H](C)[C@]1(O)CO,
9544,DB11513,Diperodon,small molecule,vet_approved,,[H]N(C(=O)OCC(CN1CCCCC1)OC(=O)N([H])C1=CC=CC=C1)C1=CC=CC=C1,
9545,DB11516,Dithiazanine,small molecule,vet_approved,"Anthelmintics|Anti-Infective Agents|Antinematodal Agents|Antiparasitic Agents|Benzothiazoles|Coloring Agents|Compounds used in a research, industrial, or household setting|Fluorescent Dyes|Heterocyclic Compounds, Fused-Ring|Indicators and Reagents|Laboratory Chemicals|Luminescent Agents|Sulfur Compounds|Thiazoles",[H]C(C([H])=C([H])C1=[N+](CC)C2=CC=CC=C2S1)=C([H])C([H])=C1SC2=C(C=CC=C2)N1CC,
9546,DB11517,Etymemazine,small molecule,experimental|vet_approved,,CCC1=CC2=C(SC3=CC=CC=C3N2CC(C)CN(C)C)C=C1,
9547,DB11518,Flunixin,small molecule,vet_approved,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antipyretics|Antirheumatic Agents|Central Nervous System Agents|Nephrotoxic agents|Nicotinic Acids|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Pyridines|Sensory System Agents|Veterinary Drugs",CC1=C(C=CC=C1NC1=C(C=CC=N1)C(O)=O)C(F)(F)F,
9548,DB11519,Fluprostenol,small molecule,vet_approved,"Abortifacient Agents|Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Luteolytic Agents|Prostaglandins|Prostaglandins, Synthetic|Reproductive Control Agents",[H]\C(CCCC(O)=O)=C(/[H])C[C@@]1([H])[C@@]([H])(O)C[C@@]([H])(O)[C@]1([H])C(\[H])=C(/[H])[C@@]([H])(O)COC1=CC=CC(=C1)C(F)(F)F,
9549,DB11520,Hygromycin B,small molecule,vet_approved,Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anthelmintics|Anti-Bacterial Agents|Anti-Infective Agents|Antiparasitic Agents|Carbohydrates|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Glycosides|Narrow Therapeutic Index Drugs|Nephrotoxic agents,CN[C@H]1C[C@@H](N)[C@H](O)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@@H]3OC4(O[C@H]23)O[C@H]([C@@H](N)CO)[C@H](O)[C@H](O)[C@H]4O)[C@@H]1O,
9550,DB11521,Imidocarb,small molecule,vet_approved,Amides|Amines|Anilides|Aniline Compounds|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Benzene Derivatives|Carbanilides|Phenylurea Compounds,O=C(NC1=CC=CC(=C1)C1=NCCN1)NC1=CC=CC(=C1)C1=NCCN1,
9551,DB11522,Isoflupredone,small molecule,vet_approved,"Fused-Ring Compounds|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated",[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@]([H])(O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,
9552,DB11525,Maduramicin,small molecule,vet_approved,Anti-Bacterial Agents|Anti-Infective Agents|Ionophores,N.[H][C@@](C)([C@@]1([H])O[C@@]2(CC[C@](C)(O2)[C@@]2([H])CC[C@](C)(O2)[C@]2([H])O[C@]([H])(C[C@]2([H])O[C@]2([H])C[C@]([H])(OC)[C@@]([H])(OC)[C@]([H])(C)O2)[C@@]2([H])O[C@](C)(O)[C@]([H])(C)C[C@]2([H])C)C[C@]([H])(O)[C@@]1([H])C)[C@]1([H])O[C@](O)(CC(O)=O)[C@@]([H])(C)[C@]([H])(OC)[C@@]1([H])OC,
9553,DB11526,Masitinib,small molecule,investigational|vet_approved,Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Protein Kinase Inhibitors|Sulfur Compounds,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC(=CS3)C3=CN=CC=C3)=C2)CC1,
9554,DB11529,Melengestrol,small molecule,vet_approved,"Adrenal Cortex Hormones|Corticosteroids|Corticosteroids for Systemic Use|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Pregnadienes|Pregnanes|Steroids",[H][C@@]12CC(=C)[C@](O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=C(C)C2=CC(=O)CC[C@]12C,
9555,DB11530,Metoserpate,small molecule,vet_approved,"Alkaloids|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles",[H][C@]12C[C@H](OC)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2,
9556,DB11534,Butyl chloride,small molecule,vet_approved,"Alkanes|Hydrocarbons, Acyclic",CCCCCl,
9557,DB11537,Pirlimycin,small molecule,vet_approved,Anti-Bacterial Agents|Carbohydrates|Glycosides|Lincosamides|Neurotoxic agents|Pyrrolidines,[H][C@@](NC(=O)[C@@H]1C[C@H](CC)CCN1)([C@H](C)Cl)[C@@]1([H])O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O,
9558,DB11540,Propiopromazine,small molecule,experimental|vet_approved,"Antipsychotic Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Neurotoxic agents|Phenothiazines|Sulfur Compounds",CCC(=O)C1=CC=C2SC3=C(C=CC=C3)N(CCCN(C)C)C2=C1,
9559,DB11541,Ractopamine,small molecule,vet_approved,Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Amines|Ethylamines|Growth Substances|Neurotransmitter Agents,CC(CCC1=CC=C(O)C=C1)NCC(O)C1=CC=C(O)C=C1,
9560,DB11543,Romifidine,small molecule,vet_approved,Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Anesthetics|Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives|Neurotransmitter Agents,FC1=CC=CC(Br)=C1NC1=NCCN1,
9561,DB11544,Salinomycin,small molecule,vet_approved,Anti-Bacterial Agents|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Coccidiostats|Ionophores|P-glycoprotein inhibitors,[H][C@@](C)(C(=O)[C@]([H])(CC)[C@@]1([H])O[C@@]2(O[C@@]3(CC[C@](C)(O3)[C@@]3([H])CC[C@](O)(CC)[C@]([H])(C)O3)[C@]([H])(O)C=C2)[C@]([H])(C)C[C@]1([H])C)[C@@]([H])(O)[C@]([H])(C)[C@]1([H])O[C@]([H])(CC[C@]1([H])C)[C@@]([H])(CC)C(O)=O,
9562,DB11545,Semduramicin,small molecule,vet_approved,Furans|Ionophores|Pyrans,[H][C@@]1(C[C@H](O[C@@]2([H])CC[C@H](OC)[C@@H](C)O2)[C@@]([H])(O1)[C@]1(C)CC[C@@]([H])(O1)[C@]1(C)CC[C@]2(C[C@H](O)[C@@H](C)[C@]([H])(O2)[C@@H](C)[C@]2([H])O[C@](O)(CC(O)=O)[C@@H](C)[C@H](O)[C@H]2OC)O1)[C@@]1([H])O[C@](C)(O)[C@H](C)C[C@@H]1C,
9563,DB11547,Sulfabromomethazine,small molecule,vet_approved,,CC1=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=NC(C)=C1Br,
9564,DB11549,Tiletamine,small molecule,vet_approved,"Anesthetics|Anesthetics, Dissociative|Anesthetics, General|Anesthetics, Intravenous|Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Cyclohexanes|Cyclohexanones|Cycloparaffins|Ketones|Sulfur Compounds|Thiophenes",CCNC1(CCCCC1=O)C1=CC=CS1,
9565,DB11551,Trenbolone,small molecule,vet_approved,"Anabolic Agents|Estranes|Estrenes|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids",[H][C@@]12CC[C@H](O)[C@@]1(C)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H],
9566,DB11552,Tricaine,small molecule,vet_approved,"Acids, Carbocyclic|Anesthetics|Benzene Derivatives|Benzoates|Central Nervous System Agents|Central Nervous System Depressants",CCOC(=O)C1=CC(N)=CC=C1,
9567,DB11554,Tylvalosin,small molecule,vet_approved,Anti-Bacterial Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Polyketides,CC[C@H]1OC(=O)C[C@@H](OC(C)=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H](CC=O)C[C@@H](C)C(=O)\C=C\C(\C)=C\[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC,
9568,DB11555,Zolazepam,small molecule,vet_approved,"Anti-Anxiety Agents|Central Nervous System Agents|Central Nervous System Depressants|GABA Agents|GABA Modulators|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|Psychotropic Drugs|Tranquilizing Agents",CN1N=C(C)C2=C1N(C)C(=O)CN=C2C1=CC=CC=C1F,
9569,DB11556,Detomidine,small molecule,vet_approved,Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives|Neurotransmitter Agents|Peripheral Nervous System Agents|Sensory System Agents,CC1=C(C)C(CC2=CN=CN2)=CC=C1,
9570,DB11558,Toluene,small molecule,vet_approved,"Benzene Derivatives|Compounds used in a research, industrial, or household setting|Solvents",CC1=CC=CC=C1,1140
9571,DB11560,Lesinurad,small molecule,approved|investigational,"Acetates|Acids, Acyclic|Antigout Preparations|Antirheumatic Agents|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Fatty Acids|Fatty Acids, Volatile|Lipids|Musculo-Skeletal System|Preparations Increasing Uric Acid Excretion|Renal Agents|Sulfhydryl Compounds|Sulfur Compounds|Urate Transporter 1 Inhibitor|Urate Transporter 1 Inhibitors|Uricosuric Agents",OC(=O)CSC1=NN=C(Br)N1C1=CC=C(C2CC2)C2=C1C=CC=C2,53465279
9572,DB11561,Aminacrine,small molecule,experimental,"Acridine Derivatives|Acridines|Aminoacridines|Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Coloring Agents|Compounds used in a research, industrial, or household setting|Dermatologicals|Fluorescent Dyes|Heterocyclic Compounds, Fused-Ring|Indicators and Reagents|Laboratory Chemicals|Luminescent Agents|Mutagens|Noxae|Toxic Actions",NC1=C2C=CC=CC2=NC2=C1C=CC=C2,7019
9573,DB11562,Bicuculline,small molecule,experimental,"Alkaloids|Benzylisoquinolines|Central Nervous System Agents|Central Nervous System Stimulants|Convulsants|GABA Agents|GABA Antagonists|GABA-A Receptor Antagonists|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Neurotransmitter Agents",[H][C@]1(OC(=O)C2=C1C=CC1=C2OCO1)[C@@]1([H])N(C)CCC2=CC3=C(OCO3)C=C12,10237
9579,DB11570,Padimate O,small molecule,approved,"Acids, Carbocyclic|Aminobenzoates|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Cosmetics|Dermatologicals|Household Products|Protective Agents|Radiation-Protective Agents|Sunscreen Agents",CCCCC(CC)COC(=O)C1=CC=C(C=C1)N(C)C,30541
9582,DB11573,Aluminum chlorohydrate,small molecule,approved,Astringents and Deodorants|Dermatologicals|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Medicated Dressings|Medicated Dressings With Antiinfectives|Musculo-Skeletal System,O.[OH-].[OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Cl-],71586946
9583,DB11574,Elbasvir,small molecule,approved,"Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Antivirals for treatment of HCV infections|Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Direct Acting Antivirals|Experimental Unapproved Treatments for COVID-19|Hepatitis C Virus NS5A Inhibitor|Heterocyclic Compounds, Fused-Ring|P-glycoprotein inhibitors|P-glycoprotein substrates",[H][C@]1(CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C)C1=NC=C(N1)C1=CC2=C(C=C1)N1[C@@H](OC3=C(C=CC(=C3)C3=CN=C(N3)[C@]3([H])CCCN3C(=O)[C@@H](NC(=O)OC)C(C)C)C1=C2)C1=CC=CC=C1,71661251
9584,DB11575,Grazoprevir,small molecule,approved,"Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Antivirals for treatment of HCV infections|Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Direct Acting Antivirals|HCV NS3/4A Protease Inhibitors|Heterocyclic Compounds, Fused-Ring|NS3/4A Protease Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein substrates",COC1=CC2=NC3=C(CCCCC[C@@H]4C[C@H]4OC(=O)N[C@H](C(=O)N4C[C@@H](C[C@H]4C(=O)N[C@@]4(C[C@H]4C=C)C(=O)NS(=O)(=O)C4CC4)O3)C(C)(C)C)N=C2C=C1,44603531
9585,DB11576,Ferric oxide,small molecule,experimental,Contrast Media|Iron Compounds|Magnetic Resonance Imaging Contrast Media|Organometallic Compounds|Superparamagnetic Contrast Media,O=[Fe]O[Fe]=O,
9586,DB11577,Indigotindisulfonic acid,small molecule,approved,"Coloring Agents|Compounds used in a research, industrial, or household setting|Diagnostic Agents|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Indoles|Kidney Function|Tests for Renal Function and Ureteral Injuries",OS(=O)(=O)C1=CC2=C(N\C(C2=O)=C2\NC3=C(C=C(C=C3)S(O)(=O)=O)C2=O)C=C1,5282430
9587,DB11578,Hard fat,small molecule,approved,Pharmaceutical Vehicles|Suppositories,,
9588,DB11579,Light Mineral Oil,small molecule,approved,Basic Ointments and Protectants,,
9590,DB11581,Venetoclax,small molecule,approved|investigational,Amides|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCL-2 Inhibitor|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Increased Cellular Death|Narrow Therapeutic Index Drugs|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Sulfones|Sulfur Compounds,CC1(C)CCC(CN2CCN(CC2)C2=CC=C(C(=O)NS(=O)(=O)C3=CC=C(NCC4CCOCC4)C(=C3)[N+]([O-])=O)C(OC3=CN=C4NC=CC4=C3)=C2)=C(C1)C1=CC=C(Cl)C=C1,49846579
9591,DB11582,Thiocolchicoside,small molecule,experimental,"Alkaloids|Central Nervous System Depressants|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System",COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC,9915886
9592,DB11583,Cetalkonium,small molecule,approved,"Alcohols|Amines|Ammonium Compounds|Anti-Infective Agents|Anti-Infective Agents, Local|Compounds used in a research, industrial, or household setting|Lipids|Nitrogen Compounds|Onium Compounds|Surface-Active Agents",CCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1,31203
9593,DB11584,Pipradrol,small molecule,approved,"Nervous System|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics",[H]N1CCCCC1C(O)(C1=CC=CC=C1)C1=CC=CC=C1,
9594,DB11585,Drometrizole trisiloxane,small molecule,approved,"Compounds used in a research, industrial, or household setting|Macromolecular Substances|Organosilicon Compounds|Polymers|Silicon Compounds",CC(CC1=C(O)C(=CC(C)=C1)N1N=C2C=CC=CC2=N1)C[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C,
9595,DB11586,Asunaprevir,small molecule,approved|investigational|withdrawn,"Amides|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Antivirals for treatment of HCV infections|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (weak)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Direct Acting Antivirals|Enzyme Inhibitors|HCV Protease Inhibitors|Heterocyclic Compounds, Fused-Ring|HIV Protease Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Protease Inhibitors|Sulfones|Sulfur Compounds",COC1=CN=C(O[C@@H]2C[C@H](N(C2)C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)N[C@@]2(C[C@H]2C=C)C(=O)NS(=O)(=O)C2CC2)C2=C1C=CC(Cl)=C2,16076883
9596,DB11587,Etafedrine,small molecule,approved,Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Drugs that are Mainly Renally Excreted|Ethylamines|Phenethylamines|Propanolamines|Propanols,CCN(C)[C@@H](C)[C@H](O)C1=CC=CC=C1,
9597,DB11588,Carbon monoxide,small molecule,approved|investigational,"Anions|Carbon Compounds, Inorganic|Electrolytes|Gases|Gasotransmitters|Ions|Neurotransmitter Agents|Noxae|Oxides|Oxygen Compounds|Toxic Actions",,281
9598,DB11589,Neon,small molecule,approved|investigational,Elements|Gases|Noble Gases,[Ne],23935
9599,DB11590,Thimerosal,small molecule,approved,"Alkylmercury Compounds|Antiseptics and Disinfectants|Cell-mediated Immunity|Compounds used in a research, industrial, or household setting|Dermatologicals|Ethylmercury Compounds|Increased Histamine Release|Mercurial Products|Organomercury Compounds|Organometallic Compounds|Pharmaceutic Aids|Pharmaceutical Preparations|Preservatives, Pharmaceutical|Standardized Chemical Allergen",[Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O,16684434
9600,DB11591,Bilastine,small molecule,approved|investigational,"Antihistamines for Systemic Use|Heterocyclic Compounds, Fused-Ring|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Potential QTc-Prolonging Agents|QTc Prolonging Agents",CCOCCN1C(=NC2=CC=CC=C12)C1CCN(CCC2=CC=C(C=C2)C(C)(C)C(O)=O)CC1,185460
9601,DB11592,Nitrocefin,small molecule,experimental,"Amides|beta-Lactams|Compounds used in a research, industrial, or household setting|Heterocyclic Compounds, Fused-Ring|Indicators and Reagents|Laboratory Chemicals|Lactams|Sulfur Compounds|Thiazines",[H][C@]12SCC(\C=C\C3=CC=C(C=C3[N+]([O-])=O)[N+]([O-])=O)=C(N1C(=O)[C@H]2NC(=O)CC1=CC=CS1)C(O)=O,6436140
9602,DB11593,Isatoic anhydride,small molecule,experimental,Anti-Bacterial Agents|Anti-Infective Agents|beta-Lactamase Inhibitors|Enzyme Inhibitors,O=C1NC2=CC=CC=C2C(=O)O1,8359
9603,DB11594,Domiphen,small molecule,approved|experimental,Alimentary Tract and Metabolism|Amines|Ammonium Compounds|Antiinfectives and Antiseptics for Local Oral Treatment|Miscellaneous Anti-infectives|Miscellaneous Local Anti-infectives|Nitrogen Compounds|Onium Compounds|Stomatological Preparations,CCCCCCCCCCCC[N+](C)(C)CCOC1=CC=CC=C1,3149
9605,DB11596,Levoleucovorin,small molecule,approved|investigational,"Antidotes|Biological Factors|Coenzymes|Compounds used in a research, industrial, or household setting|Detoxifying Agents for Antineoplastic Treatment|Enzymes and Coenzymes|Folate Analog|Folic Acid Analogues|Folic Acid and Derivatives|Formyltetrahydrofolates|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Protective Agents|Pteridines|Pterins|Tetrahydrofolates|Vitamin B Complex|Vitamins",NC1=NC(=O)C2=C(NC[C@H](CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2C=O)N1,149436
9608,DB11599,"Starch, corn",small molecule,approved|nutraceutical,"Biopolymers|Carbohydrates|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Dietary Carbohydrates|Food|Food and Beverages|Glucans|Macromolecular Substances|Physiological Phenomena|Polymers|Polysaccharides|Starch",,
9611,DB11602,Hydroxyethyl cellulose,small molecule,approved,"Biopolymers|Carbohydrates|Compounds used in a research, industrial, or household setting|Glucans|Macromolecular Substances|Ophthalmic Solutions|Polymers|Polysaccharides|Saliva, Artificial",CC(O)COCC1OC(OC2C(COCC(C)O)OC(OCC(C)O)C(OCC(C)O)C2OCC(C)O)C(OCC(C)O)C(OCC(C)O)C1OCC(C)O,4327536
9614,DB11605,Myrrh,small molecule,approved,,,
9618,DB11609,Normethadone,small molecule,approved|illicit,Analgesics|Antitussive Agents|Central Nervous System Agents|Central Nervous System Depressants|Cough and Cold Preparations|Ketones|Narcotics|Opioids|Opium Alkaloids and Derivatives|Peripheral Nervous System Agents|Respiratory System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,CCC(=O)C(CCN(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,10090
9619,DB11610,Oxilofrine,small molecule,approved,Alcohols|Amines|Amino Alcohols|Ethylamines|Phenethylamines|Propanolamines|Propanols,[H][C@@](C)(NC)[C@]([H])(O)C1=CC=C(O)C=C1,688009
9620,DB11611,Lifitegrast,small molecule,approved,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Anti-Inflammatory Agents|Anti-inflammatory Agents, Miscellaneous|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Lymphocyte Function-Associated Antigen-1|Lymphocyte Function-Associated Antigen-1 Antagonist|Lymphocyte Function-Associated Antigen-1 Antagonists|Ophthalmic Solutions|Ophthalmologicals|Pharmaceutical Preparations|Pharmaceutical Solutions|Sensory Organs|Solutions|Sulfur Compounds",CS(=O)(=O)C1=CC(C[C@H](NC(=O)C2=C(Cl)C3=C(CN(CC3)C(=O)C3=CC=C4C=COC4=C3)C=C2Cl)C(O)=O)=CC=C1,11965427
9621,DB11613,Velpatasvir,small molecule,approved|investigational,"Acids, Acyclic|Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Antivirals for treatment of HCV infections|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Direct Acting Antivirals|Hepatitis C Virus NS5A Inhibitor|Heterocyclic Compounds, Fused-Ring|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|Organic Anion Transporting Polypeptide 2B1 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates",COC[C@H]1C[C@H](N(C1)C(=O)[C@H](NC(=O)OC)C1=CC=CC=C1)C1=NC=C(N1)C1=CC=C2C(COC3=CC4=C(C=CC5=C4NC(=N5)[C@@H]4CC[C@H](C)N4C(=O)[C@@H](NC(=O)OC)C(C)C)C=C23)=C1,67683363
9622,DB11614,Rupatadine,small molecule,approved,"Antihistamines for Systemic Use|Benzocycloheptenes|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dibenzocycloheptenes|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Piperidines|Platelet Activating Factor, antagonists & inhibitors|Potential QTc-Prolonging Agents|QTc Prolonging Agents",CC1=CC(CN2CCC(CC2)=C2C3=CC=C(Cl)C=C3CCC3=C2N=CC=C3)=CN=C1,133017
9623,DB11616,Pirarubicin,small molecule,investigational,Anthracyclines|Anthracyclines and Related Substances|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Cytotoxic Antibiotics and Related Substances|Glycosides|Immunosuppressive Agents|Naphthacenes,[H][C@]1(N)C[C@]([H])(O[C@@]2([H])C[C@@](O)(CC3=C(O)C4=C(C(O)=C23)C(=O)C2=C(C=CC=C2OC)C4=O)C(=O)CO)O[C@@]([H])(C)[C@@]1([H])O[C@]1([H])CCCCO1,11296583
9624,DB11617,Aclarubicin,small molecule,investigational,"Anthracyclines|Anthracyclines and Related Substances|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Cytotoxic Antibiotics and Related Substances|Enzyme Inhibitors|Glycosides|Naphthacenes|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",CC[C@@]1(O)C[C@H](O[C@H]2C[C@@H]([C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)N(C)C)C2=C(O)C3=C(C=C2[C@H]1C(=O)OC)C(=O)C1=C(C(O)=CC=C1)C3=O,451415
9625,DB11618,Zorubicin,small molecule,experimental,"Anthracyclines|Anthracyclines and Related Substances|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Cytotoxic Antibiotics and Related Substances|Glycosides|Naphthacenes",[H][C@@]1(C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(C=CC=C1OC)C3=O)C(C)=NNC(=O)C1=CC=CC=C1)O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,9595290
9626,DB11619,Gestrinone,small molecule,approved,"Adrenal Cortex Hormones|Antigonadotropins and Similar Agents|Contraceptive Agents, Female|Contraceptives, Oral|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Norpregnanes|Norpregnatrienes|Norsteroids|Progestin Contraceptives|Progestins|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids",[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H],27812
9627,DB11620,Neridronic Acid,small molecule,experimental|investigational,Organophosphonates|Organophosphorus Compounds,NCCCCCC(O)(P(O)(O)=O)P(O)(O)=O,71237
9629,DB11622,Dehydrocholic acid,small molecule,approved|investigational,Bile Acids and Salts|Cholagogues and Choleretics|Cholanes|Cholic Acids|Fused-Ring Compounds|Gastrointestinal Agents|Laxatives|Steroids,[H][C@@]1(CC[C@@]2([H])[C@]3([H])C(=O)C[C@]4([H])CC(=O)CC[C@]4(C)[C@@]3([H])CC(=O)[C@]12C)[C@H](C)CCC(O)=O,6674
9630,DB11623,Candoxatrilat,small molecule,experimental,"Acids, Carbocyclic|Cyclohexanes|Cycloparaffins|Enzyme Inhibitors|Neprilysin, antagonists & inhibitors|Protease Inhibitors",COCCOC[C@H](CC1(CCCC1)C(=O)N[C@H]1CC[C@H](CC1)C(O)=O)C(O)=O,443380
9632,DB11625,Perflenapent,small molecule,investigational|withdrawn,"Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Hydrocarbons, Fluorinated|Hydrocarbons, Halogenated|Ultrasound Contrast Media",FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,
9635,DB11628,Depreotide,small molecule,withdrawn,"Amino Acids, Peptides, and Proteins|Peptides",CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CC2=CC=CC=C2)N(C)C(=O)[C@H](CCSCC(=O)NC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(N)=O)NC1=O,
9636,DB11629,Laropiprant,small molecule,approved|investigational|withdrawn,"Heterocyclic Compounds, Fused-Ring",CS(=O)(=O)C1=C2N(CC3=CC=C(Cl)C=C3)C3=C(CC[C@@H]3CC(O)=O)C2=CC(F)=C1,
9637,DB11630,Temoporfin,small molecule,approved|investigational,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Biological Factors|Dermatologicals|Heterocyclic Compounds, Fused-Ring|Narrow Therapeutic Index Drugs|Photosensitizing Agents|Pigments, Biological|Porphyrins|Radiation-Sensitizing Agents|Sensitizers Used in Photodynamic/radiation Therapy",OC1=CC=CC(=C1)C-1=C2\CCC(=N2)\C(=C2/N\C(\C=C2)=C(/C2=N/C(/C=C2)=C(\C2=CC=C\-1N2)C1=CC(O)=CC=C1)C1=CC(O)=CC=C1)\C1=CC(O)=CC=C1,
9639,DB11632,Opicapone,small molecule,approved|investigational,Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Central Nervous System Agents|COMT Inhibitors|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Enzyme Inhibitors|Nervous System|Oxazoles,CC1=C(C2=NOC(=N2)C2=CC(=C(O)C(O)=C2)[N+]([O-])=O)C(Cl)=[N+]([O-])C(C)=C1Cl,
9640,DB11633,Isavuconazole,small molecule,approved|investigational,Anti-Infective Agents|Antifungal Agents|Antiinfectives for Systemic Use|Antimycotics for Systemic Use|Azole Antifungals|BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (weak)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (moderate)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Isavuconazole and Prodrugs|OCT2 Inhibitors|P-glycoprotein inhibitors|Triazole Derivatives|UGT1A9 Inhibitors,C[C@@H](C1=NC(=CS1)C1=CC=C(C=C1)C#N)[C@](O)(CN1C=NC=N1)C1=C(F)C=CC(F)=C1,
9641,DB11634,Colestilan chloride,small molecule,approved|investigational|withdrawn,Drugs for Treatment of Hyperkalemia and Hyperphosphatemia|Fused-Ring Compounds|Steroids,,
9642,DB11635,Tocofersolan,small molecule,approved,"Alimentary Tract and Metabolism|Benzopyrans|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drug Carriers|Heterocyclic Compounds, Fused-Ring|Pyrans|Vitamin E|Vitamins|Vitamins (Fat Soluble)",,
9643,DB11636,Nomegestrol,small molecule,approved,"Adrenal Cortex Hormones|Antineoplastic Agents, Hormonal|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Pregnadien Derivatives|Pregnadienes|Pregnanes|Progesterone Congeners|Progestins|Progestogens and Estrogens, Sequential Preparations|Sex Hormones and Modulators of the Genital System|Steroids",CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C,
9644,DB11637,Delamanid,small molecule,approved|investigational,Antiinfectives for Systemic Use|Antimycobacterials|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs for Treatment of Tuberculosis|Imidazoles|Moderate Risk QTc-Prolonging Agents|Nitro Compounds|QTc Prolonging Agents,C[C@]1(COC2=CC=C(C=C2)N2CCC(CC2)OC2=CC=C(OC(F)(F)F)C=C2)CN2C=C(N=C2O1)[N+]([O-])=O,
9645,DB11638,Artenimol,small molecule,experimental|investigational,"Anions|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Artemisia|Artemisinin and Derivatives, Plain|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Electrolytes|Free Radicals|Ions|Oxides|Oxygen Compounds|Peroxides|Reactive Oxygen Species|Sesquiterpenes|Terpenes|UGT1A9 Substrates|UGT2B7 substrates",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4,
9647,DB11640,Amifampridine,small molecule,approved|investigational,Amines|Aminopyridines|Cardiovascular Agents|Iodine Radioisotopes|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Nervous System|Peripheral Nervous System Agents|Potassium Channel Antagonists|Potassium Channel Blockers|Pyridines|QTc Prolonging Agents,NC1=CC=NC=C1N,
9648,DB11641,Vinflunine,small molecule,approved|investigational,"Alkaloids|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|Narrow Therapeutic Index Drugs|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Secologanin Tryptamine Alkaloids|Vinca Alkaloids",CC[C@@]12C=CCN3CC[C@@]4([C@H]13)[C@@H](N(C)C1=CC(OC)=C(C=C41)[C@]1(C[C@@H]3C[C@H](C[N@@](C3)CC3=C1NC1=CC=CC=C31)C(C)(F)F)C(=O)OC)[C@](O)([C@@H]2OC(C)=O)C(=O)OC,
9649,DB11642,Pitolisant,small molecule,approved|investigational,"Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strength unknown)|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs causing inadvertant photosensitivity|Drugs that are Mainly Renally Excreted|Histamine Antagonists|Moderate Risk QTc-Prolonging Agents|Nervous System|OCT1 inhibitors|Photosensitizing Agents|QTc Prolonging Agents|Receptors, Histamine H3",ClC1=CC=C(CCCOCCCN2CCCCC2)C=C1,
9651,DB11644,Tafamidis,small molecule,approved|investigational,"Anti-Inflammatory Agents|BCRP/ABCG2 Inhibitors|Fused-Ring Compounds|Heterocyclic Compounds, Fused-Ring|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunologic Factors|Miscellaneous Cardiac Drugs|Nervous System|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors",OC(=O)C1=CC=C2N=C(OC2=C1)C1=CC(Cl)=CC(Cl)=C1,11001318
9652,DB11645,PF-4191834,small molecule,investigational,"Acids|Acids, Noncarboxylic|Anions|Electrolytes|Gases|Hydrogen Sulfide|Ions|Sulfur Compounds",CN1N=CC=C1C1=CC=C(SC2=CC=CC(=C2)C2(CCOCC2)C(N)=O)C=C1,24986635
9654,DB11647,Incyclinide,small molecule,investigational,Naphthacenes,[H][C@@]12CC3=C(C(O)=CC=C3)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)C[C@]1([H])C2,54678924
9655,DB11648,Afuresertib,small molecule,investigational,Amines|Polyamines|Sulfur Compounds,CN1N=CC(Cl)=C1C1=C(Cl)SC(=C1)C(=O)N[C@H](CN)CC1=CC=CC(F)=C1,46843057
9656,DB11649,Lersivirine,small molecule,investigational,RNA-Directed DNA Polymerase,CCC1=NN(CCO)C(CC)=C1OC1=CC(=CC(=C1)C#N)C#N,16739244
9657,DB11650,HT-0712,small molecule,investigational,Piperidines,COC1=CC=C(C=C1OC1CCCC1)[C@H]1CNC(=O)[C@H](CC2=CC(C)=CC=C2)C1,9865375
9658,DB11651,Dactolisib,small molecule,investigational,"Antineoplastic Agents|Heterocyclic Compounds, Fused-Ring",CN1C(=O)N(C2=C1C=NC1=CC=C(C=C21)C1=CN=C2C=CC=CC2=C1)C1=CC=C(C=C1)C(C)(C)C#N,11977753
9659,DB11652,Tucatinib,small molecule,approved|investigational,BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 Substrates|MATE 1 Inhibitors|MATE 2 Inhibitors|MATE inhibitors|OCT2 Inhibitors|P-glycoprotein substrates|Tyrosine Kinase Inhibitors,CC1=CC(NC2=NC=NC3=CC=C(NC4=NC(C)(C)CO4)C=C23)=CC=C1OC1=CC2=NC=NN2C=C1,51039094
9660,DB11653,Bremelanotide,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Melanocortins|Melanocyte-Stimulating Hormones|Nerve Tissue Proteins|Neuropeptides|Peptide Hormones|Peptides|Pituitary Hormones|Pituitary Hormones, Anterior|Pro-Opiomelanocortin|Protein Precursors|Proteins|Receptor, Melanocortin, Type 3, agonists|Receptor, Melanocortin, Type 4, agonists",CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CN=CN2)NC1=O)C(O)=O,9941379
9661,DB11654,T-2000,small molecule,investigational,,COCN1C(=O)N(COC)C(=O)C(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1,9907289
9662,DB11655,Evacetrapib,small molecule,investigational,"Anticholesteremic Agents|Benzazepines|Cholesterol Ester Transfer Proteins, antagonists & inhibitors|Heterocyclic Compounds, Fused-Ring|Hypolipidemic Agents|Lipid Regulating Agents|Noxae|Toxic Actions",CN1N=NC(=N1)N(CC1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)[C@H]1CCCN(C[C@H]2CC[C@@H](CC2)C(O)=O)C2=C1C=C(C)C=C2C,49836058
9663,DB11656,Rebamipide,small molecule,investigational,"Alimentary Tract and Metabolism|Amino Acids|Amino Acids, Peptides, and Proteins|Anti-Ulcer Agents|Antioxidants|Compounds used in a research, industrial, or household setting|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Enzyme Inhibitors|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Protective Agents|Quinolines",OC(=O)C(CC1=CC(=O)NC2=C1C=CC=C2)NC(=O)C1=CC=C(Cl)C=C1,5042
9665,DB11658,QAV-680,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CC1=C(CC(O)=O)C2=CC=CN=C2N1CC1=CC=C(C=C1)S(C)(=O)=O,11508736
9666,DB11659,Indium,small molecule,investigational,"Acids|Acids, Noncarboxylic|Anions|Electrolytes|Elements|Indium Radioisotopes|Ions|Metals|Metals, Heavy|Nitric Acid|Nitrogen Compounds",[In],5359967
9667,DB11660,Latanoprostene bunod,small molecule,approved|investigational,"Autacoids|Biological Factors|Drugs that are Mainly Renally Excreted|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Prostaglandin analogs reducing intraocular pressure (IOP)|Prostaglandins|Prostaglandins, Synthetic",O[C@H](CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(=O)OCCCCO[N+]([O-])=O)CCC1=CC=CC=C1,11156438
9669,DB11662,Rabusertib,small molecule,investigational,Antineoplastic Agents|Benzene Derivatives|Protein Kinase Inhibitors,CC1=NC=C(NC(=O)NC2=C(OC[C@@H]3CNCCO3)C=C(C)C(Br)=C2)N=C1,11955855
9670,DB11663,Pictilisib,small molecule,investigational,"Amides|Heterocyclic Compounds, Fused-Ring|Phosphatidylinositol 3-Kinases, antagonists & inhibitors|Pyrazoles|Sulfones|Sulfur Compounds",CS(=O)(=O)N1CCN(CC2=CC3=C(S2)C(=NC(=N3)C2=C3C=NNC3=CC=C2)N2CCOCC2)CC1,17755052
9671,DB11664,Psilocybin,small molecule,investigational,"Alkaloids|Amines|Biogenic Amines|Biogenic Monoamines|Central Nervous System Agents|Central Nervous System Depressants|Hallucinogens|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|Psychotropic Drugs|Tryptamines",CN(C)CCC1=CNC2=C1C(OP(O)(O)=O)=CC=C2,10624
9672,DB11665,BMS-690514,small molecule,investigational,Carbon Radioisotopes,COC1=CC=CC(NC2=NC=NN3C=CC(CN4CC[C@@H](N)[C@H](O)C4)=C23)=C1,11349170
9673,DB11666,Buparlisib,small molecule,investigational,"Amines|Oxazines|Phosphatidylinositol 3-Kinase, antagonists & inhibitors|Pyridines",NC1=CC(=C(C=N1)C1=NC(=NC(=C1)N1CCOCC1)N1CCOCC1)C(F)(F)F,16654980
9674,DB11667,2'-cyano-2'-deoxy-1-(beta-D-arabinofuranosyl)cytosine,small molecule,investigational,"Arabinonucleosides|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1C#N,119184
9676,DB11669,Ortataxel,small molecule,investigational,Antineoplastic Agents|Cyclodecanes|Cycloparaffins|Diterpenes|Terpenes,CC(C)C[C@H](NC(=O)OC(C)(C)C)[C@@H](O)C(=O)O[C@H]1[C@@H]2OC(=O)O[C@@]22[C@@H](OC(=O)C3=CC=CC=C3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C(=C1C)C2(C)C)OC(C)=O,6918412
9677,DB11670,SP-8203,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Quinazolines",CC(=O)N(CCCCNCCCN1C(=O)NC2=CC=CC=C2C1=O)CCCN1C(=O)NC2=CC=CC=C2C1=O,44229378
9678,DB11671,AZD-4877,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Pyrimidines",CC(C)C(N(CCCN)C(=O)C1=CC=C(C)C=C1)C1=NC2=C(C(C)=NS2)C(=O)N1CC1=CC=CC=C1,10368812
9679,DB11672,Curcumin,small molecule,approved|experimental|investigational,"Alkanes|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antineoplastic Agents|Antirheumatic Agents|Benzene Derivatives|Catechols|Central Nervous System Agents|Coloring Agents|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Diarylheptanoids|Enzyme Inhibitors|Heptanes|Hydrocarbons, Acyclic|P-glycoprotein inhibitors|P-glycoprotein substrates|Peripheral Nervous System Agents|Phenols|Sensory System Agents",COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC(OC)=C(O)C=C2)=CC=C1O,969516
9680,DB11673,Pyridoxamine,small molecule,investigational,"Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Micronutrients|Physiological Phenomena|Picolines|Pyridines|Vitamin B Complex|Vitamins",CC1=C(O)C(CN)=C(CO)C=N1,1052
9681,DB11674,Equol,small molecule,investigational,"Benzopyrans|Chromones|Estrogens|Estrogens, Non-Steroidal|Flavonoids|Heterocyclic Compounds, Fused-Ring|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Isoflavones|Phytoestrogens|Pyrans",OC1=CC=C(C=C1)[C@H]1COC2=C(C1)C=CC(O)=C2,91469
9682,DB11675,Mosapride,small molecule,investigational,"Acids, Carbocyclic|Amides|Anti-Ulcer Agents|Antidepressive Agents|Benzene Derivatives|Benzoates|Central Nervous System Depressants|Gastrointestinal Agents|Neurotransmitter Agents|Oxazines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Agonists",CCOC1=CC(N)=C(Cl)C=C1C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1,119584
9683,DB11676,Galidesivir,small molecule,investigational,"Carbohydrates|Experimental Unapproved Treatments for COVID-19|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine-Nucleoside Phosphorylase, antagonists & inhibitors|Purines",[H][C@]1(N[C@H](CO)[C@@H](O)[C@H]1O)C1=CNC2=C1N=CN=C2N,10445549
9684,DB11677,Triheptanoin,small molecule,approved|investigational,Glycerides|Lipids,CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC,69286
9685,DB11678,Treosulfan,small molecule,investigational,"Acids|Acids, Noncarboxylic|Alcohols|Alkanes|Alkanesulfonates|Alkanesulfonic Acids|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Butylene Glycols|Glycols|Hydrocarbons, Acyclic|Mesylates|Noxae|Sulfonic Acids|Sulfur Acids|Sulfur Compounds|Toxic Actions",CS(=O)(=O)OC[C@H](O)[C@@H](O)COS(C)(=O)=O,9882105
9686,DB11679,Fruquintinib,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CNC(=O)C1=C(C)OC2=CC(OC3=NC=NC4=CC(OC)=C(OC)C=C34)=CC=C12,44480399
9688,DB11681,Tofimilast,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CCC1=NN(C2CCCC2)C2=C1CCN1C(=NN=C21)C1=CC=CS1,9896267
9689,DB11682,Daprodustat,small molecule,investigational,"Amino Acids|Amino Acids, Peptides, and Proteins|Pyrimidines|Pyrimidinones",OC(=O)CNC(=O)C1C(=O)N(C2CCCCC2)C(=O)N(C2CCCCC2)C1=O,91617630
9690,DB11683,PF-06282999,small molecule,investigational,"Acetates|Acids, Acyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Lipids|Pyrimidines",COC1=CC=C(Cl)C=C1C1=CC(=O)NC(=S)N1CC(N)=O,71571306
9691,DB11684,APR-246,small molecule,investigational,,COCC1(CO)N2CCC(CC2)C1=O,52918385
9693,DB11686,Iferanserin,small molecule,investigational,"Acids, Carbocyclic|Antidepressive Agents|Central Nervous System Depressants|Serotonin Agents|Serotonin Receptor Antagonists",CN1CCCC[C@H]1CCC1=CC=CC=C1NC(=O)\C=C\C1=CC=CC=C1,6445539
9694,DB11687,E-6201,small molecule,investigational,,CCNC1=CC2=C(C(O)=C1)C(=O)O[C@@H](C)[C@H](C)\C=C/C(=O)[C@@H](O)[C@@H](O)C\C=C\2,10172827
9695,DB11688,2-chloroethyl-3-sarcosinamide-1-nitrosourea,small molecule,investigational,Antineoplastic Agents|Nitroso Compounds|Nitrosourea Compounds,CN(CC(N)=O)C(=O)N(CCCl)N=O,100773
9696,DB11689,Selumetinib,small molecule,approved|investigational,"BCRP/ABCG2 Substrates|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|P-glycoprotein substrates|Tyrosine Kinase Inhibitors|UGT1A1 Substrates",CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,10127622
9698,DB11691,Naldemedine,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Alkaloids|Drugs for Constipation|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Morphinans|Opiate Alkaloids|Opioid Antagonists|Peripheral Opioid Receptor Antagonists|Phenanthrenes|UGT1A3 substrates",[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CC6)CC[C@@]14[C@@]5(O)CC(C(=O)NC(C)(C)C1=NC(=NO1)C1=CC=CC=C1)=C2O)=CC=C3O,54732242
9699,DB11692,Pavinetant,small molecule,investigational,"Amides|Heterocyclic Compounds, Fused-Ring|Quinolines|Receptors, Neurokinin-3, antagonists & inhibitors|Sulfones|Sulfur Compounds",CC[C@H](NC(=O)C1=C(NS(C)(=O)=O)C(=NC2=CC=CC=C12)C1=CC=CC=C1)C1=CC=CC=C1,23649245
9700,DB11693,Voclosporin,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Calcineurin Inhibitors|Cyclosporins|Immunosuppressive Agents|Peptides|Peptides, Cyclic",CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C=C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,6918486
9701,DB11694,Ilorasertib,small molecule,investigational,Amines|Antineoplastic Agents|Benzene Derivatives|Enzyme Inhibitors|Protein Kinase Inhibitors|Pyridines,NC1=C2C(SC=C2C2=CC=C(NC(=O)NC3=CC(F)=CC=C3)C=C2)=C(C=N1)C1=CN(CCO)N=C1,46207586
9702,DB11695,Carnosine,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Dipeptides|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptides|Proteins",NCCC(=O)N[C@@H](CC1=CN=CN1)C(O)=O,439224
9703,DB11696,Racecadotril,small molecule,investigational,"Alimentary Tract and Metabolism|Amino Acids|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Antidiarrheals|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Enzyme Inhibitors|Gastrointestinal Agents|N-substituted Glycines|Neprilysin, antagonists & inhibitors|Peptides|Peptoids|Protease Inhibitors|Sulfur Compounds",CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC1=CC=CC=C1,107751
9704,DB11697,Pacritinib,small molecule,investigational,"fms-Like Tyrosine Kinase 3, antagonists & inhibitors|Janus Kinase 2, antagonists & inhibitors|Tyrosine Kinase Inhibitors",C(CN1CCCC1)OC1=CC=C2NC3=NC=CC(=N3)C3=CC(COC\C=C\COCC1=C2)=CC=C3,46216796
9705,DB11698,Ipragliflozin,small molecule,investigational,Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Carbohydrates|Drugs Used in Diabetes|Glycosides|Sodium-glucose co-transporter 2 (SGLT2) inhibitors|Sodium-Glucose Transporter 2 Inhibitors|Sulfur Compounds,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC=C(F)C(CC2=CC3=CC=CC=C3S2)=C1,10453870
9706,DB11699,Tropisetron,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Antiarrhythmic agents|Antidepressive Agents|Antiemetics|Antiemetics and Antinauseants|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Drugs that are Mainly Renally Excreted|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Indoles|Neurotransmitter Agents|Peripheral Nervous System Agents|Serotonin 5-HT3 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists",[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C1=CNC3=CC=CC=C13)N2C,656665
9707,DB11700,Setmelanotide,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Anti-Obesity Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Melanocortins|Melanocyte-Stimulating Hormones|Nerve Tissue Proteins|Neuropeptides|Peptide Hormones|Peptides|Pituitary Hormones|Pituitary Hormones, Anterior|Pro-Opiomelanocortin|Protein Precursors|Proteins|Receptor, Melanocortin, Type 4, agonists",[H]N([H])C(=O)[C@@H]1CSSC[C@H](N([H])C(=O)[C@H](CCCN=C(N([H])[H])N([H])[H])N([H])C(C)=O)C(=O)N[C@H](C)C(=O)N[C@@H](CC2=CN=CN2[H])C(=O)N[C@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC2=CN([H])C3=CC=CC=C23)C(=O)N1,11993702
9708,DB11701,Amenamevir,small molecule,investigational,Oxazoles,CC1=CC=CC(C)=C1N(CC(=O)NC1=CC=C(C=C1)C1=NOC=N1)C(=O)C1CCS(=O)(=O)CC1,11397521
9709,DB11702,Antineoplaston A10,small molecule,investigational,"Acetamides|Acetates|Acids, Acyclic|Amides|Benzene Derivatives|Fatty Acids|Fatty Acids, Volatile|Lipids|Piperidines",O=C(CC1=CC=CC=C1)N[C@H]1CCC(=O)NC1=O,56260
9710,DB11703,Acalabrutinib,small molecule,approved|investigational,"Acids, Carbocyclic|Amides|Antineoplastic Agents|Benzene Derivatives|Benzoates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Kinase Inhibitor|Tyrosine Kinase Inhibitors",CC#CC(=O)N1CCC[C@H]1C1=NC(=C2N1C=CN=C2N)C1=CC=C(C=C1)C(=O)NC1=CC=CC=N1,71226662
9711,DB11704,Adomeglivant,small molecule,investigational,Benzene Derivatives,CC1=CC(O[C@@H](CCC(F)(F)F)C2=CC=C(C=C2)C(=O)NCCC(O)=O)=CC(C)=C1C1=CC=C(C=C1)C(C)(C)C,91933867
9712,DB11705,Iomeprol,small molecule,approved|investigational,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Iodobenzoates|Triiodobenzoic Acids|Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media|X-Ray Contrast Media, Iodinated",CN(C(=O)CO)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I,3731
9713,DB11706,Raxatrigine,small molecule,investigational,"Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Benzene Derivatives|Ethers|Imines|Imino Acids|Phenols",NC(=O)[C@@H]1CC[C@@H](N1)C1=CC=C(OCC2=CC=CC=C2F)C=C1,16046068
9714,DB11707,Olaptesed Pegol,small molecule,investigational,Pegylated agents,,
9715,DB11708,Peficitinib,small molecule,investigational,Cycloparaffins|Enzyme Inhibitors|Immunologic Factors|Immunosuppressive Agents|Nicotinic Acids|Pyridines,NC(=O)C1=CN=C2NC=CC2=C1N[C@H]1[C@H]2CC3C[C@@H]1C[C@@](O)(C3)C2,57928403
9716,DB11709,Acetyl hexapeptide-3,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Peptides",CSCC[C@H](NC(=O)[C@H](CCC(O)=O)NC(=C)[C@H](CCC(O)=O)NC(C)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O,71587772
9717,DB11710,Trigonellamide,small molecule,investigational,Nicotinic Acids|Pyridines,C[N+]1=CC=CC(=C1)C(N)=O,457
9718,DB11711,Navarixin,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Cycloparaffins|Receptors, Interleukin-8A, antagonists & inhibitors|Receptors, Interleukin-8B, antagonists & inhibitors",CCC[C@@H](NC1=C(CC2=CC=CC(C(=O)N(C)C)=C2O)C(=O)C1=O)C1=CC=C(C)O1,71587743
9719,DB11712,Tezacaftor,small molecule,approved|investigational,"BCRP/ABCG2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Dioxoles|Heterocyclic Compounds, Fused-Ring|P-glycoprotein inhibitors|P-glycoprotein substrates",CC(C)(CO)C1=CC2=CC(NC(=O)C3(CC3)C3=CC=C4OC(F)(F)OC4=C3)=C(F)C=C2N1C[C@@H](O)CO,46199646
9720,DB11713,Ruzasvir,small molecule,investigational,"Anti-Infective Agents|Antiviral Agents|Heterocyclic Compounds, Fused-Ring|Sulfur Compounds",COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C1=NC=C(N1)C1=CC=C2N3[C@@H](OC4=C(C3=CC2=C1)C(F)=CC(=C4)C1=CN=C(N1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C)C1=CN=C(S1)C1CC1,91936863
9723,DB11716,Misonidazole,small molecule,investigational,Anti-Infective Agents|Antineoplastic Agents|Antiparasitic Agents|Antiprotozoals|Imidazoles|Nitro Compounds|Nitroimidazoles|Radiation-Sensitizing Agents,COCC(O)CN1C=CN=C1[N+]([O-])=O,26105
9724,DB11717,Epacadostat,small molecule,investigational,Amides|Amines|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Hydroxylamines|Sulfones|Sulfur Compounds,NS(=O)(=O)NCCNC1=NON=C1\C(NC1=CC=C(F)C(Br)=C1)=N\O,91826917
9725,DB11718,Encorafenib,small molecule,approved|investigational,"Acids, Acyclic|Amides|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Moderate Risk QTc-Prolonging Agents|Protein Kinase Inhibitors|QTc Prolonging Agents|Sulfones|Sulfur Compounds",COC(=O)N[C@@H](C)CNC1=NC=CC(=N1)C1=CN(N=C1C1=CC(Cl)=CC(NS(C)(=O)=O)=C1F)C(C)C,50922675
9726,DB11719,UK-390957,small molecule,investigational,,CSC1=CC=C(OC2=CC=C(C=C2CN(C)C)S(N)(=O)=O)C=C1,9884876
9727,DB11720,Angiotensin 1-7,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Angiotensins|Antihypertensive Agents|Autacoids|Biological Factors|Cardiovascular Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Inflammation Mediators|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Proteins|Vasodilating Agents",[H][C@](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)([C@@H](C)CC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N1CCC[C@H]1C(O)=O,123805
9728,DB11721,Mitoglitazone,small molecule,investigational,Sulfur Compounds|Thiazoles,CCC1=CN=C(C=C1)C(=O)COC1=CC=C(CC2SC(=O)NC2=O)C=C1,10429242
9729,DB11723,Dutogliptin,small molecule,investigational,"Acids|Acids, Noncarboxylic|Agents causing angioedema|Blood Glucose Lowering Agents|Boron Compounds|DPP-IV Inhibitors",OB(O)[C@@H]1CCCN1C(=O)CN[C@@H]1CCNC1,11253490
9730,DB11724,Bombesin,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Amphibian Venoms|Biological Factors|Bodily Secretions|Bombesin, antagonists & inhibitors|Complex Mixtures|Fluids and Secretions|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Nerve Tissue Proteins|Neuropeptides|Neurotransmitter Agents|Peptide Hormones|Peptides|Proteins|Toxins, Biological|Venoms",[H]N=C(N([H])[H])N([H])CCC[C@H](N([H])C(=O)[C@H](CCC(=O)N([H])[H])N([H])C(=O)[C@@H]1CCC(=O)N1[H])C(=O)N([H])[C@@H](CC(C)C)C(=O)N([H])CC(=O)N([H])[C@@H](CC(=O)N([H])[H])C(=O)N([H])[C@@H](CCC(=O)N([H])[H])C(=O)N([H])[C@@H](CC1=CN([H])C2=CC=CC=C12)C(=O)N([H])[C@@H](C)C(=O)N([H])[C@@H](C(C)C)C(=O)N([H])CC(=O)N([H])[C@@H](CC1=CN([H])C=N1)C(=O)N([H])[C@@H](CC(C)C)C(=O)N([H])[C@@H](CCSC)C(=O)N([H])[H],
9731,DB11725,Latrepirdine,small molecule,investigational,"Alzheimer Disease|Heterocyclic Compounds, Fused-Ring",CN1CCC2=C(C1)C1=CC(C)=CC=C1N2CCC1=CC=C(C)N=C1,197033
9732,DB11726,Encenicline,small molecule,investigational,Nicotinic Agonists|Sulfur Compounds,ClC1=C2SC(=CC2=CC=C1)C(=O)N[C@H]1CN2CCC1CC2,46196517
9734,DB11729,GSK-2330672,small molecule,investigational,Amines|Azepines|Sulfur Compounds|Thiepins,CCCC[C@]1(CC)CS(=O)(=O)C2=CC(CNC(CC(O)=O)CC(O)=O)=C(OC)C=C2[C@H](N1)C1=CC=CC=C1,53492727
9735,DB11730,Ribociclib,small molecule,approved|investigational,"Amines|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|Kinase Inhibitor|Protein Kinase Inhibitors|Pyridines|QTc Prolonging Agents",CN(C)C(=O)C1=CC2=CN=C(NC3=CC=C(C=N3)N3CCNCC3)N=C2N1C1CCCC1,44631912
9737,DB11732,Lasmiditan,small molecule,approved|investigational,Amides|BCRP/ABCG2 Inhibitors|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|MATE 1 Inhibitors|MATE 2 Inhibitors|MATE inhibitors|OCT1 inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,CN1CCC(CC1)C(=O)C1=CC=CC(NC(=O)C2=C(F)C=C(F)C=C2F)=N1,11610526
9738,DB11734,Fedovapagon,small molecule,investigational,,CN(C)C(=O)[C@@H]1CCCN1C(=O)NCC1=CC=C(C=C1C)C(=O)N1CCCCC2=C1C=CC=C2,10298385
9739,DB11735,Galactose,small molecule,approved|investigational,Carbohydrates|Contrast Media|Diagnostic Agents|Hexoses|Monosaccharides|Tests for Liver Functional Capacity|Ultrasound Contrast Media,[H]C(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO,3037556
9740,DB11736,PF-00489791,small molecule,investigational,"Amides|Heterocyclic Compounds, Fused-Ring|Sulfones|Sulfur Compounds",CCOCCN1N=C(C(=O)NS(C)(=O)=O)C2=NC(=NC(NC3=CC(C)=CC=N3)=C12)N(C)CC,11465695
9741,DB11737,Icotinib,small molecule,experimental|investigational,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Crown Compounds|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (moderate)|Cytochrome P-450 CYP3A5 Inducers (weak)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Ethers|Ethers, Cyclic|Heterocyclic Compounds, Fused-Ring|Protein Kinase Inhibitors|Tyrosine Kinase Inhibitors",C#CC1=CC=CC(NC2=NC=NC3=CC4=C(OCCOCCOCCO4)C=C23)=C1,22024915
9742,DB11738,Rilmenidine,small molecule,approved|investigational,"Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Antiadrenergic Agents, Centrally Acting|Antihypertensive Agents|Autonomic Agents|Cardiovascular Agents|Imidazoline Receptor Agonists|Neurotransmitter Agents|Oxazoles|Peripheral Nervous System Agents|Sympatholytics",C1CC1C(NC1=NCCO1)C1CC1,68712
9743,DB11739,Vonoprazan,small molecule,investigational,Amides|Sulfones|Sulfur Compounds,CNCC1=CN(C(=C1)C1=CC=CC=C1F)S(=O)(=O)C1=CC=CN=C1,15981397
9744,DB11740,MK-1775,small molecule,investigational,Enzyme Inhibitors,CN1CCN(CC1)C1=CC=C(NC2=NC=C3C(=O)N(CC=C)N(C3=N2)C2=NC(=CC=C2)C(C)(C)O)C=C1,24856436
9745,DB11741,Famitinib,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Receptor Protein-Tyrosine Kinases, antagonists & inhibitors",CCN(CC)CCN1CCC2=C(C(C)=C(N2)\C=C2/C(=O)NC3=CC=C(F)C=C23)C1=O,16662431
9746,DB11742,Ebastine,small molecule,approved|investigational,Antihistamines for Systemic Use|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Ketones|Neurotransmitter Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1,3191
9747,DB11743,Ipatasertib,small molecule,investigational,"Proto-Oncogene Proteins c-akt, antagonists & inhibitors",[H][C@](CNC(C)C)(C(=O)N1CCN(CC1)C1=NC=NC2=C1[C@]([H])(C)C[C@@]2([H])O)C1=CC=C(Cl)C=C1,24788740
9748,DB11744,Epetraborole,small molecule,investigational,"Anti-Bacterial Agents|Leucine-tRNA Ligase, antagonists & inhibitors",NC[C@H]1OB(O)C2=C1C=CC=C2OCCCO,46836890
9749,DB11745,Otenabant,small molecule,investigational,"Cannabinoid Receptor Antagonists|Cannabinoids and similars|Heterocyclic Compounds, Fused-Ring|Receptor, Cannabinoid, CB1, antagonists & inhibitors",CCNC1(CCN(CC1)C1=C2N=C(N(C2=NC=N1)C1=CC=C(Cl)C=C1)C1=CC=CC=C1Cl)C(N)=O,10052040
9751,DB11747,Barasertib,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Organophosphorus Compounds|Protein Kinase Inhibitors",CCN(CCCOC1=CC=C2C(NC3=CC(CC(=O)NC4=CC=CC(F)=C4)=NN3)=NC=NC2=C1)CCOP(O)(O)=O,11497983
9752,DB11748,Benfotiamine,small molecule,approved|experimental,"Adjuvants, Immunologic|Alimentary Tract and Metabolism|Compounds used in a research, industrial, or household setting|Immunologic Factors|Pyrimidines|Sequestering Agents|Sulfur Compounds|Thiazoles|Vitamin B Complex|Vitamins",C\C(N(CC1=CN=C(C)N=C1N)C=O)=C(/CCOP(O)(O)=O)SC(=O)C1=CC=CC=C1,3032771
9753,DB11749,(R)-Praziquantel,small molecule,investigational,,[H][C@@]12CN(CC(=O)N1CCC1=CC=CC=C21)C(=O)C1CCCCC1,445900
9754,DB11750,Clobetasol,small molecule,approved|experimental|investigational,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Very Potent (Group IV)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Dermatologicals|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated|Thyroxine-binding globulin inhibitors",[H][C@@]12C[C@H](C)[C@](O)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,5311051
9755,DB11751,Cabotegravir,small molecule,investigational,Anti-HIV Agents|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|Pyridines,C[C@H]1CO[C@@H]2CN3C=C(C(=O)NCC4=CC=C(F)C=C4F)C(=O)C(O)=C3C(=O)N12,54713659
9756,DB11752,Bryostatin 1,small molecule,investigational,"Adjuvants, Immunologic|Anti-Bacterial Agents|Antineoplastic Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Activation|Immunologic Factors|Lactones|Macrolides",,22524140
9757,DB11753,Rifamycin,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antiinfectives for Systemic Use|Antimycobacterials|Antirheumatic Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strong)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Drugs for Treatment of Tuberculosis|Heterocyclic Compounds, Fused-Ring|Lactams|Lactams, Macrocyclic|MATE 1 Inhibitors|MATE inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Ophthalmologicals|Otologicals|P-glycoprotein inhibitors|P-glycoprotein substrates|Rifamycins|Sensory Organs",CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C=C(O)C4=C3C2=O,
9759,DB11755,Tetrahydrocannabivarin,small molecule,investigational,Agents that produce hypertension|Antidepressive Agents|Central Nervous System Depressants|Serotonin 5-HT1 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists,CCCC1=CC(O)=C2[C@@H]3C=C(C)CC[C@H]3C(C)(C)OC2=C1,93147
9761,DB11757,Istradefylline,small molecule,approved|investigational,"Adenosine A2 Receptor Antagonists|BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|MATE 1 Inhibitors|MATE 2 Inhibitors|MATE inhibitors|Neurotransmitter Agents|OAT1/SLC22A6 inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein inhibitors|Purinergic Agents|Purinergic Antagonists|Purinergic P1 Receptor Antagonists",[H]\C(=C(\[H])C1=CC(OC)=C(OC)C=C1)C1=NC2=C(N1C)C(=O)N(CC)C(=O)N2CC,5311037
9762,DB11758,Cenicriviroc,small molecule,investigational,"Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|CCR5 Receptor Antagonists|Receptors, CCR2, antagonists & inhibitors",CCCCOCCOC1=CC=C(C=C1)C1=CC2=C(C=C1)N(CC(C)C)CCC\C(=C/2)C(=O)NC1=CC=C(C=C1)[S@@](=O)CC1=CN=CN1CCC,11285792
9763,DB11759,Pevonedistat,small molecule,investigational,Cycloparaffins|Enzyme Inhibitors,[H][C@]1(O)C[C@@]([H])(C[C@@]1([H])COS(N)(=O)=O)N1C=CC2=C(N[C@@]3([H])CCC4=CC=CC=C34)N=CN=C12,16720766
9764,DB11760,Talazoparib,small molecule,approved|investigational,Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Enzyme Inhibitors|Narrow Therapeutic Index Drugs|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Poly(ADP-ribose) Polymerase Inhibitors|Pyridazines,CN1N=CN=C1[C@@H]1[C@H](NC2=C3C1=NNC(=O)C3=CC(F)=C2)C1=CC=C(F)C=C1,44819241
9765,DB11761,Tenapanor,small molecule,approved|investigational,"Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Sulfur Compounds",CN1C[C@@H](C2=CC(=CC=C2)S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)C2=CC(=CC=C2)[C@@H]2CN(C)CC3=C2C=C(Cl)C=C3Cl)C2=C(C1)C(Cl)=CC(Cl)=C2,71587953
9766,DB11762,Marizomib,small molecule,investigational,,C[C@@]12OC(=O)[C@@]1(NC(=O)[C@@H]2CCCl)[C@@H](O)[C@H]1CCCC=C1,11347535
9767,DB11763,Momelotinib,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Enzyme Inhibitors|Protein Kinase Inhibitors",O=C(NCC#N)C1=CC=C(C=C1)C1=CC=NC(NC2=CC=C(C=C2)N2CCOCC2)=N1,25062766
9768,DB11764,Spebrutinib,small molecule,investigational,"Acids, Acyclic|Acrylates|Amides|Protein Kinase Inhibitors",COCCOC1=CC=C(NC2=NC=C(F)C(NC3=CC=CC(NC(=O)C=C)=C3)=N2)C=C1,59174488
9769,DB11765,PF-04991532,small molecule,investigational,"Enzyme Inhibitors|Glucokinase, antagonists & inhibitors|Pyridines",OC(=O)C1=CC=C(NC(=O)[C@H](CC2CCCC2)N2C=NC(=C2)C(F)(F)F)N=C1,46181428
9770,DB11766,AZD-1305,small molecule,investigational,"Acids, Acyclic|Aza Compounds",CC(C)(C)OC(=O)NCCN1C[C@H]2CN(CCOC3=CC=C(C=C3F)C#N)C[C@@H](C1)O2,44182376
9772,DB11768,Zytron,small molecule,approved|investigational,Amines|Organophosphorus Compounds|Sulfur Compounds,COP(=S)(NC(C)C)OC1=CC=C(Cl)C=C1Cl,9299
9773,DB11769,Funapide,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",FC(F)(F)C1=CC=C(CN2C(=O)[C@@]3(COC4=C3C=C3OCOC3=C4)C3=CC=CC=C23)O1,49836093
9774,DB11770,Talinolol,small molecule,investigational,"Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Beta Blocking Agents, Selective|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Neurotransmitter Agents|P-glycoprotein substrates|Potential QTc-Prolonging Agents|Propanols|QTc Prolonging Agents",CC(C)(C)NCC(O)COC1=CC=C(NC(=O)NC2CCCCC2)C=C1,68770
9776,DB11772,Pilaralisib,small molecule,investigational,"Amides|Heterocyclic Compounds, Fused-Ring|Phosphatidylinositol 3-Kinase, antagonists & inhibitors|Sulfones|Sulfur Compounds",COC1=CC=C(Cl)C(NC2=C(NS(=O)(=O)C3=CC(NC(=O)C(C)(C)N)=CC=C3)N=C3C=CC=CC3=N2)=C1,56599306
9777,DB11773,BMS-903452,small molecule,investigational,Pyridines|Sulfur Compounds,CS(=O)(=O)C1=CC=C(N2C=C(Cl)C(OC3CCN(CC3)C3=NC=C(Cl)C=N3)=CC2=O)C(F)=C1,53477157
9778,DB11774,Pazufloxacin,small molecule,investigational,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antituberculosis Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",[H][C@]1(C)COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2C1(N)CC1,65957
9779,DB11775,PF-03758309,small molecule,investigational,"p21-Activated Kinases, antagonists & inhibitors",CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC2=C3SC=CC3=NC(C)=N2)C1(C)C)C1=CC=CC=C1,25227462
9782,DB11778,Danusertib,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Protein Kinase Inhibitors",CO[C@@H](C(=O)N1CC2=C(C1)C(NC(=O)C1=CC=C(C=C1)N1CCN(C)CC1)=NN2)C1=CC=CC=C1,11442891
9783,DB11779,Danoprevir,small molecule,investigational,Amides|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Sulfones|Sulfur Compounds,CC(C)(C)OC(=O)N[C@H]1CCCCC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C1=O)OC(=O)N1CC2=CC=CC(F)=C2C1)C(=O)NS(=O)(=O)C1CC1,11285588
9784,DB11780,Allicin,small molecule,investigational,"Acids|Acids, Noncarboxylic|Anti-Infective Agents|Antioxidants|Blood Glucose Lowering Agents|Compounds used in a research, industrial, or household setting|Free Radical Scavengers|Hypolipidemic Agents|Lipid Regulating Agents|Noxae|Protective Agents|Sulfur Acids|Sulfur Compounds|Toxic Actions",C=CCSS(=O)CC=C,65036
9785,DB11781,Tosedostat,small molecule,investigational,"Amines|Amino Acids|Amino Acids, Peptides, and Proteins|Enzyme Inhibitors|Hydroxy Acids|Hydroxylamines",CC(C)C[C@H]([C@H](O)C(=O)NO)C(=O)N[C@H](C(=O)OC1CCCC1)C1=CC=CC=C1,15547703
9786,DB11782,Birinapant,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Heterocyclic Compounds, Fused-Ring|Oligopeptides|Peptides",CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1CC1=C(NC2=CC(F)=CC=C12)C1=C(C[C@@H]2C[C@H](O)CN2C(=O)[C@H](CC)NC(=O)[C@H](C)NC)C2=CC=C(F)C=C2N1,49836020
9787,DB11783,Imidapril,small molecule,investigational,Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Enzyme Inhibitors|Hypotensive Agents|Imidazoles|Protease Inhibitors,[H][C@@](C)(N[C@@]([H])(CCC1=CC=CC=C1)C(=O)OCC)C(=O)N1C(=O)N(C)C[C@@]1([H])C(O)=O,5464343
9788,DB11784,NRX-1074,small molecule,investigational,,C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@@]1(CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(N)=O,71249967
9789,DB11785,Anisodamine,small molecule,investigational,"Adrenergic Agents|Adrenergic Agonists|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents producing tachycardia|Agents that produce hypertension|Alkaloids|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Ulcer Agents|Antiarrhythmic agents|Antioxidants|Antirheumatic Agents|Autonomic Agents|Bradycardia-Causing Agents|Cardiovascular Agents|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Drugs, Chinese Herbal|Free Radical Scavengers|Gastrointestinal Agents|Neurotransmitter Agents|Parasympatholytics|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|Protective Agents|QTc Prolonging Agents|Sensory System Agents|Vasodilating Agents",CN1[C@@H]2C[C@H](O)[C@H]1C[C@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,6918612
9790,DB11786,Pefcalcitol,small molecule,investigational,,C[C@H](OCC(=O)NCC(F)(F)C(F)(F)F)C1=CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C,16122802
9791,DB11787,Ralimetinib,small molecule,investigational,"Mitogen-Activated Protein Kinase 14, antagonists & inhibitors",CC(C)(C)CN1C(N)=NC2=CC=C(N=C12)C1=C(NC(=N1)C(C)(C)C)C1=CC=C(F)C=C1,11539025
9793,DB11789,Hyodeoxycholic Acid,small molecule,investigational,Bile Acids and Salts|Cholanes|Cholic Acids|Fused-Ring Compounds|Steroids,[H][C@@]1(CC[C@@]2([H])[C@]3([H])C[C@H](O)[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,5283820
9794,DB11790,Radafaxine,small molecule,investigational,Ketones|Propiophenones,C[C@@H]1NC(C)(C)CO[C@@]1(O)C1=CC=CC(Cl)=C1,9795056
9795,DB11791,Capmatinib,small molecule,approved|investigational,"Acids, Carbocyclic|Amides|Antineoplastic Agents|BCRP/ABCG2 Inhibitors|Benzene Derivatives|Benzoates|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|MATE 1 Inhibitors|MATE 2 Inhibitors|MATE inhibitors|P-glycoprotein substrates|Tyrosine Kinase Inhibitors",CNC(=O)C1=C(F)C=C(C=C1)C1=NN2C(CC3=CC4=C(C=C3)N=CC=C4)=CN=C2N=C1,25145656
9796,DB11792,Mirodenafil,small molecule,investigational,Amides|Enzyme Inhibitors|Phosphodiesterase 5 Inhibitors|Phosphodiesterase Inhibitors|Pyrimidines|Sulfones|Sulfur Compounds|Vasodilating Agents,CCCOC1=CC=C(C=C1C1=NC2=C(N(CC)C=C2CCC)C(=O)N1)S(=O)(=O)N1CCN(CCO)CC1,12001014
9797,DB11793,Niraparib,small molecule,approved|investigational,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Narrow Therapeutic Index Drugs|Poly(ADP-ribose) Polymerase Inhibitors|Pyrazoles",NC(=O)C1=CC=CC2=CN(N=C12)C1=CC=C(C=C1)[C@@H]1CCCNC1,24958200
9798,DB11794,Berzosertib,small molecule,investigational,,CNCC1=CC=C(C=C1)C1=NOC(=C1)C1=NC(=CN=C1N)C1=CC=C(C=C1)S(=O)(=O)C(C)C,59472121
9799,DB11795,GSK-2636771,small molecule,investigational,Antineoplastic Agents|Enzyme Inhibitors|Oxazines|Protein Kinase Inhibitors,CC1=NC2=C(C=C(C=C2N1CC1=C(C)C(=CC=C1)C(F)(F)F)N1CCOCC1)C(O)=O,56949517
9800,DB11796,Fostemsavir,small molecule,investigational,Organophosphorus Compounds,COC1=C2C(=CN(COP(O)(O)=O)C2=C(N=C1)N1C=NC(C)=N1)C(=O)C(=O)N1CCN(CC1)C(=O)C1=CC=CC=C1,11319217
9801,DB11797,Aceneuramic acid,small molecule,investigational,Musculo-Skeletal System,CC(=O)N[C@H]([C@@H](O)CC(=O)C(O)=O)[C@@H](O)[C@H](O)[C@H](O)CO,14017587
9802,DB11798,Tanzisertib,small molecule,investigational,"Alcohols|Carbon Radioisotopes|Cyclohexanes|Cycloparaffins|Fatty Alcohols|Heterocyclic Compounds, Fused-Ring|Hexanols|JNK Mitogen-Activated Protein Kinases, antagonists & inhibitors|Lipids",[H][C@@]1(CCOC1)N1C(NC2=C(F)C=C(F)C=C2F)=NC2=CN=C(N[C@@]3([H])CC[C@]([H])(O)CC3)N=C12,11597537
9803,DB11799,Bictegravir,small molecule,approved|investigational,"Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Direct Acting Antivirals|Heterocyclic Compounds, Fused-Ring|MATE 1 Inhibitors|MATE inhibitors|UGT1A1 Substrates",OC1=C2N(C[C@H]3O[C@@H]4CC[C@@H](C4)N3C2=O)C=C(C(=O)NCC2=C(F)C=C(F)C=C2F)C1=O,90311989
9804,DB11800,Tivozanib,small molecule,investigational,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Benzene Derivatives|Heterocyclic Compounds, Fused-Ring|Protein Kinase Inhibitors|Receptors, Vascular Endothelial Growth Factor, antagonists & inhibitors",COC1=C(OC)C=C2C(OC3=CC(Cl)=C(NC(=O)NC4=NOC(C)=C4)C=C3)=CC=NC2=C1,9911830
9805,DB11801,Rapastinel,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Peptides",C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(N)=O,14539800
9807,DB11804,AZD-5672,small molecule,investigational,"Acetamides|Acetates|Acids, Acyclic|Amides|Anti-HIV Agents|Anti-Infective Agents|Benzene Derivatives|CCR5 Receptor Antagonists|Fatty Acids|Fatty Acids, Volatile|Lipids|Sulfones|Sulfur Compounds",CCN(C1CCN(CC[C@H](C2=CC=C(C=C2)S(C)(=O)=O)C2=CC(F)=CC(F)=C2)CC1)C(=O)CC1=CC=C(C=C1)S(C)(=O)=O,16007088
9808,DB11805,Saracatinib,small molecule,investigational,"Antineoplastic Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Dioxoles|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Tyrosine Kinase Inhibitors",CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,10302451
9809,DB11806,VTP-194204,small molecule,investigational,Fatty Acids|Ligands|Lipids|Naphthalenes,C\C(\C=C\[C@@H]1C[C@]1(C)C1=CC=C2C(=C1)C(C)(C)CCC2(C)C)=C/C(O)=O,9863341
9810,DB11807,Dexmecamylamine,small molecule,investigational,,CN[C@@]1(C)[C@@H]2CC[C@@H](C2)C1(C)C,12358972
9811,DB11808,Faldaprevir,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Antivirals for treatment of HCV infections|Direct Acting Antivirals|Peptides|Protease Inhibitors|Sulfur Compounds",COC1=C(Br)C2=C(C=C1)C(O[C@@H]1C[C@H](N(C1)C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)N[C@@]1(C[C@H]1C=C)C(O)=O)=CC(=N2)C1=CSC(NC(=O)C(C)C)=N1,42601552
9812,DB11809,Artefenomel,small molecule,investigational,Anions|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiprotozoals|Cycloparaffins|Electrolytes|Free Radicals|Ions|Oxides|Oxygen Compounds|Reactive Oxygen Species,C(CN1CCOCC1)OC1=CC=C(C=C1)[C@H]1CC[C@]2(CC1)OOC1(O2)C2CC3CC(C2)CC1C3,24999143
9813,DB11810,Etarfolatide,small molecule,investigational,,N[C@@H](CNC(=O)CC[C@@H](NC(=O)C1=CC=C(NCC2=CNC3=NC=NC(=O)C3=N2)C=C1)C(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CS)C(O)=O,76958396
9814,DB11811,Arhalofenate,small molecule,investigational,"Acetates|Acids, Acyclic|Acids, Carbocyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Lipids",CC(=O)NCCOC(=O)[C@H](OC1=CC=CC(=C1)C(F)(F)F)C1=CC=C(Cl)C=C1,12082259
9815,DB11812,Talaporfin,small molecule,investigational,"Antineoplastic Agents|Biological Factors|Dermatologicals|Heterocyclic Compounds, Fused-Ring|Photosensitizing Agents|Pigments, Biological|Radiation-Sensitizing Agents",CCC1=C(C)\C2=C\C3=C(C=C)C(C)=C(N3)\C=C3/N=C([C@@H](CCC(O)=O)[C@@H]3C)/C(/CC(=O)N[C@@H](CC(O)=O)C(O)=O)=C3\N\C(=C/C1=N2)C(C)=C3C(O)=O,5486799
9816,DB11813,Mipsagargin,small molecule,investigational,,CCCCCCCC(=O)O[C@@H]1[C@@H](OC(=O)C(\C)=C/C)C(C)=C2[C@@H]3OC(=O)[C@@](C)(O)[C@@]3(O)[C@H](C[C@](C)(OC(C)=O)[C@@H]12)OC(=O)CCCCCCCCCCCNC(=O)C[C@H](N)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(O)=O)C(O)=O)C(O)=O)C(O)=O)C(O)=O,24772106
9817,DB11814,PF-03882845,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Pyrazoles",OC(=O)C1=CC2=C(C=C1)C1=NN([C@@H](C3CCCC3)[C@H]1CC2)C1=CC=C(C#N)C(Cl)=C1,46871935
9818,DB11815,Tilarginine,small molecule,approved|investigational,"Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Arginine|Enzyme Inhibitors|Nitric Oxide Synthase, antagonists & inhibitors",CNC(=N)NCCC[C@H](N)C(O)=O,132862
9819,DB11816,Omecamtiv Mecarbil,small molecule,investigational,,COC(=O)N1CCN(CC2=C(F)C(NC(=O)NC3=CC=C(C)N=C3)=CC=C2)CC1,11689883
9820,DB11817,Baricitinib,small molecule,approved|investigational,Amides|Antineoplastic and Immunomodulating Agents|Azetines|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Immunosuppressive Agents|Janus Kinase Inhibitor|Janus Kinase Inhibitors|MATE 2 Inhibitors|MATE 2 Substrates|MATE 2 Substrates with a Narrow Therapeutic Index|MATE inhibitors|MATE substrates|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OATP1B3 inhibitors|OCT2 Inhibitors|P-glycoprotein substrates|Selective Immunosuppressants|Sulfones|Sulfur Compounds,CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,44205240
9821,DB11818,Retosiban,small molecule,investigational,,CC[C@H](C)[C@H]1N([C@@H](C(=O)N2CCOCC2)C2=COC(C)=N2)C(=O)[C@H](NC1=O)C1CC2=CC=CC=C2C1,11340891
9822,DB11819,ASP-4058,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Oxazoles",C[C@H](OC1=CC=C(C=C1C(F)(F)F)C1=NC(=NO1)C1=CC=C2NC=NC2=C1)C(F)(F)F,16755143
9823,DB11820,Nifurtimox,small molecule,investigational,"Agents Against Leishmaniasis and Trypanosomiasis|Anti-Infective Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Furans|Nitro Compounds|Nitrofuran Derivatives|Nitrofurans|Sulfur Compounds|Thiazines|Trypanocidal Agents",CC1CS(=O)(=O)CCN1\N=C\C1=CC=C(O1)[N+]([O-])=O,6842999
9824,DB11821,Danegaptide,small molecule,investigational,"Acids, Acyclic|Acids, Carbocyclic|Amides|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Benzene Derivatives|Benzoates|Imines|Imino Acids|Oligopeptides|Peptides",NCC(=O)N1C[C@@H](C[C@H]1C(O)=O)NC(=O)C1=CC=CC=C1,16656685
9825,DB11822,TMC-647055,small molecule,investigational,"Amides|Heterocyclic Compounds, Fused-Ring|Sulfones|Sulfur Compounds",COC1=CC=C2C3=C(C4CCCCC4)C4=CC=C5C=C4N3CC(=CC2=C1)C(=O)N(C)CCOCCN(C)S(=O)(=O)NC5=O,44556044
9826,DB11823,Esketamine,small molecule,approved|investigational,"Agents producing tachycardia|Anesthetics|Anesthetics, General|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Cyclohexanes|Cycloparaffins|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (weak)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Nervous System|Psychotropic Drugs",CN[C@@]1(CCCCC1=O)C1=CC=CC=C1Cl,182137
9827,DB11824,Tofogliflozin,small molecule,investigational,Benzene Derivatives|Blood Glucose Lowering Agents|Carbohydrates|Glycosides|Sodium-Glucose Transporter 2 Inhibitors,CCC1=CC=C(CC2=CC=C3CO[C@]4(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3=C2)C=C1,46908929
9828,DB11825,Mirogabalin,small molecule,investigational,,CCC1=C[C@@H]2[C@@H](C[C@]2(CN)CC(O)=O)C1,59509752
9830,DB11827,Ertugliflozin,small molecule,approved|investigational,Alimentary Tract and Metabolism|BCRP/ABCG2 Substrates|Blood Glucose Lowering Agents|Diuretics|Drugs Used in Diabetes|P-glycoprotein substrates|Sodium-glucose co-transporter 2 (SGLT2) inhibitors|Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors|Sodium-Glucose Transporter 2 Inhibitors|UGT1A1 Inhibitors|UGT1A4 Inhibitors|UGT1A9 Substrates|UGT2B7 substrates,CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@]23OC[C@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)C=C1,44814423
9831,DB11828,Neratinib,small molecule,approved|investigational,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Kinase Inhibitor|P-glycoprotein inhibitors|Protein Kinase Inhibitors|Tyrosine Kinase Inhibitors",CCOC1=C(NC(=O)\C=C\CN(C)C)C=C2C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C(C=NC2=C1)C#N,9915743
9832,DB11829,Ruboxistaurin,small molecule,investigational,"Acids, Acyclic|Dicarboxylic Acids|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Imides|Maleates|Protein Kinase C, antagonists & inhibitors",CN(C)C[C@@H]1CCN2C=C(C3=C2C=CC=C3)C2=C(C(=O)NC2=O)C2=CN(CCO1)C1=C2C=CC=C1,153999
9833,DB11830,Mocetinostat,small molecule,investigational,"Acids, Carbocyclic|Amides|Antineoplastic Agents|Benzene Derivatives|Benzoates|Enzyme Inhibitors|Histone Deacetylase Inhibitors|Moderate Risk QTc-Prolonging Agents|QTc Prolonging Agents",NC1=CC=CC=C1NC(=O)C1=CC=C(CNC2=NC=CC(=N2)C2=CC=CN=C2)C=C1,9865515
9834,DB11831,Dinitrochlorobenzene,small molecule,investigational,"Antigens|Benzene Derivatives|Biological Factors|Chlorobenzenes|Compounds used in a research, industrial, or household setting|Dinitrobenzenes|Epitopes|Haptens|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Indicators and Reagents|Irritants|Laboratory Chemicals|Nitro Compounds|Nitrobenzenes|Noxae|Toxic Actions",ClC1=C(C=C(C=C1)N(=O)=O)N(=O)=O,6
9835,DB11832,Crenolanib,small molecule,investigational,"Antineoplastic Agents|Heterocyclic Compounds, Fused-Ring|Receptor, Platelet-Derived Growth Factor alpha, antagonists & inhibitors|Receptor, Platelet-Derived Growth Factor beta, antagonists & inhibitors|Tyrosine Kinase Inhibitors",CC1(COC2=CC=C3N(C=NC3=C2)C2=CC=C3C=CC=C(N4CCC(N)CC4)C3=N2)COC1,10366136
9836,DB11833,Basimglurant,small molecule,investigational,,CC1=NC(C#CC2=CC=NC(Cl)=C2)=C(C)N1C1=CC=C(F)C=C1,11438771
9838,DB11835,Indium In-111 pentetreotide,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Diagnostic Radiopharmaceuticals|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Indium (111In) Compounds|Indium Radioisotopes|Nerve Tissue Proteins|Neuropeptides|Pancreatic Hormones|Peptide Hormones|Peptides|Pituitary Hormone Release Inhibiting Hormones|Proteins|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Tumour Detection",[111In+3].CC(O)C(CO)N=C(O)C1CSSCC(N=C(O)C(CC2=CC=CC=C2)N=C([O-])CN(CCN(CCC(C(O)=O)C(O)=O)CC([O-])=O)CC([O-])=O)C(O)=NC(CC2=CC=CC=C2)C(O)=NC(CC2=CNC3=CC=CC=C23)C(O)=NC(CCCCN)C([O-])=NC(C(C)O)C(O)=N1,131704321
9839,DB11836,Sapanisertib,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CC(C)N1N=C(C2=C(N)N=CN=C12)C1=CC=C2OC(N)=NC2=C1,45375953
9840,DB11837,Osilodrostat,small molecule,approved|investigational,"Cytochrome P-450 CYP11B2, antagonists & inhibitors|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|MATE 1 Inhibitors|MATE inhibitors|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OCT1 inhibitors|OCT2 Inhibitors|UGT1A4 substrates|UGT2B7 substrates",FC1=C(C=CC(=C1)C#N)[C@H]1CCC2=CN=CN12,44139752
9841,DB11838,Revamilast,small molecule,investigational,,[O-][N+]1=CC(Cl)=C(NC(=O)C2=CC=C(OC(F)F)C3=C2C2=CN=CC=C2O3)C(Cl)=C1,11546664
9842,DB11839,PZ-128,small molecule,investigational,,CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,72187679
9844,DB11841,Entinostat,small molecule,investigational,"Acids, Carbocyclic|Amides|Antineoplastic Agents|Benzene Derivatives|Benzoates|Enzyme Inhibitors|Histone Deacetylase Inhibitors|Moderate Risk QTc-Prolonging Agents|QTc Prolonging Agents",NC1=CC=CC=C1NC(=O)C1=CC=C(CNC(=O)OCC2=CN=CC=C2)C=C1,4261
9845,DB11842,Angiotensin II,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Angiotensin II, antagonists & inhibitors|Angiotensins|Autacoids|Biological Factors|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Inflammation Mediators|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Proteins|Vasoconstriction|Vasoconstrictor Agents",CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O,172198
9846,DB11843,PF-04958242,small molecule,investigational,Amides|Sulfones|Sulfur Compounds,CC(C)S(=O)(=O)N[C@H]1COC[C@H]1OC1=CC=C(C=C1)C1=CC=C(S1)C#N,49853967
9847,DB11844,Pritelivir,small molecule,investigational,Anti-Infective Agents|Antiviral Agents|Enzyme Inhibitors|Sulfur Compounds,CN(C(=O)CC1=CC=C(C=C1)C1=CC=CC=N1)C1=NC(C)=C(S1)S(N)(=O)=O,491941
9848,DB11845,Lucitanib,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CNC(=O)C1=C2C=CC(OC3=C4C=C(OC)C(OCC5(N)CC5)=CC4=NC=C3)=CC2=CC=C1,25031915
9849,DB11846,Creatinine,small molecule,investigational,Imidazoles,CN1CC(=O)NC1=N,588
9850,DB11847,Cadazolid,small molecule,investigational,Oxazoles,OC[C@H]1CN(C(=O)O1)C1=CC(F)=C(OCC2(O)CCN(CC2)C2=C(F)C=C3C(=O)C(=CN(C4CC4)C3=C2)C(O)=O)C=C1,44242317
9851,DB11848,Mannose 6-phosphate,small molecule,investigational,,[H][C@@](O)(COP(O)(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)C=O,6101690
9854,DB11851,Bafetinib,small molecule,investigational,Enzyme Inhibitors|Protein Kinase Inhibitors,CN(C)[C@H]1CCN(CC2=C(C=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CN=C3)=C2)C(F)(F)F)C1,11387605
9855,DB11852,Tegobuvir,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",FC1=CC=CC=C1C1=NC2=CN(CC3=CC=C(N=N3)C3=CC=C(C=C3C(F)(F)F)C(F)(F)F)C=CC2=N1,23649154
9856,DB11853,Relugolix,small molecule,investigational,"Benzene Derivatives|Pyrimidines|Receptors, LHRH, antagonists & inhibitors",CONC(=O)NC1=CC=C(C=C1)C1=C(CN(C)C)C2=C(S1)N(CC1=C(F)C=CC=C1F)C(=O)N(C2=O)C1=CC=C(OC)N=N1,10348973
9858,DB11855,Revefenacin,small molecule,approved|investigational,Amides|Anticholinergic Agents|BCRP/ABCG2 Substrates|Benzene Derivatives|Bronchodilator Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Muscarinic Antagonists|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein substrates,CN(CCN1CCC(CC1)OC(=O)NC1=CC=CC=C1C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1,11753673
9861,DB11858,Leukotriene D4,small molecule,investigational,"Arachidonic Acids|Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Essential|Fatty Acids, Unsaturated|Inflammation Mediators|Leukotrienes|Lipids|SRS-A",CCCCC\C=C/C\C=C/C=C/C=C/[C@@H](SC[C@H](N)C(=O)NCC(O)=O)[C@@H](O)CCCC(O)=O,5280878
9862,DB11859,Brexanolone,small molecule,approved|investigational,"Anesthetics|Anticonvulsants|Biopolymers|Carbohydrates|Central Nervous System Agents|Central Nervous System Depressants|Compounds used in a research, industrial, or household setting|Corpus Luteum Hormones|Cyclodextrins|Dextrins|Diet, Food, and Nutrition|Dietary Carbohydrates|Food|Food and Beverages|Fused-Ring Compounds|GABA Modulators|Glucans|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Macromolecular Substances|Pharmaceutical Preparations|Physiological Phenomena|Polymers|Polysaccharides|Pregnanes|Pregnenediones|Pregnenes|Progesterone Congeners|Starch|Steroids",[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O,92786
9863,DB11860,Aramchol,small molecule,investigational,Bile Acids and Salts|Cholanes|Fused-Ring Compounds|Steroids,CCCCCCCCCCCCCCCCCCCC(=O)N[C@H]1CC[C@@]2(C)[C@H](C[C@@H](O)[C@H]3[C@@H]4CC[C@H]([C@H](C)CCC(O)=O)[C@@]4(C)[C@@H](O)C[C@H]23)C1,18738120
9864,DB11861,Litronesib,small molecule,investigational,Amides|Sulfones|Sulfur Compounds|Thiazoles,CCNCCS(=O)(=O)NC[C@]1(SC(NC(=O)C(C)(C)C)=NN1C(=O)C(C)(C)C)C1=CC=CC=C1,25167017
9866,DB11863,Alvelestat,small molecule,investigational,"Leukocyte Elastase, antagonists & inhibitors|Pyridines|Sulfur Compounds",CN1N=CC=C1C1=C(C)N(C2=CC=CC(=C2)C(F)(F)F)C(=O)C(=C1)C(=O)NCC1=NC=C(C=C1)S(C)(=O)=O,71587812
9867,DB11864,Preladenant,small molecule,investigational,,COCCOC1=CC=C(C=C1)N1CCN(CCN2N=CC3=C2N=C(N)N2N=C(N=C32)C2=CC=CO2)CC1,10117987
9868,DB11865,Brivanib alaninate,small molecule,investigational,"Amino Acids|Amino Acids, Peptides, and Proteins",C[C@H](COC1=CN2N=CN=C(OC3=CC=C4NC(C)=CC4=C3F)C2=C1C)OC(=O)[C@H](C)N,11154925
9870,DB11867,JNJ-39393406,small molecule,investigational,,CN(C)C(=O)CCN1N=C(NC2=CC=C3OC(F)(F)OC3=C2)N=C1C1=CC=NC=C1,16755766
9871,DB11868,Etiracetam,small molecule,investigational,"Acetamides|Acetates|Acids, Acyclic|Amides|Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Fatty Acids|Fatty Acids, Volatile|Lipids|Nootropic Agents|Pyrrolidines|Pyrrolidinones",CCC(N1CCCC1=O)C(N)=O,59708
9872,DB11869,Valspodar,small molecule,investigational,"Amino Acids, Peptides, and Proteins|ATP Binding Cassette Transporter, Subfamily B, Member 1|Drug Resistance, Multiple|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Peptides|Peptides, Cyclic",C\C=C\C[C@@H](C)C(=O)[C@@H]1N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@@H](NC1=O)C(C)C)C(C)C,5281884
9873,DB11870,RG-4733,small molecule,investigational,"Amyloid Precursor Protein Secretases, antagonists & inhibitors|Heterocyclic Compounds, Fused-Ring",CC(C)(C(=O)NCC(F)(F)C(F)(F)F)C(=O)N[C@H]1C2=CC=CC=C2C2=CC=CC=C2NC1=O,49867930
9874,DB11871,PF-00610355,small molecule,investigational,"Acetamides|Acetates|Acids, Acyclic|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Amides|Benzene Derivatives|Fatty Acids|Fatty Acids, Volatile|Lipids|Sulfones|Sulfur Compounds",CC(C)(CC1=CC=CC(CC(=O)NCC2=CC=CC(=C2)C2=CC=C(O)C=C2)=C1)NC[C@H](O)C1=CC=C(O)C(NS(C)(=O)=O)=C1,11505444
9875,DB11872,ZD-6126,small molecule,investigational,,COC1=C(OC)C(OC)=C2C(CC[C@H](NC(C)=O)C3=C2C=CC(OP(O)(O)=O)=C3)=C1,9896434
9876,DB11873,Verinurad,small molecule,investigational,"Acids, Acyclic|Antigout Preparations|Antirheumatic Agents|Fatty Acids|Fatty Acids, Volatile|Lipids",CC(C)(SC1=CC=NC=C1C1=C2C=CC=CC2=C(C=C1)C#N)C(O)=O,54767229
9877,DB11874,Crocin,small molecule,investigational,"Alkenes|Biological Factors|Condiments|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Terpenes",C\C(\C=C\C=C(/C)C(=O)O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)=C/C=C/C=C(\C)/C=C/C=C(\C)C(=O)O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O,5281233
9878,DB11875,"3,3'-diindolylmethane",small molecule,investigational,"Anticarcinogenic Agents|Compounds used in a research, industrial, or household setting|Heterocyclic Compounds, Fused-Ring|Protective Agents",C(C1=CNC2=CC=CC=C12)C1=CNC2=CC=CC=C12,3071
9879,DB11876,Alanyl glutamine,small molecule,investigational,"Amino Acids|Amino Acids, Peptides, and Proteins|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|I.V. Solution Additives|Oligopeptides|Peptides",C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(O)=O,123935
9880,DB11877,Basmisanil,small molecule,investigational,,CC1=C(COC2=CC=C(C=N2)C(=O)N2CCS(=O)(=O)CC2)C(=NO1)C1=CC=C(F)C=C1,57336276
9881,DB11878,Filibuvir,small molecule,investigational,"Pyrans|RNA Replicase, antagonists & inhibitors",CCC1=CC(CC[C@@]2(CC(O)=C(CC3=NN4C(=N3)N=C(C)C=C4C)C(=O)O2)C2CCCC2)=CC(CC)=N1,54708673
9882,DB11879,Dusquetide,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Peptides",CC[C@H](C)C(NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(N)=O,71722017
9883,DB11880,Acridine Carboxamide,small molecule,investigational,"Antineoplastic Agents|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",CN(C)CCNC(=O)C1=C2N=C3C=CC=CC3=CC2=CC=C1,107805
9884,DB11881,AUY922,small molecule,investigational,"Benzene Derivatives|HSP90 Heat-Shock Proteins, antagonists & inhibitors|Phenols",CCNC(=O)C1=NOC(=C1C1=CC=C(CN2CCOCC2)C=C1)C1=CC(=C(O)C=C1O)C(C)(C)C,10480258
9885,DB11882,BPC-157,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Anti-Ulcer Agents|Gastrointestinal Agents|Peptides",CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)CN)C(=O)N[C@@H](C(C)C)C(O)=O,9941957
9886,DB11883,SB-705498,small molecule,investigational,"TRPV Cation Channels, antagonists & inhibitors",FC(F)(F)C1=CC=C(N=C1)N1CC[C@H](C1)NC(=O)NC1=CC=CC=C1Br,9910486
9888,DB11885,Anlotinib,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",COC1=CC2=C(OC3=CC=C4NC(C)=CC4=C3F)C=CN=C2C=C1OCC1(N)CC1,25017411
9889,DB11886,Infigratinib,small molecule,investigational,"Antineoplastic Agents|Benzene Derivatives|Receptor, Fibroblast Growth Factor, Type 1, antagonists & inhibitors",CCN1CCN(CC1)C1=CC=C(NC2=CC(=NC=N2)N(C)C(=O)NC2=C(Cl)C(OC)=CC(OC)=C2Cl)C=C1,53235510
9890,DB11888,Laninamivir octanoate,small molecule,investigational,"Acids, Acyclic|Amidines|Amino Sugars|Anti-Infective Agents|Antiviral Agents|Carbohydrates|Guanidines|Hydroxy Acids|Neuraminic Acids|Neuraminidase, antagonists & inhibitors|Pyrans|Sialic Acids|Sugar Acids",[H][C@]1(OC(=C[C@H](NC(N)=N)[C@H]1NC(C)=O)C(O)=O)[C@H](OC)[C@H](O)COC(=O)CCCCCCC,9847629
9891,DB11889,Lanicemine,small molecule,investigational,"Amines|Antidepressive Agents|Central Nervous System Depressants|Ethylamines|Receptors, N-Methyl-D-Aspartate, antagonists & inhibitors",N[C@@H](CC1=CC=CC=N1)C1=CC=CC=C1,9794203
9892,DB11890,Cilengitide,small molecule,investigational,"Biological Factors|Bodily Secretions|Complex Mixtures|Fluids and Secretions|Toxins, Biological|Venoms",CC(C)[C@@H]1N(C)C(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O,176873
9893,DB11891,CUDC-907,small molecule,investigational,"Antineoplastic Agents|Histone Deacetylase Inhibitors|Oxazines|Phosphatidylinositol 3-Kinase, antagonists & inhibitors|Potential QTc-Prolonging Agents|QTc Prolonging Agents",COC1=CC=C(C=N1)C1=NC(N2CCOCC2)=C2SC(CN(C)C3=NC=C(C=N3)C(=O)NO)=CC2=N1,54575456
9894,DB11892,Prulifloxacin,small molecule,investigational,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Dioxoles|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",CC1SC2=C(C(O)=O)C(=O)C3=CC(F)=C(C=C3N12)N1CCN(CC2=C(C)OC(=O)O2)CC1,65947
9895,DB11893,Avagacestat,small molecule,investigational,"Amides|Amyloid Precursor Protein Secretases, antagonists & inhibitors|Oxazoles|Sulfones|Sulfur Compounds",NC(=O)[C@@H](CCC(F)(F)F)N(CC1=CC=C(C=C1F)C1=NOC=N1)S(=O)(=O)C1=CC=C(Cl)C=C1,46883536
9896,DB11894,Efatutazone,small molecule,investigational,"Antineoplastic Agents|PPAR gamma, antagonists & inhibitors|Sulfur Compounds|Thiazoles",CN1C(COC2=CC=C(CC3SC(=O)NC3=O)C=C2)=NC2=CC=C(OC3=CC(C)=C(N)C(C)=C3)C=C12,9832447
9898,DB11896,Gedatolisib,small molecule,investigational,Enzyme Inhibitors|Oxazines|Protein Kinase Inhibitors,CN(C)C1CCN(CC1)C(=O)C1=CC=C(NC(=O)NC2=CC=C(C=C2)C2=NC(=NC(=N2)N2CCOCC2)N2CCOCC2)C=C1,44516953
9899,DB11898,"2,4-thiazolidinedione",small molecule,investigational,Blood Glucose Lowering Agents|Ligands|Sulfur Compounds|Thiazoles,O=C1CSC(=O)N1,5437
9900,DB11899,MK-8776,small molecule,investigational,,CN1C=C(C=N1)C1=C2N=C([C@@H]3CCCNC3)C(Br)=C(N)N2N=C1,46239015
9901,DB11900,OC-459,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Indoles",CC1=C(CC2=CC=C3C=CC=CC3=N2)C2=CC(F)=CC=C2N1CC(O)=O,11462174
9902,DB11901,Apalutamide,small molecule,approved|investigational,"Antiandrogens|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inducers|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strong)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (weak)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Endocrine Therapy|Hormone Antagonists and Related Agents|Imidazoles|Imidazolidines|MATE 1 Inhibitors|MATE 2 Inhibitors|MATE inhibitors|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inducers|OCT2 Inhibitors|P-glycoprotein inducers|Prostatic Neoplasms, drug therapy",CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F,24872560
9903,DB11902,Gisadenafil,small molecule,investigational,"Amides|Cyclic Nucleotide Phosphodiesterases, Type 5|Pyrimidines|Sulfones|Sulfur Compounds",CCOC1=NC=C(C=C1C1=NC2=C(CC)N(CCOC)N=C2C(=O)N1)S(=O)(=O)N1CCN(CC)CC1,9892860
9904,DB11903,GW842166,small molecule,investigational,"Agents producing tachycardia|Cannabinoid Receptor Agonists|Cannabinoids and similars|Receptor, Cannabinoid, CB2, agonists",FC(F)(F)C1=NC(NC2=C(Cl)C=C(Cl)C=C2)=NC=C1C(=O)NCC1CCOCC1,10253143
9905,DB11904,Flumatinib,small molecule,investigational,"Acids, Carbocyclic|Amides|Amines|Benzene Derivatives|Benzoates|Enzyme Inhibitors|Protein Kinase Inhibitors|Pyridines|Tyrosine Kinase Inhibitors",CN1CCN(CC2=CC=C(C=C2C(F)(F)F)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CC=CN=C3)=C(C)N=C2)CC1,46848036
9906,DB11905,Sutezolid,small molecule,investigational,"Acetates|Acids, Acyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Lipids|Oxazoles|Tuberculosis, Pulmonary, drug therapy",CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(N2CCSCC2)C(F)=C1,465951
9907,DB11906,Acyline,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Gonadotropin-Releasing Hormone, antagonists & inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Peptides",CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=C(NC(C)=O)C=C1)NC(=O)[C@H](CC1=CC=C(NC(C)=O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC=C2C=CC=CC2=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,16137348
9908,DB11907,Rociletinib,small molecule,investigational,"Acids, Acyclic|Acrylates|Amides|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Protein Kinase Inhibitors",COC1=CC(=CC=C1NC1=NC=C(C(NC2=CC=CC(NC(=O)C=C)=C2)=N1)C(F)(F)F)N1CCN(CC1)C(C)=O,57335384
9909,DB11909,Varespladib,small molecule,investigational,"Acids, Acyclic|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Heterocyclic Compounds, Fused-Ring|Lipids|Phospholipase A2 Inhibitors|Phospholipases A, antagonists & inhibitors",CCC1=C(C(=O)C(N)=O)C2=C(OCC(O)=O)C=CC=C2N1CC1=CC=CC=C1,155815
9910,DB11910,MK-0249,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Quinazolines",CC1=NC2=CC=CC(=C2C(=O)N1C1=CC=C(OCCCN2CCCC2)C=C1)C(F)(F)F,11697697
9911,DB11911,Galunisertib,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CC1=CC=CC(=N1)C1=NN2CCCC2=C1C1=C2C=C(C=CC2=NC=C1)C(N)=O,10090485
9912,DB11912,Lanopepden,small molecule,investigational,Amines|Anti-Bacterial Agents|Enzyme Inhibitors|Hydroxy Acids|Hydroxylamines,CC1=NC(NNC(=O)[C@H](CC2CCCC2)CN(O)C=O)=C(F)C(=N1)N1CCN2CCOC[C@@H]2C1,52918384
9913,DB11913,LY-2090314,small molecule,investigational,"Acids, Acyclic|Dicarboxylic Acids|Glycogen Synthase Kinase 3, antagonists & inhibitors|Heterocyclic Compounds, Fused-Ring|Imides|Maleates",FC1=CC2=C3N(CCN(C2)C(=O)N2CCCCC2)C=C(C3=C1)C1=C(C(=O)NC1=O)C1=CN=C2C=CC=CN12,10029385
9915,DB11915,Valbenazine,small molecule,approved|investigational,"Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Nervous System|Quinolizines|Vesicular Monoamine Transporter 2 Inhibitor|Vesicular Monoamine Transporter 2 Inhibitors",COC1=C(OC)C=C2[C@H]3C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN3CCC2=C1,24795069
9916,DB11916,Indium In-111,small molecule,investigational,,[111In],5462099
9917,DB11917,Vatiquinone,small molecule,investigational,Benzoquinones|Coenzymes|Enzymes and Coenzymes|Quinones,CC(C)=CCC\C(C)=C\CC\C(C)=C\CC[C@@](C)(O)CCC1=C(C)C(=O)C(C)=C(C)C1=O,46184405
9918,DB11918,Guadecitabine,small molecule,investigational,"Antineoplastic Agents|Aza Compounds|Carbohydrates|Glycosides|Immunologic Factors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",NC1=NC(=O)C2=C(N1)N(C=N2)[C@H]1C[C@H](O)[C@@H](COP(O)(=O)O[C@H]2C[C@@H](O[C@@H]2CO)N2C=NC(N)=NC2=O)O1,71587872
9919,DB11919,6-O-benzylguanine,small molecule,investigational,"Antineoplastic Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Purines|Purinones|Xanthine derivatives",NC1=NC(OCC2=CC=CC=C2)=C2N=CNC2=N1,4578
9920,DB11920,Lesogaberan,small molecule,investigational,"Acids|Acids, Noncarboxylic|Amines|GABA Agents|GABA Agonists|GABA-A Receptor Agonists|Gastrointestinal Agents|Neurotransmitter Agents|Organophosphorus Compounds|Phosphorus Acids|Phosphorus Compounds",NC[C@@H](F)CP(O)=O,9833984
9921,DB11921,Deflazacort,small molecule,approved|investigational,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Fused-Ring Compounds|Glucocorticoids|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Steroids|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@]([H])(O)C[C@]3(C)[C@@]1(N=C(C)O2)C(=O)COC(C)=O,189821
9922,DB11922,Danirixin,small molecule,investigational,Sulfur Compounds,CC1=C(NC(=O)NC2=CC=C(Cl)C(=C2O)S(=O)(=O)[C@H]2CCCNC2)C=CC=C1F,24780598
9923,DB11923,Decoglurant,small molecule,investigational,,NC1=CC=C(C=N1)C#CC1=C2N=C(C=C(N2N=C1)C(F)(F)F)C1=CC=C(C=C1)C(F)(F)F,71533696
9924,DB11924,Safingol,small molecule,investigational,"Alcohols|Amines|Amino Alcohols|Enzyme Inhibitors|Glycols|Protein Kinase C, antagonists & inhibitors",CCCCCCCCCCCCCCC[C@H](O)[C@@H](N)CO,3058739
9925,DB11925,Vistusertib,small molecule,investigational,Oxazines|Protein Kinase Inhibitors,CNC(=O)C1=CC(=CC=C1)C1=CC=C2C(N=C(N=C2N2CCOC[C@@H]2C)N2CCOC[C@@H]2C)=N1,25262792
9927,DB11927,Lodenafil carbonate,small molecule,investigational,"Acids|Acids, Noncarboxylic|Alkalies|Anions|Carbon Compounds, Inorganic|Carbonic Acid|Electrolytes|Ions",CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(CCOC(=O)OCCN2CCN(CC2)S(=O)(=O)C2=CC=C(OCC)C(=C2)C2=NC3=C(N(C)N=C3CCC)C(=O)N2)CC1,9963284
9929,DB11929,Vaniprevir,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",[H][C@]1(C[C@@H]2CN1C(=O)[C@@H](NC(=O)OCC(C)(C)CCCCC1=C3CN(CC3=CC=C1)C(=O)O2)C(C)(C)C)C(=O)N[C@@]1(C[C@H]1CC)C(=O)NS(=O)(=O)C1CC1,24765256
9931,DB11932,Abametapir,small molecule,investigational,,CC1=CC=C(N=C1)C1=CC=C(C)C=N1,15664
9932,DB11933,Riboprine,small molecule,investigational,,[H][C@]1(CO)O[C@@]([H])(N2C=NC3=C(NCC=C(C)C)N=CN=C23)[C@]([H])(O)[C@]1([H])O,24405
9933,DB11934,Epelsiban,small molecule,investigational,Oxazines|Piperazines,CC[C@H](C)[C@H]1N([C@@H](C(=O)N2CCOCC2)C2=CC=C(C)N=C2C)C(=O)[C@H](NC1=O)C1CC2=CC=CC=C2C1,11634973
9934,DB11935,Flomoxef,small molecule,investigational,"Amides|Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Second-Generation Cephalosporins|Sulfur Compounds|Thiazines",CO[C@]1(NC(=O)CSC(F)F)[C@H]2OCC(CSC3=NN=NN3CCO)=C(N2C1=O)C(O)=O,65864
9935,DB11936,Bempedoic acid,small molecule,approved|investigational,"Acids, Acyclic|Enzyme Inhibitors|Hypolipidemic Agents|Hypolipidemic Agents Indicated for Hyperlipidemia|Lipid Regulating Agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|OATP1B3 substrates|UGT2B7 substrates",CC(C)(CCCCCC(O)CCCCCC(C)(C)C(O)=O)C(O)=O,10472693
9936,DB11937,Kynurenic Acid,small molecule,investigational,"Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Heterocyclic Compounds, Fused-Ring|Hydroxyquinolines|Neurotransmitter Agents|Quinolines|Xanthurenates",OC(=O)C1=CC(=O)C2=CC=CC=C2N1,3845
9937,DB11938,Difelikefalin,small molecule,investigational,,CC(C)C[C@@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O,24794466
9938,DB11939,Henagliflozin,small molecule,investigational,,CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@@]23OC[C@@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)C=C1F,56832738
9939,DB11940,Triapine,small molecule,investigational,Semicarbazides|Semicarbazones|Sulfur Compounds,NC(=S)N\N=C\C1=C(N)C=CC=N1,9571836
9940,DB11941,Tasisulam,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Sulfones|Sulfur Compounds",ClC1=CC(Cl)=C(C=C1)C(=O)NS(=O)(=O)C1=CC=C(Br)S1,10160238
9941,DB11942,Selinexor,small molecule,approved|investigational,Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|OATP1B3 inhibitors,FC(F)(F)C1=CC(=CC(=C1)C1=NN(\C=C/C(=O)NNC2=NC=CN=C2)C=N1)C(F)(F)F,71481097
9942,DB11943,Delafloxacin,small molecule,approved|investigational,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (weak)|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP2E1 Inducers (weak)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 Enzyme Inducers|Drugs that are Mainly Renally Excreted|Fluoroquinolone Antibacterial|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones|UGT1A1 Substrates|UGT1A3 substrates",NC1=NC(N2C=C(C(O)=O)C(=O)C3=CC(F)=C(N4CC(O)C4)C(Cl)=C23)=C(F)C=C1F,487101
9943,DB11944,Ingavirin,small molecule,investigational,"Acids, Acyclic|Anti-Infective Agents|Antiviral Agents|Fatty Acids|Fatty Acids, Volatile|Lipids",OC(=O)CCCC(=O)NCCC1=CNC=N1,9942657
9945,DB11946,AZD-1981,small molecule,investigational,,CC(=O)NC1=C2C(=CC=C1)N(CC(O)=O)C(C)=C2SC1=CC=C(Cl)C=C1,11292191
9946,DB11947,Pridopidine,small molecule,investigational,,CCCN1CCC(CC1)C1=CC=CC(=C1)S(C)(=O)=O,9795739
9947,DB11948,Lapachone,small molecule,investigational,Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Enzyme Inhibitors|Naphthalenes|Nucleic Acid Synthesis Inhibitors|Quinones|Radiation-Sensitizing Agents|Reverse Transcriptase Inhibitors,CC1(C)CCC2=C(O1)C1=CC=CC=C1C(=O)C2=O,3885
9948,DB11949,Vestipitant,small molecule,investigational,"Benzene Derivatives|Hydrocarbons, Fluorinated|Hydrocarbons, Halogenated|Neurokinin-1 Receptor Antagonists|Neurotransmitter Agents",C[C@@H](N(C)C(=O)N1CCNC[C@@H]1C1=CC=C(F)C=C1C)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,9832383
9949,DB11950,Teneligliptin,small molecule,investigational,Agents causing angioedema|Blood Glucose Lowering Agents|DPP-IV Inhibitors|Sulfur Compounds|Thiazoles,[H][C@]1(CN[C@@]([H])(C1)C(=O)N1CCSC1)N1CCN(CC1)C1=CC(C)=NN1C1=CC=CC=C1,11949652
9950,DB11951,Lemborexant,small molecule,approved|investigational,"Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Orexin Receptor Antagonists|P-glycoprotein substrates|Sleep Aids, Pharmaceutical|Sleep Initiation and Maintenance Disorders",CC1=NC=C(OC[C@]2(C[C@H]2C(=O)NC2=NC=C(F)C=C2)C2=CC=CC(F)=C2)C(C)=N1,56944144
9951,DB11952,Duvelisib,small molecule,approved|investigational,"BCRP/ABCG2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|P-glycoprotein substrates|Phosphatidylinositol 3-Kinases, antagonists & inhibitors",C[C@H](NC1=C2N=CNC2=NC=N1)C1=CC2=CC=CC(Cl)=C2C(=O)N1C1=CC=CC=C1,50905713
9952,DB11953,PF-04447943,small molecule,investigational,Phosphodiesterase Inhibitors|Pyrimidines,C[C@@H]1CN(CC2=NC=CC=N2)C[C@H]1C1=NC2=C(C=NN2C2CCOCC2)C(=O)N1,25115162
9953,DB11954,Lomibuvir,small molecule,investigational,Alcohols|Cyclohexanes|Cycloparaffins|Fatty Alcohols|Hexanols|Lipids|Sulfur Compounds,C[C@H]1CC[C@@H](CC1)C(=O)N([C@H]1CC[C@H](O)CC1)C1=C(SC(=C1)C#CC(C)(C)C)C(O)=O,24798764
9955,DB11956,Delanzomib,small molecule,investigational,"Acids|Acids, Noncarboxylic|Amino Acids|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Boron Compounds|Enzyme Inhibitors|Protease Inhibitors|Proteasome Inhibitors",CC(C)C[C@H](NC(=O)[C@@H](NC(=O)C1=CC=CC(=N1)C1=CC=CC=C1)[C@@H](C)O)B(O)O,24800541
9956,DB11957,Idalopirdine,small molecule,investigational,"Amines|Antidepressive Agents|Benzene Derivatives|Benzyl Compounds|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Serotonin Agents|Serotonin Receptor Antagonists",FC(F)C(F)(F)COC1=CC=CC(CNCCC2=CNC3=CC(F)=CC=C23)=C1,21071390
9957,DB11958,Brivanib,small molecule,investigational,"Amino Acids|Amino Acids, Peptides, and Proteins",C[C@@H](O)COC1=CN2N=CN=C(OC3=CC=C4NC(C)=CC4=C3F)C2=C1C,11234052
9959,DB11960,Carboxyamidotriazole,small molecule,investigational,Agents causing hyperkalemia|Antiarrhythmic agents|Antineoplastic Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Membrane Transport Modulators,NC(=O)C1=C(N)N(CC2=CC(Cl)=C(C(=O)C3=CC=C(Cl)C=C3)C(Cl)=C2)N=N1,108144
9960,DB11961,AZD-1236,small molecule,investigational,,C[C@]1(CS(=O)(=O)N2CCC(CC2)OC2=CC=C(Cl)C=N2)NC(=O)NC1=O,24751752
9961,DB11962,GSK-1059615,small molecule,investigational,,O=C1NC(=O)\C(S1)=C\C1=CC=C2N=CC=C(C3=CC=NC=C3)C2=C1,23582824
9962,DB11963,Dacomitinib,small molecule,approved|investigational,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|OCT1 inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Protein Kinase Inhibitors|Quinazolines|Tyrosine Kinase Inhibitors|UGT1A1 Inhibitors",COC1=C(NC(=O)\C=C\CN2CCCCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1,11511120
9963,DB11964,Ilaprazole,small molecule,investigational,"Anti-Ulcer Agents|Benzimidazoles|Gastric Acid Lowering Agents|Heterocyclic Compounds, Fused-Ring|Proton Pump Inhibitors|Pyridines|Sulfoxides|Sulfur Compounds",COC1=C(C)C(CS(=O)C2=NC3=C(N2)C=CC(=C3)N2C=CC=C2)=NC=C1,214351
9964,DB11965,SJG-136,small molecule,investigational,"Benzazepines|Heterocyclic Compounds, Fused-Ring",COC1=CC2=C(C=C1OCCCOC1=CC3=C(C=C1OC)C(=O)N1CC(=C)C[C@H]1C=N3)N=C[C@@H]1CC(=C)CN1C2=O,393111
9965,DB11966,BMS-986094,small molecule,investigational,"Carbohydrates|Glycosides|Guanine Nucleotides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",COC1=C2N=CN([C@@H]3O[C@H](COP(=O)(N[C@@H](C)C(=O)OCC(C)(C)C)OC4=C5C=CC=CC5=CC=C4)[C@@H](O)[C@@]3(C)O)C2=NC(N)=N1,46700744
9966,DB11967,Binimetinib,small molecule,approved|investigational,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|MAP Kinase Kinase 1, antagonists & inhibitors|MAP Kinase Kinase 2, antagonists & inhibitors|P-glycoprotein substrates with narrow therapeutic index|Protein Kinase Inhibitors|UGT1A1 Substrates|UGT1A1 substrates with narrow therapeutic index",CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3F)=C(C=C12)C(=O)NOCCO,10288191
9967,DB11968,MK-7145,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CC1=C2COC(=O)C2=CC=C1[C@@H](O)CN1CCN(C[C@H](O)C2=C(C)C3=C(C=C2)C(=O)OC3)CC1,59568713
9968,DB11969,Uprosertib,small molecule,investigational,Amines|Polyamines,CN1N=CC(Cl)=C1C1=C(Cl)OC(=C1)C(=O)N[C@H](CN)CC1=CC=C(F)C(F)=C1,51042438
9969,DB11970,Burixafor,small molecule,investigational,,NC1=NC(NC[C@H]2CC[C@H](CNCCCNC3CCCCC3)CC2)=NC(=C1)N1CCN(CCP(O)(O)=O)CC1,44479007
9970,DB11971,Vilaprisan,small molecule,investigational,Fused-Ring Compounds,C[C@]12C[C@H](C3=CC=C(C=C3)S(C)(=O)=O)C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)C(F)(F)C(F)(F)F,50915138
9972,DB11973,Tesevatinib,small molecule,investigational,"Antineoplastic Agents|Aza Compounds|Enzyme Inhibitors|ErbB Receptors, antagonists & inhibitors|Heterocyclic Compounds, Fused-Ring|Protein Kinase Inhibitors|Receptor, EphB4, antagonists & inhibitors|Receptor, ErbB-2, antagonists & inhibitors|Tyrosine Kinase Inhibitors|Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitors",COC1=C(OC[C@H]2C[C@H]3CN(C)C[C@H]3C2)C=C2N=CN=C(NC3=CC=C(Cl)C(Cl)=C3F)C2=C1,10458325
9973,DB11974,PF-04691502,small molecule,investigational,"Phosphatidylinositol 3-Kinases, antagonists & inhibitors|Pyridines",COC1=CC=C(C=N1)C1=CC2=C(C)N=C(N)N=C2N([C@H]2CC[C@@H](CC2)OCCO)C1=O,25033539
9974,DB11975,TAK-448,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Biological Factors|Intercellular Signaling Peptides and Proteins|Neoplasm Proteins|Nerve Tissue Proteins|Neuropeptides|Peptides|Proteins|Tumor Suppressor Proteins",[H][C@]1(C[C@@H](O)CN1C(=O)[C@@H](CC1=CC=C(O)C=C1)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NNC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)NC)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(N)=O,46700761
9976,DB11977,Golvatinib,small molecule,investigational,"Amines|Pyridines|Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitors",CN1CCN(CC1)C1CCN(CC1)C(=O)NC1=CC(OC2=CC=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C(F)=C2)=CC=N1,16118392
9977,DB11978,Glasdegib,small molecule,approved|investigational,"Antineoplastic Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Benzene Derivatives|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Hedgehog Pathway Inhibitor|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|MATE 1 Inhibitors|MATE 2 Inhibitors|MATE inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|QTc Prolonging Agents|Smoothened Receptor Antagonists|UGT1A9 Substrates",CN1CC[C@H](C[C@@H]1C1=NC2=CC=CC=C2N1)NC(=O)NC1=CC=C(C=C1)C#N,25166913
9978,DB11979,Elagolix,small molecule,approved|investigational,"Antigonadotropins and Similar Agents|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Gonadotropin-releasing Hormone Antagonists|Hydrocarbons, Halogenated|OATP1B1/SLCO1B1 Substrates|P-glycoprotein inhibitors|P-glycoprotein substrates|UGT1A1 Substrates",COC1=CC=CC(=C1F)C1=C(C)N(CC2=C(C=CC=C2F)C(F)(F)F)C(=O)N(C[C@H](NCCCC(O)=O)C2=CC=CC=C2)C1=O,11250647
9979,DB11980,Carbon Black,small molecule,investigational,,,
9980,DB11981,Elamipretide,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Peptides",CC1=CC(O)=CC(C)=C1C[C@H](NC(=O)[C@H](N)CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,11764719
9981,DB11982,GDC-0623,small molecule,investigational,Nicotinic Acids|Pyridines,OCCONC(=O)C1=C(NC2=C(F)C=C(I)C=C2)N2C=NC=C2C=C1,42642654
9983,DB11984,Letaxaban,small molecule,investigational,Anticoagulants|Antithrombins|Enzyme Inhibitors|Factor Xa Inhibitors|Hematologic Agents|Protease Inhibitors|Pyrimidines|Serine Protease Inhibitors|Sulfur Compounds,O[C@H](CS(=O)(=O)C1=CC=C2C=C(Cl)C=CC2=C1)C(=O)N1CCC(CC1)N1CCCNC1=O,11641515
9984,DB11985,Dapaconazole,small molecule,investigational,,FC(F)(F)C1=CC=C(COC(CN2C=CN=C2)C2=CC=C(Cl)C=C2Cl)C=C1,51001696
9985,DB11986,Entrectinib,small molecule,approved|investigational,"Amides|Antineoplastic Agents|Benzene Derivatives|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Protein Kinase Inhibitors|Pyrazoles|QTc Prolonging Agents|Tyrosine Kinase Inhibitors",CN1CCN(CC1)C1=CC=C(C(=O)NC2=NNC3=CC=C(CC4=CC(F)=CC(F)=C4)C=C23)C(NC2CCOCC2)=C1,25141092
9986,DB11987,GSK-2018682,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Oxazoles",CC(C)OC1=C(Cl)C=C(C=N1)C1=NC(=NO1)C1=C2C=CN(CCCC(O)=O)C2=CC=C1,24988201
9988,DB11989,Benznidazole,small molecule,approved|investigational,"Agents Against Leishmaniasis and Trypanosomiasis|Anti-Infective Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Drugs that are Mainly Renally Excreted|Imidazoles|Immunologic Factors|Mutagens|Nitro Compounds|Nitroimidazole Derivatives|Noxae|Toxic Actions|Trypanocidal Agents",[O-][N+](=O)C1=NC=CN1CC(=O)NCC1=CC=CC=C1,31593
9989,DB11990,MK-0812,small molecule,investigational,,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](CN2CCC3=C(C2)C=C(C=N3)C(F)(F)F)(C1)C(C)C,71587773
9990,DB11991,Oprozomib,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Peptides",COC[C@H](NC(=O)[C@H](COC)NC(=O)C1=CN=C(C)S1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)[C@@]1(C)CO1,25067547
9991,DB11992,Omarigliptin,small molecule,investigational,"Agents causing angioedema|Blood Glucose Lowering Agents|DPP-IV Inhibitors|Heterocyclic Compounds, Fused-Ring",CS(=O)(=O)N1C=C2CN(CC2=N1)[C@H]1CO[C@@H]([C@@H](N)C1)C1=CC(F)=CC=C1F,46209133
9992,DB11993,PF-03463275,small molecule,investigational,"Aza Compounds|Glycine Plasma Membrane Transport Proteins, antagonists & inhibitors",[H][C@@]12CN(C)C[C@]1([H])[C@H]2CN(CC1=CC(Cl)=C(F)C=C1)C(=O)C1=CN(C)C=N1,44156901
9993,DB11994,Diacerein,small molecule,approved|investigational,"Anthracenes|Anti-Inflammatory Agents|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Musculo-Skeletal System|Quinones",CC(=O)OC1=CC=CC2=C1C(=O)C1=C(OC(C)=O)C=C(C=C1C2=O)C(O)=O,26248
9994,DB11995,Avatrombopag,small molecule,approved|investigational,"BCRP/ABCG2 Inhibitors|Blood and Blood Forming Organs|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (weak)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (weak)|Cytochrome P-450 Enzyme Inducers|Hemostatics|OAT3/SLC22A8 Inhibitors|P-glycoprotein substrates|Receptors, Thrombopoietin, agonists|Sulfur Compounds",OC(=O)C1CCN(CC1)C1=C(Cl)C=C(C=N1)C(=O)NC1=NC(C2=CC(Cl)=CS2)=C(S1)N1CCN(CC1)C1CCCCC1,9852519
9995,DB11996,Thymopentin,small molecule,investigational,"Adjuvants, Immunologic|Antineoplastic and Immunomodulating Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunologic Factors|Thymopoietins|Thymus Hormones",CC(C)C(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O,451417
9997,DB11998,Sorivudine,small molecule,investigational,"Anti-Infective Agents|Antiviral Agents|Arabinonucleosides|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",OC[C@H]1O[C@H]([C@@H](O)[C@@H]1O)N1C=C(\C=C\Br)C(=O)NC1=O,5282192
9998,DB11999,Vosaroxin,small molecule,investigational,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Heterocyclic Compounds, Fused-Ring|Sulfur Compounds",CN[C@H]1CN(C[C@@H]1OC)C1=CC=C2C(=O)C(=CN(C3=NC=CS3)C2=N1)C(O)=O,9952884
9999,DB12000,Apabetalone,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Quinazolines",COC1=CC2=C(C(=O)N=C(N2)C2=CC(C)=C(OCCO)C(C)=C2)C(OC)=C1,24871506
10000,DB12001,Abemaciclib,small molecule,approved|investigational,"Amines|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Kinase Inhibitor|MATE 1 Inhibitors|MATE 1 Substrates|MATE 1 Substrates with a Narrow Therapeutic Index|MATE 2 Inhibitors|MATE inhibitors|MATE substrates|OCT2 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Protein Kinase Inhibitors|Pyridines",CCN1CCN(CC2=CC=C(NC3=NC=C(F)C(=N3)C3=CC(F)=C4N=C(C)N(C(C)C)C4=C3)N=C2)CC1,46220502
10001,DB12002,AZD-4818,small molecule,investigational,,CNC(=O)C1=C(OC[C@@H](O)CN2CCC3(CC4=CC(Cl)=CC=C4O3)CC2)C=C(OC(C)(C)C(O)=O)C(Cl)=C1,24955007
10003,DB12004,Briciclib,small molecule,investigational,,COC1=CC(OC)=C(\C=C\S(=O)(=O)CC2=CC=C(OC)C(OP(O)(O)=O)=C2)C(OC)=C1,11248490
10004,DB12005,Nirogacestat,small molecule,investigational,"Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Amyloid Precursor Protein Secretases, antagonists & inhibitors|Naphthalenes",CCC[C@H](N[C@H]1CCC2=CC(F)=CC(F)=C2C1)C(=O)NC1=CN(C=N1)C(C)(C)CNCC(C)(C)C,46224413
10005,DB12006,BMS-906024,small molecule,investigational,"Benzazepines|Heterocyclic Compounds, Fused-Ring",CN1C2=CC=CC=C2C(=N[C@H](NC(=O)[C@H](CCC(F)(F)F)[C@H](CCC(F)(F)F)C(N)=O)C1=O)C1=CC=CC=C1,66550890
10006,DB12007,Isoflavone,small molecule,experimental,Drugs that are Mainly Renally Excreted,O=C1C(=COC2=CC=CC=C12)C1=CC=CC=C1,72304
10007,DB12008,Prexasertib,small molecule,investigational,,COC1=CC=CC(OCCCN)=C1C1=CC(NC2=CN=C(C=N2)C#N)=NN1,46700756
10008,DB12009,GW-406381,small molecule,investigational,,CCOC1=CC=C(C=C1)C1=NN2N=CC=CC2=C1C1=CC=C(C=C1)S(C)(=O)=O,9832687
10009,DB12010,Fostamatinib,small molecule,approved|investigational,BCRP/ABCG2 Inhibitors|Blood and Blood Forming Organs|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Hemostatics|Phosphodiesterase 5 Inhibitors|Tyrosine Kinase Inhibitors|UGT1A1 Inhibitors|UGT1A9 Substrates|Vasodilating Agents,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC,11671467
10010,DB12011,Fevipiprant,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Indoles",CC1=C(CC(O)=O)C2=CC=CN=C2N1CC1=CC=C(C=C1C(F)(F)F)S(C)(=O)=O,23582412
10011,DB12012,PF-04457845,small molecule,investigational,,FC(F)(F)C1=CC=C(OC2=CC=CC(C=C3CCN(CC3)C(=O)NC3=CC=CN=N3)=C2)N=C1,24771824
10012,DB12013,Axelopran,small molecule,investigational,"Acids, Carbocyclic|Alkaloids|Amides|Aza Compounds|Azabicyclo Compounds|Benzene Derivatives|Benzoates|Opioid Antagonists",NC(=O)C1=CC=CC(=C1)[C@@H]1C[C@@H]2CC[C@H](C1)N2CCN(CC1CCCCC1)C(=O)[C@@H](O)CO,67156338
10014,DB12015,Alpelisib,small molecule,approved|investigational,"Antineoplastic Agents|BCRP/ABCG2 Substrates|Breast Cancer Resistance Protein Inhibitors|Breast Neoplasms|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (moderate)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (moderate)|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|P-glycoprotein inhibitors|Phosphatidylinositol 3-Kinases, antagonists & inhibitors|Sulfur Compounds",CC1=C(SC(NC(=O)N2CCC[C@H]2C(N)=O)=N1)C1=CC(=NC=C1)C(C)(C)C(F)(F)F,56649450
10015,DB12016,Ponesimod,small molecule,investigational,"Receptors, Lysosphingolipid, antagonists & inhibitors|Sulfur Compounds",CCC\N=C1/S\C(=C/C2=CC=C(OC[C@H](O)CO)C(Cl)=C2)C(=O)N1C1=CC=CC=C1C,11363176
10016,DB12017,Ozagrel,small molecule,investigational,"Acids, Acyclic|Acrylates|Cardiovascular Agents|Enzyme Inhibitors|Fibrin Modulating Agents|Hematologic Agents|Histamine Agents|Neurotransmitter Agents|Thromboxane-A Synthase, antagonists & inhibitors",OC(=O)\C=C\C1=CC=C(CN2C=CN=C2)C=C1,5282440
10018,DB12019,Tesetaxel,small molecule,investigational,Cyclodecanes|Cycloparaffins|Diterpenes|Terpenes,CN(C)C[C@@H]1O[C@H]2[C@@H](O1)[C@]1(C)CC[C@H]3OC[C@@]3(OC(C)=O)[C@H]1[C@H](OC(=O)C1=CC=CC=C1)[C@]1(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C3=C(F)C=CC=N3)C(C)=C2C1(C)C,6918574
10019,DB12020,Tecovirimat,small molecule,approved|investigational,"Acids, Carbocyclic|Amides|Antiviral Agents|Benzene Derivatives|Benzoates|Heterocyclic Compounds, Fused-Ring|UGT1A1 Substrates|UGT1A4 substrates",FC(F)(F)C1=CC=C(C=C1)C(=O)NN1C(=O)[C@H]2[C@H]([C@H]3C=C[C@@H]2[C@@H]2C[C@H]32)C1=O,16124688
10020,DB12021,Dinaciclib,small molecule,investigational,"Cyclin-Dependent Kinases, antagonists & inhibitors|Pyridines",CCC1=C2N=C(C=C(NCC3=CC=C[N+]([O-])=C3)N2N=C1)N1CCCC[C@H]1CCO,46926350
10021,DB12022,Evatanepag,small molecule,investigational,,CC(C)(C)C1=CC=C(CN(CC2=CC=CC(OCC(O)=O)=C2)S(=O)(=O)C2=CC=CN=C2)C=C1,9890801
10023,DB12024,PF-04418948,small molecule,investigational,"Azetines|Receptors, Prostaglandin E, EP2 Subtype",COC1=CC=C2C=C(OCC3(CN(C3)C(=O)C3=CC=C(F)C=C3)C(O)=O)C=CC2=C1,25114442
10024,DB12025,Triptolide,small molecule,investigational,"Adrenal Cortex Hormones|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antispermatogenic Agents|Contraceptive Agents, Male|Ethers|Ethers, Cyclic|Hormonal Contraceptives for Systemic Use|Immunologic Factors|Immunosuppressive Agents|Noxae|Reproductive Control Agents|Terpenes|Toxic Actions|Tripterygium",CC(C)[C@]12O[C@H]1[C@@H]1O[C@]11[C@]3(O[C@H]3C[C@H]3C4=C(CC[C@]13C)C(=O)OC4)[C@@H]2O,107985
10025,DB12026,Voxilaprevir,small molecule,approved|investigational,Amides|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Antivirals for treatment of HCV infections|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Direct Acting Antivirals|HCV NS3/4A Protease Inhibitors|NS3/4A Protease Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 inhibitors|OATP1B3 substrates|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Sulfones|Sulfur Compounds,CC[C@@H]1[C@@H]2CN([C@@H]1C(=O)N[C@@]1(C[C@H]1C(F)F)C(=O)NS(=O)(=O)C1(C)CC1)C(=O)[C@@H](NC(=O)O[C@@H]1C[C@H]1CCCCC(F)(F)C1=C(O2)N=C2C=C(OC)C=CC2=N1)C(C)(C)C,89921642
10026,DB12027,Serdemetan,small molecule,investigational,"Amines|Biogenic Amines|Biogenic Monoamines|Heterocyclic Compounds, Fused-Ring|Indoles|Radiation-Sensitizing Agents",C(CC1=CNC2=CC=CC=C12)NC1=CC=C(NC2=CC=NC=C2)C=C1,11609586
10027,DB12028,Broxuridine,small molecule,investigational,"Anti-Infective Agents|Antimetabolites|Antineoplastic Agents|Carbohydrates|Deoxyribonucleosides|Deoxyuridine|Glycosides|Noxae|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Radiation-Sensitizing Agents|Ribonucleosides|Toxic Actions",OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(Br)C(=O)NC1=O,6035
10028,DB12029,Chlorogenic Acid,small molecule,investigational,"Acids, Carbocyclic|Cinnamates|Cyclohexanecarboxylic Acids|Cyclohexanes|Cycloparaffins",O[C@@H]1C[C@](O)(C[C@@H](OC(=O)\C=C\C2=CC(O)=C(O)C=C2)[C@@H]1O)C(O)=O,1794427
10029,DB12030,Fluorescein lisicol,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Spiro Compounds|Xanthenes",C[C@H](CCC(=O)N[C@@H](CCCCNC(=S)NC1=CC=C(C2C3=CC=C(O)C=C3OC3=C2C=CC(O)=C3)C(=C1)C(O)=O)C(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,76958588
10030,DB12031,Ammonio methacrylate copolymer type A,small molecule,investigational,,,
10031,DB12032,Atagabalin,small molecule,investigational,"Acids, Acyclic|Cycloparaffins|Fatty Acids|Fatty Acids, Volatile|Lipids",C[C@H]1CC(CN)(CC(O)=O)C[C@@H]1C,9794485
10033,DB12035,Sarecycline,small molecule,approved|investigational,Anti-Acne Preparations|Anti-Acne Preparations for Systemic Use|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Dermatologicals|Naphthacenes|P-glycoprotein inhibitors|Tetracyclines,[H][C@@]12CC3=C(CN(C)OC)C=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2,54681908
10034,DB12036,Naquotinib,small molecule,investigational,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,CCC1=C(O[C@@H]2CCN(C2)C(=O)C=C)N=C(NC2=CC=C(C=C2)N2CCC(CC2)N2CCN(C)CC2)C(=N1)C(N)=O,71667668
10035,DB12037,Vedroprevir,small molecule,investigational,"Antiviral Agents|Heterocyclic Compounds, Fused-Ring",CC[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)O[C@@H]1C[C@@H]2C[C@@H]2C1)C(C)(C)C)OC1=C2C=CC(OCCN3CCOCC3)=C(Cl)C2=NC(=C1)C1=CSC(NC(C)C)=N1)C(O)=O,25167947
10037,DB12039,Epicatechin,small molecule,investigational,"Benzopyrans|Catechin|Chromans|Chromones|Flavonoids|Heterocyclic Compounds, Fused-Ring|Pyrans",O[C@@H]1CC2=C(O)C=C(O)C=C2O[C@@H]1C1=CC(O)=C(O)C=C1,72276
10038,DB12040,2-octyl cyanoacrylate,small molecule,investigational,"Acids, Acyclic|Acrylates|Compounds used in a research, industrial, or household setting|Equipment and Supplies|Macromolecular Substances|Nitriles|Polymers|Surgical Equipment|Surgical Fixation Devices|Tissue Adhesives",CCCCCCC(C)OC(=O)C(=C)C#N,9815689
10039,DB12041,Mapracorat,small molecule,investigational,"Alcohols|Fatty Alcohols|Heterocyclic Compounds, Fused-Ring|Lipids|Receptors, Glucocorticoid, agonists",CC1=CC=C2C(NC[C@](O)(CC(C)(C)C3=CC(F)=CC4=C3OCC4)C(F)(F)F)=CC=CC2=N1,24795088
10040,DB12042,Ibodutant,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Oligopeptides|Peptides|Receptors, Neurokinin-2, antagonists & inhibitors|Sulfur Compounds",CC1=CC=C2C=C(SC2=C1)C(=O)NC1(CCCC1)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)NCC1CCN(CC2CCOCC2)CC1,11527495
10041,DB12043,Sepetaprost,small molecule,investigational,"Ethers|Ethers, Cyclic",CC(C)OC(=O)CCC[C@H]1CC[C@H]2[C@H](C[C@@H](O)[C@@H]2\C=C\[C@@H](O)COC2=CC(F)=CC=C2F)OC1,50902259
10042,DB12044,MK-0893,small molecule,investigational,"Alanine|Amino Acids|Amino Acids, Peptides, and Proteins|Receptors, Glucagon, antagonists & inhibitors",COC1=CC2=CC=C(C=C2C=C1)C1=CC(=NN1[C@@H](C)C1=CC=C(C=C1)C(=O)NCCC(O)=O)C1=CC(Cl)=CC(Cl)=C1,11570626
10043,DB12045,Mericitabine,small molecule,investigational,"Carbohydrates|Deoxyribonucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",CC(C)C(=O)OC[C@H]1O[C@@H](N2C=CC(N)=NC2=O)[C@](C)(F)[C@@H]1OC(=O)C(C)C,16122663
10044,DB12046,Atopaxar,small molecule,investigational,"Receptors, Thrombin, antagonists & inhibitors",CCOC1=CC2=C(C(=N)N(CC(=O)C3=CC(=C(OC)C(=C3)N3CCOCC3)C(C)(C)C)C2)C(F)=C1OCC,10459564
10045,DB12047,Ganetespib,small molecule,investigational,"HSP90 Heat-Shock Proteins, antagonists & inhibitors",CC(C)C1=C(O)C=C(O)C(=C1)C1=NNC(=O)N1C1=CC2=C(C=C1)N(C)C=C2,23624255
10046,DB12048,Savolitinib,small molecule,investigational,Tyrosine Kinase Inhibitors,C[C@H](N1N=NC2=NC=C(N=C12)C1=CN(C)N=C1)C1=CN2C=CN=C2C=C1,68289010
10047,DB12049,Dasolampanel etibutil,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CCC(CC)COC(=O)[C@@H]1C[C@H]2C[C@H](CC[C@H]2CN1)OC1=CC=CC(Cl)=C1C1=NN=NN1,53307207
10048,DB12050,LY-3039478,small molecule,investigational,,C[C@H](NC(=O)CCC(F)(F)F)C(=O)N[C@H]1C2=CC=CC=C2C2=CC=CN=C2N(CCO)C1=O,71236992
10049,DB12051,Setrobuvir,small molecule,investigational,"Amides|Heterocyclic Compounds, Fused-Ring|Quinolines|Sulfonamides|Sulfones|Sulfur Compounds",CS(=O)(=O)NC1=CC=C2NC(=NS(=O)(=O)C2=C1)C1=C(O)[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2N(CC2=CC=C(F)C=C2)C1=O,126843190
10050,DB12052,Icariin,small molecule,investigational,"Benzopyrans|Chromones|Drugs, Chinese Herbal|Heterocyclic Compounds, Fused-Ring|Pyrans",COC1=CC=C(C=C1)C1=C(O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)C(=O)C2=C(O)C=C(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C(CC=C(C)C)=C2O1,5318997
10052,DB12054,BQ-123,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Antihypertensive Agents|Cardiovascular Agents|Endothelin Receptor Antagonists|Peptides",CC(C)C[C@@H]1NC(=O)[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CC(O)=O)NC(=O)[C@@H](CC2=CNC3=CC=CC=C23)NC1=O)C(C)C,443289
10053,DB12055,MK-0767,small molecule,investigational,Sulfur Compounds,COC1=CC=C(CC2OC(=O)NC2=O)C=C1C(=O)NCC1=CC=C(C=C1)C(F)(F)F,56842109
10055,DB12057,ORM-12741,small molecule,investigational,"Adrenergic alpha-2 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Heterocyclic Compounds, Fused-Ring|Quinolizines",COC[C@@]1(C)CCCN2CCC3=C(OC4=CC=CC=C34)[C@H]12,71301276
10056,DB12058,Recoflavone,small molecule,investigational,"Benzopyrans|Chromones|Heterocyclic Compounds, Fused-Ring|Pyrans",COC1=CC=C(C=C1OC)C1=CC(=O)C2=C(OC)C=C(OCC(O)=O)C=C2O1,9952125
10057,DB12059,JNJ-40411813,small molecule,investigational,Pyridines,CCCCN1C=CC(N2CCC(CC2)C2=CC=CC=C2)=C(Cl)C1=O,25195461
10058,DB12060,RRx-001,small molecule,investigational,Azetines|Carbon Radioisotopes,[O-][N+](=O)C1(CN(C1)C(=O)CBr)[N+]([O-])=O,15950826
10059,DB12061,Pardoprunox,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CN1CCN(CC1)C1=C2OC(=O)NC2=CC=C1,6918525
10060,DB12062,Volasertib,small molecule,investigational,"Antineoplastic Agents|Heterocyclic Compounds, Fused-Ring",CC[C@H]1N(C(C)C)C2=NC(NC3=CC=C(C=C3OC)C(=O)N[C@H]3CC[C@@H](CC3)N3CCN(CC4CC4)CC3)=NC=C2N(C)C1=O,10461508
10061,DB12063,CERC-301,small molecule,investigational,"Receptors, N-Methyl-D-Aspartate, antagonists & inhibitors",CC1=CC=C(COC(=O)N2CC[C@H](CNC3=NC=CC=N3)[C@H](F)C2)C=C1,11394238
10062,DB12064,BMS-777607,small molecule,investigational,Amines|Pyridines,CCOC1=C(C(=O)NC2=CC=C(OC3=C(Cl)C(N)=NC=C3)C(F)=C2)C(=O)N(C=C1)C1=CC=C(F)C=C1,24794418
10063,DB12065,Radalbuvir,small molecule,investigational,Sulfur Compounds,CC1=CC[C@@H](CC1)C(=O)N([C@H]1CC[C@](O)(CO[C@H]2CCOC2)CC1)C1=C(SC(=C1)C#CC(C)(C)C)C(O)=O,53259022
10064,DB12066,Orteronel,small molecule,investigational,,CNC(=O)C1=CC=C2C=C(C=CC2=C1)[C@@]1(O)CCN2C=NC=C12,9796590
10065,DB12067,BMS-394136,small molecule,investigational,,CC1=C([C@H](N2N=CC=C2N1)C1=CC=C(Cl)C(Cl)=C1)C(=O)N1CCC[C@H]1C1=CC=C(F)C=C1,11583651
10066,DB12068,T-900607,small molecule,investigational,Amides|Sulfones|Sulfur Compounds,COC1=CC=C(NS(=O)(=O)C2=C(F)C(F)=C(F)C(F)=C2F)C=C1NC(N)=O,9812416
10067,DB12069,Sovaprevir,small molecule,investigational,,COC1=CC2=NC(=CC(O[C@@H]3C[C@H](N(C3)C(=O)[C@@H](CC(=O)N3CCCCC3)C(C)(C)C)C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C3CC3)=C2C=C1)C1=CC=CC=C1,53362096
10068,DB12070,Letermovir,small molecule,approved|investigational,"Acids, Acyclic|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BCRP/ABCG2 Inhibitors|BSEP/ABCB11 Inhibitors|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (moderate)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Cytomegalovirus DNA Terminase Complex Inhibitor|Direct Acting Antivirals|DNA Terminase Complex Inhibitors|Fatty Acids|Fatty Acids, Volatile|Heterocyclic Compounds, Fused-Ring|Lipids|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|UGT1A1 Substrates|UGT1A3 substrates",COC1=CC=CC(=C1)N1CCN(CC1)C1=NC2=C(C=CC=C2F)[C@H](CC(O)=O)N1C1=CC(=CC=C1OC)C(F)(F)F,
10069,DB12071,Vabicaserin,small molecule,investigational,"Antidepressive Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Agonists|Serotonin 5-HT2C Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists",C1C[C@H]2CN3CCNCC4=C3C(=CC=C4)[C@H]2C1,11521822
10070,DB12072,Orantinib,small molecule,investigational,"Acids, Acyclic|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Heterocyclic Compounds, Fused-Ring|Lipids|Protein Kinase Inhibitors",CC1=C(CCC(O)=O)C(C)=C(N1)\C=C1/C(=O)NC2=CC=CC=C12,5329099
10071,DB12073,Albaconazole,small molecule,investigational,"Anti-Infective Agents|Antifungal Agents|Azole Antifungals|Heterocyclic Compounds, Fused-Ring|Stereoisomerism|Triazoles",C[C@@H](N1C=NC2=CC(Cl)=CC=C2C1=O)[C@](O)(CN1C=NC=N1)C1=CC=C(F)C=C1F,208952
10072,DB12074,Censavudine,small molecule,investigational,"Anti-HIV Agents|Carbohydrates|Deoxyribonucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Reverse Transcriptase Inhibitors",CC1=CN([C@@H]2O[C@](CO)(C=C2)C#C)C(=O)NC1=O,3008897
10074,DB12076,Surotomycin,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Lipids|Peptides",,
10076,DB12078,Enobosarm,small molecule,investigational,Amides|Amines|Aniline Compounds,C[C@](O)(COC1=CC=C(C=C1)C#N)C(=O)NC1=CC=C(C#N)C(=C1)C(F)(F)F,11326715
10077,DB12079,Gefarnate,small molecule,investigational,"Alimentary Tract and Metabolism|Anti-Ulcer Agents|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Fatty Acids|Fatty Acids, Unsaturated|Gastrointestinal Agents|Lipids|Terpenes",[H]\C(CC\C(C)=C(/[H])CCC(=O)OC\C([H])=C(/C)CCC=C(C)C)=C(\C)CCC=C(C)C,5282182
10078,DB12080,Ritobegron,small molecule,investigational,"Acids, Acyclic|Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-3 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Ethylamines|Fatty Acids|Fatty Acids, Volatile|Lipids|Neurotransmitter Agents|Phenethylamines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetics",C[C@H](NCCC1=C(C)C=C(OCC(O)=O)C(C)=C1)[C@H](O)C1=CC=C(O)C=C1,9820882
10079,DB12081,Anecortave,small molecule,investigational,"11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Adrenal Cortex Hormones|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Antineovascularisation Agents|Fused-Ring Compounds|Growth Inhibitors|Growth Substances|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Ocular Vascular Disorder Agents|Ophthalmologicals|Pregnanes|Pregnenediones|Pregnenes|Sensory Organs|Steroids",C[C@]12CC=C3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO,7074810
10080,DB12082,Vesnarinone,small molecule,investigational,"Adjuvants, Immunologic|Anti-Infective Agents|Antineoplastic Agents|Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Immunologic Factors|Phosphodiesterase Inhibitors|Protective Agents",COC1=C(OC)C=C(C=C1)C(=O)N1CCN(CC1)C1=CC=C2NC(=O)CCC2=C1,5663
10081,DB12083,Mafosfamide,small molecule,investigational,"Acids|Acids, Noncarboxylic|Adjuvants, Immunologic|Anions|Antineoplastic Agents|Electrolytes|Hydrocarbons, Halogenated|Immunologic Factors|Ions|Mustard Compounds|Nitrogen Mustard Compounds|Organophosphorus Compounds|Phosphoramide Mustards|Phosphoramides|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds",OS(=O)(=O)CCS[C@H]1CCO[P@@](=O)(N1)N(CCCl)CCCl,76968809
10082,DB12084,ADP-597,small molecule,investigational,,COC1=C(NC2=C(C)N=C(C=C2)S(C)(=O)=O)N=CN=C1OC1CCN(CC1)C(=O)OC(C)C,11691484
10083,DB12085,LCL-161,small molecule,investigational,"Antineoplastic Agents|Proto-Oncogene Proteins c-bcl-2, antagonists & inhibitors|Sulfur Compounds",CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C1=NC(=CS1)C(=O)C1=CC=C(F)C=C1,24737642
10084,DB12086,Oxitropium,small molecule,investigational,"Agents producing tachycardia|Alkaloids|Anticholinergic Agents|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Drugs for Obstructive Airway Diseases|Muscarinic Antagonists|Parasympatholytics|Peripheral Nervous System Agents|Synthetic Anticholinergics, Quaternary Ammonium Compounds|Tropanes",CC[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1,6917866
10085,DB12087,Vanillyl alcohol,small molecule,investigational,Alcohols|Benzene Derivatives|Benzyl Compounds,COC1=C(O)C=CC(CO)=C1,62348
10086,DB12088,TT-232,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Pancreatic Hormones|Peptide Hormones|Peptides|Pituitary Hormone Release Inhibiting Hormones|Proteins",C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=CC=CC=C23)C(=O)N[C@@H](CCCCN)C(=O)N1)C(N)=O,6918265
10089,DB12091,Gadolinium,small molecule,approved|investigational,"Anti-Inflammatory Agents|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Elements|Lanthanoid Series Elements|Metals|Metals, Rare Earth",[Gd],23982
10090,DB12092,Naftopidil,small molecule,investigational,Adrenergic Agents|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Antiarrhythmic agents|Antihypertensive Agents|Antiplatelet agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Hematologic Agents|Membrane Transport Modulators|Neurotransmitter Agents|Vasodilating Agents,COC1=CC=CC=C1N1CCN(CC(O)COC2=CC=CC3=CC=CC=C23)CC1,4418
10091,DB12093,Tetrahydropalmatine,small molecule,investigational,"Adrenergic Agents|Agents causing hyperkalemia|Alkaloids|Analgesics|Analgesics, Non-Narcotic|Antiarrhythmic agents|Antihypertensive Agents|Antipsychotic Agents|Benzylisoquinolines|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Membrane Transport Modulators|Neurotoxic agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|Psychotropic Drugs|QTc Prolonging Agents|Sensory System Agents|Tranquilizing Agents|Vasodilating Agents",COC1=CC=C2C[C@@H]3N(CCC4=CC(OC)=C(OC)C=C34)CC2=C1OC,72301
10092,DB12094,Semapimod,small molecule,investigational,"Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antirheumatic Agents|Central Nervous System Agents|Hydrazines|Immunologic Factors|Peripheral Nervous System Agents|Sensory System Agents",C\C(=N/NC(N)=N)C1=CC(=CC(NC(=O)CCCCCCCCC(=O)NC2=CC(=CC(=C2)C(\C)=N\NC(N)=N)C(\C)=N\NC(N)=N)=C1)C(\C)=N\NC(N)=N,5745214
10093,DB12095,Telotristat ethyl,small molecule,approved|investigational,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Antidiarrheals|Tryptophan Hydroxylase Inhibitor",CCOC(=O)[C@@H](N)CC1=CC=C(C=C1)C1=NC(N)=NC(O[C@H](C2=CC=C(Cl)C=C2N2C=CC(C)=N2)C(F)(F)F)=C1,25025298
10094,DB12096,PF-05175157,small molecule,investigational,,CC(C)N1N=CC2=C1C(=O)CC1(CCN(CC1)C(=O)C1=CC=C3N=C(C)NC3=C1)C2,52934180
10095,DB12097,Mannitol busulfan,small molecule,approved|investigational,Agents causing hyperkalemia,CS(=O)(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)COS(C)(=O)=O,142775
10096,DB12098,L-Baclofen,small molecule,investigational,,NC[C@@H](CC(O)=O)C1=CC=C(Cl)C=C1,44600
10097,DB12099,"UK-396,082",small molecule,investigational,"Amino Acids, Peptides, and Proteins",[H][C@](CCCN)(CC1=CN(CCC)C=N1)C(O)=O,11241908
10098,DB12100,Abediterol,small molecule,investigational,"Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Heterocyclic Compounds, Fused-Ring|Quinolines",O[C@@H](CNCCCCCCOCC(F)(F)C1=CC=CC=C1)C1=C2C=CC(=O)NC2=C(O)C=C1,11962616
10099,DB12101,CC-220,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",O=C1N(CC2=C1C=CC=C2OCC1=CC=C(CN2CCOCC2)C=C1)[C@H]1CCC(=O)NC1=O,67335295
10102,DB12105,Imagabalin,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Anti-Anxiety Agents|Central Nervous System Depressants",CCC[C@@H](C)C[C@H](N)CC(O)=O,10236037
10103,DB12106,PF-06305591,small molecule,investigational,,C[C@H]([C@H](N)C1=NC2=CC=C(C=C2N1)C(C)(C)C)C(N)=O,71666749
10104,DB12107,Vaborbactam,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactamase Inhibitors|Boron Compounds|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors",OB1O[C@H](CC(O)=O)CC[C@@H]1NC(=O)CC1=CC=CS1,56649692
10105,DB12108,Taselisib,small molecule,investigational,"Antineoplastic Agents|Azepines|Phosphatidylinositol 3-Kinases, antagonists & inhibitors",CC(C)N1N=C(C)N=C1C1=CN2CCOC3=CC(=CC=C3C2=N1)C1=CN(N=C1)C(C)(C)C(N)=O,51001932
10106,DB12109,CPI-613,small molecule,investigational,"Acids|Acids, Acyclic|Acids, Noncarboxylic|Anions|Electrolytes|Fatty Acids|Gases|Hydrogen Sulfide|Ions|Lipids|Sulfur Compounds",OC(=O)CCCCC(CCSCC1=CC=CC=C1)SCC1=CC=CC=C1,24770514
10107,DB12110,m-Chlorophenylpiperazine,small molecule,investigational,Antidepressive Agents|Central Nervous System Depressants|Neurotransmitter Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists,ClC1=CC(=CC=C1)N1CCNCC1,1355
10108,DB12111,MK-212,small molecule,investigational,Antidepressive Agents|Central Nervous System Depressants|Neurotransmitter Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Agonists,ClC1=NC(=CN=C1)N1CCNCC1,107992
10109,DB12112,Zuretinol acetate,small molecule,investigational,"Adjuvants, Immunologic|Alkenes|Anticarcinogenic Agents|Biological Factors|Carotenoids|Compounds used in a research, industrial, or household setting|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Immunologic Factors|Pigments, Biological|Polyenes|Protective Agents|Retinoids|Terpenes",CC(=O)OC\C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C,10245972
10110,DB12113,CE-224535,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Purinergic P2X Receptor Agonists|Pyrimidines|Pyrimidinones",COC[C@H](O)CN1C(=O)C=NN(C1=O)C1=CC=C(Cl)C(=C1)C(=O)NCC1(O)CCCCCC1,11547499
10111,DB12114,Poziotinib,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",COC1=C(OC2CCN(CC2)C(=O)C=C)C=C2C(NC3=CC=C(Cl)C(Cl)=C3F)=NC=NC2=C1,25127713
10112,DB12115,AZD-9164,small molecule,investigational,"Receptor, Muscarinic M3, antagonists & inhibitors",C[C@@](N1CCCCC1)(C(=O)O[C@H]1C[N+]2(CCC3=CC=C(F)C=C3)CCC1CC2)C1=CC=CC=C1,44517831
10113,DB12116,Epigallocatechin gallate,small molecule,investigational,"Anticarcinogenic Agents|Antimutagenic Agents|Antineoplastic Agents|Antioxidants|Benzopyrans|Central Nervous System Agents|Chromans|Chromones|Compounds used in a research, industrial, or household setting|Flavonoids|Heterocyclic Compounds, Fused-Ring|Neuroprotective Agents|Protective Agents|Pyrans|Radiation-Protective Agents|Urokinase-Type Plasminogen Activator, antagonists & inhibitors",OC1=CC(O)=C2C[C@@H](OC(=O)C3=CC(O)=C(O)C(O)=C3)[C@H](OC2=C1)C1=CC(O)=C(O)C(O)=C1,65064
10114,DB12117,Mitometh,small molecule,investigational,"Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated",CC(Cl)(Cl)C(C1=CC=C(Cl)C=C1)C1=CC=CC=C1Cl,129873
10117,DB12120,Avoralstat,small molecule,investigational,,COC1=CC(=C(C=C1C=C)C(=O)NC1=CC=C(C=C1)C(N)=N)C1=CC=C(N=C1C(O)=O)C(=O)NCC1CC1,86566678
10118,DB12121,Entospletinib,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Pyrazoles",C1CN(CCO1)C1=CC=C(NC2=NC(=CN3C=CN=C23)C2=CC3=C(C=NN3)C=C2)C=C1,59473233
10119,DB12122,Figopitant,small molecule,investigational,"Acetamides|Acetates|Acids, Acyclic|Amides|Benzene Derivatives|Fatty Acids|Fatty Acids, Volatile|Lipids",CN(CCC1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C(=O)[C@@H](N1CCN(CC2CC2)CC1)C1=CC=CC=C1,9914857
10120,DB12123,Cinepazide,small molecule,investigational,Cardiovascular Agents|Peripheral Vasodilators|Vasodilating Agents,COC1=CC(\C=C\C(=O)N2CCN(CC(=O)N3CCCC3)CC2)=CC(OC)=C1OC,5282459
10121,DB12124,Namitecan,small molecule,investigational,"Alkaloids|Antineoplastic Agents|Antineoplastic Agents, Phytogenic",CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=CC=CC1=C3\C=N\OCCN)C2=O,10950142
10122,DB12125,Dianicline,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",C1C[C@@]23C[N@@]1CC[C@@H]2OC1=C(C3)N=CC=C1,10176764
10123,DB12126,Bradykinin,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Autacoids|Biological Factors|Bradykinin, agonists|Bradykinin, antagonists & inhibitors|Cardiovascular Agents|Inflammation Mediators|Intercellular Signaling Peptides and Proteins|Kinins|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptides|Proteins|Vasodilating Agents",N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O,439201
10124,DB12127,Sultamicillin,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Penicillin G|Penicillins|Sulfur Compounds",[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(=O)OCOC(=O)[C@@H]1N2C(=O)C[C@@]2([H])S(=O)(=O)C1(C)C,444022
10125,DB12128,Ulimorelin,small molecule,investigational,,C[C@@H]1CN[C@@H](C2CC2)C(=O)N(C)[C@H](C)C(=O)N[C@H](CC2=CC=C(F)C=C2)C(=O)NCCCC2=CC=CC=C2O1,11526696
10126,DB12129,Tideglusib,small molecule,investigational|withdrawn,"Glycogen Synthase Kinase 3, antagonists & inhibitors|Sulfur Compounds|Thiazoles",O=C1SN(C(=O)N1CC1=CC=CC=C1)C1=C2C=CC=CC2=CC=C1,11313622
10127,DB12130,Lorlatinib,small molecule,approved|investigational,Amides|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Kinase Inhibitor|Lactams|Protein Kinase Inhibitors|UGT1A3 substrates,C[C@H]1OC2=C(N)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=C1C=C(F)C=C2,71731823
10128,DB12131,Vinpocetine,small molecule,investigational,"Agents causing hyperkalemia|Alkaloids|Antiarrhythmic agents|Anticonvulsants|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|Nervous System|Neuroprotective Agents|Nootropic Agents|Phosphodiesterase Inhibitors|Protective Agents|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Secologanin Tryptamine Alkaloids|Vasodilating Agents",[H][C@]12N3CCC[C@@]1(CC)C=C(N1C4=CC=CC=C4C(CC3)=C21)C(=O)OCC,443955
10130,DB12133,BLXA4,small molecule,investigational,,CCCCC[C@@H](O)\C=C\C1=CC=CC=C1\C=C\[C@@H](O)[C@@H](O)CCCC(O)=O,58185197
10131,DB12134,Gepotidacin,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Naphthalenes",O=C1C=CC2=C3N1C[C@@H](CN1CCC(CC1)NCC1=CC4=C(OCCC4)C=N1)N3C(=O)C=N2,25101874
10132,DB12135,Elubrixin,small molecule,investigational,"Amides|Benzene Derivatives|Receptors, Interleukin-8B, antagonists & inhibitors|Sulfones|Sulfur Compounds",OC1=C(C(Cl)=CC=C1NC(=O)NC1=C(Cl)C(F)=CC=C1)S(=O)(=O)N1CCNCC1,10479502
10134,DB12137,GSK-256066,small molecule,investigational,"Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Phosphodiesterase 4 Inhibitors|Phosphodiesterase Inhibitors|Quinolines|Sulfur Compounds",COC1=CC=CC(NC2=C(C=NC3=C(C)C=C(C=C23)S(=O)(=O)C2=CC(=CC=C2)C(=O)N(C)C)C(N)=O)=C1,9827968
10135,DB12138,PF-03715455,small molecule,investigational,"Aza Compounds|p38 Mitogen-Activated Protein Kinases, antagonists & inhibitors",CC(C)(C)C1=NN(C(NC(=O)NCC2=CC=CC=C2SC2=CN3C(C=C2)=NN=C3C2=CC=CC=C2SCCO)=C1)C1=CC=C(O)C(Cl)=C1,11714580
10136,DB12139,Alisporivir,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Cyclosporin Derivatives|Peptides|Peptides, Cyclic",CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(CC)C(=O)[C@@H](C)N(C)C1=O)C(C)C,11513676
10137,DB12140,Dilmapimod,small molecule,investigational,"p38 Mitogen-Activated Protein Kinases, antagonists & inhibitors|Pyridines",CC1=CC(F)=CC=C1C1=C2C=CC(=O)N(C2=NC(NC(CO)CO)=N1)C1=C(F)C=CC=C1F,10297982
10138,DB12141,Gilteritinib,small molecule,approved|investigational,Amines|Antineoplastic Agents|BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|MATE 1 Inhibitors|MATE inhibitors|Moderate Risk QTc-Prolonging Agents|OCT1 inhibitors|P-glycoprotein substrates|QTc Prolonging Agents|Tyrosine Kinase Inhibitors,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O,49803313
10140,DB12143,Rezatomidine,small molecule,investigational,,C[C@H](C1=CNC(=S)N1)C1=C(C)C(C)=CC=C1,11287722
10141,DB12144,BMS-275183,small molecule,investigational,,COC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]1(C)[C@@H]2[C@H](OC(=O)C2=CC=CC=C2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(C)=C([C@@H](OC(C)=O)C1=O)C2(C)C,6918594
10142,DB12145,AZD-0328,small molecule,investigational,"Receptors, Nicotinic",C1C2=C(O[C@]11CN3CCC1CC3)N=CC=C2,9794392
10143,DB12146,Rigosertib,small molecule,investigational,"Amino Acids|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors|Sulfur Compounds",COC1=CC(OC)=C(\C=C\S(=O)(=O)CC2=CC=C(OC)C(NCC(O)=O)=C2)C(OC)=C1,6918736
10144,DB12147,Erdafitinib,small molecule,approved|investigational,"Antineoplastic Agents|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|OCT2 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Receptors, Fibroblast Growth Factor, antagonists & inhibitors|Tumor Suppressor Proteins|Tyrosine Kinase Inhibitors",COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC=C2N=CC(=NC2=C1)C1=CN(C)N=C1,67462786
10145,DB12148,Menatetrenone,small molecule,investigational,Coagulants|Diterpenes|Hematologic Agents|Hemostatics|Naphthalenes|Naphthoquinones|Phytol|Quinones|Terpenes|Vitamin K|Vitamins|Vitamins (Fat Soluble),[H]\C(CC\C(C)=C(/[H])CC\C(C)=C(/[H])CC1=C(C)C(=O)C2=CC=CC=C2C1=O)=C(\C)CCC=C(C)C,5282367
10146,DB12149,S-3304,small molecule,investigational,"Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Matrix Metalloproteinase Inhibitors|Protease Inhibitors|Sulfur Compounds",CC1=CC=C(C=C1)C#CC1=CC=C(S1)S(=O)(=O)N[C@H](CC1=CNC2=CC=CC=C12)C(O)=O,10718956
10147,DB12150,Pelubiprofen,small molecule,investigational,"Acids, Carbocyclic",[H]\C(C1=CC=C(C=C1)C(C)C(O)=O)=C1\CCCCC1=O,5282203
10148,DB12151,Brincidofovir,small molecule,investigational,Drugs that are Mainly Renally Excreted|Nephrotoxic agents|Organophosphorus Compounds|Pyrimidines|Pyrimidinones,CCCCCCCCCCCCCCCCOCCCOP(O)(=O)CO[C@H](CO)CN1C=CC(N)=NC1=O,483477
10150,DB12153,Citicoline,small molecule,approved|experimental,"Alcohols|Amines|Amino Alcohols|Ammonium Compounds|Carbohydrates|Central Nervous System Agents|Cytidine Diphosphate|Cytosine Nucleotides|Ethanolamines|Glycosides|Nervous System|Nitrogen Compounds|Nootropic Agents|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Onium Compounds|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Pyrimidine Nucleotides|Pyrimidines|Quaternary Ammonium Compounds|Ribonucleotides|Trimethyl Ammonium Compounds",C[N+](C)(C)CCOP([O-])(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(N)=NC1=O,
10151,DB12154,Itacitinib,small molecule,investigational,Azetines|Pyridines,FC1=C(N=CC=C1C(=O)N1CCC(CC1)N1CC(CC#N)(C1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1)C(F)(F)F,53380437
10152,DB12155,Napabucasin,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Naphthalenes|Quinones",CC(=O)C1=CC2=C(O1)C(=O)C1=CC=CC=C1C2=O,10331844
10153,DB12156,Cordycepin,small molecule,investigational,"Anti-Infective Agents|Antifungal Agents|Antineoplastic Agents|Carbohydrates|Deoxyribonucleosides|Glycosides|Heterocyclic Compounds, Fused-Ring|Mutagens|Noxae|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides|Toxic Actions",[H][C@@]1(CO)C[C@@]([H])(O)[C@@]([H])(O1)N1C=NC2=C(N)N=CN=C12,6303
10155,DB12158,Filorexant,small molecule,investigational,,C[C@@H]1CC[C@@H](COC2=CC=C(F)C=N2)CN1C(=O)C1=CC(C)=CC=C1C1=NC=CC=N1,25128145
10157,DB12160,Bucillamine,small molecule,investigational,"Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antiinflammatory and Antirheumatic Products|Antioxidants|Antirheumatic Agents|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Musculo-Skeletal System|Penicillamine and Similar Agents|Peripheral Nervous System Agents|Protective Agents|Sensory System Agents|Specific Antirheumatic Agents|Sulfhydryl Compounds|Sulfur Compounds",CC(C)(S)C(=O)N[C@@H](CS)C(O)=O,656604
10158,DB12161,Deutetrabenazine,small molecule,approved|investigational,"Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|QTc Prolonging Agents|Quinolizines",[2H]C([2H])([2H])OC1=CC2=C(C=C1OC([2H])([2H])[2H])[C@@H]1CC(=O)[C@@H](CC(C)C)CN1CC2,73442840
10159,DB12162,HX-1171,small molecule,investigational,Benzene Derivatives|Phenols,CCCCCCOC1=CC(C)=C(O)C(C)=C1C,119193
10160,DB12163,Sarpogrelate,small molecule,investigational,"Acids, Acyclic|Antidepressive Agents|Antiplatelet agents|Cardiovascular Agents|Central Nervous System Depressants|Dicarboxylic Acids|Fibrin Modulating Agents|Hematologic Agents|Neurotransmitter Agents|Serotonin Agents|Serotonin Receptor Antagonists",COC1=CC(CCC2=CC=CC=C2OCC(CN(C)C)OC(=O)CCC(O)=O)=CC=C1,5160
10161,DB12165,Presatovir,small molecule,investigational,Amides|Sulfones|Sulfur Compounds,CC1=CN2N=C(C=C2N=C1N1CC[C@H](N)C1)[C@@H]1CCCCN1C(=O)C1=CC(Cl)=CC=C1NS(C)(=O)=O,58029842
10162,DB12167,LY-3023414,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Quinolines",CO[C@@H](C)CN1C(=O)N(C)C2=C1C1=CC(=CC=C1N=C2)C1=CC(=CN=C1)C(C)(C)O,57519748
10163,DB12168,MK-0557,small molecule,investigational,Cycloparaffins,FC1=C(C=CC=C1)N1C=CC(NC(=O)[C@H]2CC[C@@]3(CC2)OC(=O)C2=C3C=NC=C2)=N1,11491176
10165,DB12170,Veledimex,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CCC[C@@H](N(NC(=O)C1=CC=CC(OC)=C1CC)C(=O)C1=CC(C)=CC(C)=C1)C(C)(C)C,57751161
10167,DB12172,Nimorazole,small molecule,investigational,"Anti-Infective Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Antitrichomonal Agents|Imidazoles|Nitro Compounds|Nitroimidazole Derivatives|Nitroimidazoles",O=N(=O)C1=CN=CN1CCN1CCOCC1,23009
10168,DB12173,Diphencyprone,small molecule,investigational,Cycloparaffins,O=C1C(=C1C1=CC=CC=C1)C1=CC=CC=C1,65057
10169,DB12174,CUDC-101,small molecule,investigational,"Amines|Antineoplastic Agents|Heterocyclic Compounds, Fused-Ring|Histone Deacetylase Inhibitors|Hydroxy Acids|Hydroxylamines|Moderate Risk QTc-Prolonging Agents|QTc Prolonging Agents",COC1=C(OCCCCCCC(=O)NO)C=C2C(NC3=CC=CC(=C3)C#C)=NC=NC2=C1,24756910
10170,DB12176,Tricaprylin,small molecule,investigational,"Acids, Acyclic|Alzheimer Disease, drug therapy|Compounds used in a research, industrial, or household setting|Drug Delivery Systems|Excipients|Fatty Acids|Glycerides|Lipids|Pharmaceutic Aids|Pharmaceutical Preparations|Pharmaceutical Vehicles",[H]C(COC(=O)CCCCCCC)(COC(=O)CCCCCCC)OC(=O)CCCCCCC,10850
10171,DB12177,Eplivanserin,small molecule,investigational,"Antidepressive Agents|Benzene Derivatives|Cardiovascular Agents|Central Nervous System Depressants|Fibrin Modulating Agents|Hematologic Agents|Hydrocarbons, Fluorinated|Hydrocarbons, Halogenated|Neurotransmitter Agents|Serotonin Agents|Serotonin Receptor Antagonists",CN(C)CCO\N=C(\C=C\C1=CC=C(O)C=C1)/C1=CC=CC=C1F,5486684
10172,DB12178,Telinavir,small molecule,investigational,,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(N)=O)NC(=O)C1=CC=C2C=CC=CC2=N1)C(=O)NC(C)(C)C,382974
10173,DB12179,Secoisolariciresinol,small molecule,investigational,"Alcohols|Benzene Derivatives|Benzyl Compounds|Estrogens, Non-Steroidal|Glycols|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Phytoestrogens",COC1=C(O)C=CC(C[C@@H](CO)[C@H](CO)CC2=CC(OC)=C(O)C=C2)=C1,65373
10174,DB12180,Apitolisib,small molecule,investigational,"Phosphatidylinositol 3-Kinase, antagonists & inhibitors",C[C@H](O)C(=O)N1CCN(CC2=C(C)C3=NC(=NC(N4CCOCC4)=C3S2)C2=CN=C(N)N=C2)CC1,25254071
10175,DB12181,Dalcetrapib,small molecule,investigational,Anticholesteremic Agents|Hypolipidemic Agents|Lipid Regulating Agents|Noxae|Sulfur Compounds|Toxic Actions,CCC(CC)CC1(CCCCC1)C(=O)NC1=CC=CC=C1SC(=O)C(C)C,6918540
10177,DB12183,Sapitinib,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CNC(=O)CN1CCC(CC1)OC1=C(OC)C=C2N=CN=C(NC3=CC=CC(Cl)=C3F)C2=C1,11488320
10178,DB12184,Gepirone,small molecule,investigational,Anti-Anxiety Agents|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Nervous System|Neurotransmitter Agents|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Agonists|Tranquilizing Agents,CC1(C)CC(=O)N(CCCCN2CCN(CC2)C2=NC=CC=N2)C(=O)C1,55191
10179,DB12185,Exatecan,small molecule,investigational,Alkaloids|Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase I Inhibitors|Topoisomerase Inhibitors,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=C(F)C(C)=C4CC[C@H](N)C3=C14)C2=O,151115
10180,DB12186,SRT-2104,small molecule,investigational,"Enzyme Activators|Heterocyclic Compounds, Fused-Ring",CC1=C(SC(=N1)C1=CC=CN=C1)C(=O)NC1=CC=CC=C1C1=CN2C(CN3CCOCC3)=CSC2=N1,25108829
10181,DB12187,Abacavir hydroxyacetate,small molecule,investigational,Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,NC1=NC(NC2CC2)=C2N=CN([C@@H]3C[C@H](COC(=O)CO)C=C3)C2=N1,71605071
10182,DB12188,Zicronapine,small molecule,investigational,,CN1CCN(CC1(C)C)[C@@H]1C[C@H](C2=C1C=C(Cl)C=C2)C1=CC=CC=C1,11465618
10184,DB12190,Faropenem,small molecule,investigational,"Amides|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Heterocyclic Compounds, Fused-Ring|Lactams|Sulfur Compounds",[H][C@]12SC([C@H]3CCCO3)=C(N1C(=O)[C@@H]2[C@@H](C)O)C(O)=O,65894
10185,DB12191,Obatoclax,small molecule,investigational,Enzyme Inhibitors,COC1=CC(=N\C1=C/C1=C(C)C=C(C)N1)C1=CC2=CC=CC=C2N1,11404337
10186,DB12192,Emeramide,small molecule,investigational,"Chelating Agents|Compounds used in a research, industrial, or household setting|Sequestering Agents|Sulfur Compounds",SCCNC(=O)C1=CC(=CC=C1)C(=O)NCCS,21133161
10187,DB12193,Ajulemic acid,small molecule,investigational,"Agents producing tachycardia|Cannabinoid Receptor Agonists|Cannabinoids and similars|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Neurotransmitter Agents|Terpenes",[H][C@@]12CC(=CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC)C(O)=O,3083542
10188,DB12194,Atamestane,small molecule,investigational,"17-Ketosteroids|Adrenal Cortex Hormones|Androstanes|Androstenes|Enzyme Inhibitors|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Steroids|Testosterone Congeners",CC1=CC(=O)C=C2CC[C@H]3[C@@H]4CCC(=O)[C@@]4(C)CC[C@@H]3[C@@]12C,57050
10189,DB12195,VP-14637,small molecule,investigational,Benzene Derivatives,CC1=NN=NN1N=CC1=CC=C(O)C(=C1)C(C1=CC=C(O)C=C1)C1=CC(C=NN2N=NN=C2C)=CC=C1O,9806362
10190,DB12196,CP-866087,small molecule,investigational,Aza Compounds,CC[C@]1([C@H]2CN(CC3(O)CC4=CC=CC=C4C3)C[C@@H]12)C1=CC=CC(NS(C)(=O)=O)=C1,11154544
10191,DB12197,Auriclosene,small molecule,investigational,"Acids|Acids, Noncarboxylic|Alkanes|Alkanesulfonic Acids|Hydrocarbons, Acyclic|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",CC(C)(CS(O)(=O)=O)N(Cl)Cl,11708365
10192,DB12198,Fosdagrocorat,small molecule,investigational,Organophosphorus Compounds,[H][C@]12CCC3=C(C=CC(=C3)C(=O)NC3=C(C)N=CC=C3)[C@]1(CC1=CC=CC=C1)CC[C@](C2)(OP(O)(O)=O)C(F)(F)F,24872952
10193,DB12199,TRV-120027,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Peptides",[H][C@](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC)C(C)C)([C@@H](C)CC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(O)=O,3082475
10194,DB12200,Tivantinib,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Proto-Oncogene Proteins c-met, antagonists & inhibitors|Pyrrolidines",O=C1NC(=O)[C@H]([C@@H]1C1=CNC2=CC=CC=C12)C1=CN2CCCC3=C2C1=CC=C3,11494412
10195,DB12201,PF-03654746,small molecule,investigational,Cycloparaffins|Histamine H3 Antagonists,CCNC(=O)[C@H]1C[C@](F)(C1)C1=CC(F)=C(CN2CCCC2)C=C1,16119086
10197,DB12203,Tozadenant,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Sulfur Compounds|Thiazoles",COC1=C2N=C(NC(=O)N3CCC(C)(O)CC3)SC2=C(C=C1)N1CCOCC1,11618368
10198,DB12204,Terbogrel,small molecule,investigational,,CC(C)(C)N\C(NC#N)=N\C1=CC(=CC=C1)C(=C/CCCC(O)=O)\C1=CC=CN=C1,6449876
10200,DB12206,N-6022,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates",CC1=CC(=CC=C1N1C(CCC(O)=O)=CC=C1C1=CC=C(C=C1)N1C=CN=C1)C(N)=O,44623946
10201,DB12207,Verdinexor,small molecule,investigational,"Acids, Acyclic|Acrylates|Amides",FC(F)(F)C1=CC(=CC(=C1)C1=NN(\C=C/C(=O)NNC2=CC=CC=N2)C=N1)C(F)(F)F,71492799
10202,DB12208,Iron isomaltoside 1000,small molecule,approved|investigational,Carbohydrates|Hematinics|Hematologic Agents|Iron Compounds|Oligosaccharides|Organometallic Compounds|Polysaccharides,,
10203,DB12209,Tirasemtiv,small molecule,investigational,,CCC(CC)N1C(=O)NC2=NC=C(N=C12)C#C,23729157
10204,DB12210,AZD-6280,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Receptors, Opioid, delta, agonists",CCCNC(=O)C1=NN=C2C(=CC=CC2=C1N)C1=CC(OC)=CC=C1OC,23630026
10205,DB12211,PSI-697,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|P-Selectin|Quinolines",OC(=O)C1=C2C=CC3=C(CCCC3)C2=NC(CC2=CC=C(Cl)C=C2)=C1O,12004316
10206,DB12212,Landiolol,small molecule,investigational,"Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Beta Blocking Agents, Selective|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Neurotransmitter Agents|Oxazines",CC1(C)OC[C@@H](COC(=O)CCC2=CC=C(OC[C@@H](O)CNCCNC(=O)N3CCOCC3)C=C2)O1,114905
10208,DB12214,Luseogliflozin,small molecule,investigational,Alcohols|Carbohydrates|Sugar Alcohols,CCOC1=CC=C(CC2=CC([C@@H]3S[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)=C(OC)C=C2C)C=C1,11988953
10209,DB12216,Bergapten,small molecule,investigational,"Anti-Inflammatory Agents|Antipsoriatics|Antipsoriatics for Systemic Use|Benzopyrans|Coumarins|Dermatologicals|Furocoumarins|Heterocyclic Compounds, Fused-Ring|Photosensitizing Agents|Photosensitizing agents used for phototherapy|Psoralens for Systemic Use|Pyrans|Radiation-Sensitizing Agents",COC1=C2C=CC(=O)OC2=CC2=C1C=CO2,2355
10210,DB12218,Capivasertib,small molecule,investigational,"Proto-Oncogene Proteins c-akt, antagonists & inhibitors",NC1(CCN(CC1)C1=C2C=CNC2=NC=N1)C(=O)N[C@@H](CCO)C1=CC=C(Cl)C=C1,25227436
10211,DB12219,GSK-424887,small molecule,investigational,"Acetates|Acids, Acyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Lipids",C[C@H](N(C)C(=O)CC1(CCN(C)CC1)C1=CC=C(F)C=C1)C1=C2C=CC=CC2=CC(Cl)=C1,76958276
10212,DB12220,ORG-25935,small molecule,investigational,Naphthalenes,COC1=CC=C2[C@H]([C@@H](CN(C)CC(O)=O)CCC2=C1)C1=CC=CC=C1,11717074
10213,DB12221,Canrenone,small molecule,investigational,"Agents causing hyperkalemia|Cardiovascular Agents|Diuretics|Fused-Ring Compounds|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Mineralocorticoid Receptor Antagonists|Natriuretic Agents|Potassium-Sparing Diuretics|Pregnadienes|Pregnanes|Steroids",[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@]12C,13789
10214,DB12222,Lurtotecan,small molecule,investigational,Alkaloids|Antineoplastic Agents,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=C4OCCOC4=CC1=C3CN1CCN(C)CC1)C2=O,60956
10215,DB12223,Squaric acid dibutyl ester,small molecule,investigational,"Adjuvants, Immunologic|Allergens|Cycloparaffins|Immunologic Factors",CCCCOC1=C(OCCCC)C(=O)C1=O,65108
10216,DB12224,Oxothiazolidinecarboxylic acid,small molecule,investigational,"Acids, Acyclic|Amino Acids|Amino Acids, Acidic|Amino Acids, Cyclic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Glutamates|Imines|Imino Acids|Pyrrolidines|Pyrrolidinones|Sulfur Compounds|Thiazoles",OC(=O)[C@@H]1CSC(=O)N1,72390
10217,DB12225,Beclabuvir,small molecule,investigational,"Antiviral Agents|Heterocyclic Compounds, Fused-Ring",COC1=CC=C2C3=C(C4CCCCC4)C4=CC=C(C=C4N3C[C@]3(C[C@H]3C2=C1)C(=O)N1[C@H]2CC[C@@H]1CN(C)C2)C(=O)NS(=O)(=O)N(C)C,56934415
10218,DB12226,Terameprocol,small molecule,investigational,Benzene Derivatives|Benzyl Compounds|Catechols|Lignans|Phenols,COC1=CC=C(C[C@H](C)[C@H](C)CC2=CC=C(OC)C(OC)=C2)C=C1OC,476861
10219,DB12227,Tetulomab tetraxetan Lu-177,small molecule,investigational,,N[C@@H](CCCCNC(=S)NC1=CC=C(CC2CN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CCN2CC(O)=O)C=C1)C(O)=O,131704322
10220,DB12228,Telcagepant,small molecule,investigational,,FC1=C(F)C(=CC=C1)[C@@H]1CC[C@@H](NC(=O)N2CCC(CC2)N2C(=O)NC3=C2C=CC=N3)C(=O)N(CC(F)(F)F)C1,11319053
10221,DB12229,Cerlapirdine,small molecule,investigational,"Antidepressive Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Pyrazoles|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds",CN(C)CCCOC1=CC=C2NN=C(C2=C1)S(=O)(=O)C1=C2C=CC=CC2=CC=C1,16071605
10222,DB12230,Bunazosin,small molecule,investigational,"Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|Peripheral alpha-1 blockers",CCCC(=O)N1CCCN(CC1)C1=NC(N)=C2C=C(OC)C(OC)=CC2=N1,2472
10223,DB12231,Temefos,small molecule,investigational,"Agrochemicals|Compounds used in a research, industrial, or household setting|Insecticides|Organophosphates|Organophosphorus Compounds|Organothiophosphates|Organothiophosphorus Compounds|Pesticides|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sulfur Compounds|Toxic Actions",COP(=S)(OC)OC1=CC=C(SC2=CC=C(OP(=S)(OC)OC)C=C2)C=C1,5392
10224,DB12232,KRN-7000,small molecule,investigational,"Adjuvants, Immunologic|Amides|Antineoplastic Agents|Carbohydrates|Ceramides|Cerebrosides|Glycoconjugates|Glycolipids|Glycosphingolipids|Immunologic Factors|Lipids|Membrane Lipids|Neutral Glycosphingolipids|Sphingolipids",CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@H](O)CCCCCCCCCCCCCC,2826713
10225,DB12233,Iguratimod,small molecule,investigational,"Amides|Benzopyrans|Heterocyclic Compounds, Fused-Ring|Pyrans|Sulfones|Sulfur Compounds",CS(=O)(=O)NC1=CC2=C(C=C1OC1=CC=CC=C1)C(=O)C(NC=O)=CO2,124246
10226,DB12234,BMS-214662,small molecule,investigational,"Benzazepines|Heterocyclic Compounds, Fused-Ring",[H][C@@]1(CC2=CC=CC=C2)CN(CC2=CN=CN2)C2=C(CN1S(=O)(=O)C1=CC=CS1)C=C(C=C2)C#N,448545
10227,DB12235,Estetrol,small molecule,investigational,"Estradiol Congeners|Estranes|Estrenes|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids",[H][C@@]1(O)[C@]([H])(O)[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]2(C)[C@@]1([H])O,27125
10228,DB12236,Bexagliflozin,small molecule,investigational,,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC=C(Cl)C(CC2=CC=C(OCCOC3CC3)C=C2)=C1,25195624
10229,DB12237,GW-274150,small molecule,investigational,"Acids|Acids, Noncarboxylic|Anions|Electrolytes|Gases|Hydrogen Sulfide|Ions|Nitric Oxide Synthase, antagonists & inhibitors|Sulfur Compounds",CC(=N)NCCSCC[C@H](N)C(O)=O,9797017
10230,DB12238,MK-0777,small molecule,investigational,,CCN1N=CN=C1COC1=NN2C(C=C1C(C)(C)C)=NN=C2C1=CC=CC=C1F,9908684
10231,DB12239,Balicatib,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates",CCCN1CCN(CC1)C1=CC=C(C=C1)C(=O)NC1(CCCCC1)C(=O)NCC#N,10201696
10233,DB12241,TAK-733,small molecule,investigational,Pyridines|Pyrimidines,[H][C@](O)(CO)CN1C=NC2=C(C1=O)C(NC1=C(F)C=C(I)C=C1)=C(F)C(=O)N2C,24963252
10234,DB12242,AZD-7762,small molecule,investigational,Sulfur Compounds,NC(=O)NC1=C(SC(=C1)C1=CC=CC(F)=C1)C(=O)N[C@H]1CCCNC1,11152667
10235,DB12243,Edaravone,small molecule,approved|investigational,"Antioxidants|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Free Radical Scavengers|Miscellaneous Central Nervous System Agents|Nervous System|Neuroprotective Agents|OAT1/SLC22A6 Substrates|OAT3/SLC22A8 Substrates|Protective Agents|Pyrazoles|Pyrazolones",CC1=NN(C(=O)C1)C1=CC=CC=C1,4021
10236,DB12244,CP-601927,small molecule,investigational,,FC(F)(F)C1=CC2=C(C=C1)[C@H]1C[C@@H]2CNC1,11498153
10237,DB12245,Triclabendazole,small molecule,approved|investigational,"Anthelmintics|Anti-Infective Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiplatyhelmintic Agents|Antitrematodals|Benzimidazoles|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Potential QTc-Prolonging Agents|QTc Prolonging Agents",CSC1=NC2=C(N1)C=C(Cl)C(OC1=CC=CC(Cl)=C1Cl)=C2,50248
10239,DB12247,AZD-4547,small molecule,investigational,,COC1=CC(OC)=CC(CCC2=CC(NC(=O)C3=CC=C(C=C3)N3C[C@H](C)N[C@H](C)C3)=NN2)=C1,51039095
10240,DB12248,Tulobuterol,small molecule,investigational,"Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Drugs for Obstructive Airway Diseases|Ethanolamines|Neurotransmitter Agents|Peripheral Nervous System Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists",CC(C)(C)NCC(O)C1=CC=CC=C1Cl,5606
10243,DB12251,Moxaverine,small molecule,investigational,"Alimentary Tract and Metabolism|Alkaloids|Autonomic Agents|Benzylisoquinolines|Drugs for Functional Gastrointestinal Disorders|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Opiate Alkaloids|Papaverine and Derivatives|Parasympatholytics|Peripheral Nervous System Agents",CCC1=NC(CC2=CC=CC=C2)=C2C=C(OC)C(OC)=CC2=C1,70882
10244,DB12252,PG-701,small molecule,investigational,,CC(C)[C@]12O[C@H]1[C@@H]1O[C@]11[C@]3(O[C@H]3C[C@@]3(O)C4=C(CC[C@]13C)C(=O)OC4)[C@@H]2O,10317383
10245,DB12253,GDC-0810,small molecule,investigational,"Acids, Carbocyclic|Heterocyclic Compounds, Fused-Ring|Pyrazoles",CC\C(=C(\C1=CC=C(\C=C\C(O)=O)C=C1)C1=CC=C2NN=CC2=C1)C1=CC=C(F)C=C1Cl,56941241
10246,DB12254,ABT-751,small molecule,investigational,Amides|Amines|Aniline Compounds|Benzene Derivatives|Phenols|Sulfones|Sulfur Compounds,COC1=CC=C(C=C1)S(=O)(=O)NC1=C(NC2=CC=C(O)C=C2)N=CC=C1,3035714
10247,DB12255,Vadadustat,small molecule,investigational,"Amino Acids|Amino Acids, Peptides, and Proteins|Pyridines",OC(=O)CNC(=O)C1=C(O)C=C(C=N1)C1=CC(Cl)=CC=C1,23634441
10249,DB12257,Platinum,small molecule,investigational,"Antineoplastic Agents|Chlorine Compounds|Compounds used in a research, industrial, or household setting|Cross-Linking Reagents|Elements|Indicators and Reagents|Laboratory Chemicals|Metals|Metals, Heavy|Nitrogen Compounds|Platinum Compounds|Radiation-Sensitizing Agents|Transition Elements",[Pt],23939
10251,DB12259,CG-200745,small molecule,investigational,Amines|Antineoplastic Agents|Histone Deacetylase Inhibitors|Hydroxy Acids|Hydroxylamines,CN(C)CCCNC(=O)C(\COC1=C2C=CC=CC2=CC=C1)=C\CCCCC(=O)NO,16117309
10252,DB12260,Radiprodil,small molecule,investigational,"Acetates|Acids, Acyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Lipids",FC1=CC=C(CC2CCN(CC2)C(=O)C(=O)NC2=CC=C3NC(=O)OC3=C2)C=C1,10200813
10254,DB12262,CRS-3123,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Methionine-tRNA Ligase, antagonists & inhibitors|Pyrans|Sulfur Compounds",BrC1=CC2=C(OCC[C@H]2NCCCNC2=CC(=O)C3=C(N2)C=CS3)C(Br)=C1,16744283
10255,DB12263,Begacestat,small molecule,investigational,Amides|Amyloid Precursor Protein Secretases|Sulfones|Sulfur Compounds,OC[C@@H](NS(=O)(=O)C1=CC=C(Cl)S1)C(C(F)(F)F)C(F)(F)F,11269353
10256,DB12264,Atevirdine,small molecule,investigational,Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Enzyme Inhibitors|Nucleic Acid Synthesis Inhibitors|Reverse Transcriptase Inhibitors,CCNC1=CC=CN=C1N1CCN(CC1)C(=O)C1=CC2=CC(OC)=CC=C2N1,60848
10257,DB12265,Fexinidazole,small molecule,investigational,"Agents Against Leishmaniasis and Trypanosomiasis|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Imidazoles|Nitro Compounds|Nitroimidazole Derivatives",CSC1=CC=C(OCC2=NC=C(N2C)[N+]([O-])=O)C=C1,68792
10258,DB12266,Epofolate,small molecule,investigational,"Anti-Bacterial Agents|Antineoplastic Agents|Biological Factors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Lactones|Macrolides|Pigments, Biological|Polyketides|Pteridines|Pterins",,
10259,DB12267,Brigatinib,small molecule,approved|investigational,Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Kinase Inhibitor|MATE 1 Inhibitors|MATE 2 Inhibitors|MATE inhibitors|Protein Kinase Inhibitors|Tyrosine Kinase Inhibitors,COC1=CC(=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1)N1CCC(CC1)N1CCN(C)CC1,68165256
10260,DB12268,Carmegliptin,small molecule,investigational,"Agents causing angioedema|Blood Glucose Lowering Agents|Dipeptidyl Peptidase 4|DPP-IV Inhibitors|Heterocyclic Compounds, Fused-Ring",[H][C@@]1(CF)CN(C(=O)C1)[C@@]1([H])CN2CCC3=CC(OC)=C(OC)C=C3[C@]2([H])C[C@]1([H])N,11417567
10261,DB12269,PF-06273340,small molecule,investigational,,CC(C)(CO)N1C=C(C(=O)C2=CC(NC(=O)CC3=CC=C(Cl)C=N3)=CN=C2)C2=CN=C(N)N=C12,66571548
10262,DB12270,Losmapimod,small molecule,investigational,Cycloparaffins|p38 Mitogen-Activated Protein Kinases|Protein Kinase Inhibitors,CC1=C(C=C(C=C1F)C(=O)NC1CC1)C1=CC=C(C=N1)C(=O)NCC(C)(C)C,11552706
10263,DB12271,ORE-1001,small molecule,investigational,"Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins",CC(C)C[C@H](N[C@@H](CC1=CN=CN1CC1=CC(Cl)=CC(Cl)=C1)C(O)=O)C(O)=O,448281
10264,DB12272,Vidupiprant,small molecule,investigational,"Acids, Carbocyclic|Amides|Sulfones|Sulfur Compounds",CC(C)(C)NC(=O)C1=CC=C(OC2=CC(F)=C(CC(O)=O)C=C2Cl)C(NS(=O)(=O)C2=CC=C(C=C2Cl)C2CC2)=C1,42641863
10265,DB12273,Ecopipam,small molecule,investigational,"Antipsychotic Agents|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Heterocyclic Compounds, Fused-Ring|Neurotoxic agents|Neurotransmitter Agents|Psychotropic Drugs|Tranquilizing Agents",[H][C@]12CCC3=CC=CC=C3[C@]1([H])C1=CC(O)=C(Cl)C=C1CCN2C,107930
10267,DB12275,Seviteronel,small molecule,investigational,,CC(C)[C@@](O)(C1=CN=NN1)C1=CC=C2C=C(OC(F)F)C(OC(F)F)=CC2=C1,78357816
10268,DB12276,Apomine,small molecule,investigational,Organophosphonates|Organophosphorus Compounds,CC(C)OP(=O)(OC(C)C)C(CC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C)P(=O)(OC(C)C)OC(C)C,176405
10269,DB12277,Polihexanide,small molecule,approved|investigational,"Amidines|Anti-Infective Agents|Antiseptics and Disinfectants|Biguanides and Amidines|Compounds used in a research, industrial, or household setting|Dermatologicals|Disinfectants|Guanidines",,
10270,DB12278,Propiverine,small molecule,approved|investigational,"Acids, Carbocyclic|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Anticholinergic Agents|Autonomic Agents|Cholinergic Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Diphenylacetic Acids|Drugs for Urinary Frequency and Incontinence|Drugs that are Mainly Renally Excreted|Genito Urinary System and Sex Hormones|Hydroxy Acids|Muscarinic Antagonists|Neurotransmitter Agents|Parasympatholytics|Peripheral Nervous System Agents|Phenylacetates|Urological Agents|Urologicals",CCCOC(C(=O)OC1CCN(C)CC1)(C1=CC=CC=C1)C1=CC=CC=C1,4942
10271,DB12279,OBP-801,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Histone Deacetylase Inhibitors|Peptides",CC(C)[C@H]1NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C)C(=O)N2)OC(=O)C[C@@H]1O,11178958
10272,DB12280,AZD-5423,small molecule,investigational,"Acetates|Acids, Acyclic|Amides|Anti-Asthmatic Agents|Fatty Acids|Fatty Acids, Volatile|Heterocyclic Compounds, Fused-Ring|Lipids|Pyrazoles|Receptors, Glucocorticoid, agonists",COC1=CC(=CC=C1)[C@@H](OC1=CC=C2N(N=CC2=C1)C1=CC=C(F)C=C1)[C@H](C)NC(=O)C(F)(F)F,24825740
10274,DB12282,Defactinib,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Focal Adhesion Kinase 1, antagonists & inhibitors|Sulfones|Sulfur Compounds",CNC(=O)C1=CC=C(NC2=NC=C(C(NCC3=C(N=CC=N3)N(C)S(C)(=O)=O)=N2)C(F)(F)F)C=C1,25117126
10275,DB12283,Balapiravir,small molecule,investigational,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides",CC(C)C(=O)OC[C@]1(O[C@H]([C@H](OC(=O)C(C)C)[C@@H]1OC(=O)C(C)C)N1C=CC(N)=NC1=O)N=[N+]=[N-],11691726
10276,DB12284,LY-2608204,small molecule,investigational,,O=C(NC1=NC=C(SCCN2CCCC2)S1)[C@@]1(C[C@H]1C1CCCCC1)C1=CC=C(C=C1)S(=O)(=O)C1CC1,46832368
10277,DB12285,Verubecestat,small molecule,investigational,Sulfur Compounds|Thiazines,CN1C(N)=N[C@@](C)(CS1(=O)=O)C1=CC(NC(=O)C2=CC=C(F)C=N2)=CC=C1F,51352361
10278,DB12286,Simendan,small molecule,investigational,"Antiarrhythmic agents|Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Hydrazines|Hydrazones|Moderate Risk QTc-Prolonging Agents|Phosphodiesterase 3 Inhibitors|Phosphodiesterase Inhibitors|Protective Agents|Pyridazines|QTc Prolonging Agents|Vasodilating Agents",CC1CC(O)=NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1,60867
10279,DB12287,Talsaclidine,small molecule,investigational,,C#CCO[C@H]1CN2CCC1CC2,71792
10280,DB12288,Piromelatine,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",COC1=CC=C2NC=C(CCNC(=O)C3=CC(=O)C=CO3)C2=C1,24815904
10281,DB12289,Darexaban,small molecule,investigational,"Acids, Carbocyclic|Amides|Anticoagulants|Antithrombins|Benzene Derivatives|Benzoates|Enzyme Inhibitors|Factor Xa Inhibitors|Hematologic Agents|Protease Inhibitors|Serine Protease Inhibitors",COC1=CC=C(C=C1)C(=O)NC1=C(NC(=O)C2=CC=C(C=C2)N2CCCN(C)CC2)C(O)=CC=C1,9912771
10282,DB12290,Puerarin,small molecule,investigational,"Benzopyrans|Cardiovascular Agents|Chromones|Flavonoids|Heterocyclic Compounds, Fused-Ring|Pyrans|Vasodilating Agents",OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=C(O)C=CC2=C1OC=C(C2=O)C1=CC=C(O)C=C1,5281807
10283,DB12291,Tacedinaline,small molecule,investigational,,CC(=O)NC1=CC=C(C=C1)C(=O)NC1=CC=CC=C1N,2746
10284,DB12292,Barusiban,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Peptides|Receptors, Oxytocin, antagonists & inhibitors",CC[C@H](C)[C@@H]1NC(=O)[C@@H](CC2=CNC3=CC=CC=C23)NC(=O)CCSCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC1=O)[C@H](C)CC)C(=O)N(C)[C@H](CO)CCCN,9832431
10285,DB12293,Nefopam,small molecule,approved|investigational,"Analgesics|Analgesics, Non-Narcotic|Azocines|Central Nervous System Agents|Nervous System|Oxazocines|Peripheral Nervous System Agents|Sensory System Agents",CN1CCOC(C2=CC=CC=C2)C2=CC=CC=C2C1,4450
10287,DB12295,Evodenoson,small molecule,investigational,,COC(=O)N1CCC(CC#CC2=NC(N)=C3N=CN([C@@H]4O[C@@H]([C@@H](O)[C@H]4O)C(=O)NC4CC4)C3=N2)CC1,11627443
10289,DB12297,GLPG-0187,small molecule,investigational,"Amides|Heterocyclic Compounds, Fused-Ring|Sulfones|Sulfur Compounds",COC1=CC=C(C=C1)S(=O)(=O)N[C@@H](CNC1=C(C)C(=NC(C)=N1)N1CCC(CC1)C1=CC=C2CCCNC2=N1)C(O)=O,53340771
10290,DB12298,5-(hydroxymethyl)-2-furaldehyde,small molecule,investigational,,OCC1=CC=C(O1)C=O,237332
10291,DB12299,Bavisant,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Histamine H3 Antagonists",O=C(N1CCN(CC1)C1CC1)C1=CC=C(CN2CCOCC2)C=C1,16061509
10292,DB12300,P-nitrobiphenyl,small molecule,approved|experimental|investigational,,O=N(=O)C1=CC=C(C=C1)C1=CC=CC=C1,7114
10293,DB12301,Doravirine,small molecule,approved|investigational,Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Direct Acting Antivirals|Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor|Non-Nucleoside Reverse Transcriptase Inhibitors|Nonnucleoside Reverse Transcriptase Inhibitors|Pyridines,CN1C(=O)NN=C1CN1C=CC(=C(OC2=CC(=CC(Cl)=C2)C#N)C1=O)C(F)(F)F,58460047
10294,DB12302,CP-724714,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Receptor, ErbB-2, antagonists & inhibitors",COCC(=O)NC\C=C\C1=CC=C2N=CN=C(NC3=CC=C(OC4=CC=C(C)N=C4)C(C)=C3)C2=C1,9874913
10295,DB12303,Motolimod,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Toll-Like Receptor 8, agonists",CCCN(CCC)C(=O)C1=CC2=CC=C(C=C2N=C(N)C1)C1=CC=C(C=C1)C(=O)N1CCCC1,16049404
10297,DB12305,Dasotraline,small molecule,investigational,Amines|Cycloparaffins|Naphthalenes,N[C@@H]1CC[C@@H](C2=CC=C(Cl)C(Cl)=C2)C2=CC=CC=C12,9947999
10298,DB12306,Cipargamin,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",C[C@H]1CC2=C(NC3=CC(Cl)=C(F)C=C23)[C@@]2(N1)C(=O)NC1=CC=C(Cl)C=C21,44469321
10299,DB12307,Foretinib,small molecule,investigational,"Amides|Amines|Aniline Compounds|Heterocyclic Compounds, Fused-Ring|Receptors, Vascular Endothelial Growth Factor, antagonists & inhibitors|Tyrosine Kinase Inhibitors",COC1=C(OCCCN2CCOCC2)C=C2N=CC=C(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3F)C2=C1,42642645
10300,DB12308,Eltanolone,small molecule,investigational,Anesthetics|Central Nervous System Agents|Central Nervous System Depressants|Fused-Ring Compounds|Pregnanes|Steroids,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@H](O)CC[C@]12C,31402
10301,DB12309,GI-181771X,small molecule,investigational,"Benzazepines|Heterocyclic Compounds, Fused-Ring|Receptor, Cholecystokinin A, agonists",CC(C)N(C(=O)CN1C2=CC=CC=C2N(C2=CC=CC=C2)C(=O)[C@@H](NC(=O)NC2=CC=CC(=C2)C(O)=O)C1=O)C1=CC=CC=C1,51353551
10302,DB12310,Trehalose,small molecule,investigational,"Biopolymers|Carbohydrates|Compounds used in a research, industrial, or household setting|Disaccharides|Glucans|Macromolecular Substances|Oligosaccharides|Polymers|Polysaccharides",OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,7427
10303,DB12311,CP1-1189,small molecule,investigational,"Alkanes|Hydrocarbons, Acyclic",CC(=O)NC1=CC=C(C=C1)C(=O)NC(C)(C)C,151118
10304,DB12312,ORG-25435,small molecule,investigational,Benzene Derivatives,CC[C@@H](N(CCOC)CCOC)C(=O)OC1=C(OC)C=C(C)C=C1OC,9885653
10305,DB12313,Dopexamine,small molecule,approved|investigational,Adrenergic Agents|Adrenergic Agonists|Adrenergic and Dopaminergic Agents|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Amines|Benzene Derivatives|Biogenic Amines|Biogenic Monoamines|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Catecholamines|Catechols|Dopamine Agents|Dopamine Agonists|Neurotransmitter Agents|Nonergot-derivative Dopamine Receptor Agonists|Phenols|Vasodilating Agents,OC1=C(O)C=C(CCNCCCCCCNCCC2=CC=CC=C2)C=C1,55483
10306,DB12314,Chlorproguanil,small molecule,investigational,Amidines|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiprotozoals|Biguanides|Guanidines,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C(Cl)=C1,9571037
10307,DB12316,9CUAB30,small molecule,investigational,Fatty Acids|Lipids,[H]/C(=C(/[H])\C(\C)=C(/[H])C(O)=O)/C(/[H])=C(/C)\C(\[H])=C1/CCCC2=CC=CC=C12,9904203
10309,DB12318,BMS-599626,small molecule,investigational,"Acids, Acyclic|ErbB Receptors, antagonists & inhibitors",CC1=C2N(C=C1NC(=O)OC[C@@H]1COCCN1)N=CN=C2NC1=CC=C2N(CC3=CC=CC(F)=C3)N=CC2=C1,10437018
10310,DB12319,Benzbromarone,small molecule,investigational|withdrawn,"Antigout Preparations|Antirheumatic Agents|Benzofurans|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Musculo-Skeletal System|OATP1B1/SLCO1B1 Inhibitors|Preparations Increasing Uric Acid Excretion|Renal Agents|Uricosuric Agents",CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=CC=CC=C2O1,2333
10311,DB12320,Palovarotene,small molecule,investigational,Benzene Derivatives|Benzylidene Compounds,CC1(C)CCC(C)(C)C2=C1C=C(CN1C=CC=N1)C(\C=C\C1=CC=C(C=C1)C(O)=O)=C2,10295295
10312,DB12321,Ifetroban,small molecule,investigational,Antiplatelet agents|Hematologic Agents,CCCCCNC(=O)C1=COC(=N1)[C@@H]1[C@H]2CC[C@H](O2)[C@@H]1CC1=CC=CC=C1CCC(O)=O,3037233
10313,DB12322,GW-870086,small molecule,investigational,Fused-Ring Compounds,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C1C(C)(C)C1(C)C)C(=O)OCC#N,11376392
10314,DB12323,Radotinib,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Tyrosine Kinase Inhibitors",CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=N3)=C2)=CC(=C1)C(F)(F)F,16063245
10315,DB12325,Idasanutlin,small molecule,investigational,"Acids, Carbocyclic|Aminobenzoates|Benzene Derivatives|Benzoates|Proto-Oncogene Proteins c-mdm2, antagonists & inhibitors",COC1=CC(=CC=C1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@](C#N)([C@H]1C1=CC=CC(Cl)=C1F)C1=CC=C(Cl)C=C1F)C(O)=O,53358942
10316,DB12326,Antroquinonol,small molecule,investigational,Benzoquinones|Coenzymes|Enzymes and Coenzymes|Quinones,COC1=C(OC)C(=O)[C@H](C)[C@@H](C\C=C(/C)CC\C=C(/C)CCC=C(C)C)[C@H]1O,24875259
10317,DB12327,Salvinorin A,small molecule,investigational,Central Nervous System Agents|Central Nervous System Depressants|Diterpenes|Hallucinogens|Psychotropic Drugs|Salvia|Terpenes,COC(=O)[C@@H]1C[C@H](OC(C)=O)C(=O)[C@H]2[C@@]1(C)CC[C@H]1C(=O)O[C@@H](C[C@]21C)C1=COC=C1,128563
10318,DB12328,Cantharidin,small molecule,approved|investigational,"Benzofurans|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Irritants|Noxae|Toxic Actions",[H][C@]12CC[C@]([H])(O1)[C@]1(C)C(=O)OC(=O)[C@]21C,5944
10319,DB12329,Eravacycline,small molecule,approved|investigational,Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Monoamine Oxidase A Substrates|Naphthacenes|Tetracyclines,[H][C@@]12CC3=C(F)C=C(NC(=O)CN4CCCC4)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2,54726192
10322,DB12332,Rucaparib,small molecule,approved|investigational,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (moderate)|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (weak)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|MATE 1 Inhibitors|MATE 2 Inhibitors|MATE inhibitors|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|OCT1 inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Poly(ADP-ribose) Polymerase Inhibitors|UGT1A1 Inhibitors",CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=C2C(N1)=CC(F)=C3,9931954
10323,DB12333,SPK-843,small molecule,investigational,"Alkenes|Hydrocarbons, Acyclic",,
10324,DB12334,Milataxel,small molecule,investigational,Cyclodecanes|Cycloparaffins|Diterpenes|Taxoids|Terpenes,CCC(=O)O[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)[C@H]2[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C4=CC=CO4)C(C)=C([C@@H](O)C(=O)[C@]12C)C3(C)C,6918589
10326,DB12336,GDC-0917,small molecule,investigational,,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)NC1=C(N=C(S1)C1=NC=CO1)C1=CC=CC=C1,71600094
10327,DB12337,N-acetylsulfanilyl chloride,small molecule,investigational,,CC(=O)NC1=CC=C(C=C1)S(Cl)(=O)=O,8481
10328,DB12338,Carisbamate,small molecule,investigational,"Acids, Acyclic|Anticonvulsants|Central Nervous System Depressants|Nervous System",NC(=O)OC[C@@H](O)C1=CC=CC=C1Cl,6918474
10329,DB12339,Radezolid,small molecule,investigational,Anti-Bacterial Agents|Anti-Infective Agents|Oxazoles,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C(F)=C1)C1=CC=C(CNCC2=CN=NN2)C=C1,11224409
10330,DB12340,Navitoclax,small molecule,investigational,Amides|Amines|Antineoplastic Agents|Sulfones|Sulfur Compounds,[H][C@@](CCN1CCOCC1)(CSC1=CC=CC=C1)NC1=C(C=C(C=C1)S(=O)(=O)NC(=O)C1=CC=C(C=C1)N1CCN(CC2=C(CCC(C)(C)C2)C2=CC=C(Cl)C=C2)CC1)S(=O)(=O)C(F)(F)F,24978538
10331,DB12341,LY-2456302,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Central Nervous System Agents|Opioid Antagonists|Peripheral Nervous System Agents|Sensory System Agents",CC1=CC(=CC(C)=C1)[C@@H]1CCCN1CC1=CC=C(OC2=CC=C(C=C2F)C(N)=O)C=C1,44129648
10333,DB12343,Temocillin,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds",CO[C@]1(NC(=O)C(C(O)=O)C2=CSC=C2)[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O,171758
10335,DB12345,MBX-2982,small molecule,investigational,Sulfur Compounds,CCC1=CN=C(N=C1)N1CCC(CC1)C1=NC(COC2=CC=C(C=C2)N2C=NN=N2)=CS1,25025505
10337,DB12347,CG-400549,small molecule,investigational,Sulfur Compounds,CC1=C(CN2C=CC(OCCC3=CC=CS3)=CC2=O)C=CC=C1N,11844916
10338,DB12348,"5-amino-1,3,4-thiadiazole-2-thiol",small molecule,investigational,Sulfur Compounds|Thiazoles,NC1=NN=C(S)S1,2723847
10340,DB12350,Rostafuroxin,small molecule,investigational,Androstanes|Fused-Ring Compounds|Steroids,C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@]34C)[C@@]1(O)CC[C@]2(O)C1=COC=C1,153976
10341,DB12351,Siagoside,small molecule,investigational,Acidic Glycosphingolipids|Carbohydrates|Gangliosides|Glycoconjugates|Glycolipids|Glycosphingolipids|Lipids|Membrane Lipids|Sphingolipids,,
10342,DB12352,Bizelesin,small molecule,investigational,"Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Compounds used in a research, industrial, or household setting|Cross-Linking Reagents|Heterocyclic Compounds, Fused-Ring|Indicators and Reagents|Laboratory Chemicals|Noxae|Toxic Actions",CC1=CNC2=C(O)C=C3N(C[C@@H](CCl)C3=C12)C(=O)C1=CC2=CC(NC(=O)NC3=CC=C4NC(=CC4=C3)C(=O)N3C[C@@H](CCl)C4=C5C(C)=CNC5=C(O)C=C34)=CC=C2N1,60794
10343,DB12353,Ulodesine,small molecule,investigational,Carbohydrates|Imines|Imino Sugars|Pyrimidines|Pyrrolidines,OC[C@H]1CN(CC2=CNC3=C2N=CNC3=O)C[C@@H]1O,447268
10344,DB12354,Imrecoxib,small molecule,investigational,"Acids|Acids, Noncarboxylic|Anions|Electrolytes|Gases|Hydrogen Sulfide|Ions|Sulfur Compounds",CCCN1CC(=C(C1=O)C1=CC=C(C)C=C1)C1=CC=C(C=C1)S(C)(=O)=O,11682175
10345,DB12355,Netazepide,small molecule,investigational,"Benzazepines|Benzene Derivatives|Heterocyclic Compounds, Fused-Ring|Receptors, Cholecystokinin, antagonists & inhibitors",CNC1=CC(NC(=O)N[C@@H]2N=C(C3=CC=CC=N3)C3=CC=CC=C3N(CC(=O)C(C)(C)C)C2=O)=CC=C1,9870520
10347,DB12357,BMS-863233,small molecule,investigational,,[H][C@]1(CCCN1)C1=NC2=C(OC3=C2C=C(Cl)C=C3)C(=O)N1,57899889
10348,DB12358,Enbucrilate,small molecule,investigational,"Acids, Acyclic|Acrylates|Compounds used in a research, industrial, or household setting|Cyanoacrylates|Equipment and Supplies|Macromolecular Substances|Nitriles|Polymers|Surgical Equipment|Surgical Fixation Devices|Tissue Adhesives",CCCCOC(=O)C(=C)C#N,23087
10349,DB12359,BIIB021,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|HSP90 Heat-Shock Proteins, antagonists & inhibitors|Purines",COC1=C(C)C=NC(CN2C=NC3=C(Cl)N=C(N)N=C23)=C1C,16736529
10350,DB12360,PF-03654764,small molecule,investigational,Cycloparaffins|Histamine H3 Antagonists,CC(C)CNC(=O)[C@H]1C[C@](F)(C1)C1=CC(F)=C(CN2CCCC2)C=C1,16119082
10351,DB12361,Piclozotan,small molecule,investigational,Agents that produce hypertension|Antidepressive Agents|Azepines|Central Nervous System Depressants|Neurotransmitter Agents|Serotonin 5-HT1 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists,ClC1=COC2=CC=CC=C2C(=O)N1CCCCN1CCC(=CC1)C1=CC=CC=N1,9801640
10352,DB12362,Diaminopropanol tetraacetic acid,small molecule,approved|investigational,,OC(CN(CC(O)=O)CC(O)=O)CN(CC(O)=O)CC(O)=O,18465
10354,DB12364,Betrixaban,small molecule,approved|investigational,"Acids, Carbocyclic|Amides|Anticoagulants|Antithrombins|Benzene Derivatives|Benzoates|Enzyme Inhibitors|Factor Xa Inhibitors|Hematologic Agents|P-glycoprotein substrates|Protease Inhibitors|Serine Protease Inhibitors",COC1=CC=C(NC(=O)C2=CC=C(C=C2)C(=N)N(C)C)C(=C1)C(=O)NC1=CC=C(Cl)C=N1,10275777
10355,DB12365,Perzinfotel,small molecule,investigational,Aza Compounds|Organophosphorus Compounds,OP(O)(=O)CCN1CCCNC2=C1C(=O)C2=O,6918236
10357,DB12367,Selurampanel,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Quinazolines",CC(C)C1=C(C=C2C(NC(=O)N(NS(C)(=O)=O)C2=O)=C1)C1=CC=NN1C,45381907
10358,DB12368,AZD-3839,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",NC1=N[C@@](C2=CC=CC(F)=C12)(C1=CC=CC(=C1)C1=CN=CN=C1)C1=CC=NC(=C1)C(F)F,46202416
10359,DB12369,Sotrastaurin,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CN1CCN(CC1)C1=NC(C2=C(C(=O)NC2=O)C2=CNC3=C2C=CC=C3)=C2C=CC=CC2=N1,10296883
10360,DB12370,Ipamorelin,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Peptides",CC(C)(N)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@H](CC1=CC=C2C=CC=CC2=C1)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(N)=O,9831659
10361,DB12371,Siponimod,small molecule,approved|investigational,"Agents that produce hypertension|Azetines|Benzene Derivatives|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Immunomodulatory Agents|Immunosuppressive Agents|Receptors, Lysosphingolipid, antagonists & inhibitors",CCC1=CC(=CC=C1CN1CC(C1)C(O)=O)C(\C)=N\OCC1=CC=C(C2CCCCC2)C(=C1)C(F)(F)F,44599207
10364,DB12375,Oglemilast,small molecule,investigational,,CS(=O)(=O)NC1=CC2=C(OC3=C2C(=CC=C3OC(F)F)C(=O)NC2=C(Cl)C=NC=C2Cl)C=C1,11387409
10365,DB12376,Ricolinostat,small molecule,investigational,Amines|Antineoplastic Agents|Enzyme Inhibitors|Histone Deacetylase Inhibitors|Hydroxy Acids|Hydroxylamines|Moderate Risk QTc-Prolonging Agents|QTc Prolonging Agents,ONC(=O)CCCCCCNC(=O)C1=CN=C(N=C1)N(C1=CC=CC=C1)C1=CC=CC=C1,53340666
10366,DB12377,Relebactam,small molecule,approved|investigational,Aza Compounds|beta-Lactamase Inhibitors|Enzyme Inhibitors|MATE 1 Substrates|MATE 2 Substrates|MATE substrates|OAT3/SLC22A8 Substrates,OS(=O)(=O)ON1[C@H]2C[N@]([C@@H](CC2)C(=O)NC2CCNCC2)C1=O,44129647
10367,DB12378,Apricoxib,small molecule,investigational,Amides|Sulfones|Sulfur Compounds,CCOC1=CC=C(C=C1)C1=CC(C)=CN1C1=CC=C(C=C1)S(N)(=O)=O,9820073
10368,DB12379,Indirubin,small molecule,investigational,"Antibiotics, Antineoplastic|Antineoplastic Agents|Coloring Agents|Compounds used in a research, industrial, or household setting|Heterocyclic Compounds, Fused-Ring|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|Protein Kinase Inhibitors",O=C1NC2=C(C=CC=C2)\C1=C1/NC2=C(C=CC=C2)C1=O,5359405
10369,DB12380,GDC-0152,small molecule,investigational,Cycloparaffins,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)NC1=C(N=NS1)C1=CC=CC=C1,46940575
10370,DB12381,Merestinib,small molecule,investigational,"Antineoplastic Agents|Heterocyclic Compounds, Fused-Ring|Nicotinic Acids|Protein Kinase Inhibitors|Pyrazoles|Pyridines",CN1N=CC2=CC(OC3=C(F)C=C(NC(=O)C4=CC=C(C)N(C4=O)C4=CC=C(F)C=C4)C=C3)=C(C=C12)C1=CNN=C1,44603533
10371,DB12382,R-306465,small molecule,investigational,Amines|Antineoplastic Agents|Enzyme Inhibitors|Histone Deacetylase Inhibitors|Hydroxy Acids|Hydroxylamines|Sulfur Compounds,ONC(=O)C1=CN=C(N=C1)N1CCN(CC1)S(=O)(=O)C1=CC2=CC=CC=C2C=C1,10309899
10372,DB12383,Cytochlor,small molecule,investigational,,NC1=NC(=O)N(C=C1Cl)[C@H]1C[C@H](O)[C@@H](CO)O1,100802
10373,DB12384,AR-67,small molecule,investigational,Alkaloids,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=CC(O)=CC1=C3[Si](C)(C)C(C)(C)C)C2=O,6712744
10374,DB12385,10-hydroxycamptothecin,small molecule,investigational,"Alkaloids|Antineoplastic Agents|Antineoplastic Agents, Phytogenic",CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=CC(O)=CC1=C3)C2=O,97226
10376,DB12387,OSI-027,small molecule,investigational,,COC1=C2NC(=CC2=CC=C1)C1=C2N(N=CN=C2N)C(=N1)[C@H]1CC[C@@H](CC1)C(O)=O,72698550
10377,DB12388,Evocalcet,small molecule,investigational,,C[C@@H](N[C@H]1CCN(C1)C1=CC=C(CC(O)=O)C=C1)C1=C2C=CC=CC2=CC=C1,71242808
10378,DB12389,Zamicastat,small molecule,investigational,"Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Pyrans",FC1=CC(F)=C2OC[C@@H](CC2=C1)N1C(=S)NC=C1CCNCC1=CC=CC=C1,25052630
10379,DB12390,MBX-8025,small molecule,investigational,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids|PPAR delta, agonists",CCO[C@H](COC1=CC=C(C=C1)C(F)(F)F)CSC1=CC=C(OCC(O)=O)C(C)=C1,11236126
10380,DB12391,Sagopilone,small molecule,investigational,"Anti-Bacterial Agents|Antineoplastic Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Lactones|Macrolides|Polyketides|Sulfur Compounds|Thiazoles",C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](CC=C)[C@H]1O)C1=CC=C2SC(C)=NC2=C1,11284169
10381,DB12392,Resminostat,small molecule,investigational,Amides|Amines|Hydroxy Acids|Hydroxylamines|Sulfones|Sulfur Compounds,CN(C)CC1=CC=C(C=C1)S(=O)(=O)N1C=CC(\C=C\C(=O)NO)=C1,11609955
10382,DB12393,Fanapanel,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Organophosphorus Compounds",OP(O)(=O)CN1C(=O)C(=O)NC2=C1C=C(N1CCOCC1)C(=C2)C(F)(F)F,208953
10383,DB12394,Eleclazine,small molecule,investigational,Azepines,FC(F)(F)OC1=CC=C(C=C1)C1=CC=C2OCCN(CC3=NC=CC=N3)C(=O)C2=C1,71183216
10384,DB12395,Esreboxetine,small molecule,investigational,Adrenergic Uptake Inhibitors|Antidepressive Agents|Central Nervous System Depressants|Oxazines,[H][C@]1(CNCCO1)[C@@H](OC1=CC=CC=C1OCC)C1=CC=CC=C1,65856
10386,DB12397,DSM-265,small molecule,investigational,,CC1=NC2=NC(=NN2C(NC2=CC=C(C=C2)S(F)(F)(F)(F)F)=C1)C(C)(F)F,51347395
10387,DB12398,Naproxen etemesil,small molecule,investigational,,COC1=CC2=CC=C(C=C2C=C1)[C@H](C)C(=O)OCCS(C)(=O)=O,25170420
10388,DB12399,Polmacoxib,small molecule,investigational,"Amides|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|COX-2 Inhibitors|Cyclooxygenase Inhibitors|Musculo-Skeletal System|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sulfones|Sulfur Compounds",CC1(C)OC(=C(C1=O)C1=CC=CC(F)=C1)C1=CC=C(C=C1)S(N)(=O)=O,9841854
10389,DB12400,Voxtalisib,small molecule,investigational,"Amides|Heterocyclic Compounds, Fused-Ring|Phosphatidylinositol 3-Kinase, antagonists & inhibitors|Sulfones|Sulfur Compounds",CCN1C(=O)C(=CC2=C(C)N=C(N)N=C12)C1=CC=NN1,16123056
10390,DB12401,Bromperidol,small molecule,approved|investigational,Antipsychotic Agents|Butyrophenone Derivatives|Butyrophenones|Central Nervous System Agents|Central Nervous System Depressants|Ketones|Nervous System|Neurotoxic agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Br)C=C1,2448
10391,DB12402,Pumosetrag,small molecule,investigational,,O=C(N[C@H]1CN2CCC1CC2)C1=CNC2=C(SC=C2)C1=O,154104
10392,DB12403,Samarium,small molecule,investigational,"Elements|Lanthanoid Series Elements|Metals|Metals, Rare Earth",[Sm],23951
10393,DB12404,Remimazolam,small molecule,investigational,"Benzazepines|Heterocyclic Compounds, Fused-Ring",COC(=O)CC[C@@H]1N=C(C2=CC=CC=N2)C2=CC(Br)=CC=C2N2C(C)=CN=C12,9867812
10394,DB12405,Triciribine,small molecule,investigational,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides",CN1N=C(N)C2=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C3=C2C1=NC=N3,65399
10395,DB12406,Lisofylline,small molecule,investigational,"Adjuvants, Immunologic|Alkaloids|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antirheumatic Agents|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Immunologic Factors|Peripheral Nervous System Agents|Purines|Purinones|Radiation-Sensitizing Agents|Sensory System Agents|Xanthine derivatives",C[C@@H](O)CCCCN1C(=O)N(C)C2=C(N(C)C=N2)C1=O,501254
10396,DB12407,Iobitridol,small molecule,approved|investigational,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Iodobenzoates|Triiodobenzoic Acids|Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media|X-Ray Contrast Media, Iodinated",CN(CC(O)CO)C(=O)C1=C(I)C(C(=O)N(C)CC(O)CO)=C(I)C(NC(=O)C(CO)CO)=C1I,65985
10397,DB12408,PF-03635659,small molecule,investigational,"Acids, Carbocyclic|Azetines|Phenylacetates|Receptor, Muscarinic M3, antagonists & inhibitors",CC(C)(CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=C1)N1CC(C1)OC1=CC=CC(O)=C1,16065403
10399,DB12410,Sabarubicin,small molecule,investigational,Anthracyclines|Carbohydrates|Glycosides|Naphthacenes|Oligosaccharides|Polysaccharides,[H][C@]1(N)C[C@]([H])(O[C@]2([H])[C@]([H])(C)O[C@]([H])(C[C@]2([H])O)O[C@@]2([H])C[C@@](O)(CC3=C(O)C4=C(C(O)=C23)C(=O)C2=CC=CC=C2C4=O)C(=O)CO)O[C@@]([H])(C)[C@@]1([H])O,151897
10400,DB12411,R-428,small molecule,investigational,,NC1=NC(NC2=CC=C3CC[C@@H](CCC3=C2)N2CCCC2)=NN1C1=CC2=C(N=N1)C1=CC=CC=C1CCC2,46215462
10401,DB12412,Gemigliptin,small molecule,investigational,"Agents causing angioedema|Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Diabetes Mellitus, Type 2, drug therapy|DPP-IV Inhibitors|Drugs Used in Diabetes|Piperidines",N[C@H](CN1CC(F)(F)CCC1=O)CC(=O)N1CCC2=C(C1)N=C(N=C2C(F)(F)F)C(F)(F)F,11953153
10403,DB12414,Usistapide,small molecule,investigational,,COC(=O)[C@H](N1CCC(CC1)C1=CC=C(NC(=O)C2=CC=CC=C2C2=CC=C(C=C2)C(F)(F)F)C=C1)C1=CC=CC=C1,56842069
10404,DB12415,Galeterone,small molecule,investigational,"Androstanes|Androstenes|Enzyme Inhibitors|Fused-Ring Compounds|Heterocyclic Compounds, Fused-Ring|Steroid 17-alpha-Hydroxylase, antagonists & inhibitors|Steroids",[H][C@@]12CC=C(N3C=NC4=CC=CC=C34)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C,11188409
10405,DB12416,VTP-27999,small molecule,investigational,"Acids, Acyclic|Agents Acting on the Renin-Angiotensin System|Renin-Inhibitors",[H][C@]1(CCCN(C1)C(=O)NC[C@H](C[C@H]1CCCOC1)NC)[C@@H](OCCNC(=O)OC)C1=CC=CC(Cl)=C1,16126898
10406,DB12417,Anagliptin,small molecule,investigational,Agents causing angioedema|Blood Glucose Lowering Agents|DPP-IV Inhibitors|Enzyme Inhibitors|Protease Inhibitors,CC1=NN2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N,44513473
10407,DB12418,Saccharin,small molecule,investigational,"Benzothiazoles|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Flavoring Agents|Food|Food Additives|Food and Beverages|Food Ingredients|Heterocyclic Compounds, Fused-Ring|Pharmaceutic Aids|Pharmaceutical Preparations|Physiological Phenomena|Sulfur Compounds|Sweetening Agents|Thiazoles",O=C1NS(=O)(=O)C2=C1C=CC=C2,5143
10408,DB12419,HSD-016,small molecule,investigational,Alcohols,C[C@@H]1CN(CCN1S(=O)(=O)C1=CC=CC(=C1)[C@@](C)(O)C(F)(F)F)C1=CC=C(F)C=C1C(F)(F)F,16721125
10409,DB12420,Diazepinomicin,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Terpenes",CC(C)=CCC\C(C)=C\CC\C(C)=C\CN1C2=CC(O)=CC(O)=C2NC2=C(C=CC=C2O)C1=O,9868980
10411,DB12422,Sulforaphane,small molecule,investigational,"Anticarcinogenic Agents|Antineoplastic Agents|Compounds used in a research, industrial, or household setting|Isocyanates|Protective Agents|Sulfur Compounds",C[S@@](=O)CCCCN=C=S,9577379
10412,DB12423,Fozivudine Tidoxil,small molecule,investigational,"Carbohydrates|Deoxyribonucleosides|Dideoxynucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines",CCCCCCCCCCCCSCC(COP(O)(=O)OC[C@H]1O[C@H](C[C@@H]1N=[N+]=[N-])N1C=C(C)C(=O)NC1=O)OCCCCCCCCCC,64140
10413,DB12424,MK-3207,small molecule,investigational,"Receptors, Calcitonin Gene-Related Peptide, antagonists & inhibitors",FC1=CC(=CC(F)=C1)[C@@H]1CNC2(CCCC2)C(=O)N1CC(=O)NC1=CC=C2C[C@]3(CC2=C1)C(=O)NC1=C3C=CC=N1,25019940
10414,DB12425,Liothyronine I-131,small molecule,investigational,Thyroxine-binding globulin substrates,N[C@@H](CC1=CC([131I])=C(OC2=CC([131I])=C(O)C=C2)C([131I])=C1)C(O)=O,23724940
10415,DB12426,Bitopertin,small molecule,investigational,Sulfur Compounds,C[C@H](OC1=CC=C(C=C1C(=O)N1CCN(CC1)C1=C(F)C=C(C=N1)C(F)(F)F)S(C)(=O)=O)C(F)(F)F,24946690
10416,DB12427,Orvepitant,small molecule,investigational,Antidepressive Agents|Central Nervous System Depressants,C[C@@H](N(C)C(=O)N1CC[C@@H](C[C@@H]1C1=CC=C(F)C=C1C)N1CCN2[C@@H](CCC2=O)C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,9852175
10417,DB12428,PAC-14028,small molecule,investigational,"Acids, Acyclic|Acrylates|Amides|TRPV Cation Channels, antagonists & inhibitors",CCCC1=C(\C=C\C(=O)N[C@H](C)C2=CC(F)=C(NS(C)(=O)=O)C(F)=C2)C=CC(=N1)C(F)(F)F,56649347
10418,DB12429,CI-1040,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Calcium-Calmodulin-Dependent Protein Kinases",FC1=C(F)C(NC2=CC=C(I)C=C2Cl)=C(C=C1)C(=O)NOCC1CC1,6918454
10420,DB12432,CC-401,small molecule,investigational,"JNK Mitogen-Activated Protein Kinases, antagonists & inhibitors|Pyrazoles",C(CN1CCCCC1)OC1=CC=CC(=C1)C1=NNC2=CC=C(C=C12)C1=NNC=N1,10430360
10421,DB12433,SCH-900271,small molecule,investigational,,CC1(CCCC2=CC(=O)OC3=C2C(=O)NC(=O)N3)CC1,56950369
10422,DB12434,Steviolbioside,small molecule,approved|investigational,"Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Diterpenes|Flavoring Agents|Food|Food Additives|Food and Beverages|Food Ingredients|Pharmaceutic Aids|Pharmaceutical Preparations|Physiological Phenomena|Stevia|Sweetening Agents|Terpenes",C[C@@]12CCC[C@](C)([C@H]1CC[C@@]13CC(=C)[C@@](C1)(CC[C@@H]23)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(O)=O,16401639
10423,DB12435,Tipelukast,small molecule,investigational,,CCCC1=C(O)C(=CC=C1SCCCOC1=C(CCC)C(OCCCC(O)=O)=C(C=C1)C(C)=O)C(C)=O,9893228
10424,DB12436,Vofopitant,small molecule,investigational,Antiemetics|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Neurokinin-1 Receptor Antagonists|Neurotransmitter Agents|Peripheral Nervous System Agents,COC1=CC=C(C=C1CN[C@H]1CCCN[C@H]1C1=CC=CC=C1)N1N=NN=C1C(F)(F)F,6918331
10425,DB12438,Filociclovir,small molecule,investigational,,NC1=NC2=C(N=CN2\C=C2\CC2(CO)CO)C(=O)N1,3006048
10426,DB12439,Ioforminol,small molecule,investigational,"Acids, Acyclic|Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Formates|Iodine Radioisotopes|Iodobenzoates",OCC(O)CNC(=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(N(CC(O)CN(C=O)C2=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C2I)C=O)=C1I,25222171
10427,DB12440,Verdiperstat,small molecule,investigational,Pyrimidines,CC(C)OCCN1C2=C(NC=C2)C(=O)NC1=S,11528958
10428,DB12441,Tavilermide,small molecule,investigational,,NCCCC[C@@H]1NC(=O)[C@H](CCC(O)=O)NC(=O)C2=C(OCC[C@H](NC1=O)C(=O)NCC(O)=O)C=CC(=C2)[N+]([O-])=O,9808372
10429,DB12442,Alvespimycin,small molecule,investigational,Amides|HSP90 Heat-Shock Proteins|Lactams|Quinones,CO[C@H]1C[C@H](C)CC2=C(NCCN(C)C)C(=O)C=C(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O,5288674
10430,DB12443,Sonedenoson,small molecule,investigational,"Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides",NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC(OCCC2=CC=C(Cl)C=C2)=N1,9910098
10431,DB12444,Theanine,small molecule,investigational,"Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins",CCNC(=O)CC[C@H](N)C(O)=O,439378
10432,DB12445,Nitroaspirin,small molecule,investigational,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiplatelet agents|Antirheumatic Agents|Benzene Derivatives|Benzoates|Cardiovascular Agents|Central Nervous System Agents|Cysteine Proteinase Inhibitors|Enzyme Inhibitors|Fibrin Modulating Agents|Hematologic Agents|Hydroxy Acids|Hydroxybenzoates|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Phenols|Protease Inhibitors|Salicylates|Sensory System Agents",CC(=O)OC1=CC=CC=C1C(=O)OC1=CC=CC(CO[N+]([O-])=O)=C1,119032
10433,DB12446,Derenofylline,small molecule,investigational,,O[C@H]1CC[C@@H](CC1)NC1=C2C=CNC2=NC(=N1)C1=CC=CC=C1,9953065
10434,DB12447,Nadifloxacin,small molecule,investigational,"Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Bacterial Agents|Anti-Infective Agents|Antiinfectives for Treatment of Acne|Dermatologicals|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",CC1CCC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N1CCC(O)CC1,4410
10435,DB12448,Lifibrol,small molecule,investigational,"Acids, Carbocyclic|Alcohols|Benzene Derivatives|Benzoates|Fatty Alcohols|Hydroxy Acids|Lipids|Phenols",CC(C)(C)C1=CC=C(CCC(O)COC2=CC=C(C=C2)C(O)=O)C=C1,57112
10436,DB12449,Tempol,small molecule,investigational,"Antioxidants|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Drug Synergism|Enzyme Inhibitors|Free Radicals|Neuroprotective Agents|Protective Agents|Protein Synthesis Inhibitors|Radiation-Protective Agents|Spin Labels",CC1(C)CC(O)CC(C)(C)N1[O],137994
10437,DB12450,Propyl Gallate,small molecule,investigational,"Acids, Carbocyclic|Antioxidants|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Gallic Acid|Hydroxy Acids|Hydroxybenzoates|Phenols|Protective Agents",CCCOC(=O)C1=CC(O)=C(O)C(O)=C1,4947
10438,DB12451,SCY-635,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Peptides|Peptides, Cyclic",CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)(C)O)N(C)C(=O)[C@@H](SCCN(C)C)N(C)C1=O)C(C)C,6479267
10439,DB12452,Caprylic alcohol,small molecule,investigational,"Alcohols|Compounds used in a research, industrial, or household setting|Fatty Alcohols|Lipids|Octanols|Solvents",CCCCCCCCO,957
10440,DB12453,Chlorine Dioxide,small molecule,investigational,"Anions|Anti-Infective Agents|Compounds used in a research, industrial, or household setting|Dental Disinfectants|Disinfectants|Electrolytes|Ions|Oxygen Compounds",O=[Cl]=O,24870
10441,DB12454,Zalypsis,small molecule,investigational,"Alkaloids|Heterocyclic Compounds, Fused-Ring|Isoquinolines",COC1=C(O)C2=C(C[C@H]3[C@H](O)N4[C@@H](CC5=C([C@@H]4CNC(=O)\C=C\C4=CC=CC(=C4)C(F)(F)F)C4=C(OCO4)C(C)=C5OC(C)=O)[C@@H]2N3C)C=C1C,16061448
10442,DB12455,Omadacycline,small molecule,approved|investigational,Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Naphthacenes|P-glycoprotein substrates|Tetracyclines,[H][C@@]12CC3=C(C=C(CNCC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2)N(C)C,54697325
10444,DB12457,Rimegepant,small molecule,approved|investigational,Antimigraine Preparations|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|MATE 1 Inhibitors|MATE inhibitors|Migraine Disorders|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|OCT2 Inhibitors|P-glycoprotein substrates,N[C@H]1[C@@H](CC[C@@H](OC(=O)N2CCC(CC2)N2C(=O)NC3=NC=CC=C23)C2=C1C=CC=N2)C1=C(F)C(F)=CC=C1,51049968
10445,DB12458,Muscimol,small molecule,investigational,"Biological Factors|GABA Agents|GABA Agonists|GABA-A Receptor Agonists|Mycotoxins|Neurotransmitter Agents|Oxazoles|Toxins, Biological",NCC1=CC(=O)NO1,4266
10446,DB12459,Belotecan,small molecule,investigational,Alkaloids|Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase I Inhibitors|Topoisomerase Inhibitors,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=CC=CC1=C3CCNC(C)C)C2=O,6456014
10448,DB12461,GLPG-0492,small molecule,investigational,Androgens|Imidazoles|Imidazolidines,CN1C(=O)N(C(=O)[C@@]1(CO)C1=CC=CC=C1)C1=CC=C(C#N)C(=C1)C(F)(F)F,59317190
10449,DB12462,Ralinepag,small molecule,investigational,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids",OC(=O)COC[C@H]1CC[C@H](COC(=O)N(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)CC1,44219292
10450,DB12463,Semagacestat,small molecule,investigational,"Amino Acids|Amino Acids, Peptides, and Proteins|Amyloid Precursor Protein Secretases, antagonists & inhibitors",CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@H]1C2=CC=CC=C2CCN(C)C1=O,9843750
10451,DB12464,Bevenopran,small molecule,investigational,,COC1=CC(CNCCC2CCOCC2)=CC=C1OC1=CN=C(C=N1)C(N)=O,10452732
10452,DB12465,Ketanserin,small molecule,investigational,"Antidepressive Agents|Antihypertensive Agents|Antiplatelet agents|Cardiovascular Agents|Central Nervous System Depressants|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|Piperidines|Quinazolines|Quinazolinones|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Antagonists",FC1=CC=C(C=C1)C(=O)C1CCN(CCN2C(=O)NC3=CC=CC=C3C2=O)CC1,3822
10453,DB12466,Favipiravir,small molecule,approved|investigational,Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Experimental Unapproved Treatments for COVID-19|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|P-glycoprotein inhibitors,NC(=O)C1=NC(F)=CN=C1O,492405
10454,DB12467,TU-100,small molecule,investigational,"DNA Topoisomerases, Type I|DNA Topoisomerases, Type II|Naphthalenes|Quinones|Topoisomerase Inhibitors",CN1C2C3=C(C1C1=CC=CC=C1C2=O)C(=O)C1=CC=CC=C1C3=O,72942015
10455,DB12468,Pf-04531083,small molecule,investigational,,COC1=CC=C(Cl)C(=C1)C1=CC=C(NC(=O)C2=CC=NN2C)N=C1N,57582353
10456,DB12470,Dexelvucitabine,small molecule,investigational,"Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Carbohydrates|Deoxycytidine|Deoxyribonucleosides|Dideoxynucleosides|Enzyme Inhibitors|Glycosides|HIV Reverse Transcriptase|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Reverse Transcriptase Inhibitors|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Reverse Transcriptase Inhibitors|Ribonucleosides",NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](CO)C=C1,64973
10457,DB12471,MK-3118,small molecule,investigational,Carbohydrates|Terpenes,CC(C)[C@@H](C)[C@@]1(C)CC[C@]2(C)[C@H]3CC[C@H]4[C@@]5(C)COC[C@@]4(C[C@H]([C@@H]5OC[C@](C)(N)C(C)(C)C)N4N=CN=C4C4=CC=NC=C4)C3=CC[C@@]2(C)[C@@H]1C(O)=O,46871657
10458,DB12472,Levodropropizine,small molecule,investigational,Alcohols|Antitussive Agents|Central Nervous System Agents|Cough and Cold Preparations|Glycols|Respiratory System Agents,[H][C@@](O)(CO)CN1CCN(CC1)C1=CC=CC=C1,65859
10459,DB12473,Taurolidine,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Alkanes|Alkanesulfonic Acids|Anti-Infective Agents|Anti-Infective Agents, Local|Antineoplastic Agents|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Hydrocarbons, Acyclic|Irrigating Solutions|Sulfonic Acids|Sulfur Acids|Sulfur Compounds|Thiazines",O=S1(=O)CCN(CN2CCS(=O)(=O)NC2)CN1,29566
10460,DB12474,Lynestrenol,small molecule,approved|investigational,"Adrenal Cortex Hormones|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Estren Derivatives|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Norpregnanes|Norpregnenes|Norsteroids|Progestin Contraceptives|Progestins|Progestogens and Estrogens, Sequential Preparations|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids",C[C@]12CC[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,5857
10461,DB12475,Biphenyl dimethyl dicarboxylate,small molecule,investigational,,COC(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)C(=O)OC,13099
10462,DB12476,CPG-52852,small molecule,investigational,,CCC1=NC2=C(N1CCCCNS(C)(=O)=O)C1=CC=CC=C1N=C2N,10309114
10463,DB12477,Perfluoro tert-butylcyclohexane,small molecule,investigational,"Hydrocarbons, Fluorinated|Hydrocarbons, Halogenated",FC(F)(F)C(C(F)(F)F)(C(F)(F)F)C1(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C1(F)F,15710945
10464,DB12478,Piribedil,small molecule,investigational,Anti-Dyskinesia Agents|Anti-Parkinson Agents (Dopamine Agonist)|Anti-Parkinson Drugs|Central Nervous System Agents|Dopamine Agents|Dopamine Agonists|Nervous System|Neurotransmitter Agents|Nonergot-derivative Dopamine Receptor Agonists|Piperazines,C(N1CCN(CC1)C1=NC=CC=N1)C1=CC2=C(OCO2)C=C1,4850
10465,DB12479,Zabofloxacin,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Quinolines|Quinolones",CON=C1CN(CC11CNC1)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=N1)C(O)=O,9952872
10466,DB12480,Betulinic Acid,small molecule,investigational,"Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-HIV Agents|Anti-Infective Agents|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Retroviral Agents|Antimalarials|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Antiparasitic Agents|Antiprotozoals|Antirheumatic Agents|Antiviral Agents|Central Nervous System Agents|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Prostaglandin Antagonists|Sensory System Agents|Terpenes",[H]OC(=O)[C@]12CC[C@@]([H])(C(C)=C)[C@]1([H])[C@@]1([H])CC[C@]3([H])[C@@]4(C)CC[C@]([H])(O[H])C(C)(C)[C@]4([H])CC[C@@]3(C)[C@]1(C)CC2,64971
10467,DB12481,Barium,small molecule,investigational,"Elements|Metals|Metals, Alkaline Earth|Metals, Heavy",[Ba],5355457
10468,DB12482,Acotiamide,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Cholinergic Agents|Cholinesterase Inhibitors|Enzyme Inhibitors|Gastrointestinal Agents|Neurotransmitter Agents|Sulfur Compounds",COC1=C(OC)C=C(C(=O)NC2=NC(=CS2)C(=O)NCCN(C(C)C)C(C)C)C(O)=C1,5282338
10469,DB12483,Copanlisib,small molecule,approved|investigational,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Kinase Inhibitor|MATE 2 Inhibitors|MATE inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index",COC1=C(OCCCN2CCOCC2)C=CC2=C1N=C(NC(=O)C1=CN=C(N)N=C1)N1CCN=C21,24989044
10470,DB12484,Tetrahydrouridine,small molecule,investigational,"Antimetabolites|Carbohydrates|Glycosides|Noxae|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides|Toxic Actions",OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CCC(O)NC1=O,29243
10471,DB12485,Pimonidazole,small molecule,investigational,Imidazoles|Nitro Compounds|Radiation-Sensitizing Agents,OC(CN1C=CN=C1[N+]([O-])=O)CN1CCCCC1,50981
10472,DB12486,Elobixibat,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Azepines|Oligopeptides|Peptides|Sulfur Compounds|Thiepins",CCCCC1(CCCC)CN(C2=CC=CC=C2)C2=CC(SC)=C(OCC(=O)N[C@@H](C(=O)NCC(O)=O)C3=CC=CC=C3)C=C2S(=O)(=O)C1,9939892
10473,DB12487,Promestriene,small molecule,investigational,"Estradiol Congeners|Estranes|Estrenes|Estrogens|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Natural and Semisynthetic Estrogens, Plain|Sex Hormones and Modulators of the Genital System|Steroids",,
10476,DB12491,Fasiglifam,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Sulfur Compounds",CC1=CC(OCCCS(C)(=O)=O)=CC(C)=C1C1=CC=CC(COC2=CC=C3[C@H](CC(O)=O)COC3=C2)=C1,24857286
10477,DB12492,Piritramide,small molecule,approved|investigational,Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Diphenylpropylamine Derivatives|Isonipecotic Acids|Narcotics|Nervous System|Opioids|Peripheral Nervous System Agents|Piperidines|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,NC(=O)C1(CCN(CCC(C#N)(C2=CC=CC=C2)C2=CC=CC=C2)CC1)N1CCCCC1,9331
10478,DB12493,PD-217014,small molecule,investigational,"Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Aminobutyrates|Butyrates|Fatty Acids|Fatty Acids, Volatile|Ligands|Lipids",COC(=O)C[C@@]1(CN)C[C@@H]2CC[C@@H]2C1,45098889
10479,DB12494,SGI-1776,small molecule,investigational,,CN1CCC(CNC2=NN3C(C=C2)=NC=C3C2=CC=CC(OC(F)(F)F)=C2)CC1,24795070
10480,DB12495,Selepressin,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary Hormones|Pituitary Hormones, Posterior|Proteins|Receptors, Vasopressin, agonists|Vasopressin and Analogues|Vasopressins",CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O,53330936
10481,DB12497,Alagebrium,small molecule,investigational,Sulfur Compounds,CC1=C(C)[N+](CC(=O)C2=CC=CC=C2)=CS1,216305
10483,DB12499,Clascoterone,small molecule,investigational,"17-Hydroxycorticosteroids|Acids, Acyclic|Adrenal Cortex Hormones|Fatty Acids|Fatty Acids, Volatile|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Lipids|Pregnanes|Pregnenediones|Pregnenes|Steroids",[H][C@@]12CC[C@](OC(=O)CC)(C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,11750009
10484,DB12500,Fedratinib,small molecule,approved|investigational,Amides|BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|MATE 1 Inhibitors|MATE 2 Inhibitors|MATE inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Sulfones|Sulfur Compounds|Tyrosine Kinase Inhibitors,CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C,16722836
10485,DB12501,ABT-384,small molecule,investigational,"11-beta-Hydroxysteroid Dehydrogenase Type 1, antagonists & inhibitors|Cycloparaffins",CC(C)(N1CCN(CC1)C1=NC=C(C=C1)C(F)(F)F)C(=O)N[C@H]1C2CC3CC1C[C@@](C3)(C2)C(N)=O,11670435
10486,DB12504,JNJ-40346527,small molecule,investigational,,CC1(C)CCC(=CC1)C1=C(NC(=O)C2=NC=C(N2)C#N)C=CC(=N1)C1CC(C)(C)OC(C)(C)C1,25230468
10487,DB12505,E-7820,small molecule,investigational,"Amides|Heterocyclic Compounds, Fused-Ring|Sulfones|Sulfur Compounds",CC1=C2C(=CNC2=C(NS(=O)(=O)C2=CC=CC(=C2)C#N)C=C1)C#N,196970
10488,DB12506,Fenamole,small molecule,investigational,,NC1=NN=NN1C1=CC=CC=C1,21640
10489,DB12507,Atecegatran metoxil,small molecule,investigational,Azetines,CO\N=C(/N)C1=CC=C(CNC(=O)[C@@H]2CCN2C(=O)[C@H](O)C2=CC(OC(F)F)=CC(Cl)=C2)C=C1,9961205
10490,DB12508,E7107,small molecule,investigational,,CC[C@H](O)[C@@H](C)[C@H]1O[C@@H]1C[C@@](C)(O)\C=C\C=C(/C)[C@H]1OC(=O)C[C@H](O)CC[C@@](C)(O)[C@@H](OC(=O)N2CCN(CC2)C2CCCCCC2)\C=C\[C@@H]1C,16202132
10491,DB12509,Imeglimin,small molecule,investigational,,C[C@@H]1NC(N)=NC(=N1)N(C)C,24812808
10492,DB12510,Ozone,small molecule,investigational,"Chalcogens|Compounds used in a research, industrial, or household setting|Elements|Gases|Noxae|Oxidants|Oxidants, Photochemical|Toxic Actions",[O-][O+]=O,24823
10493,DB12511,Imiglitazar,small molecule,investigational,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids",CC1=C(COC2=CC=C(CO\N=C(/CCC(O)=O)C3=CC=CC=C3)C=C2)N=C(O1)C1=CC=CC=C1,9890879
10494,DB12512,Verucerfont,small molecule,investigational,"Aza Compounds|Oxazoles|Receptors, Corticotropin-Releasing Hormone, antagonists & inhibitors",CC[C@H](NC1=CC(C)=NC2=C(C(C)=NN12)C1=CC=C(OC)C=C1C)C1=NC(C)=NO1,11596613
10495,DB12513,Omaveloxolone,small molecule,investigational,Terpenes,CC(F)(F)C(=O)N[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@]4(C)C=C(C#N)C(=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2,71811910
10496,DB12514,Iofolastat I-123,small molecule,investigational,"Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins",OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNCC1=CC=C([123I])C=C1)C(O)=O)C(O)=O,25194767
10497,DB12515,9-aminocamptothecin,small molecule,investigational,Alkaloids|Antineoplastic Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=CC=C(N)C1=C3)C2=O,72402
10498,DB12517,PF-00446687,small molecule,investigational,"Receptor, Melanocortin, Type 4, agonists",C[C@H]1CN(C[C@@H](C)[C@]1(O)C1=CC=CC=C1)C(=O)[C@@H]1CN(C[C@H]1C1=CC=C(F)C=C1F)C(C)(C)C,11328898
10499,DB12518,Raclopride,small molecule,investigational,"Acids, Carbocyclic|Amides|Antipsychotic Agents|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Central Nervous System Agents|Central Nervous System Depressants|Chlorobenzoates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Neurotoxic agents|Neurotransmitter Agents|Psychotropic Drugs|Tranquilizing Agents",CCN1CCC[C@H]1CNC(=O)C1=C(O)C(Cl)=CC(Cl)=C1OC,3033769
10500,DB12519,Sarcosine,small molecule,investigational,"Amino Acids|Amino Acids, Peptides, and Proteins|N-substituted Glycines|Peptides|Peptoids",CNCC(O)=O,1088
10502,DB12521,Methyl pyrrolidone,small molecule,investigational,Noxae|Polymers|Pyrrolidines|Teratogens|Toxic Actions,CN1CCCC1=O,13387
10503,DB12522,Toreforant,small molecule,investigational,,CN1CCC(CCCNC2=NC=C(C3=NC4=C(C)C=C(C)C=C4N3)C(C)=N2)CC1,23650961
10504,DB12523,Mizolastine,small molecule,approved|investigational,"Antihistamines for Systemic Use|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|QTc Prolonging Agents",CN(C1CCN(CC1)C1=NC2=C(C=CC=C2)N1CC1=CC=C(F)C=C1)C1=NC=CC(=O)N1,65906
10505,DB12524,BI-671800,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates",CN(C)C1=NC(CC2=CC=C(NC(=O)C3=CC=C(C=C3)C(F)(F)F)C=C2)=NC(N(C)C)=C1CC(O)=O,45270144
10507,DB12526,Batefenterol,small molecule,investigational,"Acids, Acyclic|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Anticholinergic Agents|Heterocyclic Compounds, Fused-Ring|Muscarinic Antagonists|Quinolines",COC1=CC(NC(=O)CCN2CCC(CC2)OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)=C(Cl)C=C1CNC[C@H](O)C1=C2C=CC(=O)NC2=C(O)C=C1,10372836
10508,DB12527,Sofinicline,small molecule,investigational,Aza Compounds,ClC1=C(Cl)N=CC(=C1)N1C[C@@H]2CN[C@@H]2C1,10131048
10509,DB12528,Glyceryl Trierucate,small molecule,investigational,,CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCC\C=C/CCCCCCCC)OC(=O)CCCCCCCCCCC\C=C/CCCCCCCC,5463075
10510,DB12529,Nitrite,small molecule,approved|investigational,,[O-]N=O,946
10512,DB12531,Lobucavir,small molecule,investigational,"Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Nucleic Acid Synthesis Inhibitors|Purines|Purinones|Reverse Transcriptase Inhibitors|Xanthine derivatives",NC1=NC2=C(N=CN2[C@@H]2C[C@H](CO)[C@H]2CO)C(=O)N1,60786
10513,DB12532,Oxetacaine,small molecule,approved|investigational,"Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Anesthetics|Anesthetics, Local|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Vasoprotectives",CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)CC1=CC=CC=C1)C(C)(C)CC1=CC=CC=C1,4621
10514,DB12533,Cevipabulin,small molecule,investigational,,CNCCCOC1=CC(F)=C(C(F)=C1)C1=C(N[C@@H](C)C(F)(F)F)N2N=CN=C2N=C1Cl,11488110
10516,DB12535,AC-430,small molecule,investigational,,CC1=CC(NC2=NC(=NC3=CC=CC=C23)C(O)C2=CC=C(F)C=C2)=NN1,46892373
10517,DB12536,N-acetylmannosamine,small molecule,investigational,Amino Sugars|Carbohydrates,[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(NC(C)=O)C=O,65150
10518,DB12537,Benzodiazepine,small molecule,approved|investigational,"Benzazepines|Benzodiazepines and benzodiazepine derivatives|Benzodiazepines, antagonists & inhibitors|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring",N1N=CC=CC2=CC=CC=C12,134664
10519,DB12538,Nepadutant,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Peptides|Peripheral Nervous System Agents|Receptors, Tachykinin, antagonists & inhibitors|Respiratory System Agents",CC(C)C[C@@H]1NC(=O)[C@@H]2CNC(=O)C[C@H](NC(=O)[C@H](CC(=O)N[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3NC(C)=O)NC1=O)C(=O)N[C@@H](CC1=CNC3=CC=CC=C13)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2,9876321
10520,DB12539,Oltipraz,small molecule,investigational,"Anthelmintics|Anti-Infective Agents|Anticarcinogenic Agents|Antineoplastic Agents|Antiparasitic Agents|Antiplatyhelmintic Agents|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Nucleic Acid Synthesis Inhibitors|Protective Agents|Reverse Transcriptase Inhibitors|Schistosomicides",CC1=C(SSC1=S)C1=CN=CC=N1,47318
10521,DB12540,Lecozotan,small molecule,investigational,,C[C@H](CN(C(=O)C1=CC=C(C=C1)C#N)C1=CC=CC=N1)N1CCN(CC1)C1=CC=CC2=C1OCCO2,10116877
10522,DB12541,SAR-405838,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CC(C)(C)C[C@@H]1N[C@H]([C@H](C2=C(F)C(Cl)=CC=C2)[C@]11C(=O)NC2=C1C=CC(Cl)=C2)C(=O)N[C@H]1CC[C@H](O)CC1,53476877
10523,DB12542,GSK-356278,small molecule,investigational,Oxazoles|Sulfur Compounds,CCN1N=CC2=C(NC3CCOCC3)C(=CN=C12)C1=NN=C(CC2=C(C)N=C(C)S2)O1,10252640
10524,DB12543,Samidorphan,small molecule,investigational,"Alkaloids|Central Nervous System Agents|Heterocyclic Compounds, Fused-Ring|Morphinans|Opiate Alkaloids|Opioid Antagonists|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents",NC(=O)C1=C(O)C2=C(C[C@H]3N(CC4CC4)CC[C@@]22CC(=O)CC[C@@]32O)C=C1,11667832
10525,DB12545,Indobufen,small molecule,investigational,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiplatelet agents|Antirheumatic Agents|Blood and Blood Forming Organs|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Platelet Aggregation Inhibitors Excl. Heparin|Sensory System Agents",CCC(C(O)=O)C1=CC=C(C=C1)N1CC2=CC=CC=C2C1=O,107641
10526,DB12547,LY-2886721,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Pyridines",NC1=N[C@]2(COC[C@H]2CS1)C1=C(F)C=CC(NC(=O)C2=CC=C(F)C=N2)=C1,49837968
10527,DB12548,Sparsentan,small molecule,investigational,,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C(COCC)=C1)C1=CC=CC=C1S(=O)(=O)NC1=NOC(C)=C1C,10257882
10528,DB12549,Pyrazoloacridine,small molecule,investigational,"Antineoplastic Agents|Compounds used in a research, industrial, or household setting|Heterocyclic Compounds, Fused-Ring|Indicators and Reagents|Intercalating Agents|Laboratory Chemicals",COC1=CC=C2NC3=C4C(=CC=C3[N+]([O-])=O)N(CCCN(C)C)N=C4C2=C1,5351360
10529,DB12550,Taladegib,small molecule,investigational,Pyridazines,CN(C1CCN(CC1)C1=NN=C(C2=CC=NN2C)C2=CC=CC=C12)C(=O)C1=C(C=C(F)C=C1)C(F)(F)F,49848070
10530,DB12551,Idazoxan,small molecule,investigational,"Adrenergic Agents|Adrenergic alpha-2 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Dioxanes|Heterocyclic Compounds, Fused-Ring|Imidazoles|Neurotransmitter Agents",C1CN=C(N1)C1COC2=CC=CC=C2O1,54459
10531,DB12553,Fluocinolone,small molecule,investigational,"Adrenal Cortex Hormones|Fused-Ring Compounds|Pregnadienes|Pregnanes|Steroids|Steroids, Fluorinated",C[C@]12C[C@H](O)[C@@]3(F)[C@@H](C[C@H](F)C4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO,91488
10532,DB12554,Mebeverine,small molecule,approved|investigational,"Agents Causing Muscle Toxicity|Agents producing tachycardia|Alimentary Tract and Metabolism|Amines|Anticholinergic Agents|Autonomic Agents|Central Nervous System Agents|Drugs for Functional Gastrointestinal Disorders|Ethylamines|Muscarinic Antagonists|Parasympatholytics|Peripheral Nervous System Agents|Synthetic Anticholinergics, Esters With Tertiary Amino Group",CCN(CCCCOC(=O)C1=CC(OC)=C(OC)C=C1)C(C)CC1=CC=C(OC)C=C1,4031
10533,DB12555,Nelotanserin,small molecule,investigational,Benzene Derivatives,COC1=CC=C(NC(=O)NC2=CC=C(F)C=C2F)C=C1C1=C(Br)C=NN1C,11683556
10534,DB12556,MK-5108,small molecule,investigational,"Acids, Carbocyclic|Cyclohexanes|Cycloparaffins|Protein Kinase Inhibitors|Sulfur Compounds",OC(=O)[C@@]1(CC2=CC=CC(NC3=NC=CS3)=N2)CC[C@@H](CC1)OC1=C(F)C(Cl)=CC=C1,24748204
10535,DB12557,FK-614,small molecule,investigational,,CCCCCS(=O)(=O)NC(=O)C1=CC=C2N=C(C)N(CC3=CC=C(Cl)C=C3Cl)C2=C1,9869229
10536,DB12558,AEE-788,small molecule,investigational,"ErbB Receptors, antagonists & inhibitors|Heterocyclic Compounds, Fused-Ring|Receptors, Vascular Endothelial Growth Factor, antagonists & inhibitors",CCN1CCN(CC2=CC=C(C=C2)C2=CC3=C(N2)N=CN=C3N[C@H](C)C2=CC=CC=C2)CC1,10297043
10537,DB12559,EC-17,small molecule,investigational,,NC(=O)CC[C@H](N(CCNC(=S)NC1=CC=C2C(=C1)C(=O)OC21C2=CC=C(O)C=C2OC2=C1C=CC(O)=C2)C(=O)C1=CC=C(NCC2=CN=C3N=C(N)NC(=O)C3=N2)C=C1)C(O)=O,71587764
10539,DB12561,WNT-974,small molecule,investigational,Enzyme Inhibitors,CC1=CC(=CC=N1)C1=NC=C(CC(=O)NC2=CC=C(C=N2)C2=CN=CC=N2)C=C1C,46926973
10540,DB12562,Setipiprant,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",OC(=O)CN1C2=C(CN(CC2)C(=O)C2=CC=CC3=CC=CC=C23)C2=CC(F)=CC=C12,49843471
10541,DB12563,MK-0686,small molecule,investigational,"Acetates|Acids, Acyclic|Acids, Carbocyclic|Amides|Benzene Derivatives|Fatty Acids|Fatty Acids, Volatile|Lipids",COC(=O)C1=C(Cl)C=CC=C1C1=CC=C([C@@H](C)NC(=O)C2(CC2)NC(=O)C(F)(F)F)C(F)=C1,16102897
10542,DB12564,Gemcitabine elaidate,small molecule,investigational,"Carbohydrates|Deoxyribonucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",CCCCCCCC\C=C\CCCCCCCC(=O)OC[C@H]1O[C@@H](N2C=CC(N)=NC2=O)C(F)(F)[C@@H]1O,9828310
10543,DB12565,Abexinostat,small molecule,investigational,"Amines|Antineoplastic Agents|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Histone Deacetylase Inhibitors|Hydroxy Acids|Hydroxylamines|Moderate Risk QTc-Prolonging Agents|QTc Prolonging Agents",CN(C)CC1=C(OC2=CC=CC=C12)C(=O)NCCOC1=CC=C(C=C1)C(=O)NO,11749858
10544,DB12566,Decernotinib,small molecule,investigational,"Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Heterocyclic Compounds, Fused-Ring",CC[C@@](C)(NC1=CC=NC(=N1)C1=CNC2=NC=CC=C12)C(=O)NCC(F)(F)F,59422203
10545,DB12567,Camicinal,small molecule,investigational,,C[C@H]1CN(CC2=CC=C(CC(=O)N3CCC(CC3)NC3=CC=CC(F)=C3)C=C2)CCN1,15984937
10547,DB12569,Tonapofylline,small molecule,investigational,"Alkaloids|Heterocyclic Compounds, Fused-Ring|Purines|Purinones|Receptor, Adenosine A1",CCCN1C2=C(NC(=N2)C23CCC(CCC(O)=O)(CC2)CC3)C(=O)N(CCC)C1=O,216466
10548,DB12570,CC-223,small molecule,investigational,,CO[C@H]1CC[C@@H](CC1)N1C(=O)CNC2=C1N=C(C=N2)C1=CN=C(C=C1)C(C)(C)O,58298316
10549,DB12571,Rimacalib,small molecule,investigational,Enzyme Inhibitors|Oxazines|Protein Kinase Inhibitors,[H][C@@](C)(C1=NOC(NC(=N)N2CCOCC2)=C1)C1=CC=C(C(F)=C1)C1=CC=CC=C1,9800765
10550,DB12572,Pexacerfont,small molecule,investigational,,CC[C@@H](C)NC1=NC(C)=NC2=C(C(C)=NN12)C1=CC=C(OC)N=C1C,9884366
10551,DB12573,LY-2452473,small molecule,investigational,"Acids, Acyclic",CC(C)OC(=O)N[C@@H]1CC2=C(C1)C1=CC(=CC=C1N2CC1=CC=CC=N1)C#N,24963749
10552,DB12574,LY-295501,small molecule,investigational,"Benzene Derivatives|Heterocyclic Compounds, Fused-Ring",ClC1=C(Cl)C=C(NC(=O)NS(=O)(=O)C2=CC=C3OCCC3=C2)C=C1,127737
10553,DB12575,Ronopterin,small molecule,investigational,"Biological Factors|Coenzymes|Enzymes and Coenzymes|Heterocyclic Compounds, Fused-Ring|Nitric Oxide Synthase, antagonists & inhibitors|Pigments, Biological|Pteridines|Pterins",[H][C@@]1(CNC2=C(N1)C(N)=NC(N)=N2)[C@@H](O)[C@H](C)O,5287516
10554,DB12576,AZD-3043,small molecule,investigational,"Acids, Carbocyclic|Central Nervous System Depressants|Hypnotics and Sedatives",CCCOC(=O)CC1=CC=C(OCC(=O)N(CC)CC)C(OCC)=C1,10286834
10555,DB12577,Fosbretabulin,small molecule,investigational,"Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Benzene Derivatives|Benzylidene Compounds",COC1=CC=C(\C=C/C2=CC(OC)=C(OC)C(OC)=C2)C=C1OP(O)(O)=O,5351387
10556,DB12578,Lexaptepid Pegol,small molecule,investigational,"Anti-Inflammatory Agents|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Oligonucleotides|Pegylated agents|Polynucleotides",,
10557,DB12579,JNJ-37822681,small molecule,investigational,Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Neurotransmitter Agents,FC1=C(F)C=C(CN2CCC(CC2)NC2=CC=C(N=N2)C(F)(F)F)C=C1,16058752
10558,DB12580,Tradipitant,small molecule,investigational,,FC(F)(F)C1=CC(=CC(CN2N=NC(=C2C2=CC=NC=C2)C2=NC=CC=C2C(=O)C2=CC=CC=C2Cl)=C1)C(F)(F)F,9916461
10559,DB12581,Ozarelix,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Peptides",[H]N=C(N([H])[H])N([H])CCC[C@H](N([H])C(=O)[C@H](CCCC)N([H])C(=O)[C@@H](CCCCN([H])C(=O)N([H])[H])N([H])C(=O)[C@H](CC1=CC=C(O)C=C1)N(C)C(=O)[C@H](CO)N([H])C(=O)[C@@H](CC1=CN=CC=C1)N([H])C(=O)[C@@H](CC1=CC=C(Cl)C=C1)N([H])C(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)N([H])C(C)=O)C(=O)N1CCC[C@H]1C(=O)N([H])[C@H](C)C(=O)N([H])[H],25080293
10560,DB12582,Piperine,small molecule,investigational,"Alkenes|Alkynes|Amides|Chemically-Induced Disorders|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Dioxoles|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Hydrocarbons, Acyclic|P-glycoprotein inhibitors|Piper nigrum|UDPglucose 4-Epimerase, antagonists & inhibitors",O=C(\C=C\C=C\C1=CC2=C(OCO2)C=C1)N1CCCCC1,638024
10561,DB12583,Maltodextrin,small molecule,investigational,Carbohydrates,,
10563,DB12585,Ondelopran,small molecule,investigational,Amines|Benzene Derivatives|Benzyl Compounds|Nicotinic Acids|Opioid Antagonists|Pyridines,NC(=O)C1=CC=C(OC2=C(F)C=C(CNCCC3CCOCC3)C=C2)N=C1,10457387
10564,DB12586,Anhydrovinblastine,small molecule,investigational,,CCC1=C[C@@H]2C[N@](C1)CCC1=C(NC3=CC=CC=C13)[C@@](C2)(C(=O)OC)C1=CC2=C(C=C1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC,11104750
10565,DB12587,Razupenem,small molecule,investigational,"Amides|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Sulfur Compounds",C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(SC3=NC(=CS3)C3=C[C@H](C)NC3)=C(N2C1=O)C(O)=O,10993211
10566,DB12588,AZD-1480,small molecule,investigational,"Janus Kinase 2, antagonists & inhibitors",C[C@H](NC1=NC=C(Cl)C(NC2=NNC(C)=C2)=N1)C1=NC=C(F)C=N1,16659841
10568,DB12590,Indiplon,small molecule,investigational,"Benzazepines|Central Nervous System Agents|Central Nervous System Depressants|GABA Agents|GABA Modulators|Heterocyclic Compounds, Fused-Ring|Hypnotics (Nonbenzodiazepine)|Hypnotics and Sedatives|Neurotransmitter Agents|Sulfur Compounds",CN(C(C)=O)C1=CC=CC(=C1)C1=CC=NC2=C(C=NN12)C(=O)C1=CC=CS1,6450813
10569,DB12591,BMS-911543,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Janus Kinase 2, antagonists & inhibitors",CCN1C(=CC2=C3N(C)C=NC3=C(NC3=NN(C)C(C)=C3)N=C12)C(=O)N(C1CC1)C1CC1,50922691
10570,DB12592,EC-18,small molecule,investigational,,CCCCCCCCCCCCCCCC(=O)OCC(COC(C)=O)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC,9960925
10571,DB12593,Apaziquone,small molecule,investigational,"Antineoplastic Agents|Azirines|Heterocyclic Compounds, Fused-Ring|Indoles|Quinones",CN1C(\C=C\CO)=C(CO)C2=C1C(=O)C=C(N1CC1)C2=O,5813717
10572,DB12594,AZD-9056,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Cycloparaffins",OCCCNCCCC1=CC(C(=O)NCC23CC4CC(CC(C4)C2)C3)=C(Cl)C=C1,10161381
10574,DB12596,Combretastatin,small molecule,investigational,"Antimitotic Agents|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Benzene Derivatives|Benzyl Compounds|Benzylidene Compounds|Combretum|Mitosis Modulators|Stilbenes|Tubulin Modulators",COC1=CC=C(C[C@@H](O)C2=CC(OC)=C(OC)C(OC)=C2)C=C1O,9895264
10575,DB12597,ABL-001,small molecule,investigational,Nicotinic Acids|Pyridines,O[C@@H]1CCN(C1)C1=C(C=C(C=N1)C(=O)NC1=CC=C(OC(F)(F)Cl)C=C1)C1=CC=NN1,72165228
10576,DB12598,Nafamostat,small molecule,investigational,"Amidines|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anticoagulants|Antirheumatic Agents|Central Nervous System Agents|Complement Inactivating Agents|Enzyme Inhibitors|Fibrinolysin, antagonists & inhibitors|Hematologic Agents|Immunologic Factors|Kallikreins, antagonists & inhibitors|OCT1 substrates|OCT2 Substrates|Peripheral Nervous System Agents|Protease Inhibitors|Sensory System Agents|Serine Protease Inhibitors|Trypsin Inhibitors",NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC2=C(C=C1)C=C(C=C2)C(N)=N,4413
10577,DB12601,Sonolisib,small molecule,investigational,Fused-Ring Compounds|Steroids,COC[C@H]1OC(=O)\C(=C\N(CC=C)CC=C)C2=C(O)C(=O)C3=C([C@@H](C[C@@]4(C)[C@H]3CCC4=O)OC(C)=O)[C@@]12C,9849735
10578,DB12602,Pentetreotide,small molecule,approved|investigational,"Acetates|Acids, Acyclic|Amines|Amino Acids, Peptides, and Proteins|Compounds used in a research, industrial, or household setting|Diagnostic Uses of Chemicals|Fatty Acids|Fatty Acids, Volatile|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Indicators and Reagents|Indium Radioisotopes|Laboratory Chemicals|Lipids|Nerve Tissue Proteins|Neuropeptides|Pancreatic Hormones|Peptide Hormones|Peptides|Peptides, Cyclic|Pituitary Hormone Release Inhibiting Hormones|Polyamines|Proteins|Radiopharmaceuticals|Terbium",C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN(CCN(CCN(CC(O)=O)CC(O)=O)CC(O)=O)CC(O)=O)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@H](CC2=CNC3=CC=CC=C23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1,72128
10579,DB12604,Sisomicin,small molecule,investigational,Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Carbohydrates|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Enzyme Inhibitors|Gentamicins|Glycosides|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Protein Synthesis Inhibitors,[H][C@@]1(N)CC=C(CN)O[C@]1([H])O[C@]1([H])[C@@]([H])(N)C[C@@]([H])(N)[C@]([H])(O[C@@]2([H])OC[C@](C)(O)[C@]([H])(NC)[C@@]2([H])O)[C@@]1([H])O,36119
10580,DB12605,Etripamil,small molecule,investigational,,COC(=O)C1=CC(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC=C(OC)C(OC)=C2)=CC=C1,91824132
10581,DB12606,Netivudine,small molecule,investigational,"Arabinonucleosides|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",CC#CC1=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)C(=O)NC1=O,55281
10583,DB12608,Emixustat,small molecule,investigational,Alcohols|Amines|Amino Alcohols|Benzene Derivatives|Ethers|Phenols|Propanols,NCC[C@@H](O)C1=CC(OCC2CCCCC2)=CC=C1,25221720
10585,DB12610,Ebselen,small molecule,investigational,"Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Ulcer Agents|Antioxidants|Antirheumatic Agents|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Gastrointestinal Agents|Neuroprotective Agents|Peripheral Nervous System Agents|Protective Agents|Selenium Compounds|Sensory System Agents",O=C1N([Se]C2=CC=CC=C12)C1=CC=CC=C1,3194
10586,DB12611,PF-477736,small molecule,investigational,"Benzazepines|Heterocyclic Compounds, Fused-Ring",CN1C=C(C=N1)C1=C2C=NNC(=O)C3=C2C(N1)=CC(NC(=O)[C@H](N)C1CCCCC1)=C3,16750408
10587,DB12612,Ozanimod,small molecule,approved|investigational,Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Immunosuppressive Agents|Indenes|Oxazoles|P-glycoprotein substrates|Selective Immunosuppressants,CC(C)OC1=C(C=C(C=C1)C1=NC(=NO1)C1=C2CC[C@H](NCCO)C2=CC=C1)C#N,52938427
10588,DB12613,Davunetide,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Peptides",CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O,9832404
10589,DB12614,Reparixin,small molecule,investigational,Amides|Sulfones|Sulfur Compounds,CC(C)CC1=CC=C(C=C1)[C@@H](C)C(=O)NS(C)(=O)=O,9838712
10590,DB12615,Plazomicin,small molecule,approved|investigational,Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Carbohydrates|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Gentamicins|Glycosides|MATE 1 Inhibitors|MATE 2 Inhibitors|MATE inhibitors|Narrow Therapeutic Index Drugs|Nephrotoxic agents,CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@@H](C[C@H](N)[C@@H](O[C@H]3OC(CNCCO)=CC[C@H]3N)[C@@H]2O)NC(=O)[C@@H](O)CCN)OC[C@]1(C)O,42613186
10592,DB12617,Mizoribine,small molecule,investigational,"Analgesics|Analgesics, Non-Narcotic|Anti-Infective Agents|Anti-Inflammatory Agents|Antibiotics, Antineoplastic|Antimalarials|Antineoplastic Agents|Antiparasitic Agents|Antiprotozoals|Antirheumatic Agents|Carbohydrates|Central Nervous System Agents|Enzyme Inhibitors|Glycosides|Immunologic Factors|Immunosuppressive Agents|IMP Dehydrogenase, antagonists & inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Peripheral Nervous System Agents|Sensory System Agents",NC(=O)C1=C(O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,104762
10593,DB12618,Apocynin,small molecule,investigational,"Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antioxidants|Antirheumatic Agents|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Ketones|Peripheral Nervous System Agents|Protective Agents|Sensory System Agents",COC1=C(O)C=CC(=C1)C(C)=O,2214
10594,DB12619,BMS-188797,small molecule,investigational,Cyclodecanes|Cycloparaffins|Diterpenes|Terpenes,COC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]1(C)[C@@H]2[C@H](OC(=O)C2=CC=CC=C2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C3=CC=CC=C3)C3=CC=CC=C3)C(C)=C([C@@H](OC(C)=O)C1=O)C2(C)C,6918494
10596,DB12621,ST-101,small molecule,investigational,Indenes,O=C1N=C2C=CC=CN2C11CC2=CC=CC=C2C1,10220323
10597,DB12622,Lupeol,small molecule,investigational,Anti-Inflammatory Agents|Terpenes|Triterpenes,[H][C@]12[C@@H](CC[C@]1(C)CC[C@]1(C)[C@]2([H])CC[C@]2([H])[C@@]3(C)CC[C@H](O)C(C)(C)[C@]3([H])CC[C@@]12C)C(C)=C,259846
10598,DB12623,Taprenepag,small molecule,investigational,"Acids, Acyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Lipids|Receptors, Prostaglandin E, EP2 Subtype, agonists|Sulfones|Sulfur Compounds",OC(=O)COC1=CC=CC(CN(CC2=CC=C(C=C2)N2C=CC=N2)S(=O)(=O)C2=CC=CN=C2)=C1,18376177
10599,DB12624,Octenidine,small molecule,investigational,"Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Quaternary Ammonium Compounds|Throat Preparations",CCCCCCCCN=C1C=CN(CCCCCCCCCCN2C=CC(C=C2)=NCCCCCCCC)C=C1,51167
10600,DB12625,Evogliptin,small molecule,investigational,Agents causing angioedema|Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Dipeptidyl Peptidase 4|DPP-IV Inhibitors|Drugs Used in Diabetes,CC(C)(C)OC[C@H]1N(CCNC1=O)C(=O)C[C@H](N)CC1=CC(F)=C(F)C=C1F,25022354
10602,DB12627,GSK-1292263,small molecule,investigational,,CC(C)C1=NOC(=N1)N1CCC(COC2=CC=C(N=C2)C2=CC=C(C=C2)S(C)(=O)=O)CC1,24996872
10603,DB12628,Methyl-D9-choline,small molecule,investigational,,[2H]C([2H])([2H])[N+](CCO)(C([2H])([2H])[2H])C([2H])([2H])[2H],16213540
10604,DB12629,"3,5-diiodothyropropionic acid",small molecule,investigational,"Acids, Acyclic|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fatty Acids|Fatty Acids, Volatile|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Lipids|Thyroid Products|Thyronines",OC(=O)CCC1=CC(I)=C(OC2=CC=C(O)C=C2)C(I)=C1,160565
10605,DB12630,Isopentyl 2-cyanoacrylate,small molecule,investigational,,CC(C)CCOC(=O)C(=C)C#N,29626
10606,DB12631,Aclerastide,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Angiotensins|Autacoids|Biological Factors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Inflammation Mediators|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Proteins",[H]N([C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N1CCC[C@H]1C(O)=O)C(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CCCC)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O,9811551
10607,DB12632,JNJ-41443532,small molecule,investigational,"Acids, Carbocyclic|Amides|Azetines|Benzene Derivatives|Benzoates",O[C@]1(CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)C1=CC=CC(=C1)C(F)(F)F)C1=CN=CS1,46208367
10608,DB12633,BMS-184476,small molecule,investigational,Cyclodecanes|Cycloparaffins|Diterpenes|Terpenes,CSCO[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)[C@H]2[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]12C)C3(C)C,6918461
10610,DB12635,Aleplasinin,small molecule,investigational,,CC1=CC=CC(=C1)C1=CC=C2N(CC3=CC=C(C=C3)C(C)(C)C)C=C(C(=O)C(O)=O)C2=C1,10224267
10612,DB12637,Onapristone,small molecule,investigational,"Antineoplastic Agents|Fertility Agents|Fertility Agents, Female|Fused-Ring Compounds|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Reproductive Control Agents|Steroids",CN(C)C1=CC=C(C=C1)[C@H]1C[C@]2(C)[C@@H](CC[C@]2(O)CCCO)[C@@H]2CCC3=CC(=O)CCC3=C12,5311505
10613,DB12638,PU-H71,small molecule,investigational,"Antineoplastic Agents|Dioxoles|Heterocyclic Compounds, Fused-Ring",CC(C)NCCCN1C(SC2=C(I)C=C3OCOC3=C2)=NC2=C(N)N=CN=C12,9549213
10615,DB12640,CP-609754,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Quinolines",CN1C=NC=C1[C@@](O)(C1=CC=C(Cl)C=C1)C1=CC=C2N(C)C(=O)C=C(C3=CC=CC(=C3)C#C)C2=C1,46208720
10616,DB12641,Tedatioxetine,small molecule,investigational,,CC1=CC=C(SC2=CC=CC=C2C2CCNCC2)C=C1,9878913
10617,DB12642,Olumacostat glasaretil,small molecule,investigational,,CCCCCCCCCCCCCCOC1=CC=C(O1)C(=O)OCC(=O)N(C)CC(=O)OCC,89497391
10618,DB12643,Nelivaptan,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",[H][C@]1(O)CN([C@@]([H])(C1)C(=O)N(C)C)[C@@]1(C(=O)N(C2=C1C=C(Cl)C=C2)S(=O)(=O)C1=C(OC)C=C(OC)C=C1)C1=CC=CC=C1OC,9895468
10619,DB12644,AZD-2066,small molecule,investigational,,C[C@@H](OC1=NN=C(N1C)C1=CC=NC=C1)C1=NOC(=C1)C1=CC=CC(Cl)=C1,16041426
10620,DB12645,Givinostat,small molecule,investigational,"Acids, Acyclic|Antineoplastic Agents|Histone Deacetylase Inhibitors|Potential QTc-Prolonging Agents|QTc Prolonging Agents",CCN(CC)CC1=CC=C2C=C(COC(=O)NC3=CC=C(C=C3)C(=O)NO)C=CC2=C1,9804992
10621,DB12647,Tocotrienol,small molecule,investigational,"Antioxidants|Benzopyrans|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Heterocyclic Compounds, Fused-Ring|Micronutrients|Physiological Phenomena|Protective Agents|Pyrans|Vitamin E|Vitamins|Vitamins (Fat Soluble)",CC(C)=CCC\C(C)=C\CC\C(C)=C\CCC1(C)CCC2=CC(O)=CC=C2O1,9929901
10622,DB12648,Nona-arginine,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Furin, antagonists & inhibitors|Peptides",N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O,25077438
10623,DB12649,Ibipinabant,small molecule,investigational,"Agents producing tachycardia|Amides|Cannabinoid Receptor Antagonists|Cannabinoids and similars|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Neurotransmitter Agents|Receptor, Cannabinoid, CB1, antagonists & inhibitors|Sulfones|Sulfur Compounds",CNC(=NS(=O)(=O)C1=CC=C(Cl)C=C1)N1C[C@@H](C(=N1)C1=CC=C(Cl)C=C1)C1=CC=CC=C1,9826744
10624,DB12650,L-deprenyl-D2 C-11,small molecule,investigational,,[2H]C([2H])(C#C)N([11CH3])[C@H](C)CC1=CC=CC=C1,90274764
10625,DB12651,Bardoxolone,small molecule,investigational,,CC1(C)CC[C@@]2(CC[C@]3(C)[C@@H]([C@@H]2C1)C(=O)C=C1[C@@]2(C)C=C(C#N)C(=O)C(C)(C)[C@@H]2CC[C@@]31C)C(O)=O,400010
10627,DB12654,GSK-376501,small molecule,investigational,,COCCOC1=CC(OCCOC)=CC(CN2C3=CC=CC=C3C(=C2C(O)=O)C2=CC=C(C=C2)C(C)(C)C)=C1,24946920
10628,DB12655,Patidegib,small molecule,investigational,Alkaloids,C[C@@H]1[C@@H]2NC[C@@H](C)C[C@H]2O[C@]11CC[C@H]2[C@@H]3CC[C@@H]4C[C@@H](CC[C@]4(C)[C@H]3CC2=C(C)C1)NS(C)(=O)=O,25027363
10630,DB12657,JNJ-42396302,small molecule,investigational,,COCCC1=CC=C(C=N1)C1=C(C)N=C2N1N=CC=C2N1CCOCC1,51352628
10631,DB12658,AFN-1252,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Pyrans",CN(CC1=C(C)C2=CC=CC=C2O1)C(=O)\C=C\C1=CC2=C(NC(=O)CC2)N=C1,10407120
10632,DB12659,SJ-733,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",FC1=CC=C(NC(=O)[C@@H]2[C@H](N(CC(F)(F)F)C(=O)C3=CC=CC=C23)C2=CC=CN=C2)C=C1C#N,89508529
10633,DB12660,Samatasvir,small molecule,investigational,"Acids, Acyclic|Heterocyclic Compounds, Fused-Ring",COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C1=NC2=CC=C(C=C2N1)C1=CSC2=C1SC=C2C1=CC=C(C=C1)C1=CN=C(N1)[C@@H]1CCCN1C(=O)[C@H](NC(=O)OC)C1=CC=CC=C1,58310140
10634,DB12661,Urapidil,small molecule,investigational,"Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antiadrenergic Agents, Peripherally Acting|Antidepressive Agents|Antihypertensive Agents|Cardiovascular Agents|Central Nervous System Depressants|Neurotransmitter Agents|Peripheral alpha-1 blockers|Serotonin Agents|Serotonin Receptor Agonists|Vasodilating Agents",COC1=CC=CC=C1N1CCN(CCCNC2=CC(=O)N(C)C(=O)N2C)CC1,5639
10635,DB12662,Naveglitazar,small molecule,investigational,"Acids, Carbocyclic|PPAR alpha, agonists|PPAR gamma, agonists",CO[C@@H](CC1=CC=C(OCCCOC2=CC=C(OC3=CC=CC=C3)C=C2)C=C1)C(O)=O,9888484
10636,DB12663,Letrazuril,small molecule,investigational,Nitriles,FC1=CC=C(C=C1)C(C#N)C1=C(Cl)C=C(C=C1Cl)N1N=CC(=O)NC1=O,59745
10637,DB12664,Indantadol,small molecule,investigational,"Amino Acids|Amino Acids, Peptides, and Proteins|Indenes",NC(=O)CNC1CC2=CC=CC=C2C1,10192617
10638,DB12665,Isoquercetin,small molecule,investigational,"Benzopyrans|Carbohydrates|Chromones|Flavonoids|Flavonols|Glycosides|Heterocyclic Compounds, Fused-Ring|Pyrans",OC[C@H]1O[C@@H](OC2=C(OC3=C(C(O)=CC(O)=C3)C2=O)C2=CC=C(O)C(O)=C2)[C@H](O)[C@@H](O)[C@@H]1O,5280804
10639,DB12666,Emapunil,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CCN(CC1=CC=CC=C1)C(=O)CN1C(=O)N(C)C2=CN=C(N=C12)C1=CC=CC=C1,6433109
10640,DB12667,Protionamide,small molecule,approved|investigational,Anti-Bacterial Agents|Anti-Infective Agents|Antiinfectives for Systemic Use|Antimycobacterials|Antituberculosis Agents|Drugs for Treatment of Tuberculosis|Isonicotinic Acids|Pyridines|Thiocarbamide Derivatives,CCCC1=CC(=CC=N1)C(N)=S,666418
10641,DB12668,Metenkefalin,small molecule,investigational,"Experimental Unapproved Treatments for COVID-19|Neuropeptides|Receptors, Opioid, delta, agonists|Receptors, Opioid, mu, agonists",CSCC[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1)C(O)=O,443363
10642,DB12669,4SC-203,small molecule,investigational,,COC1=CC=C(C)C=C1NC(=O)NC1=NC2=CC=C(NC3=NC=NC4=CC(OCCCN5CCN(C)CC5)=C(OC)C=C34)C=C2S1,44467821
10643,DB12670,Rolofylline,small molecule,investigational,"Alkaloids|Cardiovascular Agents|Diuretics|Heterocyclic Compounds, Fused-Ring|Natriuretic Agents|Purines|Purinones",CCCN1C2=C(NC(=N2)C23C[C@@H]4CC2C[C@H](C3)C4)C(=O)N(CCC)C1=O,11948288
10644,DB12671,Beloranib,small molecule,investigational,"Acids, Carbocyclic|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Cycloparaffins|Ethers|Ethers, Cyclic|Growth Inhibitors|Growth Substances|Terpenes",CO[C@@H]1[C@@H](CC[C@]2(CO2)[C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C)OC(=O)\C=C\C1=CC=C(OCCN(C)C)C=C1,6918502
10645,DB12672,Icaritin,small molecule,investigational,"Benzopyrans|Chromones|Heterocyclic Compounds, Fused-Ring|Pyrans",COC1=CC=C(C=C1)C1=C(O)C(=O)C2=C(O)C=C(O)C(CC=C(C)C)=C2O1,5318980
10646,DB12673,ATX-914,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Quinazolines",CC(C)C1=CC=C(C=C1)C1=NC(=O)N(CC2=CC=C3N=C(Br)C=NC3=C2)C2=CC=C(OCC#C)C=C12,119026214
10647,DB12674,Lurbinectedin,small molecule,approved|investigational,"Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Indoles|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|OCT1 inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Pyridines",[H][C@@]12[C@@H]3SC[C@]4(NCCC5=C4NC4=CC=C(OC)C=C54)C(=O)OC[C@H](N1[C@@H](O)[C@@H]1CC4=CC(C)=C(OC)C(O)=C4[C@@]2([H])N1C)C1=C2OCOC2=C(C)C(OC(C)=O)=C31,57327016
10648,DB12675,PF-04995274,small molecule,investigational,,OC1(CN2CCC(COC3=NOC4=CC=CC(O[C@@H]5CCOC5)=C34)CC2)CCOCC1,53354764
10649,DB12676,Modufolin,small molecule,investigational,,[H][C@@]12CN(CN1C1=C(NC2)N=C(N)NC1=O)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,445117
10650,DB12677,Soblidotin,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Peptides",CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)NCCC1=CC=CC=C1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C,6918315
10651,DB12678,Relamorelin,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Peptides",NC(=O)C1(CCNCC1)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@@H](CC1=CSC2=CC=CC=C12)NC(=O)C1CCNCC1,44251769
10652,DB12679,WP 1066,small molecule,investigational,,C[C@H](NC(=O)C(=C\C1=CC=CC(Br)=N1)\C#N)C1=CC=CC=C1,11210478
10653,DB12680,Intepirdine,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Sulfur Compounds",O=S(=O)(C1=CC=CC=C1)C1=CN=C2C(C=CC=C2N2CCNCC2)=C1,11256720
10654,DB12681,Salirasib,small molecule,investigational,"Acids, Carbocyclic|Alcohols|Antineoplastic Agents|Benzene Derivatives|Benzoates|Calcium-Calmodulin-Dependent Protein Kinases, antagonists & inhibitors|Enzyme Inhibitors|Fatty Alcohols|Hydroxy Acids|Hydroxybenzoates|Lipids|Phenols|Sesquiterpenes|Terpenes",CC(C)=CCC\C(C)=C\CC\C(C)=C\CSC1=CC=CC=C1C(O)=O,5469318
10655,DB12682,Mubritinib,small molecule,investigational,,FC(F)(F)C1=CC=C(\C=C\C2=NC(COC3=CC=C(CCCCN4C=CN=N4)C=C3)=CO2)C=C1,6444692
10658,DB12685,K-134,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",O[C@@H]1CCCC[C@H]1N(C1CC1)C(=O)NCCCOC1=CC=C2NC(=O)C=CC2=C1,9908900
10659,DB12686,PHA-793887,small molecule,investigational,"Cyclin-Dependent Kinases, antagonists & inhibitors",CC(C)CC(=O)NC1=NNC2=C1CN(C(=O)C1CCN(C)CC1)C2(C)C,46191454
10660,DB12687,Vesatolimod,small molecule,investigational,"Anti-Infective Agents|Antiviral Agents|Heterocyclic Compounds, Fused-Ring|Toll-Like Receptor 7, agonists",CCCCOC1=NC(N)=C2NC(=O)CN(CC3=CC=CC(CN4CCCC4)=C3)C2=N1,46241268
10662,DB12689,Azeliragon,small molecule,investigational,,CCCCC1=NC(=CN1C1=CC=C(OC2=CC=C(Cl)C=C2)C=C1)C1=CC=C(OCCCN(CC)CC)C=C1,11180124
10663,DB12690,LY-2584702,small molecule,investigational,"Ribosomal Protein S6 Kinases, 70-kDa, antagonists & inhibitors",CN1C=C(N=C1C1CCN(CC1)C1=C2C=NNC2=NC=N1)C1=CC=C(F)C(=C1)C(F)(F)F,25118925
10664,DB12691,UK-432097,small molecule,investigational,"Adenosine A2 Receptor Agonists|Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides",CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=C(N=C2NCC(C1=CC=CC=C1)C1=CC=CC=C1)C(=O)NCCNC(=O)NC1CCN(CC1)C1=NC=CC=C1,9833519
10665,DB12692,Gusperimus,small molecule,investigational,"Amidines|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Compounds used in a research, industrial, or household setting|Immunologic Factors|Immunosuppressive Agents|Protective Agents|Radiation-Protective Agents|Selective Immunosuppressants",NCCCNCCCCNC(=O)C(O)NC(=O)CCCCCCNC(N)=N,55362
10666,DB12693,Ritanserin,small molecule,investigational,"Anti-Anxiety Agents|Antidepressive Agents|Antidepressive Agents, Second-Generation|Antipsychotic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Hypoglycemia-Associated Agents|Neurotoxic agents|Neurotransmitter Agents|Piperidines|Psychotropic Drugs|Pyrimidines|Pyrimidinones|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists|Tranquilizing Agents",CC1=C(CCN2CCC(CC2)=C(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)C(=O)N2C=CSC2=N1,5074
10667,DB12694,CE-326597,small molecule,investigational,"Benzazepines|Heterocyclic Compounds, Fused-Ring",CC(C)N(CC1=CC=CC=C1)C(=O)CN1C2=CC=CC=C2N2C(=NN=C2C2=CC=CC=C2)[C@H](CC2=CNC3=CC=CC=C23)C1=O,52949124
10668,DB12695,Phenethyl Isothiocyanate,small molecule,investigational,"Aldehyde Dehydrogenase, antagonists & inhibitors|Anticarcinogenic Agents|Antineoplastic Agents|Carcinogens|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Isocyanates|Noxae|Protective Agents|Sulfur Compounds|Toxic Actions",S=C=NCCC1=CC=CC=C1,16741
10669,DB12696,BMS-582949,small molecule,investigational,"Mitogen-Activated Protein Kinase 14, antagonists & inhibitors",CCCNC(=O)C1=CN2N=CN=C(NC3=CC(=CC=C3C)C(=O)NC3CC3)C2=C1C,10409068
10670,DB12697,Methylselenocysteine,small molecule,investigational,"Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Anticarcinogenic Agents|Antineoplastic Agents|Compounds used in a research, industrial, or household setting|Cysteine|Organoselenium Compounds|Protective Agents|Selenium Compounds|Sulfhydryl Compounds|Sulfur Compounds",C[Se]C[C@H](N)C(O)=O,147004
10673,DB12700,Solamargine,small molecule,investigational,Alkaloids,C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC=C5C[C@H](CC[C@]5(C)[C@H]4CC[C@]23C)O[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)O[C@]11CC[C@@H](C)CN1,73611
10675,DB12702,Velusetrag,small molecule,investigational,Aza Compounds,CC(C)N1C(=O)C(=CC2=CC=CC=C12)C(=O)N[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@@H](O)CN(C)S(C)(=O)=O,11842633
10676,DB12703,Omipalisib,small molecule,investigational,"Amides|Heterocyclic Compounds, Fused-Ring|Phosphatidylinositol 3-Kinases, antagonists & inhibitors|Sulfones|Sulfur Compounds",COC1=C(NS(=O)(=O)C2=C(F)C=C(F)C=C2)C=C(C=N1)C1=CC2=C(C=CN=C2C=C1)C1=CN=NC=C1,25167777
10677,DB12704,Spiradoline,small molecule,investigational,"Analgesics|Antiarrhythmic agents|Cardiovascular Agents|Central Nervous System Agents|Diuretics|Natriuretic Agents|Peripheral Nervous System Agents|Receptors, Opioid, kappa, agonists|Sensory System Agents",[H][C@@]1(CC[C@@]2(CCCO2)C[C@]1([H])N1CCCC1)N(C)C(=O)CC1=CC(Cl)=C(Cl)C=C1,55652
10678,DB12705,Cenerimod,small molecule,investigational,,CCC1=CC(=CC(C)=C1OC[C@@H](O)CO)C1=NOC(=N1)C1=CC(=NC(OC)=C1)C1CCCC1,49871973
10679,DB12706,Seletalisib,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",[O-][N+]1=CC(=CC=C1)C1=NC2=C(Cl)C=CC=C2C=C1[C@@H](NC1=NC=NC2=CC=CN=C12)C(F)(F)F,56928390
10680,DB12707,AR-42,small molecule,investigational,,CC(C)[C@H](C(=O)NC1=CC=C(C=C1)C(=O)NO)C1=CC=CC=C1,6918848
10681,DB12708,Sulprostone,small molecule,investigational,"Abortifacient Agents|Abortifacient Agents, Nonsteroidal|Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Genito Urinary System and Sex Hormones|Inflammation Mediators|Lipids|Menstruation-Inducing Agents|Prostaglandins|Prostaglandins E|Reproductive Control Agents|Uterotonic agents",CS(=O)(=O)NC(=O)CCC\C=C/C[C@@H]1[C@@H](\C=C\[C@@H](O)COC2=CC=CC=C2)[C@H](O)CC1=O,5312153
10682,DB12709,Tributyrin,small molecule,investigational,Glycerides|Lipids,CCCC(=O)OCC(COC(=O)CCC)OC(=O)CCC,6050
10683,DB12710,Perazine,small molecule,approved|investigational,"Antipsychotic Agents|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Phenothiazines|Phenothiazines With Piperazine Structure|Psycholeptics|Psychotropic Drugs|Sulfur Compounds|Tranquilizing Agents",CN1CCN(CCCN2C3=CC=CC=C3SC3=CC=CC=C23)CC1,4744
10684,DB12711,LTX-109,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Peptides|Peptidomimetics",CC(C)(C)C1=C(C[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCCC2=CC=CC=C2)C2=C(N1)C(=CC(=C2)C(C)(C)C)C(C)(C)C,25242323
10685,DB12712,Pilsicainide,small molecule,investigational,Acetanilides|Amides|Amines|Anilides|Aniline Compounds|Antiarrhythmic agents|BSEP/ABCB11 Substrates|Cardiovascular Agents|Membrane Transport Modulators|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sodium Channel Blockers,CC1=CC=CC(C)=C1NC(=O)CC12CCCN1CCC2,4820
10686,DB12713,Sotagliflozin,small molecule,investigational,"Blood Glucose Lowering Agents|Carbohydrates|Sodium-Glucose Transporter 1, antagonists & inhibitors|Sodium-Glucose Transporter 2 Inhibitors",CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@@H]2O[C@H](SC)[C@@H](O)[C@H](O)[C@H]2O)C=C1,24831714
10687,DB12714,Nerispirdine,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CCCN(N1C=C(C)C2=CC=CC=C12)C1=CC=NC=C1F,3081185
10688,DB12715,MSX-122,small molecule,investigational,"Receptors, CXCR4, antagonists & inhibitors",C(NC1=NC=CC=N1)C1=CC=C(CNC2=NC=CC=N2)C=C1,11687907
10689,DB12716,NB-001,small molecule,investigational,"Adenine Nucleotides|Adenylyl Cyclase Inhibitors|Carbohydrates|Enzyme Inhibitors|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",NC1=C2N=CN(CCNCCCCCO)C2=NC=N1,2815031
10690,DB12717,Mibampator,small molecule,investigational,Amides|Benzene Derivatives|Sulfones|Sulfur Compounds,CC(C)S(=O)(=O)NC[C@H](C)C1=CC=C(C=C1)C1=CC=C(CCNS(C)(=O)=O)C=C1,9889366
10692,DB12719,Turofexorate isopropyl,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CC(C)OC(=O)C1=CN(CC(C)(C)C2=C1NC1=CC=CC=C21)C(=O)C1=CC(F)=C(F)C=C1,10026128
10693,DB12720,Nivocasan,small molecule,investigational,,CC(C)[C@]1(CC(=NO1)C1=NC=CC2=CC=CC=C12)C(=O)N[C@H]1CC(=O)O[C@]1(O)CF,11633038
10694,DB12721,RO-5028442,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CN(C)CCN1C=C(C(=O)N2CCC3(CC2)OCC2=CC=CC=C32)C2=CC=C(Cl)C=C12,59657596
10696,DB12724,AZD-7295,small molecule,investigational,,CCCS(=O)(=O)N1CCN(CC2=CC=C(NC(=O)C3=CC=C(C=C3)C3=CC(NC(=O)C4CC4)=CC=C3OC(F)(F)F)C=C2)CC1,57339445
10697,DB12725,TD-8954,small molecule,investigational,"Antidepressive Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT4 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists",COC(=O)N1CCC(CN2CCC(CNC(=O)C3=C4NC(=NC4=CC=C3)C(C)C)CC2)CC1,11961293
10699,DB12727,Perfosfamide,small molecule,investigational,"Acids|Acids, Noncarboxylic|Anions|Electrolytes|Hydrocarbons, Halogenated|Ions|Mustard Compounds|Nitrogen Mustard Compounds|Organophosphorus Compounds|Phosphoramide Mustards|Phosphoramides|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds",OO[C@@H]1CCO[P@](=O)(N1)N(CCCl)CCCl,9554809
10700,DB12728,Fenpropidin,small molecule,approved|experimental,"Agrochemicals|Compounds used in a research, industrial, or household setting|Fungicides, Industrial|Pesticides|Toxic Actions",CC(CN1CCCCC1)CC1=CC=C(C=C1)C(C)(C)C,91694
10701,DB12729,ASP-3026,small molecule,investigational,Sulfur Compounds,COC1=CC(=CC=C1NC1=NC(NC2=CC=CC=C2S(=O)(=O)C(C)C)=NC=N1)N1CCC(CC1)N1CCN(C)CC1,25134326
10702,DB12730,Dolastatin 10,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Peptides|Peptides, Cyclic|Tubulin Modulators",CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C1=NC=CS1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C,9810929
10703,DB12731,Daporinad,small molecule,investigational,"Acids, Acyclic|Acrylates|Amides",O=C(NCCCCC1CCN(CC1)C(=O)C1=CC=CC=C1)\C=C\C1=CC=CN=C1,6914657
10704,DB12732,Firategrast,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Anti-Inflammatory Agents|Antibodies|Blood Proteins|Globulins|Immunoproteins|Proteins|Serum Globulins",CCOCC1=CC(OC)=C(C(OC)=C1)C1=CC=C(C[C@H](NC(=O)C2=C(F)C=CC=C2F)C(O)=O)C=C1,9935681
10705,DB12733,Dipraglurant,small molecule,investigational,,FC1=CN2C=C(CCC#CC3=CC=CC=N3)N=C2C=C1,44557636
10707,DB12736,Etanidazole,small molecule,investigational,Antineoplastic Agents|Imidazoles|Nitro Compounds|Nitroimidazoles|Radiation-Sensitizing Agents,OCCNC(=O)CN1C=CN=C1[N+]([O-])=O,3276
10710,DB12739,Bindarit,small molecule,investigational,"Acids, Acyclic|Anti-Inflammatory Agents|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Heterocyclic Compounds, Fused-Ring|Lipids|Protein Synthesis Inhibitors|Pyrazoles",CC(C)(OCC1=NN(CC2=CC=CC=C2)C2=CC=CC=C12)C(O)=O,71354
10711,DB12740,CC-115,small molecule,investigational,,CCN1C(=O)CNC2=C1N=C(C=N2)C1=CC=C(N=C1C)C1=NN=CN1,58298318
10712,DB12741,DTP-348,small molecule,investigational,,CC1=NC=C(N1CCNS(N)(=O)=O)N(=O)=O,57413968
10713,DB12742,Amuvatinib,small molecule,investigational,,S=C(NCC1=CC=C2OCOC2=C1)N1CCN(CC1)C1=NC=NC2=C1OC1=C2C=CC=C1,11282283
10714,DB12743,Z-160,small molecule,investigational,,O=C(CC(C1=CC=CC=C1)C1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,4988454
10715,DB12744,CGI-1842,small molecule,investigational,"Benzene Derivatives|Heterocyclic Compounds, Fused-Ring|Receptor, EphB4, antagonists & inhibitors",COC1=CC=C(Br)C=C1NC(=O)NC1=C2C=CN(CC3=CC=NC(N)=C3)C2=CC=C1,11691242
10716,DB12745,GSK-690693,small molecule,investigational,Oxazoles,[H][C@]1(COC2=C3N(CC)C(=NC3=C(N=C2)C#CC(C)(C)O)C2=NON=C2N)CCCNC1,16725726
10717,DB12746,AKN-028,small molecule,investigational,,NC1=C(NC2=CC=C3NC=CC3=C2)N=C(C=N1)C1=CC=NC=C1,44177328
10719,DB12748,LTX-315,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Peptides",NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](C(C1=CC=CC=C1)C1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(N)=O,46200994
10720,DB12749,Butylphthalide,small molecule,investigational,"Antiplatelet agents|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Drugs, Chinese Herbal|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|Neuroprotective Agents|Protective Agents",CCCCC1OC(=O)C2=C1C=CC=C2,61361
10721,DB12750,N-omega-nitro-L-arginine methyl ester,small molecule,investigational,"Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Arginine|Enzyme Inhibitors",COC(=O)[C@@H](N)CCCNC(=N)N[N+]([O-])=O,39836
10722,DB12751,Malic acid,small molecule,investigational,"Acids, Acyclic|Dicarboxylic Acids|Hydroxy Acids",OC(CC(O)=O)C(O)=O,525
10723,DB12752,Bucindolol,small molecule,investigational,Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Autonomic Agents|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Neurotransmitter Agents|Peripheral Nervous System Agents|Propanols|Sympathomimetics|Vasodilating Agents,CC(C)(CC1=CNC2=CC=CC=C12)NCC(O)COC1=CC=CC=C1C#N,51045
10724,DB12753,Racivir,small molecule,investigational,"Anti-Infective Agents|Antiviral Agents|Carbohydrates|Deoxycytidine|Deoxyribonucleosides|Dideoxynucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",,
10725,DB12754,Iodide,small molecule,approved|experimental,,[I-],30165
10726,DB12755,Zoptarelin doxorubicin,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Anthracyclines|Carbohydrates|Glycosides|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Naphthacenes|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary Hormone-Releasing Hormones|Proteins",,
10727,DB12756,TAK-901,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Indoles|Protein Kinase Inhibitors|Pyridines|Sulfur Compounds",CCS(=O)(=O)C1=CC=CC(=C1)C1=CC(C(=O)NC2CCN(C)CC2)=C(C)C2=C1C1=C(N2)N=CC(C)=C1,16124208
10728,DB12757,Pelitrexol,small molecule,investigational,Sulfur Compounds,CC1=C(CC[C@@H]2CNC3=C(C2)C(=O)NC(N)=N3)SC(=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,6450821
10729,DB12758,Atreleuton,small molecule,investigational,Enzyme Inhibitors|Lipoxygenase Inhibitors,C[C@H](C#CC1=CC=C(CC2=CC=C(F)C=C2)S1)N(O)C(N)=O,3086671
10731,DB12760,GW-493838,small molecule,investigational,,CC(C)(C)C1=NN=C(O1)[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(NC3=CC=C(Cl)C=C3F)N=CN=C12,9810927
10732,DB12761,Timcodar,small molecule,investigational,,COC1=CC(=CC(OC)=C1OC)C(=O)C(=O)N(C)[C@@H](CC1=CC=C(Cl)C=C1)C(=O)N(CC1=CC=CC=C1)C(CCC1=CC=NC=C1)CCC1=CC=NC=C1,9811664
10733,DB12762,Rabacfosadine,small molecule,investigational,"Amino Acids|Amino Acids, Peptides, and Proteins|Heterocyclic Compounds, Fused-Ring",CCOC(=O)[C@H](C)NP(=O)(COCCN1C=NC2=C(NC3CC3)N=C(N)N=C12)N[C@@H](C)C(=O)OCC,16047979
10734,DB12763,MK-1496,small molecule,investigational,,C[C@H](N)C1=CC=C(C=C1)[C@H](O)CNC(C)(C)C,67313626
10735,DB12764,ABC-294640,small molecule,investigational,Cycloparaffins,ClC1=CC=C(C=C1)C12CC3CC(CC(C3)(C1)C(=O)NCC1=CC=NC=C1)C2,15604015
10736,DB12765,Methyl isocyanate,small molecule,investigational,Antisickling Agents|Hematologic Agents,CN=C=O,12228
10737,DB12766,Cicletanine,small molecule,investigational,"Antiarrhythmic agents|Antihypertensive Agents|Cardiovascular Agents|Diuretics|Low-Ceiling Diuretics, Excl. Thiazides|Natriuretic Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents",CC1=C(O)C2=C(C=N1)C(OC2)C1=CC=C(Cl)C=C1,54910
10738,DB12767,Gaxilose,small molecule,approved|investigational,Carbohydrates|Oligosaccharides|Polysaccharides,OC[C@@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@@H](O)C=O,3082054
10740,DB12769,Lometrexol,small molecule,investigational,"Antimetabolites|Antineoplastic Agents|Biological Factors|Coenzymes|Enzyme Inhibitors|Enzymes and Coenzymes|Folic Acid Analogues|Folic Acid Antagonists|Heterocyclic Compounds, Fused-Ring|Noxae|Pigments, Biological|Pteridines|Pterins|Toxic Actions",NC1=NC(=O)C2=C(NC[C@H](CCC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C2)N1,148138
10741,DB12770,Lafutidine,small molecule,investigational,"Acetates|Acids, Acyclic|Alimentary Tract and Metabolism|Amides|Anti-Ulcer Agents|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Fatty Acids|Fatty Acids, Volatile|Gastric Acid Lowering Agents|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Histamine H2 Antagonists|Lipids|Neurotransmitter Agents",O=C(CS(=O)CC1=CC=CO1)NC\C=C/COC1=NC=CC(CN2CCCCC2)=C1,5282136
10742,DB12771,Hydroxytyrosol,small molecule,investigational,"Alcohols|Anti-Infective Agents|Antioxidants|Antiplatelet agents|Compounds used in a research, industrial, or household setting|Hematologic Agents|Protective Agents",OCCC1=CC=C(O)C(O)=C1,82755
10744,DB12774,AZD-8055,small molecule,investigational,Oxazines,COC1=CC=C(C=C1CO)C1=CC=C2C(=N1)N=C(N=C2N1CCOC[C@@H]1C)N1CCOC[C@@H]1C,25262965
10746,DB12776,E-6005,small molecule,investigational,"Acids, Carbocyclic|Antipruritics|Heterocyclic Compounds, Fused-Ring|Phosphodiesterase 4 Inhibitors|Phosphodiesterase Inhibitors",CNC1=NC(C2=CC=CC(NC(=O)C3=CC=C(C=C3)C(=O)OC)=C2)=C2C=C(OC)C(OC)=CC2=N1,24864553
10747,DB12777,Somatoprim,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Pancreatic Hormones|Peptide Hormones|Peptides|Pituitary Hormone Release Inhibiting Hormones|Proteins",C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)CCCNC(=O)CCCN(CC(N)=O)C(=O)[C@H](CC2=CC=CC=C2)NC1=O,9919857
10748,DB12778,Rivipansel,small molecule,investigational,Carbohydrates|Glycoconjugates|Lipids,[H][C@@](CC1CCCCC1)(O[C@H]1[C@@H](O)[C@@H](CO)O[C@@H](O[C@@H]2C[C@@H](C[C@H](NC(=O)C3=CC(=O)NC(=O)N3)[C@H]2O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)C(=O)NCCNC(=O)COCCOCC(=O)NC2=C3C(=CC(=C2)S(O)(=O)=O)C=C(C=C3S(O)(=O)=O)S(O)(=O)=O)[C@@H]1OC(=O)C1=CC=CC=C1)C(O)=O,
10749,DB12779,Higenamine,small molecule,investigational,"Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antirheumatic Agents|Cardiotonic Agents|Cardiovascular Agents|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Fibrin Modulating Agents|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Neurotransmitter Agents|Peripheral Nervous System Agents|Protective Agents|Sensory System Agents",OC1=CC=C(CC2NCCC3=C2C=C(O)C(O)=C3)C=C1,114840
10750,DB12780,Quinfamide,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",ClC(Cl)C(=O)N1CCCC2=CC(OC(=O)C3=CC=CO3)=CC=C12,71743
10751,DB12781,Balaglitazone,small molecule,investigational,"Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Sulfur Compounds|Thiazoles|Thiazolidinediones",CN1C(COC2=CC=C(CC3SC(=O)NC3=O)C=C2)=NC2=CC=CC=C2C1=O,9889200
10752,DB12782,SCH-486757,small molecule,investigational,Aza Compounds,O[C@]1(C[C@@H]2CC[C@H](C1)N2C(C1=CC=CC=C1Cl)C1=CC=CC=C1Cl)C1=NC=CC=N1,11597355
10753,DB12783,Benserazide,small molecule,approved|investigational,Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Aromatic L-amino Acid Decarboxylase Inhibitors|Central Nervous System Agents|Dopamine Agents|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Hydrazines|Neurotransmitter Agents,NC(CO)C(=O)NNCC1=C(O)C(O)=C(O)C=C1,2327
10754,DB12784,NS-018,small molecule,investigational,,C[C@H](NC1=CC(=CC(NC2=CN=CC=N2)=N1)C1=CN(C)N=C1)C1=CC=C(F)C=C1,46866319
10755,DB12785,Furaprevir,small molecule,investigational,,CC(C)OC1=CC=C(C=C1)C1=NC2=C(OC3=C2C=CC=C3)C(O[C@@H]2C[C@@H]3N(C2)C(=O)[C@H](CCCCC\C=C/[C@@H]2C[C@]2(NC3=O)C(=O)NS(=O)(=O)C2(C)CC2)NC(=O)OC2CCCC2)=N1,51037069
10757,DB12787,Norethandrolone,small molecule,investigational,"Alimentary Tract and Metabolism|Anabolic Agents|Anabolic Agents for Systemic Use|Anabolic Steroids|Androstan Derivatives|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Norpregnanes|Norpregnenes|Norsteroids|Steroids",CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C,5858
10759,DB12789,Dinoprost,small molecule,approved|investigational,"Abortifacient Agents|Abortifacient Agents, Nonsteroidal|Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Genito Urinary System and Sex Hormones|Inflammation Mediators|Lipids|Prostaglandins|Prostaglandins F|Reproductive Control Agents|Uterotonic agents",[H]\C(CCCC(O)=O)=C(/[H])C[C@@]1([H])[C@@]([H])(O)C[C@@]([H])(O)[C@]1([H])C(\[H])=C(/[H])[C@@]([H])(O)CCCCC,5280363
10760,DB12791,Laninamivir,small molecule,investigational,"Acids, Acyclic|Amidines|Amino Sugars|Anti-Infective Agents|Antiviral Agents|Carbohydrates|Guanidines|Hydroxy Acids|Neuraminic Acids|Neuraminidase, antagonists & inhibitors|Pyrans|Sialic Acids|Sugar Acids",[H][C@]1(OC(=C[C@H](NC(N)=N)[C@H]1NC(C)=O)C(O)=O)[C@H](OC)[C@H](O)CO,502272
10761,DB12792,Boscalid,small molecule,approved|experimental,Benzene Derivatives|Nicotinic Acids|Pyridines,ClC1=CC=C(C=C1)C1=C(NC(=O)C2=C(Cl)N=CC=C2)C=CC=C1,213013
10763,DB12794,p-Quaterphenyl,small molecule,investigational,,C1=CC=C(C=C1)C1=CC=C(C=C1)C1=CC=C(C=C1)C1=CC=CC=C1,8677
10764,DB12795,CMX-2043,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Coenzymes|Enzymes and Coenzymes|Fatty Acids|Lipids|Oligopeptides|Peptides|Sulfur Compounds|Thiophenes",C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)CCCC[C@@H]1CCSS1)C(O)=O,49802864
10765,DB12796,MRX-I,small molecule,investigational,,FC1=C(N2CCC(=O)C=C2)C(F)=C(F)C(=C1)N1C[C@H](CNC2=NOC=C2)OC1=O,25184541
10767,DB12798,Relenopride,small molecule,investigational,"Acids, Acyclic|Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates",COC1=CC(N)=C(Cl)C=C1C(=O)NCC1CCN(CC[C@H](OC(N)=O)C2=CC=C(F)C=C2)CC1,45275554
10768,DB12799,Laniquidar,small molecule,investigational,"ATP Binding Cassette Transporter, Subfamily B, Member 1, antagonists & inhibitors|Carbon Radioisotopes|Drug Resistance, Multiple|Heterocyclic Compounds, Fused-Ring|P-glycoprotein inhibitors",COC(=O)C1=CN=C2N1CCC1=CC=CC=C1C2=C1CCN(CCC2=CC=C(OCC3=CC=C4C=CC=CC4=N3)C=C2)CC1,6450806
10769,DB12800,CHF-6001,small molecule,investigational,"Acids, Carbocyclic|Amides|Aminobenzoates|Benzene Derivatives|Benzoates|Sulfones|Sulfur Compounds",CS(=O)(=O)NC1=CC=C(C=C1OCC1CC1)C(=O)O[C@@H](CC1=C(Cl)C=[N+]([O-])C=C1Cl)C1=CC=C(OC(F)F)C(OCC2CC2)=C1,70662473
10770,DB12802,Picropodophyllin,small molecule,investigational,Benzene Derivatives|Benzyl Compounds|Insulin-Like Growth Factor I|Lignans|Naphthalenes|Podophyllum|Tetrahydronaphthalenes,COC1=CC(=CC(OC)=C1OC)[C@H]1[C@H]2[C@H](COC2=O)[C@@H](O)C2=CC3=C(OCO3)C=C12,72435
10771,DB12803,Dichloroisoproterenol,small molecule,investigational,Alcohols|Amines|Amino Alcohols|Benzene Derivatives|Catecholamines|Catechols|Ethanolamines|Phenols,CC(C)NCC(O)C1=CC=C(Cl)C(Cl)=C1,5806
10772,DB12804,Daniquidone,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",NC1=CC=C2N=C3N(CC2=C1)C(=O)C1=CC=CC=C31,71750
10773,DB12805,Ataciguat,small molecule,investigational,"Acids, Carbocyclic|Amides|Aminobenzoates|Benzene Derivatives|Benzoates|Enzyme Activators|Sulfones|Sulfur Compounds",ClC1=CC=C(S1)S(=O)(=O)NC1=C(C=C(Cl)C=C1)C(=O)NC1=CC=C(C=C1)S(=O)(=O)N1CCOCC1,213037
10774,DB12806,GSK-1004723,small molecule,investigational,Histamine Antagonists|Histamine H1 Antagonists|Pyridazines,ClC1=CC=C(CC2=NN(C[C@H]3CCCN3CCCCC3=CC=C(OCCCN4CCCCCC4)C=C3)C(=O)C3=CC=CC=C23)C=C1,17747460
10776,DB12808,Trifarotene,small molecule,approved|investigational,Alkenes|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dermatologicals|Misc. Skin and Mucous Membrane Agents|Polyenes|Retinoids for Topical Use in Acne,CC(C)(C)C1=CC(=CC=C1N1CCCC1)C1=CC(=CC=C1OCCO)C1=CC=C(C=C1)C(O)=O,11518241
10777,DB12809,BK-MDA,small molecule,investigational,,CC(N)C(=O)C1=CC=C2OCOC2=C1,57465250
10778,DB12810,AN-2718,small molecule,investigational,,OB1OCC2=CC(Cl)=CC=C12,11845944
10779,DB12812,Palomid 529,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Pyrans",COC1=CC=C(COC2=C(OC)C=C3C(OC(=O)C4=CC(=CC=C34)C(C)O)=C2)C=C1,11998575
10780,DB12813,Radium Ra-223,small molecule,investigational,"Elements|Elements, Radioactive|Isotopes|Metals|Metals, Alkaline Earth|Metals, Heavy|Radioisotopes",[223Ra],6335825
10783,DB12816,Terpinen-4-ol,small molecule,investigational,,CC(C)C1(O)CCC(C)=CC1,11230
10784,DB12817,Zoliflodacin,small molecule,investigational,Pyrimidines|Pyrimidinones,[H][C@]12[C@H](C)O[C@H](C)CN1C1=C(CC22C(=O)NC(=O)NC2=O)C=C2C(ON=C2N2[C@@H](C)COC2=O)=C1F,76685216
10785,DB12818,NM-3,small molecule,investigational,,COC1=CC(O)=C2C(=O)OC(=CC2=C1)C(C)C(O)=O,5493470
10786,DB12819,GSI-136,small molecule,investigational,,CCC(CC)[C@@H](CO)NS(=O)(=O)C1=CC=C(Cl)S1,11358855
10788,DB12821,Perflubutane,small molecule,approved|investigational,"Anions|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Electrolytes|Elements|Hydrocarbons, Fluorinated|Hydrocarbons, Halogenated|Ions|Iron Compounds|Metals|Metals, Heavy|Organometallic Compounds|Oxygen Compounds|Transition Elements",FC(F)(F)C(F)(F)C(F)(F)C(F)(F)F,9638
10790,DB12823,Tecarfarin,small molecule,investigational,"Acids, Carbocyclic|Benzene Derivatives|Benzopyrans|Coumarins|Heterocyclic Compounds, Fused-Ring|Pyrans",CC(OC(=O)C1=CC=C(CC2=C(O)C3=CC=CC=C3OC2=O)C=C1)(C(F)(F)F)C(F)(F)F,54718618
10792,DB12825,Lefamulin,small molecule,approved|investigational,Acetates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|P-glycoprotein substrates|QTc Prolonging Agents|Sulfur Compounds,[H][C@@]12C(=O)CC[C@]11CCC(C)[C@@]2(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]1C)OC(=O)CS[C@@H]1CC[C@@H](N)C[C@H]1O,25185057
10794,DB12827,Indoximod,small molecule,investigational,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Tryptophan Oxygenase, antagonists & inhibitors",CN1C=C(C[C@@H](N)C(O)=O)C2=CC=CC=C12,405012
10795,DB12829,Amithiozone,small molecule,investigational,Anti-Bacterial Agents|Anti-Infective Agents|Antiinfectives for Systemic Use|Antimycobacterials|Antituberculosis Agents|Drugs for Treatment of Tuberculosis|Semicarbazides|Semicarbazones|Sulfur Compounds|Thiosemicarbazones,CC(=O)NC1=CC=C(\C=N\NC(N)=S)C=C1,9568512
10796,DB12830,Cebranopadol,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CN(C)[C@]1(CC[C@@]2(CC1)OCCC1=C2NC2=CC=C(F)C=C12)C1=CC=CC=C1,11848225
10797,DB12831,Gabexate,small molecule,investigational,Amidines|Anticoagulants|Enzyme Inhibitors|Guanidines|Hematologic Agents|Protease Inhibitors|Serine Protease Inhibitors,CCOC(=O)C1=CC=C(OC(=O)CCCCCNC(N)=N)C=C1,3447
10798,DB12832,Prednimustine,small molecule,investigational,"Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Fused-Ring Compounds|Hydrocarbons, Halogenated|Mustard Compounds|Nitrogen Mustard Analogues|Nitrogen Mustard Compounds|Noxae|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Toxic Actions",[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCCC3=CC=C(C=C3)N(CCCl)CCCl)[C@@]1(C)C[C@]([H])(O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,34457
10799,DB12833,Tandospirone,small molecule,investigational,"Anti-Anxiety Agents|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Agonists|Tranquilizing Agents",[H][C@]12CC[C@]([H])(C1)[C@]1([H])C(=O)N(CCCCN3CCN(CC3)C3=NC=CC=N3)C(=O)[C@]21[H],91273
10800,DB12834,Secnidazole,small molecule,approved,"Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Imidazoles|Nitro Compounds|Nitroimidazole Antimicrobial|Nitroimidazole Derivatives|Nitroimidazoles",CC(O)CN1C(C)=NC=C1N(=O)=O,71815
10802,DB12836,Grapiprant,small molecule,investigational|vet_approved,Amides|P-glycoprotein substrates|Sulfones|Sulfur Compounds,CCC1=NC2=C(C)N=C(C)C=C2N1C1=CC=C(CCNC(=O)NS(=O)(=O)C2=CC=C(C)C=C2)C=C1,11677589
10803,DB12837,UK-500001,small molecule,investigational,,CC1=CC(C(=O)N[C@H]2CC[C@H](CC2)NC(=O)C2=C(OC3=CC(F)=C(F)C=C3)N=CC(F)=C2)=C(O)C=C1,9876393
10804,DB12838,Tetrasul,small molecule,investigational,"Benzene Derivatives|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated",ClC1=CC=C(SC2=C(Cl)C=C(Cl)C(Cl)=C2)C=C1,16685
10805,DB12839,Pegvaliase,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Ammonia-Lyases|Carbon-Nitrogen Lyases|Enzymes|Enzymes and Coenzymes|Lyases|Pegylated agents|Proteins",COCCOCCCCCC(=O)NCCCC[C@H](N)C(O)=O,86278362
10806,DB12840,Pirnabine,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Enzyme Activators|Gastrointestinal Agents|Guanylyl Cyclase C Agonists|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Peptide Hormones|Peptides|Receptors, Guanylate Cyclase-Coupled, agonists",CC1CCC2=C(C1)C1=C(OC2(C)C)C=C(C)C=C1OC(C)=O,50137
10808,DB12842,Pegamotecan,small molecule,investigational,"Alcohols|Alkaloids|Compounds used in a research, industrial, or household setting|Ethylene Glycols|Glycols|Macromolecular Substances|Pegylated agents|Polymers",,
10809,DB12843,Oleandrin,small molecule,experimental|investigational,Carbohydrates|Cardanolides|Cardiac Glycosides|Fused-Ring Compounds|Glycosides|Steroids,CO[C@H]1C[C@H](O[C@H]2CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@H]([C@H](C[C@]43O)OC(C)=O)C3=CC(=O)OC3)C2)O[C@@H](C)[C@@H]1O,11541511
10812,DB12846,Reproterol,small molecule,investigational,"Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Alkaloids|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Benzene Derivatives|Bronchodilator Agents|Catecholamines|Catechols|Drugs for Obstructive Airway Diseases|Ethanolamines|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|Peripheral Nervous System Agents|Pharmaceutical Preparations|Phenols|Purines|Purinones|Respiratory System Agents|Selective Beta 2-adrenergic Agonists",CN1C2=C(N(CCCNCC(O)C3=CC(O)=CC(O)=C3)C=N2)C(=O)N(C)C1=O,25654
10813,DB12847,Pyroxamide,small molecule,investigational,Amines|Hydroxy Acids|Hydroxylamines|Pyridines,ONC(=O)CCCCCCC(=O)NC1=CN=CC=C1,4996
10814,DB12848,PF-04217903,small molecule,investigational,,OCCN1C=C(C=N1)C1=CN=C2N=NN(CC3=CC4=CC=CN=C4C=C3)C2=N1,17754438
10816,DB12850,Etalocib,small molecule,investigational,"Acids, Carbocyclic|Benzene Derivatives",CCCC1=C(OCCCOC2=CC(O)=C(C=C2CC)C2=CC=C(F)C=C2)C=CC=C1OC1=CC=CC=C1C(O)=O,177941
10818,DB12852,MK-0752,small molecule,investigational,"Acids, Acyclic|Amyloid Precursor Protein Secretases, antagonists & inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|Sulfur Compounds",OC(=O)CC[C@H]1CC[C@@](CC1)(C1=C(F)C=CC(F)=C1)S(=O)(=O)C1=CC=C(Cl)C=C1,9803433
10819,DB12853,DA-6886,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates",COC1=CC(N)=C(Cl)C=C1C(=O)NCC1CCN(CCCN2C=CN=N2)CC1,54575171
10820,DB12854,BMS-908662,small molecule,investigational,,COC(=O)NC1=NC2=CC(=CC=C2N1)C1(O)N(C(=O)C2=CC=CC=C12)C1=CC(Cl)=CC=C1C,56931136
10821,DB12855,Apricitabine,small molecule,investigational,"Carbohydrates|Deoxyribonucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",NC1=NC(=O)N(C=C1)[C@H]1CO[C@@H](CO)S1,455041
10822,DB12856,Timonacic,small molecule,investigational,,OC(=O)C1CSCN1,9934
10823,DB12857,NVP-LEQ-506,small molecule,investigational,,C[C@@H]1CN(CCN1C1=CN=C(C=N1)C(C)(C)O)C1=NN=C(CC2=CC=CC=C2)C(C)=C1C,45100669
10824,DB12858,LY-377604,small molecule,investigational,,CC(C)(CC1=CC=C(OC2=CC=C(C=N2)C(N)=O)C=C1)NC[C@H](O)COC1=CC=CC2=C1C1=C(N2)C=CC=C1,9849699
10825,DB12859,Tantalum,small molecule,investigational,"Elements|Metals|Metals, Heavy|Transition Elements",[Ta],23956
10826,DB12860,Actinium,small molecule,investigational,"Actinoid Series Elements|Elements|Elements, Radioactive|Isotopes|Metals|Metals, Heavy|Radioisotopes",[Ac],23965
10827,DB12861,Rimeporide,small molecule,investigational,,CC1=CC(=C(C=C1C(=O)NC(N)=N)S(C)(=O)=O)S(C)(=O)=O,9799487
10829,DB12863,Sivelestat,small molecule,investigational,"Amides|Amino Acids|Amino Acids, Peptides, and Proteins|Enzyme Inhibitors|Protease Inhibitors|Serine Protease Inhibitors|Sulfones|Sulfur Compounds",CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=C1C(=O)NCC(O)=O,107706
10830,DB12864,Melarsoprol,small molecule,investigational,"Agents Against Leishmaniasis and Trypanosomiasis|Anti-Infective Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Arsenicals|Organometallic Compounds|Trypanocidal Agents",NC1=NC(NC2=CC=C(C=C2)[As]2SCC(CO)S2)=NC(N)=N1,10311
10831,DB12865,Etelcalcetide,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Anti-Parathyroid Agents|Calcium Homeostasis|Calcium-sensing Receptor Agonist|Increased Calcium-sensing Receptor Sensitivity|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",C[C@@H](NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](C)NC(=O)[C@@H](CSSC[C@H](N)C(O)=O)NC(C)=O)C(=O)N[C@H](CCCNC(N)=N)C(N)=O,71511839
10832,DB12866,Pradigastat,small molecule,investigational,"Acids, Acyclic|Amines|Fatty Acids|Fatty Acids, Volatile|Lipids|OAT3/SLC22A8 Inhibitors|Pyridines",OC(=O)C[C@H]1CC[C@@H](CC1)C1=CC=C(C=C1)C1=NC=C(NC2=CN=C(C=C2)C(F)(F)F)C=C1,53387035
10833,DB12867,Benperidol,small molecule,approved|investigational,Antipsychotic Agents|Butyrophenone Derivatives|Butyrophenones|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Ketones|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents,OC1=NC2=CC=CC=C2N1C1CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1,16363
10834,DB12868,Intoplicine,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CN(C)CCCNC1=NC=C(C)C2=C1C1=C(N2)C=CC2=CC(O)=CC=C12,65954
10835,DB12869,Eliprodil,small molecule,investigational,"Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Neuroprotective Agents|Neurotransmitter Agents|Protective Agents|Receptors, Neurotransmitter",OC(CN1CCC(CC2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,60703
10836,DB12870,Buthionine Sulfoximine,small molecule,investigational,"Amino Acids|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Antimetabolites|Antineoplastic Agents|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Noxae|Protective Agents|Radiation-Protective Agents|Radiation-Sensitizing Agents|Sulfur Compounds|Toxic Actions",CCCCS(=N)(=O)CCC(N)C(O)=O,21157
10839,DB12873,Dianhydrogalactitol,small molecule,investigational,"Alcohols|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Carbohydrates|Galactitol|Noxae|Sugar Alcohols|Toxic Actions",O[C@@H]([C@@H](O)[C@H]1CO1)[C@@H]1CO1,15942827
10840,DB12874,Quizartinib,small molecule,investigational,"Benzene Derivatives|Heterocyclic Compounds, Fused-Ring|Sulfur Compounds|Thiazoles",CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1,24889392
10841,DB12875,Mavatrep,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CC(C)(O)C1=CC=CC=C1C1=CC=C2N=C(NC2=C1)\C=C\C1=CC=C(C=C1)C(F)(F)F,17751090
10842,DB12876,GS-9256,small molecule,investigational,"Acids|Acids, Noncarboxylic|Amino Acids, Peptides, and Proteins|Organophosphorus Compounds|Peptides|Phosphorus Acids|Phosphorus Compounds",COC1=C(Cl)C2=NC(=CC(O[C@@H]3C[C@@H]4N(C3)C(=O)[C@H](CCCCCCC[C@@H]3C[C@]3(NC4=O)P(O)(=O)CC3=C(F)C=CC=C3F)NC(=O)OC3CCCC3)=C2C=C1)C1=CSC(NC(C)C)=N1,24823649
10843,DB12877,Oxatomide,small molecule,approved|investigational,Anti-Allergic Agents|Anti-Asthmatic Agents|Antihistamines for Systemic Use|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|Piperazine Derivatives|QTc Prolonging Agents|Respiratory System Agents,O=C1NC2=C(C=CC=C2)N1CCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,4615
10844,DB12878,AV-101,small molecule,investigational,"Amino Acids|Amino Acids, Peptides, and Proteins|Sweetening Agents",N[C@@H](CC(=O)C1=C(N)C=C(Cl)C=C1)C(O)=O,9859632
10845,DB12879,Omigapil,small molecule,investigational,"Ethers|Ethers, Cyclic",CN(CC#C)CC1=CC2=CC=CC=C2OC2=CC=CC=C12,6419718
10847,DB12881,Indole-3-carbinol,small molecule,investigational,"Anticarcinogenic Agents|Antineoplastic Agents|Compounds used in a research, industrial, or household setting|Heterocyclic Compounds, Fused-Ring|Protective Agents",OCC1=CNC2=CC=CC=C12,3712
10848,DB12882,Ombrabulin,small molecule,investigational,"Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins",COC1=CC=C(\C=C/C2=CC(OC)=C(OC)C(OC)=C2)C=C1NC(=O)[C@@H](N)CO,6918405
10849,DB12883,Eltoprazine,small molecule,investigational,Antidepressive Agents|Central Nervous System Depressants|Neurotransmitter Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Agonists,C1CN(CCN1)C1=C2OCCOC2=CC=C1,65853
10850,DB12884,Lavoltidine,small molecule,investigational,Gastric Acid Lowering Agents|Histamine Agents|Histamine Antagonists|Histamine H2 Antagonists|Neurotransmitter Agents,CN1N=C(CO)N=C1NCCCOC1=CC=CC(CN2CCCCC2)=C1,55473
10851,DB12885,CF-102,small molecule,investigational,,CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(NCC3=CC=CC(I)=C3)N=C(Cl)N=C12,3035850
10852,DB12886,GSK-1521498,small molecule,investigational,"Indenes|Receptors, Opioid, mu",FC1=CC(=CC(F)=C1CNC1CC2=CC=CC=C2C1)C1=CC=CC(=C1)C1=NNC=N1,24737629
10853,DB12887,Tazemetostat,small molecule,approved|investigational,Amides|BCRP/ABCG2 Substrates|Benzene Derivatives|Benzoates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|MATE 1 Inhibitors|MATE 2 Inhibitors|MATE inhibitors|P-glycoprotein substrates|Pyridines,CCN(C1CCOCC1)C1=C(C)C(=CC(=C1)C1=CC=C(CN2CCOCC2)C=C1)C(=O)NCC1=C(C)C=C(C)NC1=O,66558664
10854,DB12888,Ezutromid,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CCS(=O)(=O)C1=CC=C2OC(=NC2=C1)C1=CC=C2C=CC=CC2=C1,25109292
10855,DB12889,Velneperit,small molecule,investigational,,CC(C)(C)S(=O)(=O)N[C@H]1CC[C@@H](CC1)C(=O)NC1=NC=C(C=C1)C(F)(F)F,20629114
10856,DB12890,Dihydrexidine,small molecule,investigational,"Dopamine Agents|Dopamine Agonists|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|Nonergot-derivative Dopamine Receptor Agonists",OC1=C(O)C=C2[C@H]3[C@H](CCC2=C1)NCC1=CC=CC=C31,5311070
10858,DB12892,MGB-BP-3,small molecule,investigational,,CN1C=C(NC(=O)C2=CC(NC(=O)C3=CC=C(\C=C\C4=CN=C5C=CC=CC5=C4)C=C3)=CN2C)C=C1C(=O)NCCN1CCOCC1,23730143
10860,DB12894,Raluridine,small molecule,investigational,"Carbohydrates|Deoxyribonucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides",OC[C@H]1O[C@H](C[C@@H]1F)N1C=C(Cl)C(=O)NC1=O,451480
10861,DB12895,TD-139,small molecule,investigational,,OC[C@H]1O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@@H]([C@H]2O)N2C=C(N=N2)C2=CC=CC(F)=C2)[C@H](O)[C@H]([C@H]1O)N1C=C(N=N1)C1=CC(F)=CC=C1,73774610
10862,DB12896,PSI-352938,small molecule,investigational,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides",CCOC1=C2N=CN([C@@H]3O[C@@H]4CO[P@@](=O)(OC(C)C)O[C@H]4[C@@]3(C)F)C2=NC(N)=N1,45102284
10863,DB12897,MK-7622,small molecule,investigational,,CC1=CC=C(CC2=CC3=C(N=CN([C@H]4CCCC[C@@H]4O)C3=O)C3=CC=CC=C23)C=N1,46207733
10865,DB12899,TT-301,small molecule,investigational,,C1CN(CCN1C1=NC=CC=N1)C1=C(C=C(N=N1)C1=CC=CC=C1)C1=CC=NC=C1,54576073
10866,DB12900,Irdabisant,small molecule,investigational,"Receptors, Histamine H3",C[C@@H]1CCCN1CCCOC1=CC=C(C=C1)C1=NNC(=O)C=C1,25070031
10867,DB12901,Fiacitabine,small molecule,investigational,"Anti-Infective Agents|Antineoplastic Agents|Antiviral Agents|Arabinonucleosides|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",NC1=NC(=O)N(C=C1I)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F,50312
10868,DB12902,Trofosfamide,small molecule,investigational,"Acids|Acids, Noncarboxylic|Alkylating Drugs|Anions|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Electrolytes|Hydrocarbons, Halogenated|Immunologic Factors|Immunosuppressive Agents|Ions|Mustard Compounds|Mutagens|Nitrogen Mustard Analogues|Nitrogen Mustard Compounds|Noxae|Organophosphorus Compounds|Phosphoramide Mustards|Phosphoramides|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Toxic Actions",ClCCN(CCCl)P1(=O)OCCCN1CCCl,65702
10869,DB12903,DEBIO-1347,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CC1=NC2=CC=C(C=C2N1)N1N=CC(C(=O)C2=CC3=CC=CC=C3N2)=C1N,66555680
10870,DB12904,ZSTK-474,small molecule,investigational,,FC(F)C1=NC2=CC=CC=C2N1C1=NC(=NC(=N1)N1CCOCC1)N1CCOCC1,11647372
10871,DB12905,Samarium Sm-153,small molecule,investigational,"Elements|Isotopes|Lanthanoid Series Elements|Metals|Metals, Rare Earth",[153Sm],114941
10872,DB12906,LY-2334737,small molecule,investigational,"Carbohydrates|Deoxyribonucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",CCCC(CCC)C(=O)NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,11646777
10873,DB12907,Mannose,small molecule,investigational,Carbohydrates|Hexoses|Monosaccharides,[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)C=O,161658
10876,DB12910,Emicerfont,small molecule,investigational,"Corticotropin-Releasing Hormone, antagonists & inhibitors",COC1=CC=C(N2CCC3=C2N=C(C)C=C3N2C=CC(=N2)N2CCNC2=O)C(C)=C1,11223423
10877,DB12911,Nicoboxil,small molecule,approved|investigational,Drugs that are Mainly Renally Excreted|Pyridines,CCCCOCCOC(=O)C1=CN=CC=C1,14866
10878,DB12912,Nolatrexed,small molecule,investigational,"Antimetabolites|Antineoplastic Agents|Enzyme Inhibitors|Folic Acid Antagonists|Heterocyclic Compounds, Fused-Ring|Noxae|Thymidylate Synthase, antagonists & inhibitors|Toxic Actions",CC1=CC=C2N=C(N)NC(=O)C2=C1SC1=CC=NC=C1,108189
10879,DB12914,MGL-3196,small molecule,investigational,Pyrimidines|Pyrimidinones,CC(C)C1=CC(OC2=C(Cl)C=C(C=C2Cl)N2N=C(C#N)C(=O)NC2=O)=NNC1=O,15981237
10880,DB12915,Corticorelin acetate,small molecule,investigational,,,
10881,DB12916,Mitolactol,small molecule,investigational,"Alcohols|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Carbohydrates|Galactitol|Noxae|Sugar Alcohols|Toxic Actions",O[C@@H](CBr)[C@@H](O)[C@@H](O)[C@H](O)CBr,5284380
10883,DB12919,T-62,small molecule,investigational,,NC1=C(C(=O)C2=CC=C(Cl)C=C2)C2=C(CCCC2)S1,855908
10884,DB12920,Pinometostat,small molecule,investigational,"Antineoplastic Agents|Heterocyclic Compounds, Fused-Ring",[H][C@]1(CCC2=NC3=C(N2)C=C(C=C3)C(C)(C)C)C[C@]([H])(C1)N(C[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O)C(C)C,57345410
10885,DB12921,Chlorsulfaquinoxaline,small molecule,investigational,"Amides|Amines|Aniline Compounds|Heterocyclic Compounds, Fused-Ring|Sulfonamides|Sulfones|Sulfur Compounds",NC1=CC=C(C=C1)S(=O)(=O)NC1=NC2=CC=CC(Cl)=C2N=C1,72462
10886,DB12923,Gallopamil,small molecule,investigational,Agents causing hyperkalemia|Amines|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Ethylamines|Membrane Transport Modulators|P-glycoprotein inhibitors|Phenethylamines|Phenylalkylamine Derivatives|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Selective Calcium Channel Blockers With Direct Cardiac Effects|Vasodilating Agents|Verapamil and analogues,COC1=CC(=CC(OC)=C1OC)C(CCCN(C)CCC1=CC(OC)=C(OC)C=C1)(C#N)C(C)C,1234
10887,DB12924,Ozenoxacin,small molecule,approved|investigational,"Amines|Anti-Bacterial Agents|Antibiotics for Topical Use|Dermatologicals|Heterocyclic Compounds, Fused-Ring|Pyridines|Quinolines|Quinolone Antimicrobial",CNC1=NC=C(C=C1C)C1=CC=C2C(=O)C(=CN(C3CC3)C2=C1C)C(O)=O,9863827
10888,DB12925,Crolibulin,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Pyrans",COC1=CC(=CC(Br)=C1OC)[C@@H]1C2=CC=C(N)C(N)=C2OC(N)=C1C#N,23649181
10889,DB12926,Cafedrine,small molecule,investigational,"Adrenergic and Dopaminergic Agents|Alcohols|Alkaloids|Amines|Amino Alcohols|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Propanolamines|Propanols|Purines|Purinones|Vasodilating Agents|Xanthine derivatives",C[C@H](NCCN1C=NC2=C1C(=O)N(C)C(=O)N2C)[C@H](O)C1=CC=CC=C1,5489638
10890,DB12927,Theodrenaline,small molecule,investigational,"Adrenergic and Dopaminergic Agents|Agents that produce hypertension|Alcohols|Alkaloids|Amines|Amino Alcohols|Benzene Derivatives|Biogenic Amines|Biogenic Monoamines|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Catecholamines|Catechols|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Epinephrine and similars|Ethanolamines|Heterocyclic Compounds, Fused-Ring|Phenols|Purines|Purinones|Xanthine derivatives",CN1C2=C(N(CCNCC(O)C3=CC(O)=C(O)C=C3)C=N2)C(=O)N(C)C1=O,71857
10891,DB12928,GET-73,small molecule,investigational,,COCCCC(=O)NCC1=CC=C(C=C1)C(F)(F)F,10221200
10892,DB12929,JNJ-39220675,small molecule,investigational,Histamine H3 Antagonists,FC1=CC=C(OC2=CC=C(C=N2)C(=O)N2CCCN(CC2)C2CCC2)C=C1,24771368
10893,DB12930,Opipramol,small molecule,investigational,"Adrenergic Agents|Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Antidepressive Agents, Tricyclic|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Dibenzazepines|Heterocyclic Compounds, Fused-Ring|Membrane Transport Modulators|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Non-Selective Monoamine Reuptake Inhibitors|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",OCCN1CCN(CCCN2C3=CC=CC=C3C=CC3=CC=CC=C23)CC1,9417
10894,DB12931,Fenobam,small molecule,investigational,,CN1CC(=O)N=C1NC(=O)NC1=CC=CC(Cl)=C1,162834
10895,DB12932,Merotocin,small molecule,investigational,,CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCCSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)CC1=CC=C(F)C=C1,76073634
10896,DB12933,RO-4987655,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates",OCCONC(=O)C1=CC(CN2OCCCC2=O)=C(F)C(F)=C1NC1=CC=C(I)C=C1F,11548630
10897,DB12934,Granotapide,small molecule,investigational,"Acids, Acyclic|Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Dicarboxylic Acids",CCOC(=O)C(COC(=O)CC1=CC=C(NC(=O)C2=CC=CC=C2C2=CC=C(C=C2)C(F)(F)F)C(=C1)C(=O)N(C)C)(C(=O)OCC)C1=CC=CC=C1,11607299
10898,DB12935,Remogliflozin etabonate,small molecule,investigational,Blood Glucose Lowering Agents|Carbohydrates|Glycosides|Sodium-Glucose Transporter 2 Inhibitors,CCOC(=O)OC[C@H]1O[C@@H](OC2=NN(C(C)C)C(C)=C2CC2=CC=C(OC(C)C)C=C2)[C@H](O)[C@@H](O)[C@@H]1O,9871420
10899,DB12937,Quercetin-3'-O-phosphate,small molecule,investigational,,OC1=CC(O)=C2C(=O)C(O)=C(OC2=C1)C1=CC(OP(O)(O)=O)=C(O)C=C1,20833257
10900,DB12938,Isoxaflutole,small molecule,approved|experimental|investigational,"Amino Acids, Peptides, and Proteins|Membrane Proteins|Neoplasm Proteins|Proteins|Tumor Suppressor Proteins",[H]C1=NOC(=C1C(=O)C1=C(C([H])=C(C([H])=C1[H])C(F)(F)F)S(=O)(=O)C([H])([H])[H])C1([H])C([H])([H])C1([H])[H],84098
10901,DB12939,Nikkomycin Z,small molecule,investigational,Anti-Infective Agents|Antifungal Agents|Carbohydrates|Enzyme Inhibitors|Glycosides,C[C@@H]([C@H](N)C(=O)N[C@@H]([C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O)C(O)=O)[C@H](O)C1=CC=C(O)C=N1,456557
10902,DB12940,Helium He-3,small molecule,investigational,Elements|Gases|Noble Gases,[3He],6857639
10903,DB12941,Darolutamide,small molecule,approved|investigational,"Antiandrogens|Antiandrogens, non-steroidal|Antineoplastic Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein substrates|UGT1A1 Substrates|UGT1A9 Substrates",C[C@@H](CN1C=CC(=N1)C1=CC=C(C#N)C(Cl)=C1)NC(=O)C1=NNC(=C1)C(C)O,67171867
10904,DB12942,Lactitol,small molecule,approved|investigational,"Alcohols|Alimentary Tract and Metabolism|Carbohydrates|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Drugs for Constipation|Flavoring Agents|Food|Food Additives|Food and Beverages|Food Ingredients|Gastrointestinal Agents|Laxatives|Osmotic Laxatives|Pharmaceutic Aids|Pharmaceutical Preparations|Sweetening Agents",OC[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO,157355
10906,DB12944,Phloroglucinol,small molecule,investigational,"Alimentary Tract and Metabolism|Benzene Derivatives|Compounds used in a research, industrial, or household setting|Drugs for Functional Gastrointestinal Disorders|Indicators and Reagents|Laboratory Chemicals|Phenols",OC1=CC(O)=CC(O)=C1,359
10907,DB12945,Dihydralazine,small molecule,approved|experimental,"Antihypertensive Agents|Arteriolar Smooth Muscle, Agents Acting On|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Hydrazinophthalazine Derivatives|Hydrazinophthalazine Derivatives and Diuretics|Phthalazines|Pyridazines",NNC1=C2C=CC=CC2=C(NN)N=N1,10230
10908,DB12946,"8-cyclopentyl-1,3-dipropylxanthine",small molecule,investigational,"Adenosine A1 Receptor Antagonists|Alkaloids|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|Purinergic Agents|Purinergic Antagonists|Purinergic P1 Receptor Antagonists|Purines|Purinones",CCCN1C2=C(N=C(N2)C2CCCC2)C(=O)N(CCC)C1=O,1329
10909,DB12947,Doxifluridine,small molecule,investigational,"Antimetabolites|Antineoplastic Agents|Appetite Stimulants|Carbohydrates|Central Nervous System Agents|Central Nervous System Stimulants|Deoxyribonucleosides|Deoxyuridine|Fluoropyrimidines|Fluorouracil and prodrugs|Glycosides|Immunologic Factors|Immunosuppressive Agents|Isomerism|Noxae|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides|Toxic Actions",C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=C(F)C(=O)NC1=O,18343
10910,DB12948,Didox,small molecule,investigational,"Amines|Antineoplastic Agents|Enzyme Inhibitors|Hydroxy Acids|Hydroxylamines|Ribonucleotide Reductases, antagonists & inhibitors",ONC(=O)C1=CC(O)=C(O)C=C1,3045
10911,DB12949,PF-03382792,small molecule,investigational,,CC1(C)C(=O)N(C(=O)NCC2CCN(CC3(O)CCOCC3)CC2)C2=CC(F)=CC=C12,71451950
10913,DB12951,Pivagabine,small molecule,investigational,"Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Aminobutyrates|Antidepressive Agents|Butyrates|Central Nervous System Depressants|Fatty Acids|Fatty Acids, Volatile|Lipids|Nervous System|Psychoanaleptics",CC(C)(C)C(=O)NCCCC(O)=O,68888
10914,DB12952,Methylprednisone,small molecule,approved|investigational,Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates,C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)CC(=O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,124653
10916,DB12954,Terizidone,small molecule,approved|investigational,Antiinfectives for Systemic Use|Antimycobacterials|Drugs for Treatment of Tuberculosis|Oxazoles,O=C1NOCC1\N=C\C1=CC=C(\C=N\C2CONC2=O)C=C1,65720
10917,DB12955,Delparantag,small molecule,investigational,,COC1=CC=C(NC(=O)[C@H](CCCCN)NC(=O)C2=CC(NC(=O)[C@H](CCCCN)NC(=O)C3=CC(NC(=O)[C@H](CCCCN)NC(=O)C4=CC(NC(=O)[C@@H](N)CCCCN)=CC=C4OC)=CC=C3OC)=CC=C2OC)C=C1C(N)=O,51349239
10919,DB12957,5-fluoro-2'-deoxycytidine,small molecule,investigational,"Carbohydrates|Deoxyribonucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",NC1=NC(=O)N(C=C1F)[C@H]1C[C@H](O)[C@@H](CO)O1,515328
10920,DB12958,Prothipendyl,small molecule,investigational,Antipsychotic Agents|Central Nervous System Depressants|Nervous System|Neurotoxic agents|Psycholeptics|Sulfur Compounds,CN(C)CCCN1C2=CC=CC=C2SC2=C1N=CC=C2,14670
10921,DB12959,IOWH-032,small molecule,investigational,,OC1=C(Br)C=C(C=C1Br)C1=NOC(=N1)C(=O)NCC1=CC=C(OC2=CC=CC=C2)C=C1,44241539
10922,DB12960,INCB-9471,small molecule,investigational,"Receptors, CCR4, antagonists & inhibitors",CCO[C@@H]1CC2=CC(=CC=C2[C@H]1N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)C1=C(C)N=CN=C1C)C(F)(F)F,49871007
10923,DB12961,Leukotriene B4,small molecule,investigational,"Arachidonic Acids|Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Essential|Fatty Acids, Unsaturated|Inflammation Mediators|Leukotriene B4, antagonists & inhibitors|Leukotrienes|Lipids",CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O,5280492
10924,DB12962,CP-547632,small molecule,investigational,Sulfur Compounds,NC(=O)C1=C(NC(=O)NCCCCN2CCCC2)SN=C1OCC1=C(F)C=C(Br)C=C1F,9811611
10925,DB12963,CCX-354,small molecule,investigational,,COC1=CC(=CC=C1Cl)N1CCN(CC1)C(=O)CN1N=C(C2=NC=CN2)C2=CC=CN=C12,25016615
10926,DB12964,Lerisetron,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",C(N1C2=CC=CC=C2N=C1N1CCNCC1)C1=CC=CC=C1,65997
10927,DB12965,Silver,small molecule,approved|investigational,"Antiseptics and Disinfectants|Dermatologicals|Elements|Metals|Metals, Heavy|Silver Compounds|Transition Elements",[Ag],23954
10928,DB12966,Falnidamol,small molecule,investigational,,CN1CCC(CC1)NC1=NC=C2N=CN=C(NC3=CC=C(F)C(Cl)=C3)C2=N1,6918508
10929,DB12967,Mitoguazone,small molecule,investigational,Amidines|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Enzyme Inhibitors|Guanidines,C\C(\C=N\N=C(N)N)=N/N=C(N)N,5351154
10930,DB12968,DONU,small molecule,investigational,Nitroso Compounds,O[C@H]1CCC[C@@H](O)[C@@H]1NC(=O)N(CCCl)N=O,319665
10931,DB12969,Methylinositol,small molecule,investigational,Alcohols|Carbohydrates|Sugar Alcohols,CO[C@@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@H]1O,164619
10932,DB12970,Levoglucose,small molecule,investigational,"Compounds used in a research, industrial, or household setting",OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)C=O,10954115
10933,DB12971,Pactimibe,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Indoles|Sterol O-Acyltransferase, antagonists & inhibitors",CCCCCCCCN1CCC2=C1C(NC(=O)C(C)(C)C)=C(C)C(CC(O)=O)=C2C,3081927
10934,DB12972,Sepranolone,small molecule,investigational,Anesthetics|Central Nervous System Agents|Fused-Ring Compounds|Pregnanes|Steroids,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@@H](O)CC[C@]12C,92787
10935,DB12973,Serlopitant,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Neurokinin-1 Receptor Antagonists|Neurotransmitter Agents",C[C@@H](O[C@H]1CC[C@@H]2CN(C[C@H]2[C@@H]1C1=CC=C(F)C=C1)C1=CC(=O)CC1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,23653789
10936,DB12974,Roniciclib,small molecule,investigational,Sulfur Compounds,C[C@@H](O)[C@@H](C)OC1=C(C=NC(NC2=CC=C(C=C2)[S@](=N)(=O)C2CC2)=N1)C(F)(F)F,71494949
10937,DB12975,Pyronaridine,small molecule,investigational,"Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Heterocyclic Compounds, Fused-Ring",COC1=NC2=C(NC3=CC(CN4CCCC4)=C(O)C(CN4CCCC4)=C3)C3=CC=C(Cl)C=C3N=C2C=C1,5485198
10939,DB12977,Simenepag isopropyl,small molecule,investigational,,CCCCC[C@H](O)C1=CC=C(C=C1)N1[C@@H](COCC2=CC=C(S2)C(=O)OC(C)C)CCC1=O,46902081
10940,DB12978,Pexidartinib,small molecule,approved|investigational,Amines|Antineoplastic Agents|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Hepatotoxic Agents|MATE 1 Inhibitors|MATE 2 Inhibitors|MATE inhibitors|Narrow Therapeutic Index Drugs|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Pyridines|Tyrosine Kinase Inhibitors|UGT1A1 Inhibitors|UGT1A4 substrates,FC(F)(F)C1=CC=C(CNC2=NC=C(CC3=CNC4=NC=C(Cl)C=C34)C=C2)C=N1,25151352
10941,DB12979,Nepicastat,small molecule,investigational,"Dopamine beta-Hydroxylase, antagonists & inhibitors|Sulfur Compounds",NCC1=CNC(=S)N1[C@H]1CCC2=C(C1)C=C(F)C=C2F,9796181
10942,DB12980,CHS-828,small molecule,investigational,"Acids|Acids, Noncarboxylic|Amidines|Anions|Electrolytes|Hydrogen Cyanide|Ions|Nitrogen Compounds",ClC1=CC=C(OCCCCCCN\C(NC#N)=N\C2=CC=NC=C2)C=C1,148198
10943,DB12981,XL-888,small molecule,investigational,"Acids, Carbocyclic|Aza Compounds|HSP90 Heat-Shock Proteins, antagonists & inhibitors",CC[C@@H](C)NC1=C(C=C(C)C(=C1)C(=O)N[C@@H]1C[C@@H]2CC[C@H](C1)N2C1=CC=C(C=N1)C(=O)C1CC1)C(N)=O,60147023
10944,DB12982,Silicon,small molecule,approved|investigational,"Diet, Food, and Nutrition|Elements|Food|Food and Beverages|Growth Substances|Metalloids|Micronutrients|Minerals|Physiological Phenomena|Trace Elements",[Si],5461123
10945,DB12983,Phthalocyanine,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Radiation-Sensitizing Agents",N1C2=C3C=CC=CC3=C1\N=C1/N=C(/N=C3\N=C(NC4=N\C(=N/2)C2=CC=CC=C42)C2=CC=CC=C32)C2=CC=CC=C12,5282330
10946,DB12984,Larotaxel,small molecule,investigational,Cyclodecanes|Cycloparaffins|Diterpenes|Terpenes,CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C3=CC=CC=C3)[C@H]3[C@]4(C[C@H]4C[C@H]4OC[C@@]34OC(C)=O)C1=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,6918260
10947,DB12985,Quisinostat,small molecule,investigational,Amines|Hydroxy Acids|Hydroxylamines,CN1C=C(CNCC2CCN(CC2)C2=NC=C(C=N2)C(=O)NO)C2=CC=CC=C12,11538455
10948,DB12986,VS-5584,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Oxazines",CC(C)N1C(C)=NC2=C(N=C(N=C12)N1CCOCC1)C1=CN=C(N)N=C1,46912230
10949,DB12987,Penclomedine,small molecule,investigational,Antineoplastic Agents|Pyridines,COC1=C(Cl)C(OC)=C(Cl)C(=N1)C(Cl)(Cl)Cl,60203
10950,DB12988,LY-518674,small molecule,investigational,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids",CC1=CC=C(CN2N=C(CCCC3=CC=C(OC(C)(C)C(O)=O)C=C3)NC2=O)C=C1,9909438
10951,DB12989,Neosaxitoxin,small molecule,investigational,"Agrochemicals|Biological Factors|Central Nervous System Depressants|Compounds used in a research, industrial, or household setting|Heterocyclic Compounds, Fused-Ring|Insecticides|Marine Toxins|Neuromuscular Agents|Neuromuscular Blocking Agents|Peripheral Nervous System Agents|Pesticides|Purines|Toxic Actions|Toxins, Biological",[H][C@@]12N=C(N)N[C@]11N(CCC1(O)O)C(=N)N(O)[C@H]2COC(N)=O,21117946
10952,DB12990,Icosabutate,small molecule,investigational,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids",CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCOC(CC)C(O)=O,78210211
10953,DB12991,Deoxyspergualin,small molecule,investigational,"Amidines|Antibiotics, Antineoplastic|Antineoplastic Agents|Compounds used in a research, industrial, or household setting|Immunologic Factors|Immunosuppressive Agents|Protective Agents|Radiation-Protective Agents",NCCCNCCCCNC(=O)[C@H](O)NC(=O)CCCCCCNC(N)=N,91272
10954,DB12992,Bleomycin A6,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Carbohydrates|Glycoconjugates|Glycopeptides|Peptides",,
10955,DB12993,Berkelium,small molecule,investigational,"Actinoid Series Elements|Elements|Elements, Radioactive|Isotopes|Metals|Metals, Heavy|Radioisotopes",[Bk],23971
10956,DB12994,MIP-1095 I-123,small molecule,investigational,,OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)NC1=CC=C([123I])C=C1)C(O)=O)C(O)=O,25168442
10957,DB12996,Acteoside,small molecule,investigational,"Anti-Infective Agents|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Antioxidants|Benzene Derivatives|Carbohydrates|Chelating Agents|Compounds used in a research, industrial, or household setting|Glycosides|Immunologic Factors|Immunosuppressive Agents|Protective Agents|Sequestering Agents|Verbenaceae",C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCC3=CC(O)=C(O)C=C3)O[C@H](CO)[C@H]2OC(=O)\C=C\C2=CC(O)=C(O)C=C2)[C@H](O)[C@H](O)[C@H]1O,5281800
10958,DB12997,Brilacidin,small molecule,investigational,Amidines,NC(=N)NCCCCC(=O)NC1=CC(=CC(NC(=O)C2=CC(=NC=N2)C(=O)NC2=C(O[C@@H]3CCNC3)C(NC(=O)CCCCNC(N)=N)=CC(=C2)C(F)(F)F)=C1O[C@@H]1CCNC1)C(F)(F)F,25023695
10959,DB12998,PF-00217830,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",O=C1CCC2=CC=C(OCCCCN3CCN(CC3)C3=CC=CC4=CC=CC=C34)N=C2N1,11697676
10960,DB12999,MK-6186,small molecule,investigational,,ClC1=CC(OC2=C3C=NN(CC4=NNC5=NC=CC=C45)C3=CC=C2Cl)=CC(=C1)C#N,24988948
10961,DB13000,PCI-27483,small molecule,investigational,"Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Excitatory Amino Acids|Heterocyclic Compounds, Fused-Ring",NC(=N)C1=CC=C2N=C(NC2=C1)C1=CC(CC(=O)N[C@@H](CC(O)=O)C(O)=O)=CC(=C1O)C1=CC(=CC=C1O)S(N)(=O)=O,71587837
10962,DB13001,Tinoridine,small molecule,investigational,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antirheumatic Agents|Central Nervous System Agents|Heterocyclic Compounds, Fused-Ring|Nephrotoxic agents|Peripheral Nervous System Agents|Pyridines|Sensory System Agents|Sulfur Compounds|Thiophenes",CCOC(=O)C1=C(N)SC2=C1CCN(CC1=CC=CC=C1)C2,5480
10963,DB13002,HKI-357,small molecule,investigational,,CCOC1=C(NC(=O)\C=C\CN(C)C)C=C2C(NC3=CC=C(OCC4=CC=CC(F)=C4)C(Cl)=C3)=C(C=NC2=C1)C#N,11238512
10964,DB13003,Cortivazol,small molecule,investigational,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Fused-Ring Compounds|Glucocorticoids|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Pregnanes|Steroids|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",C[C@@H]1C[C@H]2[C@@H]3C=C(C)C4=CC5=C(C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O)C=NN5C1=CC=CC=C1,66249
10965,DB13004,Mavoglurant,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",COC(=O)N1CC[C@@H]2[C@H]1CCC[C@@]2(O)C#CC1=CC(C)=CC=C1,9926832
10966,DB13005,Rebastinib,small molecule,investigational,"Antineoplastic Agents|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Leukemia, Myelogenous, Chronic, BCR-ABL Positive, drug therapy|Protein Kinase Inhibitors",CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC(=NN3C3=CC4=CC=CN=C4C=C3)C(C)(C)C)C(F)=C2)=CC=N1,25066467
10967,DB13006,Cibinetide,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Peptides",CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O,91810664
10969,DB13008,"2,2-bis(4-hydroxy-3-tert-butylphenyl)propane",small molecule,investigational,,CC(C)(C)C1=CC(=CC=C1O)C(C)(C)C1=CC=C(O)C(=C1)C(C)(C)C,66237
10970,DB13009,Carbendazim,small molecule,investigational,"Acids, Acyclic|Agrochemicals|Anthelmintics|Anti-Infective Agents|Antinematodal Agents|Antiparasitic Agents|Compounds used in a research, industrial, or household setting|Fungicides, Industrial|Heterocyclic Compounds, Fused-Ring|Mutagens|Noxae|Pesticides|Toxic Actions",COC(=O)NC1=NC2=CC=CC=C2N1,25429
10971,DB13010,4-isothioureidobutyronitrile,small molecule,investigational,,NC(=N)SCCCC#N,437740
10972,DB13011,Diethylhomospermine,small molecule,investigational,,CCNCCCCNCCCCNCCCCNCC,60702
10973,DB13012,AQX-1125,small molecule,investigational,Alcohols|Cyclohexanes|Cycloparaffins|Fatty Alcohols|Hexanols|Indenes|Lipids,C[C@]12CC[C@@H]([C@@H](CN)[C@@H]1CCC2=C)[C@@]1(C)CC[C@H](O)C[C@@H]1CO,76965484
10974,DB13013,LFF-571,small molecule,investigational,Sulfur Compounds,CNC(=O)C[C@@H]1NC(=O)C2=CSC(=N2)C2=CC=C(N=C2C2=CSC(=N2)C2=CSC(=N2)[C@@H](NC(=O)CNC(=O)C2=C(COC)SC(=N2)[C@@H](NC(=O)C2=C(C)SC1=N2)C(C)C)[C@@H](O)C1=CC=CC=C1)C1=NC(=CS1)N(CCCCC(O)=O)C(=O)O[C@H]1CC[C@@H](CC1)C(O)=O,42638236
10975,DB13014,Hypericin,small molecule,investigational,"Anti-Infective Agents|Antidepressive Agents|Antineoplastic Agents|Benz(a)Anthracenes|Central Nervous System Agents|Central Nervous System Depressants|Enzyme Inhibitors|Immunologic Factors|Immunosuppressive Agents|Phenalenes|Protein Kinase C, antagonists & inhibitors|Psychotropic Drugs|Radiation-Sensitizing Agents",CC1=C2C3=C(C)C=C(O)C4=C3C3=C5C2=C(C(O)=C1)C(=O)C1=C5C(=C(O)C=C1O)C1=C(O)C=C(O)C(C4=O)=C31,5281051
10976,DB13016,LY-2300559,small molecule,investigational,"Acids, Carbocyclic|Benzene Derivatives|Ketones",CCCC1=C(OCC2=CC=C(C=C2)[C@H](O)C2=CC=CC(=C2)C(O)=O)C=CC(C(C)=O)=C1O,11611800
10978,DB13018,Dimiracetam,small molecule,investigational,,O=C1CN2C(CCC2=O)N1,65955
10979,DB13019,Henatinib,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Vascular Endothelial Growth Factors, antagonists & inhibitors",CC1=C(NC2=C1C(=O)N(C[C@H](O)CN1CCOCC1)CCC2)\C=C1/C(=O)NC2=CC=C(F)C=C12,25116064
10980,DB13020,Apratastat,small molecule,investigational,Oxazines,CC1(C)SCCN([C@H]1C(=O)NO)S(=O)(=O)C1=CC=C(OCC#CCO)C=C1,11452716
10981,DB13021,123I-iodometomidate,small molecule,investigational,,COC(=O)C1=CN=CN1[C@H](C)C1=CC=C(I)C=C1,11660398
10982,DB13022,LY-2874455,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Pyrazoles|Receptors, Fibroblast Growth Factor, antagonists & inhibitors",C[C@@H](OC1=CC=C2NN=C(\C=C\C3=CN(CCO)N=C3)C2=C1)C1=C(Cl)C=NC=C1Cl,46944259
10983,DB13023,IPI-493,small molecule,investigational,"Amides|HSP90 Heat-Shock Proteins, antagonists & inhibitors|Lactams|Protein-Serine-Threonine Kinases, antagonists & inhibitors|Quinones",CO[C@H]1C[C@H](C)CC2=C(N)C(=O)C=C(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O,9893658
10984,DB13024,MK-8245,small molecule,investigational,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids|Stearoyl-CoA Desaturase, antagonists & inhibitors",OC(=O)CN1N=NC(=N1)C1=CC(=NO1)N1CCC(CC1)OC1=C(Br)C=CC(F)=C1,24988881
10985,DB13025,Tiapride,small molecule,investigational,"Acids, Carbocyclic|Amides|Amines|Antipsychotic Agents|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs that are Mainly Renally Excreted|Ethylamines|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents",CCN(CC)CCNC(=O)C1=CC(=CC=C1OC)S(C)(=O)=O,5467
10986,DB13026,Ornidazole,small molecule,investigational,"Amebicides|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Antitrichomonal Agents|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Imidazole Derivatives|Imidazoles|Nitro Compounds|Nitroimidazole Derivatives|Nitroimidazoles|Radiation-Sensitizing Agents",CC1=NC=C(N1CC(O)CCl)N(=O)=O,28061
10987,DB13027,Tucaresol,small molecule,investigational,"Acids, Carbocyclic|Aldehydes|Benzene Derivatives",OC(=O)C1=CC=C(COC2=CC=CC(O)=C2C=O)C=C1,55223
10988,DB13028,Biapenem,small molecule,investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Carbapenems|Heterocyclic Compounds, Fused-Ring|Lactams|Sulfur Compounds",[H][C@](C)(O)[C@@]1([H])C(=O)N2C(C([O-])=O)=C(SC3CN4C=NC=[N+]4C3)[C@]([H])(C)[C@]12[H],71339
10989,DB13029,MK-0873,small molecule,investigational,"Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Phosphodiesterase 4 Inhibitors|Phosphodiesterase Inhibitors",[O-][N+]1=CC(=CC=C1)C#CC1=CC(=CC=C1)N1C=C(C(=O)NC2CC2)C(=O)C2=CC=CN=C12,9919680
10990,DB13030,2'-fluoro-5-ethylarabinosyluracil,small molecule,investigational,"Arabinonucleosides|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",OC[C@H]1O[C@H]([C@@H](F)[C@@H]1O)N1C=CC(=O)NC1=O,3007908
10991,DB13031,Niobium,small molecule,investigational,"Elements|Metals|Metals, Heavy|Transition Elements",[Nb],23936
10992,DB13032,Enecadin,small molecule,investigational,,CC1=NC(=CC(OCCCCCN2CCCCC2)=N1)C1=CC=C(F)C=C1,6433114
10994,DB13034,Foxy-5,small molecule,investigational,,CSCC[C@H](NC=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O,44628955
10995,DB13035,AG-24322,small molecule,investigational,"CDC2 Protein Kinase, antagonists & inhibitors|Cyclin-Dependent Kinase 2, antagonists & inhibitors|Cyclin-Dependent Kinase 4, antagonists & inhibitors|Heterocyclic Compounds, Fused-Ring|Pyrazoles",CCNCC1=CN=CC(=C1C)C1=CC=C2NN=C(C3=NC4=C(F)C=C(F)C=C4N3)C2=C1,6918834
10996,DB13036,Ramatroban,small molecule,investigational,"Amides|Antiplatelet agents|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|Indoles|Receptors, Thromboxane, antagonists & inhibitors|Sulfones|Sulfur Compounds",[H][C@]1(CCC2=C(C1)C1=CC=CC=C1N2CCC(O)=O)NS(=O)(=O)C1=CC=C(F)C=C1,123879
10998,DB13038,Glyceryl Trioleate,small molecule,investigational,"Fats|Fats, Unsaturated|Glycerides|Lipids|Triglycerides",CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COC(=O)CCCCCCC\C=C/CCCCCCCC)OC(=O)CCCCCCC\C=C/CCCCCCCC,5497163
10999,DB13039,Aminaphthone,small molecule,investigational,"Acids, Carbocyclic|Aminobenzoates|Benzene Derivatives|Benzoates|Coagulants|Hematologic Agents|Hemostatics",CC1=C(OC(=O)C2=CC=C(N)C=C2)C(O)=C2C=CC=CC2=C1O,84621
11000,DB13040,Gandotinib,small molecule,investigational,"Janus Kinase 2, antagonists & inhibitors",CC1=CC(NC2=NN3C(CC4=CC=C(Cl)C=C4F)=C(C)N=C3C(CN3CCOCC3)=C2)=NN1,46213929
11001,DB13041,Odalasvir,small molecule,investigational,"Acids, Acyclic|Anti-Infective Agents|Antiviral Agents|Heterocyclic Compounds, Fused-Ring",COC(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](C[C@@H]2CCCC[C@H]12)C1=NC2=CC=C(C=C2N1)C1=CC2=CC=C1CCC1=CC=C(CC2)C(=C1)C1=CC=C2N=C(NC2=C1)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)[C@@H](NC(=O)OC)C(C)C,71474517
11002,DB13042,Fenoverine,small molecule,investigational,"Alimentary Tract and Metabolism|Autonomic Agents|Drugs for Functional Gastrointestinal Disorders|Heterocyclic Compounds, Fused-Ring|Parasympatholytics|Peripheral Nervous System Agents|Sulfur Compounds",O=C(CN1CCN(CC2=CC3=C(OCO3)C=C2)CC1)N1C2=CC=CC=C2SC2=CC=CC=C12,72098
11003,DB13044,Gossypol,small molecule,investigational,"Adrenal Cortex Hormones|Contraceptive Agents, Male|Hormonal Contraceptives for Systemic Use|Reproductive Control Agents|Sesquiterpenes|Terpenes",CC(C)C1=C2C=C(C)C(=C(O)C2=C(C=O)C(O)=C1O)C1=C(O)C2=C(C=O)C(O)=C(O)C(C(C)C)=C2C=C1C,3503
11005,DB13046,Tocladesine,small molecule,investigational,"Adenine Nucleotides|Antineoplastic Agents|Carbohydrates|Cyclic AMP|Glycosides|Heterocyclic Compounds, Fused-Ring|Immunologic Factors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Nucleotides, Cyclic|Purine Nucleotides|Purines|Ribonucleotides",NC1=C2N=C(Cl)N([C@@H]3O[C@@H]4COP(O)(=O)O[C@H]4[C@H]3O)C2=NC=N1,100299
11006,DB13047,Pentavalent Antimony,small molecule,investigational,,[Sb+5],73608879
11007,DB13048,PAC-1,small molecule,investigational,,OC1=C(\C=N\NC(=O)CN2CCN(CC3=CC=CC=C3)CC2)C=CC=C1CC=C,6851947
11008,DB13049,Lobaplatin,small molecule,investigational,Cycloparaffins|Organometallic Compounds,,
11009,DB13050,Tirilazad,small molecule,investigational,"Antioxidants|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Fused-Ring Compounds|Nervous System|Neuroprotective Agents|Pregnanes|Protective Agents|Steroids",C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN1CCN(CC1)C1=CC(=NC(=N1)N1CCCC1)N1CCCC1,104903
11010,DB13051,CH-5132799,small molecule,investigational,"Amides|Class I Phosphatidylinositol 3-Kinases, antagonists & inhibitors|Sulfones|Sulfur Compounds",CS(=O)(=O)N1CCC2=C(N=C(N=C12)N1CCOCC1)C1=CN=C(N)N=C1,49784945
11011,DB13052,Upamostat,small molecule,investigational,"Amides|Sulfones|Sulfur Compounds|Urokinase-Type Plasminogen Activator, antagonists & inhibitors",CCOC(=O)N1CCN(CC1)C(=O)[C@H](CC1=CC=CC(=C1)C(\N)=N/O)NS(=O)(=O)C1=C(C=C(C=C1C(C)C)C(C)C)C(C)C,9852201
11012,DB13053,CP-195543,small molecule,investigational,"Benzopyrans|Heterocyclic Compounds, Fused-Ring|Pyrans",O[C@@H]1[C@@H](CC2=CC=CC=C2)COC2=CC(=CC=C12)C1=CC(=CC=C1C(O)=O)C(F)(F)F,9823886
11013,DB13054,ACT-451840,small molecule,investigational,"Acids, Acyclic|Acrylates|Amides",CC(=O)N1CCN(CC1)C1=CC=C(CN([C@@H](CC2=CC=CC=C2)C(=O)N2CCN(CC3=CC=C(C=C3)C#N)CC2)C(=O)\C=C\C2=CC=C(C=C2)C(C)(C)C)C=C1,53303762
11014,DB13055,Oteseconazole,small molecule,investigational,,O[C@@](CN1C=NN=N1)(C1=CC=C(F)C=C1F)C(F)(F)C1=CC=C(C=N1)C1=CC=C(OCC(F)(F)F)C=C1,77050711
11015,DB13056,Irsogladine,small molecule,investigational,"Anti-Ulcer Agents|Anticarcinogenic Agents|Compounds used in a research, industrial, or household setting|Gastrointestinal Agents|Protective Agents|Radiation-Protective Agents",NC1=NC(=NC(N)=N1)C1=C(Cl)C=CC(Cl)=C1,3752
11017,DB13058,Methanesulfonyl Fluoride,small molecule,investigational,Cholinergic Agents|Cholinesterase Inhibitors|Enzyme Inhibitors|Neurotransmitter Agents|Sulfur Compounds,CS(F)(=O)=O,11207
11018,DB13059,PF-03814735,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Protein Kinase Inhibitors",CC(=O)NCC(=O)N1[C@H]2CC[C@@H]1C1=C2C=CC(NC2=NC=C(C(NC3CCC3)=N2)C(F)(F)F)=C1,51346455
11019,DB13060,CEP-37440,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates",CNC(=O)C1=CC=CC=C1NC1=C(Cl)C=NC(NC2=CC=C3C[C@H](CCCC3=C2OC)N2CCN(CCO)CC2)=N1,71721648
11020,DB13061,MLN8054,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Protein Kinase Inhibitors",OC(=O)C1=CC=C(NC2=NC=C3CN=C(C4=C(C=CC(Cl)=C4)C3=N2)C2=C(F)C=CC=C2F)C=C1,11712649
11021,DB13062,ME-344,small molecule,investigational,"Benzopyrans|Chromones|Flavonoids|Heterocyclic Compounds, Fused-Ring|Pyrans",CC1=C(O)C=CC2=C1OC[C@H]([C@H]2C1=CC=C(O)C=C1)C1=CC=C(O)C=C1,68026984
11022,DB13063,Parthenolide,small molecule,approved|investigational,"Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antirheumatic Agents|Asteraceae|Cell-mediated Immunity|Central Nervous System Agents|Increased Histamine Release|Magnoliaceae|NF-kappa B, antagonists & inhibitors|Peripheral Nervous System Agents|Sensory System Agents|Standardized Chemical Allergen|Terpenes",C\C1=C/CC[C@@]2(C)O[C@H]2[C@H]2OC(=O)C(=C)[C@@H]2CC1,6473881
11023,DB13064,Tramazoline,small molecule,investigational,"Agents producing tachycardia|Agents that produce hypertension|Autonomic Agents|Nasal Preparations|Peripheral Nervous System Agents|Sympathomimetics|Sympathomimetics, Plain",C1CN=C(NC2=CC=CC3=C2CCCC3)N1,5524
11024,DB13065,LY-2811376,small molecule,investigational,Sulfur Compounds,C[C@]1(CCSC(N)=N1)C1=CC(=C(F)C=C1F)C1=CN=CN=C1,44251605
11025,DB13066,Liarozole,small molecule,investigational,"Antineoplastic Agents|Antineoplastic Agents, Hormonal|Dermatologicals|Enzyme Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists",ClC1=CC=CC(=C1)C(N1C=CN=C1)C1=CC=C2N=CNC2=C1,60652
11026,DB13067,Rotigaptide,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Peptides",C[C@@H](NC(=O)CNC(=O)[C@H]1C[C@H](O)CN1C(=O)[C@H]1CCCN1C(=O)[C@@H](CC1=CC=C(O)C=C1)NC(C)=O)C(=O)NCC(N)=O,9938933
11027,DB13068,9-(N-methyl-L-isoleucine)-cyclosporin A,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Cyclosporins|Immunosuppressive Agents|Peptides|Peptides, Cyclic",CC[C@H](C)[C@@H]1N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC1=O)C(C)C,6473876
11028,DB13069,Nimustine,small molecule,investigational,Alkylating Drugs|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Nitroso Compounds|Nitrosourea Compounds|Nitrosoureas,CC1=NC=C(CNC(=O)N(CCCl)N=O)C(N)=N1,39214
11029,DB13070,Surinabant,small molecule,investigational,"Agents producing tachycardia|Cannabinoid Receptor Antagonists|Cannabinoids and similars|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Neurotransmitter Agents|Receptor, Cannabinoid, CB1, antagonists & inhibitors",CCC1=C(N(N=C1C(=O)NN1CCCCC1)C1=CC=C(Cl)C=C1Cl)C1=CC=C(Br)C=C1,9849616
11030,DB13071,Creatinolfosfate,small molecule,investigational,Cardiac Therapy,CN(CCOP(O)(O)=O)C(N)=N,23342
11031,DB13072,GDC-0349,small molecule,investigational,Benzene Derivatives,CCNC(=O)NC1=CC=C(C=C1)C1=NC2=C(CCN(C2)C2COC2)C(=N1)N1CCOC[C@@H]1C,59239165
11033,DB13074,Macimorelin,small molecule,approved|investigational,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Diagnostic Agents|Growth Hormone Secretagogue Receptor Agonist|Growth Hormone Secretagogue Receptor Agonists|Heterocyclic Compounds, Fused-Ring|Highest Risk QTc-Prolonging Agents|QTc Prolonging Agents|Tests for Pituitary Function",CC(C)(N)C(=O)N[C@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@H](CC1=CNC2=CC=CC=C12)NC=O,
11034,DB13075,Menaquinone 7,small molecule,investigational,Coagulants|Diterpenes|Hematologic Agents|Hemostatics|Naphthalenes|Naphthoquinones|Phytol|Quinones|Terpenes|Vitamin K|Vitamins|Vitamins (Fat Soluble),[H]\C(CC\C(C)=C(/[H])CC\C(C)=C(/[H])CC\C(C)=C(/[H])CC\C(C)=C(/[H])CC\C(C)=C(/[H])CC1=C(C)C(=O)C2=CC=CC=C2C1=O)=C(\C)CCC=C(C)C,5287554
11035,DB13076,Yttrium Y-90,small molecule,approved|investigational,"Acids, Acyclic|Anti-Inflammatory Agents|Elements|Isotopes|Metals|Metals, Rare Earth|Radioisotopes|Therapeutic Radiopharmaceuticals|Transition Elements|Tricarboxylic Acids|Yttrium|Yttrium (90Y) Compounds|Yttrium Isotopes|Yttrium Radioisotopes",[90Y],104760
11036,DB13077,LCB01-0371,small molecule,investigational,Anti-Bacterial Agents|Anti-Infective Agents|Enzyme Inhibitors|Oxazoles|Protein Synthesis Inhibitors,CN1CCN(C=N1)C1=CC=C(C=C1F)N1C[C@H](CO)OC1=O,44205191
11037,DB13078,KOSN-1724,small molecule,investigational,,C[C@H]1\C=C/C\C(C)=C/C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(\C)=C\C1=NOC(C)=C1,71587784
11038,DB13080,Roluperidone,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",FC1=CC=C(C=C1)C(=O)CN1CCC(CN2CC3=CC=CC=C3C2=O)CC1,9799284
11039,DB13082,Nefiracetam,small molecule,investigational,"Central Nervous System Agents|Central Nervous System Depressants|Compounds used in a research, industrial, or household setting|Neuroprotective Agents|Nootropic Agents|Protective Agents|Psychotropic Drugs|Pyrrolidines",CC1=CC=CC(C)=C1NC(=O)CN1CCCC1=O,71157
11040,DB13083,Talarozole,small molecule,investigational,"Chemically-Induced Disorders|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Sulfur Compounds|Thiazoles",CCC(CC)C(N1C=NC=N1)C1=CC=C(NC2=NC3=CC=CC=C3S2)C=C1,9799888
11041,DB13084,Pyritinol,small molecule,investigational,"Nervous System|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Pyridines",CC1=C(O)C(CO)=C(CSSCC2=C(CO)C(O)=C(C)N=C2)C=N1,14190
11042,DB13085,Riamet,small molecule,approved|investigational,,,
11043,DB13086,SCYX-7158,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates",CC1(C)OB(O)C2=CC(NC(=O)C3=CC=C(F)C=C3C(F)(F)F)=CC=C12,44178354
11044,DB13087,Miridesap,small molecule,investigational,,OC(=O)[C@H]1CCCN1C(=O)CCCCC(=O)N1CCC[C@@H]1C(O)=O,125516
11045,DB13088,AZD-0424,small molecule,investigational,"Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Protein Kinase Inhibitors",CC(C)OC1=C2C(NC3=C(Cl)C=NC4=C3OCO4)=NC=NC2=CC(OCCN2CCN(CC2)C(C)=O)=C1,9893171
11046,DB13089,Enoxolone,small molecule,investigational,Anti-Inflammatory Agents|Cicatrizants|Dermatologicals|Pentacyclic Triterpenes|Preparations for Treatment of Wounds and Ulcers|Terpenes|Triterpenes,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O,10114
11047,DB13090,Zidebactam,small molecule,investigational,Aza Compounds|Cycloparaffins,OS(=O)(=O)ON1[C@H]2C[N@]([C@@H](CC2)C(=O)NNC(=O)[C@@H]2CCCNC2)C1=O,77846445
11048,DB13091,Tiropramide,small molecule,investigational,"Alimentary Tract and Metabolism|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Autonomic Agents|Drugs for Functional Gastrointestinal Disorders|Parasympatholytics|Peripheral Nervous System Agents|Synthetic Antispasmodics, Amides With Tertiary Amines",CCCN(CCC)C(=O)C(CC1=CC=C(OCCN(CC)CC)C=C1)NC(=O)C1=CC=CC=C1,42262
11049,DB13092,Meclocycline,small molecule,investigational,Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Bacterial Agents|Anti-Infective Agents|Antiinfectives for Treatment of Acne|Dermatologicals|Naphthacenes|Tetracyclines,[H][C@@]12[C@@H](O)[C@]3([H])C(=C)C4=C(C(O)=CC=C4Cl)C(=O)C3=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C,54676539
11050,DB13093,TAK-593,small molecule,investigational,"Aza Compounds|Receptors, Platelet-Derived Growth Factor, antagonists & inhibitors|Receptors, Vascular Endothelial Growth Factor, antagonists & inhibitors",CN1N=C(C)C=C1C(=O)NC1=CC(OC2=NN3C=C(NC(=O)C4CC4)N=C3C=C2)=CC=C1C,24767976
11051,DB13094,Pruvanserin,small molecule,investigational,,FC1=CC=C(CCN2CCN(CC2)C(=O)C2=C3NC=C(C#N)C3=CC=C2)C=C1,6433122
11052,DB13095,JTK-853,small molecule,investigational,,FC1=C(OC(F)(F)F)C=CC(CNC(=O)[C@H]2CN(CCN2S(=O)(=O)C2=CC=C(C=C2)C(F)(F)F)C2=NC3=C(S2)C=NC(=N3)C2CC2)=C1,57519700
11053,DB13096,Gacyclidine,small molecule,investigational,"Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Cyclohexanes|Cycloparaffins|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Neuroprotective Agents|Neurotransmitter Agents|Protective Agents",C[C@H]1CCCC[C@]1(N1CCCCC1)C1=CC=CS1,176265
11054,DB13097,1alpha-Hydroxyvitamin D5,small molecule,investigational,Cholestanes|Cholestenes|Fused-Ring Compounds|Lipids|Membrane Lipids|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble),CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)C(C)C,10025615
11055,DB13098,CT-2584,small molecule,investigational,"Alkaloids|Heterocyclic Compounds, Fused-Ring|Phospholipase D, antagonists & inhibitors|Purines|Purinones",CCCCCCCCCCCCNCC(O)CCCCCCCCCN1C(=O)N(C)C2=C(N(C)C=N2)C1=O,3081346
11056,DB13099,Valnoctamide,small molecule,investigational,Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Psycholeptics,CCC(C)C(CC)C(N)=O,20140
11057,DB13100,Biguanide,small molecule,approved|investigational,,NC(=N)NC(N)=N,5939
11058,DB13101,4SC-202,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates",CN1C=C(C=N1)C1=CC=C(C=C1)S(=O)(=O)N1C=CC(\C=C\C(=O)NC2=CC=CC=C2N)=C1,15985904
11059,DB13102,AZD-8418,small molecule,investigational,,C[C@@H](C1CC1)N1CC2=CC(=CC(Cl)=C2C1=O)C1=CC(=NO1)C(=O)N(C)C,44556193
11060,DB13103,GPX-150,small molecule,investigational,Anthracyclines|Carbohydrates|Glycosides|Naphthacenes,COC1=C2C(=N)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]4C[C@H](N)[C@H](O)[C@H](C)O4)C(=O)CO)C(O)=C3C(=O)C2=CC=C1,10392558
11061,DB13104,X-396,small molecule,investigational,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,C[C@@H](OC1=CC(=NN=C1N)C(=O)NC1=CC=C(C=C1)C(=O)N1CCN(C)CC1)C1=C(Cl)C=CC(F)=C1Cl,56960447
11062,DB13105,Resolvin E1,small molecule,investigational,"Autacoids|Biological Factors|Diet, Food, and Nutrition|Dietary Fats|Dietary Fats, Unsaturated|Eicosanoids|Fats|Fatty Acids|Fatty Acids, Omega-3|Fatty Acids, Unsaturated|Fish Oils|Food|Food and Beverages|Inflammation Mediators|Lipids|Oils|Physiological Phenomena",CC[C@@H](O)\C=C\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O,10473088
11063,DB13106,Glycovir,small molecule,investigational,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids",CCCCN1C[C@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@H](OC(=O)CCC)[C@H]1COC(=O)CCC,60807
11064,DB13107,QGC-001,small molecule,investigational,"Acids|Acids, Noncarboxylic|Anions|Electrolytes|Gases|Glutamyl Aminopeptidase, antagonists & inhibitors|Hydrogen Sulfide|Ions|Sulfides|Sulfur Acids|Sulfur Compounds",N[C@@H](CCS(O)(=O)=O)CSSC[C@@H](N)CCS(O)(=O)=O,24851355
11065,DB13108,Mephedrone,small molecule,investigational,Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Designer Drugs|Ethylamines|Phenethylamines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Street Drugs|Sympathomimetics,CNC(C)C(=O)C1=CC=C(C)C=C1,45266826
11066,DB13109,PKI-179,small molecule,investigational,Oxazines,O=C(NC1=CC=NC=C1)NC1=CC=C(C=C1)C1=NC(=NC(=N1)N1[C@H]2CC[C@@H]1COC2)N1CCOCC1,76958312
11067,DB13110,Antimony,small molecule,investigational,"Elements|Metalloids|Metals|Metals, Heavy",[Sb],5354495
11068,DB13111,Chromanol,small molecule,investigational,"Antioxidants|Benzopyrans|Compounds used in a research, industrial, or household setting|Heterocyclic Compounds, Fused-Ring|Protective Agents|Pyrans",CC1=C(O)C(C)=C2CCC(C)(C)OC2=C1C,99479
11070,DB13113,JNJ-38877605,small molecule,investigational,,CN1C=C(C=N1)C1=NN2C(C=C1)=NN=C2C(F)(F)C1=CC=C2N=CC=CC2=C1,46911863
11071,DB13114,Amitriptylinoxide,small molecule,approved|investigational,"Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Antidepressive Agents, Tricyclic|Benzocycloheptenes|Central Nervous System Depressants|Dibenzocycloheptenes|Narrow Therapeutic Index Drugs|Neurotoxic agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",CN(C)(=O)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,20313
11072,DB13115,Saroglitazar,small molecule,investigational,"Acids, Carbocyclic",CCO[C@@H](CC1=CC=C(OCCN2C(C)=CC=C2C2=CC=C(SC)C=C2)C=C1)C(O)=O,60151560
11073,DB13116,Norflurane,small molecule,approved|experimental,"Aerosol Propellants|Aerosols|Anesthetics|Central Nervous System Agents|Colloids|Complex Mixtures|Hydrocarbons, Halogenated|Investigative Techniques|Pharmaceutical Preparations",FCC(F)(F)F,13129
11074,DB13117,Pentafluoropropane,small molecule,approved|investigational,"Hydrocarbons, Halogenated",FC(F)CC(F)(F)F,68030
11075,DB13118,Paquinimod,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CCN(C(=O)C1=C(O)C2=C(CC)C=CC=C2N(C)C1=O)C1=CC=CC=C1,54684617
11076,DB13119,GSK-364735,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CN1C(=O)C(C(=O)NCCO)=C(O)C2=NC=C(CC3=CC=C(F)C=C3)C=C12,54718859
11077,DB13120,Deferitazole,small molecule,investigational,Ethers|Iron Chelating Agents|Sulfur Compounds,COCCOCCOCCOC1=C(O)C(=CC=C1)C1=N[C@](C)(CS1)C(O)=O,16736198
11078,DB13121,Hydroxypropyl tetrahydropyrantriol,small molecule,investigational,,CC(O)C[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O,16666733
11079,DB13122,Trabodenoson,small molecule,investigational,"Acids|Acids, Noncarboxylic|Adenosine A1 Receptor Agonists|Anions|Carbohydrates|Electrolytes|Glycosides|Heterocyclic Compounds, Fused-Ring|Ions|Nitric Acid|Nitrogen Compounds|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides",O[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@H]([C@@H]1O)N1C=NC2=C(NC3CCCC3)N=CN=C12,11610599
11080,DB13123,OTX-008,small molecule,investigational,,CN(C)CCNC(=O)COC1=C2CC3=CC=CC(CC4=CC=CC(CC5=C(OCC(=O)NCCN(C)C)C(CC1=CC=C2)=CC=C5)=C4OCC(=O)NCCN(C)C)=C3OCC(=O)NCCN(C)C,11953346
11081,DB13124,Troxerutin,small molecule,investigational,"Anticoagulants|Benzopyrans|Capillary Stabilizing Agents|Chromones|Flavonoids|Flavonols|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|Pyrans|Radiation-Protective Agents|Vasoprotectives",C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3=C(OC4=CC(OCCO)=CC(O)=C4C3=O)C3=CC(OCCO)=C(OCCO)C=C3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,5486699
11082,DB13125,Lusutrombopag,small molecule,approved|investigational,"Acids, Carbocyclic|BCRP/ABCG2 Substrates|Blood and Blood Forming Organs|Hemostatics|P-glycoprotein substrates|Sulfur Compounds",CCCCCCO[C@@H](C)C1=C(OC)C(=CC=C1)C1=CSC(NC(=O)C2=CC(Cl)=C(\C=C(/C)C(O)=O)C(Cl)=C2)=N1,49843517
11083,DB13126,BMS-986115,small molecule,investigational,"Benzazepines|Heterocyclic Compounds, Fused-Ring",CC1=CC=CC2=C1NC(=O)[C@@H](NC(=O)[C@H](CCC(F)(F)F)[C@H](CCC(F)(F)F)C(N)=O)N=C2C1=CC=CC(F)=C1,73388393
11085,DB13128,Sizofiran,small molecule,investigational,"Adjuvants, Immunologic|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|beta-Glucans|Biopolymers|Carbohydrates|Compounds used in a research, industrial, or household setting|Glucans|Immunologic Factors|Macromolecular Substances|Polymers|Polysaccharides",,
11086,DB13129,Trimegestone,small molecule,investigational,"Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Norpregnadienes|Norpregnanes|Norsteroids|Progestogens and Estrogens, Sequential Preparations|Sex Hormones and Modulators of the Genital System|Steroids",C[C@H](O)C(=O)[C@@]1(C)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3CC[C@]12C,68926
11088,DB13132,Artemisinin,small molecule,investigational,"Anions|Anti-Infective Agents|Antimalarials|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Artemisia|Artemisinin and Derivatives, Plain|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Electrolytes|Free Radicals|Ions|Oxides|Oxygen Compounds|Peroxides|Reactive Oxygen Species|Sesquiterpenes|Terpenes",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C(=O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4,68827
11090,DB13134,Fluorine F-18,small molecule,investigational,Isotopes|Radioisotopes,[18F],131704324
11091,DB13135,AGN-201904,small molecule,investigational,"2-Pyridinylmethylsulfinylbenzimidazoles|Benzimidazoles|Heterocyclic Compounds, Fused-Ring|Pyridines|Sulfoxides|Sulfur Compounds",COC1=CC2=C(C=C1)N(C(=N2)S(=O)CC1=NC=C(C)C(OC)=C1C)S(=O)(=O)C1=CC=C(OCC(O)=O)C=C1,9829253
11092,DB13136,Fluindione,small molecule,approved|investigational,Anticoagulants|Blood and Blood Forming Organs|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Hematologic Agents|Indans|Indenes|Narrow Therapeutic Index Drugs|Vitamin K Antagonists,FC1=CC=C(C=C1)C1C(=O)C2=CC=CC=C2C1=O,68942
11093,DB13137,PM-060184,small molecule,investigational,Lactones|Pyrans,COC1=CC[C@H](OC1=O)[C@@H](C)\C=C(/C)\C=C/C=C\C(=O)N[C@H](C(=O)N\C=C/C[C@H](C\C=C/C)OC(N)=O)C(C)(C)C,57788271
11094,DB13138,Neladenoson bialanate,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Oligopeptides|Peptides",C[C@H](N)C(=O)N[C@@H](C)C(=O)OCCOC1=CC=C(C=C1)C1=C(C#N)C(=NC(SCC2=CSC(=N2)C2=CC=C(Cl)C=C2)=C1C#N)N1CCCC1,56848985
11095,DB13139,Levosalbutamol,small molecule,approved|investigational,Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Alcohols|Amines|Amino Alcohols|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Drugs that are Mainly Renally Excreted|Ethanolamines|Ethylamines|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|Phenethylamines,CC(C)(C)NC[C@H](O)C1=CC(CO)=C(O)C=C1,123600
11097,DB13141,Ambroxol acefyllinate,small molecule,experimental|investigational,"Alkaloids|Amines|Aniline Compounds|Cyclohexanes|Cyclohexylamines|Cycloparaffins|Heterocyclic Compounds, Fused-Ring|Purines|Purinones",CN1C2=C(N(CC(O)=O)C=N2)C(=O)N(C)C1=O.NC1=C(Br)C=C(Br)C=C1CN[C@@H]1CC[C@H](O)CC1,176595
11098,DB13142,Calcium glubionate anhydrous,small molecule,approved,Alimentary Tract and Metabolism|Calcium Salts|Carbohydrates|Infant Food|Mineral Supplements|Oligosaccharides|Polysaccharides,OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)O[Ca]OC(=O)[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO,131704325
11099,DB13143,Methallenestril,small molecule,experimental,"Estrogens|Genito Urinary System and Sex Hormones|Sex Hormones and Modulators of the Genital System|Synthetic Estrogens, Plain",CC[C@H](C1=CC=C2C=C(OC)C=CC2=C1)C(C)(C)C(O)=O,59084697
11101,DB13145,Nedaplatin,small molecule,approved|investigational,Antineoplastic Agents|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Organometallic Compounds|Platinum Compounds,[H][N]([H])([H])[Pt]1(OCC(=O)O1)[N]([H])([H])[H],9548889
11102,DB13146,Fluciclovine (18F),small molecule,approved,Cycloparaffins|Diagnostic Radiopharmaceuticals|Positron Emitting Activity|Radioactive Diagnostic Agent|Tumour Detection,N[C@]1(C[C@H]([18F])C1)C(O)=O,450601
11109,DB13153,Levomenol,small molecule,approved|experimental,Biological Products|Complex Mixtures|Lipids|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|Oils|Pharmaceutical Preparations|Plant Preparations|Terpenes,[H][C@@]1(CCC(C)=CC1)[C@@](C)(O)CCC=C(C)C,442343
11110,DB13154,Parachlorophenol,small molecule,approved,"Anti-Infective Agents|Anti-Infective Agents, Local|Benzene Derivatives|Chlorobenzenes|Drugs that are Mainly Renally Excreted|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|OATP1B3 substrates|Phenols",OC1=CC=C(Cl)C=C1,4684
11111,DB13155,Esculin,small molecule,approved,"Benzopyrans|Carbohydrates|Coumarins|Glucosides|Glycosides|Heterocyclic Compounds, Fused-Ring|Pyrans",OC[C@H]1O[C@@H](OC2=C(O)C=C3OC(=O)C=CC3=C2)[C@H](O)[C@@H](O)[C@@H]1O,5281417
11112,DB13156,Inosine pranobex,small molecule,approved,"Acetanilides|Adjuvants, Immunologic|Amides|Amines|Anilides|Aniline Compounds|Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Carbohydrates|Drugs that are Mainly Renally Excreted|Glycosides|Heterocyclic Compounds, Fused-Ring|Immunologic Factors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides",C[C@@H](O)CN(C)C.C[C@@H](O)CN(C)C.C[C@@H](O)CN(C)C.CC(=O)NC1=CC=C(C=C1)C(O)=O.CC(=O)NC1=CC=C(C=C1)C(O)=O.CC(=O)NC1=CC=C(C=C1)C(O)=O.OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CNC2=O,131704326
11113,DB13157,Sodium lauryl sulfoacetate,small molecule,approved|experimental,Alimentary Tract and Metabolism|Drugs for Constipation|Enemas,[Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O,23668827
11114,DB13158,Clobetasone,small molecule,approved,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Moderately Potent (Group II)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dermatologicals|Drugs that are Mainly Renally Excreted|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Ointments|Ophthalmologicals|Pregnadienes|Pregnadienetriols|Pregnanes|Sensory Organs|Steroids|Steroids, Fluorinated",[H][C@]1(C)C[C@@]2([H])[C@]3([H])CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)C(=O)C[C@]2(C)[C@@]1(O)C(=O)CCl,71387
11115,DB13160,Alphaprodine,small molecule,illicit,Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Narcotics|Opioids|Peripheral Nervous System Agents|Piperidines|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,CCC(=O)O[C@]1(CCN(C)C[C@H]1C)C1=CC=CC=C1,204163
11117,DB13163,Terpin hydrate,small molecule,approved|experimental,Alcohols|Cyclohexanes|Cyclohexanols|Cycloparaffins|Expectorants|Fatty Alcohols|Hexanols|Lipids|Monoterpenes|Respiratory System Agents|Terpenes,O.CC(C)(O)[C@H]1CC[C@@](C)(O)CC1,17141
11118,DB13164,Olmutinib,small molecule,investigational,Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Protein Kinase Inhibitors,CN1CCN(CC1)C1=CC=C(NC2=NC(OC3=CC=CC(NC(=O)C=C)=C3)=C3SC=CC3=N2)C=C1,54758501
11119,DB13165,Ripasudil,small molecule,experimental,"Amides|Heterocyclic Compounds, Fused-Ring|rho-Associated Kinases, antagonists & inhibitors|Sulfones|Sulfur Compounds",C[C@H]1CNCCCN1S(=O)(=O)C1=C2C(F)=CN=CC2=CC=C1,9863672
11120,DB13166,Zofenopril,small molecule,approved,"ACE Inhibitors and Diuretics|Acids, Acyclic|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Enzyme Inhibitors|Imines|Imino Acids|Protease Inhibitors",C[C@H](CSC(=O)C1=CC=CC=C1)C(=O)N1C[C@H](C[C@H]1C(O)=O)SC1=CC=CC=C1,92400
11121,DB13167,Alclofenac,small molecule,approved|withdrawn,"Acetic Acid Derivatives and Related Substances|Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|Drugs that are Mainly Renally Excreted|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Sensory System Agents",OC(=O)CC1=CC(Cl)=C(OCC=C)C=C1,30951
11122,DB13168,Omega-6 fatty acids,small molecule,nutraceutical,"Fatty Acids|Fatty Acids, Unsaturated|Lipids",,
11123,DB13169,Nandrolone,small molecule,experimental|investigational,"Alimentary Tract and Metabolism|Anabolic Agents|Anabolic Agents for Systemic Use|Anabolic Steroids|Androgens|Estranes|Estren Derivatives|Estrenes|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Nandrolone and esters|Ophthalmologicals|Sensory Organs|Steroids|Testosterone Congeners|Thyroxine-binding globulin inhibitors",[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],9904
11124,DB13170,Plecanatide,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Drugs for Constipation|Enzyme Activators|Gastrointestinal Agents|Guanylate Cyclase Activators|Guanylate Cyclase-C Agonist|Guanylyl Cyclase C Agonists|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Laxatives|Peptide Hormones|Peptides|Receptors, Guanylate Cyclase-Coupled, agonists",[H][C@@]12CSSC[C@H](NC(=O)CNC(=O)[C@@]([H])(NC(=O)[C@]([H])(CSSC[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC2=O)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O,70693500
11125,DB13171,Glyceryl 1-oleate,small molecule,experimental,Lipids,[H]\C(CCCCCCCC)=C(/[H])CCCCCCCC(=O)OCC(O)CO,5283468
11126,DB13172,Tunicamycin,small molecule,experimental,"Anti-Bacterial Agents|Anti-Infective Agents|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines",,
11128,DB13174,Rhein,small molecule,experimental,"Anthracenes|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Mixed Function Oxygenases|NADH, NADPH Oxidoreductases, antagonists & inhibitors|Quinones",OC(=O)C1=CC2=C(C(O)=C1)C(=O)C1=C(C=CC=C1O)C2=O,10168
11129,DB13175,Rheinanthrone,small molecule,experimental,,OC(=O)C1=CC(O)=C2C(CC3=C(C(O)=CC=C3)C2=O)=C1,119396
11130,DB13177,4-methylumbelliferyl beta-D-glucoside,small molecule,experimental,"Benzopyrans|Carbohydrates|Coumarins|Glycosides|Heterocyclic Compounds, Fused-Ring|Pyrans|Umbelliferones",CC1=CC(=O)OC2=CC(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)=CC=C12,
11131,DB13178,Inositol,small molecule,approved|investigational|withdrawn,"Alcohols|Alimentary Tract and Metabolism|Carbohydrates|Diet, Food, and Nutrition|Drugs that are Mainly Renally Excreted|Food|Food and Beverages|Growth Substances|Micronutrients|Other Nutritional Agents|Physiological Phenomena|Sugar Alcohols|Vitamin B Complex|Vitamins",O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O,
11132,DB13179,Troleandomycin,small molecule,approved,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strong)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Lactones|Macrolides|Macrolides, Lincosamides and Streptogramins|P-glycoprotein inhibitors|Polyketides",CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]3(CO3)C(=O)[C@H](C)[C@@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1OC(C)=O,202225
11133,DB13180,Gluconic Acid,small molecule,approved|investigational,"Acids, Acyclic|Carbohydrates|Chelating Agents|Hydroxy Acids|Laxatives|Osmotic Laxatives|Sugar Acids",OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O,10690
11134,DB13181,Methylbenactyzium,small molecule,experimental,Amines|Ammonium Compounds|Nitrogen Compounds|Onium Compounds,CC[N+](C)(CC)CCOC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,4134
11135,DB13182,Daidzein,small molecule,experimental,"Antineoplastic Agents|Benzopyrans|Chromones|Enzyme Inhibitors|Estrogens, Non-Steroidal|Flavonoids|Growth Inhibitors|Heterocyclic Compounds, Fused-Ring|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Phytoestrogens|Pyrans|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",OC1=CC=C(C=C1)C1=COC2=C(C=CC(O)=C2)C1=O,
11136,DB13183,Technetium Tc-99m etifenin,small molecule,experimental,Diagnostic Radiopharmaceuticals|Hepatic and Reticulo Endothelial System|Technetium (99Mtc) Compounds,[98Tc].CCC1=CC=CC(CC)=C1NC(=O)CN(CC(O)=O)CC(O)=O.CCC1=CC=CC(CC)=C1\N=C(/[O-])CN(CC([O-])=O)CC([O-])=O,131704327
11137,DB13185,Oxabolone cipionate,small molecule,experimental,"Alimentary Tract and Metabolism|Anabolic Agents for Systemic Use|Anabolic Steroids|Drugs that are Mainly Renally Excreted|Estradiol Congeners|Estranes|Estren Derivatives|Estrenes|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids",[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=C(O)C(=O)CC[C@]4([H])[C@@]3([H])CC[C@]12C)OC(=O)CCC1CCCC1,68952
11139,DB13191,Phosphocreatine,small molecule,nutraceutical,"Amidines|Amino Acids|Amino Acids, Peptides, and Proteins|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Drugs that are Mainly Renally Excreted|Guanidines|Phosphoamino Acids|Protective Agents",CN(CC(O)=O)C(=N)NP(O)(O)=O,9548602
11150,DB13202,Piprozolin,small molecule,experimental,Alimentary Tract and Metabolism|Bile and Liver Therapy|Bile Therapy|Sulfur Compounds|Thiazoles,[H]\C(C(=O)OCC)=C1\SC(N2CCCCC2)C(=O)N1CC,
11151,DB13203,Bamifylline,small molecule,experimental,"Alkaloids|Analgesics|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cardiovascular Agents|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Drugs for Obstructive Airway Diseases|Heterocyclic Compounds, Fused-Ring|Peripheral Nervous System Agents|Purines|Purinones|Respiratory System Agents|Sensory System Agents|Vasodilating Agents|Xanthine derivatives",CCN(CCO)CCN1C(CC2=CC=CC=C2)=NC2=C1C(=O)N(C)C(=O)N2C,
11152,DB13204,Dimethyl carbate,small molecule,experimental,"Antiparasitic Products, Insecticides and Repellents|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Insecticides and Repellents",COC(=O)[C@H]1[C@@H]2C[C@@H](C=C2)[C@H]1C(=O)OC,
11153,DB13205,Teclozan,small molecule,experimental,"Amines|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Benzene Derivatives|Benzyl Compounds|Dichloroacetamide Derivatives",CCOCCN(CC1=CC=C(CN(CCOCC)C(=O)C(Cl)Cl)C=C1)C(=O)C(Cl)Cl,
11154,DB13206,Bamethan,small molecule,experimental,2-Amino-1-Phenylethanol Derivatives|Alcohols|Amines|Amino Alcohols|Cardiovascular Agents|Ethylamines|Peripheral Vasodilators|Vasodilating Agents,CCCCNCC(O)C1=CC=C(O)C=C1,
11155,DB13207,Arginine glutamate,small molecule,investigational,"Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Bile and Liver Therapy|Liver Therapy|Liver Therapy, Lipotropics|Oligopeptides|Peptides",N[C@@H](CCC(O)=O)C(O)=O.N[C@@H](CCCNC(N)=N)C(O)=O,
11156,DB13208,Prednylidene,small molecule,experimental,"Adrenal Cortex Hormones|Corticosteroids|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Fused-Ring Compounds|Glucocorticoids|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC(=C)[C@]2(O)C(=O)CO,
11157,DB13209,Bismuth subnitrate,small molecule,approved,"Alimentary Tract and Metabolism|Antacids|Bismuth containing drugs|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Elements|Elements, Radioactive|Gastric Acid Lowering Agents|Gastrointestinal Agents|Isotopes|Metals|Metals, Heavy|Neurotoxic agents|Radioisotopes",[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[O--].[Bi+3].[Bi+3].[Bi+3].[Bi+3].[Bi+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O,
11158,DB13210,Sodium chlorite,small molecule,experimental,"Acids|Acids, Noncarboxylic|Anions|Chlorine Compounds|Cicatrizants|Dermatologicals|Electrolytes|Ions|Preparations for Treatment of Wounds and Ulcers",[Na+].[O-][Cl]=O,
11159,DB13211,Guanoxan,small molecule,approved,"Amidines|Antiadrenergic Agents, Peripherally Acting|Antihypertensive Agents|Guanidine Derivatives",NC(=N)NCC1COC2=C(O1)C=CC=C2,
11160,DB13212,Phenolsulfonphthalein,small molecule,experimental,"Benzene Derivatives|Coloring Agents|Compounds used in a research, industrial, or household setting|Diagnostic Agents|Indicators and Reagents|Laboratory Chemicals|Phenolphthaleins|Phenols|Tests for Renal Function and Ureteral Injuries",OC1=CC=C(C=C1)C1(OS(=O)(=O)C2=CC=CC=C12)C1=CC=C(O)C=C1,
11161,DB13213,Butaperazine,small molecule,approved,"Antipsychotic Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotoxic agents|Phenothiazines|Phenothiazines With Piperazine Structure|Psycholeptics|Sulfur Compounds",CCCC(=O)C1=CC2=C(SC3=CC=CC=C3N2CCCN2CCN(C)CC2)C=C1,
11162,DB13214,Sulfadicramide,small molecule,experimental,Anti-Infective Agents|Ophthalmologicals|Sensory Organs|Sulfonamides,CC(C)=CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1,
11163,DB13215,Sulfobromophthalein,small molecule,experimental,"Benzene Derivatives|Coloring Agents|Compounds used in a research, industrial, or household setting|Diagnostic Agents|Indicators and Reagents|Laboratory Chemicals|Phenolphthaleins|Phenols|Tests for Liver Functional Capacity",OC1=CC=C(C=C1S(O)(=O)=O)C1(OC(=O)C2=C1C(Br)=C(Br)C(Br)=C2Br)C1=CC(=C(O)C=C1)S(O)(=O)=O,
11164,DB13216,Oxolamine,small molecule,approved,Antitussive Agents|Central Nervous System Agents|Cough and Cold Preparations|Oxazoles|Respiratory System Agents,CCN(CC)CCC1=NC(=NO1)C1=CC=CC=C1,
11165,DB13217,Fentiazac,small molecule,experimental,"Acetic Acid Derivatives and Related Substances|Acids, Acyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antirheumatic Agents|Central Nervous System Agents|Fatty Acids|Fatty Acids, Volatile|Lipids|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Sensory System Agents|Sulfur Compounds|Topical Products for Joint and Muscular Pain",OC(=O)CC1=C(N=C(S1)C1=CC=CC=C1)C1=CC=C(Cl)C=C1,
11166,DB13218,Mandelic acid,small molecule,approved,"Acids, Carbocyclic|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Hydroxy Acids|Irrigating Solutions",OC(C(O)=O)C1=CC=CC=C1,
11167,DB13219,Medifoxamine,small molecule,approved,Amines|Antidepressive Agents|Central Nervous System Depressants|Nervous System|Psychoanaleptics,CN(C)CC(OC1=CC=CC=C1)OC1=CC=CC=C1,
11168,DB13220,Ferrous aspartate,small molecule,experimental,"Antianemic Preparations|Blood and Blood Forming Organs|Iron Bivalent, Oral Preparations|Iron Preparations",[Fe++].N[C@@H](CC([O-])=O)C([O-])=O,
11169,DB13221,Apronalide,small molecule,approved,Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Psycholeptics,CC(C)C(CC=C)C(=O)NC(N)=O,
11170,DB13222,Tilbroquinol,small molecule,approved,"Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Heterocyclic Compounds, Fused-Ring|Hydroxyquinoline Derivatives|Hydroxyquinolines|Quinolines",CC1=C2C=CC=NC2=C(O)C(Br)=C1,
11171,DB13223,Fluocortin,small molecule,experimental,"Adrenal Cortex Hormones|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Moderately Potent (Group II)|Dermatologicals|Immunosuppressive Agents",C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@H]1C(=O)C(O)=O,
11172,DB13224,Piperidione,small molecule,experimental,Cough and Cold Preparations,CCC1(CC)C(=O)CCNC1=O,
11173,DB13225,Dibenzepin,small molecule,approved,"Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Antidepressive Agents, Tricyclic|Central Nervous System Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Non-Selective Monoamine Reuptake Inhibitors|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",CN(C)CCN1C2=CC=CC=C2N(C)C2=CC=CC=C2C1=O,
11174,DB13226,Acetylleucine,small molecule,experimental,"Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Antivertigo Preparations|Nervous System",CC(C)CC(NC(C)=O)C(O)=O,
11175,DB13227,Tribenoside,small molecule,experimental,"Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antirheumatic Agents|Capillary Stabilizing Agents|Carbohydrates|Central Nervous System Agents|Peripheral Nervous System Agents|Sensory System Agents|Vasoprotectives",CCOC1O[C@H]([C@@H](COCC2=CC=CC=C2)OCC2=CC=CC=C2)[C@H](OCC2=CC=CC=C2)[C@H]1O,
11176,DB13228,Flosequinan,small molecule,approved,"Cardiac Therapy|Cardiovascular Agents|Heterocyclic Compounds, Fused-Ring|Quinolone Vasodilators|Vasodilating Agents|Vasodilators Used in Cardiac Diseases",CN1C=C(C(=O)C2=C1C=C(F)C=C2)S(C)=O,
11177,DB13229,Enibomal,small molecule,experimental,"Anesthetics|Anesthetics, General|Nervous System|Pyrimidines|Pyrimidinones",CC(C)C1(CC(Br)=C)C(=O)NC(=O)N(C)C1=O,
11178,DB13230,Gestonorone,small molecule,experimental,Adrenal Cortex Hormones|Antineoplastic and Immunomodulating Agents|Endocrine Therapy|Genito Urinary System and Sex Hormones|Hormones and Related Agents|Pregnen (4) Derivatives|Progestins|Sex Hormones and Modulators of the Genital System,[H][C@@]12CC[C@](O)(C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],
11179,DB13231,Calcium lactate,small molecule,approved|investigational|vet_approved,Alimentary Tract and Metabolism|Calcium Salts|Hydroxy Acids|Mineral Supplements,[Ca++].CC(O)C([O-])=O.CC(O)C([O-])=O,13144
11180,DB13232,Suxibuzone,small molecule,experimental,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antirheumatic Agents|Central Nervous System Agents|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Pyrazoles|Pyrazolones|Sensory System Agents|Topical Products for Joint and Muscular Pain",CCCCC1(COC(=O)CCC(O)=O)C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C1,
11181,DB13233,Alaproclate,small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Psychoanaleptics|Psychotropic Drugs|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators",CC(N)C(=O)OC(C)(C)CC1=CC=C(Cl)C=C1,2081
11182,DB13234,Propanidid,small molecule,experimental,"Acids, Carbocyclic|Amines|Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Central Nervous System Agents|Central Nervous System Depressants|Diethylamines|Ethylamines|Nervous System|Phenylacetates",CCCOC(=O)CC1=CC(OC)=C(OCC(=O)N(CC)CC)C=C1,
11183,DB13235,Perboric acid,small molecule,approved,"Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Anions|Antiinfectives and Antiseptics for Local Oral Treatment|Boric Acids|Boron Compounds|Electrolytes|Ions|Stomatological Preparations|Tooth Bleaching",OOB=O,
11184,DB13236,Stibophen,small molecule,experimental,"Acids|Acids, Noncarboxylic|Anthelmintics|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antitrematodals|Arylsulfonates|Arylsulfonic Acids|Benzene Derivatives|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",O.O.O.O.O.O.O.[Na+].[Na+].[Na+].[Na+].[Na+].[Sb+3].[O-]C1=C([O-])C(=CC(=C1)S([O-])(=O)=O)S([O-])(=O)=O.[O-]C1=C([O-])C(=CC(=C1)S([O-])(=O)=O)S([O-])(=O)=O,
11185,DB13237,Clofoctol,small molecule,experimental,Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Benzene Derivatives|Phenols,CC(C)(C)CC(C)(C)C1=CC=C(O)C(CC2=C(Cl)C=C(Cl)C=C2)=C1,
11186,DB13238,Tuaminoheptane,small molecule,experimental,"Nasal Preparations|Sympathomimetics, Plain",CCCCCC(C)N,
11187,DB13239,Neltenexine,small molecule,experimental,Amines|Aniline Compounds|Cough and Cold Preparations|Cyclohexanes|Cyclohexylamines|Cycloparaffins|Expectorants,O[C@H]1CC[C@@H](CC1)NCC1=CC(Br)=CC(Br)=C1NC(=O)C1=CC=CS1,
11188,DB13240,Cymarin,small molecule,experimental,"Antiarrhythmic agents|Carbohydrates|Cardanolides|Cardenolides|Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Fused-Ring Compounds|Glycosides|Protective Agents|Steroids|Strophanthins|Strophanthus Glycosides",[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4(O)C[C@H](CC[C@]4(C=O)[C@@]3([H])CC[C@]12C)O[C@H]1C[C@H](OC)[C@H](O)[C@@H](C)O1)C1=CC(=O)OC1,
11190,DB13242,Bucladesine,small molecule,experimental,"Adenine Nucleotides|Carbohydrates|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cyclic AMP|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Nucleotides, Cyclic|Phosphodiesterase Inhibitors|Purine Nucleotides|Purines|Ribonucleotides",CCCC(=O)NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1OC(=O)CCC,
11191,DB13243,Tiazofurine,small molecule,experimental,"Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Glycosides|Noxae|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Ribonucleosides|Toxic Actions",NC(=O)C1=CSC(=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,
11192,DB13244,Aminomethylbenzoic acid,small molecule,experimental,Amino Acids|Antifibrinolytic Agents|Blood and Blood Forming Organs|Hemostatics,NCC1=CC=C(C=C1)C(O)=O,
11193,DB13245,Thiram,small molecule,approved|experimental,"Acids, Acyclic|Agrochemicals|Antiparasitic Products, Insecticides and Repellents|Carbamates|Cell-mediated Immunity|Compounds used in a research, industrial, or household setting|Dimethyldithiocarbamate|Ectoparasiticides, Incl. Scabicides|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Fungicides, Industrial|Increased Histamine Release|Mutagens|Noxae|Pesticides|Standardized Chemical Allergen|Sulfur Compounds|Sulfur Containing Products|Thiocarbamates|Toxic Actions",CN(C)C(=S)SSC(=S)N(C)C,
11194,DB13246,Quinupramine,small molecule,approved,"Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Antidepressive Agents, Tricyclic|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Non-Selective Monoamine Reuptake Inhibitors|Psychoanaleptics|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",C1CN2CCC1C(C2)N1C2=CC=CC=C2CCC2=CC=CC=C12,
11195,DB13247,Pramiracetam,small molecule,approved,"Nervous System|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics",CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C,
11196,DB13248,Phthalylsulfathiazole,small molecule,approved,"Alimentary Tract and Metabolism|Amides|Amines|Aniline Compounds|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Intestinal Antiinfectives|Sulfanilamides|Sulfonamides|Sulfones|Sulfur Compounds|Thiazoles",OC(=O)C1=CC=CC=C1C(=O)NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CS1,
11197,DB13249,Magnesium silicate,small molecule,approved,"Acids|Acids, Noncarboxylic|Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Aluminum and magnesium containing antacids|Anions|Antacids|Drugs for Acid Related Disorders|Electrolytes|Gastric Acid Lowering Agents|Ions|Magnesium Compounds|Metal cations|Metal divalent cations|Minerals|Oxides|Oxygen Compounds|Silicates|Silicon Compounds",[O--].[O--].[O--].[Mg++].[Si+4],
11198,DB13250,Methylmethionine chloride,small molecule,experimental,Alimentary Tract and Metabolism|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),[Cl-].C[S+](C)CC[C@H](N)C(O)=O,
11199,DB13251,Octopamine,small molecule,experimental,Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Biogenic Amines|Biogenic Monoamines|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Ethanolamines|Ethylamines|Neurotransmitter Agents|Phenethylamines|Vasoconstrictor Agents,NCC(O)C1=CC=C(O)C=C1,
11200,DB13252,Tropatepine,small molecule,experimental,"Agents producing tachycardia|Anti-Parkinson Drugs|Anticholinergic Agents|Heterocyclic Compounds, Fused-Ring|Muscarinic Antagonists|Nervous System|Sulfur Compounds|Tertiary Amines|Thiepins",CN1[C@H]2CC[C@@H]1CC(C2)=C1C2=CC=CC=C2CSC2=C1C=CC=C2,
11201,DB13253,Proxibarbal,small molecule,approved,"Barbiturates, Plain|Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Psycholeptics|Pyrimidines|Pyrimidinones",CC(O)CC1(CC=C)C(=O)NC(=O)NC1=O,
11202,DB13254,Prifinium,small molecule,experimental,"Agents producing tachycardia|Alimentary Tract and Metabolism|Anticholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Synthetic Anticholinergics, Quaternary Ammonium Compounds",CC[N+]1(CC)CCC(C1C)=C(C1=CC=CC=C1)C1=CC=CC=C1,
11203,DB13255,Propatyl nitrate,small molecule,experimental|investigational,Alcohols|Antianginal Agents|Cardiac Therapy|Glycols|Organic Nitrates|Vasodilating Agents|Vasodilators Used in Cardiac Diseases,CCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O,
11204,DB13256,Clothiapine,small molecule,approved,"Antipsychotic Agents|Azepines|Central Nervous System Agents|Central Nervous System Depressants|Diazepines, Oxazepines, Thiazepines and Oxepines|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotoxic agents|Psycholeptics|Psychotropic Drugs|Sulfur Compounds|Thiazepines|Thiepins|Tranquilizing Agents",CN1CCN(CC1)C1=NC2=CC=CC=C2SC2=C1C=C(Cl)C=C2,
11205,DB13257,Ferrous sulfate anhydrous,small molecule,approved,"Anemia, Iron-Deficiency|Delayed-Action Preparations|Hematinics|Iron Compounds|Iron Preparations|Minerals|Organometallic Compounds|Pharmaceutical Preparations|Polyvalent cation containing laxatives, antacids, oral supplements",[Fe++].[O-]S([O-])(=O)=O,62662
11206,DB13258,Etofamide,small molecule,approved,"Acetates|Acids, Acyclic|Amebicides|Amides|Anti-Infective Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Dichloroacetamide Derivatives|Fatty Acids|Fatty Acids, Volatile|Lipids",CCOCCN(CC1=CC=C(OC2=CC=C(C=C2)[N+]([O-])=O)C=C1)C(=O)C(Cl)Cl,
11207,DB13259,Ethyl chloride,small molecule,approved|experimental|investigational,"Anesthetics|Anesthetics, Local|Central Nervous System Agents|Central Nervous System Depressants|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Nervous System|Peripheral Nervous System Agents|Sensory System Agents",CCCl,6337
11209,DB13261,Sitafloxacin,small molecule,experimental|investigational,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Moderate Risk QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",O.O.O.N[C@@H]1CN(CC11CC1)C1=C(F)C=C2C(=O)C(=CN([C@@H]3C[C@@H]3F)C2=C1Cl)C(O)=O.N[C@@H]1CN(CC11CC1)C1=C(F)C=C2C(=O)C(=CN([C@@H]3C[C@@H]3F)C2=C1Cl)C(O)=O,
11210,DB13262,Aceclidine,small molecule,approved,Antiglaucoma Preparations and Miotics|Autonomic Agents|Miotics|Ophthalmologicals|Parasympathomimetics|Peripheral Nervous System Agents|Sensory Organs,CC(=O)OC1CN2CCC1CC2,
11212,DB13264,Penimepicycline,small molecule,experimental,"Agents that produce neuromuscular block (indirect)|Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Naphthacenes|Sulfur Compounds|Tetracyclines",[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)COC1=CC=CC=C1)C(O)=O.[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(=O)NCN1CCN(CCO)CC1)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,
11213,DB13265,Hexobendine,small molecule,approved,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Cardiac Therapy|Cardiovascular Agents|Ethers|Hydroxy Acids|Hydroxybenzoate Ethers|Hydroxybenzoates|Phenols|Phenyl Ethers|Vasodilating Agents|Vasodilators Used in Cardiac Diseases",COC1=CC(=CC(OC)=C1OC)C(=O)OCCCN(C)CCN(C)CCCOC(=O)C1=CC(OC)=C(OC)C(OC)=C1,
11214,DB13266,Cefatrizine,small molecule,experimental,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|First-Generation Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines",[H][C@@]1(NC(=O)[C@H](N)C2=CC=C(O)C=C2)C(=O)N2C(C(O)=O)=C(CSC3=CNN=N3)CS[C@]12[H],
11215,DB13267,Ritiometan,small molecule,approved,Nasal Preparations,OC(=O)CSC(SCC(O)=O)SCC(O)=O,
11216,DB13268,Acetarsol,small molecule,approved|withdrawn,"Agents Against Leishmaniasis and Trypanosomiasis|Alimentary Tract and Metabolism|Anti-Infective Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Arsenicals|Drugs that are Mainly Renally Excreted|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Intestinal Antiinfectives|Organometallic Compounds",CC(=O)NC1=CC(=CC=C1O)[As](O)(O)=O,
11217,DB13269,Dichlorobenzyl alcohol,small molecule,approved,"Alcohols|Anti-Infective Agents, Local|Benzene Derivatives|Benzyl Compounds|Drugs that are Mainly Renally Excreted|Throat Preparations",OCC1=C(Cl)C=C(Cl)C=C1,
11218,DB13270,Dibekacin,small molecule,approved,Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Carbohydrates|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Glycosides|Narrow Therapeutic Index Drugs|Nephrotoxic agents,NC[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)O1,
11219,DB13271,Wood creosote,small molecule,experimental|investigational,Benzene Derivatives|Cough and Cold Preparations|Cresols|Expectorants|Phenols,,
11220,DB13272,Meladrazine,small molecule,experimental,Drugs for Urinary Frequency and Incontinence|Genito Urinary System and Sex Hormones|Urologicals,CCN(CC)C1=NC(=NN)N=C(N1)N(CC)CC,
11221,DB13273,Sultopride,small molecule,approved,"Acids, Carbocyclic|Amides|Antidepressive Agents|Antidepressive Agents, Second-Generation|Antipsychotic Agents|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Moderate Risk QTc-Prolonging Agents|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Tranquilizing Agents",CCN1CCCC1CNC(=O)C1=CC(=CC=C1OC)S(=O)(=O)CC,
11222,DB13274,Micronomicin,small molecule,approved,Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Benzalkonium Compounds|Carbohydrates|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Glycosides|Irritants|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Ophthalmic Solutions|Ophthalmologicals|Sensory Organs,CNC[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1,
11223,DB13275,Clorindione,small molecule,experimental,Anticoagulants|Blood and Blood Forming Organs|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Substrates|Indenes|Narrow Therapeutic Index Drugs|Vitamin K Antagonists,ClC1=CC=C(C=C1)C1C(=O)C2=CC=CC=C2C1=O,
11224,DB13276,Idanpramine,small molecule,experimental,Alimentary Tract and Metabolism|Drugs for Functional Gastrointestinal Disorders,COC1=CC=C(C=C1)C1(NC(=O)N(CCN2CCCCC2)C1=O)C1=CC=C(OC)C=C1,
11225,DB13277,Benziodarone,small molecule,approved|withdrawn,"Antigout Preparations|Antirheumatic Agents|Cardiac Therapy|Heterocyclic Compounds, Fused-Ring|Renal Agents|Uricosuric Agents|Vasodilators Used in Cardiac Diseases",CCC1=C(C(=O)C2=CC(I)=C(O)C(I)=C2)C2=CC=CC=C2O1,
11226,DB13278,Bucetin,small molecule,approved|withdrawn,Amines|Aminophenols|Analgesics|Anilides|Aniline Compounds|Benzene Derivatives|Ethers|Ethyl Ethers|Nervous System|Phenols|Phenyl Ethers,CCOC1=CC=C(NC(=O)CC(C)O)C=C1,
11227,DB13279,Carbocromen,small molecule,approved|withdrawn,"Benzopyrans|Cardiac Therapy|Cardiovascular Agents|Coumarins|Heterocyclic Compounds, Fused-Ring|Pyrans|Vasodilating Agents|Vasodilators Used in Cardiac Diseases",CCOC(=O)COC1=CC2=C(C=C1)C(C)=C(CCN(CC)CC)C(=O)O2,
11228,DB13280,Aluminium acetoacetate,small molecule,experimental,Alimentary Tract and Metabolism|Aluminium Compounds|Aluminum and magnesium containing antacids|Antacids|Drugs for Acid Related Disorders|Gastric Acid Lowering Agents|Metal cations|Metal divalent cations,[Al+3].CC(=O)CC([O-])=O.CC(=O)CC([O-])=O.CC(=O)CC([O-])=O,
11230,DB13282,Benzododecinium,small molecule,approved,"Amines|Ammonium Compounds|Anti-Infective Agents|Anti-Infective Agents, Local|Benzylammonium Compounds|Compounds used in a research, industrial, or household setting|Dermatologicals|Disinfectants|Medicated Dressings|Medicated Dressings With Antiinfectives|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds",CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1,
11231,DB13283,Sulfaisodimidine,small molecule,experimental,Amides|Amines|Aniline Compounds|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Short-Acting Sulfonamides|Sulfanilamides|Sulfonamides|SULFONAMIDES AND TRIMETHOPRIM|Sulfones|Sulfur Compounds,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NC(C)=N1,
11232,DB13284,Meticrane,small molecule,approved,"Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Low-Ceiling Diuretics, Excl. Thiazides|Sulfonamides",CC1=CC2=C(C=C1S(N)(=O)=O)S(=O)(=O)CCC2,
11233,DB13285,Etilamfetamine,small molecule,experimental,"Alimentary Tract and Metabolism|Antiobesity Preparations, Excl. Diet Products|Centrally Acting Antiobesity Products",CCNC(C)CC1=CC=CC=C1,
11234,DB13286,Bumadizone,small molecule,approved,"Acetic Acid Derivatives and Related Substances|Acids, Acyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|Dicarboxylic Acids|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Sensory System Agents",CCCCC(C(O)=O)C(=O)N(NC1=CC=CC=C1)C1=CC=CC=C1,
11236,DB13288,Tromantadine,small molecule,approved,Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cyclic Amines|Cycloparaffins|Dermatologicals|Direct Acting Antivirals,CN(C)CCOCC(=O)NC12CC3CC(CC(C3)C1)C2,
11237,DB13289,Rimazolium,small molecule,experimental,Analgesics|Nervous System|Pyrimidines,CCOC(=O)C1=C[N+](C)=C2CCCC(C)N2C1=O,
11238,DB13290,Olaflur,small molecule,experimental,"Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Amines|Anions|Caries Prophylactic Agents|Cariostatic Agents|Compounds used in a research, industrial, or household setting|Electrolytes|Fluorine Compounds|Hydrofluoric Acid|Ions|Polyamines|Protective Agents|Stomatological Preparations",F.F.CCCCCCCCCCCCCCCCCCN(CCO)CCCN(CCO)CCO,
11239,DB13291,Cloridarol,small molecule,experimental,"Cardiac Therapy|Heterocyclic Compounds, Fused-Ring|Vasodilators Used in Cardiac Diseases",OC(C1=CC2=CC=CC=C2O1)C1=CC=C(Cl)C=C1,
11240,DB13292,Pimethixene,small molecule,approved,"Antihistamines for Systemic Use|Heterocyclic Compounds, Fused-Ring|Sulfur Compounds|Xanthenes",CN1CCC(CC1)=C1C2=CC=CC=C2SC2=CC=CC=C12,
11241,DB13293,Ipecac,small molecule,approved|withdrawn,Agents Causing Muscle Toxicity|Antidotes|Autonomic Agents|Biological Products|Central Nervous System Agents|Complex Mixtures|Cough and Cold Preparations|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Emetics|Expectorants|Gastrointestinal Agents|Peripheral Nervous System Agents|Pharmaceutical Preparations|Plant Extracts|Plant Preparations,,
11242,DB13294,Azidamfenicol,small molecule,experimental,Alcohols|Anti-Bacterial Agents|Anti-Infective Agents|Benzene Derivatives|Glycols|Nitro Compounds|Nitrobenzenes|Ophthalmologicals|Propylene Glycols|Sensory Organs,OC[C@@H](NC(=O)CN=[N+]=[N-])[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O,
11243,DB13295,Atracurium,small molecule,approved|experimental|investigational,"Alkaloids|Anticholinergic Agents|Benzylisoquinolines|Central Nervous System Depressants|Cholinergic Agents|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular Nondepolarizing Blockade|Neuromuscular-Blocking Agents (Nondepolarizing)|Neurotransmitter Agents|Nicotinic Antagonists|Peripheral Nervous System Agents",,
11244,DB13296,Propamidine,small molecule,experimental|investigational,Amidines|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Antiseptics and Disinfectants|Biguanides and Amidines|Dermatologicals|Ophthalmologicals|Sensory Organs,NC(=N)C1=CC=C(OCCCOC2=CC=C(C=C2)C(N)=N)C=C1,
11245,DB13297,Idrocilamide,small molecule,experimental,Alcohols|Amines|Amino Alcohols|Musculo-Skeletal System|Topical Products for Joint and Muscular Pain,OCCNC(=O)\C=C\C1=CC=CC=C1,
11246,DB13298,Alsactide,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Diagnostic Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Melanocortins|Nerve Tissue Proteins|Neuropeptides|Peptide Hormones|Peptides|Pituitary Hormones|Pituitary Hormones, Anterior|Pro-Opiomelanocortin|Protein Precursors|Proteins|Tests for Renal Function and Ureteral Injuries",,
11247,DB13299,Sulglicotide,small molecule,experimental,"Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Anti-Ulcer Agents|Carbohydrates|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Gastrointestinal Agents|Glycoconjugates|Glycopeptides|Glycoproteins|Peptides|Proteins",,
11248,DB13300,Epicillin,small molecule,experimental,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Penicillin G|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds",CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3=CCC=CC3)C(=O)N2[C@H]1C(O)=O,
11249,DB13302,Hachimycin,small molecule,experimental,Anti-Infective Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Antiinfectives for Systemic Use|Antimycotics for Systemic Use|Antiparasitic Agents|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics,,
11250,DB13303,Febarbamate,small molecule,experimental,"Carbamic Acid Esters|Central Nervous System Depressants|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System|Pyrimidines|Pyrimidinones",CCCCOCC(CN1C(=O)NC(=O)C(CC)(C1=O)C1=CC=CC=C1)OC(N)=O,
11251,DB13304,Triaziquone,small molecule,experimental,"Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Aziridines|Azirines|Ethylene Imines|Noxae|Toxic Actions",O=C1C=C(N2CC2)C(=O)C(N2CC2)=C1N1CC1,
11252,DB13305,Tolpropamine,small molecule,experimental,"Amines|Antihistamines for Topical Use|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Benzene Derivatives|Dermatologicals",CN(C)CCC(C1=CC=CC=C1)C1=CC=C(C)C=C1,
11253,DB13306,Chlorquinaldol,small molecule,approved,"Anti-Infective Agents|Anti-Infective Agents, Local|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Antiseptics and Disinfectants|Cell-mediated Immunity|Chloroquinolinols|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Heterocyclic Compounds, Fused-Ring|Hydroxyquinoline Derivatives|Hydroxyquinolines|Increased Histamine Release|Quinoline Derivatives|Quinolines|Standardized Chemical Allergen|Throat Preparations",CC1=NC2=C(C=C1)C(Cl)=CC(Cl)=C2O,
11254,DB13307,Proscillaridin,small molecule,experimental,"Bufanolides|Carbohydrates|Cardanolides|Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Fused-Ring Compounds|Glycosides|Protective Agents|Scilla Glycosides|Steroids",[H][C@@]1(CC[C@]2(O)[C@]3([H])CCC4=C[C@]([H])(CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@]1([H])O[C@@]([H])(C)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O)C1=COC(=O)C=C1,5284613
11255,DB13308,Oxametacin,small molecule,experimental,"Acetic Acid Derivatives and Related Substances|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Musculo-Skeletal System",COC1=CC=C2N(C(=O)C3=CC=C(Cl)C=C3)C(C)=C(CC(=O)NO)C2=C1,
11256,DB13309,Benproperine,small molecule,experimental,Benzene Derivatives|Cough and Cold Preparations,CC(COC1=CC=CC=C1CC1=CC=CC=C1)N1CCCCC1,
11257,DB13310,Ormeloxifene,small molecule,experimental,"Adrenal Cortex Hormones|Contraceptive Agents, Female|Contraceptives, Oral|Genito Urinary System and Sex Hormones|Heterocyclic Compounds, Fused-Ring|Hormonal Contraceptives for Systemic Use|Pyrans|Selective Estrogen Receptor Modulators|Sex Hormones and Modulators of the Genital System",[H][C@@]1(C2=CC=C(OCCN3CCCC3)C=C2)C2=C(OC(C)(C)[C@@]1([H])C1=CC=CC=C1)C=C(OC)C=C2,
11258,DB13311,Trepibutone,small molecule,experimental,Alimentary Tract and Metabolism|Drugs for Functional Gastrointestinal Disorders,CCOC1=CC(OCC)=C(OCC)C=C1C(=O)CCC(O)=O,
11259,DB13312,Delapril,small molecule,investigational,ACE Inhibitors and Calcium Channel Blockers|ACE Inhibitors and Diuretics|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Enzyme Inhibitors|Indenes|Protease Inhibitors,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N(CC(O)=O)C1CC2=C(C1)C=CC=C2,
11260,DB13313,Melevodopa,small molecule,experimental,"Amines|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Benzene Derivatives|Catecholamines|Catechols|Central Nervous System Agents|Dihydroxyphenylalanine|Dopa and Dopa Derivatives|Dopamine Agents|Nervous System|Phenols|Phenylalanine",COC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1,
11261,DB13314,Alminoprofen,small molecule,experimental,"Acids, Acyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|Fatty Acids|Fatty Acids, Volatile|Lipids|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Propionates|Sensory System Agents",CC(C(O)=O)C1=CC=C(NCC(C)=C)C=C1,
11262,DB13315,Sobrerol,small molecule,experimental,Cough and Cold Preparations|Expectorants|Respiratory System Agents,CC1=CC[C@H](C[C@@H]1O)C(C)(C)O,
11263,DB13316,Ibopamine,small molecule,experimental,"Adrenergic and Dopaminergic Agents|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Autonomic Agents|Benzene Derivatives|Biogenic Amines|Biogenic Monoamines|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Catecholamines|Catechols|Compounds used in a research, industrial, or household setting|Diuretics|Dopamine Agents|Dopamine Agonists|Dopamine D1 Receptor Agonists|Epinephrine and similars|Ethanolamines|Mydriatics|Mydriatics and Cycloplegics|Natriuretic Agents|Neurotransmitter Agents|Ophthalmologicals|Peripheral Nervous System Agents|Phenols|Protective Agents|Sensory Organs|Sympathomimetics Excl. Antiglaucoma Preparations|Vasodilating Agents",CNCCC1=CC(OC(=O)C(C)C)=C(OC(=O)C(C)C)C=C1,
11264,DB13317,Flunoxaprofen,small molecule,experimental,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Products for Vaginal Administration|Antirheumatic Agents|Central Nervous System Agents|Genito Urinary System and Sex Hormones|Heterocyclic Compounds, Fused-Ring|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Propionates|Sensory System Agents",C[C@H](C(O)=O)C1=CC=C2OC(=NC2=C1)C1=CC=C(F)C=C1,
11265,DB13318,Demecolcine,small molecule,experimental,"Alkaloids|Antimitotic Agents|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Antineoplastic and Immunomodulating Agents|Colchicine Derivatives|Mitosis Modulators|Tubulin Modulators",[H][C@@]1(CCC2=CC(OC)=C(OC)C(OC)=C2C2=CC=C(OC)C(=O)C=C12)NC,
11266,DB13319,Propenidazole,small molecule,experimental,"Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Imidazole Derivatives|Nitroimidazole Derivatives",CCOC(=O)C(=C\C1=NC=C(N1C)[N+]([O-])=O)\C(C)=O,
11267,DB13320,Sulfaperin,small molecule,experimental,Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Long-Acting Sulfonamides|Sulfonamides|SULFONAMIDES AND TRIMETHOPRIM,CC1=CN=C(NS(=O)(=O)C2=CC=C(N)C=C2)N=C1,
11268,DB13321,Methiodal,small molecule,experimental,"Acids|Acids, Noncarboxylic|Alkanes|Alkanesulfonates|Alkanesulfonic Acids|Contrast Media|Hydrocarbons, Acyclic|Sulfonic Acids|Sulfur Acids|Sulfur Compounds|Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media|X-Ray Contrast Media, Iodinated",OS(=O)(=O)CI,
11269,DB13322,Hydrotalcite,small molecule,approved|experimental|investigational,Alimentary Tract and Metabolism|Alkalies|Aluminium Compounds|Aluminum and magnesium containing antacids|Anions|Antacids|Drugs for Acid Related Disorders|Electrolytes|Gastric Acid Lowering Agents|Gastrointestinal Agents|Hydroxides|Ions|Magnesium Compounds|Metal cations|Metal divalent cations,O.O.O.O.O.O.O.O.O.O.O.O.[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[Mg++].[Mg++].[Mg++].[Mg++].[Mg++].[Mg++].[Al+3].[Al+3].[O-]C([O-])=O,
11270,DB13323,Trichloroethylene,small molecule,approved,"Agents that produce hypertension|Anesthetics|Anesthetics, General|Anesthetics, Inhalation|Central Nervous System Agents|Central Nervous System Depressants|Compounds used in a research, industrial, or household setting|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Nervous System|Solvents",ClC=C(Cl)Cl,
11271,DB13324,Tetrazepam,small molecule,experimental,"Benzazepines|Central Nervous System Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Peripheral Nervous System Agents",CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CCCCC1,
11272,DB13325,Nifurzide,small molecule,experimental,"Alimentary Tract and Metabolism|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Furans|Intestinal Antiinfectives|Nitro Compounds",[O-][N+](=O)C1=CC=C(O1)\C=C\C=N\NC(=O)C1=CC=C(S1)[N+]([O-])=O,
11273,DB13326,Euflavine,small molecule,experimental,"Acridine Derivatives|Acridines|Antiseptics and Disinfectants|Dermatologicals|Heterocyclic Compounds, Fused-Ring",[Cl-].C[N+]1=C2C=C(N)C=CC2=CC2=C1C=C(N)C=C2,
11274,DB13327,Picotamide,small molecule,experimental,"Acids, Carbocyclic|Antiplatelet agents|Blood and Blood Forming Organs|Hematologic Agents|Platelet Aggregation Inhibitors Excl. Heparin",COC1=CC=C(C=C1C(=O)NCC1=CC=CN=C1)C(=O)NCC1=CC=CN=C1,
11275,DB13328,Butanilicaine,small molecule,experimental,"Amides|Amines|Anesthetics|Anesthetics, Local|Anilides|Aniline Compounds|Nervous System",CCCCNCC(=O)NC1=C(C)C=CC=C1Cl,
11276,DB13329,Guaiazulen,small molecule,experimental,Cycloheptanes|Cycloparaffins|Ophthalmologicals|Sensory Organs|Terpenes,CC(C)C1=CC2=C(C)C=CC2=C(C)C=C1,
11277,DB13330,Amezinium metilsulfate,small molecule,experimental,Adrenergic and Dopaminergic Agents|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy,COS([O-])(=O)=O.COC1=CC(N)=CN=[N+]1C1=CC=CC=C1,
11278,DB13331,Pyrithyldione,small molecule,experimental,Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Piperidinedione Derivatives|Psycholeptics|Pyridines,CCC1(CC)C(=O)NC=CC1=O,
11279,DB13332,Dibutylsuccinate,small molecule,experimental,"Antiparasitic Products, Insecticides and Repellents|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Insecticides and Repellents",CCCCOC(=O)CCC(=O)OCCCC,
11280,DB13333,Efloxate,small molecule,experimental,"Benzopyrans|Cardiac Therapy|Chromones|Heterocyclic Compounds, Fused-Ring|Pyrans|Vasodilators Used in Cardiac Diseases",CCOC(=O)COC1=CC2=C(C=C1)C(=O)C=C(O2)C1=CC=CC=C1,
11281,DB13334,Mannosulfan,small molecule,experimental,"Acids|Acids, Noncarboxylic|Alkanes|Alkanesulfonates|Alkanesulfonic Acids|Alkylating Drugs|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Hydrocarbons, Acyclic|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",CS(=O)(=O)OC[C@@H](OS(C)(=O)=O)[C@@H](O)[C@H](O)[C@@H](COS(C)(=O)=O)OS(C)(=O)=O,
11282,DB13335,Pinazepam,small molecule,experimental,"Anti-Anxiety Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Nervous System|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents",ClC1=CC2=C(C=C1)N(CC#C)C(=O)CN=C2C1=CC=CC=C1,
11283,DB13336,Dimethylphthalate,small molecule,experimental,"Acids, Carbocyclic|Agrochemicals|Antiparasitic Products, Insecticides and Repellents|Compounds used in a research, industrial, or household setting|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Fixatives|Insect Repellents|Insecticides and Repellents|Pesticides|Plasticizers|Protective Agents|Toxic Actions",COC(=O)C1=CC=CC=C1C(=O)OC,
11284,DB13337,Pheneticillin,small molecule,approved,Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|Beta-Lactamase Sensitive Penicillins|beta-Lactams|Penicillins,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C(C)OC1=CC=CC=C1)C(O)=O,
11285,DB13338,Flurithromycin,small molecule,experimental,"Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Lactones|Leukocyte Elastase, antagonists & inhibitors|Macrolides|Macrolides, Lincosamides and Streptogramins|Polyketides",CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@](C)(F)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,
11286,DB13339,Etoglucid,small molecule,experimental,"Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Epoxy Compounds|Ethers|Ethers, Cyclic|Noxae|Toxic Actions",C(COCCOCC1CO1)OCCOCC1CO1,
11287,DB13340,Suloctidil,small molecule,experimental,Alcohols|Amines|Amino Alcohols|Cardiovascular Agents|Ethylamines|Peripheral Vasodilators|Phenethylamines|Propanolamines|Propanols|Vasodilating Agents,CCCCCCCCN[C@@H](C)[C@H](O)C1=CC=C(SC(C)C)C=C1,
11288,DB13341,Fenozolone,small molecule,experimental,"Agents producing tachycardia|Agents that produce hypertension|Autonomic Agents|Centrally Acting Sympathomimetics|Nervous System|Oxazoles|Peripheral Nervous System Agents|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Sympathomimetics",CCNC1=NC(=O)C(O1)C1=CC=CC=C1,
11289,DB13342,Cinepazet,small molecule,experimental,Cardiac Therapy|Vasodilators Used in Cardiac Diseases,CCOC(=O)CN1CCN(CC1)C(=O)\C=C\C1=CC(OC)=C(OC)C(OC)=C1,
11290,DB13343,Tioxolone,small molecule,experimental,Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Dermatologicals|Preparations Containing Sulfur,OC1=CC2=C(SC(=O)O2)C=C1,
11291,DB13344,Mercuric amidochloride,small molecule,experimental,"Acids|Acids, Noncarboxylic|Anions|Antiseptics and Disinfectants|Chlorides|Chlorine Compounds|Dermatologicals|Electrolytes|Gases|Ions|Mercurial Products|Mercury Compounds|Nitrogen Compounds",[NH2-].[Cl-].[Hg++],
11292,DB13345,Dihydroergocristine,small molecule,approved|experimental,"Adrenergic Agents|Adrenergic Antagonists|Agents that produce hypertension|Alkaloids|BSEP/ABCB11 Substrates|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Ergot Alkaloids and Derivatives|Ergotamines|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|Peripheral Vasodilators|Vasodilating Agents",[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C,
11293,DB13346,Bufexamac,small molecule,approved|withdrawn,"Acetamides|Acetates|Acetic Acid Derivatives and Related Substances|Acids, Acyclic|Agents causing hyperkalemia|Amides|Amines|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antineoplastic Agents|Antirheumatic Agents|Benzene Derivatives|Benzeneacetamides|Central Nervous System Agents|Fatty Acids|Fatty Acids, Volatile|Histone Deacetylase Inhibitors|Hydroxamic Acids|Hydroxy Acids|Hydroxylamines|Lipids|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Sensory System Agents|Topical Products for Joint and Muscular Pain",CCCCOC1=CC=C(CC(=O)NO)C=C1,2466
11294,DB13347,Diphenadione,small molecule,experimental,Anticoagulants|Blood and Blood Forming Organs|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Indans|Indenes|Vitamin K Antagonists,O=C(C(C1=CC=CC=C1)C1=CC=CC=C1)C1C(=O)C2=CC=CC=C2C1=O,
11295,DB13348,Tiadenol,small molecule,experimental,"Alcohols|Hypolipidemic Agents|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Lipids|Noxae|Toxic Actions",OCCSCCCCCCCCCCSCCO,
11296,DB13349,Talastine,small molecule,experimental,Antihistamines for Systemic Use|Pyridazines|Substituted Alkylamines,CN(C)CCN1N=C(CC2=CC=CC=C2)C2=CC=CC=C2C1=O,
11297,DB13350,Azanidazole,small molecule,experimental,"Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Imidazole Derivatives|Imidazoles|Nitro Compounds|Nitroimidazole Derivatives",CN1C(\C=C\C2=CC=NC(N)=N2)=NC=C1[N+]([O-])=O,
11298,DB13351,Piperidolate,small molecule,experimental,"Acids, Carbocyclic|Agents producing tachycardia|Alimentary Tract and Metabolism|Anticholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Phenylacetates|Synthetic Anticholinergics, Esters With Tertiary Amino Group",CCN1CCCC(C1)OC(=O)C(C1=CC=CC=C1)C1=CC=CC=C1,
11299,DB13352,Deanol,small molecule,experimental,"Alcohols|Amines|Amino Alcohols|Anti-Dyskinesia Agents|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Ethanolamines|Methylamines|Nervous System|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Psychotropic Drugs",CN(C)CCO,7902
11300,DB13353,Viminol,small molecule,experimental,Alcohols|Amines|Amino Alcohols|Analgesics|Nervous System,CCC(C)N(CC(O)C1=CC=CN1CC1=CC=CC=C1Cl)C(C)CC,
11301,DB13354,Phenprobamate,small molecule,experimental,"Acids, Acyclic|Carbamic Acid Esters|Central Nervous System Depressants|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System",NC(=O)OCCCC1=CC=CC=C1,
11302,DB13355,Visnadine,small molecule,experimental|investigational,"Benzopyrans|Heterocyclic Compounds, Fused-Ring|Peripheral Vasodilators|Pyrans",[H][C@@](C)(CC)C(=O)O[C@]1([H])[C@]([H])(OC(C)=O)C2=C(OC1(C)C)C=CC1=C2OC(=O)C=C1,
11303,DB13356,Mesulfen,small molecule,experimental,"Acids|Acids, Noncarboxylic|Anions|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Antiparasitic Products, Insecticides and Repellents|Dermatologicals|Ectoparasiticides, Incl. Scabicides|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Electrolytes|Gases|Hydrogen Sulfide|Ions|Preparations Containing Sulfur|Sulfides|Sulfur Compounds|Sulfur Containing Products",CC1=CC=C2SC3=CC(C)=CC=C3SC2=C1,
11304,DB13357,Styramate,small molecule,experimental,"Carbamic Acid Esters|Central Nervous System Depressants|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System",NC(=O)OCC(O)C1=CC=CC=C1,
11305,DB13358,Cibenzoline,small molecule,experimental,"Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ia|Cardiac Therapy|Cardiovascular Agents|Hypoglycemia-Associated Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents",C1C(C2=NCCN2)C1(C1=CC=CC=C1)C1=CC=CC=C1,
11306,DB13359,Magnesium aspartate,small molecule,experimental,Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Magnesium Compounds|Metal cations|Metal divalent cations|Mineral Supplements,,
11307,DB13360,Tolciclate,small molecule,experimental,"Acids, Acyclic|Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Carbamates|Dermatologicals|Sulfur Compounds",CN(C(=S)OC1=CC=C2[C@H]3CC[C@H](C3)C2=C1)C1=CC(C)=CC=C1,
11308,DB13361,Trimethyldiphenylpropylamine,small molecule,experimental,Alimentary Tract and Metabolism|Drugs for Functional Gastrointestinal Disorders,CC(CC(C1=CC=CC=C1)C1=CC=CC=C1)N(C)C,
11309,DB13362,Pheneturide,small molecule,experimental,Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Nervous System,CCC(C(=O)NC(N)=O)C1=CC=CC=C1,
11310,DB13363,Oxaceprol,small molecule,experimental,"Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Dermatologicals|Imines|Imino Acids|Musculo-Skeletal System",[H][C@]1(O)CN(C(C)=O)[C@@]([H])(C1)C(O)=O,
11311,DB13364,Feprazone,small molecule,experimental,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antirheumatic Agents|Central Nervous System Agents|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Pyrazoles|Pyrazolones|Sensory System Agents|Topical Products for Joint and Muscular Pain",CC(C)=CCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C1,
11312,DB13365,Calcium lactate gluconate,small molecule,experimental,Alimentary Tract and Metabolism|Calcium Salts|Mineral Supplements,,
11313,DB13366,Hydrochloric acid,small molecule,experimental,"Acid Preparations|Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Chlorine Compounds|Digestives, Incl. Enzymes|Electrolyte Solutions|I.V. Solution Additives",Cl,
11314,DB13367,Cloricromen,small molecule,experimental,"Antiplatelet agents|Benzopyrans|Blood and Blood Forming Organs|Coumarins|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|Platelet Aggregation Inhibitors Excl. Heparin|Pyrans",CCOC(=O)COC1=CC=C2C(C)=C(CCN(CC)CC)C(=O)OC2=C1Cl,
11315,DB13368,Motretinide,small molecule,experimental,"Alkenes|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Dermatologicals|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Retinoids|Retinoids for Topical Use in Acne|Terpenes|Vitamin A|Vitamins|Vitamins (Fat Soluble)",CCNC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C=C(OC)C(C)=C1C,
11316,DB13369,Benzilone,small molecule,experimental,"Agents producing tachycardia|Alimentary Tract and Metabolism|Anticholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Synthetic Anticholinergics, Quaternary Ammonium Compounds",CC[N+]1(CC)CCC(C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,
11317,DB13370,Bromisoval,small molecule,experimental,Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Psycholeptics,CC(C)C(Br)C(=O)NC(N)=O,
11318,DB13371,Difenpiramide,small molecule,experimental,"Acetates|Acetic Acid Derivatives and Related Substances|Acids, Acyclic|Agents causing hyperkalemia|Agents that produce hypertension|Amides|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|Fatty Acids|Fatty Acids, Volatile|Lipids|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Sensory System Agents",O=C(CC1=CC=C(C=C1)C1=CC=CC=C1)NC1=CC=CC=N1,
11319,DB13372,Calcium alginate,small molecule,approved|experimental,"Blood and Blood Forming Organs|Compounds used in a research, industrial, or household setting|Hemostatics|Local Hemostatics",,
11320,DB13373,Acriflavinium chloride,small molecule,experimental,"Anti-Infective Agents, Local|Throat Preparations",,
11321,DB13374,Vincamine,small molecule,experimental,"Alkaloids|Antihypertensive Agents|Antineoplastic Agents|Cardiovascular Agents|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|Peripheral Vasodilators|Secologanin Tryptamine Alkaloids|Vasodilating Agents|Vinca Alkaloids",[H][C@]12N3CCC[C@@]1(CC)C[C@@](O)(N1C4=CC=CC=C4C(CC3)=C21)C(=O)OC,15376
11323,DB13376,Succinimide,small molecule,experimental,Genito Urinary System and Sex Hormones|Imides|Pyrrolidines|Pyrrolidinones|Urologicals,O=C1CCC(=O)N1,
11324,DB13377,Vinbarbital,small molecule,experimental,"Barbiturates, Plain|Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Psycholeptics",CC\C=C(/C)C1(CC)C(=O)NC(=O)NC1=O,
11325,DB13378,Norfenefrine,small molecule,experimental,Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Biogenic Amines|Biogenic Monoamines|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Ethanolamines|Ethylamines|Neurotransmitter Agents|Phenethylamines,NCC(O)C1=CC(O)=CC=C1,
11326,DB13379,Chiniofon,small molecule,experimental,"Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Heterocyclic Compounds, Fused-Ring|Quinolines",[Na+].OC([O-])=O.OC1=C(I)C=C(C2=CC=CN=C12)S(O)(=O)=O,
11327,DB13380,Difemerine,small molecule,experimental,"Acids, Carbocyclic|Agents producing tachycardia|Alimentary Tract and Metabolism|Anticholinergic Agents|Diphenylacetic Acids|Drugs for Functional Gastrointestinal Disorders|Hydroxy Acids|Muscarinic Antagonists|Phenylacetates|Synthetic Anticholinergics, Esters With Tertiary Amino Group",CN(C)C(C)(C)COC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,
11328,DB13381,Sodium feredetate,small molecule,approved,"Acetates|Acids, Acyclic|Amines|Antianemic Preparations|Blood and Blood Forming Organs|Compounds used in a research, industrial, or household setting|Diamines|Ethylenediamines|Fatty Acids|Fatty Acids, Volatile|Iron Chelating Agents|Iron Compounds|Iron Preparations|Iron Trivalent, Oral Preparations|Organometallic Compounds|Parenteral Iron Replacement|Polyamines|Sequestering Agents",[Na+].[O-]C(=O)C[N+]12CC[N+]34CC(=O)O[Fe--]13(OC(=O)C2)OC(=O)C4,
11329,DB13382,Chlorproethazine,small molecule,experimental,"Antipsychotic Agents|Central Nervous System Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Neuromuscular Agents|Neurotoxic agents|Peripheral Nervous System Agents|Phenothiazines|Phenothiazines With Aliphatic Side-Chain|Psycholeptics|Sulfur Compounds",CCN(CC)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,
11330,DB13383,Diiodohydroxypropane,small molecule,experimental,Alcohols|Antiseptics and Disinfectants|Dermatologicals|Iodine Products,OC(CI)CI,
11331,DB13384,Melitracen,small molecule,experimental|investigational,"Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Antidepressive Agents, Tricyclic|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 Substrates|Nervous System|Neurotoxic agents|Non-Selective Monoamine Reuptake Inhibitors|Psychoanaleptics|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",CN(C)CCC=C1C2=CC=CC=C2C(C)(C)C2=CC=CC=C12,
11332,DB13385,Dihydroergocryptine,small molecule,experimental,"Agents that produce hypertension|Alkaloids|Anti-Parkinson Drugs|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Dopamine Agents|Dopamine Agonists|Ergot Alkaloids and Derivatives|Ergot-derivative Dopamine Receptor Agonists|Ergotamines|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotransmitter Agents|Vasodilating Agents",,
11333,DB13386,Epimestrol,small molecule,experimental,"Estranes|Estrenes|Estrogens|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ovulation Stimulants, Synthetic|Sex Hormones and Modulators of the Genital System|Steroids",COC1=CC=C2[C@H]3CC[C@]4(C)[C@H](O)[C@H](O)C[C@H]4[C@@H]3CCC2=C1,
11334,DB13387,Hematin,small molecule,experimental,"Biological Factors|Blood and Blood Forming Organs|Heme|Heterocyclic Compounds, Fused-Ring|Metalloporphyrins|Pigments, Biological|Porphyrins",[OH-].[Fe+3].CC1=C2[N-]C(\C=C3/N=C(/C=C4\[N-]\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O,
11335,DB13388,Phenylmercuric nitrate,small molecule,experimental,Dermatologicals|Medicated Dressings|Medicated Dressings With Antiinfectives,[O-][N+](=O)O[Hg]C1=CC=CC=C1,
11336,DB13389,Iopydol,small molecule,experimental,"Contrast Media|Non-Watersoluble X-Ray Contrast Media|X-Ray Contrast Media, Iodinated",OCC(O)CN1C=C(I)C(=O)C(I)=C1,
11337,DB13391,Levoverbenone,small molecule,experimental,Cough and Cold Preparations|Expectorants,[H][C@]12C[C@]([H])(C(=O)C=C1C)C2(C)C,
11338,DB13392,Merbromin,small molecule,experimental,Antiseptics and Disinfectants|Dermatologicals|Mercurial Products|Organomercury Compounds|Organometallic Compounds,[Na+].[Na+].O[Hg]C1=C([O-])C(Br)=CC2=C1OC1=CC(=O)C(Br)=CC1=C2C1=CC=CC=C1C([O-])=O,2724062
11339,DB13393,Emetine,small molecule,experimental,"Agents Causing Muscle Toxicity|Alkaloids|Amebicides|Anti-Infective Agents|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Autonomic Agents|Central Nervous System Agents|Emetics|Enzyme Inhibitors|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Peripheral Nervous System Agents|Protein Synthesis Inhibitors",[H][C@]1(C[C@@]2([H])C[C@]3([H])N(CCC4=CC(OC)=C(OC)C=C34)C[C@]2([H])CC)NCCC2=CC(OC)=C(OC)C=C12,
11340,DB13394,Adrenalone,small molecule,experimental,Alcohols|Alimentary Tract and Metabolism|Amines|Amino Alcohols|Benzene Derivatives|Biogenic Amines|Biogenic Monoamines|Blood and Blood Forming Organs|Cardiovascular Agents|Catecholamines|Catechols|Coagulants|Ethanolamines|Hematologic Agents|Hemostatics|Local Hemostatics|Phenols|Stomatological Preparations|Vasoconstrictor Agents,CNCC(=O)C1=CC(O)=C(O)C=C1,
11341,DB13395,Eprozinol,small molecule,experimental,Drugs for Obstructive Airway Diseases,COC(CN1CCN(CCC(O)C2=CC=CC=C2)CC1)C1=CC=CC=C1,
11342,DB13396,Neocitrullamon,small molecule,experimental,Anticonvulsants|Central Nervous System Depressants|Hydantoins|Nervous System|Thyroxine-binding globulin substrates,NC(CCCN1C(=O)NC(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1)C(O)=O,
11343,DB13397,Prenoxdiazine,small molecule,experimental,Cough and Cold Preparations,C(CC1=NC(CC(C2=CC=CC=C2)C2=CC=CC=C2)=NO1)N1CCCCC1,
11344,DB13398,Oxyfedrine,small molecule,experimental,"Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Ethylamines|Ketones|Neurotransmitter Agents|Phenethylamines|Propanolamines|Propanols|Propiophenones|Protective Agents|Vasodilating Agents|Vasodilators Used in Cardiac Diseases",COC1=CC(=CC=C1)C(=O)CCN[C@@H](C)[C@H](O)C1=CC=CC=C1,
11345,DB13399,Terguride,small molecule,experimental,"Agents that produce hypertension|Alkaloids|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Dopamine Agents|Ergolines|Ergot Alkaloids and Derivatives|Genito Urinary System and Sex Hormones|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|Prolactine Inhibitors",[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CN2C)NC(=O)N(CC)CC,
11346,DB13400,Linsidomine,small molecule,experimental,"Antihypertensive Agents|Antiplatelet agents|Cardiac Therapy|Cardiovascular Agents|Enzyme Inhibitors|Hematologic Agents|Morpholines|Nitric Oxide Donors|Oxadiazoles|Oxazines|Oxazoles|Sodium-Potassium-Exchanging ATPase, antagonists & inhibitors|Sydnones|Vasodilating Agents|Vasodilators Used in Cardiac Diseases",[NH-]C1=C[N+](=NO1)N1CCOCC1,
11347,DB13401,Metildigoxin,small molecule,experimental,"Antiarrhythmic agents|Carbohydrates|Cardanolides|Cardenolides|Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Digitalis Glycosides|Digoxin and derivatives|Enzyme Inhibitors|Fused-Ring Compounds|Glycosides|Protective Agents|Steroids",[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@]([H])(CC[C@]4(C)[C@@]3([H])C[C@@]([H])(O)[C@]12C)O[C@@]1([H])C[C@]([H])(O)[C@]([H])(O[C@@]2([H])C[C@]([H])(O)[C@]([H])(O[C@@]3([H])C[C@]([H])(O)[C@]([H])(OC)[C@@]([H])(C)O3)[C@@]([H])(C)O2)[C@@]([H])(C)O1)C1=CC(=O)OC1,
11348,DB13402,Acetylglycinamide chloral hydrate,small molecule,experimental,Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Psycholeptics,OC(O)C(Cl)(Cl)Cl.CC(=O)NCC(O)=O,
11349,DB13403,Oxypertine,small molecule,experimental,Antipsychotic Agents|Central Nervous System Depressants|Indole Derivatives|Nervous System|Neurotoxic agents|Psycholeptics,COC1=C(OC)C=C2C(NC(C)=C2CCN2CCN(CC2)C2=CC=CC=C2)=C1,
11350,DB13404,Edetate sodium,small molecule,experimental,Ophthalmologicals|Sensory Organs,[Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O,
11351,DB13405,Mefruside,small molecule,experimental,"Amides|Cardiovascular Agents|Diuretics|Low-Ceiling Diuretics, Excl. Thiazides|Natriuretic Agents|Sulfonamides|Sulfones|Sulfur Compounds",CN(CC1(C)CCCO1)S(=O)(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O,
11352,DB13406,Carbutamide,small molecule,experimental,Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Drugs Used in Diabetes|Sulfones|Sulfonylureas|Sulfur Compounds,CCCCNC(=O)NS(=O)(=O)C1=CC=C(N)C=C1,
11353,DB13407,Nifenazone,small molecule,experimental,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antirheumatic Agents|Central Nervous System Agents|Musculo-Skeletal System|Nephrotoxic agents|Nervous System|Nicotinic Acids|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Pyrazoles|Pyrazolones|Pyridines|Sensory System Agents|Topical Products for Joint and Muscular Pain",CN1N(C(=O)C(NC(=O)C2=CC=CN=C2)=C1C)C1=CC=CC=C1,
11354,DB13408,Methylpropylpropanediol dinitrate,small molecule,experimental,Antianginal Agents|Cardiac Therapy|Organic Nitrates|Vasodilating Agents|Vasodilators Used in Cardiac Diseases,CCCC(C)(CO[N+]([O-])=O)CO[N+]([O-])=O,
11355,DB13409,Rokitamycin,small molecule,experimental,"Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Macrolides, Lincosamides and Streptogramins|Polyketides",CCCC(=O)O[C@H]1[C@H](C)O[C@H](C[C@@]1(C)OC(=O)CC)O[C@@H]1[C@@H](C)O[C@@H](O[C@H]2[C@@H](CC=O)C[C@@H](C)[C@@H](O)\C=C\C=C\C[C@@H](C)OC(=O)C[C@@H](O)[C@@H]2OC)[C@H](O)[C@H]1N(C)C,
11356,DB13410,Guanoxabenz,small molecule,experimental,"Amidines|Antiadrenergic Agents, Peripherally Acting|Antihypertensive Agents|Guanidine Derivatives|Guanidines",ONC(=N)N\N=C\C1=C(Cl)C=CC=C1Cl,
11357,DB13411,Lofepramine,small molecule,experimental,"Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Antidepressive Agents, Tricyclic|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 Substrates|Dibenzazepines|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotoxic agents|Non-Selective Monoamine Reuptake Inhibitors|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",CN(CCCN1C2=CC=CC=C2CCC2=CC=CC=C12)CC(=O)C1=CC=C(Cl)C=C1,
11358,DB13412,Pirisudanol,small molecule,experimental,"Nervous System|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics",CN(C)CCOC(=O)CCC(=O)OCC1=C(CO)C(O)=C(C)N=C1,
11359,DB13413,Phenglutarimide,small molecule,experimental,Agents producing tachycardia|Anti-Parkinson Drugs|Anticholinergic Agents|Cholinergic Agents|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|Piperidines|Piperidones|Tertiary Amines,CCN(CC)CCC1(CCC(=O)NC1=O)C1=CC=CC=C1,
11360,DB13414,Fenyramidol,small molecule,experimental,"Central Nervous System Depressants|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System",OC(CNC1=CC=CC=N1)C1=CC=CC=C1,
11361,DB13415,Pentetrazol,small molecule,experimental,Azepines|Central Nervous System Agents|Central Nervous System Stimulants|Convulsants|GABA Agents|GABA Antagonists|Neurotransmitter Agents|Respiratory System Agents,C1CCN2N=NN=C2CC1,
11362,DB13416,Sulbutiamine,small molecule,experimental,Alimentary Tract and Metabolism|Pyrimidines|Sulfur Compounds|Thiazoles|Vitamin B Complex|Vitamins,CC(C)C(=O)OCC\C(SS\C(CCOC(=O)C(C)C)=C(/C)N(CC1=C(N)N=C(C)N=C1)C=O)=C(\C)N(CC1=C(N)N=C(C)N=C1)C=O,3002120
11363,DB13417,Morinamide,small molecule,experimental,Antiinfectives for Systemic Use|Antimycobacterials|Drugs for Treatment of Tuberculosis,O=C(NCN1CCOCC1)C1=NC=CN=C1,
11364,DB13418,Moxestrol,small molecule,experimental,"Estradiol Congeners|Estrogen Antagonists|Estrogenic Steroids, Alkylated|Estrogens|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormone Antagonists|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Norpregnanes|Norpregnatrienes|Norsteroids|Sex Hormones and Modulators of the Genital System|Steroids|Synthetic Estrogens, Plain",CO[C@H]1C[C@@]2(C)[C@@H](CC[C@@]2(O)C#C)[C@@H]2CCC3=CC(O)=CC=C3[C@@H]12,
11365,DB13419,Troxipide,small molecule,experimental,Alimentary Tract and Metabolism|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),COC1=CC(=CC(OC)=C1OC)C(=O)NC1CCCNC1,
11366,DB13420,Thiazinam,small molecule,experimental,"Amines|Antihistamines for Systemic Use|Antipsychotic Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Neurotoxic agents|Phenothiazine Derivatives|Phenothiazines|Propylamines|Sulfur Compounds",CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)[N+](C)(C)C,
11367,DB13421,Edoxudine,small molecule,approved|investigational|withdrawn,"Anti-Infective Agents|Antiviral Agents|Carbohydrates|Deoxyribonucleosides|Dermatologicals|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",CCC1=CN([C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)NC1=O,66377
11368,DB13422,Nicofuranose,small molecule,experimental,"Cardiovascular Agents|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Nicotinic Acid and Derivatives|Nicotinic Acids|Pyridines|Vasodilating Agents",[H][C@]1(COC(=O)C2=CN=CC=C2)O[C@](O)(COC(=O)C2=CN=CC=C2)[C@@]([H])(OC(=O)C2=CN=CC=C2)[C@]1([H])OC(=O)C1=CN=CC=C1,
11369,DB13423,Ferric hydroxide,small molecule,experimental,"Antianemic Preparations|Blood and Blood Forming Organs|Iron Compounds|Iron Preparations|Iron Trivalent, Oral Preparations|Organometallic Compounds",[OH-].[OH-].[OH-].[Fe+3],
11370,DB13424,Clofenotane,small molecule,experimental,"Antiparasitic Products, Insecticides and Repellents|Chlorine Containing Products|Ectoparasiticides, Incl. Scabicides|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated",ClC1=CC=C(C=C1)C(C1=CC=C(Cl)C=C1)C(Cl)(Cl)Cl,
11371,DB13425,Flutrimazole,small molecule,experimental,Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Azole Antifungals|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Imidazole and Triazole Derivatives|Imidazole Derivatives|Imidazoles,FC1=CC=C(C=C1)C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1F,
11372,DB13427,Gold Au-198,small molecule,experimental,"Anti-Inflammatory Agents|Elements|Gold|Gold Isotopes|Isotopes|Metals|Metals, Heavy|Radioisotopes|Therapeutic Radiopharmaceuticals|Transition Elements",[198Au],
11373,DB13428,Iobenzamic acid,small molecule,experimental,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Iodobenzoates|Watersoluble, Hepatotropic X-Ray Contrast Media|X-Ray Contrast Media, Iodinated",NC1=C(I)C=C(I)C(C(=O)N(CCC(O)=O)C2=CC=CC=C2)=C1I,
11374,DB13429,Tolonidine,small molecule,experimental,"Antiadrenergic Agents, Centrally Acting|Antihypertensive Agents|Imidazoles|Imidazoline Receptor Agonists|Imidazolines",CC1=CC=C(NC2=NCCN2)C(Cl)=C1,
11375,DB13430,Mebutizide,small molecule,experimental,"Amides|Diuretics|Heterocyclic Compounds, Fused-Ring|Hyperglycemia-Associated Agents|Low-Ceiling Diuretics and Potassium-Sparing Agents|Sulfonamides|Sulfones|Sulfur Compounds|Thiazides",CCC(C)C(C)C1NC2=CC(Cl)=C(C=C2S(=O)(=O)N1)S(N)(=O)=O,
11376,DB13431,Proglumide,small molecule,experimental,"Alimentary Tract and Metabolism|Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Anti-Ulcer Agents|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Gastrointestinal Agents|Glutamine",CCCN(CCC)C(=O)C(CCC(O)=O)NC(=O)C1=CC=CC=C1,
11377,DB13432,Lonazolac,small molecule,experimental,"Acetic Acid Derivatives and Related Substances|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Prostaglandin Antagonists|Sensory System Agents",OC(=O)CC1=CN(N=C1C1=CC=C(Cl)C=C1)C1=CC=CC=C1,
11378,DB13433,Simfibrate,small molecule,experimental,"Acids, Acyclic|Agents Causing Muscle Toxicity|Benzene Derivatives|Butyrates|Clofibric Acid|Ethers|Fatty Acids|Fatty Acids, Volatile|Fibric Acids|Isobutyrates|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Lipids|Phenols|Phenyl Ethers",CC(C)(OC1=CC=C(Cl)C=C1)C(=O)OCCCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1,
11379,DB13434,Fenticonazole,small molecule,experimental,Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Azole Antifungals|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Imidazole and Triazole Derivatives|Imidazole Derivatives,ClC1=CC(Cl)=C(C=C1)C(CN1C=CN=C1)OCC1=CC=C(SC2=CC=CC=C2)C=C1,
11380,DB13435,Endralazine,small molecule,experimental,"Antihypertensive Agents|Arteriolar Smooth Muscle, Agents Acting On|Cardiovascular Agents|Hydrazinophthalazine Derivatives|Vasodilating Agents",N\N=C1/NN=C2CCN(CC2=C1)C(=O)C1=CC=CC=C1,
11381,DB13436,Droxypropine,small molecule,experimental,Cough and Cold Preparations,CCC(=O)C1(CCN(CCOCCO)CC1)C1=CC=CC=C1,
11382,DB13437,Medazepam,small molecule,experimental,"Anti-Anxiety Agents|Anticonvulsants|Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|GABA Agents|GABA Modulators|Heterocyclic Compounds, Fused-Ring|Hypnotics and Sedatives|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Neuromuscular Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents",CN1CCN=C(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,
11383,DB13438,Prolintane,small molecule,experimental,"Central Nervous System Agents|Central Nervous System Stimulants|Nervous System|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics",CCCC(CC1=CC=CC=C1)N1CCCC1,
11384,DB13439,Fenpiprane,small molecule,experimental,Alimentary Tract and Metabolism|Benzene Derivatives|Drugs for Functional Gastrointestinal Disorders,C(CN1CCCCC1)C(C1=CC=CC=C1)C1=CC=CC=C1,
11385,DB13441,Niceritrol,small molecule,experimental,"Hypolipidemic Agents|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Nicotinic Acid and Derivatives|Nicotinic Acids|Noxae|Pyridines|Toxic Actions",O=C(OCC(COC(=O)C1=CN=CC=C1)(COC(=O)C1=CN=CC=C1)COC(=O)C1=CN=CC=C1)C1=CN=CC=C1,
11386,DB13442,Citiolone,small molecule,experimental,"Alimentary Tract and Metabolism|Bile and Liver Therapy|Expectorants|Liver Therapy|Liver Therapy, Lipotropics|Sulfur Compounds",CC(=O)NC1CCSC1=O,
11387,DB13443,Esatenolol,small molecule,experimental,"Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Antihypertensive Agents|Beta Blocking Agents, Selective|Bradycardia-Causing Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates",CC(C)NC[C@H](O)COC1=CC=C(CC(N)=O)C=C1,
11388,DB13444,Ioxitalamic acid,small molecule,approved,"Acids, Carbocyclic|Alcohols|Amino Sugars|Benzene Derivatives|Benzoates|Carbohydrates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Hexosamines|Iodobenzoates|Sugar Alcohols|Triiodobenzoic Acids|Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media|X-Ray Contrast Media, Iodinated",CC(=O)NC1=C(I)C(C(O)=O)=C(I)C(C(=O)NCCO)=C1I,
11389,DB13445,Nepinalone,small molecule,experimental,Cough and Cold Preparations,CC1(CCN2CCCCC2)C(=O)CCC2=CC=CC=C12,
11390,DB13446,Guar gum,small molecule,experimental,"Alimentary Tract and Metabolism|Biological Products|Biopolymers|Blood Glucose Lowering Agents|Carbohydrates|Complex Mixtures|Compounds used in a research, industrial, or household setting|Dietary Fiber|Drugs Used in Diabetes|Macromolecular Substances|Plant Exudates|Polymers|Polysaccharides",,
11391,DB13447,Prethcamide,small molecule,experimental,"Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Butyrates|Fatty Acids|Fatty Acids, Volatile|Lipids|Respiratory System Agents",,
11392,DB13448,Mazaticol,small molecule,experimental,"Acetates|Acids, Acyclic|Agents producing tachycardia|Anti-Parkinson Drugs|Anticholinergic Agents|Fatty Acids|Fatty Acids, Volatile|Hydroxy Acids|Lipids|Muscarinic Antagonists|Nervous System|Sulfur Compounds|Synthetic Anticholinergics, Esters With Tertiary Amino Group|Tertiary Amines",CN1[C@@H]2CCC(C)(C)[C@@H]1C[C@@H](C2)OC(=O)C(O)(C1=CC=CS1)C1=CC=CS1,
11393,DB13449,Proxyphylline,small molecule,experimental,"Alkaloids|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Drugs for Obstructive Airway Diseases|Heterocyclic Compounds, Fused-Ring|Peripheral Nervous System Agents|Purines|Purinones|Respiratory System Agents|Xanthine derivatives|Xanthines and Adrenergics",CC(O)CN1C=NC2=C1C(=O)N(C)C(=O)N2C,
11394,DB13451,Tioclomarol,small molecule,experimental,"Anticoagulants|Benzopyrans|Blood and Blood Forming Organs|Heterocyclic Compounds, Fused-Ring|Pyrans|Vitamin K Antagonists",OC(CC(C1=CC=C(Cl)S1)C1=C(O)C2=CC=CC=C2OC1=O)C1=CC=C(Cl)C=C1,
11395,DB13452,Cadralazine,small molecule,experimental,"Antihypertensive Agents|Arteriolar Smooth Muscle, Agents Acting On|Cardiovascular Agents|Hydrazinophthalazine Derivatives|Vasodilating Agents",CCOC(=O)NNC1=NN=C(C=C1)N(CC)CC(C)O,
11396,DB13453,Xenon,small molecule,experimental,"Agents that produce hypertension|Anesthetics|Anesthetics, General|Anesthetics, Inhalation|Central Nervous System Agents|Elements|Gases|Nervous System|Noble Gases|Xenon",[Xe],
11397,DB13454,Nicomorphine,small molecule,experimental,"Alkaloids|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Morphinans|Narcotics|Natural Opium Alkaloids|Nervous System|Opiate Alkaloids|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Pyridines|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",[H][C@@]12OC3=C(OC(=O)C4=CN=CC=C4)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@]2([H])OC(=O)C1=CN=CC=C1,
11398,DB13455,Phenibut,small molecule,experimental,"Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Aminobutyrates|Anticonvulsants|Butyrates|Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Stimulants|Convulsants|Fatty Acids|Fatty Acids, Volatile|GABA Agents|GABA Agonists|Hypnotics and Sedatives|Lipids|Nervous System|Neurotransmitter Agents|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Psychotropic Drugs|Tranquilizing Agents",NCC(CC(O)=O)C1=CC=CC=C1,
11399,DB13456,Midecamycin,small molecule,experimental,"Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Lactones|Macrolides|Macrolides, Lincosamides and Streptogramins|Polyketides",[H][C@@]1(C[C@@](C)(O)[C@@H](OC(=O)CC)[C@H](C)O1)O[C@@H]1[C@@H](C)O[C@@]([H])(O[C@H]2[C@@H](CC=O)C[C@@H](C)[C@@H](O)\C=C\C=C\C[C@@H](C)OC(=O)C[C@@]([H])(OC(=O)CC)[C@@H]2OC)[C@H](O)[C@H]1N(C)C,
11400,DB13457,Oxaflozane,small molecule,experimental,Antidepressive Agents|Central Nervous System Depressants|Nervous System|Oxazines|Psychoanaleptics,CC(C)N1CCOC(C1)C1=CC=CC(=C1)C(F)(F)F,
11401,DB13458,Thebacon,small molecule,experimental,Cough and Cold Preparations|Opium Alkaloids and Derivatives,COC1=CC=C2C[C@@H]3[C@@H]4CC=C(OC(C)=O)[C@@H]5OC1=C2[C@]45CCN3C,
11402,DB13459,Pecilocin,small molecule,experimental,Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Dermatologicals|Pyrrolidines,CCCC[C@@H](O)\C=C(/C)\C=C\C=C\C(=O)N1CCCC1=O,
11403,DB13460,Ronifibrate,small molecule,experimental,"Agents Causing Muscle Toxicity|Fibric Acids|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents",CC(C)(OC1=CC=C(Cl)C=C1)C(=O)OCCCOC(=O)C1=CN=CC=C1,
11404,DB13461,Cefcapene,small molecule,experimental,Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cephalosporins|Nephrotoxic agents|Third-Generation Cephalosporins,CC\C=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(O)=O)C1=CSC(N)=N1,
11405,DB13462,Bephenium,small molecule,experimental,"Anthelmintics|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents",C[N+](C)(CCOC1=CC=CC=C1)CC1=CC=CC=C1,
11406,DB13463,Oxetorone,small molecule,experimental,"Analgesics|Antimigraine Preparations|Heterocyclic Compounds, Fused-Ring|Nervous System",CN(C)CCC=C1C2=C(COC3=CC=CC=C13)C1=CC=CC=C1O2,
11407,DB13464,Ornipressin,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Cardiovascular Agents|Coagulants|Hematologic Agents|Hemostatics|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormones|Pituitary Hormones, Posterior|Posterior Pituitary Lobe Hormones|Proteins|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Vasoconstrictor Agents|Vasopressin and Analogues|Vasopressins",NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,
11408,DB13465,Ciclobendazole,small molecule,experimental,"Anthelmintics|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Benzimidazole Derivatives|Heterocyclic Compounds, Fused-Ring",COC(=O)NC1=NC2=C(N1)C=CC(=C2)C(=O)C1CC1,
11409,DB13466,Deptropine,small molecule,experimental,Alkaloids|Antihistamines for Systemic Use|Aza Compounds|Azabicyclo Compounds|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC1C2=CC=CC=C2CCC2=C1C=CC=C2,
11410,DB13467,Lanatoside C,small molecule,experimental,Carbohydrates|Cardanolides|Cardenolides|Cardiac Glycosides|Cardiac Therapy|Digitalis Glycosides|Fused-Ring Compounds|Glycosides|Steroids,[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@]([H])(CC[C@]4(C)[C@@]3([H])C[C@@]([H])(O)[C@]12C)O[C@@]1([H])C[C@]([H])(O)[C@]([H])(O[C@@]2([H])C[C@]([H])(O)[C@]([H])(O[C@@]3([H])C[C@]([H])(OC(C)=O)[C@]([H])(O[C@]4([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]4([H])O)[C@@]([H])(C)O3)[C@@]([H])(C)O2)[C@@]([H])(C)O1)C1=CC(=O)OC1,
11411,DB13468,Etybenzatropine,small molecule,experimental,Agents producing tachycardia|Alkaloids|Anti-Parkinson Drugs|Anticholinergic Agents|Aza Compounds|Azabicyclo Compounds|Ethers of Tropine or Tropine Derivatives|Muscarinic Antagonists|Nervous System,CCN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(C1=CC=CC=C1)C1=CC=CC=C1,
11412,DB13469,Phanquinone,small molecule,experimental,"Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Heterocyclic Compounds, Fused-Ring",O=C1C(=O)C2=C(C=CC=N2)C2=C1N=CC=C2,
11413,DB13470,Cefodizime,small molecule,experimental,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephacetrile|Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins",[H][C@]12SCC(CSC3=NC(C)=C(CC(O)=O)S3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,
11414,DB13471,Nalfurafine,small molecule,experimental|investigational,"Alkaloids|Heterocyclic Compounds, Fused-Ring|Opiate Alkaloids|Phenanthrenes|Receptors, Opioid, kappa, agonists",CN([C@@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CC2)[C@H]1O5)C(=O)\C=C\C1=COC=C1,
11415,DB13472,Cyclofenil,small molecule,experimental,"Benzene Derivatives|Cresols|Fertility Agents|Fertility Agents, Female|Genito Urinary System and Sex Hormones|Ovulation Stimulants, Synthetic|Phenols|Reproductive Control Agents|Selective Estrogen Receptor Modulators|Sex Hormones and Modulators of the Genital System",CC(=O)OC1=CC=C(C=C1)C(=C1CCCCC1)C1=CC=C(OC(C)=O)C=C1,
11416,DB13473,Antimony pentasulfide,small molecule,experimental,"Acids|Acids, Noncarboxylic|Air Pollutants|Anions|Cough and Cold Preparations|Electrolytes|Elements|Expectorants|Gases|Hydrogen Sulfide|Ions|Metalloids|Metals|Metals, Heavy|Sulfur Compounds",[S--].[S--].[S--].[S--].[S--].[Sb+5].[Sb+5],
11417,DB13474,Tipepidine,small molecule,experimental,Cough and Cold Preparations,CN1CCCC(C1)=C(C1=CC=CS1)C1=CC=CS1,
11418,DB13475,Furazidin,small molecule,experimental,"Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Furans|Nitro Compounds|Nitrofuran Derivatives|Nitrofurans|Renal Agents",[O-][N+](=O)C1=CC=C(O1)\C=C\C=N\N1CC(=O)NC1=O,
11419,DB13476,Diisopromine,small molecule,experimental,Alimentary Tract and Metabolism|Drugs for Functional Gastrointestinal Disorders,CC(C)N(CCC(C1=CC=CC=C1)C1=CC=CC=C1)C(C)C,
11420,DB13477,Sodium apolate,small molecule,experimental,"Acids|Acids, Noncarboxylic|Alkenes|Antivaricose Therapy|Compounds used in a research, industrial, or household setting|Hydrocarbons, Acyclic|Macromolecular Substances|Phosphogluconate Dehydrogenase, antagonists & inhibitors|Plastics|Polyenes|Polymers|Sulfur Acids|Sulfur Compounds|Vasoprotectives|Vinyl Compounds",,
11421,DB13478,Meptazinol,small molecule,experimental,Analgesics|Azepines|Central Nervous System Agents|Central Nervous System Depressants|Narcotics|Nervous System|Opioid Antagonists|Opioids|Peripheral Nervous System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,CCC1(CCCCN(C)C1)C1=CC(O)=CC=C1,
11422,DB13479,Histapyrrodine,small molecule,experimental,Antihistamines for Systemic Use|Substituted Ethylene Diamines,C(CN1CCCC1)N(CC1=CC=CC=C1)C1=CC=CC=C1,
11423,DB13480,Lentinan,small molecule,experimental|investigational,"Adjuvants, Immunologic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|beta-Glucans|Biopolymers|Carbohydrates|Compounds used in a research, industrial, or household setting|Glucans|Immunologic Factors|Macromolecular Substances|Polymers|Polysaccharides",,
11424,DB13481,Tenidap,small molecule,experimental,"Agents causing hyperkalemia|Agents that produce hypertension|Alkaloids|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Sensory System Agents",NC(=O)N1C(=O)\C(=C(/O)C2=CC=CS2)C2=C1C=CC(Cl)=C2,
11425,DB13482,Dimefline,small molecule,experimental,"Benzopyrans|Chromones|Heterocyclic Compounds, Fused-Ring|Pyrans|Respiratory System Agents",COC1=CC=C2C(=O)C(C)=C(OC2=C1CN(C)C)C1=CC=CC=C1,
11426,DB13483,Etamsylate,small molecule,experimental,"Acids|Acids, Noncarboxylic|Arylsulfonates|Arylsulfonic Acids|Benzene Derivatives|Benzenesulfonates|Blood and Blood Forming Organs|Coagulants|Hematologic Agents|Hemostatics|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",CCNCC.OC1=CC(=C(O)C=C1)S(O)(=O)=O,
11427,DB13484,Quinbolone,small molecule,experimental,Alimentary Tract and Metabolism|Anabolic Agents for Systemic Use|Anabolic Steroids|Androstan Derivatives|Androstanes|Androstenes|Fused-Ring Compounds|Steroids,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2OC1=CCCC1,
11428,DB13485,Sulfametomidine,small molecule,experimental,Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Long-Acting Sulfonamides|Sulfonamides|SULFONAMIDES AND TRIMETHOPRIM,COC1=NC(C)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1,
11429,DB13486,Magnesium peroxide,small molecule,experimental,Alimentary Tract and Metabolism|Aluminum and magnesium containing antacids|Anions|Antacids|Drugs for Acid Related Disorders|Drugs for Constipation|Electrolytes|Free Radicals|Gastric Acid Lowering Agents|Ions|Laxatives|Magnesium Compounds|Metal cations|Metal divalent cations|Osmotic Laxatives|Oxides|Oxygen Compounds|Reactive Oxygen Species,[Mg++].[O-][O-],
11430,DB13487,Iodine (131I) norcholesterol,small molecule,experimental,Cholestanes|Cholestenes|Diagnostic Radiopharmaceuticals|Fused-Ring Compounds|Iodine (131I) Compounds|Lipids|Membrane Lipids|Steroids|Sterols,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C[C@@H](C[131I])C4=C(CC[C@H](O)C4)[C@H]3CC[C@]12C,
11431,DB13488,Bencyclane,small molecule,experimental,Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cycloheptanes|Cycloparaffins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Membrane Transport Modulators|Peripheral Vasodilators|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Vasodilating Agents,CN(C)CCCOC1(CC2=CC=CC=C2)CCCCCC1,
11432,DB13489,Bamipine,small molecule,experimental,"Antihistamines for Systemic Use|Antihistamines for Topical Use|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Dermatologicals|Histamine Agents|Histamine Antagonists|Neurotransmitter Agents",CN1CCC(CC1)N(CC1=CC=CC=C1)C1=CC=CC=C1,
11433,DB13490,Hidrosmin,small molecule,experimental,"Benzopyrans|Capillary Stabilizing Agents|Chromones|Flavones|Flavonoids|Heterocyclic Compounds, Fused-Ring|Pyrans|Vasoprotectives",COC1=CC=C(C=C1O)C1=CC(=O)C2=C(OCCO)C=C(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)C=C2O1,
11434,DB13491,Fluperolone,small molecule,experimental,"Adrenal Cortex Hormones|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Moderately Potent (Group II)|Dermatologicals|Immunosuppressive Agents",C[C@H](O)C(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C,
11435,DB13492,Policresulen,small molecule,experimental|investigational,Antiseptics and Disinfectants|Benzene Derivatives|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Pharmaceutical Preparations|Phenol and Derivatives|Phenols,,
11436,DB13493,Cyclobutyrol,small molecule,experimental,"Acids, Acyclic|Alimentary Tract and Metabolism|Bile and Liver Therapy|Bile Therapy|Fatty Acids|Fatty Acids, Volatile|Lipids",CCC(C(O)=O)C1(O)CCCCC1,
11437,DB13494,Dimetofrine,small molecule,experimental,Adrenergic and Dopaminergic Agents|Alcohols|Amines|Amino Alcohols|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy,CNCC(O)C1=CC(OC)=C(O)C(OC)=C1,
11438,DB13495,Paraoxon,small molecule,experimental,"Agrochemicals|Antiglaucoma Preparations and Miotics|Cholinergic Agents|Cholinesterase Inhibitors|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Insecticides|Neurotransmitter Agents|Ophthalmologicals|Organophosphates|Organophosphorus Compounds|Parasympathomimetics|Pesticides|Sensory Organs|Toxic Actions",CCOP(=O)(OCC)OC1=CC=C(C=C1)[N+]([O-])=O,
11439,DB13496,Iprindole,small molecule,experimental,"Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Antidepressive Agents, Tricyclic|Central Nervous System Agents|Central Nervous System Depressants|Cyclooctanes|Cycloparaffins|Heterocyclic Compounds, Fused-Ring|Indoles|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Non-Selective Monoamine Reuptake Inhibitors|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",CN(C)CCCN1C2=C(CCCCCC2)C2=CC=CC=C12,
11440,DB13497,Valethamate,small molecule,experimental,Alimentary Tract and Metabolism|Amines|Ammonium Compounds|Drugs for Functional Gastrointestinal Disorders|Nitrogen Compounds|Onium Compounds,CCC(C)C(C(=O)OCC[N+](C)(CC)CC)C1=CC=CC=C1,
11441,DB13499,Cefsulodin,small molecule,experimental,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins",NC(=O)C1=CC=[N+](CC2=C(N3[C@H](SC2)[C@H](NC(=O)[C@@H](C2=CC=CC=C2)S(O)(=O)=O)C3=O)C([O-])=O)C=C1,
11442,DB13500,Otilonium,small molecule,experimental|investigational,"Agents causing hyperkalemia|Agents producing tachycardia|Alimentary Tract and Metabolism|Amines|Ammonium Compounds|Antiarrhythmic agents|Anticholinergic Agents|Autonomic Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cholinergic Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs for Functional Gastrointestinal Disorders|Gastrointestinal Agents|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Muscarinic Antagonists|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Parasympatholytics|Peripheral Nervous System Agents|QTc Prolonging Agents|Synthetic Anticholinergics, Quaternary Ammonium Compounds|Vasodilating Agents",CCCCCCCCOC1=CC=CC=C1C(=O)NC1=CC=C(C=C1)C(=O)OCC[N+](C)(CC)CC,
11443,DB13501,Bendazac,small molecule,approved|withdrawn,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antirheumatic Agents|Central Nervous System Agents|Heterocyclic Compounds, Fused-Ring|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Ophthalmologicals|Peripheral Nervous System Agents|Pyrazoles|Sensory Organs|Sensory System Agents|Topical Products for Joint and Muscular Pain",OC(=O)COC1=NN(CC2=CC=CC=C2)C2=CC=CC=C12,
11444,DB13502,Budipine,small molecule,experimental,Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Central Nervous System Agents|Dopamine Agents|Nervous System,CC(C)(C)N1CCC(CC1)(C1=CC=CC=C1)C1=CC=CC=C1,
11445,DB13503,Tyrothricin,small molecule,approved,"Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Local|Antibiotics for Topical Use|Cholinesterase Inhibitors|Dermatologicals|Ophthalmologicals|Peptides|Peptides, Cyclic|Sensory Organs|Throat Preparations",,
11446,DB13504,Cefetamet,small molecule,experimental,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephacetrile|Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins",[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,
11447,DB13505,Emepronium,small molecule,experimental,Agents producing tachycardia|Alimentary Tract and Metabolism|Amines|Ammonium Compounds|Anticholinergic Agents|Autonomic Agents|Central Nervous System Depressants|Cholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Drugs for Urinary Frequency and Incontinence|Genito Urinary System and Sex Hormones|Hypnotics and Sedatives|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Parasympatholytics|Peripheral Nervous System Agents|Psycholeptics|Quaternary Ammonium Compounds|Urological Agents|Urologicals,CC[N+](C)(C)C(C)CC(C1=CC=CC=C1)C1=CC=CC=C1,
11448,DB13506,Carfecillin,small molecule,experimental,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Urinary|beta-Lactams|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Heterocyclic Compounds, Fused-Ring|Lactams|Penicillin G|Penicillins|Renal Agents|Sulfur Compounds",CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)OC3=CC=CC=C3)C3=CC=CC=C3)C(=O)N2[C@H]1C(O)=O,
11449,DB13507,Poldine,small molecule,experimental,"Acids, Carbocyclic|Agents producing tachycardia|Alimentary Tract and Metabolism|Anticholinergic Agents|Diphenylacetic Acids|Drugs for Functional Gastrointestinal Disorders|Hydroxy Acids|Muscarinic Antagonists|Phenylacetates|Synthetic Anticholinergics, Quaternary Ammonium Compounds",C[N+]1(C)CCCC1COC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,
11450,DB13508,Cloranolol,small molecule,experimental,"Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antihypertensive Agents|Beta Blocking Agents, Non-Selective|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Neurotransmitter Agents|Propanols",CC(C)(C)NCC(O)COC1=CC(Cl)=CC=C1Cl,
11451,DB13509,Aloxiprin,small molecule,experimental,"Acids, Carbocyclic|Analgesics|Benzene Derivatives|Benzoates|Blood and Blood Forming Organs|Hydroxy Acids|Hydroxybenzoates|Nervous System|Phenols|Platelet Aggregation Inhibitors Excl. Heparin|Salicylates|Salicylic Acid and Derivatives",[O--].[O--].[O--].[Al+3].[Al+3].CC(=O)OC1=CC=CC=C1C(O)=O,
11452,DB13510,Buflomedil,small molecule,experimental,Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antiplatelet agents|Cardiovascular Agents|Peripheral Vasodilators|Vasodilating Agents,COC1=CC(OC)=C(C(=O)CCCN2CCCC2)C(OC)=C1,
11453,DB13511,Clebopride,small molecule,experimental,"Acids, Carbocyclic|Alimentary Tract and Metabolism|Amides|Antiemetics|Autonomic Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Dopamine Antagonists|Drugs for Functional Gastrointestinal Disorders|Gastrointestinal Agents|Peripheral Nervous System Agents|Propulsives",COC1=CC(N)=C(Cl)C=C1C(=O)NC1CCN(CC2=CC=CC=C2)CC1,
11454,DB13512,Clefamide,small molecule,experimental,"Acetates|Acids, Acyclic|Amides|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Benzene Derivatives|Dichloroacetamide Derivatives|Fatty Acids|Fatty Acids, Volatile|Lipids|Nitro Compounds|Phenols",OCCN(CC1=CC=C(OC2=CC=C(C=C2)N(=O)=O)C=C1)C(=O)C(Cl)Cl,
11455,DB13513,Tribromometacresol,small molecule,experimental,Antifungals for Dermatological Use|Antifungals for Topical Use|Dermatologicals,CC1=C(Br)C=C(Br)C(O)=C1Br,
11456,DB13514,Pranoprofen,small molecule,experimental|investigational,"Acids, Acyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antigout Preparations|Antirheumatic Agents|Central Nervous System Agents|Fatty Acids|Fatty Acids, Volatile|Heterocyclic Compounds, Fused-Ring|Lipids|Nephrotoxic agents|Non COX-2 selective NSAIDS|Ophthalmologicals|Peripheral Nervous System Agents|Pyrans|Sensory Organs|Sensory System Agents",CC(C(O)=O)C1=CC2=C(OC3=C(C2)C=CC=N3)C=C1,
11457,DB13515,Levomethadone,small molecule,experimental,Drugs Used in Addictive Disorders|Drugs Used in Opioid Dependence|Nervous System,CCC(=O)C(C[C@@H](C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,
11458,DB13516,Clodantoin,small molecule,experimental,Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Imidazoles|Imidazolidines,CCCCC(CC)C1NC(=O)N(SC(Cl)(Cl)Cl)C1=O,
11459,DB13517,Angiotensinamide,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Angiotensins|Autacoids|Biological Factors|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Inflammation Mediators|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Proteins|Vasoconstrictor Agents",CC(C)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O,
11460,DB13518,Alginic acid,small molecule,approved|investigational,"Acids, Acyclic|Acids, Aldehydic|Alginates|Alimentary Tract and Metabolism|Carbohydrates|Compounds used in a research, industrial, or household setting|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Glucuronates|Hexuronic Acids|Hydroxy Acids|Polysaccharides|Sugar Acids|Uronic Acids",,131704328
11461,DB13519,Cerium oxalate,small molecule,experimental,Alimentary Tract and Metabolism|Antiemetics and Antinauseants,[Ce+3].[Ce+3].[O-]C(=O)C([O-])=O.[O-]C(=O)C([O-])=O.[O-]C(=O)C([O-])=O,
11462,DB13520,Metergoline,small molecule,approved,"Agents that produce hypertension|Alkaloids|Antidepressive Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Agonists|Ergolines|Ergot Alkaloids and Derivatives|Ergot-derivative Dopamine Receptor Agonists|Genito Urinary System and Sex Hormones|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|Prolactine Inhibitors|Serotonin Agents|Serotonin Receptor Agonists",[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)[C@@]1([H])C[C@@H](CNC(=O)OCC1=CC=CC=C1)CN2C,28693
11464,DB13522,Mebicar,small molecule,experimental,Analgesics|Anti-Anxiety Agents|Central Nervous System Agents|Central Nervous System Depressants|Nervous System|Peripheral Nervous System Agents|Psychoanaleptics|Psychotropic Drugs|Sensory System Agents|Tranquilizing Agents,CN1[C@H]2[C@@H](N(C)C1=O)N(C)C(=O)N2C,
11465,DB13523,Veralipride,small molecule,experimental,"Acids, Carbocyclic|Amides|Antipsychotic Agents|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Central Nervous System Agents|Central Nervous System Depressants|Menopause, drug effects|Nervous System|Neurotoxic agents|Psycholeptics|Psychophysiologic Disorders, drug therapy|Psychotropic Drugs|Tranquilizing Agents",COC1=CC(=CC(C(=O)NCC2CCCN2CC=C)=C1OC)S(N)(=O)=O,
11466,DB13524,Propyphenazone,small molecule,experimental,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antirheumatic Agents|Central Nervous System Agents|Nephrotoxic agents|Nervous System|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Pyrazoles|Pyrazolones|Sensory System Agents",CC(C)C1=C(C)N(C)N(C1=O)C1=CC=CC=C1,
11467,DB13525,Althea root,small molecule,experimental,Cough and Cold Preparations|Expectorants,,
11468,DB13526,Pentaerithrityl,small molecule,experimental,Alcohols|Alimentary Tract and Metabolism|Drugs for Constipation|Glycols|Laxatives|Osmotic Laxatives,OCC(CO)(CO)CO,
11469,DB13527,Proglumetacin,small molecule,experimental,"Acetic Acid Derivatives and Related Substances|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|Heterocyclic Compounds, Fused-Ring|Indoles|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Sensory System Agents",CCCN(CCC)C(=O)C(CCC(=O)OCCCN1CCN(CCOC(=O)CC2=C(C)N(C(=O)C3=CC=C(Cl)C=C3)C3=C2C=C(OC)C=C3)CC1)NC(=O)C1=CC=CC=C1,
11470,DB13528,Chlormadinone,small molecule,experimental,"Adrenal Cortex Hormones|Antiandrogens|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Pregnadien Derivatives|Pregnadienes|Pregnanes|Progestin Contraceptives|Progestins|Progestogens and Estrogens, Sequential Preparations|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids|Steroids, Chlorinated",[H][C@@]12CC[C@](O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=C(Cl)C2=CC(=O)CC[C@]12C,
11471,DB13529,Dobesilic acid,small molecule,experimental|investigational,"Acids|Acids, Noncarboxylic|Antivaricose Therapy|Arylsulfonates|Arylsulfonic Acids|Benzene Derivatives|Benzenesulfonates|Coagulants|Hematologic Agents|Hemostatics|Sulfonic Acids|Sulfur Acids|Sulfur Compounds|Vasoprotectives",OC1=CC(=C(O)C=C1)S(O)(=O)=O,
11472,DB13530,Mepindolol,small molecule,experimental,"Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Beta Blocking Agents, Non-Selective|Bradycardia-Causing Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Neurotransmitter Agents|Phenoxypropanolamines|Propanolamines|Propanols",CC(C)NCC(O)COC1=CC=CC2=C1C=C(C)N2,
11473,DB13531,Nicofetamide,small molecule,experimental,"Alimentary Tract and Metabolism|Drugs for Functional Gastrointestinal Disorders|Synthetic Antispasmodics, Amides With Tertiary Amines",O=C(NC(CC1=CC=CC=C1)C1=CC=CC=C1)C1=CC=CN=C1,
11474,DB13532,Cyclopenthiazide,small molecule,approved,"Amides|Antihypertensive Agents|Benzothiadiazines|Cardiovascular Agents|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Heterocyclic Compounds, Fused-Ring|Hyperglycemia-Associated Agents|Low-Ceiling Diuretics and Potassium-Sparing Agents|Membrane Transport Modulators|Natriuretic Agents|Sodium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds|Thiazides",NS(=O)(=O)C1=CC2=C(NC(CC3CCCC3)NS2(=O)=O)C=C1Cl,2904
11475,DB13533,Methylestrenolone,small molecule,experimental,Adrenal Cortex Hormones|Estranes|Estren Derivatives|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Progesterone Congeners|Progestins|Sex Hormones and Modulators of the Genital System|Steroids,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C,
11476,DB13534,Gedocarnil,small molecule,experimental,Anti-Anxiety Agents|Central Nervous System Depressants|Hypnotics (Nonbenzodiazepine)|Hypnotics and Sedatives|Nervous System|Psycholeptics,COCC1=C(N=CC2=C1C1=C(N2)C=CC=C1OC1=CC=C(Cl)C=C1)C(=O)OC(C)C,
11478,DB13536,Broxyquinoline,small molecule,experimental,"Alimentary Tract and Metabolism|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Heterocyclic Compounds, Fused-Ring|Hydroxyquinoline Derivatives|Hydroxyquinolines|Intestinal Antiinfectives|Quinoline Derivatives|Quinolines",OC1=C2N=CC=CC2=C(Br)C=C1Br,
11479,DB13537,Gitoformate,small molecule,experimental,Carbohydrates|Cardanolides|Cardenolides|Cardiac Glycosides|Cardiac Therapy|Digitalis Glycosides|Fused-Ring Compounds|Glycosides|Isomerism|Steroids,C[C@H]1O[C@H](C[C@H](OC=O)[C@@H]1OC=O)O[C@@H]1[C@@H](C)O[C@H](C[C@@H]1OC=O)O[C@@H]1[C@@H](C)O[C@H](C[C@@H]1OC=O)O[C@H]1CC[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@H]([C@H](C[C@]32O)OC=O)C2=CC(=O)OC2)C1,
11480,DB13538,Guacetisal,small molecule,experimental,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antirheumatic Agents|Antitussive Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Expectorants|Hydroxy Acids|Hydroxybenzoates|Nephrotoxic agents|Nervous System|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Phenols|Respiratory System Agents|Salicylates|Salicylic Acid and Derivatives|Sensory System Agents",COC1=CC=CC=C1OC(=O)C1=CC=CC=C1OC(C)=O,
11481,DB13539,Iodoxamic acid,small molecule,experimental,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Iodobenzoates|Watersoluble, Hepatotropic X-Ray Contrast Media|X-Ray Contrast Media, Iodinated",OC(=O)C1=C(I)C(NC(=O)CCOCCOCCOCCOCCC(=O)NC2=C(I)C(C(O)=O)=C(I)C=C2I)=C(I)C=C1I,
11482,DB13540,Isepamicin,small molecule,experimental,Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Carbohydrates|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Glycosides|Narrow Therapeutic Index Drugs|Nephrotoxic agents,[H][C@]1(O[C@H]2[C@@H](C[C@H](N)[C@@H](O[C@@]3([H])O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]2O)NC(=O)[C@@H](O)CN)OC[C@](C)(O)[C@H](NC)[C@H]1O,
11483,DB13541,Iprazochrome,small molecule,experimental,"Analgesics|Antidepressive Agents|Antimigraine Preparations|Biological Factors|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Indoles|Nervous System|Neurotransmitter Agents|Pigments, Biological|Quinones|Serotonin Agents|Serotonin Receptor Antagonists",CC(C)N1CC(O)C2=C\C(=N\NC(N)=O)C(=O)C=C12,
11484,DB13542,Bevonium,small molecule,experimental,"Acids, Carbocyclic|Agents producing tachycardia|Alimentary Tract and Metabolism|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anticholinergic Agents|Antirheumatic Agents|Central Nervous System Agents|Diphenylacetic Acids|Drugs for Functional Gastrointestinal Disorders|Hydroxy Acids|Muscarinic Antagonists|Peripheral Nervous System Agents|Phenylacetates|Sensory System Agents|Synthetic Anticholinergics, Quaternary Ammonium Compounds",C[N+]1(C)CCCCC1COC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,
11485,DB13543,Mitobronitol,small molecule,experimental,"Alcohols|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Carbohydrates|Noxae|Sugar Alcohols|Toxic Actions",[H][C@@](O)(CBr)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)CBr,
11486,DB13544,Ethenzamide,small molecule,experimental,"Agents causing hyperkalemia|Agents that produce hypertension|Amides|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antirheumatic Agents|Central Nervous System Agents|Nephrotoxic agents|Nervous System|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Salicylic Acid and Derivatives|Sensory System Agents",CCOC1=C(C=CC=C1)C(N)=O,
11487,DB13545,Isobromindione,small molecule,experimental,Antigout Preparations|Musculo-Skeletal System|Preparations Increasing Uric Acid Excretion,BrC1=CC=C2C(=O)C(C(=O)C2=C1)C1=CC=CC=C1,
11488,DB13546,Nizofenone,small molecule,experimental,"Antiarrhythmic agents|Cardiovascular Agents|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Moderate Risk QTc-Prolonging Agents|Nervous System|Neuroprotective Agents|Protective Agents|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|QTc Prolonging Agents",CCN(CC)CC1=NC=CN1C1=C(C=C(C=C1)N(=O)=O)C(=O)C1=CC=CC=C1Cl,
11489,DB13547,Sulfatolamide,small molecule,experimental,Amides|Amines|Aniline Compounds|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Sulfonamides|Sulfones|Sulfur Compounds,NCC1=CC=C(C=C1)S(N)(=O)=O.NC(=S)NS(=O)(=O)C1=CC=C(N)C=C1,
11490,DB13548,Dibrompropamidine,small molecule,experimental,"Amidines|Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Biguanides and Amidines|Dermatologicals|Ophthalmologicals|Sensory Organs",NC(=N)C1=CC=C(OCCCOC2=CC=C(C=C2Br)C(N)=N)C(Br)=C1,
11491,DB13549,4-dimethylaminophenol,small molecule,experimental,"Amines|Aniline Compounds|Antidotes|Benzene Derivatives|Compounds used in a research, industrial, or household setting|Hydrogen Cyanide|Phenols|Protective Agents",CN(C)C1=CC=C(O)C=C1,
11492,DB13550,Bifemelane,small molecule,experimental,Antidepressive Agents|Benzene Derivatives|Central Nervous System Agents|Central Nervous System Depressants|Nervous System|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,CNCCCCOC1=CC=CC=C1CC1=CC=CC=C1,
11493,DB13551,Cinchophen,small molecule,experimental,"Antigout Preparations|Heterocyclic Compounds, Fused-Ring|Musculo-Skeletal System|Preparations With No Effect on Uric Acid Metabolism",OC(=O)C1=CC(=NC2=CC=CC=C12)C1=CC=CC=C1,
11494,DB13552,Trifluperidol,small molecule,experimental,Antipsychotic Agents|Butyrophenone Derivatives|Butyrophenones|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Ketones|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC(=CC=C1)C(F)(F)F,
11495,DB13553,Carumonam,small molecule,experimental,"Amides|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Monobactams|Sulfur Compounds",NC(=O)OC[C@@H]1[C@H](NC(=O)C(=N/OCC(O)=O)\C2=CSC(N)=N2)C(=O)N1S(O)(=O)=O,
11496,DB13554,Moperone,small molecule,experimental,Antipsychotic Agents|Butyrophenone Derivatives|Central Nervous System Depressants|Ketones|Nervous System|Neurotoxic agents|Psycholeptics,CC1=CC=C(C=C1)C1(O)CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1,
11497,DB13555,Prajmaline,small molecule,experimental,"Alkaloids|Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ia|Antiarrhythmics, Class Ic|Cardiac Therapy|Cardiovascular Agents|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Secologanin Tryptamine Alkaloids",CCC[N@@+]12[C@H]3C[C@]45[C@H](O)[C@H]3[C@@H](C[C@H]1[C@@H]4N(C)C1=C5C=CC=C1)[C@H](CC)[C@H]2O,
11498,DB13556,Sulfamazone,small molecule,experimental,Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Long-Acting Sulfonamides|Sulfonamides|SULFONAMIDES AND TRIMETHOPRIM,COC1=CC=C(NS(=O)(=O)C2=CC=C(NC(C3=C(C)N(C)N(C3=O)C3=CC=CC=C3)S(O)(=O)=O)C=C2)N=N1,
11499,DB13557,Thiopropazate,small molecule,experimental,"Antipsychotic Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotoxic agents|Phenothiazines With Piperazine Structure|Psycholeptics|Sulfur Compounds",CC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,
11500,DB13558,Morclofone,small molecule,experimental,Benzene Derivatives|Cough and Cold Preparations|Ketones,COC1=CC(=CC(OC)=C1OCCN1CCOCC1)C(=O)C1=CC=C(Cl)C=C1,
11501,DB13559,Rimiterol,small molecule,experimental,"Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-Agonists|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Benzene Derivatives|Drugs for Obstructive Airway Diseases|Neurotransmitter Agents|Phenols|Selective Beta 2-adrenergic Agonists",O[C@@H]([C@@H]1CCCCN1)C1=CC(O)=C(O)C=C1,
11502,DB13560,Dextranomer,small molecule,experimental,"Biopolymers|Carbohydrates|Cicatrizants|Compounds used in a research, industrial, or household setting|Dermatologicals|Glucans|Macromolecular Substances|Polymers|Polysaccharides|Preparations for Treatment of Wounds and Ulcers|Sorption Detoxification|Vesico-Ureteral Reflux",,
11503,DB13561,Clobenzorex,small molecule,experimental,"Alimentary Tract and Metabolism|Amines|Antiobesity Preparations, Excl. Diet Products|Central Nervous System Stimulants|Centrally Acting Antiobesity Products|Ethylamines|Phenethylamines",C[C@@H](CC1=CC=CC=C1)NCC1=CC=CC=C1Cl,
11504,DB13563,Norgestrienone,small molecule,experimental,"Adrenal Cortex Hormones|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Norpregnanes|Norpregnatrienes|Norsteroids|Progestin Contraceptives|Progestins|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids",[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H],
11505,DB13564,Zipeprol,small molecule,experimental,Antitussive Agents|Central Nervous System Agents|Cough and Cold Preparations|Respiratory System Agents,COC(CN1CCN(CC(O)C(OC)C2=CC=CC=C2)CC1)C1=CC=CC=C1,
11506,DB13565,Benzoxonium,small molecule,experimental,Alimentary Tract and Metabolism|Amines|Ammonium Compounds|Antiinfectives and Antiseptics for Local Oral Treatment|Antiseptics and Disinfectants|Benzylammonium Compounds|Dermatologicals|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds|Stomatological Preparations,CCCCCCCCCCCC[N+](CCO)(CCO)CC1=CC=CC=C1,
11507,DB13566,Sequifenadine,small molecule,experimental,Antihistamines for Systemic Use,CC1=CC=CC=C1C(O)(C1CN2CCC1CC2)C1=CC=CC=C1C,
11508,DB13567,Desaspidin,small molecule,experimental,"Anthelmintics|Anticestodals|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Ketones",CCCC(=O)C1=C(O)C=C(OC)C(CC2=C(O)C(C)(C)C(O)=C(C(=O)CCC)C2=O)=C1O,
11509,DB13568,Diodone,small molecule,experimental,"Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Iodopyridones|Pyridines|Pyridones|Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media|X-Ray Contrast Media, Iodinated",OCCNCCO.OC(=O)CN1C=C(I)C(=O)C(I)=C1,
11510,DB13569,Ferrous chloride,small molecule,experimental,"Antianemic Preparations|Blood and Blood Forming Organs|Iron Bivalent, Oral Preparations|Iron Compounds|Iron Preparations|Organometallic Compounds",[Cl-].[Cl-].[Fe++],
11511,DB13570,Oxidized cellulose,small molecule,experimental,"Biopolymers|Blood and Blood Forming Organs|Carbohydrates|Cellulose|Coagulants|Compounds used in a research, industrial, or household setting|Glucans|Hematologic Agents|Hemostatics|Local Hemostatics|Macromolecular Substances|Polymers|Polysaccharides",,
11512,DB13571,Pentamycin,small molecule,experimental,"Alkenes|Antifungal Agents|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hydrocarbons, Acyclic|Lactones|Polyketides",CCCCC[C@@H](O)[C@@H]1[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)[C@@H](O)[C@H](O)\C(C)=C\C=C\C=C\C=C\C=C\[C@H](O)[C@@H](C)OC1=O,
11513,DB13572,Emylcamate,small molecule,experimental,"Acids, Acyclic|Anti-Anxiety Agents|Carbamates|Central Nervous System Depressants|Nervous System|Psycholeptics",CCC(C)(CC)OC(N)=O,
11514,DB13573,Acefylline,small molecule,experimental,"Alkaloids|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Drugs for Obstructive Airway Diseases|Heterocyclic Compounds, Fused-Ring|Purines|Purinones|Xanthine derivatives",CN1C2=C(N(CC(O)=O)C=N2)C(=O)N(C)C1=O,
11515,DB13574,Heptaminol,small molecule,experimental,Alcohols|Amines|Amino Alcohols|Cardiac Therapy|Vasodilators Used in Cardiac Diseases,CC(N)CCCC(C)(C)O,
11516,DB13575,Bietaserpine,small molecule,experimental,"Alkaloids|Antiadrenergic Agents, Centrally Acting|Antihypertensive Agents|Cardiovascular Agents|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|Secologanin Tryptamine Alkaloids",CCN(CC)CCN1C2=CC(OC)=CC=C2C2=C1[C@H]1C[C@H]3[C@H](C[C@@H](OC(=O)C4=CC(OC)=C(OC)C(OC)=C4)[C@H](OC)[C@H]3C(=O)OC)CN1CC2,
11517,DB13576,Aluminium nicotinate,small molecule,experimental,"Lipid Modifying Agents|Lipid Modifying Agents, Plain|Nicotinic Acid and Derivatives",[Al+3].[O-]C(=O)C1=CN=CC=C1.[O-]C(=O)C1=CN=CC=C1.[O-]C(=O)C1=CN=CC=C1,
11518,DB13577,Allobarbital,small molecule,experimental,"Barbiturates, Plain|Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Psycholeptics|Pyrimidines|Pyrimidinones",C=CCC1(CC=C)C(=O)NC(=O)NC1=O,
11519,DB13578,Metabutethamine,small molecule,experimental,"Anesthetics|Anesthetics, Local|Esters of Aminobenzoic Acid|Nervous System",CC(C)CNCCOC(=O)C1=CC=CC(N)=C1,
11520,DB13579,Mepixanox,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Respiratory System Agents|Xanthenes",COC1=CC=C2C(=O)C3=CC=CC=C3OC2=C1CN1CCCCC1,
11521,DB13580,Succinylsulfathiazole,small molecule,experimental,"Alimentary Tract and Metabolism|Amides|Amines|Aniline Compounds|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Intestinal Antiinfectives|Sulfanilamides|Sulfonamides|Sulfones|Sulfur Compounds|Thiazoles",OC(=O)CCC(=O)NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CS1,
11522,DB13581,Rociverine,small molecule,experimental,"Acids, Carbocyclic|Agents producing tachycardia|Alimentary Tract and Metabolism|Anticholinergic Agents|Autonomic Agents|Cyclohexanes|Cycloparaffins|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Parasympatholytics|Peripheral Nervous System Agents|Synthetic Anticholinergics, Esters With Tertiary Amino Group",CCN(CC)CC(C)OC(=O)[C@H]1CCCC[C@]1(O)C1CCCCC1,
11523,DB13582,Ferric (59Fe) citrate,small molecule,experimental,Diagnostic Radiopharmaceuticals|Various Diagnostic Radiopharmaceuticals,[59Fe+3].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,
11524,DB13583,Mephenesin,small molecule,approved,"Alcohols|Central Nervous System Agents|Central Nervous System Depressants|Glycols|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Peripheral Nervous System Agents|Propylene Glycols",CC1=CC=CC=C1OCC(O)CO,
11525,DB13584,Gallamine,small molecule,experimental,"Amines|Ammonium Compounds|Anticholinergic Agents|Central Nervous System Depressants|Cholinergic Agents|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular-Blocking Agents (Nondepolarizing)|Neurotoxic agents|Neurotransmitter Agents|Nicotinic Antagonists|Nitrogen Compounds|Onium Compounds|Peripheral Nervous System Agents|Quaternary Ammonium Compounds",CCN(CC)CCOC1=CC=CC(OCCN(CC)CC)=C1OCCN(CC)CC,
11526,DB13585,Aminoethyl nitrate,small molecule,experimental,"Acids|Acids, Noncarboxylic|Anions|Cardiac Therapy|Electrolytes|Ions|Nitric Acid|Nitrogen Compounds|Vasodilators Used in Cardiac Diseases",NCCO[N+]([O-])=O,
11527,DB13586,Metandienone,small molecule,experimental,"Alimentary Tract and Metabolism|Anabolic Agents|Anabolic Agents for Systemic Use|Anabolic Steroids|Androgens for Topical Use|Androstadienes|Androstan Derivatives|Androstanes|Androstenes|Dermatologicals|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids",[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,
11528,DB13587,Mesterolone,small molecule,experimental,"5-Androstanon (3) Derivatives|Anabolic Agents|Androgens|Androstanes|Androstanols|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Sex Hormones and Modulators of the Genital System|Steroids|Testosterone Congeners",[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)C[C@H](C)[C@]12C,15020
11529,DB13588,Naftidrofuryl,small molecule,experimental,Antidepressive Agents|Cardiovascular Agents|Central Nervous System Depressants|Furans|Neurotransmitter Agents|Peripheral Vasodilators|Serotonin Agents|Serotonin Receptor Antagonists|Vasodilating Agents,CCN(CC)CCOC(=O)C(CC1CCCO1)CC1=C2C=CC=CC2=CC=C1,
11530,DB13590,Calcium pangamate,small molecule,experimental,"Acids, Acyclic|Alimentary Tract and Metabolism|Amines|Amino Acids|Amino Acids, Peptides, and Proteins|Calcium Salts|Carbohydrates|Gluconates|Hydroxy Acids|Mineral Supplements|Peptides|Peptoids|Sugar Acids",[Ca++].CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O,
11531,DB13591,Metopimazine,small molecule,experimental,Alimentary Tract and Metabolism|Antiemetics|Antiemetics and Antinauseants|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Peripheral Nervous System Agents|Piperidines,CS(=O)(=O)C1=CC=C2SC3=C(C=CC=C3)N(CCCN3CCC(CC3)C(N)=O)C2=C1,
11532,DB13592,Etamiphylline,small molecule,experimental,"Alkaloids|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Drugs for Obstructive Airway Diseases|Heterocyclic Compounds, Fused-Ring|Peripheral Nervous System Agents|Purines|Purinones|Respiratory System Agents|Xanthine derivatives|Xanthines and Adrenergics",CCN(CC)CCN1C=NC2=C1C(=O)N(C)C(=O)N2C,
11533,DB13593,Zolimidine,small molecule,experimental,Alimentary Tract and Metabolism|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),CS(=O)(=O)C1=CC=C(C=C1)C1=CN2C=CC=CC2=N1,
11534,DB13595,Almasilate,small molecule,approved|experimental,"Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Aluminum and magnesium containing antacids|Anions|Antacids|Drugs for Acid Related Disorders|Drugs that are Mainly Renally Excreted|Electrolytes|Gastric Acid Lowering Agents|Ions|Minerals|Oxides|Oxygen Compounds|Pharmaceutic Aids|Silicon Compounds",O.[Mg++].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-],131704329
11535,DB13596,Oxycinchophen,small molecule,experimental,Antiinflammatory and Antirheumatic Products|Musculo-Skeletal System|Quinolines|Specific Antirheumatic Agents,OC(=O)C1=C(O)C(=NC2=CC=CC=C12)C1=CC=CC=C1,
11536,DB13597,Moroxydine,small molecule,experimental,Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Direct Acting Antivirals|Oxazines,NC(=N)NC(=N)N1CCOCC1,
11537,DB13598,Diethyl ether,small molecule,experimental,"Agents that produce hypertension|Anesthetics|Anesthetics, General|Anesthetics, Inhalation|Central Nervous System Agents|Central Nervous System Depressants|Compounds used in a research, industrial, or household setting|Ethers|Ethyl Ethers|Nervous System|Neurotoxic agents|Solvents",CCOCC,
11538,DB13599,Difetarsone,small molecule,experimental,"Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Arsenicals",O[As](O)(=O)C1=CC=C(NCCNC2=CC=C(C=C2)[As](O)(O)=O)C=C1,
11539,DB13600,Deltamethrin,small molecule,experimental,"Agrochemicals|Antiparasitic Products, Insecticides and Repellents|Compounds used in a research, industrial, or household setting|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Insecticides|Insecticides and Repellents|Monoterpenes|Pesticides|Pyrethrines|Terpenes|Toxic Actions",[H][C@@](OC(=O)[C@]1([H])[C@]([H])(C=C(Br)Br)C1(C)C)(C#N)C1=CC(OC2=CC=CC=C2)=CC=C1,
11540,DB13601,Oxiracetam,small molecule,experimental,"Central Nervous System Agents|Central Nervous System Depressants|Nervous System|Nootropic Agents|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Psychotropic Drugs",NC(=O)CN1CC(O)CC1=O,
11541,DB13602,Promegestone,small molecule,experimental,Adrenal Cortex Hormones|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Norpregnadienes|Norpregnanes|Norsteroids|Pregnadien Derivatives|Progestins|Sex Hormones and Modulators of the Genital System|Steroids,CCC(=O)[C@@]1(C)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3CC[C@]12C,
11542,DB13603,Pyrrolnitrin,small molecule,experimental,Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Dermatologicals,[O-][N+](=O)C1=C(Cl)C=CC=C1C1=CNC=C1Cl,
11543,DB13604,Guanazodine,small molecule,experimental,"Amidines|Antiadrenergic Agents, Peripherally Acting|Antihypertensive Agents|Guanidine Derivatives|Guanidines",NC(=N)NCC1CCCCCCN1,
11544,DB13605,Phenoperidine,small molecule,experimental,"Analgesics|Anesthetics|Anesthetics, General|Central Nervous System Agents|Central Nervous System Depressants|Isonipecotic Acids|Narcotics|Nervous System|Opioid Anesthetics|Opioids|Peripheral Nervous System Agents|Piperidines|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",CCOC(=O)C1(CCN(CCC(O)C2=CC=CC=C2)CC1)C1=CC=CC=C1,
11545,DB13606,Phenazocine,small molecule,experimental,"Alkaloids|Analgesics|Benzomorphan Derivatives|Benzomorphans|Central Nervous System Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Morphinans|Narcotics|Nervous System|Opiate Alkaloids|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",C[C@H]1[C@H]2CC3=CC=C(O)C=C3[C@]1(C)CCN2CCC1=CC=CC=C1,
11546,DB13607,Picloxydine,small molecule,experimental,Anti-Infective Agents|Ophthalmologicals|Sensory Organs,ClC1=CC=C(NC(=N)NC(=N)N2CCN(CC2)C(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1,
11547,DB13608,Tiocarlide,small molecule,experimental,Antiinfectives for Systemic Use|Antimycobacterials|Drugs for Treatment of Tuberculosis|Thiocarbamide Derivatives,CC(C)CCOC1=CC=C(NC(=S)NC2=CC=C(OCCC(C)C)C=C2)C=C1,
11548,DB13609,Umifenovir,small molecule,investigational,"Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Substrates|Direct Acting Antivirals|Experimental Unapproved Treatments for COVID-19|Heterocyclic Compounds, Fused-Ring|UGT1A9 Inhibitors|UGT1A9 Substrates|UGT2B7 Inhibitors",CCOC(=O)C1=C(CSC2=CC=CC=C2)N(C)C2=CC(Br)=C(O)C(CN(C)C)=C12,
11549,DB13610,Flumedroxone,small molecule,experimental,"Analgesics|Antimigraine Preparations|Corpus Luteum Hormones|Corticosteroid Derivatives|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Migraine Disorders, drug therapy|Nervous System|Pregnanes|Pregnenediones|Pregnenes|Progesterone and Derivatives|Progesterone Congeners|Steroids",CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@@H](C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(F)(F)F,
11550,DB13611,Chlormidazole,small molecule,experimental,"Antifungals for Dermatological Use|Antifungals for Topical Use|Dermatologicals|Heterocyclic Compounds, Fused-Ring|Imidazole and Triazole Derivatives",CC1=NC2=CC=CC=C2N1CC1=CC=C(Cl)C=C1,
11551,DB13612,Carbaspirin calcium,small molecule,experimental|investigational,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antirheumatic Agents|Benzene Derivatives|Benzoates|Blood and Blood Forming Organs|Central Nervous System Agents|Hydroxy Acids|Hydroxybenzoates|Nephrotoxic agents|Nervous System|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Phenols|Platelet Aggregation Inhibitors Excl. Heparin|Salicylates|Salicylic Acid and Derivatives|Sensory System Agents",[Ca++].NC(N)=O.CC(=O)OC1=CC=CC=C1C([O-])=O.CC(=O)OC1=CC=CC=C1C([O-])=O,
11552,DB13613,Ticlatone,small molecule,experimental,Antifungals for Dermatological Use|Antifungals for Topical Use|Dermatologicals|Sulfur Compounds,ClC1=CC2=C(C=C1)C(=O)NS2,
11553,DB13614,Metizoline,small molecule,experimental,"Nasal Preparations|Sympathomimetics, Plain",CC1=C(CC2=NCCN2)C2=CC=CC=C2S1,
11554,DB13615,Mifamurtide,small molecule,approved|experimental,"Acids, Acyclic|Adjuvants, Immunologic|Alcohols|Amino Acids, Peptides, and Proteins|Amino Sugars|Antineoplastic and Immunomodulating Agents|Carbohydrates|Glycerophosphates|Glycerophospholipids|Glycoconjugates|Glycopeptides|Hydroxy Acids|Immunologic Factors|Lipids|Membrane Lipids|Muramic Acids|Peptides|Phosphatidic Acids|Phospholipids|Sugar Acids|Sugar Alcohols|Sugar Phosphates|Triose Sugar Alcohols",O.[Na+].CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCCNC(=O)[C@H](C)NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@@H]([C@H](O)[C@H](O)CO)[C@@H](NC(C)=O)C=O)C(N)=O)OC(=O)CCCCCCCCCCCCCCC,
11555,DB13616,Melagatran,small molecule,experimental,Amines|Anticoagulants|Antithrombins|Azetines|Benzene Derivatives|Benzyl Compounds|Blood and Blood Forming Organs|Enzyme Inhibitors|Hematologic Agents|Protease Inhibitors|Serine Protease Inhibitors,[H][C@]1(CCN1C(=O)[C@H](NCC(O)=O)C1CCCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N,
11556,DB13617,Clorexolone,small molecule,experimental,"Amides|Diuretics|Heterocyclic Compounds, Fused-Ring|Low-Ceiling Diuretics, Excl. Thiazides|Sulfonamides|Sulfones|Sulfur Compounds",NS(=O)(=O)C1=C(Cl)C=C2CN(C3CCCCC3)C(=O)C2=C1,
11557,DB13618,Ipriflavone,small molecule,experimental,"Benzopyrans|Bone Remodeling|Chromones|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Flavonoids|Heterocyclic Compounds, Fused-Ring|Musculo-Skeletal System|Pyrans",CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C1=CC=CC=C1,
11558,DB13619,Bornaprine,small molecule,experimental,Agents producing tachycardia|Anti-Parkinson Drugs|Anticholinergic Agents|Cholinergic Agents|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|Tertiary Amines,CCN(CC)CCCOC(=O)C1(C[C@@H]2CC[C@H]1C2)C1=CC=CC=C1,
11559,DB13620,Potassium gluconate,small molecule,approved,Alimentary Tract and Metabolism|Mineral Supplements|Potassium Salt,[K+].[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O,16760467
11560,DB13621,Tetragalacturonic acid hydroxymethylester,small molecule,experimental,Blood and Blood Forming Organs|Hemostatics|Local Hemostatics,OCOC(=O)[C@H]1O[C@H](O[C@@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@H]3[C@H](O)[C@@H](O)[C@@H](O[C@@H]4[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]4C(=O)OCO)O[C@@H]3C(=O)OCO)O[C@@H]2C(=O)OCO)[C@H](O)[C@@H](O)[C@H]1O,
11561,DB13622,Selenium (75Se) norcholesterol,small molecule,experimental,Diagnostic Radiopharmaceuticals|Selenium Compounds|Various Diagnostic Radiopharmaceuticals,C[75Se]C[C@@H]1C[C@H]2[C@@H]3CC[C@H]([C@H](C)CCCC(C)C)[C@@]3(C)CC[C@@H]2C2=C1C[C@@H](O)CC2,
11562,DB13623,Fabomotizole,small molecule,experimental,Anti-Anxiety Agents|Central Nervous System Depressants|Nervous System|Psycholeptics,CCOC1=CC=C2NC(SCCN3CCOCC3)=NC2=C1,
11563,DB13624,Methoxyphenamine,small molecule,approved,Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Drugs for Obstructive Airway Diseases|Ethylamines|Neurotransmitter Agents|Non-selective Beta-adrenergic Agonists|Phenethylamines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetics,CNC(C)CC1=CC=CC=C1OC,
11564,DB13625,Carbuterol,small molecule,experimental,"Adrenergics for Systemic Use|Adrenergics, Inhalants|Alcohols|Amines|Amino Alcohols|Drugs for Obstructive Airway Diseases|Selective Beta 2-adrenergic Agonists",CC(C)(C)NCC(O)C1=CC(NC(N)=O)=C(O)C=C1,
11565,DB13626,Aluminium glycinate,small molecule,experimental,"Alimentary Tract and Metabolism|Alkalies|Aluminium Compounds|Aluminum and magnesium containing antacids|Amino Acids|Amino Acids, Peptides, and Proteins|Anions|Antacids|Drugs for Acid Related Disorders|Electrolytes|Gastric Acid Lowering Agents|Hydroxides|Ions|Metal cations|Metal divalent cations",O.[OH-].[OH-].[Al+3].NCC([O-])=O,
11566,DB13627,Oxolinic acid,small molecule,experimental,"4-Quinolones|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antineoplastic Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones|Renal Agents|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",CCN1C=C(C(O)=O)C(=O)C2=CC3=C(OCO3)C=C12,
11567,DB13628,Ethyl hydroxybenzoate,small molecule,approved|experimental,"Acids, Carbocyclic|Antifungals for Dermatological Use|Antifungals for Topical Use|Benzene Derivatives|Benzoates|Cell-mediated Immunity|Dermatologicals|Hydroxy Acids|Hydroxybenzoates|Increased Histamine Release|Phenols|Standardized Chemical Allergen",CCOC(=O)C1=CC=C(O)C=C1,
11568,DB13629,Mofebutazone,small molecule,experimental,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antirheumatic Agents|Butylpyrazolidines|Central Nervous System Agents|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Pyrazoles|Pyrazolones|Sensory System Agents|Topical Products for Joint and Muscular Pain",CCCCC1C(=O)NN(C1=O)C1=CC=CC=C1,
11569,DB13630,Bibenzonium,small molecule,experimental,Cough and Cold Preparations,C[N+](C)(C)CCOC(CC1=CC=CC=C1)C1=CC=CC=C1,
11570,DB13631,Methoserpidine,small molecule,experimental,"Antiadrenergic Agents, Centrally Acting|Antihypertensive Agents|Secologanin Tryptamine Alkaloids",CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=CC=C(OC)C=C45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C1=CC(OC)=C(OC)C(OC)=C1,
11571,DB13632,Protiofate,small molecule,experimental,Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics,CCCOC(=O)C1=C(O)C(O)=C(S1)C(=O)OCCC,
11572,DB13633,Mepartricin,small molecule,experimental,"Alimentary Tract and Metabolism|Alkenes|Anti-Bacterial Agents|Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Antiinfectives and Antiseptics for Local Oral Treatment|Antiparasitic Agents|Antiprotozoals|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Drugs Used in Benign Prostatic Hypertrophy|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hydrocarbons, Acyclic|Lactones|Macrolides|Polyenes|Polyketides|Stomatological Preparations|Urological Agents|Urologicals",,
11573,DB13634,Pentifylline,small molecule,experimental,"Alkaloids|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Peripheral Vasodilators|Purine Derivatives|Purines|Purinones|Xanthine derivatives",CCCCCCN1C(=O)N(C)C2=C(N(C)C=N2)C1=O,
11574,DB13635,Tiracizine,small molecule,experimental,"Antiarrhythmic agents|Cardiac Therapy|Cardiovascular Agents|Central Nervous System Agents|Heterocyclic Compounds, Fused-Ring",CCOC(=O)NC1=CC2=C(CCC3=CC=CC=C3N2C(=O)CN(C)C)C=C1,
11575,DB13636,Etanautine,small molecule,experimental,"Agents producing tachycardia|Anti-Parkinson Drugs|Anticholinergic Agents|Ethers, Chemically Close to Antihistamines|Muscarinic Antagonists|Nervous System",CN1C2=C(N(CC(O)=O)C=N2)C(=O)N(C)C1=O.CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1,
11576,DB13637,Tenitramine,small molecule,experimental,Amines|Antianginal Agents|Cardiac Therapy|Diamines|Organic Nitrates|Polyamines|Vasodilating Agents|Vasodilators Used in Cardiac Diseases,[O-][N+](=O)OCCN(CCO[N+]([O-])=O)CCN(CCO[N+]([O-])=O)CCO[N+]([O-])=O,
11577,DB13638,Cefbuperazone,small molecule,experimental,"Amides|Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Second-Generation Cephalosporins|Sulfur Compounds|Thiazines",CCN1CCN(C(=O)N[C@H]([C@H](C)O)C(=O)N[C@@]2(OC)[C@H]3SCC(CSC4=NN=NN4C)=C(N3C2=O)C(O)=O)C(=O)C1=O,
11578,DB13639,Ferrous tartrate,small molecule,experimental,"Antianemic Preparations|Blood and Blood Forming Organs|Iron Bivalent, Oral Preparations|Iron Preparations",[Fe++].O[C@H]([C@@H](O)C([O-])=O)C([O-])=O,
11579,DB13640,Acetoxolone,small molecule,experimental,Alimentary Tract and Metabolism|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Pentacyclic Triterpenes|Terpenes|Triterpenes,CC(=O)O[C@H]1CC[C@@]2(C)[C@@H](CC[C@]3(C)[C@@H]2C(=O)C=C2[C@@H]4C[C@](C)(CC[C@]4(C)CC[C@@]32C)C(O)=O)C1(C)C,
11580,DB13641,Metisazone,small molecule,experimental,"Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Direct Acting Antivirals|Heterocyclic Compounds, Fused-Ring|Indoles|Semicarbazides|Semicarbazones|Sulfur Compounds|Thiosemicarbazones",CN1C(=O)\C(=N/NC(N)=S)C2=C1C=CC=C2,
11581,DB13642,Pridinol,small molecule,experimental,"Central Nervous System Depressants|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System",OC(CCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1,
11582,DB13643,Loprazolam,small molecule,experimental,"Anti-Anxiety Agents|Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Hypnotics and Sedatives|Nervous System|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents",[H]\C(N1CCN(C)CC1)=C1\N=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(=C3)N(=O)=O)N2C1=O,3033860
11583,DB13644,Methylthiouracil,small molecule,experimental,"Antithyroid agents|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Pyrimidines|Pyrimidinones|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thiouracil|Thiouracils|Thyroid Products",CC1=CC(=O)NC(=S)N1,
11584,DB13645,Ethacizine,small molecule,experimental,"Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ic|Cardiac Therapy|Cardiovascular Agents|Central Nervous System Agents|Heterocyclic Compounds, Fused-Ring|Sulfur Compounds",CCOC(=O)NC1=CC2=C(SC3=CC=CC=C3N2C(=O)CCN(CC)CC)C=C1,
11586,DB13647,Semustine,small molecule,experimental|investigational,"Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Nitroso Compounds|Nitrosourea Compounds|Nitrosoureas|Noxae|Toxic Actions",,
11587,DB13648,Alcuronium,small molecule,experimental,"Adjuvants, Anesthesia|Alkaloids|Amines|Ammonium Compounds|Anticholinergic Agents|Benzylisoquinolines|Central Nervous System Agents|Central Nervous System Depressants|Cholinergic Agents|Curare Alkaloids|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular-Blocking Agents (Nondepolarizing)|Neurotransmitter Agents|Nicotinic Antagonists|Nitrogen Compounds|Onium Compounds|Peripheral Nervous System Agents|Quaternary Ammonium Compounds|Tetrahydroisoquinolines|Toxiferine",[H][C@@]12C[C@@]3([H])\C(C[N@+]1(CC=C)CC[C@@]21C2=C(C=CC=C2)N2\C=C4/[C@]5([H])N(\C=C3/[C@@]12[H])C1=C(C=CC=C1)[C@@]51CC[N@@+]2(CC=C)C\C(=C\CO)[C@]4([H])C[C@@]12[H])=C/CO,
11588,DB13649,Proquazone,small molecule,experimental,"Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Sensory System Agents",CC(C)N1C(=O)N=C(C2=CC=CC=C2)C2=CC=C(C)C=C12,
11589,DB13650,Aloglutamol,small molecule,experimental,Alcohols|Alimentary Tract and Metabolism|Alkalies|Aluminium Compounds|Aluminum and magnesium containing antacids|Anions|Antacids|Drugs for Acid Related Disorders|Electrolytes|Gastric Acid Lowering Agents|Glycols|Hydroxides|Ions|Metal cations|Metal divalent cations|Propylene Glycols,NC(CO)(CO)CO.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)O[Al](O)O,
11590,DB13651,Lorajmine,small molecule,experimental,"Alkaloids|Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ia|Cardiac Therapy|Cardiovascular Agents|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Secologanin Tryptamine Alkaloids",CC[C@@H]1[C@@H](O)N2[C@H]3C[C@]45[C@H](OC(=O)CCl)[C@H]3[C@H]1C[C@H]2[C@@H]4N(C)C1=CC=CC=C51,
11591,DB13652,Bunaftine,small molecule,experimental,"Antiarrhythmic agents|Antiarrhythmics, Class III|Cardiac Therapy|Cardiovascular Agents|Moderate Risk QTc-Prolonging Agents|Naphthalenes|QTc Prolonging Agents",CCCCN(CCN(CC)CC)C(=O)C1=C2C=CC=CC2=CC=C1,
11592,DB13653,Lorcainide,small molecule,experimental,"Acetamides|Acetates|Acids, Acyclic|Amides|Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ic|Benzene Derivatives|Cardiac Therapy|Cardiovascular Agents|Fatty Acids|Fatty Acids, Volatile|Lipids|Moderate Risk QTc-Prolonging Agents|QTc Prolonging Agents",CC(C)N1CCC(CC1)N(C(=O)CC1=CC=CC=C1)C1=CC=C(Cl)C=C1,
11593,DB13654,Montmorillonite,small molecule,experimental|investigational,"Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Aluminium Compounds|Aluminum Silicates|Anions|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antidotes|Compounds used in a research, industrial, or household setting|Electrolytes|Intestinal Adsorbents|Ions|Metal cations|Metal divalent cations|Minerals|Oxides|Oxygen Compounds|Protective Agents|Silicates|Silicon Compounds",O.[O--].[O--].[O--].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O,
11594,DB13655,Nikethamide,small molecule,experimental,Central Nervous System Agents|Central Nervous System Stimulants|Convulsants|Nicotinic Acids|Pyridines|Respiratory System Agents|Vitamin B Complex|Vitamins,CCN(CC)C(=O)C1=CN=CC=C1,
11595,DB13656,Eberconazole,small molecule,experimental,Antifungals for Dermatological Use|Antifungals for Topical Use|Cycloparaffins|Dermatologicals|Imidazole and Triazole Derivatives,ClC1=CC(Cl)=C2C(N3C=CN=C3)C3=CC=CC=C3CCC2=C1,
11596,DB13657,Benorilate,small molecule,approved,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Amides|Amines|Analgesics|Analgesics, Non-Narcotic|Anilides|Aniline Compounds|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antirheumatic Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Hydroxy Acids|Hydroxybenzoates|Nephrotoxic agents|Nervous System|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Phenols|Salicylic Acid and Derivatives|Sensory System Agents",CC(=O)NC1=CC=C(OC(=O)C2=CC=CC=C2OC(C)=O)C=C1,
11597,DB13658,Hemoglobin raffimer,small molecule,experimental|investigational,Blood and Blood Forming Organs|Blood and Related Products|Blood Substitutes and Perfusion Solutions|Blood Substitutes and Plasma Protein Fractions,,
11598,DB13659,Tenonitrozole,small molecule,experimental,"Antiparasitic Products, Insecticides and Repellents|Antiprotozoals",O=C(NC1=NC=C(S1)N(=O)=O)C1=CC=CS1,
11599,DB13660,Propicillin,small molecule,experimental,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|Beta-Lactamase Sensitive Penicillins|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Penicillins|Sulfur Compounds",[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C(CC)OC1=CC=CC=C1)C(O)=O,
11600,DB13661,Niridazole,small molecule,experimental,"Amebicides|Anthelmintics|Anti-Infective Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiplatyhelmintic Agents|Antiprotozoals|Antitrematodals|Imidazoles|Schistosomicides|Sulfur Compounds|Thiazoles",[O-][N+](=O)C1=CN=C(S1)N1CCNC1=O,
11601,DB13662,Hexapropymate,small molecule,experimental,"Acids, Acyclic|Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Psycholeptics",NC(=O)OC1(CC#C)CCCCC1,
11602,DB13663,Clofenamide,small molecule,experimental,"Diuretics|Low-Ceiling Diuretics, Excl. Thiazides|Sulfonamides",NS(=O)(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O,
11603,DB13664,Formocortal,small molecule,experimental,Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Immunosuppressive Agents|Ophthalmologicals|Sensory Organs,CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3CC(C=O)=C4C=C(CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]21C)OCCCl,
11604,DB13665,Fluanisone,small molecule,experimental,Antipsychotic Agents|Butyrophenone Derivatives|Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives|Ketones|Nervous System|Neurotoxic agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents,COC1=CC=CC=C1N1CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1,
11605,DB13666,Tiemonium iodide,small molecule,experimental,"Agents producing tachycardia|Alimentary Tract and Metabolism|Anticholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Oxazines|Synthetic Anticholinergics, Quaternary Ammonium Compounds",[I-].C[N+]1(CCC(O)(C2=CC=CS2)C2=CC=CC=C2)CCOCC1,
11606,DB13667,Cefozopran,small molecule,experimental,"Amides|Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|Fourth-Generation Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines",[H][C@]12SCC(C[N+]3=C4C=CC=NN4C=C3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=NSC(N)=N1)C([O-])=O,
11607,DB13668,Ipidacrine,small molecule,experimental,"Anti-Dementia Drugs|Cholinesterase Inhibitors|Heterocyclic Compounds, Fused-Ring|Nervous System|Psychoanaleptics|Quinolines",NC1=C2CCCC2=NC2=C1CCCC2,
11608,DB13669,Morpholine,small molecule,experimental,Analgesics|Nervous System|Oxazines|Salicylic Acid and Derivatives,C1COCCN1,
11609,DB13670,Oxantel,small molecule,experimental,"Anthelmintics|Anti-Infective Agents|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Pyrimidines|Sulfur Compounds|Tetrahydropyrimidine Derivatives|Thiophenes",CN1CCCN=C1\C=C\C1=CC=CC(O)=C1,
11610,DB13671,Sulbentine,small molecule,experimental,Antifungals for Dermatological Use|Antifungals for Topical Use|Dermatologicals,S=C1SCN(CC2=CC=CC=C2)CN1CC1=CC=CC=C1,
11611,DB13672,Dimethylaminopropionylphenothiazine,small molecule,experimental,"Alimentary Tract and Metabolism|Drugs for Functional Gastrointestinal Disorders|Synthetic Antispasmodics, Amides With Tertiary Amines",CC(N(C)C)C(=O)N1C2=CC=CC=C2SC2=CC=CC=C12,
11612,DB13673,Bekanamycin,small molecule,experimental,Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Carbohydrates|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Glycosides|Narrow Therapeutic Index Drugs|Nephrotoxic agents,[H][C@]1(N)C[C@@]([H])(N)[C@]([H])(O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(N)[C@@]2([H])O)[C@@]([H])(O)[C@]1([H])O[C@@]1([H])O[C@]([H])(CN)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])N,
11613,DB13674,Cridanimod,small molecule,experimental,"Adjuvants, Immunologic|Antineoplastic and Immunomodulating Agents|Heterocyclic Compounds, Fused-Ring|Immunologic Factors|Interferon Inducers",OC(=O)CN1C2=CC=CC=C2C(=O)C2=CC=CC=C12,
11614,DB13675,Metahexamide,small molecule,experimental,Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Substrates|Drugs Used in Diabetes|Sulfones|Sulfonylureas|Sulfur Compounds,CC1=CC=C(C=C1N)S(=O)(=O)NC(=O)NC1CCCCC1,
11615,DB13676,Mosapramine,small molecule,experimental,"Antipsychotic Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotoxic agents|Psycholeptics",ClC1=CC2=C(CCC3=CC=CC=C3N2CCCN2CCC3(CC2)N2CCCCC2NC3=O)C=C1,
11616,DB13677,Carboquone,small molecule,experimental,"Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Aziridines|Azirines|Benzoquinones|Ethylene Imines|Noxae|Quinones|Toxic Actions",COC(COC(N)=O)C1=C(N2CC2)C(=O)C(C)=C(N2CC2)C1=O,
11617,DB13678,Dihexyverine,small molecule,experimental,"Agents producing tachycardia|Alimentary Tract and Metabolism|Anticholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Synthetic Anticholinergics, Esters With Tertiary Amino Group",O=C(OCCN1CCCCC1)C1(CCCCC1)C1CCCCC1,
11618,DB13679,Dexchlorpheniramine,small molecule,experimental|investigational,Agents that reduce seizure threshold|Antihistamines for Systemic Use|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|Pyridines|QTc Prolonging Agents|Stereoisomerism|Substituted Alkylamines,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1,33036
11619,DB13680,Naftazone,small molecule,approved,Capillary Stabilizing Agents|Coagulants|Hematologic Agents|Hemostatics|Naphthalenes|Quinones|Vasoprotectives,NC(=O)N\N=C1/C=CC2=CC=CC=C2C1=O,
11620,DB13681,Butalamine,small molecule,experimental,Cardiovascular Agents|Oxazoles|Peripheral Vasodilators|Vasodilating Agents,CCCCN(CCCC)CCNC1=NC(=NO1)C1=CC=CC=C1,
11621,DB13682,Cefpirome,small molecule,approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|Fourth-Generation Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines",[H][C@]12SCC(C[N+]3=C4CCCC4=CC=C3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C([O-])=O,
11622,DB13683,Quinisocaine,small molecule,experimental,"Anesthetics|Anesthetics for Topical Use|Anesthetics, Local|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Central Nervous System Agents|Dermatologicals|Heterocyclic Compounds, Fused-Ring|Peripheral Nervous System Agents|Sensory System Agents",CCCCC1=CC2=CC=CC=C2C(OCCN(C)C)=N1,
11623,DB13684,Omoconazole,small molecule,experimental,Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Azole Antifungals|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Imidazole and Triazole Derivatives|Imidazole Derivatives,C\C(N1C=CN=C1)=C(\OCCOC1=CC=C(Cl)C=C1)C1=C(Cl)C=C(Cl)C=C1,
11624,DB13685,Quingestanol,small molecule,experimental,"Adrenal Cortex Hormones|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Postcoital|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Norpregnanes|Norsteroids|Progestin Contraceptives|Progestins|Sex Hormones and Modulators of the Genital System|Steroids",C[C@]12CC[C@H]3[C@@H](CC=C4C=C(CC[C@H]34)OC3CCCC3)[C@@H]1CC[C@@]2(O)C#C,
11625,DB13686,Clometocillin,small molecule,experimental,Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|Beta-Lactamase Sensitive Penicillins|beta-Lactams|Penicillins,COC(C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)C1=CC=C(Cl)C(Cl)=C1,
11626,DB13687,Niaprazine,small molecule,experimental,Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Nicotinic Acids|Psycholeptics|Pyridines,CC(CCN1CCN(CC1)C1=CC=C(F)C=C1)NC(=O)C1=CN=CC=C1,
11627,DB13688,Drisapersen,small molecule,experimental|investigational,"Carbohydrates|Glycosides|Musculo-Skeletal System|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Polynucleotides",,
11628,DB13689,Tacalcitol,small molecule,experimental|investigational,Anti-Inflammatory Agents|Antipsoriatics|Antipsoriatics for Topical Use|Cholestanes|Cholestenes|Dermatologicals|Fused-Ring Compounds|Lipids|Membrane Lipids|Ointments|Psoriasis|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble),CC(C)[C@H](O)CC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C,
11629,DB13690,Vinyl ether,small molecule,experimental,"Alkenes|Anesthetics|Anesthetics, General|Central Nervous System Agents|Central Nervous System Depressants|Ethers|Hydrocarbons, Acyclic|Nervous System",C=COC=C,
11630,DB13691,Acetyldigoxin,small molecule,experimental,"Antiarrhythmic agents|Cardiac Glycosides|Cardiac Therapy|Compounds used in a research, industrial, or household setting|Digitalis Glycosides|Digoxin and derivatives|Glycosides|Potential QTc-Prolonging Agents|QTc Prolonging Agents",C[C@H]1O[C@H](C[C@H](OC(C)=O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@H](CC[C@@H]5[C@@H]4C[C@@H](O)[C@]4(C)[C@H](CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C,
11631,DB13692,Tretoquinol,small molecule,experimental,"Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Alkaloids|Anti-Asthmatic Agents|Autonomic Agents|Benzylisoquinolines|Bronchodilator Agents|Drugs for Obstructive Airway Diseases|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Neurotransmitter Agents|Peripheral Nervous System Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists|Sympathomimetics",COC1=CC(C[C@@H]2NCCC3=CC(O)=C(O)C=C23)=CC(OC)=C1OC,
11632,DB13693,Sulbenicillin,small molecule,experimental,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Penicillin G|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds",CC1(C)S[C@@H]2[C@H](NC(=O)[C@@H](C3=CC=CC=C3)S(O)(=O)=O)C(=O)N2[C@H]1C(O)=O,
11633,DB13694,Distigmine,small molecule,experimental,Cholinergic Agents|Cholinesterase Inhibitors|Enzyme Inhibitors|Nervous System|Neurotransmitter Agents|Parasympathomimetics|Pyridines,CN(CCCCCCN(C)C(=O)OC1=C[N+](C)=CC=C1)C(=O)OC1=C[N+](C)=CC=C1,3116
11634,DB13695,Penthienate,small molecule,experimental,"Agents producing tachycardia|Alimentary Tract and Metabolism|Amines|Ammonium Compounds|Anticholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Nitrogen Compounds|Onium Compounds|Synthetic Anticholinergics, Quaternary Ammonium Compounds",CC[N+](C)(CC)CCOC(=O)C(O)(C1CCCC1)C1=CC=CS1,
11635,DB13696,Bromochlorosalicylanilide,small molecule,experimental,Antifungals for Dermatological Use|Antifungals for Topical Use|Dermatologicals,OC1=CC=C(Br)C=C1C(=O)NC1=CC=C(Cl)C=C1,
11636,DB13697,Ambazone,small molecule,experimental,"Amidines|Anti-Infective Agents, Local|Guanidines|Throat Preparations",NC(=N)NN=C1C=CC(C=C1)=NNC(N)=S,
11637,DB13698,Ferrous carbonate,small molecule,experimental,"Antianemic Preparations|Blood and Blood Forming Organs|Iron Bivalent, Oral Preparations|Iron Preparations",[Fe++].[O-]C([O-])=O,
11638,DB13699,Sulfathiourea,small molecule,experimental,Amides|Amines|Aniline Compounds|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Short-Acting Sulfonamides|Sulfonamides|SULFONAMIDES AND TRIMETHOPRIM|Sulfones|Sulfur Compounds,NC(=S)NS(=O)(=O)C1=CC=C(N)C=C1,
11639,DB13700,Protamine,small molecule,experimental|investigational,Antidotes|Heparin Binding Activity|Heparin Reversal Agent|Reversed Anticoagulation Activity,,
11640,DB13701,Ioglicic acid,small molecule,experimental,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Contrast Media|Iodobenzoates|Triiodobenzoic Acids|Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media|X-Ray Contrast Media, Iodinated",CNC(=O)CNC(=O)C1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I,
11641,DB13702,Tibezonium iodide,small molecule,experimental,Alimentary Tract and Metabolism|Antiinfectives and Antiseptics for Local Oral Treatment|Stomatological Preparations,[I-].CC[N+](C)(CC)CCSC1=NC2=CC=CC=C2N=C(C1)C1=CC=C(SC2=CC=CC=C2)C=C1,
11642,DB13703,Gepefrine,small molecule,experimental,Adrenergic and Dopaminergic Agents|Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Ethylamines|Phenethylamines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetics,[H][C@@](C)(N)CC1=CC(O)=CC=C1,
11643,DB13704,Pristinamycin,small molecule,experimental|investigational,"Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Macrolides, Lincosamides and Streptogramins|Peptides|Peptides, Cyclic|Streptogramins",,
11644,DB13705,Decamethoxine,small molecule,experimental,"Amines|Ammonium Compounds|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Bis-Trimethylammonium Compounds|Dermatologicals|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds",[Cl-].[Cl-].CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C[N+](C)(C)CCCCCCCCCC[N+](C)(C)CC(=O)O[C@@H]1C[C@H](C)CC[C@H]1C(C)C,
11645,DB13706,Eosin,small molecule,experimental,"Antiseptics and Disinfectants|Coloring Agents|Compounds used in a research, industrial, or household setting|Dermatologicals|Fluoresceins|Fluorescent Dyes|Heterocyclic Compounds, Fused-Ring|Indicators and Reagents|Laboratory Chemicals|Luminescent Agents|Spiro Compounds|Xanthenes",[Na+].[Na+].[O-]C(=O)C1=C(C=CC=C1)C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C1C=C(Br)C([O-])=C2Br,
11646,DB13707,Sodium tartrate,small molecule,approved,"Acids, Acyclic|Alimentary Tract and Metabolism|Carbohydrates|Dicarboxylic Acids|Drugs for Constipation|Hydroxy Acids|Laxatives|Osmotic Laxatives|Sugar Acids",[Na+].[Na+].O[C@H]([C@@H](O)C([O-])=O)C([O-])=O,162637
11647,DB13708,Fenquizone,small molecule,experimental,"Cardiovascular Agents|Diuretics|Heterocyclic Compounds, Fused-Ring|Low-Ceiling Diuretics, Excl. Thiazides|Natriuretic Agents|Sulfonamides",NS(=O)(=O)C1=C(Cl)C=C2NC(NC(=O)C2=C1)C1=CC=CC=C1,
11648,DB13709,Ciclonicate,small molecule,experimental,Nicotinic Acid and Derivatives|Peripheral Vasodilators|Pyridines,C[C@@H]1C[C@H](CC(C)(C)C1)OC(=O)C1=CC=CN=C1,
11649,DB13710,Metenolone,small molecule,experimental,"Alimentary Tract and Metabolism|Anabolic Agents|Anabolic Agents for Systemic Use|Anabolic Steroids|Androstan Derivatives|Androstanes|Androstenes|Androstenols|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone Congeners",[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])CC(=O)C=C(C)[C@]4(C)[C@@]3([H])CC[C@]12C,
11650,DB13711,Tritoqualine,small molecule,approved,"Antihistamines for Systemic Use|Cholagogues and Choleretics|Heterocyclic Compounds, Fused-Ring|Histamine Agents|Histamine Antagonists|Neurotransmitter Agents",CCOC1=C(OCC)C(OCC)=C(N)C2=C1C(OC2=O)C1N(C)CCC2=CC3=C(OCO3)C(OC)=C12,
11651,DB13712,Dixanthogen,small molecule,experimental,"Acids|Acids, Noncarboxylic|Anions|Antiparasitic Products, Insecticides and Repellents|Ectoparasiticides, Incl. Scabicides|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Electrolytes|Gases|Hydrogen Sulfide|Ions|Sulfides|Sulfur Compounds|Sulfur Containing Products",CCOC(=S)SSC(=S)OCC,
11652,DB13713,Quifenadine,small molecule,experimental,Antihistamines for Systemic Use|Benzene Derivatives|Histamine Agents|Histamine Antagonists|Neurotransmitter Agents,OC(C1CN2CCC1CC2)(C1=CC=CC=C1)C1=CC=CC=C1,
11653,DB13714,Xibornol,small molecule,experimental,Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Monoterpenes|Norbornanes|Terpenes,CC1=CC(O)=C(C=C1C)[C@H]1C[C@@H]2CC[C@@]1(C)C2(C)C,
11654,DB13715,Dilazep,small molecule,experimental,Azepines|Cardiac Therapy|Cardiovascular Agents|Vasodilating Agents|Vasodilators Used in Cardiac Diseases,COC1=CC(=CC(OC)=C1OC)C(=O)OCCCN1CCCN(CCCOC(=O)C2=CC(OC)=C(OC)C(OC)=C2)CC1,
11655,DB13716,Dibutylphthalate,small molecule,experimental,"Acids, Carbocyclic|Antiparasitic Products, Insecticides and Repellents|Compounds used in a research, industrial, or household setting|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Insecticides and Repellents|Phthalic Acids|Plasticizers",CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC,
11656,DB13717,Phenothrin,small molecule,experimental,"Agrochemicals|Antiparasitic Products, Insecticides and Repellents|Compounds used in a research, industrial, or household setting|Ectoparasiticides, Incl. Scabicides|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Insecticides|Monoterpenes|Pesticides|Pyrethrines, Incl. Synthetic Compounds|Terpenes|Toxic Actions",CC(C)=CC1C(C(=O)OCC2=CC=CC(OC3=CC=CC=C3)=C2)C1(C)C,
11657,DB13718,Hydroquinine,small molecule,experimental,"Alkaloids|Antiarrhythmic agents|Autonomic Agents|Cardiovascular Agents|Cinchona Alkaloids|Heterocyclic Compounds, Fused-Ring|Musculo-Skeletal System|Parasympatholytics|Peripheral Nervous System Agents|Quinolines|Quinuclidines",CC[C@H]1C[N@@]2CC[C@H]1C[C@H]2[C@H](O)C1=C2C=C(OC)C=CC2=NC=C1,
11658,DB13719,Trolnitrate,small molecule,experimental,"Acids|Acids, Noncarboxylic|Alcohols|Amines|Amino Alcohols|Anions|Antianginal Agents|Cardiac Therapy|Electrolytes|Ions|Nitric Acid|Nitrogen Compounds|Organic Nitrates|Vasodilating Agents|Vasodilators Used in Cardiac Diseases",O=N(=O)OCCN(CCON(=O)=O)CCON(=O)=O,
11659,DB13720,Diphemanil,small molecule,approved|vet_approved|withdrawn,"Agents producing tachycardia|Alimentary Tract and Metabolism|Anti-Asthmatic Agents|Anticholinergic Agents|Autonomic Agents|Bronchodilator Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Parasympatholytics|Peripheral Nervous System Agents|Respiratory System Agents|Synthetic Anticholinergics, Quaternary Ammonium Compounds",C[N+]1(C)CCC(CC1)=C(C1=CC=CC=C1)C1=CC=CC=C1,
11660,DB13721,Cypermethrin,small molecule,experimental,"Agrochemicals|Antiparasitic Products, Insecticides and Repellents|Compounds used in a research, industrial, or household setting|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Insecticides|Insecticides and Repellents|Monoterpenes|Pesticides|Pyrethrines|Terpenes|Toxic Actions",CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=CC(OC2=CC=CC=C2)=C1,
11661,DB13722,Pirprofen,small molecule,experimental,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Propionates|Sensory System Agents",CC(C(O)=O)C1=CC(Cl)=C(C=C1)N1CC=CC1,
11662,DB13723,Meldonium,small molecule,experimental,"Adjuvants, Immunologic|Cardiac Therapy|Cardiovascular Agents|Hydrazines|Immunologic Factors",C[N+](C)(C)NCCC([O-])=O,
11663,DB13724,Nifuratel,small molecule,experimental,Anti-Infective Agents|Antifungal Agents|Antiparasitic Agents|Antiprotozoals|Antitrichomonal Agents|Furans|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Nitro Compounds|Nitrofurans|Oxazoles|Oxazolidinones,CSCC1CN(\N=C\C2=CC=C(O2)[N+]([O-])=O)C(=O)O1,
11664,DB13725,Terodiline,small molecule,experimental,"Agents causing hyperkalemia|Alkanes|Amines|Antiarrhythmic agents|Autonomic Agents|Bradycardia-Causing Agents|Butanes|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs for Urinary Frequency and Incontinence|Genito Urinary System and Sex Hormones|Highest Risk QTc-Prolonging Agents|Hydrocarbons, Acyclic|Membrane Transport Modulators|Parasympatholytics|Peripheral Nervous System Agents|QTc Prolonging Agents|Urologicals|Vasodilating Agents",CC(CC(C1=CC=CC=C1)C1=CC=CC=C1)NC(C)(C)C,
11665,DB13726,Sulfaguanidine,small molecule,experimental,"Alimentary Tract and Metabolism|Amides|Amidines|Amines|Aniline Compounds|Anti-Infective Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Guanidines|Intestinal Antiinfectives|Sulfanilamides|Sulfonamides|Sulfones|Sulfur Compounds",NC(=N)NS(=O)(=O)C1=CC=C(N)C=C1,
11666,DB13727,Azapetine,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Peripheral Vasodilators",C=CCN1CC2=CC=CC=C2C2=CC=CC=C2C1,
11667,DB13728,Halometasone,small molecule,experimental,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Dermatologicals|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated",C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C(Cl)=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,
11668,DB13729,Camostat,small molecule,experimental,Amidines|Antifibrinolytic Agents|Blood and Blood Forming Organs|Enzyme Inhibitors|Guanidines|Hemostatics|Protease Inhibitors|Proteinase Inhibitors|Serine Protease Inhibitors|Trypsin Inhibitors,CN(C)C(=O)COC(=O)CC1=CC=C(OC(=O)C2=CC=C(NC(N)=N)C=C2)C=C1,
11669,DB13730,Nifurtoinol,small molecule,experimental,"Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Furans|Nitro Compounds|Nitrofuran Derivatives|Nitrofurans|Renal Agents",OCN1C(=O)CN(\N=C\C2=CC=C(O2)[N+]([O-])=O)C1=O,
11670,DB13731,Butamirate,small molecule,experimental,"Acids, Carbocyclic|Cough and Cold Preparations",CCC(C(=O)OCCOCCN(CC)CC)C1=CC=CC=C1,
11671,DB13732,Meglumine antimoniate,small molecule,experimental|investigational,"Agents Against Leishmaniasis and Trypanosomiasis|Alcohols|Amino Sugars|Anti-Infective Agents|Antimony Compounds|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Carbohydrates|Hexosamines|Sugar Alcohols",O[Sb](=O)=O.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,
11672,DB13733,Methylpentynol,small molecule,experimental,Alcohols|Central Nervous System Depressants|Fatty Alcohols|Hypnotics and Sedatives|Lipids|Nervous System|Psycholeptics,CCC(C)(O)C#C,
11673,DB13734,Biphenylol,small molecule,experimental,Antiseptics and Disinfectants|Dermatologicals|Phenol and Derivatives,,
11674,DB13735,Potassium Guaiacolsulfonate,small molecule,experimental,Benzene Derivatives|Catechols|Ethers|Methyl Ethers|Phenols|Phenyl Ethers|Potassium Salt,,
11675,DB13736,Fenoxazoline,small molecule,experimental,"Nasal Preparations|Sympathomimetics, Plain",CC(C)C1=CC=CC=C1OCC1=NCCN1,
11676,DB13737,Cyclobarbital,small molecule,experimental,"Barbiturates, Plain|Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Psycholeptics|Pyrimidines|Pyrimidinones",CCC1(C(=O)NC(=O)NC1=O)C1=CCCCC1,
11677,DB13738,Camylofin,small molecule,experimental,"Agents producing tachycardia|Alimentary Tract and Metabolism|Amino Acids|Amino Acids, Peptides, and Proteins|Anticholinergic Agents|Autonomic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Parasympatholytics|Peripheral Nervous System Agents|Synthetic Anticholinergics, Esters With Tertiary Amino Group",CCN(CC)CCNC(C(=O)OCCC(C)C)C1=CC=CC=C1,
11678,DB13739,Penamecillin,small molecule,experimental,"Amides|Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|Beta-Lactamase Sensitive Penicillins|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Penicillins|Sulfur Compounds",[H][C@]12SC(C)(C)[C@@]([H])(N1C(=O)[C@@]2([H])NC(=O)CC1=CC=CC=C1)C(=O)OCOC(C)=O,
11679,DB13740,Bemegride,small molecule,experimental,Central Nervous System Agents|Central Nervous System Stimulants|Convulsants|Pyridines|Pyridones|Respiratory System Agents,CCC1(C)CC(=O)NC(=O)C1,
11680,DB13741,Ioglycamic acid,small molecule,experimental,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Iodobenzoates|Triiodobenzoic Acids|Watersoluble, Hepatotropic X-Ray Contrast Media|X-Ray Contrast Media, Iodinated",OC(=O)C1=C(I)C(NC(=O)COCC(=O)NC2=C(I)C=C(I)C(C(O)=O)=C2I)=C(I)C=C1I,
11681,DB13742,Elcatonin,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Anti-Parathyroid Agents|Bone Density Conservation Agents|Calcitonin Preparations|Calcium Homeostasis|Calcium-Regulating Hormones and Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Nerve Tissue Proteins|Neuropeptides|Peptide Hormones|Peptides|Proteins|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thyroid Products",,
11682,DB13743,Sodium aurotiosulfate,small molecule,approved|experimental,"Acids|Acids, Noncarboxylic|Anions|Antiinflammatory and Antirheumatic Products|Antirheumatic Agents|Electrolytes|Gold Compounds|Gold Preparations|Ions|Laxatives|Musculo-Skeletal System|Osmotic Laxatives|Sodium Compounds|Specific Antirheumatic Agents|Sulfates|Sulfur Acids|Sulfur Compounds|Sulfuric Acids|Thiosulfates",O.O.[Na+].[Na+].[Na+].[Au+].[O-]S([S-])(=O)=O.[O-]S([S-])(=O)=O,
11683,DB13744,Piromidic acid,small molecule,experimental,"Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Nicotinic Acids|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Quinolones|Renal Agents",CCN1C=C(C(O)=O)C(=O)C2=CN=C(N=C12)N1CCCC1,
11684,DB13745,Fazadinium bromide,small molecule,experimental,"Central Nervous System Depressants|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Pyridines",[Br-].[Br-].CC1=C(N(\N=N\N2C3=CC=CC=[N+]3C(C)=C2C2=CC=CC=C2)C2=CC=CC=[N+]12)C1=CC=CC=C1,
11685,DB13746,Bioallethrin,small molecule,approved|experimental,"Agents causing hyperkalemia|Agrochemicals|Antiarrhythmic agents|Antiparasitic Products, Insecticides and Repellents|Bradycardia-Causing Agents|Calcium Channel Blockers|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Ectoparasiticides, Incl. Scabicides|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Insecticides|Monoterpenes|Pesticides|Pyrethrines, Incl. Synthetic Compounds|Pyrethrins|Stereoisomerism|Terpenes|Toxic Actions",,15558638
11686,DB13747,Trolamine,small molecule,approved,Alcohols|Amines|Amino Alcohols|Cicatrizants|Dermatologicals|Drugs that are Mainly Renally Excreted|Preparations for Treatment of Wounds and Ulcers,OCCN(CCO)CCO,7618
11687,DB13748,Tidiacic arginine,small molecule,experimental,"Alimentary Tract and Metabolism|Bile and Liver Therapy|Liver Therapy|Liver Therapy, Lipotropics",OC(=O)C1CSC(N1)C(O)=O.N[C@@H](CCCNC(N)=N)C(O)=O,
11688,DB13749,Magnesium gluconate,small molecule,approved|investigational,"Acids, Acyclic|Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Carbohydrates|Hydroxy Acids|Magnesium Compounds|Metal cations|Metal divalent cations|Mineral Supplements|Sugar Acids",O.O.[Mg++].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O,71587201
11689,DB13750,Obidoxime,small molecule,experimental,Amines|Antidotes|Cholinergic Agents|Cholinesterase Reactivators|Enzyme Reactivators|Hydroxylamines|Neurotransmitter Agents|Oximes|Pyridines|Pyridinium Compounds,O\N=C\C1=CC=[N+](COC[N+]2=CC=C(\C=N\O)C=C2)C=C1,
11690,DB13751,Glycyrrhizic acid,small molecule,approved|experimental,"Alimentary Tract and Metabolism|Anti-Inflammatory Agents|Bile and Liver Therapy|BSEP/ABCB11 Substrates|Liver Therapy|Liver Therapy, Lipotropics|Pentacyclic Triterpenes|Terpenes|Triterpenes",[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O,
11691,DB13752,Tetramethrin,small molecule,experimental,"Agrochemicals|Antiparasitic Products, Insecticides and Repellents|Compounds used in a research, industrial, or household setting|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Insecticides|Insecticides and Repellents|Monoterpenes|Pesticides|Pyrethrines|Terpenes|Toxic Actions",CC(C)=CC1C(C(=O)OCN2C(=O)C3=C(CCCC3)C2=O)C1(C)C,
11692,DB13753,Cetiedil,small molecule,experimental,Antisickling Agents|Cardiovascular Agents|Hematologic Agents|Peripheral Vasodilators|Vasodilating Agents,O=C(OCCN1CCCCCC1)C(C1CCCCC1)C1=CSC=C1,
11693,DB13754,Mephenoxalone,small molecule,experimental,"Anti-Anxiety Agents|Central Nervous System Depressants|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Psycholeptics",COC1=C(OCC2CNC(=O)O2)C=CC=C1,
11694,DB13755,Iocarmic acid,small molecule,experimental,"Acids, Carbocyclic|Alcohols|Amino Sugars|Benzene Derivatives|Benzoates|Carbohydrates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Hexosamines|Iodobenzoates|Sugar Alcohols|Triiodobenzoic Acids|Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media|X-Ray Contrast Media, Iodinated",CNC(=O)C1=C(I)C(C(O)=O)=C(I)C(NC(=O)CCCCC(=O)NC2=C(I)C(C(O)=O)=C(I)C(C(=O)NC)=C2I)=C1I,
11695,DB13756,Peruvoside,small molecule,experimental,"Carbohydrates|Cardanolides|Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Fused-Ring Compounds|Glycosides|Protective Agents|Steroids",CO[C@@H]1[C@@H](O)[C@H](C)O[C@@H](O[C@H]2CC[C@@]3(C=O)[C@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@H](CC[C@]43O)C3=CC(=O)OC3)C2)[C@H]1O,
11696,DB13757,Epanolol,small molecule,experimental,"Acetamides|Acetates|Acids, Acyclic|Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amides|Amines|Amino Alcohols|Antihypertensive Agents|Autonomic Agents|Benzene Derivatives|Beta Blocking Agents, Selective|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Fatty Acids|Fatty Acids, Volatile|Lipids|Neurotransmitter Agents|Peripheral Nervous System Agents|Propanols|Sympathomimetics",OC(CNCCNC(=O)CC1=CC=C(O)C=C1)COC1=CC=CC=C1C#N,
11697,DB13758,Meclofenoxate,small molecule,experimental,"Acetates|Acids, Acyclic|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Fatty Acids|Fatty Acids, Volatile|Glycolates|Hydroxy Acids|Lipids|Nervous System|Neuroprotective Agents|Nootropic Agents|Phenoxyacetates|Protective Agents|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics",CN(C)CCOC(=O)COC1=CC=C(Cl)C=C1,
11698,DB13759,Fenpiverinium,small molecule,experimental,"Agents producing tachycardia|Alimentary Tract and Metabolism|Anticholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Synthetic Anticholinergics, Quaternary Ammonium Compounds",C[N+]1(CCC(C(N)=O)(C2=CC=CC=C2)C2=CC=CC=C2)CCCCC1,
11699,DB13760,Niperotidine,small molecule,experimental|investigational,Alimentary Tract and Metabolism|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Gastric Acid Lowering Agents|Histamine Antagonists|Histamine H2 Antagonists,CN(C)CC1=CC=C(CSCCNC(NCC2=CC=C3OCOC3=C2)=C[N+]([O-])=O)O1,
11701,DB13762,Dexrabeprazole,small molecule,experimental,"2-Pyridinylmethylsulfinylbenzimidazoles|Acid Reducers|Alimentary Tract and Metabolism|Anti-Ulcer Agents|Benzimidazoles|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 Substrates|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Enzyme Inhibitors|Gastric Acid Lowering Agents|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Proton Pump Inhibitors|Pyridines|Sulfoxides|Sulfur Compounds",COCCCOC1=CC=NC(C[S@@](=O)C2=NC3=CC=CC=C3N2)=C1C,
11702,DB13763,Aurotioprol,small molecule,experimental,Alcohols|Antiinflammatory and Antirheumatic Products|Antirheumatic Agents|Gold Preparations|Musculo-Skeletal System|Organometallic Compounds|Specific Antirheumatic Agents|Sulfur Compounds,[Na+].[Au+].OC(C[S-])CS([O-])(=O)=O,
11703,DB13764,Monoxerutin,small molecule,experimental,Capillary Stabilizing Agents|Flavonoids|Vasoprotectives,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3=C(OC4=CC(OCCO)=CC(O)=C4C3=O)C3=CC=C(O)C(O)=C3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,
11704,DB13765,Mercuric chloride,small molecule,experimental,"Acids|Acids, Noncarboxylic|Anions|Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Chlorides|Chlorine Compounds|Compounds used in a research, industrial, or household setting|Dermatologicals|Disinfectants|Electrolytes|Ions|Mercurial Products|Mercury Compounds",Cl[Hg]Cl,
11705,DB13766,Lidoflazine,small molecule,approved|experimental,Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Membrane Transport Modulators|Non-Selective Calcium Channel Blockers|Piperazines|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Vasodilating Agents,CC1=CC=CC(C)=C1NC(=O)CN1CCN(CCCC(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)CC1,
11706,DB13767,Vorozole,small molecule,experimental,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Aromatase Inhibitors|Carbon Radioisotopes|Endocrine Therapy|Enzyme Inhibitors|Estrogen Antagonists|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors",CN1N=NC2=CC=C(C=C12)[C@@H](N1C=NC=N1)C1=CC=C(Cl)C=C1,
11707,DB13768,Domiodol,small molecule,experimental,Cough and Cold Preparations|Dioxoles|Expectorants,OCC1COC(CI)O1,
11708,DB13769,Emetonium iodide,small molecule,experimental,"Agents producing tachycardia|Alimentary Tract and Metabolism|Anticholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Synthetic Anticholinergics, Quaternary Ammonium Compounds",[I-].CC[N+](C)(CC)CCOC(C1=CC=CC=C1)C1=CC=CC=C1,
11709,DB13770,Vinylbital,small molecule,experimental,"Barbiturates, Plain|Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Psycholeptics|Pyrimidines|Pyrimidinones",CCCC(C)C1(C=C)C(=O)NC(=O)NC1=O,
11710,DB13771,Ferric sodium citrate,small molecule,experimental,"Antianemic Preparations|Blood and Blood Forming Organs|Iron Preparations|Iron Trivalent, Oral Preparations",[Na+].[Fe+3].[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O,
11711,DB13772,Rufloxacin,small molecule,experimental,"Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Heterocyclic Compounds, Fused-Ring|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",CN1CCN(CC1)C1=C(F)C=C2C(=O)C(=CN3CCSC1=C23)C(O)=O,
11712,DB13773,Sulfamethoxypyridazine,small molecule,experimental,Amides|Amines|Aniline Compounds|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Long-Acting Sulfonamides|Sulfanilamides|Sulfonamide Antibacterial|Sulfonamides|SULFONAMIDES AND TRIMETHOPRIM|Sulfones|Sulfur Compounds,COC1=NN=C(NS(=O)(=O)C2=CC=C(N)C=C2)C=C1,
11713,DB13774,Myristalkonium,small molecule,experimental,"Anti-Infective Agents, Local|Throat Preparations",CCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1,
11714,DB13775,Tertatolol,small molecule,experimental,"Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Beta Blocking Agents, Non-Selective|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Neurotransmitter Agents|Propanols|Sulfur Compounds",CC(C)(C)NCC(O)COC1=CC=CC2=C1SCCC2,
11715,DB13776,Ibacitabine,small molecule,experimental,Antiviral Agents|Dermatologicals,NC1=NC(=O)N(C=C1I)[C@H]1C[C@H](O)[C@@H](CO)O1,
11716,DB13777,Prenalterol,small molecule,experimental,"Adrenergic Agents|Adrenergic Agonists|Adrenergic and Dopaminergic Agents|Adrenergic beta-1 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Autonomic Agents|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenoxypropanolamines|Propanolamines|Propanols|Protective Agents|Sympathomimetics",CC(C)NC[C@H](O)COC1=CC=C(O)C=C1,
11717,DB13778,Cefazedone,small molecule,experimental,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|First-Generation Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines",CC1=NN=C(SCC2=C(N3[C@H](SC2)[C@H](NC(=O)CN2C=C(Cl)C(=O)C(Cl)=C2)C3=O)C(O)=O)S1,
11718,DB13779,Guanoclor,small molecule,experimental,"Amidines|Antiadrenergic Agents, Peripherally Acting|Antihypertensive Agents|Guanidine Derivatives",NC(=N)NNCCOC1=C(Cl)C=CC=C1Cl,
11719,DB13780,Aluminium clofibrate,small molecule,experimental,"Agents Causing Muscle Toxicity|Fibric Acids|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents",[OH-].[Al+3].CC(C)(OC1=CC=C(Cl)C=C1)C([O-])=O.CC(C)(OC1=CC=C(Cl)C=C1)C([O-])=O,
11720,DB13781,Xamoterol,small molecule,approved,Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-1 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Morpholines|Neurotransmitter Agents|Oxazines|Phenoxypropanolamines|Propanolamines|Propanols,OC(CNCCNC(=O)N1CCOCC1)COC1=CC=C(O)C=C1,155774
11721,DB13782,Imipramine oxide,small molecule,experimental,"Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents|Antidepressive Agents, Tricyclic|Central Nervous System Depressants|Dibenzazepines|Heterocyclic Compounds, Fused-Ring|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Non-Selective Monoamine Reuptake Inhibitors|Psychoanaleptics|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",CN(C)(=O)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,
11722,DB13783,Acemetacin,small molecule,approved|investigational,"Acetic Acid Derivatives and Related Substances|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antigout Preparations|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antirheumatic Agents|Central Nervous System Agents|Heterocyclic Compounds, Fused-Ring|Indoles|Musculo-Skeletal System|Nephrotoxic agents|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Sensory System Agents|UGT2B7 substrates",COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)OCC(O)=O,1981
11723,DB13784,Dixyrazine,small molecule,experimental,"Analgesics|Analgesics, Non-Narcotic|Antiemetics|Antipsychotic Agents|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotoxic agents|Peripheral Nervous System Agents|Phenothiazines|Phenothiazines With Piperazine Structure|Psycholeptics|Psychotropic Drugs|Sensory System Agents|Sulfur Compounds|Tranquilizing Agents",CC(CN1CCN(CCOCCO)CC1)CN1C2=CC=CC=C2SC2=CC=CC=C12,
11724,DB13785,Dropropizine,small molecule,experimental,Alcohols|Antitussive Agents|Central Nervous System Agents|Cough and Cold Preparations|Glycols|Respiratory System Agents,OCC(O)CN1CCN(CC1)C1=CC=CC=C1,
11725,DB13786,Magnesium orotate,small molecule,experimental,Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Magnesium Compounds|Metal cations|Metal divalent cations|Mineral Supplements|Pyrimidines|Pyrimidinones,[Mg++].[O-]C(=O)C1=CC(=O)NC(=O)N1.[O-]C(=O)C1=CC(=O)NC(=O)N1,3036905
11726,DB13787,Tilidine,small molecule,experimental,"Acids, Carbocyclic|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Cyclohexanecarboxylic Acids|Cyclohexanes|Cycloparaffins|Narcotics|Nervous System|Opioids|Peripheral Nervous System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",[H][C@]1(C=CCC[C@]1(C(=O)OCC)C1=CC=CC=C1)N(C)C,
11727,DB13788,Chlorbenzoxamine,small molecule,experimental,Alimentary Tract and Metabolism|Drugs for Functional Gastrointestinal Disorders,CC1=CC=CC=C1CN1CCN(CCOC(C2=CC=CC=C2)C2=CC=CC=C2Cl)CC1,
11728,DB13789,Aluminium acetotartrate,small molecule,experimental,Anti-Infective Agents|Otologicals|Sensory Organs,[Al+3].CC([O-])=O.O[C@H]([C@@H](O)C([O-])=O)C([O-])=O,
11729,DB13790,Fipexide,small molecule,experimental,"Nervous System|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics",ClC1=CC=C(OCC(=O)N2CCN(CC3=CC4=C(OCO4)C=C3)CC2)C=C1,
11730,DB13791,Penfluridol,small molecule,experimental,Agents causing hyperkalemia|Antiarrhythmic agents|Antipsychotic Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Diphenylbutylpiperidine Derivatives|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Moderate Risk QTc-Prolonging Agents|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Piperidines|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Tranquilizing Agents,OC1(CCN(CCCC(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)CC1)C1=CC(=C(Cl)C=C1)C(F)(F)F,
11731,DB13792,Clopamide,small molecule,experimental,"Amides|Cardiovascular Agents|Diuretics|Low-Ceiling Diuretics, Excl. Thiazides|Natriuretic Agents|Piperidines|Sulfonamides|Sulfones|Sulfur Compounds",C[C@H]1CCC[C@@H](C)N1NC(=O)C1=CC=C(Cl)C(=C1)S(N)(=O)=O,12492
11732,DB13793,Vinburnine,small molecule,experimental,"Alkaloids|Cardiovascular Agents|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|Peripheral Vasodilators|Secologanin Tryptamine Alkaloids|Vasodilating Agents",[H][C@]12N3CCC[C@@]1(CC)CC(=O)N1C4=CC=CC=C4C(CC3)=C21,
11733,DB13794,Dimethoxanate,small molecule,experimental,Cough and Cold Preparations,CN(C)CCOCCOC(=O)N1C2=CC=CC=C2SC2=CC=CC=C12,
11734,DB13795,Brodimoprim,small molecule,experimental,Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Enzyme Inhibitors|Folic Acid Antagonists|Pyrimidines|SULFONAMIDES AND TRIMETHOPRIM|Trimethoprim and Derivatives,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1Br,
11735,DB13796,Dibunate,small molecule,experimental,Cough and Cold Preparations,CC(C)(C)C1=CC=C2C(C=CC(=C2S(O)(=O)=O)C(C)(C)C)=C1,
11736,DB13797,Iodocholesterol (131I),small molecule,experimental,Diagnostic Radiopharmaceuticals|Iodine (131I) Compounds,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C[131I])[C@H]3CC[C@]12C,
11737,DB13798,Demoxytocin,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Oxytocin and Analogues|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormones|Pituitary Hormones, Posterior|Posterior Pituitary Lobe Hormones|Reproductive Control Agents|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Uterotonic agents",CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O,
11738,DB13799,Ethadione,small molecule,experimental,Anticonvulsants|Central Nervous System Depressants|Nervous System|Oxazolidine Derivatives,CCN1C(=O)OC(C)(C)C1=O,
11739,DB13800,Calcium levulinate,small molecule,approved|experimental,Alimentary Tract and Metabolism|Calcium Salts|Enzyme Inhibitors|Keto Acids|Mineral Supplements,[Ca++].CC(=O)CCC([O-])=O.CC(=O)CCC([O-])=O,
11740,DB13801,Muzolimine,small molecule,approved|withdrawn,Antihypertensive Agents|Cardiovascular Agents|Diuretics|High-Ceiling Diuretics|Natriuretic Agents|Pyrazoles|Pyrazolone Derivatives,CC(N1N=C(N)CC1=O)C1=CC(Cl)=C(Cl)C=C1,
11741,DB13802,Epomediol,small molecule,experimental,"Alimentary Tract and Metabolism|Bile and Liver Therapy|Cholagogues and Choleretics|Gastrointestinal Agents|Liver Therapy|Liver Therapy, Lipotropics",CC1(C)O[C@@]2(C)[C@@H](O)C[C@@H]1C[C@H]2O,
11742,DB13803,Xipamide,small molecule,experimental,"Amides|Antihypertensive Agents|Cardiovascular Agents|Diuretics|Low-Ceiling Diuretics, Excl. Thiazides|Natriuretic Agents|Sulfonamides|Sulfones|Sulfur Compounds",CC1=CC=CC(C)=C1NC(=O)C1=CC(=C(Cl)C=C1O)S(N)(=O)=O,
11743,DB13804,Benzylthiouracil,small molecule,experimental,"Antithyroid agents|Pyrimidines|Pyrimidinones|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thiouracils|Thyroid Products|Uridine Phosphorylase, antagonists & inhibitors",O=C1NC(=S)NC(CC2=CC=CC=C2)=C1,
11744,DB13805,Reposal,small molecule,experimental,"Amines|Barbiturates, Plain|Benzene Derivatives|Central Nervous System Depressants|Enzyme Inhibitors|Hydroxy Acids|Hydroxylamines|Hypnotics and Sedatives|Nervous System|Psycholeptics",CCC1(C(=O)NC(=O)NC1=O)C1=CC2CCC(C2)C1,
11745,DB13806,Linopirdine,small molecule,experimental,"Cardiovascular Agents|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Heterocyclic Compounds, Fused-Ring|Membrane Transport Modulators|Nervous System|Neuroprotective Agents|Potassium Channel Blockers|Protective Agents|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics",O=C1N(C2=CC=CC=C2C1(CC1=CC=NC=C1)CC1=CC=NC=C1)C1=CC=CC=C1,
11746,DB13807,Tisopurine,small molecule,experimental,"Antigout Preparations|Antirheumatic Agents|Heterocyclic Compounds, Fused-Ring|Musculo-Skeletal System|Preparations Inhibiting Uric Acid Production|Purines",S=C1N=CNC2=C1C=NN2,
11747,DB13808,Mebhydrolin,small molecule,experimental,"Antihistamines for Systemic Use|Heterocyclic Compounds, Fused-Ring|Indoles|Pyridines",CN1CCC2=C(C1)C1=CC=CC=C1N2CC1=CC=CC=C1,
11748,DB13809,Paclitaxel poliglumex,small molecule,experimental|investigational,"Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cardiotoxic antineoplastic agents|Cyclodecanes|Cycloparaffins|Diterpenes|Glutamates|Peptides|Taxoids|Terpenes",,
11749,DB13810,Dimemorfan,small molecule,experimental,"Alkaloids|Antitussive Agents|Central Nervous System Agents|Cough and Cold Preparations|Heterocyclic Compounds, Fused-Ring|Opiate Alkaloids|Opium Alkaloids and Derivatives|Phenanthrenes|Respiratory System Agents",CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC1=CC=C(C)C=C31,
11750,DB13811,Oblimersen,small molecule,experimental|investigational,"Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Antisense Elements (Genetics)|Carbohydrates|Compounds used in a research, industrial, or household setting|Diagnostic Uses of Chemicals|DNA|DNA, Antisense|Glycosides|Laboratory Chemicals|Molecular Probes|Nucleic Acid Probes|Nucleic Acids|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Oligodeoxyribonucleotides, Antisense|Oligonucleotides|Oligonucleotides, Antisense|Polynucleotides|Sulfur Compounds",,
11751,DB13812,Bufylline,small molecule,experimental,"Alkaloids|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Drugs for Obstructive Airway Diseases|Heterocyclic Compounds, Fused-Ring|Peripheral Nervous System Agents|Purines|Purinones|Respiratory System Agents|Vasodilating Agents|Xanthine derivatives",CC(C)(N)CO.CN1C2=C(N=CN2)C(=O)N(C)C1=O,
11752,DB13813,Iodoform,small molecule,approved|experimental|vet_approved,"Dermatologicals|Hydrocarbons, Halogenated|Medicated Dressings|Medicated Dressings With Antiinfectives|Miscellaneous Local Anti-infectives",[H]C(I)(I)I,6374
11753,DB13814,Talampicillin,small molecule,experimental,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Penicillin G|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds",CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3=CC=CC=C3)C(=O)N2[C@H]1C(=O)OC1OC(=O)C2=CC=CC=C12,
11754,DB13815,Xenysalate,small molecule,experimental,Dermatologicals|Medicated Shampoos,CCN(CC)CCOC(=O)C1=CC=CC(=C1O)C1=CC=CC=C1,
11755,DB13816,Aspoxicillin,small molecule,experimental,"Amides|Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Penicillin G|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds",CNC(=O)C[C@@H](N)C(=O)N[C@@H](C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)C1=CC=C(O)C=C1,
11756,DB13817,Carbromal,small molecule,experimental,Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Psycholeptics,CCC(Br)(CC)C(=O)NC(N)=O,
11757,DB13818,Bibrocathol,small molecule,experimental,Anti-Infective Agents|Benzene Derivatives|Ophthalmologicals|Phenols|Sensory Organs,[OH-].[Bi+3].[O-]C1=C([O-])C(Br)=C(Br)C(Br)=C1Br,
11758,DB13819,Proxazole,small molecule,experimental,Alimentary Tract and Metabolism|Drugs for Functional Gastrointestinal Disorders|Oxazoles,CCC(C1=NOC(CCN(CC)CC)=N1)C1=CC=CC=C1,
11759,DB13820,Oxomemazine,small molecule,experimental,"Antihistamines for Systemic Use|Heterocyclic Compounds, Fused-Ring|Phenothiazine Derivatives|Sulfur Compounds",CC(CN(C)C)CN1C2=CC=CC=C2S(=O)(=O)C2=CC=CC=C12,
11760,DB13821,Ceftezole,small molecule,experimental,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Cephalosporins|First-Generation Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines",OC(=O)C1=C(CSC2=NN=CS2)CS[C@@H]2[C@H](NC(=O)CN3C=NN=N3)C(=O)N12,
11761,DB13822,Meprotixol,small molecule,experimental,Cough and Cold Preparations,COC1=CC2=C(SC3=CC=CC=C3C2(O)CCCN(C)C)C=C1,
11762,DB13823,Pipemidic acid,small molecule,experimental,"Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Fluoroquinolones|Nicotinic Acids|Piperazines|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Renal Agents",CCN1C=C(C(O)=O)C(=O)C2=CN=C(N=C12)N1CCNCC1,
11763,DB13824,Enprostil,small molecule,experimental,"Alimentary Tract and Metabolism|Anti-Ulcer Agents|Autacoids|Biological Factors|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Gastrointestinal Agents|Inflammation Mediators|Lipids|Prostaglandins|Prostaglandins E, Synthetic|Prostaglandins, Synthetic",COC(=O)CCC=C=CC[C@H]1[C@H](\C=C\[C@H](O)COC2=CC=CC=C2)[C@@H](O)CC1=O,
11764,DB13825,Fedrilate,small molecule,experimental,Cough and Cold Preparations,CC(CCN1CCOCC1)OC(=O)C1(CCOCC1)C1=CC=CC=C1,
11765,DB13826,Etohexadiol,small molecule,experimental,"Alcohols|Antiparasitic Products, Insecticides and Repellents|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Insecticides and Repellents|Solvents",CCCC(O)C(CC)CO,
11766,DB13827,Indanazoline,small molecule,experimental,"Nasal Preparations|Sympathomimetics, Plain",C1CC2=C(C1)C(NC1=NCCN1)=CC=C2,
11767,DB13828,Cyfluthrin,small molecule,experimental,"Agrochemicals|Antiparasitic Products, Insecticides and Repellents|Compounds used in a research, industrial, or household setting|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Insecticides|Insecticides and Repellents|Monoterpenes|Pesticides|Pyrethrines|Terpenes|Toxic Actions",CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=C(F)C(OC2=CC=CC=C2)=C1,
11768,DB13829,Calcium silicate,small molecule,experimental,"Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Anions|Antacids|Bone Substitutes|Calcium Compounds|Drugs for Acid Related Disorders|Electrolytes|Gastric Acid Lowering Agents|Ions|Minerals|Oxides|Oxygen Compounds|Silicon Compounds",[Ca++].O[Si](O)(O)[O-].O[Si](O)(O)[O-],
11769,DB13830,Copper usnate,small molecule,experimental,Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics,[Cu++].CC(=O)C1C(=O)C=C2OC3=C(C(C)=O)C([O-])=C(C)C([O-])=C3C2(C)C1=O,
11770,DB13831,Potassium permanganate,small molecule,experimental|investigational,"Antidotes|Antiseptics and Disinfectants|Compounds used in a research, industrial, or household setting|Dermatologicals|Indicators and Reagents|Laboratory Chemicals|Manganese Compounds|Potassium Compounds|Potassium Salt",[K+].[O-][Mn](=O)(=O)=O,
11771,DB13832,Ranimustine,small molecule,experimental,Alkylating Drugs|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Nitroso Compounds|Nitrosoureas,CO[C@H]1O[C@H](CNC(=O)N(CCCl)N=O)[C@@H](O)[C@H](O)[C@H]1O,
11772,DB13833,Methylatropine,small molecule,experimental,"Alimentary Tract and Metabolism|Alkaloids|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Belladonna Alkaloids|Belladonna Alkaloids, Semisynthetic, Quaternary Ammonium Compounds|Belladonna and Derivatives, Plain|Drugs for Functional Gastrointestinal Disorders|Parasympatholytics|Peripheral Nervous System Agents|Solanaceous Alkaloids|Tropanes",C[N+]1(C)[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,
11773,DB13834,Phenylmercuric borate,small molecule,experimental,Antiseptics and Disinfectants|Dermatologicals|Mercurial Products,[OH-].OB(O)[O-].[Hg+]C1=CC=CC=C1.[Hg+]C1=CC=CC=C1,
11774,DB13835,Caroverine,small molecule,experimental,"Agents causing hyperkalemia|Alimentary Tract and Metabolism|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs for Functional Gastrointestinal Disorders|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Heterocyclic Compounds, Fused-Ring|Membrane Transport Modulators|Neurotransmitter Agents|Vasodilating Agents",CCN(CC)CCN1C(=O)C(CC2=CC=C(OC)C=C2)=NC2=CC=CC=C12,
11775,DB13836,Metampicillin,small molecule,experimental,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Penicillin G|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds",[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N=C)C1=CC=CC=C1)C(O)=O,
11776,DB13837,Doxefazepam,small molecule,experimental,"Benzazepines|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Hypnotics and Sedatives|Nervous System|Psycholeptics",OCCN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1F,
11777,DB13838,Noxytiolin,small molecule,approved,"Anti-Infective Agents|Anti-Infective Agents, Local|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Irrigating Solutions|Sulfur Compounds|Thiourea",CNC(=S)NCO,
11778,DB13839,Dipyrocetyl,small molecule,experimental,Analgesics|Antiinflammatory and Antirheumatic Products|Musculo-Skeletal System|Nervous System|Salicylic Acid and Derivatives,CC(=O)OC1=CC=CC(C(O)=O)=C1OC(C)=O,
11779,DB13840,Hydroxyethylpromethazine,small molecule,experimental,Antihistamines for Systemic Use|Phenothiazine Derivatives,CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)[N+](C)(C)CCO,
11780,DB13841,Clopenthixol,small molecule,experimental,"Antipsychotic Agents|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Sulfur Compounds|Thioxanthene Derivatives|Thioxanthenes|Tranquilizing Agents|Xanthenes",[H]C(CCN1CCN(CCO)CC1)=C1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2,
11781,DB13842,Etofylline nicotinate,small molecule,experimental,Peripheral Vasodilators|Purine Derivatives,CN1C2=C(N(CCOC(=O)C3=CC=CN=C3)C=N2)C(=O)N(C)C1=O,
11782,DB13843,Cloprednol,small molecule,experimental,"Adrenal Cortex Hormones|Corticosteroids|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Fused-Ring Compounds|Glucocorticoids|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Pregnanes|Pregnenes|Steroids|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@]([H])(O)[C@@]1([H])[C@@]2([H])C=C(Cl)C2=CC(=O)C=C[C@]12C,
11783,DB13844,Pipenzolate,small molecule,experimental,"Agents producing tachycardia|Alimentary Tract and Metabolism|Anticholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Synthetic Anticholinergics, Quaternary Ammonium Compounds",CC[N+]1(C)CCCC(C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,
11784,DB13845,Etafenone,small molecule,experimental,Cardiac Therapy|Cardiovascular Agents|Ketones|Propiophenones|Vasodilating Agents|Vasodilators Used in Cardiac Diseases,CCN(CC)CCOC1=CC=CC=C1C(=O)CCC1=CC=CC=C1,
11785,DB13846,Pyrrobutamine,small molecule,experimental,Antihistamines for Systemic Use,ClC1=CC=C(CC(=CCN2CCCC2)C2=CC=CC=C2)C=C1,
11786,DB13847,Rhenium Re-186 sulfide,small molecule,experimental,Anti-Inflammatory Agents|Therapeutic Radiopharmaceuticals,[S--].[S--].[S--].[S--].[S--].[S--].[S--].[186Re].[186Re],
11787,DB13848,Fluorodopa (18F),small molecule,approved|experimental,"Amines|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Benzene Derivatives|Catecholamines|Catechols|Diagnostic Radiopharmaceuticals|Fluorine Radioisotopes|Phenols|Phenylalanine",N[C@@H](CC1=CC(O)=C(O)C=C1[18F])C(O)=O,
11788,DB13849,Clofibride,small molecule,experimental,"Acids, Acyclic|Agents Causing Muscle Toxicity|Benzene Derivatives|Butyrates|Clofibric Acid|Ethers|Fatty Acids|Fatty Acids, Volatile|Fibric Acids|Isobutyrates|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Lipids|Phenols|Phenyl Ethers",CN(C)C(=O)CCCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1,
11789,DB13850,Timepidium,small molecule,experimental,"Agents producing tachycardia|Alimentary Tract and Metabolism|Anticholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Synthetic Anticholinergics, Quaternary Ammonium Compounds",COC1CC(C[N+](C)(C)C1)=C(C1=CC=CS1)C1=CC=CS1,
11790,DB13851,Artemotil,small molecule,approved,"Amebicides|Anions|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiplatyhelmintic Agents|Antiprotozoals|Artemisinin and Derivatives, Plain|Electrolytes|Free Radicals|Ions|Oxides|Oxygen Compounds|Peroxides|Reactive Oxygen Species|Schistosomicides|Sesquiterpenes|Terpenes",[H][C@@]12CC[C@@H](C)[C@]3([H])CC[C@@]4(C)OO[C@@]13[C@]([H])(O[C@H](OCC)[C@@H]2C)O4,
11791,DB13852,Mefenorex,small molecule,experimental,"Agents producing tachycardia|Agents that produce hypertension|Alimentary Tract and Metabolism|Amines|Antiobesity Preparations, Excl. Diet Products|Autonomic Agents|Centrally Acting Antiobesity Products|Ethylamines|Peripheral Nervous System Agents|Phenethylamines|Sympathomimetics",CC(CC1=CC=CC=C1)NCCCCl,
11792,DB13853,Anethole trithione,small molecule,approved|experimental,"Alimentary Tract and Metabolism|Anisoles|Benzene Derivatives|EENT Drugs, Miscellaneous|Ethers|Gastrointestinal Agents|Methyl Ethers|Phenols|Phenyl Ethers|Sulfur Compounds|Thiones|Various Alimentary Tract and Metabolism Products",COC1=CC=C(C=C1)C1=CC(=S)SS1,2194
11793,DB13854,Gamolenic acid,small molecule,approved|investigational,"Agents that reduce seizure threshold|Dermatologicals|Fatty Acids|Fatty Acids, Essential|Fatty Acids, Omega-6|Fatty Acids, Unsaturated|Linolenic Acids|Lipids",CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O,
11794,DB13855,Nifuroxazide,small molecule,experimental,"Acids, Carbocyclic|Alimentary Tract and Metabolism|Anti-Infective Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Benzene Derivatives|Benzoates|Furans|Hydroxy Acids|Intestinal Antiinfectives|Nitro Compounds|Phenols",OC1=CC=C(C=C1)C(=O)N\N=C\C1=CC=C(O1)[N+]([O-])=O,
11795,DB13856,Fluclorolone,small molecule,experimental,"Adrenal Cortex Hormones|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Dermatologicals|Immunosuppressive Agents",C[C@]12C[C@H](Cl)[C@@]3(Cl)[C@@H](C[C@H](F)C4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO,
11796,DB13857,Demegestone,small molecule,experimental,"Adrenal Cortex Hormones|Contraceptive Agents, Female|Contraceptives, Oral|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Norpregnanes|Norpregnenes|Norsteroids|Pregnadien Derivatives|Progesterone Congeners|Progestin Contraceptives|Progestins|Sex Hormones and Modulators of the Genital System|Steroids",[H][C@@]12CC[C@](C)(C(C)=O)[C@@]1(C)CCC1=C3CCC(=O)C=C3CC[C@@]21[H],
11797,DB13858,Dimazole,small molecule,approved|withdrawn,Antifungals for Dermatological Use|Antifungals for Topical Use|Dermatologicals|Sulfur Compounds,CCN(CC)CCOC1=CC2=C(C=C1)N=C(S2)N(C)C,
11798,DB13860,Imidazole salicylate,small molecule,experimental,"Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antirheumatic Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Hydroxy Acids|Hydroxybenzoates|Nephrotoxic agents|Nervous System|Non COX-2 selective NSAIDS|Peripheral Nervous System Agents|Phenols|Salicylic Acid and Derivatives|Sensory System Agents",N1C=CN=C1.OC(=O)C1=CC=CC=C1O,
11799,DB13861,Iopentol,small molecule,experimental,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Iodobenzoates|Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media|X-Ray Contrast Media, Iodinated",COCC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I,
11800,DB13862,Magnesium phosphate,small molecule,experimental,"Acids|Acids, Noncarboxylic|Agents that produce neuromuscular block (indirect)|Anions|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Electrolyte Solutions|Electrolytes|I.V. Solution Additives|Ions|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds",[Mg++].[Mg++].[Mg++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O,
11801,DB13863,Fosfructose,small molecule,experimental,"Antiarrhythmic agents|Carbohydrates|Cardiac Therapy|Cardiovascular Agents|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Fructosephosphates|Hexosediphosphates|Hexosephosphates|Immunologic Factors|Neuroprotective Agents|Protective Agents|Sugar Phosphates",[H][C@@](O)(COP(O)(O)=O)[C@@]([H])(O)[C@]([H])(O)C(=O)COP(O)(O)=O,
11803,DB13865,Dehydroemetine,small molecule,investigational,"Alkaloids|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Heterocyclic Compounds, Fused-Ring|Isoquinolines",[H][C@@]12CC(C[C@H]3NCCC4=C3C=C(OC)C(OC)=C4)=C(CC)CN1CCC1=C2C=C(OC)C(OC)=C1,
11804,DB13866,Etynodiol,small molecule,experimental,Adrenal Cortex Hormones|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Estren Derivatives|Fused-Ring Compounds|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Norpregnanes|Norpregnenes|Norsteroids|Progestins|Sex Hormones and Modulators of the Genital System|Steroids,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CC[C@H](O)C=C3CC[C@@]21[H],14687
11805,DB13867,Fluticasone,small molecule,approved|experimental,"Adrenal Cortex Hormones|Androstadienes|Androstanes|Androstenes|Anti-Allergic Agents|Anti-Asthmatic Agents|Anti-Inflammatory Agents|Autonomic Agents|Bronchodilator Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Drugs for Obstructive Airway Diseases|Fused-Ring Compounds|Glucocorticoids|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Nasal Preparations|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein substrates|Peripheral Nervous System Agents|Respiratory System Agents|Steroids|Thyroxine-binding globulin inhibitors",[H][C@@]12C[C@@H](C)[C@](O)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,
11806,DB13868,Adefovir,small molecule,investigational,"Anti-Infective Agents|Antiviral Agents|Enzyme Inhibitors|Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Heterocyclic Compounds, Fused-Ring|Nephrotoxic agents|Nucleic Acid Synthesis Inhibitors|Nucleoside Reverse Transcriptase Inhibitors|Organophosphorus Compounds|Purines|Reverse Transcriptase Inhibitors",NC1=C2N=CN(CCOCP(O)(O)=O)C2=NC=N1,
11807,DB13869,2-Methoxy-6-{(E)-[(4-methylphenyl)imino]methyl}phenol,small molecule,experimental,Benzene Derivatives|Benzylidene Compounds,COC1=C(O)C(\C=N\C2=CC=C(C)C=C2)=CC=C1,5476587
11808,DB13871,Albendazole oxide,small molecule,experimental,"Acids, Acyclic|Anthelmintics|Anti-Infective Agents|Anticestodal Agents|Antiparasitic Agents|Antiplatyhelmintic Agents|Benzimidazoles|Carbamates|Heterocyclic Compounds, Fused-Ring",CCCS(=O)C1=CC=C2NC(NC(=O)OC)=NC2=C1,83969
11809,DB13872,Lormetazepam,small molecule,approved,"Benzazepines|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Hypnotics and Sedatives|Nervous System|Psycholeptics",CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1Cl,13314
11810,DB13873,Fenofibric acid,small molecule,approved,"Acids, Acyclic|Agents Causing Muscle Toxicity|Anticholesteremic Agents|Benzene Derivatives|Benzophenones|Butyrates|Drugs that are Mainly Renally Excreted|Ethers|Fatty Acids|Fatty Acids, Volatile|Fibric Acids|Hypolipidemic Agents|Hypolipidemic Agents Indicated for Hyperlipidemia|Isobutyrates|Ketones|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Lipids|Noxae|Peroxisome Proliferator Receptor alpha Agonist|Phenols|Phenyl Ethers|Toxic Actions",CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O,64929
11811,DB13874,Enasidenib,small molecule,approved|investigational,Amines|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Isocitrate Dehydrogenase 2 Inhibitor|Isocitrate Dehydrogenase 2 Inhibitors|OAT1/SLC22A6 inhibitors|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|OCT2 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|Pyridines|UGT1A1 Inhibitors|UGT1A1 Substrates|UGT1A1 substrates with narrow therapeutic index|UGT1A3 substrates|UGT1A3 substrates with narrow therapeutic index|UGT1A4 substrates|UGT1A9 Substrates|UGT1A9 substrates with narrow therapeutic index|UGT2B7 substrates|UGT2B7 substrates with narrow therapeutic index,CC(C)(O)CNC1=NC(=NC(NC2=CC(=NC=C2)C(F)(F)F)=N1)C1=NC(=CC=C1)C(F)(F)F,89683805
11812,DB13875,Harmaline,small molecule,experimental,"Agents that produce hypertension|Agents that reduce seizure threshold|Alkaloids|Antidepressive Agents|Carbolines|Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Stimulants|Enzyme Inhibitors|Harmala Alkaloids|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|Monoamine Oxidase Inhibitors|Pyridines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",COC1=CC2=C(C=C1)C1=C(N2)C(C)=NCC1,5280951
11813,DB13876,Brofaromine,small molecule,experimental,Antidepressive Agents|Central Nervous System Depressants|Enzyme Inhibitors|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Monoamine Oxidase Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,COC1=CC2=C(OC(=C2)C2CCNCC2)C(Br)=C1,44571
11814,DB13877,Iniparib,small molecule,investigational,"Acids, Carbocyclic|Amides|Antineoplastic Agents|Benzene Derivatives|Benzoates|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors",NC(=O)C1=CC(=C(I)C=C1)[N+]([O-])=O,
11815,DB13878,Pibrentasvir,small molecule,approved|investigational,"Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Antivirals for treatment of HCV infections|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Direct Acting Antivirals|Hepatitis C Virus NS5A Inhibitor|Heterocyclic Compounds, Fused-Ring|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|UGT1A1 Inhibitors",CO[C@H](C)[C@H](NC(=O)OC)C(=O)N1CCC[C@H]1C1=NC2=C(N1)C=C(F)C(=C2)[C@H]1CC[C@@H](N1C1=CC(F)=C(N2CCC(CC2)C2=CC=C(F)C=C2)C(F)=C1)C1=CC2=C(NC(=N2)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)OC)[C@@H](C)OC)C=C1F,58031952
11816,DB13879,Glecaprevir,small molecule,approved|investigational,"Amides|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Antivirals for treatment of HCV infections|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Direct Acting Antivirals|HCV NS3/4A Protease Inhibitors|Heterocyclic Compounds, Fused-Ring|NS3/4A Protease Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 inhibitors|OATP1B3 substrates|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Sulfones|Sulfur Compounds|UGT1A1 Inhibitors",[H][C@@]12CN(C(=O)[C@@]([H])(NC(=O)O[C@]3([H])CCC[C@@]3([H])OC\C=C\C(F)(F)C3=NC4=C(C=CC=C4)N=C3O1)C(C)(C)C)[C@@]([H])(C2)C(=O)N[C@@]1(C[C@H]1C(F)F)C(=O)NS(=O)(=O)C1(C)CC1,66828839
11818,DB13882,Methyl nicotinate,small molecule,approved,Anti-Inflammatory Agents|Erythema|Inflammation|Nicotinic Acids|Pyridines,COC(=O)C1=CN=CC=C1,7151
11821,DB13885,Ferric subsulfate,small molecule,approved|experimental,"Acids|Acids, Noncarboxylic|Anions|Coagulants|Electrolytes|Hematologic Agents|Hemostatics|Ions|Iron Compounds|Organometallic Compounds|Parenteral Iron Replacement|Phosphate Binder|Sulfur Acids|Sulfur Compounds|Sulfuric Acids",,
11844,DB13908,Amylmetacresol,small molecule,approved,Benzene Derivatives|Miscellaneous Anti-infectives|Phenols,CCCCCC1=CC=C(C)C=C1O,
11845,DB13909,Bismuth subgallate,small molecule,approved,"Acids, Carbocyclic|Antacids and Adsorbents|Anti-Infective Agents|Antidiarrheals|Benzene Derivatives|Benzoates|Bismuth containing drugs|Coagulants|Drugs that are Mainly Renally Excreted|Hematologic Agents|Hemostatics|Hydroxy Acids|Hydroxybenzoates|Neurotoxic agents|Phenols",O[Bi]1OC2=CC(=CC(O)=C2O1)C(O)=O,
11846,DB13910,Valproate bismuth,small molecule,approved,"Bismuth containing drugs|EENT Drugs, Miscellaneous|Neurotoxic agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",[Bi+3].CCCC(CCC)C([O-])=O.CCCC(CCC)C([O-])=O.CCCC(CCC)C([O-])=O,
11847,DB13911,Phloxine B,small molecule,approved,"Coloring Agents|Compounds used in a research, industrial, or household setting|Dental Agents|Fluoresceins|Fluorescent Dyes|Heterocyclic Compounds, Fused-Ring|Indicators and Reagents|Laboratory Chemicals|Luminescent Agents|Spiro Compounds|Xanthenes",[Na+].[Na+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C1C=C(Br)C([O-])=C2Br,
11848,DB13912,Coumermycin A1,small molecule,experimental,"Antineoplastic Agents|Benzopyrans|Coumarins|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Pyrans|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",CO[C@H]1[C@H](OC(=O)C2=CC=C(C)N2)[C@H](O)[C@@H](OC2=C(C)C3=C(C=C2)C(O)=C(NC(=O)C2=C(C)C(=CN2)C(=O)NC2=C(O)C4=C(OC2=O)C(C)=C(O[C@H]2OC(C)(C)[C@@H](OC)[C@H](OC(=O)C5=CC=C(C)N5)[C@@H]2O)C=C4)C(=O)O3)OC1(C)C,54697785
11850,DB13914,Volixibat,small molecule,experimental|investigational,"Carbohydrates|Heterocyclic Compounds, Fused-Ring|Lipid Regulating Agents|Sulfur Compounds",[H][C@@]1([C@@H](O)[C@](CC)(CCCC)CS(=O)(=O)C2=CC=C(C=C12)N(C)C)C1=CC=CC(NC(=O)N[C@@H]2O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](OCC3=CC=CC=C3)[C@H]2O)=C1,24987688
11852,DB13916,Toyocamycin,small molecule,experimental,"Antibiotics, Antineoplastic|Antimetabolites|Antineoplastic Agents|Carbohydrates|Glycosides|Noxae|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Ribonucleosides|Toxic Actions",NC1=C2C(=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1)C#N,
11853,DB13917,Deoxyepinephrine,small molecule,experimental,Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Benzene Derivatives|Biogenic Amines|Biogenic Monoamines|Catecholamines|Catechols|Epinephrine and similars|Ethanolamines|Phenols,CNCCC1=CC(O)=C(O)C=C1,
11854,DB13918,Diclofop-methyl,small molecule,experimental,Benzene Derivatives|Ethers|Phenols|Phenyl Ethers,COC(=O)C(C)OC1=CC=C(OC2=C(Cl)C=C(Cl)C=C2)C=C1,
11855,DB13919,Candesartan,small molecule,experimental,"Agents Acting on the Renin-Angiotensin System|Agents causing hyperkalemia|Angiotensin 2 Receptor Blocker|Angiotensin II receptor blockers (ARBs) and calcium channel blockers|Angiotensin II receptor blockers (ARBs) and diuretics|Angiotensin II receptor blockers (ARBs), plain|Angiotensin II Type 2 Receptor Blockers|Angiotensin Receptor Antagonists|Antihypertensive Agents|Cardiovascular Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein inhibitors|UGT1A3 substrates",CCOC1=NC2=CC=CC(C(O)=O)=C2N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1,2541
11856,DB13920,Valopicitabine,small molecule,experimental,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidines",CC(C)[C@H](N)C(=O)O[C@@H]1[C@@H](CO)O[C@@H](N2C=CC(N)=NC2=O)[C@]1(C)O,6918726
11857,DB13921,2'-C-methylcytidine,small molecule,experimental,"Carbohydrates|Deoxyribonucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1N1C=CC(N)=NC1=O,
11860,DB13925,Dotatate gallium Ga-68,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Gallium Radioisotopes|Peptides|Peptides, Cyclic|Positron Emitting Activity|Radioactive Diagnostic Agent",[68Ga+3].C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=C2C=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(O)=O,
11862,DB13927,anle138b,small molecule,experimental,"Dioxoles|Heterocyclic Compounds, Fused-Ring",BrC1=CC=CC(=C1)C1=NNC(=C1)C1=CC2=C(OCO2)C=C1,
11863,DB13928,Semaglutide,small molecule,approved|investigational,"Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Drugs Used in Diabetes|Gastrointestinal Hormones|GLP-1 Agonists|Glucagon-like Peptide-1 (GLP-1) Agonists|Glucagon-like peptide-1 (GLP-1) analogues|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Incretin Mimetics|Pancreatic Hormones|Peptide Hormones|Peptides|Proteins",CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)CC1=CNC=N1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O,
11864,DB13929,Relcovaptan,small molecule,investigational,"Antiplatelet agents|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists",COC1=CC=C(C=C1OC)S(=O)(=O)N1[C@@H](C(=O)N2CCC[C@H]2C(N)=O)[C@](O)(C2=CC(Cl)=CC=C12)C1=CC=CC=C1Cl,
11865,DB13930,Ulixertinib,small molecule,investigational,Amines|Pyridines,[H]N([C@H](CO)C1=CC(Cl)=CC=C1)C(=O)C1=CC(=CN1[H])C1=CC(=NC=C1Cl)N([H])C(C)C,
11866,DB13931,Netarsudil,small molecule,approved,"Acids, Carbocyclic|Alanine|Amino Acids|Amino Acids, Peptides, and Proteins|Antiglaucoma Preparations and Miotics|Benzene Derivatives|Ophthalmologicals|Rho Kinase Inhibitor|Rho Kinase Inhibitors|Sensory Organs",CC1=CC(C)=C(C=C1)C(=O)OCC1=CC=C(C=C1)[C@@H](CN)C(=O)NC1=CC=C2C=NC=CC2=C1,
11869,DB13934,Ligandrol,small molecule,investigational,,O[C@H]([C@H]1CCCN1C1=CC=C(C#N)C(=C1)C(F)(F)F)C(F)(F)F,
11870,DB13935,AC-262536,small molecule,experimental,Aza Compounds,[H][C@]12CC[C@]([H])(C[C@H](O)C1)N2C1=CC=C(C#N)C2=CC=CC=C12,
11871,DB13936,JNJ-28330835,small molecule,experimental,,[H]N(C(=O)[C@]1(C)CC(=NN1[H])C(F)(F)F)C1=CC(=C(C=C1)C#N)C(F)(F)F,
11872,DB13937,LGD-3303,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Quinolines",CCC1=C(C)C2=C(C=CC3=C2C(Cl)=CC(=O)N3)N1CC(F)(F)F,
11873,DB13938,S-40503,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring",[H][C@]1(C[C@]([H])(N(C)C)C2=C(N1)C=CC(=C2)N(=O)=O)C(C)(C)CO,
11874,DB13939,RAD-140,small molecule,experimental|investigational,Oxazoles,[H][C@@](C)(O)[C@@]([H])(NC1=C(C)C(Cl)=C(C=C1)C#N)C1=NN=C(O1)C1=CC=C(C=C1)C#N,
11875,DB13940,"2,5-Dimethoxy-4-ethylthioamphetamine",small molecule,experimental,Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Antidepressive Agents|Central Nervous System Depressants|Ethylamines|Phenethylamines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists|Sympathomimetics,CCSC1=CC(OC)=C(CC(C)N)C=C1OC,
11876,DB13941,Piperaquine,small molecule,experimental|investigational,"Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP2E1 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring",ClC1=CC2=C(C=C1)C(=CC=N2)N1CCN(CCCN2CCN(CC2)C2=CC=NC3=C2C=CC(Cl)=C3)CC1,
11877,DB13943,Testosterone cypionate,small molecule,approved,"Anabolic Agents|Androgens|Androstanes|Androstenes|Androstenols|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Delayed-Action Preparations|Drugs that are Mainly Renally Excreted|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|OAT3/SLC22A8 Inducers|P-glycoprotein inhibitors|Steroids|Testosterone and derivatives|Testosterone Congeners|Thyroxine-binding globulin inhibitors",C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2OC(=O)CCC1CCCC1,
11878,DB13944,Testosterone enanthate,small molecule,approved,"Adrenal Cortex Hormones|Androgens|Androstanes|Androstenes|Androstenols|BCRP/ABCG2 Substrates|Contraceptive Agents, Male|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|OAT3/SLC22A8 Inducers|P-glycoprotein inhibitors|Steroids|Testosterone and derivatives|Testosterone Congeners|Thyroxine-binding globulin inhibitors",[H][C@@]12CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
11879,DB13946,Testosterone undecanoate,small molecule,approved|investigational,"Androgens|Androstanes|Androstenes|Androstenols|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|OAT3/SLC22A8 Inducers|P-glycoprotein inhibitors|Steroids|Testosterone and derivatives|Testosterone Congeners|Thyroxine-binding globulin inhibitors",CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,
11880,DB13947,Testosterone enantate benzilic acid hydrazone,small molecule,approved|experimental,"Androstanes|Androstenes|Androstenols|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone and derivatives|Testosterone Congeners",[H]N(N=C1CC[C@@]2(C)C(CC[C@@]3([H])[C@]4([H])CC[C@H](OC(=O)CCCCCC)[C@@]4(C)CC[C@]23[H])=C1)C(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,
11881,DB13948,"N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine",small molecule,experimental,Antidepressive Agents|Central Nervous System Depressants|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists,COC1=CC(C#N)=C(OC)C=C1CCNCC1=C(O)C=CC=C1,
11882,DB13949,Ferric cation,small molecule,approved,"Iron Compounds|Parenteral Iron Replacement|Phosphate Binder|Phosphate Chelating Activity|Polyvalent cation containing laxatives, antacids, oral supplements",[Fe+3],
11883,DB13950,WIN 55212-2,small molecule,experimental,"Agents causing hyperkalemia|Agents producing tachycardia|Analgesics|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cannabinoid Receptor Antagonists|Cannabinoids and similars|Cardiovascular Agents|Central Nervous System Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Membrane Transport Modulators|Oxazines|Peripheral Nervous System Agents|Receptor, Cannabinoid, CB1, antagonists & inhibitors|Sensory System Agents",CC1=C(C(=O)C2=CC=CC3=CC=CC=C23)C2=C3N1[C@H](CN1CCOCC1)COC3=CC=C2,
11884,DB13951,Stanolone acetate,small molecule,experimental,P-glycoprotein substrates|Testosterone and derivatives,[H][C@@]12CC[C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C,
11885,DB13952,Estradiol acetate,small molecule,approved|investigational|vet_approved,BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Estrogens|OATP1B1/SLCO1B1 Inhibitors|OCT1 inhibitors|OCT2 Inhibitors|P-glycoprotein substrates|Thyroxine-binding globulin inducers|UGT1A1 Substrates,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OC(C)=O)C=C3CC[C@@]21[H],9818306
11886,DB13953,Estradiol benzoate,small molecule,approved|investigational|vet_approved,"Adrenal Cortex Hormones|BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Estradiol Congeners|Estranes|Estrenes|Estrogens|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|OATP1B1/SLCO1B1 Inhibitors|OCT1 inhibitors|OCT2 Inhibitors|P-glycoprotein substrates|Reproductive Control Agents|Steroids|UGT1A1 Substrates",[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(OC(=O)C5=CC=CC=C5)=CC=C4[C@@]3([H])CC[C@]12C,222757
11887,DB13954,Estradiol cypionate,small molecule,approved|investigational|vet_approved,"Adrenal Cortex Hormones|BCRP/ABCG2 Inhibitors|Contraceptive Agents, Female|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Estradiol Congeners|Estranes|Estrenes|Estrogen Contraceptives|Estrogens|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|OATP1B1/SLCO1B1 Inhibitors|OCT1 inhibitors|OCT2 Inhibitors|P-glycoprotein substrates|Reproductive Control Agents|Steroids|Thyroxine-binding globulin inducers|UGT1A1 Substrates",[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]12C)OC(=O)CCC1CCCC1,9403
11888,DB13955,Estradiol dienanthate,small molecule,approved|investigational|vet_approved,"BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Estradiol Congeners|Estranes|Estrenes|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|OATP1B1/SLCO1B1 Inhibitors|OCT1 inhibitors|OCT2 Inhibitors|P-glycoprotein substrates|Steroids|UGT1A1 Substrates",CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(OC(=O)CCCCCC)=CC=C4[C@H]3CC[C@]12C,
11889,DB13956,Estradiol valerate,small molecule,approved|investigational|vet_approved,"Adrenal Cortex Hormones|BCRP/ABCG2 Inhibitors|Contraceptive Agents, Female|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Estradiol Congeners|Estradiol, agonists|Estranes|Estrenes|Estrogen Contraceptives|Estrogens|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|OATP1B1/SLCO1B1 Inhibitors|OCT1 inhibitors|OCT2 Inhibitors|P-glycoprotein substrates|Steroids|Thyroxine-binding globulin inducers|UGT1A1 Substrates",[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,13791
11890,DB13957,J147,small molecule,experimental,"Alkanes|Benzene Derivatives|Catechols|Diarylheptanoids|Heptanes|Hydrocarbons, Acyclic|Phenols",COC1=CC(\C=N\N(C(=O)C(F)(F)F)C2=C(C)C=C(C)C=C2)=CC=C1,
11891,DB13958,Trestolone acetate,small molecule,experimental,"Estranes|Estrenes|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone and derivatives|Testosterone Congeners",[H][C@@]12CC[C@H](OC(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3C[C@@H](C)[C@@]21[H],
11892,DB13959,Medium-chain triglycerides,small molecule,approved,,,
11893,DB13960,Bronopol,small molecule,approved,"Alcohols|Anti-Infective Agents|Anti-Infective Agents, Local|Cell-mediated Immunity|Compounds used in a research, industrial, or household setting|Drugs that are Mainly Renally Excreted|Glycols|Increased Histamine Release|Indicators and Reagents|Laboratory Chemicals|Preservatives, Pharmaceutical|Standardized Chemical Allergen",OCC(Br)(CO)[N+]([O-])=O,
11895,DB13962,Calcium saccharate,small molecule,approved|experimental,Replacement Preparations,[Ca++].[H][C@](O)(C([O-])=O)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)C([O-])=O,
11896,DB13963,"1,2-dichlorobenzene",small molecule,experimental,"Agrochemicals|Benzene Derivatives|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 Substrates|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Insecticides|Pesticides|Toxic Actions",ClC1=C(Cl)C=CC=C1,
11899,DB13966,Isopropyl myristate,small molecule,approved|experimental,Fatty Acids|Lipids|Myristic Acids|Scabicides and Pediculicides,CCCCCCCCCCCCCC(=O)OC(C)C,
11900,DB13967,Patent Blue,small molecule,approved,"Amines|Aniline Compounds|Coloring Agents|Compounds used in a research, industrial, or household setting|Drugs that are Mainly Renally Excreted|Other Diagnostics",CCN(CC)C1=CC=C(C=C1)C(=C1C=CC(C=C1)=[N+](CC)CC)C1=C(C=C(C(O)=C1)S(O)(=O)=O)S(O)(=O)=O,
11902,DB13969,Quaternium-24,small molecule,experimental,,[Cl-].CCCCCCCCCC[N+](C)(C)CCCCCCCC,
11903,DB13970,Dioctyldimonium,small molecule,approved|experimental,Amines|Ammonium Compounds|Nitrogen Compounds|Onium Compounds,CCCCCCCC[N+](C)(C)CCCCCCCC,
11904,DB13971,Vanadium,small molecule,approved|experimental,"Diet, Food, and Nutrition|Elements|Food|Food and Beverages|Growth Substances|Metals|Metals, Heavy|Micronutrients|Physiological Phenomena|Trace Elements|Transition Elements",[V],
11905,DB13972,Racemethionine,small molecule,approved|experimental,"Amino Acids|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Sulfur Compounds",CSCCC(N)C(O)=O,
11910,DB13977,Potassium carbonate,small molecule,approved,"Acids|Acids, Noncarboxylic|Alkalies|Anions|Carbon Compounds, Inorganic|Carbonic Acid|Electrolytes|Elements|Ions|Metals|Metals, Alkali|Metals, Light|Potassium Salt",[K+].[K+].[O-]C([O-])=O,
11911,DB13978,Selisistat,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Indoles|Sirtuin 1, antagonists & inhibitors",NC(=O)C1CCCC2=C1NC1=C2C=C(Cl)C=C1,
11913,DB13980,Copper Cu-64,small molecule,approved,,,
11914,DB13981,Nomegestrol acetate,small molecule,investigational,"Adrenal Cortex Hormones|Antineoplastic Agents, Hormonal|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Hormonal Contraceptives for Systemic Use|Norpregnanes|Norsteroids|Pregnadienes|Pregnanes|Progesterone Congeners|Progestin Contraceptives|Progestins|Steroids",[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3C(C)=C[C@@]21[H],
11915,DB13982,Lutetium Lu-177,small molecule,approved,"Elements|Isotopes|Lanthanoid Series Elements|Metals|Metals, Rare Earth|Transition Elements",[177Lu],
11916,DB13983,"5,7,2′-trihydroxy-6,8-dimethoxyflavone",small molecule,experimental,,COC1=C(O)C(OC)=C2OC(=CC(=O)C2=C1O)C1=CC=CC=C1O,
11917,DB13984,Cyclopropane,small molecule,experimental,Anesthetics|Central Nervous System Agents|Central Nervous System Depressants|Cycloparaffins,C1CC1,
11918,DB13985,Lutetium Lu 177 dotatate,small molecule,approved|investigational,"Amino Acids, Peptides, and Proteins|Lutetium|Organometallic Compounds|Peptides|Peptides, Cyclic",[177Lu+3].C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=C2C=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(O)=O,
11919,DB13987,Strontium chloride,small molecule,approved,"Drugs that are Mainly Renally Excreted|Elements|Metals|Metals, Alkaline Earth|Metals, Heavy|Strontium Radioisotopes",[Cl-].[Cl-].[Sr++],
11920,DB13988,SB-269970,small molecule,investigational,Amides|Benzene Derivatives|Sulfones|Sulfur Compounds,CC1CCN(CC[C@H]2CCCN2S(=O)(=O)C2=CC=CC(O)=C2)CC1,
11921,DB13989,Epitizide,small molecule,experimental,Diuretics|Low-Ceiling Diuretics and Potassium-Sparing Agents|Sodium Chloride Symporter Inhibitors,NS(=O)(=O)C1=CC2=C(NC(CSCC(F)(F)F)NS2(=O)=O)C=C1Cl,
11922,DB13990,Dipropyl-4-hydroxytryptamine,small molecule,experimental,,CCCN(CCC)CCC1=CNC2=C1C(O)=CC=C2,
11923,DB13991,Pipequaline,small molecule,experimental,"Central Nervous System Agents|Heterocyclic Compounds, Fused-Ring",C(CC1=C2C=CC=CC2=NC(=C1)C1=CC=CC=C1)C1CCNCC1,
11924,DB13992,Azintamide,small molecule,investigational,,CCN(CC)C(=O)CSC1=CC=C(Cl)N=N1,
11925,DB13993,MRK-409,small molecule,experimental,"Anti-Anxiety Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Hydrocarbons, Halogenated",CN1N=CN=C1COC1=NN2C(C=C1C1CCC1)=NN=C2C1=C(F)C=CC=C1F,
11926,DB13994,AZD-7325,small molecule,investigational,"GABA Modulators|Heterocyclic Compounds, Fused-Ring",CCCNC(=O)C1=C(N)C2=CC=CC(=C2N=N1)C1=C(F)C=CC=C1OC,
11927,DB13995,Ferric pyrophosphate citrate,small molecule,approved|investigational,Enzymes|Enzymes and Coenzymes|Hydrolases|Parenteral Iron Replacement|Peptide Hydrolases|Phosphate Binder|Phosphate salts,[Fe+3].[Fe+3].[Fe+3].[Fe+3].OP(O)(=O)OP(O)(O)=O.OP(O)(=O)OP(O)(O)=O.OP([O-])(=O)OP([O-])([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,
11928,DB13996,Magnesium acetate,small molecule,approved,Agents that produce neuromuscular block (indirect)|Calculi Dissolution Agent|Laxatives|Osmotic Laxatives,[Mg++].CC([O-])=O.CC([O-])=O,
11929,DB13997,Baloxavir marboxil,small molecule,approved|investigational,Anti-Infective Agents|Antiviral Agents|Antivirals for Systemic Use|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Direct Acting Antivirals|Enzyme Inhibitors|Sulfur Compounds|UGT1A3 substrates,[H][C@@]12COCCN1C(=O)C1=C(OCOC(=O)OC)C(=O)C=CN1N2[C@H]1C2=CC=C(F)C(F)=C2CSC2=CC=CC=C12,
11932,DB14000,Tetraglyme,small molecule,experimental,Alcohols|Glycols,COCCOCCOCCOCCOC,
11933,DB14001,alpha-Tocopherol succinate,small molecule,approved|nutraceutical|vet_approved,"Antioxidants|Benzopyrans|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Heterocyclic Compounds, Fused-Ring|Micronutrients|Physiological Phenomena|Protective Agents|Pyrans|Tocopherols|Vitamin E|Vitamins|Vitamins (Fat Soluble)",[H][C@@](C)(CCCC(C)C)CCC[C@@]([H])(C)CCC[C@]1(C)CCC2=C(C)C(OC(=O)CCC(O)=O)=C(C)C(C)=C2O1,
11934,DB14002,D-alpha-Tocopherol acetate,small molecule,approved|nutraceutical|vet_approved,"Compounds used in a research, industrial, or household setting|Tocopherols|Vitamin E|Vitamins|Vitamins (Fat Soluble)",CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(C)C(OC(C)=O)=C(C)C(C)=C2O1,
11935,DB14003,alpha-Tocopherol acetate,small molecule,approved,"Antioxidants|Benzopyrans|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Heterocyclic Compounds, Fused-Ring|Micronutrients|P-glycoprotein substrates|Physiological Phenomena|Protective Agents|Pyrans|Tocopherols|Vitamin E|Vitamins|Vitamins (Fat Soluble)",,
11937,DB14005,Dimethicone 410,small molecule,approved,,,
11938,DB14006,Choline salicylate,small molecule,approved|nutraceutical,"Acids, Carbocyclic|Alcohols|Amines|Amino Alcohols|Ammonium Compounds|Analgesics|Benzene Derivatives|Benzoates|Drugs that are Mainly Renally Excreted|Ethanolamines|Hydroxy Acids|Hydroxybenzoates|Nervous System|Nitrogen Compounds|OCT1 inhibitors|OCT1 substrates|OCT2 Inhibitors|OCT2 Substrates|Onium Compounds|Pharmaceutical Preparations|Phenols|Quaternary Ammonium Compounds|Salicylates|Salicylic Acid and Derivatives|Trimethyl Ammonium Compounds",C[N+](C)(C)CCO.OC1=CC=CC=C1C([O-])=O,
11939,DB14007,Pentetic acid,small molecule,approved,"Acetates|Acids, Acyclic|Amines|Antidotes|Chelating Agents|Compounds used in a research, industrial, or household setting|Drugs that are Mainly Renally Excreted|Fatty Acids|Fatty Acids, Volatile|Iron Chelating Agents|Lead Chelating Activity|Lead Chelator|Lipids|Polyamines|Protective Agents|Sequestering Agents",OC(=O)CN(CCN(CC(O)=O)CC(O)=O)CCN(CC(O)=O)CC(O)=O,
11940,DB14008,Hispidulin,small molecule,experimental,"Benzopyrans|Chromones|Flavonoids|Heterocyclic Compounds, Fused-Ring|Pyrans",COC1=C(O)C2=C(OC(=CC2=O)C2=CC=C(O)C=C2)C=C1O,
11942,DB14010,"5-methoxy-N,N-dimethyltryptamine",small molecule,experimental|illicit,Agents that produce hypertension|Antidepressive Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Substrates|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists,COC1=CC=C2NC=C(CCN(C)C)C2=C1,
11943,DB14011,Nabiximols,small molecule,investigational,Agents producing tachycardia|Analgesics|BCRP/ABCG2 Inhibitors|Cannabinoid Receptor Agonists|Cannabinoids and similars|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Peripheral Nervous System Agents|Pharmaceutical Preparations|Sensory System Agents|Terpenes,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C,
11945,DB14013,SR-9009,small molecule,experimental,Sulfur Compounds,CCOC(=O)N1CCC(CN(CC2=CC=C(S2)[N+]([O-])=O)CC2=CC=C(Cl)C=C2)C1,
11946,DB14014,SR-9011,small molecule,experimental,Sulfur Compounds,CCCCCNC(=O)N1CCC(CN(CC2=CC=C(S2)[N+]([O-])=O)CC2=CC=C(Cl)C=C2)C1,
11947,DB14015,Sodium bisulfite,small molecule,approved,"Anions|Anti-Infective Agents|Anti-Infective Agents, Local|Antioxidants|Compounds used in a research, industrial, or household setting|Electrolytes|Ions|Mutagens|Noxae|Protective Agents|Sulfur Compounds|Toxic Actions",[Na+].OS([O-])=O,
11949,DB14017,H3B-8800,small molecule,investigational,,C[C@H](\C=C\C=C(/C)[C@H]1OC(=O)C[C@H](O)CC[C@@](C)(O)[C@@H](OC(=O)N2CCN(C)CC2)\C=C\[C@@H]1C)C1=CC=CC=N1,
11950,DB14018,Bromotheophylline,small molecule,approved,"Alcohols|Alkaloids|Amines|Amino Alcohols|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Diuretics|Drugs for Obstructive Airway Diseases|Heterocyclic Compounds, Fused-Ring|Pharmaceutical Preparations|Propanols|Purines|Purinones|Xanthine derivatives",CN1C2=C(NC(Br)=N2)C(=O)N(C)C1=O,
11951,DB14019,Fosnetupitant,small molecule,approved,Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Netupitant and prodrug|Substance P/Neurokinin-1 Receptor Antagonist,CN(C(=O)C(C)(C)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C1=CN=C(C=C1C1=CC=CC=C1C)N1CC[N+](C)(COP(O)([O-])=O)CC1,
11952,DB14020,Benzoin,small molecule,approved|experimental,Acetophenones|Ketones,OC(C(=O)C1=CC=CC=C1)C1=CC=CC=C1,
11954,DB14025,Clinafloxacin,small molecule,investigational,"Anti-Bacterial Agents|Anti-Infective Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Hypoglycemia-Associated Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",NC1CCN(C1)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1Cl)C(O)=O,
11955,DB14026,Thiosalicylic acid,small molecule,experimental,"Acids, Carbocyclic|Alkylmercury Compounds|Analgesics|Analgesics, Non-Narcotic|Benzene Derivatives|Benzoates|Central Nervous System Agents|Ethylmercury Compounds|Hydroxy Acids|Hydroxybenzoates|Organomercury Compounds|Organometallic Compounds|Peripheral Nervous System Agents|Phenols|Salicylates|Sensory System Agents|Sulfur Compounds",OC(=O)C1=C(S)C=CC=C1,
11956,DB14027,Taspoglutide,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Gastrointestinal Hormones|GLP-1 Agonists|Glucagon-Like Peptides|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Pancreatic Hormones|Peptide Hormones|Peptides|Proglucagon|Protein Precursors|Proteins",CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)CC1=CNC=N1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O,
11957,DB14028,Nordazepam,small molecule,experimental,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Anti-Anxiety Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|GABA Agents|GABA Modulators|Heterocyclic Compounds, Fused-Ring|Nervous System|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents",ClC1=CC=C2NC(=O)CN=C(C3=CC=CC=C3)C2=C1,
11958,DB14029,Furafylline,small molecule,experimental,"Alkaloids|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Purines|Purinones|Xanthine derivatives",FC1=C(C=C(C=N1)C1CC2CCC1N2)C1=CC=C(C=C1)C#N,
11959,DB14030,PZM21,small molecule,experimental,,C[C@@H](CC1=CSC=C1)NC(=O)NC[C@H](CC1=CC=C(O)C=C1)N(C)C,
11960,DB14031,Tretamine,small molecule,experimental,"Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Aziridines|Azirines|Cholinesterase Inhibitors|Noxae|Toxic Actions|Triazines",C1CN1C1=NC(=NC(=N1)N1CC1)N1CC1,
11961,DB14033,Acetyl sulfisoxazole,small molecule,approved|vet_approved,Amides|Amines|Aniline Compounds|Anti-Bacterial Agents|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Sulfanilamides|Sulfonamide Antibacterial|Sulfonamides|Sulfones|Sulfur Compounds,CC(=O)N(C1=C(C)C(C)=NO1)S(=O)(=O)C1=CC=C(N)C=C1,6662
11962,DB14034,Darglitazone,small molecule,experimental,Sulfur Compounds|Thiazoles,CC1=C(CCC(=O)C2=CC=C(CC3SC(=O)NC3=O)C=C2)N=C(O1)C1=CC=CC=C1,
11963,DB14035,Englitazone,small molecule,experimental,"Blood Glucose Lowering Agents|Heterocyclic Compounds, Fused-Ring|Pyrans|Sulfur Compounds|Thiazoles",O=C1NC(=O)C(CC2=CC=C3O[C@@H](CC4=CC=CC=C4)CCC3=C2)S1,
11964,DB14037,Madecassic acid,small molecule,experimental,Terpenes,[H][C@]12CC=C3[C@]4([H])[C@@H](C)[C@H](C)CC[C@@]4(CC[C@@]3(C)[C@]1(C)C[C@@H](O)[C@@]1([H])[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]21C)C(O)=O,
11965,DB14038,beta-Sitosterol,small molecule,experimental,Biological Factors|Cholestanes|Cholestenes|Fused-Ring Compounds|Hypolipidemic Agents|Lipid Regulating Agents|Lipids|Membrane Lipids|Noxae|Phytochemicals|Phytosterols|Steroids|Sterols|Toxic Actions,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CC[C@@H](CC)C(C)C,
11970,DB14043,Palmidrol,small molecule,experimental|nutraceutical,"Agents producing tachycardia|Alcohols|Amines|Amino Alcohols|Analgesics|Analgesics, Non-Narcotic|Anti-Infective Agents|Anti-Inflammatory Agents|Antirheumatic Agents|Cannabinoids and similars|Central Nervous System Agents|Fatty Acids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Lipids|Neurotransmitter Agents|Peripheral Nervous System Agents|Sensory System Agents",CCCCCCCCCCCCCCCC(=O)NCCO,
11971,DB14044,Hopantenic acid,small molecule,experimental,"Acids, Acyclic|Alanine|Amino Acids|Amino Acids, Peptides, and Proteins|Aminobutyrates|Butyrates|Central Nervous System Agents|Fatty Acids|Fatty Acids, Volatile|Imides|Lipids|Nootropic Agents",CC(C)(CO)[C@@H](O)C(=O)NCCCC(O)=O,
11972,DB14045,Cholesteryl chloride,small molecule,experimental,Cholestanes|Fused-Ring Compounds|Steroids,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](Cl)CC[C@]4(C)[C@H]3CC[C@]12C,
11973,DB14046,Dichlorobenzene,small molecule,approved|experimental,Benzene Derivatives|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 Substrates,,
11974,DB14048,Sodium zirconium cyclosilicate,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Anions|Drugs for Treatment of Hyperkalemia and Hyperphosphatemia|Electrolytes|Gastric Acid Lowering Agents|Ions|Minerals|Oxides|Oxygen Compounds|Potassium Binder|Potassium-removing Agents|Silicon Compounds",[Na+].[Na+].[Zr].[O-][Si]1([O-])O[Si]([O-])([O-])O[Si]([O-])([O-])O1,
11975,DB14049,Nitrate,small molecule,experimental|investigational,"Acids|Acids, Noncarboxylic|Anions|Antianginal Agents|Electrolytes|Ions|Nitrates|Nitric Acid|Nitrogen Compounds|Organic Nitrates|Vasodilating Agents",[O-]N(=O)=O,
11976,DB14050,Cannabidivarin,small molecule,investigational,Anticonvulsants|Central Nervous System Depressants|Terpenes,[H][C@]1(CCC(C)=C[C@H]1C1=C(O)C=C(CCC)C=C1O)C(C)=C,
11977,DB14051,Malacidin A,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Lipids|Malacidins|Peptides",CC(C)CC\C=C/C=C/C(=O)N[C@@H](C(C)C(O)=O)C(=O)N[C@H]1C(C)NC(=O)[C@@H]2C[C@@H](C)CN2C(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](NC1=O)C(C)C)C(O)C(O)=O)C(C)C(O)=O)C(C)C,
11978,DB14052,Malacidin B,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Lipids|Malacidins|Peptides",CCC(C)CC\C=C/C=C/C(=O)N[C@@H](C(C)C(O)=O)C(=O)N[C@H]1C(C)NC(=O)[C@@H]2C[C@@H](C)CN2C(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](NC1=O)C(C)C)C(O)C(O)=O)C(C)C(O)=O)C(C)C,
11979,DB14054,Asiatic acid,small molecule,experimental,Terpenes|Triterpenes,[H][C@@]12CC[C@]3(C)[C@]([H])(CC=C4[C@]5([H])[C@@H](C)[C@H](C)CC[C@@]5(CC[C@@]34C)C(O)=O)[C@@]1(C)C[C@@H](O)[C@H](O)[C@@]2(C)CO,
11980,DB14055,(S)-Warfarin,small molecule,experimental|investigational,Anticoagulants|Cytochrome P-450 CYP2C18 Substrates|Cytochrome P-450 CYP2C18 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Vitamin K Antagonists,CC(=O)C[C@@H](C1=CC=CC=C1)C1=C(O)C2=C(OC1=O)C=CC=C2,
11981,DB14056,Nigericin,small molecule,experimental,"Anti-Bacterial Agents|Anti-Infective Agents|Compounds used in a research, industrial, or household setting|Furans|Ionophores|Membrane Transport Modulators|Pyrans",[H][C@@]1(C[C@H](C)[C@@]([H])(O1)[C@]1(C)CC[C@@]([H])(O1)[C@]1(C)C[C@@H](C)[C@]2(O1)O[C@]([H])(C[C@@]1([H])CC[C@H](C)[C@@]([H])(O1)[C@@H](C)C(O)=O)C[C@@H](OC)[C@H]2C)[C@@]1([H])O[C@@](O)(CO)[C@H](C)C[C@@H]1C,
11982,DB14057,Valinomycin,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|BSEP/ABCB11 Inhibitors|Compounds used in a research, industrial, or household setting|Depsipeptides|Ionophores|Membrane Transport Modulators|P-glycoprotein inhibitors|P-glycoprotein substrates|Peptides|Peptides, Cyclic",CC(C)[C@@H]1NC(=O)[C@H](C)OC(=O)[C@H](NC(=O)[C@H](OC(=O)[C@@H](NC(=O)[C@H](C)OC(=O)[C@H](NC(=O)[C@H](OC(=O)[C@@H](NC(=O)[C@H](C)OC(=O)[C@H](NC(=O)[C@H](OC1=O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C,
11983,DB14058,Basifungin,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antifungal Agents|Enzyme Inhibitors|Peptides|Peptides, Cyclic",CC[C@@H](C)[C@@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)N(C)C(=O)[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC2=CC=CC=C2)N(C)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)C(NC1=O)C(C)C)[C@H](C)C(C)C,
11984,DB14059,SC-236,small molecule,experimental|investigational,"Agents causing hyperkalemia|Agents that produce hypertension|Amides|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antirheumatic Agents|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Nephrotoxic agents|Peripheral Nervous System Agents|Sensory System Agents|Sulfones|Sulfur Compounds",NS(=O)(=O)C1=CC=C(C=C1)N1N=C(C=C1C1=CC=C(Cl)C=C1)C(F)(F)F,
11985,DB14060,NS-398,small molecule,experimental,"Agents causing hyperkalemia|Agents that produce hypertension|Amides|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antirheumatic Agents|Benzene Derivatives|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Nephrotoxic agents|Nitro Compounds|Peripheral Nervous System Agents|Sensory System Agents|Sulfones|Sulfur Compounds",CS(=O)(=O)NC1=CC=C(C=C1OC1CCCCC1)[N+]([O-])=O,
11986,DB14061,Hycanthone,small molecule,experimental,"Anthelmintics|Anti-Infective Agents|Antiparasitic Agents|Antiplatyhelmintic Agents|Heterocyclic Compounds, Fused-Ring|P-glycoprotein inhibitors|Schistosomicides|Sulfur Compounds|Thioxanthenes|Xanthenes",CCN(CC)CCNC1=C2C(=O)C3=CC=CC=C3SC2=C(CO)C=C1,
11987,DB14062,Concanamycin A,small molecule,experimental,"Anti-Infective Agents|Enzyme Inhibitors|Lactones|P-glycoprotein inhibitors|Polyketides|Proton-Translocating ATPases, antagonists & inhibitors",[H][C@@]1(OC(=O)\C(OC)=C\C(\C)=C\[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C\C(C)=C\C=C\[C@@H]1OC)[C@@H](C)[C@@H](O)[C@H](C)[C@@]1(O)C[C@@H](O[C@H]2C[C@@H](O)[C@H](OC(N)=O)[C@@H](C)O2)[C@H](C)[C@H](O1)\C=C\C,
11988,DB14063,Dexverapamil,small molecule,experimental,Agents causing hyperkalemia|Amines|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Ethylamines|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|P-glycoprotein inhibitors|Phenethylamines|QTc Prolonging Agents|Vasodilating Agents,COC1=CC=C(CCN(C)CCC[C@@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1OC,
11989,DB14064,Emopamil,small molecule,experimental,Agents causing hyperkalemia|Amines|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Ethylamines|Membrane Transport Modulators|P-glycoprotein inhibitors|Phenethylamines,CC(C)C(CCCN(C)CCC1=CC=CC=C1)(C#N)C1=CC=CC=C1,
11990,DB14065,Lomerizine,small molecule,experimental,Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Membrane Transport Modulators|P-glycoprotein inhibitors,COC1=CC=C(CN2CCN(CC2)C(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)C(OC)=C1OC,
11991,DB14066,Tetrandrine,small molecule,experimental,"Agents causing hyperkalemia|Alkaloids|Anti-Infective Agents|Antiarrhythmic agents|Antimalarials|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Antiparasitic Agents|Antiprotozoals|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drugs, Chinese Herbal|Heterocyclic Compounds, Fused-Ring|Immunologic Factors|Immunosuppressive Agents|Isoquinolines|Membrane Transport Modulators|P-glycoprotein inhibitors",COC1=CC=C2C[C@@H]3N(C)CCC4=C3C(OC3=CC5=C(CCN(C)[C@H]5CC5=CC=C(OC1=C2)C=C5)C=C3OC)=C(OC)C(OC)=C4,
11992,DB14067,Dofequidar,small molecule,experimental|investigational,"Antineoplastic Agents|Heterocyclic Compounds, Fused-Ring|P-glycoprotein inhibitors",OC(COC1=CC=CC2=C1C=CC=N2)CN1CCN(CC1)C(=O)C(C1=CC=CC=C1)C1=CC=CC=C1,
11993,DB14068,Dexniguldipine,small molecule,experimental,Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Antineoplastic Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Membrane Transport Modulators|P-glycoprotein inhibitors|Pyridines,[H]N1C(C)=C([C@@H](C2=CC(=CC=C2)[N+]([O-])=O)C(C(=O)OCCCN2CCC(CC2)(C2=CC=CC=C2)C2=CC=CC=C2)=C1C)C(=O)OC,
11994,DB14069,ONT-093,small molecule,investigational,"Drug Resistance, Multiple|P-glycoprotein inhibitors",[H]\C(COCC)=C(\[H])C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC=C(NC(C)C)C=C1)C1=CC=C(NC(C)C)C=C1,
11995,DB14070,HM-30181,small molecule,experimental,"ATP Binding Cassette Transporter, Subfamily B, Member 1, antagonists & inhibitors|Heterocyclic Compounds, Fused-Ring|P-glycoprotein inhibitors|Pyrans",[H]N(C(=O)C1=CC(=O)C2=CC=CC=C2O1)C1=CC(OC)=C(OC)C=C1C1=NN(N=N1)C1=CC=C(CCN2CCC3=CC(OC)=C(OC)C=C3C2)C=C1,
11996,DB14071,Desmethylsertraline,small molecule,experimental,1-Naphthylamine|Agents that reduce seizure threshold|Amines|Naphthalenes|P-glycoprotein inhibitors,[H][C@]1(N)CC[C@@]([H])(C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,
11997,DB14072,Reversin 121,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Drug Resistance, Multiple|P-glycoprotein inhibitors|Peptides",CC(C)(C)OC(=O)N[C@@H](CC(=O)OCC1=CC=CC=C1)C(=O)N[C@@H](CCCCNC(=O)OCC1=CC=CC=C1)C(=O)OC(C)(C)C,
11998,DB14073,Gondoic acid,small molecule,experimental,"Fatty Acids|Fatty Acids, Unsaturated|Lipids",CCCCCCCC\C=C/CCCCCCCCCC(O)=O,
11999,DB14074,Icaridin,small molecule,experimental,Insect Repellents|Piperidines,CCC(C)OC(=O)N1CCCCC1CCO,
12000,DB14075,Imidurea,small molecule,approved|experimental,"Cell-mediated Immunity|Increased Histamine Release|Pharmaceutic Aids|Preservatives, Pharmaceutical|Standardized Chemical Allergen",OCN1C(NC(=O)NCNC(=O)NC2N(CO)C(=O)NC2=O)C(=O)NC1=O,
12002,DB14077,Magnesium stearate,small molecule,investigational,Agents that produce neuromuscular block (indirect)|Fatty Acids|Lipids,[Mg++].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O,
12003,DB14078,Medronic acid,small molecule,approved|investigational,,OP(O)(=O)CP(O)(O)=O,
12004,DB14079,Hydroxybutyloxide,small molecule,experimental,,CC(O)CCOCCC(C)O,
12005,DB14080,Acetylcysteine magnesium,small molecule,experimental,,[Mg++].[H]N([C@@H](CS)C([O-])=O)C(C)=O.[H]N([C@@H](CS)C([O-])=O)C(C)=O,
12006,DB14081,Asiaticoside,small molecule,experimental,Anti-Infective Agents|Terpenes,[H][C@@]12CC[C@]3(C)[C@]([H])(CC=C4[C@]5([H])[C@@H](C)[C@H](C)CC[C@@]5(CC[C@@]34C)C(=O)O[C@@H]3O[C@H](CO[C@@H]4O[C@H](CO)[C@@H](O[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)[C@@]1(C)C[C@@H](O)[C@H](O)[C@@]2(C)CO,
12007,DB14082,Betiatide,small molecule,approved|experimental,,OC(=O)CNC(=O)CNC(=O)CNC(=O)CSC(=O)C1=CC=CC=C1,
12008,DB14083,Bisphenol A diglycidyl ether,small molecule,approved|experimental,"Benzene Derivatives|Carcinogens|Cell-mediated Immunity|Ethers|Ethers, Cyclic|Increased Histamine Release|Noxae|Standardized Chemical Allergen|Toxic Actions",CC(C)(C1=CC=C(OCC2CO2)C=C1)C1=CC=C(OCC2CO2)C=C1,
12009,DB14084,Butylparaben,small molecule,approved|experimental,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Cell-mediated Immunity|Hydroxy Acids|Hydroxybenzoates|Increased Histamine Release|Phenols|Standardized Chemical Allergen",CCCCOC(=O)C1=CC=C(O)C=C1,
12010,DB14085,Cadmium,small molecule,experimental,"Elements|Metals|Metals, Heavy|Transition Elements",[Cd],
12011,DB14086,Cianidanol,small molecule,approved|withdrawn,"Benzopyrans|Catechin|Chromans|Chromones|Flavonoids|Heterocyclic Compounds, Fused-Ring|Pyrans",O[C@H]1CC2=C(O)C=C(O)C=C2O[C@@H]1C1=CC=C(O)C(O)=C1,
12012,DB14087,Morrhuic acid,small molecule,experimental,"Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Fatty Acids|Lipids|Pharmaceutical Preparations|Pharmaceutical Solutions|Sclerosing Solutions|Solutions",,
12013,DB14088,Osbond acid,small molecule,experimental,Fatty Acids|Lipids,CCCCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O,
12014,DB14089,Dimercaptosuccinic acid,small molecule,approved|experimental,"Chelating Agents|Compounds used in a research, industrial, or household setting|Metal Chelator",OC(=O)C(S)C(S)C(O)=O,
12015,DB14090,Dimethyl sulfone,small molecule,experimental|investigational,Anti-Inflammatory Agents|Sulfoxides|Sulfur Compounds,CS(C)(=O)=O,
12016,DB14091,Carbomer homopolymer type C,small molecule,experimental|investigational,"Anti-Infective Agents|Compounds used in a research, industrial, or household setting|Dental Cavity Preparation|Dental Materials|Dentin-Bonding Agents|Macromolecular Substances|Ophthalmic Solutions|Pharmaceutical Preparations|Pharmaceutical Solutions|Plastics|Polymers|Resins, Synthetic|Solutions",,
12017,DB14092,8-epi-Cyanocobalamin,small molecule,experimental,,[Co+3].[C-]#N.[H][C@@](C)(CN=C(O)CC[C@@]1(C)C2=NC([H])([C@]1([H])CC(O)=N)[C@]1(C)NC(=C(C)C3=NC(=CC4=NC(=C2C)[C@@]([H])(CCC([O-])=N)C4(C)C)[C@]([H])(CCC([O-])=N)[C@]3(C)CC(O)=N)[C@@]([H])(CCC([O-])=N)[C@]1(C)CC(O)=N)OP(O)(=O)O[C@]1([H])[C@@]([H])(CO)O[C@]([H])([N+]2=CNC3=C2C=C(C)C(C)=C3)[C@]1([H])O,
12018,DB14093,"(1,2,6,7-3H)Testosterone",small molecule,experimental,Testosterone and derivatives,[3H]C1C([3H])C2=CC(=O)C([3H])C([3H])[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12,
12019,DB14094,Tocopherylquinone,small molecule,experimental|investigational,"Anticoagulants|Antihypertensive Agents|Antioxidants|Benzopyrans|Cardiovascular Agents|Compounds used in a research, industrial, or household setting|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|Protective Agents|Pyrans",CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@@](C)(O)CCC1=C(C)C(=O)C(C)=C(C)C1=O,
12020,DB14096,"1,2-icosapentoyl-sn-glycero-3-phosphoserine",small molecule,approved|experimental,,[H]C(N)(COP(O)(=O)OCC([H])(COC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC)OC(=O)CCCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC)C(O)=O,
12021,DB14097,13-cis-12-(3'-Carboxyphenyl)retinoic acid,small molecule,experimental,"Alkenes|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Phospholipases A, antagonists & inhibitors|Pigments, Biological|Polyenes|Retinoids|Terpenes|Vitamin A|Vitamins|Vitamins (Fat Soluble)",[H]\C(=C(\[H])C1=C(C)CCCC1(C)C)\C(\C)=C(/[H])C([H])=C(\C(C)=C(\[H])C(O)=O)C1=CC(=CC=C1)C(O)=O,
12022,DB14098,Cobalamin,small molecule,experimental,"Corrinoids|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Heterocyclic Compounds, Fused-Ring|Micronutrients|Physiological Phenomena|Vitamin B 12, biosynthesis|Vitamin B Complex|Vitamins",[Co++].[H]N([H])C(=O)CC[C@@H]1C2=N\C(=C(C)/C3=N[C@@](C)([C@]4([H])[N-]\C(=C(C)/C5=N/C(=C\2)/C(C)(C)[C@@H]5CCC(=O)N([H])[H])[C@](C)(CCC(=O)N([H])C[C@H](C)OP([O-])(=O)O[C@@H]2[C@@H](CO)O[C@@H]([C@@H]2O)N2C=NC5=C2C=C(C)C(C)=C5)[C@H]4CC(=O)N([H])[H])[C@@](C)(CC(=O)N([H])[H])[C@@H]3CCC(=O)N([H])[H])\[C@@]1(C)CC(=O)N([H])[H],
12023,DB14099,"1,2-Distearoyllecithin",small molecule,approved|experimental,Alcohols|Carbohydrates|Glycerophosphates|Glycerophospholipids|Lipids|Membrane Lipids|Phosphatidic Acids|Phospholipids|Sugar Alcohols|Sugar Phosphates|Triose Sugar Alcohols,CCCCCCCCCCCCCCCCCC(=O)OCC(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,
12025,DB14101,Soy isoflavones,small molecule,approved|experimental,,,
12026,DB14102,Triethylhexanoin,small molecule,experimental,"Acids, Acyclic|Compounds used in a research, industrial, or household setting|Drug Delivery Systems|Excipients|Fatty Acids|Glycerides|Lipids|Pharmaceutic Aids|Pharmaceutical Preparations|Pharmaceutical Vehicles",,
12027,DB14103,Methionine sulfoximine,small molecule,experimental,"Amino Acids|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Sulfur Compounds",CS(=N)(=O)CC[C@H](N)C(O)=O,
12028,DB14104,Linoleic acid,small molecule,approved|experimental,"Fatty Acids|Fatty Acids, Essential|Fatty Acids, Omega-6|Fatty Acids, Unsaturated|Linoleic Acids|Lipids",CCCCC\C=C/C\C=C/CCCCCCCC(O)=O,
12029,DB14105,"Sodium 1,2-Dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol)",small molecule,approved|experimental,,[Na+].[H][C@@](COC(=O)CCCCCCCCCCCCCCC)(COP([O-])(=O)OCC(O)CO)OC(=O)CCCCCCCCCCCCCCC,
12030,DB14106,Tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroborate,small molecule,approved,,[Cu+].F[B-](F)(F)F.COC(C)(C)C[N+]#[C-].COC(C)(C)C[N+]#[C-].COC(C)(C)C[N+]#[C-].COC(C)(C)C[N+]#[C-],
12031,DB14107,7-Aminodesacetoxycephalosporanic acid,small molecule,experimental,"Amides|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Sulfur Compounds|Thiazines",[H][C@]12SCC(C)=C(N1C(=O)[C@H]2N)C(O)=O,
12032,DB14108,"1,2-Hexanediol",small molecule,experimental,"Alcohols|Alkanes|Hydrocarbons, Acyclic",CCCCC(O)CO,
12033,DB14109,alpha-Arbutin,small molecule,approved|experimental,,OC[C@H]1O[C@H](OC2=CC=C(O)C=C2)[C@H](O)[C@@H](O)[C@@H]1O,
12034,DB14110,Butylene glycol,small molecule,approved|experimental,Alcohols|Glycols,CC(O)CCO,
12035,DB14111,Ceramide NP,small molecule,experimental,"Antigens, Neoplasm|Carbohydrates|Glycoconjugates|Glycolipids|Lipids|Membrane Lipids|Sphingolipids",CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC,
12040,DB14116,Silodrate,small molecule,approved|experimental,,O.[O--].[O--].[Mg++].[Mg++].[Al+3].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O,
12041,DB14117,Silica dimethyl silylate,small molecule,experimental,,,
12042,DB14119,Phytosphingosine,small molecule,experimental,Alcohols|Amines|Amino Alcohols|Glycols,CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO,
12043,DB14120,Phenylethyl resorcinol,small molecule,approved|experimental,Benzene Derivatives|Phenols,CC(C1=CC=CC=C1)C1=CC=C(O)C=C1O,
12044,DB14121,Parasorbic acid,small molecule,experimental,,C[C@H]1CC=CC(=O)O1,
12045,DB14122,Dihydroxymethoxychalcone,small molecule,experimental,"Benzopyrans|Chromones|Flavonoids|Heterocyclic Compounds, Fused-Ring|Ketones|Propiophenones|Pyrans|Zingiberaceae",COC1=C(C(=O)\C=C\C2=CC=CC=C2)C(O)=CC(O)=C1,
12046,DB14123,Racementhol,small molecule,approved|experimental,,,
12047,DB14124,Cyclomethicone,small molecule,experimental,"Compounds used in a research, industrial, or household setting|Macromolecular Substances|Organosilicon Compounds|Polymers|Silicon Compounds",,
12048,DB14125,Benazeprilat,small molecule,experimental,"Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Decreased Blood Pressure|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Protease Inhibitors",[H][C@@]1(CCC2=CC=CC=C2N(CC(O)=O)C1=O)N[C@@H](CCC1=CC=CC=C1)C(O)=O,
12049,DB14126,Tenofovir,small molecule,experimental|investigational,"Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Enzyme Inhibitors|Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Heterocyclic Compounds, Fused-Ring|Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Nephrotoxic agents|Nucleic Acid Synthesis Inhibitors|Nucleoside Reverse Transcriptase Inhibitors|OAT3/SLC22A8 Substrates|Organophosphonates|Organophosphorus Compounds|P-glycoprotein substrates|Purines|Reverse Transcriptase Inhibitors|Tenofovir and prodrugs",C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(O)(O)=O,
12050,DB14127,Sacubitrilat,small molecule,experimental,"Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Benzene Derivatives|Butyrates|Fatty Acids|Fatty Acids, Volatile|Lipids|Neprilysin Inhibitor|Neprilysin Inhibitors",C[C@H](C[C@@H](CC1=CC=C(C=C1)C1=CC=CC=C1)NC(=O)CCC(O)=O)C(O)=O,
12051,DB14128,Nadide,small molecule,experimental,"Adenine Nucleotides|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides",NC(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O,
12052,DB14129,Macelignan,small molecule,experimental,Benzene Derivatives|Benzyl Compounds,COC1=CC(C[C@H](C)[C@H](C)CC2=CC3=C(OCO3)C=C2)=CC=C1O,
12053,DB14130,Methyl salicylate 2-ethylbutyrate,small molecule,experimental,,CCC(CC)C(=O)OC1=CC=CC=C1C(=O)OC,
12055,DB14132,8-chlorotheophylline,small molecule,experimental,"Alkaloids|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Purines|Purinones|Xanthine derivatives",CN1C2=C(NC(Cl)=N2)C(=O)N(C)C1=O,
12056,DB14134,Octyldodecanol,small molecule,experimental,Alcohols|Lipids,CCCCCCCCCCC(CO)CCCCCCCC,
12057,DB14135,Hypochlorous acid,small molecule,experimental,"Acids|Acids, Noncarboxylic|Anions|Chlorine Compounds|Compounds used in a research, industrial, or household setting|Electrolytes|Free Radicals|Ions|Noxae|Oxidants|Oxides|Oxygen Compounds|Reactive Oxygen Species|Toxic Actions",OCl,
12058,DB14136,(-)-menthol 1-propylene glycol carbonate,small molecule,experimental,,[H]C(C)(O)COC(=O)O[C@]1([H])C[C@]([H])(C)CC[C@@]1([H])C(C)C,
12059,DB14137,Palmitoyl tetrapeptide-7,small molecule,experimental,,[H]N([H])C(=O)CC[C@H](N([H])C(=O)CN([H])C(=O)CCCCCCCCCCCCCCC)C(=O)N1CCC[C@H]1C(=O)N([H])[C@@H](CCCN=C(N([H])[H])N([H])[H])C(O)=O,
12060,DB14138,Silicic acid,small molecule,experimental,"Acids|Acids, Noncarboxylic|Anions|Electrolytes|Ions|Minerals|Oxides|Oxygen Compounds|Silicon Compounds",O.O=[Si]=O,
12061,DB14139,Hydroxyethyl ethylcellulose,small molecule,approved|experimental,"Biopolymers|Carbohydrates|Compounds used in a research, industrial, or household setting|Glucans|Macromolecular Substances|Polymers|Polysaccharides",,
12062,DB14140,Dipropylene glycol,small molecule,experimental,,,
12063,DB14141,p-Phenylenediamine,small molecule,approved|experimental,"Amines|Aniline Compounds|Antigens|Antigens, Bacterial|Azo Compounds|Biological Factors|Cell-mediated Immunity|Coloring Agents|Compounds used in a research, industrial, or household setting|Diamines|Increased Histamine Release|Indicators and Reagents|Laboratory Chemicals|Polyamines|Standardized Chemical Allergen|Tuberculin",NC1=CC=C(N)C=C1,
12064,DB14142,Methoxy PEG-12 retinamide,small molecule,experimental,Pegylated agents,,
12065,DB14143,Distearyldimonium,small molecule,approved|experimental,"Adjuvants, Immunologic|Amines|Ammonium Compounds|Anti-Infective Agents|Compounds used in a research, industrial, or household setting|Immunologic Factors|Nitrogen Compounds|Onium Compounds|Surface-Active Agents",CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC,
12066,DB14144,p-Aminophenol,small molecule,experimental,Amines|Aniline Compounds|Benzene Derivatives|Mutagens|Noxae|Phenols|Toxic Actions,NC1=CC=C(O)C=C1,
12068,DB14146,Loxicodegol,small molecule,investigational,"Alkaloids|Heterocyclic Compounds, Fused-Ring|Opiate Alkaloids|Phenanthrenes",[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CC[C@]2([H])OCCOCCOCCOCCOCCOCCOC,
12070,DB14149,Glyceryl stearate SE,small molecule,experimental,,[Na+].[K+].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO.[H][C@](O)(CO)COC(=O)CCCCCCCCCCCCCCCCC.[H][C@@](O)(CO)COC(=O)CCCCCCCCCCCCCCCCC,
12071,DB14150,Chloric acid,small molecule,approved|experimental,"Agrochemicals|Anions|Chlorine Compounds|Compounds used in a research, industrial, or household setting|Electrolytes|Herbicides|Ions|Pesticides|Toxic Actions",[H]O[Cl](=O)=O,
12072,DB14151,Phosphorus,small molecule,approved|experimental,Elements|Phosphorus,[P],
12073,DB14152,Ginsenosides,small molecule,experimental,Carbohydrates|Glycosides|Saponins|Terpenes|Triterpenes,[H][C@@]1(CC[C@]2(C)C1([H])CC[C@]1([H])[C@@]3(C)CC[C@]([H])(O)C(C)(C)[C@]3([H])CC[C@@]21C)C(C)(O)CCC=C(C)C,
12074,DB14153,Polysorbate 60,small molecule,experimental,,,
12075,DB14154,Gold,small molecule,experimental,"Cell-mediated Immunity|Elements|Gold|Gold Compounds|Increased Histamine Release|Metals|Metals, Heavy|Standardized Chemical Allergen|Transition Elements",[Au],
12076,DB14155,Chitosan low molecular weight (20-200 mpa.s),small molecule,experimental,,,
12077,DB14156,Synthetic camphor,small molecule,approved|experimental,,CC1(C)C2CCC1(C)C(=O)C2,
12078,DB14157,Hydrogenated soybean lecithin,small molecule,experimental,,,
12079,DB14158,Microcrystalline cellulose,small molecule,approved|experimental|investigational,"Biopolymers|Carbohydrates|Cellulose|Compounds used in a research, industrial, or household setting|Drug Delivery Systems|Excipients|Glucans|Macromolecular Substances|Pharmaceutic Aids|Pharmaceutical Preparations|Pharmaceutical Vehicles|Polymers|Polysaccharides",,
12080,DB14159,Oxidronic acid,small molecule,approved,Organophosphonates|Organophosphorus Compounds,OC(P(O)(O)=O)P(O)(O)=O,
12081,DB14160,Titanium,small molecule,experimental,"Elements|Metals|Metals, Light|Transition Elements",[Ti],
12082,DB14161,"Lecithin, soybean",small molecule,experimental,,,
12094,DB14173,Diazolidinylurea,small molecule,approved|experimental,Cell-mediated Immunity|Increased Histamine Release|Standardized Chemical Allergen,OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O,
12095,DB14174,Dipentamethylenethiuram disulfide,small molecule,approved|experimental,Cell-mediated Immunity|Increased Histamine Release|Standardized Chemical Allergen,S=C(SSC(=S)N1CCCCC1)N1CCCCC1,
12096,DB14175,alpha-Amyl cinnamaldehyde,small molecule,approved|experimental,Cell-mediated Immunity|Increased Histamine Release|Perfume|Standardized Chemical Allergen,CCCCC\C(C=O)=C\C1=CC=CC=C1,
12097,DB14176,Benzylparaben,small molecule,approved|experimental,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Cell-mediated Immunity|Hydroxy Acids|Hydroxybenzoates|Increased Histamine Release|Phenols|Standardized Chemical Allergen",OC1=CC=C(C=C1)C(=O)OCC1=CC=CC=C1,
12098,DB14177,Propylparaben,small molecule,approved|experimental,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Cell-mediated Immunity|Compounds used in a research, industrial, or household setting|Hydroxy Acids|Hydroxybenzoates|Increased Histamine Release|Pharmaceutic Aids|Pharmaceutical Preparations|Phenols|Preservatives, Pharmaceutical|Standardized Chemical Allergen",CCCOC(=O)C1=CC=C(O)C=C1,
12099,DB14178,Tetramethylthiuram monosulfide,small molecule,approved|experimental,"Acids, Acyclic|Carbamates|Cell-mediated Immunity|Dimethyldithiocarbamate|Increased Histamine Release|Standardized Chemical Allergen|Sulfur Compounds|Thiocarbamates",CN(C)C(=S)SC(=S)N(C)C,
12101,DB14180,Nickel sulfate,small molecule,approved|experimental,"Compounds used in a research, industrial, or household setting|Elements|Irritants|Metals|Metals, Heavy|Noxae|Toxic Actions|Transition Elements",[Ni++].[O-]S([O-])(=O)=O,
12102,DB14181,Lanolin alcohols,small molecule,approved|experimental,Cell-mediated Immunity|Increased Histamine Release|Standardized Chemical Allergen,,
12103,DB14182,Dichromate,small molecule,approved|investigational,"Anions|Caustics|Chromates|Chromium Compounds|Coloring Agents|Compounds used in a research, industrial, or household setting|Electrolytes|Ions|Noxae|Toxic Actions",[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O,
12104,DB14183,Geraniol,small molecule,approved|experimental,Cell-mediated Immunity|Increased Histamine Release|Standardized Chemical Allergen,CC(C)=CCC\C(C)=C\CO,
12105,DB14184,Cinnamaldehyde,small molecule,approved|experimental,"Aldehydes|Antimutagenic Agents|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Cell-mediated Immunity|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Drugs that are Mainly Renally Excreted|Flavoring Agents|Food|Food Additives|Food and Beverages|Food Ingredients|Increased Histamine Release|Pharmaceutic Aids|Pharmaceutical Preparations|Physiological Phenomena|Protective Agents|Standardized Chemical Allergen",O=C\C=C\C1=CC=CC=C1,
12106,DB14185,Aripiprazole lauroxil,small molecule,approved|investigational,"Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antidepressive Agents|Antipsychotic Agents|Aripiprazole and prodrugs|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring|Histamine Antagonists|Histamine H1 Antagonists|Neurotoxic agents|Piperazines|Potential QTc-Prolonging Agents|Psychotropic Drugs|QTc Prolonging Agents|Quinolines|Quinolones|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Tranquilizing Agents",CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12,
12107,DB14186,Cinnamyl alcohol,small molecule,approved|experimental,Alcohols|Cell-mediated Immunity|Drugs that are Mainly Renally Excreted|Increased Histamine Release|Standardized Chemical Allergen,OC\C=C\C1=CC=CC=C1,
12108,DB14187,Hydroxycitronellal,small molecule,approved|experimental,Cell-mediated Immunity|Increased Histamine Release|Perfume|Standardized Chemical Allergen,[H]C(=O)CC(C)CCCC(C)(C)O,
12109,DB14188,Isoeugenol,small molecule,approved|experimental,"Acids, Carbocyclic|Caffeic Acids|Cell-mediated Immunity|Cinnamates|Increased Histamine Release|Standardized Chemical Allergen",COC1=CC(C=CC)=CC=C1O,
12110,DB14189,Ethylenediamine,small molecule,approved|experimental,"Allergens|Amines|Cell-mediated Immunity|Dermatitis, Contact|Diamines|Increased Histamine Release|Polyamines|Standardized Chemical Allergen",NCCN,
12111,DB14190,P-Tert-Butylphenol-Formaldehyde Resin (Low Molecular Weight),small molecule,approved|experimental,Cell-mediated Immunity|Increased Histamine Release|Standardized Chemical Allergen,,
12112,DB14191,Diphenylguanidine,small molecule,approved|experimental,Amidines|Cell-mediated Immunity|Increased Histamine Release|Standardized Chemical Allergen,N=C(NC1=CC=CC=C1)NC1=CC=CC=C1,
12113,DB14192,"N,N'-diphenyl-1,4-phenylenediamine",small molecule,approved|experimental,"Amines|Aniline Compounds|Antioxidants|Cell-mediated Immunity|Compounds used in a research, industrial, or household setting|Diamines|Increased Histamine Release|Polyamines|Protective Agents|Standardized Chemical Allergen",,
12114,DB14193,Ditiocarb zinc,small molecule,approved,"Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Allergens|Cell-mediated Immunity|Compounds used in a research, industrial, or household setting|Increased Histamine Release|Metal cations|Metal divalent cations|Standardized Chemical Allergen|Vasoprotectives|Zinc Compounds",[Zn++].CCN(CC)C([S-])=S.CCN(CC)C([S-])=S,
12115,DB14194,Zinc dibutyldithiocarbamate,small molecule,approved|experimental,"Acids, Acyclic|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Carbamates|Cell-mediated Immunity|Increased Histamine Release|Metal cations|Metal divalent cations|Standardized Chemical Allergen|Sulfur Compounds|Vasoprotectives|Zinc Compounds",[Zn++].CCCCN(CCCC)C([S-])=S.CCCCN(CCCC)C([S-])=S,
12116,DB14195,4-(Isopropylamino)diphenylamine,small molecule,approved|experimental,"Amines|Aniline Compounds|Antioxidants|Cell-mediated Immunity|Compounds used in a research, industrial, or household setting|Diamines|Increased Histamine Release|Polyamines|Protective Agents|Standardized Chemical Allergen",CC(C)NC1=CC=C(NC2=CC=CC=C2)C=C1,
12117,DB14196,"N-Cyclohexyl-N'-phenyl-1,4-phenylenediamine",small molecule,approved,Amines|Aniline Compounds|Cell-mediated Immunity|Diamines|Increased Histamine Release|Polyamines|Standardized Chemical Allergen,C1CCC(CC1)NC1=CC=C(NC2=CC=CC=C2)C=C1,
12118,DB14197,Methylchloroisothiazolinone,small molecule,approved|experimental,"Anti-Infective Agents|Cell-mediated Immunity|Compounds used in a research, industrial, or household setting|Disinfectants|Increased Histamine Release|Preservatives, Pharmaceutical|Standardized Chemical Allergen|Sulfur Compounds",CN1SC(Cl)=CC1=O,
12119,DB14198,Quaternium-15,small molecule,approved|experimental,"Amines|Cell-mediated Immunity|Cycloparaffins|Increased Histamine Release|Polyamines|Preservatives, Pharmaceutical|Standardized Chemical Allergen",[Cl-].[H]C(Cl)=C([H])C[N+]12CN3CN(CN(C3)C1)C2,
12120,DB14199,Bromothalonil,small molecule,approved|experimental,"Allergens|Cell-mediated Immunity|Compounds used in a research, industrial, or household setting|Increased Histamine Release|Pharmaceutic Aids|Pharmaceutical Preparations|Preservatives, Pharmaceutical|Standardized Chemical Allergen",BrCC(Br)(CCC#N)C#N,
12121,DB14200,Thiohexam,small molecule,approved|experimental,"Cell-mediated Immunity|Heterocyclic Compounds, Fused-Ring|Increased Histamine Release|Standardized Chemical Allergen|Sulfur Compounds|Thiazoles",C1CCC(CC1)NSC1=NC2=CC=CC=C2S1,
12122,DB14201,"2,2'-Dibenzothiazyl disulfide",small molecule,approved|experimental,"Cell-mediated Immunity|Heterocyclic Compounds, Fused-Ring|Increased Histamine Release|Latex Hypersensitivity|Standardized Chemical Allergen|Sulfur Compounds|Thiazoles",S(SC1=NC2=CC=CC=C2S1)C1=NC2=CC=CC=C2S1,
12123,DB14202,Morpholinylmercaptobenzothiazole,small molecule,approved|experimental,"Cell-mediated Immunity|Heterocyclic Compounds, Fused-Ring|Increased Histamine Release|Oxazines|Standardized Chemical Allergen|Sulfur Compounds|Thiazoles",C1CN(CCO1)SC1=NC2=CC=CC=C2S1,
12124,DB14203,Disperse Blue 106,small molecule,approved|experimental,Allergens|Cell-mediated Immunity|Increased Histamine Release|Standardized Chemical Allergen,CCN(CCO)C1=CC=C(\N=N\C2=NC=C(S2)N(=O)=O)C(C)=C1,
12125,DB14204,Nickel cation,small molecule,experimental,,[Ni++],
12126,DB14205,Cobaltous cation,small molecule,experimental,,[Co++],
12127,DB14206,Cobalt chloride,small molecule,approved|experimental,"Antimutagenic Agents|Compounds used in a research, industrial, or household setting|Elements|Metals|Metals, Heavy|Protective Agents|Transition Elements",[Cl-].[Cl-].[Co++],
12128,DB14207,Fosinoprilat,small molecule,experimental,"Acids|Acids, Acyclic|Acids, Noncarboxylic|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Angiotensin-Converting Enzyme Inhibitors|Antiarrhythmic agents|Antihypertensive Agents|Cardiovascular Agents|Enzyme Inhibitors|Imines|Imino Acids|Organophosphorus Compounds|Phosphinic Acids|Phosphorus Acids|Phosphorus Compounds|Prodrugs|Protease Inhibitors",[H][C@]1(C[C@H](N(C1)C(=O)CP(O)(=O)CCCCC1=CC=CC=C1)C(O)=O)C1CCCCC1,
12129,DB14208,Ramiprilat,small molecule,experimental,"Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Protease Inhibitors",[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(O)=O,
12130,DB14209,Trandolaprilat,small molecule,experimental,"Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Angiotensin-Converting Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring",[H][C@@](C)(N[C@@]([H])(CCC1=CC=CC=C1)C(O)=O)C(=O)N1[C@@]([H])(C[C@@]2([H])CCCC[C@]12[H])C(O)=O,
12131,DB14210,Moexiprilat,small molecule,experimental,"Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Angiotensin-Converting Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Isoquinolines",COC1=C(OC)C=C2CN([C@@H](CC2=C1)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(O)=O,
12133,DB14212,Methylparaben,small molecule,approved,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Cell-mediated Immunity|Compounds used in a research, industrial, or household setting|Hydroxy Acids|Hydroxybenzoates|Increased Histamine Release|Pharmaceutic Aids|Pharmaceutical Preparations|Phenols|Preservatives, Pharmaceutical|Standardized Chemical Allergen",COC(=O)C1=CC=C(O)C=C1,
12134,DB14213,Perindoprilat,small molecule,experimental,"Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Protease Inhibitors",[H][C@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC)C(O)=O)[C@@]1([H])CCCC2)C(O)=O,
12135,DB14214,Rose bengal lactone,small molecule,experimental,,OC1=C(I)C2=C(C=C1I)C1(OC(=O)C3=C1C(Cl)=C(Cl)C(Cl)=C3Cl)C1=CC(I)=C(O)C(I)=C1O2,
12136,DB14217,Quinaprilat,small molecule,experimental,"Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Isoquinolines|Protease Inhibitors",C[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CC2=C(C[C@H]1C(O)=O)C=CC=C2,
12137,DB14218,Telotristat,small molecule,experimental,"Alimentary Tract and Metabolism|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Tryptophan Hydroxylase Inhibitor|Tryptophan Hydroxylase Inhibitors|Various Alimentary Tract and Metabolism Products",CC1=NN(C=C1)C1=CC(Cl)=CC=C1[C@@H](OC1=NC(N)=NC(=C1)C1=CC=C(C[C@H](N)C(O)=O)C=C1)C(F)(F)F,
12138,DB14219,Monomethyl fumarate,small molecule,experimental|investigational,"Acids, Acyclic|Dicarboxylic Acids|Immunosuppressive Agents",COC(=O)\C=C\C(O)=O,
12139,DB14221,Beclomethasone 17-monopropionate,small molecule,experimental,"Adrenal Cortex Hormones|Fused-Ring Compounds|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Chlorinated",[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,
12145,DB14227,Technetium Tc-99m,small molecule,experimental,"Elements|Elements, Radioactive|Isotopes|Metals|Metals, Heavy|Radioisotopes|Transition Elements",[99Tc],
12146,DB14228,Threonic acid,small molecule,experimental,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids",,
12149,DB14231,Quinoline Yellow WS,small molecule,experimental,"Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents that produce hypertension|Angiotensin-Converting Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring",,
12150,DB14232,Deacetylbisacodyl,small molecule,experimental,Benzene Derivatives|Contact Laxatives|Cresols|Increased Large Intestinal Motility|Laxatives|Phenols|Stimulation Large Intestine Fluid/Electrolyte Secretion,OC1=CC=C(C=C1)C(C1=CC=C(O)C=C1)C1=CC=CC=N1,
12386,DB14471,2-Ethylhexyl 4-phenylbenzophenone-2'-carboxylate,small molecule,experimental,,CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)C1=CC=C(C=C1)C1=CC=CC=C1,
12389,DB14474,Sorbitan,small molecule,experimental,,[H][C@@](O)(CO)[C@@]1([H])OC[C@]([H])(O)[C@@]1([H])O,
12390,DB14475,L-Lactic acid,small molecule,experimental,,C[C@H](O)C(O)=O,
12391,DB14476,DL-alpha-Tocopherol,small molecule,approved|experimental|investigational,Vitamin E|Vitamins|Vitamins (Fat Soluble),CC(C)CCCC(C)CCCC(C)CCCC1(C)CCC2=C(C)C(O)=C(C)C(C)=C2O1,
12392,DB14477,DL-alpha tocopheryl acetate,small molecule,approved|experimental,,,
12393,DB14478,Povidone K30,small molecule,approved|experimental,,,
12394,DB14479,Acetylcysteine zinc,small molecule,experimental,"Compounds used in a research, industrial, or household setting|Copper Absorption Inhibitor|Metal cations|Metal divalent cations|Zinc Compounds",[Zn++].CC(=O)N[C@@H](CS)C([O-])=O.CC(=O)N[C@@H](CS)C([O-])=O,
12395,DB14480,Acetylcysteine amide,small molecule,experimental,"Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Cysteine|Sulfhydryl Compounds|Sulfur Compounds",[H]N([H])C(=O)[C@H](CS)N([H])C(C)=O,
12396,DB14481,Calcium phosphate dihydrate,small molecule,approved,"Acids|Acids, Noncarboxylic|Anions|Calcium Compounds|Electrolytes|Ions|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds",O.O.[Ca++].OP([O-])([O-])=O,
12397,DB14482,Sodium ascorbate,small molecule,approved|nutraceutical,"Compounds used in a research, industrial, or household setting|Laxatives|Osmotic Laxatives|Urinary Acidifying Agents|Vitamin C and analogues|Vitamins",[Na+].[H][C@@]1(OC(=O)C(O)=C1[O-])[C@@H](O)CO,
12398,DB14483,Calcium ascorbate,small molecule,approved|nutraceutical,"Acids, Acyclic|Antioxidants|Carbohydrates|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Hydroxy Acids|Micronutrients|Physiological Phenomena|Protective Agents|Sugar Acids|Urinary Acidifying Agents|Vitamin C and analogues|Vitamins",[Ca++].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-],
12399,DB14484,Magnesium ascorbate,small molecule,approved|nutraceutical,"Compounds used in a research, industrial, or household setting|Urinary Acidifying Agents",[Mg++].[H][C@@]1(OC(=O)C(O)=C1[O-])[C@@H](O)CO.[H][C@@]1(OC(=O)C(O)=C1[O-])[C@@H](O)CO,
12400,DB14485,Zinc ascorbate,small molecule,approved|nutraceutical,"Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Metal cations|Metal divalent cations|Polyvalent cation containing laxatives, antacids, oral supplements|Urinary Acidifying Agents|Vasoprotectives|Vitamin C and analogues|Vitamins|Zinc Compounds",[Zn++].[H][C@@]1(OC(=O)C(O)=C1[O-])[C@@H](O)CO.[H][C@@]1(OC(=O)C(O)=C1[O-])[C@@H](O)CO,
12401,DB14486,Niacinamide ascorbate,small molecule,approved|nutraceutical,Urinary Acidifying Agents|Vitamin C and analogues|Vitamins,NC(=O)C1=CN=CC=C1.[H]C(O)(CO)[C@@]1([H])OC(=O)C(O)=C1O,
12402,DB14487,Zinc acetate,small molecule,approved|investigational,"Acetates|Acids, Acyclic|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Alimentary Tract and Metabolism|Copper Absorption Inhibitor|Fatty Acids|Fatty Acids, Volatile|Lipids|Metal cations|Metal divalent cations|Various Alimentary Tract and Metabolism Products|Vasoprotectives|Zinc Compounds",[Zn++].CC([O-])=O.CC([O-])=O,
12403,DB14488,Ferrous gluconate,small molecule,approved,"Anemia, Iron-Deficiency|Antianemia Drugs|Antianemic Preparations|Blood and Blood Forming Organs|Hematinics|Hematologic Agents|Iron Bivalent, Oral Preparations|Iron Compounds|Iron Preparations|Minerals|Organometallic Compounds|Polyvalent cation containing laxatives, antacids, oral supplements",[Fe++].[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O.[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O,9291
12404,DB14489,Ferrous succinate,small molecule,approved,"Antianemic Preparations|Blood and Blood Forming Organs|Hematinics|Hematologic Agents|Iron Bivalent, Oral Preparations|Iron Compounds|Iron Preparations|Organometallic Compounds",[Fe++].[O-]C(=O)CCC([O-])=O,159252
12405,DB14490,Ferrous ascorbate,small molecule,approved,"Antianemic Preparations|Blood and Blood Forming Organs|Compounds used in a research, industrial, or household setting|Iron Bivalent, Oral Preparations|Iron Preparations|Polyvalent cation containing laxatives, antacids, oral supplements|Urinary Acidifying Agents",[Fe++].[H][C@](O)(CO)[C@@]1([H])OC(=O)C(O)=C1O.[H][C@](O)(CO)[C@@]1([H])OC(=O)C([O-])=C1[O-],54710214
12406,DB14491,Ferrous fumarate,small molecule,approved,"Antianemic Preparations|Blood and Blood Forming Organs|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Iron Bivalent, Oral Preparations|Iron Compounds|Iron Preparations|Micronutrients|Minerals|Organometallic Compounds|Physiological Phenomena|Trace Elements",[Fe++].[H]\C(=C(\[H])C([O-])=O)C([O-])=O,6433164
12407,DB14492,Potassium triiodide,small molecule,experimental,"Anions|Coagulants|Coloring Agents|Compounds used in a research, industrial, or household setting|Disinfectants|Electrolytes|Hematologic Agents|Hemostatics|Iodine Compounds|Ions|Irritants|Noxae|Potassium Salt|Toxic Actions",[K+].I[I-]I,
12408,DB14493,Zinc glycinate,small molecule,experimental,"Amino Acids|Amino Acids, Peptides, and Proteins|Antigens, Neoplasm|Biomarkers, Tumor|Copper Absorption Inhibitor|Metal cations|Metal divalent cations|Zinc Compounds",[Zn++].[H]N([H])CC([O-])=O.[H]N([H])CC([O-])=O,
12409,DB14494,Zinc carbonate,small molecule,experimental,"Acids|Acids, Noncarboxylic|Alkalies|Anions|Carbon Compounds, Inorganic|Carbonic Acid|Copper Absorption Inhibitor|Electrolytes|Ions|Metal cations|Metal divalent cations|Polyvalent cation containing laxatives, antacids, oral supplements|Zinc Compounds",[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Zn++].[Zn++].[Zn++].[Zn++].[Zn++].[O-]C([O-])=O.[O-]C([O-])=O,
12410,DB14495,Manganese citrate,small molecule,experimental,Paramagnetic Contrast Agent,[Mn++].[Mn++].[Mn++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,
12411,DB14496,Sodium molybdate,small molecule,approved|experimental,"Elements|Metals|Metals, Heavy|Transition Elements",[Na+].[Na+].[O-][Mo]([O-])(=O)=O,
12412,DB14497,Calcium magnesium potassium carbonate chloride hydroxide,small molecule,experimental,,[OH-].[OH-].[OH-].[Mg++].[Cl-].[K++].[K++].[Ca++].[O-]C([O-])=O,
12413,DB14498,Potassium acetate,small molecule,approved|investigational,"Acetates|Acids, Acyclic|Agents causing hyperkalemia|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Drugs that are Mainly Renally Excreted|Electrolyte Solutions|Fatty Acids|Fatty Acids, Volatile|I.V. Solution Additives|Lipids|Potassium Compounds|Potassium Salt|Replacement Preparations",[K+].CC([O-])=O,
12414,DB14499,Potassium sulfate,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Anions|Drugs that are Mainly Renally Excreted|Electrolytes|Ions|Laxatives|Osmotic Laxatives|Potassium Salt|Sulfur Acids|Sulfur Compounds|Sulfuric Acids",[K+].[K+].[O-]S([O-])(=O)=O,
12415,DB14500,Potassium,small molecule,approved|experimental,"Agents causing hyperkalemia|Diuretics|Elements|High-Ceiling Diuretics|Low-Ceiling Diuretics, Excl. Thiazides|Metals|Metals, Alkali|Metals, Light|Minerals|Potassium Salt|Replacement Preparations",[KH],
12416,DB14501,Ferrous glycine sulfate,small molecule,approved,"Antianemic Preparations|Blood and Blood Forming Organs|Iron Bivalent, Oral Preparations|Iron Preparations",[Fe++].NCC([O-])=O.NCC([O-])=O.OS(O)(=O)=O,167159
12417,DB14502,"Sodium phosphate, dibasic",small molecule,approved,"Acids|Acids, Noncarboxylic|Anions|Electrolytes|Ions|Laxatives|Osmotic Laxatives|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Urinary Acidifying Agents",[Na+].[Na+].OP([O-])([O-])=O,
12418,DB14503,"Sodium phosphate, monobasic, unspecified form",small molecule,approved,Laxatives|Osmotic Laxatives,,
12419,DB14504,"Sodium phosphate, dibasic, unspecified form",small molecule,approved|experimental,Laxatives|Osmotic Laxatives,,
12420,DB14505,Sodium borate,small molecule,approved|experimental,"Acids|Acids, Noncarboxylic|Anions|Anti-Infective Agents|Boric Acids|Boron Compounds|Electrolytes|Ions|Ophthalmologicals|Sensory Organs",[Na+].[Na+].[O-]B1OB2OB([O-])OB(O1)O2,
12421,DB14506,Lithium hydroxide,small molecule,approved|withdrawn,Drugs that are Mainly Renally Excreted|Lithium Compounds,[Li+].[OH-],
12422,DB14507,Lithium citrate,small molecule,approved,"Acids, Acyclic|Antidepressive Agents|Antimanic Agents|Central Nervous System Depressants|Drugs that are Mainly Renally Excreted|Lithium Compounds|Mood Stabilizer|Nephrotoxic agents|Neurotoxic agents|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Tricarboxylic Acids",[Li+].[Li+].[Li+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,
12423,DB14508,Lithium succinate,small molecule,experimental,"Acids, Acyclic|Dermatologicals|Dicarboxylic Acids|Lithium Compounds|Ointments",[Li+].[Li+].[O-]C(=O)CCC([O-])=O,
12424,DB14509,Lithium carbonate,small molecule,approved,"Acids|Acids, Noncarboxylic|Alkalies|Anions|Antidepressive Agents|Antimanic Agents|Carbon Compounds, Inorganic|Carbonates|Carbonic Acid|Central Nervous System Agents|Central Nervous System Depressants|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Electrolytes|Enzyme Inhibitors|Ions|Lithium Compounds|Mood Stabilizer|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Nervous System|Neurotoxic agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Tranquilizing Agents",[Li+].[Li+].[O-]C([O-])=O,
12425,DB14510,Ferrous cation,small molecule,experimental,,[Fe++],
12426,DB14511,Acetate,small molecule,experimental,,CC([O-])=O,
12427,DB14512,Mometasone furoate,small molecule,approved|investigational|vet_approved,"Adrenal Cortex Hormones|Adrenals|Adrenergics, Inhalants|Anti-Allergic Agents|Anti-Inflammatory Agents|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Dermatologicals|Drugs for Obstructive Airway Diseases|Fused-Ring Compounds|Glucocorticoids|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Nasal Preparations|Pregnadienes|Steroids|Thyroxine-binding globulin inhibitors",[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,
12428,DB14513,Magnesium,small molecule,approved|experimental|investigational,"Calculi Dissolution Agent|Elements|Laxatives|Magnesium Compounds|Metal cations|Metal divalent cations|Metals|Metals, Alkaline Earth|Metals, Light|Minerals|Osmotic Laxatives",[MgH2],
12429,DB14514,Magnesium levulinate,small molecule,nutraceutical,Alimentary Tract and Metabolism|Enzyme Inhibitors|Keto Acids|Magnesium Compounds|Metal cations|Metal divalent cations|Mineral Supplements,[Mg++].CC(=O)CCC([O-])=O.CC(=O)CCC([O-])=O,
12430,DB14515,Magnesium lactate,small molecule,nutraceutical,Alimentary Tract and Metabolism|Magnesium Compounds|Metal cations|Metal divalent cations|Mineral Supplements,[Mg++].CC(O)C([O-])=O.CC(O)C([O-])=O,
12431,DB14516,Sodium cation,small molecule,experimental,Increased Large Intestinal Motility|Inhibition Large Intestine Fluid/Electrolyte Absorption|Laxatives|Osmotic Activity|Osmotic Laxatives,[Na+],
12432,DB14517,Aluminium phosphate,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Adjuvants, Immunologic|Alimentary Tract and Metabolism|Aluminium Compounds|Aluminum and magnesium containing antacids|Anions|Antacids|Drugs for Acid Related Disorders|Electrolytes|Gastric Acid Lowering Agents|Gastrointestinal Agents|Immunologic Factors|Ions|Metal cations|Metal divalent cations|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds",[Al+3].[O-]P([O-])([O-])=O,
12433,DB14518,Aluminum acetate,small molecule,approved|investigational,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids",[Al+3].CC([O-])=O.CC([O-])=O.CC([O-])=O,
12434,DB14519,Aluminum cation,small molecule,experimental,"Polyvalent cation containing laxatives, antacids, oral supplements",[Al+3],
12435,DB14520,Tetraferric tricitrate decahydrate,small molecule,approved,"Anemia, Iron-Deficiency|Drugs for Treatment of Hyperkalemia and Hyperphosphatemia|Iron Compounds|Organometallic Compounds|Phosphate Binder",O.O.O.O.O.O.O.O.O.O.[Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O,
12436,DB14521,Silver cation,small molecule,experimental,Anti-Bacterial Agents,[Ag+],
12437,DB14522,Hydroxide ion,small molecule,experimental,Alkalies|Anions|Electrolytes|Ions,[O-][H],
12438,DB14523,Phosphate ion,small molecule,experimental,"Acids|Acids, Noncarboxylic|Anions|Electrolytes|Ions|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds",[O-]P([O-])([O-])=O,
12439,DB14524,Gallium cation,small molecule,experimental,,[Ga+3],
12440,DB14525,Chromic cation,small molecule,experimental,,[Cr+3],
12441,DB14526,Chromic citrate,small molecule,experimental,Drugs that are Mainly Renally Excreted,[Cr+3].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,
12442,DB14527,Chromic nitrate,small molecule,approved,"Acids|Acids, Noncarboxylic|Anions|Drugs that are Mainly Renally Excreted|Electrolytes|Ions|Nitric Acid|Nitrogen Compounds",[Cr+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O,
12443,DB14528,Chromium gluconate,small molecule,approved,Drugs that are Mainly Renally Excreted,[Cr+3].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O,
12444,DB14529,Chromium nicotinate,small molecule,approved|experimental,Drugs that are Mainly Renally Excreted|Nicotinic Acids,[Cr+3].[O-]C(=O)C1=CN=CC=C1.[O-]C(=O)C1=CN=CC=C1.[O-]C(=O)C1=CN=CC=C1,
12445,DB14530,Chromous sulfate,small molecule,approved,Drugs that are Mainly Renally Excreted,[Cr++].[O-]S([O-])(=O)=O,
12446,DB14531,Carbonate ion,small molecule,experimental,,[O-]C([O-])=O,
12447,DB14532,Zinc cation,small molecule,experimental,"Copper Absorption Inhibitor|Decreased Copper Ion Absorption|Metal cations|Metal divalent cations|Polyvalent cation containing laxatives, antacids, oral supplements|Zinc Compounds",[Zn++],
12448,DB14533,Zinc chloride,small molecule,approved|investigational,"Acids|Acids, Noncarboxylic|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Anions|Basic Ointments and Protectants|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Chlorine Compounds|Compounds used in a research, industrial, or household setting|Copper Absorption Inhibitor|Cosmetics|Dental Agents|EENT Drugs, Miscellaneous|Electrolyte Solutions|Electrolytes|Household Products|I.V. Solution Additives|Ions|Metal cations|Metal divalent cations|Mouthwashes|Skin Ulcer, drug therapy|Vasoprotectives|Zinc Compounds",[Cl-].[Cl-].[Zn++],
12449,DB14534,Gold cation (1+),small molecule,experimental,,[Au+],
12450,DB14535,Indium cation In-111,small molecule,experimental,,[111In+3],
12451,DB14536,Strontium cation Sr-89,small molecule,experimental,Radioactive Therapeutic Agent|Radiopharmaceutical Activity,[89Sr++],
12452,DB14537,Chromate ion Cr-51,small molecule,experimental,Radioactive Diagnostic Agent|Radiopharmaceutical Activity,[O-][51Cr]([O-])(=O)=O,
12453,DB14538,Hydrocortisone aceponate,small molecule,experimental|vet_approved,"11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Adrenal Cortex Hormones|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Dermatologicals|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydrocortisone and derivatives|Hydroxycorticosteroids|Immunosuppressive Agents|Pregnanes|Pregnenediones|Pregnenes|Steroids",[H][C@@]12CC[C@](OC(=O)CC)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
12454,DB14539,Hydrocortisone acetate,small molecule,approved|vet_approved,"11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Administration, Topical|Adrenal Cortex Hormones|Aerosols|Anti-Inflammatory Agents|Corticosteroids|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydrocortisone and derivatives|Hydroxycorticosteroids|Immunosuppressive Agents|Pregnanes|Pregnenediones|Pregnenes|Steroids",[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,5744
12455,DB14540,Hydrocortisone butyrate,small molecule,approved|vet_approved,"11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Administration, Topical|Adrenal Cortex Hormones|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Moderately Potent (Group II)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Dermatologicals|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydrocortisone and derivatives|Hydroxycorticosteroids|Immunosuppressive Agents|Pregnanes|Pregnenediones|Pregnenes|Steroids",[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
12456,DB14541,Hydrocortisone cypionate,small molecule,approved|investigational|vet_approved,"11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Adrenal Cortex Hormones|Corticosteroids|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydrocortisone and derivatives|Hydroxycorticosteroids|Pregnanes|Pregnenediones|Pregnenes|Steroids",[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC3CCCC3)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
12457,DB14542,Hydrocortisone phosphate,small molecule,approved|vet_approved,"11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Adrenal Cortex Hormones|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydrocortisone and derivatives|Hydroxycorticosteroids|Pregnanes|Pregnenediones|Pregnenes|Steroids",[H][C@@]12CC[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
12458,DB14543,Hydrocortisone probutate,small molecule,approved|vet_approved,"11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Moderately Potent (Group II)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Dermatologicals|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydrocortisone and derivatives|Hydroxycorticosteroids|Immunosuppressive Agents|Pregnanes|Pregnenediones|Pregnenes|Steroids",[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,636398
12459,DB14544,Hydrocortisone valerate,small molecule,approved|vet_approved,"11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydrocortisone and derivatives|Hydroxycorticosteroids|Immunosuppressive Agents|Pregnanes|Pregnenediones|Pregnenes|Steroids",[H][C@@]12CC[C@](OC(=O)CCCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,5282494
12460,DB14545,Hydrocortisone succinate,small molecule,approved,"11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydrocortisone and derivatives|Hydroxycorticosteroids|Immunosuppressive Agents|Pregnanes|Pregnenediones|Pregnenes|Steroids",[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
12461,DB14546,Sulfate ion,small molecule,experimental|investigational,Increased Large Intestinal Motility|Inhibition Large Intestine Fluid/Electrolyte Absorption|Laxatives|Osmotic Activity|Osmotic Laxatives,[O-]S([O-])(=O)=O,
12462,DB14547,Chloride ion,small molecule,experimental,Adrenergic Agonists,[Cl-],
12463,DB14548,"Zinc sulfate, unspecified form",small molecule,approved|experimental,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Copper Absorption Inhibitor|Metal cations|Metal divalent cations|Vasoprotectives|Zinc Compounds,,
12464,DB14549,Gallium cation Ga-67,small molecule,experimental,,[67Ga+3],
12465,DB14550,Gallium chloride Ga-67,small molecule,approved,,[Cl-].[Cl-].[Cl-].[67Ga+3],
12466,DB14551,Phosphorus P-32,small molecule,experimental,Elements|Isotopes|Phosphorus|Phosphorus Isotopes|Radioisotopes,[H][32P]([H])[H],
12467,DB14552,Cupric cation,small molecule,experimental,,[Cu++],
12468,DB14553,Borate ion,small molecule,experimental,"Acids|Acids, Noncarboxylic|Anions|Boric Acids|Boron Compounds|Electrolytes|Ions",[O-]B1OB2OB([O-])OB(O1)O2,
12469,DB14554,Dotatate,small molecule,approved|experimental,Radioactive Diagnostic Agent,C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=C2C=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(O)=O,
12470,DB14555,Ursadiol,small molecule,experimental,,[H][C@@]12CC[C@]3(C)[C@]([H])(CCC4=C5CC(C)(C)CC[C@]5(C)[C@@H](O)C[C@@]34C)[C@@]1(C)CC[C@H](O)C2(C)C,
12471,DB14556,Peracetic acid,small molecule,experimental,"Acetates|Acids, Acyclic|Anti-Infective Agents|Compounds used in a research, industrial, or household setting|Disinfectants|Fatty Acids|Fatty Acids, Volatile|Lipids|Noxae|Oxidants|Toxic Actions",CC(=O)OO,
12472,DB14557,Ethylhexylglycerin,small molecule,experimental,Alcohols|Carbohydrates|Ethers|Sugar Alcohols|Triose Sugar Alcohols,CCCCC(CC)COCC(O)CO,
12482,DB14567,Brown iron oxide,small molecule,approved|experimental,,,
12483,DB14568,Ivosidenib,small molecule,approved|investigational,"Amino Acids|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Enzyme Inhibitors|Moderate Risk QTc-Prolonging Agents|OAT3/SLC22A8 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|P-glycoprotein substrates with narrow therapeutic index|QTc Prolonging Agents",[H][C@@](N(C(=O)[C@]1([H])CCC(=O)N1C1=NC=CC(=C1)C#N)C1=CC(F)=CN=C1)(C(=O)NC1CC(F)(F)C1)C1=C(Cl)C=CC=C1,
12484,DB14569,Tedizolid,small molecule,approved|investigational,Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Breast Cancer Resistance Protein Inhibitors|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|Oxazoles|Oxazolidinone Antibacterial,CN1N=NC(=N1)C1=NC=C(C=C1)C1=C(F)C=C(C=C1)N1C[C@H](CO)OC1=O,
12485,DB14570,Hydroxyprogesterone,small molecule,experimental,Adrenal Cortex Hormones|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Genito Urinary System and Sex Hormones|Pregnen (4) Derivatives|Progestins|Sex Hormones and Modulators of the Genital System,[H][C@@]12CC[C@](O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
12486,DB14571,Radium Ra-223 cation,small molecule,experimental,alpha-Particle Emitting Activity|Radioactive alpha-Particle Emitting Therapeutic Agent,[223Ra++],
12487,DB14572,Bismuth cation,small molecule,experimental,,[Bi+3],
12488,DB14573,Phosphate ion P-32,small molecule,experimental,Radioactive Therapeutic Agent|Radiopharmaceutical Activity,[O-][32P]([O-])([O-])=O,
12489,DB14574,Cobalt,small molecule,approved|experimental,"Cell-mediated Immunity|Cobalt|Diet, Food, and Nutrition|Elements|Food|Food and Beverages|Growth Substances|Increased Histamine Release|Metals|Metals, Heavy|Micronutrients|Physiological Phenomena|Standardized Chemical Allergen|Trace Elements|Transition Elements",[Co],
12490,DB14575,Eslicarbazepine,small molecule,approved,"Anticonvulsants|Carboxamide Derivatives|Cardiovascular Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Eslicarbazepine and prodrugs|Heterocyclic Compounds, Fused-Ring|Membrane Transport Modulators|Nervous System|Sodium Channel Blockers|UGT1A1 Substrates|Voltage-Gated Sodium Channel Blockers",NC(=O)N1C2=C(C[C@H](O)C3=C1C=CC=C3)C=CC=C2,
12491,DB14576,Thallous cation Tl-201,small molecule,experimental,Radioactive Diagnostic Agent|Radiopharmaceutical Activity,[201Tl+],
12492,DB14577,Calcium cation,small molecule,experimental,"Blood Coagulation Factors|Calcium Salts|Increased Coagulation Factor Activity|Polyvalent cation containing laxatives, antacids, oral supplements",[Ca++],
12493,DB14578,Gadolinium cation (3+),small molecule,experimental,Gadolinium-based Contrast Agent|Magnetic Resonance Contrast Activity,[Gd+3],
12494,DB14579,Lanthanum III cation,small molecule,experimental,Metal cations|Phosphate Binder|Phosphate Chelating Activity,[La+3],
12496,DB14581,CPI-1205,small molecule,investigational,"Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring",COC1=C(CNC(=O)C2=C(C)N([C@H](C)C3CCN(CC(F)(F)F)CC3)C3=CC=CC=C23)C(=O)NC(C)=C1,
12498,DB14583,Segesterone acetate,small molecule,approved|experimental|investigational,"Adrenal Cortex Hormones|Contraceptive Agents, Female|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Drug Implants|Fused-Ring Compounds|Hormonal Contraceptives for Systemic Use|Intravaginal Contraceptives|Norpregnanes|Norpregnenes|Norsteroids|Reproductive Control Agents|Steroids",[H][C@@]12CC(=C)[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],
12499,DB14584,Segesterone,small molecule,experimental,,[H][C@@]12CC(=C)[C@](O)(C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],
12501,DB14586,Citrus bioflavonoids,small molecule,approved|experimental,"Benzopyrans|Chromones|Flavonoids|Heterocyclic Compounds, Fused-Ring|Pyrans",,
12504,DB14589,Caprylyl glycol,small molecule,experimental,Alcohols|Fatty Alcohols|Lipids,CCCCCCC(O)CO,
12511,DB00873,Loteprednol,small molecule,approved|experimental,Adrenal Cortex Hormones|Androstadienes|Androstanes|Androstenes|Anti-Allergic Agents|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Fused-Ring Compounds|Ophthalmologicals|Sensory Organs|Steroids,[H][C@@]12CC[C@](O)(C(=O)OCCl)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,
12513,DB14598,Edetate calcium disodium anhydrous,small molecule,approved,"Anticoagulants|Calcium Chelating Activity|Calcium Chelating Agents|Chelating Activity|Chelating Agents|Compounds used in a research, industrial, or household setting|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Iron Chelating Activity|Iron Chelating Agents|Lead Chelating Activity|Lead Chelator|Metal Chelating Activity|Metal Chelator",[Na+].[Na+].[Ca++].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O,6109
12514,DB14599,Edetate copper disodium,small molecule,experimental,,[Na+].[Na+].[Cu++].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O,
12515,DB14600,Edetate disodium anhydrous,small molecule,approved|vet_approved,Anticoagulants|Calcium Chelating Activity|Calcium Chelating Agents|Chelating Activity|Chelating Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Iron Chelating Agents|Lead Chelator|Metal Chelator,[Na+].[Na+].OC(=O)CN(CCN(CC(O)=O)CC([O-])=O)CC([O-])=O,8759
12536,DB14622,Sodium phosphate tribasic dodecahydrate,small molecule,experimental,"Acids|Acids, Noncarboxylic|Anions|Electrolytes|Ions|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds",O.O.O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[Na+].[O-]P([O-])([O-])=O,
12537,DB14623,Acetyl chloride,small molecule,experimental,"Acids|Acids, Acyclic|Acids, Noncarboxylic|Anions|Chlorine Compounds|Electrolytes|Fatty Acids|Fatty Acids, Volatile|Ions|Lipids",CC(Cl)=O,
12538,DB14624,Nandrolone hydrogen sulfate,small molecule,experimental|investigational,,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2OS(O)(=O)=O,
12539,DB14625,Meprednisone acetate,small molecule,experimental,,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O,
12540,DB14626,Pregnenolone acetate,small molecule,investigational,,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@H](CC[C@]12C)OC(C)=O,
12541,DB14627,Oxyphenisatin acetate,small molecule,approved|investigational|withdrawn,"Gastrointestinal Agents|Heterocyclic Compounds, Fused-Ring|Indoles|Laxatives",CC(=O)OC1=CC=C(C=C1)C1(C(=O)NC2=CC=CC=C12)C1=CC=C(OC(C)=O)C=C1,
12542,DB14628,Pseudosaccharin chloride,small molecule,experimental,,ClC1=NS(=O)(=O)C2=CC=CC=C12,
12543,DB14629,Trifluoroethyl acetate,small molecule,experimental,,CC(=O)OCC(F)(F)F,
12544,DB14630,Tyramine O-sulfate,small molecule,experimental,Amines|Biogenic Amines|Biogenic Monoamines,NCCC1=CC=C(OS(O)(=O)=O)C=C1,
12545,DB14631,Prednisolone phosphate,small molecule,approved|vet_approved,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Cytochrome P-450 CYP2A6 Inducers|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|OAT3/SLC22A8 Substrates|P-glycoprotein inducers|P-glycoprotein substrates|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids",[H][C@@]12CC[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,
12546,DB14632,Prednisolone tebutate,small molecule,approved|vet_approved,Fused-Ring Compounds|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CC(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,93055
12547,DB14633,Prednisolone hemisuccinate,small molecule,experimental,"Adrenal Cortex Hormones|Corticosteroids|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids",[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,
12548,DB14634,Fluprednidene acetate,small molecule,experimental,"Adrenal Cortex Hormones|Corticosteroids|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Pregnadienes|Pregnanes|Steroids",[H][C@@]12CC(=C)[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,
12549,DB14635,Curcumin sulfate,small molecule,experimental,Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC=C(OS(O)(=O)=O)C(OC)=C2)=CC=C1O,
12550,DB14636,Triciribine phosphate,small molecule,investigational,"Carbohydrates|Glycosides|Naphthalenes|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides",CN1N=C(N)C2=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C3=C2C1=NC=N3,
12551,DB14637,Fluprednisolone acetate,small molecule,experimental,Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C,
12552,DB14638,Diloxanide furoate,small molecule,approved,Amebicides|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals,CN(C(=O)C(Cl)Cl)C1=CC=C(OC(=O)C2=CC=CO2)C=C1,
12553,DB14639,Boldenone undecylenate,small molecule,illicit|vet_approved,"Androstanes|Androstenes|Androstenols|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids",C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2OC(=O)CCCCCCCCC=C,
12554,DB14640,Isoflupredone acetate,small molecule,vet_approved,"Fused-Ring Compounds|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated",[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,
12555,DB14641,Estriol tripropionate,small molecule,experimental,,[H][C@]1(C[C@@]2([H])[C@]3([H])CCC4=CC(OC(=O)CC)=CC=C4[C@@]3([H])CC[C@]2(C)[C@@]1([H])OC(=O)CC)OC(=O)CC,102232
12556,DB14642,Lypressin,small molecule,approved,"Amino Acids, Peptides, and Proteins|Antidiuretic Agents|Cardiovascular Agents|Coagulants|Hematologic Agents|Hemostatics|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Natriuretic Agents|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormones|Pituitary Hormones, Posterior|Posterior Pituitary Lobe Hormones|Proteins|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Vasoconstrictor Agents|Vasopressin and Analogues|Vasopressins",[H]N([H])C(=O)C[C@]1([H])NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](N)CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)NC([H])(CCCCN)C(=O)NCC(N)=O,
12557,DB14643,Methylprednisolone aceponate,small molecule,approved|vet_approved,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Dermatologicals|Fused-Ring Compounds|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids",[H][C@@]12CC[C@](OC(=O)CC)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,
12558,DB14644,Methylprednisolone hemisuccinate,small molecule,approved,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Corticosteroids|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Neuroprotective Agents|Pregnadienes|Pregnadienetriols|Pregnanes|Protective Agents|Steroids",[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,
12559,DB14645,Nitrogen trichloride,small molecule,experimental,"Acids|Acids, Noncarboxylic|Anions|Chlorine Compounds|Electrolytes|Ions",ClN(Cl)Cl,
12560,DB14646,Prednisone acetate,small molecule,approved|experimental|investigational,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Corticosteroids|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Pregnadienediols|Pregnadienes|Pregnanes|Steroids|Thyroxine-binding globulin inhibitors",[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,
12561,DB14647,Sulfur chloride,small molecule,experimental,,ClSSCl,
12562,DB14648,Acetyl simvastatin,small molecule,experimental,,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@H](CC(=O)O3)OC(C)=O)[C@@H]12,
12563,DB14649,Dexamethasone acetate,small molecule,approved|investigational|vet_approved,"Anti-Inflammatory Agents|BCRP/ABCG2 Inhibitors|BSEP/ABCB11 inducers|Cytochrome P-450 CYP2A6 Inducers|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strength unknown)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strength unknown)|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP2E1 Inducers (strength unknown)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (moderate)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (moderate)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inducers|Cytochrome P-450 CYP3A7 Inducers (strength unknown)|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Fused-Ring Compounds|OAT3/SLC22A8 Substrates|P-glycoprotein inducers|P-glycoprotein inhibitors|P-glycoprotein substrates|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated",[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,236702
12564,DB14650,Menadiol diphosphate,small molecule,approved|nutraceutical,Diterpenes|Naphthalenes|Naphthoquinones|Phytol|Quinones|Terpenes,CC1=C(OP(O)(O)=O)C2=CC=CC=C2C(OP(O)(O)=O)=C1,8556
12565,DB14651,Perphenazine enanthate,small molecule,experimental,"Antipsychotic Agents|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring|Neurotoxic agents|Phenothiazines|Sulfur Compounds",CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,23623915
12566,DB14652,Clocortolone acetate,small molecule,experimental,"Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Pregnadienediols|Pregnadienes|Pregnanes|Steroids|Steroids, Fluorinated",[H][C@@]12C[C@@H](C)[C@H](C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,
12567,DB14653,Clocortolone caproate,small molecule,experimental,,CCCCCC(=O)OCC(=O)[C@H]1[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]12C,
12568,DB14654,Bisoxatin acetate,small molecule,experimental,,CC(=O)OC1=CC=C(C=C1)C1(OC2=C(NC1=O)C=CC=C2)C1=CC=C(OC(C)=O)C=C1,
12569,DB14655,Drostanolone propionate,small molecule,approved|illicit,Androstanes|Fused-Ring Compounds|Steroids|Testosterone and derivatives,[H][C@@]12CC[C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)[C@H](C)C[C@]12C,
12570,DB14656,Chlorphenesin carbamate,small molecule,approved|vet_approved|withdrawn,Alcohols|Glycols|Propylene Glycols,NC(=O)OCC(O)COC1=CC=C(Cl)C=C1,
12571,DB14657,Paramethasone acetate,small molecule,approved,"Fused-Ring Compounds|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated",[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,
12572,DB14658,Chloramphenicol palmitate,small molecule,approved|vet_approved,Alcohols|Benzene Derivatives|Glycols|Nitro Compounds|Nitrobenzenes|Propylene Glycols,CCCCCCCCCCCCCCCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O,
12573,DB14659,Melengestrol acetate,small molecule,experimental,"Adrenal Cortex Hormones|Corticosteroids|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Pregnadienes|Pregnanes|Steroids",[H][C@@]12CC(=C)[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=C(C)C2=CC(=O)CC[C@]12C,
12574,DB14660,Trenbolone acetate,small molecule,vet_approved,"Anabolic Agents|Estranes|Estrenes|Fused-Ring Compounds|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids",[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CCC4=C3C=C[C@]12C)OC(C)=O,
12575,DB14661,Loperamide oxide,small molecule,experimental,"Alimentary Tract and Metabolism|Antidiarrheals|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antipropulsives|Gastrointestinal Agents|Piperidines",CN(C)C(=O)C(CC[N+]1([O-])CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1,
12576,DB14662,Flunisolide acetate,small molecule,experimental,,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,
12577,DB14663,Ribavirin monophosphate,small molecule,experimental,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides",NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O,
12578,DB14664,Difluocortolone pivalate,small molecule,experimental,,[H][C@@]12C[C@@H](C)[C@H](C(=O)COC(=O)C(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,
12579,DB14665,Bornyl acetate,small molecule,experimental,Monoterpenes|Norbornanes|Terpenes,CC(=O)O[C@@H]1C[C@@H]2CC[C@@]1(C)C2(C)C,
12580,DB14666,Oleoyl chloride,small molecule,experimental,,CCCCCCCC\C=C/CCCCCCCC(Cl)=O,
12581,DB14667,Phenyl hydrogen sulfate,small molecule,experimental,"Acids|Acids, Noncarboxylic|Sulfur Acids|Sulfur Compounds|Sulfuric Acids",OS(=O)(=O)OC1=CC=CC=C1,
12582,DB14668,Dienestrol diacetate,small molecule,experimental,Benzene Derivatives|Phenols,C\C=C(\C(=C\C)\C1=CC=C(OC(C)=O)C=C1)/C1=CC=C(OC(C)=O)C=C1,
12583,DB14669,Betamethasone phosphate,small molecule,approved|vet_approved,"Adrenal Cortex Hormones|Corticosteroids|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|OAT3/SLC22A8 Substrates|P-glycoprotein inducers|P-glycoprotein substrates|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated",[H][C@@]12C[C@H](C)[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,
12584,DB14670,Lauroyl chloride,small molecule,experimental,,CCCCCCCCCCCC(Cl)=O,
12585,DB14671,Temazepam acetate,small molecule,experimental,,CN1C2=CC=C(Cl)C=C2C(=NC(OC(C)=O)C1=O)C1=CC=CC=C1,
12586,DB14672,Oxazepam acetate,small molecule,experimental,"Benzazepines|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring",CC(=O)OC1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O,
12587,DB14673,Flurandrenolide acetate,small molecule,experimental,,CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]21C,
12588,DB14674,Estramustine phosphate,small molecule,approved|investigational,,[H][C@@]12CC[C@H](OP(O)(O)=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC(=O)N(CCCl)CCCl)C=C3,
12589,DB14675,Temsavir,small molecule,investigational,HIV Fusion Inhibitors,COC1=CN=C(N2C=NC(C)=N2)C2=C1C(=CN2)C(=O)C(=O)N1CCN(CC1)C(=O)C1=CC=CC=C1,
12590,DB14676,Fagrocorat,small molecule,experimental,,[H][C@]12CCC3=C(C=CC(=C3)C(=O)NC3=C(C)N=CC=C3)[C@]1(CC1=CC=CC=C1)CC[C@@](O)(C2)C(F)(F)F,
12591,DB14677,Gestonorone caproate,small molecule,approved,Fused-Ring Compounds|Norpregnanes|Norpregnenes|Norsteroids|Pregnanes|Pregnenediones|Pregnenes|Steroids,[H][C@@]12CC[C@](OC(=O)CCCCC)(C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],
12592,DB14678,Norethindrone enanthate,small molecule,experimental,"Adrenal Cortex Hormones|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fused-Ring Compounds|Hormonal Contraceptives for Systemic Use|Norpregnanes|Norpregnenes|Norsteroids|Progesterone Congeners|Progestins|Reproductive Control Agents|Steroids",[H][C@@]12CC[C@@](OC(=O)CCCCCC)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],
12593,DB14679,Quingestanol acetate,small molecule,experimental,Adrenal Cortex Hormones|Fused-Ring Compounds|Norpregnanes|Norsteroids|Progestins|Steroids,[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(OC4CCCC4)=CC3=CC[C@@]21[H],
12594,DB14680,Combretastatin A4,small molecule,experimental,"Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Benzene Derivatives|Benzylidene Compounds",COC1=CC=C(\C=C/C2=CC(OC)=C(OC)C(OC)=C2)C=C1O,
12595,DB14681,Cortisone,small molecule,experimental,"17-Hydroxycorticosteroids|Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strength unknown)|Cytochrome P-450 Enzyme Inducers|Fused-Ring Compounds|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Ophthalmologicals|Pregnanes|Pregnenes|Sensory Organs|Steroids|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
12596,DB14682,Dextrorphan,small molecule,experimental,"Alkaloids|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Heterocyclic Compounds, Fused-Ring|Morphinans|Neuroprotective Agents|Neurotransmitter Agents|Opiate Alkaloids|Phenanthrenes|Protective Agents",[H][C@]12CC3=C(C=C(O)C=C3)[C@@]3(CCCC[C@]13[H])CCN2C,
12597,DB14683,Prezatide copper,small molecule,experimental,,[Cu++].NCCCC[C@H](NC(=O)[C@H](CC1=CN=CN1)NC(=O)CN)C([O-])=O,
12598,DB14684,Calcium polycarbophil,small molecule,approved,"Alimentary Tract and Metabolism|Antidiarrheals|Bulk-Forming Laxatives|Calcium Salts|Compounds used in a research, industrial, or household setting|Dental Materials|Drug Carriers|Drugs for Constipation|Gastrointestinal Agents|Laxatives|Macromolecular Substances|Phosphate Binder|Plastics|Polymers|Resins, Synthetic",,
12609,DB14695,Ferric oxyhydroxide,small molecule,experimental,Iron Compounds|Organometallic Compounds|Phosphate Binder|Phosphate Chelating Activity,[OH-].[O--].[Fe+3],
12615,DB14701,Ethyl 8-hydroxy-alpha-(2-propynylamino)-5-quinolinepropanoate,small molecule,experimental,,CCOC(=O)C(CC1=C2C=CC=NC2=C(O)C=C1)NCC#C,
12616,DB14702,Sodium metavanadate,small molecule,approved|experimental,Vanadates,[Na+].[O-][V](=O)=O,
12617,DB14703,Dexamethasone metasulfobenzoate,small molecule,approved|experimental,"Fused-Ring Compounds|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated",[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COC(=O)C3=CC=CC(=C3)S(O)(=O)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,
12618,DB14704,Ribitol,small molecule,experimental,Alcohols|Carbohydrates|Sugar Alcohols,OC[C@H](O)[C@H](O)[C@H](O)CO,
12619,DB14705,Ceramide AP,small molecule,experimental,Amides|Carbohydrates|Glycoconjugates|Glycolipids|Glycosphingolipids|Lipids|Membrane Lipids|Neutral Glycosphingolipids|Sphingolipids,CCCCCCCCCCCCCCCCC(O)C(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC,
12620,DB14706,Ceramide NG,small molecule,experimental,Amides|Carbohydrates|Glycoconjugates|Glycolipids|Glycosphingolipids|Lipids|Membrane Lipids|Neutral Glycosphingolipids|Sphingolipids,CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC,
12622,DB14708,Tosylchloramide,small molecule,experimental,"Amines|Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Benzene Derivatives|Chlorine Compounds|Compounds used in a research, industrial, or household setting|Dermatologicals|Disinfectants|Indicators and Reagents|Laboratory Chemicals|Noxae|Oxidants|Sulfonamides|Sulfones|Sulfur Compounds|Toxic Actions",CC1=CC=C(C=C1)S(=O)(=O)NCl,
12628,DB14714,Tenivastatin,small molecule,experimental,,[H][C@@](O)(CC[C@@]1([H])[C@@H](C)C=CC2=C[C@H](C)C[C@H](OC(=O)C(C)(C)CC)[C@]12[H])C[C@@H](O)CC(O)=O,
12629,DB14715,Cinazepam,small molecule,experimental,"Benzazepines|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Depressants|Heterocyclic Compounds, Fused-Ring",OC(=O)CCC(=O)OC1N=C(C2=CC=CC=C2Cl)C2=CC(Br)=CC=C2NC1=O,
12630,DB14716,Clonazolam,small molecule,experimental,,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(=C3)N(=O)=O)N12,
12631,DB14717,Nitrazolam,small molecule,experimental,,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(=C3)[N+]([O-])=O)N12,
12632,DB14718,Pyrazolam,small molecule,experimental,"Benzazepines|Central Nervous System Agents|Central Nervous System Depressants|GABA Agents|GABA Modulators|Heterocyclic Compounds, Fused-Ring|Hypnotics and Sedatives|Neurotransmitter Agents|Street Drugs",CC1=NN=C2CN=C(C3=CC=CC=N3)C3=C(C=CC(Br)=C3)N12,
12633,DB14719,Bentazepam,small molecule,experimental,Anti-Anxiety Agents|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Psycholeptics,O=C1CN=C(C2=C(N1)SC1=C2CCCC1)C1=CC=CC=C1,
12634,DB14720,Brovanexine,small molecule,experimental,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates",COC1=C(OC(C)=O)C=CC(=C1)C(=O)NC1=C(CN(C)C2CCCCC2)C=C(Br)C=C1Br,
12635,DB14721,MK-1454,small molecule,investigational,,,
12636,DB14722,ADU-S100,small molecule,investigational,,,
12637,DB14723,Larotrectinib,small molecule,approved|investigational,Antineoplastic Agents|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|P-glycoprotein substrates|Tyrosine Kinase Inhibitors,O[C@H]1CCN(C1)C(=O)NC1=C2N=C(C=CN2N=C1)N1CCC[C@@H]1C1=C(F)C=CC(F)=C1,
12639,DB14725,Cefamandole nafate,small molecule,approved,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|beta-Lactams|Cephalosporins|Heterocyclic Compounds, Fused-Ring|Lactams|Sulfur Compounds|Thiazines",[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@H]2NC(=O)[C@H](OC=O)C1=CC=CC=C1)C(O)=O,
12640,DB14726,Dabigatran,small molecule,investigational,"Anticoagulants|Antithrombins|Benzimidazoles|Enzyme Inhibitors|Hematologic Agents|Heterocyclic Compounds, Fused-Ring|Protease Inhibitors|Pyridines|Serine Protease Inhibitors",CN1C(CNC2=CC=C(C=C2)C(N)=N)=NC2=C1C=CC(=C2)C(=O)N(CCC(O)=O)C1=NC=CC=C1,
12641,DB14727,Riboflavin tetrabutyrate,small molecule,experimental,"Biological Factors|Coenzymes|Enzymes and Coenzymes|Flavins|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Pteridines",CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@H](CN1C2=C(C=C(C)C(C)=C2)N=C2C(=O)NC(=O)N=C12)OC(=O)CCC,
12642,DB14728,Mebenil,small molecule,experimental,Amides|Amines|Aniline Compounds,,
12643,DB14729,Rebeccamycin,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring|Indoles",CO[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@@H]1CO)N1C2=C(C3=C1C(Cl)=CC=C3)C1=C(C(=O)NC1=O)C1=C2NC2=C1C=CC=C2Cl,
12646,DB14732,Queuine,small molecule,experimental|nutraceutical,"Heterocyclic Compounds, Fused-Ring|Purines|Purinones",NC1=NC2=C(C(CN[C@H]3C=C[C@H](O)[C@@H]3O)=CN2)C(=O)N1,
12647,DB14733,Ceftobiprole medocaril,small molecule,experimental|investigational,"Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|beta-Lactams|Heterocyclic Compounds, Fused-Ring|Lactams|Sulfur Compounds|Thiazines",[H][C@@]1(NC(=O)C(=N/O)\C2=NSC(N)=N2)C(=O)N2C(C(O)=O)=C(CS[C@]12[H])\C=C1/CCN(C1=O)[C@]1([H])CCN(C1)C(=O)OCC1=C(C)OC(=O)O1,
12648,DB14734,Cannabigerol,small molecule,experimental,Terpenes,CCCCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1,
12649,DB14735,Cannabichromene,small molecule,experimental,Terpenes,CCCCCC1=CC2=C(C=CC(C)(CCC=C(C)C)O2)C(O)=C1,
12650,DB14736,Cannabivarin,small molecule,experimental,Terpenes,CCCC1=CC(O)=C2C(OC(C)(C)C3=C2C=C(C)C=C3)=C1,
12651,DB14737,Cannabinol,small molecule,experimental|investigational,Cannabinoids and similars|Terpenes,CCCCCC1=CC2=C(C(O)=C1)C1=C(C=CC(C)=C1)C(C)(C)O2,
12653,DB14739,Phenolsulfonic acid,small molecule,experimental,,OC1=CC=C(C=C1)S(O)(=O)=O,
12656,DB00781,Polymyxin B,small molecule,approved|vet_approved,"Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antiinfectives for Systemic Use|Antimicrobial Cationic Peptides|Intestinal Antiinfectives|Lipopeptides|Neurotoxic agents|Ophthalmological and Otological Preparations|Ophthalmologicals|Otologicals|Peptides|Peptides, Cyclic|Polymyxin-class Antibacterial|Polymyxins|Pore Forming Cytotoxic Proteins|Proteins|Sensory Organs",[H][C@]1(NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](CCN)NC(=O)[C@H](CCNC1=O)NC(=O)[C@H](CCN)NC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)CCCCC(C)CC)[C@@H](C)O)[C@@H](C)O,
12660,DB14746,Lauryl glucoside,small molecule,experimental,,CCCCCCCCCCCCOC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,
12664,DB14750,Cidoxepin,small molecule,experimental,,CN(C)CC\C=C1\C2=CC=CC=C2COC2=C1C=CC=C2,
12666,DB14752,Racephedrine,small molecule,approved|experimental,Adrenergic Agonists|Alpha-and Beta-adrenergic Agonists|Herbs and Natural Products|Sympathomimetic (Adrenergic) Agents,,
12667,DB14753,Hydroxystilbamidine,small molecule,approved,Amidines|Benzene Derivatives|Benzylidene Compounds|Stilbenes,NC(=N)C1=CC=C(\C=C\C2=C(O)C=C(C=C2)C(N)=N)C=C1,
12668,DB14754,Solriamfetol,small molecule,approved,"Acids, Acyclic|Adrenergic Agents|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that produce hypertension|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Uptake Inhibitors|Drugs that are Mainly Renally Excreted|MATE 1 Substrates|MATE substrates|Norepinephrine Reuptake Inhibitor|OCT2 Substrates",N[C@@H](COC(N)=O)CC1=CC=CC=C1,
12669,DB14755,beta-Isosparteine,small molecule,experimental,,[H][C@@]12CCCCN1C[C@@H]1C[C@H]2CN2CCCC[C@@]12[H],
12670,DB14756,meso-Tartaric acid,small molecule,experimental,,O[C@@H]([C@@H](O)C(O)=O)C(O)=O,
12674,DB14760,Narlaprevir,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Oligopeptides|Peptides|Sulfur Compounds",CCCCC(NC(=O)C1[C@@H]2[C@H](CN1C(=O)C(NC(=O)NC1(CS(=O)(=O)C(C)(C)C)CCCCC1)C(C)(C)C)C2(C)C)C(=O)C(=O)NC1CC1,
12675,DB14761,Remdesivir,small molecule,investigational,"Amino Acids|Amino Acids, Peptides, and Proteins|Antiviral Agents|BSEP/ABCB11 Inhibitors|Carbohydrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Experimental Unapproved Treatments for COVID-19|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 inhibitors|P-glycoprotein substrates",CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@](C#N)([C@H](O)[C@@H]1O)C1=CC=C2N1N=CN=C2N)OC1=CC=CC=C1,
12677,DB14763,Cycloguanil,small molecule,approved,"Amidines|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Biguanides|Enzyme Inhibitors|Folic Acid Antagonists|Guanidines",CC1(C)N=C(N)N=C(N)N1C1=CC=C(Cl)C=C1,
12679,DB14765,Rivoceranib,small molecule,investigational,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,O=C(NC1=CC=C(C=C1)C1(CCCC1)C#N)C1=CC=CN=C1NCC1=CC=NC=C1,
12680,DB14766,Etrasimod,small molecule,investigational,,OC(=O)C[C@H]1CCC2=C1NC1=C2C=C(OCC2=CC(=C(C=C2)C2CCCC2)C(F)(F)F)C=C1,
12682,DB14768,PF-06459988,small molecule,investigational,,CO[C@H]1CN(C[C@@H]1COC1=C2C(Cl)=CNC2=NC(NC2=CN(C)N=C2)=N1)C(=O)C=C,
12683,DB14769,Pamiparib,small molecule,investigational,,C[C@]12CCCN1CC1=NNC(=O)C3=C4C(NC2=C14)=CC(F)=C3,
12684,DB14770,Lanraplenib,small molecule,investigational,,NC1=CN=CC(=N1)C1=CN2C=CN=C2C(NC2=CC=C(C=C2)N2CCN(CC2)C2COC2)=N1,
12685,DB14771,Polyacrylamide (crosslinked; 2 mole percent bisacrylamide),small molecule,investigational,"Biocompatible Materials|Colloids|Complex Mixtures|Compounds used in a research, industrial, or household setting|Dental Materials|Investigative Techniques|Macromolecular Substances|Pharmaceutical Preparations|Plastics|Polymers|Resins, Synthetic",,
12686,DB14772,DCFBC F-18,small molecule,investigational,,OC(=O)CC[C@H](NC(=O)N[C@@H](CSCC1=CC=C([18F])C=C1)C(O)=O)C(O)=O,
12687,DB14773,Lifirafenib,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",FC(F)(F)C1=CC2=C(C=C1)N=C(N2)[C@@H]1[C@H]2OC3=C(C=C(OC4=C5CCC(=O)NC5=NC=C4)C=C3)[C@@H]12,
12688,DB14774,Balipodect,small molecule,investigational,,COC1=CN(N=C(C2=CC=NN2C2=CC=CC=C2)C1=O)C1=CC=C(C=C1F)N1C=CC=N1,
12689,DB14775,Cavosonstat,small molecule,investigational,Benzene Derivatives,OC(=O)C1=CC(Cl)=C(C=C1)C1=NC2=CC=C(O)C=C2C=C1,
12691,DB14777,Murepavadin,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Peptides",CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CCN)NC(=O)[C@@H](CCN)NC(=O)[C@H](CCCN)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O,
12693,DB14779,LGD-6972,small molecule,investigational,"Acids|Acids, Carbocyclic|Acids, Noncarboxylic|Alkanes|Alkanesulfonic Acids|Amides|Benzene Derivatives|Benzoates|Hydrocarbons, Acyclic|Sulfonic Acids|Sulfur Acids|Sulfur Compounds",CC1=CC(C)=C(C(C)=C1)C1=CC=C(NC(=O)[C@H](CC2=CC=C(C=C2)C(=O)NCCS(O)(=O)=O)C2=CC=C(C=C2)C2=CC=C(C=C2)C(C)(C)C)C=C1,
12697,DB14783,Diroximel fumarate,small molecule,approved|investigational,Fumarates|Hepatotoxic Agents,COC(=O)\C=C\C(=O)OCCN1C(=O)CCC1=O,
12699,DB14785,Fenebrutinib,small molecule,investigational,Pyridines,C[C@H]1CN(CCN1C1=CC=C(NC2=CC(=CN(C)C2=O)C2=C(CO)C(=NC=C2)N2CCN3C4=C(CC(C)(C)C4)C=C3C2=O)N=C1)C1COC1,
12700,DB14786,Nerofe,small molecule,investigational,"Amino Acids, Peptides, and Proteins",CC(C)C[C@@H](NC(=O)[C@H](NC(=O)[C@@H](CO)NC(=O)[C@H]1CCCN1C(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](NC(=O)[C@@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](N)CC1=CNC2=C1C=CC=C2)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCCN)C(O)=O,
12701,DB14787,BMS-830216,small molecule,investigational,,COC1=CC(=CC=C1OC[C@H](OP(O)(O)=O)C1CC1)N1C=NC2=C(SC(=C2)C2=CC=C(Cl)C=C2)C1=O,
12704,DB14790,BPN-14770,small molecule,investigational,,NC(=O)CC1=CC=C(NC2=NC(=NC(=C2)C(F)(F)F)C2=CC=CC(Cl)=C2)C=C1,
12705,DB14791,GDC-0425,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CCN1CCC(CC1)OC1=C(N=CC2=C1C1=C(N2)N=CC=C1)C#N,
12706,DB14792,AZD-5991,small molecule,investigational,Antineoplastic Agents,CN1N=C2CSCC3=NN(C)C(CSC4=CC5=C(C=CC=C5)C(OCCCC5=C(N(C)C6=C5C=CC(Cl)=C6C2=C1C)C(O)=O)=C4)=C3,
12707,DB14793,RO-5045337,small molecule,investigational,,CCOC1=C(C=CC(=C1)C(C)(C)C)C1=N[C@@](C)(C2=CC=C(Cl)C=C2)[C@](C)(N1C(=O)N1CCN(CCCS(C)(=O)=O)CC1)C1=CC=C(Cl)C=C1,
12709,DB14795,AZD-3759,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",COC1=C(OC(=O)N2CCN(C)C[C@H]2C)C=C2C(NC3=C(F)C(Cl)=CC=C3)=NC=NC2=C1,
12713,DB14799,PF-06821497,small molecule,investigational,,CO[C@H](C1COC1)C1=C(Cl)C2=C(CCN(CC3=C(OC)C=C(C)NC3=O)C2=O)C(Cl)=C1,
12715,DB14801,Lanifibranor,small molecule,investigational,"Amides|Heterocyclic Compounds, Fused-Ring|Sulfones|Sulfur Compounds|Thiazoles",OC(=O)CCCC1=CC2=C(C=CC(Cl)=C2)N1S(=O)(=O)C1=CC2=C(C=C1)N=CS2,
12716,DB14802,ONO-2952,small molecule,investigational,"Cycloparaffins|Heterocyclic Compounds, Fused-Ring",COC1=C(C=CC(Cl)=C1)[C@@H]1N(CC2(CC2)C2=C1NC1=C2C(F)=CC=C1)C(C)=O,
12717,DB14803,AMY-101,small molecule,investigational,,CC[C@H](C)[C@H](NC(=O)[C@H](N)CC1=CC=C(O)C=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](C)NC(=O)CN(C)C(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CN(C)C3=C2C=CC=C3)NC(=O)[C@@H](NC1=O)C(C)C)C(=O)N(C)[C@@H]([C@@H](C)CC)C(N)=O,
12718,DB14804,Iodine I-125,small molecule,investigational,,[125I],
12719,DB14805,DCFPyL F-18,small molecule,investigational,,OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)C1=CC=C([18F])N=C1)C(O)=O)C(O)=O,
12720,DB14806,Avexitide,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Glucagon-Like Peptide 1|Peptides|Venoms",CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O,
12721,DB14807,Demplatin pegraglumer,small molecule,investigational,"Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Glutamates|Organometallic Compounds|Peptides",,
12722,DB14808,Lumicitabine,small molecule,investigational,"Carbohydrates|Deoxyribonucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",CC(C)C(=O)OC[C@@]1(CCl)O[C@H]([C@H](F)[C@@H]1OC(=O)C(C)C)N1C=CC(N)=NC1=O,
12724,DB14810,AZD-1656,small molecule,investigational,Azetines|Glucokinase,COC[C@H](C)OC1=CC(=CC(OC2=NC=C(N=C2)C(=O)N2CCC2)=C1)C(=O)NC1=NC=C(C)N=C1,
12727,DB14813,PF-232798,small molecule,investigational,Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Aza Compounds|CCR5 Receptor Antagonists,CC(C)C(=O)N1CCC2=C(C1)N=C(C)N2[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(C)=O)C1=CC=CC(F)=C1,
12728,DB14814,Lanabecestat,small molecule,investigational,,CO[C@H]1CC[C@@]2(CC3=CC=C(C=C3[C@@]22N=C(C)C(N)=N2)C2=CC(=CN=C2)C#CC)CC1,
12729,DB14815,Ginsenoside B2,small molecule,investigational,Carbohydrates|Glycosides|Panax|Saponins|Terpenes|Triterpenes,[H][C@@]1(CC[C@]2(C)[C@]1([H])[C@H](O)C[C@]1([H])[C@@]3(C)CC[C@H](O)C(C)(C)[C@]3([H])[C@H](C[C@@]21C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O)C(C)(CCC=C(C)C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,
12734,DB14820,Profoxydim,small molecule,investigational,,CCCC(=NOCC(C)OC1=CC=C(Cl)C=C1)C1=C(O)CC(CC1=O)C1CCCSC1,
12735,DB14821,Macozinone,small molecule,investigational,Sulfur Compounds,[O-][N+](=O)C1=C2SC(=NC(=O)C2=CC(=C1)C(F)(F)F)N1CCN(CC2CCCCC2)CC1,
12736,DB14822,SB-649868,small molecule,investigational,"Carbon Radioisotopes|Heterocyclic Compounds, Fused-Ring|Sulfur Compounds",CC1=NC(C(=O)N2CCCC[C@H]2CNC(=O)C2=CC=CC3=C2C=CO3)=C(S1)C1=CC=C(F)C=C1,
12737,DB14823,Balovaptan,small molecule,investigational,,CN1CC2=NN=C([C@H]3CC[C@@H](CC3)OC3=NC=CC=C3)N2C2=CC=C(Cl)C=C2C1,
12740,DB14826,Topramezone,small molecule,investigational,,CN1N=CC(C(=O)C2=C(C)C(C3=NOCC3)=C(C=C2)S(C)(=O)=O)=C1O,
12742,DB14828,ABX-464,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",FC(F)(F)OC1=CC=C(NC2=CC=C3C=CC=C(Cl)C3=N2)C=C1,
12743,DB14829,Uproleselan,small molecule,investigational,,CC[C@H]1C[C@H](C[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H](CC3CCCCC3)C(O)=O)[C@H]2NC(C)=O)[C@@H]1O[C@@H]1O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]1O)C(=O)NCCNC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,
12744,DB14830,Fluoromisonidazole F-18,small molecule,investigational,,OC(C[18F])CN1C=CN=C1[N+]([O-])=O,
12746,DB14832,Polydioxanone,small molecule,investigational,"Biocompatible Materials|Compounds used in a research, industrial, or household setting|Macromolecular Substances|Polyesters|Polymers",,
12749,DB14835,SUVN-G3031,small molecule,investigational,,O=C(CN1CCOCC1)NC1=CC=C(OC2CCN(CC2)C2CCC2)C=C1,
12750,DB14836,Polydextrose,small molecule,investigational,"Biopolymers|Carbohydrates|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Food|Food Additives|Food and Beverages|Food Ingredients|Macromolecular Substances|Physiological Phenomena|Polymers|Polysaccharides",,
12752,DB14839,TOP-1288,small molecule,investigational,,COCCOCCOCCNC(=O)C1=CC(=CC(NC2=NC=CC(OC3=C4C=CC=CC4=C(NC(=O)NC4=CC(=CC(NS(C)(=O)=O)=C4OC)C(C)(C)C)C=C3)=N2)=C1)C#C,
12753,DB14840,Ripretinib,small molecule,approved,BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|MATE 1 Inhibitors|MATE inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Protein Kinase Inhibitors,CCN1C(=O)C(=CC2=C1C=C(NC)N=C2)C1=C(Br)C=C(F)C(NC(=O)NC2=CC=CC=C2)=C1,
12754,DB14841,Centanafadine,small molecule,investigational,,C1[C@@H]2CNC[C@]12C1=CC=C2C=CC=CC2=C1,
12756,DB14844,ONC-201,small molecule,investigational,"Antineoplastic Agents|Heterocyclic Compounds, Fused-Ring",CC1=CC=CC=C1CN1C2=NCCN2C2=C(CN(CC3=CC=CC=C3)CC2)C1=O,
12757,DB14845,Filgotinib,small molecule,investigational,"Janus Kinase 1, antagonists & inhibitors",O=C(NC1=NN2C(C=CC=C2C2=CC=C(CN3CCS(=O)(=O)CC3)C=C2)=N1)C1CC1,
12758,DB14846,Bimiralisib,small molecule,investigational,,NC1=NC=C(C2=NC(=NC(=N2)N2CCOCC2)N2CCOCC2)C(=C1)C(F)(F)F,
12761,DB14849,Nebicapone,small molecule,investigational,Ketones,OC1=C(O)C(=CC(=C1)C(=O)CC1=CC=CC=C1)[N+]([O-])=O,
12762,DB14850,Deleobuvir,small molecule,investigational,"Acids, Acyclic|Heterocyclic Compounds, Fused-Ring",CN1C2=C(C=CC(\C=C\C(O)=O)=C2)N=C1C1(CCC1)NC(=O)C1=CC2=C(C=C1)C(C1CCCC1)=C(N2C)C1=NC=C(Br)C=N1,
12766,DB14854,TC-6987,small molecule,investigational,,FC1=CC(=CC(F)=C1)C(=O)N[C@@H]1C2CCN(CC2)[C@H]1CC1=CN=CC=C1,
12767,DB14855,2-(aminomethyl)phenol,small molecule,investigational,Amines|Benzene Derivatives|Benzyl Compounds,NCC1=CC=CC=C1O,
12768,DB14856,PF-05089771,small molecule,investigational,Amides|Benzene Derivatives|Ethers|Phenols|Sulfones|Sulfur Compounds,NC1=C(C=NN1)C1=CC(Cl)=CC=C1OC1=CC(F)=C(C=C1Cl)S(=O)(=O)NC1=CSC=N1,
12769,DB14857,Avadomide,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Piperidines|Quinazolines",CC1=NC2=C(C(N)=CC=C2)C(=O)N1C1CCC(=O)NC1=O,
12771,DB14859,Fosifloxuridine nafalbenamide,small molecule,investigational,,C[C@H](NP(=O)(OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(F)C(=O)NC1=O)OC1=C2C=CC=CC2=CC=C1)C(=O)OCC1=CC=CC=C1,
12772,DB14860,Ensartinib,small molecule,investigational,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,C[C@@H](OC1=CC(=NN=C1N)C(=O)NC1=CC=C(C=C1)C(=O)N1C[C@H](C)N[C@H](C)C1)C1=C(Cl)C=CC(F)=C1Cl,
12773,DB14862,PF-06815345,small molecule,investigational,,CCOC(=O)O[C@@H](C)N1N=NN=C1C1=C(C=NN1C)C1=CC=C(C=C1F)C(=O)N([C@@H]1CCCNC1)C1=NC=CC=C1Cl,
12776,DB14866,Amcasertib,small molecule,investigational,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=CC=C(C=C23)C2=CSC(=N2)C2=CC=CC=C2)=C1C,
12777,DB14867,Parsaclisib,small molecule,investigational,,CCOC1=C(C=C(Cl)C(F)=C1[C@@H]1CNC(=O)C1)[C@H](C)N1N=C(C)C2=C1N=CN=C2N,
12778,DB14868,AZD-8848,small molecule,investigational,"Acids, Carbocyclic|Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides",CCCCOC1=NC2=C(NC(=O)N2CCCN(CCCN2CCOCC2)CC2=CC=CC(CC(=O)OC)=C2)C(N)=N1,
12779,DB14869,Remetinostat,small molecule,investigational,,COC(=O)C1=CC=C(OC(=O)CCCCCCC(=O)NO)C=C1,
12780,DB14870,PF-5190457,small molecule,investigational,Azetines,CC1=CN2C=C(CC(=O)N3CCC4(CN(C4)[C@@H]4CCC5=C4C=CC(=C5)C4=CC(C)=NC=N4)CC3)N=C2S1,
12782,DB14872,Lucerastat,small molecule,investigational,Alkaloids|Carbohydrates|Imines|Imino Pyranoses|Imino Sugars|Piperidines,CCCCN1C[C@H](O)[C@@H](O)[C@@H](O)[C@H]1CO,
12785,DB14875,AZD-4017,small molecule,investigational,"11-beta-Hydroxysteroid Dehydrogenase Type 1, antagonists & inhibitors|Nicotinic Acids|Pyridines",CCCSC1=C(C=CC(=N1)N1CCC[C@@H](CC(O)=O)C1)C(=O)NC1CCCCC1,
12786,DB14876,TAS-116,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates",CCC1=CC(=CC=C1N1N=C(C(C)C)C2=C1N=CC=C2N1C=NC(=C1)C1=CN(C)N=C1)C(N)=O,
12788,DB14878,Liafensine,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CN1C[C@@H](C2=CC3=C(C=CC=C3)C=C2)C2=CC=C(C=C2C1)C1=NN=C(N)C=C1,
12789,DB14879,Cefiderocol,small molecule,approved|investigational,"Amides|Anti-Bacterial Agents|beta-Lactams|Cephalosporins|Drugs that are Mainly Renally Excreted|Heterocyclic Compounds, Fused-Ring|Lactams|Sulfur Compounds",[H][C@]12SCC(C[N+]3(CCNC(=O)C4=C(Cl)C(O)=C(O)C=C4)CCCC3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC(N)=N1)C([O-])=O,
12791,DB14881,Oliceridine,small molecule,investigational,Ligands|Sulfur Compounds,COC1=C(CNCC[C@]2(CCOC3(CCCC3)C2)C2=NC=CC=C2)SC=C1,
12792,DB14882,CEP-9722,small molecule,investigational,"Acids, Carbocyclic|Heterocyclic Compounds, Fused-Ring|Imides|Indoles|Isoindoles|Phthalic Acids",COC1=CC=CC2=C1C1=C(N2)C2=C(CCC2)C2=C1C(=O)N(CN1CCN(C)CC1)C2=O,
12793,DB14883,Lorecivivint,small molecule,investigational,"Anti-Inflammatory Agents|Heterocyclic Compounds, Fused-Ring|Pyrazoles",CC(C)CC(=O)NC1=CC(=CN=C1)C1=CC2=C(NN=C2C2=NC3=C(C=NC=C3N2)C2=CC=CC(F)=C2)C=C1,
12795,DB14885,PF-05180999,small molecule,investigational,,CN1N=CC(C2=C3N(N=CN=C3N3CCC3)C(C)=N2)=C1C1=NC=C(C=C1)C(F)(F)F,
12796,DB14886,BIO-11006,small molecule,investigational,,C[C@@H](O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC(C)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O,
12797,DB14887,PF-04620110,small molecule,investigational,Azepines|Diacylglycerol O-Acyltransferase,NC1=NC=NC2=C1C(=O)N(CCO2)C1=CC=C(C=C1)[C@H]1CC[C@H](CC(O)=O)CC1,
12798,DB14888,IQP-0528,small molecule,investigational,Anti-HIV Agents|Pyrimidines,CC(C)C1=C(N(CC2CC2)C(=O)NC1=O)C(=O)C1=CC(C)=CC(C)=C1,
12799,DB14889,Derazantinib,small molecule,investigational,,COCCNCCC1=CC(NC2=NC=C3C[C@@H](C4=CC=CC=C4F)C4=CC=CC=C4C3=N2)=CC=C1,
12800,DB14890,Obicetrapib,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CCOC(=O)N1[C@H](CC)C[C@H](N(CC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)C2=NC=C(OCCCC(O)=O)C=N2)C2=C1C=CC(=C2)C(F)(F)F,
12803,DB14894,Galicaftor,small molecule,investigational,,OC(=O)C1=CC=C(C=C1)[C@H]1C[C@@H](NC(=O)C2(CC2)C2=CC3=C(OC(F)(F)O3)C=C2)C2=C(O1)C=C(OC(F)F)C=C2,
12804,DB14895,Vibegron,small molecule,investigational,Pyrimidines,O[C@@H]([C@H]1CC[C@@H](CC2=CC=C(NC(=O)[C@@H]3CCC4=NC=CC(=O)N34)C=C2)N1)C1=CC=CC=C1,
12805,DB14896,Selitrectinib,small molecule,investigational,Enzyme Inhibitors,C[C@@H]1CCC2=C(C=C(F)C=N2)[C@H]2CCCN2C2=NC3=C(C=NN3C=C2)C(=O)N1,
12807,DB14898,Retagliptin,small molecule,investigational,,COC(=O)C1=C2CN(CCN2C(=N1)C(F)(F)F)C(=O)C[C@H](N)CC1=CC(F)=C(F)C=C1F,
12808,DB14899,Tavapadon,small molecule,investigational,,CN1C(=O)NC(=O)C(C)=C1C1=C(C)C=C(OC2=NC=CC=C2C(F)(F)F)C=C1,
12809,DB14900,ISO-1 F-18,small molecule,investigational,,COC1=C(OC)C=C2CN(CCCCNC(=O)C3=C(OCC[18F])C=CC(C)=C3)CCC2=C1,
12811,DB14902,JHU-75528 C-11,small molecule,investigational,,[11CH3]OC1=CC=C(C=C1)C1=C(C#N)C(=NN1C1=CC=C(Cl)C=C1Cl)C(=O)NN1CCCCC1,
12812,DB14903,Rovafovir etalafenamide,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Purines",CCOC(=O)[C@H](C)N[P@@](=O)(CO[C@H]1O[C@@H](N2C=NC3=C2N=CN=C3N)C(F)=C1)OC1=CC=CC=C1,
12813,DB14904,Pimasertib,small molecule,investigational,Nicotinic Acids|Protein Kinase Inhibitors|Pyridines,OC[C@@H](O)CNC(=O)C1=C(NC2=C(F)C=C(I)C=C2)C=NC=C1,
12815,DB14906,Adafosbuvir,small molecule,investigational,"Amino Acids|Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antiviral Agents|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@@]1(F)O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(O)[C@@H]1O)OC1=CC=CC=C1,
12818,DB14909,Imetelstat,small molecule,investigational,"Carbohydrates|Enzyme Inhibitors|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Polynucleotides|Telomerase, antagonists & inhibitors",CCCCCCCCCCCCCCCC(=O)NCC(O)COP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1N)N1C=NC2=C1N=CN=C2N)N1C=NC2=C1N=CN=C2N)N1C=CC(N)=NC1=O)N1C=NC2=C1N=CN=C2N)N1C=NC2=C1N=C(N)NC2=O)N1C=NC2=C1N=CN=C2N)N1C=C(C)C(=O)NC1=O)N1C=C(C)C(=O)NC1=O)N1C=NC2=C1N=C(N)NC2=O)N1C=NC2=C1N=C(N)NC2=O)N1C=NC2=C1N=C(N)NC2=O)N1C=NC2=C1N=CN=C2N)N1C=C(C)C(=O)NC1=O,
12820,DB14911,Risuteganib,small molecule,investigational,,C[C@@H](O)[C@H](NC(=O)[C@H](CS(O)(=O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)CN)C(=O)N1CCC[C@H]1C(O)=O,
12822,DB14913,5-methyl-2'-fluoroarauracil F-18,small molecule,investigational,,CC1=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2[18F])C(=O)NC1=O,
12823,DB14914,Flortaucipir F-18,small molecule,approved|investigational,"Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Heterocyclic Compounds, Fused-Ring|Indoles|Pyridines",[18F]C1=CC=C(C=N1)C1=CC=C2C(NC3=C2C=NC=C3)=C1,
12825,DB14916,Selonsertib,small molecule,investigational,,CC(C)N1C=NN=C1C1=CC=CC(NC(=O)C2=CC(N3C=NC(=C3)C3CC3)=C(C)C=C2F)=N1,
12826,DB14917,Ceralasertib,small molecule,investigational,Sulfur Compounds,C[C@@H]1COCCN1C1=CC(=NC(=N1)C1=CN=CC2=C1C=CN2)C1(CC1)[S@](C)(=N)=O,
12827,DB14918,Branaplam,small molecule,investigational,,CC1(C)CC(CC(C)(C)N1)OC1=NN=C(C=C1)C1=C(O)C=C(C=C1)C1=CNN=C1,
12830,DB14921,Mavacamten,small molecule,investigational,Amines|Benzene Derivatives|Benzyl Compounds|Pyrimidines|Pyrimidinones,CC(C)N1C(=O)NC(N[C@@H](C)C2=CC=CC=C2)=CC1=O,
12832,DB14923,Satavaptan,small molecule,investigational,Antidiuretic Hormone Receptor Antagonists|Cardiovascular Agents|Natriuretic Agents|Oxazines,CCOC1=CC=C2N(C(=O)[C@@]3(CC[C@@H](CC3)OCCN3CCOCC3)C2=C1)S(=O)(=O)C1=CC=C(C=C1OC)C(=O)NC(C)(C)C,
12833,DB14924,PF-06651600,small molecule,investigational,,C[C@H]1CC[C@H](CN1C(=O)C=C)NC1=NC=NC2=C1C=CN2,
12834,DB14925,Tenofovir exalidex,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Organophosphorus Compounds|Purines",CCCCCCCCCCCCCCCCOCCCOP(O)(=O)CO[C@H](C)CN1C=NC2=C1N=CN=C2N,
12836,DB14927,Amylopectin,small molecule,investigational,"Biopolymers|Carbohydrates|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Dietary Carbohydrates|Food|Food and Beverages|Glucans|Macromolecular Substances|Physiological Phenomena|Polymers|Polysaccharides|Starch",,
12838,DB14929,Elsulfavirine,small molecule,investigational,,CCC(=O)NS(=O)(=O)C1=CC(Cl)=C(NC(=O)CC2=CC=C(Br)C(OC3=CC(=CC(Cl)=C3)C#N)=C2F)C=C1,
12839,DB14930,Alovudine F-18,small molecule,investigational,"Anti-Infective Agents|Antiviral Agents|Carbohydrates|Deoxyribonucleosides|Fluorine Radioisotopes|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides",CC1=CN([C@H]2C[C@H]([18F])[C@@H](CO)O2)C(=O)NC1=O,
12840,DB14931,Cobomarsen,small molecule,investigational,,CC1=CN(C2OC3(COP(O)(=S)OC4C5OCC4(COP(O)(=S)OC4CC(OC4COP(O)(=S)OC4CC(OC4COP(O)(=S)OC4C6OCC4(COP(O)(=S)OC4CC(OC4COP(O)(=S)OC4C7OCC4(CO)OC7N4C=C(C)C(N)=NC4=O)N4C=NC7=C4N=CN=C7N)OC6N4C=C(C)C(N)=NC4=O)N4C=NC6=C4N=C(N)NC6=O)N4C=NC6=C4N=CN=C6N)OC5N4C=C(C)C(=O)NC4=O)COC2C3OP(O)(=S)OCC2OC(CC2OP(O)(=S)OCC23COC(C(O2)N2C=NC4=C2N=C(N)NC4=O)C3OP(O)(=S)OCC2OC(CC2OP(O)(=S)OCC23COC(C(O2)N2C=NC4=C2N=CN=C4N)C3OP(O)(=S)OCC23COC(C(O2)N2C=C(C)C(=O)NC2=O)C3OP(O)(=S)OCC23COC(C(O2)N2C=C(C)C(=O)NC2=O)C3OP(O)(=S)OCC23COC(C2O)C(O3)N2C=NC3=C2N=CN=C3N)N2C=CC(N)=NC2=O)N2C=NC3=C2N=CN=C3N)C(=O)NC1=O,
12841,DB14932,Coleneuramide,small molecule,investigational,"Acids, Acyclic|Amino Sugars|Carbohydrates|Hydroxy Acids|Neuraminic Acids|Sugar Acids",CO[C@@]1(C[C@H](O)[C@@H](NC(C)=O)[C@@H](O1)[C@H](O)[C@H](O)CO)C(=O)N[C@@H]1CC[C@@]2(C)[C@@H](CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@H]23)C1,
12842,DB14933,Nicotinamide riboside,small molecule,investigational,Nicotinic Acids|Pyridines,NC(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,
12843,DB14934,GDC-0927,small molecule,investigational,,CC1=C([C@@H](OC2=CC=C(O)C=C12)C1=CC=C(OCCN2CC(CF)C2)C=C1)C1=CC(O)=CC=C1,
12844,DB14935,Serabelisib,small molecule,investigational,"Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Oxazines",NC1=NC2=CC(=CC=C2O1)C1=CN2C(C=C1)=NC=C2C(=O)N1CCOCC1,
12845,DB14936,Menaquinone 6,small molecule,investigational,"Coagulants|Diet, Food, and Nutrition|Diterpenes|Fibrin Modulating Agents|Food|Food and Beverages|Growth Substances|Hematologic Agents|Hemostatics|Micronutrients|Naphthalenes|Naphthoquinones|Physiological Phenomena|Phytol|Quinones|Terpenes|Vitamin K|Vitamin K 2|Vitamins|Vitamins (Fat Soluble)",CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC1=C(C)C(=O)C2=C(C=CC=C2)C1=O,
12846,DB14937,MK-8666,small molecule,investigational,,CC1=CC(OCCCS(C)(=O)=O)=CC(C)=C1C1=CC(COC2=CC3=C(C=N2)[C@H]2[C@@H](C3)[C@@H]2C(O)=O)=CC=C1,
12847,DB14938,Flurbiprofen axetil,small molecule,investigational,"Acids, Acyclic|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antirheumatic Agents|Benzene Derivatives|Biphenyl Compounds|Central Nervous System Agents|Fatty Acids|Fatty Acids, Volatile|Lipids|Peripheral Nervous System Agents|Propionates|Sensory System Agents",CC(OC(C)=O)OC(=O)C(C)C1=CC(F)=C(C=C1)C1=CC=CC=C1,
12848,DB14939,Motixafortide,small molecule,investigational,"Amino Acids, Peptides, and Proteins",NCCCC[C@@H]1NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CC1=CC=C2C=CC=CC2=C1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)C1=CC=C(F)C=C1,
12849,DB14940,Aspartyl-alanyl-diketopiperazine,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Oligopeptides|Peptides",C[C@@H]1NC(=O)[C@H](CC(O)=O)NC1=O,
12850,DB14941,BMS-817399,small molecule,investigational,"Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins",CC(C)[C@@H](NC(=O)NCC(C)(C)O)C(=O)N1CC[C@](O)(C2=CC=C(Cl)C=C2)C(C)(C)C1,
12851,DB14942,BMS-986141,small molecule,investigational,,COC1=NN2C=C(N=C2S1)C1=CC2=C(O1)C=C(OC)C=C2OCC1=CSC(=N1)C1=CC=C(C=C1)C(=O)N(C)C,
12852,DB14943,LGH-447,small molecule,investigational,,C[C@@H]1C[C@H](N)C[C@@H](C1)C1=C(NC(=O)C2=NC(=C(F)C=C2)C2=C(F)C=CC=C2F)C=NC=C1,
12853,DB14944,Tarloxotinib,small molecule,investigational,,CN1C=NC(=C1C[N+](C)(C)C\C=C\C(=O)NC1=NC=C2N=CN=C(NC3=CC(Br)=C(Cl)C=C3)C2=C1)[N+]([O-])=O,
12854,DB14945,Florbenazine F-18,small molecule,investigational,,COC1=C(OCCC[18F])C=C2CCN3C[C@@H](CC(C)C)[C@H](O)C[C@@H]3C2=C1,
12855,DB14946,PCO-371,small molecule,investigational,Imidazoles,CC1=CC(=CC(C)=C1CCS(=O)(=O)N1CCC2(CC1)N=C(NC2=O)C1=CC=C(OC(F)(F)F)C=C1)N1C(=O)NC(=O)C1(C)C,
12857,DB14948,BMS-986020,small molecule,investigational,,C[C@@H](OC(=O)NC1=C(ON=C1C)C1=CC=C(C=C1)C1=CC=C(C=C1)C1(CC1)C(O)=O)C1=CC=CC=C1,
12858,DB14949,AZD-7687,small molecule,investigational,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids",CC1=NC(C)=C(N=C1C1=CC=C(C=C1)[C@H]1CC[C@H](CC(O)=O)CC1)C(N)=O,
12859,DB14950,BMS-929075,small molecule,investigational,,CNC(=O)C1=C(OC2=C1C(F)=C(C=C2)C1=C(C)C=CC(=C1)C(=O)NC1(CC1)C1=NC=CC=N1)C1=CC=C(F)C=C1,
12860,DB14951,Etirinotecan pegol,small molecule,investigational,"Alcohols|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Compounds used in a research, industrial, or household setting|Enzyme Inhibitors|Ethylene Glycols|Glycols|Heterocyclic Compounds, Fused-Ring|Macromolecular Substances|Polymers|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",,
12862,DB14953,Firtecan pegol,small molecule,investigational,"Alcohols|Alkaloids|Compounds used in a research, industrial, or household setting|Ethylene Glycols|Glycols|Macromolecular Substances|Polymers",,
12864,DB14955,PF-04634817,small molecule,investigational,Aza Compounds,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](C1)(C(C)C)C(=O)N1C[C@@H]2C[C@H]1CN2C1=NC=NC(=C1)C(F)(F)F,
12866,DB14957,MK-3577,small molecule,investigational,,CCC[C@@H]([C@@H](C1=CNC2=C1C=C(C)C=C2F)C1=CC=C(Cl)C=C1)C1=CC=C(C=C1)C(=O)NCCC(O)=O,
12870,DB14961,Seltorexant,small molecule,investigational,,CC1=CC(C)=NC(=N1)N1C[C@@H]2CN(C[C@@H]2C1)C(=O)C1=C(F)C=CC=C1N1N=CC=N1,
12872,DB14963,Konjac mannan,small molecule,investigational,Carbohydrates|Gastrointestinal Agents|Laxatives|Plants|Polysaccharides,,
12874,DB14965,CTT-1057,small molecule,investigational,,OC(=O)CC[C@H](NP(O)(=O)OCCC[C@H](NC(=O)CC[C@H](NC(=O)CCCCCNC(=O)C1=CC=C(F)C=C1)C(O)=O)C(O)=O)C(O)=O,
12875,DB14966,Venglustat,small molecule,investigational,"Acids, Acyclic",CC(C)(NC(=O)O[C@@H]1CN2CCC1CC2)C1=CSC(=N1)C1=CC=C(F)C=C1,
12878,DB14969,GTX-758,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates",OC1=CC=C(C=C1)N(C(=O)C1=CC=C(O)C(F)=C1)C1=CC=C(F)C=C1,
12879,DB14970,Alobresib,small molecule,investigational,,CC1=C(C(C)=NO1)C1=CC(=C2N=C(NC2=C1)C1CC1)C(O)(C1=CC=CC=N1)C1=NC=CC=C1,
12880,DB14971,Iomazenil,small molecule,investigational,"Benzazepines|Benzodiazepinones|Heterocyclic Compounds, Fused-Ring|Iodine Radioisotopes",CCOC(=O)C1=C2CN(C)C(=O)C3=C(I)C=CC=C3N2C=N1,
12881,DB14972,Methamidophos,small molecule,investigational,"Agrochemicals|Compounds used in a research, industrial, or household setting|Insecticides|Organophosphorus Compounds|Pesticides|Sulfur Compounds|Toxic Actions",COP(N)(=O)SC,
12882,DB14973,Abrocitinib,small molecule,investigational,,CCCS(=O)(=O)N[C@H]1C[C@H](C1)N(C)C1=C2C=CNC2=NC=N1,
12883,DB14974,Pimodivir,small molecule,investigational,,OC(=O)[C@H]1C2CCC(CC2)[C@@H]1NC1=C(F)C=NC(=N1)C1=CNC2=C1C=C(F)C=N2,
12884,DB14975,Voxelotor,small molecule,approved|investigational,Aldehydes|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Hematologic Agents,CC(C)N1N=CC=C1C1=C(COC2=CC=CC(O)=C2C=O)C=CC=N1,
12885,DB14976,Relacorilant,small molecule,investigational,,CN1C=C(C=N1)S(=O)(=O)N1CCC2=CC3=C(C[C@@]2(C1)C(=O)C1=CC(=CC=N1)C(F)(F)F)C=NN3C1=CC=C(F)C=C1,
12886,DB14977,Padsevonil,small molecule,investigational,,COCC1=NN2C(CN3C[C@@H](CC(F)(F)Cl)CC3=O)=C(N=C2S1)C(F)(F)F,
12887,DB14978,MIP-1095 I-131,small molecule,investigational,,OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)NC1=CC=C([131I])C=C1)C(O)=O)C(O)=O,
12888,DB14979,Martinostat,small molecule,investigational,Amines|Carbon Radioisotopes|Cycloparaffins|Hydroxy Acids|Hydroxylamines,CN(CC1=CC=C(\C=C\C(=O)NO)C=C1)CC12CC3CC(CC(C3)C1)C2,
12889,DB14980,AZD-6482,small molecule,investigational,"Acids, Carbocyclic|Aminobenzoates|Benzene Derivatives|Benzoates|Class Ia Phosphatidylinositol 3-Kinase, antagonists & inhibitors|Pyrimidines",C[C@@H](NC1=CC=CC=C1C(O)=O)C1=CC(C)=CN2C(=O)C=C(N=C12)N1CCOCC1,
12890,DB14981,Fytic acid,small molecule,investigational,,OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O,
12891,DB14982,Miransertib,small molecule,investigational,Amines|Pyridines,NC1=NC=CC=C1C1=NC2=CC=C(N=C2N1C1=CC=C(C=C1)C1(N)CCC1)C1=CC=CC=C1,
12892,DB14983,Cimlanod,small molecule,investigational,,CC1=CC=C(O1)S(=O)(=O)NO,
12894,DB14985,Enarodustat,small molecule,investigational,,OC(=O)CNC(=O)C1=C(O)C=C(CCC2=CC=CC=C2)N2N=CN=C12,
12895,DB14986,Linrodostat,small molecule,investigational,"Acetates|Acids, Acyclic|Amides|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Heterocyclic Compounds, Fused-Ring|Lipids",[H][C@@]1(CC[C@]([H])(CC1)C1=C2C=C(F)C=CC2=NC=C1)[C@@H](C)C(=O)NC1=CC=C(Cl)C=C1,
12896,DB14987,Difamilast,small molecule,investigational,,CCOC1=CC=CC=C1C(=O)NCC1=COC(=N1)C1=CC=C(OC(F)F)C(OC(C)C)=C1,
12898,DB14989,Umbralisib,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CC(C)OC1=C(F)C=C(C=C1)C1=NN([C@@H](C)C2=C(C3=CC=CC(F)=C3)C(=O)C3=CC(F)=CC=C3O2)C2=C1C(N)=NC=N2,
12902,DB14993,Pyrotinib,small molecule,investigational,"Acids, Acyclic|Acrylates|Amides|Heterocyclic Compounds, Fused-Ring|Quinolines",CCOC1=C(NC(=O)\C=C\[C@H]2CCCN2C)C=C2C(=C1)N=CC(C#N)=C2NC1=CC=C(OCC2=NC=CC=C2)C(Cl)=C1,
12903,DB14995,NP-G2-044,small molecule,investigational,,CC1=C(C=CO1)C(=O)NC1=NN(CC2=CC=C(C=C2)C(F)(F)F)C2=CC=CC=C12,
12906,DB14998,Olorinab,small molecule,investigational,,CC(C)(C)[C@@H](CO)NC(=O)C1=NN(C2=C1C[C@@H]1C[C@H]21)C1=C[N+]([O-])=CC=N1,
12911,DB15003,PF-06700841,small molecule,investigational,Enzyme Inhibitors|Protein Kinase Inhibitors,CN1C=C(NC2=NC=CC(=N2)N2C[C@@H]3CC[C@H](C2)N3C(=O)[C@@H]2CC2(F)F)C=N1,
12914,DB15006,Flufenoxuron,small molecule,investigational,Benzene Derivatives,FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=C(F)C=C(OC2=C(Cl)C=C(C=C2)C(F)(F)F)C=C1,
12915,DB15007,Sevuparin,small molecule,investigational,Carbohydrates|Glycosaminoglycans|Polysaccharides,,
12916,DB15008,GO-203-2C,small molecule,investigational,,[H][C@](CCCNC(N)=N)(N=C(C)O)C(O)=N[C@]([H])(CCCNC(N)=N)C(O)=N[C@]([H])(CCCNC(N)=N)C(O)=N[C@]([H])(CCCNC(N)=N)C(O)=N[C@]([H])(CCCNC(N)=N)C(O)=N[C@]([H])(CCCNC(N)=N)C(O)=N[C@]([H])(CCCNC(N)=N)C(O)=N[C@]([H])(CCCNC(N)=N)C(O)=N[C@]([H])(CCCNC(N)=N)C(O)=N[C@]1([H])CSSC[C@@]([H])(N=C(O)[C@@]([H])(CCC(O)=N)N=C1O)C(O)=N[C@]([H])(CCCNC(N)=N)C(O)=N[C@]([H])(CCCNC(N)=N)C(O)=N[C@]([H])(CCCCN)C(O)=N[C@]([H])(CC(O)=N)C(O)=O,
12917,DB15009,PF-04937319,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CN(C)C(=O)C1=NC=C(OC2=CC(=CC3=C2C=C(C)O3)C(=O)NC2=NC=C(C)N=C2)C=N1,
12918,DB15010,Edasalonexent,small molecule,investigational,"Amides|Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Essential|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids",CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(=O)NCCNC(=O)C1=C(O)C=CC=C1,
12919,DB15011,Avacopan,small molecule,investigational,Amines|Piperidines,CC1=CC=C(NC(=O)[C@H]2CCCN([C@H]2C2=CC=C(NC3CCCC3)C=C2)C(=O)C2=C(F)C=CC=C2C)C=C1C(F)(F)F,
12920,DB15012,Farampator,small molecule,investigational,Oxazoles,O=C(N1CCCCC1)C1=CC2=NON=C2C=C1,
12921,DB15013,TAK-243,small molecule,investigational,"Amides|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Sulfones|Sulfur Compounds",NS(=O)(=O)OC[C@H]1C[C@@H](NC2=CC=NC3=CC(=NN23)C2=CC=CC(SC(F)(F)F)=C2)[C@H](O)[C@@H]1O,
12924,DB15016,Palladium Pd-103,small molecule,investigational,,[103Pd],
12928,DB15020,Mureletecan,small molecule,investigational,,,
12929,DB15021,Leriglitazone,small molecule,investigational,,CC(O)C1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,
12931,DB15023,BMS-791826,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Sulfur Compounds|Thiazoles",CCN(C)C(=O)C1=CC=C(C=C1F)C1=NC2=C(C=C1)[C@H](C1=CC=CC=C1O2)C(C)(C)C(=O)NC1=NN=CS1,
12932,DB15024,Apararenone,small molecule,investigational,,CC1(C)OC2=CC(NS(C)(=O)=O)=CC=C2N(C2=CC=C(F)C=C2)C1=O,
12934,DB15026,CXA-10,small molecule,investigational,,CCCCCCCC\C(=C/CCCCCCCC(O)=O)[N+]([O-])=O,
12935,DB15027,Adriforant,small molecule,investigational,,CN[C@@H]1CCN(C1)C1=CC(NCC2CC2)=NC(N)=N1,
12936,DB15028,MK-1064,small molecule,investigational,,COC1=CC=C(CNC(=O)C2=CC(=CN=C2C2=NC=CC=C2)C2=CN=CC(Cl)=C2)N=C1OC,
12937,DB15029,AZD-8186,small molecule,investigational,"Amines|Benzopyrans|Heterocyclic Compounds, Fused-Ring|Pyrans",C[C@@H](NC1=CC(F)=CC(F)=C1)C1=CC(=CC2=C1OC(=CC2=O)N1CCOCC1)C(=O)N(C)C,
12939,DB15031,Nemorexant,small molecule,investigational,,COC1=CC(C(=O)N2CCC[C@@]2(C)C2=NC3=C(N2)C=CC(Cl)=C3C)=C(C=C1)N1N=CC=N1,
12941,DB15033,Flortaucipir,small molecule,investigational,"Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Heterocyclic Compounds, Fused-Ring|Indoles|Pyridines",FC1=CC=C(C=N1)C1=CC=C2C(NC3=C2C=NC=C3)=C1,
12942,DB15034,PRI-724,small molecule,investigational,Pyrimidines,C[C@H]1[C@H]2N([C@@H](CC3=CC=C(OP(O)(O)=O)C=C3)C(=O)N1CC1=CC=CC3=C1N=CC=C3)C(=O)CN(C)N2C(=O)NCC1=CC=CC=C1,
12943,DB15035,Zanubrutinib,small molecule,approved|investigational,Antineoplastic Agents|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strength unknown)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Enzyme Inhibitors|Hematologic Agents|Narrow Therapeutic Index Drugs|P-glycoprotein substrates|Protein Kinase Inhibitors|Teratogens,NC(=O)C1=C2NCC[C@@H](C3CCN(CC3)C(=O)C=C)N2N=C1C1=CC=C(OC2=CC=CC=C2)C=C1,
12944,DB15036,Sitravatinib,small molecule,investigational,Amides|Amines|Aniline Compounds,COCCNCC1=CC=C(N=C1)C1=CC2=C(S1)C(OC1=C(F)C=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2,
12945,DB15037,Poly(lactic acid),small molecule,investigational,"Compounds used in a research, industrial, or household setting|Delayed-Action Preparations|Dental Implants|Drug Delivery Systems|Macromolecular Substances|Membranes, Artificial|Polymers",,
12946,DB15038,Litoxetine,small molecule,investigational,,C(OC1CCNCC1)C1=CC=C2C=CC=CC2=C1,
12947,DB15039,ITI-214,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CN1C2=N[C@@H]3CCC[C@@H]3N2C2=NN(CC3=CC=C(C=C3)C3=NC(F)=CC=C3)C(NC3=CC=CC=C3)=C2C1=O,
12948,DB15040,TP-271,small molecule,investigational,Naphthacenes,[H][C@@]12CC3=C(F)C=C(NC(=O)[C@@H]4CCCN4C)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2,
12949,DB15041,Florilglutamic acid F-18,small molecule,investigational,,N[C@@H](C[C@H](CCC[18F])C(O)=O)C(O)=O,
12954,DB15046,LY-2881835,small molecule,investigational,,CC#C[C@@H](CC(O)=O)C1=CC=C(OCC2=CC=C(CN3CCC4(CC3)C=CC3=C4C=CC=C3)C=C2)C=C1,
12955,DB15047,BMS-919373,small molecule,investigational,,NS(=O)(=O)C1=CN=CC(=C1)C1=NC(NCC2=NC=CC=C2)=C2C(C=CC=C2C2=CC=CC=C2)=N1,
12956,DB15048,Licogliflozin,small molecule,investigational,,CCC1=CC=C(C=C1CC1=CC2=C(OCCO2)C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,
12957,DB15050,Neopterin,small molecule,investigational,"Biological Factors|Coenzymes|Enzymes and Coenzymes|Heterocyclic Compounds, Fused-Ring|Pigments, Biological|Pteridines|Pterins",NC1=NC2=C(N=C(C=N2)[C@H](O)[C@H](O)CO)C(=O)N1,
12958,DB15051,Ethaselen,small molecule,investigational,Selenium Compounds,O=C1N(CCN2[Se]C3=C(C=CC=C3)C2=O)[Se]C2=C1C=CC=C2,
12959,DB15052,Ansofaxine,small molecule,investigational,,CN(C)CC(C1=CC=C(OC(=O)C2=CC=C(C)C=C2)C=C1)C1(O)CCCCC1,
12961,DB15054,TAS-117,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",C[C@@]1(O)C[C@@](N)(C1)C1=CC=C(C=C1)C1=C(N2COC3=CC=NC=C3C2=N1)C1=CC=CC=C1,
12962,DB15055,ABT-639,small molecule,investigational,"Amides|Heterocyclic Compounds, Fused-Ring|Sulfones|Sulfur Compounds",FC1=CC=CC=C1NS(=O)(=O)C1=C(F)C=C(Cl)C(=C1)C(=O)N1CCN2CCC[C@@H]2C1,
12963,DB15056,Bifenthrin,small molecule,investigational,"Monoterpenes|Sarcoma, Experimental, chemically induced|Terpenes|Tremor, chemically induced",CC1=C(C=CC=C1COC(=O)[C@@H]1[C@H](\C=C(/Cl)C(F)(F)F)C1(C)C)C1=CC=CC=C1,
12964,DB15057,NUC-1031,small molecule,investigational,"Antineoplastic Agents|Carbohydrates|Cytosine Nucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides",C[C@H](NP(=O)(OC[C@H]1O[C@@H](N2C=CC(N)=NC2=O)C(F)(F)[C@@H]1O)OC1=CC=CC=C1)C(=O)OCC1=CC=CC=C1,
12965,DB15058,Flutemetamol,small molecule,investigational,"Amines|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Heterocyclic Compounds, Fused-Ring|Indicators and Reagents|Laboratory Chemicals|Radiopharmaceuticals|Sulfur Compounds|Thiazoles",CNC1=C(F)C=C(C=C1)C1=NC2=C(S1)C=C(O)C=C2,
12966,DB15059,Aprocitentan,small molecule,investigational,Amides|Sulfones|Sulfur Compounds,NS(=O)(=O)NC1=C(C(OCCOC2=NC=C(Br)C=N2)=NC=N1)C1=CC=C(Br)C=C1,
12968,DB15062,Inarigivir,small molecule,investigational,,CO[C@@H]1[C@H](OP(S)(=O)OC[C@H]2O[C@H](C[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](CO)O[C@H]1N1C=CC(=O)NC1=O,
12969,DB15063,Inarigivir soproxil,small molecule,investigational,,CO[C@@H]1[C@H](OP(=O)(OC[C@H]2O[C@H](C[C@@H]2O)N2C=NC3=C2N=CN=C3N)SCOC(=O)OC(C)C)[C@@H](CO)O[C@H]1N1C=CC(=O)NC1=O,
12971,DB15065,PF-06291874,small molecule,investigational,"Alanine|Amino Acids|Amino Acids, Peptides, and Proteins",CCC[C@H](OC1=CC(C)=C(N2C=C(C=N2)C(F)(F)F)C(C)=C1)C1=CC=C(C=C1)C(=O)NCCC(O)=O,
12974,DB15068,Agerafenib,small molecule,investigational,,COC1=C(OC)C=C2C(OC3=CC=CC(NC(=O)NC4=NOC(=C4)C(C)(C)C(F)(F)F)=C3)=NC=NC2=C1,
12977,DB15071,Omidenepag isopropyl,small molecule,investigational,,CC(C)OC(=O)CNC1=CC=CC(CN(CC2=CC=C(C=C2)N2C=CC=N2)S(=O)(=O)C2=CC=CN=C2)=N1,
12979,DB15073,Ribose,small molecule,investigational,Carbohydrates|Monosaccharides|Pentoses,[H]C(=O)[C@H](O)[C@H](O)[C@H](O)CO,
12981,DB15075,4-demethyl-4-cholesteryloxycarbonylpenclomedine,small molecule,investigational,,COC1=C(Cl)C(OC(=O)O[C@H]2CC[C@]3(C)[C@H]4CC[C@]5(C)[C@H](CC[C@H]5[C@@H]4CC=C3C2)[C@H](C)CCCC(C)C)=C(Cl)C(=N1)C(Cl)(Cl)Cl,
12984,DB15078,Rogaratinib,small molecule,investigational,Sulfur Compounds,COCC1=C(CN2CCNC(=O)C2)N2N=CN=C(N)C2=C1C1=CC2=C(S1)C(OC)=CC(C)=C2,
12985,DB15079,Troriluzole,small molecule,investigational,,CN(CC(=O)NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2)C(=O)CNC(=O)CN,
12986,DB15080,ELX-02,small molecule,investigational,,C[C@@H](N)[C@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O[C@H]2O[C@H]([C@@H](C)O)[C@@H](O)[C@H](O)[C@H]2N)[C@H](O)[C@@H]1O,
12990,DB15084,GS-9191,small molecule,investigational,"Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins",CC(C)COC(=O)[C@H](CC1=CC=CC=C1)NP(=O)(COCCN1C=NC2=C1N=C(N)N=C2NC1CC1)N[C@@H](CC1=CC=CC=C1)C(=O)OCC(C)C,
12991,DB15085,Fulacimstat,small molecule,investigational,,CN1C(=O)OC2=CC(=CC=C12)N1C=C(C(O)=O)C(=O)N([C@@H]2CCC3=C(C=CC=C23)C(F)(F)F)C1=O,
12992,DB15086,Ocrylate,small molecule,investigational,"Acids, Acyclic|Acrylates|Compounds used in a research, industrial, or household setting|Equipment and Supplies|Macromolecular Substances|Nitriles|Polymers|Surgical Equipment|Surgical Fixation Devices|Tissue Adhesives",CCCCCCCCOC(=O)C(=C)C#N,
12993,DB15087,Psicose,small molecule,investigational,Carbohydrates|Hexoses|Ketoses|Monosaccharides,OC[C@@H](O)[C@@H](O)[C@@H](O)C(=O)CO,
12997,DB15091,Upadacitinib,small molecule,approved|investigational,"Antirheumatic Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Disease-modifying Antirheumatic Agents|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Janus Kinase Inhibitors|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Protein Kinase Inhibitors",CC[C@@H]1CN(C[C@@H]1C1=CN=C2C=NC3=C(C=CN3)N12)C(=O)NCC(F)(F)F,
12998,DB15092,LY-2624803,small molecule,investigational,,CC(C)(CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=CC=CC=C12)C(O)=O,
13002,DB15096,18-methoxycoronaridine,small molecule,investigational,"Alkaloids|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|Secologanin Tryptamine Alkaloids",COCC[C@H]1C[C@H]2CN3CCC4=C(NC5=C4C=CC=C5)[C@](C2)([C@H]13)C(=O)OC,
13003,DB15097,Gefapixant,small molecule,investigational,,COC1=C(C=C(OC2=CN=C(N)N=C2N)C(=C1)C(C)C)S(N)(=O)=O,
13004,DB15098,Morinidazole,small molecule,investigational,Imidazoles|Nitro Compounds,CC1=NC=C(N1CC(O)CN1CCOCC1)[N+]([O-])=O,
13005,DB15099,GW-468816,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Receptors, N-Methyl-D-Aspartate, antagonists & inhibitors",OC(=O)[C@H]1C\C(=C2\CCN(C2=O)C2=CC=CC=C2)C2=CC=C(Cl)C=C2N1,
13008,DB15102,Pemigatinib,small molecule,approved|investigational,"Antineoplastic Agents|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Fibroblast Growth Factor 2, antagonists & inhibitors|Kinase Inhibitor|MATE 1 Inhibitors|MATE inhibitors|OCT2 Inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|Receptor, Fibroblast Growth Factor, Type 1, antagonists & inhibitors|Receptors, Fibroblast Growth Factor, antagonists & inhibitors",CCN1C(=O)N(CC2=CN=C3NC(CN4CCOCC4)=CC3=C12)C1=C(F)C(OC)=CC(OC)=C1F,
13010,DB15105,PF-06751979,small molecule,investigational,,C[C@H]1C[C@H]2CSC(N)=N[C@]2(CO1)C1=NC(NC(=O)C2=NC=C(OC(F)F)C=C2)=CS1,
13011,DB15106,Surufatinib,small molecule,investigational,,CN(C)CCNS(=O)(=O)CC1=CC(NC2=NC(OC3=CC4=C(NC(C)=C4)C=C3)=CC=N2)=CC=C1,
13012,DB15108,Tipranavir C-14,small molecule,investigational,,CCC[C@@]1(CCC2=CC=CC=C2)CC(O)=C([14C@H](CC)C2=CC=CC(NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)=C2)C(=O)O1,
13013,DB15109,Ingenol disoxate,small molecule,investigational,Terpenes,CCC1=C(C(=O)O[C@H]2C(C)=C[C@@]34[C@H](C)C[C@@H]5[C@H]([C@H](C=C(CO)[C@@H](O)[C@]23O)C4=O)C5(C)C)C(CC)=NO1,
13014,DB15110,Onvansertib,small molecule,investigational,,CN1CCN(CC1)C1=CC(NC2=NC=C3CCC4=C(N(CCO)N=C4C(N)=O)C3=N2)=C(OC(F)(F)F)C=C1,
13015,DB15111,Acetic acid C-11,small molecule,investigational,,C[11C](O)=O,
13018,DB15114,Vamorolone,small molecule,investigational,Anti-Inflammatory Agents|Fused-Ring Compounds|Pregnadienes|Pregnanes|Steroids,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@@]1(O)C(=O)CO,
13021,DB15117,Transfluthrin,small molecule,investigational,"Agrochemicals|Benzene Derivatives|Compounds used in a research, industrial, or household setting|Cycloparaffins|Hydrocarbons, Fluorinated|Hydrocarbons, Halogenated|Insecticides|Pesticides|Toxic Actions",CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)OCC1=C(F)C(F)=CC(F)=C1F,
13024,DB15120,GSK-239512,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Histamine Antagonists|Nootropic Agents",O=C1CCCN1C1=CC=C(OC2=CC3=C(CCN(CC3)C3CCC3)C=C2)N=C1,
13025,DB15121,AT-001,small molecule,investigational,,OC(=O)CC1=NN(CC2=NC3=C(S2)C=CC(=C3)C(F)(F)F)C(=O)C2=C1N=CC=N2,
13026,DB15122,PCS-499,small molecule,investigational,"Alkaloids|Deuterium|Heterocyclic Compounds, Fused-Ring|Purines|Purinones|Xanthine derivatives",[2H]C([2H])([2H])[C@H](O)C([2H])([2H])CCCN1C(=O)N(C)C2=C(N(C)C=N2)C1=O,
13027,DB15123,Dorzagliatin,small molecule,investigational,,CC(C)C[C@H](N1CC(OC2=C(Cl)C=CC=C2)=CC1=O)C(=O)NC1=NN(C[C@@H](O)CO)C=C1,
13028,DB15124,PF-05241328,small molecule,investigational,,CC(C)COC1=NC=C(C=C1Cl)N1N=C(C)C2=C1C=CC(=C2)C(=O)NS(C)(=O)=O,
13029,DB15125,Belapectin,small molecule,investigational,,,
13030,DB15126,IMG-7289,small molecule,investigational,,CN1CCN(CC1)C(=O)[C@H](CCCN[C@@H]1C[C@H]1C1=CC=C(F)C=C1)NC(=O)C1=CC=C(C=C1)N1C=CN=N1,
13031,DB15127,Hydrogen,small molecule,investigational,Elements|Gases,,
13034,DB15130,Dexpramipexole,small molecule,investigational,"Anti-Dyskinesia Agents|Anti-Parkinson Agents (Dopamine Agonist)|Anti-Parkinson Drugs|Antioxidants|Benzothiazoles|Central Nervous System Agents|Compounds used in a research, industrial, or household setting|Dopamine Agents|Dopamine Agonists|Heterocyclic Compounds, Fused-Ring|Neurotransmitter Agents|Protective Agents|Sulfur Compounds|Thiazoles",CCCN[C@@H]1CCC2=C(C1)SC(N)=N2,
13036,DB15132,AZD-8165,small molecule,investigational,,CCC(=O)O[C@@H](C(=O)N1N=CC[C@H]1C(=O)NCC1=C(C=CC(Cl)=C1)N1C=NN=N1)C1=CC=C(F)C=C1,
13037,DB15133,Tepotinib,small molecule,investigational,,CN1CCC(COC2=CN=C(N=C2)C2=CC(CN3N=C(C=CC3=O)C3=CC(=CC=C3)C#N)=CC=C2)CC1,
13038,DB15134,Fluoroazomycin arabinoside F-18,small molecule,investigational,"Compounds used in a research, industrial, or household setting|Diagnostic Uses of Chemicals|Fluorine Radioisotopes|Imidazoles|Indicators and Reagents|Laboratory Chemicals|Nitro Compounds|Radiopharmaceuticals",O[C@H]1[C@H](O)[C@H](O[C@@H]1C[18F])N1C=CN=C1[N+]([O-])=O,
13040,DB15136,Rebaudioside A,small molecule,investigational,Diterpenes|Sweetening Agents|Terpenes,C[C@@]12CCC[C@](C)([C@H]1CC[C@@]13CC(=C)[C@@](C1)(CC[C@@H]23)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,
13041,DB15137,VK-2809,small molecule,investigational,,CC(C)C1=CC(CC2=C(C)C=C(OC[P@@]3(=O)OCC[C@H](O3)C3=CC=CC(Cl)=C3)C=C2C)=CC=C1O,
13042,DB15138,AZD-9496,small molecule,investigational,"Acids, Carbocyclic|Heterocyclic Compounds, Fused-Ring",C[C@@H]1CC2=C(NC3=C2C=CC=C3)[C@H](N1CC(C)(C)F)C1=C(F)C=C(\C=C\C(O)=O)C=C1F,
13045,DB15141,Deutivacaftor,small molecule,investigational,,[2H]C([2H])([2H])C(C1=CC(=C(NC(=O)C2=CNC3=C(C=CC=C3)C2=O)C=C1O)C(C)(C)C)(C([2H])([2H])[2H])C([2H])([2H])[2H],
13046,DB15143,PF-06650833,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CC[C@H]1[C@@H](COC2=C3C=C(OC)C(=CC3=CC=N2)C(N)=O)NC(=O)[C@H]1F,
13047,DB15144,Altropane I-123,small molecule,investigational,,COC(=O)[C@@H]1[C@H]2CC[C@@H](C[C@@H]1C1=CC=C(F)C=C1)N2C\C=C\[123I],
13048,DB15145,Ziresovir,small molecule,investigational,,CC1=CC2=C(NCC3(N)COC3)N=C(N=C2C=C1)N1CCS(=O)(=O)C2=CC=CC=C2C1,
13049,DB15146,Adrabetadex,small molecule,investigational,,CC(O)COC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](COCC(C)O)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](COCC(C)O)O[C@H](O[C@H]1C[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](OCC(C)O)[C@H]3O,
13050,DB15147,Tinostamustine,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CN1C(CCCCCCC(=O)NO)=NC2=CC(=CC=C12)N(CCCl)CCCl,
13052,DB15149,Futibatinib,small molecule,investigational,,COC1=CC(=CC(OC)=C1)C#CC1=NN([C@H]2CCN(C2)C(=O)C=C)C2=C1C(N)=NC=N2,
13054,DB15151,RO-6870810,small molecule,investigational,,CN1CCN(CCCNC(=O)C[C@@H]2N=C(C3=C(SC(C)=C3C)N3C(C)=NN=C23)C2=CC=C(Cl)C=C2)CC1,
13055,DB15152,TMC-649128,small molecule,investigational,,CC(C)C(=O)OC[C@]1(O[C@H]([C@@H](C)[C@@H]1OC(=O)C(C)C)N1C=CC(N)=NC1=O)N=[N+]=[N-],
13059,DB15156,ABT-072,small molecule,investigational,Amides|Pyrimidines|Pyrimidinones|Sulfones|Sulfur Compounds,COC1=C(\C=C\C2=CC=C(NS(C)(=O)=O)C=C2)C=C(C=C1C(C)(C)C)N1C=CC(=O)NC1=O,
13060,DB15157,Voruciclib,small molecule,investigational,"Antineoplastic Agents|Carbohydrates|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Imines|Imino Sugars|Protein Kinase Inhibitors|Pyrans|Pyrrolidines",CN1CC[C@H]([C@@H]1CO)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=C(C=C1Cl)C(F)(F)F,
13064,DB15161,Pittsburgh Compound B,small molecule,investigational,Amines|Carbon Radioisotopes|Sulfur Compounds,[11CH3]NC1=CC=C(C=C1)C1=NC2=C(S1)C=C(O)C=C2,
13066,DB15163,Selatogrel,small molecule,investigational,Organophosphorus Compounds,CCCCOC(=O)N1CCN(CC1)C(=O)[C@H](CP(O)(O)=O)NC(=O)C1=CC(=NC(=N1)C1=CC=CC=C1)N1CC[C@@H](C1)OC,
13069,DB15166,Albuvirtide,small molecule,investigational,"Acids, Acyclic|Amino Acids, Peptides, and Proteins|Dicarboxylic Acids|Imides|Maleates",CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCNC(=O)COCCOCCNC(=O)CCN1C(=O)C=CC1=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O,
13070,DB15167,Fallypride,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Neurotransmitter Agents",COC1=C(OC)C(=CC(CCCF)=C1)C(=O)NC[C@@H]1CCCN1CC=C,
13071,DB15168,Cilofexor,small molecule,investigational,,OC(=O)C1=CC=NC(=C1)N1CC(O)(C1)C1=C(Cl)C=C(OCC2=C(ON=C2C2=C(Cl)C=CC=C2Cl)C2CC2)C=C1,
13072,DB15169,H3B-6527,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",CCN1CCN(CC1)C1=CC=C(NC2=CC(=NC=N2)N(C)C(=O)NC2=C(Cl)C(OC)=CC(OC)=C2Cl)C(NC(=O)C=C)=C1,
13073,DB15170,Evobrutinib,small molecule,investigational,,NC1=NC=NC(NCC2CCN(CC2)C(=O)C=C)=C1C1=CC=C(OC2=CC=CC=C2)C=C1,
13076,DB15173,JNJ-42165279,small molecule,investigational,,FC1(F)OC2=CC=C(CN3CCN(CC3)C(=O)NC3=C(Cl)C=CN=C3)C=C2O1,
13079,DB15177,VX-659,small molecule,investigational,Chloride Channel Agonists|Membrane Transport Modulators,C[C@@H]1CN(C2=C(C=CC(=N2)N2C=CC(OCCC3(CC3)C(F)(F)F)=N2)C(=O)NS(=O)(=O)C2=CC=CC=C2)C(C)(C)C1,
13082,DB15183,Fosmanogepix,small molecule,investigational,,NC1=C(C=CC=[N+]1COP(O)([O-])=O)C1=CC(CC2=CC=C(COC3=NC=CC=C3)C=C2)=NO1,
13084,DB15186,GDC-0084,small molecule,investigational,Enzyme Inhibitors,CC1(C)OCCN2C1=NC1=C(N=C(N=C21)C1=CN=C(N)N=C1)N1CCOCC1,
13085,DB15187,Dubermatinib,small molecule,investigational,Amides|Sulfones|Sulfur Compounds,CN(C)S(=O)(=O)C1=CC=CC=C1NC1=NC(NC2=CC=C(CN3CCN(C)CC3)C=C2)=NC=C1Cl,
13086,DB15188,Livoletide,small molecule,investigational,,[H][C@@]12CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCC(O)=O)NC2=O)C(C)C,
13087,DB15189,Birabresib,small molecule,investigational,"Amides|Amines|Anilides|Aniline Compounds|Heterocyclic Compounds, Fused-Ring",CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NC1=CC=C(O)C=C1)N=C2C1=CC=C(Cl)C=C1,
13088,DB15190,GLPG-0259,small molecule,investigational,,CC(C)N1C[C@@H]2C[C@H]1CN2C1=CC=C(NC2=NC=C(N3N=CN=C23)C2=COC(=C2)C(N)=O)C=C1,
13089,DB15191,MAX-40279,small molecule,investigational,,COC1=CC(F)=CC=C1C1=C(C)SC2=CN=C(NC3=CN(N=C3)C3CCNCC3)N=C12,
13090,DB15192,ABT-288,small molecule,investigational,Histamine Antagonists,CN1C[C@H]2CCN([C@H]2C1)C1=CC=C(C=C1)C1=CC=C(C=C1)N1N=CC=CC1=O,
13091,DB15193,BMS-955176,small molecule,investigational,Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Terpenes,CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC=C(C6=CC=C(C=C6)C(O)=O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)NCCN1CCS(=O)(=O)CC1,
13092,DB15194,Cotadutide,small molecule,investigational,"Amino Acids, Peptides, and Proteins",CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCCC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CNC=N1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(O)=O)C(O)=O,
13093,DB15195,Mibenratide,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Peptides",CC(C)[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N2,
13094,DB15197,RSV-604,small molecule,investigational,"Benzazepines|Benzene Derivatives|Heterocyclic Compounds, Fused-Ring",FC1=C(NC(=O)N[C@H]2N=C(C3=CC=CC=C3)C3=C(NC2=O)C=CC=C3)C=CC=C1,
13095,DB15198,Dextromethadone,small molecule,investigational,"Analgesics|Analgesics, Non-Narcotic|Central Nervous System Agents|Ketones|Peripheral Nervous System Agents|Sensory System Agents",CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,
13096,DB15199,Ciraparantag,small molecule,investigational,"Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins",N[C@@H](CCCNC(N)=N)C(=O)NCCCN1CCN(CCCNC(=O)[C@@H](N)CCCNC(N)=N)CC1,
13097,DB15200,Bixalomer,small molecule,investigational,Amines,,
13098,DB15201,Norbixin,small molecule,investigational,"Alkenes|Biological Factors|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Terpenes",C\C(\C=C\C=C(/C)\C=C\C(O)=O)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C(O)=O,
13099,DB15202,Fluoroacetic acid F-18,small molecule,investigational,,OC(=O)C[18F],
13100,DB15203,JNJ-26489112,small molecule,investigational,Amides|Anticonvulsants|Central Nervous System Depressants|Sulfones|Sulfur Compounds,NS(=O)(=O)NC[C@H]1COC2=C(O1)C=CC(Cl)=C2,
13101,DB15204,Fosravuconazole,small molecule,investigational,,C[C@@H](C1=NC(=CS1)C1=CC=C(C=C1)C#N)[C@@](CN1C=NC=N1)(OCOP(O)(O)=O)C1=CC=C(F)C=C1F,
13102,DB15205,Capromorelin,small molecule,investigational,,CN1N=C2CCN(C[C@@]2(CC2=CC=CC=C2)C1=O)C(=O)[C@@H](COCC1=CC=CC=C1)NC(=O)C(C)(C)N,
13103,DB15206,Uprifosbuvir,small molecule,investigational,"Anti-Infective Agents|Antiviral Agents|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",CC(C)OC(=O)[C@@H](C)N[P@@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(Cl)[C@@H]1O)OC1=CC=CC=C1,
13104,DB15207,Esaxerenone,small molecule,investigational,Sulfur Compounds,CC1=C(N(CCO)C=C1C(=O)NC1=CC=C(C=C1)S(C)(=O)=O)C1=C(C=CC=C1)C(F)(F)F,
13105,DB15208,NOP-1A,small molecule,investigational,,CNC(=O)[C@H](CN1CCC2(CC1)OCCC1=C2SC(F)=C1)CC1=CC=CC=C1F,
13106,DB15209,MK-0736,small molecule,investigational,,CCS(=O)(=O)CCCC12CCC(CC1)(CC2)C1=NN=C(N1C)C1=CC=CC=C1C(F)(F)F,
13109,DB15212,Pemafibrate,small molecule,investigational,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Heterocyclic Compounds, Fused-Ring|Lipids",CC[C@@H](OC1=CC(CN(CCCOC2=CC=C(OC)C=C2)C2=NC3=C(O2)C=CC=C3)=CC=C1)C(O)=O,
13110,DB15213,25-desacetylrifapentine,small molecule,investigational,"Amides|Anti-Bacterial Agents|Heterocyclic Compounds, Fused-Ring|Lactams|Lactams, Macrocyclic|Rifamycins",CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(CC4)C4CCCC4)=C(NC(=O)\C(C)=C/C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](O)[C@@H]1C)C(O)=C2C(O)=C3C,
13111,DB15214,BMS-986104,small molecule,investigational,,CCCCCC[C@@H]1CCC2=C(C1)C=CC(=C2)[C@H]1CC[C@](N)(CO)C1,
13112,DB15215,KRN-5500,small molecule,investigational,"Antineoplastic Agents|Carbohydrates|Enzyme Inhibitors|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Protein Synthesis Inhibitors|Purines",CCCCCCCCC\C=C\C=C\C(=O)NCC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](NC2=C3N=CNC3=NC=N2)O[C@H]1[C@@H](O)CO,
13113,DB15216,Amylose,small molecule,investigational,"Biopolymers|Carbohydrates|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Dietary Carbohydrates|Food|Food and Beverages|Glucans|Macromolecular Substances|Physiological Phenomena|Polymers|Polysaccharides|Starch",,
13116,DB15219,Tomivosertib,small molecule,investigational,,CC1=C2N(C(=O)C(NC3=CC(N)=NC=N3)=C1)C1(CCCCC1)NC2=O,
13117,DB15220,Seliforant,small molecule,investigational,,CNC1CN(C1)C1=CC(N)=NC(CC(C)C)=N1,
13118,DB15221,PF-06260414,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",C[C@@H]1CNS(=O)(=O)N(C1)C1=CC2=CC=NC(C#N)=C2C=C1,
13119,DB15222,GS-6620,small molecule,investigational,"Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides",CC(C)OC(=O)[C@H](C)NP(=O)(OC[C@H]1O[C@@](C#N)(C2=CC=C3N2N=CN=C3N)[C@](C)(O)[C@@H]1OC(=O)C(C)C)OC1=CC=CC=C1,
13121,DB15224,Lisavanbulin,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Oxazoles",NCCCC[C@H](N)C(=O)NC1=CC=C(C=C1)C(=O)CN1C2=C(C=CC=C2)N=C1C1=NON=C1NCCC#N,
13124,DB15227,Tirabrutinib,small molecule,investigational,,CC#CC(=O)N1CC[C@H](C1)N1C(=O)N(C2=C(N)N=CN=C12)C1=CC=C(OC2=CC=CC=C2)C=C1,
13126,DB15229,CNV-2197944,small molecule,investigational,,C[C@H]1CN(CCN1C(=O)C1=CC=CN=C1C)S(=O)(=O)C1=CC=C(C=C1)C(F)(F)F,
13127,DB15230,Dithiopyr,small molecule,investigational,,CSC(=O)C1=C(N=C(C(C(=O)SC)=C1CC(C)C)C(F)(F)F)C(F)F,
13128,DB15231,Brimapitide,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Neuroprotective Agents",CC(C)C[C@@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@H]1CCCN1C(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](NC(=O)[C@H]1CCCN1C(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CO)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](N)CC(O)=O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@H]([C@H](C)O)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCCN)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,
13129,DB15232,Telaglenastat,small molecule,investigational,"Acetamides|Acetates|Acids, Acyclic|Amides|Benzene Derivatives|Fatty Acids|Fatty Acids, Volatile|Lipids|Sulfur Compounds|Thiazoles",FC(F)(F)OC1=CC(CC(=O)NC2=NN=C(CCCCC3=NN=C(NC(=O)CC4=NC=CC=C4)S3)C=C2)=CC=C1,
13130,DB15233,Avapritinib,small molecule,approved|investigational,Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Protein Kinase Inhibitors,CN1C=C(C=N1)C1=CN2N=CN=C(N3CCN(CC3)C3=NC=C(C=N3)[C@@](C)(N)C3=CC=C(F)C=C3)C2=C1,
13132,DB15235,Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone,small molecule,investigational,Semicarbazides|Semicarbazones|Sulfur Compounds,CN(C1CCCCC1)C(=S)NN=C(C1=CC=CC=N1)C1=NC=CC=C1,
13133,DB15236,Fucose,small molecule,investigational,Carbohydrates|Deoxy Sugars,C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C=O,
13134,DB15237,Fluciclovine,small molecule,investigational,,N[C@]1(C[C@H](F)C1)C(O)=O,
13135,DB15238,Olinciguat,small molecule,investigational,,NC(=O)[C@](O)(CNC1=C(F)C=NC(=N1)C1=NN(CC2=C(F)C=CC=C2)C(=C1)C1=NOC=C1)C(F)(F)F,
13136,DB15239,PTI-428,small molecule,investigational,,C[C@@H](O)C1=NN=C(O1)[C@H]1C[C@@H](C1)NC(=O)C1=CC(=NO1)C1=CC=CC=C1,
13138,DB15241,Methylsamidorphan,small molecule,investigational,,C[N@+]1(CC2CC2)CC[C@]23CC(=O)CC[C@@]2(O)[C@H]1CC1=C3C(O)=C(C=C1)C(N)=O,
13139,DB15242,MK-0533,small molecule,investigational,,CC[C@@H](OC1=CC(=CC=C1)N1C(C)=C(C(=O)C2=CC=C(OC)C=C2)C2=CC=C(OC(F)(F)F)C=C12)C(O)=O,
13140,DB15243,2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a,small molecule,investigational,"Biological Factors|Heterocyclic Compounds, Fused-Ring|Metalloporphyrins|Pigments, Biological|Porphyrins",CCCCCCOC(C)C1=C2NC(\C=C3/N=C([C@@H](CCC(O)=O)[C@@H]3C)C3=C4N\C(=C/C5=N/C(=C\2)/C(C)=C5CC)C(C)=C4C(=O)C3)=C1C,
13141,DB15244,NM-404 I-131,small molecule,investigational,,C[N+](C)(C)CCOP([O-])(=O)OCCCCCCCCCCCCCCCCCCC1=CC=C([131I])C=C1,
13142,DB15245,Olorofim,small molecule,investigational,"Acetates|Acids, Acyclic|Amides|Anti-Infective Agents|Antifungal Agents|Fatty Acids|Fatty Acids, Volatile|Lipids",CN1C(C)=CC(=C1C(=O)C(=O)NC1=CC=C(C=C1)N1CCN(CC1)C1=NC=C(F)C=N1)C1=CC=CC=C1,
13143,DB15246,Salvianolic acid A,small molecule,investigational,"4-Nitrophenylphosphatase, antagonists & inhibitors|Acids, Carbocyclic|Cinnamates|Drugs, Chinese Herbal|Enzyme Inhibitors|Gastric Acid Lowering Agents|Hydroxy Acids",OC(=O)[C@@H](CC1=CC(O)=C(O)C=C1)OC(=O)\C=C\C1=C(/C=C/C2=CC(O)=C(O)C=C2)C(O)=C(O)C=C1,
13144,DB15247,Vorolanib,small molecule,investigational,,CN(C)C(=O)N1CC[C@@H](C1)NC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
13146,DB15249,MK-6325,small molecule,investigational,,COC1=CC2=C(C=C1)N=C1CCCCC[C@@H]3CCC[C@H]3OC(=O)N[C@H]3CCCCC\C=C\[C@@H]4C[C@]4(NC(=O)[C@@H]4C[C@H](CN4C3=O)OC1=N2)C(=O)NS(=O)(=O)C1(C)CC1,
13147,DB15250,Vercirnon,small molecule,investigational,Amides|Sulfones|Sulfur Compounds,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC1=C(C=C(Cl)C=C1)C(=O)C1=CC=[N+]([O-])C=C1,
13148,DB15251,Antipain,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Enzyme Inhibitors|Oligopeptides|Peptides|Protease Inhibitors",CC(C)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C=O,
13151,DB15254,RO-5126766 free base,small molecule,investigational,"Benzopyrans|Heterocyclic Compounds, Fused-Ring|Protein Kinase Inhibitors|Pyrans",CNS(=O)(=O)NC1=C(F)C(CC2=C(C)C3=C(OC2=O)C=C(OC2=NC=CC=N2)C=C3)=CC=N1,
13152,DB15256,Reldesemtiv,small molecule,investigational,,NC(=O)C1=CN(C=C1)C1=CN=C(NC[C@@]2(C[C@H](F)C2)C2=NC=CC=C2F)N=C1,
13153,DB15257,Milademetan,small molecule,investigational,,CC1(C)CCC2(CC1)N[C@H]([C@H](C1=C(F)C(Cl)=NC=C1)[C@]21C(=O)NC2=CC(Cl)=CC=C12)C(=O)N[C@@H]1CC[C@H](OC1)C(N)=O,
13155,DB15259,VB-201,small molecule,investigational,Alcohols|Biological Products|Carbohydrates|Complex Mixtures|Glycerophosphates|Glycerophospholipids|Lecithins|Lipids|Membrane Lipids|Pharmaceutical Preparations|Phosphatidic Acids|Phosphatidylcholines|Phospholipids|Plant Extracts|Plant Preparations|Sugar Alcohols|Sugar Phosphates|Triose Sugar Alcohols,CCCCCCCCCCCCCCCCOC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OCCCCC(O)=O,
13157,DB15261,Butafenacil,small molecule,investigational,"Hydrocarbons, Halogenated",CN1C(=O)N(C(=O)C=C1C(F)(F)F)C1=CC=C(Cl)C(=C1)C(=O)OC(C)(C)C(=O)OCC=C,
13160,DB15264,PD-0299685,small molecule,investigational,,CCC[C@@H](C)C[C@H](CN)CC(O)=O,
13161,DB15265,USL-311,small molecule,investigational,,CC(C)N1CCC(CC1)N1CCCN(CC1)C1=CC=CC(=N1)C(=O)NC1=CC=NC=C1,
13162,DB15266,TAK-580,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",C[C@@H](NC(=O)C1=C(Cl)C(N)=NC=N1)C1=NC=C(S1)C(=O)NC1=NC=C(Cl)C(=C1)C(F)(F)F,
13164,DB15268,Afabicin,small molecule,investigational,,CN(CC1=C(C)C2=CC=CC=C2O1)C(=O)\C=C\C1=CN=C2N(COP(O)(O)=O)C(=O)CCC2=C1,
13165,DB15269,ALK-4290,small molecule,investigational,,CN(C)C(=O)C1=CC(NC(=O)[C@H]2CCC(=O)N2C2CCN(CC3=CC=C(Cl)C(C)=C3)CC2)=NC(C)=C1,
13168,DB15272,Edratide,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoproteins|Peptides|Proteins|Serum Globulins",CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(O)=O,
13169,DB15273,VS-4718,small molecule,investigational,"Amines|Focal Adhesion Protein-Tyrosine Kinases, antagonists & inhibitors|Pyridines",CNC(=O)C1=CC=CC=C1NC1=CC(NC2=C(OC)C=C(C=C2)N2CCOCC2)=NC=C1C(F)(F)F,
13171,DB15275,GDC-0077,small molecule,investigational,,C[C@H](NC1=CC=C2C3=NC(=CN3CCOC2=C1)N1[C@@H](COC1=O)C(F)F)C(N)=O,
13175,DB15279,CB-103,small molecule,investigational,,CC(C)(C)C1=CC=C(OC2=CC=C(N)C=N2)C=C1,
13177,DB15281,Ravoxertinib,small molecule,investigational,,CN1N=CC=C1NC1=NC=CC(=N1)C1=CC(=O)N(C=C1)[C@H](CO)C1=CC(F)=C(Cl)C=C1,
13178,DB15282,Fluorofuranylnorprogesterone F-18,small molecule,investigational,,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1C[C@H]1O[C@H](O[C@@]21C(=O)C[18F])C1=CC=CO1,
13180,DB15284,Sulopenem,small molecule,investigational,Amides,[H][C@]12SC(S[C@H]3CC[S@@+]([O-])C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,
13182,DB15286,CB-1158,small molecule,investigational,Enzyme Inhibitors,C[C@H](N)C(=O)N1C[C@H](CCCB(O)O)[C@@](N)(C1)C(O)=O,
13183,DB15287,Elismetrep,small molecule,investigational,,OC(=O)C1=CC=C(C=C1)S(=O)(=O)N(CC1=CC=C(OC(F)(F)F)C=C1)C1=NC=C2C=CC=CC2=C1C1CC1,
13184,DB15288,Etamicastat,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Pyrans",NCCC1=CNC(=S)N1[C@H]1COC2=C(C1)C=C(F)C=C2F,
13185,DB15289,Perillyl alcohol,small molecule,investigational,Antineoplastic Agents|Enzyme Inhibitors|Perilla|Terpenes,CC(=C)[C@H]1CCC(CO)=CC1,
13187,DB15291,BMS-986142,small molecule,investigational,,CN1C(=O)N(C(=O)C2=C1C(F)=CC=C2)C1=C(C)C(=CC=C1)C1=C2C3=C(C[C@H](CC3)C(C)(C)O)NC2=C(C=C1F)C(N)=O,
13188,DB15292,Foliglurax,small molecule,investigational,,O\N=C1/C=C(OC2=C1C=C(CCCN1CCOCC1)C=C2)C1=CC2=C(C=CS2)C=N1,
13189,DB15293,Epalrestat,small molecule,investigational,Enzyme Inhibitors|Sulfur Compounds|Thiazoles,C\C(\C=C1/SC(=S)N(CC(O)=O)C1=O)=C/C1=CC=CC=C1,
13190,DB15294,SB-1578,small molecule,investigational,"fms-Like Tyrosine Kinase 3, antagonists & inhibitors|Heterocyclic Compounds, Fused-Ring|Janus Kinase 2, antagonists & inhibitors",C(CN1CCCC1)OC1=C2COC\C=C\COCC3=CC=C(O3)C3=CC=NC(NC(C=C1)=C2)=N3,
13191,DB15295,Tenalisib,small molecule,investigational,,CC[C@H](NC1=C2N=CNC2=NC=N1)C1=C(C(=O)C2=CC=CC=C2O1)C1=CC=CC(F)=C1,
13192,DB15296,D-fluoromethyltyrosine F-18,small molecule,investigational,,N[C@H](CC1=CC=C(OC[18F])C=C1)C(O)=O,
13193,DB15297,Petesicatib,small molecule,investigational,,CN1C=C(C=N1)C1=CC(=C(C=C1)S(=O)(=O)[C@@H]1C[C@H](N(C1)C(=O)C1(CC1)C(F)(F)F)C(=O)NC1(CC1)C#N)C(F)(F)F,
13195,DB15299,AMG-232,small molecule,investigational,,CC(C)[C@@H](CS(=O)(=O)C(C)C)N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)C1=CC=CC(Cl)=C1)C1=CC=C(Cl)C=C1,
13196,DB15300,Hydroquinidine,small molecule,investigational,"Alkaloids|Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ia|Autonomic Agents|Cardiac Therapy|Cardiovascular Agents|Cinchona Alkaloids|Heterocyclic Compounds, Fused-Ring|Parasympatholytics|Peripheral Nervous System Agents|Quinolines|Quinuclidines",CC[C@H]1C[N@@]2CC[C@H]1C[C@@H]2[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1,
13198,DB15302,2-fluorofucose,small molecule,investigational,,C[C@H](O)[C@@H](O)[C@@H](O)[C@H](F)C=O,
13200,DB15304,iota-Carrageenan,small molecule,investigational,,,
13201,DB15305,Risdiplam,small molecule,investigational,Peripheral Nervous System Agents,CC1=CN2N=C(C=C(C)C2=N1)C1=CC(=O)N2C=C(C=CC2=N1)N1CCNC2(CC2)C1,
13203,DB15307,Atabecestat,small molecule,investigational,,C[C@]1(C=CSC(N)=N1)C1=CC(NC(=O)C2=NC=C(C=C2)C#N)=CC=C1F,
13204,DB15308,Ridinilazole,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",N1C2=CC(=CC=C2N=C1C1=CC=NC=C1)C1=CC2=C(C=C1)N=C(N2)C1=CC=NC=C1,
13205,DB15310,Vactosertib,small molecule,investigational,,CC1=NC(=CC=C1)C1=C(N=C(CNC2=C(F)C=CC=C2)N1)C1=CN2N=CN=C2C=C1,
13206,DB15311,Davanat,small molecule,investigational,Carbohydrates|Hexoses|Monosaccharides,,
13209,DB15314,Modimelanotide,small molecule,investigational,Pyridines,CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O,
13210,DB15315,Coblopasvir,small molecule,investigational,,COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C1=NC=C(N1)C1=CC=C(C=C1)C1=CC=C(C2=CN=C(N2)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)OC)C(C)C)C2=C1OCO2,
13211,DB15316,Florasulam,small molecule,investigational,Amides|Sulfones|Sulfur Compounds,COC1=NC=C(F)C2=NC(=NN12)S(=O)(=O)NC1=C(F)C=CC=C1F,
13212,DB15317,Posiphen,small molecule,investigational,"Acids, Acyclic|Alkaloids|Carbamates|Cholinergic Agents|Cholinesterase Inhibitors|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Indole Alkaloids|Indoles|Neurotransmitter Agents|Phenylcarbamates|Stereoisomerism",CN1CC[C@@]2(C)[C@@H]1N(C)C1=CC=C(OC(=O)NC3=CC=CC=C3)C=C21,
13213,DB15318,Neodymium,small molecule,investigational,"Elements|Lanthanoid Series Elements|Metals|Metals, Rare Earth",[Nd],
13214,DB15319,VM4-037,small molecule,investigational,"Amides|Amino Acids, Peptides, and Proteins|Fluorine Radioisotopes|Oligopeptides|Peptides|Sulfones|Sulfur Compounds",CC(C)[C@H](N1C=C(COC2=CC3=C(C=C2)N=C(S3)S(N)(=O)=O)N=N1)C(=O)N[C@@H](CC1=CC=C(OCCF)C=C1)C(O)=O,
13215,DB15321,Tefinostat,small molecule,investigational,Amides|Amines|Aniline Compounds|Antineoplastic Agents|Histone Deacetylase Inhibitors|Hydroxy Acids|Hydroxylamines,ONC(=O)CCCCCCC(=O)NC1=CC=C(CN[C@H](C(=O)OC2CCCC2)C2=CC=CC=C2)C=C1,
13217,DB15323,Trelagliptin,small molecule,investigational,Pyrimidines|Pyrimidinones,CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC2=CC(F)=CC=C2C#N)C1=O,
13218,DB15324,ORM-13070 C-11,small molecule,investigational,Carbon Radioisotopes,[11CH3]OCC1=CC=CN=C1N1CCN(C[C@H]2COC3=CC=CC=C3O2)CC1,
13219,DB15325,ONO-8539,small molecule,investigational,"Acids, Carbocyclic|Benzene Derivatives|Receptors, Prostaglandin E, EP1 Subtype, antagonists & inhibitors|Sulfur Compounds",CC(C)CN(C1=CC2=C(CCC2)C=C1OCC1=CC=C(C=C1C)C(O)=O)S(=O)(=O)C1=NC=CS1,
13220,DB15326,CXL-1020,small molecule,investigational,,CS(=O)(=O)C1=CC=CC=C1S(=O)(=O)NO,
13221,DB15327,Abivertinib,small molecule,investigational,Enzyme Inhibitors|Protein Kinase Inhibitors,CN1CCN(CC1)C1=CC=C(NC2=NC3=C(C=CN3)C(OC3=CC(NC(=O)C=C)=CC=C3)=N2)C=C1F,
13222,DB15328,Ubrogepant,small molecule,approved|investigational,Antimigraine Preparations|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 inhibitors|OATP1B3 substrates|OCT2 Inhibitors|P-glycoprotein substrates|UGT1A1 Inhibitors,C[C@@H]1[C@@H](C[C@H](NC(=O)C2=CN=C3C[C@]4(CC3=C2)C(=O)NC2=NC=CC=C42)C(=O)N1CC(F)(F)F)C1=CC=CC=C1,
13227,DB15333,AZD-1386,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",C[C@H](NC(=O)CN1C=NC2=C1C(F)=C(F)C=C2)C1=CC=C(C=C1)C(C)(C)C,
13228,DB15334,Biochanin A,small molecule,investigational,"Anticarcinogenic Agents|Antineoplastic Agents|Benzopyrans|Chromones|Compounds used in a research, industrial, or household setting|Estrogens|Estrogens, Non-Steroidal|Flavonoids|Heterocyclic Compounds, Fused-Ring|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Isoflavones|Phytoestrogens|Protective Agents|Pyrans",COC1=CC=C(C=C1)C1=COC2=C(C(O)=CC(O)=C2)C1=O,
13229,DB15335,Formononetin,small molecule,investigational,"Benzopyrans|Chromones|Estrogens|Estrogens, Non-Steroidal|Flavonoids|Heterocyclic Compounds, Fused-Ring|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Phytoestrogens|Pyrans",COC1=CC=C(C=C1)C1=COC2=C(C=CC(O)=C2)C1=O,
13231,DB15338,Rovatirelin,small molecule,investigational,Oxazoles,C[C@@H]1CCCN1C(=O)[C@H](CC1=CSC=N1)NC(=O)[C@H]1NC(=O)O[C@H]1C,
13232,DB15339,Methcathinone,small molecule,investigational,Ketones,CNC(C)C(=O)C1=CC=CC=C1,
13233,DB15340,EC-0652,small molecule,investigational,,N[C@@H](CNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CCCCCCCNC(=O)CC[C@H](NC(=O)N[C@@H](CCC(O)=O)C(O)=O)C(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CS)C(O)=O,
13234,DB15341,Dinalbuphine sebacate,small molecule,investigational,,O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(OC(=O)CCCCCCCCC(=O)OC5=C6O[C@H]7[C@@H](O)CC[C@@]8(O)[C@H]9CC(C=C5)=C6[C@@]78CCN9CC5CCC5)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5,
13236,DB15343,HM-43239,small molecule,investigational,,C[C@H]1CN(CC2=CC(=CC(NC3=NC=C(Cl)C(=N3)C3=CNC4=C3C=CC(C)=C4)=C2)C2CC2)C[C@@H](C)N1,
13237,DB15344,beta-Hydroxyisovaleric acid,small molecule,investigational,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids",CC(C)(O)CC(O)=O,
13238,DB15345,GSK-945237,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",FC1=C2[C@H](CN3CCC(CC3)NCC3=NN=C4OCCOC4=C3)CN3C2=C(C=C1)C=CC3=O,
13239,DB15346,GLPG-1205,small molecule,investigational,,O=C1N=C(OC[C@@H]2COCCO2)C=C2N1CCC1=CC(=CC=C21)C#CC1CC1,
13240,DB15347,Branebrutinib,small molecule,investigational,,CC#CC(=O)N[C@H]1CCCN(C1)C1=C2C(C)=C(C)NC2=C(C=C1F)C(N)=O,
13241,DB15348,Ampreloxetine,small molecule,investigational,Benzene Derivatives|Ethers|Phenols,FC1=CC(F)=C(OCC2=CC=CC=C2C2CCNCC2)C(F)=C1,
13243,DB15350,D-chiro-Inositol,small molecule,investigational,,O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@H]1O,
13245,DB15353,Nacubactam,small molecule,investigational,,NCCONC(=O)[C@@H]1CC[C@@H]2C[N@]1C(=O)N2OS(O)(=O)=O,
13247,DB15355,PL-3994,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Bronchodilator Agents|Peptides|Receptors, Atrial Natriuretic Factor, agonists",CCCCCCC(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](CCCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CNC=N2)NC1=O)[C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1C[C@@H](NC(=O)[C@@H]1CCCNC(N)=N)C(N)=O,
13248,DB15356,SLV-334,small molecule,investigational,,OC(=O)CN1C2=CC=CC=C2CC[C@H](NC(=O)C2(C[C@@H](CCC3=CC=CC4=CC=CC=C34)C(O)=O)CCCC2)C1=O,
13249,DB15357,Xanomeline,small molecule,investigational,Autonomic Agents|Central Nervous System Agents|Cholinergic Agents|Cholinergic Agonists|Muscarinic Agonists|Neurotransmitter Agents|Parasympathomimetics|Peripheral Nervous System Agents|Sulfur Compounds|Thiazoles,CCCCCCOC1=NSN=C1C1=CCCN(C)C1,
13250,DB15358,JNJ-54175446,small molecule,investigational,,C[C@H]1N(CCC2=C1N=NN2C1=NC=C(F)C=N1)C(=O)C1=C(Cl)C(=CC=C1)C(F)(F)F,
13251,DB15359,Xanthohumol,small molecule,investigational,"Benzopyrans|Chromones|Heterocyclic Compounds, Fused-Ring|Ketones|Pyrans",COC1=C(C(=O)\C=C\C2=CC=C(O)C=C2)C(O)=C(CC=C(C)C)C(O)=C1,
13252,DB15360,"Carfentanil, C-11",small molecule,investigational,Analgesics|Carbon Radioisotopes|Central Nervous System Agents|Central Nervous System Depressants|Narcotics|Opioids|Peripheral Nervous System Agents|Piperidines|Sensory System Agents,CCC(=O)N(C1=CC=CC=C1)C1(CCN(CCC2=CC=CC=C2)CC1)C(=O)O[11CH3],
13253,DB15361,Thallium Tl-201,small molecule,investigational,Isotopes|Radioisotopes,[201Tl],
13254,DB15362,LSZ-102,small molecule,investigational,,CC(F)(F)C1=C(C=CC(F)=C1)C1=C(OC2=CC=C(\C=C\C(O)=O)C=C2)C2=CC=C(O)C=C2S1,
13257,DB15366,SOR-C13,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Antiarrhythmic agents|Antineoplastic Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Carbohydrates|Cardiovascular Agents|Carrier Proteins|Glycoconjugates|Glycoproteins|Ion Channels|Membrane Glycoproteins|Membrane Proteins|Membrane Transport Modulators|Membrane Transport Proteins|Proteins|Transient Receptor Potential Channels",CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O,
13258,DB15367,LY-2623091,small molecule,investigational,,C[C@H](CN1CCOCC1)N1C(NC(N)=O)=NC2=C1C=CC(\C=C1/C3=CC=CC=C3COC3=CC(F)=CC=C13)=C2,
13262,DB15371,MK-2748,small molecule,investigational,Sulfur Compounds,COC1=CC2=C(C=C1)C(=O)N1CCCCC[C@@H]3CCC[C@H]3OC(=O)N[C@@H](C3CCCC3)C(=O)N3C[C@@H](C[C@H]3C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C3(C)CC3)OC1=N2,
13263,DB15372,JNJ-27548547,small molecule,investigational,,CCCCCCCCCCCCCCCCCC(=O)OCC(CSSC1=CC=C(COC(=O)N2[C@H]3CN4C5=C([C@@H](COC(N)=O)[C@@]4(OC)[C@@H]23)C(=O)C(N)=C(C)C5=O)C=C1)OC(=O)CCCCCCCCCCCCCCCCC,
13264,DB15373,Tilmanocept,small molecule,investigational,,,
13265,DB15374,Cobalt Co-60,small molecule,investigational,"Cobalt|Cobalt Isotopes|Elements|Isotopes|Metals|Metals, Heavy|Radioisotopes|Transition Elements",[60Co],
13266,DB15375,Tozuleristide,small molecule,investigational,"Arthropod Venoms|Biological Factors|Bodily Secretions|Complex Mixtures|Fluids and Secretions|Heterocyclic Compounds, Fused-Ring|Indoles|Toxins, Biological|Venoms",CSCCC(N)C(=O)NC1CSSCC2NC(=O)C(CC(O)=O)NC(=O)C(CC(O)=O)NC(=O)C3CSSCC4NC(=O)C(CCC(N)=O)NC(=O)C5CCCN5C(=O)CNC(=O)C(CC5=CC=C(O)C=C5)NC(=O)C(CSSCC(NC(=O)C5CCCN5C(=O)C(CCSC)NC1=O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)O)C(=O)NC(C(C)O)C(=O)NC(CC(O)=O)C(=O)NC(CC1=CNC=N1)C(=O)NC(CCC(N)=O)C(=O)NC(CCSC)C(=O)NC(C)C(=O)NC(CCCNC(N)=N)C(=O)NC(CCCNC(N)=N)C(=O)N3)NC(=O)C(CCCCNC(=O)CCCCCN1\C(=C/C=C/C=C/C=C/C3=[N+](CCCCS([O-])(=O)=O)C5=C(C6=CC=CC=C6C=C5)C3(C)C)C(C)(C)C3=C1C=CC1=CC=CC=C31)NC(=O)CNC(=O)C(CCCNC(N)=N)NC(=O)CNC(=O)C(CCCNC(N)=N)NC(=O)CNC(=O)CNC(=O)C(CSSCC(NC(=O)C(CC(C)C)NC4=O)C(=O)NC(CCCNC(N)=N)C(O)=O)NC2=O,
13268,DB15377,ATB-346,small molecule,investigational,Naphthaleneacetic Acids|Naphthalenes,COC1=CC2=CC=C(C=C2C=C1)C(C)C(=O)OC1=CC=C(C=C1)C(N)=S,
13270,DB15379,Hydroxypropyl betadex,small molecule,investigational,"beta-Cyclodextrins|Biopolymers|Carbohydrates|Compounds used in a research, industrial, or household setting|Cyclodextrins|Dextrins|Diet, Food, and Nutrition|Dietary Carbohydrates|Drug Delivery Systems|Excipients|Food|Food and Beverages|Glucans|Macromolecular Substances|Pharmaceutic Aids|Pharmaceutical Preparations|Pharmaceutical Vehicles|Physiological Phenomena|Polymers|Polysaccharides|Starch",CC(O)COC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](COCC(C)O)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](COCC(C)O)O[C@H](O[C@H]1C[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7OCC(C)O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](OCC(C)O)[C@H]4O)[C@H](OCC(C)O)[C@H]3O,
13271,DB15380,Flutriciclamide F-18,small molecule,investigational,,CCN(CC)C(=O)[C@H]1CCCC2=C1C1=C(OC)C=CC=C1N2CC[18F],
13272,DB15381,Menaquinone,small molecule,investigational,"Coagulants|Diet, Food, and Nutrition|Diterpenes|Fibrin Modulating Agents|Food|Food and Beverages|Growth Substances|Hematologic Agents|Hemostatics|Micronutrients|Naphthalenes|Naphthoquinones|Physiological Phenomena|Phytol|Quinones|Terpenes|Vitamin K|Vitamin K 2|Vitamins|Vitamins (Fat Soluble)",CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC1=C(C)C(=O)C2=C(C=CC=C2)C1=O,
13273,DB15382,SAR-125844,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Sulfur Compounds|Thiazoles",FC1=CC=C(C=C1)C1=NN2C(SC3=CC=C4N=C(NC(=O)NCCN5CCOCC5)SC4=C3)=NN=C2C=C1,
13275,DB15384,Simotaxel,small molecule,investigational,Cyclodecanes|Cycloparaffins|Diterpenes|Terpenes,CC(C)OC(=O)N[C@H]([C@@H](O)C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(=O)C3CCCC3)C(=C1C)C2(C)C)OC(C)=O)C1=CC=CS1,
13276,DB15385,Acebilustat,small molecule,investigational,"Acids, Carbocyclic|Aza Compounds|Benzene Derivatives",OC(=O)C1=CC=C(CN2C[C@@H]3C[C@H]2CN3CC2=CC=C(OC3=CC=C(C=C3)C3=NC=CO3)C=C2)C=C1,
13282,DB15391,Elenbecestat,small molecule,investigational,,C[C@H]1OC[C@@]2(N=C(N)SC[C@H]12)C1=CC(NC(=O)C2=NC=C(N=C2)C(F)F)=CC=C1F,
13283,DB15392,Cesium,small molecule,investigational,"Elements|Metals|Metals, Alkali|Metals, Heavy",[Cs],
13284,DB15393,Telatinib,small molecule,investigational,,CNC(=O)C1=CC(COC2=C3OC=CC3=C(NC3=CC=C(Cl)C=C3)N=N2)=CC=N1,
13285,DB15394,gamma-Tocopherol,small molecule,investigational,"Antioxidants|Benzopyrans|Compounds used in a research, industrial, or household setting|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Heterocyclic Compounds, Fused-Ring|Micronutrients|Physiological Phenomena|Protective Agents|Pyrans|Tocopherols|Vitamin E|Vitamins|Vitamins (Fat Soluble)",CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2,
13287,DB15396,PF-114,small molecule,investigational,,CN1CCN(CC2=C(C=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=NN=C4C=CC=CN34)C=C2)C(F)(F)F)CC1,
13289,DB15398,Dihydrocapsiate,small molecule,investigational,"Alkaloids|Alkenes|Alkynes|Amides|Benzene Derivatives|Catechols|Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Hydrocarbons, Acyclic|Lipids|Phenols|Polyunsaturated Alkamides|Solanaceous Alkaloids",COC1=C(O)C=CC(COC(=O)CCCCCCC(C)C)=C1,
13290,DB15399,BMS-754807,small molecule,investigational,,C[C@]1(CCCN1C1=NN2C=CC=C2C(NC2=NNC(=C2)C2CC2)=N1)C(=O)NC1=CN=C(F)C=C1,
13292,DB15401,Danicopan,small molecule,investigational,,CC(=O)C1=NN(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2=CC=CC(Br)=N2)C2=C1C=C(C=C2)C1=CN=C(C)N=C1,
13294,DB15403,Ziritaxestat,small molecule,investigational,,CCC1=C(N(C)C2=NC(=C(S2)C#N)C2=CC=C(F)C=C2)N2C=C(C=C(C)C2=N1)N1CCN(CC(=O)N2CC(O)C2)CC1,
13295,DB15404,"Heparin, bovine",small molecule,investigational,,,
13296,DB15405,FET F-18,small molecule,investigational,,N[C@@H](CC1=CC=C(OCC[18F])C=C1)C(O)=O,
13297,DB15406,GLPG-0974,small molecule,investigational,"Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids|Sulfur Compounds",C[C@@]1(CCN1C(=O)C1=CSC2=C1C=CC=C2)C(=O)N(CCCC(O)=O)CC1=CC=CC(Cl)=C1,
13298,DB15407,Acalisib,small molecule,investigational,,C[C@H](NC1=NC=NC2=C1NC=N2)C1=NC2=C(C=C(F)C=C2)C(=O)N1C1=CC=CC=C1,
13299,DB15408,Silmitasertib,small molecule,investigational,"Casein Kinase II, antagonists & inhibitors|Heterocyclic Compounds, Fused-Ring",OC(=O)C1=CC2=C(C=C1)C1=C(C=CN=C1)C(NC1=CC(Cl)=CC=C1)=N2,
13301,DB15410,(S)-Propafenone,small molecule,investigational,,CCCNC[C@H](O)COC1=CC=CC=C1C(=O)CCC1=CC=CC=C1,
13302,DB15411,ABP-700,small molecule,investigational,,COC(=O)C1(CC1)OC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1,
13303,DB15412,LB-100,small molecule,investigational,,CN1CCN(CC1)C(=O)C1[C@@H]2CC[C@@H](O2)C1C(O)=O,
13304,DB15413,OTL-38,small molecule,investigational,,CC1(C)\C(=C/C=C2\CCCC(\C=C\C3=[N+](CCCCS(O)(=O)=O)C4=CC=C(C=C4C3(C)C)S([O-])(=O)=O)=C2OC2=CC=C(C[C@H](NC(=O)C3=CC=C(NCC4=CN=C5N=C(N)NC(=O)C5=N4)C=C3)C(O)=O)C=C2)N(CCCCS(O)(=O)=O)C2=CC=C(C=C12)S(O)(=O)=O,
13305,DB15414,CM-4307,small molecule,investigational,,[2H]C([2H])([2H])NC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,
13307,DB15416,PX-102,small molecule,investigational,,OC(=O)C1=CC=C(C=C1)[C@H]1C[C@@H]1C1=C(Cl)C=C(OCC2=C(ON=C2C2=C(Cl)C=CC=C2Cl)C2CC2)C=C1,
13309,DB15418,AZD-9977,small molecule,investigational,"Acids, Carbocyclic|Benzene Derivatives",CNC(=O)C[C@H]1COC2=C(C=CC(F)=C2)N1C(=O)C1=CC2=C(OCC(=O)N2)C=C1,
13310,DB15419,Nanatinostat,small molecule,investigational,Antineoplastic Agents|Aza Compounds|Histone Deacetylase Inhibitors,ONC(=O)C1=CN=C(N=C1)N1C[C@H]2[C@@H](C1)[C@@H]2NCC1=NC2=CC=C(F)C=C2C=C1,
13313,DB15422,ILS-920,small molecule,investigational,,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)/[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)[C@@H]3CC[C@@H](ON3C3=CC=CC=C3)\C=C(C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1O,
13314,DB15423,Disaccharide tripeptide glycerol dipalmitoyl,small molecule,investigational,,CCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)[C@H](C)NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]([C@@H](NC(C)=O)C=O)[C@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O)[C@H](O)CO)C(N)=O)OC(=O)CCCCCCCCCCCCCCC,
13315,DB15424,Bfpet F-18,small molecule,investigational,,[18F]C1=CC=C(C=C1)[P+](C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1,
13316,DB15425,CYC-065,small molecule,investigational,"Carbohydrates|Glycosides|Heterocyclic Compounds, Fused-Ring|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides",CC[C@H](NC1=NC(NCC2=C(C)C=C(C)N=C2)=C2N=CN(C(C)C)C2=N1)[C@@H](C)O,
13317,DB15426,Giripladib,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzene Derivatives|Group IV Phospholipases A2, antagonists & inhibitors|Radiation-Sensitizing Agents|Sulfones|Sulfur Compounds",OC(=O)C1=CC=C(CCCC2=C(CCNS(=O)(=O)CC3=C(C=CC=C3)C(F)(F)F)N(C(C3=CC=CC=C3)C3=CC=CC=C3)C3=C2C=C(Cl)C=C3)C=C1,
13318,DB15427,Fialuridine,small molecule,investigational,"Anti-Infective Agents|Antiviral Agents|Arabinonucleosides|Carbohydrates|Glycosides|Iodine Radioisotopes|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",OC[C@H]1O[C@H]([C@@H](F)[C@@H]1O)N1C=C(I)C(=O)NC1=O,
13320,DB15429,Thioglycolic acid,small molecule,investigational,"Acetates|Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids|Sulfhydryl Compounds|Sulfur Compounds",OC(=O)CS,
13322,DB15431,M-2698,small molecule,investigational,,NC(=O)C1=CC=CC2=C1N=CN=C2N[C@H](CN1CCC1)C1=CC(=C(Cl)C=C1)C(F)(F)F,
13326,DB15435,BMS-986158,small molecule,investigational,,CN1N=NC(C)=C1C1=CC2=C(N=C1)C1=C(C=C(C=C1)C(C)(C)O)N2[C@@H](C1CCOCC1)C1=CC=CC=C1,
13327,DB15436,Glucoraphanin,small molecule,investigational,Carbohydrates|Glucosides|Glycosides|Imides|Sulfur Compounds|Thioglucosides|Thioglycosides,C[S+]([O-])CCCC\C(S[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)=N/OS(O)(=O)=O,
13328,DB15437,Rocacetrapib,small molecule,investigational,"Hydrocarbons, Halogenated",COC1=C(C=C(C(C)C)C(F)=C1)C1=C(CN2[C@@H](C)[C@H](OC2=O)C2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)CC(C)(C)CC1,
13330,DB15439,Navoximod,small molecule,investigational,,O[C@H](C[C@@H]1N2C=NC=C2C2=CC=CC(F)=C12)[C@H]1CC[C@H](O)CC1,
13331,DB15440,GSK-3117391,small molecule,investigational,,ONC(=O)CCC1=NC=C(CN[C@@H](C2CCCCC2)C(=O)OC2CCCC2)C=C1,
13333,DB15442,Trilaciclib,small molecule,investigational,,CN1CCN(CC1)C1=CN=C(NC2=NC3=C(C=C4N3C3(CCCCC3)CNC4=O)C=N2)C=C1,
13335,DB15444,Elexacaftor,small molecule,approved|investigational,Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 inhibitors (strength unknown)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A4 Substrates (strength unknown)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Membrane Transport Modulators|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates,C[C@@H]1CN(C2=NC(=CC=C2C(=O)NS(=O)(=O)C2=CN(C)N=C2C)N2C=CC(OCC(C)(C)C(F)(F)F)=N2)C(C)(C)C1,
13336,DB15445,Iodohippuric acid,small molecule,investigational,"Acids, Carbocyclic|Amides|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Compounds used in a research, industrial, or household setting|Contrast Media|Diagnostic Uses of Chemicals|Hippurates|Keto Acids",OC(=O)CNC(=O)C1=CC=CC=C1I,
13337,DB15446,Vidofludimus,small molecule,investigational,"Acids, Acyclic|Benzene Derivatives",COC1=CC(=CC=C1)C1=CC=C(NC(=O)C2=C(CCC2)C(O)=O)C(F)=C1,
13338,DB15447,Setogepram,small molecule,investigational,,CCCCCC1=CC(CC(O)=O)=CC=C1,
13339,DB15448,Acumapimod,small molecule,investigational,,CC1=CC=C(C=C1N1N=CC(C(=O)C2=CC=CC(=C2)C#N)=C1N)C(=O)NC1CC1,
13340,DB15449,Citarinostat,small molecule,investigational,,ONC(=O)CCCCCCNC(=O)C1=CN=C(N=C1)N(C1=CC=CC=C1)C1=CC=CC=C1Cl,
13341,DB15450,PF-05105679,small molecule,investigational,,C[C@@H](N(CC1=CC(=CC=C1)C(O)=O)C(=O)C1=CC2=C(C=CC=C2)N=C1)C1=CC=C(F)C=C1,
13346,DB15456,Vericiguat,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring",COC(=O)NC1=C(N)N=C(N=C1N)C1=NN(CC2=CC=CC=C2F)C2=NC=C(F)C=C12,
13347,DB15457,Snubh-nm-333 F-18,small molecule,investigational,,CNC1=CC=C(C=C1)C1=NC2=C(S1)C=C([18F])C=C2,
13348,DB15458,Norleucine,small molecule,investigational,"Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Aminocaproates|Caproates|Fatty Acids|Fatty Acids, Volatile|Lipids",CCCC[C@H](N)C(O)=O,
13349,DB15460,AGG-523,small molecule,investigational,,CC(C)(CC1=CC=C(F)C=C1)NC(=O)[C@H](CCC(O)=O)NC(=O)C1=CC=C(C=C1)C1=CC=CC=C1,
13351,DB15462,Fucoxanthin,small molecule,investigational,"Alkenes|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Terpenes",,
13352,DB15463,PT2977,small molecule,investigational,,,
13353,DB15464,Urolithin A,small molecule,investigational,"Benzopyrans|Heterocyclic Compounds, Fused-Ring|Pyrans",OC1=CC2=C(C=C1)C1=C(C=C(O)C=C1)C(=O)O2,
13354,DB15465,Benzhydrocodone,small molecule,approved,Opioids,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CC=C2OC(=O)C1=CC=CC=C1,
13355,DB15466,Tallimustine,small molecule,experimental,"Alkylating Drugs|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Hydrocarbons, Halogenated|Mustard Compounds|Noxae|Peptides|Toxic Actions",CN1C=C(NC(=O)C2=CC(NC(=O)C3=CC(NC(=O)C4=CC=C(C=C4)N(CCCl)CCCl)=CN3C)=CN2C)C=C1C(=O)NCCC(N)=N,
13356,DB15467,Cinoxate,small molecule,approved,"Acids, Carbocyclic|Sunscreen Agents",CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1,
13357,DB15468,Iscotrizinol,small molecule,experimental,Sunscreen Agents,CCCCC(CC)COC(=O)C1=CC=C(NC2=NC(NC3=CC=C(C=C3)C(=O)OCC(CC)CCCC)=NC(NC3=CC=C(C=C3)C(=O)NC(C)(C)C)=N2)C=C1,
13358,DB15469,Octyl triazone,small molecule,experimental,"Acids, Carbocyclic|Benzene Derivatives|Sunscreen Agents",[H]N(C1=CC=C(C=C1)C(=O)OCC(CC)CCCC)C1=NC(=NC(=N1)N([H])C1=CC=C(C=C1)C(=O)OCC(CC)CCCC)N([H])C1=CC=C(C=C1)C(=O)OCC(CC)CCCC,
13366,DB15477,Alloin,small molecule,approved|experimental,Anthracenes|Anthraquinones|Biological Products|Cascara|Complex Mixtures|Gastrointestinal Agents|Laxatives|Pharmaceutical Preparations|Plant Extracts|Plant Preparations|Quinones,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1C2=CC=CC(O)=C2C(=O)C2=C1C=C(CO)C=C2O,
13368,DB15479,Zirconium chloride hydroxide,small molecule,approved|experimental,,O[Zr]Cl,
13369,DB15480,Resorcinol monoacetate,small molecule,approved|experimental,Benzene Derivatives|Phenols,CC(=O)OC1=CC(O)=CC=C1,
13377,DB15488,Echinacoside,small molecule,experimental,Carbohydrates|COMT Substrates|Herbs and Natural Products,C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCC3=CC(O)=C(O)C=C3)O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]2OC(=O)\C=C\C2=CC(O)=C(O)C=C2)[C@H](O)[C@H](O)[C@H]1O,
13378,DB15489,Mexazolam,small molecule,experimental,"Benzazepines|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Substrates|Heterocyclic Compounds, Fused-Ring",CC1COC2(N1CC(O)=NC1=C2C=C(Cl)C=C1)C1=CC=CC=C1Cl,
13379,DB15490,Zuranolone,small molecule,experimental,Antidepressive Agents|Central Nervous System Depressants,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@](C)(O)CC[C@]4([H])[C@@]3([H])CC[C@]12C)C(=O)CN1C=C(C=N1)C#N,
13380,DB15491,Oxazolam,small molecule,experimental,"Benzazepines|Heterocyclic Compounds, Fused-Ring",CC1CN2CC(=O)NC3=C(C=C(Cl)C=C3)C2(O1)C1=CC=CC=C1,
13381,DB15492,Eticlopride,small molecule,experimental,Amides|Dopamine Agents|Dopamine Antagonists|Neurotransmitter Agents,CCN1CCC[C@H]1CNC(=O)C1=C(O)C(CC)=CC(Cl)=C1OC,
13382,DB15493,Cambinol,small molecule,experimental,Pyrimidines,OC1=C(CC2=C(NC(=S)NC2=O)C2=CC=CC=C2)C2=CC=CC=C2C=C1,
13383,DB15494,Edotreotide gallium Ga-68,small molecule,approved,Diagnostic Radiopharmaceuticals|Gallium Radioisotopes|Radiopharmaceuticals|Tumour Detection,[68Ga+3].C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=C2C=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1,
13384,DB15495,Rocaglamide,small molecule,experimental,"Heterocyclic Compounds, Fused-Ring",COC1=CC=C(C=C1)[C@@]12OC3=C(C(OC)=CC(OC)=C3)[C@]1(O)[C@H](O)[C@@H]([C@H]2C1=CC=CC=C1)C(=O)N(C)C,
13385,DB15496,Didesmethylrocaglamide,small molecule,experimental,,COC1=CC=C(C=C1)[C@@]12OC3=CC(OC)=CC(OC)=C3[C@]1(O)[C@H](O)[C@@H]([C@H]2C1=CC=CC=C1)C(N)=O,
13387,DB15498,BOS172722,small molecule,experimental,,CCOC1=CC(=CC=C1NC1=NC=C2C=C(C)N=C(NCC(C)(C)C)C2=N1)C1=NN=CN1C,
13388,DB15499,Cerdulatinib,small molecule,investigational,Sulfur Compounds,CCS(=O)(=O)N1CCN(CC1)C1=CC=C(NC2=NC=C(C(N)=O)C(NC3CC3)=N2)C=C1,
13416,DB15527,Umirolimus,small molecule,experimental,Anti-Bacterial Agents|Anti-Inflammatory Agents|Immunologic Factors|Immunosuppressive Agents|Lactones|Macrolides|Polyketides,[H][C@@]12CC[C@@H](C)[C@@](O)(O1)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@]([H])(CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C2)OC)[C@H](C)C[C@@H]1CC[C@@H](OCCOCC)[C@@H](C1)OC,
13421,DB15532,Madecassoside,small molecule,experimental,Terpenes,[H][C@@]1(O[C@@H]2[C@@H](CO)O[C@@H](OC[C@H]3O[C@@H](OC(=O)[C@]45CC[C@@H](C)[C@H](C)[C@@]4([H])C4=CC[C@]6([H])[C@@]7(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@]7([H])[C@H](O)C[C@@]6(C)[C@]4(C)CC5)[C@H](O)[C@@H](O)[C@@H]3O)[C@H](O)[C@H]2O)O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O,
13422,DB15533,Calcium sulfate,small molecule,experimental,"Acids|Acids, Noncarboxylic|Anions|Blood Coagulation Factors|Calcium Compounds|Compounds used in a research, industrial, or household setting|Dental Materials|Electrolytes|Ions|Minerals|Sulfates|Sulfur Acids|Sulfur Compounds|Sulfuric Acids",[Ca++].[O-]S([O-])(=O)=O,
13423,DB15534,Colchiceine,small molecule,approved|experimental,Alkaloids|Colchicine Derivatives|Tubulin Inhibiting Agent,COC1=C(OC)C(OC)=C2C(CCC(NC(C)=O)C3=CC(=O)C(O)=CC=C23)=C1,
13424,DB15535,Cuprous chloride,small molecule,experimental,"Elements|Metals|Metals, Heavy|Transition Elements",Cl[Cu],
13425,DB15536,Ferric chloride,small molecule,experimental,"Acids|Acids, Noncarboxylic|Anions|Anticoagulants|Caustics|Chlorine Compounds|Electrolytes|Fibrinolytic Agents|Ions|Iron Compounds|Noxae|Organometallic Compounds|Toxic Actions",Cl[Fe](Cl)Cl,
13439,DB15550,Pradefovir,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Purines",NC1=NC=NC2=C1N=CN2CCOC[P@@]1(=O)OCC[C@H](O1)C1=CC=CC(Cl)=C1,
13440,DB15551,Leptazoline A,small molecule,experimental,,C[C@@H]1OC(=N[C@H]1[C@H](O)CC(O)=O)C1=CC(Cl)=CC=C1O,
13441,DB15552,Leptazoline B,small molecule,experimental,,C[C@@H]1OC(=N[C@H]1[C@H](O)[C@H](O)C(=O)NC(CO)CO)C1=CC(Cl)=CC=C1O,
13442,DB15553,Leptazoline C,small molecule,experimental,,C[C@@H]1OC(=N[C@H]1[C@H](O)CC(O)=O)C1=CC=CC=C1O,
13443,DB15554,Leptazoline D,small molecule,experimental,,C[C@@H]1OC(=N[C@H]1[C@H](O)[C@H](O)C(=O)NC(CO)CO)C1=CC=CC=C1O,
13444,DB15555,Magnesium malate,small molecule,experimental,,[Mg++].OC(CC([O-])=O)C([O-])=O,
13445,DB15556,Zinc glycinate citrate,small molecule,experimental,,[Zn++].NCC([O-])=O.NCC([O-])=O.OC(=O)CC(O)(CC(O)=O)C(O)=O,
13446,DB15557,"24-Homo-1,25-dihydroxyvitamin D3",small molecule,experimental,Cholestanes|Cholestenes|Fused-Ring Compounds|Lipids|Membrane Lipids|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble),[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)CCCCC(C)(C)O,
13454,DB15565,Cilazaprilat,small molecule,experimental,Agents Acting on the Renin-Angiotensin System|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Enzyme Inhibitors|Protease Inhibitors|Pyridazines,OC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]1CCCN2CCC[C@H](N2C1=O)C(O)=O,
13455,DB15566,Prednisolone acetate,small molecule,approved|vet_approved,Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strength unknown)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Substrates|Fused-Ring Compounds|P-glycoprotein substrates|Pregnadienes|Pregnadienetriols|Pregnanes|Prodrugs|Steroids,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@]([H])(O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,5834
13456,DB15567,PCLX-001,small molecule,investigational,,,
13457,DB15568,MRTX849,small molecule,investigational,,,
13458,DB15569,AMG-510,small molecule,investigational,,CC(C)C1=NC=CC(C)=C1N1C(=O)N=C(N2CCN(C[C@@H]2C)C(=O)C=C)C2=CC(F)=C(N=C12)C1=C(O)C=CC=C1F,
13459,DB15570,FLX475,small molecule,investigational,,,
13460,DB15571,(12R)-12-hydroxyeicosapentaenoic acid,small molecule,experimental,,CC\C=C/C\C=C/C[C@@H](O)\C=C\C=C/C\C=C/CCCC(O)=O,
13462,DB15573,alpha-Pinene,small molecule,experimental,Terpenes,CC1=CCC2CC1C2(C)C,
13463,DB15574,beta-Pinene,small molecule,experimental,Terpenes,CC1(C)C2CC1C(=C)CC2,
13464,DB15575,Padeliporfin,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Biological Factors|Chlorophyll|Heterocyclic Compounds, Fused-Ring|Metalloporphyrins|Palladium|Photoreceptors, Microbial|Photosensitizing Agents|Pigments, Biological|Porphyrins|Proteins|Sensitizers Used in Photodynamic/radiation Therapy",[Pd++].[H][C@]1(C)\C2=C\C3=C(C(C)=O)C(C)=C([N-]3)\C=C3/N=C(/C(/CC(=O)OC)=C4\[N-]\C(=C/C(=N2)[C@]1([H])CC)C(C)=C4C(=O)NCCS(O)(=O)=O)[C@@]([H])(CCC(O)=O)[C@]3([H])C,
13465,DB15576,Ethyl salicylate,small molecule,approved|experimental,"Acids, Carbocyclic|Benzene Derivatives|Benzoates|Hydroxy Acids|Hydroxybenzoates|Phenols",CCOC(=O)C1=CC=CC=C1O,
13466,DB15578,Desfesoterodine,small molecule,experimental,Drugs for Urinary Frequency and Incontinence|Genito Urinary System and Sex Hormones|Urologicals,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=CC(CO)=CC=C1O)C(C)C,
13467,DB15579,Cryptotanshinone,small molecule,experimental,"Drugs, Chinese Herbal",C[C@H]1COC2=C1C(=O)C(=O)C1=C2C=CC2=C1CCCC2(C)C,
13468,DB15580,Climbazole,small molecule,experimental,,CC(C)(C)C(=O)C(OC1=CC=C(Cl)C=C1)N1C=CN=C1,
13469,DB15581,Chrysin,small molecule,experimental,"Benzopyrans|Chromones|Heterocyclic Compounds, Fused-Ring|Pyrans",OC1=CC(O)=C2C(=O)C=C(OC2=C1)C1=CC=CC=C1,
13470,DB15582,Echinomycin,small molecule,experimental,"Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics, Antineoplastic|Antineoplastic Agents|Enzyme Inhibitors|Heterocyclic Compounds, Fused-Ring|Nucleic Acid Synthesis Inhibitors|Peptides|Peptides, Cyclic|Quinoxalines",CSC1SC[C@@H]2N(C)C(=O)[C@H](C)NC(=O)[C@@H](COC(=O)[C@H](C(C)C)N(C)C(=O)[C@H]1N(C)C(=O)[C@H](C)NC(=O)[C@@H](COC(=O)[C@H](C(C)C)N(C)C2=O)NC(=O)C1=NC2=C(C=CC=C2)N=C1)NC(=O)C1=NC2=C(C=CC=C2)N=C1,
13471,DB15583,Fluazuron,small molecule,experimental,Benzene Derivatives,FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC=C(Cl)C(OC2=NC=C(C=C2Cl)C(F)(F)F)=C1,
13472,DB15584,Luteolin,small molecule,experimental,"Benzopyrans|Chromones|Flavones|Flavonoids|Heterocyclic Compounds, Fused-Ring|Pyrans",OC1=CC(O)=C2C(=O)C=C(OC2=C1)C1=CC=C(O)C(O)=C1,
13473,DB15585,ORG-31710,small molecule,experimental,Estranes|Fused-Ring Compounds|Steroids,[H][C@@]12CC[C@@]3(CCCO3)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3[C@H](C)C[C@@]21[H],
13474,DB15586,Patulin,small molecule,experimental,"Biological Factors|Compounds used in a research, industrial, or household setting|Mutagens|Mycotoxins|Noxae|Poisons|Pyrans|Toxic Actions|Toxins, Biological",OC1OCC=C2OC(=O)C=C12,
13475,DB15587,Antimony potassium tartrate,small molecule,experimental,Anthelmintics|Anti-Infective Agents|Antiparasitic Agents|Antiplatyhelmintic Agents|Organometallic Compounds|Schistosomicides,O.O.O.[K+].[K+].[Sb+3].[Sb+3].[O-][C@H]([C@@H]([O-])C([O-])=O)C([O-])=O.[O-][C@H]([C@@H]([O-])C([O-])=O)C([O-])=O,
13476,DB15588,Ursolic acid,small molecule,experimental,"Analgesics|Analgesics, Non-Narcotic|Anti-Infective Agents|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Antirheumatic Agents|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Peripheral Nervous System Agents|Sensory System Agents|Terpenes",[H][C@@]12[C@@H](C)[C@H](C)CC[C@@]1(CC[C@]1(C)C2=CC[C@]2([H])[C@@]3(C)CC[C@H](O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O,
13477,DB15589,Zingerone,small molecule,experimental,Benzene Derivatives|Catechols|Ethers|Methyl Ethers|Phenols|Phenyl Ethers,COC1=CC(CCC(C)=O)=CC=C1O,
13478,DB15590,beta-Apopicropodophyllin,small molecule,experimental,Biological Products|Complex Mixtures|Pharmaceutical Preparations|Plant Extracts|Plant Preparations,COC1=CC(=CC(OC)=C1OC)[C@H]1C2=C(COC2=O)CC2=C1C=C1OCOC1=C2,
13482,DB15594,Brilliant blue G,small molecule,approved,"Amines|Aniline Compounds|Compounds used in a research, industrial, or household setting|Indicators and Reagents|Laboratory Chemicals",[Na+].CCOC1=CC=C(NC2=CC=C(C=C2)C(=C2\C=C/C(/C=C2C)=[N+](/CC)CC2=CC(=CC=C2)S([O-])(=O)=O)\C2=C(C)C=C(C=C2)N(CC)CC2=CC(=CC=C2)S([O-])(=O)=O)C=C1,
13484,DB15596,Aminopromazine,small molecule,experimental|vet_approved,,CN(C)CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C,
13485,DB15597,Aminopentamide,small molecule,experimental|vet_approved,Benzene Derivatives,CC(CC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=C1)N(C)C,
13486,DB15598,Ferric maltol,small molecule,approved,"Antianemic Preparations|Blood and Blood Forming Organs|Hematinics|Hematologic Agents|Iron Compounds|Iron Preparations|Iron Trivalent, Oral Preparations|Organometallic Compounds|Pyrans|UGT1A6 substrate",[Fe+3].CC1=C([O-])C(=O)C=CO1.CC1=C([O-])C(=O)C=CO1.CC1=C([O-])C(=O)C=CO1,
13487,DB15599,MIV-711,small molecule,investigational,Anti-Inflammatory Agents|Antineoplastic Agents|Antirheumatic Agents,,
13488,DB15601,NNZ-2591,small molecule,investigational,"Amino Acids, Peptides, and Proteins|Peptides|Piperazines",C=CC[C@@]12CCCN1C(=O)CNC2=O,
13496,DB15609,JPC-3210,small molecule,experimental,Antimalarials|Antiviral Agents,CC(C)(C)NCC1=C(O)C(=CC(=C1)C(C)(C)C)C1=CN=C(C(F)=C1)C(F)(F)F,
13497,DB15610,(4-(trifluoromethoxy)phenyl)urea,small molecule,experimental,,NC(=O)NC1=CC=C(OC(F)(F)F)C=C1,
13501,DB15614,Previtamin D(3),small molecule,experimental,Cholestanes|Cholestenes|Fused-Ring Compounds|Lipids|Membrane Lipids|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble),[H][C@@]1(CC[C@@]2([H])C(\C=C/C3=C(C)CC[C@H](O)C3)=CCC[C@]12C)[C@H](C)CCCC(C)C,
13503,DB15616,REC-994,small molecule,investigational,,,
13504,DB15617,Ferric derisomaltose,small molecule,approved,"Anemia, Iron-Deficiency|Antianemia Drugs|Antianemic Preparations|Iron Compounds|Parenteral Iron Replacement",[Fe+3].OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O,
13505,DB15618,"(5E,7E,9)-decatrien-2-one",small molecule,experimental,,CC(=O)CC\C=C/C=C/C=C,
13506,DB15619,"(5Z,7E,9)-decatrien-2-one",small molecule,experimental,,CC(=O)CC\C=C\C=C\C=C,
13509,DB15622,Triazavirin,small molecule,experimental,Antiviral Agents|Experimental Unapproved Treatments for COVID-19|Guanine Nucleotides,CSC1=NN2C(NN=C(C2=O)[N+]([O-])=O)=N1,
13510,DB15623,TMC-310911,small molecule,investigational,Anti-HIV Agents|Antiviral Agents|Antivirals for Systemic Use|Experimental Unapproved Treatments for COVID-19|HIV Protease Inhibitors,[H][C@@]12CCO[C@]1([H])OC[C@@H]2OC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](O)CN(CC(C)C)S(=O)(=O)C1=CC=C2N=C(NC3CCN(CC3)C3CCCC3)SC2=C1,
13511,DB15624,Halicin,small molecule,experimental,,NC1=NN=C(SC2=NC=C(S2)[N+]([O-])=O)S1,
13516,DB15630,Glumetinib,small molecule,investigational,,CN1C=C(C=N1)C1=CN2C(C=C1)=NC=C2S(=O)(=O)N1N=CC2=NC=C(C=C12)C1=CN(C)N=C1,
13522,DB15636,Zilucoplan,small molecule,investigational,,CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CNC2=NC=CC=C12)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)N(C)C(=O)[C@@H]1CC(=O)NCCCC[C@H](NC(C)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N1)C(C)(C)C)C1CCCCC1)C(O)=O)C(O)=O,
13523,DB15637,Fluzoparib,small molecule,investigational,,FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN2N=C(N=C2C1)C(F)(F)F,
13524,DB15638,Brensocatib,small molecule,investigational,"Azepines|Heterocyclic Compounds, Fused-Ring",CN1C(=O)OC2=CC=C(C=C12)C1=CC=C(C[C@H](NC(=O)[C@@H]2CNCCCO2)C#N)C=C1,
13525,DB15639,AMG-337,small molecule,investigational,Antineoplastic Agents|Pyridines,COCCOC1=CC2=C(C=CN([C@H](C)C3=NN=C4N3C=C(C=C4F)C3=CN(C)N=C3)C2=O)N=C1,
13526,DB15640,CDC-801,small molecule,investigational,,COC1=CC=C(C=C1OC1CCCC1)C(CC(N)=O)N1C(=O)C2=C(C=CC=C2)C1=O,
13527,DB15641,Droloxifene,small molecule,investigational,"Antineoplastic Agents|Antioxidants|Benzene Derivatives|Benzylidene Compounds|Compounds used in a research, industrial, or household setting|Estrogen Antagonists|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Protective Agents|Stilbenes",,
13528,DB15642,Molidustat,small molecule,investigational,,O=C1N(NC=C1N1C=CN=N1)C1=NC=NC(=C1)N1CCOCC1,
13529,DB15643,N-(2-Aminoethyl)-1-aziridineethanamine,small molecule,experimental,ACE Inhibitors and Calcium Channel Blockers|ACE Inhibitors and Diuretics|Agents Acting on the Renin-Angiotensin System|Angiotensin-Converting Enzyme Inhibitors,NCCNCCN1CC1,
13530,DB15644,Ochromycinone,small molecule,investigational,Anthracenes|Quinones,C[C@@H]1CC(=O)C2=C3C(=O)C4=C(C(O)=CC=C4)C(=O)C3=CC=C2C1,
13531,DB15645,Dihydromyricetin,small molecule,investigational,"Benzopyrans|Chromones|Flavonoids|Heterocyclic Compounds, Fused-Ring|Pyrans",O[C@@H]1[C@H](OC2=C(C(O)=CC(O)=C2)C1=O)C1=CC(O)=C(O)C(O)=C1,
13532,DB15646,Fasitibant,small molecule,investigational,"Amides|Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Peptides, and Proteins|Bradykinin B2 Receptor Antagonists|Bradykinin Receptor Antagonists|Complement Inactivating Agents|Immunologic Factors|Immunosuppressive Agents|Sulfones|Sulfur Compounds",CC1=NC2=C(C=CC=C2OCC2=C(Cl)C=CC(=C2Cl)S(=O)(=O)NC2(CCOCC2)C(=O)N2CCN(CC2)C(=O)[C@@H](N)CCC[N+](C)(C)C)C(C)=C1,
13533,DB15647,Ketodarolutamide,small molecule,experimental,"Antiandrogens|Antiandrogens, non-steroidal",C[C@@H](CN1C=CC(=N1)C1=CC=C(C#N)C(Cl)=C1)NC(=O)C1=NNC(=C1)C(C)=O,
13534,DB15648,Calcium oxide,small molecule,experimental,"Anions|Compounds used in a research, industrial, or household setting|Dental Materials|Electrolytes|Ions|Oxygen Compounds|Root Canal Filling Materials",O=[Ca],
13535,DB15649,Carbomer,small molecule,experimental,"Compounds used in a research, industrial, or household setting|Dental Materials|Drug Carriers|Macromolecular Substances|Plastics|Polymers|Protease Inhibitors|Resins, Synthetic",,
13537,DB15651,Valomaciclovir stearate,small molecule,investigational,"Antiviral Agents|Herpes Zoster|Heterocyclic Compounds, Fused-Ring|Purines|Purinones|Varicellovirus|Xanthine derivatives",CCCCCCCCCCCCCCCCCC(=O)OC[C@H](CCOC(=O)[C@@H](N)C(C)C)CN1C=NC2=C1N=C(N)NC2=O,
13538,DB15652,Ravidasvir,small molecule,investigational,"Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Antiviral Agents|Heterocyclic Compounds, Fused-Ring",COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C1=NC(=CN1)C1=CC2=C(C=C1)C=C(C=C2)C1=CC2=C(NC(=N2)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)OC)C(C)C)C=C1,
13539,DB15653,Islatravir,small molecule,investigational,"Alcohols|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Azo Compounds|Carbohydrates|Deoxyribonucleosides|Enzyme Inhibitors|Fatty Alcohols|Glycosides|Heterocyclic Compounds, Fused-Ring|Lipids|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Reverse Transcriptase Inhibitors|Ribonucleosides|Sesquiterpenes|Terpenes",NC1=NC(F)=NC2=C1N=CN2[C@H]1C[C@H](O)[C@@](CO)(O1)C#C,
13543,DB15657,Ala-geninthiocin,small molecule,experimental,Anti-Bacterial Agents,C\C=C1/NC(=O)[C@@H](NC(=O)C2=CSC(=N2)C2=CC=C(N=C2C2=COC(=N2)C(=C)NC(=O)C(=C)NC(=O)C2=C(C)OC(=N2)C(=C)NC(=O)[C@@H](NC(=O)C(=C)NC(=O)C2=COC1=N2)C(C)(C)O)C(=O)NC(=C)C(=O)N[C@@H](C)C(N)=O)[C@H](C)O,
13544,DB15658,"2-chloro-4,5-dimethylphenol",small molecule,experimental,,CC1=CC(O)=C(Cl)C=C1C,
13545,DB15659,"alpha,alpha-Dibromo-D-camphor",small molecule,experimental,,CC1(C)[C@@H]2CC[C@@]1(C)C(=O)C2(Br)Br,
13546,DB15660,N4-Hydroxycytidine,small molecule,experimental,"Carbohydrates|Cytosine Nucleotides|Experimental Unapproved Treatments for COVID-19|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides",OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(NO)=NC1=O,
13547,DB15661,EIDD-2801,small molecule,experimental,Cytosine Nucleotides|Esters|Experimental Unapproved Treatments for COVID-19|Prodrugs,CC(C)C(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=C\C(NC1=O)=N\O,
13548,DB15662,Myristyl glyceryl ether,small molecule,experimental,,CCCCCCCCCCCCCCOCC(O)CO,
13550,DB15664,Vitamin K7,small molecule,experimental,,CC1=CC(O)=C2C=CC=CC2=C1N,
13551,DB15665,SEP-363856,small molecule,investigational,,CNC[C@@H]1OCCC2=C1SC=C2,
13552,DB15666,Iodopropynyl butylcarbamate,small molecule,experimental,"Acids, Acyclic|Allergens",CCCCNC(=O)OCC#CI,
13554,DB15668,Silver oxide,small molecule,experimental,Anions|Anti-Infective Agents|Electrolytes|Ions|Oxygen Compounds,[Ag]O[Ag],
13555,DB15669,Fezolinetant,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Sulfur Compounds|Thiazoles",C[C@H]1N(CCN2C1=NN=C2C1=NC(C)=NS1)C(=O)C1=CC=C(F)C=C1,
13556,DB15670,Gusacitinib,small molecule,investigational,,OC1CCN(CC1)C1=CC=C(NC2=C3C(=O)NN=CC3=NC(=N2)N2CCC(CC#N)CC2)C=C1,
13557,DB15671,Besifovir,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Organophosphorus Compounds|Purines|Purinones|Xanthine derivatives",NC1=NC=C2N=CN(CC3(CC3)OCP(O)(O)=O)C2=N1,
13558,DB15672,Rilematovir,small molecule,investigational,"Heterocyclic Compounds, Fused-Ring|Imidazoles",CS(=O)(=O)CCCN1C(CN2C(=O)N(CC(F)(F)F)C3=C2C=NC=C3)=CC2=C1C=CC(Cl)=C2,
13559,DB15673,Lenacapavir,small molecule,investigational,,[H][C@]12C[C@@]1([H])C(F)(F)C1=C2C(=NN1CC(=O)N[C@@H](CC1=CC(F)=CC(F)=C1)C1=NC(=CC=C1C1=CC=C(Cl)C2=C1N(CC(F)(F)F)N=C2NS(C)(=O)=O)C#CC(C)(C)S(C)(=O)=O)C(F)(F)F,
13560,DB15674,Sisunatovir,small molecule,investigational,,NCC1=CC2=C(C=C1)N(CCCC(F)(F)F)C(CN1C(=O)C3(CC3)C3=C1C=C(F)C=C3)=N2,
13561,DB15675,Baloxavir,small molecule,investigational,Anti-Infective Agents|Antiviral Agents|Chelating Activity|Enzyme Inhibitors|Polymerase Acidic Endonuclease Inhibitor|Polymerase Acidic Endonuclease Inhibitors|Sulfur Compounds,[H][C@@]12COCCN1C(=O)C1=C(O)C(=O)C=CN1N2[C@@H]1C2=C(SCC3=C1C=CC(F)=C3F)C=CC=C2,
13563,DB15677,Polyaminopropyl biguanide,small molecule,experimental,"Amidines|Guanidines|Preservatives, Pharmaceutical",,
13564,DB15678,Calcium undecylenate,small molecule,approved|experimental,,[Ca++].[O-]C(=O)CCCCCCCCC=C.[O-]C(=O)CCCCCCCCC=C,
13565,DB15679,Aluminum subacetate,small molecule,approved|experimental,Astringents,CC(=O)O[Al](O)OC(C)=O,
13570,DB15684,"2,3-dichloro-5,6-dicyanobenzoquinone",small molecule,experimental,Quinones,ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O,
13571,DB15685,Selpercatinib,small molecule,approved|investigational,Agents that produce hypertension|Antineoplastic Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Hepatotoxic Agents|MATE 1 Inhibitors|MATE inhibitors|P-glycoprotein inhibitors|P-glycoprotein substrates|QTc Prolonging Agents|Tyrosine Kinase Inhibitors,COC1=NC=C(CN2C3CC2CN(C3)C2=CC=C(C=N2)C2=CC(OCC(C)(C)O)=CN3N=CC(C#N)=C23)C=C1,
13572,DB15686,GS-441524,small molecule,experimental,Adenine Nucleotides|Antiviral Agents|Antivirals for Systemic Use|Direct Acting Antivirals|Experimental Unapproved Treatments for COVID-19|Nucleoside Analog Antiviral,NC1=NC=NN2C1=CC=C2[C@@]1(O[C@H](CO)[C@@H](O)[C@H]1O)C#N,
13573,DB15687,Tridecactide,small molecule,investigational,Experimental Unapproved Treatments for COVID-19|Melanocyte-Stimulating Hormones,CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O,
13574,DB15688,Vazegepant,small molecule,investigational,"Antimigraine Preparations|Calcitonin-gene-related Peptide (Cgrp) Antagonists|Experimental Unapproved Treatments for COVID-19|Heterocyclic Compounds, Fused-Ring|Pyrazoles|Quinolines|Receptors, Calcitonin Gene-Related Peptide, antagonists & inhibitors",CN1CCC(CC1)N1CCN(CC1)C(=O)[C@@H](CC1=CC2=C(NN=C2)C(C)=C1)NC(=O)N1CCC(CC1)C1=CC2=C(NC1=O)C=CC=C2,
13575,DB15689,Azoximer bromide,small molecule,investigational,,,
13576,DB15690,Fluoroestradiol F-18,small molecule,approved,"Estradiol Congeners|Estranes|Estrogens|Estrogens, agonists|Fluorine Radioisotopes|Fused-Ring Compounds|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids",[H][C@@]12C[C@@H]([18F])[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,
